PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Takar, M; Wu, YT; Graham, TR				Takar, Mehmet; Wu, Yuantai; Graham, Todd R.			The Essential Neo1 Protein from Budding Yeast Plays a Role in Establishing Aminophospholipid Asymmetry of the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; TRANS-GOLGI NETWORK; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID FLIPPASE; HEREDITARY CHOLESTASIS; ENDOPLASMIC-RETICULUM; TRANSLOCASE ACTIVITY; PHOSPHATIDYLSERINE; DRS2P; PHOSPHATIDYLETHANOLAMINE	Eukaryotic organisms typically express multiple type IV P-type ATPases (P4-ATPases), which establish plasma membrane asymmetry by flipping specific phospholipids from the exofacial to the cytosolic leaflet. Saccharomyces cerevisiae, for example, expresses five P4-ATPases, including Neo1, Drs2, Dnf1, Dnf2, and Dnf3. Neo1 is thought to be a phospholipid flippase, although there is currently no experimental evidence that Neo1 catalyzes this activity or helps establish membrane asymmetry. Here, we use temperature-conditional alleles (neo1(ts)) to test whether Neo1 deficiency leads to loss of plasma membrane asymmetry. Wild-type (WT) yeast normally restrict most of the phosphatidylserine (PS) and phosphatidylethanolamine (PE) to the inner cytosolic leaflet of the plasma membrane. However, the neo1-1(ts) and neo1-2(ts) mutants display a loss of PS and PE asymmetry at permissive growth temperatures as measured by hypersensitivity to pore-forming toxins that target PS (papuamide A) or PE (duramycin) exposed in the extracellular leaflet. When shifted to a semi-permissive growth temperature, the neo1-1ts mutant became extremely hypersensitive to duramycin, although the sensitivity to papuamide A was unchanged, indicating preferential exposure of PE. This loss of asymmetry occurs despite the presence of other flippases that flip PS and/or PE. Even when overexpressed, Drs2 and Dnf1 were unable to correct the loss of asymmetry caused by neo1ts. However, modest overexpression of Neo1 weakly suppressed loss of membrane asymmetry caused by drs2 Delta with a more significant correction of PE asymmetry than PS. These results indicate that Neo1 plays an important role in establishing PS and PE plasma membrane asymmetry in budding yeast.	[Takar, Mehmet; Wu, Yuantai; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Graham, TR (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	tr.graham@vanderbilt.edu			Vanderbilt Ingram Cancer Center by National Institutes of Health [P30 CA68485]; Vanderbilt Digestive Disease Research Center by National Institutes of Health [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107978] Funding Source: NIH RePORTER	Vanderbilt Ingram Cancer Center by National Institutes of Health; Vanderbilt Digestive Disease Research Center by National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jeff Brodsky for anti-Kar2 and Amy Chang for anti-Pma1 antibodies. Flow cytometry experiments were performed in the Vanderbilt University Medical Center (VUMC) Flow Cytometry Shared Resource. We also thank Hannah M. Hankins for reviewing an earlier version of the manuscript. The VUMC Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center by National Institutes of Health Grant P30 CA68485 and Vanderbilt Digestive Disease Research Center by National Institutes of Health DK058404.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; AOKI Y, 1994, J BIOCHEM-TOKYO, V116, P291, DOI 10.1093/oxfordjournals.jbchem.a124522; Baldridge RD, 2013, J BIOL CHEM, V288, P19516, DOI 10.1074/jbc.M113.476911; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; BRETSCHER MS, 1972, J MOL BIOL, V71, P523, DOI 10.1016/0022-2828(72)90028-4; Brett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017619; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Gaynor EC, 1998, MOL BIOL CELL, V9, P653, DOI 10.1091/mbc.9.3.653; Georgiev AG, 2011, TRAFFIC, V12, P1341, DOI 10.1111/j.1600-0854.2011.01234.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; GORDESKY SE, 1975, J MEMBRANE BIOL, V20, P111, DOI 10.1007/BF01870631; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Hankins HM, 2015, MOL BIOL CELL, V26, P4674, DOI 10.1091/mbc.E15-07-0487; Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hua ZL, 2003, MOL BIOL CELL, V14, P4971, DOI 10.1091/mbc.E03-07-0463; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jarmoszewicz K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039582; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Liu K, 2007, MOL BIOL CELL, V18, P487, DOI 10.1091/mbc.E06-07-0592; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Puts CF, 2012, J BIOL CHEM, V287, P30529, DOI 10.1074/jbc.M112.371088; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; SIKORSKI RS, 1989, GENETICS, V122, P19; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Veen S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00048; VERKLEIJ AJ, 1973, BIOCHIM BIOPHYS ACTA, V323, P178, DOI 10.1016/0005-2736(73)90143-0; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004; Xu P, 2013, J CELL BIOL, V202, P875, DOI 10.1083/jcb.201305094; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	63	36	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15727	15739		10.1074/jbc.M115.686253	http://dx.doi.org/10.1074/jbc.M115.686253			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27235400	Green Published, hybrid			2022-12-26	WOS:000380584200026
J	Kumordzi, BB; Gundale, MJ; Nilsson, MC; Wardle, DA				Kumordzi, Bright B.; Gundale, Michael J.; Nilsson, Marie-Charlotte; Wardle, David A.			Shifts in Aboveground Biomass Allocation Patterns of Dominant Shrub Species across a Strong Environmental Gradient	PLOS ONE			English	Article							ECOSYSTEM PROPERTIES; ISLAND AREA; PLANTS; SHOOT; ROOT; VARIABILITY; PLASTICITY; RESPONSES; NITROGEN; CAPTURE	Most plant biomass allocation studies have focused on allocation to shoots versus roots, and little is known about drivers of allocation for aboveground plant organs. We explored the drivers of within-and between-species variation of aboveground biomass allocation across a strong environmental resource gradient, i.e., a long-term chronosequence of 30 forested islands in northern Sweden across which soil fertility and plant productivity declines while light availability increases. For each of the three coexisting dominant understory dwarf shrub species on each island, we estimated the fraction of the total aboveground biomass produced year of sampling that was allocated to sexual reproduction (i.e., fruits), leaves and stems for each of two growing seasons, to determine how biomass allocation responded to the chronosequence at both the within-species and whole community levels. Against expectations, within-species allocation to fruits was least on less fertile islands, and allocation to leaves at the whole community level was greatest on intermediate islands. Consistent with expectations, different coexisting species showed contrasting allocation patterns, with the species that was best adapted for more fertile conditions allocating the most to vegetative organs, and with its allocation pattern showing the strongest response to the gradient. Our study suggests that co-existing dominant plant species can display highly contrasting biomass allocations to different aboveground organs within and across species in response to limiting environmental resources within the same plant community. Such knowledge is important for understanding how community assembly, trait spectra, and ecological processes driven by the plant community vary across environmental gradients and among contrasting ecosystems.	[Kumordzi, Bright B.; Gundale, Michael J.; Nilsson, Marie-Charlotte; Wardle, David A.] Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden; [Kumordzi, Bright B.] Univ Laval, Dept Sci Bois & Foret, Pavillon Abitibi Price,2405 Rue Terrasse, Quebec City, PQ G1V 0A6, Canada	Swedish University of Agricultural Sciences; Laval University	Kumordzi, BB (corresponding author), Swedish Univ Agr Sci, Dept Forest Ecol & Management, SE-90183 Umea, Sweden.; Kumordzi, BB (corresponding author), Univ Laval, Dept Sci Bois & Foret, Pavillon Abitibi Price,2405 Rue Terrasse, Quebec City, PQ G1V 0A6, Canada.	brightkumordzi@yahoo.com	Hegethorn, Marie-Charlotte Nilsson/B-1802-2017; Wardle, David A./F-6031-2011; Gundale, Michael J/O-1265-2013	Hegethorn, Marie-Charlotte Nilsson/0000-0002-9254-2223; Wardle, David A./0000-0002-0476-7335; Gundale, Michael J/0000-0003-2447-609X	Swedish Research Council (Vetenskapsradet); Wallenberg Scholars award	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Wallenberg Scholars award	This work was funded by a grant from the Swedish Research Council (Vetenskapsradet, http://www.vr.se) and a Wallenberg Scholars award (http://www.wallenberg.com/kaw/) to DAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON WG, 1979, EVOLUTION, V33, P517, DOI 10.1111/j.1558-5646.1979.tb04705.x; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; ALMUFTI MM, 1977, J ECOL, V65, P759, DOI 10.2307/2259378; [Anonymous], 1994, WHOLE PLANT PERSPECT; Bazzaz FA, 2000, SEEDS ECOLOGY REGENE; BROUWER R., 1963, Jaarboek. Instituut voor biologisch en scheikundig Onderzoek van Landbouwgewassen 1963, P31; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; CRICK JC, 1987, NEW PHYTOL, V107, P403, DOI 10.1111/j.1469-8137.1987.tb00192.x; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Freschet GT, 2015, J VEG SCI, V26, P431, DOI 10.1111/jvs.12259; Freschet GT, 2013, ECOL EVOL, V3, P1065, DOI 10.1002/ece3.520; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; GOODALL DW, 1952, AUST J SCI RES SER B, V5, P1, DOI 10.1071/BI9520001; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Gundale MJ, 2012, ECOLOGY, V93, P1695, DOI 10.1890/11-1877.1; IWASA Y, 1984, THEOR POPUL BIOL, V25, P78, DOI 10.1016/0040-5809(84)90007-8; Jackson BG, 2013, J ECOL, V101, P1409, DOI 10.1111/1365-2745.12155; Kichenin E, 2013, FUNCT ECOL, V27, P1254, DOI 10.1111/1365-2435.12116; Kruse J, 2010, PLANT SOIL, V332, P387, DOI 10.1007/s11104-010-0305-6; Kumordzi BB, 2015, J VEG SCI, V26, P32, DOI 10.1111/jvs.12218; Kumordzi BB, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00339.1; Lagerstrom A., 2013, PLANT SOIL, P1; Le Bagousse-Pinguet Y, 2014, J ECOL, V102, P466, DOI 10.1111/1365-2745.12201; Li LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089063; Li LP, 2014, AQUAT BOT, V112, P84, DOI 10.1016/j.aquabot.2013.08.002; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Niklas KJ, 2003, EVOL ECOL RES, V5, P79; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Peltzer DA, 2010, ECOL MONOGR, V80, P509, DOI 10.1890/09-1552.1; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Poorter L, 2003, PLANT ECOL, V166, P295, DOI 10.1023/A:1023295806147; R-Core Development Team, 2013, R LANG ENV STAT COMP; Siefert A, 2012, OECOLOGIA, V170, P767, DOI 10.1007/s00442-012-2351-7; Taneda H, 2004, AM J BOT, V91, P1949, DOI 10.3732/ajb.91.12.1949; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Wardle DA, 2005, NATURE, V435, P806, DOI 10.1038/nature03611; Wardle DA, 2012, ECOLOGY, V93, P521, DOI 10.1890/11-0930.1; Wardle DA, 2009, FUNCT ECOL, V23, P442, DOI 10.1111/j.1365-2435.2008.01513.x; Yagi T, 2000, J PLANT RES, V113, P171, DOI 10.1007/PL00013928	44	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157136	10.1371/journal.pone.0157136	http://dx.doi.org/10.1371/journal.pone.0157136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270445	Green Submitted, gold, Green Published			2022-12-26	WOS:000377561000066
J	Cosma, G; Acampora, G; Brown, D; Rees, RC; Khan, M; Pockley, AG				Cosma, Georgina; Acampora, Giovanni; Brown, David; Rees, Robert C.; Khan, Masood; Pockley, A. Graham			Prediction of Pathological Stage in Patients with Prostate Cancer: A Neuro-Fuzzy Model	PLOS ONE			English	Article							RISK; CLASSIFICATION; RECURRENCE; NOMOGRAMS; NETWORKS; SYSTEM; TABLES	The prediction of cancer staging in prostate cancer is a process for estimating the likelihood that the cancer has spread before treatment is given to the patient. Although important for determining the most suitable treatment and optimal management strategy for patients, staging continues to present significant challenges to clinicians. Clinical test results such as the pre-treatment Prostate-Specific Antigen (PSA) level, the biopsy most common tumor pattern (Primary Gleason pattern) and the second most common tumor pattern (Secondary Gleason pattern) in tissue biopsies, and the clinical T stage can be used by clinicians to predict the pathological stage of cancer. However, not every patient will return abnormal results in all tests. This significantly influences the capacity to effectively predict the stage of prostate cancer. Herein we have developed a neuro-fuzzy computational intelligence model for classifying and predicting the likelihood of a patient having Organ-Confined Disease (OCD) or Extra-Prostatic Disease (ED) using a prostate cancer patient dataset obtained from The Cancer Genome Atlas (TCGA) Research Network. The system input consisted of the following variables: Primary and Secondary Gleason biopsy patterns, PSA levels, age at diagnosis, and clinical T stage. The performance of the neuro-fuzzy system was compared to other computational intelligence based approaches, namely the Artificial Neural Network, Fuzzy C-Means, Support Vector Machine, the Naive Bayes classifiers, and also the AJCC pTNM Staging Nomogram which is commonly used by clinicians. A comparison of the optimal Receiver Operating Characteristic (ROC) points that were identified using these approaches, revealed that the neuro-fuzzy system, at its optimal point, returns the largest Area Under the ROC Curve (AUC), with a low number of false positives (FPR = 0.274, TPR = 0.789, AUC = 0.812). The proposed approach is also an improvement over the AJCC pTNM Staging Nomogram (FPR = 0.032, TPR = 0.197, AUC = 0.582).	[Cosma, Georgina; Acampora, Giovanni; Brown, David] Nottingham Trent Univ, Sch Sci & Technol, Comp & Technol, Nottingham, England; [Rees, Robert C.; Pockley, A. Graham] Nottingham Trent Univ, John van Geest Canc Res Ctr, Nottingham, England; [Khan, Masood] Univ Hosp Leicester NHS Trust, Dept Urol, Leicester, Leics, England	Nottingham Trent University; Nottingham Trent University; University Hospitals of Leicester NHS Trust; University of Leicester	Cosma, G (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Comp & Technol, Nottingham, England.	georgina.cosma@ntu.ac.uk	Pockley, Alan G/I-4704-2015; Brown, David J/A-1777-2009; Cosma, Georgina/G-3508-2019	Pockley, Alan G/0000-0001-9593-6431; Cosma, Georgina/0000-0002-4663-6907; brown, david/0000-0002-1677-7485; Acampora, Giovanni/0000-0003-4082-5616	NHS Nottingham City Clinical Commissioning Group's allocation of NIHR Research Capability Funding [CCG/NTU/02/RCF/13-14]; John and Lucille van Geest Foundation; Healthcare and Bioscience iNet, an ERDF	NHS Nottingham City Clinical Commissioning Group's allocation of NIHR Research Capability Funding; John and Lucille van Geest Foundation; Healthcare and Bioscience iNet, an ERDF	This study was funded from the NHS Nottingham City Clinical Commissioning Group's allocation of NIHR Research Capability Funding (Contract Number: CCG/NTU/02/RCF/13-14). The authors would also like to acknowledge the financial support of the John and Lucille van Geest Foundation and the Healthcare and Bioscience iNet, an ERDF funded initiative managed by Medilink East Midlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, J CLIN PATHOL; Benecchi L, 2006, UROLOGY, V68, P357, DOI 10.1016/j.urology.2006.03.003; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; BLUTE ML, 1989, J UROLOGY, V142, P1262, DOI 10.1016/S0022-5347(17)39051-1; Boehm K, 2015, EUROPEAN UROLOGY; Brawer K, 2013, J CLIN ONCOL, P31; Briganti Alberto, 2009, Eur Urol, V55, P743, DOI 10.1016/j.eururo.2008.11.038; Burford D., 2009, PROSTATE CANC RISK M; Castanho MJP, 2013, EXPERT SYST APPL, V40, P466, DOI 10.1016/j.eswa.2012.07.046; Chun FKH, 2007, BJU INT, V99, P794, DOI 10.1111/j.1464-410X.2006.06694.x; Cinar M, 2009, EXPERT SYST APPL, V36, P6357, DOI 10.1016/j.eswa.2008.08.010; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; Cristianini N, 2000, INTRO SUPPORT VECTOR; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Dotan ZA, 2009, EUR UROL SUPPL, V8, P721, DOI 10.1016/j.eursup.2009.06.013; Edge SB, 2010, AJCC CANC STAGING MA; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; EPSTEIN JI, 1993, CANCER-AM CANCER SOC, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO;2-Y; Falzarano S., 2010, DIAGN HISTOPATHOL, V16, P432, DOI DOI 10.1016/J.MPDHP.2010.06.010; Han J., 2011, DATA MINING CONCEPTS, V2nd; Hastie T.J., 2001, ELEMENTS STAT LEARNI; Heijnsdijk E, 2012, J UROLOGY, V187, pE491, DOI 10.1016/j.juro.2012.02.1502; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; JANG JSR, 1993, IEEE T SYST MAN CYB, V23, P665, DOI 10.1109/21.256541; Jang JSR, 1996, FUZZ-IEEE '96 - PROCEEDINGS OF THE FIFTH IEEE INTERNATIONAL CONFERENCE ON FUZZY SYSTEMS, VOLS 1-3, P1493, DOI 10.1109/FUZZY.1996.552396; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Keles A, 2007, COMPUT BIOL MED, V37, P1617, DOI 10.1016/j.compbiomed.2007.03.006; Lujan M, 2012, ACTAS UROL ESP, V36, P403, DOI 10.1016/j.acuro.2011.10.013; Makarov DV, 2007, UROLOGY, V69, P1095, DOI 10.1016/j.urology.2007.03.042; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; Partin AW, 2001, UROLOGY, V58, P843, DOI 10.1016/S0090-4295(01)01441-8; Saritas I, 2010, EXPERT SYST APPL, V37, P6646, DOI 10.1016/j.eswa.2010.03.056; Schroder FH, 2012, EUR UROL, V62, P745, DOI 10.1016/j.eururo.2012.05.068; Shariat SF, 2009, FUTURE ONCOL, V5, P1555, DOI [10.2217/fon.09.121, 10.2217/FON.09.121]; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Sugeno M., 1993, IEEE Transactions on Fuzzy Systems, V1, P7, DOI 10.1109/TFUZZ.1993.390281; Tamblyn DJ, 2011, BJU INT, V108, DOI 10.1111/j.1464-410X.2011.10687.x; Tewari A, 2001, MOL UROL, V5, P147, DOI 10.1089/10915360152745812; Tsao CW, 2014, J CHIN MED ASSOC, V77, P513, DOI 10.1016/j.jcma.2014.06.014; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	40	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155856	10.1371/journal.pone.0155856	http://dx.doi.org/10.1371/journal.pone.0155856			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258119	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700022
J	Dube, E; Gagnon, D; Ouakki, M; Bettinger, JA; Guay, M; Halperin, S; Wilson, K; Graham, J; Witteman, HO; MacDonald, S; Fisher, W; Monnais, L; Tran, D; Gagneur, A; Guichon, J; Saini, V; Heffernan, JM; Meyer, S; Driedger, SM; Greenberg, J; MacDougall, H				Dube, Eve; Gagnon, Dominique; Ouakki, Manale; Bettinger, Julie A.; Guay, Maryse; Halperin, Scott; Wilson, Kumanan; Graham, Janice; Witteman, Holly O.; MacDonald, Shannon; Fisher, William; Monnais, Laurence; Tran, Dat; Gagneur, Arnaud; Guichon, Juliet; Saini, Vineet; Heffernan, Jane M.; Meyer, Samantha; Driedger, S. Michelle; Greenberg, Joshua; MacDougall, Heather		Canadian Immunization Res Network	Understanding Vaccine Hesitancy in Canada: Results of a Consultation Study by the Canadian Immunization Research Network	PLOS ONE			English	Article							PATIENT ENGAGEMENT; WEB 2.0; PHYSICIAN COMMUNICATION; NONMEDICAL EXEMPTIONS; DECISION-MAKING; HERD-IMMUNITY; UNITED-STATES; PUBLIC TRUST; PARENTS; REQUIREMENTS	"Vaccine hesitancy" is a concept now frequently used in vaccination discourse. The increased popularity of this concept in both academic and public health circles is challenging previously held perspectives that individual vaccination attitudes and behaviours are a simple dichotomy of accept or reject. A consultation study was designed to assess the opinions of experts and health professionals concerning the definition, scope, and causes of vaccine hesitancy in Canada. We sent online surveys to two panels (1-vaccination experts and 2-front-line vaccine providers). Two questionnaires were completed by each panel, with data from the first questionnaire informing the development of questions for the second. Our participants defined vaccine hesitancy as an attitude (doubts, concerns) as well as a behaviour (refusing some / many vaccines, delaying vaccination). Our findings also indicate that both vaccine experts and front-line vaccine providers have the perception that vaccine rates have been declining and consider vaccine hesitancy an important issue to address in Canada. Diffusion of negative information online and lack of knowledge about vaccines were identified as the key causes of vaccine hesitancy by the participants. A common understanding of vaccine hesitancy among researchers, public health experts, policy-makers and health care providers will better guide interventions that can more effectively address vaccine hesitancy within Canada.	[Dube, Eve] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Dube, Eve; Gagnon, Dominique; Ouakki, Manale; Guay, Maryse] Inst Natl Sante Publ Quebec, Malad Infect, Quebec City, PQ, Canada; [Dube, Eve] Univ Laval, CHU Quebec, Ctr Rech, Malad Infect & Immunitaires, Quebec City, PQ, Canada; [Bettinger, Julie A.] BC Childrens Hosp, Vaccine Evaluat Ctr, Vancouver, BC, Canada; [Bettinger, Julie A.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Guay, Maryse] Univ Sherbrooke, Dept Sci Sante Communautaire, Sherbrooke, PQ J1K 2R1, Canada; [Halperin, Scott] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Wilson, Kumanan] Univ Ottawa, Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Graham, Janice] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Witteman, Holly O.] Univ Laval, Dept Med Familiale & Med Urgence, Quebec City, PQ, Canada; [Witteman, Holly O.] Univ Laval, CHU Quebec, Ctr Rech, Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada; [MacDonald, Shannon] Univ Alberta, Nursing Fac, Edmonton, AB, Canada; [MacDonald, Shannon] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Fisher, William] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Monnais, Laurence] Univ Montreal, Dept Hist, Montreal, PQ H3C 3J7, Canada; [Tran, Dat] Hosp Sick Children, Div Infect Dis, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Gagneur, Arnaud] Univ Sherbrooke, Serv Neonatol, Dept Pediat, Sherbrooke, PQ J1K 2R1, Canada; [Guichon, Juliet] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Saini, Vineet] Univ Calgary, Dept Prod Anim Hlth, Calgary, AB, Canada; [Saini, Vineet] Alberta Hlth Serv, Calgary, AB, Canada; [Heffernan, Jane M.] York Univ, Dept Math & Stat, Toronto, ON M3J 2R7, Canada; [Meyer, Samantha] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada; [Driedger, S. Michelle] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Greenberg, Joshua] Carleton Univ, Sch Journalism & Commun, Ottawa, ON K1S 5B6, Canada; [MacDougall, Heather] Univ Waterloo, Dept Hist, Waterloo, ON N2L 3G1, Canada	Laval University; Institut national de sante publique du Quebec (INSPQ); Laval University; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of Sherbrooke; Dalhousie University; University of Ottawa; Ottawa Hospital Research Institute; Dalhousie University; Laval University; Laval University; University of Alberta; University of Calgary; Western University (University of Western Ontario); Universite de Montreal; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Sherbrooke; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; York University - Canada; University of Waterloo; University of Manitoba; Carleton University; University of Waterloo	Dube, E (corresponding author), Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada.; Dube, E (corresponding author), Inst Natl Sante Publ Quebec, Malad Infect, Quebec City, PQ, Canada.; Dube, E (corresponding author), Univ Laval, CHU Quebec, Ctr Rech, Malad Infect & Immunitaires, Quebec City, PQ, Canada.	eve.dube@inspq.qc.ca	gagneur, arnaud/AAD-6001-2022	Bettinger, Julie/0000-0002-2118-4174; MacDonald, Shannon E./0000-0003-4675-4433; Driedger, S. Michelle/0000-0003-3769-5785; Graham, Janice/0000-0002-6326-8122; Halperin, Scott/0000-0003-0525-589X; Witteman, Holly/0000-0003-4192-0682	Canadian Immunization Research Network (Canadian Institute of Health Research of Canada); Canadian Immunization Research Network (Public Health Agency of Canada); Alberta Innovates [201201082] Funding Source: researchfish	Canadian Immunization Research Network (Canadian Institute of Health Research of Canada); Canadian Immunization Research Network (Public Health Agency of Canada); Alberta Innovates	This study was funded by the Canadian Immunization Research Network (Canadian Institute of Health Research and Public Health Agency of Canada).	Adler M, 1996, DELPHI METHOD ITS AP, P252; Angus D, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-4; Basrur S, 2005, RUBELLA OUTBREAK SO; Benin AL, 2006, PEDIATRICS, V117, P1532, DOI 10.1542/peds.2005-1728; Betsch C, 2011, EUROSURVEILLANCE, V16, P15; Betsch C., 2015, POLICY INSIGHTS BEHA, V2, P61, DOI [10.1177/2372732215600716, DOI 10.1177/2372732215600716]; Betsch C, 2012, VACCINE, V30, P3727, DOI 10.1016/j.vaccine.2012.02.025; Blume S, 2006, SOC SCI MED, V62, P628, DOI 10.1016/j.socscimed.2005.06.020; Brownlie J, 2006, SOC SCI MED, V62, P433, DOI 10.1016/j.socscimed.2005.05.033; Burton-Jeangros C, 2005, REV EPIDEMIOL SANTE, V53, P341, DOI 10.1016/S0398-7620(05)84616-4; Cassell JA, 2006, PUBLIC HEALTH, V120, P783, DOI 10.1016/j.puhe.2006.03.011; Cooper LZ, 2008, PEDIATRICS, V122, P149, DOI 10.1542/peds.2008-0987; Davies P, 2002, ARCH DIS CHILD, V87, P22, DOI 10.1136/adc.87.1.22; Dempsey AF, 2011, PEDIATRICS, V128, P848, DOI 10.1542/peds.2011-0400; Dentzer S, 2013, HEALTH AFFAIR, V32, P202, DOI 10.1377/hlthaff.2013.0037; Dube E, 2013, HUM VACCINES, V9, P1; Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212; Dube E, 2014, VACCINE, V32, P6649, DOI 10.1016/j.vaccine.2014.09.039; Dube E, 2013, HUM VACC IMMUNOTHER, V9, P1763, DOI 10.4161/hv.24657; Ekos Research Associates Inc, 2011, SURV PAR KEY ISS REL, P53; Enropean Centrer for Disease Prevention and Control, 2015, VACC HES HEALTHC WOR; Eskola J, 2015, VACCINE, V33, P4215, DOI 10.1016/j.vaccine.2015.04.043; Fabry P, 2011, VACCINE, V29, P1824, DOI 10.1016/j.vaccine.2010.12.109; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225; Gruman J, 2010, PATIENT EDUC COUNS, V78, P350, DOI 10.1016/j.pec.2010.02.002; Guay M, 2009, POURQUOI COUVERTURES, P62; Gust DA, 2008, PEDIATRICS, V122, P718, DOI 10.1542/peds.2007-0538; HALPERIN SA, 2000, CAN J CONTIN MED ED, V12, P62; Healy CM, 2011, PEDIATRICS, V127, pS127, DOI 10.1542/peds.2010-1722S; Henrikson NB, 2015, PEDIATRICS, V136, P70, DOI 10.1542/peds.2014-3199; Hibbard JH, 2013, HEALTH AFFAIR, V32, P207, DOI 10.1377/hlthaff.2012.1061; Hobson-West P, 2003, HEALTH RISK SOC, V5, P273, DOI 10.1080/13698570310001606978; Hsu CC, 2007, PARE, V12, P1; Kahan DM, 2013, SCIENCE, V342, P53, DOI 10.1126/science.1245724; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Kata A, 2010, VACCINE, V28, P1709, DOI 10.1016/j.vaccine.2009.12.022; Kaufman SR, 2010, ETHOS, V38, P8, DOI 10.1111/j.1548-1352.2009.01079.x; Keelan J, 2010, VACCINE, V28, P1535, DOI 10.1016/j.vaccine.2009.11.060; Kennedy A, 2011, HEALTH AFFAIR, V30, P1151, DOI 10.1377/hlthaff.2011.0396; Koppaka Ram, 2011, Morbidity and Mortality Weekly Report, V60, P814; Lantos JD, 2010, CURR PROB PEDIATR AD, V40, P38, DOI 10.1016/j.cppeds.2010.01.003; Laroche J, 2010, 9 CAN IMM C QUEB CAN; Larson HJ, 2013, LANCET INFECT DIS, V13, P606, DOI 10.1016/S1473-3099(13)70108-7; Leach M., 2007, VACCINE ANXIETIES GL; Leask J, 2015, PEDIATRICS, V136, P180, DOI 10.1542/peds.2015-1382; Leask J, 2014, HUM VACC IMMUNOTHER, V10, P2600, DOI 10.4161/hv.29725; Leask J, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-154; Leask J, 2011, NATURE, V473, P443, DOI 10.1038/473443a; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; National Advisory Committee on Immunization, 2006, CAN IMM GUID, P410; National Vaccine Advisory Committee, 2015, ASS STAT VACC CONF U; Nyhan B, 2015, VACCINE, V33, P459, DOI 10.1016/j.vaccine.2014.11.017; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; Omer SB, 2006, JAMA-J AM MED ASSOC, V296, P1757, DOI 10.1001/jama.296.14.1757; Opel DJ, 2012, VACCINE, V30, P1269, DOI 10.1016/j.vaccine.2011.12.129; Opel DJ, 2011, VACCINE, V29, P6598, DOI 10.1016/j.vaccine.2011.06.115; Osborn R, 2012, J AMBUL CARE MANAG, V35, P118, DOI 10.1097/JAC.0b013e31824a579b; Pelletier LR, 2013, NURS OUTLOOK, V61, P51, DOI 10.1016/j.outlook.2012.11.003; Peretti-Watel Patrick, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.6844c80ff9f5b273f34c91f71b7fc289; Quadri-Sheriff M, 2012, PEDIATRICS, V130, P522, DOI 10.1542/peds.2012-0140; Quebec Gouvervement du, 2003, PROGR NAT SANT PUBL, P133; Rainford J., 2015, POLICY OPTIONS; Remes O, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1047; Richards JL, 2013, VACCINE, V31, P3009, DOI 10.1016/j.vaccine.2013.04.053; Robichaud P, 2012, VACCINE, V30, P3763, DOI 10.1016/j.vaccine.2012.03.074; Safi H, 2012, AM J PREV MED, V42, P602, DOI 10.1016/j.amepre.2012.02.022; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Scullard P, 2010, ARCH DIS CHILD, V95, P580, DOI 10.1136/adc.2009.168856; Shourie S, 2013, VACCINE, V31, P6003, DOI 10.1016/j.vaccine.2013.10.025; Siddiqui M, 2013, HUM VACC IMMUNOTHER, V9, P2643, DOI 10.4161/hv.27243; Smith JC, 2013, ADV EXP MED BIOL, V764, P81, DOI 10.1007/978-1-4614-4726-9_6; Smith M, 2015, GLOBE MAIL      0721; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Verger P, 2015, EBIOMEDICINE, V2, P891, DOI 10.1016/j.ebiom.2015.06.018; Watanabe M, 2005, EXPERT REV VACCINES, V4, P173, DOI 10.1586/14760584.4.2.173; Wilson Sarah E, 2015, CMAJ Open, V3, pE317, DOI 10.9778/cmajo.20140088; Witteman HO, 2015, RISK ANAL, V35, P1801, DOI 10.1111/risa.12418; Witteman HO, 2015, PEDIATRICS, V136, P215, DOI 10.1542/peds.2015-0949; Witteman HO, 2012, VACCINE, V30, P3734, DOI 10.1016/j.vaccine.2011.12.039; Wolfe RM, 2002, JAMA-J AM MED ASSOC, V287, P3245, DOI 10.1001/jama.287.24.3245; Wroe AL, 2005, HEALTH PSYCHOL, V24, P539, DOI 10.1037/0278-6133.24.6.539; Zipprich J, 2015, MMWR-MORBID MORTAL W, V64, P153	84	81	81	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156118	10.1371/journal.pone.0156118	http://dx.doi.org/10.1371/journal.pone.0156118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257809	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700036
J	Mariani, E; Canella, V; Cattini, L; Kon, E; Marcacci, M; Di Matteo, B; Pulsatelli, L; Filardo, G				Mariani, Erminia; Canella, Valentina; Cattini, Luca; Kon, Elizaveta; Marcacci, Maurilio; Di Matteo, Berardo; Pulsatelli, Lia; Filardo, Giuseppe			Leukocyte-Rich Platelet-Rich Plasma Injections Do Not Up-Modulate Intra-Articular Pro-Inflammatory Cytokines in the Osteoarthritic Knee	PLOS ONE			English	Article							SYNOVIAL-FLUID; GROWTH-FACTOR; SURGICAL-TREATMENT; FORMULATIONS; PROFILES; BLOOD	Introduction The presence of leukocytes in platelet concentrates is deemed to cause deleterious effects when injected intra articularly. The aim of this study is to analyse both local and systemic effects induced by leukocyte-rich Platelet-rich Plasma (PRP) injections through a proteomic characterization of serial synovial fluid and blood samples obtained from subjects treated for knee OA. Secondary aim was to compare the effects on knee homeostasis and systemic response with those obtained with visco-supplementation. Methods Thirty-six OA patients treated either by autologous L-PRP or HA intra-articular knee injections, administered in series of three at one-week intervals, were analyzed. Just before the injection, 1 ml of synovial fluid was collected through the same needle way. In the same time, a peripheral blood sample was obtained and plasma separated. A further peripheral blood sample was collected at 2, 6, and 12 months. L-PRP, plasma and synovial fluid were tested by multiplex bead-based sandwich immunoassay by means of the Bio-Plex suspension array system (Bio-Rad Laboratories) for the presence of pro-and anti-inflammatory cytokines (IL-1beta, IL-6, IL-8, IL-17 and IL-4, IL-10, IL-13) and growth factors (FGF-b, HGF, PDGF-AB/BB). Results In general, pro-inflammatory cytokine levels were similar at basal condition and after treatment whereas anti-inflammatory ones were nearly undetectable. L-PRP administration did not modulate significant changes of cytokine concentrations either in synovial fluid or plasma, whatever the time points analyzed. No different trend was observed between L-PRP and HA administration in terms of pro- and anti-inflammatory cytokines, as well as growth factors. Conclusions In contrast with the evidence reported by "in vitro" studies, where a cellular pro-inflammatory response appears to be induced by the presence of leukocytes, these results suggest that the presence leukocyte-rich PRP doesn't induce a relevant in vivo up regulation of proinflammatory mediators.	[Mariani, Erminia; Canella, Valentina; Cattini, Luca; Pulsatelli, Lia] Rizzoli Orthopaed Inst, Lab Immunorheumatol & Tissue Regenerat RAMSES, Bologna, Italy; [Mariani, Erminia] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy; [Kon, Elizaveta; Marcacci, Maurilio; Di Matteo, Berardo; Filardo, Giuseppe] Rizzoli Orthopaed Inst, Orthopaed & Traumatol Clin 2, Lab Biomech & Technol Innovat NABI, Bologna, Italy	IRCCS Istituto Ortopedico Rizzoli; University of Bologna; IRCCS Istituto Ortopedico Rizzoli	Di Matteo, B (corresponding author), Rizzoli Orthopaed Inst, Orthopaed & Traumatol Clin 2, Lab Biomech & Technol Innovat NABI, Bologna, Italy.	bdimatteo@biomec.ior.it	Mariani, Erminia/AAE-8110-2021; Pulsatelli, Lia/D-4092-2019; Mariani, Erminia/C-6881-2019; Filardo, Giuseppe/K-5088-2016	Mariani, Erminia/0000-0002-4407-6707; Pulsatelli, Lia/0000-0003-3031-170X; Mariani, Erminia/0000-0002-4407-6707; MARCACCI, MAURILIO/0000-0002-7484-1246; Di Matteo, Berardo/0000-0002-9807-0271; Filardo, Giuseppe/0000-0002-8136-0977; KON, ELIZAVETA/0000-0003-0649-2336	Rizzoli Orthopaedic Institute (Ricerca Corrente); University of Bologna (RFO funds); Italian Ministry of Health (Project RF) [1498841]; Emilia-Romagna Region (Region-University Program: Regenerative Medicine of Cartilage and Bone)	Rizzoli Orthopaedic Institute (Ricerca Corrente); University of Bologna (RFO funds); Italian Ministry of Health (Project RF); Emilia-Romagna Region (Region-University Program: Regenerative Medicine of Cartilage and Bone)	This work was supported by grants from Rizzoli Orthopaedic Institute (Ricerca Corrente), "5x1000" funds, University of Bologna (RFO funds to EM), Italian Ministry of Health (Project RF-2009 grant no. 1498841) and Emilia-Romagna Region (Region-University Program 2010-2012: Regenerative Medicine of Cartilage and Bone). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitua E, 2014, J BIOMED MAT RES A; Anitua E, 2013, ANN ANAT, V195, P461, DOI 10.1016/j.aanat.2013.04.004; Assirelli E., 2014, KNEE SURG SPORTS TRA; Braun HJ, 2014, AM J SPORT MED, V42, P1204, DOI 10.1177/0363546514525593; Browning Shawn R, 2012, J Bone Joint Surg Am, V94, pe1721, DOI 10.2106/JBJS.K.01501; Cavallo C, 2014, J BONE JOINT SURG AM, V96A, P423, DOI 10.2106/JBJS.M.00726; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009; Filardo G, 2015, AM J SPORT MED; Filardo G., 2013, KNEE SURG SPORTS TRA; Filardo G, 2013, AM J SPORT MED, V41, P95, DOI 10.1177/0363546512463675; Filardo G, 2012, KNEE SURG SPORT TR A, V20, P2078, DOI 10.1007/s00167-011-1837-x; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P468, DOI 10.1007/s00167-011-1714-7; Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Haseeb A, 2013, CLIN IMMUNOL, V146, P185, DOI 10.1016/j.clim.2012.12.011; Johnson VL, 2014, BEST PRACT RES CL RH, V28, P5, DOI 10.1016/j.berh.2014.01.004; Kaneko S, 2000, CYTOKINES CELL MOL T, V6, P71, DOI 10.1080/13684730050515796; Kon Elizaveta, 2013, Open Orthop J, V7, P120, DOI 10.2174/1874325001307010120; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Liu-Bryan R, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0323-5; Mabey T, 2014, INT ORTHOP, V38, P1885, DOI 10.1007/s00264-014-2406-y; Mariani E, 2008, EXP GERONTOL, V43, P462, DOI 10.1016/j.exger.2007.12.003; Mariani E, 2006, BIOGERONTOLOGY, V7, P449, DOI 10.1007/s10522-006-9060-8; McCarrel Taralyn M, 2012, J Bone Joint Surg Am, V94, DOI 10.2106/JBJS.L.00019; Perut F, 2013, CYTOTHERAPY, V15, P830, DOI 10.1016/j.jcyt.2013.01.220; Poole A Robin, 2012, HSS J, V8, P4, DOI 10.1007/s11420-011-9248-6; Rios DL, 2015, CYTOKINE, V76, P505, DOI 10.1016/j.cyto.2015.07.008; Smyth NA, 2013, ARTHROSCOPY, V29, P1399, DOI 10.1016/j.arthro.2013.03.004; Sundman EA, 2011, AM J SPORT MED, V39, P2135, DOI 10.1177/0363546511417792; Textor JA, 2013, VET J, V198, P217, DOI 10.1016/j.tvjl.2013.07.020; Tschon Matilde, 2011, Front Biosci (Elite Ed), V3, P96	33	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156137	10.1371/journal.pone.0156137	http://dx.doi.org/10.1371/journal.pone.0156137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258008	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700039
J	Mukudu, H; Otwombe, K; Laher, F; Lazarus, E; Manentsa, M; Lebina, L; Mapulanga, V; Bowa, K; Martinson, N				Mukudu, Hillary; Otwombe, Kennedy; Laher, Fatima; Lazarus, Erica; Manentsa, Mmatsie; Lebina, Limakatso; Mapulanga, Victor; Bowa, Kasonde; Martinson, Neil			A Cross Sectional Study of the Prevalence of Preputial and Penile Scrotal Abnormalities among Clients Undergoing Voluntary Medical Male Circumcision in Soweto, South Africa	PLOS ONE			English	Article							HIV PREVENTION; DEVICE; PHIMOSIS; SAFETY; MEN	Objective Medical device use is currently approved for males without preputial or major penile scrotal abnormalities for voluntary medical male circumcision (VMMC). We determined the prevalence of preputial abnormalities at a busy VMMC centre in Soweto, South Africa. Methods This was a cross-sectional record review at a high-volume VMMC centre in South Africa. We collated pre-circumcision demographic and genital examination findings from clients 8 years and older who had undergone VMMC from 01 May 2013 to 30 April 2014. Logistic regression was used to determine factors associated with preputial abnormalities. Findings During the review period, 6861 circumcisions were conducted and 37.1%(n = 2543) were 8-13 year olds. Median age was 15 years (IQR: 12-23 years). Fifteen percent (n = 1030) had preputial abnormalities or major penile scrotal abnormalities. Age-specific prevalence of preputial or major genital abnormalities were 27.3%, 10.6% and 6.0% in 8-13, 14-18 and > 18 year olds respectively. The odds of preputial or major penile scrotal abnormality were higher in younger clients aged 8-13 years (OR = 5.9; 95% CI = 4.8-7.1) and 14-18 years (OR = 1.9; 95% CI = 1.5-2.4) compared to older clients above 18 years and in those testing for HIV outside our clinic network (OR = 1.9; 95% CI = 1.4-2.7). Conclusion The high prevalence of preputial and penile scrotal abnormalities observed suggests a need for VMMC sites to provide for both open surgical and devices methods in the provision of VMMC services. This is especially so among young male subjects presenting themselves for VMMC services at the various sites being developed in sub Saharan African countries.	[Mukudu, Hillary; Otwombe, Kennedy; Laher, Fatima; Lazarus, Erica; Manentsa, Mmatsie; Lebina, Limakatso; Martinson, Neil] Univ Witwatersrand, PHRU, MRC Soweto Matlosana Collaborating Ctr HIV AIDS &, Fac Hlth Sci, Johannesburg, South Africa; [Mapulanga, Victor] Univ Zambia, Sch Med, Lusaka, Zambia; [Bowa, Kasonde] Copperbelt Univ, Sch Med, Ndola, Zambia	University of Witwatersrand; University of Zambia; Copperbelt University	Mukudu, H (corresponding author), Univ Witwatersrand, PHRU, MRC Soweto Matlosana Collaborating Ctr HIV AIDS &, Fac Hlth Sci, Johannesburg, South Africa.	hmukudu@mweb.co.za	Manentsa, Mmatsie/B-8658-2017; Bowa, Kasonde/A-8770-2019	Manentsa, Mmatsie/0000-0003-4671-7122; Bowa, Kasonde/0000-0001-7032-7998	PEPFAR through the CDC; Society for Family Health (SFH)	PEPFAR through the CDC; Society for Family Health (SFH)	The KNMMCC was funded by PEPFAR through the CDC, and Society for Family Health (SFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to circumcision clients for the use of their records; Chris Hani Baragwanath Academic Hospital for the clinic facilities and permission to use the records; as well as the data staff, Kedidimetse Matshidiso, Nomvula Zulu and Petros Tlou, for their kind assistance. The KNMMCC was funded by PEPFAR through the CDC, and Society for Family Health (SFH). The views expressed herein do not necessarily reflect those of the US Government, CDC or SFH.	[Anonymous], 2015, WHO PROGR BRIEF VOL; Barone MA, 2011, JAIDS-J ACQ IMM DEF, V57, pE7, DOI 10.1097/QAI.0b013e3182158967; Bitega JP, 2011, JAIDS-J ACQ IMM DEF, V58, pE127, DOI 10.1097/QAI.0b013e3182354e65; Chrouser K, 2013, J UROLOGY, V190, P544, DOI 10.1016/j.juro.2013.02.3200; Duffy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063134; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Galukande M, 2014, PLOS ONE, V9, P2, DOI DOI 10.1371/J0URNAL.P0NE.0086631; Hsieh TF, 2006, INT J UROL, V13, P968, DOI 10.1111/j.1442-2042.2006.01449.x; Kigozi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100008; Kigozi G, 2013, JAIDS-J ACQ IMM DEF, V63, P617, DOI 10.1097/QAI.0b013e3182968dda; Ko MC, 2007, J FORMOS MED ASSOC, V106, P302, DOI 10.1016/S0929-6646(09)60256-4; Mehta SD, 2013, AIDS; Mutabazi V, 2012, JAIDS-J ACQ IMM DEF, V61, P49, DOI 10.1097/QAI.0b013e3182631d69; Njeuhmeli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082533; Robertson LM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-141; Shankar KR, 1999, BJU INT, V84, P101; Shisana O, 2009, S AFRICAN NATL HIV P; UNAIDS, 2013, PAED HIV SURV INF CH; WHO, WHO WHO UNAIDS ANN R; WHO, 2013, GUID US DEV AD MAL C; WHO, 2013, WHO TRADITIONAL MED, P15; WHO, 2013, EV 2 AD DEV; WHO, 2016, WHO, V0205, P3111; WHO, GLOB HLTH SECT STRAT; WHO, MAL CIRC LOC AN VERS	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156265	10.1371/journal.pone.0156265	http://dx.doi.org/10.1371/journal.pone.0156265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253372	Green Submitted, gold, Green Published			2022-12-26	WOS:000377218700017
J	Kim, YJ; Lee, HS; Kim, YK; Park, S; Kim, JM; Yun, JH; Yu, HY; Kim, BJ				Kim, Yeon-Jung; Lee, Heun-Sik; Kim, Yun Kyoung; Park, Suyeon; Kim, Jeong-Min; Yun, Jun Ho; Yu, Ho-Yeong; Kim, Bong-Jo			Association of Metabolites with Obesity and Type 2 Diabetes Based on FTO Genotype	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; C-REACTIVE PROTEIN; BODY-MASS INDEX; GENETIC-VARIANTS; DIETARY-INTAKE; EARLY-ONSET; FAT MASS; RISK; METAANALYSIS; INSIGHTS	The single nucleotide polymorphism rs9939609 of the gene FTO, which encodes fat mass and obesity-associated protein, is strongly associated with obesity and type 2 diabetes (T2D) in multiple populations; however, the underlying mechanism of this association is unclear. The present study aimed to investigate FTO genotype-dependent metabolic changes in obesity and T2D. To elucidate metabolic dysregulation associated with disease risk genotype, genomic and metabolomic datasets were recruited from 2,577 participants of the Korean Association REsource (KARE) cohort, including 40 homozygous carriers of the FTO risk allele (AA), 570 heterozygous carriers (AT), and 1,967 participants carrying no risk allele (TT). A total of 134 serum metabolites were quantified using a targeted metabolomics approach. Through comparison of various statistical methods, seven metabolites were identified that are significantly altered in obesity and T2D based on the FTO risk allele (adjusted p < 0.05). These identified metabolites are relevant to phosphatidylcholine metabolic pathway, and previously reported to be metabolic markers of obesity and T2D. In conclusion, using metabolomics with the information from genome-wide association studies revealed significantly altered metabolites depending on the FTO genotype in complex disorders. This study may contribute to a better understanding of the biological mechanisms linking obesity and T2D.	[Kim, Yeon-Jung; Lee, Heun-Sik; Kim, Yun Kyoung; Park, Suyeon; Kim, Jeong-Min; Yun, Jun Ho; Yu, Ho-Yeong; Kim, Bong-Jo] Korea Natl Inst Hlth, Div Struct & Funct Genom, Ctr Genome Sci, Chungcheongbuk Do, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science	Kim, BJ (corresponding author), Korea Natl Inst Hlth, Div Struct & Funct Genom, Ctr Genome Sci, Chungcheongbuk Do, South Korea.	kbj6181@cdc.go.kr		Kim, Jeong-Min/0000-0002-4305-5162	Korea National Institute of Health [2013-NG73001-00]; Korean Genome Analysis Project [4845-301]; Korea Biobank Project [4851-307, KBP-2014-02]; Korea Center for Disease Control and Prevention, Republic of Korea	Korea National Institute of Health; Korean Genome Analysis Project; Korea Biobank Project; Korea Center for Disease Control and Prevention, Republic of Korea	This work was supported by intramural grants from the Korea National Institute of Health (2013-NG73001-00). Biospecimens and data were obtained from the Korean Genome Analysis Project (4845-301), the Korean Genome and Epidemiology Study (4851-302), and the Korea Biobank Project (4851-307, KBP-2014-02), which are supported by the Korea Center for Disease Control and Prevention, Republic of Korea.	Adamski J, 2013, CURR OPIN BIOTECH, V24, P39, DOI 10.1016/j.copbio.2012.10.003; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hochberge YBY., 1955, CONTROLLING FALSE DI, V50, P289; Isa S. A., 2010, NIGERIAN J BASIC APP, V18, P50; Kahn SE, 2006, DIABETES, V55, P2357, DOI 10.2337/db06-0116; Kato Makiko, 1996, Tokushima Journal of Experimental Medicine, V43, P1; Kawada T, 1993, Sangyo Igaku, V35, P38; Kopelman P, 2007, OBES REV, V8, P13, DOI 10.1111/j.1467-789X.2007.00311.x; Lee HJ, 2010, CLIN CHIM ACTA, V411, P1716, DOI 10.1016/j.cca.2010.07.010; Liu GF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-57; Liu Y, 2010, OBESITY, V18, P1619, DOI 10.1038/oby.2009.469; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Marrachelli VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098227; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Moore SC, 2014, METABOLOMICS, V10, P259, DOI 10.1007/s11306-013-0574-1; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Nishida Makoto, 2009, Nihon Rinsho, V67, P301; Njajou OT, 2009, DIABETES-METAB RES, V25, P733, DOI 10.1002/dmrr.1011; Omura Minoru, 1993, Fukuoka Acta Medica, V84, P305; Park W, 2013, ERGONOMICS, V56, P692, DOI 10.1080/00140139.2012.752529; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Qi QB, 2014, HUM MOL GENET, V23, P6961, DOI 10.1093/hmg/ddu411; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ried JS, 2013, ALLERGY, V68, P629, DOI 10.1111/all.12110; Suhre K, 2012, NAT REV GENET, V13, P759, DOI 10.1038/nrg3314; Suzuki Koji, 2003, Asian Pac J Cancer Prev, V4, P259; Then C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078430; Binh TQ, 2013, GENE, V513, P31, DOI 10.1016/j.gene.2012.10.082; Urata H, 2001, Nihon Koshu Eisei Zasshi, V48, P560; Wallace M, 2014, MOL BIOSYST, V10, P1586, DOI 10.1039/c3mb70529c; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Xie WJ, 2013, DIABETES, V62, P2141, DOI 10.2337/db12-0876; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	40	25	28	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156612	10.1371/journal.pone.0156612	http://dx.doi.org/10.1371/journal.pone.0156612			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249024	Green Submitted, Green Published, gold			2022-12-26	WOS:000377184700058
J	Borkowska, M; Millar, JK; Price, DJ				Borkowska, Malgorzata; Millar, J. Kirsty; Price, David J.			Altered Disrupted-in-Schizophrenia-1 Function Affects the Development of Cortical Parvalbumin Interneurons by an Indirect Mechanism	PLOS ONE			English	Article							DISC1-L100P MUTANT MICE; MAJOR MENTAL-ILLNESS; PREFRONTAL CORTEX; TRANSGENIC MICE; VISUAL-CORTEX; FRONTAL-CORTEX; PSYCHIATRIC-DISORDERS; BEHAVIORAL PHENOTYPES; POSTNATAL-DEVELOPMENT; NEURITE OUTGROWTH	Disrupted-in-Schizophrenia-1 (DISC1) gene has been linked to schizophrenia and related major mental illness. Mouse Disc1 has been implicated in brain development, mainly in the proliferation, differentiation, lamination, neurite outgrowth and synapse formation and maintenance of cortical excitatory neurons. Here, the effects of two loss-of-function point mutations in the mouse Disc1 sequence (Q31L and L100P) on cortical inhibitory interneurons were investigated. None of the mutations affected the overall number of interneurons. However, the 100P, but not the 31L, mutation resulted in a significant decrease in the numbers of interneurons expressing parvalbumin mRNA and protein across the sensory cortex. To investigate role of Disc1 in regulation of parvalbumin expression, mouse wild-type Disc-1 or the 100P mutant form were electroporated in utero into cortical excitatory neurons. Overexpression of wild-type Disc1 in these cells caused increased densities of parvalbumin-expressing interneurons in the electroporated area and in areas connected with it, whereas expression of Disc1-100P did not. We conclude that the 100P mutation prevents expression of parvalbumin by a normally sized cohort of interneurons and that altering Disc1 function in cortical excitatory neurons indirectly affects parvalbumin expression by cortical interneurons, perhaps as a result of altered functional input from the excitatory neurons.	[Borkowska, Malgorzata; Price, David J.] Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland; [Millar, J. Kirsty] Univ Edinburgh, MRC Inst Genet & Mol Med, Ctr Genom & Expt Med, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland; [Borkowska, Malgorzata] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Hammersmith Hosp Campus,Du Cane Rd, London W12, England	University of Edinburgh; University of Edinburgh; Imperial College London	Borkowska, M (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.; Borkowska, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Hammersmith Hosp Campus,Du Cane Rd, London W12, England.	malgorzata.borkowska@csc.mrc.ac.uk		Borkowska, Malgorzata/0000-0002-8567-7218	Medical Research Council [G0800429, J003662/1, G0902166]; MRC Capacity Building Studentship; BBSRC [BB/N006542/1] Funding Source: UKRI; MRC [MR/J003662/1, G0800429, G0902166] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N006542/1] Funding Source: researchfish; Medical Research Council [MR/J003662/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Capacity Building Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by Medical Research Council grants G0800429 and J003662/1 (DJP), G0902166 (JKM) and an MRC Capacity Building Studentship to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCANTARA S, 1993, ANAT EMBRYOL, V188, P63; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Austin CP, 2004, NEUROSCIENCE, V124, P3, DOI 10.1016/j.neuroscience.2003.11.010; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Buetfering C, 2014, NAT NEUROSCI, V17, P710, DOI 10.1038/nn.3696; Chandran JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108088; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.02.033, 10.1016/j.neuron.2014.01.027]; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; Fung SJ, 2010, AM J PSYCHIAT, V167, P1479, DOI 10.1176/appi.ajp.2010.09060784; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hague FN, 2012, BEHAV BRAIN RES, V233, P337, DOI 10.1016/j.bbr.2012.05.037; HAIECH J, 1979, BIOCHEMISTRY-US, V18, P2752, DOI 10.1021/bi00580a010; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Kas MJH, 2009, AM J MED GENET B, V150B, P309, DOI 10.1002/ajmg.b.30815; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kubota Y, 2011, CEREB CORTEX, V21, P1803, DOI 10.1093/cercor/bhq252; Lee FHF, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-20; Lee FHF, 2011, SCHIZOPHR RES, V129, P74, DOI 10.1016/j.schres.2011.03.032; Lee FHF, 2011, J NEUROSCI, V31, P3197, DOI 10.1523/JNEUROSCI.4219-10.2011; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; Levelt CN, 2012, ANNU REV NEUROSCI, V35, P309, DOI 10.1146/annurev-neuro-061010-113813; Lewis DA, 2014, CURR OPIN NEUROBIOL, V26, P22, DOI 10.1016/j.conb.2013.11.003; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; Lipina TV, 2010, GENES BRAIN BEHAV, V9, P777, DOI 10.1111/j.1601-183X.2010.00615.x; Lipina TV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051562; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Millar JK, 2007, J PHYSIOL-LONDON, V584, P401, DOI 10.1113/jphysiol.2007.140210; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, GENOMICS, V67, P69, DOI 10.1006/geno.2000.6239; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Morris HM, 2009, SCHIZOPHR RES, V115, P261, DOI 10.1016/j.schres.2009.09.014; Niwa M, 2010, NEURON, V65, P480, DOI 10.1016/j.neuron.2010.01.019; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Patz S, 2004, CEREB CORTEX, V14, P342, DOI 10.1093/cercor/bhg132; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Reynolds GP, 2001, J CHEM NEUROANAT, V22, P95, DOI 10.1016/S0891-0618(01)00113-2; Reynolds GP, 2001, BRAIN RES BULL, V55, P579, DOI 10.1016/S0361-9230(01)00526-3; Roberts RC, 2007, SCHIZOPHRENIA BULL, V33, P11, DOI 10.1093/schbul/sbl063; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Shoji Hirotaka, 2012, BMC Res Notes, V5, P108, DOI 10.1186/1756-0500-5-108; Soares DC, 2011, ACS CHEM NEUROSCI, V2, P609, DOI 10.1021/cn200062k; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Steinecke A, 2012, J NEUROSCI, V32, P738, DOI 10.1523/JNEUROSCI.5036-11.2012; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Tanahira C, 2009, NEUROSCI RES, V63, P213, DOI 10.1016/j.neures.2008.12.007; Taniguchi Y, 2012, NEUROSCIENTIST, V18, P169, DOI 10.1177/1073858411399925; Thomson Pippa A, 2013, Front Biol (Beijing), V8, P1; Van de Werd HJJM, 2014, BRAIN STRUCT FUNCT, V219, P433, DOI 10.1007/s00429-013-0630-7; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	72	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156082	10.1371/journal.pone.0156082	http://dx.doi.org/10.1371/journal.pone.0156082			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244370	gold, Green Submitted, Green Published			2022-12-26	WOS:000377146100015
J	Hapuarachchige, S; Kato, Y; Ngen, EJ; Smith, B; Delannoy, M; Artemov, D				Hapuarachchige, Sudath; Kato, Yoshinori; Ngen, Ethel J.; Smith, Barbara; Delannoy, Michael; Artemov, Dmitri			Non-Temperature Induced Effects of Magnetized Iron Oxide Nanoparticles in Alternating Magnetic Field in Cancer Cells	PLOS ONE			English	Review							IN-VIVO MRI; CONTRAST AGENTS; STEM-CELLS	This paper reports the damaging effects of magnetic iron-oxide nanoparticles (MNP) on magnetically labeled cancer cells when subjected to oscillating gradients in a strong external magnetic field. Human breast cancer MDA-MB-231 cells were labeled with MNP, placed in the high magnetic field, and subjected to oscillating gradients generated by an imaging gradient system of a 9.4T preclinical MRI system. Changes in cell morphology and a decrease in cell viability were detected in cells treated with oscillating gradients. The cytotoxicity was determined qualitatively and quantitatively by microscopic imaging and cell viability assays. An approximately 26.6% reduction in cell viability was detected in magnetically labeled cells subjected to the combined effect of a static magnetic field and oscillating gradients. No reduction in cell viability was observed in unlabeled cells subjected to gradients, or in MNP-labeled cells in the static magnetic field. As no increase in local temperature was observed, the cell damage was not a result of hyperthermia. Currently, we consider the coherent motion of internalized and aggregated nanoparticles that produce mechanical moments as a potential mechanism of cell destruction. The formation and dynamics of the intracellular aggregates of nanoparticles were visualized by optical and transmission electron microscopy (TEM). The images revealed a rapid formation of elongated MNP aggregates in the cells, which were aligned with the external magnetic field. This strategy provides a new way to eradicate a specific population of MNP-labeled cells, potentially with magnetic resonance imaging guidance using standard MRI equipment, with minimal side effects for the host.	[Hapuarachchige, Sudath; Kato, Yoshinori; Ngen, Ethel J.; Artemov, Dmitri] Johns Hopkins Univ, Sch Med, Div Canc Imaging Res, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA; [Kato, Yoshinori; Artemov, Dmitri] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Smith, Barbara; Delannoy, Michael] Johns Hopkins Univ, Sch Med, Cell Biol Imaging Facil, Baltimore, MD 21205 USA; [Kato, Yoshinori] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Life Sci Tokyo Adv Res Ctr L StaR, Shinagawa Ku, Tokyo 142, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Hoshi University	Artemov, D (corresponding author), Johns Hopkins Univ, Sch Med, Div Canc Imaging Res, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21205 USA.; Artemov, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA.	dartemo2@jhmi.edu		Kato, Yoshinori/0000-0002-6218-8710; Ngen, Ethel/0000-0003-2668-5311; Hapuarachchige, Sudath/0000-0002-1166-8247	Susan G. Komen for the Cure [KG100594]; National Institutes of Health [CA154738]	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by research grants KG100594 from Susan G. Komen for the Cure and CA154738 from the National Institutes of Health.	Bigini P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032326; Bouchlaka MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048049; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Carrey J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4810972; Chen C-C, 2013, PLOS ONE, V8; Colombo M, 2012, CHEM SOC REV, V41, P4306, DOI 10.1039/c2cs15337h; Creixell M, 2011, ACS NANO, V5, P7124, DOI 10.1021/nn201822b; Domenech M, 2013, ACS NANO, V7, P5091, DOI 10.1021/nn4007048; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Henning TD, 2009, CONTRAST MEDIA MOL I, V4, P165, DOI 10.1002/cmmi.276; Ivkov R, 2005, CLIN CANCER RES, V11, p7093S, DOI 10.1158/1078-0432.CCR-1004-0016; Kim DH, 2010, NAT MATER, V9, P165, DOI [10.1038/NMAT2591, 10.1038/nmat2591]; Kraitchman DL, 2011, METHODS MOL BIOL, V680, P141, DOI 10.1007/978-1-60761-901-7_10; Kut C, 2012, NANOMEDICINE-UK, V7, P1697, DOI [10.2217/NNM.12.65, 10.2217/nnm.12.65]; Li L, 2012, J NANOSCI NANOTECHNO, V12, P9010, DOI 10.1166/jnn.2012.6755; Liu D, 2012, NANO LETT, V12, P5117, DOI 10.1021/nl301928z; LIU ZQ, 1991, APPL OPTICS, V30, P1369, DOI 10.1364/AO.30.001369; Mitsunaga M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-345; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; Ngen EJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13628; Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Penet MF, 2013, NMR BIOMED, V26, P745, DOI 10.1002/nbm.2980; REIMER P, 1995, RADIOLOGY, V195, P489, DOI 10.1148/radiology.195.2.7724772; Sanchez C, 2014, ACS NANO, V8, P1350, DOI 10.1021/nn404954s; Schafer R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-22; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Swierczewska M, 2012, CHEM SOC REV, V41, P2641, DOI 10.1039/c1cs15238f; Tseng P, 2012, NAT METHODS, V9, P1113, DOI [10.1038/NMETH.2210, 10.1038/nmeth.2210]; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P35, DOI 10.3978/j.issn.2223-4292.2011.08.03; Willenbrock S, 2012, IN VIVO, V26, P31; Woolley AJ, 2011, J NEUROSCI METH, V201, P67, DOI 10.1016/j.jneumeth.2011.07.012; Zhang EM, 2014, ACS NANO, V8, P3192, DOI 10.1021/nn406302j	34	20	20	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156294	10.1371/journal.pone.0156294	http://dx.doi.org/10.1371/journal.pone.0156294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244470	Green Submitted, Green Published, gold			2022-12-26	WOS:000377146100025
J	Kong, BW; Lassiter, K; Piekarski-Welsher, A; Dridi, S; Reverter-Gomez, A; Hudson, NJ; Bottje, WG				Kong, Byung-Whi; Lassiter, Kentu; Piekarski-Welsher, Alissa; Dridi, Sami; Reverter-Gomez, Antonio; Hudson, Nicholas James; Bottje, Walter Gay			Proteomics of Breast Muscle Tissue Associated with the Phenotypic Expression of Feed Efficiency within a Pedigree Male Broiler Line: I. Highlight on Mitochondria	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; ACTIVATED PROTEIN-KINASE; MESSENGER-RNA EXPRESSION; STIMULATED GLUCOSE-TRANSPORT; COMBINED TRENBOLONE ACETATE; GLOBAL GENE-EXPRESSION; GROWTH-FACTOR-I; SKELETAL-MUSCLE; THYROID-HORMONE; GLYCOGEN-SYNTHASE	As feed represents 60 to 70% of the cost of raising an animal to market weight, feed efficiency (the amount of dry weight intake to amount of wet weight gain) remains an important genetic trait in animal agriculture. To gain greater understanding of cellular mechanisms of feed efficiency (FE), shotgun proteomics was conducted using in-gel trypsin digestion and tandem mass spectrometry on breast muscle samples obtained from pedigree male (PedM) broilers exhibiting high feed efficiency (FE) or low FE phenotypes (n = 4 per group). The high FE group had greater body weight gain (P = 0.004) but consumed the same amount of feed (P = 0.30) from 6 to 7 wk resulting in higher FE (P < 0.001). Over 1800 proteins were identified, of which 152 were different (P < 0.05) by at least 1.3 fold and <= 15 fold between the high and low FE phenotypes. Data were analyzed for a modified differential expression (DE) metric (Phenotypic Impact Factors or PIF) and interpretation of protein expression data facilitated using the Ingenuity Pathway Analysis (IPA) program. In the entire data set, 228 mitochondrial proteins were identified whose collective expression indicates a higher mitochondrial expression in the high FE phenotype (binomial probability P < 0.00001). Within the top up and down 5% PIF molecules in the dataset, there were 15 mitoproteome proteins up-regulated and only 5 down-regulated in the high FE phenotype. Pathway enrichment analysis also identified mitochondrial dysfunction and oxidative phosphorylation as the number 1 and 5 differentially expressed canonical pathways (up-regulated in high FE) in the proteomic dataset. Upstream analysis (based on DE of downstream molecules) predicted that insulin receptor, insulin like growth receptor 1, nuclear factor, erythroid 2-like 2, AMP activated protein kinase (a subunit), progesterone and triiodothyronine would be activated in the high FE phenotype whereas rapamycin independent companion of target of rapamycin, mitogen activated protein kinase 4, and serum response factor would be inhibited in the high FE phenotype. The results provide additional insight into the fundamental molecular landscape of feed efficiency in breast muscle of broilers as well as further support for a role of mitochondria in the phenotypic expression of FE.	[Kong, Byung-Whi; Lassiter, Kentu; Piekarski-Welsher, Alissa; Dridi, Sami; Bottje, Walter Gay] Univ Arkansas, Dept Poultry Sci, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA; [Reverter-Gomez, Antonio; Hudson, Nicholas James] Queensland Biosci Precinct, CSIRO Livestock Ind, 306 Carmody Rd, St Lucia, Qld 4067, Australia	University of Arkansas System; University of Arkansas Fayetteville; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Bottje, WG (corresponding author), Univ Arkansas, Dept Poultry Sci, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA.	wbottje@uark.edu	Hudson, Nicholas J/D-1606-2011; Reverter, Antonio/C-9699-2013; Dridi, Sami/Q-8207-2019; Hudson, Nick/AAF-5644-2020	Hudson, Nicholas J/0000-0002-3549-9396; Reverter, Antonio/0000-0002-4681-9404; Hudson, Nick/0000-0002-3549-9396	USDA-NIFA [2013-01953]; Arkansas Biosciences Institute (Little Rock, AR); McMaster Fellowship (AUS); Agricultural Experiment Station (Univ. of Arkansas, Fayetteville)	USDA-NIFA(United States Department of Agriculture (USDA)); Arkansas Biosciences Institute (Little Rock, AR); McMaster Fellowship (AUS); Agricultural Experiment Station (Univ. of Arkansas, Fayetteville)	Funding provided by USDA-NIFA (#2013-01953), Arkansas Biosciences Institute (Little Rock, AR), McMaster Fellowship (AUS to WB) and the Agricultural Experiment Station (Univ. of Arkansas, Fayetteville).	Ackema KB, 2014, EMBO J, V33, P2659, DOI 10.15252/embj.201489039; Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Baumann CA, 2001, J BIOL CHEM, V276, P6065, DOI 10.1074/jbc.C000856200; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bottje W, 2013, J ANIM SCI, V91, P1582, DOI 10.2527/jas.2012-5787; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; Bottje WG, 2012, POULTRY SCI, V91, P2576, DOI 10.3382/ps.2012-02204; Bottje WG, 2009, J ANIM SCI, V87, pE48, DOI 10.2527/jas.2008-1379; Bottje W. G., 2014, BIOCH PHYSL, V3, P1, DOI DOI 10.1093/PS/81.4.546; BOXER LM, 1989, MOL CELL BIOL, V9, P515, DOI 10.1128/MCB.9.2.515; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen Y, 2011, ANIM GENET, V42, P475, DOI 10.1111/j.1365-2052.2011.02182.x; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Chien KY, 2012, J PROTEOME RES, V11, P5663, DOI 10.1021/pr300471y; Clement K, 2002, GENOME RES, V12, P281, DOI 10.1101/gr.207702; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Davis ME, 2012, FEED EFFICIENCY BEEF, P175; Duclos M J, 2005, J Physiol Pharmacol, V56 Suppl 3, P25; Dupont J, 2015, STURKIE'S AVIAN PHYSIOLOGY, 6TH EDITION, P613; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Enriquez JA, 1999, MOL CELL BIOL, V19, P657; Fan ZJ, 2012, VIRUS RES, V167, P314, DOI 10.1016/j.virusres.2012.05.016; Fawcett J, 2014, PROTEIN PEPTIDE LETT, V21, P584, DOI 10.2174/0929866521666140221151905; FUENTES EN, 2011, AM J PHYSIOL-REG I, V300, P1532, DOI DOI 10.1152/AJPREGU.00535.2010; Galban VD, 2001, MOL CELL BIOCHEM, V225, P35, DOI 10.1023/A:1012260605910; Galganska H, 2010, BBA-BIOENERGETICS, V1797, P1276, DOI 10.1016/j.bbabio.2010.02.004; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guntur KVP, 2010, J BIOL CHEM, V285, P6595, DOI 10.1074/jbc.M109.068502; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hag K, 2010, VET IMMUNOL IMMUNOP, V138, P292, DOI 10.1016/j.vetimm.2010.10.007; HALL JC, 1960, J BIOL CHEM, V235, P1536; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hu XM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-256; Hudson NJ, 2009, PLOS COMPUTATIONAL B, V5, DOI 10.1371/journal.pcbi.1000382; Iqbal M, 2004, POULTRY SCI, V83, P474, DOI 10.1093/ps/83.3.474; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jing L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11953; Johnson BJ, 1998, J ANIM SCI, V76, P491; Johnson BJ, 1996, J ANIM SCI, V74, P372; Kaweewong K, 2013, PROTEIN J, V32, P297, DOI 10.1007/s10930-013-9487-0; Khan AH, 2002, DIABETOLOGIA, V45, P1475, DOI 10.1007/s00125-002-0974-7; KIESSLING KH, 1977, COMP BIOCHEM PHYS B, V57, P287, DOI 10.1016/0305-0491(77)90055-4; Kim H, 2001, EXP CELL RES, V265, P339, DOI 10.1006/excr.2001.5207; Kim YB, 2005, MOL CELL BIOL, V25, P9713, DOI 10.1128/MCB.25.21.9713-9723.2005; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kong BW, 2011, POULTRY SCI, V90, P2535, DOI 10.3382/ps.2011-01435; Kono T, 2005, BRIT POULTRY SCI, V46, P510, DOI 10.1080/00071660500181289; Krebs HA, 1938, BIOCHEM J, V32, P913, DOI 10.1042/bj0320913; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Lee J, 2015, MOL GENET GENOMICS, V290, P1673, DOI 10.1007/s00438-015-1025-7; LEE TC, 1991, MOL CELL BIOL, V11, P5090, DOI 10.1128/MCB.11.10.5090; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Liu YJ, 2013, POULTRY SCI, V92, P1897, DOI 10.3382/ps.2012-02986; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Merforth S, 1999, MOL BIOL REP, V26, P83, DOI 10.1023/A:1006966005662; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; Mu PQ, 2013, PROTEOMICS, V13, P3175, DOI 10.1002/pmic.201300015; Nakai W, 2013, MOL BIOL CELL, V24, P2570, DOI 10.1091/mbc.E13-04-0197; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; Nisoli E, 2004, BIOCHEM PHARMACOL, V67, P1, DOI 10.1016/j.bcp.2003.10.015; Nixon R, 2012, NEW YORK TIMES BUSIN; Noh YH, 2009, J BIOL CHEM, V284, P8470, DOI 10.1074/jbc.M808981200; Ojano-Dirain C, 2005, POULTRY SCI, V84, P782, DOI 10.1093/ps/84.5.782; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Picard B, 2010, BRIEF FUNCT GENOMICS, V9, P259, DOI 10.1093/bfgp/elq005; Piekarski A, 2015, THESIS U ARKANSAS FA; Preston RL, 1999, ADV DRUG DELIVER REV, V38, P123, DOI 10.1016/S0169-409X(99)00012-5; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; Psarra AMG, 2008, IUBMB LIFE, V60, P210, DOI 10.1002/iub.37; QUEST AFG, 1990, FEBS LETT, V262, P299, DOI 10.1016/0014-5793(90)80214-4; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Rabouille C, 2014, EMBO J, V33, P2604, DOI 10.15252/embj.201489899; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Sen B, 2014, J BONE MINER RES, V29, P78, DOI 10.1002/jbmr.2031; Sharifabadi HR, 2012, J ANIM SCI, V90, P1807, DOI 10.2527/jas.2011-4791; Shorr E, 1939, BIOCHEM J, V33, P1798, DOI 10.1042/bj0331798; SIMMONS J, 2010, TECHNOLOGYS ROLE 21; SMITH OLK, 1989, DIABETES, V38, P1117, DOI 10.2337/diabetes.38.9.1117; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sokale A, 2011, PROTEOMICS, V11, P4262, DOI 10.1002/pmic.201000795; Stipanuk MH, 2004, ANNU REV NUTR, V24, P539, DOI 10.1146/annurev.nutr.24.012003.132418; Sun CJ, 2013, PROTEOMICS, V13, P3523, DOI 10.1002/pmic.201300286; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; THOMPSON SH, 1989, ENDOCRINOLOGY, V124, P2110, DOI 10.1210/endo-124-5-2110; Tokushima Y, 2005, COMP BIOCHEM PHYS B, V141, P43, DOI 10.1016/j.cbpc.2005.01.008; Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108; Vincent A, 2015, J ANIM SCI, V93, P2745, DOI 10.2527/jas.2015-8928; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wang MX, 2013, MOL CELL BIOL, V33, P678, DOI 10.1128/MCB.00618-12; Watabe S, 1997, EUR J BIOCHEM, V249, P52, DOI 10.1111/j.1432-1033.1997.t01-1-00052.x; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Wonsey DR, 2002, P NATL ACAD SCI USA, V99, P6649, DOI 10.1073/pnas.102523299; Wu YP, 2012, PROTEOMICS, V12, P1844, DOI 10.1002/pmic.201100479; Zanetti E, 2011, PROTEOMICS, V11, P2613, DOI 10.1002/pmic.201000639; Zhao JP, 2012, J ANIM SCI, V90, P4337, DOI 10.2527/jas.2012-5100; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	110	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155679	10.1371/journal.pone.0155679	http://dx.doi.org/10.1371/journal.pone.0155679			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244447	gold, Green Published, Green Submitted			2022-12-26	WOS:000377146100005
J	Zhu, YJ; Wang, GJ; Li, RQ				Zhu, Yajuan; Wang, Guojie; Li, Renqiang			Seasonal Dynamics of Water Use Strategy of Two Salix Shrubs in Alpine Sandy Land, Tibetan Plateau	PLOS ONE			English	Article							SYLVESTRIS VAR. MONGOLICA; STABLE-ISOTOPES; DESERT PLANTS; PRECIPITATION; GRASSLAND; REGION; PULSE; AREA	Water is a limiting factor for plant growth and vegetation dynamics in alpine sandy land of the Tibetan Plateau, especially with the increasing frequency of extreme precipitation events and drought caused by climate change. Therefore, a relatively stable water source from either deeper soil profiles or ground water is necessary for plant growth. Understanding the water use strategy of dominant species in the alpine sandy land ecosystem is important for vegetative rehabilitation and ecological restoration. The stable isotope methodology of delta D, delta O-18, and delta C-13 was used to determine main water source and long-term water use efficiency of Salix psammophila and S. cheilophila, two dominant shrubs on interdune of alpine sandy land in northeastern Tibetan Plateau. The root systems of two Salix shrubs were investigated to determine their distribution pattern. The results showed that S. psammophila and S. cheilophila absorbed soil water at different soil depths or ground water in different seasons, depending on water availability and water use strategy. Salix psammophila used ground water during the growing season and relied on shallow soil water recharged by rain in summer. Salix cheilophila used ground water in spring and summer, but relied on shallow soil water recharged by rain in spring and deep soil water recharged by ground water in fall. The two shrubs had dimorphic root systems, which is coincident with their water use strategy. Higher biomass of fine roots in S. psammophila and longer fine roots in S. cheilophila facilitated to absorb water in deeper soil layers. The long-term water use efficiency of two Salix shrubs increased during the dry season in spring. The long-term water use efficiency was higher in S. psammophila than in S. cheilophila, as the former species is better adapted to semiarid climate of alpine sandy land.	[Zhu, Yajuan] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China; [Zhu, Yajuan] Nanjing Univ Informat Sci & Technol, Sch Environm Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Wang, Guojie] Oregon State Univ, Eastern Oregon Univ, Agr Program, La Grande, OR USA; [Li, Renqiang] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China	Chinese Academy of Forestry; Institute of Desertification Studies, CAF; Nanjing University of Information Science & Technology; Eastern Oregon University; Oregon State University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Zhu, YJ (corresponding author), Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China.; Zhu, YJ (corresponding author), Nanjing Univ Informat Sci & Technol, Sch Environm Sci & Engn, Nanjing, Jiangsu, Peoples R China.; Li, RQ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	zhuyajuan80@gmail.com; renqiangli@igsnrr.ac.cn			Natural Science Foundation of China [41301095]; Fundamental Research Funds for the Central Non-profit Research Institute of Chinese Academy of Forestry [CAFYBB2014QB023]; Project on Promoting New Rural Construction with Science and Technology in Qinghai Province [2013-N-556]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Non-profit Research Institute of Chinese Academy of Forestry; Project on Promoting New Rural Construction with Science and Technology in Qinghai Province	This study was provided by the Natural Science Foundation of China (No. 41301095, YZ) (http://www.nsfc.gov.cn/), the Fundamental Research Funds for the Central Non-profit Research Institute of Chinese Academy of Forestry (No. CAFYBB2014QB023, YZ) (http://www.caf.ac.cn/), and Project on Promoting New Rural Construction with Science and Technology in Qinghai Province (2013-N-556) (http://www.qhlyt.gov.cn).	Cheng XR, 2009, PLANT SOIL, V315, P149, DOI 10.1007/s11104-008-9739-5; Cheng XL, 2006, PLANT ECOL, V184, P1, DOI 10.1007/s11258-005-9047-6; Chimner RA, 2004, PLANT SOIL, V260, P225, DOI 10.1023/B:PLSO.0000030190.70085.e9; Cui YQ, 2015, J ARID LAND, V7, P73, DOI 10.1007/s40333-014-0037-1; Dai Y, 2015, PLANT SOIL, V389, P73, DOI 10.1007/s11104-014-2342-z; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Ehleringer J. R., 1993, Stable isotopes and plant carbon-water relations., P155; Farquhar G.D., 1989, STABLE ISOTOPES ECOL, V68, P21, DOI [10.1007/978-1-4612-3498-2_2, DOI 10.1007/978-1-4612-3498-2_2]; Feng YM, 2011, INT J SUST DEV WORLD, V18, P357, DOI 10.1080/13504509.2011.562004; [巩国丽 Gong Guoli], 2011, [生态学报, Acta Ecologica Sinica], V31, P7533; Harris RB, 2010, J ARID ENVIRON, V74, P1, DOI 10.1016/j.jaridenv.2009.06.014; Hou YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070114; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jia ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045902; Kowaljow E, 2011, J ARID ENVIRON, V75, P211, DOI 10.1016/j.jaridenv.2010.10.004; Kray JA, 2012, J ARID ENVIRON, V83, P25, DOI 10.1016/j.jaridenv.2012.03.009; Li SG, 2007, J HYDROL, V333, P109, DOI 10.1016/j.jhydrol.2006.07.020; Lin G.H., 2013, STABLE ISOTOPE ECOLO; Liu SB, 2015, ECOL RES, V30, P581, DOI 10.1007/s11284-015-1270-6; Liu SW, 1997, FLORA QINGHAIICA, V1, P117; Ma YQ, 1985, FLORA INTRAMONGOLICA, V1, P53; McCole AA, 2007, J HYDROL, V342, P238, DOI 10.1016/j.jhydrol.2007.05.024; Ogle K, 2004, OECOLOGIA, V141, P282, DOI 10.1007/s00442-004-1507-5; Ohte N, 2003, ECOL APPL, V13, P337, DOI 10.1890/1051-0761(2003)013[0337:WUONAP]2.0.CO;2; Pataki DE, 2005, ECOL APPL, V15, P1009, DOI 10.1890/04-1272; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Schwinning S, 2003, OECOLOGIA, V136, P252, DOI 10.1007/s00442-003-1255-y; Song LN, 2014, TREES-STRUCT FUNCT, V28, P971, DOI 10.1007/s00468-014-1010-5; Su H, 2014, TREES-STRUCT FUNCT, V28, P41, DOI 10.1007/s00468-013-0928-3; Wei YF, 2013, TREES-STRUCT FUNCT, V27, P1249, DOI 10.1007/s00468-013-0873-1; West AG, 2007, OECOLOGIA, V153, P787, DOI 10.1007/s00442-007-0777-0; Xia JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032088; [邢星 Xing Xing], 2014, [生态学报, Acta Ecologica Sinica], V34, P6277; Xu GQ, 2011, ECOL RES, V26, P1071, DOI 10.1007/s11284-011-0858-8; Yang H, 2011, PLANT SOIL, V340, P303, DOI 10.1007/s11104-010-0307-4; Zeng FJ, 2013, ARID LAND RES MANAG, V27, P298, DOI 10.1080/15324982.2012.748709; Zhang D.S., 2009, LAND DESERTIFICATION; Zhu Y, 2014, J DES RES, V34, P814; Zhu Y.J., 2011, ACTA ECOL SIN, V31, P341, DOI [10.1016/j.chnaes.2011.09.004, DOI 10.1016/J.CHNAES.2011.09.004]; Zhu YJ, 2011, J FOOD AGRIC ENVIRON, V9, P832; Zhu YaJuan, 2010, Scientia Silvae Sinicae, V46, P15	41	6	10	13	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156586	10.1371/journal.pone.0156586	http://dx.doi.org/10.1371/journal.pone.0156586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243772	Green Published, gold, Green Submitted			2022-12-26	WOS:000377146100050
J	Onozato, M; Nishigaki, A; Okoshi, K				Onozato, Mayu; Nishigaki, Atsuko; Okoshi, Kenji			Polycyclic Aromatic Hydrocarbons in Sediments and Bivalves on the Pacific Coast of Japan: Influence of Tsunami and Fire	PLOS ONE			English	Article							RUDITAPES-PHILIPPINARUM; HEAVY-METALS; PAH RATIOS; HONG-KONG; BIOACCUMULATION; BIOAVAILABILITY; DISTRIBUTIONS; EARTHQUAKE; OYSTERS; MARINE	Surface sediments and at least one edible bivalve species (Ruditapes philippinarum, Mytilus galloprovincialis, and Crassostrea gigas) were collected from each of seven intertidal sites in Japan in 2013. The sites had experienced varying levels of tsunami and fire disturbance following the major earthquake of 2011. Eight polycyclic aromatic hydrocarbons (PAHs) were identified and analyzed by gas chromatography-mass spectrometry. Total sediment PAH concentration (C-T), the sum of the average concentrations of the eight PAHs, was 21-1447 mu g kg(-1)-dry. Relative to the average level of one type of PAH in sediments collected around Japan in 2002 (benzo[a] pyrene = 21 mu g kg(-1)-dry), five of the seven sites showed concentrations significantly lower than this average in 2013. The C-Ts for the three bivalves (134-450 mu g kg(-1)-dry) were within the range of the previous reports (2.2-5335 mu g kg(-1)-dry). The data suggest that the natural disaster did not increase PAH concentrations or affect the distribution within sediment or bivalves in Tohoku district. Although PAH concentrations at the sites pose no risk to human health, the findings highlight that the observed PAH levels derive from pre-rather than post-quake processes.	[Onozato, Mayu; Nishigaki, Atsuko; Okoshi, Kenji] Toho Univ, Fac Sci, Dept Environm Sci, Funabashi, Chiba 274, Japan; [Onozato, Mayu] Toho Univ, Fac Pharmaceut Sci, Dept Analyt Chem, 2-2-1 Miyama, Funabashi, Chiba 274, Japan	Toho University; Toho University	Onozato, M (corresponding author), Toho Univ, Fac Sci, Dept Environm Sci, Funabashi, Chiba 274, Japan.; Onozato, M (corresponding author), Toho Univ, Fac Pharmaceut Sci, Dept Analyt Chem, 2-2-1 Miyama, Funabashi, Chiba 274, Japan.	mayu.onozato@phar.toho-u.ac.jp						Barreira LA, 2007, J ENVIRON MONITOR, V9, P187, DOI 10.1039/b614919g; Baumard P, 1998, ESTUAR COAST SHELF S, V47, P77, DOI 10.1006/ecss.1998.0337; BLUMER M, 1976, SCI AM, V234, P35; BOEHM PD, 1977, MAR BIOL, V44, P227, DOI 10.1007/BF00387704; Clemons JH, 1998, ENVIRON SCI TECHNOL, V32, P1853, DOI 10.1021/es971124n; Fang JKH, 2009, MAR POLLUT BULL, V58, P615, DOI 10.1016/j.marpolbul.2008.12.016; FREEMAN DJ, 1990, ENVIRON SCI TECHNOL, V24, P1581, DOI 10.1021/es00080a019; Hirai Y, 2013, 22 S ENV CHEM PROGR, P452; Hokugo A, 2013, PROCEDIA ENGINEER, V62, P140, DOI 10.1016/j.proeng.2013.08.051; IRWIN RJ, 1997, ENV CONTAMINANTS ENC; Jaffe R, 1998, MAR POLLUT BULL, V36, P925, DOI 10.1016/S0025-326X(98)00090-3; Japan Weather Association, 2011, SUMM 2011 PAC COAS 3; Kanaya G., 2014, GLOB ENVIRON RES, V18, P35; Kanaya G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135125; Kasai A, 2004, FISHERIES SCI, V70, P11, DOI 10.1111/j.1444-2906.2003.00764.x; Kumar KS, 2008, MAR POLLUT BULL, V56, P136, DOI 10.1016/j.marpolbul.2007.08.011; Landrum PF, 2003, CHEMOSPHERE, V51, P481, DOI 10.1016/S0045-6535(02)00863-9; Li GC, 2006, ENVIRON POLLUT, V144, P985, DOI 10.1016/j.envpol.2006.01.047; Lim LH, 1999, ENVIRON SCI TECHNOL, V33, P3538, DOI 10.1021/es990392d; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; Ma HQ, 2009, CHIN J OCEANOL LIMN, V27, P887, DOI 10.1007/s00343-009-9223-y; Ministry of the Environment Government of Japan, 2003, REP ENV SURV MON CHE; Moschino V, 2012, ENVIRON POLLUT, V171, P52, DOI 10.1016/j.envpol.2012.07.024; Moschino V, 2011, ENVIRON MONIT ASSESS, V177, P649, DOI 10.1007/s10661-010-1663-5; Neff J.M., 1980, POLYCYCL AROMAT COMP, V18; Norena-Barroso E, 1999, MAR POLLUT BULL, V38, P637, DOI 10.1016/S0025-326X(98)00165-9; Okoshi K, 2013, J JPN SOC WATER ENV, V36, P44; Okoshi K., 2015, MARINE PRODUCTIVITY, P55; Okoshi K, 2012, JPN J BENTHOLOGY, V66, P117; Onozato M, 2013, BUNSEKI KAGAKU, V62, P25, DOI 10.2116/bunsekikagaku.62.25; Onozato M, 2008, POLYCYCL AROMAT COMP, V28, P462, DOI 10.1080/10406630802414600; Tanaka H., 2010, J ENV CHEM, V20, P137, DOI [10.5985/jec.20.137, DOI 10.5985/JEC.20.137]; Tanaka T, 2012, FIRE SAFETY J, V54, P197, DOI 10.1016/j.firesaf.2012.07.002; The 2011 Tohoku Earthquake Tsunami Joint Survey (TTJS) Group, 2011 PAC COAST TOH E; Thompson RE, 2000, ECOL MODEL, V135, P231, DOI 10.1016/S0304-3800(00)00367-7; Thorsen WA, 2004, ENVIRON SCI TECHNOL, V38, P2029, DOI 10.1021/es0306056; *US EPA, INT RISK INF SYST IR; Yoshimine RV, 2012, J BRAZIL CHEM SOC, V23, P1429, DOI 10.1590/S0103-50532012005000003; Yoshino H, 1996, J JPN SOC ATMOS ENV, V31, P61; Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5; Zhang HB, 2006, ENVIRON POLLUT, V141, P107, DOI 10.1016/j.envpol.2005.08.031	41	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156447	10.1371/journal.pone.0156447	http://dx.doi.org/10.1371/journal.pone.0156447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232189	Green Submitted, Green Published, gold			2022-12-26	WOS:000376883000037
J	Trairatphisan, P; Wiesinger, M; Bahlawane, C; Haan, S; Sauter, T				Trairatphisan, Panuwat; Wiesinger, Monique; Bahlawane, Christelle; Haan, Serge; Sauter, Thomas			A Probabilistic Boolean Network Approach for the Analysis of Cancer-Specific Signalling: A Case Study of Deregulated PDGF Signalling in GIST	PLOS ONE			English	Article							PROTEIN-KINASE INHIBITORS; GENE REGULATORY NETWORKS; NEGATIVE FEEDBACK; BAYESIAN NETWORKS; SYSTEMS BIOLOGY; CELL; PATHWAYS; RECEPTOR; ACTIVATION; MODELS	Background Signal transduction networks are increasingly studied with mathematical modelling approaches while each of them is suited for a particular problem. For the contextualisation and analysis of signalling networks with steady-state protein data, we identified probabilistic Boolean network (PBN) as a promising framework which could capture quantitative changes of molecular changes at steady-state with a minimal parameterisation. Results and Conclusion In our case study, we successfully applied the PBN approach to model and analyse the deregulated Platelet-Derived Growth Factor (PDGF) signalling pathway in Gastrointestinal Stromal Tumour (GIST). We experimentally determined a rich and accurate dataset of steady-state profiles of selected downstream kinases of PDGF-receptor-alpha mutants in combination with inhibitor treatments. Applying the tool optPBN, we fitted a literature-derived candidate network model to the training dataset consisting of single perturbation conditions. Model analysis suggested several important crosstalk interactions. The validity of these predictions was further investigated experimentally pointing to relevant ongoing crosstalk from PI3K to MAPK signalling in tumour cells. The refined model was evaluated with a validation dataset comprising multiple perturbation conditions. The model thereby showed excellent performance allowing to quantitatively predict the combinatorial responses from the individual treatment results in this cancer setting. The established optPBN pipeline is also widely applicable to gain a better understanding of other signalling networks at steady-state in a context-specific fashion.	[Trairatphisan, Panuwat; Wiesinger, Monique; Sauter, Thomas] Univ Luxembourg, Life Sci Res Unit, Syst Biol Grp, Luxembourg, Luxembourg; [Bahlawane, Christelle; Haan, Serge] Univ Luxembourg, Life Sci Res Unit, Mol Dis Mech Grp, Luxembourg, Luxembourg	University of Luxembourg; University of Luxembourg	Sauter, T (corresponding author), Univ Luxembourg, Life Sci Res Unit, Syst Biol Grp, Luxembourg, Luxembourg.	thomas.sauter@uni.lu	Bahlawane, Christelle/AAB-7943-2020; Christelle, Bahlawane/A-8758-2013	Trairatphisan, Panuwat/0000-0001-9015-5855; Sauter, Thomas/0000-0001-8225-2954; Bahlawane, Christelle/0000-0003-2728-2397	University of Luxembourg [F1R-LSC-PUL-09PDGF, F1R-LSC-PUL-11PDGF]; Fonds National de la Recherche Luxembourg (AFR) [1233900]	University of Luxembourg; Fonds National de la Recherche Luxembourg (AFR)(Luxembourg National Research Fund)	This work was supported by the grants F1R-LSC-PUL-09PDGF and F1R-LSC-PUL-11PDGF of the University of Luxembourg. Panuwat Trairatphisan is a recipient of fellowships allocated by the Fonds National de la Recherche Luxembourg (AFR grant number 1233900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Aldridge BB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000340; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bachmann J, 2012, J INTERN MED, V271, P155, DOI 10.1111/j.1365-2796.2011.02492.x; Bahlawane C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0096-8; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bazenet CE, 1996, MOL CELL BIOL, V16, P6926; Bradshaw R, 2009, HDB CELL SIGNALLING; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Grammer TC, 1997, ONCOGENE, V14, P1635, DOI 10.1038/sj.onc.1201000; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heldin CH, 2014, J NEUROIMMUNE PHARM, V9, P69, DOI 10.1007/s11481-013-9484-2; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Hill SM, 2012, BIOINFORMATICS, V28, P2804, DOI 10.1093/bioinformatics/bts514; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; ISHIZUKA T, 1995, DIABETES RES CLIN PR, V29, P143, DOI 10.1016/0168-8227(95)01111-0; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Konrath F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003528; Lahdesmaki H, 2006, SIGNAL PROCESS, V86, P814, DOI 10.1016/j.sigpro.2005.06.008; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lee HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10305; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lommel MJ, 2016, FASEB J, V30, P1218, DOI 10.1096/fj.15-276311; Lynch DK, 2002, EMBO J, V21, P72, DOI 10.1093/emboj/21.1.72; Markevich N. I., 2004, Systems Biology, V1, P104, DOI 10.1049/sb:20045003; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466; MIRANDA EN, 1989, EUROPHYS LETT, V10, P293, DOI 10.1209/0295-5075/10/4/002; Mizera A, 2016, TECHNICAL REPORT; Park HS, 2012, EXPERT SYST APPL, V39, P4240, DOI 10.1016/j.eswa.2011.09.110; Qixia Yuan, 2012, Transactions on Computational Systems Biology XIV. Special Issue on Computational Models for Cell Processes, P151, DOI 10.1007/978-3-642-35524-0_7; Rammohan A, 2013, WORLD J GASTRO ONCOL, V5, P102, DOI 10.4251/wjgo.v5.i6.102; Rangamani P, 2007, J BIOSCIENCES, V32, P157, DOI 10.1007/s12038-007-0014-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Sakhanenko NA, 2012, J COMPUT BIOL, V19, P316, DOI 10.1089/cmb.2011.0234; Sakhanenko NA, 2010, J COMPUT BIOL, V17, P1491, DOI 10.1089/cmb.2010.0044; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Tan Christopher B, 2012, ISRN Gastroenterol, V2012, P595968, DOI 10.5402/2012/595968; Trairatphisan P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098001; Trairatphisan P, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-46; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Wang Zhixiang, 2002, Mol Interv, V2, P352, DOI 10.1124/mi.2.6.352; YU JC, 1994, J CELL BIOL, V127, P479, DOI 10.1083/jcb.127.2.479; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	52	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156223	10.1371/journal.pone.0156223	http://dx.doi.org/10.1371/journal.pone.0156223			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232499	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000015
J	Renault, AL; Lesueur, F; Coulombe, Y; Gobeil, S; Soucy, P; Hamdi, Y; Desjardins, S; Le Calvez-Kelm, F; Vallee, M; Voegele, C; Hopper, JL; Andrulis, IL; Southey, MC; John, EM; Masson, JY; Tavtigian, SV; Simard, J				Renault, Anne-Laure; Lesueur, Fabienne; Coulombe, Yan; Gobeil, Stephane; Soucy, Penny; Hamdi, Yosr; Desjardins, Sylvie; Le Calvez-Kelm, Florence; Vallee, Maxime; Voegele, Catherine; Hopper, John L.; Andrulis, Irene L.; Southey, Melissa C.; John, Esther M.; Masson, Jean-Yves; Tavtigian, Sean V.; Simard, Jacques		Breast Canc Family Registry	ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MISSENSE SUBSTITUTIONS; GERMLINE MUTATIONS; BRCA1; PROTEIN; RARE; COMPLEX; CCDC98; SITE; CONTRIBUTE	Approximately half of the familial aggregation of breast cancer remains unexplained. This proportion is less for early-onset disease where familial aggregation is greater, suggesting that other susceptibility genes remain to be discovered. The majority of known breast cancer susceptibility genes are involved in the DNA double-strand break repair pathway. ABRAXAS is involved in this pathway and mutations in this gene impair BRCA1 recruitment to DNA damage foci and increase cell sensitivity to ionizing radiation. Moreover, a recurrent germline mutation was reported in Finnish high-risk breast cancer families. To determine if ABRAXAS could be a breast cancer susceptibility gene in other populations, we conducted a population-based case-control mutation screening study of the coding exons and exon/intron boundaries of ABRAXAS in the Breast Cancer Family Registry. In addition to the common variant p.Asp373Asn, sixteen distinct rare variants were identified. Although no significant difference in allele frequencies between cases and controls was observed for the identified variants, two variants, p.Gly39Val and p.Thr141Ile, were shown to diminish phosphorylation of gamma-H2AX in MCF7 human breast adenocarcinoma cells, an important biomarker of DNA double-strand breaks. Overall, likely damaging or neutral variants were evenly represented among cases and controls suggesting that rare variants in ABRAXAS may explain only a small proportion of hereditary breast cancer.	[Renault, Anne-Laure; Gobeil, Stephane; Soucy, Penny; Hamdi, Yosr; Desjardins, Sylvie; Vallee, Maxime; Simard, Jacques] Ctr Hosp Univ Quebec, Genom Ctr, Quebec City, PQ, Canada; [Renault, Anne-Laure; Gobeil, Stephane; Soucy, Penny; Hamdi, Yosr; Desjardins, Sylvie; Vallee, Maxime; Simard, Jacques] Univ Laval, Quebec City, PQ, Canada; [Lesueur, Fabienne] INSERM, U900, Mines ParisTech, Inst Curie, Paris, France; [Coulombe, Yan; Masson, Jean-Yves] Ctr Hosp Univ Quebec Res Ctr, Oncol Axis, Genome Stabil Lab, HDQ Pavillon, Quebec City, PQ, Canada; [Le Calvez-Kelm, Florence; Vallee, Maxime; Voegele, Catherine] Int Agcy Res Canc, Genet Canc Susceptibil Grp, 150 Cours Albert Thomas, F-69372 Lyon, France; [Hopper, John L.] Univ Melbourne, Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic 3010, Australia; [Andrulis, Irene L.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Southey, Melissa C.] Univ Melbourne, Genet Epidemiol Lab, Melbourne, Vic 3010, Australia; [John, Esther M.] Stanford Univ, Sch Med, Fremont, MA USA; [John, Esther M.] Stanford Canc Inst, Fremont, MA USA; [John, Esther M.; Breast Canc Family Registry] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada; [Masson, Jean-Yves] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA; [Tavtigian, Sean V.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA	Laval University; Laval University; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Laval University; World Health Organization; International Agency for Research on Cancer (IARC); University of Melbourne; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Melbourne; Stanford Cancer Institute; Laval University; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Simard, J (corresponding author), Ctr Hosp Univ Quebec, Genom Ctr, Quebec City, PQ, Canada.; Simard, J (corresponding author), Univ Laval, Quebec City, PQ, Canada.	Jacques.Simard@crchudequebec.ulaval.ca	Andrulis, Irene L./E-7267-2013; Lesueur, Fabienne/R-2178-2017	Lesueur, Fabienne/0000-0001-7404-4549; Renault, Anne-Laure/0000-0001-6321-3458; Vallee, Maxime/0000-0002-3616-9508; Hamdi, Yosr/0000-0002-2815-1834; Le Calvez-Kelm, Florence/0000-0003-0063-5068; Masson, Jean Yves/0000-0002-4403-7169; Southey, Melissa/0000-0002-6313-9005; Durocher, Francine/0000-0001-8012-4641; Simard, Jacques/0000-0001-6906-3390	Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program [CRN-87521]; Ministry of Economic Development, Innovation and Export Trade [PSR-SIIRI-701]; Government of Canada through Genome Canada; Canadian Institutes of Health Research [GPH-129344]; Ministere de l'Economia, de la Science et de l'Innovation du Quebec through Genome Quebec; Quebec Breast Cancer Foundation for the PERSPECTIVE project; National Cancer Institute (NCI); National Institute of Health (NIH) [R01 CA121245]; National Cancer Institute [UM1 CA164920]	Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Export Trade; Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministere de l'Economia, de la Science et de l'Innovation du Quebec through Genome Quebec; Quebec Breast Cancer Foundation for the PERSPECTIVE project; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program - grant # CRN-87521, the Ministry of Economic Development, Innovation and Export Trade - grant # PSR-SIIRI-701 and by the Government of Canada through Genome Canada and the Canadian Institutes of Health Research (GPH-129344), the Ministere de l'Economia, de la Science et de l'Innovation du Quebec through Genome Quebec, the Quebec Breast Cancer Foundation for the PERSPECTIVE project, the National Cancer Institute (NCI) and the National Institute of Health (NIH) grant R01 CA121245. This work was also supported by grant UM1 CA164920 from the National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the BCFR. J.S. is Chairholder of the Canada Research Chair in Oncogenetics. J-Y.M. is a FQRS chercheur national investigator and was supported by a Canadian Institutes of Health Research operating grant. I.L.A is the Anne and Max Tanenbaum Chair in Molecular Medicine at the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; BORRESEN AL, 1992, CANCER RES, V52, P3234; Castillo A, 2014, CELL REP, V8, P807, DOI 10.1016/j.celrep.2014.06.050; Coleman KA, 2011, J BIOL CHEM, V286, P13669, DOI 10.1074/jbc.M110.213728; Couch FJ, 1996, NAT GENET, V13, P123, DOI 10.1038/ng0596-123; Damiola F, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3669; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dever SM, 2011, AGING-US, V3, P515, DOI 10.18632/aging.100325; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Feunteun J, 1996, BBA-REV CANCER, V1242, P177, DOI 10.1016/0304-419X(95)00016-9; Foulkes WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMra0802968; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Greenberg RA, 2008, CHROMOSOMA, V117, P305, DOI 10.1007/s00412-008-0154-8; Harris JL, 2011, AGING-US, V3, P461, DOI 10.18632/aging.100334; Hu X, 2011, J BIOL CHEM, V286, P11734, DOI 10.1074/jbc.M110.200857; Hu YD, 2011, GENE DEV, V25, P685, DOI 10.1101/gad.2011011; John EM, 2004, BREAST CANCER RES, V6, pR375, DOI 10.1186/bcr801; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Le Calvez-Kelm F, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2810; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Meijers-Heijboer H, 2003, AM J HUM GENET, V72, P1308, DOI 10.1086/375121; Mok MTS, 2012, TRAFFIC, V13, P800, DOI 10.1111/j.1600-0854.2012.01355.x; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Novak DJ, 2009, BREAST CANCER RES TR, V117, P453, DOI 10.1007/s10549-008-0134-y; Osorio A, 2009, BREAST CANCER RES TR, V113, P371, DOI 10.1007/s10549-008-9933-4; Park DJ, 2012, AM J HUM GENET, V90, P734, DOI 10.1016/j.ajhg.2012.02.027; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Pertea M, 2001, NUCLEIC ACIDS RES, V29, P1185, DOI 10.1093/nar/29.5.1185; Pinheiro J, 2020, R PACKAGE VERSION 31; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Solyom S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003223; Tavtigian SV, 2008, HUM MUTAT, V29, P1327, DOI 10.1002/humu.20892; Tavtigian SV, 2009, AM J HUM GENET, V85, P427, DOI 10.1016/j.ajhg.2009.08.018; Tischkowitz M, 2012, HUM MUTAT, V33, P674, DOI 10.1002/humu.22022; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Werner Thomas, 2002, In Silico Biology, V2, P249; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	46	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156820	10.1371/journal.pone.0156820	http://dx.doi.org/10.1371/journal.pone.0156820			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270457	gold, Green Published			2022-12-26	WOS:000377561000040
J	Garbers, C; Wachtler, T				Garbers, Christian; Wachtler, Thomas			Wavelength Discrimination in Drosophila Suggests a Role of Rhodopsin 1 in Color Vision	PLOS ONE			English	Article							R8 PHOTORECEPTOR CELLS; PSYCHOMETRIC FUNCTION; RECEPTOR NOISE; MELANOGASTER; EXPRESSION; HONEYBEE; R7; SENSITIVITY; THRESHOLDS; BEHAVIOR	Among the five photoreceptor opsins in the eye of Drosophila, Rhodopsin 1 (Rh1) is expressed in the six outer photoreceptors. In a previous study that combined behavioral genetics with computational modeling, we demonstrated that flies can use the signals from Rh1 for color vision. Here, we provide an in-depth computational analysis of wildtype Drosophila wavelength discrimination specifically considering the consequences of different choices of computations in the preprocessing of the behavioral data. The results support the conclusion that Drosophila wavelength discrimination behavior can best be explained by a contribution of Rh1. These findings are corroborated by results of an information-theoretical analysis that shows that Rh1 provides information for discrimination of natural reflectance spectra.	[Wachtler, Thomas] Ludwig Maximilians Univ Munchen, Dept Biol 2, Planegg Martinsried, Germany; Bernstein Ctr Computat Neurosci Munich, Munich, Germany	University of Munich	Wachtler, T (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 2, Planegg Martinsried, Germany.	wachtler@biologie.uni-muenchen.de	Wachtler, Thomas/K-3714-2014	Wachtler, Thomas/0000-0003-2015-6590	Bundesministerium fur Bildung und Forschung [01GQ1004A]; Bernstein Center Munich (BMBF grant) [01GQ1004A]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Bernstein Center Munich (BMBF grant)	This work was supported by Bundesministerium fur Bildung und Forschung grant 01GQ1004A (https://www.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Hiromu Tanimoto and Christopher Schnaitmann for fruitful discussions, as well as Franziska Hellmundt and Christian Kellner for their valuable comments on the manuscript. This works was supported by Bernstein Center Munich (BMBF grant 01GQ1004A).	Arnold SEJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014287; BACKHAUS W, 1987, BIOL CYBERN, V55, P321, DOI 10.1007/BF02281978; BARLOW HB, 1982, VISION RES, V22, P635, DOI 10.1016/0042-6989(82)90099-2; Brandt R, 1997, VISION RES, V37, P425, DOI 10.1016/S0042-6989(96)00195-2; Busse L, 2011, J NEUROSCI, V31, P11351, DOI 10.1523/JNEUROSCI.6689-10.2011; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; DESALOMON CH, 1983, J COMP PHYSIOL, V150, P31, DOI 10.1007/BF00605285; DEVALOIS RL, 1974, VISION RES, V14, P69, DOI 10.1016/0042-6989(74)90117-5; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FORTINI ME, 1991, CELL TISSUE RES, V265, P185, DOI 10.1007/BF00318153; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; Garbers C, 2015, J VISION, V15, DOI 10.1167/15.1.13; HARDIE RC, 1983, BIOPHYS STRUCT MECH, V9, P171, DOI 10.1007/BF00537814; Hardie RC, 1985, FUNCTIONAL ORG FLY R; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Huber A, 1997, FEBS LETT, V406, P6, DOI 10.1016/S0014-5793(97)00210-X; Jones E., 2001, SCIPY OPEN SOURCE SC; Kelber A, 2001, ENTOMOL EXP APPL, V99, P231, DOI 10.1023/A:1019244619503; Kelber A, 2013, CURR BIOL, V23, pR1043, DOI 10.1016/j.cub.2013.10.025; KIRSCHFE.K, 1968, KYBERNETIK, V5, P47, DOI 10.1007/BF00272694; KIRSCHFELD K, 1983, BIOPHYS STRUCT MECH, V10, P81, DOI 10.1007/BF00535544; Klockner A, 2012, PARALLEL COMPUT, V38, P157, DOI 10.1016/j.parco.2011.09.001; Koshitaka H, 2008, P ROY SOC B-BIOL SCI, V275, P947, DOI 10.1098/rspb.2007.1614; Kotel'nikov VA, 2006, PHYS-USP+, V49, P736, DOI 10.1070/PU2006v049n07ABEH006160; Lewis A, 2006, J VISION, V6, P285, DOI 10.1167/6.3.8; Lunau K, 2014, J COMP PHYSIOL A, V200, P497, DOI 10.1007/s00359-014-0895-1; MALONEY LT, 1986, J OPT SOC AM A, V3, P1673, DOI 10.1364/JOSAA.3.001673; Mazzoni EO, 2008, PLOS BIOL, V6, P825, DOI 10.1371/journal.pbio.0060097; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; MENNE D, 1977, J COMP PHYSIOL, V114, P301, DOI 10.1007/BF00657325; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; Prins N, 2012, J VISION, V12, DOI 10.1167/12.6.25; Rister J, 2013, DEVELOPMENT, V140, P493, DOI 10.1242/dev.079095; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Salcedo E, 2003, J NEUROSCI, V23, P10873; Schnaitmann C, 2013, CURR BIOL, V23, P2375, DOI 10.1016/j.cub.2013.10.037; STILES WS, 1946, P PHYS SOC LOND, V58, P41, DOI 10.1088/0959-5309/58/1/305; TROJE N, 1993, Z NATURFORSCH C, V48, P96; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 2001, VISION RES, V41, P639, DOI 10.1016/S0042-6989(00)00288-1; Vorobyev M., 1997, COSTS BENEFITS INCRE, P280; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wright WD, 1934, P PHYS SOC, V46, P459, DOI 10.1088/0959-5309/46/3/317; YEH T, 1995, J OPT SOC AM A, V12, P456, DOI 10.1364/JOSAA.12.000456	47	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155728	10.1371/journal.pone.0155728	http://dx.doi.org/10.1371/journal.pone.0155728			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258000	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700019
J	Jang, H; Ngunjiri, JM; Lee, CW				Jang, Hyesun; Ngunjiri, John M.; Lee, Chang-Won			Association between Interferon Response and Protective Efficacy of NS1-Truncated Mutants as Influenza Vaccine Candidates in Chickens	PLOS ONE			English	Article							AVIAN INFLUENZA; A VIRUS; IMMUNE-RESPONSES; STIMULATED GENES; INFECTION; OUTBREAK; EXPRESSION; CELLS; PCR; H5	Influenza virus mutants that encode C-terminally truncated NS1 proteins (NS1-truncated mutants) are attractive candidates for avian live attenuated influenza vaccine (LAIV) development because they are both attenuated and immunogenic in chickens. We previously showed that a high protective efficacy of NS1-truncated LAIV in chickens corresponds with induction of high levels of type I interferon (IFN) responses in chicken embryonic fibroblast cells. In this study, we investigated the relationship between induction of IFN and IFN-stimulated gene responses in vivo and the immunogenicity and protective efficacy of NS1-truncated LAIV. Our data demonstrates that accelerated antibody induction and protective efficacy of NS1-truncated LAIV correlates well with upregulation of IFN-stimulated genes. Further, through oral administration of recombinant chicken IFN alpha in drinking water, we provide direct evidence that type I IFN can promote rapid induction of adaptive immune responses and protective efficacy of influenza vaccine in chickens.	[Jang, Hyesun; Ngunjiri, John M.; Lee, Chang-Won] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA; [Jang, Hyesun; Lee, Chang-Won] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ngunjiri, JM; Lee, CW (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Wooster, OH 44691 USA.; Lee, CW (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA.	ngunjiri.1@osu.edu; lee.2854@osu.edu	Ngunjiri, John/AAB-3798-2021; Jang, Hyesun/AAG-7814-2021	Ngunjiri, John/0000-0002-2131-1698; Jang, Hyesun/0000-0002-8142-8222	SEEDS fund [2012009]; Ohio Agricultural Research and Development Center, The Ohio State University	SEEDS fund; Ohio Agricultural Research and Development Center, The Ohio State University(Ohio State University)	This study was supported by the SEEDS fund (2012009) and other funds from the Ohio Agricultural Research and Development Center, The Ohio State University.	BEAN WJ, 1985, J VIROL, V54, P151, DOI 10.1128/JVI.54.1.151-160.1985; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bracci L, 2006, VACCINE S2, V24, pS2; Braun D, 2002, INT IMMUNOL, V14, P411, DOI 10.1093/intimm/14.4.411; Capua I, 2004, AVIAN PATHOL, V33, P393, DOI 10.1080/03079450410001724085; Capua I, 2002, ACTA TROP, V83, P7, DOI 10.1016/S0001-706X(02)00057-8; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Cyranoski D, 2001, NATURE, V412, P261, DOI 10.1038/35085715; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Elaish M, 2015, VACCINE, V33, P4901, DOI 10.1016/j.vaccine.2015.07.049; Feng L, 2014, EURO SURVEILL, V19; Forrest BD, 2008, CLIN VACCINE IMMUNOL, V15, P1042, DOI 10.1128/CVI.00397-07; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Hvistendahl M, 2015, SCIENCE, V348, P741, DOI 10.1126/science.348.6236.741; Ibrahim M, 2015, VACCINE, V33, P2670, DOI 10.1016/j.vaccine.2015.04.023; Jang H, 2013, POULTRY SCI, V92, P2290, DOI 10.3382/ps.2013-03116; Kapczynski DR, 2014, METHODS MOL BIOL, V1161, P217, DOI 10.1007/978-1-4939-0758-8_18; Kim Y, 2011, ANTIVIR RES, V89, P165, DOI 10.1016/j.antiviral.2010.11.016; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Le Bon A, 2006, J IMMUNOL, V176, P4682, DOI 10.4049/jimmunol.176.8.4682; Lee Chang-Won, 2005, Animal Health Research Reviews, V6, P1, DOI 10.1079/AHR2005101; Lee CW, 2014, METHODS MOL BIOL, V1161, P37, DOI 10.1007/978-1-4939-0758-8_4; Lee CW, 2004, J VIROL METHODS, V119, P151, DOI 10.1016/j.jviromet.2004.03.014; Liang JF, 2013, POULTRY SCI, V92, P2651, DOI 10.3382/ps.2013-03193; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Marcus PI, 2007, EMERG INFECT DIS, V13, P1608, DOI 10.3201/eid1310.061552; Marcus PI, 2010, J VIROL, V84, P10974, DOI 10.1128/JVI.00502-10; Menachery VD, 2014, MBIO, V5, DOI 10.1128/mBio.01174-14; Meng SS, 2011, J INTERF CYTOK RES, V31, P533, DOI 10.1089/jir.2010.0123; Nagao Y, 1998, J INTERF CYTOK RES, V18, P661, DOI 10.1089/jir.1998.18.661; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nfon C, 2012, VACCINE, V30, P7187, DOI 10.1016/j.vaccine.2012.10.021; Ngunjiri JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118934; Ngunjiri JM, 2012, J INTERF CYTOK RES, V32, P280, DOI 10.1089/jir.2011.0102; Pawar SD, 2015, J VIROL METHODS, V222, P28, DOI 10.1016/j.jviromet.2015.05.004; Penski N, 2011, J VIROL, V85, P7730, DOI 10.1128/JVI.00063-11; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Pulit-Penaloza JA, 2012, VIROLOGY, V425, P82, DOI 10.1016/j.virol.2012.01.006; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richt JA, 2009, CURR TOP MICROBIOL, V333, P177, DOI 10.1007/978-3-540-92165-3_9; Sasaki S, 2014, J INFECT DIS, V210, P865, DOI 10.1093/infdis/jiu190; SEKELLICK MJ, 1994, J INTERFERON RES, V14, P71, DOI 10.1089/jir.1994.14.71; Sen GC, 2007, ADV VIRUS RES, V70, P233, DOI 10.1016/S0065-3527(07)70006-4; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; STONE HD, 1987, AVIAN DIS, V31, P483, DOI 10.2307/1590728; Swayne DE, 2008, IMMUNOL REV, V225, P314, DOI 10.1111/j.1600-065X.2008.00668.x; Tang RB, 2013, J CHIN MED ASSOC, V76, P245, DOI 10.1016/j.jcma.2013.04.003; Wang L, 2008, VACCINE, V26, P3580, DOI 10.1016/j.vaccine.2008.05.001; Wang YF, 2014, VIROLOGY, V468, P621, DOI 10.1016/j.virol.2014.09.010; Wright P.F., 2013, FIELDS VIROLOGY, P1186	52	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156603	10.1371/journal.pone.0156603	http://dx.doi.org/10.1371/journal.pone.0156603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257989	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700088
J	Kim, JE; Yoo, HJ; Gu, JY; Kim, HK				Kim, Ji Eun; Yoo, Hyun Ju; Gu, Ja Yoon; Kim, Hyun Kyung			Histones Induce the Procoagulant Phenotype of Endothelial Cells through Tissue Factor Up-Regulation and Thrombomodulin Down-Regulation	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; EXTRACELLULAR HISTONES; CIRCULATING NUCLEOSOMES; THROMBIN GENERATION; C ACTIVATION; RISK-FACTORS; MECHANISMS; PHOSPHATIDYLSERINE; INFLAMMATION; COAGULATION	The high circulating levels of histones found in various thrombotic diseases may compromise the anticoagulant barrier of endothelial cells. We determined how histones affect endothelial procoagulant tissue factor (TF) and anticoagulant thrombomodulin (TM). Surface antigens, soluble forms, and mRNA levels of TF and TM were measured by flow cytometry, ELISA, and real-time RT-PCR, respectively. TF and TM activity were measured using procoagulant activity, thrombin generation, or chromogenic assays. Involvement of the toll-like receptor (TLR) was assessed using the neutralizing antibodies. Histones dose-dependently induced surface antigens, activity and mRNA levels of endothelial TF. Histone-treated endothelial cells significantly shortened the lag time and enhanced the endogenous thrombin potential of normal plasma, which was normalized by a TF neutralizing antibody. Histones induced phosphatidylserine and protein-disulfide isomerase expression in endothelial cells. Histones also reduced the surface antigen, activity, and mRNA levels of endothelial TM. Polysialic acid and heparin reversed the histone-induced TF up-regulation and TM down-regulation. Activated protein C did not affect the TF up-regulation, but interrupted TM down-regulation. TLR2, and TLR4 inhibitors partially blocked the TF up-regulation. Histones induced the endothelial procoagulant phenotype through TF up-regulation and TM down-regulation. The effects of histones were partly mediated by TLR2, TLR4. Strategies to inhibit the harmful effects of histones in endothelial cells may be required in order to prevent a thrombotic environment.	[Kim, Ji Eun] Seoul Natl Univ, Bundang Hosp, Dept Hematooncol, Healthcare Innovat Pk, Gyeonggi Do, South Korea; [Yoo, Hyun Ju; Gu, Ja Yoon; Kim, Hyun Kyung] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Yoo, Hyun Ju; Gu, Ja Yoon; Kim, Hyun Kyung] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, HK (corresponding author), Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.; Kim, HK (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	lukekhk@snu.ac.kr			Korea Health Industry Development Institute (KHIDI) [HI13C0954]; National Research Foundation of Korea (NRF) [2013-068572]	Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This study was supported by the Korea Health Industry Development Institute (KHIDI), grant number HI13C0954, and the National Research Foundation of Korea (NRF), grant number 2013-068572.	Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Ammollo CT, 2011, J THROMB HAEMOST, V9, P1795, DOI 10.1111/j.1538-7836.2011.04422.x; Arai Y, 2013, BIOL BLOOD MARROW TR, V19, P1683, DOI 10.1016/j.bbmt.2013.09.005; Bode M, 2014, VASC PHARMACOL, V62, P57, DOI 10.1016/j.vph.2014.05.005; Borissoff JI, 2013, ARTERIOSCL THROM VAS, V33, P2032, DOI 10.1161/ATVBAHA.113.301627; Carestia A, 2013, THROMB HAEMOSTASIS, V110, P1035, DOI 10.1160/TH13-02-0174; Chen QX, 2012, INT J INFECT DIS, V16, pE558, DOI 10.1016/j.ijid.2012.03.007; Chen VMY, 2013, SEMIN THROMB HEMOST, V39, P40, DOI 10.1055/s-0032-1333311; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Dhainaut JF, 2004, J THROMB HAEMOST, V2, P1924, DOI 10.1111/j.1538-7836.2004.00955.x; Ekaney ML, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0543-8; Goldmann O, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00420; Henriksson CE, 2005, THROMB HAEMOSTASIS, V94, P1236, DOI 10.1160/TH05-07-0463; Kim JE, 2015, THROMB RES, V135, P1064, DOI 10.1016/j.thromres.2015.03.014; Kowalska MA, 2014, ARTERIOSCL THROM VAS, V34, P120, DOI 10.1161/ATVBAHA.113.302236; Langer F, 2014, THROMB HAEMOSTASIS, V111, P590, DOI 10.1160/TH13-09-0802; LE DT, 1994, THROMB HAEMOSTASIS, V72, P848; Levi M, 2012, SEMIN THROMB HEMOST, V38, P506, DOI 10.1055/s-0032-1305782; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; PAL PK, 1983, THROMB RES, V31, P69, DOI 10.1016/0049-3848(83)90008-7; Popescu NI, 2010, BLOOD, V116, P993, DOI 10.1182/blood-2009-10-249607; Rao LVM, 2012, J THROMB HAEMOST, V10, P2242, DOI 10.1111/jth.12003; Regnault V, 2003, THROMB HAEMOSTASIS, V89, P208, DOI 10.1055/s-0037-1613433; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; van Montfoort ML, 2013, ARTERIOSCL THROM VAS, V33, P147, DOI 10.1161/ATVBAHA.112.300498; Wang L, 2007, AM J RESP CELL MOL, V36, P497, DOI 10.1165/rcmb.2005-0425OC; Wolberg AS, 2000, BIOCHEM BIOPH RES CO, V272, P332, DOI 10.1006/bbrc.2000.2783; Wu HL, 2008, BIOCHEM BIOPH RES CO, V367, P162, DOI 10.1016/j.bbrc.2007.12.135; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95	35	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156763	10.1371/journal.pone.0156763	http://dx.doi.org/10.1371/journal.pone.0156763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258428	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700122
J	Maeda, J; Froning, CE; Brents, CA; Rose, BJ; Thamm, DH; Kato, TA				Maeda, Junko; Froning, Coral E.; Brents, Colleen A.; Rose, Barbara J.; Thamm, Douglas H.; Kato, Takamitsu A.			Intrinsic Radiosensitivity and Cellular Characterization of 27 Canine Cancer Cell Lines	PLOS ONE			English	Article							HISTONE H2AX PHOSPHORYLATION; RADIATION-INDUCED APOPTOSIS; DOUBLE-STRAND BREAKS; IONIZING-RADIATION; HUMAN TUMOR; PROGNOSTIC-FACTOR; DNA; RADIOTHERAPY; SENSITIVITY; EXPRESSION	Canine cancer cell lines have progressively been developed, but are still underused resources for radiation biology research. Measurement of the cellular intrinsic radiosensitivity is important because understanding the difference may provide a framework for further elucidating profiles for prediction of radiation therapy response. Our studies have focused on characterizing diverse canine cancer cell lines in vitro and understanding parameters that might contribute to intrinsic radiosensitivity. First, intrinsic radiosensitivity of 27 canine cancer cell lines derived from ten tumor types was determined using a clonogenic assay. The 27 cell lines had varying radiosensitivities regardless tumor type (survival fraction at 2 Gy, SF2 = 0.19-0.93). In order to understand parameters that might contribute to intrinsic radiosensitivity, we evaluated the relationships of cellular radiosensitivity with basic cellular characteristics of the cell lines. There was no significant correlation of SF2 with S-phase fraction, doubling time, chromosome number, ploidy, or number of metacentric chromosomes, while there was a statistically significant correlation between SF2 and plating efficiency. Next, we selected the five most radiosensitive cell lines as the radiosensitive group and the five most radioresistant cell lines as the radioresistant group. Then, we evaluated known parameters for cell killing by ionizing radiation, including radiation-induced DNA double strand break (DSB) repair and apoptosis, in the radiosensitive group as compared to the radioresistant group. High levels of residual gamma-H2AX foci at the sites of DSBs were present in the four out of the five radiosensitive canine cancer cell lines. Our studies suggested that substantial differences in intrinsic radiosensitivity exist in canine cancer cell lines, and radiation-induced DSB repair was related to radiosensitivity, which is consistent with previous human studies. These data may assist further investigations focusing on the detection of DSB for predicting individual response to radiation therapy for dogs, regardless of tumor type.	[Maeda, Junko; Froning, Coral E.; Brents, Colleen A.; Kato, Takamitsu A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Rose, Barbara J.; Thamm, Douglas H.] Colorado State Univ, Dept Clin Sci, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Kato, TA (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.	Takamitsu.Kato@Colostate.edu	Thamm, Douglas H/I-5976-2013; Thamm, Douglas/AAG-3672-2020; Kato, Takamitsu A/D-7969-2015	Thamm, Douglas H/0000-0002-8914-7767; Kato, Takamitsu/0000-0002-6263-600X	Dr. Akiko Ueno Radiobiology Fund (TAK)	Dr. Akiko Ueno Radiobiology Fund (TAK)	Funding was provided by Dr. Akiko Ueno Radiobiology Fund (TAK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge DR, 1998, CANCER RES, V58, P2817; Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; Begg AC, 2009, INT J RADIAT BIOL, V85, P825, DOI 10.3109/09553000903184366; Bjork-Eriksson T, 2000, INT J RADIAT ONCOL, V46, P13, DOI 10.1016/S0360-3016(99)00373-9; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; BUSH C, 1993, BRIT J CANCER, V67, P102, DOI 10.1038/bjc.1993.17; Chaurasia M, 2016, FREE RADICAL RES, V50, P273, DOI 10.3109/10715762.2015.1129534; DEWEY WC, 1995, INT J RADIAT ONCOL, V33, P781, DOI 10.1016/0360-3016(95)00214-8; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Dunne AL, 2003, BRIT J CANCER, V89, P2277, DOI 10.1038/sj.bjc.6601427; Fowlers J, 2016, VET COMP ON IN PRESS; Fujii Y, 2010, ONCOL REP, V23, P199, DOI 10.3892/or_00000623; FURTH EE, 1981, ANAL BIOCHEM, V110, P1, DOI 10.1016/0003-2697(81)90103-2; Genet SC, 2013, J CELL PHYSIOL, V228, P1473, DOI 10.1002/jcp.24302; Hall JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086329; Limsirichaikul S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp023; MACEWEN EG, 1990, CANCER METAST REV, V9, P125, DOI 10.1007/BF00046339; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Maeda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043355; Mahrhofer H, 2006, INT J RADIAT ONCOL, V64, P573, DOI 10.1016/j.ijrobp.2005.09.037; Matt S, 2016, CELL MOL LIFE SCI, V73, P2829, DOI 10.1007/s00018-016-2130-4; Moldovan GL, 2009, CELL, V139, P1222, DOI 10.1016/j.cell.2009.12.006; NAGASAWA H, 1983, MUTAT RES, V109, P297, DOI 10.1016/0027-5107(83)90054-4; Paoloni MC, 2007, VET CLIN N AM-SMALL, V37, P1023, DOI 10.1016/j.cvsm.2007.08.003; Peng YL, 2002, CANCER RES, V62, P6400; Reimann N, 1999, J NATL CANCER I, V91, P1688, DOI 10.1093/jnci/91.19.1688; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SCHWARTZ JL, 1992, RADIAT RES, V129, P96, DOI 10.2307/3577908; Schwartz JL, 1999, BRIT J CANCER, V79, P744, DOI 10.1038/sj.bjc.6690119; Schwartz JL, 1998, RADIAT RES, V149, P319, DOI 10.2307/3579692; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; TOBEY RA, 1971, CANCER RES, V31, P46; Torres-Roca Javier F, 2008, Cancer Control, V15, P151; van Veelen LR, 2005, MUTAT RES-FUND MOL M, V574, P34, DOI 10.1016/j.mrfmmm.2005.01.020; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; WEST CML, 1995, INT J RADIAT ONCOL, V31, P841, DOI 10.1016/0360-3016(94)00508-7; West CML, 1997, BRIT J CANCER, V76, P1184, DOI 10.1038/bjc.1997.531; Yu T, 2006, DNA REPAIR, V5, P935, DOI 10.1016/j.dnarep.2006.05.040	40	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156689	10.1371/journal.pone.0156689	http://dx.doi.org/10.1371/journal.pone.0156689			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257868	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700107
J	Zhou, FF; Fang, KY; Zhang, F; Dong, ZP; Chen, D				Zhou, Feifei; Fang, Keyan; Zhang, Fen; Dong, Zhipeng; Chen, Dan			Climate-Driven Synchronized Growth of Alpine Trees in the Southeast Tibetan Plateau	PLOS ONE			English	Article							RING GROWTH; TEMPERATURE RECONSTRUCTION; SPATIOTEMPORAL VARIABILITY; RESPONSES; MOUNTAINS; DROUGHT; PRECIPITATION; MOISTURE; REGION; ALASKA	Knowledge about the spatiotemporal tree growth variability and its associations with climate provides key insights into forest dynamics under future scenarios of climate change. We synthesized 17 tree-ring width chronologies from four tree species at the high-elevation sites in the southeast Tibetan Plateau (SETP) to study the regional tree growth variability and climate-growth relationships. Despite of diverse habitats and different physiological characteristics of these species, these tree-ring chronologies shared a significant common variance in SETP. An unprecedented increase in the shared variance is found along the latter half of the 20th century, coinciding with the enhancement of the frequency of extreme rings among chronologies. It is found that minimum winter temperature tends to be the dominant climate for trees in this region. The site-specific responses in cold (1965-1980) and warm (1990-2005) intervals by means of Fuzzy Cmeans (FCM) clustering reveal that the remarkable enhancement of growth synchrony among trees mainly occur in warm conditions. This is different from previous findings indicating that increased consistence among temperature sensitive tree rings in cold periods. This may be related to the reduced temperature sensitivity of regional tree growth as winter minimum temperature is lower than a certain threshold, which is in agreement with the "principle of ecological amplitude". In addition, it is worth noting that precipitation in June have started to restrain the tree growth since the beginning of the 1980s, which is possibly an important contributor for synchronized growth among trees in SETP.	[Zhou, Feifei; Fang, Keyan; Dong, Zhipeng; Chen, Dan] Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc MOE, Fuzhou 350007, Peoples R China; [Fang, Keyan] Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing 100029, Peoples R China; [Zhang, Fen] Lanzhou Univ, Key Lab Western Chinas Environm Syst MOE, Lanzhou 730000, Peoples R China	Fujian Normal University; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Lanzhou University	Fang, KY (corresponding author), Fujian Normal Univ, Key Lab Humid Subtrop Ecogeog Proc MOE, Fuzhou 350007, Peoples R China.; Fang, KY (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Key Lab Cenozo Geol & Environm, Beijing 100029, Peoples R China.	kfang@fjnu.edu.cn	dong, zhipeng/AFN-4971-2022; Chen, Dan/GRY-2691-2022	Chen, Dan/0000-0002-1570-9034	National Natural Science Foundation of China [41471172, U1405231, 41404047]; Fujian Province [2014R1034-2, 2015J06008]; fundamental research funds for the central universities [lzujbky-2014-114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Province; fundamental research funds for the central universities(Fundamental Research Funds for the Central Universities)	This work is funded by the National Natural Science Foundation of China (No. 41471172, No. U1405231 and No. 41404047) (http://www.nsfc.gov.cn/), non-profit research funds of Fujian Province (2014R1034-2) (http://www.fjkjt.gov.cn/), the Fellowship for Distinguished Young Scholars of Fujian Province (2015J06008) and the fundamental research funds for the central universities (No. lzujbky-2014-114) (http://kyc.lzu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Andreu L, 2007, GLOBAL CHANGE BIOL, V13, P804, DOI 10.1111/j.1365-2486.2007.01322.x; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; Briffa KR, 1998, NATURE, V391, P678, DOI 10.1038/35596; Carrer M, 2004, ECOLOGY, V85, P730, DOI 10.1890/02-0478; Carrer M, 2013, PLOS ONE, V7; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cook E.R., 2013, METHODS DENDROCHRONO; Cook E. R., 1985, TIME SERIES ANAL APP; Cook ER, 2001, ECOL APPL, V11, P883, DOI 10.1890/1051-0761(2001)011[0883:IFGOTI]2.0.CO;2; Deng Y, 2014, TIBET PLATEAU Q RES, V18, P513; Driscoll WW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024258; Duan JP, 2012, CLIM DYNAM, V39, P919, DOI 10.1007/s00382-011-1232-9; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; EQUIHUA M, 1990, J ECOL, V78, P519, DOI 10.2307/2261127; Ettinger AK, 2011, ECOLOGY, V92, P1323, DOI 10.1890/10-1639.1; Fan ZX, 2008, INT J CLIMATOL, V28, P1879, DOI 10.1002/joc.1689; Fang KY, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034010; Fang KY, 2012, CLIM DYNAM, V39, P1697, DOI 10.1007/s00382-012-1371-7; Fang KY, 2012, TREES-STRUCT FUNCT, V26, P1471, DOI 10.1007/s00468-012-0721-8; Fang KY, 2010, CLIM DYNAM, V35, P577, DOI 10.1007/s00382-009-0636-2; Fang KY, 2009, IAWA J, V30, P443, DOI 10.1163/22941932-90000231; Fritts H., 1976, TREE RINGS CLIMATE; Gershunov A, 2001, J CLIMATE, V14, P2486, DOI 10.1175/1520-0442(2001)014<2486:LFMOTE>2.0.CO;2; Gou X., 2013, NW CHINA BIOGEOSCI D, V10, P9969, DOI [10.5194/bgd-10-9969-2013, DOI 10.5194/BGD-10-9969-2013]; Gou XH, 2007, INT J CLIMATOL, V27, P1497, DOI 10.1002/joc.1480; Holmes R.L., 1994, DENDROCHRONOLOGY PRO; Ji F, 2014, NAT CLIM CHANGE, V4, P462, DOI [10.1038/nclimate2223, 10.1038/NCLIMATE2223]; Liang EY, 2009, THEOR APPL CLIMATOL, V98, P9, DOI 10.1007/s00704-008-0085-6; Liang EY, 2008, GLOBAL PLANET CHANGE, V61, P313, DOI 10.1016/j.gloplacha.2007.10.008; Liang EY, 2006, CLIMATIC CHANGE, V79, P403, DOI 10.1007/s10584-006-9082-x; Liang E, 2014, ECOLOGY, V95, P2453, DOI 10.1890/13-1904.1; Liang E, 2010, CAN J FOREST RES, V40, P200, DOI 10.1139/X09-186; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Ni FB, 2002, INT J CLIMATOL, V22, P1645, DOI 10.1002/joc.804; Salzer MW, 2009, P NATL ACAD SCI USA, V106, P20348, DOI 10.1073/pnas.0903029106; Shao XM., 1999, QUATERNARY SCI, V19, P81, DOI DOI 10.3321/j.issn:1001-7410.1999.01.010; Shi JF, 2013, PALAEOGEOGR PALAEOCL, V381, P92, DOI 10.1016/j.palaeo.2013.04.018; Solberg BO, 2002, ECOSCIENCE, V9, P79, DOI 10.1080/11956860.2002.11682693; Tardif J, 2003, ECOL MONOGR, V73, P241, DOI 10.1890/0012-9615(2003)073[0241:SVITGI]2.0.CO;2; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Wilson R, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008318; Woodhouse CA, 2001, J AM WATER RESOUR AS, V37, P561, DOI 10.1111/j.1752-1688.2001.tb05493.x; Wu XC, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024016; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Yang B, 2014, P NATL ACAD SCI USA, V111, P2903, DOI 10.1073/pnas.1319238111; Zhang Q, 2015, NATURE COMMUNICATION, V6; Zhang QB, 2000, FOREST SCI, V46, P229; Zhang YX, 2009, PLANT ECOL, V201, P39, DOI [10.1007/s11258-008-9478-y, 10.1007/978-90-481-2795-5_4]; Zhu HF, 2009, CLIM PAST, V5, P661, DOI 10.5194/cp-5-661-2009	54	6	6	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156126	10.1371/journal.pone.0156126	http://dx.doi.org/10.1371/journal.pone.0156126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257971	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700038
J	Silva-Andrade, HL; de Andrade, LP; Muniz, LS; Telino, WR; Albuquerque, UP; Lyra-Neves, RM				Silva-Andrade, Horasa Lima; de Andrade, Luciano Pires; Muniz, Lauana Souza; Telino-Junior, Wallace Rodrigues; Albuquerque, Ulysses Paulino; Lyra-Neves, Rachel Maria			Do Farmers Using Conventional and Non-Conventional Systems of Agriculture Have Different Perceptions of the Diversity of Wild Birds? Implications for Conservation	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; PEOPLE; AREAS	Farmers' perceptions of birds' interactions with agricultural production systems are fundamental to species conservation efforts. In the present study, we evaluated the perceptions of birds held by farmers who engage in conventional and non-conventional agricultural production processes and the implications of potential differences in these perceptions on species conservation. To accomplish this, data were collected using questionnaires, semi-structured interviews, and other complementary sources of information gathered from 191 farmers in northeastern Brazil. Although some similarities were identified among the farmers in their perceptions and local ecological knowledge (LEK) of birds, differences existed between the conventional and non-conventional farmers in their attitudes toward, conflicts with, and usage of bird species. Compared to the conventional farmers, the non-conventional farmers could identify more bird species, possessed more favorable attitudes toward birds, and engaged in practices more beneficial to the conservation of avifauna. The perceptions that were identified were related to the type of agriculture practiced, and such perceptions may affect the conservation of bird species. Therefore, the adoption of certain agricultural practices has important implications for conservation. Our results indicate the need for investment in public policies, programs and actions that account for farmers' knowledge and perceptions. Such investments will contribute to the development and adoption of practices supporting wild bird conservation in agricultural areas.	[Silva-Andrade, Horasa Lima; de Andrade, Luciano Pires; Telino-Junior, Wallace Rodrigues; Albuquerque, Ulysses Paulino; Lyra-Neves, Rachel Maria] Univ Fed Rural Pernambuco, Grad Program Ethnobiol & Nat Conservat PPGEtno, Dept Biol, Recife, PE, Brazil; [Silva-Andrade, Horasa Lima; de Andrade, Luciano Pires; Telino-Junior, Wallace Rodrigues; Lyra-Neves, Rachel Maria] Univ Fed Rural Pernambuco, Garanhuns Campus, Garanhuns, PE, Brazil; [Muniz, Lauana Souza] Univ Fed Pernambuco, Grad Program Management Sustainable Local Dev, Recife, PE, Brazil; [Albuquerque, Ulysses Paulino] Univ Fed Rural Pernambuco, Lab Ecol & Evolut Social Ecol Syst, Dept Biol, Recife, PE, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Pernambuco; Universidade Federal Rural de Pernambuco (UFRPE)	Silva-Andrade, HL (corresponding author), Univ Fed Rural Pernambuco, Grad Program Ethnobiol & Nat Conservat PPGEtno, Dept Biol, Recife, PE, Brazil.; Silva-Andrade, HL (corresponding author), Univ Fed Rural Pernambuco, Garanhuns Campus, Garanhuns, PE, Brazil.	horasaa@gmail.com	Albuquerque, Ulysses P/I-5037-2012	Albuquerque, Ulysses P/0000-0002-8131-8429; Silva-Andrade, Horasa/0000-0002-5366-6610; Pires de Andrade, Luciano/0000-0001-5818-711X	PPGEtno-UFRPE; LEA/UFRPE; Garanhuns campus at UFRPE; Zoology teaching and Volant Vertebrate Ecology Laboratory at UFRPE/Garanhuns campus; AGROFAMILIAR Vocational Technological Nucleus; Center at UFRPE/Garanhuns campus	PPGEtno-UFRPE; LEA/UFRPE; Garanhuns campus at UFRPE; Zoology teaching and Volant Vertebrate Ecology Laboratory at UFRPE/Garanhuns campus; AGROFAMILIAR Vocational Technological Nucleus; Center at UFRPE/Garanhuns campus	We are grateful to the farmers of the Catonho, Lacre, and Mine associations in Jupi, Pernambuco (Brazil), and all other partners and collaborators. We would also like to thank the PPGEtno-UFRPE, LEA/UFRPE, the Garanhuns campus at UFRPE, the Zoology teaching and Volant Vertebrate Ecology Laboratory at UFRPE/Garanhuns campus, and the AGROFAMILIAR Vocational Technological Nucleus and Center at UFRPE/Garanhuns campus for their support during the development of this research.	Albuquerque U. P., 2014, METHODS TECHNIQUES E, Vfirst, P1, DOI DOI 10.1007/978-1-4614-8636-7; Albuquerque UP, 2014, METHODS TECHNIQUES E, P451; Altieri M., 2012, AGROECOLOGIA UNICA E, V3a; Alves RRN, 2009, J ETHNOBIOL ETHNOMED, V5, DOI 10.1186/1746-4269-5-12; Alves RRN, 2012, BIRD CONSERV INT, P1, DOI DOI 10.1017/S095927091200010X; [Anonymous], 2011, RELATORIOS TECNICOS; Ayres M, 2007, BIO ESTAT APLICACOES; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Bolwing S., 2006, DANISH J GEOGR, V106, P115, DOI DOI 10.1080/00167223.2006.10649561; Caporal F, 2009, AGROECOLOGIA CIENCIA, V1ra; Costa Neto E., 2009, MANUAL ETNOZOOLOGIA; Alves RRD, 2010, HUM ECOL, V38, P147, DOI 10.1007/s10745-009-9295-5; Fernandes-Ferreira H, 2012, BIODIVERS CONSERV, V21, P221, DOI 10.1007/s10531-011-0179-9; Florentino Alissandra Trajano Nunes, 2007, Acta Bot. Bras., V21, P37, DOI 10.1590/S0102-33062007000100005; Fraser JA, 2011, ECON BOT, V65, P1, DOI 10.1007/s12231-010-9143-y; Freemark KE, 2001, BIOL CONSERV, V101, P337, DOI 10.1016/S0006-3207(01)00079-9; Frisch J.D., 2005, AVES BRASILEIRAS PLA; GLIESSMAN S. R., 2000, AGROECOLOGIA PROCESS; Goulart FF, 2013, AGR ECOSYST ENVIRON, V164, P114, DOI 10.1016/j.agee.2012.09.011; Goulart FF, 2011, AGROFOREST SYST, V82, P239, DOI 10.1007/s10457-011-9398-z; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey CA, 2008, CONSERV BIOL, V22, P8, DOI 10.1111/j.1523-1739.2007.00863.x; Herzon I, 2007, J NAT CONSERV, V15, P10, DOI 10.1016/j.jnc.2006.08.001; IBGE, I BRAS GEOGR EST; ICMBio  Instituto Chico Mendes de ConservacAo da Biodiversidade, SUM EX PLAN AC NAC C; Jacobson SK, 2003, CONSERV BIOL, V17, P595, DOI 10.1046/j.1523-1739.2003.01472.x; Kai Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092931; Kaltenborn B.R.P., 2006, HUMAN DIMENSIONS WIL, V11, P397, DOI DOI 10.1080/10871200600984323; Leyequien E, 2010, BIOTROPICA, V42, P236, DOI 10.1111/j.1744-7429.2009.00553.x; Magurran A. E., 2004, MEASUREMENT BIOL DIV; Bezerra DMM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-3; Bezerra DMM, 2012, TROP CONSERV SCI, V5, P50, DOI 10.1177/194008291200500106; McMahon BJ, 2012, ECOL INDIC, V18, P676, DOI 10.1016/j.ecolind.2012.01.013; Medeiros PM, 2014, REV BRAS FARMACOGN, V24, P103, DOI 10.1016/j.bjp.2014.01.010; Nekaris KAI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069215; NOLAN J.M., 2001, J LINGUIST ANTHROPOL, V11, P240; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Primack RB., 2001, BIOL CONSERVACAO; Shen XL, 2012, BIOL CONSERV, V145, P160, DOI 10.1016/j.biocon.2011.10.027; Sick H, 2001, ORNITOLOGIA BRASILEI; Silva J.M.C., 2003, ECOLOGIA CONSERVACA, P237; Silva RW, 2010, ORNITOLOIGA CONSERVA, P505; Tavares Mendonca Livia Emanuelle, 2011, Sitientibus Serie Ciencias Biologicas, V11, P185; Teillard F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119674; Tobias J.A., 2013, KEY TOPICS CONSERVAT, P258; TOLEDO V.M., 2010, ETNOBIOLOGIA ETNOECO, P13; Weladji RB, 2003, ORYX, V37, P72, DOI 10.1017/S0030605303000140; Williams VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105397; Wood BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105203	49	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156307	10.1371/journal.pone.0156307	http://dx.doi.org/10.1371/journal.pone.0156307			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243222	Green Submitted, gold, Green Published			2022-12-26	WOS:000377146100027
J	Lu, JH; Wu, PP; Zhang, XH; Feng, L; Dong, B; Chu, X; Liu, XF; Peng, DX; Liu, Y; Ma, HL; Hou, JB; Tang, YH				Lu, Jihu; Wu, Peipei; Zhang, Xuehua; Feng, Lei; Dong, Bin; Chu, Xuan; Liu, Xiufan; Peng, Daxin; Liu, Yuan; Ma, Huailiang; Hou, Jibo; Tang, Yinghua			Immunopotentiators Improve the Efficacy of Oil-Emulsion-Inactivated Avian Influenza Vaccine in Chickens, Ducks and Geese	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; IMMUNE-RESPONSE; H5N1 VIRUSES; POULTRY; CHINA; PATHOGENICITY; INFECTION; IMMUNIZATION; STRATEGIES; PROTECTION	Combination of CVCVA5 adjuvant and commercial avian influenza (AI) vaccine has been previously demonstrated to provide good protection against different AI viruses in chickens. In this study, we further investigated the protective immunity of CVCVA5-adjuvanted oil-emulsion inactivated AI vaccine in chickens, ducks and geese. Compared to the commercial H5 inactivated vaccine, the H5-CVCVA5 vaccine induced significantly higher titers of hemaglutinin inhibitory antibodies in three lines of broiler chickens and ducks, elongated the antibody persistence periods in geese, elevated the levels of cross serum neutralization antibody against different clade and subclade H5 AI viruses in chicken embryos. High levels of mucosal antibody were detected in chickens injected with the H5 or H9-CVCA5 vaccine. Furthermore, cellular immune response was markedly improved in terms of increasing the serum levels of cytokine interferon-gamma and interleukine 4, promoting proliferation of splenocytes and upregulating cytotoxicity activity in both H5- and H9-CVCVA5 vaccinated chickens. Together, these results provide evidence that AI vaccines supplemented with CVCVA5 adjuvant is a promising approach for overcoming the limitation of vaccine strain specificity of protection.	[Lu, Jihu; Wu, Peipei; Zhang, Xuehua; Feng, Lei; Dong, Bin; Chu, Xuan; Hou, Jibo; Tang, Yinghua] Jiangsu Acad Agr Sci, Key Lab Vet Biol Engn & Technol, Natl Res Ctr Engn & Technol Vet Biol, Minist Agr, Nanjing, Jiangsu, Peoples R China; [Liu, Xiufan; Peng, Daxin] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China; [Liu, Yuan] Georgia State Univ, Ctr Inflammat Immun & Infect, Dept Biol, Program Cellular Biol & Immunol, Atlanta, GA 30303 USA; [Ma, Huailiang] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Yangzhou University; University System of Georgia; Georgia State University; Emory University	Hou, JB; Tang, YH (corresponding author), Jiangsu Acad Agr Sci, Key Lab Vet Biol Engn & Technol, Natl Res Ctr Engn & Technol Vet Biol, Minist Agr, Nanjing, Jiangsu, Peoples R China.; Peng, DX (corresponding author), Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.	pengdx@yzu.edu.cn; houjibo@yahoo.com; tyinghua@yahoo.com	Tang, Yinghua/O-6038-2015; Ma, Huailiang/C-3403-2017; Peng, Daxin/AAJ-3476-2021; Feng, Lei/AAO-6967-2020		National Natural Science Foundation [31201904]; Special Fund for Agro-scientific Research in the Public Interest [201303046]; National High Technology Research and Development Program of China [2011AA10A213]; Central Finance Funds for Agro-technical Popularization [TG(14)067]; Independent Innovation of Agricultural Sciences Program of Jiangsu Province [CX(14)5045]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Central Finance Funds for Agro-technical Popularization; Independent Innovation of Agricultural Sciences Program of Jiangsu Province	This work was supported by the National Natural Science Foundation (31201904), Special Fund for Agro-scientific Research in the Public Interest (201303046), National High Technology Research and Development Program of China (2011AA10A213), Central Finance Funds for Agro-technical Popularization (TG(14)067) and the Independent Innovation of Agricultural Sciences Program of Jiangsu Province (CX(14)5045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chua Tze-Hoong, 2010, Influenza Res Treat, V2010, P489213, DOI 10.1155/2010/489213; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Forrest HL, 2013, INFLUENZA OTHER RESP, V7, P1194, DOI 10.1111/irv.12140; Hasegawa H, 2015, CURR TOP MICROBIOL, V386, P371, DOI 10.1007/82_2014_402; Kayali G, 2013, POULTRY SCI, V92, P114, DOI 10.3382/ps.2012-02637; Lee DH, 2011, POULTRY SCI, V90, P1020, DOI 10.3382/ps.2010-01258; Li CJ, 2014, TRENDS BIOTECHNOL, V32, P147, DOI 10.1016/j.tibtech.2014.01.001; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Liu CG, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-321; Mallick AI, 2012, VIRAL IMMUNOL, V25, P226, DOI 10.1089/vim.2011.0085; Middleton D, 2007, VIROLOGY, V359, P66, DOI 10.1016/j.virol.2006.08.046; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Pfeiffer J, 2010, AVIAN DIS, V54, P262, DOI 10.1637/8715-031909-Reg.1; Poetri O, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-74; Santiago FW, 2011, VACCINE, V29, P8888, DOI 10.1016/j.vaccine.2011.09.069; Seo SH, 2001, J VIROL, V75, P2516, DOI 10.1128/JVI.75.6.2516-2525.2001; Swayne DE, 2011, REV SCI TECH OIE, V30, P839; Swayne DE, 2008, IMMUNOL REV, V225, P314, DOI 10.1111/j.1600-065X.2008.00668.x; Swayne DE, 2012, AVIAN DIS, V56, P818, DOI 10.1637/10183-041012-Review.1; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang YH, 2014, VET MICROBIOL, V172, P120, DOI 10.1016/j.vetmic.2014.05.007; Tang YH, 2009, AVIAN PATHOL, V38, P457, DOI 10.1080/03079450903349147; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Tsai TF, 2011, YAKUGAKU ZASSHI, V131, P1733, DOI 10.1248/yakushi.131.1733; Wu ZQ, 2010, POULTRY SCI, V89, P1136, DOI 10.3382/ps.2010-00695; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Zhang PH, 2009, J VIROL, V83, P8428, DOI 10.1128/JVI.00659-09; Zhang XJ, 2015, VET MICROBIOL, V175, P244, DOI 10.1016/j.vetmic.2014.12.011; Zhou F, 2012, J VIROL, V86, P6970, DOI 10.1128/JVI.06930-11	29	7	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156573	10.1371/journal.pone.0156573	http://dx.doi.org/10.1371/journal.pone.0156573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232188	Green Submitted, Green Published, gold			2022-12-26	WOS:000376883000045
J	Tan, T; Ong, WS; Rajasekaran, T; Koo, KN; Chan, LL; Poon, D; Chowdhury, AR; Krishna, L; Kanesvaran, R				Tan, Tira; Ong, Whee Sze; Rajasekaran, Tanujaa; Koo, Khai Nee; Chan, Li Li; Poon, Donald; Chowdhury, Anupama Roy; Krishna, Lalit; Kanesvaran, Ravindran			Identification of Comprehensive Geriatric Assessment Based Risk Factors for Malnutrition in Elderly Asian Cancer Patients	PLOS ONE			English	Article							NUTRITIONAL HEALTH CHECKLIST; OLDER PATIENTS; ONCOLOGY; CHEMOTHERAPY; PREVALENCE; PREDICTORS; MORBIDITY; MORTALITY; CACHEXIA; VALIDITY	Purpose Elderly cancer patients are at increased risk for malnutrition. We aim to identify comprehensive geriatric assessment (CGA) based clinical factors associated with increased nutritional risk and develop a clinical scoring system to identify nutritional risk in elderly cancer patients. Patients and Methods CGA data was collected from 249 Asian patients aged 70 years or older. Nutritional risk was assessed based on the Nutrition Screening Initiative (NSI) checklist. Univariate and multivariate logistic regression analyses were applied to assess the association between patient clinical factors together with domains within the CGA and moderate to high nutritional risk. Goodness of fit was assessed using Hosmer-Lemeshow test. Discrimination ability was assessed based on the area under the receiver operating characteristics curve (AUC). Internal validation was performed using simulated datasets via bootstrapping. Results Among the 249 patients, 184 (74%) had moderate to high nutritional risk. Multivariate logistic regression analysis identified stage 3-4 disease (Odds Ratio [OR] 2.54; 95% CI, 1.14-5.69), ECOG performance status of 2-4 (OR 3.04; 95% CI, 1.57-5.88), presence of depression (OR 5.99; 95% CI, 1.99-18.02) and haemoglobin levels <12 g/dL (OR 3.00; 95% CI 1.54-5.84) as significant independent factors associated with moderate to high nutritional risk. The model achieved good calibration (Hosmer-Lemeshow test's p = 0.17) and discrimination (AUC = 0.80). It retained good calibration and discrimination (bias-corrected AUC = 0.79) under internal validation. Conclusion Having advanced stage of cancer, poor performance status, depression and anaemia were found to be predictors of moderate to high nutritional risk. Early identification of patients with these risk factors will allow for nutritional interventions that may improve treatment tolerance, quality of life and survival outcomes.	[Tan, Tira; Rajasekaran, Tanujaa; Chan, Li Li; Krishna, Lalit; Kanesvaran, Ravindran] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore; [Ong, Whee Sze] Natl Canc Ctr Singapore, Div Clin Trials & Epidemiol Sci, Singapore, Singapore; [Koo, Khai Nee] Perdana Univ, Grad Sch Med, Selangor, Malaysia; [Poon, Donald] Raffles Canc Ctr, Singapore, Singapore; [Poon, Donald; Krishna, Lalit; Kanesvaran, Ravindran] Duke NUS Grad Med Sch, Singapore, Singapore; [Chowdhury, Anupama Roy] Changi Gen Hosp, Singapore, Singapore	National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); Perdana University; National University of Singapore; Changi General Hospital	Kanesvaran, R (corresponding author), Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore.; Kanesvaran, R (corresponding author), Duke NUS Grad Med Sch, Singapore, Singapore.	ravindran.kanesvaran@singhealth.com.sg		Kanesvaran, Ravindran/0000-0002-2351-881X	National Cancer Centre Singapore Research Fund [NRFGO08103]	National Cancer Centre Singapore Research Fund	This work was funded by the National Cancer Centre Singapore Research Fund Grant No. NRFGO08103 (to DP and RK). http://www.nccs.com.sg/GIVING/NCCRESEARCHFUND/Pages/Home.aspx. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aaldriks AA, 2013, BREAST, V22, P753, DOI 10.1016/j.breast.2013.01.011; Aapro M, 2014, ANN ONCOL, V25, P1492, DOI 10.1093/annonc/mdu085; Attar A, 2012, NUTR CANCER, V64, P535, DOI 10.1080/01635581.2012.670743; Balducci L, 2000, ONCOLOGY-NY, V14, P221; Barret M, 2011, ONCOLOGY-BASEL, V81, P395, DOI 10.1159/000335478; Beck AM, 1999, BRIT J NUTR, V81, P31, DOI 10.1017/S0007114599000860; Bozzetti F, 2012, SUPPORT CARE CANCER, V20, P1919, DOI 10.1007/s00520-012-1387-x; Bozzetti F, 2009, SUPPORT CARE CANCER, V17, P279, DOI 10.1007/s00520-008-0476-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Daudt HML, 2012, SUPPORT CARE CANCER, V20, P1417, DOI 10.1007/s00520-011-1224-7; Davies Michelle, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS64, DOI 10.1016/j.ejon.2005.09.005; de Groot LCPGM, 1998, EUR J CLIN NUTR, V52, P877, DOI 10.1038/sj.ejcn.1600658; de Onis M., 2005, ENV BURD DIS SER, V12, P43; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Extermann M, 2005, CRIT REV ONCOL HEMAT, V55, P241, DOI 10.1016/j.critrevonc.2005.06.003; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guigoz Y, 2002, CLIN GERIATR MED, V18, P737, DOI 10.1016/S0749-0690(02)00059-9; Hopkinson J, 2006, J ADV NURS, V54, P304, DOI 10.1111/j.1365-2648.2006.03818.x; Isenring E, 2015, NUTRITION, V31, P594, DOI 10.1016/j.nut.2014.12.027; Jang RW, 2014, J ONCOL PRACT; Kanesvaran R, 2011, J CLIN ONCOL, V29, P3620, DOI 10.1200/JCO.2010.32.0796; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Landi F, 1999, J AM GERIATR SOC, V47, P1072, DOI 10.1111/j.1532-5415.1999.tb05229.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Mancuso A, 2006, ANN ONCOL, V17, P146, DOI 10.1093/annonc/mdj038; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Paillaud E, 2014, CLIN NUTR, V33, P330, DOI 10.1016/j.clnu.2013.05.014; POSNER BM, 1993, AM J PUBLIC HEALTH, V83, P972, DOI 10.2105/AJPH.83.7.972; Pressoir M, 2010, BRIT J CANCER, V102, P966, DOI 10.1038/sj.bjc.6605578; Prevost V, 2012, EUR J CANCER CARE, V21, P581, DOI 10.1111/j.1365-2354.2012.01363.x; Sahyoun NR, 1997, J AM DIET ASSOC, V97, P760, DOI 10.1016/S0002-8223(97)00188-0; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Sinnett Stephanie, 2010, Journal of Nutrition for the Elderly, V29, P393, DOI 10.1080/01639366.2010.521031; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Stratton RJ, 2004, BRIT J NUTR, V92, P799, DOI 10.1079/BJN20041258; VANMARWIJK HWJ, 1995, BRIT J GEN PRACT, V45, P195; Wells JL, 2006, CLIN INTERV AGING, V1, P67, DOI 10.2147/ciia.2006.1.1.67; Wie GA, 2010, NUTRITION, V26, P263, DOI 10.1016/j.nut.2009.04.013; WOLINSKY FD, 1990, J NUTR, V120, P1549, DOI 10.1093/jn/120.suppl_11.1549	41	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156008	10.1371/journal.pone.0156008	http://dx.doi.org/10.1371/journal.pone.0156008			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27231951	Green Published, gold, Green Submitted			2022-12-26	WOS:000376883000012
J	Maisonneuve, P; Caillet-Saguy, C; Vaney, MC; Bibi-Zainab, E; Sawyer, K; Raynal, B; Haouz, A; Delepierre, M; Lafon, M; Cordier, F; Wolff, N				Maisonneuve, Pierre; Caillet-Saguy, Celia; Vaney, Marie-Christine; Bibi-Zainab, Edoo; Sawyer, Kristi; Raynal, Bertrand; Haouz, Ahmed; Delepierre, Muriel; Lafon, Monique; Cordier, Florence; Wolff, Nicolas			Molecular Basis of the Interaction of the Human Protein Tyrosine Phosphatase Non-receptor Type 4 (PTPN4) with the Mitogen-activated Protein Kinase p38 gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; PDZ DOMAIN; STRUCTURE VALIDATION; CELL-DEATH; PTPMEG; DELTA-2; MAPK	The human protein tyrosine phosphatase non-receptor type 4 (PTPN4) prevents cell death induction in neuroblastoma and glioblastoma cell lines in a PDZ center dot PDZ binding motifs-dependent manner, but the cellular partners of PTPN4 involved in cell protection are unknown. Here, we described the mitogen-activated protein kinase p38 gamma as a cellular partner of PTPN4. The main contribution to the p38 gamma center dot PTPN4 complex formation is the tight interaction between the C terminus of p38 gamma and the PDZ domain of PTPN4. We solved the crystal structure of the PDZ domain of PTPN4 bound to the p38 gamma C terminus. We identified the molecular basis of recognition of the C-terminal sequence of p38 gamma that displays the highest affinity among all endogenous partners of PTPN4. We showed that the p38 gamma C terminus is also an efficient inducer of cell death after its intracellular delivery. In addition to recruiting the kinase, the binding of the C-terminal sequence of p38 gamma to PTPN4 abolishes the catalytic auto-inhibition of PTPN4 and thus activates the phosphatase, which can efficiently dephosphorylate the activation loop of p38 gamma. We presume that the p38 gamma center dot PTPN4 interaction promotes cellular signaling, preventing cell death induction.	[Maisonneuve, Pierre; Caillet-Saguy, Celia; Bibi-Zainab, Edoo; Sawyer, Kristi; Delepierre, Muriel; Cordier, Florence; Wolff, Nicolas] Inst Pasteur, Dept Biol Struct & Chim, Unite Resonance Magnet Nucl Biomol, F-75724 Paris, France; [Vaney, Marie-Christine] Inst Pasteur, Unite Virol Struct, Dept Virol, F-75724 Paris, France; [Lafon, Monique] Inst Pasteur, Unite Neuroimmunol Virale, Dept Virol, F-75724 Paris, France; [Raynal, Bertrand] Inst Pasteur, Plate Forme Biophys Macromol, F-75724 Paris, France; [Haouz, Ahmed] Inst Pasteur, Plate Forme Cristallog, F-75724 Paris, France; [Maisonneuve, Pierre; Caillet-Saguy, Celia; Bibi-Zainab, Edoo; Sawyer, Kristi; Raynal, Bertrand; Haouz, Ahmed; Delepierre, Muriel; Cordier, Florence; Wolff, Nicolas] CNRS, UMR 3528, F-75724 Paris, France; [Vaney, Marie-Christine; Lafon, Monique] CNRS, UMR 3569, F-75724 Paris, France; [Maisonneuve, Pierre] Univ Paris 06, Cellule Pasteur UPMC, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Wolff, N (corresponding author), Inst Pasteur, CNRS, UMR 3528, Unite RMN Biomol, 28 Rue Dr Roux, F-75724 Paris, France.	nicolas.wolff@pasteur.fr	Caillet-Saguy, Célia/AAC-1249-2022	raynal, Bertrand/0000-0001-5634-0408; HAOUZ, Ahmed/0000-0003-1196-1635; Cordier, Florence/0000-0002-5963-7773; Sawyer, Kristi/0000-0003-3485-2028; Lafon, Monique/0000-0002-4423-7996; Maisonneuve, Pierre/0000-0001-8292-5741	TGIR-RMN-THC [Fr3050 CNRS]; Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale [FDT20130927999]; Bourse Roux postdoctoral fellowship from the Pasteur Institute; Erasmus+ Programme	TGIR-RMN-THC; Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Bourse Roux postdoctoral fellowship from the Pasteur Institute; Erasmus+ Programme	This work was supported by TGIR-RMN-THC Fr3050 CNRS. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by grants from the Ministere de l'Enseignement Superieur et de la Recherche and the Fondation pour la Recherche Medicale FDT20130927999.r Recipient of a Bourse Roux postdoctoral fellowship from the Pasteur Institute.r Supported by a student mobility grant through the Erasmus+ Programme.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Babault N, 2011, STRUCTURE, V19, P1518, DOI 10.1016/j.str.2011.07.007; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Caillet-Saguy C, 2015, PROG BIOPHYS MOL BIO, V119, P53, DOI 10.1016/j.pbiomolbio.2015.02.007; Chen KE, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005722; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Gu MX, 1996, J BIOL CHEM, V271, P27751, DOI 10.1074/jbc.271.44.27751; Gu MX, 1996, P NATL ACAD SCI USA, V93, P12980, DOI 10.1073/pnas.93.23.12980; Harris BZ, 2001, J CELL SCI, V114, P3219; Hironaka K, 2000, J BIOL CHEM, V275, P16167, DOI 10.1074/jbc.M909302199; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Huai WW, 2015, J IMMUNOL, V194, P4458, DOI 10.4049/jimmunol.1402183; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kina S, 2007, EUR J NEUROSCI, V26, P2269, DOI 10.1111/j.1460-9568.2007.05829.x; Kohda K, 2013, P NATL ACAD SCI USA, V110, pE948, DOI 10.1073/pnas.1218380110; Kukkonen-Macchi A, 2011, J CELL SCI, V124, P216, DOI 10.1242/jcs.068254; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maisonneuve P, 2014, FEBS J, V281, P4852, DOI 10.1111/febs.13024; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Prehaud C, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000510; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Vogtherr M, 2005, J BIOMOL NMR, V32, P175, DOI 10.1007/s10858-005-2449-x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Young JA, 2008, MOL IMMUNOL, V45, P3756, DOI 10.1016/j.molimm.2008.05.023; Zhou J, 2013, CELL MOL BIOL LETT, V18, P297, DOI 10.2478/s11658-013-0090-3	30	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16699	16708		10.1074/jbc.M115.707208	http://dx.doi.org/10.1074/jbc.M115.707208			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27246854	Green Published, hybrid			2022-12-26	WOS:000380826700027
J	Tachfouti, N; Najdi, A; Alonso, S; Sicuri, E; El Idrissi, AL; Nejjari, C; Picado, A				Tachfouti, Nabil; Najdi, Adil; Alonso, Sergi; Sicuri, Elisa; Laamrani El Idrissi, Abderahmane; Nejjari, Chakib; Picado, Albert			Cost of Pediatric Visceral Leishmaniasis Care in Morocco	PLOS ONE			English	Article							MANAGEMENT	Background Visceral leishmaniasis (VL) is a neglected parasitic disease that is fatal if left untreated. VL is endemic in Morocco and other countries in North Africa were it mainly affects children from rural areas. In Morocco, the direct observation of Leishmania parasites in bone marrow aspirates and serological tests are used to diagnose VL. Glucantime is the first line of treatment. The objective of this study was to report the costs associated to standard clinical management of pediatric VL from the provider perspective in Morocco. As a secondary objective we described the current clinical practices and the epidemiological characteristics of pediatric VL patients. Methods From March to June 2014 we conducted a survey in eight hospitals treating pediatric VL patients in Morocco. A pro-forma was used to collect demographic, clinical and management data from medical records. We specifically collected data on VL diagnosis and treatment. We also estimated the days of hospitalization and the time to start VL treatment. Costs were estimated by multiplying the use of resources in terms of number of days in hospital, tests performed and drugs provided by the official prices. For patients receiving part of their treatment at Primary Health Centers (PHC) we estimated the cost of administering the Glucantime as outpatient. We calculated the median cost per VL patient. We also estimated the cost of managing a VL case when different treatment strategies were applied: inpatient and outpatient. Results We obtained data from 127 VL patients. The median total cost per pediatric VL case in Morocco is 520 US$. The cost in hospitals applying an outpatient strategy is significantly lower (307 US$) than hospitals keeping the patients for the whole treatment (636 US$). However the outpatient strategy is not yet recommended as VL treatment for children in the Moroccan guidelines. VL diagnosis and treatment regimens should be standardized following the current guidelines in Morocco.	[Tachfouti, Nabil; Najdi, Adil; Nejjari, Chakib] Sidi Mohamed Ben Abdellah Univ, Fac Med & Pharm Fez, Lab Epidemiol Clin Res & Community Hlth, Fes, Morocco; [Alonso, Sergi; Sicuri, Elisa; Picado, Albert] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Laamrani El Idrissi, Abderahmane] Minist Hlth, Ctr Epidemiol & Dis Control, Rabat, Morocco; [Nejjari, Chakib] Minist Hlth, ENSP, Rabat, Morocco	Sidi Mohamed Ben Abdellah University of Fez; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona	Picado, A (corresponding author), Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	albert.picado@isglobal.org	Alonso, Sergi/GQZ-1236-2022; Sicuri, Elisa/L-8012-2014; Alonso, Sergi/AAL-1960-2021	Sicuri, Elisa/0000-0002-2499-2732; Alonso, Sergi/0000-0001-6664-3736; Najdi, Adil/0000-0002-3646-6908; Picado, Albert/0000-0001-7344-628X	Thrasher Research Fund, Salt Lake City, USA-Early Career Award [12021]	Thrasher Research Fund, Salt Lake City, USA-Early Career Award	Funding was provided by Thrasher Research Fund, Salt Lake City, USA-Early Career Award # 12021 (https://www.thrasherresearch.org/). The funder of the study had no role in the study design, data collection and analysis, interpretation or reporting of this work, or the decision to submit the work for publication.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Cascio A, 2002, EUR J CLIN MICROBIOL, V21, P277, DOI 10.1007/s10096-002-0707-3; Houda T, 2011, THESIS; Kafetzis DA, 2005, INT J ANTIMICROB AG, V25, P26, DOI 10.1016/j.ijantimicag.2004.09.011; Lakhdar Idrissi M, 2007, JAL PEDIAT PUERICULT, V20, P136; Maltezou HC, 2000, CLIN INFECT DIS, V31, P1139, DOI 10.1086/317455; Meheus F, 2006, TROP MED INT HEALTH, V11, P1715, DOI 10.1111/j.1365-3156.2006.01732.x; Meheus F, 2013, AM J TROP MED HYG, V89, P1146, DOI 10.4269/ajtmh.12-0585; Ministere de la Sante, 2012, LUTT LEISHM GUID ACT; Rhajaoui M, 2011, PATHOL BIOL, V59, P226, DOI 10.1016/j.patbio.2009.09.003; Tachfouti N, 2012, ASIAN PAC J CANCER P, V13, P1547, DOI 10.7314/APJCP.2012.13.4.1547; The World Bank, OFF EXCH RAT LCU PER; The World Bank, INFL CONS PRIC ANN; Walters Stephen J, 2004, Health Qual Life Outcomes, V2, P26, DOI 10.1186/1477-7525-2-26; WHO, 2010, WHO TECH REP SER, V949, P1; Zougaghi L, 2009, ARCH PEDIATRIE, V16, P1513, DOI 10.1016/j.arcped.2009.05.003	16	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155482	10.1371/journal.pone.0155482	http://dx.doi.org/10.1371/journal.pone.0155482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257808	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700016
J	Tonelli, A; Brayda, L; Gori, M				Tonelli, Alessia; Brayda, Luca; Gori, Monica			Depth Echolocation Learnt by Novice Sighted People	PLOS ONE			English	Article							PHYSICAL ANALYSIS; ORGANIC SIGNALS; BLIND; DISCRIMINATION; HUMANS; EXPERT; SHAPE; IDENTIFICATION; LISTENERS; ABILITY	Some blind people have developed a unique technique, called echolocation, to orient themselves in unknown environments. More specifically, by self-generating a clicking noise with the tongue, echolocators gain knowledge about the external environment by perceiving more detailed object features. It is not clear to date whether sighted individuals can also develop such an extremely useful technique. To investigate this, here we test the ability of novice sighted participants to perform a depth echolocation task. Moreover, in order to evaluate whether the type of room (anechoic or reverberant) and the type of clicking sound (with the tongue or with the hands) influences the learning of this technique, we divided the entire sample into four groups. Half of the participants produced the clicking sound with their tongue, the other half with their hands. Half of the participants performed the task in an anechoic chamber, the other half in a reverberant room. Subjects stood in front of five bars, each of a different size, and at five different distances from the subject. The dimension of the bars ensured a constant subtended angle for the five distances considered. The task was to identify the correct distance of the bar. We found that, even by the second session, the participants were able to judge the correct depth of the bar at a rate greater than chance. Improvements in both precision and accuracy were observed in all experimental sessions. More interestingly, we found significantly better performance in the reverberant room than in the anechoic chamber. The type of clicking did not modulate our results. This suggests that the echolocation technique can also be learned by sighted individuals and that room reverberation can influence this learning process. More generally, this study shows that total loss of sight is not a prerequisite for echolocation skills this suggests important potential implications on rehabilitation settings for persons with residual vision.	[Tonelli, Alessia; Gori, Monica] Ist Italiano Tecnol, U VIP Unit Visually Impaired People Sci & Technol, Via Morego 30, Genoa, Italy; [Tonelli, Alessia; Brayda, Luca; Gori, Monica] Fdn Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Via Morego 30, I-16163 Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Istituto Italiano di Tecnologia - IIT	Tonelli, A (corresponding author), Ist Italiano Tecnol, U VIP Unit Visually Impaired People Sci & Technol, Via Morego 30, Genoa, Italy.; Tonelli, A (corresponding author), Fdn Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Via Morego 30, I-16163 Genoa, Italy.	alessia.tonelli@iit.it	Gori, Monica/A-1238-2014; Gori, Monica/AAS-9963-2021; Tonelli, Alessia/AAE-8909-2021; Brayda, Luca/E-5365-2015	Gori, Monica/0000-0002-5616-865X; Brayda, Luca/0000-0002-6673-2971; Tonelli, Alessia/0000-0003-0317-2599				Arnott SR, 2013, NEUROPSYCHOLOGIA, V51, P938, DOI 10.1016/j.neuropsychologia.2013.01.024; BILSEN FA, 1974, J ACOUST SOC AM, V55, P292, DOI 10.1121/1.1914500; DeLong CM, 2007, J ACOUST SOC AM, V121, P605, DOI 10.1121/1.2400848; Gibson J.J., 2014, ECOLOGICAL APPROACH, DOI [DOI 10.4324/9781315740218, 10.4324/9781315740218]; HAUSFELD S, 1982, PERCEPT MOTOR SKILL, V55, P623, DOI 10.2466/pms.1982.55.2.623; Heinrich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061577; Kolarik AJ, 2014, HEARING RES, V310, P60, DOI 10.1016/j.heares.2014.01.010; Kolarik AJ, 2013, EXP BRAIN RES, V224, P623, DOI 10.1007/s00221-012-3340-0; Libbey B, 2004, J ACOUST SOC AM, V116, P3141, DOI 10.1121/1.1781621; Rojas JAM, 2010, ACTA ACUST UNITED AC, V96, P1069, DOI 10.3813/AAA.918368; Rojas JAM, 2009, ACTA ACUST UNITED AC, V95, P325, DOI 10.3813/AAA.918155; Milne JL, 2015, NEUROCASE, V21, P465, DOI 10.1080/13554794.2014.922994; Milne JL, 2014, ATTEN PERCEPT PSYCHO, V76, P1828, DOI 10.3758/s13414-014-0695-2; Moore BC, 2012, INTRO PSYCHOL HEARIN; Papadopoulos T, 2011, BIOMED SIGNAL PROCES, V6, P280, DOI 10.1016/j.bspc.2011.03.005; RICE CE, 1965, SCIENCE, V148, P1107, DOI 10.1126/science.148.3673.1107; Rowan D, 2013, HEARING RES, V300, P56, DOI 10.1016/j.heares.2013.03.005; Schenkman B, 1985, HUMAN ECHOLOCATION D; Schenkman BN, 2011, PERCEPTION, V40, P840, DOI 10.1068/p6898; Schenkman BN, 2010, PERCEPTION, V39, P483, DOI 10.1068/p6473; Schornich S, 2013, ADV EXP MED BIOL, V787, P311, DOI 10.1007/978-1-4614-1590-9_35; Schornich S, 2012, JARO-J ASSOC RES OTO, V13, P673, DOI 10.1007/s10162-012-0338-z; Shinn-Cunningham BG, 2005, J ACOUST SOC AM, V117, P3100, DOI 10.1121/1.1872572; Teng S, 2012, EXP BRAIN RES, V216, P483, DOI 10.1007/s00221-011-2951-1; Teng S, 2011, J VISUAL IMPAIR BLIN, V105, P20, DOI 10.1177/0145482X1110500103; Thaler L, 2014, J NEUROPHYSIOL, V111, P112, DOI 10.1152/jn.00501.2013; Thaler L, 2014, EXP BRAIN RES, V232, P1915, DOI 10.1007/s00221-014-3883-3; Thaler L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00098; Thaler L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020162; Vercillo T, 2015, NEUROPSYCHOLOGIA, V67, P35, DOI 10.1016/j.neuropsychologia.2014.12.001; Wallmeier L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115363	31	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156654	10.1371/journal.pone.0156654	http://dx.doi.org/10.1371/journal.pone.0156654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257689	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700095
J	Zhang, L; Jiang, W; Wang, QJ; Zhao, H; Zhang, HX; Marcec, RM; Willard, ST; Kouba, AJ				Zhang, Lu; Jiang, Wei; Wang, Qi-Jun; Zhao, Hu; Zhang, Hong-Xing; Marcec, Ruth M.; Willard, Scott T.; Kouba, Andrew J.			Reintroduction and Post-Release Survival of a Living Fossil: The Chinese Giant Salamander	PLOS ONE			English	Article							BODY CONDITION; ANDRIAS-DAVIDIANUS; RADIO TRANSMITTERS; AMPHIBIANS; TRANSLOCATION; EXTINCTIONS; BEHAVIOR; REPTILES; GROWTH	Captive rearing and reintroduction / translocation are increasingly used as tools to supplement wild populations of threatened species. Reintroducing captive-reared Chinese giant salamanders may help to augment the declining wild populations and conserve this critically endangered amphibian. We released 31 captive-reared juvenile giant salamanders implanted with VHF radio transmitters at the Heihe River (n = 15) and the Donghe River (n = 16) in the Qinling Mountains of central China. Salamanders were monitored every day for survival from April 28th 2013 to September 3rd 2014. We attempted to recapture all living individuals by the end of the study, measured their body mass and total body length, and checked for abnormalities and presence of external parasites. Two salamanders at the Heihe River and 10 animals at the Donghe River survived through the project timeline. Nine salamanders were confirmed dead, while the status of the other 10 animals was undetermined. The annual survival rate of giant salamanders at the Donghe River (0.702) was 1.7-fold higher than that at the Heihe River (0.405). Survival increased as individuals were held longer following surgery, whereas body mass did not have a significant impact on survival rate. All salamanders recaptured from the Donghe River (n = 8) increased in mass (0.50 +/- 0.13 kg) and length (5.5 +/- 1.5 cm) after approximately 11 months in the wild, and they were only 7% lighter than wild animals of the same length (mean residual = -0.033 +/- 0.025). Our results indicate that captive-reared Chinese giant salamanders can survive in the wild one year after release and adequate surgical recovery time is extremely important to post-release survival. Future projects may reintroduce older juveniles to achieve better survival and longer monitoring duration.	[Zhang, Lu; Marcec, Ruth M.; Willard, Scott T.] Mississippi State Univ, Biochem Mol Biol Entomol & Plant Pathol Dept, Mississippi State, MS 39762 USA; [Zhang, Lu; Kouba, Andrew J.] Memphis Zool Soc, Conservat & Res Dept, Memphis, TN USA; [Jiang, Wei; Wang, Qi-Jun; Zhao, Hu; Zhang, Hong-Xing] Shaanxi Inst Zool, Xian, Shaanxi, Peoples R China; [Kouba, Andrew J.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University	Kouba, AJ (corresponding author), Memphis Zool Soc, Conservat & Res Dept, Memphis, TN USA.; Kouba, AJ (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA.	a.kouba@msstate.edu		Zhang, Lu/0000-0002-1795-9563	U.S. Forest Service International Programs (Asia-Pacific Office); Ocean Park Conservation Foundation, Hong Kong; Shaanxi science and technology plan projects [2013KW20]; Shaanxi Institute of Zoology; Mississippi State University; Memphis Zoo; Los Angeles Zoo; Omaha Henry Doorly Zoo	U.S. Forest Service International Programs (Asia-Pacific Office); Ocean Park Conservation Foundation, Hong Kong; Shaanxi science and technology plan projects; Shaanxi Institute of Zoology; Mississippi State University; Memphis Zoo; Los Angeles Zoo; Omaha Henry Doorly Zoo	Funding was provided by 1) the U.S. Forest Service International Programs (Asia-Pacific Office) (http://www.fs.fed.us/about-agency/international-programs); 2) Ocean Park Conservation Foundation, Hong Kong (http://www.opcf.org.hk/en/); 3) the Shaanxi science and technology plan projects (2013KW20); 4) the Shaanxi Institute of Zoology (http://sxdws.xab.cas.cn/en/); and 5) Mississippi State University (http://www.msstate.edu/). In addition, the following zoos contributed funds to support the project including: 1) Memphis Zoo (http://www.memphiszoo.org/); 2) Los Angeles Zoo (http://www.lazoo.org/); and 3) Omaha Henry Doorly Zoo (http://www.omahazoo.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NS, 1998, T AM FISH SOC, V127, P128, DOI 10.1577/1548-8659(1998)127&lt;0128:EOSAGI&gt;2.0.CO;2; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Berger L., 1999, DECLINES DISAPPEARAN, V1999, P23; Bodinof CM, 2012, COPEIA, P150, DOI 10.1643/CH-11-024; Browne Robert K., 2012, Amphibian & Reptile Conservation, V5, P1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Dervo B, 2010, AMPHIBIA-REPTILIA, V31, P229, DOI 10.1163/156853810791069128; DODD CK, 1991, HERPETOLOGICA, V47, P336; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; GASCON C, 2007, AMPHIBIAN CONSERVATI; Geng Y, 2011, J COMP PATHOL, V145, P95, DOI 10.1016/j.jcpa.2010.11.012; Germano JM, 2009, CONSERV BIOL, V23, P7, DOI 10.1111/j.1523-1739.2008.01123.x; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Liang G, 2004, ANDRIAS DAVIDIANUS; Luo Qinghua, 2009, Shengwu Duoyangxing, V17, P310, DOI 10.3724/SP.J.1003.2009.08041; Marcec R, 2016, J ZOO WILDLIFE MED, V47, P187, DOI 10.1638/2015-0044.1; Martin Steven W., 1995, North American Journal of Fisheries Management, V15, P494, DOI 10.1577/1548-8675(1995)015<0494:COSGDA>2.3.CO;2; Matsui M, 2008, MOL PHYLOGENET EVOL, V49, P318, DOI 10.1016/j.ympev.2008.07.020; NEWTON SF, 1993, J ZOOL, V229, P561, DOI 10.1111/j.1469-7998.1993.tb02657.x; PETERSON CL, 1983, COPEIA, P225, DOI 10.2307/1444718; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Reimer A, 2014, ANIM CONSERV, V17, P235, DOI 10.1111/acv.12085; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Schmutz JA, 1999, J WILDLIFE MANAGE, V63, P1239, DOI 10.2307/3802841; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1021, DOI 10.1139/cjz-79-6-1021; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Souza MJ, 2012, J WILDLIFE DIS, V48, P560, DOI 10.7589/0090-3558-48.3.560; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Wang XMM, 2004, ORYX, V38, P197, DOI 10.1017/S0030605304000341; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Xie F, 2007, SCI CHINA SER C, V50, P265, DOI 10.1007/s11427-007-0021-5; Zhang L, 2014, HERPETOLOGICA, V70, P369, DOI 10.1655/HERPETOLOGICA-D-14-00011R1; Zhao E., 1998, CHINA RED DATA BOOK; Zheng HX, 2010, ASIAN HERPETOL RES, V1, P31, DOI 10.3724/SP.J.1.245.2010.00031; Zhou Z. Y., 2012, African Journal of Biotechnology, V11, P15130	38	16	17	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156715	10.1371/journal.pone.0156715	http://dx.doi.org/10.1371/journal.pone.0156715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258650	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700113
J	Bouchami, O; de Lencastre, H; Miragaia, M				Bouchami, Ons; de Lencastre, Herminia; Miragaia, Maria			Impact of Insertion Sequences and Recombination on the Population Structure of Staphylococcus haemolyticus	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN RESISTANCE; BIOFILM FORMATION; AUREUS; SUSCEPTIBILITY; IDENTIFICATION; TRANSPOSON; ELEMENT; CLONING	Staphylococcus haemolyticus is one of the most common pathogens associated with medical-device related infections, but its molecular epidemiology is poorly explored. In the current study, we aimed to better understand the genetic mechanisms contributing to S. haemolyticus diversity in the hospital environment and their impact on the population structure and clinical relevant phenotypic traits. The analysis of a representative S. haemolyticus collection by multilocus sequence typing (MLST) has identified a single highly prevalent and diverse genetic lineage of nosocomial S. haemolyticus clonal complex (CC) 29 accounting for 91% of the collection of isolates disseminated worldwide. The examination of the sequence changes at MLST loci during clonal diversification showed that recombination had a higher impact than mutation in shaping the S. haemolyticus population. Also, we ascertained that another mechanism contributing significantly to clonal diversification and adaptation was mediated by insertion sequence (IS) elements. We found that all nosocomial S. haemolyticus, belonging to different STs, were rich in IS1272 copies, as determined by Southern hybridization of macrorestriction patterns. In particular, we observed that the chromosome of a S. haemolyticus strain within CC29 was highly unstable during serial growth in vitro which paralleled with IS1272 transposition events and changes in clinically relevant phenotypic traits namely, mannitol fermentation, susceptibility to beta-lactams, biofilm formation and hemolysis. Our results suggest that recombination and IS transposition might be a strategy of adaptation, evolution and pathogenicity of the major S. haemolyticus prevalent lineage in the hospital environment.	[Bouchami, Ons; de Lencastre, Herminia; Miragaia, Maria] Inst Tecnol Quim & Biol ITQB Antonio Xavier, Mol Genet Lab, Oeiras, Portugal; [Bouchami, Ons; Miragaia, Maria] Inst Tecnol Quim & Biol ITQB Antonio Xavier, Lab Bacterial Evolut & Mol Epidemiol, Oeiras, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10021 USA	Rockefeller University	Miragaia, M (corresponding author), Inst Tecnol Quim & Biol ITQB Antonio Xavier, Mol Genet Lab, Oeiras, Portugal.; Miragaia, M (corresponding author), Inst Tecnol Quim & Biol ITQB Antonio Xavier, Lab Bacterial Evolut & Mol Epidemiol, Oeiras, Portugal.	miragaia@itqb.unl.pt	Miragaia, Maria/J-2704-2015	Miragaia, Maria/0000-0002-1323-7184; Bouchami, Ons/0000-0002-9425-3513; /0000-0001-6816-8932	Fundacao para a Ciencia e Tecnologia, Lisbon, Portugal [PTDC/BIA-EVF/117507/2010, SFRH/BPD/98317/2013, UID/CBQ/04612/2013]	Fundacao para a Ciencia e Tecnologia, Lisbon, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Fundacao para a Ciencia e Tecnologia, Lisbon, Portugal (Project PTDC/BIA-EVF/117507/2010 to M. M., fellowship SFRH/BPD/98317/2013 to O. B.) and R&D Unit, UID/CBQ/04612/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer GL, 1996, ANTIMICROB AGENTS CH, V40, P924, DOI 10.1128/AAC.40.4.924; Barros EM, 2012, J CLIN MICROBIOL, V50, P166, DOI 10.1128/JCM.05563-11; Boerlin P, 2003, J CLIN MICROBIOL, V41, P767, DOI 10.1128/JCM.41.2.767-771.2003; Bouchami O, 2012, EUR J CLIN MICROBIOL, V31, P605, DOI 10.1007/s10096-011-1354-3; Cavanagh JP, 2014, J ANTIMICROB CHEMOTH, V69, P2920, DOI 10.1093/jac/dku271; Cavanagh JP, 2012, J MICROBIOL METH, V89, P159, DOI 10.1016/j.mimet.2012.03.014; Chlebowicz MA, 2010, ANTIMICROB AGENTS CH, V54, P783, DOI 10.1128/AAC.00696-09; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Couto I, 2001, J CLIN MICROBIOL, V39, P3099, DOI 10.1128/JCM.39.9.3099-3103.2001; DELENCASTRE H, 1994, EUR J CLIN MICROBIOL, V13, P64, DOI 10.1007/BF02026129; Dominique SA, 2004, RES MICROBIOL, V155, P319, DOI 10.1016/j.resmic.2003.12.008; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2000, RES MICROBIOL, V151, P465, DOI 10.1016/S0923-2508(00)00168-6; Flahaut S, 2008, J BACTERIOL, V190, P1649, DOI 10.1128/JB.01648-07; Frebourg NB, 2000, J CLIN MICROBIOL, V38, P877, DOI 10.1128/JCM.38.2.877-880.2000; Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08; Hira V, 2013, J CLIN MICROBIOL, V51, P595, DOI 10.1128/JCM.02935-12; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kristof K, 2011, EUR J CLIN MICROBIOL, V30, P691, DOI 10.1007/s10096-010-1142-5; MATSUHASHI M, 1986, J BACTERIOL, V167, P975, DOI 10.1128/jb.167.3.975-980.1986; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; Okuma K, 2002, J CLIN MICROBIOL, V40, P4289, DOI 10.1128/JCM.40.11.4289-4294.2002; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Rosenstein R, 2013, CURR TOP MICROBIOL, V358, P33, DOI 10.1007/82_2012_286; Shore AC, 2013, INT J MED MICROBIOL, V303, P350, DOI 10.1016/j.ijmm.2013.02.002; Silva PV, 2013, MEM I OSWALDO CRUZ, V108, P812, DOI 10.1590/0074-0276108062013022; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; Takeuchi F, 2005, J BACTERIOL, V187, P7292, DOI 10.1128/JB.187.21.7292-7308.2005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang H, 2010, J PAEDIATR CHILD H, V46, P668, DOI 10.1111/j.1440-1754.2010.01814.x; Watanabe S, 2007, J BACTERIOL, V189, P2921, DOI 10.1128/JB.01485-06; Wayne P., 2014, M100S24 CLSI, V34, P50; Wu ZW, 2015, ANTIMICROB AGENTS CH, V59, P7597, DOI 10.1128/AAC.01692-15; Zhang ZG, 2011, J MOL MICROB BIOTECH, V21, P59, DOI 10.1159/000333108	42	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156653	10.1371/journal.pone.0156653	http://dx.doi.org/10.1371/journal.pone.0156653			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249649	Green Published, gold, Green Submitted			2022-12-26	WOS:000377184700062
J	Kumar, H; Jain, R; Douglas, RG; Tawhai, MH				Kumar, Haribalan; Jain, Ravi; Douglas, Richard G.; Tawhai, Merryn H.			Airflow in the Human Nasal Passage and Sinuses of Chronic Rhinosinusitis Subjects	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; MAXILLARY SINUS; DRUG-DELIVERY; NUMERICAL-SIMULATION; LOTHROP PROCEDURE; SURGERY; CAVITY; DEPOSITION	Endoscopic surgery is performed on patients with chronic inflammatory disease of the paranasal sinuses to improve sinus ventilation. Little is known about how sinus surgery affects sinonasal airflow. In this study nasal passage geometry was reconstructed from computed tomographic imaging from healthy normal, pre-operative, and post-operative subjects. Transient air flow through the nasal passage during calm breathing was simulated. Subject-specific differences in ventilation of the nasal passage were observed. Velocity magnitude at ostium was different between left and right airway. In FESS, airflow in post-surgical subjects, airflow at the maxillary sinus ostium was upto ten times higher during inspiration. In a Lothrop procedure, airflow at the frontal sinus ostium can be upto four times higher during inspiration. In both post-operative subjects, airflow at ostium was not quasi-steady. The subject-specific effect (of surgery) on sinonasal interaction evaluated through airflow simulations may have important consequences for pre- and post-surgical assessment and surgical planning, and design for improvement of the delivery efficiency of nasal therapeutics.	[Kumar, Haribalan; Tawhai, Merryn H.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Jain, Ravi; Douglas, Richard G.] Univ Auckland, Dept Surg, Auckland 1, New Zealand	University of Auckland; University of Auckland	Kumar, H (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand.	h.kumar@auckland.ac.nz						Abouali O, 2012, RESP PHYSIOL NEUROBI, V181, P335, DOI 10.1016/j.resp.2012.03.002; Chen XB, 2012, J LARYNGOL OTOL, V126, P487, DOI 10.1017/S0022215112000205; Chen XB, 2011, AM J RHINOL ALLERGY, V25, P388, DOI 10.2500/ajra.2011.25.3669; CHIEN WL, 1986, J FLUID MECH, V170, P355, DOI 10.1017/S0022112086000927; Djupesland PG, 2013, DRUG DELIV TRANSL RE, V3, P42, DOI 10.1007/s13346-012-0108-9; Doorly DJ, 2008, RESP PHYSIOL NEUROBI, V163, P100, DOI 10.1016/j.resp.2008.07.027; ElBadawey MR, 2014, AM J RHINOL ALLERGY, V28, P428, DOI 10.2500/ajra.2014.28.4063; Frank DO, 2013, INT FORUM ALLERGY RH, V3, P834, DOI 10.1002/alr.21203; Frank-Ito DO, 2016, J AEROSOL MED PULM D, V29, P46, DOI 10.1089/jamp.2014.1188; Ge QJ, 2012, INHAL TOXICOL, V24, P492, DOI 10.3109/08958378.2012.694494; Hood CM, 2009, J APPL PHYSIOL, V107, P1195, DOI 10.1152/japplphysiol.91615.2008; Horner M, 2002, J FLUID MECH, V452, P199, DOI 10.1017/S0022112001006917; Kennedy D, 2001, DIS SINUSES DIAGNOSI; Kessler R, 2010, NOTES NUMER FLUID ME, V112, P521, DOI 10.1007/978-3-642-14243-7_64; Khong JJ, 2004, J LARYNGOL OTOL, V118, P352, DOI 10.1258/002221504323086534; Kolsek T, 2007, APPL MATH MODEL, V31, P2355, DOI 10.1016/j.apm.2006.10.010; Kountakis S, 2005, THE FRONTAL SINUS; Kumar H, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3567066; Leclerc L, 2014, PHARM RES-DORDR, V31, P2335, DOI 10.1007/s11095-014-1330-6; Liang Jonathan, 2013, Curr Otorhinolaryngol Rep, V1, P51; Lindemann J, 2005, AM J OTOLARYNG, V26, P175, DOI 10.1016/j.amjoto.2005.02.010; Loudon C, 1998, J THEOR BIOL, V191, P63, DOI 10.1006/jtbi.1997.0564; Moller W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074991; Penttila M, 1997, ACTA OTO-LARYNGOL, P173; Ramprasad VH, 2016, J BIOMECH, V49, P450, DOI 10.1016/j.jbiomech.2016.01.009; Rennie CE, 2011, OTOLARYNG HEAD NECK, V145, P165, DOI 10.1177/0194599811401202; Snidvongs K, 2013, AM J RHINOL ALLERGY, V27, P221, DOI 10.2500/ajra.2013.27.3880; Taylor DJ, 2010, J R SOC INTERFACE, V7, P515, DOI 10.1098/rsif.2009.0306; Thompson CF, 2015, CURR OPIN OTOLARYNGO, V23, P34, DOI 10.1097/MOO.0000000000000128; Ting JY, 2014, LARYNGOSCOPE, V124, P1066, DOI 10.1002/lary.24422; Vinchurkar S, 2008, COMPUT FLUIDS, V37, P317, DOI 10.1016/j.compfluid.2007.05.001; Wang X, 2014, INFLAMMATION, V37, P871, DOI 10.1007/s10753-013-9807-8; Weber Rainer K, 2015, GMS Curr Top Otorhinolaryngol Head Neck Surg, V14, pDoc08, DOI 10.3205/cto000123; Wen J, 2008, RESP PHYSIOL NEUROBI, V161, P125, DOI 10.1016/j.resp.2008.01.012; Wofford MR, 2015, RHINOLOGY, V53, P41, DOI [10.4193/Rhino13.065, 10.4193/Rhin13.065]; Wood AJ, 2010, POSTGRAD MED J, V86, P359, DOI 10.1136/pgmj.2009.094813; Xiong GX, 2008, AM J RHINOL, V22, P477, DOI 10.2500/ajr.2008.22.3211; Xiong GX, 2008, MED BIOL ENG COMPUT, V46, P1161, DOI 10.1007/s11517-008-0384-1; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zachow S, 2006, INT J COMPUT ASS RAD, V1, P165; Zhao K, 2014, INT FORUM ALLERGY RH, V4, P435, DOI 10.1002/alr.21319; Zhu JH, 2014, RESP PHYSIOL NEUROBI, V194, P29, DOI 10.1016/j.resp.2014.01.004	42	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156379	10.1371/journal.pone.0156379	http://dx.doi.org/10.1371/journal.pone.0156379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249219	Green Published, gold, Green Submitted			2022-12-26	WOS:000377184700039
J	Lambie, M; Chess, J; Do, JY; Noh, H; Lee, HB; Kim, YL; Summers, A; Williams, PF; Davison, S; Dorval, M; Topley, N; Davies, SJ				Lambie, Mark; Chess, James; Do, Jun-Young; Noh, Hyunjin; Lee, Hi-Bahl; Kim, Yong-Lim; Summers, Angela; Williams, Paul Ford; Davison, Sara; Dorval, Marc; Topley, Nick; Davies, Simon John		Global Fluid Study Investigators	Peritoneal Dialysate Glucose Load and Systemic Glucose Metabolism in Non-Diabetics: Results from the GLOBAL Fluid Cohort Study	PLOS ONE			English	Article							HYPERGLYCEMIA; ASSOCIATION; DEFINITION; ICODEXTRIN; TRANSPORT; DISEASE	Background and Objectives Glucose control is a significant predictor of mortality in diabetic peritoneal dialysis (PD) patients. During PD, the local toxic effects of intra-peritoneal glucose are well recognized, but despite large amounts of glucose being absorbed, the systemic effects of this in non-diabetic patients are not clear. We sought to clarify whether dialysate glucose has an effect upon systemic glucose metabolism. Methods and Materials We analysed the Global Fluid Study cohort, a prospective, observational cohort study initiated in 2002. A subset of 10 centres from 3 countries with high data quality were selected (368 incident and 272 prevalent non-diabetic patients), with multilevel, multivariable analysis of the reciprocal of random glucose levels, and a stratified-by-centre Cox survival analysis. Results The median follow up was 5.6 and 6.4 years respectively in incident and prevalent patients. On multivariate analysis, serum glucose increased with age (beta = -0.007, 95% CI -0.010, -0.004) and decreased with higher serum sodium (beta = 0.002, 95% CI 0.0005, 0.003) in incident patients and increased with dialysate glucose (beta = -0.0002, 95% CI -0.0004, -0.00006) in prevalent patients. Levels suggested undiagnosed diabetes in 5.4% of prevalent patients. Glucose levels predicted death in unadjusted analyses of both incident and prevalent groups but in an adjusted survival analysis they did not (for random glucose 6-10 compared with <6, Incident group HR 0.92, 95% CI 0.58, 1.46, Prevalent group HR 1.42, 95% CI 0.86, 2.34). Conclusions In prevalent non-diabetic patients, random glucose levels at a diabetic level are under-recognised and increase with dialysate glucose load. Random glucose levels predict mortality in unadjusted analyses, but this association has not been proven in adjusted analyses.	[Lambie, Mark; Davies, Simon John] Keele Univ, Inst Appl Clin Res, Stoke On Trent, Staffs, England; [Chess, James; Topley, Nick] Cardiff Univ, Sch Med, Inst Nephrol, Heath Pk, Cardiff CF10 3AX, S Glam, Wales; [Chess, James] Morriston Hosp, Renal Unit, Swansea, W Glam, Wales; [Do, Jun-Young] Yeungnam Univ Hosp, Div Nephrol, Daegu, South Korea; [Noh, Hyunjin; Lee, Hi-Bahl] Soonchunhyang Univ, Hyonam Kidney Lab, Seoul, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ Hosp, Div Nephrol, Daegu, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ Hosp, Clin Res Ctr ESRD Korea, Daegu, South Korea; [Summers, Angela] Manchester Royal Infirm, Manchester Inst Nephrol & Transplantat, Oxford Rd, Manchester M13 9WL, Lancs, England; [Williams, Paul Ford] Ipswich Hosp NHS Trust Ipswich Hosp, Heath Rd, Ipswich, Suffolk, England; [Davison, Sara] Univ Alberta, Div Nephrol & Immunol, Edmonton, AB, Canada; [Dorval, Marc] Dr Georges L Dumont Univ Hosp Ctr, Div Nephrol, Moncton, NB, Canada	Keele University; Cardiff University; Morriston Hospital; Yeungnam University; Yeungnam University Hospital; Soonchunhyang University; Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University Hospital; University of Manchester; Ipswich Hospital NHS Trust; Ipswich Hospital; University of Alberta	Davies, SJ (corresponding author), Keele Univ, Inst Appl Clin Res, Stoke On Trent, Staffs, England.; Topley, N (corresponding author), Cardiff Univ, Sch Med, Inst Nephrol, Heath Pk, Cardiff CF10 3AX, S Glam, Wales.	topley@cf.ac.uk; simondavies1@compuserve.com	Dorval, Marc/M-7219-2015; Lambie, Mark/AAA-9104-2020; Summers, Angela/AAC-9038-2019	Dorval, Marc/0000-0002-9548-978X; Lambie, Mark/0000-0002-6285-5368; Davies, Simon/0000-0001-5127-4755	Baxter Healthcare Renal Division; International Society for Peritoneal Dialysis	Baxter Healthcare Renal Division; International Society for Peritoneal Dialysis	Infrastructure support for the establishment of the GLOBAL fluid study was provided as unrestricted educational grants from Baxter Healthcare Renal Division (www.baxter.com) and the International Society for Peritoneal Dialysis (www.ispd.org). This study was officially endorsed by the ISPD (www.ispd.org) and by the British Renal Society (BRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Infrastructure support for the establishment of the GLOBAL fluid study was provided as unrestricted educational grants from Baxter Healthcare Renal Division and the International Society for Peritoneal Dialysis. This study was officially endorsed by the ISPD (www.ispd.org) and by the British Renal Society (BRS) (www.britishrenal.org). The authors would like to acknowledge the support of Anna-Clare Smith, Kathryn Craig, Maureen Fallon and Charlotte James in the co-ordination of the GLOBAL study, Christopher Huckvale in the development of PDDB, and the following clinical staff in the centres for co-ordination of sample and clinical data collection; Hilary Huxtable SRN., Renal Unit, Morriston Hospital, Swansea, UK; Gill Gilbert RGN BSc (Hons), Ipswich Hospital NHS Trust; Catherine Jones RGN, John Torode RGN and Jane Hollis RGN BSc (Hons), Cambridge University Hospitals NHS Foundation Trust; Jung-Ju Seo, RN, MS., Kyungpook National University Hospital, Daegu, South Korea; Kei-Lim Shin, RN., Yeungnam University Hospital, Daegu, South Korea; Sung Hee Chung, R.N., Ph.D., Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, South Korea; Joanne Leblanc-Chiasson, RN, Rachel Belliveau, RN, Regina Arsenault, RN, research assistant, Dr Georges-L.-Dumont Hospital, Moncton, New-Brunswick, Canada; Kathy Yetzer RN and Donna Hackman RN, Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Canada and the nursing teams on the PD Units of the University Hospital of Wales, Cardiff and University Hospital of North Staffordshire, Stoke-on-Trent.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2005, DIABETES CARE, V28, pS4; Borch-Johnsen K, 1999, LANCET, V354, P617; BOYER J, 1967, ANN INTERN MED, V67, P568, DOI 10.7326/0003-4819-67-3-568; Bremer AA, 2012, PEDIATRICS, V129, P557, DOI 10.1542/peds.2011-2912; Caduff A, 2011, DIABETOLOGIA, V54, P2678, DOI 10.1007/s00125-011-2210-9; Chou CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087891; Chung SH, 2015, INT UROL NEPHROL, V47, P1017, DOI 10.1007/s11255-015-0987-z; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; Garcia-Lopez E, 2005, PERITON DIALYSIS INT, V25, P181; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jiang N, 2008, BLOOD PURIFICAT, V26, P423, DOI 10.1159/000153248; Lambie M, 2013, J AM SOC NEPHRO 0905; Lee SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057762; Li PKT, 2013, J AM SOC NEPHROL, V24, P1889, DOI 10.1681/ASN.2012100987; Paniagua R, 2009, PERITON DIALYSIS INT, V29, P422; RASBASH J, 2005, MLWIN VERSION 2 02; Shai I, 2006, DIABETES CARE, V29, P1585, DOI 10.2337/dc06-0057; Szeto CC, 2007, AM J KIDNEY DIS, V49, P524, DOI 10.1053/j.ajkd.2007.01.018; Wong TYH, 2003, KIDNEY INT, V63, P1404, DOI 10.1046/j.1523-1755.2003.00883.x; Woodward RS, 2003, AM J TRANSPLANT, V3, P590, DOI 10.1034/j.1600-6143.2003.00082.x	22	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155564	10.1371/journal.pone.0155564	http://dx.doi.org/10.1371/journal.pone.0155564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249020	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000377184700018
J	Marino, D; Perkovic, M; Hain, A; Vasudevan, AAJ; Hofmann, H; Hanschmann, KM; Muhlebach, MD; Schumann, GG; Konig, R; Cichutek, K; Haussinger, D; Munk, C				Marino, Daniela; Perkovic, Mario; Hain, Anika; Vasudevan, Ananda A. Jaguva; Hofmann, Henning; Hanschmann, Kay-Martin; Muehlebach, Michael D.; Schumann, Gerald G.; Koenig, Renate; Cichutek, Klaus; Haeussinger, Dieter; Muenk, Carsten			APOBEC4 Enhances the Replication of HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RNA EDITING ENZYME; B MESSENGER-RNA; CYTIDINE DEAMINASE AID; CLASS SWITCH RECOMBINATION; MALE GENITAL-TRACT; VIF PROTEIN; IN-SITU; ANTIRETROVIRAL THERAPY; MOLECULAR-CLONING	APOBEC4 (A4) is a member of the AID/APOBEC family of cytidine deaminases. In this study we found a high mRNA expression of A4 in human testis. In contrast, there were only low levels of A4 mRNA detectable in 293T, HeLa, Jurkat or A3.01 cells. Ectopic expression of A4 in HeLa cells resulted in mostly cytoplasmic localization of the protein. To test whether A4 has antiviral activity similar to that of proteins of the APOBEC3 (A3) subfamily, A4 was co-expressed in 293T cells with wild type HIV-1 and HIV-1 luciferase reporter viruses. We found that A4 did not inhibit the replication of HIV-1 but instead enhanced the production of HIV-1 in a dose-dependent manner and seemed to act on the viral LTR. A4 did not show detectable cytidine deamination activity in vitro and weakly interacted with single-stranded DNA. The presence of A4 in virus producer cells enhanced HIV-1 replication by transiently transfected A4 or stably expressed A4 in HIV-susceptible cells. APOBEC4 was capable of similarly enhancing transcription from a broad spectrum of promoters, regardless of whether they were viral or mammalian. We hypothesize that A4 may have a natural role in modulating host promoters or endogenous LTR promoters.	[Marino, Daniela; Perkovic, Mario; Hain, Anika; Vasudevan, Ananda A. Jaguva; Hofmann, Henning; Haeussinger, Dieter; Muenk, Carsten] Univ Dusseldorf, Fac Med, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Marino, Daniela; Perkovic, Mario; Hofmann, Henning; Muehlebach, Michael D.; Schumann, Gerald G.; Cichutek, Klaus; Muenk, Carsten] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany; [Hanschmann, Kay-Martin] Paul Ehrlich Inst, Biostat, Langen, Germany; [Muehlebach, Michael D.] Paul Ehrlich Inst, Prod Testing Immunol Med Prod Vet Uses, Langen, Germany; [Koenig, Renate] Paul Ehrlich Inst, Host Pathogen Interact, Langen, Germany; [Koenig, Renate] Sanford Burnham Prebys Med Discovery Inst, Immun & Pathogenesis Program, La Jolla, CA USA; [Perkovic, Mario] Johannes Gutenberg Univ Mainz, TRON Translat Oncol Univ Med Ctr, D-55122 Mainz, Germany; [Hofmann, Henning] Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany	Heinrich Heine University Dusseldorf; Paul Ehrlich Institute; Paul Ehrlich Institute; Paul Ehrlich Institute; Paul Ehrlich Institute; Sanford Burnham Prebys Medical Discovery Institute; Johannes Gutenberg University of Mainz; Robert Koch Institute	Munk, C (corresponding author), Univ Dusseldorf, Fac Med, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany.; Munk, C (corresponding author), Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany.	carsten.muenk@med.uni-duesseldorf.de	Perkovic, Mario/AAZ-2653-2021; Vasudevan, Ananda Ayyappan Jaguva/A-2272-2013; König, Renate/AAB-8918-2019	Vasudevan, Ananda Ayyappan Jaguva/0000-0001-7049-9458; König, Renate/0000-0003-4882-9179; Muehlebach, Michael/0000-0002-7069-5018; Perkovic, Mario/0000-0002-8969-5157	Heinz-Ansmann foundation for AIDS research	Heinz-Ansmann foundation for AIDS research	CM is supported by the Heinz-Ansmann foundation for AIDS research	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Bednar MM, 2015, J VIROL, V89, P10688, DOI 10.1128/JVI.01842-15; Beggel B, 2013, J VIRAL HEPATITIS, V20, P882, DOI 10.1111/jvh.12110; Bishop KN, 2004, SCIENCE, V305, P645, DOI 10.1126/science.1100658; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Cronauer MV, 2004, ONCOGENE, V23, P3541, DOI 10.1038/sj.onc.1207346; Crowell RC, 2007, BIOCHEM SOC T, V35, P629, DOI 10.1042/BST0350629; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; Esnault C, 2006, NUCLEIC ACIDS RES, V34, P1522, DOI 10.1093/nar/gkl054; Fehrholz M, 2012, J GEN VIROL, V93, P565, DOI 10.1099/vir.0.038919-0; Fieni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076367; FOLKS T, 1985, P NATL ACAD SCI USA, V82, P4539, DOI 10.1073/pnas.82.13.4539; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; Hoffmeyer A, 1999, J BIOL CHEM, V274, P4319, DOI 10.1074/jbc.274.7.4319; Houzet L, 2014, J INFECT DIS, V210, pS622, DOI 10.1093/infdis/jiu328; Ikeda T, 2008, NUCLEIC ACIDS RES, V36, P6859, DOI 10.1093/nar/gkn802; Ikeda T, 2016, SCI REP-UK, V6, DOI 10.1038/srep19035; Ikeda T, 2011, NUCLEIC ACIDS RES, V39, P5538, DOI 10.1093/nar/gkr124; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Jang H, 2015, J BIOL CHEM, V290, P9465, DOI 10.1074/jbc.M114.620724; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kolokithas A, 2010, J VIROL, V84, P10933, DOI 10.1128/JVI.01023-10; Lada AG, 2011, BIOCHEMISTRY-MOSCOW+, V76, P131, DOI 10.1134/S0006297911010135; Le Tortorec A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001792; Lochelt M, 2005, P NATL ACAD SCI USA, V102, P7982, DOI 10.1073/pnas.0501445102; Lowe SH, 2004, AIDS, V18, P1353, DOI 10.1097/01.aids.0000125979.64033.96; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; MacDuff DA, 2009, NUCLEIC ACIDS RES, V37, P1854, DOI 10.1093/nar/gkp030; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Mariani R, 2001, J VIROL, V75, P3141, DOI 10.1128/JVI.75.7.3141-3151.2001; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Matusali G, 2015, J VIROL, V89, P5772, DOI 10.1128/JVI.03628-14; McDougall WM, 2011, J BIOL CHEM, V286, P30655, DOI 10.1074/jbc.M111.269506; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Metzner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049358; Muciaccia B, 1998, J REPROD IMMUNOL, V41, P81, DOI 10.1016/S0165-0378(98)00050-3; Muciaccia B, 1998, FASEB J, V12, P151, DOI 10.1096/fasebj.12.2.151; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Munk C, 2012, VIRUSES-BASEL, V4, P3132, DOI 10.3390/v4113132; Munk C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-71; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Navaratnam N, 2006, INT J HEMATOL, V83, P195, DOI 10.1532/IJH97.06032; NAVARATNAM N, 1993, J BIOL CHEM, V268, P20709; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; NUOVO GJ, 1994, AM J PATHOL, V144, P1142; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Paranjpe S, 2002, AIDS RES HUM RETROV, V18, P1271, DOI 10.1089/088922202320886316; Peng ZG, 2011, HEPATOLOGY, V53, P1080, DOI 10.1002/hep.24160; Perkovic M, 2009, J BIOL CHEM, V284, P5819, DOI 10.1074/jbc.M808853200; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Petit V, 2009, J MOL BIOL, V385, P65, DOI 10.1016/j.jmb.2008.10.043; Polevoda B, 2015, NUCLEIC ACIDS RES, V43, P9434, DOI 10.1093/nar/gkv970; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Prohaska KM, 2014, WIRES RNA, V5, P493, DOI 10.1002/wrna.1226; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994; Rosenberg BR, 2011, NAT STRUCT MOL BIOL, V18, P230, DOI 10.1038/nsmb.1975; Roulet V, 2006, AM J PATHOL, V169, P2094, DOI 10.2353/ajpath.2006.060191; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; Santangelo PJ, 2015, NAT METHODS, V12, P427, DOI [10.1038/NMETH.3320, 10.1038/nmeth.3320]; Sato Y, 2010, J BIOL CHEM, V285, P7111, DOI 10.1074/jbc.M109.052977; Schumann GG, 2010, INT REV CEL MOL BIO, V285, P115, DOI 10.1016/S1937-6448(10)85003-8; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shehu-Xhilaga M, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-7; Shevchuk MM, 1998, J REPROD IMMUNOL, V41, P69, DOI 10.1016/S0165-0378(98)00049-7; SIMM M, 1995, J VIROL, V69, P4582, DOI 10.1128/JVI.69.7.4582-4586.1995; SIMON JHM, 1995, J VIROL, V69, P4166, DOI 10.1128/JVI.69.7.4166-4172.1995; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Stavrou S, 2015, CELL HOST MICROBE, V17, P478, DOI 10.1016/j.chom.2015.02.021; Stavrou S, 2013, P NATL ACAD SCI USA, V110, P9078, DOI 10.1073/pnas.1217399110; Steinhoff C, 2004, MOL GENET GENOMICS, V270, P394, DOI 10.1007/s00438-003-0931-2; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Tsuge M, 2010, VIRUS RES, V149, P211, DOI 10.1016/j.virusres.2010.01.019; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Vasudevan AAJ, 2013, BIOL CHEM, V394, P1357, DOI 10.1515/hsz-2013-0165; Vasudevan AAJ, 2013, J VIROL, V87, P9030, DOI 10.1128/JVI.03385-12; WAGNER E, 1991, P NATL ACAD SCI USA, V88, P4255, DOI 10.1073/pnas.88.10.4255; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wu LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021929; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	92	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155422	10.1371/journal.pone.0155422	http://dx.doi.org/10.1371/journal.pone.0155422			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249646	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700012
J	Sena-Velez, M; Redondo, C; Graham, JH; Cubero, J				Sena-Velez, Marta; Redondo, Cristina; Graham, James H.; Cubero, Jaime			Presence of Extracellular DNA during Biofilm Formation by Xanthomonas citri subsp citri Strains with Different Host Range	PLOS ONE			English	Article							AXONOPODIS PV. CITRI; PSEUDOMONAS-AERUGINOSA; TWITCHING MOTILITY; BACTERIAL BIOFILMS; MICROBIAL BIOFILMS; IV PILI; PROTEIN; VIRULENCE; CAMPESTRIS; CANKER	Xanthomonas citri subsp. citri (Xcc) A strain causes citrus bacterial canker, a serious leaf, fruit and stem spotting disease of several Citrus species. X. alfalfae subsp. citrumelonis (Xac) is the cause of citrus bacterial spot, a minor disease of citrus nursery plants and X. campestris pv. campestris (Xc) is a systemic pathogen that causes black rot of cabbage. Xanthomonas spp. form biofilms in planta that facilitate the host infection process. Herein, the role of extracellular DNA (eDNA) was evaluated in the formation and stabilization of the biofilm matrix at different stages of biofilm development. Fluorescence and light microscopy, as well as DNAse treatments, were used to determine the presence of eDNA in biofilms and bacterial cultures. DNAse treatments of Xcc strains and Xac reduced biofilm formation at the initial stage of development, as well as disrupted preformed biofilm. By comparison, no significant effect of the DNAse was detected for biofilm formation by Xc. DNAse effects on biofilm formation or disruption varied among Xcc strains and Xanthomonas species which suggest different roles for eDNA. Variation in the structure of fibers containing eDNA in biofilms, bacterial cultures, and in twitching motility was also visualized by microscopy. The proposed roles for eDNA are as an adhesin in the early stages of biofilm formation, as an structural component of mature bacterial aggregates, and twitching motility structures.	[Sena-Velez, Marta; Redondo, Cristina; Cubero, Jaime] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Plant Protect, Madrid, Spain; [Graham, James H.] Univ Florida, CREC, Lake Alfred, FL USA	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); State University System of Florida; University of Florida	Cubero, J (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Plant Protect, Madrid, Spain.	cubero@inia.es	Cubero, Jaime/D-2322-2017; Sena Velez, Marta/HDN-4763-2022	Cubero, Jaime/0000-0002-4314-857X; Sena Velez, Marta/0000-0001-9256-6084; REDONDO, CRISTINA/0000-0001-6303-3297	Citrus Research and Development Foundation [CRDF546]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) project [RTA2008-00048]	Citrus Research and Development Foundation; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) project	This work was supported by Citrus Research and Development Foundation project CRDF546 (JHG JC) and Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) project RTA2008-00048 (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Astua-Monge G, 2005, J BACTERIOL, V187, P1201, DOI 10.1128/JB.187.3.1201-1205.2005; Bakkali M, 2013, ARCH MICROBIOL, V195, P279, DOI 10.1007/s00203-013-0870-1; Bockelmann U, 2006, FEMS MICROBIOL LETT, V262, P31, DOI 10.1111/j.1574-6968.2006.00361.x; Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440; Catlin WB, 1956, SCIENCE, V124, P441; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Chimileski S, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0065-5; Conover MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016861; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; Cubero J, 2011, PLANT PATHOL, V60, P977, DOI 10.1111/j.1365-3059.2011.02450.x; Cubero J, 2002, APPL ENVIRON MICROB, V68, P1257, DOI 10.1128/AEM.68.3.1257-1264.2002; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dunger G, 2014, MOL PLANT MICROBE IN, V27, P1132, DOI 10.1094/MPMI-06-14-0184-R; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Gloag ES, 2013, P NATL ACAD SCI USA, V110, P11541, DOI 10.1073/pnas.1218898110; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; GRAHAM JH, 1990, PHYTOPATHOLOGY, V80, P190, DOI 10.1094/Phyto-80-190; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hayward A. C., 1993, Xanthomonas., P1; Jakubovics NS, 2013, LETT APPL MICROBIOL, V57, P467, DOI 10.1111/lam.12134; Jalan N, 2013, GENOME ANNOUNCEMENTS, V1; Jalan N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-551; Kraiselburd I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038226; Lawrence JR, 2003, APPL ENVIRON MICROB, V69, P5543, DOI 10.1128/AEM.69.9.5543-5554.2003; Li JY, 2011, MOL PLANT PATHOL, V12, P381, DOI 10.1111/j.1364-3703.2010.00681.x; Liao SM, 2014, J BACTERIOL, V196, P2355, DOI 10.1128/JB.01493-14; Malamud F, 2013, MICROBIOL-SGM, V159, P1911, DOI 10.1099/mic.0.064709-0; Malamud F, 2011, MICROBIOL-SGM, V157, P819, DOI 10.1099/mic.0.044255-0; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; MOREIRA L, 2014, FUNCTIONAL AND INTEG, V15, P197, DOI DOI 10.1007/S10142-014-0414-Z; Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Nemoto K, 2003, CHEMOTHERAPY, V49, P121, DOI 10.1159/000070617; Nijland R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015668; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Rigano LA, 2007, MOL PLANT MICROBE IN, V20, P1222, DOI 10.1094/mpmi-20-10-1222; Schaad Norman W, 2006, Syst Appl Microbiol, V29, P690, DOI 10.1016/j.syapm.2006.08.001; Sena-Velez M, 2015, PLANT PATHOL, V64, P767, DOI 10.1111/ppa.12311; Sena-Velez M, 2012, XII INTERNATIONAL CI, V197; Sgro GG, 2012, MOL PLANT PATHOL, V13, P1047, DOI 10.1111/j.1364-3703.2012.00814.x; Shields RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055339; Strelkova EA, 2013, MICROBIOLOGY+, V82, P119, DOI 10.1134/S002626171302015X; Sun XA, 2004, PLANT DIS, V88, P1179, DOI 10.1094/PDIS.2004.88.11.1179; van Schaik EJ, 2005, J BACTERIOL, V187, P1455, DOI 10.1128/JB.187.4.1455-1464.2005; Verniere C, 1998, EUR J PLANT PATHOL, V104, P477, DOI 10.1023/A:1008676508688; Vicente JG, 2013, MOL PLANT PATHOL, V14, P2, DOI 10.1111/j.1364-3703.2012.00833.x; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Wengelnik K, 1996, J BACTERIOL, V178, P1061, DOI 10.1128/jb.178.4.1061-1069.1996; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yaryura PM, 2015, ENV MICROBIOL; Zimaro T, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-96; Zimaro T, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-186	57	25	26	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156695	10.1371/journal.pone.0156695	http://dx.doi.org/10.1371/journal.pone.0156695			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248687	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700066
J	Zhang, WD; Wang, WH; Jia, S				Zhang, Wang-Dong; Wang, Wen-Hui; Jia, Shuai			The Distribution of SIgA and IgG Antibody-Secreting Cells in the Small Intestine of Bactrian Camels (Camelus bactrianus) of Different Ages	PLOS ONE			English	Article							AGGREGATED LYMPHOID NODULES; HUMAN GUT MICROBIOME; COMMENSAL BACTERIA; MUCOSAL SURFACES; DENDRITIC CELLS; B-CELLS; RESPONSES; COLONIZATION; HOMEOSTASIS; INFECTION	Secretory immunoglobulin A (SIgA) and immunoglobulin G (IgG) antibody-secreting cells (ASCs) are two important cell types in the mucosal immune system. This study aimed to explore the distribution of these ASC populations in the small intestine of Bactrian camels of different ages. Twenty-four Alashan Bactrian camels were divided into the following four age groups: young (1-2 years), pubertal (3-5 years), middle-aged (6-16 years) and old (17-20 years). SIgA and IgG ASCs in the intestinal mucosa lamina propria (LP) were observed and analyzed using immunohistochemcal techniques. The results from all age groups show that both SIgA and IgG ASCs were diffusely distributed in the intestinal LP, and some cells aggregated around the crypts. Moreover, the densities of the two ASC populations gradually increased from the duodenum to the jejunum and then decreased in the ileum. Meanwhile, there were more SIgA ASCs than IgG ASCs in the duodenum, jejunum, and ileum, and these differences were significant in the young and pubertal groups (P<0.05). In addition, the SIgA and IgG ASC densities increased from the young to the pubertal period, peaked at puberty, and then gradually decreased with age. The results demonstrate that the SIgA and IgG ASC distributions help to form two immunoglobulin barriers in the intestinal mucosa to provide full protection, helping to maintain homeostasis. These findings also underscore the importance of researching the development and degeneration of intestinal mucosal immunity in Bactrian camels.	[Zhang, Wang-Dong; Wang, Wen-Hui; Jia, Shuai] Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University	Wang, WH (corresponding author), Gansu Agr Univ, Coll Vet Med, Lanzhou, Gansu, Peoples R China.	wwh777@126.com		, Wang-Dong/0000-0002-4277-3437	National Natural Scientific Foundation [31260595, 30671549]; Fostering Foundation for the Excellent Ph.D. Dissertation of Gansu Agricultural University [2013001]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Fostering Foundation for the Excellent Ph.D. Dissertation of Gansu Agricultural University	This project was supported in part by the National Natural Scientific Foundation (Project Grant No. 31260595; 30671549) to Professor Wen-Hui Wang (http://www.nsfc.gov.cn), and the Fostering Foundation for the Excellent Ph.D. Dissertation of Gansu Agricultural University (Project Grant No. 2013001) to Professor Wen-Hui Wang (http://www.gsau.edu.cn/).	Abdel-Magied EM, 2003, ANAT HISTOL EMBRYOL, V32, P42, DOI 10.1046/j.1439-0264.2003.00436.x; Allen RH, 2008, AM J CLIN NUTR, V87, P1324, DOI 10.1093/ajcn/87.5.1324; Anderson PJ, 2008, J BACTERIOL, V190, P1160, DOI 10.1128/JB.01386-07; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Aydar Y, 2004, AGEING RES REV, V3, P15, DOI 10.1016/j.arr.2003.08.002; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barnich N, 2007, J CLIN INVEST, V117, P1566, DOI 10.1172/JCI30504; Barone F, 2011, GASTROENTEROLOGY, V140, P947, DOI 10.1053/j.gastro.2010.12.005; Berneman A, 1998, INFECT IMMUN, V66, P4163; Brandtzaeg P, 1999, IMMUNOL REV, V171, P45, DOI 10.1111/j.1600-065X.1999.tb01342.x; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; Cerutti A, 2010, SCIENCE, V328, P1646, DOI 10.1126/science.1192488; Corthesy B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00185; Deschacht N, 2010, J IMMUNOL, V184, P5696, DOI 10.4049/jimmunol.0903722; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Johansen FE, 2011, MUCOSAL IMMUNOL, V4, P598, DOI 10.1038/mi.2011.37; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; Kim SC, 2007, INFLAMM BOWEL DIS, V13, P1457, DOI 10.1002/ibd.20246; Kraehenbuhl JP, 2000, ANNU REV CELL DEV BI, V16, P301, DOI 10.1146/annurev.cellbio.16.1.301; Latiff AHA, 2007, ANN CLIN BIOCHEM, V44, P131, DOI 10.1258/000456307780117993; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lin-Jiang Z, 2012, STUDY DISTRIBUTION B; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Qi SS, 2011, TROP ANIM HEALTH PRO, V43, P1219, DOI 10.1007/s11250-011-9829-x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Schmucker Douglas L, 2003, Clin Dev Immunol, V10, P167, DOI 10.1080/10446670310001642168; Shikina T, 2004, J IMMUNOL, V172, P6259, DOI 10.4049/jimmunol.172.10.6259; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Szakal AK, 2002, SEMIN IMMUNOL, V14, P267, DOI 10.1016/S1044-5323(02)00059-3; Tillib SV, 2011, MOL BIOL+, V45, P66, DOI 10.1134/S0026893311010134; Tokuhara D, 2010, P NATL ACAD SCI USA, V107, P8794, DOI 10.1073/pnas.0914121107; Wang WH, 2003, VET J, V166, P205, DOI 10.1016/S1090-0233(02)00263-0; Wang-dong Z, 2012, STUDY ON THE PURIFIC; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Xu XH, 2010, VET J, V184, P362, DOI 10.1016/j.tvjl.2009.03.003; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang WD, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0538-y; Zhang WD, 2012, VET IMMUNOL IMMUNOP, V147, P147, DOI 10.1016/j.vetimm.2012.04.007; Zhaxi YP, 2014, ANAT REC, V297, P1292, DOI 10.1002/ar.22939	52	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156635	10.1371/journal.pone.0156635	http://dx.doi.org/10.1371/journal.pone.0156635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249417	Green Submitted, Green Published, gold			2022-12-26	WOS:000377184700061
J	Iqbal, Q; Lubeck-Schricker, M; Wells, E; Wolfe, MK; Lantagne, D				Iqbal, Qais; Lubeck-Schricker, Maya; Wells, Emma; Wolfe, Marlene K.; Lantagne, Daniele			Shelf-Life of Chlorine Solutions Recommended in Ebola Virus Disease Response	PLOS ONE			English	Article								In Ebola Virus Disease (EVD) outbreaks, it is widely recommended to wash living things (handwashing) with 0.05% (500 mg/L) chlorine solution and non-living things (surfaces, personal protective equipment, dead bodies) with 0.5% (5,000 mg/L) chlorine solution. Chlorine solutions used in EVD response are primarily made from powdered calcium hypochlorite (HTH), granular sodium dichloroisocyanurate (NaDCC), and liquid sodium hypochlorite (NaOCl), and have a pH range of 5-11. Chlorine solutions degrade following a reaction highly dependent on, and unusually sensitive to, pH, temperature, and concentration. We determined the shelf-life of 0.05% and 0.5% chlorine solutions used in EVD response, including HTH, NaDCC, stabilized NaOCl, generated NaOCl, and neutralized NaOCl solutions. Solutions were stored for 30 days at 25, 30, and 35 degrees C, and tested daily for chlorine concentration and pH. Maximum shelf-life was defined as days until initial concentration fell to <90% of initial concentration in ideal laboratory conditions. At 25-35 degrees C, neutralized-NaOCl solutions (pH = 7) had a maximum shelf-life of a few hours, NaDCC solutions (pH = 6) 2 days, generated NaOCl solutions (pH = 9) 6 days, and HTH and stabilized NaOCl solutions (pH 9-11) >30 days. Models were developed for solutions with maximum shelf-lives between 1-30 days. Extrapolating to 40 degrees C, the maximum predicted shelf-life for 0.05% and 0.5% NaDCC solutions were 0.38 and 0.82 hours, respectively; predicted shelf-life for 0.05% and 0.5% generated NaOCl solutions were >30 and 5.4 days, respectively. Each chlorine solution type offers advantages and disadvantages to responders, as: NaDCC is an easy-to-import high-concentration effervescent powder; HTH is similar, but forms a precipitate that may clog pipes; and, NaOCl solutions can be made locally, but are difficult to transport. We recommend responders chose the most appropriate source chlorine compound for their use, and ensure solutions are stored at appropriate temperatures and used or replaced before expiring.	[Iqbal, Qais; Wells, Emma; Wolfe, Marlene K.; Lantagne, Daniele] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA; [Lubeck-Schricker, Maya] Concord Acad, Concord, MA USA	Tufts University	Lantagne, D (corresponding author), Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA.	daniele.lantagne@tufts.edu			United States Agency for International Development, Office of Foreign Disaster Assistance [AID-OFDA-A-15-00026]; National Science Foundation [0966093]	United States Agency for International Development, Office of Foreign Disaster Assistance(United States Agency for International Development (USAID)); National Science Foundation(National Science Foundation (NSF))	This study was funded by a grant from the United States Agency for International Development, Office of Foreign Disaster Assistance (AID-OFDA-A-15-00026). MW was supported by the National Science Foundation (grant 0966093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders were provided a final version of the manuscript before submission, and had only minor grammatical comments.	[Anonymous], EB EB VIR DIS TRANSM; [Anonymous], EB EB VIR DIS SIGNS; [Anonymous], HAND HYG W AFR GEN N; Clasen T, 2006, INT J HYG ENVIR HEAL, V209, P173, DOI 10.1016/j.ijheh.2005.11.004; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Emmanueal Jorge N Babacar, 2015, ASSESSMENT RECOMMEND; Gordon G., 1996, AWWA WAT QUAL TECHN; Gordon G., 1995, MINIMIZING CHLORATE; Henze M, 2008, BIOLOGICAL WASTEWATER TREATMENT: PRINCIPLES, MODELLING AND DESIGN, P1; Lantagne D, 2011, J ENVIRON ENG-ASCE, V137, P131, DOI 10.1061/(ASCE)EE.1943-7870.0000299; National Research Council (US) Safe Drinking Water Committee, 1980, DRINK WAT HLTH, V2; Rice E.W., 2012, STANDARD METHODS EXA; Rutala WA, 2004, CLIN INFECT DIS, V39, P702, DOI 10.1086/423182; Sterk E, MED SANS FRONTIERES; Walker J., 2014, DECONTAMINATION HOSP; WHO, 2009, WHO GUID HAND HYG HE; WHO CDC, 1998, INF CONTR VIR HAEM F; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization, EB VIR DIS	19	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156136	10.1371/journal.pone.0156136	http://dx.doi.org/10.1371/journal.pone.0156136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244552	gold, Green Published, Green Submitted			2022-12-26	WOS:000377146100016
J	Naffaa, MM; Absalom, N; Solomon, VR; Chebib, M; Hibbs, DE; Hanrahan, JR				Naffaa, Moawiah M.; Absalom, Nathan; Solomon, V. Raja; Chebib, Mary; Hibbs, David E.; Hanrahan, Jane R.			Investigating the Role of Loop C Hydrophilic Residue 'T244' in the Binding Site of rho 1 GABA(C) Receptors via Site Mutation and Partial Agonism	PLOS ONE			English	Article							RETINAL BIPOLAR CELLS; XENOPUS OOCYTES; PHARMACOLOGY; ACID; SUBUNIT; ANTAGONISTS; ACTIVATION; EXPRESSION; TEMPLATES; CHANNELS	The loop C hydrophilic residue, threonine 244 lines the orthosteric binding site of rho 1 GABA(C) receptors was studied by point mutation into serine, alanine and cysteine, and tested with GABA, some representative partial agonists and antagonists. Thr244 has a hydroxyl group essential for GABA activity that is constrained by the threonine methyl group, orienting it toward the binding site. Significant decreases in activation effects of the studied ligands at rho 1 T244S mutant receptors, suggests a critical role for this residue. Results of aliphatic and heteroaromatic partial agonists demonstrate different pharmacological effects at rho 1 T244S mutant receptors when co-applied with GABA EC50 responses. rho 1 T244A and rho 1 T244C mutant receptors have minimal sensitivity to GABA at high mM concentrations, whereas, the rho 1 WT partial agonists, beta-alanine and MTSEA demonstrate more efficacy and potency, respectively, than GABA at these mutant receptors. This study explores the role of Thr244 in the binding of agonists as an initial step during channel gating by moving loop C towards the ligand.	[Naffaa, Moawiah M.; Absalom, Nathan; Solomon, V. Raja; Chebib, Mary; Hibbs, David E.; Hanrahan, Jane R.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of Sydney	Hanrahan, JR (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia.	jane.hanrahan@sydney.edu.au	Hanrahan, Jane R/A-8155-2010; Viswas, Raja Solomon/AAA-1020-2022; Viswas, Raja Solomon/F-6654-2011	Hanrahan, Jane R/0000-0001-8205-0260; Viswas, Raja Solomon/0000-0002-9863-4452; Viswas, Raja Solomon/0000-0002-9863-4452; naffaa, moawiah/0000-0003-0451-5901				Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; [Anonymous], 2013, GLID VERS 5 9; [Anonymous], 2013, LIGPREP VERS 2 6; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Arnaud C, 2001, PSYCHOPHARMACOLOGY, V154, P415, DOI 10.1007/s002130000653; Bailey MES, 1999, BBA-GENE STRUCT EXPR, V1447, P307, DOI 10.1016/S0167-4781(99)00167-0; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Blednov YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085525; Bormann J, 2000, TRENDS PHARMACOL SCI, V21, P16, DOI 10.1016/S0165-6147(99)01413-3; Boue-Grabot E, 2000, ENDOCRINOLOGY, V141, P1627, DOI 10.1210/en.141.5.1627; Boue-Grabot E, 1998, J NEUROCHEM, V70, P899; Braman J, 1996, Methods Mol Biol, V57, P31; CALVO DJ, 1995, NEUROREPORT, V6, P1118, DOI 10.1097/00001756-199505300-00011; Chebib M, 1999, CLIN EXP PHARMACOL P, V26, P937, DOI 10.1046/j.1440-1681.1999.03151.x; CUTTING GR, 1992, GENOMICS, V12, P801, DOI 10.1016/0888-7543(92)90312-G; CUTTING GR, 1991, P NATL ACAD SCI USA, V88, P2673, DOI 10.1073/pnas.88.7.2673; FEIGENSPAN A, 1994, EUR J PHARM-MOLEC PH, V288, P97, DOI 10.1016/0922-4106(94)90014-0; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; Fletcher EL, 1998, J COMP NEUROL, V396, P351, DOI 10.1002/(SICI)1096-9861(19980706)396:3<351::AID-CNE6>3.0.CO;2-1; Hanrahan JR, 2001, J CHEM SOC PERK T 1, P2389, DOI 10.1039/b105989k; Jensen RJ, 2012, EXP EYE RES, V105, P21, DOI 10.1016/j.exer.2012.10.005; JOHNSTON GA, 1975, J NEUROCHEM, V24, P157, DOI 10.1111/j.1471-4159.1975.tb07642.x; Johnston GAR, 1998, NEUROLOGICALLY ACTIV; Johnston Graham A. R., 2002, Current Topics in Medicinal Chemistry, V2, P903, DOI 10.2174/1568026023393453; JOHNSTON TP, 1961, J ORG CHEM, V26, P3780, DOI 10.1021/jo01068a037; KUSAMA T, 1993, BRIT J PHARMACOL, V109, P200, DOI 10.1111/j.1476-5381.1993.tb13554.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lopez-Chavez A, 2005, NEUROSCI RES, V53, P421, DOI 10.1016/j.neures.2005.08.014; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Naffaa MM, 2015, J MOL GRAPH MODEL, V62, P43, DOI 10.1016/j.jmgm.2015.09.002; Ochoa-de la Paz LD, 2008, NEUROSCI RES, V61, P302, DOI 10.1016/j.neures.2008.03.009; QIAN HH, 1993, NATURE, V361, P162, DOI 10.1038/361162a0; Ragozzino D, 1996, MOL PHARMACOL, V50, P1024; Schrodinger, 2013, MAESTR; Schrodinger, 2013, PRIM VERS 3 2; WOODWARD RM, 1993, MOL PHARMACOL, V43, P609; Yamamoto I, 2012, ACS CHEM NEUROSCI, V3, P665, DOI 10.1021/cn3000229; Yang L, 2003, J NEUROCHEM, V87, P791, DOI 10.1046/j.1471-4159.2003.02069.x; Zhang DX, 2001, TRENDS PHARMACOL SCI, V22, P121, DOI 10.1016/S0165-6147(00)01625-4	41	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156618	10.1371/journal.pone.0156618	http://dx.doi.org/10.1371/journal.pone.0156618			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244450	Green Submitted, gold, Green Published			2022-12-26	WOS:000377146100056
J	Byrt, CS; Betts, NS; Tan, HT; Lim, WL; Ermawar, RA; Nguyen, HY; Shirley, NJ; Lahnstein, J; Corbin, K; Fincher, GB; Knauf, V; Burton, RA				Byrt, Caitlin S.; Betts, Natalie S.; Tan, Hwei-Ting; Lim, Wai Li; Ermawar, Riksfardini A.; Hai Yen Nguyen; Shirley, Neil J.; Lahnstein, Jelle; Corbin, Kendall; Fincher, Geoffrey B.; Knauf, Vic; Burton, Rachel A.			Prospecting for Energy-Rich Renewable Raw Materials: Sorghum Stem Case Study	PLOS ONE			English	Article							CELL-WALL; GENETIC-VARIATION; SWEET SORGHUM; ETHANOL YIELD; CELLULOSE; BARLEY; BIOMASS; COMPONENTS; GENOME; (1,3/1,4)-BETA-D-GLUCAN	Sorghum vegetative tissues are becoming increasingly important for biofuel production. The composition of sorghum stem tissues is influenced by genotype, environment and photoperiod sensitivity, and varies widely between varieties and also between different stem tissues (outer rind vs inner pith). Here, the amount of cellulose, (1,3;1,4)-beta-glucan, arabinose and xylose in the stems of twelve diverse sorghum varieties, including four photoperiod-sensitive varieties, was measured. At maturity, most photoperiod-insensitive lines had 1% w/w (1,3;1,4)-beta-glucan in stem pith tissue whilst photoperiod-sensitive varieties remained in a vegetative stage and accumulated up to 6% w/w (1,3;1,4)-beta-glucan in the same tissue. Three sorghum lines were chosen for further study: a cultivated grain variety (Sorghum bicolor BTx623), a sweet variety (S. bicolor Rio) and a photoperiod-sensitive wild line (S. bicolor ssp. verticilliflorum Arun). The Arun line accumulated 5.5% w/w (1,3;1,4)-beta-glucan and had higher SbCslF6 and SbCslH3 transcript levels in pith tissues than did photoperiodinsensitive varieties Rio and BTx623 (< 1% w/w pith (1,3;1,4)-beta-glucan). To assess the digestibility of the three varieties, stem tissue was treated with either hydrolytic enzymes or dilute acid and the release of fermentable glucose was determined. Despite having the highest lignin content, Arun yielded significantly more glucose than the other varieties, and theoretical calculation of ethanol yields was 10 344 L ha(-1) from this sorghum stem tissue. These data indicate that sorghum stem (1,3;1,4)-beta-glucan content may have a significant effect on digestibility and bioethanol yields. This information opens new avenues of research to generate sorghum lines optimised for biofuel production.	[Byrt, Caitlin S.; Betts, Natalie S.; Tan, Hwei-Ting; Lim, Wai Li; Ermawar, Riksfardini A.; Hai Yen Nguyen; Shirley, Neil J.; Lahnstein, Jelle; Corbin, Kendall; Fincher, Geoffrey B.; Burton, Rachel A.] Univ Adelaide, Sch Agr Food & Wine, Australian Res Council, Ctr Excellence Plant Cell Walls, Urrbrae, SA, Australia; [Knauf, Vic] Arcadia Biosci, Davis, CA USA	University of Adelaide	Byrt, CS (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Australian Res Council, Ctr Excellence Plant Cell Walls, Urrbrae, SA, Australia.	caitlin.byrt@adelaide.edu.au	Betts, Natalie/F-2794-2012; Burton, Rachel A/C-4441-2011; Byrt, Caitlin/I-9785-2018	Betts, Natalie/0000-0002-3345-8160; Burton, Rachel A/0000-0002-0638-4709; Byrt, Caitlin/0000-0001-8549-2873; Ermawar, Riksfardini/0000-0001-6356-9999; Shirley, Neil/0000-0001-8114-9891; Lim, Wai Li/0000-0003-2514-3799	Australian Researcher Council [DE150100837]; Arcadia Biosciences	Australian Researcher Council; Arcadia Biosciences	CSB received an Australian Researcher Council Discovery Early Career Research Award (DE150100837); Australian Research Council Centre of Excellence in Plant Cell Walls http://www.arc.gov.au/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Arcadia Biosciences provided support in the form of salaries for author VK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Aditya J, 2015, NEW PHYTOL; Amaducci S, 2004, IND CROP PROD, V20, P111, DOI 10.1016/j.indcrop.2003.12.016; Arundale RA, 2015, BIOENERG RES, P1; Bacic A., 1988, BIOCHEM PLANT, V14, P297, DOI [DOI 10.1016/B978-0-08-092615-5.50014-X, 10.1016/B978-0-08-092615-5.50014-X]; Bennett AS, 2009, BIORESOURCE TECHNOL, V100, P1595, DOI 10.1016/j.biortech.2008.09.023; Betts NS, 2015, J CEREAL SCI, V63, P64, DOI 10.1016/j.jcs.2015.02.007; Burton RA, 2000, PLANT CELL, V12, P691, DOI 10.1105/tpc.12.5.691; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Burton RA, 2008, PLANT PHYSIOL, V146, P1821, DOI 10.1104/pp.107.114694; Burton RA, 2011, PLANT BIOTECHNOL J, V9, P117, DOI 10.1111/j.1467-7652.2010.00532.x; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; Byrt CS, 2013, BIOFUEL CROPS: PRODUCTION, PHYSIOLOGY AND GENETICS, P135, DOI 10.1079/9781845938857.0135; Byrt CS, 2011, J INTEGR PLANT BIOL, V53, P120, DOI 10.1111/j.1744-7909.2010.01023.x; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Chowdhury J, 2014, NEW PHYTOL, V204, P650, DOI 10.1111/nph.12974; Corbin KR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135382; Davis J, 2010, PLANT J, V64, P1028, DOI 10.1111/j.1365-313X.2010.04392.x; Dien BS, 2009, BIOENERG RES, V2, P153, DOI 10.1007/s12155-009-9041-2; Dillon Sally L., 2005, Plant Genetic Resources Characterization and Utilization, V3, P19, DOI 10.1079/PGR200454; Dillon SL, 2004, PLANT SYST EVOL, V249, P233, DOI 10.1007/s00606-004-0210-7; Dillon SL, 2001, PLANT SYST EVOL, V230, P97, DOI 10.1007/s006060170007; Doblin MS, 2009, P NATL ACAD SCI USA, V106, P5996, DOI 10.1073/pnas.0902019106; Ejeta G, 2005, Crop Ferality and Volunteerism, P123; Energy USDoEEaR, 2014, THEOR ETH YIELD CALC; Ermawar RA, 2015, J INTEGR PLANT BIOL, V57, P429, DOI 10.1111/jipb.12338; Fincher G.B., 2004, ENCY GRAIN SCI, P206, DOI [10.1016/B0-12-765490-9/00107-5, DOI 10.1016/B0-12-765490-9/00107-5]; Folliard A, 2004, FIELD CROP RES, V89, P59, DOI 10.1016/j.fcr.2004.01.006; Grof C. P. L., 2013, PHLOEM TRANSPORT RES; HARLAN JR, 1972, CROP SCI, V12, P172, DOI 10.2135/cropsci1972.0011183X001200020005x; Jahn CE, 2011, PLANT PHYSIOL, V155, P157, DOI 10.1104/pp.110.165654; Mace ES, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-26; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Martin AP, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-186; MCBEE GG, 1990, AGRON J, V82, P687, DOI 10.2134/agronj1990.00021962008200040008x; MCBEE GG, 1988, BIOMASS, V17, P203, DOI 10.1016/0144-4565(88)90114-X; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; Mullet J, 2014, J EXPT BOT; Murray SC, 2008, CROP SCI, V48, P2180, DOI 10.2135/cropsci2008.01.0068; Nemeth C, 2010, PLANT PHYSIOL, V152, P1209, DOI 10.1104/pp.109.151712; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pauly M, 2011, INVENTORSMAIZE VARIE; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; Pollock C, 2003, J EXP BOT, V54, P489, DOI 10.1093/jxb/erg037; Price HJ, 2005, ANN BOT-LONDON, V95, P219, DOI 10.1093/aob/mci015; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Raghuwanshi A, 2010, PLANT CELL REP, V29, P997, DOI 10.1007/s00299-010-0885-x; RICHIE WR, 1991, BIORESOURCE TECHNOL, V38, P15, DOI 10.1016/0960-8524(91)90216-7; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Roulin S, 2002, PLANTA, V215, P51, DOI 10.1007/s00425-001-0721-1; Saballos A, 2012, PLANT J, V70, P818, DOI 10.1111/j.1365-313X.2012.04933.x; Sattler SE, 2009, PLANT PHYSIOL, V150, P584, DOI 10.1104/pp.109.136408; Selig M. J., 2010, Industrial Biotechnology, V6, P104, DOI 10.1089/ind.2010.0009; Shakoor N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-35; Slewinski TL, 2012, J EXP BOT, V63, P4647, DOI 10.1093/jxb/ers124; Snider JL, 2012, IND CROP PROD, V37, P527, DOI 10.1016/j.indcrop.2011.07.032; Stefaniak TR, 2012, CROP SCI, V52, P1949, DOI 10.2135/cropsci2011.10.0534; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Tang P, 2015, BIOENERG RES, P1; THEANDER O, 1986, J AGR FOOD CHEM, V34, P330, DOI 10.1021/jf00068a045; Trafford K, 2013, J EXPT BOT; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vancov T, 2012, APPL ENERG, V92, P421, DOI 10.1016/j.apenergy.2011.11.053; Vancov T, 2011, ENERG FUEL, V25, P2754, DOI 10.1021/ef200241s; Vega-Sanchez ME, 2015, PLANT BIOTECHNOLOGY; Weng JK, 2008, CURR OPIN BIOTECH, V19, P166, DOI 10.1016/j.copbio.2008.02.014; WILSON JR, 1993, J SCI FOOD AGR, V63, P407, DOI 10.1002/jsfa.2740630406; Wong SC, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0208-6; Zhao YL, 2009, FIELD CROP RES, V111, P55, DOI 10.1016/j.fcr.2008.10.006; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114	70	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156638	10.1371/journal.pone.0156638	http://dx.doi.org/10.1371/journal.pone.0156638			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232754	Green Submitted, gold, Green Published			2022-12-26	WOS:000376883000049
J	Villuendas-Gonzalez, ER; Gonzalez-Garrido, AA				Rogelio Villuendas-Gonzalez, Erwin; Antonio Gonzalez-Garrido, Andres			Feedback-Related ERP Components Are Modulated by Social Distance during Non-Contingent Evaluation of Someone Else's Performance	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; BRAIN POTENTIALS; ERROR-DETECTION; NEURAL SYSTEM; REWARD; P300; SELF; NEGATIVITY; RESPONSES; DYNAMICS	Performance monitoring depends on cortical structures that are also activated in vicarious monitoring. While many experiments have shown that vicarious and on-line monitoring have a similar basis, most such experiments have focused on simple tasks. In order to assess the effect of non-contingent feedback on vicarious monitoring, 23 young volunteer adults were evaluated: in one session, they performed a rule-based category formation task, receiving no feedback on their performance. In a second session, Event Related Potentials (ERPs) were obtained while participants passively reviewed performances attributed to themselves and peers they had previously rated as either socially close or distant. Feedback Related Negativity (FRN) and Feedback Related P300 (fP300) components were analyzed with respect to feedback valence and agent. Results show that both components can be elicited through non-contingent feedback related to prior performance. In addition, FRN waves are modulated by the valence of the feedback, and fP300 is modulated by the agent to whom performance feedback is attributed. This experiment constitutes a novel approach to the evaluation of ERP correlates of vicarious monitoring through non-contingent feedback and its relations to empathy processing.	[Rogelio Villuendas-Gonzalez, Erwin] Univ Michoacana, Fac Psicol, Morelia, Michoacan, Mexico; [Rogelio Villuendas-Gonzalez, Erwin; Antonio Gonzalez-Garrido, Andres] Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Inst Neurociencias, Lab Neurofisiol Clin, Guadalajara 44430, Jalisco, Mexico; [Antonio Gonzalez-Garrido, Andres] Univ Guadalajara, Hosp Civil Fray Antonio Alcalde, Guadalajara 44430, Jalisco, Mexico	Universidad Michoacana de San Nicolas de Hidalgo; Universidad de Guadalajara; Universidad de Guadalajara	Villuendas-Gonzalez, ER (corresponding author), Univ Michoacana, Fac Psicol, Morelia, Michoacan, Mexico.; Villuendas-Gonzalez, ER (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Biol & Agr, Inst Neurociencias, Lab Neurofisiol Clin, Guadalajara 44430, Jalisco, Mexico.	erwinvilluendas@gmail.com	González-Garrido, Andrés A./T-3044-2019	González-Garrido, Andrés A./0000-0003-4594-5270; Villuendas Gonzalez, Erwin/0000-0001-9141-8514				Apps MAJ, 2015, J NEUROSCI, V35, P2904, DOI 10.1523/JNEUROSCI.3669-14.2015; Bartholow B. D., 2009, METHODS SOCIAL NEURO, P198; Bauchl C, 2010, THESIS U WIEN; Bellebaum C, 2010, CEREB CORTEX, V20, P2874, DOI 10.1093/cercor/bhq038; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Carp J, 2009, SOC NEUROSCI-UK, V4, P85, DOI 10.1080/17470910802083167; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Donchin E, 1998, BEHAV BRAIN SCI, V21, P152, DOI 10.1017/S0140525X98230950; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, V1, P192; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P905, DOI 10.1111/j.1469-8986.2007.00567.x; Heldmann M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-33; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2006, BRAIN RES, V1105, P93, DOI 10.1016/j.brainres.2005.12.015; Koban L, 2012, COGN AFFECT BEHAV NE, V12, P460, DOI 10.3758/s13415-012-0091-0; Leng Y, 2010, NEUROPSYCHOLOGIA, V48, P448, DOI 10.1016/j.neuropsychologia.2009.10.002; Luck S.J., 2005, INTRO EVENT RELATED; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P313, DOI 10.1111/j.1469-8986.2008.00760.x; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Shane MS, 2008, NEUROIMAGE, V42, P450, DOI 10.1016/j.neuroimage.2007.12.067; TREADWELL TW, 1993, SMALL GR RES, V24, P155, DOI 10.1177/1046496493242001; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; van Noordt SJR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00197; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Villuendas Erwin, 2016, OPEN SCI FRAMEWORK; Wu Y, 2011, BIOL PSYCHOL, V88, P253, DOI 10.1016/j.biopsycho.2011.08.009; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yu RJ, 2006, NEUROREPORT, V17, P1649, DOI 10.1097/01.wnr.0000236866.39328.1d; Yu RJ, 2006, NEUROREPORT, V17, P1747, DOI 10.1097/01.wnr.0000239960.98813.50	41	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156656	10.1371/journal.pone.0156656	http://dx.doi.org/10.1371/journal.pone.0156656			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232887	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000050
J	Cornelissen, A; Sadovskaya, I; Vinogradov, E; Blangy, S; Spinelli, S; Casey, E; Mahony, J; Noben, JP; Dal Bello, F; Cambillau, C; van Sinderen, D				Cornelissen, Anneleen; Sadovskaya, Irina; Vinogradov, Evgeny; Blangy, Stephanie; Spinelli, Silvia; Casey, Eoghan; Mahony, Jennifer; Noben, Jean-Paul; Dal Bello, Fabio; Cambillau, Christian; van Sinderen, Douwe			The Baseplate of Lactobacillus delbrueckii Bacteriophage Ld17 Harbors a Glycerophosphodiesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALL TEICHOIC-ACIDS; COMPLETE GENOME SEQUENCE; VI-PHAGE 2; CELL-WALL; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; PHOSPHODIESTERASE GDPD; LIPOTEICHOIC ACIDS	Glycerophosphodiester phosphodiesterases (GDPDs; EC 3.1.4.46) typically hydrolyze glycerophosphodiesters to sn-glycerol 3-phosphate (Gro3P) and their corresponding alcohol during patho/physiological processes in bacteria and eukaryotes. GDPD(-like) domains were identified in the structural particle of bacterial viruses (bacteriophages) specifically infecting Gram-positive bacteria. The GDPD of phage 17 (Ld17; GDPD(Ld17)), representative of the group b Lactobacillus delbrueckii subsp. bulgaricus (Ldb)-infecting bacteriophages, was shown to hydrolyze, besides the simple glycerophosphodiester, two complex surface-associated carbohydrates of the Ldb17 cell envelope: the Gro3P decoration of the major surface polysaccharide D-galactan and the oligo(glycerol phosphate) backbone of the partially glycosylated cell wall teichoic acid, a minor Ldb17 cell envelope component. Degradation of cell wall teichoic acid occurs according to an exolytic mechanism, and Gro3P substitution is presumed to be inhibitory for GDPD(Ld17) activity. The presence of the GDPD(Ld17) homotrimer in the viral baseplate structure involved in phage-host interaction together with the dependence of native GDPD activity, adsorption, and efficiency of plating of Ca2+ ions supports a role for GDPD(Ld17) activity during phage adsorption and/or phage genome injection. In contrast to GDPD(Ld17), we could not identify any enzymatic activity for the GDPD-like domain in the neck passage structure of phage 340, a 936-type Lactococcus lactis subsp. lactis bacteriophage.	[Cornelissen, Anneleen; Casey, Eoghan; Mahony, Jennifer; van Sinderen, Douwe] Univ Coll Cork, Sch Microbiol, Western Rd, Cork, Ireland; [van Sinderen, Douwe] Univ Coll Cork, APC Microbiome Inst, Western Rd, Cork, Ireland; [Sadovskaya, Irina] Univ Littoral Cote dOpale, Equipe Biochim Prod Aquat, Blvd Bassin Napoleon,BP 120, F-62327 Boulogne Sur Mer, France; [Vinogradov, Evgeny] CNR, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada; [Blangy, Stephanie; Spinelli, Silvia; Cambillau, Christian] Aix Marseille Univ, Architecture & Fonct Macromol Biol, Campus Luminy, F-13288 Marseille 09, France; [Blangy, Stephanie; Spinelli, Silvia; Cambillau, Christian] CNRS, Architecture & Fonct Macromol Biol, UMR 6098, Campus Luminy, F-13288 Marseille 09, France; [Noben, Jean-Paul] Hasselt Univ, Biomed Res Inst Biomed, Agoralaan Bldg C, BE-3590 Diepenbeek, Belgium; [Noben, Jean-Paul] Hasselt Univ, Sch Life Sci, Transnat Univ Limburg, Agoralaan Bldg C, BE-3590 Diepenbeek, Belgium; [Dal Bello, Fabio] Sacco Srl, I-22071 Cadorago, CO, Italy	University College Cork; University College Cork; Universite du Littoral-Cote-d'Opale; National Research Council Canada; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Hasselt University; Hasselt University	van Sinderen, D (corresponding author), Univ Coll Cork, Sch Microbiol, Western Rd, Cork, Ireland.; van Sinderen, D (corresponding author), Univ Coll Cork, APC Microbiome Inst, Western Rd, Cork, Ireland.	d.vansinderen@ucc.ie	Van Sinderen, Douwe/A-6778-2015; Noben, Jean-Paul/E-8066-2011; mahony, jennifer/AAG-8357-2020	Van Sinderen, Douwe/0000-0003-1823-7957; Noben, Jean-Paul/0000-0003-3368-5686; mahony, jennifer/0000-0001-5846-6303	EMPOWER postdoctoral fellowship of the Irish Research Council;  [08/IN.1/B1909];  [13/IA/1953]	EMPOWER postdoctoral fellowship of the Irish Research Council; ; 	This work was supported by a Principal Investigator Awards 08/IN.1/B1909 and 13/IA/1953 (to D. v. S.) and an EMPOWER postdoctoral fellowship of the Irish Research Council (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahren IL, 2001, MICROB PATHOGENESIS, V31, P151, DOI 10.1006/mpat.2001.0456; ARCHIBALD AR, 1976, J BACTERIOL, V127, P956, DOI 10.1128/JB.127.2.956-960.1976; ARMSTRONG JJ, 1960, BIOCHEM J, V76, P610, DOI 10.1042/bj0760610; Baptista C, 2008, J BACTERIOL, V190, P4989, DOI 10.1128/JB.00349-08; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauge T, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv229; CALDENTEY J, 1992, BIOCHIM BIOPHYS ACTA, V1159, P44, DOI 10.1016/0167-4838(92)90073-M; Casey E, 2014, APPL ENVIRON MICROB, V80, P5623, DOI 10.1128/AEM.01268-14; Castro-Nallar E, 2012, GENOME BIOL EVOL, V4, P382, DOI 10.1093/gbe/evs017; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; CHATTERJEE AN, 1969, J BACTERIOL, V98, P519, DOI 10.1128/JB.98.2.519-527.1969; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Cheng LY, 2011, PLANT PHYSIOL, V156, P1131, DOI 10.1104/pp.111.173724; Cheng YX, 2011, PLANT J, V66, P781, DOI 10.1111/j.1365-313X.2011.04538.x; Corda D, 2014, FEBS J, V281, P998, DOI 10.1111/febs.12699; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; COYETTE J, 1968, BIOCHEMISTRY-US, V7, P2385, DOI 10.1021/bi00846a048; Cui ZL, 2012, J VIROL, V86, P13880, DOI 10.1128/JVI.02728-12; Douillard FP, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-66; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5825, DOI 10.1128/AEM.70.10.5825-5832.2004; ERIKSSON U, 1979, J GEN VIROL, V43, P503, DOI 10.1099/0022-1317-43-3-503; Eugster MR, 2012, J BACTERIOL, V194, P6498, DOI 10.1128/JB.00808-12; Gallazzini M, 2008, P NATL ACAD SCI USA, V105, P11026, DOI 10.1073/pnas.0805496105; GIVAN AL, 1982, ARCH MICROBIOL, V133, P318, DOI 10.1007/BF00521298; Gu JM, 2012, J VIROL, V86, P8914, DOI 10.1128/JVI.01313-12; HALLENBECK PC, 1987, J BIOL CHEM, V262, P3553; Hanlon GW, 2001, APPL ENVIRON MICROB, V67, P2746, DOI 10.1128/AEM.67.6.2746-2753.2001; Hughes KA, 1998, J APPL MICROBIOL, V85, P583, DOI 10.1046/j.1365-2672.1998.853541.x; KARAMATA D, 1987, MOL GEN GENET, V207, P73, DOI 10.1007/BF00331493; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Kornspan JD, 2012, FEMS MICROBIOL LETT, V332, P34, DOI 10.1111/j.1574-6968.2012.02571.x; KUSSER W, 1983, J BACTERIOL, V155, P302, DOI 10.1128/JB.155.1.302-310.1983; KUSSER W, 1984, FEBS LETT, V166, P301, DOI 10.1016/0014-5793(84)80100-3; KUSSER W, 1982, FEBS LETT, V149, P67, DOI 10.1016/0014-5793(82)81073-9; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSON TJ, 1988, ARCH BIOCHEM BIOPHYS, V260, P577, DOI 10.1016/0003-9861(88)90484-5; LARSON TJ, 1983, J BIOL CHEM, V258, P5428; Lavigne R, 2006, MICROBIOL-SGM, V152, P529, DOI 10.1099/mic.0.28431-0; LINDBERG AA, 1978, J VIROL, V27, P38, DOI 10.1128/JVI.27.1.38-44.1978; Mahony J, 2013, APPL ENVIRON MICROB, V79, P4385, DOI 10.1128/AEM.00653-13; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Moak M, 2000, MOL MICROBIOL, V37, P345, DOI 10.1046/j.1365-2958.2000.01995.x; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Munsch-Alatossava P, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00408; Munsch-Alatossava P, 2013, INT J MOL SCI, V14, P5668, DOI 10.3390/ijms14035668; Murphy J, 2016, SCI REP-UK, V6, DOI 10.1038/srep21345; Raisanen L, 2004, J BACTERIOL, V186, P5529, DOI 10.1128/JB.186.16.5529-5532.2004; Raisanen L, 2007, J BACTERIOL, V189, P4135, DOI 10.1128/JB.00078-07; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Ravin V, 2002, J BACTERIOL, V184, P2455, DOI 10.1128/JB.184.9.2455-2459.2002; Riipinen KA, 2011, ARCH VIROL, V156, P1217, DOI 10.1007/s00705-011-0980-5; Rousseau GM, 2009, APPL ENVIRON MICROB, V75, P5336, DOI 10.1128/AEM.00761-09; Rydman PS, 2000, MOL MICROBIOL, V37, P356, DOI 10.1046/j.1365-2958.2000.01996.x; Sadovskaya I, 2004, CARBOHYD RES, V339, P1467, DOI 10.1016/j.carres.2004.03.017; Sadovskaya I, 2006, FEMS IMMUNOL MED MIC, V47, P75, DOI 10.1111/j.1574-695X.2006.00068.x; Sambrook J, 2001, MOL CLONING LAB MANU, P51; Sciara G, 2008, J BIOL CHEM, V283, P2716, DOI 10.1074/jbc.M707533200; Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921; Simockova M, 2008, J BIOL CHEM, V283, P17107, DOI 10.1074/jbc.M800868200; Stockdale SR, 2013, J BIOL CHEM, V288, P5581, DOI 10.1074/jbc.M112.444901; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Stummeyer K, 2006, MOL MICROBIOL, V60, P1123, DOI 10.1111/j.1365-2958.2006.05173.x; SUNDARALINGAM M, 1965, SCIENCE, V150, P1035, DOI 10.1126/science.150.3699.1035; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Szklarczyk R, 2004, BIOINFORMATICS, V20, P311, DOI 10.1093/bioinformatics/bth911; TAKEDA K, 1973, VIROLOGY, V52, P148, DOI 10.1016/0042-6822(73)90405-4; TAYLOR K, 1966, ACTA BIOCHIM POL, V13, P97; TAYLOR K, 1965, BIOCHEM BIOPH RES CO, V20, P752, DOI 10.1016/0006-291X(65)90081-1; TOMMASSEN J, 1991, MOL GEN GENET, V226, P321, DOI 10.1007/BF00273621; Vandersteegen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024418; Vinogradov E, 2006, CARBOHYD RES, V341, P738, DOI 10.1016/j.carres.2006.01.012; Vinogradov E, 2015, CARBOHYD RES, V413, P93, DOI 10.1016/j.carres.2015.06.001; Wang SH, 2010, INT J FOOD MICROBIOL, V137, P22, DOI 10.1016/j.ijfoodmicro.2009.10.024; Wendlinger G, 1996, MICROBIOL-UK, V142, P985, DOI 10.1099/00221287-142-4-985; Wittmann Johannes, 2011, Bacteriophage, V1, P6, DOI 10.4161/bact.1.1.13873; ZOURARI A, 1992, LAIT, V72, P1	77	7	7	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16816	16827		10.1074/jbc.M116.728279	http://dx.doi.org/10.1074/jbc.M116.728279			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27268053	Green Published, hybrid			2022-12-26	WOS:000380826700037
J	Jin, X; Starke, S; Li, Y; Sethupathi, S; Kung, G; Dodhiawala, P; Wang, YQ				Jin, Xin; Starke, Samuel; Li, Yang; Sethupathi, Sheetal; Kung, George; Dodhiawala, Paarth; Wang, Yuqi			Nitrogen Starvation-induced Phosphorylation of Ras1 Protein and Its Potential Role in Nutrient Signaling and Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ADENYLATE-CYCLASE; ALPHA-SUBUNIT; BUDDING YEAST; AUTOPHAGY; MECHANISM; PATHWAY; MACHINERY; GROWTH; SITES	Ras1 is a small GTPase in the budding yeast Saccharomyces cerevisiae that regulates nutrient signaling. It has been shown that Ras1 undergoes phosphorylation, but the functional consequences and regulation of Ras1 phosphorylation remain unknown. Here we identify Ser-226 as an important residue for Ras1 phosphorylation, as mutating this residue to an alanine drastically diminishes the level of Ras1 phosphorylation. Notably, phosphorylated Ras1 accumulates as the cells approach the stationary phase of growth. Likewise, subjecting cells to nitrogen starvation also elevates the level of Ras1 phosphorylation. Interestingly, blocking Ras1 phosphorylation diminishes the level of autophagy and also renders the cells more sensitive to heat shock. Together, these data suggest a role of Ras1 phosphorylation in modulating nutrient signaling and stress response.	[Jin, Xin; Starke, Samuel; Li, Yang; Sethupathi, Sheetal; Kung, George; Dodhiawala, Paarth; Wang, Yuqi] St Louis Univ, Dept Biol, 128 Macelwane Hall,3507 Laclede Ave, St Louis, MO 63103 USA	Saint Louis University	Wang, YQ (corresponding author), St Louis Univ, Dept Biol, 128 Macelwane Hall,3507 Laclede Ave, St Louis, MO 63103 USA.	ywang8@slu.edu		Li, Yang/0000-0001-5714-0416; Dodhiawala, Paarth/0000-0002-6362-5847	National Institutes of Health [1R15GM106330-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM106330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R15GM106330-01 (to Y. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bai XJ, 2010, FEBS LETT, V584, P2333, DOI 10.1016/j.febslet.2010.04.011; Belotti F, 2012, BBA-MOL CELL RES, V1823, P1208, DOI 10.1016/j.bbamcr.2012.04.016; Bivona TG, 2006, MOL CELL, V21, P481, DOI 10.1016/j.molcel.2006.01.012; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; COBITZ AR, 1989, P NATL ACAD SCI USA, V86, P858, DOI 10.1073/pnas.86.3.858; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; Guimaraes RS, 2015, METHODS, V75, P141, DOI 10.1016/j.ymeth.2014.11.023; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Klionsky DJ, 2013, J INNATE IMMUN, V5, P427, DOI 10.1159/000351979; Li Y, 2013, J BIOL CHEM, V288, P11358, DOI 10.1074/jbc.M112.449751; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Pereira J, 2009, YEAST, V26, P641, DOI 10.1002/yea.1711; Ramachandran V, 2011, GENETICS, V187, P441, DOI 10.1534/genetics.110.123372; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Roelants FM, 2004, MICROBIOL-SGM, V150, P3289, DOI 10.1099/mic.0.27286-0; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; Tamanoi Fuyuhiko, 2011, Genes Cancer, V2, P210, DOI 10.1177/1947601911407322; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; THEVELEIN JM, 1992, ANTON LEEUW INT J G, V62, P109, DOI 10.1007/BF00584466; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Umekawa M., 2012, INT J CELL BIOL, V2012, DOI [DOI 10.1155/2012/142634, 10.1155/ 2012/142634]; Whistler JL, 1997, J BIOL CHEM, V272, P18790, DOI 10.1074/jbc.272.30.18790; Xiao Y, 2000, MOL CELL BIOL, V20, P5447, DOI 10.1128/MCB.20.15.5447-5453.2000	36	6	6	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16231	16239		10.1074/jbc.M115.713206	http://dx.doi.org/10.1074/jbc.M115.713206			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27261458	hybrid, Green Published			2022-12-26	WOS:000380585400027
J	Tunc-Ozdemir, M; Urano, D; Jaiswal, DK; Clouse, SD; Jones, AM				Tunc-Ozdemir, Meral; Urano, Daisuke; Jaiswal, Dinesh Kumar; Clouse, Steven D.; Jones, Alan M.			Direct Modulation of Heterotrimeric G Protein-coupled Signaling by a Receptor Kinase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; G protein; phosphorylation; receptor protein serine; threonine kinase; regulator of G protein signaling (RGS); receptor-like kinases; BAK1; FLS2; flg22; AtRGS1	CELL-DEATH; INNATE IMMUNITY; DISEASE RESISTANCE; G-ALPHA; ARABIDOPSIS; PHOSPHORYLATION; BAK1; TRAFFICKING; ACTIVATION; INTERACTS	Plants and some protists have heterotrimeric G protein complexes that activate spontaneously without canonical G protein-coupled receptors (GPCRs). In Arabidopsis, the sole 7-transmembrane regulator of G protein signaling 1 (AtRGS1) modulates the G protein complex by keeping it in the resting state (GDP-bound). However, it remains unknown how a myriad of biological responses is achieved with a single G protein modulator. We propose that in complete contrast to G protein activation in animals, plant leucine-rich repeat receptor-like kinases (LRR RLKs), not GPCRs, provide this discrimination through phosphorylation of AtRGS1 in a ligand-dependent manner. G protein signaling is directly activated by the pathogen-associated molecular pattern flagellin peptide 22 through its LRR RLK, FLS2, and co-receptor BAK1.	[Tunc-Ozdemir, Meral; Urano, Daisuke; Jaiswal, Dinesh Kumar; Jones, Alan M.] Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Clouse, Steven D.] North Carolina State Univ, Dept Hort Sci, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu	Jaiswal, Dinesh Kumar/AAJ-7867-2020; , Proteomics Core UNC/AAH-3777-2022; , Proteomics Core UNC/AFQ-7201-2022	Jaiswal, Dinesh Kumar/0000-0003-4478-0080; Urano, Daisuke/0000-0003-4541-1076	National Institutes of Health-NCI [CA016086]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989] Funding Source: NIH RePORTER	National Institutes of Health-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is based in part upon work conducted using the UNC Michael Hooker Proteomics Center, which is supported in part by the National Institutes of Health-NCI Grant CA016086 to the Lineberger Comprehensive Cancer Center.	Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; Bommert P, 2013, NATURE, V502, P555, DOI 10.1038/nature12583; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Clement ST, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004143; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Du JB, 2016, PLANT J, V85, P520, DOI 10.1111/tpj.13125; Fu Y, 2014, CELL, V156, P1084, DOI 10.1016/j.cell.2014.01.013; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Halter T, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28944; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Hok S, 2011, PLANT CELL ENVIRON, V34, P1944, DOI 10.1111/j.1365-3040.2011.02390.x; Ishida T, 2014, EMBO REP, V15, P1202, DOI 10.15252/embr.201438660; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Kadota Y, 2015, PLANT CELL PHYSIOL, V56, P1472, DOI 10.1093/pcp/pcv063; Kassel KM, 2010, J BIOL CHEM, V285, P33727, DOI 10.1074/jbc.M110.178566; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Lee SM, 2015, EUR J PHARMACOL, V763, P196, DOI 10.1016/j.ejphar.2015.05.013; Li B, 2016, PROTEIN EXPRES PURIF, V126, P33, DOI 10.1016/j.pep.2016.04.016; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liang XX, 2016, ELIFE, V5, DOI 10.7554/eLife.13568; Liu JM, 2013, PLANT PHYSIOL, V161, P2146, DOI 10.1104/pp.112.212431; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; Macho AP, 2015, TRENDS PLANT SCI, V20, P269, DOI 10.1016/j.tplants.2015.02.005; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Mitra SK, 2015, PLANT J, V82, P1042, DOI 10.1111/tpj.12863; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Duc NM, 2015, EUR J PHARMACOL, V763, P214, DOI 10.1016/j.ejphar.2015.05.016; Nurnberg B, 1996, BIOCHEM J, V318, P717; Oliviusson P, 2006, PLANT CELL, V18, P1239, DOI 10.1105/tpc.105.035907; Postel S, 2010, EUR J CELL BIOL, V89, P169, DOI 10.1016/j.ejcb.2009.11.001; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ross A, 2014, EMBO J, V33, P62, DOI 10.1002/embj.201284303; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Thung L, 2012, J PLANT PHYSIOL, V169, P542, DOI 10.1016/j.jplph.2011.11.010; Torii KU, 2004, INT REV CYTOL, V234, P1, DOI 10.1016/S0074-7696(04)34001-5; Torres MP, 2011, J BIOL CHEM, V286, P20208, DOI 10.1074/jbc.M111.239343; Tunc-Ozdemir M, 2016, METHODS MOL BIOL, V1363, P155, DOI 10.1007/978-1-4939-3115-6_13; Urano D, 2014, ANNU REV PLANT BIOL, V65, P365, DOI 10.1146/annurev-arplant-050213-040133; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2013, PLANT PHYSIOL, V161, P1097, DOI 10.1104/pp.112.212324; Urano D, 2012, NAT CELL BIOL, V14, P1079, DOI 10.1038/ncb2568; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang YL, 2014, J PROTEOMICS, V108, P484, DOI 10.1016/j.jprot.2014.06.009; Wang Z, 2011, PLANT J, V67, P1081, DOI 10.1111/j.1365-313X.2011.04659.x; Zhang W, 2008, PLANT J, V56, P984, DOI 10.1111/j.1365-313X.2008.03657.x; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zulawski M, 2015, METHODS MOL BIOL, V1306, P1, DOI 10.1007/978-1-4939-2648-0_1	54	43	44	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					13918	13925		10.1074/jbc.C116.736702	http://dx.doi.org/10.1074/jbc.C116.736702			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27235398	Green Published, hybrid			2022-12-26	WOS:000379975100002
J	Suzuki, T; Kazuki, Y; Oshimura, M; Hara, T				Suzuki, Teruhiko; Kazuki, Yasuhiro; Oshimura, Mitsuo; Hara, Takahiko			Highly Efficient Transfer of Chromosomes to a Broad Range of Target Cells Using Chinese Hamster Ovary Cells Expressing Murine Leukemia Virus-Derived Envelope Proteins	PLOS ONE			English	Article							HUMAN ARTIFICIAL CHROMOSOMES; FUSION	Microcell-mediated chromosome transfer (MMCT) is an essential step for introducing chromosomes from donor cells to recipient cells. MMCT allows not only for genetic/epigenetic analysis of specific chromosomes, but also for utilization of human and mouse artificial chromosomes (HACs/MACs) as gene delivery vectors. Although the scientific demand for genome scale analyses is increasing, the poor transfer efficiency of the current method has hampered the application of chromosome engineering technology. Here, we developed a highly efficient chromosome transfer method, called retro-MMCT, which is based on Chinese hamster ovary cells expressing envelope proteins derived from ecotropic or amphotropic murine leukemia viruses. Using this method, we transferred MACs to NIH3T3 cells with 26.5 times greater efficiency than that obtained using the conventional MMCT method. Retro-MMCT was applicable to a variety of recipient cells, including embryonic stem cells. Moreover, retro-MMCT enabled efficient transfer of MAC to recipient cells derived from humans, monkeys, mice, rats, and rabbits. These results demonstrate the utility of retro-MMCT for the efficient transfer of chromosomes to various types of target cell.	[Suzuki, Teruhiko; Hara, Takahiko] Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Tokyo 113, Japan; [Kazuki, Yasuhiro] Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Tottori 680, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr, Tottori 680, Japan	Tokyo Metropolitan Institute of Medical Science; Tottori University; Tottori University	Suzuki, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Stem Cell Project, Tokyo 113, Japan.	suzuki-tr@igakuken.or.jp			Japan Society for the Promotion of Science KAKENHI [24790696, 15K18392, 23390256]; Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [16H04728, 15K18392] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Japan Society for the Promotion of Science KAKENHI Grant numbers 24790696, 15K18392 (T.S.) and 23390256 (T.H.) (http://www.jsps.go.jp/english/index.html); Regional Innovation Strategy Support Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doherty AMO, 2003, MAMM GENOME, V14, P583, DOI 10.1007/s00335-003-4002-0; Hiratsuka M, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0142-z; Hiratsuka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025961; Hoshiya H, 2009, MOL THER, V17, P309, DOI 10.1038/mt.2008.253; Jensen N, 2013, J MOL NEUROSCI, V51, P994, DOI 10.1007/s12031-013-0085-6; Karavanas G, 1998, CRIT REV ONCOL HEMAT, V28, P7, DOI 10.1016/S1040-8428(98)00007-9; Katoh M, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-37; Kazuki Y, 2013, HUM MOL GENET, V22, P578, DOI 10.1093/hmg/dds468; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kitajima K, 2013, STEM CELLS, V31, P2680, DOI 10.1002/stem.1500; Kouprina N, 2014, EXPERT OPIN DRUG DEL, V11, P517, DOI 10.1517/17425247.2014.882314; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; Kuroiwa Y, 2002, NAT BIOTECHNOL, V20, P889, DOI 10.1038/nbt727; Miller AD, 1996, J VIROL, V70, P1804, DOI 10.1128/JVI.70.3.1804-1809.1996; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Oshimura M, 2015, CHROMOSOME RES, V23, P111, DOI 10.1007/s10577-014-9459-z; Paulis M, 2007, STEM CELLS, V25, P2543, DOI 10.1634/stemcells.2007-0052; Paulis M, 2011, METHODS MOL BIOL, V738, P57, DOI 10.1007/978-1-61779-099-7_4; Perkins CP, 1997, GENE DEV, V11, P914, DOI 10.1101/gad.11.7.914; RAGHEB JA, 1994, J VIROL, V68, P3220, DOI 10.1128/JVI.68.5.3220-3231.1994; Suzuki N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1168; Suzuki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110404; Takiguchi M, 2014, ACS SYNTH BIOL, V3, P903, DOI 10.1021/sb3000723; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Uno N, 2013, CYTOTECHNOLOGY, V65, P803, DOI 10.1007/s10616-013-9548-4; Yamaguchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017267; Yamaguchi Shigeyuki, 2006, Chromosome Science, V9, P65	27	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157187	10.1371/journal.pone.0157187	http://dx.doi.org/10.1371/journal.pone.0157187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271046	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000069
J	Botesteanu, DA; Lee, JM; Levy, D				Botesteanu, Dana-Adriana; Lee, Jung-Min; Levy, Doron			Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early Detection	PLOS ONE			English	Article							FALLOPIAN-TUBE; CLINICAL-IMPLICATIONS; MUTATION CARRIERS; SURVIVAL; HISTORY; BREAST; BRCA1; WOMEN; RESISTANCE; EVOLUTION	High-grade serous ovarian cancer (HGSOC) represents the majority of ovarian cancers and accounts for the largest proportion of deaths from the disease. A timely detection of low volume HGSOC should be the goal of any screening studies. However, numerous transvaginal ultrasound (TVU) detection-based population studies aimed at detecting low-volume disease have not yielded reduced mortality rates. A quantitative invalidation of TVU as an effective HGSOC screening strategy is a necessary next step. Herein, we propose a mathematical model for a quantitative explanation on the reported failure of TVU-based screening to improve HGSOC low-volume detectability and overall survival. We develop a novel in silico mathematical assessment of the efficacy of a unimodal TVU monitoring regimen as a strategy aimed at detecting low-volume HGSOC in cancer-positive cases, defined as cases for which the inception of the first malignant cell has already occurred. Our findings show that the median window of opportunity interval length for TVU monitoring and HGSOC detection is approximately 1.76 years. This does not translate into reduced mortality levels or improved detection accuracy in an in silico cohort across multiple TVU monitoring frequencies or detection sensitivities. We demonstrate that even a semiannual, unimodal TVU monitoring protocol is expected to miss detectable HGSOC. Lastly, we find that circa 50% of the simulated HGSOC growth curves never reach the baseline detectability threshold, and that on average, 5-7 infrequent, rate-limiting stochastic changes in the growth parameters are associated with reaching HGSOC detectability and mortality thresholds respectively. Focusing on a malignancy poorly studied in the mathematical oncology community, our model captures the dynamic, temporal evolution of HGSOC progression. Our mathematical model is consistent with recent case reports and prospective TVU screening population studies, and provides support to the empirical recommendation against frequent HGSOC screening.	[Botesteanu, Dana-Adriana; Levy, Doron] Univ Maryland, Dept Math, College Pk, MD 20742 USA; [Botesteanu, Dana-Adriana; Levy, Doron] Univ Maryland, Ctr Sci Computat & Math Modeling CSCAMM, College Pk, MD 20742 USA; [Botesteanu, Dana-Adriana; Lee, Jung-Min] NCI, Womens Malignancies Branch, Ctr Canc Res, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Levy, D (corresponding author), Univ Maryland, Dept Math, College Pk, MD 20742 USA.; Levy, D (corresponding author), Univ Maryland, Ctr Sci Computat & Math Modeling CSCAMM, College Pk, MD 20742 USA.	dlevy@math.umd.edu		Botesteanu, Dana-Adriana/0000-0002-5509-8987	Intramural Research Program of the National Institutes of Health; Center for Cancer Research, National Cancer Institute as part of a seed grant from the UMD-NCI Partnership for Cancer Technology; John Simon Guggenheim Memorial Foundation; NATIONAL CANCER INSTITUTE [ZIABC011525] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, National Cancer Institute as part of a seed grant from the UMD-NCI Partnership for Cancer Technology; John Simon Guggenheim Memorial Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the Intramural Research Program of the National Institutes of Health, Center for Cancer Research, National Cancer Institute as part of a seed grant from the UMD-NCI Partnership for Cancer Technology. The work of DL was supported in part by the John Simon Guggenheim Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse S. F., 1975, SEER CANC STAT REV 1; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bodelon C, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju262; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Brown PO, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000114; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Buys SS, 2005, AM J OBSTET GYNECOL, V193, P1630, DOI 10.1016/j.ajog.2005.05.005; Byrne HM, 2006, PHILOS T R SOC A, V364, P1563, DOI 10.1098/rsta.2006.1786; Callahan MJ, 2007, J CLIN ONCOL, V25, P3985, DOI 10.1200/JCO.2007.12.2622; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Carcangiu ML, 2006, AM J SURG PATHOL, V30, P1222, DOI 10.1097/01.pas.0000202161.80739.ac; Carduner L, 2014, EXP CELL RES, V320, P329, DOI 10.1016/j.yexcr.2013.11.011; Chignola R, 2005, IEEE T BIO-MED ENG, V52, P808, DOI 10.1109/TBME.2005.845219; CIAMPI A, 1986, CELL TISSUE KINET, V19, P129, DOI 10.1111/j.1365-2184.1986.tb00723.x; Correa RJM, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0182-y; Cristini V., 2010, MULTISCALE MODELING; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; Crum CP, 2012, CLIN OBSTET GYNECOL, V55, P24, DOI 10.1097/GRF.0b013e31824b1725; Danesh K, 2012, J THEOR BIOL, V314, P10, DOI 10.1016/j.jtbi.2012.08.025; Goff BA, 2007, CANCER, V109, P221, DOI 10.1002/cncr.22371; Harlow SD, 2012, CLIMACTERIC, V15, P105, DOI [10.3109/13697137.2011.650656, 10.1016/j.fertnstert.2012.01.128, 10.1210/jc.2011-3362, 10.1097/gme.0b013e31824d8f40]; Hermsen BBJ, 2007, BRIT J CANCER, V96, P1335, DOI 10.1038/sj.bjc.6603725; Hori SS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003110; Horiuchi A, 2003, GYNECOL ONCOL, V88, P309, DOI 10.1016/S0090-8258(02)00104-X; Jacobs I, 2011, OBSTET GYNECOL, V118, P1209, DOI 10.1097/AOG.0b013e31823b49b3; Jacobs IJ, 2015, LANCET; Jain HV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081582; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Klein JD, 2006, PEDIATRICS, V118, P2245, DOI 10.1542/peds.2006-2481; Kobayashi H, 2008, INT J GYNECOL CANCER, V18, P414, DOI 10.1111/j.1525-1438.2007.01035.x; Kobel M, 2014, CONTROVERSIES MANAGE, P29; Kohandel M, 2006, J THEOR BIOL, V242, P62, DOI 10.1016/j.jtbi.2006.02.001; Kohn EC, 2013, ANN ONCOL, V24, P22, DOI 10.1093/annonc/mdt464; Ledermann JA, 2013, ANN ONCOL, V24, P24, DOI 10.1093/annonc/mdt333; Li J, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-8; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Maini PK, 2006, CANC BIOINFORMATICS, P95; McGuire V, 2004, AM J EPIDEMIOL, V160, P613, DOI 10.1093/aje/kwh284; Menon U, 2014, GYNECOL ONCOL, V132, P490, DOI 10.1016/j.ygyno.2013.11.030; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Modugno F, 2012, MOL MECH PERS MED M; Moyer VA, 2012, ANN INTERN MED, V157, P900, DOI 10.7326/0003-4819-157-11-201212040-00539; Panetta JC, 1997, MATH BIOSCI, V146, P89, DOI 10.1016/S0025-5564(97)00077-1; Pavlik EJ, 2000, GYNECOL ONCOL, V77, P410, DOI 10.1006/gyno.2000.5783; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Schwarz RF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001789; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; SPEER JF, 1984, CANCER RES, V44, P4124; Stirling D, 2005, J CLIN ONCOL, V23, P5588, DOI 10.1200/JCO.2005.05.097; van der Velde NM, 2009, INT J CANCER, V124, P919, DOI 10.1002/ijc.24038; van Nagell JR, 2007, CANCER-AM CANCER SOC, V109, P1887, DOI 10.1002/cncr.22594; van Nagell JR, 2014, INT J WOMENS HEALTH, V6, P25, DOI 10.2147/IJWH.S38347; van Nagell JR, 2011, OBSTET GYNECOL, V118, P1212, DOI 10.1097/AOG.0b013e318238d030; Weinberg R. A., 2013, BIOL CANC; Wodarz D, 2014, DYNAMICS CANC MATH F; Xing H, 2005, J CANCER RES CLIN, V131, P511, DOI 10.1007/s00432-005-0677-9; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	58	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156661	10.1371/journal.pone.0156661	http://dx.doi.org/10.1371/journal.pone.0156661			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257824	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700096
J	Brierley, ME; Brooks, KR; Mond, J; Stevenson, RJ; Stephen, ID				Brierley, Mary-Ellen; Brooks, Kevin R.; Mond, Jonathan; Stevenson, Richard J.; Stephen, Ian D.			The Body and the Beautiful: Health, Attractiveness and Body Composition in Men's and Women's Bodies	PLOS ONE			English	Article							PHYSICAL ATTRACTIVENESS; MASS INDEX; RISK-FACTORS; OLDER MEN; FAT; OBESITY; WEIGHT; FITNESS; SIZE; ASSOCIATION	The dominant evolutionary theory of physical attraction posits that attractiveness reflects physiological health, and attraction is a mechanism for identifying a healthy mate. Previous studies have found that perceptions of the healthiest body mass index (weight scaled for height; BMI) for women are close to healthy BMI guidelines, while the most attractive BMI is significantly lower, possibly pointing to an influence of sociocultural factors in determining attractive BMI. However, less is known about ideal body size for men. Further, research has not addressed the role of body fat and muscle, which have distinct relationships with health and are conflated in BMI, in determining perceived health and attractiveness. Here, we hypothesised that, if attractiveness reflects physiological health, the most attractive and healthy appearing body composition should be in line with physiologically healthy body composition. Thirty female and 33 male observers were instructed to manipulate 15 female and 15 male body images in terms of their fat and muscle to optimise perceived health and, separately, attractiveness. Observers were unaware that they were manipulating the muscle and fat content of bodies. The most attractive apparent fat mass for female bodies was significantly lower than the healthiest appearing fat mass (and was lower than the physiologically healthy range), with no significant difference for muscle mass. The optimal fat and muscle mass for men's bodies was in line with the healthy range. Male observers preferred a significantly lower overall male body mass than did female observers. While the body fat and muscle associated with healthy and attractive appearance is broadly in line with physiologically healthy values, deviations from this pattern suggest that future research should examine a possible role for internalization of body ideals in influencing perceptions of attractive body composition, particularly in women.	[Brierley, Mary-Ellen; Brooks, Kevin R.; Mond, Jonathan; Stevenson, Richard J.; Stephen, Ian D.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Stephen, Ian D.] ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Brooks, Kevin R.; Stevenson, Richard J.; Stephen, Ian D.] Macquarie Univ, Fac Human Sci, PARC, Sydney, NSW 2109, Australia	Macquarie University; Macquarie University	Stephen, ID (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.; Stephen, ID (corresponding author), ARC Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia.; Stephen, ID (corresponding author), Macquarie Univ, Fac Human Sci, PARC, Sydney, NSW 2109, Australia.	ian.stephen@mq.edu.au	Stephen, Ian/ABA-6218-2021	Stephen, Ian/0000-0001-9714-8295; Mond, Jonathan/0000-0002-0410-091X; Brooks, Kevin/0000-0003-1424-4092; Stevenson, Richard/0000-0002-2461-5777	Macquarie University Research Development Grant [MQRDG9201401548]	Macquarie University Research Development Grant	This work was funded by a Macquarie University Research Development Grant received by IDS, KRB, RJS; mq.edu.au; MQRDG9201401548. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRONSON FH, 1991, BIOL REPROD, V44, P945, DOI 10.1095/biolreprod44.6.945; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Cafri G, 2005, CLIN PSYCHOL REV, V25, P215, DOI 10.1016/j.cpr.2004.09.003; Cazzato V, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00235; Coetzee V, 2011, BODY IMAGE, V8, P190, DOI 10.1016/j.bodyim.2010.12.003; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; Cornelissen KK, 2016, BRIT J HEALTH PSYCH, V21, P555, DOI 10.1111/bjhp.12185; Cornelissen KK, 2015, BODY IMAGE, V13, P75, DOI 10.1016/j.bodyim.2015.01.001; Cornelissen PL, 2009, J THEOR BIOL, V256, P343, DOI 10.1016/j.jtbi.2008.09.041; Coy AE, 2014, BODY IMAGE, V11, P282, DOI 10.1016/j.bodyim.2014.04.003; Crossley KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050601; Doyle JF., 2009, J SOCIAL EVOLUTIONAR, V3, P81, DOI [DOI 10.1037/H0099329, 10.1037/h0099329]; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; FALLON AE, 1985, J ABNORM PSYCHOL, V94, P102, DOI 10.1037/0021-843X.94.1.102; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Frederick D. A., 2007, PSYCHOL MEN MASCULIN, V8, P103, DOI [10.1037/1524-9220.8.2.103, DOI 10.1037/1524-9220.8.2.103]; FRISCH RE, 1987, HUM REPROD, V2, P521, DOI 10.1093/oxfordjournals.humrep.a136582; FRISCH RE, 1994, P NUTR SOC, V53, P113, DOI 10.1079/PNS19940015; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Gardner RM, 1996, BRIT J PSYCHOL, V87, P327, DOI 10.1111/j.2044-8295.1996.tb02593.x; Gomez-Ambrosi J, 2012, INT J OBESITY, V36, P286, DOI 10.1038/ijo.2011.100; Gomez-Ambrosi J, 2011, OBESITY, V19, P1439, DOI 10.1038/oby.2011.36; Groesz LM, 2002, EFFECT EXPT PRESENTA, DOI [10.1002/eat.10005, DOI 10.1002/EAT.10005]; Honekopp J, 2007, EVOL HUM BEHAV, V28, P106, DOI 10.1016/j.evolhumbehav.2006.09.001; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Jebb SA, 2000, BRIT J NUTR, V83, P115, DOI 10.1017/S0007114500000155; Johnson W, 2015, BEHAV GENET, V45, P84, DOI 10.1007/s10519-014-9690-6; Lara-Esqueda A, 2004, INT J OBESITY, V28, P1443, DOI 10.1038/sj.ijo.0802705; Lassek WD, 2009, EVOL HUM BEHAV, V30, P322, DOI 10.1016/j.evolhumbehav.2009.04.002; MISHKIND ME, 1986, AM BEHAV SCI, V29, P545, DOI 10.1177/000276486029005004; Mitchison D, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0058-y; Murray SB, BR J PSYCHIAT; Mvo Z, 1999, Curationis, V22, P27; Nicklas BJ, 2004, AM J EPIDEMIOL, V160, P741, DOI 10.1093/aje/kwh281; Olivardia R., 2004, PSYCHOL MEN MASCULIN, V5, P112, DOI [10.1037/1524-9220.5.2.112, DOI 10.1037/1524-9220.5.2.112]; Pasquali R, 2006, MATURITAS, V54, P363, DOI 10.1016/j.maturitas.2006.04.018; Pope HG, 2001, PSYCHOTHER PSYCHOSOM, V70, P189, DOI 10.1159/000056252; Probst M, 1998, J PSYCHOSOM RES, V44, P451, DOI 10.1016/S0022-3999(97)00270-5; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rothman KJ, 2008, INT J OBESITY, V32, pS56, DOI 10.1038/ijo.2008.87; SEGAL KR, 1987, J CLIN INVEST, V80, P1050, DOI 10.1172/JCI113159; Shinichi Nakagawa, 2016, EFFECTS SEX HORMONES, DOI DOI 10.1111/BRV.12243; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Stephen ID, 2014, BODY IMAGE, V11, P183, DOI 10.1016/j.bodyim.2013.11.007; Stephen ID, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086302; Stephen ID, 2011, EVOL HUM BEHAV, V32, P216, DOI 10.1016/j.evolhumbehav.2010.09.003; Stephen ID, 2014, HLTH BODY HLTH FACE; Swami Viren, 2005, Body Image, V2, P383, DOI 10.1016/j.bodyim.2005.08.001; Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702; Swami V, 2009, BRIT J PSYCHOL, V100, P313, DOI 10.1348/000712608X329525; Symons D, 1979, EVOLUTION HUMAN SEXU; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; Tovee MJ, 1999, P ROY SOC B-BIOL SCI, V266, P211, DOI 10.1098/rspb.1999.0624; Tovee MJ, 2007, HLTH BODY EQUALS BEA, P108; Visser M, 1998, AM J CLIN NUTR, V68, P584, DOI 10.1093/ajcn/68.3.584; Weeden J, 2005, PSYCHOL BULL, V131, P635, DOI 10.1037/0033-2909.131.5.635; WENTZ AC, 1980, OBSTET GYNECOL, V56, P482; Womersley J, 1973, Br J Nutr, V32, P77, DOI 10.1079/BJN19740060	59	48	49	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156722	10.1371/journal.pone.0156722	http://dx.doi.org/10.1371/journal.pone.0156722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257677	gold, Green Submitted, Green Published			2022-12-26	WOS:000377369700115
J	Chao, WC; Wu, CL; Liu, PY; Shieh, CC				Chao, Wen-Cheng; Wu, Chieh-Liang; Liu, Po-Yu; Shieh, Chi-Chang			Regular Sputum Check-Up for Early Diagnosis of Tuberculosis after Exposure in Healthcare Facilities	PLOS ONE			English	Article							NEW-YORK-CITY; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; COST-EFFECTIVENESS; TRANSMISSION; INFECTION; OUTBREAK	Background The early diagnosis of patients with TB disease is critical after an outbreak of tuberculosis (TB) infection in healthcare facilities. In this study, we report a catastrophic TB outbreak in a psychiatric healthcare facility and analyze the role of regular sputum check-ups and other diagnostic tools to facilitate an early diagnosis. Methods Every exposed participant received regular sputum check-ups and chest X-rays (CXR) as part of the outbreak management protocol. We retrospectively analyzed data from the contact participants to identify risk factors for eventual TB development and investigated the diagnostic efficacy of regular sputum check-ups. Results Among 133 contact participants, 16 (12.0%) developed TB during the 4-year follow-up period. Low body-mass-index (BMI) (<21) (adjusted hazard ratio (aHR) 3.16, 95% confidence interval (CI) 1.11-8.98) and long duration of contact (>3 months) (aHR 8.70, 95% CI, 1.14-63.34) independently predicted the development of TB. Even though regular sputum check-ups required significant resources, they did facilitate the early identification of new TB cases among the contact participants. Regular sputum check-ups for high-risk patients based on BMI, contact duration and CXR findings may be a practical approach when compared with universal sputum follow-up, with a slightly decreased sensitivity but high positive likelihood ratio (88%, [95% CI, 62-98%] and 5.12, [95% CI, 3.30-7.95], respectively). Conclusion While regular sputum check-ups for all contact participants facilitated the early identification of cases after the outbreak of TB in the healthcare facility, regular sputum check-ups for high-risk patients might be an effective alternative in resource-limited settings.	[Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chao, Wen-Cheng; Shieh, Chi-Chang] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Wu, Chieh-Liang; Liu, Po-Yu] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Wu, Chieh-Liang] Taichung Vet Gen Hosp, Ctr Qual Management, Taichung, Taiwan; [Shieh, Chi-Chang] Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70428, Taiwan	Taichung Veterans General Hospital; National Cheng Kung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Shieh, CC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan.; Shieh, CC (corresponding author), Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70428, Taiwan.	cshieh@mail.ncku.edu.tw	LIU, PO-YU/AHB-4861-2022	Liu, Po-Yu/0000-0001-8006-4917				Alisjahbana B, 2005, INT J TUBERC LUNG D, V9, P814; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Bell DJ, 2009, INT J TUBERC LUNG D, V13, P99; Bhargava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077979; Biadglegne F, 2015, EPIDEMIOL INFECT, V143, P887, DOI 10.1017/S095026881400288X; Buregyeya E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-360; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P801; Chao WC, 2015, MICROBES INFECT, V17, P195, DOI 10.1016/j.micinf.2014.11.009; da Costa PA, 2009, J HOSP INFECT, V72, P57, DOI 10.1016/j.jhin.2009.01.016; de Vries G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-151; Desta Z, 2001, ANTIMICROB AGENTS CH, V45, P382, DOI 10.1128/AAC.45.2.382-392.2001; Djukanovic R, 2002, EUR RESPIR J, V20, p1S, DOI 10.1183/09031936.02.00000102; Gasner MR, 1999, NEW ENGL J MED, V340, P359, DOI 10.1056/NEJM199902043400506; Harris TG, 2013, AM J INFECT CONTROL, V41, P155, DOI 10.1016/j.ajic.2012.02.015; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Jou R, 2009, INT J TUBERC LUNG D, V13, P1142; Kik SV, 2008, AM J RESP CRIT CARE, V178, P96, DOI 10.1164/rccm.200708-1256OC; Lee SW, 2010, CHEST, V137, P1057, DOI 10.1378/chest.09-1513; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Neely F, 2010, J PUBLIC HEALTH-UK, V32, P44, DOI 10.1093/pubmed/fdp056; Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247; Pachi Argiro, 2013, Tuberc Res Treat, V2013, P489865, DOI 10.1155/2013/489865; Pepper T, 2008, INT J TUBERC LUNG D, V12, P397; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Saito M, 2004, INT J TUBERC LUNG D, V8, P842; Schepisi MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121639; van Cleeff MRA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-111; van't Hoog AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038691; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; Wang QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082660; Warren JR, 2000, AM J RESP CRIT CARE, V161, P1559, DOI 10.1164/ajrccm.161.5.9908063; Yen CL, 2015, INT J OBESITY, V39, P270, DOI 10.1038/ijo.2014.93	35	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157054	10.1371/journal.pone.0157054	http://dx.doi.org/10.1371/journal.pone.0157054			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258370	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700173
J	Geraldo, MT; Takeda, AAS; Braz, ASK; Lemke, N				Geraldo, Marcos Tadeu; Sekijima Takeda, Agnes Alessandra; Kimus Braz, Antonio Sergio; Lemke, Ney			Bending-Twisting Motions and Main Interactions in Nucleoplasmin Nuclear Import	PLOS ONE			English	Article							LOCALIZATION SEQUENCE-BINDING; LINEAR CONSTRAINT SOLVER; NORMAL-MODE ANALYSIS; STRUCTURAL BASIS; MOLECULAR-DYNAMICS; PROTEIN IMPORT; CRYSTALLOGRAPHIC ANALYSIS; ALPHA; RECOGNITION; SIGNALS	Alpha solenoid proteins play a key role in regulating the classical nuclear import pathway, recognizing a target protein and transporting it into the nucleus. Importin-alpha (Imp alpha) is the solenoid responsible for cargo protein recognition, and it has been extensively studied by X-ray crystallography to understand the binding specificity. To comprehend the main motions of Imp alpha and to extend the information about the critical interactions during carrier-cargo recognition, we surveyed different conformational states based on molecular dynamics (MD) and normal mode (NM) analyses. Our model of study was a crystallographic structure of Imp alpha complexed with the classical nuclear localization sequence (cNLS) from nucleoplasmin (Npl), which was submitted to multiple 100 ns of MD simulations. Representative conformations were selected for calculating the 87 lowest frequencies NMs of vibration, and a displacement approach was applied along each NM. Based on geometric criteria, using the radius of curvature and inter-repeat angles as the reference metrics, the main motions of Imp alpha were described. Moreover, we determined the salt bridges, hydrogen bonds and hydrophobic interactions in the Imp alpha-NplNLS interface. Our results show the bending and twisting motions participating in the recognition of nuclear proteins, allowing the accommodation and adjustment of a classical bipartite NLS sequence. The essential contacts for the nuclear import were also described and were mostly in agreement with previous studies, suggesting that the residues in the cNLS linker region establish important contacts with Imp alpha adjusting the cNLS backbone. The MD simulations combined with NM analysis can be applied to the Imp alpha-NLS system to help understand interactions between Imp alpha and cNLSs and the analysis of non-classic NLSs.	[Geraldo, Marcos Tadeu; Sekijima Takeda, Agnes Alessandra; Lemke, Ney] UNESP Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Fis & Biofis, Lab Bioinformat & Biofis Computac, BR-18618970 Botucatu, SP, Brazil; [Sekijima Takeda, Agnes Alessandra] UNESP Univ Estadual Paulista, Inst Biotecnol IBTEC, BR-18607440 Botucatu, SP, Brazil; [Kimus Braz, Antonio Sergio] UFABC Univ Fed ABC, Ctr Ciencias Nat & Humanas, Lab Biol Computac & Bioinformat, BR-09210170 Santo Andre, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Geraldo, MT (corresponding author), UNESP Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Fis & Biofis, Lab Bioinformat & Biofis Computac, BR-18618970 Botucatu, SP, Brazil.	mtgeraldo@gmail.com	Lemke, Ney/L-6761-2019; Geraldo, Marcos Tadeu/H-7187-2016; Lemke, Ney/A-8213-2008; Geraldo, Marcos Tadeu/S-4028-2019; Takeda, Agnes/AAH-3413-2020; Braz, Antonio Sergio/U-5377-2017	Lemke, Ney/0000-0001-7463-4303; Geraldo, Marcos Tadeu/0000-0001-8250-2159; Lemke, Ney/0000-0001-7463-4303; Geraldo, Marcos Tadeu/0000-0001-8250-2159; Takeda, Agnes/0000-0001-5000-6652; Braz, Antonio Sergio/0000-0003-2900-8703	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/19447-2, 2014/21976-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [142110/2012-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant numbers 2012/19447-2; 2014/21976-9) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grant number 142110/2012-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov V, 2005, PROTEIN SCI, V14, P633, DOI 10.1110/ps.04882105; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bernardes NE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128687; BROOKS B, 1985, P NATL ACAD SCI USA, V82, P4995, DOI 10.1073/pnas.82.15.4995; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUSCHWEILER R, 1995, J CHEM PHYS, V102, P3396, DOI 10.1063/1.469213; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christie M, 2015, JOURNAL OF MOLECULAR; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; de Barros AC, 2016, JOURNAL OF MOLECULAR; de Barros AC, 2012, ACTA CRYSTALLOGR D, V68, P743, DOI 10.1107/S0907444912010281; Dingwall C, 1990, Semin Cell Biol, V1, P11; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Doyle L, 2015, NATURE, V528, P585, DOI 10.1038/nature16191; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Falces J, 2010, BIOCHEMISTRY-US, V49, P9756, DOI 10.1021/bi101179g; Floquet N, 2015, BIOPHYS J, V109, P1179, DOI 10.1016/j.bpj.2015.07.003; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Forwood JK, 2010, STRUCTURE, V18, P1171, DOI 10.1016/j.str.2010.06.015; Genheden S, 2012, PHYS CHEM CHEM PHYS, V14, P8662, DOI 10.1039/c2cp23961b; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Grossfield A, 2009, ANN REP COMP CHEM, V5, P23, DOI 10.1016/S1574-1400(09)00502-7; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kajava AV, 2001, J STRUCT BIOL, V134, P132, DOI 10.1006/jsbi.2000.4328; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kappel C, 2010, BIOPHYS J, V99, P1596, DOI 10.1016/j.bpj.2010.06.032; Keskin O, 2002, BIOPHYS J, V83, P663, DOI 10.1016/S0006-3495(02)75199-0; Kirby TW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13405; Kobe B, 2000, TRENDS BIOCHEM SCI, V25, P509, DOI 10.1016/S0968-0004(00)01667-4; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SJ, 2000, J MOL BIOL, V302, P251, DOI 10.1006/jmbi.2000.4055; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lyman E, 2006, BIOPHYS J, V91, P164, DOI 10.1529/biophysj.106.082941; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Matsuura Y, 2004, NATURE, V432, P872, DOI 10.1038/nature03144; Moroianu J, 1996, P NATL ACAD SCI USA, V93, P7059, DOI 10.1073/pnas.93.14.7059; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pumroy RA, 2015, STRUCTURE, V23, P374, DOI 10.1016/j.str.2014.11.015; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schrodinger L, 2010, THE PYMOL MOLECULAR; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Settanni G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002864; Skjaerven L, 2011, PROTEINS, V79, P232, DOI 10.1002/prot.22875; Takeda AAS, 2013, PROTEIN PEPTIDE LETT, V20, P8; Tama F, 2001, PROTEIN ENG, V14, P1, DOI 10.1093/protein/14.1.1; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574	71	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157162	10.1371/journal.pone.0157162	http://dx.doi.org/10.1371/journal.pone.0157162			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258022	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700179
J	Grigoras, CA; Zervou, FN; Zacharioudakis, IM; Siettos, CI; Mylonakis, E				Grigoras, Christos A.; Zervou, Fainareti N.; Zacharioudakis, Ioannis M.; Siettos, Constantinos I.; Mylonakis, Eleftherios			Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data	PLOS ONE			English	Article							HEALTH-CARE SETTINGS; ASYMPTOMATIC CARRIERS; EPIDEMIOLOGIC MODEL; CONTACT PRECAUTIONS; HOSPITAL ADMISSION; UNITED-STATES; RISK-FACTORS; COLONIZATION; METAANALYSIS; PREVALENCE	Clostridium difficile infection is the most common hospital-acquired infection. Besides infected patients, carriers have emerged as a key player in C. difficile epidemiology. In this study, we evaluated the impact of identifying and isolating carriers upon hospital admission on the incidence of CDI incidence and hospital-acquired C. difficile colonization, as a single policy and as part of bundle approaches. We simulated C. difficile transmission using a stochastic mathematical approach, considering the contribution of carriers based on published literature. In the baseline scenario, CDI incidence was 6.18/1,000 admissions (95% CI, 5.72-6.65), simulating reported estimates from U.S. hospital discharges. The acquisition rate of C. difficile carriage was 9.72/1,000 admissions (95% CI, 9.15-10.31). Screening and isolation of colonized patients on admission to the hospital decreased CDI incidence to 4.99/1,000 admissions (95% CI, 4.59-5.42; relative reduction (RR) = 19.1%) and led to 36.2% reduction in the rate of hospital-acquired colonization. Simulating an antimicrobial stewardship program reduced CDI rate to 2.35/1,000 admissions (95% CI, 2.07-2.65). In sensitivity analysis, CDI incidence was less than 2.32/1,000 admissions (RR = 62.4%) in 95% of 1,000 simulations. The combined bundle, focusing on reducing C. difficile transmission from colonized patients and the individual risk of these patients to develop CDI, decreased significantly the incidence of both CDI and hospital-acquired colonization. Implementation of this bundle to current practice is expected to have an important impact in containing CDI.	[Grigoras, Christos A.; Zervou, Fainareti N.; Zacharioudakis, Ioannis M.; Mylonakis, Eleftherios] Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA; [Grigoras, Christos A.] Natl Tech Univ Athens, Sch Appl Math & Phys Sci, Athens, Greece	Brown University; National Technical University of Athens	Mylonakis, E (corresponding author), Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA.	emylonakis@lifespan.org						Alasmari F, 2014, CLIN INFECT DIS, V59, P216, DOI 10.1093/cid/ciu258; Allen SJ, 2013, LANCET, V382, P1249, DOI 10.1016/S0140-6736(13)61218-0; Austin M, 2014, AM J MED, V127, P479, DOI 10.1016/j.amjmed.2014.02.017; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cook PP, 2015, INT J ANTIMICROB AG, V45, P262, DOI 10.1016/j.ijantimicag.2014.11.006; Curry SR, 2013, CLIN INFECT DIS, V57, P1094, DOI 10.1093/cid/cit475; Deshpande A, 2008, CURR MED RES OPIN, V24, P329, DOI 10.1185/030079908X253735; Deshpande A, 2013, J ANTIMICROB CHEMOTH, V68, P1951, DOI 10.1093/jac/dkt129; Deshpande A, 2012, CLIN GASTROENTEROL H, V10, P225, DOI 10.1016/j.cgh.2011.09.030; Deshpande A, 2011, CLIN INFECT DIS, V53, pE81, DOI 10.1093/cid/cir505; Dhar S, 2014, INFECT CONT HOSP EP, V35, P213, DOI 10.1086/675294; Donskey CJ, 2015, INFECT DIS CLIN N AM, V29, P13, DOI 10.1016/j.idc.2014.11.001; Dubberke ER, 2008, EMERG INFECT DIS, V14, P1031, DOI 10.3201/eid1407.070867; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Feazel LM, 2014, J ANTIMICROB CHEMOTH, V69, P1748, DOI 10.1093/jac/dku046; Forster AJ, 2012, CAN MED ASSOC J, V184, P37, DOI 10.1503/cmaj.110543; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Galdys AL, 2014, EXPERT REV ANTI-INFE, V12, P967, DOI 10.1586/14787210.2014.920252; Guerrero DM, 2013, J HOSP INFECT, V85, P155, DOI 10.1016/j.jhin.2013.07.002; Johnston BC, 2012, ANN INTERN MED, V157, P878, DOI 10.7326/0003-4819-157-12-201212180-00563; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kundrapu S, 2012, CLIN INFECT DIS, V55, P1527, DOI 10.1093/cid/cis707; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Lanzas C, 2011, INFECT CONT HOSP EP, V32, P553, DOI 10.1086/660013; Lanzas C, 2014, INFECT CONT HOSP EP, V35, P1043, DOI 10.1086/677162; Leekha S, 2013, AM J INFECT CONTROL, V41, P390, DOI 10.1016/j.ajic.2012.09.023; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Morgan DJ, 2013, INFECT CONT HOSP EP, V34, P69, DOI 10.1086/668775; O'Brien JA, 2007, INFECT CONT HOSP EP, V28, P1219, DOI 10.1086/522676; O'Horo JC, 2012, MAYO CLIN PROC, V87, P643, DOI 10.1016/j.mayocp.2012.02.024; Reveles KR, 2014, AM J INFECT CONTROL, V42, P1028, DOI 10.1016/j.ajic.2014.06.011; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rodriguez C, 2014, ANAEROBE, V30, P184, DOI 10.1016/j.anaerobe.2014.08.007; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Simor AE, 2013, INFECT CONT HOSP EP, V34, P687, DOI 10.1086/670998; Starr JM, 2009, J HOSP INFECT, V71, P49, DOI 10.1016/j.jhin.2008.09.013; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Yakob L, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.43; Yakob L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-376; Yanke E, 2015, AM J INFECT CONTROL, V43, P241, DOI 10.1016/j.ajic.2014.11.026; Yokoe DS, 2014, INFECT CONT HOSP EP, V35, P967, DOI 10.1086/677216; Zacharioudakis IM, 2015, AM J GASTROENTEROL, V110, P381, DOI 10.1038/ajg.2015.22	46	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156577	10.1371/journal.pone.0156577	http://dx.doi.org/10.1371/journal.pone.0156577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258068	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700081
J	Li, L; Liang, WQ; Ye, T; Chen, ZY; Zuo, XZ; Du, X; Qian, K; Zhang, CX; Hu, XR; Li, JH; Wang, L; Ma, ZF; Yao, Y				Li, Li; Liang, Wangqun; Ye, Ting; Chen, Zhenyan; Zuo, Xuezhi; Du, Xiang; Qian, Kun; Zhang, Chunxiu; Hu, Xiangrong; Li, Junhua; Wang, Le; Ma, Zufu; Yao, Ying			The Association between Nutritional Markers and Biochemical Parameters and Residual Renal Function in Peritoneal Dialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; PROTEIN-INTAKE; CAPD PATIENTS; FLUID STATUS; ADEQUACY; PREVALENCE; MORBIDITY; MORTALITY; RISK	Residual renal function (RRF) is an important prognostic factor for peritoneal dialysis patients as it influences the quality of life and mortality. This study was conducted to explore the potential factors correlated with RRF. A cross-sectional study was conducted by recruiting 155 patients with residual GFR more than 1 mL/min per 1.73m(2) at the initiation of peritoneal dialysis. We collected the demographic characteristics, nutritional markers and biochemical parameters of all participants, and analyzed the correlation between these variables and residual GFR as well. The odds ratio of RRF loss associated with each of the nutritional markers and biochemical parameters were estimated by logistic regression model. The residual GFR was negatively correlated with serum phosphate (ORQ3 = 2.67, 95% CI: 1.03-6.92; ORQ4 = 3.45, 95% CI: 1.35-9.04), magnesium (ORQ4 = 3.77, 95% CI: 1.48-3.63), and creatinine (ORQ3 = 2.93, 95% CI: 1.09-7.88; ORQ4 = 8.64 95% CI: 2.792-6.78), while positively associated with normalized protein catabolic rate (ORQ3 = 0.24, 95% CI: 0.09-0.65; ORQ4 = 0.11, 95% CI: 0.03-0.35), 24 hours urine volume(ORQ1 = 22.87, 95% CI: 2.76-189.24; ORQ3 = 0.08, 95% CI: 0.02-0.28) and serum chlorine concentrations (ORQ1 = 5.34, 95% CI: 1.94-14.68; ORQ4 = 0.28, 95% CI: 0.09-0.85), respectively. Our study suggested that the nutritional markers and biochemical parameters, though not all, but at least in part were closely correlated with RRF in peritoneal dialysis patients.	[Li, Li; Ye, Ting; Chen, Zhenyan; Zuo, Xuezhi; Du, Xiang; Yao, Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Clin Nutr, Wuhan 430074, Peoples R China; [Liang, Wangqun; Qian, Kun; Zhang, Chunxiu; Hu, Xiangrong; Li, Junhua; Wang, Le; Ma, Zufu; Yao, Ying] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yao, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Clin Nutr, Wuhan 430074, Peoples R China.; Ma, ZF; Yao, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan 430074, Peoples R China.	mazufu@sina.com; yaoyingkk@126.com	ye, ting/HGC-5924-2022		provincial Science Foundation of Hubei [WJ2015MB011]; National Science Foundation of China (NSF) [81300592]	provincial Science Foundation of Hubei; National Science Foundation of China (NSF)(National Natural Science Foundation of China (NSFC))	This work was supported by the provincial Science Foundation of Hubei (WJ2015MB011) and the National Science Foundation of China (NSF 81300592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICI G, 1993, NEPHRON, V65, P469, DOI 10.1159/000187533; Aparicio M, 1999, NEPHROL DIAL TRANSPL, V14, P1679, DOI 10.1093/ndt/14.7.1679; Ates K, 2001, KIDNEY INT, V60, P767, DOI 10.1046/j.1523-1755.2001.060002767.x; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Chandna SM, 2005, NEPHROL DIAL TRANSPL, V20, P2130, DOI 10.1093/ndt/gfh940; Chang TI, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001276; Chauveau P, 1996, NEPHROL DIAL TRANSPL, V11, P1568; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Kerkhof JV, 2004, NEPHROL DIAL TRANSPL, V19, P910, DOI 10.1093/ndt/gfh004; Diaz-Buxo Jose A, 2013, Adv Perit Dial, V29, P19; GEORGE SL, 1979, J PEDIATR-US, V94, P342, DOI 10.1016/S0022-3476(79)80870-7; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Ikizler TA, 1999, KIDNEY INT, V55, P1945, DOI 10.1046/j.1523-1755.1999.00410.x; IKIZLER TA, 1995, J AM SOC NEPHROL, V6, P1386; Konings CJAM, 2003, NEPHROL DIAL TRANSPL, V18, P797, DOI 10.1093/ndt/gfg147; Konings CJAM, 2002, PERITON DIALYSIS INT, V22, P477; Kopple JD, 2000, KIDNEY INT, V57, P1688, DOI 10.1046/j.1523-1755.2000.00014.x; LUTES R, 1993, ADV PERIT D, V9, P97; Maeda Yoshitaka, 2013, J Rural Med, V8, P171, DOI 10.2185/jrm.8.171; Maiorca R, 1995, NEPHROL DIAL TRANSPL, V10, P2295, DOI 10.1093/ndt/10.12.2295; MCCARTHY JT, 1994, J LAB CLIN MED, V123, P495; NOLPH KD, 1993, PERITON DIALYSIS INT, V13, P178; Noordzij M, 2006, NEPHROL DIAL TRANSPL, V21, P2513, DOI 10.1093/ndt/gfl257; Park HC, 2012, J KOREAN MED SCI, V27, P64, DOI 10.3346/jkms.2012.27.1.64; Pecoits R, 2003, AM J KIDNEY DIS, V41, P1212, DOI 10.1016/S0272-6386(03)00353-6; Pollock CA, 1997, J AM SOC NEPHROL, V8, P777; Rocco M, 2000, KIDNEY INT, V58, P446, DOI 10.1046/j.1523-1755.2000.00184.x; Rroji M, 2014, INT UROL NEPHROL, V46, P175, DOI 10.1007/s11255-013-0438-7; Stengel B, 2014, NEPHROL DIAL TRANSPL, V29, P1500, DOI 10.1093/ndt/gft388; Szeto CC, 2000, KIDNEY INT, V58, P400, DOI 10.1046/j.1523-1755.2000.00179.x; Tattersall J, 1998, OXFORD TXB NEPHROLOG, P2074; Wang AYM, 2006, KIDNEY INT, V69, P1726, DOI 10.1038/sj.ki.5000382; Wang AYM, 2004, AM J KIDNEY DIS, V43, P712, DOI 10.1053/j.ajkd.2003.12.032; Weisbord SD, 2006, CLIN CARDIOL, V29, P494, DOI 10.1002/clc.4960291105; Yamada S, 2014, THER APHER DIAL, V18, P383, DOI 10.1111/1744-9987.12170; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	37	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156423	10.1371/journal.pone.0156423	http://dx.doi.org/10.1371/journal.pone.0156423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258403	gold, Green Submitted, Green Published			2022-12-26	WOS:000377369700064
J	Medina, IR; Lubovac-Pilav, Z				Medina, Ignacio Riquelme; Lubovac-Pilav, Zelmina			Gene Co-Expression Network Analysis for Identifying Modules and Functionally Enriched Pathways in Type 1 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD MONONUCLEAR-CELLS; VERSUS-HOST-DISEASE; NONALCOHOLIC STEATOHEPATITIS; SUSCEPTIBILITY GENES; CHILDREN; REGION; BETA; IDENTIFICATION; AUTOANTIGEN	Type 1 diabetes (T1D) is a complex disease, caused by the autoimmune destruction of the insulin producing pancreatic beta cells, resulting in the body's inability to produce insulin. While great efforts have been put into understanding the genetic and environmental factors that contribute to the etiology of the disease, the exact molecular mechanisms are still largely unknown. T1D is a heterogeneous disease, and previous research in this field is mainly focused on the analysis of single genes, or using traditional gene expression profiling, which generally does not reveal the functional context of a gene associated with a complex disorder. However, network-based analysis does take into account the interactions between the diabetes specific genes or proteins and contributes to new knowledge about disease modules, which in turn can be used for identification of potential new biomarkers for T1D. In this study, we analyzed public microarray data of T1D patients and healthy controls by applying a systems biology approach that combines network-based Weighted Gene Co-Expression Network Analysis (WGCNA) with functional enrichment analysis. Novel co-expression gene network modules associated with T1D were elucidated, which in turn provided a basis for the identification of potential pathways and biomarker genes that may be involved in development of T1D.	[Medina, Ignacio Riquelme; Lubovac-Pilav, Zelmina] Univ Skovde, Sch Biosci, Bioinformat Res Grp, Skovde, Sweden	University of Skovde	Lubovac-Pilav, Z (corresponding author), Univ Skovde, Sch Biosci, Bioinformat Res Grp, Skovde, Sweden.	zelmina.lubovac@his.se	Pilav, Zelmina Lubovac/E-9956-2016	Pilav, Zelmina Lubovac/0000-0001-6427-0315; Riquelme Medina, Ignacio/0000-0002-8631-7636				Aribi M, 2007, MED SCI MONITOR, V13, pCR372; Axelsson S, 2008, CRYOBIOLOGY, V57, P201, DOI 10.1016/j.cryobiol.2008.08.001; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BARKER RA, 1988, INT J NEUROSCI, V43, P1, DOI 10.3109/00207458808985773; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; BORCHJOHNSEN K, 1989, DAN MED BULL, V36, P336; Brorsson C, 2009, DIABETES OBES METAB, V11, P60, DOI 10.1111/j.1463-1326.2008.01004.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; CDC, 2014, NAT DIAB STAT REP; Chen YG, 2014, DIABETES, V63, P3960, DOI 10.2337/db14-0214; Chervonsky AV, 1997, CELL, V89, P17, DOI 10.1016/S0092-8674(00)80178-6; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dakovic D, 2013, J CLIN PEDIATR DENT, V37, P377, DOI 10.17796/jcpd.37.4.l135531h4542gj66; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Delunardo F, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1940; Dinkins MB, 2015, J ALZHEIMERS DIS, V46, P55, DOI 10.3233/JAD-150088; Fiscella M, 2003, NAT BIOTECHNOL, V21, P302, DOI 10.1038/nbt797; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gao Shouguo, 2009, J Comput Sci Syst Biol, V2, P133; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Glaab E, 2012, BIOINFORMATICS, V28, pI451, DOI 10.1093/bioinformatics/bts389; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Goldberg E, 2009, AUTOIMMUN REV, V8, P682, DOI 10.1016/j.autrev.2009.02.017; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Gustafson EA, 2010, BIOCHEM BIOPH RES CO, V395, P1, DOI 10.1016/j.bbrc.2010.02.172; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hakonarson H, 2009, SEMIN IMMUNOL, V21, P355, DOI 10.1016/j.smim.2009.06.001; Holtan SG, 2014, BLOOD, V124, P363, DOI 10.1182/blood-2014-01-514786; Hu ZJ, 2013, NUCLEIC ACIDS RES, V41, pW225, DOI 10.1093/nar/gkt401; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jarmoskaite I, 2011, WIRES RNA, V2, P135, DOI 10.1002/wrna.50; Jordan MA, 2011, DISSECTING GENETICS; Kaizer EC, 2007, J CLIN ENDOCR METAB, V92, P3705, DOI 10.1210/jc.2007-0979; Kallionpaa H, 2014, DIABETES, V63, P2402, DOI 10.2337/db13-1775; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Kurrer MO, 1997, P NATL ACAD SCI USA, V94, P213, DOI 10.1073/pnas.94.1.213; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mandrup-Poulsen T, 2010, NAT REV ENDOCRINOL, V6, P158, DOI 10.1038/nrendo.2009.271; Manton ND, 2000, MED J AUSTRALIA, V173, P476, DOI 10.5694/j.1326-5377.2000.tb139299.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Niewczas MA, 2009, CLIN J AM SOC NEPHRO, V4, P62, DOI 10.2215/CJN.03010608; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Qazi BS, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/908468; Rashid M, 2000, J PEDIATR GASTR NUTR, V30, P48, DOI 10.1097/00005176-200001000-00017; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reynier F, 2010, GENES IMMUN, V11, P269, DOI 10.1038/gene.2009.112; Schwender H, 2012, MULTIPLE TESTING USI; Shalev A, 2014, MOL ENDOCRINOL, V28, P1211, DOI 10.1210/me.2014-1095; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Xu SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099807; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao Yuxing, 2011, Inflammation & Allergy Drug Targets, V10, P208; Zipris D, 2010, ADV EXP MED BIOL, V654, P585, DOI 10.1007/978-90-481-3271-3_25; Zipris D, 2008, CURR OPIN ENDOCRINOL, V15, P326, DOI 10.1097/MED.0b013e3283073a46	66	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156006	10.1371/journal.pone.0156006	http://dx.doi.org/10.1371/journal.pone.0156006			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257970	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700028
J	Niu, YH; Meng, QX; Li, SL; Ren, LP; Zhou, B; Schonewille, T; Zhou, ZM				Niu, Yuhong; Meng, Qingxiang; Li, Shengli; Ren, Liping; Zhou, Bo; Schonewille, Thomas; Zhou, Zhenming			Effects of Diets Supplemented with Ensiled Mulberry Leaves and Sun-Dried Mulberry Fruit Pomace on the Ruminal Bacterial and Archaeal Community Composition of Finishing Steers	PLOS ONE			English	Article							DAIRY-COWS; MICROBIAL-POPULATIONS; METHANE PRODUCTION; MORUS-ALBA; RUMEN; DIVERSITY; SHEEP; FERMENTATION; ABUNDANCE; METHANOGENESIS	This study investigated the effects of ensiled mulberry leaves (EML) and sun-dried mulberry fruit pomace (SMFP) on the ruminal bacterial and archaeal community composition of finishing steers. Corn grain- and cotton meal-based concentrate was partially replaced with EML or SMFP. The diets had similar crude protein (CP), neutral detergent fiber (NDF), and metabolizable energy. Following the feeding trial, the steers were slaughtered and ruminal liquid samples were collected to study the ruminal microbiome. Extraction of DNA, amplification of the V4 region of the 16S rRNA gene, and Illumina MiSeq pyrosequencing were performed for each sample. Following sequence de-noising, chimera checking, and quality trimming, an average of 209,610 sequences were generated per sample. Quantitative real-time PCR was performed to examine the selected bacterial species in the rumen. Our results showed that the predominant phyla were Bacteroidetes (43.90%), Firmicutes (39.06%), Proteobacteria (4.31%), and Tenericutes (2.04%), and the predominant genera included Prevotella (13.82%), Ruminococcus (2.51%), Butyrivibrio (2.38%), and Succiniclasticum (2.26%). Compared to the control group, EML and SMFP groups had a higher abundance of total bacteria (p < 0.001); however, the bacterial community composition was similar among the three groups. At the phylum level, there were no significant differences in Firmicutes (p = 0.7932), Bacteroidetes (p = 0.2330), Tenericutes (p = 0.2811), or Proteobacteria (p = 0.0680) levels among the three groups; however, Fibrobacteres decreased in EML (p = 0.0431). At the genus level, there were no differences in Prevotella (p = 0.4280), Ruminococcus (p = 0.2639), Butyrivibrio (p = 0.4433), or Succiniclasticum (p = 0.0431) levels among the groups. Additionally, the dietary treatments had no significant effects on the archaeal community composition in the rumen. Therefore, EML and SMFP supplementation had no significant effects on the ruminal bacterial or archaeal community composition of finishing steers.	[Niu, Yuhong; Meng, Qingxiang; Li, Shengli; Ren, Liping; Zhou, Bo; Zhou, Zhenming] State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Niu, Yuhong; Meng, Qingxiang; Li, Shengli; Ren, Liping; Zhou, Bo; Zhou, Zhenming] China Agr Univ, Coll Anim Sci & Technol, Beijing 100193, Peoples R China; [Niu, Yuhong] China Agr Univ, Coll Agron & Biotechnol, Beijing 100193, Peoples R China; [Schonewille, Thomas] Univ Utrecht, Dept Farm Anim Hlth, NL-3584 CL Utrecht, Netherlands	China Agricultural University; China Agricultural University; Utrecht University	Zhou, ZM (corresponding author), State Key Lab Anim Nutr, Beijing 100193, Peoples R China.; Zhou, ZM (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100193, Peoples R China.	zhouzm@cau.edu.cn	Meng, Q./GSI-6185-2022		China Agricultural Research System [CARS-38]; National Natural Science Foundation of China [31372335]; Special Fund for Agro-scientific Research in the Public Interest [201503134]	China Agricultural Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by grants from the China Agricultural Research System (CARS-38), the National Natural Science Foundation of China (31372335), and Special Fund for Agro-scientific Research in the Public Interest (201503134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castro-Carrera T, 2014, J DAIRY SCI, V97, P1661, DOI 10.3168/jds.2013-7243; Cheong SH, 2012, ANIM PROD SCI, V52, P240, DOI 10.1071/AN11087; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; Ding GZ, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-24; Doran MP, 2007, ANIM FEED SCI TECH, V138, P239, DOI 10.1016/j.anifeedsci.2006.11.016; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hook SE, 2009, APPL ENVIRON MICROB, V75, P374, DOI 10.1128/AEM.01672-08; Hook SE, 2011, MICROB ECOL, V62, P94, DOI 10.1007/s00248-011-9881-0; Huo WJ, 2014, WORLD J MICROB BIOT, V30, P669, DOI 10.1007/s11274-013-1489-8; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Jewell KA, 2015, APPL ENVIRON MICROB, V81, P4697, DOI 10.1128/AEM.00720-15; Kim M, 2011, FEMS MICROBIOL ECOL, V76, P49, DOI 10.1111/j.1574-6941.2010.01029.x; Kobayashi Y, 2008, FOLIA MICROBIOL, V53, P195, DOI 10.1007/s12223-008-0024-z; Liu C, 2012, ARCH MICROBIOL, V194, P353, DOI 10.1007/s00203-011-0757-y; Liu JX, 2001, SMALL RUMINANT RES, V39, P131, DOI 10.1016/S0921-4488(00)00180-2; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mao SY, 2016, ENVIRON MICROBIOL, V18, P525, DOI 10.1111/1462-2920.12724; Mosoni P, 2011, J ANIM SCI, V89, P783, DOI 10.2527/jas.2010-2947; Patra AK, 2010, PHYTOCHEMISTRY, V71, P1198, DOI 10.1016/j.phytochem.2010.05.010; Petri RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083424; Pitta DW, 2014, ANAEROBE, V30, P11, DOI 10.1016/j.anaerobe.2014.07.008; Popova M, 2013, APPL ENVIRON MICROB, V79, P1777, DOI 10.1128/AEM.03115-12; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Sahoo A, 2011, LIVEST SCI, V136, P175, DOI 10.1016/j.livsci.2010.08.019; Salinas-Chavira J, 2011, TROP ANIM HEALTH PRO, V43, P995, DOI 10.1007/s11250-011-9797-1; Sharma SK, 2010, RANGE MANAG AGROFOR, V31, P97; Shinkai T, 2010, ANIM SCI J, V81, P72, DOI 10.1111/j.1740-0929.2009.00698.x; Singh KM, 2015, MOL BIOL REP, V42, P95, DOI 10.1007/s11033-014-3746-9; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Suen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018814; Todaro M, 2007, J ANIM VET ADV, V6, P509; Tymensen LD, 2012, APPL ENVIRON MICROB, V78, P4051, DOI 10.1128/AEM.07994-11; Vu CC, 2011, ASIAN AUSTRAL J ANIM, V24, P1233, DOI 10.5713/ajas.2011.90328; Weimer PJ, 2008, APPL MICROBIOL BIOT, V80, P135, DOI 10.1007/s00253-008-1528-9; Weimer PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00296; Wetzels SU, 2015, J DAIRY SCI, V98, P5572, DOI 10.3168/jds.2014-9166; WOJCIECHOWICZ M, 1979, APPL ENVIRON MICROB, V37, P136, DOI 10.1128/AEM.37.1.136-142.1979; Wright ADG, 2008, MICROB ECOL, V56, P390, DOI 10.1007/s00248-007-9351-x; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhang RY, 2014, J SCI FOOD AGR, V94, P1886, DOI 10.1002/jsfa.6508; Zhou B, 2012, J ANIM FEED SCI, V21, P188, DOI 10.22358/jafs/66063/2012; Zhou M, 2011, J APPL MICROBIOL, V111, P1148, DOI 10.1111/j.1365-2672.2011.05126.x; Zhou M, 2009, APPL ENVIRON MICROB, V75, P6524, DOI 10.1128/AEM.02815-08; Zhou ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085406; Zhou ZM, 2012, BIORESOURCE TECHNOL, V103, P173, DOI 10.1016/j.biortech.2011.10.013; ZIOLECKI A, 1980, APPL ENVIRON MICROB, V39, P919	51	14	15	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156836	10.1371/journal.pone.0156836	http://dx.doi.org/10.1371/journal.pone.0156836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258373	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700143
J	Shahbazi, S; Sahrawat, TR; Ray, M; Dash, S; Kar, D; Singh, S				Shahbazi, Sajad; Sahrawat, Tammanna R.; Ray, Monalisa; Dash, Swagatika; Kar, Dattatreya; Singh, Shikha			Drug Targets for Cardiovascular-Safe Anti-Inflammatory: In Silico Rational Drug Studies	PLOS ONE			English	Article							IIB/IIIA RECEPTOR ANTAGONISTS; HERG K+ CHANNELS; INDUCIBLE CYCLOOXYGENASE; PREDICTION; DOCKING; SOLUBILITY; INHIBITORS; CURCUMIN; ANALOGS; GLIDE	Cyclooxygenase-2 (COX-2) plays an important role in memory consolidation and synaptic activity, the most fundamental functions of the brain. It converts arachidonic acid to prostaglandin endoperoxide H2. In contrast, if over-expressed, it causes inflammation in response to cytokine, pro-inflammatory molecule, and growth factor. Anti-inflammatory agents, by allosteric or competitive inhibition of COX-2, alleviate the symptoms of inflammation. Coxib family drugs, particularly celecoxib, are the most famous anti-inflammatory agents available in the market showing significant inhibitory effect on COX-2 activity. Due to high cardiovascular risk of this drug group, recent researches are focused on the investigation of new safer drugs for anti-inflammatory diseases. Natural compounds, particularly, phytochemicals are found to be good candidates for drug designing and discovery. In the present study, we performed in silico studies to quantitatively scrutinize the molecular interaction of curcumin and its structural analogs with COX-2, COX-1, FXa and integrin alpha IIB beta III to investigate their therapeutic potential as a cardiovascular-safe anti-inflammatory medicine (CVSAIM). The results of both ADMET and docking study indicated that out of all the 39 compounds studied, caffeic acid had remarkable interaction with proteins involved in inflammatory response. It was also found to inhibit the proteins that are involved in thrombosis, thereby, having the potential to be developed as therapeutic agent.	[Shahbazi, Sajad] Punjab Univ, Dept Biotechnol, Chandigarh 160014, India; [Sahrawat, Tammanna R.] Punjab Univ, Ctr Syst Biol & Bioinformat, Chandigarh 160014, India; [Ray, Monalisa; Dash, Swagatika; Kar, Dattatreya; Singh, Shikha] Siksha O Anusandhan Univ, Ctr Biotechnol, Bhubaneswar, Odisha, India	Panjab University; Panjab University; Siksha 'O' Anusandhan University	Singh, S (corresponding author), Siksha O Anusandhan Univ, Ctr Biotechnol, Bhubaneswar, Odisha, India.	sajad642008@gmail.com	Shahbazi, Sajad/AAE-2750-2021; Kar, Dattatreya/ABB-8117-2020	Shahbazi, Sajad/0000-0002-6764-7963	Aravinda Biosolution Ltd.; Department of Pharmacology, Osmania University	Aravinda Biosolution Ltd.; Department of Pharmacology, Osmania University	The authors are grateful to Dr. Manoj Kumar Mahto of Aravinda Biosolution Ltd., Dr. Deepak Reddy, Department of Pharmacology, Osmania University, for providing financial support and encouraging throughout. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Dr. Manoj Kumar Mahto of Aravinda Biosolution Ltd., Dr. Deepak Reddy, Department of Pharmacology, Osmania University for providing financial support and encouraging throughout.	Abendschein DR, 2001, J PHARMACOL EXP THER, V296, P567; Ajay, 1999, J MED CHEM, V42, P4942, DOI 10.1021/jm990017w; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; [Anonymous], 2012, SUIT 2012 PRIM VERS; Aronov MM, 2005, DRUG DISCOV TODAY, V10, P149, DOI 10.1016/S1359-6446(04)03278-7; Awaad AS, 2013, J SAUDI CHEM SOC, V17, P101, DOI 10.1016/j.jscs.2012.03.002; Bertolini A, 2002, CURR MED CHEM, V9, P1033, DOI 10.2174/0929867024606650; Borer JS, 2005, ARTHRITIS RES THER, V7, pS14, DOI 10.1186/ar1794; BREDER CD, 1995, J COMP NEUROL, V355, P296, DOI 10.1002/cne.903550208; Chen IJ, 2013, BIOORGAN MED CHEM, V21, P7898, DOI 10.1016/j.bmc.2013.10.003; Cheng AL, 2003, J MED CHEM, V46, P3572, DOI 10.1021/jm020266b; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; Duffy EM, 2000, J AM CHEM SOC, V122, P2878, DOI 10.1021/ja993663t; Egan WJ, 2002, ADV DRUG DELIVER REV, V54, P273, DOI 10.1016/S0169-409X(02)00004-2; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gupta S. K., 2010, J PHARM BIOMEDICAL S, V4, P1; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Kelder J, 1999, PHARMACEUT RES, V16, P1514, DOI 10.1023/A:1015040217741; Kim HK, 2004, B KOREAN CHEM SOC, V25, P1769; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Meraj K, 2012, BIOINFORMATION, V8, P1139, DOI 10.6026/97320630081139; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nirmala JM, 2011, INT J APPL BIOL PHAR, V2, P200; Oviedo JA, 2001, BIODRUGS, V15, P563, DOI 10.2165/00063030-200115090-00001; Plow EF, 2001, THROMB HAEMOSTASIS, V86, P34; Press S., 2011, QIKPROP 3 4 USER MAN; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Ronner E, 1998, EUR HEART J, V19, P1608, DOI 10.1053/euhj.1998.1222; SEIBERT K, 1994, RECEPTOR, V4, P17; Vandenberg JI, 2001, TRENDS PHARMACOL SCI, V22, P240, DOI 10.1016/S0165-6147(00)01662-X; Venkataramana CHS., 2011, J APPL PHARM SCI, V1, P159; Vorchheimer DA, 1999, JAMA-J AM MED ASSOC, V281, P1407, DOI 10.1001/jama.281.15.1407; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286	36	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156156	10.1371/journal.pone.0156156	http://dx.doi.org/10.1371/journal.pone.0156156			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258084	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700041
J	Somal, A; Bhat, IA; Indu, B; Pandey, S; Panda, BSK; Thakur, N; Sarkar, M; Chandra, V; Saikumar, G; Sharma, GT				Somal, Anjali; Bhat, Irfan A.; Indu, B.; Pandey, Sriti; Panda, Bibhudatta S. K.; Thakur, Nipuna; Sarkar, Mihir; Chandra, Vikash; Saikumar, G.; Sharma, G. Taru			A Comparative Study of Growth Kinetics, In Vitro Differentiation Potential and Molecular Characterization of Fetal Adnexa Derived Caprine Mesenchymal Stem Cells	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; AMNIOTIC-FLUID; STROMAL CELLS; BONE-MARROW; ANIMAL-MODELS; CELLULAR-THERAPY; EXPRESSION; CULTURE; REGENERATION; FEATURES	The present study was conducted with an objective of isolation, in vitro expansion, growth kinetics, molecular characterization and in vitro differentiation of fetal adnexa derived caprine mesenchymal stem cells. Mid-gestation gravid caprine uteri (2-3 months) were collected from abattoir to derive mesenchymal stem cells (MSCs) from fetal adnexa {amniotic fluid (cAF), amniotic sac (cAS), Wharton's jelly (cWJ) and cord blood (cCB)} and expanded in vitro. These cultured MSCs were used at the 3rd passage (P3) to study growth kinetics, localization as well as molecular expression of specific surface antigens, pluripotency markers and mesenchymal tri-lineage differentiation. In comparison to cAF and cAS MSCs, cWJ and cCB MSCs showed significantly (P<0.05) higher clonogenic potency, faster growth rate and low population doubling (PDT) time. All the four types of MSCs were positive for alkaline phosphatase (AP) and differentiated into chondrogenic, osteogenic, and adipogenic lineages. These stem cells expressed MSC surface antigens (CD73, CD90 and CD105) and pluripotency markers (Oct4, Sox2, Nanog, KLF, cMyc, FoxD3) but did not express CD34, a hematopoietic stem cell marker (HSC) as confirmed by RT-PCR, immunocytochemistry and flow cytometric analysis. The relative mRNA expression of MSC surface antigens (CD73, CD90 and CD105) was significantly (P<0.05) higher in cWJ MSCs compared to the other cell lines. The mRNA expression of Oct4 was significantly (P<0.05) higher in cWJ, whereas mRNA expression of KLF and cMyc was significantly (P<0.05) higher in cWJ and cAF than that of cAS and cCB. The comparative assessment revealed that cWJ MSCs outperformed MSCs from other sources of fetal adnexa in terms of growth kinetics, relative mRNA expression of surface antigens, pluripotency markers and tri-lineage differentiation potential, hence, these MSCs could be used as a preferred source for regenerative medicine.	[Somal, Anjali; Bhat, Irfan A.; Indu, B.; Pandey, Sriti; Panda, Bibhudatta S. K.; Thakur, Nipuna; Sarkar, Mihir; Chandra, Vikash; Sharma, G. Taru] ICAR Indian Vet Res Inst, Div Physiol & Climatol, Bareilly 243122, Uttar Pradesh, India; [Saikumar, G.] ICAR Indian Vet Res Inst, Div Vet Pathol, Bareilly 243122, Uttar Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute	Sharma, GT (corresponding author), ICAR Indian Vet Res Inst, Div Physiol & Climatol, Bareilly 243122, Uttar Pradesh, India.	gts553@gmail.com	CHANDRA, VIKASH/U-6635-2019; Pandey, Sriti/AAA-2247-2020		ICAR-IVRI through the Flagship Project	ICAR-IVRI through the Flagship Project	This study was supported by ICAR-IVRI through the Flagship Project entitled 'Stem cells: Its biology and therapeutic application in livestock and pets'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAS L, 1995, J EXP MED, V182, P1603, DOI 10.1084/jem.182.5.1603; Ansari M.M., 2013, J STEM CELL RES THER, V3, P2, DOI [10.4172/2157-7633.1000141., DOI 10.4172/2157-7633.1000141]; Azari O, 2011, VET RES COMMUN, V35, P211, DOI 10.1007/s11259-011-9464-z; Babaei H., 2008, Iranian Journal of Veterinary Surgery, V3, P57; Cardoso TC, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-18; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Carrade DD, 2012, CELL MED, V4, P1, DOI 10.3727/215517912X647217; Choi SA, 2013, IN VITRO CELL DEV-AN, V49, P42, DOI 10.1007/s11626-012-9569-x; Colleoni S, 2009, VET RES COMMUN, V33, P811, DOI 10.1007/s11259-009-9229-0; Colosimo A, 2013, CYTOTHERAPY, V15, P930, DOI 10.1016/j.jcyt.2013.03.014; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Corradetti B, 2013, REPRODUCTION, V145, P391, DOI 10.1530/REP-12-0437; Cremonesi F, 2011, THERIOGENOLOGY, V75, P1400, DOI 10.1016/j.theriogenology.2010.12.032; da Cunha ER, 2014, REPROD DOMEST ANIM, V49, P806, DOI 10.1111/rda.12372; Dangi SS, 2014, INT J BIOMETEOROL, V58, P2085, DOI 10.1007/s00484-014-0809-5; De Schauwer C, 2013, EQUINE VET J, V45, P518, DOI 10.1111/evj.12003; De Schauwer C, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt395; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duff SE, 2003, FASEB J, V17, P984, DOI 10.1096/fj.02-0634rev; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Fernandes R. A., 2012, Open Journal of Animal Sciences, V2, P166, DOI 10.4236/ojas.2012.23023; Fulton L. K., 1994, ILAR News, V36, P21; Gade NE, 2013, REPROD DOMEST ANIM, V48, P358, DOI 10.1111/j.1439-0531.2012.02156.x; Gao YH, 2014, INT J MOL SCI, V15, P3698, DOI 10.3390/ijms15033698; Godwin EE, 2012, EQUINE VET J, V44, P25, DOI 10.1111/j.2042-3306.2011.00363.x; Guest DJ, 2008, STEM CELLS CLONING, V1, P1, DOI 10.2147/SCCAA.S3824; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Harding J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt171; Hoynowski SM, 2007, BIOCHEM BIOPH RES CO, V362, P347, DOI 10.1016/j.bbrc.2007.07.182; Iacono E, 2015, REPROD DOMEST ANIM, V50, P353, DOI 10.1111/rda.12499; Iacono E, 2012, VET RES COMMUN, V36, P107, DOI 10.1007/s11259-012-9520-3; Iacono E, 2012, REPRODUCTION, V143, P455, DOI 10.1530/REP-10-0408; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Ilic D, 2011, BRIT MED BULL, V98, P117, DOI 10.1093/bmb/ldr012; Jin GZ, 2008, J VET MED SCI, V70, P723, DOI 10.1292/jvms.70.723; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Klemmt PAB, 2011, EXPERT OPIN BIOL TH, V11, P1297, DOI 10.1517/14712598.2011.587800; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; KUMAR M, 2013, STEM CELL DISCOVERY, V3, P226, DOI DOI 10.4236/SCD.2013.34028; Lange-Consiglio A, 2013, EQUINE VET J, V45, P737, DOI 10.1111/evj.12052; Lange-Consiglio A, 2012, J TISSUE ENG REGEN M, V6, P622, DOI 10.1002/term.465; Lee KS, 2013, ASIAN AUSTRAL J ANIM, V26, P588, DOI 10.5713/ajas.2012.12488; Garcia-Castro IL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146082; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410; Mann A, 2013, CYTOTECHNOLOGY, V65, P23, DOI 10.1007/s10616-012-9464-z; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Mohanty N, 2014, IN VITRO CELL DEV-AN, V50, P538, DOI 10.1007/s11626-013-9729-7; Nakamura Y, 2006, BRIT J DERMATOL, V154, P1062, DOI 10.1111/j.1365-2133.2006.07209.x; Paebst F, 2014, CYTOM PART A, V85A, P678, DOI 10.1002/cyto.a.22491; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pratheesh MD, 2014, VET RES COMMUN, V38, P139, DOI 10.1007/s11259-014-9597-y; Pratheesh MD, 2013, RES VET SCI, V94, P313, DOI 10.1016/j.rvsc.2012.08.002; Raoufi MF, 2011, REPROD DOMEST ANIM, V46, P95, DOI 10.1111/j.1439-0531.2010.01594.x; Reed SA, 2008, J CELL PHYSIOL, V215, P329, DOI 10.1002/jcp.21312; Reynolds LP, 2005, PLACENTA, V26, P689, DOI 10.1016/j.placenta.2004.11.010; Rossi B, 2014, STEM CELL REV REP, V10, P712, DOI 10.1007/s12015-014-9525-0; Roubelakis MG, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/107836; Sartore S, 2005, EUR J CARDIO-THORAC, V28, P677, DOI 10.1016/j.ejcts.2005.07.019; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Semb H, 2005, APMIS, V113, P743, DOI 10.1111/j.1600-0463.2005.apm_312.x; Seo MS, 2013, J VET SCI, V14, P151, DOI 10.4142/jvs.2013.14.2.151; Seo MS, 2009, J VET SCI, V10, P181, DOI 10.4142/jvs.2009.10.3.181; Sessarego N, 2008, HAEMATOLOGICA, V93, P339, DOI 10.3324/haematol.11869; Smith RKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075697; Sreekumar T.R., 2014, J STEM CELL RES THER, V4, P207, DOI [10.4172/2157-7633.1000207, DOI 10.4172/2157-7633.1000207]; Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CR0070034; Trounson A, 2006, ENDOCR REV, V27, P208, DOI 10.1210/er.2005-0016; Udehiya RK, 2013, RES VET SCI, V94, P743, DOI 10.1016/j.rvsc.2013.01.011; Uranio MF, 2011, MOL REPROD DEV, V78, P361, DOI 10.1002/mrd.21311; Uranio MF, 2014, MOL REPROD DEV, V81, P539, DOI 10.1002/mrd.22322; Violini S, 2012, CYTOTECHNOLOGY, V64, P1, DOI 10.1007/s10616-011-9398-x; Witkowska-Zimny M, 2011, CELL MOL BIOL LETT, V16, P493, DOI 10.2478/s11658-011-0019-7	76	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156821	10.1371/journal.pone.0156821	http://dx.doi.org/10.1371/journal.pone.0156821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257959	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700138
J	Wilkins, J; Zheng, YM; Yu, JY; Liang, C; Liu, SL				Wilkins, Jordan; Zheng, Yi-Min; Yu, Jingyou; Liang, Chen; Liu, Shan-Lu			Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV	PLOS ONE			English	Article							ANCIENT ADAPTIVE EVOLUTION; WEST NILE VIRUS; ANTIVIRAL ACTIVITY; S-PALMITOYLATION; FAMILY PROTEINS; INTERFERON; INFECTION; RESTRICTION; GENE; RESISTANCE	Interferon-induced transmembrane (IFITM) proteins are potent antiviral factors shown to restrict the infection of many enveloped viruses, including HIV. Here we report cloning and characterization of a panel of nonhuman primate IFITMs. We show that, similar to human IFITM, nonhuman primate IFITM proteins inhibit HIV and other primate lentiviruses. While some nonhuman primate IFITM proteins are more potent than human counterparts to inhibit HIV-1, they are generally not effective against HIV-2 similar to that of human IFITMs. Notably, depending on SIV strains and also IFITM species tested, nonhuman primate IFITM proteins exhibit distinct activities against SIVs; no correlation was found to support the notion that IFITM proteins are most active in non-natural primate hosts. Consistent with our recent findings for human IFITMs, nonhuman primate IFITM proteins interact with HIV-1 Env and strongly act in viral producer cells to impair viral infectivity and block cell-to-cell transmission. Accordingly, knockdown of primate IFITM3 increases HIV-1 replication in nohuman primate cells. Interestingly, analysis of DNA sequences of human and nonhuman primate IFITMs suggest that IFITM proteins have been undergoing purifying selection, rather than positive selection typical for cellular restriction factors. Overall, our study reveals some new and unexpected features of IFITMs in restricting primate lentiviruses, which enhances our understanding of virus-host interaction and AIDS pathogenesis.	[Wilkins, Jordan; Zheng, Yi-Min; Yu, Jingyou; Liu, Shan-Lu] Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Liang, Chen] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Liang, Chen] McGill Univ, Dept Med, Montreal, PQ, Canada; [Liang, Chen] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada	University of Missouri System; University of Missouri Columbia; Lady Davis Institute; McGill University; McGill University; McGill University	Liu, SL (corresponding author), Univ Missouri, Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO USA.	liushan@missouri.edu	Liu, Shan-Lu/L-5923-2016	Liu, Shan-Lu/0000-0003-1620-3817	NIH [R01 AI112381]; Canadian Institutes of Health Research [MOP-133479]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI112381] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from NIH to SLL (R01 AI112381) and a grant from Canadian Institutes of Health Research to CL (MOP-133479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosto LM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003982; Bailey CC, 2013, J BIOL CHEM, P203; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Brem R, 2003, CELL MOL LIFE SCI, V60, P1235, DOI 10.1007/s00018-003-3016-9; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095; Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694; Chutiwitoonchai N, 2013, MICROBES INFECT, V15, P280, DOI 10.1016/j.micinf.2012.12.003; Compton AA, 2014, CELL HOST MICROBE, V16, P736, DOI 10.1016/j.chom.2014.11.001; Daniel-Carmi V, 2009, INT J CANCER, V125, P2810, DOI 10.1002/ijc.24669; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Ding SL, 2014, VIROLOGY, V454, P11, DOI 10.1016/j.virol.2014.01.020; EVANS SS, 1993, J IMMUNOL, V150, P736; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Jia R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118794; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; JUKES TH, 1969, SPACE LIFE SCI, V1, P469, DOI 10.1007/BF00924238; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Li K, 2015, J BIOL CHEM, V290, P4248, DOI 10.1074/jbc.M114.630780; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lim ES, 2010, J VIROL, V84, P7124, DOI 10.1128/JVI.00468-10; Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Malim MH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006940; Mazurov D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000788; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mills TC, 2014, J INFECT DIS, V209, P1028, DOI 10.1093/infdis/jit468; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Nei M, 2005, MOL BIOL EVOL, V22, P2318, DOI 10.1093/molbev/msi242; NEI M, 1986, MOL BIOL EVOL, V3, P418; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Qian J, 2015, VIROLOGY, V474, P10, DOI 10.1016/j.virol.2014.10.015; Ramos HJ, 2011, CURR OPIN VIROL, V1, P167, DOI 10.1016/j.coviro.2011.04.004; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sharp Paul M, 2010, Philos Trans R Soc Lond B Biol Sci, V365, P2487, DOI 10.1098/rstb.2010.0031; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Weston S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104341; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu Y, 2015, J BIOL CHEM, V290, P17935, DOI 10.1074/jbc.M115.665513; Xie MR, 2015, J VIROL, V89, P3049, DOI 10.1128/JVI.03416-14; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Yu JY, 2015, CELL REP, V13, P145, DOI 10.1016/j.celrep.2015.08.055; Zhang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049265; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111	71	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156739	10.1371/journal.pone.0156739	http://dx.doi.org/10.1371/journal.pone.0156739			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257969	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700118
J	Zheng, CF; Zhu, YJ; Wang, CY; Guo, TC				Zheng, Chunfeng; Zhu, Yunji; Wang, Chenyang; Guo, Tiancai			Wheat Grain Yield Increase in Response to Pre-Anthesis Foliar Application of 6-Benzylaminopurine Is Dependent on Floret Development	PLOS ONE			English	Article							STEM ELONGATION; DURUM-WHEAT; NITROGEN AVAILABILITY; WINTER-WHEAT; SPIKE GROWTH; SPRING WHEAT; CYTOKININ; NUMBER; BARLEY; PHOTOPERIOD	Wheat yield is largely determined during the period prior to flowering, when the final numbers of fertile florets and grains per spike are established. The aim of this study was to assess the dynamics of floret primordia development in winter wheat in response to pre-anthesis application of a synthetic cytokinin, 6-benzylaminopurine (6-BA). We conducted an experiment in which two foliar spray treatments were applied (water or 6-BA) to Chinese winter wheat at 25 days after jointing during two growing seasons (2012-2013 and 20132014). Both the final grain number per spike and grain yield at maturity exhibited remarkable increases in response to the 6-BA treatment. Application of 6-BA increased the number of fertile florets in basal spikelets and, to a greater extent, in central spikelets. The mechanism by which 6-BA application affected the final number of fertile florets primarily involved suppression of the floret abortion rates. Application of 6-BA considerably reduced the abortion rates of basal, central and apical spikelet florets (by as much as 77% compared with the control), as well as the degeneration rates of basal and central spikelet florets, albeit to a lesser degree. The effect of 6-BA application on the likelihood of proximal florets being set was limited to the distal florets in the whole spike, whereas obvious increases in the likelihood of grain set under 6-BA treatment were observed in distal florets, primarily in central spikelet positions. The results of this study provide important evidence that 6-BA application to florets (final fertile floret production) results in an increased grain yield.	[Zheng, Chunfeng; Zhu, Yunji; Wang, Chenyang; Guo, Tiancai] Henan Agr Univ, Coll Agron, Zhengzhou 450002, Peoples R China; [Zheng, Chunfeng; Zhu, Yunji; Wang, Chenyang; Guo, Tiancai] Henan Agr Univ, Collaborat Innovat Ctr Henan Food Crops, Zhengzhou 450002, Peoples R China; [Zheng, Chunfeng; Zhu, Yunji; Wang, Chenyang; Guo, Tiancai] Henan Agr Univ, Natl Engn Res Ctr Wheat, Zhengzhou 450002, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan Agricultural University	Zhu, YJ (corresponding author), Henan Agr Univ, Coll Agron, Zhengzhou 450002, Peoples R China.; Zhu, YJ (corresponding author), Henan Agr Univ, Collaborat Innovat Ctr Henan Food Crops, Zhengzhou 450002, Peoples R China.; Zhu, YJ (corresponding author), Henan Agr Univ, Natl Engn Res Ctr Wheat, Zhengzhou 450002, Peoples R China.	zhuzheng2014@126.com			Special Fund for Agro-scientific Research in the Public Interest [201203031, 201203096]; National Natural Science Foundation of China [31571607]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financed by the Special Fund for Agro-scientific Research in the Public Interest (201203031, 201203096) and the National Natural Science Foundation of China (31571607). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acreche MM, 2006, FIELD CROP RES, V98, P52, DOI 10.1016/j.fcr.2005.12.005; Arisnabarreta S, 2006, FIELD CROP RES, V96, P466, DOI 10.1016/j.fcr.2005.09.004; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Bingham IJ, 2007, FIELD CROP RES, V101, P212, DOI 10.1016/j.fcr.2006.11.004; Cheng X, 2013, CROP PROT, V43, P246, DOI 10.1016/j.cropro.2012.10.016; Fageria NK, 2005, ADV AGRON, V88, P97, DOI 10.1016/S0065-2113(05)88004-6; Ferrante A, 2013, J EXP BOT, V64, P169, DOI 10.1093/jxb/ers320; Ferrante A, 2012, FIELD CROP RES, V136, P52, DOI 10.1016/j.fcr.2012.07.015; Ferrante A, 2010, J EXP BOT, V61, P4351, DOI 10.1093/jxb/erq236; Fischer RA, 2008, FIELD CROP RES, V105, P15, DOI 10.1016/j.fcr.2007.04.002; Fischer RA, 2011, CROP PASTURE SCI, V62, P95, DOI 10.1071/CP10344; Gonzalez FG, 2011, J EXP BOT, V62, P4889, DOI 10.1093/jxb/err182; Gonzalez FG, 2003, FIELD CROP RES, V81, P17, DOI 10.1016/S0378-4290(02)00195-8; Gonzalez FG, 2003, FIELD CROP RES, V81, P29, DOI 10.1016/S0378-4290(02)00196-X; Leaden MI, 2007, WEED TECHNOL, V21, P406, DOI 10.1614/WT-06-102R1.1; Li CD, 2001, FIELD CROP RES, V71, P71, DOI 10.1016/S0378-4290(01)00144-7; Li CunDong, 1999, Scientia Agricultura Sinica, V32, P98; Miralles DJ, 2000, AUST J PLANT PHYSIOL, V27, P931, DOI 10.1071/PP00021; Miralles DJ, 1998, FIELD CROP RES, V59, P21, DOI 10.1016/S0378-4290(98)00103-8; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Murai N., 2014, AM J PLANT SCI, V05, P2178, DOI [10.4236/ajps.2014.514231, DOI 10.4236/AJPS.2014.514231]; Pedro A, 2012, FIELD CROP RES, V129, P59, DOI 10.1016/j.fcr.2012.01.016; PeltonenSainio P, 1997, FIELD CROP RES, V49, P169, DOI 10.1016/S0378-4290(96)01010-6; Prystupa P, 2004, FIELD CROP RES, V90, P245, DOI 10.1016/j.fcr.2004.03.001; Reynolds M, 2012, PLANT CELL ENVIRON, V35, P1799, DOI 10.1111/j.1365-3040.2012.02588.x; Reynolds M, 2009, J EXP BOT, V60, P1899, DOI 10.1093/jxb/erp016; Reynolds MP, 2005, ANN APPL BIOL, V146, P39, DOI 10.1111/j.1744-7348.2005.03100.x; Rijavec T, 2009, J INTEGR PLANT BIOL, V51, P840, DOI 10.1111/j.1744-7909.2009.00863.x; Serrago RA, 2008, EUR J AGRON, V28, P301, DOI 10.1016/j.eja.2007.08.004; [史瑞青 Shi Ruiqing], 2006, [河南农业大学学报, JOURNAL OF HENAN AGRICULTURAL UNIVERSITY], V40, P122; Slafer G. A., 2006, Handbook of seed science and technology, P95; Slafer GA, 2005, ANN APPL BIOL, V146, P61, DOI 10.1111/j.1744-7348.2005.04048.x; SLAFER GA, 1994, AUST J PLANT PHYSIOL, V21, P393, DOI 10.1071/PP9940393; Slafer GA, 2003, ANN APPL BIOL, V142, P117, DOI 10.1111/j.1744-7348.2003.tb00237.x; Slafer GA, 2001, EUPHYTICA, V119, P191, DOI 10.1023/A:1017535632171; WADDINGTON SR, 1983, ANN BOT-LONDON, V51, P119, DOI 10.1093/oxfordjournals.aob.a086434; Wang ZhaoLong, 2000, Journal of Nanjing Agricultural University, V23, P9; Wang ZL, 2001, PLANT GROWTH REGUL, V35, P225, DOI 10.1023/A:1014442006862; WILLIAMS RH, 1980, ANN BOT-LONDON, V46, P445, DOI 10.1093/oxfordjournals.aob.a085936; Zalewski W, 2010, J EXP BOT, V61, P1839, DOI 10.1093/jxb/erq052; Zhang GP, 2001, PLANT GROWTH REGUL, V35, P239; Zhang JP, 2011, MOL BIOL REP, V38, P2337, DOI 10.1007/s11033-010-0367-9; Zheng CF, 2014, FIELD CROP RES, V169, P70, DOI 10.1016/j.fcr.2014.09.005	44	17	20	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156627	10.1371/journal.pone.0156627	http://dx.doi.org/10.1371/journal.pone.0156627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258059	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700091
J	Simonetti, O; Cirioni, O; Cacciatore, I; Baldassarre, L; Orlando, F; Pierpaoli, E; Lucarini, G; Orsetti, E; Provinciali, M; Fornasari, E; Di Stefano, A; Giacometti, A; Offidani, A				Simonetti, Oriana; Cirioni, Oscar; Cacciatore, Ivana; Baldassarre, Leonardo; Orlando, Fiorenza; Pierpaoli, Elisa; Lucarini, Guendalina; Orsetti, Elena; Provinciali, Mauro; Fornasari, Erika; Di Stefano, Antonio; Giacometti, Andrea; Offidani, Annamaria			Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound	PLOS ONE			English	Article							IN-VITRO ACTIVITY; ANTIBIOTIC-RESISTANCE; AUREUS INFECTIONS; TEMPORIN-A; RAT MODEL; BIOFILM; PEPTIDE; MODULATION; BACTERIA; RIP	In staphylococci, quorum sensing regulates both biofilm formation and toxin production, moreover it has been demonstrated to be inhibited by RNAIII inhibiting peptide (RIP). Aim our study was to evaluate the in vitro activity and its in vivo efficacy of the combined administration of FS10, a novel RIP derivative, and tigecycline in an animal model of methicillin-resistant (MR) and methicillin-sensitive (MS) Staphylococcus aureus wound infection. Using a 1.x2 cm template, one full thickness wound was established through the panniculus carnosus on the back subcutaneous tissue of each animal. Infection was determined by inoculation of 5x10(7) CFU/ml of bacteria, that produced an abscess within 24 h, after this, treatment was initiated. The study included, for each strain, a control group without infection, a control infected group that did not receive any treatment and a control infected group with drug-free foam dressing, and three infected groups treated, respectively, with: FS10-soaked foam dressing (containing 20 mu g FS10), daily intraperitoneal tigecycline (7 mg/Kg), FS10-soaked foam dressing (containing 20 mu g FS10) and daily intraperitoneal injections of tigecycline (7 mg/Kg). The main outcome measures were quantitative culture and histological examination of tissue repair. The highest inhibition of infection was achieved in the group that received FS10-soaked and parenteral tigecycline reducing the bacterial load from 10(7) CFU/ml to about 10(3) CFU/g for MSSA and to about 10(4) CFU/g for MRSA. The group treated with FS10-soaked foam dressing associated with parenteral tigecycline showed, histologically, better overall healing with epithelialization and collagen scores significantly higher than those of the other groups in both strains. In conclusion, the combined use of topical FS10 with i.p. tigecycline induced positive interaction in vivo, resulting in an enhanced therapeutic benefit versus staphylococcal infections in murine wound models.	[Simonetti, Oriana; Offidani, Annamaria] Univ Politecn Marche, Osped Riuniti, Dept Clin & Mol Sci, Dermatol Clin, Ancona, Italy; [Cirioni, Oscar; Orsetti, Elena; Giacometti, Andrea] Clin Infect Dis, Ancona, Italy; [Cirioni, Oscar; Orsetti, Elena; Giacometti, Andrea] Univ Politecn Marche, Osped Riuniti, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Cacciatore, Ivana; Baldassarre, Leonardo; Fornasari, Erika; Di Stefano, Antonio] Univ G DAnnunzio, Dept Pharm, Chieti, Italy; [Orlando, Fiorenza; Pierpaoli, Elisa; Provinciali, Mauro] INRCA IRRCS, Expt Anim Models Aging Units, Res Dept, Ancona, Italy; [Lucarini, Guendalina] Univ Politecn Marche, Dermatol Clin, Dept Clin & Mol Sci, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University; G d'Annunzio University of Chieti-Pescara; IRCCS INRCA; Marche Polytechnic University	Simonetti, O (corresponding author), Univ Politecn Marche, Osped Riuniti, Dept Clin & Mol Sci, Dermatol Clin, Ancona, Italy.	o.simonetti@univpm.it	Lucarini, Guendalina/AAA-7335-2021; Pierpaoli, Elisa/J-5996-2016; Orlando, Fiorenza/AAB-3441-2021; Provinciali, Mauro/K-5683-2016; Baldassarre, Leonardo/E-4509-2013	Pierpaoli, Elisa/0000-0003-4612-7317; Orlando, Fiorenza/0000-0001-7351-4430; Provinciali, Mauro/0000-0002-0568-3002; cacciatore, ivana/0000-0001-6253-0443; Baldassarre, Leonardo/0000-0003-2194-1400; DI STEFANO, Antonio/0000-0002-3042-2234; SIMONETTI, Oriana/0000-0001-7941-5089				Balaban N, 2007, ANTIMICROB AGENTS CH, V51, P2226, DOI 10.1128/AAC.01097-06; Baldassarre L, 2013, MEDCHEMCOMM, V4, P1114, DOI 10.1039/c3md00122a; Bowler PG, 2012, INT WOUND J, V9, P387, DOI 10.1111/j.1742-481X.2012.00991.x; Cirioni O, 2006, J INFECT DIS, V193, P180, DOI 10.1086/498914; Cirioni O, 2003, CIRCULATION, V108, P767, DOI 10.1161/01.CIR.0000083717.85060.16; Cirioni O, 2007, ANTIMICROB AGENTS CH, V51, P4518, DOI 10.1128/AAC.00808-07; Cirioni O, 2013, PEPTIDES, V40, P77, DOI 10.1016/j.peptides.2012.12.002; Cirioni O, 2010, PEPTIDES, V31, P1231, DOI 10.1016/j.peptides.2010.03.034; Clinical and Laboratory Standards Institute (CLSI), 2012, M07A9 CLSI, VM07-A9; Deurenberg RH, 2009, CURR MOL MED, V9, P100, DOI 10.2174/156652409787581637; Dinar S, 2006, PLAST RECONSTR SURG, V117, P717, DOI 10.1097/01.prs.0000197907.75654.24; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Gonzalez JE, 2006, MICROBIOL MOL BIOL R, V70, P859, DOI 10.1128/MMBR.00002-06; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Krucke GW, 2009, AM J EMERG MED, V27, P344, DOI 10.1016/j.ajem.2008.03.046; Kugelberg E, 2005, ANTIMICROB AGENTS CH, V49, P3435, DOI 10.1128/AAC.49.8.3435-3441.2005; Lowery CA, 2010, J MED CHEM, V53, P7467, DOI 10.1021/jm901742e; McCarthy H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00001; Oriana S, 2013, BURNS, V39, P776, DOI 10.1016/j.burns.2012.09.013; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Peterson LR, 2008, INT J ANTIMICROB AG, V32, pS215, DOI 10.1016/S0924-8579(09)70005-6; Reffuveille F., 2014, CURR OPIN MICROBIOL, P96; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Silvestri C, 2012, EUR J CLIN MICROBIOL, V31, P1759, DOI 10.1007/s10096-011-1498-1; Simonetti O, 2012, EUR J CLIN MICROBIOL, V31, P3047, DOI 10.1007/s10096-012-1663-1; Simonetti O, 2009, PEPTIDES, V30, P1794, DOI 10.1016/j.peptides.2009.06.033; Simonetti O, 2009, BRIT J DERMATOL, V161, P249, DOI 10.1111/j.1365-2133.2009.09166.x; Simonetti O, 2008, ANTIMICROB AGENTS CH, V52, P2205, DOI 10.1128/AAC.01340-07; Simonetti O, 2008, PEPTIDES, V29, P520, DOI 10.1016/j.peptides.2007.12.011; Simonetti O, 2014, PEPTIDES, V55, P17, DOI 10.1016/j.peptides.2014.01.029; Simonetti O, 2013, INT J MOL SCI, V14, P16321, DOI 10.3390/ijms140816321; Simonetti O, 2012, J ANTIMICROB CHEMOTH, V67, P191, DOI 10.1093/jac/dkr440; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Webb DR, 2014, BIOCHEM PHARMACOL, V87, P121, DOI 10.1016/j.bcp.2013.06.014; Wolcott RD, 2010, J WOUND CARE, V19, P45, DOI 10.12968/jowc.2010.19.2.46966	36	33	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0151956	10.1371/journal.pone.0151956	http://dx.doi.org/10.1371/journal.pone.0151956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253706	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700001
J	Atwood, TC; Peacock, E; McKinney, MA; Lillie, K; Wilson, R; Douglas, DC; Miller, S; Terletzky, P				Atwood, Todd C.; Peacock, Elizabeth; McKinney, Melissa A.; Lillie, Kate; Wilson, Ryan; Douglas, David C.; Miller, Susanne; Terletzky, Pat			Rapid Environmental Change Drives Increased Land Use by an Arctic Marine Predator	PLOS ONE			English	Article							SOUTHERN BEAUFORT SEA; POLAR BEAR DISTRIBUTION; WESTERN HUDSON-BAY; OPEN-WATER PERIOD; CLIMATE-CHANGE; POPULATION ECOLOGY; URSUS-MARITIMUS; ICE; ABUNDANCE; SURVIVAL	In the Arctic Ocean's southern Beaufort Sea (SB), the length of the sea ice melt season (i.e., period between the onset of sea ice break-up in summer and freeze-up in fall) has increased substantially since the late 1990s. Historically, polar bears (Ursus maritimus) of the SB have mostly remained on the sea ice year-round (except for those that came ashore to den), but recent changes in the extent and phenology of sea ice habitat have coincided with evidence that use of terrestrial habitat is increasing. We characterized the spatial behavior of polar bears spending summer and fall on land along Alaska's north coast to better understand the nexus between rapid environmental change and increased use of terrestrial habitat. We found that the percentage of radiocollared adult females from the SB subpopulation coming ashore has tripled over 15 years. Moreover, we detected trends of earlier arrival on shore, increased length of stay, and later departure back to sea ice, all of which were related to declines in the availability of sea ice habitat over the continental shelf and changes to sea ice phenology. Since the late 1990s, the mean duration of the open-water season in the SB increased by 36 days, and the mean length of stay on shore increased by 31 days. While on shore, the distribution of polar bears was influenced by the availability of scavenge subsidies in the form of subsistence-harvested bowhead whale (Balaena mysticetus) remains aggregated at sites along the coast. The declining spatio-temporal availability of sea ice habitat and increased availability of human-provisioned resources are likely to result in increased use of land. Increased residency on land is cause for concern given that, while there, bears may be exposed to a greater array of risk factors including those associated with increased human activities.	[Atwood, Todd C.; Peacock, Elizabeth] US Geol Survey, Alaska Sci Ctr, 4210 Univ Dr, Anchorage, AK 99508 USA; [McKinney, Melissa A.] Univ Connecticut, Ctr Environm Sci & Engn, 1376 Storrs Rd, Storrs, CT 06269 USA; [McKinney, Melissa A.] Dept Nat Resources & Environm, 1376 Storrs Rd, Storrs, CT 06269 USA; [Lillie, Kate; Terletzky, Pat] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Wilson, Ryan; Miller, Susanne] US Fish & Wildlife Serv, Marine Mammals Management, 1011 E Tudor Rd, Anchorage, AK 99503 USA; [Douglas, David C.] US Geol Survey, Alaska Sci Ctr, 250 Egan Dr, Juneau, AK 99801 USA	United States Department of the Interior; United States Geological Survey; University of Connecticut; Utah System of Higher Education; Utah State University; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey	Atwood, TC (corresponding author), US Geol Survey, Alaska Sci Ctr, 4210 Univ Dr, Anchorage, AK 99508 USA.	tatwood@usgs.gov	McKinney, Melissa/W-3407-2019; Douglas, David C./AAU-1087-2021	McKinney, Melissa/0000-0002-8171-7534; Douglas, David C./0000-0003-0186-1104	US Geological Survey's Changing Arctic Ecosystems Initiative; US Geological Survey's Wildlife Program of the Ecosystems Mission Area; Arctic National Wildlife Refuge; Bureau of Land Management	US Geological Survey's Changing Arctic Ecosystems Initiative; US Geological Survey's Wildlife Program of the Ecosystems Mission Area; Arctic National Wildlife Refuge; Bureau of Land Management	Funding was provided by the US Geological Survey's Changing Arctic Ecosystems Initiative, and the US Geological Survey's Wildlife Program of the Ecosystems Mission Area. The authors thank the Arctic National Wildlife Refuge and the Bureau of Land Management for providing significant logistic and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; S. Amstrup led capture efforts from 1986-2008, and G. Durner led capture efforts from 2009-2011. G. York, K. Simac, A, Pagano, T. Donnelly, E. Regehr, and many others assisted with data collection. This work was conducted as part of the U.S. Geological Survey's Changing Arctic Ecosystems Initiative. We thank the communities of Kaktovik, Deadhorse, and Barrow for field support. We thank the Arctic National Wildlife Refuge and the Bureau of Land Management for providing significant logistic and financial support. We thank our excellent pilots for ensuring safe capture operations. This paper was reviewed and approved by USGS under their Fundamental Science Practices policy (http://www.usgs.gov/fsp). We thank K. Rode, R. Rockwell, and an anonymous reviewer for providing helpful comments on a pervious draft of this manuscript. Use of trade names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	AKAIKE H, 1973, BIOMETRIKA, V60, P255, DOI 10.2307/2334537; Allen MR, 2014, NAT CLIM CHANGE, V4, P23, DOI 10.1038/NCLIMATE2077; Allison P. D., 1999, MULTIPLE REGRESSION; Amstrup SC, 2000, CAN J ZOOL, V78, P948, DOI 10.1139/cjz-78-6-948; Amstrup SC, 2006, 20061337 US GEOL SUR; Amstrup SC, 2010, NATURE, V468, P955, DOI 10.1038/nature09653; Amstrup SC, 2008, GEOPHYS MONOGR SER, V180, P213, DOI 10.1029/180GM14; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baruch-Mordo S, 2008, J WILDLIFE MANAGE, V72, P1853, DOI 10.2193/2007-442; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Bromaghin JF, 2015, ECOL APPL, V25, P634, DOI 10.1890/14-1129.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calvert W, 1998, URSUS-SERIES, V10, P449; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; Cherry SG, 2009, POLAR BIOL, V32, P383, DOI 10.1007/s00300-008-0530-0; Comiso JC, 2012, J CLIMATE, V25, P1176, DOI 10.1175/JCLI-D-11-00113.1; Creech TG, 2012, J WILDLIFE MANAGE, V76, P877, DOI 10.1002/jwmg.331; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Durner GM, 2009, ECOL MONOGR, V79, P25, DOI 10.1890/07-2089.1; Gleason JS, 2009, ARCTIC, V62, P405; Gormezano LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128520; Gormezano LJ, 2013, ECOL EVOL, V3, P3509, DOI 10.1002/ece3.740; Hale R, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2930; Herreman J, 2013, URSUS, V24, P148, DOI 10.2192/URSUS-D-12-00030.1; Hobson KA, 2009, CAN J ZOOL, V87, P50, DOI 10.1139/Z08-137; Hooten MB, 2014, STAT METHODOL, V17, P82, DOI 10.1016/j.stamet.2012.12.001; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; IPCC, 2014, CLIM CHANG IMP AD A; Jakobsson M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033520; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Lindsay RW, 2005, J CLIMATE, V18, P4879, DOI 10.1175/JCLI3587.1; Lunn N.J., 2010, POL BEARS P 15 WORK, P87; Maslanik JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL032043; Miller S, 2015, J MAMMAL, V96, P1317, DOI 10.1093/jmammal/gyv140; Molnar PK, 2014, BIOL CONSERV, V177, P230, DOI 10.1016/j.biocon.2014.07.001; Molnar PK, 2010, BIOL CONSERV, V143, P1612, DOI 10.1016/j.biocon.2010.04.004; Neter J., 1996, APPL LINEAR STAT MOD; Orr HA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004551; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Pagano AM, 2012, CAN J ZOOL, V90, P663, DOI 10.1139/Z2012-033; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peacock E, 2013, J WILDLIFE MANAGE, V77, P463, DOI 10.1002/jwmg.489; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pilfold NW, 2015, OIKOS, V124, P1098, DOI 10.1111/oik.02000; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAMSAY MA, 1991, OECOLOGIA, V86, P598, DOI 10.1007/BF00318328; RAMSAY MA, 1988, J ZOOL, V214, P601, DOI 10.1111/j.1469-7998.1988.tb03762.x; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Robbins CT, 2012, J MAMMAL, V93, P1493, DOI 10.1644/11-MAMM-A-406.1; Rode KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142213; Rode KD, 2010, ECOL APPL, V20, P768, DOI 10.1890/08-1036.1; Rogers MC, 2015, POLAR BIOL, V38, P1035, DOI 10.1007/s00300-015-1665-4; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schliebe S, 2008, POLAR BIOL, V31, P999, DOI 10.1007/s00300-008-0439-7; Stapleton S, 2016, MAR MAMMAL SCI, V32, P181, DOI 10.1111/mms.12251; Stapleton S, 2014, BIOL CONSERV, V170, P38, DOI 10.1016/j.biocon.2013.12.040; STIRLING I, 1993, ARCTIC, V46, P240; Stirling I, 1999, ARCTIC, V52, P294; Stirling I, 2004, ARCTIC, V57, P15; Stirling I, 2006, ARCTIC, V59, P261; Stroeve JC, 2014, GEOPHYS RES LETT, V41, P1216, DOI 10.1002/2013GL058951; Taylor MK, 2005, ARCTIC, V58, P203; Thirgood S, 2005, CONSERV BIOL SER, V9, P13; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Towns L, 2009, POLAR BIOL, V32, P1529, DOI 10.1007/s00300-009-0653-y; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Whiteman JP, 2015, SCIENCE, V349, P295, DOI 10.1126/science.aaa8623	71	66	67	2	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155932	10.1371/journal.pone.0155932	http://dx.doi.org/10.1371/journal.pone.0155932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249673	Green Published, gold, Green Submitted			2022-12-26	WOS:000377184700023
J	Dalazen, CE; De Carli, AD; Bomfim, RA; dos Santos, MLM				Dalazen, Chaiane Emilia; De Carli, Alessandro Diogo; Bomfim, Rafael Aiello; Moraes dos Santos, Mara Lisiane			Contextual and Individual Factors Influencing Periodontal Treatment Needs by Elderly Brazilians: A Multilevel Analysis	PLOS ONE			English	Article							INCOME INEQUALITY; DENTAL-CARIES; HEALTH-SURVEY; TOOTH LOSS; SAO-PAULO; DISEASES; POPULATION; SERVICES; ADULTS	Objective To assess the relationship between periodontal treatment needs by elderly Brazilians and contextual as well as individual variables. Methods A cross-sectional study was carried out to assess the need for clinical periodontal treatment, based on National Oral Health Survey (SB Brasil 2010) data on the presence of dental calculus, shallow (3-5 mm) and deep (>= 6 mm) periodontal pockets, and gingival bleeding in elderly people (n = 7,619). The contextual variables included the Municipal Human Development Index (MHDI), income inequality (Gini Index) and coverage of the municipal population by the Family Health Strategy (FHS) program oral health teams.<0} The individual variables were sex, income, education level and self-reported skin color. Multilevel logistic regression models were used to calculate the odds ratio (OR) and 95% confidence intervals (CI95%) between periodontal treatment needs and the contextual as well as individual variables. Results Gingival bleeding was found in 20.7% of the elderly analyzed (n = 1,577), dental calculus in 34% (n = 2,590), shallow periodontal pockets in 15.6%(n = 1,189), and deep periodontal pockets in 4.2% (n = 320). Individual factors were correlated with all the outcomes assessed. Sex was a protective factor in regard to gingival bleeding (OR = 0.87; CI95% 0.76-1.00), dental calculus (OR = 0.86; CI95% 0.75-0.99), shallow periodontal pockets (OR = 0.69; CI95% 0.60-0.80) and deep periodontal pockets (OR = 0.58; CI95% 0.45-0.74). It was found that fewer women needed treatment. Elderly people who self-reported having nonwhite skin had higher chances of needing periodontal treatment. Skin color was a risk factor for gingival bleeding (OR = 1.32; CI95% 1.14-1.53), dental calculus (OR = 1.32; CI95% 1.14-1.54) and shallow periodontal pockets (OR = 1.27; CI95% 1.09-1.49). Education level was associated with the presence of dental calculus (OR = 0.77; CI95% 0.66-0.89), shallow periodontal pockets (OR = 0.86; CI95% 0.73-1.00) and deep periodontal pockets (OR = 0.74; CI95% 0.57-0.97), thus acting as a risk factor for undereducated elderly people. There was a correlation between population coverage by the Family Health Strategy (FHS) program oral health teams and the presence of gingival bleeding (OR = 0.67; CI95% 0.52-0.88), shallow periodontal pockets (OR = 0.76; CI95% 0.58-0.98) and deep periodontal pockets (OR = 0.62; CI95% 0.44-0.89), making these teams act as a protective factor. Conclusions This study showed evidence of the sociocontextual as well as individual sociodemographic characteristics influencing periodontal treatment needed by elderly Brazilians, based on the clinical features of periodontal disease. The results suggest the existence of inequality related to periodontal treatment needs among elderly Brazilians, especially in regard to sex and ethnicity, in addition to a potentially positive impact from the expansion of the Family Health Strategy (FHS) program oral health teams.	[Dalazen, Chaiane Emilia; De Carli, Alessandro Diogo; Bomfim, Rafael Aiello] Univ Fed Mato Grosso do Sul, Saude Colet, Fac Odontol Prof Albino Coimbra Filho, Campo Grande, MS, Brazil; [Moraes dos Santos, Mara Lisiane] Univ Fed Mato Grosso do Sul, Dept Tecnol Alimentos & Saude Colet, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	Dalazen, CE (corresponding author), Univ Fed Mato Grosso do Sul, Saude Colet, Fac Odontol Prof Albino Coimbra Filho, Campo Grande, MS, Brazil.	chaiane_1@msn.com	Bomfim, Rafael Aiello/I-9539-2016; Santos, Mara/AAU-3803-2020	Bomfim, Rafael Aiello/0000-0002-6478-8664; 				Aida J, 2006, J EPIDEMIOL, V16, P214, DOI 10.2188/jea.16.214; Albandar JM, 2002, PERIODONTOL 2000, V29, P177, DOI 10.1034/j.1600-0757.2002.290109.x; de Souza EHA, 2012, CIENC SAUDE COLETIVA, V17, P2063, DOI 10.1590/S1413-81232012000800017; Antunes JLF, 2003, INT DENT J, V53, P7, DOI 10.1111/j.1875-595X.2003.tb00649.x; Antunes José Leopoldo Ferreira, 2008, Rev. Saúde Pública, V42, P191, DOI 10.1590/S0034-89102008000200002; Baldani Márcia Helena, 2002, Cad. Saúde Pública, V18, P755, DOI 10.1590/S0102-311X2002000300019; Barbato PR, 2007, CAD SAUDE PUBLICA, V23, P1803, DOI 10.1590/S0102-311X2007000800007; BASTOS JL, 2011, CAD SAUDE PUBLICA, V27, pS141; Borrell LN, 2004, AM J PUBLIC HEALTH, V94, P748, DOI 10.2105/AJPH.94.5.748; Brazil. Ministry of Health, 2010, DATASUS HLTH INF COV; Celeste RK, 2011, CAD SAUDE PUBLICA, V27, P1111, DOI 10.1590/S0102-311X2011000600008; Corbet EF, 2002, PERIODONTOL 2000, V29, P122, DOI 10.1034/j.1600-0757.2002.290107.x; Carvalho José Alberto Magno de, 2003, Cad. Saúde Pública, V19, P725, DOI 10.1590/S0102-311X2003000300005; Department of Health, 2016, MAN CAR HOM CLOS MAN; Zaitune MPD, 2012, CAD SAUDE PUBLICA, V28, P583; Ferreira CD, 2013, REV SAUDE PUBL, V47, P90, DOI 10.1590/S0034-8910.2013047004721; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; Gomes R, 2007, CAD SAUDE PUBLICA, V23, P565, DOI 10.1590/S0102-311X2007000300015; Haas AN, 2012, J CLIN PERIODONTOL, V39, P1, DOI 10.1111/j.1600-051X.2011.01818.x; Harford J, 2009, COMMUNITY DENT ORAL, V37, P97, DOI 10.1111/j.1600-0528.2008.00441.x; Hiramatsu Daniel Afonso, 2007, Cien Saude Colet, V12, P1051, DOI 10.1590/S1413-81232007000400026; Jovino-Silveira Renata Cimoes, 2005, Oral Health Prev Dent, V3, P151; Klinge B, 2005, J CLIN PERIODONTOL, V32, P314, DOI 10.1111/j.1600-051X.2005.00801.x; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; de Carvalho JAM, 2008, CAD SAUDE PUBLICA, V24, P597, DOI 10.1590/S0102-311X2008000300013; Martins A.M.E.B.L., 2005, UNIMONTES CIENTIFICA, V7, P55; Moreira Rafael da Silveira, 2005, Cad. Saúde Pública, V21, P1665, DOI 10.1590/S0102-311X2005000600013; Morris AJ, 2001, BRIT DENT J, V191, P186, DOI 10.1038/sj.bdj.4801135a; Vasconcelos AMN, 2012, EPIDEMIOL SERV SAUDE, V21, P539, DOI 10.5123/S1679-49742012000400003; Peixoto Sérgio Viana, 2006, Cad. Saúde Pública, V22, P1925, DOI 10.1590/S0102-311X2006000900024; Peres MA, 2007, J CLIN PERIODONTOL, V34, P196, DOI 10.1111/j.1600-051X.2006.01043.x; Peres MA, 2013, REV SAUDE PUBL, V47, P78, DOI 10.1590/S0034-8910.2013047004226; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Petersen PE, 2012, PERIODONTOL 2000, V60, P7, DOI 10.1111/j.1600-0757.2012.00452.x; Rodrigues NO, 2012, CIENC SAUDE COLETIVA, V17, P2129, DOI 10.1590/S1413-81232012000800023; Sabbah W, 2007, J DENT RES, V86, P992, DOI 10.1177/154405910708601014; Sabbah W, 2010, INT DENT J, V60, P370, DOI 10.1922/IDJ_2480Sabbah05; Sheiham A, 2002, PERIODONTOL 2000, V29, P104, DOI 10.1034/j.1600-0757.2002.290106.x; Shi L. Y., 2009, Journal of Medical Sciences, V29, P43; Steele J, 2015, J DENT RES, V94, P19, DOI 10.1177/0022034514553978; Teixeira CFS, 1999, CIENCIA SAUDE COLETI, V4, P287; Tesser CD, 2010, R SAUDE PUBL SANTA C, V3; United Nations Development Programme, 2013, ATL HUM DEV BRAZ 199; Veras R., 2009, J PUBLIC HLTH, V43, P548, DOI DOI 10.1590/S0034-89102009000300020; Vettore MV, 2013, REV SAUDE PUBL, V47, P29, DOI 10.1590/S0034-8910.2013047004422; Watt RG, 2012, PERIODONTOL 2000, V60, P147, DOI 10.1111/j.1600-0757.2011.00426.x	46	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156231	10.1371/journal.pone.0156231	http://dx.doi.org/10.1371/journal.pone.0156231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27249677	gold, Green Published, Green Submitted			2022-12-26	WOS:000377184700033
J	Valverde, GL; Martin, EG; Poves, JML; Llorens, VP; Julvez, LEP				Lopez Valverde, Gloria; Garcia Martin, Elena; Larrosa Poves, Jose M.; Polo Llorens, Vicente; Pablo Julvez, Luis E.			Study of Association between Pre-Senile Cataracts and the Polymorphisms rs2228000 in XPC and rs1042522 in p53 in Spanish Population	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; AGE-RELATED CATARACT; OXIDATIVE DNA-DAMAGE; XERODERMA-PIGMENTOSUM; IN-VIVO; C PROTEIN; LENS; MUTATIONS; APOPTOSIS; RADIATION	Purpose To determine if the presence of certain polymorphisms in the DNA repair gene XPC and the apoptosis inductor gene p53 is associated with pre-senile cataract development. Methods We have performed a retrospective study over three groups of patients. The group with presenile cataract formed by 72 patients younger than 55 with cataract surgery. The group with senile cataract formed by 101 patients older than 55 with cataract surgery. The group without cataract was formed by 42 subjects older than 55 without lens opacities. We analyzed the presence of SNP rs2228000 from XPC and rs1042522 from p53; and the relationship between risk factors such as smoking, alcohol intake, hypertension or diabetes. Results The comparison of the genotype distribution in XPC, within the different groups, did not show any statistically significant association in any of our analysis (p>0,05). The comparison of the genotype distribution in p53 within the different groups did not show any statistically significant association (p>0,05); except for the comparison between the pre-senile cataract group and the group with senile cataract where the genotype Pro/Pro (C/C) in the recessive inheritancemodel showed a higher risk for developing pre-senile cataract (p = 0,031; OR = 1.04-15.97). This association decreased when we performed the analysis adjusting by the studied risk factors (p = 0.056). Conclusions Allelic variants in the gene XPC are not associated with an increased risk for developing pre-senile cataract. The presence of the genotype Pro/Pro in p53 might be associated with a major risk for developing pre-senile cataract.	[Lopez Valverde, Gloria] Hosp Royo Villanova, Zaragoza, Spain; [Lopez Valverde, Gloria; Garcia Martin, Elena; Larrosa Poves, Jose M.; Polo Llorens, Vicente; Pablo Julvez, Luis E.] Hosp Univ Miguel Servet, Zaragoza, Spain; [Garcia Martin, Elena; Larrosa Poves, Jose M.; Polo Llorens, Vicente; Pablo Julvez, Luis E.] Inst Invest Sanitaria Aragon IIS Aragon, Zaragoza, Spain	Miguel Servet University Hospital	Valverde, GL (corresponding author), Hosp Royo Villanova, Zaragoza, Spain.; Valverde, GL (corresponding author), Hosp Univ Miguel Servet, Zaragoza, Spain.	gloria_lpz@hotmail.com		Polo Llorens, Vicente/0000-0002-1402-3129; Pablo, Luis/0000-0003-2389-8282; GARCIA-MARTIN, ELENA/0000-0001-6258-2489				[Anonymous], 2011, PRESCRIRE INT, V20, P41; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bitarafan Rajabi Ahmad, 2015, Res Cardiovasc Med, V4, pe25148, DOI 10.5812/cardiovascmed.25148; Blanco Marchite C, 2011, INVEST OPHTH VIS SCI, V52, P8467, DOI [10.1167/iovs.11-7489, DOI 10.1167/IOVS.11-7489]; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; ELLEDGE RM, 1995, BIOESSAYS, V17, P923, DOI 10.1002/bies.950171105; Fanny A, 2014, J FR OPHTALMOL, V37, P388, DOI 10.1016/j.jfo.2013.11.011; Galichanin K, 2014, HEALTH PHYS, V107, P523, DOI 10.1097/HP.0000000000000152; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hamada N, 2015, CANCER LETT, V368, P262, DOI 10.1016/j.canlet.2015.02.017; Hicks SD, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-128; Hsieh HC, 2005, BIOCHEM BIOPH RES CO, V335, P181, DOI 10.1016/j.bbrc.2005.07.067; Ji WK, 2013, CURR MOL MED, V13, P968, DOI 10.2174/15665240113139990052; Jordan JJ, 2010, MOL CANCER RES, V8, P701, DOI 10.1158/1541-7786.MCR-09-0442; Kong Y, 2011, J AGING RES, DOI [10.4061/2011/963172, DOI 10.4061/2011/963172]; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Melis JPM, 2013, ANTIOXID REDOX SIGN, V18, P2409, DOI 10.1089/ars.2012.5036; Melis JPM, 2011, MUTAT RES-REV MUTAT, V728, P107, DOI 10.1016/j.mrrev.2011.07.001; Mesa R, 2013, INVEST OPHTH VIS SCI, V54, P6789, DOI 10.1167/iovs.13-12644; Miller DP, 2011, INT J CHRONIC OBSTR, V6, P467, DOI 10.2147/COPD.S14247; Okuda M, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.13; Ottonello S, 2000, OPHTHALMOLOGICA, V214, P78, DOI 10.1159/000027474; Pastor Idoate S, 2013, OPHTHALMOLOGY, V120, P623, DOI [10.1016/j.ophtha.2012.08.019, DOI 10.1016/J.OPHTHA.2012.08.019]; Phang BH, 2015, P NATL ACAD SCI USA, V112, pE6349, DOI 10.1073/pnas.1510043112; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Qin Y, 2014, BBA-MOL BASIS DIS, V1842, P2439, DOI 10.1016/j.bbadis.2014.10.002; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; Sayin N, 2015, WORLD J DIABETES, V6, P92, DOI 10.4239/wjd.v6.i1.92; Shiraishi K, 2004, J BIOL CHEM, V279, P348, DOI 10.1074/jbc.M310815200; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; Snow A, 2015, CHEM-BIOL INTERACT, V234, P247, DOI 10.1016/j.cbi.2014.12.017; SOUSSI T, 1990, ONCOGENE, V5, P945; Su S, 2013, INVEST OPHTH VIS SCI, V54, P1201, DOI 10.1167/iovs.12-10940; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Tsentalovich YP, 2015, EXP EYE RES, V134, P15, DOI 10.1016/j.exer.2015.03.008; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wang G, 2004, NUCLEIC ACIDS RES, V32, P2231, DOI 10.1093/nar/gkh541; Wang L, 2011, MOL VIS, V17, P3423; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Wiggs JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045613; Xie Q, 2013, CANCER RES, V73, P3615, DOI 10.1158/0008-5472.CAN-12-3793; Yang Mei, 2014, Zhonghua Yi Xue Za Zhi, V94, P1147; ZHANG W, 1994, EMBO J, V13, P2535, DOI 10.1002/j.1460-2075.1994.tb06543.x; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7; Zrzeszinski JY, 2014, MOL BIOL CELL, V25, P213, DOI [10.1091/mbc.E13-05-0293, DOI 10.1091/MBC.E13-05-0293]	50	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156317	10.1371/journal.pone.0156317	http://dx.doi.org/10.1371/journal.pone.0156317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248495	gold, Green Published			2022-12-26	WOS:000377184700035
J	Lee, SH; Kim, KT; Kwon, OD; Ock, Y; Kim, T; Choi, D; Kwak, D				Lee, Seung-Hun; Kim, Kyoo-Tae; Kwon, Oh-Deog; Ock, Younsung; Kim, Taeil; Choi, Donghag; Kwak, Dongmi			Novel Detection of Coxiella spp., Theileria luwenshuni, and T. ovis Endosymbionts in Deer Keds (Lipoptena fortisetosa)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BURGDORFERI-SENSU-LATO; DIPTERA HIPPOBOSCIDAE; CERVI; INFECTION; TICKS; SCHOENBUCHENSIS; BURNETII; RECORD	We describe for the first time the detection of Coxiella-like bacteria (CLB), Theileria luwenshuni, and T. ovis endosymbionts in blood-sucking deer keds. Eight deer keds attached to a Korean water deer were identified as Lipoptena fortisetosa (Diptera: Hippoboscidae) by morphological and genetic analyses. Among the endosymbionts assessed, CLB, Theileria luwenshuni, and T. ovis were identified in L. fortisetosa by PCR and nucleotide sequencing. Based on phylogeny, CLB 16S rRNA sequences were classified into clade B, sharing 99.4% identity with CLB from Haemaphysalis longicornis in South Korea. Although the virulence of CLB to vertebrates is still controversial, several studies have reported clinical symptoms in birds due to CLB infections. The 18S rRNA sequences of T. luwenshuni and T. ovis in this study were 98.8-100% identical to those in GenBank, and all of the obtained sequences of T. ovis and T. luwenshuni in this study were 100% identical to each other, respectively. Although further studies are required to positively confirm L. fortisetosa as a biological vector of these pathogens, strong genetic relationships among sequences from this and previous studies suggest potential transmission among mammalian hosts by ticks and keds.	[Lee, Seung-Hun; Kwon, Oh-Deog; Kwak, Dongmi] Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea; [Kim, Kyoo-Tae] Anim Hlth Ctr Zoo Land, Daejeon O World Theme Pk, Daejeon, South Korea; [Ock, Younsung; Kim, Taeil; Choi, Donghag] Dongin Vet Clin, Daegu, South Korea; [Kwak, Dongmi] Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea	Kyungpook National University; Kyungpook National University	Kwak, D (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea.; Kwak, D (corresponding author), Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea.	dmkwak@knu.ac.kr		Kwak, Dongmi/0000-0003-0876-3179	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2013102]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea)	This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant No. NRF-2013R1A1A2013102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan Sandra A., 2001, P18, DOI 10.1002/9780470377000.ch2; Barlough JE, 1996, VET PARASITOL, V63, P319, DOI 10.1016/0304-4017(95)00904-3; BOSE R, 1991, PARASITOL RES, V77, P723, DOI 10.1007/BF00928691; Choi CY, 2013, J MED ENTOMOL, V50, P1173, DOI 10.1603/ME12150; Chu C, 2008, J MED MICROBIOL, V57, P980, DOI 10.1099/jmm.0.47663-0; Dehio C, 2004, J CLIN MICROBIOL, V42, P5320, DOI 10.1128/JCM.42.11.5320-5323.2004; Duron O, 2015, TRENDS PARASITOL, V31, P536, DOI 10.1016/j.pt.2015.06.014; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Duron O, 2014, TICKS TICK-BORNE DIS, V5, P557, DOI 10.1016/j.ttbdis.2014.04.003; Han JI, 2009, VET PARASITOL, V164, P311, DOI 10.1016/j.vetpar.2009.05.027; Harkonen Sauli, 2009, Alces, V45, P73; Hermosilla C, 2006, VET REC, V159, P286, DOI 10.1136/vr.159.9.286; HO T, 1995, MICROBIOL IMMUNOL, V39, P663, DOI 10.1111/j.1348-0421.1995.tb03254.x; Hornok S, 2011, VECTOR-BORNE ZOONOT, V11, P1319, DOI 10.1089/vbz.2011.0649; Kim HC, 2010, J MED ENTOMOL, V47, P1227, DOI 10.1603/ME09262; Kim KH, 2014, EMERG INFECT DIS, V20, P1708, DOI 10.3201/eid2010.131680; Ko S, 2013, VECTOR-BORNE ZOONOT, V13, P415, DOI 10.1089/vbz.2012.1105; Kowal Jerzy, 2009, Dipteron - Wroclaw, V25, P27; Kubo M, 2010, J PARASITOL, V96, P437, DOI 10.1645/GE-2270.1; Lloyd John E., 2009, P339; Maa T C, 1965, J Med Entomol, V2, P233; MAA TC, 1967, PAC INSECTS, V9, P727; METELITSA AK, 1989, PARAZITOLOGIYA+, V23, P276; Moon KyoungHa, 2014, Journal of Veterinary Clinics, V31, P6; Nelder MP, 2008, EMERG INFECT DIS, V14, P1002, DOI 10.3201/eid1406.071691; Otranto D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-55; Park Joo Young, 1993, Journal of the Korean Society for Microbiology, V28, P285; PARK KH, 1993, J CLIN MICROBIOL, V31, P1831, DOI 10.1128/JCM.31.7.1831-1837.1993; PAVILANIS V, 1958, Can J Public Health, V49, P520; Razmi G, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.635; Seo MG, 2013, RES VET SCI, V94, P579, DOI 10.1016/j.rvsc.2013.01.014; Shivaprasad HL, 2008, AVIAN DIS, V52, P426, DOI 10.1637/8192-120707-Reg; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thrusfield M., 2005, VET EPIDEMIOLOGY, P98; Vapniarsky N, 2012, VET PATHOL, V49, P717, DOI 10.1177/0300985811409251; Woc-Colburn AM, 2008, VET PATHOL, V45, P247, DOI 10.1354/vp.45-2-247; Yamauchi Takeo, 2009, Medical Entomology and Zoology, V60, P131; Yin H, 2007, PARASITOL RES, V101, pS191; Zeman P, 1998, FOLIA PARASIT, V45, P319	40	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156727	10.1371/journal.pone.0156727	http://dx.doi.org/10.1371/journal.pone.0156727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244561	Green Submitted, gold, Green Published			2022-12-26	WOS:000377146100066
J	Atkinson, QD; Coomber, T; Passmore, S; Greenhill, SJ; Kushnick, G				Atkinson, Quentin D.; Coomber, Ties; Passmore, Sam; Greenhill, Simon J.; Kushnick, Geoff			Cultural and Environmental Predictors of Pre-European Deforestation on Pacific Islands	PLOS ONE			English	Article							EVOLUTION; DETERMINISM; PHYLOGENY	The varied islands of the Pacific provide an ideal natural experiment for studying the factors shaping human impact on the environment. Previous research into pre-European deforestation across the Pacific indicated a major effect of environment but did not account for cultural variation or control for dependencies in the data due to shared cultural ancestry and geographic proximity. The relative importance of environment and culture on Pacific deforestation and forest replacement and the extent to which environmental impact is constrained by cultural ancestry therefore remain unexplored. Here we use comparative phylogenetic methods to model the effect of nine ecological and two cultural variables on pre-European Pacific forest outcomes at 80 locations across 67 islands. We show that some but not all ecological features remain important predictors of forest outcomes after accounting for cultural covariates and non-independence in the data. Controlling for ecology, cultural variation in agricultural intensification predicts deforestation and forest replacement, and there is some evidence that land tenure norms predict forest replacement. These findings indicate that, alongside ecology, cultural factors also predict pre-European Pacific forest outcomes. Although forest outcomes covary with cultural ancestry, this effect disappears after controlling for geographic proximity and ecology. This suggests that forest outcomes were not tightly constrained by colonists' cultural ancestry, but instead reflect a combination of ecological constraints and the short-term responses of each culture in the face of those constraints.	[Atkinson, Quentin D.; Coomber, Ties; Passmore, Sam] Univ Auckland, Sch Psychol, Private Bag 92019, Auckland 1142, New Zealand; [Atkinson, Quentin D.; Greenhill, Simon J.] Max Planck Inst Hist & Sci, Kahlaische Str 10, D-07745 Jena, Germany; [Greenhill, Simon J.] Australian Natl Univ, Sch Culture Hist & Language, ANU Coll Asia & Pacific, Canberra, ACT, Australia; [Greenhill, Simon J.] Australian Natl Univ, ARC Ctr Excellence Dynam Language, Canberra, ACT, Australia; [Kushnick, Geoff] Australian Natl Univ, Sch Archaeol & Anthropol, ANU Coll Arts & Social Sci, Canberra, ACT, Australia	University of Auckland; Max Planck Society; Australian National University; Australian National University; Australian National University	Atkinson, QD (corresponding author), Univ Auckland, Sch Psychol, Private Bag 92019, Auckland 1142, New Zealand.; Atkinson, QD (corresponding author), Max Planck Inst Hist & Sci, Kahlaische Str 10, D-07745 Jena, Germany.	q.atkinson@auckland.ac.nz	Greenhill, Simon/I-3554-2019; Passmore, Sam/Q-6645-2019	Greenhill, Simon/0000-0001-7832-6156; Passmore, Sam/0000-0002-5302-356X; Atkinson, Quentin/0000-0002-8499-7535	Rutherford Discovery Fellowship [RDF- UOA1101]; Australian Research Council [DE120101954]	Rutherford Discovery Fellowship; Australian Research Council(Australian Research Council)	Q.D.A., T.C. and S.P. were supported by a Rutherford Discovery Fellowship (RDF- UOA1101) to Q.D.A. during completion of this work. S.J.G. was supported by the Australian Research Council's Discovery Projects funding scheme (project number DE120101954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1997, GUNS GERMS STEEL; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Currie TE, 2013, CROSS-CULT RES, V47, P102, DOI 10.1177/1069397112471803; DIAMOND J., 2005, COLLAPSE SOC CHOOSE, p[XI, 575]; Diamond J, 2007, SCIENCE, V317, P1692, DOI 10.1126/science.1138442; Drummond A.J., 2012, MOL BIOL EVOLUTION; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fagan BM, 2008, GREAT WARMING CLIMAT; Firth Raymond, 1936, WE THE TIKOPIA; Flenley J., 2003, ENIGMAS EASTER ISLAN; Freckleton RP, 2009, P ROY SOC B-BIOL SCI, V276, P21, DOI 10.1098/rspb.2008.0905; Galton F., 1889, J ROYAL ANTHR I, V18, P245; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Greenhill SJ, 2008, EVOL BIOINFORM, V4, P271; JOHNSON OEG, 1972, J LAW ECON, V15, P259, DOI 10.1086/466736; Judkins G, 2008, GEOGR J, V174, P17, DOI 10.1111/j.1475-4959.2008.00265.x; Kirch P.V., 1997, HIST ECOLOGY PACIFIC; Kirch P.V., 1984, EVOLUTION POLYNESIAN; Kirch Patrick Vinton, 1994; KIRCH PV, 1987, CURR ANTHROPOL, V28, P431, DOI 10.1086/203547; Kirch PV, 2007, GROWTH COLLAPSE PACI, pxvi; Kushnick G, 2014, EVOL HUM BEHAV, V35, P309, DOI 10.1016/j.evolhumbehav.2014.03.001; Landes D. S., 1999, WEALTH POVERTY NATIO; Livingstone DN, 2012, B HIST MED, V86, P564, DOI 10.1353/bhm.2012.0071; Merrett CD, 2003, ANTIPODE, V35, P801, DOI 10.1046/j.1467-8330.2003.00352.x; Ostrom E, 1990, GOVERNING COMMONS EV, pXVIII; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rolett B, 2004, NATURE, V431, P443, DOI 10.1038/nature02801; Rolett BV, 2008, QUATERN INT, V184, P4, DOI 10.1016/j.quaint.2007.10.016; Sachs JD, 2001, SCI AM, V284, P70, DOI 10.1038/scientificamerican0301-70; SINNOTT RW, 1984, SKY TELESCOPE, V68, P159; Sluyter A, 2003, ANTIPODE, V35, P813, DOI 10.1046/j.1467-8330.2003.00354.x; SMITH RJ, 1981, CATO J, V1, P438; Stevenson CM, 2015, P NATL ACAD SCI USA, V112, P1025, DOI 10.1073/pnas.1420712112; SWADESH M, 1952, P AM PHILOS SOC, V96, P453; Tuffley C, 1998, MATH BIOSCI, V147, P63, DOI 10.1016/S0025-5564(97)00081-3; Whistler WA, 1990, ISLANDS PLANTS POLYN, P41; Wilson E.O., 1975, P1	41	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156340	10.1371/journal.pone.0156340	http://dx.doi.org/10.1371/journal.pone.0156340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232713	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000025
J	Kurebayashi, Y; Takahashi, T; Tamoto, C; Sahara, K; Otsubo, T; Yokozawa, T; Shibahara, N; Wada, H; Minami, A; Ikeda, K; Suzuki, T				Kurebayashi, Yuuki; Takahashi, Tadanobu; Tamoto, Chihiro; Sahara, Keiji; Otsubo, Tadamune; Yokozawa, Tatsuya; Shibahara, Nona; Wada, Hirohisa; Minami, Akira; Ikeda, Kiyoshi; Suzuki, Takashi			High-Efficiency Capture of Drug Resistant-Influenza Virus by Live Imaging of Sialidase Activity	PLOS ONE			English	Article							A H3N2 VIRUSES; NEURAMINIDASE INHIBITORS; OSELTAMIVIR RESISTANCE; ANTIVIRAL RESISTANCE; IN-VITRO; PANDEMIC INFLUENZA; SUSCEPTIBILITY; MUTATION; SUBSTRATE; FITNESS	Influenza A and B viruses possess a neuraminidase protein that shows sialidase activity. Influenza virus-specific neuraminidase inhibitors (NAIs) are commonly used for clinical treatment of influenza. However, some influenza A and B viruses that are resistant to NAIs have emerged in nature. NAI-resistant viruses have been monitored in public hygiene surveys and the mechanism underlying the resistance has been studied. Here, we describe a new assay for selective detection and isolation of an NAI-resistant virus in a speedy and easy manner by live fluorescence imaging of viral sialidase activity, which we previously developed, in order to achieve high-efficiency capture of an NAI-resistant virus. An NAI-resistant virus maintains sialidase activity even at a concentration of NAI that leads to complete deactivation of the virus. Infected cells and focuses (infected cell populations) of an oseltamivir-resistant virus were selectively visualized by live fluorescence sialidase imaging in the presence of oseltamivir, resulting in high-efficiency isolation of the resistant viruses. The use of a combination of other NAIs (zanamivir, peramivir, and laninamivir) in the imaging showed that the oseltamivir-resistant virus isolated in 2008 was sensitive to zanamivir and laninamivir but resistant to peramivir. Fluorescence imaging in the presence of zanamivir also succeeded in selective live-cell visualization of cells that expressed zanamivir-resistant NA. Fluorescence imaging of NAI-resistant sialidase activity will be a powerful method for study of the NAI resistance mechanism, for public monitoring of NAI-resistant viruses, and for development of a new NAI that shows an effect on various NAI-resistant mutations.	[Kurebayashi, Yuuki; Takahashi, Tadanobu; Tamoto, Chihiro; Yokozawa, Tatsuya; Shibahara, Nona; Minami, Akira; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka, Shizuoka 4228526, Japan; [Sahara, Keiji] Shizuoka Inst Environm & Hyg, Shizuoka, Shizuoka, Japan; [Otsubo, Tadamune; Ikeda, Kiyoshi] Hiroshima Int Univ, Sch Pharmaceut Sci, Dept Organ Chem, Kure, Hiroshima, Japan; [Shibahara, Nona] Shizuoka City Inst Environm Sci & Publ Hlth, Shizuoka, Shizuoka, Japan	University of Shizuoka	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp		Otsubo, Tadamune/0000-0003-1949-9780; Kurebayashi, Yuuki/0000-0002-7523-6160	Pharmacological Research Foundation, Tokyo; Shimabara Science Promotion Foundation; Research Foundation for Electrotechnology of Chubu; Consortium of Universities in Shizuoka; Futaba Electronics Memorial Foundation; Tokai Foundation for Technology; Takahashi Industrial and Economic Research Foundation; Izumi Science and Technology Foundation; Kurata Memorial Hitachi Science and Technology Foundation; Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Research Foundation for Opto-Science and Technology; Noguchi Institute; Fujikura Foundation; Sugiyama-houkoukai; University of Shizuoka; JSPS KAKENHI [26670064, 16K15151, 15H05644]; Grants-in-Aid for Scientific Research [26460166, 15K08037] Funding Source: KAKEN	Pharmacological Research Foundation, Tokyo(Pharmacological Research Foundation, Tokyo); Shimabara Science Promotion Foundation; Research Foundation for Electrotechnology of Chubu; Consortium of Universities in Shizuoka; Futaba Electronics Memorial Foundation; Tokai Foundation for Technology; Takahashi Industrial and Economic Research Foundation; Izumi Science and Technology Foundation(Izumi Science and Technology Foundation); Kurata Memorial Hitachi Science and Technology Foundation; Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Research Foundation for Opto-Science and Technology; Noguchi Institute; Fujikura Foundation; Sugiyama-houkoukai; University of Shizuoka; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was in part supported by a grant from The Pharmacological Research Foundation, Tokyo, The Shimabara Science Promotion Foundation, Research Foundation for Electrotechnology of Chubu, The Consortium of Universities in Shizuoka, the Futaba Electronics Memorial Foundation, Tokai Foundation for Technology, Takahashi Industrial and Economic Research Foundation, Izumi Science and Technology Foundation, the Kurata Memorial Hitachi Science and Technology Foundation, Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering, Research Foundation for Opto-Science and Technology, The Noguchi Institute, The Fujikura Foundation, Sugiyama-houkoukai, University of Shizuoka and JSPS KAKENHI Grant Numbers Challenging Exploratory Research 26670064, 16K15151 and Young Scientists (A) 15H05644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2004, ANTIVIR THER, V9, P577; Aoki FY, 2007, ANTIVIR THER, V12, P603; Baranovich T, 2011, CURR OPIN VIROL, V1, P574, DOI 10.1016/j.coviro.2011.08.006; Barnett JM, 2000, ANTIMICROB AGENTS CH, V44, P78, DOI 10.1128/AAC.44.1.78-87.2000; Baz M, 2010, J INFECT DIS, V201, P740, DOI 10.1086/650464; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Boivin G, 2013, INFLUENZA OTHER RESP, V7, P18, DOI 10.1111/irv.12176; Brookes DW, 2011, J ANTIMICROB CHEMOTH, V66, P466, DOI 10.1093/jac/dkq486; Democratis J, 2006, J ANTIMICROB CHEMOTH, V58, P911, DOI 10.1093/jac/dkl376; Dixit Rashmi, 2013, Infectious Disorders - Drug Targets, V13, P34; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Greatorex JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027932; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; Hayden FG, 2011, J INFECT DIS, V203, P6, DOI 10.1093/infdis/jiq012; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Huang P, 2013, EPIDEMIOL INFECT, V141, P1061, DOI 10.1017/S0950268812001318; Hurt AC, 2004, ANTIVIR RES, V62, P37, DOI 10.1016/j.antiviral.2003.11.008; Hurt AC, 2012, LANCET INFECT DIS, V12, P240, DOI 10.1016/S1473-3099(11)70318-8; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Ison MG, 2011, CURR OPIN VIROL, V1, P563, DOI 10.1016/j.coviro.2011.09.002; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Jefferson T, 2014, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20141324T2, 10.1002/14651858.CD008965.pub4]; Kurebayashi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04877; Le TH, 2014, CLIN EXP VACCINE RES, V3, P117, DOI 10.7774/cevr.2014.3.2.117; Lee VJ, 2006, EMERG INFECT DIS, V12, P95; Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850; McKimm-Breschkin JL, 2013, INFLUENZA OTHER RESP, V7, P25, DOI 10.1111/irv.12047; Minami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081941; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nayak DP, 2004, J VIROL METHODS, V122, P9, DOI 10.1016/j.jviromet.2004.07.005; Okomo-Adhiambo M, 2013, INFLUENZA OTHER RESP, V7, P44, DOI [10.1111/irv.12113, 10.1111/irv.12051]; Okomo-Adhiambo M, 2010, ANTIMICROB AGENTS CH, V54, P1834, DOI 10.1128/AAC.01608-09; Otsubo T, 2013, BIOORG MED CHEM LETT, V23, P2245, DOI 10.1016/j.bmcl.2013.01.043; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Samson M, 2014, ANTIMICROB AGENTS CH, V58, P5220, DOI 10.1128/AAC.03313-14; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Shtyrya YA, 2009, ACTA NATURAE, V1, P26, DOI 10.32607/20758251-2009-1-2-26-32; Takahashi T, 2008, J VIROL, V82, P5940, DOI 10.1128/JVI.02496-07; Takahashi T, 2015, BIOL PHARM BULL, V38, P1214, DOI 10.1248/bpb.b15-00298; Takahashi T, 2014, J VIROL METHODS, V209, P136, DOI 10.1016/j.jviromet.2014.09.010; Takahashi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015556; Takano M, 2014, VIROLOGY, V464, P206, DOI 10.1016/j.virol.2014.04.005; Thompson CI, 2004, J ANTIMICROB CHEMOTH, V53, P759, DOI 10.1093/jac/dkh155; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003; Yen HL, 2014, J INFECT DIS, V210, P1900, DOI 10.1093/infdis/jiu353; Yingsakmongkon S, 2008, BIOL PHARM BULL, V31, P511, DOI 10.1248/bpb.31.511; Zhang XN, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.80	49	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156400	10.1371/journal.pone.0156400	http://dx.doi.org/10.1371/journal.pone.0156400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232333	Green Published, gold, Green Submitted			2022-12-26	WOS:000376883000030
J	Na, BR; Kwon, MS; Chae, MW; Kim, HR; Kim, CH; Jun, CD; Park, ZY				Na, Bo-Ra; Kwon, Min-Sung; Chae, Myoung-Won; Kim, Hye-Ran; Kim, Chang-Hyun; Jun, Chang-Duk; Park, Zee-Yong			Transgelin-2 in B-Cells Controls T-Cell Activation by Stabilizing T Cell - B Cell Conjugates	PLOS ONE			English	Article							ACTIN-BINDING PROTEIN; IMMUNOLOGICAL SYNAPSE; ANTIGEN RECEPTOR; F-ACTIN; CYTOSKELETAL DYNAMICS; CUTTING EDGE; EXPRESSION; CANCER; TRAFFICKING; LYMPHOCYTES	The immunological synapse (IS), a dynamic and organized junction between T-cells and antigen presenting cells (APCs), is critical for initiating adaptive immunity. The actin cytoskeleton plays a major role in T-cell reorganization during IS formation, and we previously reported that transgelin-2, an actin-binding protein expressed in T-cells, stabilizes cortical F-actin, promoting T-cell activation in response to antigen stimulation. Transgelin-2 is also highly expressed in B-cells, although no specific function has been reported. In this study, we found that deficiency in transgelin-2 (TAGLN2(-/-)) in B-cells had little effect on B-cell development and activation, as measured by the expression of CD69, MHC class II molecules, and CD80/86. Nevertheless, in B-cells, transgelin-2 accumulated in the IS during the interaction with T-cells. These results led us to hypothesize that transgelin-2 may also be involved in IS stability in B-cells, thereby influencing T-cell function. Notably, we found that transgelin-2 deficiency in B-cells reduced T-cell activation, as determined by the release of IL-2 and interferon-. and the expression of CD69. Furthermore, the reduced T-cell activation was correlated with reduced B-cell-T-cell conjugate formation. Collectively, these results suggest that actin stability in B-cells during IS formation is critical for the initiation of adaptive T-cell immunity.	[Na, Bo-Ra; Chae, Myoung-Won; Kim, Hye-Ran; Kim, Chang-Hyun; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Sch Life Sci, Immune Synapse Res Ctr, Gwangju, South Korea; [Na, Bo-Ra; Chae, Myoung-Won; Kim, Hye-Ran; Kim, Chang-Hyun; Jun, Chang-Duk] Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Gwangju, South Korea; [Na, Bo-Ra; Kwon, Min-Sung; Chae, Myoung-Won; Kim, Hye-Ran; Kim, Chang-Hyun; Jun, Chang-Duk; Park, Zee-Yong] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea; [Kwon, Min-Sung] World Inst Kimchi, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Jun, CD (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Immune Synapse Res Ctr, Gwangju, South Korea.; Jun, CD (corresponding author), Gwangju Inst Sci & Technol, Cell Dynam Res Ctr, Gwangju, South Korea.; Jun, CD; Park, ZY (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju, South Korea.	cdjun@gist.ac.kr; zeeyong@gist.ac.kr			Basic Science Program through National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [2015R1A2A1A15052658]; Creative Research Initiative Program through National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [2015R1A3A2066253]; Basic Science Program through NRF - Ministry of Education (MOE), Korea [2013R1A6A3A04064259]; Silver Health Bio Research Center of Gwangju Institute of Science and Technology	Basic Science Program through National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning (MSIP); Creative Research Initiative Program through National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning (MSIP); Basic Science Program through NRF - Ministry of Education (MOE), Korea; Silver Health Bio Research Center of Gwangju Institute of Science and Technology	This work was funded by the Basic Science Program (2015R1A2A1A15052658) and the Creative Research Initiative Program (2015R1A3A2066253) through the National Research Foundation (NRF) grants funded by the Ministry of Science, ICT & Future Planning (MSIP) given to CDJ; the Basic Science Program (2013R1A6A3A04064259) through the NRF grants funded by the Ministry of Education (MOE), Korea, given to HRK; and a grant from the Silver Health Bio Research Center of Gwangju Institute of Science and Technology, given to ZYP. Image acquisition was performed using the imaging facility of the Bio Imaging Research Center at GIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Alarcon B, 2011, IMMUNOLOGY, V133, P420, DOI 10.1111/j.1365-2567.2011.03458.x; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Brown BK, 2001, TRAFFIC, V2, P414, DOI 10.1034/j.1600-0854.2001.002006414.x; Burns S, 2004, BLOOD, V104, P3454, DOI 10.1182/blood-2004-04-1678; Camoretti-Mercado B, 1998, GENOMICS, V49, P452, DOI 10.1006/geno.1998.5267; Craddock JA, 2010, J IMMUNOTHER, V33, P780, DOI 10.1097/CJI.0b013e3181ee6675; Depaz I, 2003, ALCOHOL CLIN EXP RES, V27, P1481, DOI 10.1097/01.ALC.0000086060.18032.59; Depaz IM, 2005, J NEUROSCI RES, V81, P253, DOI 10.1002/jnr.20563; Di Stasi A, 2009, BLOOD, V113, P6392, DOI 10.1182/blood-2009-03-209650; Dustin ML, 2008, ANNU REV CELL DEV BI, V24, P577, DOI 10.1146/annurev.cellbio.24.110707.175226; Dustin ML, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002873; Dvorakova M, 2014, EXPERT REV PROTEOMIC, V11, P149, DOI 10.1586/14789450.2014.860358; Feil S, 2004, CIRC RES, V94, P863, DOI 10.1161/01.RES.0000126417.38728.F6; Frances R, 2006, MOL IMMUNOL, V43, P2124, DOI 10.1016/j.molimm.2005.12.011; Freeman SN, 2011, J IMMUNOL, V187, P5887, DOI 10.4049/jimmunol.1102233; Galkin VE, 2002, NAT STRUCT BIOL, V9, P518, DOI 10.1038/nsb811; Hao SL, 2005, MOL BIOL CELL, V16, P2275, DOI 10.1091/mbc.e04-10-0881; June CH, 2007, J CLIN INVEST, V117, P1466, DOI 10.1172/JCI32446; Kershaw MH, 2002, HUM GENE THER, V13, P1971, DOI 10.1089/10430340260355374; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Le Roux D, 2007, MOL BIOL CELL, V18, P3451, DOI 10.1091/mbc.E06-12-1114; Li M, 2008, J STRUCT BIOL, V162, P229, DOI 10.1016/j.jsb.2008.01.005; Liu CH, 2012, J IMMUNOL, V188, P3237, DOI 10.4049/jimmunol.1103065; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Mori K, 2004, NEUROSCI RES, V48, P439, DOI 10.1016/j.neures.2003.12.012; Na BR, 2015, J CELL BIOL, V209, P143, DOI 10.1083/jcb.201407130; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Onabajo OO, 2008, J IMMUNOL, V180, P6685, DOI 10.4049/jimmunol.180.10.6685; Paccani SR, 2005, BLOOD, V106, P626, DOI 10.1182/blood-2004-05-2051; Piragyte Indre, 2012, Immune Netw, V12, P71, DOI 10.4110/in.2012.12.3.71; Ramos CA, 2011, EXPERT OPIN BIOL TH, V11, P855, DOI 10.1517/14712598.2011.573476; Rho JH, 2009, J PROTEOME RES, V8, P5610, DOI 10.1021/pr900705r; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shen JB, 2010, CIRC RES, V106, P1351, DOI 10.1161/CIRCRESAHA.109.213900; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Spranger S, 2012, BLOOD, V119, P3440, DOI 10.1182/blood-2011-06-357939; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Zhang JCL, 2002, MECH DEVELOP, V115, P161, DOI 10.1016/S0925-4773(02)00088-6; Zhang YB, 2010, CANCER SCI, V101, P523, DOI 10.1111/j.1349-7006.2009.01424.x; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	49	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156429	10.1371/journal.pone.0156429	http://dx.doi.org/10.1371/journal.pone.0156429			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232882	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000034
J	Chen, H; Lorton, B; Gupta, V; Shechter, D				Chen, H.; Lorton, B.; Gupta, V.; Shechter, D.			A TGF beta-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression	ONCOGENE			English	Article							SYMMETRIC DIMETHYLATION; LUNG ADENOCARCINOMA; DNA METHYLATION; PRMT5; METHYLTRANSFERASE; PROTEIN; EXPRESSION; EMT; PROGRESSION; VALIDATION	Protein arginine methyltransferase 5 (PRMT5) complexed with MEP50/WDR77 catalyzes arginine methylation on histones and other proteins. PRMT5-MEP50 activity is elevated in cancer cells and its expression is highly correlated with poor prognosis in many human tumors. We demonstrate that PRMT5-MEP50 is essential for transcriptional regulation promoting cancer cell invasive phenotypes in lung adenocarcinoma, lung squamous cell carcinoma and breast carcinoma cancer cells. RNA-Seq transcriptome analysis demonstrated that PRMT5 and MEP50 are required to maintain expression of metastasis and Epithelial-to-mesenchymal transition (EMT) markers and to potentiate an epigenetic mechanism of the TGF beta response. We show that PRMT5-MEP50 activity both positively and negatively regulates expression of a wide range of genes. Exogenous TGF beta promotes EMT in a unique pathway of PRMT5-MEP50 catalyzed histone mono-and dimethylation of chromatin at key metastasis suppressor and EMT genes, defining a new mechanism regulating cancer invasivity. PRMT5 methylation of histone H3R2me1 induced transcriptional activation by recruitment of WDR5 and concomitant H3K4 methylation at targeted genes. In parallel, PRMT5 methylation of histone H4R3me2s suppressed transcription at distinct genomic loci. Our decoding of histone methylarginine at key genes supports a critical role for complementary PRMT5-MEP50 transcriptional activation and repression in cancer invasion pathways and in response to TGF beta stimulation and therefore orients future chemotherapeutic opportunities.	[Chen, H.; Lorton, B.; Shechter, D.] Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Gupta, V.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chen, H; Shechter, D (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	hongshan.chen@einstein.yu.edu; david.shechter@einstein.yu.edu	Shechter, David/B-4660-2008	Shechter, David/0000-0001-9388-6004	Albert Einstein College of Medicine; Alexandrine and Alexander Sinsheimer Fund; American Cancer Society - Robbie Sue Mudd Kidney Cancer Research Scholar Grant [124891-RSG-13-396-01-DMC]; NIH [R01GM108646-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108646] Funding Source: NIH RePORTER	Albert Einstein College of Medicine; Alexandrine and Alexander Sinsheimer Fund; American Cancer Society - Robbie Sue Mudd Kidney Cancer Research Scholar Grant(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to C. Arrowsmith, GlaxoSmithKline and the Structural Genomics Consortium for the gift of GSK591, C. Wilczek, R. Mazur and P. Bailey for preliminary knockdown experiments, E. Burgos for recombinant PRMT5-MEP50, S. Maqbool, R. Dubin, and B. Ye at the Einstein Center for Epigenomics for assistance with RNASeq and initial analysis, and members of the Shechter lab for comments. This work was supported by startup funds from the Albert Einstein College of Medicine, The Alexandrine and Alexander Sinsheimer Fund, The American Cancer Society - Robbie Sue Mudd Kidney Cancer Research Scholar Grant (124891-RSG-13-396-01-DMC) and NIH R01GM108646-01A1 (all to D.S.).	Alinari L, 2015, BLOOD, V125, P2530, DOI 10.1182/blood-2014-12-619783; Bao XX, 2013, J HISTOCHEM CYTOCHEM, V61, P206, DOI 10.1369/0022155413475452; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Burgos ES, 2015, J BIOL CHEM, V290, P9674, DOI 10.1074/jbc.M115.636894; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chen HS, 2015, MOL CELL, V59, P719, DOI 10.1016/j.molcel.2015.07.011; Chen HS, 2014, NAT STRUCT MOL BIOL, V21, P981, DOI 10.1038/nsmb.2903; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chung J, J BIOL CHEM, V288, P35534; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Dacwag CS, 2009, MOL CELL BIOL, V29, P1909, DOI 10.1128/MCB.00742-08; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; Diez-Villanueva A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0014-8; Duncan KW, 2015, ACS MED CHEM LETT; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Girardot M, 2014, NUCLEIC ACIDS RES, V42, P235, DOI 10.1093/nar/gkt884; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; Greenblatt SM, 2016, EXP HEMATOL, V44, P435, DOI 10.1016/j.exphem.2016.03.009; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057008; Ibrahim R, 2014, HUM PATHOL, V45, P1397, DOI 10.1016/j.humpath.2014.02.013; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Kakuguchi W, 2010, MOL CANCER RES, V8, P520, DOI 10.1158/1541-7786.MCR-09-0367; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Koh C.M., 2015, CURR MOL BIOL REP, V1, P19, DOI [10.1007/s40610-015-0003-5, DOI 10.1007/S40610-015-0003-5]; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li Y, 2015, CANCER DISCOV, V5, P288, DOI 10.1158/2159-8290.CD-14-0625; Liu J, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.37; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu G, 2013, SCI WORLD J, DOI 10.1155/2013/424617; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Nicklay JJ, 2009, J BIOL CHEM, V284, P1075, DOI 10.1074/jbc.M807274200; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sarkar S, 2013, INT J MOL SCI, V14, P21087, DOI 10.3390/ijms141021087; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Smil D, 2015, ACS MED CHEM LETT, V6, P408, DOI 10.1021/ml500467h; Stafford LJ, 2008, INT J BIOCHEM CELL B, V40, P874, DOI 10.1016/j.biocel.2007.12.016; Stopa N, 2015, CELL MOL LIFE SCI, V72, P2041, DOI 10.1007/s00018-015-1847-9; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tarighat SS, 2016, LEUKEMIA, V30, P789, DOI 10.1038/leu.2015.308; Wang M, 2014, BIOCHEMISTRY-US, V53, P7884, DOI 10.1021/bi501279g; Wang M, 2013, BIOCHEMISTRY-US, V52, P5430, DOI 10.1021/bi4005123; Wilczek C, 2011, J BIOL CHEM, V286, P42221, DOI 10.1074/jbc.M111.303677; Wu YC, 2016, ONCOGENE, V35, P2123, DOI 10.1038/onc.2015.274; Yan FT, 2014, CANCER RES, V74, P1752, DOI 10.1158/0008-5472.CAN-13-0884; Yan JC, 2013, HISTOL HISTOPATHOL, V28, P285, DOI 10.14670/HH-28.285; Yang HP, 2015, ONCOL REP, V34, P87, DOI 10.3892/or.2015.3961; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yuan CC, 2012, CELL REPORTS, V1, P83, DOI 10.1016/j.celrep.2011.12.008; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	61	101	108	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 19	2017	36	3					373	386		10.1038/onc.2016.205	http://dx.doi.org/10.1038/onc.2016.205			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IB	27270440	Green Accepted			2022-12-26	WOS:000394166000007
J	Hu, HQ; Gourguechon, S; Wang, CC; Li, ZY				Hu, Huiqing; Gourguechon, Stephane; Wang, Ching C.; Li, Ziyin			The G(1) Cyclin-dependent Kinase CRK1 in Trypanosoma brucei Regulates Anterograde Protein Transport by Phosphorylating the COPII Subunit Sec31	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; GTP-BINDING; VESICLE; COAT; ER; FISSION; MITOSIS; SITES	Transport of secretory proteins from the endoplasmic reticulum to the Golgi is mediated by the coat protein II (COPII) complex comprising a Sec23-Sec24 heterodimer and a Sec13-Sec31 heterotetramer. The mechanisms underlying COPII-mediated protein trafficking have been well defined, but the extent of regulation of this secretory machinery by cellular signaling pathways remains poorly understood. Here, we report that CRK1, a G(1) cyclin-dependent kinase in Trypanosoma brucei, regulates anterograde protein trafficking by phosphorylating Sec31. Depletion of CRK1 abolished anterograde transport of the secretory protein and disrupted the localization of multiple Golgi proteins, reminiscent of Sec31 depletion. CRK1 phosphorylates Sec31 at multiple serine/threonine sites, and mutation of these phosphosites to alanine recapitulates the protein trafficking defects caused by Sec31 depletion. Mutation of these CRK1 phosphosites to aspartate restored Sec31 function. Taken together, these results uncover a novel function of CRK1 in anterograde protein trafficking and elucidate the mechanistic role of CRK1 in protein trafficking through regulation of the COPII subunit Sec31.	[Hu, Huiqing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Gourguechon, Stephane; Wang, Ching C.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California San Francisco	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	ziyin.li@uth.tmc.edu		Li, Ziyin/0000-0002-3960-9716	National Institutes of Health [R01 AI118736, AI101437, R01 AI21786]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101437, R01AI118736, R01AI021786] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01 AI118736 and AI101437 (to Z. L.) and Grant R01 AI21786 (to C. C. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 2002, CURR OPIN CELL BIOL, V14, P417, DOI 10.1016/S0955-0674(02)00348-4; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Demmel L, 2011, TRAFFIC, V12, P1575, DOI 10.1111/j.1600-0854.2011.01257.x; Farhan H, 2011, J CELL SCI, V124, P171, DOI 10.1242/jcs.076455; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2003, J BIOL CHEM, V278, P22877, DOI 10.1074/jbc.M300813200; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Hertz Nicholas T, 2010, Curr Protoc Chem Biol, V2, P15, DOI 10.1002/9780470559277.ch090201; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Kano F, 2004, MOL BIOL CELL, V15, P4289, DOI 10.1091/mbc.E03-11-0822; Koreishi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054382; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Liu Y, 2013, MOL MICROBIOL, V90, P130, DOI 10.1111/mmi.12352; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Matynia A, 2002, J CELL SCI, V115, P421; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Palmer KJ, 2005, J CELL SCI, V118, P3839, DOI 10.1242/jcs.02496; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Sevova ES, 2009, MOL BIOL CELL, V20, P4739, DOI 10.1091/mbc.E09-07-0542; Sharpe LJ, 2011, TRAFFIC, V12, P19, DOI 10.1111/j.1600-0854.2010.01133.x; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; Silverman JS, 2012, CURR OPIN MICROBIOL, V15, P463, DOI 10.1016/j.mib.2012.03.002; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Tu XM, 2004, J BIOL CHEM, V279, P20519, DOI 10.1074/jbc.M312862200; Wei Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5060; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2014, INT REV CEL MOL BIO, V308, P127, DOI 10.1016/B978-0-12-800097-7.00004-X	46	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15527	15539		10.1074/jbc.M116.715185	http://dx.doi.org/10.1074/jbc.M116.715185			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27252375	Green Published, hybrid			2022-12-26	WOS:000380584200010
J	Li, HJ; Spagnol, G; Zheng, L; Stauch, KL; Sorgen, PL				Li, Hanjun; Spagnol, Gaelle; Zheng, Li; Stauch, Kelly L.; Sorgen, Paul L.			Regulation of Connexin43 Function and Expression by Tyrosine Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; RENIN-ANGIOTENSIN SYSTEM; JAK-STAT PATHWAY; V-SRC; PHOSPHORYLATION SITES; CARBOXYL-TERMINUS; JAK/STAT PATHWAY; DOWN-REGULATION; PHORBOL-ESTER; E-CADHERIN	Connexin43 (Cx43) assembly and degradation, the regulation of electrical and metabolic coupling, as well as modulating the interaction with other proteins, involve phosphorylation. Here, we identified and characterized the biological significance of a novel tyrosine kinase that phosphorylates Cx43, tyrosine kinase 2 (Tyk2). Activation of Tyk2 led to a decrease in Cx43 gap junction communication by increasing the turnover rate of Cx43 from the plasma membrane. Tyk2 directly phosphorylated Cx43 residues Tyr-247 and Tyr-265, leading to indirect phosphorylation on residues Ser-279/Ser-282 (MAPK) and Ser-368 (PKC). Although this phosphorylation pattern is similar to what has been observed following Src activation, the response caused by Tyk2 occurred when Src was inactive in NRK cells. Knockdown of Tyk2 at the permissive temperature (active v-Src) in LA-25 cells decreased Cx43 phosphorylation, indicating that although activation of Tyk2 and v-Src leads to phosphorylation of the same Cx43CT residues, they are not identical in level at each site. Additionally, angiotensin II activation of Tyk2 increased the intracellular protein level of Cx43 via STAT3. These findings indicate that, like Src, Tyk2 can also inhibit gap junction communication by phosphorylating Cx43.	[Li, Hanjun; Spagnol, Gaelle; Zheng, Li; Stauch, Kelly L.; Sorgen, Paul L.] Univ Nebraska Med Ctr, Omaha, NE 68105 USA	University of Nebraska System; University of Nebraska Medical Center	Sorgen, PL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	psorgen@unmc.edu		Spagnol, Gaelle/0000-0002-3201-4840	National Institutes of Health [GM072631, HL131712]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM072631 and HL131712. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akar FG, 2004, CIRC RES, V95, P717, DOI 10.1161/01.RES.0000144125.61927.1c; Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; ATKINSON MM, 1981, J CELL BIOL, V91, P573, DOI 10.1083/jcb.91.2.573; Axelsen LN, 2006, J MOL CELL CARDIOL, V40, P790, DOI 10.1016/j.yjmcc.2006.03.005; Axelsen LN, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00130; AZARNIA R, 1988, SCIENCE, V239, P398, DOI 10.1126/science.2447651; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Breitkopf Susanne B, 2012, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1819s98; Brikci-Nigassa AS, 2012, BIOCHEMISTRY-US, V51, P4331, DOI 10.1021/bi201806j; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Cooper CD, 2000, METHODS, V20, P196, DOI 10.1006/meth.1999.0937; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Delmar M, 2012, CURR OPIN CARDIOL, V27, P236, DOI 10.1097/HCO.0b013e328352220e; Duffy HS, 2002, J BIOL CHEM, V277, P36706, DOI 10.1074/jbc.M207016200; Emdad L, 2001, J MOL CELL CARDIOL, V33, P219, DOI 10.1006/jmcc.2000.1293; FILSON AJ, 1990, CELL GROWTH DIFFER, V1, P661; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; Fischer R, 2007, AM J PHYSIOL-HEART C, V293, pH1242, DOI 10.1152/ajpheart.01400.2006; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Girao H, 2009, EXP CELL RES, V315, P3587, DOI 10.1016/j.yexcr.2009.10.003; Govindarajan R, 2010, MOL BIOL CELL, V21, P4089, DOI 10.1091/mbc.E10-05-0403; Grosely R, 2013, J BIOL CHEM, V288, P24857, DOI 10.1074/jbc.M113.454389; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Huang QY, 2012, AM J FOREN MED PATH, V33, P215, DOI 10.1097/PAF.0b013e31823f04eb; Hussain W, 2010, J CARDIOVASC ELECTR, V21, P1276, DOI 10.1111/j.1540-8167.2010.01802.x; Johnson KE, 2013, MOL BIOL CELL, V24, P715, DOI 10.1091/mbc.E12-07-0537; Kanemitsu MY, 1997, J BIOL CHEM, V272, P22824, DOI 10.1074/jbc.272.36.22824; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kasi VS, 2007, AM J PHYSIOL-HEART C, V293, pH182, DOI 10.1152/ajpheart.00684.2006; Kieken F, 2009, CIRC RES, V104, P1103, DOI 10.1161/CIRCRESAHA.108.190454; Kodama H, 1998, CIRC RES, V82, P244; Kostin S, 2004, CARDIOVASC RES, V62, P426, DOI 10.1016/j.cardiores.2003.12.010; KURATA WE, 1994, ONCOGENE, V9, P329; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lampe PD, 2006, J CELL SCI, V119, P3435, DOI 10.1242/jcs.03089; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; LAMPE PD, 1994, J CELL BIOL, V127, P1895, DOI 10.1083/jcb.127.6.1895; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Lin R, 2001, CELL COMMUN ADHES, V8, P265, DOI 10.3109/15419060109080735; LONN EM, 1994, CIRCULATION, V90, P2056, DOI 10.1161/01.CIR.90.4.2056; LOO LWM, 1995, J BIOL CHEM, V270, P12751, DOI 10.1074/jbc.270.21.12751; Marone Maria, 2001, Biological Procedures Online, V3, P19, DOI 10.1251/bpo20; MARRERO MB, 1995, CARDIOVASC RES, V30, P530, DOI 10.1016/0008-6363(95)00094-1; MATESIC DF, 1994, MOL CARCINOGEN, V10, P226, DOI 10.1002/mc.2940100407; MEHTA PP, 1991, J MEMBRANE BIOL, V124, P207, DOI 10.1007/BF01994355; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Mitra S, 2006, MOL BIOL CELL, V17, P5400, DOI 10.1091/mbc.E06-04-0280; Mitra SS, 2012, J MEMBRANE BIOL, V245, P495, DOI 10.1007/s00232-012-9500-0; Murakami Y, 1998, J CELL PHYSIOL, V175, P220, DOI 10.1002/(SICI)1097-4652(199805)175:2<220::AID-JCP12>3.0.CO;2-C; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Ozog MA, 2004, MOL BIOL CELL, V15, P4761, DOI 10.1091/mbc.E04-03-0271; Pagliaro P, 2005, CARDIOVASC DRUG THER, V19, P77, DOI 10.1007/s10557-005-6900-8; Palatinus JA, 2012, BBA-BIOMEMBRANES, V1818, P1831, DOI 10.1016/j.bbamem.2011.08.006; Pan J, 1999, CIRC RES, V84, P1127, DOI 10.1161/01.RES.84.10.1127; Pan J, 1997, CIRC RES, V81, P611, DOI 10.1161/01.RES.81.4.611; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Saez JC, 1997, J MOL CELL CARDIOL, V29, P2131, DOI 10.1006/jmcc.1997.0447; Sato K, 2009, J CLIN IMMUNOL, V29, P815, DOI 10.1007/s10875-009-9320-x; Savitski MM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003830; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sirnes S, 2008, BIOCHEM BIOPH RES CO, V373, P597, DOI 10.1016/j.bbrc.2008.06.095; Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2008, CELL COMMUN ADHES, V15, P75, DOI 10.1080/15419060802014016; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Spagnol G, 2016, J BIOL CHEM, V291, P7637, DOI 10.1074/jbc.M115.701417; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stein M, 2009, CARDIOVASC RES, V83, P52, DOI 10.1093/cvr/cvp124; Strobl B, 2011, FRONT BIOSCI-LANDMRK, V16, P3224, DOI 10.2741/3908; SWENSON KI, 1990, CELL REGUL, V1, P989, DOI 10.1091/mbc.1.13.989; Tan L. L., 2013, SICHUAN DA XUE XUE B, V44, P549; Tan Li-Li, 2013, Sichuan Da Xue Xue Bao Yi Xue Ban, V44, P531; Ubel C, 2014, SCI REP-UK, V4, DOI 10.1038/srep05865; Wallweber HJA, 2014, NAT STRUCT MOL BIOL, V21, P443, DOI 10.1038/nsmb.2807; Wan J, 2010, J NEUROSCI, V30, P6873, DOI 10.1523/JNEUROSCI.0519-10.2010; Wang RZ, 2014, ADSORPTION REFRIGERATION TECHNOLOGY: THEORY AND APPLICATION, P1; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Yang K, 2012, EMBO J, V31, P805, DOI 10.1038/emboj.2011.453; Yoon N, 2013, EXP THER MED, V5, P1009, DOI 10.3892/etm.2013.920; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zhou L, 1999, J CELL BIOL, V144, P1033, DOI 10.1083/jcb.144.5.1033	91	14	14	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15867	15880		10.1074/jbc.M116.727008	http://dx.doi.org/10.1074/jbc.M116.727008			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27235399	Green Published, hybrid			2022-12-26	WOS:000380584200038
J	Ampah, KA; Pinho-Nascimento, CA; Kerber, S; Asare, P; De-Graft, D; Adu-Nti, F; Paixao, ICNP; Niel, C; Yeboah-Manu, D; Pluschke, G; Roltgen, K				Ampah, Kobina Assan; Pinho-Nascimento, Carlos Augusto; Kerber, Sarah; Asare, Prince; De-Graft, Daniel; Adu-Nti, Frank; Paixao, Izabel C. N. P.; Niel, Christian; Yeboah-Manu, Dorothy; Pluschke, Gerd; Roltgen, Katharina			Limited Genetic Diversity of Hepatitis B Virus in the General Population of the Offin River Valley in Ghana	PLOS ONE			English	Article							GENOTYPE-E; VIRAL-HEPATITIS; RISK-FACTORS; STRAINS; AFRICA; GENOME; SEROPREVALENCE; EPIDEMIOLOGY; DETERMINANTS; COINFECTION	Hepatitis B virus (HBV) infections account for approximately 780,000 deaths per year, most of which occur in the developing world. Co-infection with HBV and hepatitis delta virus (HDV) may lead to the most severe form of viral hepatitis. In Ghana, knowledge on the prevalence of HBV and HDV in the general population is scanty and the few genetic analyses of the prevailing HBV genotypes are dating back more than a decade. In the present study, 1,323 serum samples from individuals living in a rural area (Offin river valley) of Ghana were analyzed for the presence of the hepatitis B surface antigen (HBsAg). Positive sera were subsequently tested for the presence of anti-HDV antibodies. A total of 107 (8%) sera were HBsAg positive with an 8.4% prevalence of anti-HDV antibodies among the HBsAg positives. Phylogenetic analysis based on HBV pre-S/S sequences, attributed all 52 typable samples to genotype E. All belonged to serotype ayw4. While 19 sequences clustered with those from a number of African countries, the other 33 formed a separate cluster distinguished by an intergroup mean distance of 1.5% from the pan-African HBV/E cluster. Successful implementation of HBV vaccination in the region was reflected by the low HBsAg carrier rate of 1.8% among children <= 11 years.	[Ampah, Kobina Assan; Kerber, Sarah; Pluschke, Gerd; Roltgen, Katharina] Swiss Trop & Publ Hlth Inst, Mol Immunol, Basel, Switzerland; [Ampah, Kobina Assan; Kerber, Sarah; Pluschke, Gerd; Roltgen, Katharina] Univ Basel, Basel, Switzerland; [Ampah, Kobina Assan; Asare, Prince; De-Graft, Daniel; Yeboah-Manu, Dorothy] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Pinho-Nascimento, Carlos Augusto] Univ Fed Fluminense, Inst Biol, Mol Virol Lab, Niteroi, RJ, Brazil; [Adu-Nti, Frank] Radford Univ Coll, Accra, Ghana; [Niel, Christian] Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Ghana; Universidade Federal Fluminense; Fundacao Oswaldo Cruz	Roltgen, K (corresponding author), Swiss Trop & Publ Hlth Inst, Mol Immunol, Basel, Switzerland.; Roltgen, K (corresponding author), Univ Basel, Basel, Switzerland.	Katharina.roeltgen@unibas.ch	Paixão, Izabel/S-7490-2019; Paixão, Izabel/AAM-1668-2020; Yeboah-Manu, Dorothy/A-1933-2016	Pluschke, Gerd/0000-0003-1957-2925; Roltgen, Katharina/0000-0002-1582-1720; Yeboah-Manu, Dorothy/0000-0002-1663-6287; ADU-NTI, FRANK/0000-0002-7799-9380	Stop Buruli Initiative - UBS-Optimus Foundation	Stop Buruli Initiative - UBS-Optimus Foundation	This study was supported by the Stop Buruli Initiative funded by the UBS-Optimus Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjei A A, 2006, West Afr J Med, V25, P38; Adjei AA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-33; Ampah KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004603; Ampah KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004387; Andernach IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081690; Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Asmah R H, 2014, West Afr J Med, V33, P32; Bahri O, 2006, J MED VIROL, V78, P353, DOI 10.1002/jmv.20554; Bell TG, 2015, VIRUSES-BASEL, V7, P781, DOI 10.3390/v7020781; Candotti D, 2007, J GEN VIROL, V88, P2686, DOI 10.1099/vir.0.83102-0; Carrion AF, 2012, AM J GASTROENTEROL, V107, P691, DOI 10.1038/ajg.2012.7; Cho Y, 2012, GUT LIVER, V6, P235, DOI 10.5009/gnl.2012.6.2.235; Chu CJ, 2002, HEPATOLOGY, V35, P1274, DOI 10.1053/jhep.2002.33161; Damale NKR, 2005, INT J GYNECOL OBSTET, V90, P240, DOI 10.1016/j.ijgo.2005.05.014; Dongdem Julius Tieroyaare, 2012, BMC Res Notes, V5, P115, DOI 10.1186/1756-0500-5-115; Ezzikouri S, 2008, INFECT GENET EVOL, V8, P306, DOI 10.1016/j.meegid.2008.01.010; Forbi JC, 2013, J CLIN VIROL, V58, P59, DOI 10.1016/j.jcv.2013.06.028; Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Gram L, 2014, TROP MED INT HEALTH, V19, P802, DOI 10.1111/tmi.12324; Huang SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089753; Hubschen JM, 2008, J CLIN VIROL, V43, P376, DOI 10.1016/j.jcv.2008.08.018; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Huy TTT, 2006, J MED VIROL, V78, P178, DOI 10.1002/jmv.20525; Khelifa F, 2009, PATHOL BIOL, V57, P107, DOI 10.1016/j.patbio.2008.07.031; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kramvis A, 2005, J MED VIROL, V77, P47, DOI 10.1002/jmv.20412; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kubio C, 2012, TRANSFUSION, V52, P2161, DOI 10.1111/j.1537-2995.2012.03709.x; Kwaansa-Ansah EE, 2010, B ENVIRON CONTAM TOX, V85, P476, DOI 10.1007/s00128-010-0141-7; Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092223; Lemoine M, 2013, FUTURE VIROL, V8, P371, DOI 10.2217/FVL.13.11; Levicnik-Stezinar Snezna, 2004, Clin Lab, V50, P49; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Marcus EL, 1997, J AM GERIATR SOC, V45, P755, DOI 10.1111/j.1532-5415.1997.tb01484.x; McMahon BJ, 2009, HEPATOL INT, V3, P334, DOI 10.1007/s12072-008-9112-z; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; Mutocheluh Mohamed, 2014, BMC Res Notes, V7, P873, DOI 10.1186/1756-0500-7-873; NAUMANN H, 1993, J GEN VIROL, V74, P1627, DOI 10.1099/0022-1317-74-8-1627; Nkrumah Bernard, 2011, BMC Res Notes, V4, P529, DOI 10.1186/1756-0500-4-529; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Padmapriyadarsini C, 2006, J POSTGRAD MED, V52, P92; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Purdy MA, 2007, INTERVIROLOGY, V50, P45, DOI 10.1159/000096312; Purdy Michael A, 2007, Asian J Transfus Sci, V1, P62, DOI 10.4103/0973-6247.33445; Rizzetto M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021576; Rizzetto M, 2013, CLIN LIVER DIS, V17, P475, DOI 10.1016/j.cld.2013.05.007; Sagoe KWC, 2012, J MED VIROL, V84, P6, DOI 10.1002/jmv.22262; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sayiner AA, 2007, J CLIN VIROL, V38, P157, DOI 10.1016/j.jcv.2006.12.002; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Seremba E, 2010, J MED VIROL, V82, P1334, DOI 10.1002/jmv.21813; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Wong WM, 2000, HEPATOLOGY, V31, P201, DOI 10.1002/hep.510310129; World Health Organization, GUID PREV CAR TREATM; Zuckerman JN, 2003, ANTIVIR RES, V60, P75, DOI 10.1016/j.antiviral.2003.08.013	62	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156864	10.1371/journal.pone.0156864	http://dx.doi.org/10.1371/journal.pone.0156864			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271290	gold, Green Published, Green Submitted			2022-12-26	WOS:000377560200023
J	Li, KJ; Wu, CH; Shen, CY; Kuo, YM; Yu, CL; Hsieh, SC				Li, Ko-Jen; Wu, Cheng-Han; Shen, Chieh-Yu; Kuo, Yu-Min; Yu, Chia-Li; Hsieh, Song-Chou			Membrane Transfer from Mononuclear Cells to Polymorphonuclear Neutrophils Transduces Cell Survival and Activation Signals in the Recipient Cells via Anti-Extrinsic Apoptotic and MAP Kinase Signaling Pathways	PLOS ONE			English	Article							SURFACE-EXPRESSED LACTOFERRIN; DELAYED-TYPE HYPERSENSITIVITY; INVIVO IMMUNE-RESPONSE; RED-BLOOD-CELLS; MHC CLASS-II; T-CELLS; SELECTIVE DEPLETION; MONOCLONAL-ANTIBODY; RP-3 TREATMENT; INTERCELLULAR TRANSFER	The biological significance of membrane transfer (trogocytosis) between polymorphonuclear neutrophils (PMNs) and mononuclear cells (MNCs) remains unclear. We investigated the biological/immunological effects and molecular basis of trogocytosis among various immune cells in healthy individuals and patients with active systemic lupus erythematosus (SLE). By flow cytometry, we determined that molecules in the immunological synapse, including HLA class-I and-II, CD11b and LFA-1, along with CXCR1, are exchanged among autologous PMNs, CD4(+) T cells, and U937 cells (monocytes) after cell-cell contact. Small interfering RNA knockdown of the integrin adhesion molecule CD11a in U937 unexpectedly enhanced the level of total membrane transfer from U937 to PMN cells. Functionally, phagocytosis and IL-8 production by PMNs were enhanced after co-culture with T cells. Total membrane transfer from CD4(+) T to PMNs delayed PMN apoptosis by suppressing the extrinsic apoptotic molecules, BAX, MYC and caspase 8. This enhancement of activities of PMNs by T cells was found to be mediated via p38- and P44/42-Akt-MAP kinase pathways and inhibited by the actin-polymerization inhibitor, latrunculin B, the clathrin inhibitor, Pit-stop-2, and human immunoglobulin G, but not by the caveolin inhibitor, methyl-beta-cyclodextrin. In addition, membrane transfer from PMNs enhanced IL-2 production by recipient anti-CD3/anti-CD28 activated MNCs, and this was suppressed by inhibitors of mitogen-activated protein kinase (PD98059) and protein kinase C (Rottlerin). Of clinical significance, decreased total membrane transfer from PMNs to MNCs in patients with active SLE suppressed mononuclear IL-2 production. In conclusion, membrane transfer from MNCs to PMNs, mainly at the immunological synapse, transduces survival and activation signals to enhance PMN functions and is dependent on actin polymerization, clathrin activation, and Fc gamma receptors, while membrane transfer from PMNs to MNCs depends on MAP kinase and PKC signaling. Defective membrane transfer from PMNs to MNCs in patients with active systemic lupus erythematous suppressed activated mononuclear IL-2 production.	[Li, Ko-Jen; Hsieh, Song-Chou] Natl Yang Ming Univ, Coll Med, Inst Clin Med, Taipei 112, Taiwan; [Wu, Cheng-Han; Shen, Chieh-Yu; Kuo, Yu-Min] Natl Taiwan Univ, Coll Med, Inst Clin Med, Taipei 10764, Taiwan; [Yu, Chia-Li] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan; [Li, Ko-Jen; Wu, Cheng-Han; Shen, Chieh-Yu; Kuo, Yu-Min; Yu, Chia-Li; Hsieh, Song-Chou] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Hsieh, SC (corresponding author), Natl Yang Ming Univ, Coll Med, Inst Clin Med, Taipei 112, Taiwan.; Hsieh, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	hsiehsc@ntu.edu.tw		LI, KO-JEN/0000-0002-4544-4620; Shen, Chieh-Yu/0000-0002-3218-0689	National Sciences Council [101-2314-B-002-142-MY3, 100-2314-B-002-144, 98-2314-B-002-068]	National Sciences Council	The paper was supported by grants from the National Sciences Council (101-2314-B-002-142-MY3, 100-2314-B-002-144, 98-2314-B-002-068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman M, 2005, J INFECT DIS, V192, P399, DOI 10.1086/431680; Alvarado-Kristensson M, 2001, FASEB J, V15, P129, DOI 10.1096/fj.01-0817fje; Baba E, 2001, J IMMUNOL, V167, P875, DOI 10.4049/jimmunol.167.2.875; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Bourbie-Vaudaine S, 2006, J IMMUNOL, V177, P1460, DOI 10.4049/jimmunol.177.3.1460; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Caumartin J, 2006, TRANSPL IMMUNOL, V17, P20, DOI 10.1016/j.trim.2006.09.032; Choi KS, 2005, INFECT IMMUN, V73, P8209, DOI 10.1128/IAI.73.12.8209-8218.2005; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Davis DM, 2002, TRENDS IMMUNOL, V23, P356, DOI 10.1016/S1471-4906(02)02243-3; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; ELHAG A, 1987, J IMMUNOL, V139, P2406; Monsivais-Urenda AE, 2011, J CLIN IMMUNOL, V31, P369, DOI 10.1007/s10875-010-9496-0; Fanger NA, 1997, BLOOD, V89, P4128, DOI 10.1182/blood.V89.11.4128; Gladman DD, 2000, J RHEUMATOL, V29, P288, DOI DOI 10.3899/JRHEUM.110550; GOSSELIN EJ, 1993, J IMMUNOL, V151, P1482; HIROHATA S, 1995, CELL IMMUNOL, V160, P270, DOI 10.1016/0008-8749(95)80038-K; Hock BD, 2012, IMMUNOLOGY, V137, P249, DOI 10.1111/imm.12004; Honer H, 2007, J IMMUNOL, V179, P337; Hsieh SC, 2008, RHEUMATOLOGY, V47, P150, DOI 10.1093/rheumatology/kem320; Hsieh SC, 2003, CLIN EXP IMMUNOL, V131, P506, DOI 10.1046/j.1365-2249.2003.02084.x; Hudrisier D, 2005, EUR J IMMUNOL, V35, P2284, DOI 10.1002/eji.200526266; Iking-Konert C, 2001, KIDNEY INT, V60, P2247, DOI 10.1046/j.1523-1755.2001.00068.x; Iking-Konert C, 2005, ANN RHEUM DIS, V64, P1436, DOI 10.1136/ard.2004.034132; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; KUDO C, 1993, J IMMUNOL, V150, P3728; KUDO C, 1993, J IMMUNOL, V150, P3739; Li KJ, 2006, J LEUKOCYTE BIOL, V80, P350, DOI 10.1189/jlb.1105668; LLOYD AR, 1992, IMMUNOL TODAY, V13, P169, DOI 10.1016/0167-5699(92)90121-M; Masuda S, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/345745; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Poupot M, 2003, J IMMUNOL, V171, P2517, DOI 10.4049/jimmunol.171.5.2517; Radsak M, 2000, IMMUNOLOGY, V101, P521, DOI 10.1046/j.1365-2567.2000.00140.x; Rechavi O, 2009, FEBS LETT, V583, P1792, DOI 10.1016/j.febslet.2009.03.014; Rossi EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098315; Rossi EA, 2013, BLOOD, V122, P3020, DOI 10.1182/blood-2012-12-473744; Saba S, 2002, AM J RESP CELL MOL, V27, P561, DOI 10.1165/rcmb.2002-0019OC; SHALABY MR, 1985, J IMMUNOL, V135, P2069; Siao SC, 2011, MOLECULES, V16, P2119, DOI 10.3390/molecules16032119; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Tabiasco J, 2002, EUR J IMMUNOL, V32, P1502, DOI 10.1002/1521-4141(200205)32:5<1502::AID-IMMU1502>3.0.CO;2-Y; TAMURA M, 1994, J IMMUNOL, V153, P1301; TANAKA E, 1993, INT J CANCER, V54, P131, DOI 10.1002/ijc.2910540121; Thewissen M, 2011, MOL IMMUNOL, V48, P2094, DOI 10.1016/j.molimm.2011.07.006; Tomida T, 2015, J PHYSIOL SCI, V65, P37, DOI 10.1007/s12576-014-0332-9; Uddin M, 2010, THORAX, V65, P684, DOI 10.1136/thx.2009.120741; Wetzel SA, 2005, J IMMUNOL, V174, P80, DOI 10.4049/jimmunol.174.1.80; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yu CL, 1998, IMMUNOLOGY, V95, P480; Zhang HG, 2001, ARTHRITIS RHEUM-US, V44, P1555, DOI 10.1002/1529-0131(200107)44:7<1555::AID-ART279>3.0.CO;2-M	51	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156262	10.1371/journal.pone.0156262	http://dx.doi.org/10.1371/journal.pone.0156262			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258015	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700049
J	Haramura, T; Takeuchi, H; Crossland, MR; Shine, R				Haramura, Takashi; Takeuchi, Hirohiko; Crossland, Michael R.; Shine, Richard			Biotic Resistance to an Alien Amphibian: Larval Competition between Japanese Frogs and Invasive Cane Toads	PLOS ONE			English	Article							BUFO-MARINUS; TADPOLES; INTERFERENCE; PREDATION	Understanding negative effects of native species on introduced taxa may suggest novel ways to control the invasive species by enhancing such effects. Previous studies have reported that the larvae of invasive cane toads (Rhinella marina) are suppressed by competition with the larvae of native anurans in Australia, but not in North America. We conducted laboratory trials to measure the effect of exposure to the larvae of Japanese frogs (Micro-hyla ornata, Fejervarya sakishimensis, Rhacophorus owstoni) on rates of survival, growth and development of cane toad tadpoles in Ishigaki Island, in southern Japan. Survival rates were not affected by native species, but competition with Dicroglossids and Rhacophorids (but not Microhylids) strongly reduced rates of growth and development in the tadpoles of cane toads. Dicroglossid tadpoles also reduced the body condition to toad tadpoles in addition to effects on SVL and mass. Encouraging populations of native frogs in toad-invaded areas of Japan thus may help to reduce the numbers of invasive cane toads.	[Haramura, Takashi] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan; [Haramura, Takashi; Takeuchi, Hirohiko] Kyoto Univ, Field Sci Educ & Res Ctr, Wakayama 6492211, Japan; [Crossland, Michael R.; Shine, Richard] Univ Sydney, Sch Life & Environm Sci A08, Sydney, NSW 2006, Australia	Kyoto University; Kyoto University; University of Sydney	Haramura, T (corresponding author), Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto 6068501, Japan.; Haramura, T (corresponding author), Kyoto Univ, Field Sci Educ & Res Ctr, Wakayama 6492211, Japan.	haramura.takashi.2n@kyoto-u.ac.jp	Crossland, Michael R/G-1091-2012	Crossland, Michael R/0000-0001-9967-7158	Hakubi Center, Kyoto University; Research and Technology Development Fund of the Ministry of the Environment, Japan [4FR-1402]; Australian Research Council	Hakubi Center, Kyoto University; Research and Technology Development Fund of the Ministry of the Environment, Japan; Australian Research Council(Australian Research Council)	This work was supported by an internal grant from The Hakubi Center, Kyoto University, the Environment Research and Technology Development Fund (4FR-1402) of the Ministry of the Environment, Japan, and the Australian Research Council.	Alford RA, 1999, TADPOLES, P240; Cabrera-Guzman E, 2013, FRESHWATER BIOL, V58, P2584, DOI 10.1111/fwb.12235; Cabrera-Guzman E, 2013, AUSTRAL ECOL, V38, P896, DOI 10.1111/aec.12029; Cabrera-Guzman E, 2011, J APPL ECOL, V48, P462, DOI 10.1111/j.1365-2664.2010.01933.x; Crossland MR, 2009, OECOLOGIA, V158, P625, DOI 10.1007/s00442-008-1167-y; Dumont CP, 2011, BIOL INVASIONS, V13, P2023, DOI 10.1007/s10530-011-0018-7; Gosner K. L., 1960, Herpetologica, V16, P183; GRIFFITHS RA, 1993, J ANIM ECOL, V62, P274, DOI 10.2307/5358; GRIFFITHS RA, 1991, J ANIM ECOL, V60, P1065, DOI 10.2307/5431; Klug T, 2008, B ENTOMOL RES, V98, P379, DOI 10.1017/S0007485308005695; LEVER C., 2001, CANE TOAD HIST ECOLO; MAEDA N, 1989, FROGS TOADS JAPAN; MORIN PJ, 1988, OIKOS, V53, P398, DOI 10.2307/3565542; Ota H, 1999, PROBLEM SNAKE MANAGEMENT, P439; Prober SM, 2009, BIOL INVASIONS, V11, P171, DOI 10.1007/s10530-008-9222-5; R Core Team, 2021, R LANGUAGE ENV STAT; Richter-Boix A, 2007, AMPHIBIA-REPTILIA, V28, P247, DOI 10.1163/156853807780202549; Simberloff D, 1996, ECOLOGY, V77, P1965, DOI 10.2307/2265693; Simberloff D, 1996, BIOL CONSERV, V78, P185, DOI 10.1016/0006-3207(96)00027-4; Smith KG, 2005, BIOL CONSERV, V123, P433, DOI 10.1016/j.biocon.2005.01.005; STEINWASCHER K, 1978, ECOLOGY, V59, P1039, DOI 10.2307/1938556; Ward-Fear G, 2010, BIOL J LINN SOC, V99, P738, DOI 10.1111/j.1095-8312.2010.01395.x; Werner EE, 1996, ECOLOGY, V77, P157, DOI 10.2307/2265664	23	1	1	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156396	10.1371/journal.pone.0156396	http://dx.doi.org/10.1371/journal.pone.0156396			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253973	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700024
J	Neophytou, AM; Noth, EM; Liu, S; Costello, S; Hammond, SK; Cullen, MR; Eisen, EA				Neophytou, Andreas M.; Noth, Elizabeth M.; Liu, Sa; Costello, Sadie; Hammond, S. Katharine; Cullen, Mark R.; Eisen, Ellen A.			Ischemic Heart Disease Incidence in Relation to Fine versus Total Particulate Matter Exposure in a US Aluminum Industry Cohort	PLOS ONE			English	Article							MARGINAL STRUCTURAL MODELS; AIR-POLLUTION; OCCUPATIONAL-EXPOSURE; ULTRAFINE PARTICLES; MORTALITY; ASSOCIATIONS; PM2.5	Ischemic heart disease (IHD) has been linked to exposures to airborne particles with an aerodynamic diameter < 2.5 mu m (PM2.5) in the ambient environment and in occupational settings. Routine industrial exposure monitoring, however, has traditionally focused on total particulate matter (TPM). To assess potential benefits of PM2.5 monitoring, we compared the exposure-response relationships between both PM2.5 and TPM and incidence of IHD in a cohort of active aluminum industry workers. To account for the presence of time varying confounding by health status we applied marginal structural Cox models in a cohort followed with medical claims data for IHD incidence from 1998 to 2012. Analyses were stratified by work process into smelters (n = 6,579) and fabrication (n = 7,432). Binary exposure was defined by the 10th-percentile cut-off from the respective TPM and PM2.5 exposure distributions for each work process. Hazard Ratios (HR) comparing always exposed above the exposure cut-off to always exposed below the cut-off were higher for PM2.5, with HRs of 1.70 (95% confidence interval (CI): 1.11-2.60) and 1.48 (95% CI: 1.02-2.13) in smelters and fabrication, respectively. For TPM, the HRs were 1.25 (95% CI: 0.89-1.77) and 1.25 (95% CI: 0.88-1.77) for smelters and fabrication respectively. Although TPM and PM2.5 were highly correlated in this work environment, results indicate that, consistent with biologic plausibility, PM2.5 is a stronger predictor of IHD risk than TPM. Cardiovascular risk management in the aluminum industry, and other similar work environments, could be better guided by exposure surveillance programs monitoring PM2.5.	[Neophytou, Andreas M.; Noth, Elizabeth M.; Liu, Sa; Costello, Sadie; Hammond, S. Katharine; Eisen, Ellen A.] Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Cullen, Mark R.] Stanford Univ, Div Gen Med Disciplines, Sch Med, Stanford, CA 94305 USA	University of California System; University of California Berkeley; Stanford University	Neophytou, AM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Environm Hlth Sci, Berkeley, CA 94720 USA.	aneophytou@berkeley.edu		cullen, mark/0000-0001-7996-1864	National Institutes of Health, Institute of Aging [R01AG026291-01]; Centers for Disease Control and Prevention, National Institute of Occupational Safety and Health [R01 OH009939-01]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH009939] Funding Source: NIH RePORTER	National Institutes of Health, Institute of Aging; Centers for Disease Control and Prevention, National Institute of Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was supported by the National Institutes of Health, Institute of Aging (grant R01AG026291-01) and the Centers for Disease Control and Prevention, National Institute of Occupational Safety and Health (grant R01 OH009939-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benke G, 1998, ANN OCCUP HYG, V42, P173, DOI 10.1093/annhyg/42.3.173; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brown DM, 2015, EPIDEMIOLOGY, V26, P806, DOI 10.1097/EDE.0000000000000329; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Costello S, 2014, J EXPO SCI ENV EPID, V24, P82, DOI 10.1038/jes.2013.47; Debia M, 2012, ENVIRON POLLUT, V1, P2; Delfino RJ, 2005, ENVIRON HEALTH PERSP, V113, P934, DOI 10.1289/ehp.7938; Dockery D W, 1993, N Engl J Med, V329, P1753, DOI 10.1056/NEJM199312093292401; Donoghue AM, 2011, AM J IND MED, V54, P224, DOI 10.1002/ajim.20925; Fang SC, 2010, INT J ENV RES PUB HE, V7, P1773, DOI 10.3390/ijerph7041773; Franck U, 2011, SCI TOTAL ENVIRON, V409, P4217, DOI 10.1016/j.scitotenv.2011.05.049; Hamad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126054; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hopke PK, 2008, ATMOS ENVIRON, V42, P3192, DOI 10.1016/j.atmosenv.2008.03.002; Kampstra P., 2008, J STAT SOFTW, V28, P1, DOI [10.18637/jss.v028.c01, DOI 10.18637/JSS.V028.C01]; Liu Sa, 2014, Environ Pollut (Tor), V3, P79; Magari SR, 2001, CIRCULATION, V104, P986, DOI 10.1161/hc3401.095038; Neophytou AM, 2014, AM J EPIDEMIOL, V180, P608, DOI 10.1093/aje/kwu175; Nieboer E, 2005, J ENVIRON MONITOR, V7, P412; Noth E, 2014, OCCUPATIONAL ENV S1, V71, pA14; Noth EM, 2014, J EXPO SCI ENV EPID, V24, P89, DOI 10.1038/jes.2013.53; Occupational Safety Health Association OSHA, 2012, CHEM SAMPL INF; Ostro B, 2015, ENVIRON HEALTH PERSP, V123, P549, DOI 10.1289/ehp.1408565; Peng RD, 2008, JAMA-J AM MED ASSOC, V299, P2172, DOI 10.1001/jama.299.18.2172; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; RONNEBERG A, 1995, OCCUP ENVIRON MED, V52, P250, DOI 10.1136/oem.52.4.250; Simkhovich BZ, 2008, J AM COLL CARDIOL, V52, P719, DOI 10.1016/j.jacc.2008.05.029; Stayner L, 2003, SCAND J WORK ENV HEA, V29, P317, DOI 10.5271/sjweh.737; Thomassen Y, 2006, J ENVIRON MONITOR, V8, P127, DOI [10.1039/b514939h, 10.1039/B514939H]; Toren K, 2007, OCCUP ENVIRON MED, V64, P515, DOI 10.1136/oem.2006.029488; United States Environmental Protection Agency (USEPA), 2012, NAT AMB AIR QUAL STA; Weichenthal S, 2012, ENVIRON RES, V115, P26, DOI 10.1016/j.envres.2012.03.001	34	13	13	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156613	10.1371/journal.pone.0156613	http://dx.doi.org/10.1371/journal.pone.0156613			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249060	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700059
J	Unterberg, M; Kreuzer, MJ; Schafer, ST; Bazzi, Z; Adamzik, M; Rump, K				Unterberg, Matthias; Kreuzer, Maxmiliane Julia; Schaefer, Simon Thomas; Bazzi, Zainab; Adamzik, Michael; Rump, Katharina			NFKB1 Promoter DNA from nt+402 to nt+99 Is Hypomethylated in Different Human Immune Cells	PLOS ONE			English	Article							INSERTION/DELETION ATTG POLYMORPHISM; GENE-EXPRESSION; METHYLATION; LIPOPOLYSACCHARIDE; RISK; ACTIVATION	Sepsis, with a persistently high 90-day mortality of about 46%, is the third most frequent cause of death in intensive care units worldwide. Further understanding of the inflammatory signaling pathways occurring in sepsis is important for new efficient treatment options. Key regulator of the inflammatory response is the transcription factor NF kappa B. As we have recently shown, the -94 Ins/Del NFKB1 promoter polymorphism influences sepsis mortality. However, a molecular explanation is still missing. Thus, promoter activity might be varying depending on the NFKB1 genotype, explaining the genotype dependent mortality from sepsis, and one likely mechanism is the degree of promoter methylation. Therefore, we tested the hypothesis that NF kappa B mRNA expression is regulated by promoter methylation in human cell lines and primary immune cell cultures. First, we examined the methylation of the NFKB1 promoter in U937, REH and HL-60 cells. In the promoter region of nt+99/+229 methylation in all analyzed cell lines was below 1%. Following incubation with bacterial cell wall components, no significant changes in the frequency of promoter methylation in U937 and REH cells were measured and the methylation frequency was under 1%. However, NF kappa B1 mRNA expression was two-fold increased in U937 cells after 24 h incubation with LPS. By contrast, demethylation by 5-Aza-2 '-deoxycytidine incubation enhanced NF kappa B1 expression significantly. In addition, we analyzed NFKB1 promoter methylation in primary cells from healthy volunteers depending on the NFKB1-94 Ins/Del genotype. Methylation in the promoter region from nt+402 to nt+99 was below 1%. Genotype dependent differences occurred in neutrophil cells, where DD-genotype was significantly more methylated compared to II genotype at nt+284/+402. Besides in the promoter region from nt-227/-8 in ID-genotypes methylation of neutrophils was significantly decreased compared to lymphocytes and in II-genotypes methylation in neutrophils was significantly decreased compared to lymphocytes and monocytes. In addition, CHART-PCR showed that the hypomethylated promoter regions are highly accessible. Therefore we assume that the demethylated regions are very important for NFKB1 promoter activity.	[Unterberg, Matthias; Kreuzer, Maxmiliane Julia; Bazzi, Zainab; Adamzik, Michael; Rump, Katharina] Ruhr Univ Bochum, Klin Anasthesiol Intens Med & Schmerztherapie, Univ Klinikum Knappschaftskrankenhaus Bochum Lang, Schornau 23-25, D-44892 Bochum, Germany; [Schaefer, Simon Thomas] Klinikum Univ Ludwig Maximilians Univ Munchen, Klin Anaesthesiol, Munich, Germany	Ruhr University Bochum; University of Munich	Unterberg, M (corresponding author), Ruhr Univ Bochum, Klin Anasthesiol Intens Med & Schmerztherapie, Univ Klinikum Knappschaftskrankenhaus Bochum Lang, Schornau 23-25, D-44892 Bochum, Germany.	Matthias.unterberg@kk-bochum.de	Rump, Katharina/AAJ-9090-2020; Schaefer, Simon Thomas/AAA-8869-2021; Adamzik, Michael/HGE-9286-2022	Rump, Katharina/0000-0003-2220-519X; Schaefer, Simon Thomas/0000-0001-7289-6000; Unterberg, Matthias/0000-0002-1500-1984	Ruhr-Univeritat Bochum [FoRUM: Az: F837N-2014]	Ruhr-Univeritat Bochum	The funding the authors received for this study was FoRUM: Az: F837N-2014 from the Ruhr-Univeritat Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamzik M, 2013, ANESTHESIOLOGY, V118, P123, DOI 10.1097/ALN.0b013e318277a652; Agrawal S, 2007, CANCER RES, V67, P1370, DOI 10.1158/0008-5472.CAN-06-1681; Bone RC, 2009, CHEST, V136, pe28; Chang GJ, 2015, VET J, V203, P339, DOI 10.1016/j.tvjl.2014.12.023; Eskandari-Nasab E, 2016, CANCER BIOMARK, V16, P109, DOI 10.3233/CBM-150546; Green BB, 2014, VET IMMUNOL IMMUNOP, V157, P49, DOI 10.1016/j.vetimm.2013.10.015; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Ibrahim-Zada I, 2014, J TRAUMA ACUTE CARE, V76, P8; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu ZJ, 2014, CLIN CANCER RES, V20, P4598, DOI 10.1158/1078-0432.CCR-13-3380; Mymryk JS, 1997, METHODS, V12, P105, DOI 10.1006/meth.1997.0452; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758; Poplutz MK, 2014, IMMUNOBIOLOGY, V219, P619, DOI 10.1016/j.imbio.2014.03.016; Rhee JW, 2007, J BIOCHEM MOL BIOL, V40, P88; Rump K, 2015, METHYLIERUNGSMUSTER, V56; Rump K, 2013, SHOCK; Sakamoto Y, 2014, BIOCH BIOPHYS RES CO; Schaefer ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104953; Schorr CA, 2014, VIRULENCE, V5, P190, DOI 10.4161/viru.27409; Shuto T, 2006, FASEB J, V20, P782, DOI 10.1096/fj.05-4934fje; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; Tan YH, 2015, J TRAUMA ACUTE CARE, V78, P784, DOI 10.1097/TA.0000000000000588; TEN RM, 1992, EMBO J, V11, P195, DOI 10.1002/j.1460-2075.1992.tb05042.x; Thomas RM, 2003, J IMMUNOL, V170, P218, DOI 10.4049/jimmunol.170.1.218; Weiterer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121748; Yin JY, 2016, TUMOR BIOL, V37, P5467, DOI 10.1007/s13277-015-4373-3; Zeschnigk M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh122; Zhang XQ, 2013, MOL MED REP, V7, P1417, DOI 10.3892/mmr.2013.1405	30	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156702	10.1371/journal.pone.0156702	http://dx.doi.org/10.1371/journal.pone.0156702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249028	Green Submitted, Green Published, gold			2022-12-26	WOS:000377184700069
J	Barbado, D; Lopez-Valenciano, A; Juan-Recio, C; Montero-Carretero, C; van Dieen, JH; Vera-Garcia, FJ				Barbado, David; Lopez-Valenciano, Alejandro; Juan-Recio, Casto; Montero-Carretero, Carlos; van Dieen, Jaap H.; Vera-Garcia, Francisco J.			Trunk Stability, Trunk Strength and Sport Performance Level in Judo	PLOS ONE			English	Article							PHYSIOLOGICAL PROFILES; BALANCE	Although trunk muscle function has been suggested to be a determinant of judo performance, its contribution to high-level performance in this sport has been poorly studied. Therefore, several tests were used to assess the differences in trunk muscle function between 11 international and 14 national level judo practitioners (judokas). Trunk strength and endurance were assessed using isokinetic tests and core stability was assessed using two protocols: 1) sudden loading, to assess trunk responses to unexpected external perturbations; 2) stable and unstable sitting, to assess the participants' ability to control trunk balance. No differences between groups were found for trunk flexor isokinetic strength, trunk responses against lateral and posterior loading and trunk control while sitting. However, international level judokas showed significantly higher trunk extensor isokinetic strength (p < 0.05) and lower trunk angular displacement after anterior trunk loading (p < 0.05) than national level judokas. Few and low (r < 0.512) significant correlations were found between strength, endurance and stability parameters, which suggests that trunk strength and endurance are not limiting factors for trunk stability in competitive judokas. These results support the importance of trunk extensor strength and trunk stability against forward perturbations in elite judo performance.	[Barbado, David; Lopez-Valenciano, Alejandro; Juan-Recio, Casto; Montero-Carretero, Carlos; Vera-Garcia, Francisco J.] Miguel Hernandez Univ, Sport Res Ctr, Elche, Spain; [van Dieen, Jaap H.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Universidad Miguel Hernandez de Elche; Vrije Universiteit Amsterdam	Vera-Garcia, FJ (corresponding author), Miguel Hernandez Univ, Sport Res Ctr, Elche, Spain.	fvera@umh.es	van Dieen, Jaap/B-3937-2013; Barbado, David/P-7436-2019; Lopez-Valenciano, Alejandro/AAD-1515-2021; JUAN-RECIO, CASTO/U-2167-2019; Montero, Carlos/P-6920-2019; Montero-Carretero, Carlos/ABI-6748-2020; Vera-Garcia, Francisco J/L-7755-2014	van Dieen, Jaap/0000-0002-7719-5585; Lopez-Valenciano, Alejandro/0000-0002-5443-5101; Montero, Carlos/0000-0002-1565-8169; Vera-Garcia, Francisco J/0000-0003-4792-8087	Ministerio de Ciencia e Innovacion, Spain [DEP2010-16493]; Conselleria de Educacion de la Generalitat Valenciana, Spain [ACOMP/2011/130]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleria de Educacion de la Generalitat Valenciana, Spain	This study was made possible by financial support from: Ministerio de Ciencia e Innovacion (Plan Nacional de I+D+I; Ref.: DEP2010-16493), Spain, Conselleria de Educacion de la Generalitat Valenciana (Ref.: ACOMP/2011/130), Spain.	Azevedo PHSM, 2007, J SPORT SCI MED, V6, P10; Barbado D, 2016, GAIT POSTUR IN PRESS; Ben Kibler W, 2006, SPORTS MED, V36, P189, DOI 10.2165/00007256-200636030-00001; Cholewicki J, 2000, J BIOMECH, V33, P1377, DOI 10.1016/S0021-9290(00)00118-4; Cort JA, 2013, J ELECTROMYOGR KINES, V23, P1334, DOI 10.1016/j.jelekin.2013.09.006; Franchini E, 2003, J SPORT MED PHYS FIT, V43, P424; Franchini E., 2000, HUMAN MOVEMENT, V2, P23; Franchini E, 2011, SPORTS MED, V41, P147, DOI 10.2165/11538580-000000000-00000; GRABINER M D, 1990, Journal of Orthopaedic and Sports Physical Therapy, V11, P590; HANCOCK GR, 1995, J MOTOR BEHAV, V27, P241, DOI 10.1080/00222895.1995.9941714; Heyward VH, 2010, ADV FITNESS ASSESSME, Vxiii; Imamura Rodney, 2003, Sports Biomech, V2, P191, DOI 10.1080/14763140308522817; Imamura RT, 2006, J SPORT SCI MED, V5, P122; Iwai K, 2008, J STRENGTH COND RES, V22, P350, DOI 10.1519/JSC.0b013e3181635d25; Juan-Recio C, 2016, J STRENGTH IN PRESS; KORT HD, 1992, J ORTHOP SPORT PHYS, V16, P92, DOI 10.2519/jospt.1992.16.2.92; Krstulovic S, 2006, COLLEGIUM ANTROPOL, V30, P845; LANGRANA NA, 1984, SPINE, V9, P287, DOI 10.1097/00007632-198404000-00011; Lech G, 2015, J HUM KINET, V45, P167, DOI 10.1515/hukin-2015-0017; Margnes E, 2011, IDO MOV CULT, V11, P42; MAYER T, 1995, SPINE, V20, P920, DOI 10.1097/00007632-199504150-00007; Perrin P, 2002, GAIT POSTURE, V15, P187, DOI 10.1016/S0966-6362(01)00149-7; Perrot C, 1998, J HUMAN MOVEMENT SCI, V35, P37; TAYLOR AW, 1981, J SPORT MED PHYS FIT, V21, P160; THOMAS SG, 1989, CAN J SPORT SCI, V14, P142; van Dieen JH, 2012, EUR J APPL PHYSIOL, V112, P1307, DOI 10.1007/s00421-011-2082-1; Watkins M P, 1983, Clin Sports Med, V2, P37; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Yoshitomi Sheylla Kyoko, 2006, Rev Bras Med Esporte, V12, P159, DOI 10.1590/S1517-86922006000300010	29	46	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156267	10.1371/journal.pone.0156267	http://dx.doi.org/10.1371/journal.pone.0156267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232602	Green Published, gold, Green Submitted			2022-12-26	WOS:000376883000016
J	Lee, JW; Soman, P; Park, JH; Chen, SC; Cho, DW				Lee, Jin Woo; Soman, Pranav; Park, Jeong Hun; Chen, Shaochen; Cho, Dong-Woo			A Tubular Biomaterial Construct Exhibiting a Negative Poisson's Ratio	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; VASCULAR GRAFTS; BIODEGRADABLE POLYMER; PULMONARY-ARTERY; AUXETIC BEHAVIOR; BLOOD-VESSEL; HOLY-GRAIL; IN-VITRO; GROWTH; MODEL	Developing functional small-diameter vascular grafts is an important objective in tissue engineering research. In this study, we address the problem of compliance mismatch by designing and developing a 3D tubular construct that has a negative Poisson's ratio v(xy) (NPR). NPR constructs have the unique ability to expand transversely when pulled axially, thereby resulting in a highly-compliant tubular construct. In this work, we used projection stereolithography to 3D-print a planar NPR sheet composed of photosensitive poly(ethylene) glycol diacrylate biomaterial. We used a step-lithography exposure and a stitch process to scale up the projection printing process, and used the cut-missing rib unit design to develop a centimeter-scale NPR sheet, which was rolled up to form a tubular construct. The constructs had Poisson's ratios of -0.6 <= -v(xy) <= -0.1. The NPR construct also supports higher cellular adhesion than does the construct that has positive v(xy). Our NPR design offers a significant advance in the development of highly-compliant vascular grafts.	[Lee, Jin Woo] Gachon Univ, Sch Med, Dept Mol Med, 7-45 Songdo Dong, Inchon 406840, South Korea; [Soman, Pranav] Syracuse Univ, Dept Biomed & Chem Engn, 318 Browne Hall, Syracuse, NY 13244 USA; [Park, Jeong Hun; Cho, Dong-Woo] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, San 31, Pohang 790781, Gyeongbuk, South Korea; [Chen, Shaochen] Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr,Atkinson Hall,MC-0448, La Jolla, CA 92093 USA	Gachon University; Syracuse University; Pohang University of Science & Technology (POSTECH); University of California System; University of California San Diego	Cho, DW (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, San 31, Pohang 790781, Gyeongbuk, South Korea.; Chen, SC (corresponding author), Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr,Atkinson Hall,MC-0448, La Jolla, CA 92093 USA.	chen168@eng.ucsd.edu; dwcho@postech.ac.kr			National Institutes of Health [EB012597, EB017876]; National Research Foundation of Korea (NRF) [2014R1A1A2A16054777, 2010-0018294]; Korea Health Industry Development Institute (KHIDI) [HI14C3228]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB017876, R01EB012597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by the National Institutes of Health (EB012597 and EB017876, http://www.nih.gov/) to SC; National Research Foundation of Korea (NRF)(2014R1A1A2A16054777, http://www.nrf.re.kr/) to JWL; National Research Foundation of Korea (NRF) (2010-0018294, http://www.nrf.re.kr/) to D-WC; Korea Health Industry Development Institute (KHIDI) (HI14C3228, http://www.khidi.or.kr/) to JWL.; We greatly appreciate the financial support from National Institutes of Health (EB012597 and EB017876) to S.C, National Research Foundation (NRF) of Korea (No. 2014R1A1A2A16054777 & No. 2010-0018294) and the Korea Health Industry Development Institute (KHIDI) (HI14C3228). And We also appreciate the donation of human turbinate mesenchymal stromal cells from Prof. Sung-Won Kim (Seoul Saint Mary Hospital).	Association AH, 2003, BIOST FACTSH CARD PR; Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208; BASSIOUNY HS, 1992, J VASC SURG, V15, P708, DOI 10.1016/0741-5214(92)90019-5; Buckmann T, 2012, ADV MATER, V24, P2710, DOI 10.1002/adma.201200584; CANHAM PB, 1991, CONNECT TISSUE RES, V26, P121, DOI 10.3109/03008209109152168; Chaouat M, 2006, BIOMATERIALS, V27, P5546, DOI 10.1016/j.biomaterials.2006.06.032; Conte MS, 1998, FASEB J, V12, P43, DOI 10.1096/fasebj.12.1.43; COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602; Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Eisenstadt MM, 1971, INTRO MECH PROPERTIE; EVANS KE, 1991, NATURE, V353, P124, DOI 10.1038/353124a0; Fozdar DY, 2011, ADV FUNCT MATER, V21, P2712, DOI 10.1002/adfm.201002022; Fozdar DY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/21/215303; Fung YC, 1993, BIOMECHANICS MECH PR, DOI [10.1007/978-1-4757-2257-4_8, DOI 10.1038/NCOMMS7205]; Gaspar N, 2005, ACTA MATER, V53, P2439, DOI 10.1016/j.actamat.2005.02.006; Gibson L. J., 1997, CELLULAR SOLIDS STRU, P510, DOI [10.1017/CBO9781139878326, DOI 10.1017/CBO9781139878326]; GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P25, DOI 10.1098/rspa.1982.0087; GLAGOV S, 1979, ARTERY, V5, P295; Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4; Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0; Huynh T, 1999, NAT BIOTECHNOL, V17, P1083, DOI 10.1038/15062; Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84; Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026; Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006; Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595; Kurane A, 2007, BIOMATERIALS, V28, P2830, DOI 10.1016/j.biomaterials.2007.02.031; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; Masters IG, 1996, COMPOS STRUCT, V35, P403, DOI 10.1016/S0263-8223(96)00054-2; Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5; Ounpuu S, 2000, EUR HEART J, V21, P880, DOI 10.1053/euhj.1999.1880; Perler BA, 1995, J VASC INTERV RADIOL, V6, pS111, DOI 10.1016/S1051-0443(95)71259-3; Popov E.P., 1990, ENG MECH SOLID, V1st ed., P82; Rashid ST, 2004, BIOMATERIALS, V25, P1627, DOI 10.1016/S0142-9612(03)00522-2; Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X; SANDUSKY GE, 1992, AM J PATHOL, V140, P317; Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717; Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3; Smith CW, 2000, ACTA MATER, V48, P4349, DOI 10.1016/S1359-6454(00)00269-X; Soletti L, 2011, J BIOMED MATER RES A, V96A, P436, DOI 10.1002/jbm.a.32997; Pranav S, 2012, BIOMATERIALS, V33, P7064, DOI 10.1016/j.biomaterials.2012.06.012; Soman P, 2012, ACTA BIOMATER, V8, P2587, DOI 10.1016/j.actbio.2012.03.035; Soman P, 2012, SOFT MATTER, V8, P4946, DOI 10.1039/c2sm07354d; Sung HW, 1997, ARTIF ORGANS, V21, P50; Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1053/ejvs.2002.1654; Timmins LH, 2010, AM J PHYSIOL-HEART C, V298, pH1537, DOI 10.1152/ajpheart.00891.2009; VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P; Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5; Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481; WOLINSKY H, 1964, CIRC RES, V14, P400, DOI 10.1161/01.RES.14.5.400; Zund G, 1998, EUR J CARDIO-THORAC, V13, P160, DOI 10.1016/S1010-7940(97)00309-6	51	27	27	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155681	10.1371/journal.pone.0155681	http://dx.doi.org/10.1371/journal.pone.0155681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232181	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000005
J	Li, X; Acuff, NV; Peeks, AR; Kirkland, R; Wyatt, KD; Nagy, T; Watford, WT				Li, Xin; Acuff, Nicole V.; Peeks, Angela R.; Kirkland, Rebecca; Wyatt, Kara D.; Nagy, Tamas; Watford, Wendy T.			Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; NF-KAPPA-B; KINASE; INDUCTION; RECEPTOR; CTLA-4; DIFFERENTIATION; MACROPHAGES; THETA; ERK	The serine/threonine kinase tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF alpha, IL-1 beta, and IFN gamma. We previously demonstrated that Tpl2 regulates T cell receptor (TCR) signaling and modulates T helper cell differentiation. However, very little is known about how Tpl2 modulates the development of regulatory T cells (Tregs). Tregs are a specialized subset of T cells that express FoxP3 and possess immunosuppressive properties to limit excess inflammation. Because of the documented role of Tpl2 in promoting inflammation, we hypothesized that Tpl2 antagonizes Treg development and immunosuppressive function. Here we demonstrate that Tpl2 constrains the development of inducible Tregs. Tpl2(-/-) naive CD4(+) T cells preferentially develop into FoxP3(+) inducible Tregs in vitro as well as in vivo in a murine model of ovalbumin (OVA)-induced systemic tolerance. Treg biasing of Tpl2(-/-) T cells depended on TCR signal strength and corresponded with reduced activation of the mammalian target of rapamycin (mTOR) pathway. Importantly, Tpl2(-/-) Tregs have basally increased expression of FoxP3 and immunosuppressive molecules, IL-10 and cytotoxic T lymphocyte-associated protein 4 (CTLA-4). Furthermore, they were more immunosuppressive in vivo in a T cell transfer model of colitis, as evidenced by reduced effector T cell accumulation, systemic production of inflammatory cytokines, and colonic inflammation. These results demonstrate that Tpl2 promotes inflammation in part by constraining FoxP3 expression and Treg immunosuppressive functions. Overall, these findings suggest that Tpl2 inhibition could be used to preferentially drive Treg induction and thereby limit inflammation in a variety of autoimmune diseases.	[Li, Xin; Acuff, Nicole V.; Peeks, Angela R.; Kirkland, Rebecca; Wyatt, Kara D.; Watford, Wendy T.] Univ Georgia, Dept Infect Dis, 501 DW Brooks Dr, Athens, GA 30602 USA; [Nagy, Tamas] Univ Georgia, Dept Pathol, 501 DW Brooks Dr, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Watford, WT (corresponding author), Univ Georgia, Dept Infect Dis, 501 DW Brooks Dr, Athens, GA 30602 USA.	watfordw@uga.edu	Li, Xin V./ABA-4321-2021; Li, Xin/AAH-2983-2019	Li, Xin V./0000-0002-9444-8214; Watford, Wendy/0000-0003-4261-5399; Wyatt, Kara/0000-0002-3957-1818	NIAID, National Institutes of Health [R01AI099058]; American Association of Immunologists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099058] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Association of Immunologists; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Award R01AI099058 (to W. T. W.). This study was also supported by American Association of Immunologists Careers in Immunology fellowships (to X. L. and W. T. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Belkaid Y, 2008, IMMUNITY, V29, P362, DOI 10.1016/j.immuni.2008.08.005; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bilate AM, 2012, ANNU REV IMMUNOL, V30, P733, DOI 10.1146/annurev-immunol-020711-075043; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bluestone JA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad4134; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Gabrysova L, 2011, EUR J IMMUNOL, V41, P1242, DOI 10.1002/eji.201041073; Gantke T, 2011, CELL RES, V21, P131, DOI 10.1038/cr.2010.173; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Guo JT, 2014, J BIOL CHEM, V289, P35139, DOI 10.1074/jbc.M114.589192; Gupta S, 2008, MOL IMMUNOL, V46, P213, DOI 10.1016/j.molimm.2008.08.275; Hall JP, 2007, J BIOL CHEM, V282, P33295, DOI 10.1074/jbc.M703694200; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Liu HP, 2013, EUR J IMMUNOL, V43, P1716, DOI 10.1002/eji.201242889; Lopez-Pelaez M, 2011, EUR J IMMUNOL, V41, P1733, DOI 10.1002/eji.201041101; Ma J, 2012, J IMMUNOL, V188, P5337, DOI 10.4049/jimmunol.1102979; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Min B, 2005, J IMMUNOL, V174, P6039, DOI 10.4049/jimmunol.174.10.6039; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moss RB, 2004, EXPERT OPIN BIOL TH, V4, P1887, DOI 10.1517/14712598.4.12.1887; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Rowley SM, 2014, J BIOL CHEM, V289, P15788, DOI 10.1074/jbc.M114.559344; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Serebrennikova OB, 2012, P NATL ACAD SCI USA, V109, pE1082, DOI 10.1073/pnas.1115098109; Sojka DK, 2009, EUR J IMMUNOL, V39, P1544, DOI 10.1002/eji.200838603; Sriskantharajah S, 2014, J IMMUNOL, V192, P3518, DOI 10.4049/jimmunol.1300172; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang QZ, 2012, CURR OPIN ORGAN TRAN, V17, P349, DOI 10.1097/MOT.0b013e328355a992; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Thorstenson KM, 2001, J IMMUNOL, V167, P188, DOI 10.4049/jimmunol.167.1.188; Tsatsanis C, 2008, P NATL ACAD SCI USA, V105, P2987, DOI 10.1073/pnas.0708381104; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; Verhagen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108023; Watford WT, 2010, J IMMUNOL, V184, P105, DOI 10.4049/jimmunol.0803730; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xing Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006957; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zheng SG, 2006, J IMMUNOL, V176, P3321, DOI 10.4049/jimmunol.176.6.3321	64	9	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16802	16815		10.1074/jbc.M116.718783	http://dx.doi.org/10.1074/jbc.M116.718783			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27261457	Green Published, hybrid			2022-12-26	WOS:000380826700036
J	Martinez-Redondo, V; Jannig, PR; Correia, JC; Ferreira, DMS; Cervenka, I; Lindvall, JM; Sinha, I; Izadi, M; Pettersson-Klein, AT; Agudelo, LZ; Gimenez-Cassina, A; Brum, PC; Dahlman-Wright, K; Ruas, JL				Martinez-Redondo, Vicente; Jannig, Paulo R.; Correia, Jorge C.; Ferreira, Duarte M. S.; Cervenka, Igor; Lindvall, Jessica M.; Sinha, Indranil; Izadi, Manizheh; Pettersson-Klein, Amanda T.; Agudelo, Leandro Z.; Gimenez-Cassina, Alfredo; Brum, Patricia C.; Dahlman-Wright, Karin; Ruas, Jorge L.			Peroxisome Proliferator-activated Receptor gamma Coactivator-1 alpha Isoforms Selectively Regulate Multiple Splicing Events on Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR; PGC-1-ALPHA; PROTEIN; EXPRESSION; ANGIOGENESIS; INHIBITION; COMPLEX; GROWTH; NDRG4	Endurance and resistance exercise training induces specific and profound changes in the skeletal muscle transcriptome. Peroxisome proliferator-activated receptor gamma coactivator-1 a (PGC-1 alpha) coactivators are not only among the genes differentially induced by distinct training methods, but they also participate in the ensuing signaling cascades that allow skeletal muscle to adapt to each type of exercise. Although endurance training preferentially induces PGC-lal expression, resistance exercise activates the expression of PGC-1 alpha 2, -alpha 3, and -alpha 4. These three alternative PGC-la isoforms lack the arginine/serine-rich (RS) and RNA recognition motifs characteristic of PGC-lal. Discrete functions for PGC-lal and -alpha 4 have been described, but the biological role of PGC-1 alpha 2 and -a3 remains elusive. Here we show that different PGC-1 alpha variants can affect target gene splicing through diverse mechanisms, including alternative promoter usage. By analyzing the exon structure of the target transcripts for each PGC-la isoform, we were able to identify a large number of previously unknown PGC-1 alpha 2 and -a3 target genes and pathways in skeletal muscle. In particular, PGC-1a2 seems to mediate a decrease in the levels of cholesterol synthesis genes. Our results suggest that the conservation of the N-terminal activation and repression domains (and not the RS/RNA recognition motif) is what determines the gene programs and splicing options modulated by each PGC-la isoform. By using skeletal muscle-specific transgenic mice for PGC-lal and -alpha 4, we could validate, in vivo, splicing events observed in in vitro studies. These results show that alternative PGC-la variants can affect target gene expression both quantitatively and qualitatively and identify novel biological pathways under the control of this system of coactivators.	[Martinez-Redondo, Vicente; Jannig, Paulo R.; Correia, Jorge C.; Ferreira, Duarte M. S.; Cervenka, Igor; Izadi, Manizheh; Pettersson-Klein, Amanda T.; Agudelo, Leandro Z.; Ruas, Jorge L.] Karolinska Inst, Dept Physiol & Pharmacol, Mol & Cellular Exercise Physiol Unit, SE-17177 Stockholm, Sweden; [Gimenez-Cassina, Alfredo] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Jannig, Paulo R.; Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, BR-05508030 Sao Paulo, Brazil; [Lindvall, Jessica M.; Sinha, Indranil; Dahlman-Wright, Karin] Karolinska Inst, Dept Biosci & Nutr, Novum, SE-14183 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet; Universidade de Sao Paulo; Karolinska Institutet	Ruas, JL (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Mol & Cellular Exercise Physiol Unit, SE-17177 Stockholm, Sweden.	Jorge.Ruas@ki.se	Gimenez-Cassina, Alfredo/AAA-6550-2019; Jannig, Paulo Roberto/E-9482-2013; Brum, Patricia C/E-6605-2011; Ferreira, Duarte M Sacramento/E-4270-2012; Ruas, Jorge/AAE-6094-2019	Jannig, Paulo Roberto/0000-0002-2569-4091; Brum, Patricia C/0000-0002-4750-6506; Ferreira, Duarte M Sacramento/0000-0001-5940-7102; Ruas, Jorge/0000-0002-1110-2606; Correia, Jorge/0000-0002-6377-9053; Sinha, Indranil/0000-0002-2513-5927; Klein, Amanda/0000-0003-3998-920X; Lindvall, Jessica/0000-0002-5042-8481; Gimenez-Cassina, Alfredo/0000-0002-2768-2350	Swedish Research Council; Strategic Research Programme in Diabetes at Karolinska Institutet; Novo Nordisk Foundation (Denmark); Swedish Diabetes Foundation; Malin and Lennart Phiipson Foundation; Wenner-Gren Foundations (Sweden); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil); Svenska Sallskapet for Medicinsk Forskning (Sweden); Novo Nordisk Fonden [NNF12OC1016062] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Strategic Research Programme in Diabetes at Karolinska Institutet; Novo Nordisk Foundation (Denmark)(Novo Nordisk Foundation); Swedish Diabetes Foundation; Malin and Lennart Phiipson Foundation; Wenner-Gren Foundations (Sweden); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Svenska Sallskapet for Medicinsk Forskning (Sweden); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the Swedish Research Council, the Strategic Research Programme in Diabetes at Karolinska Institutet, the Novo Nordisk Foundation (Denmark), the Swedish Diabetes Foundation, and the Malin and Lennart Phiipson Foundation (to J. L. R). The authors declare that they have no conflicts of interest with the contents of this article.r Supported in part by a postdoctoral fellowship from the Wenner-Gren Foundations (Sweden).r Recipient of a Fundacao de Amparo a Pesquisa do Estado de Sao Paulo fellowship (Brazil).r Supported in part by Svenska Sallskapet for Medicinsk Forskning (Sweden).	Auboeuf D, 2004, P NATL ACAD SCI USA, V101, P2270, DOI 10.1073/pnas.0308133100; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Chang JS, 2012, J BIOL CHEM, V287, P9100, DOI 10.1074/jbc.M111.320200; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Cohen TV, 2015, J PHYSIOL-LONDON, V593, P2479, DOI 10.1113/JP270201; Correia JC, 2015, TRENDS ENDOCRIN MET, V26, P305, DOI 10.1016/j.tem.2015.03.010; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Du C, 2014, J LIPID RES, V55, P1886, DOI 10.1194/jlr.M047555; Du L, 1997, J CELL BIOL, V136, P5, DOI 10.1083/jcb.136.1.5; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Gellert P, 2009, BIOINFORMATICS, V25, P3323, DOI 10.1093/bioinformatics/btp577; Guo YH, 2013, J BIOL CHEM, V288, P4625, DOI 10.1074/jbc.M112.407452; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Johansson M, 2003, MOL BIOL CELL, V14, P903, DOI 10.1091/mbc.E02-08-0459; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kotipatruni RP, 2012, INTEGR BIOL-UK, V4, P1185, DOI 10.1039/c2ib20168b; Lee S, 2012, EXP CELL RES, V318, P2128, DOI 10.1016/j.yexcr.2012.06.012; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lockstone HE, 2011, BRIEF BIOINFORM, V12, P634, DOI 10.1093/bib/bbq086; Martinez-Redondo V, 2015, DIABETOLOGIA, V58, P1969, DOI 10.1007/s00125-015-3671-z; Megeney LA, 1996, DEV GENET, V19, P139, DOI 10.1002/(SICI)1520-6408(1996)19:2<139::AID-DVG5>3.0.CO;2-A; Minsky N, 2015, P NATL ACAD SCI USA, V112, pE5669, DOI 10.1073/pnas.1516219112; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Muscat GEO, 2002, J BIOL CHEM, V277, P40722, DOI 10.1074/jbc.M206681200; Nader GA, 2014, J APPL PHYSIOL, V116, P693, DOI 10.1152/japplphysiol.01366.2013; Nakada N, 2002, DEV BRAIN RES, V135, P45, DOI 10.1016/S0165-3806(02)00303-6; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qu XH, 2002, MOL CELL BIOCHEM, V229, P35, DOI 10.1023/A:1017934810825; Qu XH, 2008, DEV BIOL, V317, P486, DOI 10.1016/j.ydbio.2008.02.044; Roberts TC, 2015, HUM MOL GENET, V24, P6756, DOI 10.1093/hmg/ddv381; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Ryu S, 2006, CELL CYCLE, V5, P1140, DOI 10.4161/cc.5.11.2779; Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200; Silvennoinen M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12563; Tadaishi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028290; Thijssen-Timmer DC, 2006, J MOL ENDOCRINOL, V37, P251, DOI 10.1677/jme.1.01914; Thom R, 2014, J BIOL CHEM, V289, P8810, DOI 10.1074/jbc.M114.554394; Tian LJ, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0210-z; Trapani L, 2012, J CELL BIOCHEM, V113, P2057, DOI 10.1002/jcb.24077; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Trausch-Azar JS, 2015, J CELL PHYSIOL, V230, P842, DOI 10.1002/jcp.24812; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wen XY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/402175; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	47	48	50	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					15169	15184		10.1074/jbc.M115.705822	http://dx.doi.org/10.1074/jbc.M115.705822			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27231350	hybrid, Green Published			2022-12-26	WOS:000380583200026
J	Chylikova, B; Hrdlicka, I; Vesela, K; Rezabek, K; Liska, F				Chylikova, Blanka; Hrdlicka, Ivan; Vesela, Kamila; Rezabek, Karel; Liska, Frantisek			Recurrent Microdeletions at Xq27.3-Xq28 and Male Infertility: A Study in the Czech Population	PLOS ONE			English	Article								Background Genetic causes of male infertility are hypothesized to involve multiple types of mutations, from single gene defects to complex chromosome rearrangements. Recently, several recurrent X-chromosome microdeletions (located in subtelomeric region of the long arm) were reported to be associated with male infertility in Spanish and Italian males. The aim of our study was to test their prevalence and infertility association in population of men from the Czech Republic. Methods 107 males with pathological sperm evaluation resulting in nonobstructive infertility were compared to 131 males with normal fecundity. X-chromosome microdeletions were assessed by +/- PCR with three primer pairs for each region Xcnv64 (Xq27.3), Xcnv67 (Xq28) and Xcnv69 (Xq28). The latter microdeletion was further characterized by amplification across the deleted region, dividing the deletion into three types; A, B and C. Results We detected presence of isolated Xcnv64 deletion in 3 patients and 14 controls, and Xcnv69 in 3 patients and 6 controls (1 and 1 patient vs. 4 and 1 control for types A and B respectively). There was one control with combined Xcnv64 and Xcnv69 type B deletions, and one patient with combination of Xcnv64 and Xcnv69 type C deletions. The frequency of the deletions was thus not higher in patient compared to control group, Xcnv64 was marginally associated with controls (adjusted Fisher's exact test P = 0.043), Xcnv69 was not associated (P = 0.452). We excluded presence of more extensive rearrangements in two subjects with combined Xcnv64 and Xcnv69 deletions. There was no Xcnv67 deletion in our cohort. Conclusion In conclusion, the two previously reported X-linked microdeletions (Xcnv64 and Xcnv69) do not seem to confer a significant risk to impaired spermatogenesis in the Czech population. The potential clinical role of the previously reported patient-specific Xcnv67 remains to be determined in a larger study population.	[Chylikova, Blanka; Hrdlicka, Ivan; Vesela, Kamila; Liska, Frantisek] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Chylikova, Blanka; Hrdlicka, Ivan; Vesela, Kamila; Rezabek, Karel; Liska, Frantisek] Gen Univ Hosp, Prague, Czech Republic; [Rezabek, Karel] Charles Univ Prague, Fac Med 1, Clin Gynecol & Obstet, Ctr Assisted Reprod, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague	Liska, F (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic.; Liska, F (corresponding author), Gen Univ Hosp, Prague, Czech Republic.	frantisek.liska@lf1.cuni.cz	Liska, Frantisek/N-9192-2017; Chylikova, Blanka/D-2976-2017; Vesela, Kamila/L-2254-2017	Liska, Frantisek/0000-0002-9588-806X; Chylikova, Blanka/0000-0002-3439-1850; Vesela, Kamila/0000-0003-0270-3845	Ministry of Health of the Czech Republic [NT12269-5]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by Ministry of Health of the Czech Republic (www.mzcr.cz) grant No. NT12269-5 to FL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0032-1; Bablok L, 2011, NEUROENDOCRINOL LETT, V32, P799; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Choe JH, 2015, UROLOGY, V86, P1123, DOI 10.1016/j.urology.2015.08.014; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Foresta C, 2001, ENDOCR REV, V22, P226, DOI 10.1210/er.22.2.226; Gudeman SR, 2015, J UROLOGY, V193, P1318, DOI 10.1016/j.juro.2014.10.048; Hotaling J, 2014, ANDROLOGY-US, V2, P339, DOI 10.1111/j.2047-2927.2014.00200.x; Hotaling JM, 2014, UROL CLIN N AM, V41, P1, DOI 10.1016/j.ucl.2013.08.009; Krausz C, 2014, CURR OPIN ENDOCRINOL, V21, P244, DOI 10.1097/MED.0000000000000058; Lo Giacco D, 2014, J MED GENET, V51, P340, DOI 10.1136/jmedgenet-2013-101988; Massart A, 2012, ASIAN J ANDROL, V14, P40, DOI 10.1038/aja.2011.67; O'Brien KLO, 2010, FERTIL STERIL, V93, P1, DOI 10.1016/j.fertnstert.2009.10.045; VanAssche E, 1996, HUM REPROD, V11, P1, DOI 10.1093/humrep/11.suppl_4.1; Vincent MC, 2002, J ANDROL, V23, P18, DOI 10.1002/j.1939-4640.2002.tb02597.x	16	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156102	10.1371/journal.pone.0156102	http://dx.doi.org/10.1371/journal.pone.0156102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257673	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700035
J	Junqueira, DM; de Medeiros, RM; Graf, T; Almeida, SED				Junqueira, Dennis Maletich; de Medeiros, Rubia Marilla; Graf, Tiago; de Matos Almeida, Sabrina Esteves			Short-Term Dynamic and Local Epidemiological Trends in the South American HIV-1B Epidemic	PLOS ONE			English	Article							RIO-DE-JANEIRO; SUBTYPE-B; TRANSMISSION NETWORKS; DRUG-RESISTANCE; PHYLOGENETIC ANALYSIS; POPULATION; TYPE-1; TOOL; PREVALENCE; CLUSTERS	The human displacement and sexual behavior are the main factors driving the HIV-1 pandemic to the current profile. The intrinsic structure of the HIV transmission among different individuals has valuable importance for the understanding of the epidemic and for the public health response. The aim of this study was to characterize the HIV-1 subtype B (HIV-1B) epidemic in South America through the identification of transmission links and infer trends about geographical patterns and median time of transmission between individuals. Sequences of the protease and reverse transcriptase coding regions from 4,810 individuals were selected from GenBank. Maximum likelihood phylogenies were inferred and submitted to ClusterPicker to identify transmission links. Bayesian analyses were applied only for clusters including >= 5 dated samples in order to estimate the median maximum inter-transmission interval. This study analyzed sequences sampled from 12 South American countries, from individuals of different exposure categories, under different antiretroviral profiles, and from a wide period of time (1989-2013). Continentally, Brazil, Argentina and Venezuela were revealed important sites for the spread of HIV-1B among countries inside South America. Of note, from all the clusters identified about 70% of the HIV-1B infections are primarily occurring among individuals living in the same geographic region. In addition, these transmissions seem to occur early after the infection of an individual, taking in average 2.39 years (95% CI 1.48-3.30) to succeed. Homosexual/Bisexual individuals transmit the virus as quickly as almost half time of that estimated for the general population sampled here. Public health services can be broadly benefitted from this kind of information whether to focus on specific programs of response to the epidemic whether as guiding of prevention campaigns to specific risk groups.	[Junqueira, Dennis Maletich] Ctr Univ Ritter Reis Uniritter, Dept Ciencias Saude, Porto Alegre, RS, Brazil; [Junqueira, Dennis Maletich; de Medeiros, Rubia Marilla; de Matos Almeida, Sabrina Esteves] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Junqueira, Dennis Maletich; de Medeiros, Rubia Marilla; Graf, Tiago; de Matos Almeida, Sabrina Esteves] FEPPS, CDCT, Porto Alegre, RS, Brazil; [Graf, Tiago] Univ Fed Santa Catarina, Programa Posgrad Biotecnol & Biociencias, Florianopolis, SC, Brazil; [de Matos Almeida, Sabrina Esteves] Univ FEEVALE, Inst Ciencias Saude, Novo Hamburgo, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal de Santa Catarina (UFSC); Universidade Feevale	Junqueira, DM (corresponding author), Ctr Univ Ritter Reis Uniritter, Dept Ciencias Saude, Porto Alegre, RS, Brazil.; Junqueira, DM (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.; Junqueira, DM (corresponding author), FEPPS, CDCT, Porto Alegre, RS, Brazil.	dennismaletich@hotmail.com	Gräf, Tiago/S-8535-2019; de Medeiros, Rúbia M/L-2761-2015; Junqueira, Dennis/ABC-4378-2021	Gräf, Tiago/0000-0003-4921-7975; de Medeiros, Rúbia M/0000-0001-7403-5650; Esteves De Matos Almeida, Sabrina/0000-0003-3599-8520; Junqueira, Dennis/0000-0003-1576-484X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	DMJ, TG, and RMM were funded by a fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SEM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-306; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Audelin AM, 2013, JAIDS-J ACQ IMM DEF, V62, P102, DOI 10.1097/QAI.0b013e318276becc; Bello G, 2006, AIDS, V20, P763, DOI 10.1097/01.aids.0000216377.84313.52; Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Beyrer C, 2014, CURR OPIN HIV AIDS, V9, P95, DOI 10.1097/COH.0000000000000043; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Bezemer D, 2014, AIDS RES HUM RETROV, V30, P118, DOI [10.1089/aid.2013.0171, 10.1089/AID.2013.0171]; Biesinger Tasha, 2008, Virology (Auckl), V2008, P49; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2013, JAIDS-J ACQ IMM DEF, V63, pS248, DOI 10.1097/QAI.0b013e3182986f96; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Chalmet K, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-262; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ever-Silva WA, 2006, JAIDS-J ACQ IMM DEF, V41, P664, DOI 10.1097/01.qai.0000194736.66322.02; Eyer-Silva WA, 2007, MEM I OSWALDO CRUZ, V102, P809, DOI 10.1590/S0074-02762007005000112; Eyer-Silva WA, 2007, AIDS RES HUM RETROV, V23, P303, DOI 10.1089/aid.2006.0199; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Frost SDW, 2015, J INFECT DIS, V211, P856, DOI 10.1093/infdis/jiu563; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Hallett TB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001569; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Jia Yujiang, 2014, Biomed Res Int, V2014, P497543, DOI 10.1155/2014/497543; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Junqueira DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027489; Kaye M, 2008, JAIDS-J ACQ IMM DEF, V49, P9, DOI 10.1097/QAI.0b013e318180c8af; Lemey P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003932; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mehta SR, 2010, AIDS RES HUM RETROV, V26, P1273, DOI 10.1089/aid.2010.0021; Miller M.A., 2010, P GAT COMP ENV WORKS; Mir D, 2015, AIDS, V29, P1863, DOI 10.1097/QAD.0000000000000770; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pennings PS, 2014, J INFECT DIS, V209, P180, DOI 10.1093/infdis/jit525; Pond SLK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000581; Poon AFY, 2015, J INFECT DIS, V211, P926, DOI 10.1093/infdis/jiu560; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Ragonnet-Cronin M, 2010, JAIDS-J ACQ IMM DEF, V55, P102, DOI 10.1097/QAI.0b013e3181e8c7b0; Rambaut A., 2007, TRACER V1 4; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; Sinha S, 2012, CURR HIV RES, V10, P532, DOI 10.2174/157016212802429785; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; UNAIDS, 2013, REP GLOB AIDS EP; van de Vijver DAMC, 2010, PANNONICA ADRIAT, V19, P3; Varella RB, 2008, BRAZ J INFECT DIS, V12, P380, DOI 10.1590/S1413-86702008000500007; Volz EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001568; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524; World Health Organization (WHO), 2012, HIV DRUG RES REP; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	57	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156712	10.1371/journal.pone.0156712	http://dx.doi.org/10.1371/journal.pone.0156712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258369	gold, Green Submitted, Green Published			2022-12-26	WOS:000377369700111
J	Reynolds, LK; DuBois, K; Abbott, JM; Williams, SL; Stachowicz, JJ				Reynolds, Laura K.; DuBois, Katherine; Abbott, Jessica M.; Williams, Susan L.; Stachowicz, John J.			Response of a Habitat-Forming Marine Plant to a Simulated Warming Event Is Delayed, Genotype Specific, and Varies with Phenology	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; CLIMATE-CHANGE; ENVIRONMENTAL VARIATION; PHENOTYPIC PLASTICITY; DIVERSITY; TEMPERATURE; SEAGRASSES; ECOSYSTEM; PHOTOSYNTHESIS; HERBIVORE	Growing evidence shows that increasing global temperature causes population declines and latitudinal shifts in geographical distribution for plants living near their thermal limits. Yet, even populations living well within established thermal limits of a species may suffer as the frequency and intensity of warming events increase with climate change. Adaptive response to this stress at the population level depends on the presence of genetic variation in thermal tolerance in the populations in question, yet few data exist to evaluate this. In this study, we examined the immediate effects of a moderate warming event of 4.5 degrees C lasting 5 weeks and the legacy effects after a 5 week recovery on different genotypes of the marine plant Zostera marina (eelgrass). We conducted the experiment in Bodega Bay, CA USA, where average summer water temperatures are 14-15 degrees C, but extended warming periods of 17-18 degrees C occur episodically. Experimental warming increased shoot production by 14% compared to controls held at ambient temperature. However, after returning temperature to ambient levels, we found strongly negative, delayed effects of warming on production: shoot production declined by 27% and total biomass decreased by 50% relative to individuals that had not been warmed. While all genotypes' production decreased in the recovery phase, genotypes that grew the most rapidly under benign thermal conditions (control) were the most susceptible to the detrimental effects of warming. This suggests a potential trade-off in relative performance at normal vs. elevated temperatures. Modest short-term increases in water temperature have potentially prolonged negative effects within the species' thermal envelope, but genetic variation within these populations may allow for population persistence and adaptation. Further, intraspecific variation in phenology can result in maintenance of population diversity and lead to enhanced production in diverse stands given sufficient frequency of warming or other stress events.	[Reynolds, Laura K.; DuBois, Katherine; Abbott, Jessica M.; Williams, Susan L.; Stachowicz, John J.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [DuBois, Katherine; Williams, Susan L.] Univ Calif Davis, Bodega Marine Lab, Bodega Bay, CA 94923 USA	University of California System; University of California Davis; University of California System; University of California Davis	Reynolds, LK (corresponding author), Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA.	lkreynolds@ucdavis.edu		Reynolds, Laura K/0000-0002-4498-4641	National Science Foundation [OCE 12-1234345]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by the National Science Foundation (OCE 12-1234345 to JJS and SLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott J, 2015, THESIS U CALIFORNIA; Abe M, 2008, FISHERIES SCI, V74, P1017, DOI 10.1111/j.1444-2906.2008.01619.x; Albert CH, 2010, FUNCT ECOL, V24, P1192, DOI 10.1111/j.1365-2435.2010.01727.x; [Anonymous], 1980, HDB SEAGRASS BIOL EC; AUCLAIR AND, 1993, WATER AIR SOIL POLL, V66, P207; Becheler R, 2014, HEREDITY, V112, P114, DOI 10.1038/hdy.2013.82; Beer S, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P183, DOI 10.1016/B978-044450891-1/50010-4; Bergmann N, 2010, MOL ECOL, V19, P2870, DOI 10.1111/j.1365-294X.2010.04731.x; BIEBL R, 1971, MAR BIOL, V8, P48, DOI 10.1007/BF00349344; Bracken MES, 2013, ECOLOGY, V94, P1944, DOI 10.1890/12-2182.1; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; Crutsinger GM, 2008, OECOLOGIA, V158, P65, DOI 10.1007/s00442-008-1130-y; Cummings ME, 2003, AQUAT BOT, V75, P261, DOI 10.1016/S0304-3770(02)00180-8; Durako MJ, 2007, AQUAT BOT, V87, P83, DOI 10.1016/j.aquabot.2007.03.005; Durako MJ, 2002, AQUAT BOT, V73, P173, DOI 10.1016/S0304-3770(02)00020-7; EVANS AS, 1986, AQUAT BOT, V24, P185, DOI 10.1016/0304-3770(86)90095-1; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Franssen SU, 2011, P NATL ACAD SCI USA, V108, P19276, DOI 10.1073/pnas.1107680108; Fridley JD, 2007, J ECOL, V95, P908, DOI 10.1111/j.1365-2745.2007.01256.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Green E.P., 2003, WORLD ATLAS SEAGRASS; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI [10.1017/CBO9780511525551, DOI 10.1017/CBO9780511525551]; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HOPKINSON CS, 1984, ECOLOGY, V65, P961, DOI 10.2307/1938068; Hughes AR, 2011, J ECOL, V99, P445, DOI 10.1111/j.1365-2745.2010.01767.x; Hughes AR, 2009, ECOLOGY, V90, P1412, DOI 10.1890/07-2030.1; Hughes AR, 2009, OECOLOGIA, V159, P725, DOI 10.1007/s00442-008-1251-3; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Johnson MTJ, 2008, J ECOL, V96, P947, DOI 10.1111/j.1365-2745.2008.01410.x; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; Kamel SJ, 2012, MAR ECOL PROG SER, V447, P127, DOI 10.3354/meps09447; Kelly MW, 2013, GLOBAL CHANGE BIOL, V19, P2536, DOI 10.1111/gcb.12251; Kelly MW, 2012, P ROY SOC B-BIOL SCI, V279, P349, DOI 10.1098/rspb.2011.0542; Kettenring KM, 2014, J APPL ECOL, V51, P339, DOI 10.1111/1365-2664.12202; Kramer K, 2000, INT J BIOMETEOROL, V44, P67, DOI 10.1007/s004840000066; Lankau RA, 2007, SCIENCE, V317, P1561, DOI 10.1126/science.1147455; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; MARSH JA, 1986, J EXP MAR BIOL ECOL, V101, P257, DOI 10.1016/0022-0981(86)90267-4; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Moore KA, 2012, MAR ECOL PROG SER, V448, P247, DOI 10.3354/meps09578; Moore KA, 2008, J COASTAL RES, P135, DOI 10.2112/SI55-014; Naeem S, 2003, ECOL LETT, V6, P567, DOI 10.1046/j.1461-0248.2003.00471.x; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; ORTH RJ, 1986, AQUAT BOT, V24, P335, DOI 10.1016/0304-3770(86)90100-2; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; PENHALE PA, 1977, J EXP MAR BIOL ECOL, V26, P211, DOI 10.1016/0022-0981(77)90109-5; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; PLATT T, 1980, J MAR RES, V38, P687; QUIRING DT, 1994, ECOL ENTOMOL, V19, P230, DOI 10.1111/j.1365-2311.1994.tb00414.x; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ralph PJ, 1999, BOT MAR, V42, P11, DOI 10.1515/BOT.1999.003; Reed TE, 2011, CONSERV BIOL, V25, P56, DOI 10.1111/j.1523-1739.2010.01552.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Reusch TBH, 2014, EVOL APPL, V7, P104, DOI 10.1111/eva.12109; Reynolds LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038397; Romero J, 2007, MAR POLLUT BULL, V55, P196, DOI 10.1016/j.marpolbul.2006.08.032; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Salo T, 2015, MAR ECOL PROG SER, V519, P129, DOI 10.3354/meps11083; Sanford E, 1999, SCIENCE, V283, P2095, DOI 10.1126/science.283.5410.2095; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; SCHMITT J, 1986, EVOLUTION, V40, P830, DOI 10.1111/j.1558-5646.1986.tb00542.x; Sorte CJB, 2011, MAR ECOL PROG SER, V435, P63, DOI 10.3354/meps09234; Stiling P, 1996, ECOLOGY, V77, P2212, DOI 10.2307/2265714; Tani T, 2003, ECOL RES, V18, P15, DOI 10.1046/j.1440-1703.2003.00530.x; Taylor RB, 2003, OECOLOGIA, V136, P412, DOI 10.1007/s00442-003-1280-x; Terrados J, 1997, MAR ECOL PROG SER, V149, P267, DOI 10.3354/meps149267; Thomas RL, 2014, URBAN ECOSYST, V17, P911, DOI 10.1007/s11252-014-0360-5; TISSUE DT, 1991, PLANT CELL ENVIRON, V14, P407, DOI 10.1111/j.1365-3040.1991.tb00950.x; Tomas F, 2011, ECOLOGY, V92, P1807, DOI 10.1890/10-2095.1; Vermaat JE, 1996, AQUAT BOT, V52, P259, DOI 10.1016/0304-3770(95)00510-2; Walther GR, 2004, PERSPECT PLANT ECOL, V6, P169, DOI 10.1078/1433-8319-00076; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Williams R, 2013, ICES J MAR SCI, V70, P1273, DOI 10.1093/icesjms/fst059; Winters G, 2011, MAR ECOL PROG SER, V435, P83, DOI 10.3354/meps09213	78	30	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0154532	10.1371/journal.pone.0154532	http://dx.doi.org/10.1371/journal.pone.0154532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258011	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700009
J	Samuelsen, SV; Maity, A; Nybo, M; Macaubas, C; Lonstrup, L; Balboni, IM; Mellins, ED; Astakhova, K				Samuelsen, Simone V.; Maity, Arindam; Nybo, Mads; Macaubas, Claudia; Lonstrup, Lars; Balboni, Imelda M.; Mellins, Elizabeth D.; Astakhova, Kira			Novel Phospholipid-Protein Conjugates Allow Improved Detection of Antibodies in Patients with Autoimmune Diseases	PLOS ONE			English	Article							BINDING PLASMA-PROTEINS; ANTIPHOSPHOLIPID SYNDROME; LUPUS; AUTOANTIBODIES; PATHOGENESIS; THROMBOSIS; GENETICS; PROFILE	Reliable measurement of clinically relevant autoimmune antibodies toward phospholipid-protein conjugates is highly desirable in research and clinical assays. To date, the development in this field has been limited to the use of natural heterogeneous antigens. However, this approach does not take structural features of biologically active antigens into account and leads to low reliability and poor scientific test value. Here we describe novel phospholipid- protein conjugates for specific detection of human autoimmune antibodies. Our synthetic approach includes mild oxidation of synthetic phospholipid cardiolipin, and as the last step, coupling of the product with azide-containing linker and copper-catalyzed click chemistry with beta 2-glycoprotein I and prothrombin. To prove utility of the product antigens, we used enzyme-linked immunosorbent assay and three cohorts of samples obtained from patients in Denmark (n = 34) and the USA (n = 27 and n = 14). Afterwards we analyzed correlation of the obtained autoantibody titers with clinical parameters for each patient. Our results prove that using novel antigens clinically relevant autoantibodies can be detected with high repeatability, sensitivity and specificity. Unlike previously used antigens the obtained autoantibody titers strongly correlate with high disease activity and in particular, with arthritis, renal involvement, anti-Smith antibodies and high lymphocyte count. Importantly, chemical composition of antigens has a strong influence on the correlation of detected autoantibodies with disease activity and manifestations. This confirms the crucial importance of antigens' composition on research and diagnostic assays, and opens up exciting perspectives for synthetic antigens in future studies of autoimmunity.	[Samuelsen, Simone V.; Maity, Arindam; Astakhova, Kira] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense, Denmark; [Nybo, Mads] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Macaubas, Claudia; Balboni, Imelda M.; Mellins, Elizabeth D.] Stanford Univ, Dept Pediat, Program Immunol, Stanford, CA 94305 USA; [Lonstrup, Lars] Univ Southern Denmark, Dept Business & Econ, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Stanford University; University of Southern Denmark	Astakhova, K (corresponding author), Univ Southern Denmark, Dept Phys Chem & Pharm, Odense, Denmark.	ias@sdu.dk	Nybo, Mads/J-6040-2019; Lonstrup, Lars/AAP-3138-2020; Maity, Arindam/AAQ-4943-2020; Astakhova, Kira/D-1432-2014	Nybo, Mads/0000-0002-3029-2855; Lonstrup, Lars/0000-0002-8343-9291; Maity, Arindam/0000-0002-9418-6963; Astakhova, Kira/0000-0003-4878-0301; Mellins, Elizabeth/0000-0003-2577-139X	Villum Foundation [73516]; Augustinus Foundation [95-305-73070]	Villum Foundation(Villum Fonden); Augustinus Foundation	This study was supported by research funding from Villum Foundation (Grant. No. 73516) and Augustinus Foundation (Grant. No. 95-305-73070). URL: veluxfoundations.dk/. This grant covered expenses for the preparation of this manuscript. URL: http://www.augustinusfonden.dk/. This grant covered expenses of reagents for the preparation and testing of new complexes.	Alves JD, 2003, RHEUMATOLOGY, V42, P893, DOI 10.1093/rheumatology/keg248; [Anonymous], DRUG IND LUP ERYTH; Arroyo-Avila M, 2015, CLIN RHEUMATOL, V34, P1217, DOI 10.1007/s10067-015-2941-y; Bertolaccini Maria Laura, 2004, Clin Lab, V50, P653; Ceccarelli F, 2015, AUTOIMMUN REV, V14, P601, DOI 10.1016/j.autrev.2015.02.008; Cohen J.E., 1988, STAT POWER ANAL BEHA; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; de Laat HB, 2004, BLOOD, V104, P3598, DOI 10.1182/blood-2004-03-1107; Feldborg LN, 2012, BIOCONJUGATE CHEM, V23, P2444, DOI 10.1021/bc3005057; Flesher DLT, 2010, EXPERT REV CLIN IMMU, V6, P461, DOI [10.1586/ECI.10.8, 10.1586/eci.10.8]; Garay RP, 2012, EXPERT OPIN DRUG DEL, V9, P1319, DOI 10.1517/17425247.2012.720969; Gonnet-Gracia C, 2008, CLIN EXP RHEUMATOL, V26, P401; Grossman JM, 2009, BEST PRACT RES CL RH, V23, P495, DOI 10.1016/j.berh.2009.04.003; Hollenbach JA, 2015, J AUTOIMMUN, V64, P13, DOI 10.1016/j.jaut.2015.06.010; KWEE IL, 1988, MAGNET RESON MED, V6, P296, DOI 10.1002/mrm.1910060307; Borba HHL, 2014, BIODRUGS, V28, P211, DOI 10.1007/s40259-013-0074-x; Macmillan H, 2014, J IMMUNOL, V193, P2641, DOI 10.4049/jimmunol.1400075; Maity A, 2015, MOLECULES, V20, P10253, DOI 10.3390/molecules200610253; Mao ZF, 2014, NEUROL RES, V36, P1106, DOI 10.1179/1743132814Y.0000000400; Marion TN, 2014, SEMIN IMMUNOPATHOL, V36, P495, DOI 10.1007/s00281-014-0440-x; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Milne K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-33; MINASSIAN AA, 1988, P NATL ACAD SCI USA, V85, P6939, DOI 10.1073/pnas.85.18.6939; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Pengo V, 1996, THROMB HAEMOSTASIS, V75, P721; Pengo V, 2014, SEMIN THROMB HEMOST, V40, P860, DOI 10.1055/s-0034-1395158; Pericleous C, 2014, METHODS MOL BIOL, V1134, P221, DOI 10.1007/978-1-4939-0326-9_17; Pierangeli SS, 2008, SEMIN THROMB HEMOST, V34, P236, DOI 10.1055/s-0028-1082267; Pierangeli SS, 2008, NAT PROTOC, V3, P840, DOI 10.1038/nprot.2008.48; Reverberi Roberto, 2007, Blood Transfus, V5, P227, DOI 10.2450/2007.0047-07; Riedhammer C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00322; ROUBEY RAS, 1994, BLOOD, V84, P2854; Sacks JJ, 2002, MMWR-MORBID MORTAL W, V51, P371; Schmidheiny K, 2014, SHORT GUIDE MICROECO; Sfikakis PP, 2010, CURR DIR AUTOIMMUN, V11, P180, DOI 10.1159/000289205; Sheng YH, 1996, J IMMUNOL, V157, P3744; Stephenson FH, 2010, CALCULATIONS FOR MOLECULAR BIOLOGY AND BIOTECHNOLOGY: A GUIDE TO MATHEMATICS IN THE LABORATORY, 2ND EDITION, P1; Su DL, 2014, CLIN RHEUMATOL, V33, P1025, DOI 10.1007/s10067-014-2560-z; Testi R, 1996, TRENDS BIOCHEM SCI, V21, P468, DOI 10.1016/S0968-0004(96)10056-6; Tron GC, 2008, MED RES REV, V28, P278, DOI 10.1002/med.20107; Wolfe F., 2009, KELLEYS TXB RHEUMATO, P569; Zieve GW, 2003, AUTOIMMUN REV, V2, P235, DOI 10.1016/S1568-9972(03)00018-1	42	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156125	10.1371/journal.pone.0156125	http://dx.doi.org/10.1371/journal.pone.0156125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257889	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700037
J	Sun, X; Qian, HN				Sun, Xin; Qian, Huinan			Chinese Herbal Medicine Image Recognition and Retrieval by Convolutional Neural Network	PLOS ONE			English	Article								Chinese herbal medicine image recognition and retrieval have great potential of practical applications. Several previous studies have focused on the recognition with hand-crafted image features, but there are two limitations in them. Firstly, most of these hand-crafted features are low-level image representation, which is easily affected by noise and background. Secondly, the medicine images are very clean without any backgrounds, which makes it difficult to use in practical applications. Therefore, designing high-level image representation for recognition and retrieval in real world medicine images is facing a great challenge. Inspired by the recent progress of deep learning in computer vision, we realize that deep learning methods may provide robust medicine image representation. In this paper, we propose to use the Convolutional Neural Network (CNN) for Chinese herbal medicine image recognition and retrieval. For the recognition problem, we use the softmax loss to optimize the recognition network; then for the retrieval problem, we fine-tune the recognition network by adding a triplet loss to search for the most similar medicine images. To evaluate our method, we construct a public database of herbal medicine images with cluttered back-grounds, which has in total 5523 images with 95 popular Chinese medicine categories. Experimental results show that our method can achieve the average recognition precision of 71% and the average retrieval precision of 53% over all the 95 medicine categories, which are quite promising given the fact that the real world images have multiple pieces of occluded herbal and cluttered backgrounds. Besides, our proposed method achieves the state-of-the-art performance by improving previous studies with a large margin.	[Sun, Xin; Qian, Huinan] Beijing Univ Chinese Med, Acad Basic Med Sci, Beijing, Peoples R China; [Sun, Xin; Qian, Huinan] 11 Beisanhuan East Rd, Beijing, Peoples R China	Beijing University of Chinese Medicine	Qian, HN (corresponding author), Beijing Univ Chinese Med, Acad Basic Med Sci, Beijing, Peoples R China.; Qian, HN (corresponding author), 11 Beisanhuan East Rd, Beijing, Peoples R China.	huinan.qian@gmail.com			Natural Science Foundation of China [30171188]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is supported by the Natural Science Foundation of China (Grant No. 30171188). The funders provide the data and GPU computer servers.	Abdel-Hakim A. E., 2006, COMPUTER VISION PATT; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chatfield K, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.76; Chen X., 2013, INT C COMP VIS; Cinbis R. G., 2014, COMPUTER VISION PATT; Dalal N.B.T., 2005, COMPUTER VISION PATT; Girshick R., 2014, P IEEE C COMP VIS PA, P23; He K., 2014, ARXIV150201852; Huang J, 2015, ARXIV150507922; Huang Y., 2011, COMPUTER VISION PATT; Ke Y., 2004, COMPUTER VISION PATT; Krizhevsky A., 2012, NEURAL INFORM POCESS; Laiy H., 2014, ARXIV150403410; Le Cun Y., 1989, NEURIPS, V2, P396, DOI DOI 10.1111/DSU.12130; Lecun Y., 1995, HDB BRAIN THEORY NEU, DOI DOI 10.1109/IJCNN.2004.1381049; LeCun Y, 2010, IEEE INT SYMP CIRC S, P253, DOI 10.1109/ISCAS.2010.5537907; Lee H., 2007, NEURAL INFORM POCESS; Li Z. F., 2013, THESIS; Lin K., 2015, COMP VIS PATT REC WO; Lin Y., 2011, INT C COMP VIS; Liu L., 2011, INT C COMP VIS; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Ma L., 2011, COMPUTER ENG APPL; Mikolajczyk K., 2003, COMPUTER VISION PATT; Morioka N., 2011, INT C COMP VIS; Ng J. Yue-Hei, 2015, COMPUTER VISION PATT; Shabou A., 2012, COMPUTER VISION PATT; Simonyan Karen, ICLR 2015; Szegedy C., 2015, P CVPR BOST MA US 7, P1, DOI DOI 10.1109/CVPR.2015.7298594; Tao O., 2011, WORLD SCI TECHNOLOGY; Tao O., 2014, WORLD SCI TECHNOLOGY; Wan J., 2015, INT C MULT; Wang C, 2014, LECT NOTES COMPUT SC, V8694, P431, DOI 10.1007/978-3-319-10599-4_28; Wang J., 2014, HASHING SIMILARITY S; Wang J., 2010, COMPUTER VISION PATT; Yang J.C., 2010, COMPUTER VISION PATT; Yang TT, 2014, THESIS; Yao F., 2011, GUIDE CHINESE MED; Yue- Hei J., 2015, COMP VIS PATT REC WO; Zhai G., 2011, J LANZHOU POLYTECHNI; Zhang J., 2011, COMPUTER VISION PATT; Zhao F., 2015, COMPUTER VISION PATT	42	9	9	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156327	10.1371/journal.pone.0156327	http://dx.doi.org/10.1371/journal.pone.0156327			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258404	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700054
J	Takaishi, M; Tarutani, M; Takeda, J; Sano, S				Takaishi, Mikiro; Tarutani, Masahito; Takeda, Junji; Sano, Shigetoshi			Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer Cells	PLOS ONE			English	Article							REPRESSES E-CADHERIN; BREAST-CANCER; GASTROINTESTINAL CANCER; MOLECULAR-MECHANISMS; CARCINOMA METASTASIS; STEM-CELLS; PLURIPOTENCY; GENERATION; EXPRESSION; INVASION	Epithelial to mesenchymal transition (EMT) is a biological process of metastatic cancer. However, an effective anticancer therapy that directly targets the EMT program has not yet been discovered. Recent studies have indicated that mesenchymal to epithelial transition (MET), the reverse phenomenon of EMT, is observed in fibroblasts during the generation of induced pluripotent stem cells. In the present study, we investigated the effects of reprogramming factors (RFs) on squamous cell carcinoma (SCC) cells. RFs-introduced cancer cells (RICs) demonstrated the enhanced epithelial characteristics in morphology with altered expression of mRNA and microRNAs. The motility and invasive activities of RICs in vitro were significantly reduced. Furthermore, xenografts of RICs exhibited no lymph node metastasis, whereas metastasis was detected in parental SCC-inoculated mice. Thus, we concluded that RICs regained epithelial properties through MET and showed reduced cancer malignancy in vitro and in vivo. Therefore, the understanding of the MET process in cancer cells by introduction of RFs may lead to the designing of a novel anticancer strategy.	[Takaishi, Mikiro; Tarutani, Masahito; Sano, Shigetoshi] Kochi Univ, Kochi Med Sch, Dept Dermatol, Nankoku, Kochi, Japan; [Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka, Japan	Kochi University; Osaka University	Sano, S (corresponding author), Kochi Univ, Kochi Med Sch, Dept Dermatol, Nankoku, Kochi, Japan.	sano.derma@kochi-u.ac.jp			Japanese Ministry of Education, Science, Sports and Culture	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	M. Takaishi was supported by The Japanese Ministry of Education, Science, Sports and Culture (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Benaich N, 2014, CELL REP, V9, P104, DOI 10.1016/j.celrep.2014.08.062; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bruegger C, 2013, EXP DERMATOL, V22, P426, DOI 10.1111/exd.12153; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; Cheung KJ, 2016, P NATL ACAD SCI USA, V113, pE854, DOI 10.1073/pnas.1508541113; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Diaz-Lopez A, 2014, CANCER MANAG RES, V6, P205, DOI 10.2147/CMAR.S38156; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hajra KM, 2002, CANCER RES, V62, P1613; Hayashi E, 1995, ORAL ONCOL, V31B, P323, DOI 10.1016/0964-1955(95)00038-0; Hezova R, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0280-6; Igawa K, 2014, STEM CELL TRANSL MED, V3, P992, DOI 10.5966/sctm.2013-0179; Jamali Z, 2015, ORAL ONCOL, V51, P321, DOI 10.1016/j.oraloncology.2015.01.008; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lamouille S, 2013, CURR OPIN CELL BIOL, V25, P200, DOI 10.1016/j.ceb.2013.01.008; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Maekawa K, 2002, CLIN EXP METASTAS, V19, P513, DOI 10.1023/A:1020329411957; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Muller M, 2016, STEM CELL RES, V16, P349, DOI 10.1016/j.scr.2016.02.005; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Orang AV, 2014, ASIAN PAC J CANCER P, V15, P577, DOI 10.7314/APJCP.2014.15.2.577; Papp B, 2011, CELL RES, V21, P486, DOI 10.1038/cr.2011.28; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Severino P, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0102-4; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; TADOKORO K, 1989, ONCOGENE, V4, P499; Takahashi K, 2015, DEVELOPMENT, V142, P3274, DOI 10.1242/dev.114249; Tian LL, 2014, TUMOR BIOL, V35, P5953, DOI 10.1007/s13277-014-1790-7; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Wang H, 2015, CANCER CELL, V27, P193, DOI 10.1016/j.ccell.2014.11.017; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Yokoyama K, 2001, ORAL ONCOL, V37, P65, DOI 10.1016/S1368-8375(00)00059-2; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhang X, 2013, ONCOGENE, V32, P2249, DOI 10.1038/onc.2012.237; Zheng H, 2014, ONCOGENE, V33, P1755, DOI 10.1038/onc.2013.128	47	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156904	10.1371/journal.pone.0156904	http://dx.doi.org/10.1371/journal.pone.0156904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258152	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700152
J	Xie, W; Li, L; Zhang, M; Cheng, HP; Gong, D; Lv, YC; Yao, F; He, PP; Ouyang, XP; Lan, G; Liu, D; Zhao, ZW; Tan, YL; Zheng, XL; Yin, WD; Tang, CK				Xie, Wei; Li, Liang; Zhang, Min; Cheng, Hai-Peng; Gong, Duo; Lv, Yun-Cheng; Yao, Feng; He, Ping-Ping; Ouyang, Xin-Ping; Lan, Gang; Liu, Dan; Zhao, Zhen-Wang; Tan, Yu-Lin; Zheng, Xi-Long; Yin, Wei-Dong; Tang, Chao-Ke			MicroRNA-27 Prevents Atherosclerosis by Suppressing Lipoprotein Lipase-Induced Lipid Accumulation and Inflammatory Response in Apolipoprotein E Knockout Mice	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINE SECRETION; APOE-DEFICIENT MICE; AORTIC ATHEROSCLEROSIS; THP-1 MACROPHAGES; ACCELERATES ATHEROSCLEROSIS; CORONARY-ARTERIES; CHOLESTEROL; EXPRESSION; METABOLISM; GENE	Atherosclerotic lesions are lipometabolic disorder characterized by chronic progressive inflammation in arterial walls. Previous studies have shown that macrophage-derived lipoprotein lipase (LPL) might be a key factor that promotes atherosclerosis by accelerating lipid accumulation and proinflammatory cytokine secretion. Increasing evidence indicates that microRNA-27 (miR-27) has beneficial effects on lipid metabolism and inflammatory response. However, it has not been fully understood whether miR-27 affects the expression of LPL and subsequent development of atherosclerosis in apolipoprotein E knockout (apoE KO) mice. To address these questions and its potential mechanisms, oxidized low-density lipoprotein (ox-LDL)-treated THP-1 macrophages were transfected with the miR-27 mimics/inhibitors and apoE KO mice fed high-fat diet were given a tail vein injection with miR-27 agomir/antagomir, followed by exploring the potential roles of miR-27. MiR-27 agomir significantly down-regulated LPL expression in aorta and peritoneal macrophages by western blot and real-time PCR analyses. We performed LPL activity assay in the culture media and found that miR-27 reduced LPL activity. ELISA showed that miR-27 reduced inflammatory response as analyzed in vitro and in vivo experiments. Our results showed that miR-27 had an inhibitory effect on the levels of lipid both in plasma and in peritoneal macrophages of apoE KO mice as examined by HPLC. Consistently, miR-27 suppressed the expression of scavenger receptors associated with lipid uptake in ox-LDL-treated THP-1 macrophages. In addition, transfection with LPL siRNA inhibited the miR-27 inhibitor-induced lipid accumulation and proinflammatory cytokines secretion in ox-LDL-treated THP-1 macrophages. Finally, systemic treatment revealed that miR-27 decreased aortic plaque size and lipid content in apoE KO mice. The present results provide evidence that a novel antiatherogenic role of miR-27 was closely related to reducing lipid accumulation and inflammatory response via downregulation of LPL gene expression, suggesting a potential strategy to the diagnosis and treatment of atherosclerosis.	[Xie, Wei; Li, Liang; Zhang, Min; Cheng, Hai-Peng; Gong, Duo; Yao, Feng; He, Ping-Ping; Ouyang, Xin-Ping; Lan, Gang; Liu, Dan; Zhao, Zhen-Wang; Tan, Yu-Lin; Yin, Wei-Dong; Tang, Chao-Ke] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Key Lab Atherosclerol Hunan Prov, Inst Cardiovasc Res,Med Res Ctr, Hengyang, Hunan, Peoples R China; [Xie, Wei; Lv, Yun-Cheng] Univ South China, Lab Clin Anat, Hengyang, Hunan, Peoples R China; [Li, Liang] Univ South China, Dept Pathophysiol, Hengyang, Hunan, Peoples R China; [Zheng, Xi-Long] Univ Calgary, Hlth Sci Ctr, Dept Biochem & Mol Biol, Libin Cardiovasc Inst Alberta,Cumming Sch Med, Hosp Dr NW, Calgary, AB, Canada	University of South China; University of South China; University of South China; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Yin, WD; Tang, CK (corresponding author), Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Key Lab Atherosclerol Hunan Prov, Inst Cardiovasc Res,Med Res Ctr, Hengyang, Hunan, Peoples R China.	wdy20042004@126.com; tangchaoke@qq.com		Zheng, Xi-Long/0000-0002-0889-1827	National Natural Sciences Foundation of China, China [81570408, 81270269, 81170278]	National Natural Sciences Foundation of China, China(National Natural Science Foundation of China (NSFC))	The authors gratefully acknowledge the financial supports from the National Natural Sciences Foundation of China (http://www.nsfc.gov.cn/) (81570408, 81270269, 81170278), China. The funders had a key role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azumi H, 2003, CARDIOVASC RES, V58, P647, DOI 10.1016/S0008-6363(03)00287-6; Babaev VR, 2014, J LIPID RES, V55, P2296, DOI 10.1194/jlr.M050633; Babaev VR, 1999, J CLIN INVEST, V103, P1697, DOI 10.1172/JCI6117; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beauchamp MC, 2002, J LIPID RES, V43, P215; Bodary PF, 2005, ARTERIOSCL THROM VAS, V25, P119, DOI 10.1161/01.ATV.0000173306.47722.ec; Boon RA, 2012, THROMB HAEMOSTASIS, V108, P616, DOI 10.1160/TH12-07-0491; Chen T, 2011, FEBS LETT, V585, P657, DOI 10.1016/j.febslet.2011.01.027; Chen WJ, 2012, ATHEROSCLEROSIS, V222, P314, DOI 10.1016/j.atherosclerosis.2012.01.020; Cheng Y, 2012, INFLAMMATION, V35, P1308, DOI 10.1007/s10753-012-9443-8; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Goedeke L, 2015, ATHEROSCLEROSIS, V243, P499, DOI 10.1016/j.atherosclerosis.2015.09.033; Goldberg IJ, 1996, J LIPID RES, V37, P693; He PP, 2014, BIOCHIMIE, V106, P81, DOI 10.1016/j.biochi.2014.08.003; Hosin AA, 2014, J VASC RES, V51, P338, DOI 10.1159/000368193; Ichikawa T, 2005, ATHEROSCLEROSIS, V179, P87, DOI 10.1016/j.atherosclerosis.2004.10.044; Kobayashi J., 2015, ANN CLIN BIOCH; Koike T, 2005, CARDIOVASC RES, V65, P524, DOI 10.1016/j.cardiores.2004.10.022; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Li TR, 2011, CLIN CHIM ACTA, V412, P66, DOI 10.1016/j.cca.2010.09.029; Lv YC, 2014, ATHEROSCLEROSIS, V236, P215, DOI 10.1016/j.atherosclerosis.2014.07.005; Moore KJ, 2013, J LIPID RES, V54, P1159, DOI 10.1194/jlr.E036954; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nazari-Jahantigh M, 2015, J MOL CELL CARDIOL, V89, P35, DOI 10.1016/j.yjmcc.2014.10.021; Pennings M, 2006, FEBS LETT, V580, P5588, DOI 10.1016/j.febslet.2006.08.022; Pirillo A, 2011, ATHEROSCLEROSIS, V214, P331, DOI 10.1016/j.atherosclerosis.2010.11.006; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Qiu GS, 2007, J LIPID RES, V48, P385, DOI 10.1194/jlr.M600304-JLR200; Rao XQ, 2014, CIRC RES, V115, P770, DOI 10.1161/CIRCRESAHA.115.304666; Shimada M, 1996, P NATL ACAD SCI USA, V93, P7242, DOI 10.1073/pnas.93.14.7242; Sun L, 2014, METABOLISM, V63, P272, DOI 10.1016/j.metabol.2013.10.004; Tabas I, 2004, CELL DEATH DIFFER, V11, pS12, DOI 10.1038/sj.cdd.4401444; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Takahashi M, 2013, J LIPID RES, V54, P1124, DOI 10.1194/jlr.M035568; Tian GP, 2014, BIOCHEM BIOPH RES CO, V443, P428, DOI 10.1016/j.bbrc.2013.11.109; Tian GP, 2012, BIOCHIMIE, V94, P2749, DOI 10.1016/j.biochi.2012.08.018; TSUTSUMI K, 1993, J CLIN INVEST, V92, P411, DOI 10.1172/JCI116582; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Vickers KC, 2013, HEPATOLOGY, V57, P533, DOI 10.1002/hep.25846; Voloshyna I, 2013, EXP BIOL MED, V238, P1192, DOI 10.1177/1535370213503262; Wang JY, 2007, ARTERIOSCL THROM VAS, V27, P197, DOI 10.1161/01.ATV.0000249683.80414.d9; Westerterp M, 2013, CIRC RES, V112, P1456, DOI 10.1161/CIRCRESAHA.113.301086; Wilson K, 2001, ARTERIOSCL THROM VAS, V21, P1809, DOI 10.1161/hq1101.097805; Yagyu H, 1999, J LIPID RES, V40, P1677; Yang HT, 2015, J CELL BIOCHEM, V116, P580, DOI 10.1002/jcb.25009; Zhang M, 2014, ATHEROSCLEROSIS, V234, P54, DOI 10.1016/j.atherosclerosis.2014.02.008; Zou B, 2015, EUR J NUTR, V54, P1333, DOI 10.1007/s00394-014-0814-9	48	56	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157085	10.1371/journal.pone.0157085	http://dx.doi.org/10.1371/journal.pone.0157085			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257686	gold, Green Submitted, Green Published			2022-12-26	WOS:000377369700175
J	Mosca, O; Lauriola, M; Carleton, RN				Mosca, Oriana; Lauriola, Marco; Carleton, R. Nicholas			Intolerance of Uncertainty: A Temporary Experimental Induction Procedure	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; CONSTRUCT-VALIDITY; NEGATIVE AFFECT; WORRY; MODEL; SCALE; MANIPULATION; METAANALYSIS; DECISIONS; VERSION	Background and Objectives Intolerance of uncertainty (IU) is a trans-diagnostic construct involved in anxiety and related disorders. Research focused on cross-sectional reporting, manipulating attitudes toward objective and impersonal events or on treatments designed to reduce IU in clinical populations. The current paper presents an experimental procedure for laboratory manipulations of IU and tests mediation hypotheses following the Intolerance of Uncertainty Model. Methods On pre-test, undergraduate volunteers (Study 1, n = 43; 68% women. Study 2, n = 169; 83.8% women) were asked to provide an idiosyncratic future negative life event. State-IU, Worry, Positive and Negative Affect were assessed after that a standardized procedure was used to identify event's potential negative consequences. The same variables were assessed on post-test, after that participants were asked to read-through increasing and decreasing IU statements. Results Temporary changes on IU were consistently reproduced in both studies. Participants receiving increasing IU instructions reported greater state-IU, Worry and Negative Affect than those receiving decreasing IU instructions. However, this latter condition was not different from a control one (Study 2). Both studies revealed significant indirect effects of IU induction instructions on Worry and Negative Affect through state-IU. Limitations Both studies used undergraduate psychology students samples, younger than average population and predominantly female. Experimental manipulation and outcome measures belongs to the same semantic domain, uncertainty, potentially limiting generalizability. Conclusions Results supported the feasibility and efficacy of the proposed IU manipulation for non-clinical sample. Findings parallel clinical research showing that state-IU preceded Worry and Negative Affect states.	[Mosca, Oriana; Lauriola, Marco] Univ Roma La Sapienza, Dept Social & Dev Psychol, Rome, Italy; [Carleton, R. Nicholas] Univ Regina, Anxiety & Illness Behav Lab, Regina, SK S4S 0A2, Canada	Sapienza University Rome; University of Regina	Mosca, O (corresponding author), Univ Roma La Sapienza, Dept Social & Dev Psychol, Rome, Italy.	oriana.mosca@uniroma1.it	Mosca, Oriana/ABI-1729-2020					Balsamo M., 2012, PSYCHOLOGY, V3, P399, DOI DOI 10.4236/psych.2012.35056; Barlow DH, 2014, CLIN PSYCHOL SCI, V2, P344, DOI 10.1177/2167702613505532; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Bentler P. M., 2004, EQS 6 STRUCTURAL EQU; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Birrell J, 2011, CLIN PSYCHOL REV, V31, P1198, DOI 10.1016/j.cpr.2011.07.009; BONATE PL, 2000, ANAL PRETEST POSTTES; Boswell JF, 2013, J CLIN PSYCHOL, V69, P630, DOI 10.1002/jclp.21965; Bowlby J, 1973, ATTACHMENT LOSS; Bredemeier K, 2008, BEHAV RES THER, V46, P28, DOI 10.1016/j.brat.2007.09.006; Buhr K, 2006, J ANXIETY DISORD, V20, P222, DOI 10.1016/j.janxdis.2004.12.004; Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4; Burns D. D., 1989, FEELING GOOD HDB; Carleton RN, 2007, J ANXIETY DISORD, V21, P105, DOI 10.1016/j.janxdis.2006.03.014; Carleton RN, 2016, J ANXIETY DISORD, V39, P30, DOI 10.1016/j.janxdis.2016.02.007; Carleton RN, 2016, J BEHAV THER EXP PSY, V51, P58, DOI 10.1016/j.jbtep.2015.12.004; Carleton RN, 2012, EXPERT REV NEUROTHER, V12, P937, DOI 10.1586/ERN.12.82; Conover W. J, 1999, PRACTICAL NONPARAMET, P130; de Visser L, 2010, NEUROPSYCHOLOGIA, V48, P1598, DOI 10.1016/j.neuropsychologia.2010.01.027; Dugas MJ, 1997, COGNITIVE THER RES, V21, P593, DOI 10.1023/A:1021890322153; Dugas MJ, 2005, COGNITIVE THER RES, V29, P57, DOI 10.1007/s10608-005-1648-9; Dugas MJ, 2004, GENERALIZED ANXIETY DISORDER: ADVANCES IN RESEARCH AND PRACTICE, P143; Dugas MJ, 1998, BEHAV RES THER, V36, P215, DOI 10.1016/S0005-7967(97)00070-3; Dugas MJ, 2001, COGNITIVE THER RES, V25, P551, DOI 10.1023/A:1005553414688; Dugas MJ, 2003, J CONSULT CLIN PSYCH, V71, P821, DOI 10.1037/0022-006X.71.4.821; Dugas MJ, 2000, BEHAV MODIF, V24, P635, DOI 10.1177/0145445500245002; Einstein DA, 2014, CLIN PSYCHOL-SCI PR, V21, P280, DOI 10.1111/cpsp.12077; Fergus TA, 2014, PERS INDIV DIFFER, V58, P128, DOI 10.1016/j.paid.2013.10.017; FREESTON MH, 1994, PERS INDIV DIFFER, V17, P791, DOI 10.1016/0191-8869(94)90048-5; Gentes EL, 2011, CLIN PSYCHOL REV, V31, P923, DOI 10.1016/j.cpr.2011.05.001; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Grenier S, 2004, CAN J BEHAV SCI, V36, P56, DOI 10.1037/h0087216; Hampson SE, 2012, ANNU REV PSYCHOL, V63, P315, DOI 10.1146/annurev-psych-120710-100419; Holaway RM, 2006, J ANXIETY DISORD, V20, P158, DOI 10.1016/j.janxdis.2005.01.002; Hong RY, 2015, CLIN PSYCHOL SCI, V3, P892, DOI 10.1177/2167702614553789; Iani L, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-84; Jacoby RJ, 2016, J ANXIETY DISORD; Jacoby RJ, 2014, J ANXIETY DISORD, V28, P495, DOI 10.1016/j.janxdis.2014.05.005; Ladouceur R, 2000, BEHAV RES THER, V38, P933, DOI 10.1016/S0005-7967(99)00133-3; Laugesen N, 2003, J ABNORM CHILD PSYCH, V31, P55, DOI 10.1023/A:1021721332181; Luhmann CC, 2011, BEHAV THER, V42, P378, DOI 10.1016/j.beth.2010.09.002; Mahoney Alison E. J., 2012, Cognitive Behaviour Therapy, V41, P212, DOI 10.1080/16506073.2011.622130; Mahoney Alison E. J., 2012, Cognitive Behaviour Therapy, V41, P26, DOI 10.1080/16506073.2011.622131; Miu AC, 2008, BIOL PSYCHOL, V77, P353, DOI 10.1016/j.biopsycho.2007.11.010; Mueller EM, 2010, J BEHAV THER EXP PSY, V41, P165, DOI 10.1016/j.jbtep.2009.12.002; Nelson BD, 2011, INT J PSYCHOPHYSIOL, V81, P107, DOI 10.1016/j.ijpsycho.2011.05.003; Ottaviani C, 2014, INT J PSYCHOPHYSIOL, V93, P349, DOI 10.1016/j.ijpsycho.2014.05.010; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Scherer KR, 2013, EMOT REV, V5, P150, DOI 10.1177/1754073912468166; Scherer KR, 2009, EUR J PERSONALITY, V23, P265, DOI 10.1002/per.714; Terracciano A, 2003, EUR J PSYCHOL ASSESS, V19, P131, DOI 10.1027//1015-5759.19.2.131; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; van Breukelen GJP, 2013, MULTIVAR BEHAV RES, V48, P895, DOI 10.1080/00273171.2013.831743; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wu XW, 2015, COMMUN STAT-SIMUL C, V44, P284, DOI 10.1080/03610918.2013.775295; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127189	58	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155130	10.1371/journal.pone.0155130	http://dx.doi.org/10.1371/journal.pone.0155130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27254099	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700004
J	Heckmann, BL; Zhang, XD; Saarinen, AM; Liu, J				Heckmann, Bradlee L.; Zhang, Xiaodong; Saarinen, Alicia M.; Liu, Jun			Regulation of G0/G1 Switch Gene 2 (G0S2) Protein Ubiquitination and Stability by Triglyceride Accumulation and ATGL Interaction	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOSE-TISSUE; ENERGY-METABOLISM; LIPID-METABOLISM; LIPOLYSIS; DEGRADATION; MICE; ALPHA; LIVER	Intracellular triglyceride (TG) hydrolysis or lipolysis is catalyzed by the key intracellular triglyceride hydrolase, adipose triglyceride lipase (ATGL). The G0/G1 Switch Gene 2 (G0S2) was recently identified as the major selective inhibitor of ATGL and its hydrolase function. Since G0S2 levels are dynamically linked and rapidly responsive to nutrient status or metabolic requirements, the identification of its regulation at the protein level is of significant value. Earlier evidence from our laboratory demonstrated that G0S2 is a short-lived protein degraded through the proteasomal pathway. However, little is currently known regarding the underlying mechanisms. In the current study we find that 1) protein degradation is initiated by K48-linked polyubiquitination of the lysine-25 in G0S2; and 2) G0S2 protein is stabilized in response to ATGL expression and TG accumulation. Mutation of lysine-25 of G0S2 abolished ubiquitination and increased protein stability. More importantly, G0S2 was stabilized via different mechanisms in the presence of ATGL vs. in response to fatty acid (FA)-induced TG accumulation. Furthermore, G0S2 protein but not mRNA levels were reduced in the adipose tissue of ATGL-deficient mice, corroborating the involvement of ATGL in the stabilization of G0S2. Taken together our data illustrate for the first time a crucial multifaceted mechanism for the stabilization of G0S2 at the protein level.	[Heckmann, Bradlee L.; Zhang, Xiaodong; Saarinen, Alicia M.; Liu, Jun] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Scottsdale, AZ 85054 USA; [Heckmann, Bradlee L.; Zhang, Xiaodong; Saarinen, Alicia M.; Liu, Jun] Mayo Clin, Metab Hlth Program, Scottsdale, AZ 85054 USA; [Heckmann, Bradlee L.] Mayo Grad Sch, Rochester, MN USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic	Liu, J (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Scottsdale, AZ 85054 USA.; Liu, J (corresponding author), Mayo Clin, Metab Hlth Program, Scottsdale, AZ 85054 USA.	liu.jun@mayo.edu		Heckmann, Bradlee/0000-0002-3271-7183	National Institutes of Health [DK089178]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109096, R56DK089178] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by research grant from the National Institutes of Health (DK089178) to J.L. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; El-Assaad W, 2015, DIABETOLOGIA, V58, P149, DOI 10.1007/s00125-014-3429-z; Faggiano S, 2016, ANAL BIOCHEM, V492, P82, DOI 10.1016/j.ab.2015.09.013; Frayn KN, 2006, ESSAYS BIOCHEM, V42, P89, DOI 10.1042/bse0420089; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Heckmann BL, 2014, J BIOL CHEM, V289, P1905, DOI 10.1074/jbc.M113.522011; Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Ma T, 2014, CANCER BIOL THER, V15, P643, DOI 10.4161/cbt.28251; Patel S, 2014, P NATL ACAD SCI USA, V111, P9163, DOI 10.1073/pnas.1318791111; Petroski MD, 2003, MOL CELL, V11, P1435, DOI 10.1016/S1097-2765(03)00221-1; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Suryadinata Randy, 2014, Cells, V3, P674, DOI 10.3390/cells3030674; Turpin SM, 2011, DIABETOLOGIA, V54, P146, DOI 10.1007/s00125-010-1895-5; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang YP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057085, 10.1371/journal.pone.0065634]; Yang XY, 2011, J BIOL CHEM, V286, P40477, DOI 10.1074/jbc.M111.257923; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang L, 2013, J LIPID RES, V54, P1410, DOI 10.1194/jlr.M035774; Zhang XD, 2014, AM J PHYSIOL-ENDOC M, V307, pE1047, DOI 10.1152/ajpendo.00125.2014; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156742	10.1371/journal.pone.0156742	http://dx.doi.org/10.1371/journal.pone.0156742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248498	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700075
J	Skvortsova, YV; Kondratieva, SA; Zinovyeva, MV; Nikolaev, LG; Azhikina, TL; Gainetdinov, IV				Skvortsova, Yulia V.; Kondratieva, Sofia A.; Zinovyeva, Marina V.; Nikolaev, Lev G.; Azhikina, Tatyana L.; Gainetdinov, Ildar V.			Intragenic Locus in Human PIWIL2 Gene Shares Promoter and Enhancer Functions	PLOS ONE			English	Article							ENCODE DATA; CHROMATIN INTERACTIONS; TRANSCRIPTION FACTORS; UNIFIED ARCHITECTURE; DROSOPHILA GENOME; HUMAN TUMORS; 3D GENOME; ELEMENTS; ORGANIZATION; EXPRESSION	Recently, more evidence supporting common nature of promoters and enhancers has been accumulated. In this work, we present data on chromatin modifications and non-polyadenylated transcription characteristic for enhancers as well as results of in vitro luciferase reporter assays suggesting that PIWIL2 alternative promoter in exon 7 also functions as an enhancer for gene PHYHIP located 60Kb upstream. This finding of an intragenic enhancer serving as a promoter for a shorter protein isoform implies broader impact on understanding enhancer-promoter networks in regulation of gene expression.	[Skvortsova, Yulia V.; Kondratieva, Sofia A.; Zinovyeva, Marina V.; Nikolaev, Lev G.; Azhikina, Tatyana L.; Gainetdinov, Ildar V.] Russian Acad Sci, Dept Genom & Postgen Technol, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Gainetdinov, IV (corresponding author), Russian Acad Sci, Dept Genom & Postgen Technol, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	ildargv@gmail.com	Azhikina, Tatyana/X-8411-2018; Skvortsova, Yulia/AAP-4597-2021; Kondrateva, Sofia/ABB-3389-2020	Skvortsova, Yuliya/0000-0002-7605-8570; Kondratieva, Sofia/0000-0002-1354-5275; Gainetdinov, Ildar/0000-0003-1719-043X	Russian Foundation for Basic Research [14-04-32314-mol_a]; program of the Presidium of the Russian Academy of Sciences 'Molecular and Cellular Biology'	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); program of the Presidium of the Russian Academy of Sciences 'Molecular and Cellular Biology'	This work was supported by the Russian Foundation for Basic Research grant no. 14-04-32314-mol_a to YVS and the program of the Presidium of the Russian Academy of Sciences 'Molecular and Cellular Biology'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson R, 2015, TRENDS GENET, V31, P426, DOI 10.1016/j.tig.2015.05.007; ANDREWS PW, 1984, LAB INVEST, V50, P147; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Benabdallah NS, 2015, COLD SH Q B, V80, P45, DOI 10.1101/sqb.2015.80.027268; Bescond M, 2005, INT J BIOCHEM CELL B, V37, P775, DOI 10.1016/j.biocel.2004.12.006; Core LJ, 2014, NAT GENET, V46, P1311, DOI 10.1038/ng.3142; Czech B, 2016, TRENDS BIOCHEM SCI, V41, P324, DOI 10.1016/j.tibs.2015.12.008; De Fazio S, 2011, NATURE, V480, P259, DOI 10.1038/nature10547; Deng BW, 2013, SEMIN CANCER BIOL, V23, P65, DOI 10.1016/j.semcancer.2012.01.003; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2012, CURR OPIN GENET DEV, V22, P125, DOI 10.1016/j.gde.2011.12.006; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Feuerborn A, 2015, TRENDS GENET, V31, P483, DOI 10.1016/j.tig.2015.07.001; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gainetdinov IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112528; Gainetdinov IV, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7074; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Gomez-Diaz E, 2014, TRENDS CELL BIOL, V24, P703, DOI 10.1016/j.tcb.2014.08.003; Gushchanskaya ES, 2014, EPIGENETICS-US, V9, P951, DOI 10.4161/epi.28794; Herz HM, 2014, MOL CELL, V53, P859, DOI 10.1016/j.molcel.2014.02.033; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim JE, 2009, CELL CYCLE, V8, P2932; Kim TK, 2015, CELL, V162, P948, DOI 10.1016/j.cell.2015.08.008; Kim TK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018622; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim YW, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140126; Koh JT, 2001, MOL BRAIN RES, V87, P223, DOI 10.1016/S0169-328X(01)00004-3; Kowalczyk MS, 2012, MOL CELL, V45, P447, DOI 10.1016/j.molcel.2011.12.021; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lai F, 2014, CURR OPIN GENET DEV, V25, P38, DOI 10.1016/j.gde.2013.11.017; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Li C, 2009, GENE THER, V16, P43, DOI 10.1038/gt.2008.134; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Matharu N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005640; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211; MURAMATSU T, 1992, BIOCHEM BIOPH RES CO, V188, P265, DOI 10.1016/0006-291X(92)92379-C; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Ong CT, 2014, NAT REV GENET, V15, P234, DOI 10.1038/nrg3663; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Swamynathan SK, 2002, J BIOL CHEM, V277, P49700, DOI 10.1074/jbc.M209700200; van Arensbergen J, 2014, TRENDS CELL BIOL, V24, P695, DOI 10.1016/j.tcb.2014.07.004; Vernimmen D, 2015, TRENDS GENET, V31, P696, DOI 10.1016/j.tig.2015.10.004; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Ye Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013406; Zentner GE, 2012, J BIOL CHEM, V287, P30888, DOI 10.1074/jbc.R111.296491	66	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156454	10.1371/journal.pone.0156454	http://dx.doi.org/10.1371/journal.pone.0156454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248499	Green Published, gold, Green Submitted			2022-12-26	WOS:000377184700045
J	Aktas, B; De Wolfe, TJ; Safdar, N; Darien, BJ; Steele, JL				Aktas, Busra; De Wolfe, Travis J.; Safdar, Nasia; Darien, Benjamin J.; Steele, James L.			The Impact of Lactobacillus casei on the Composition of the Cecal Microbiota and Innate Immune System Is Strain Specific	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GERM-FREE; EXPRESSION; RECOGNITION; MATURATION; DEFENSINS; PRODUCTS; COLITIS; OBESITY; MILK	The probiotic function to impact human health is thought to be related to their ability to alter the composition of the gut microbiota and modulate the human innate immune system. The ability to function as a probiotic is believed to be strain specific. Strains of Lactobacillus casei are commonly utilized as probiotics that when consumed alter the composition of the gut microbiota and modulate the host immune response. L. casei strains are known to differ significantly in gene content. The objective of this study was to investigate seven different L. casei strains for their ability to alter the murine gut microbiota and modulate the murine immune system. C57BL/6 mice were fed L. casei strains at a dose of 108 CFU/day/mouse for seven days and sacrificed 3.5h after the last administration. The cecal content and the ileum tissue were collected for microbiota analysis and immune profiling, respectively. While 5 of the L. casei strains altered the gut microbiota in a strain specific manner, two of the strains did not alter the overall cecal microbiota composition. The observed changes cluster into three groups containing between 1 and 2 strains. Two strains that did not affect the gut microbiota composition cluster together with the control in their impact on pattern recognition receptors (PRRs) expression, suggesting that the ability to alter the cecal microbiota correlates with the ability to alter PRR expression. They also cluster together in their impact on the expression of intestinal antimicrobial peptides (AMPs). This result suggests that a relationship exists between the capability of a L. casei strains to alter the composition of the gut microbiota, PRR regulation, and AMP regulation.	[Aktas, Busra; De Wolfe, Travis J.; Steele, James L.] Univ Wisconsin, Dept Food Sci, 1605 Linden Dr, Madison, WI 53706 USA; [Safdar, Nasia] Univ Wisconsin, Dept Med, Div Infect Dis, Madison, WI USA; [Safdar, Nasia] William S Middleton Vet Affairs Hosp, Madison, WI USA; [Darien, Benjamin J.] Univ Wisconsin, Anim Hlth & Biomed Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Steele, JL (corresponding author), Univ Wisconsin, Dept Food Sci, 1605 Linden Dr, Madison, WI 53706 USA.	JLSteele@wisc.edu	De Wolfe, Travis J/C-6827-2013	De Wolfe, Travis J/0000-0001-6261-1235; Aktas, Busra/0000-0001-9863-683X	DuPont Inc. [PRJ19MQ]; WARF [PRJ66JZ]	DuPont Inc.; WARF	This work was funded by DuPont Inc. (Grant no. PRJ19MQ) and by the WARF (Grant no. PRJ66JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Aktas B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145784; [Anonymous], 2014, YAKULT ANN REPORT; Barbara G, 2012, J CLIN GASTROENTEROL, V46, pS52, DOI 10.1097/MCG.0b013e318264e918; Batista ML, 2010, CYTOKINE, V49, P102, DOI 10.1016/j.cyto.2009.10.007; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690; Cai H, 2007, MICROBIOL-SGM, V153, P2655, DOI 10.1099/mic.0.2007/006452-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceapa C, 2013, BEST PRACT RES CL GA, V27, P139, DOI 10.1016/j.bpg.2013.04.004; Chessel D., 2004, R NEWS, V4, P5; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Cunliffe RN, 2003, MOL IMMUNOL, V40, P463, DOI 10.1016/S0161-5890(03)00157-3; de Carcer DA, 2011, ISME J, V5, P801, DOI 10.1038/ismej.2010.177; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; FAO, 2006, PROB FOOD HLTH NUTR; FAO/WHO, 2002, FOOD AGR ORG UN WHO; Fernandez EM, 2011, GUT, V60, P1050, DOI [10.1136/gut.2010.232918, 10.1136/gut.2010.232918corr1]; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236, DOI 10.3748/wjg.v13.i2.236; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hormannsperger G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004365; Hwang I, 2013, J PHYSIOL PHARMACOL, V64, P11; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ivory K, 2008, CLIN EXP ALLERGY, V38, P1282, DOI 10.1111/j.1365-2222.2008.03025.x; Kamada N, 2014, GASTROENTEROLOGY, V146, P1477, DOI 10.1053/j.gastro.2014.01.060; Kandler O, 1986, BERGEYS MANUAL SYSTE, V2, P1063; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kirschning CJ, 2002, TOLL LIKE RECEPTOR F; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Leyer GJ, 2009, PEDIATRICS, V124, pE172, DOI 10.1542/peds.2008-2666; Liu YY, 2010, AM J PHYSIOL-GASTR L, V299, pG1087, DOI 10.1152/ajpgi.00124.2010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Menendez A, 2013, J INNATE IMMUN, V5, P39, DOI 10.1159/000341630; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Natividad JMM, 2013, APPL ENVIRON MICROB, V79, P7745, DOI 10.1128/AEM.02470-13; Ostaff MJ, 2013, EMBO MOL MED, V5, P1465, DOI 10.1002/emmm.201201773; Owyang C, 2014, GASTROENTEROLOGY, V146, P1433, DOI 10.1053/j.gastro.2014.03.032; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Paul W. E., 2003, FUNDAMENTAL IMMUNOLO, V5th; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; R Core Team, 2021, R LANGUAGE ENV STAT; Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12; Salminen SJ, 2005, J NUTR, V135, P1294, DOI 10.1093/jn/135.5.1294; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Schuijt TJ, 2013, TRENDS MICROBIOL, V21, P221, DOI 10.1016/j.tim.2013.02.001; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Tandee K., 2013, THESIS U WISCONSIN M; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Vogler I, 2011, J INNATE IMMUN, V3, P227, DOI 10.1159/000324112; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Yin XC, 2014, J DAIRY SCI, V97, P2049, DOI 10.3168/jds.2013-7477; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05654; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	67	23	26	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156374	10.1371/journal.pone.0156374	http://dx.doi.org/10.1371/journal.pone.0156374			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244133	gold, Green Published, Green Submitted			2022-12-26	WOS:000377146100033
J	Tripathi, S; Mathur, S; Deshmukh, P; Manjula, R; Padmanabhan, B				Tripathi, Shailesh; Mathur, Shruti; Deshmukh, Prashant; Manjula, Ramu; Padmanabhan, Balasundaram			A Novel Phenanthridionone Based Scaffold As a Potential Inhibitor of the BRD2 Bromodomain: Crystal Structure of the Complex	PLOS ONE			English	Article							HISTONE H4 RECOGNITION; SCORING FUNCTION; BET; CHROMATIN; PROTEINS; DOCKING	Bromodomain containing proteins recognize the level of histone acetylation and regulate epigenetically controlled processes like gene transcription and chromatin modification. The BET (bromodomain and extra-terminal) family proteins, which are transcriptional co-regulators, have been implicated in the pathogenesis of cancer, neurodegenerative disorders, and defects in embryonic stem cell differentiation. Inhibitors selectively targeting the BET bromodomains can pave the path for new drug discovery against several forms of major diseases. By a rational structure-based approach, we have identified a new inhibitor (NSC127133) of the second bromodomain (BD2) of the BET family protein BRD2 using the NCI Diversity Set III library. A high-resolution crystal structure of the BRD2-BD2 in complex with this compound and in apo-form is refined to 0.91 and 0.94 angstrom, respectively. The compound, which is a phenanthridinone derivative, binds well to the acetyl-lysine binding pocket of BD2 and displays significant hydrophobic and hydrophilic interactions. Moreover, the atomic resolution data obtained in this study allowed us to visualize certain structural features of BD2 which remained unobserved so far. We propose that the discovered compound may be a potential molecule to develop a new library for inhibiting the BRD2-BD2 function.	[Tripathi, Shailesh; Mathur, Shruti; Deshmukh, Prashant; Manjula, Ramu; Padmanabhan, Balasundaram] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Biophys, Hosur Rd, Bangalore 560029, Karnataka, India	National Institute of Mental Health & Neurosciences - India	Padmanabhan, B (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Biophys, Hosur Rd, Bangalore 560029, Karnataka, India.	paddy@nimhans.ac.in		Ramu, Manjula/0000-0002-2237-2599	Department of Biotechnology (DBT) [BT/PR7079/BID/7/426/2012]; Department of Science and Technology (DST) Government of India, India [SR/SO/BB-0108/2012]; DST [SR/WOS-A/LS-100/2013]; Council of Scientific and Industrial Research (CSIR) [09/490(0093) 2012-EMR-1]	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST) Government of India, India(Department of Science & Technology (India)); DST(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	BP is grateful to the Department of Biotechnology (DBT) (No. BT/PR7079/BID/7/426/2012), and Department of Science and Technology (DST) (No. SR/SO/BB-0108/2012) Government of India, India for the financial support; SM to DST for DST WOS-A fellowship (SR/WOS-A/LS-100/2013); RM is thankful to Council of Scientific and Industrial Research (CSIR) for SRF fellowship (09/490(0093) 2012-EMR-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2009, PHENIX A COMPREHENSI, V66, P213; [Anonymous], 2010, Drug Discov Today Technol, V7, pe147, DOI 10.1016/j.ddtec.2010.11.003; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Brand M, 2015, ACS CHEM BIOL, V10, P22, DOI 10.1021/cb500996u; Chaidos A, 2015, THER ADV HEMATOL, V6, P128, DOI 10.1177/2040620715576662; Chen RC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/232870; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; Deeney JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151329; Delano, PYMOL MOL GRAPH SYST; Denis GV, 2010, FEBS LETT, V584, P3260, DOI 10.1016/j.febslet.2010.05.030; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Ferri E, 2016, BIOCHEM PHARMACOL, V106, P1, DOI 10.1016/j.bcp.2015.12.005; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Ghoshal A, 2016, EXPERT OPIN THER PAT, V26, P505, DOI 10.1517/13543776.2016.1159299; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Huang HD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-57; Kaur G, 2016, CANCER LETT, V371, P225, DOI 10.1016/j.canlet.2015.12.001; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; McLure KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083190; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Patel AJ, 2014, CELL REP, V6, P81, DOI 10.1016/j.celrep.2013.12.001; Picaud S, 2013, P NATL ACAD SCI USA, V110, P19754, DOI 10.1073/pnas.1310658110; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Powell HR, 2013, ACTA CRYSTALLOGR D, V69, P1195, DOI 10.1107/S0907444912048524; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Sinha A, 2005, BIOCHEM J, V387, P257, DOI 10.1042/BJ20041793; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Umehara T, 2010, FEBS LETT, V584, P3901, DOI 10.1016/j.febslet.2010.08.013; Umehara T, 2010, J BIOL CHEM, V285, P7610, DOI 10.1074/jbc.M109.062422; Wang JH, 2013, CURR MED CHEM, V20, P2032, DOI 10.2174/0929867311320150008; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wu XC, 2016, MOL CANCER THER, V15, P1029, DOI 10.1158/1535-7163.MCT-15-0750	42	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156344	10.1371/journal.pone.0156344	http://dx.doi.org/10.1371/journal.pone.0156344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243809	Green Submitted, Green Published, gold			2022-12-26	WOS:000377146100030
J	Wang, YG; Hu, YA; Sun, CX; Zhuo, S; He, ZS; Wang, H; Yan, MH; Liu, J; Luan, Y; Dai, CG; Yang, YG; Huang, R; Zhou, B; Zhang, F; Zhai, QW				Wang, Yuangao; Hu, Yanan; Sun, Chenxia; Zhuo, Shu; He, Zhishui; Wang, Hui; Yan, Menghong; Liu, Jun; Luan, Yi; Dai, Changgui; Yang, Yonggang; Huang, Rui; Zhou, Ben; Zhang, Fang; Zhai, Qiwei			Down-regulation of Risa improves insulin sensitivity by enhancing autophagy	FASEB JOURNAL			English	Article						lncRNA; insulin resistance; glucose homeostasis; ob; ob mice	LONG NONCODING RNAS; ACTIVATES AUTOPHAGY; SIRT1; PHOSPHORYLATION; METABOLISM; OBESITY; STRESS; OVEREXPRESSION; EXPRESSION; SELECTION	It has been reported that some small noncoding RNAs are involved in the regulation of insulin sensitivity. However, whether long noncoding RNAs also participate in the regulation of insulin sensitivity is still largely unknown. We identified and characterized a long noncoding RNA, regulator of insulin sensitivity and autophagy (Risa), which is a poly(A)(+) cytoplasmic RNA. Overexpression of Risa in mouse primary hepatocytes or C2C12 myotubes attenuated insulin-stimulated phosphorylation of insulin receptor, Akt, and Gsk3, and knockdown of Risa alleviated insulin resistance. Further studies showed that overexpression of Risa in hepatocytes or myotubes decreased autophagy, and knockdown of Risa up-regulated autophagy. Moreover, knockdown of Atg7 or -5 significantly inhibited the effect of knockdown of Risa on insulin resistance, suggesting that knockdown of Risa alleviated insulin resistance via enhancing autophagy. In addition, tail vein injection of adenovirus to knock down Risa enhanced insulin sensitivity and hepatic autophagy in both C57BL/6 and ob/ob mice. Taken together, the data demonstrate that Risa regulates insulin sensitivity by affecting autophagy and suggest that Risa is a potential target for treating insulin-resistance-related diseases.Wang, Y., Hu, Y., Sun, C., Zhuo, S., He, Z., Wang, H., Yan, M., Liu, J., Luan, Y., Dai, C., Yang, Y., Huang, R., Zhou, B., Zhang, F., Zhai, Q. Down-regulation of Risa improves insulin sensitivity by enhancing autophagy.	[Wang, Yuangao; Hu, Yanan; Sun, Chenxia; Zhuo, Shu; He, Zhishui; Wang, Hui; Yan, Menghong; Liu, Jun; Luan, Yi; Dai, Changgui; Yang, Yonggang; Huang, Rui; Zhou, Ben; Zhang, Fang; Zhai, Qiwei] Chinese Acad Sci, Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci,Inst Nutr Sci, Key Lab Nutr & Metab,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhai, Qiwei] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Zhai, QW (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	qwzhai@sibs.ac.cn	Zhou, Ben/R-9844-2019; Zhou, Ben/G-1850-2017; Zhou, Ben/AAB-5808-2020	Zhou, Ben/0000-0001-7177-2882; Zhou, Ben/0000-0001-7177-2882; Zhai, Qiwei/0000-0002-9617-7403; Zhang, Fang/0000-0002-7000-554X; Luan, Yi/0000-0002-2511-0359	National Basic Research Program of China [2014CB542300]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12030204]; National Natural Science Foundation of China [31470768, 81321062, 31200595, 31200591, 81472181]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2014KIP106]	National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of Shanghai Institutes for Biological Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Grant 2014CB542300 from the National Basic Research Program of China; Grant XDA12030204 from the Strategic Priority Research Program of the Chinese Academy of Sciences; Grants 31470768, 81321062, 31200595, 31200591, and 81472181 from the National Natural Science Foundation of China; the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences; and Grant 2014KIP106 from the Chinese Academy of Sciences. Author contributions: Y. Wang, F. Zhang, and Q. Zhai designed the research; Y. Wang, Y. Hu, B. Zhou, Z. He, and Q. Zhai analyzed the data; Y. Wang, C. Sun, Y. Hu, S. Zhuo, H. Wang, Z. He, M. Yan, J. Liu, Y. Luan, C. Dai, Y. Yang, and R. Huang performed the research; and Y. Wang and Q. Zhai wrote the paper. The authors declare no conflicts of interest.	Abdelmohsen K, 2014, NUCLEIC ACIDS RES, V42, P10099, DOI 10.1093/nar/gku686; Atianand MK, 2014, TRENDS MOL MED, V20, P623, DOI 10.1016/j.molmed.2014.09.002; Bernard M, 2014, AUTOPHAGY, V10, P2193, DOI 10.4161/15548627.2014.981786; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Chooniedass-Kothari S, 2004, FEBS LETT, V566, P43, DOI 10.1016/j.febslet.2004.03.104; Diederichs S, 2014, TRENDS GENET, V30, P121, DOI 10.1016/j.tig.2014.01.004; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Ge D, 2014, AUTOPHAGY, V10, P957, DOI 10.4161/auto.28363; Grammatikakis I, 2014, AGING-US, V6, P992, DOI 10.18632/aging.100710; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Jager L, 2009, NAT PROTOC, V4, P547, DOI 10.1038/nprot.2009.4; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kim J, 2011, CELL CYCLE, V10, P1337, DOI 10.4161/cc.10.9.15291; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Kornfeld JW, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00057; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Li P, 2015, CELL METAB, V21, P455, DOI 10.1016/j.cmet.2015.02.004; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Liu S, 2014, J BIOL CHEM, V289, P13000, DOI 10.1074/jbc.M114.564658; Liu Y, 2015, DIABETES, V64, P36, DOI 10.2337/db14-0267; Meijer AJ, 2011, CURR BIOL, V21, pR227, DOI 10.1016/j.cub.2011.02.007; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Palmer Donna J., 2008, V433, P33, DOI 10.1007/978-1-59745-237-3_3; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Smith MA, 2013, NUCLEIC ACIDS RES, V41, P8220, DOI 10.1093/nar/gkt596; Sullivan BP, 2013, BLOOD, V121, P1868, DOI 10.1182/blood-2012-09-455436; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Takahashi W, 2013, CRIT CARE, V17, DOI 10.1186/cc12839; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Xu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014199; Yamada E, 2012, DIABETES, V61, P272, DOI 10.2337/db11-1199; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yin DD, 2015, CELL PHYSIOL BIOCHEM, V35, P1892, DOI 10.1159/000373999; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8	54	25	29	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3133	3145		10.1096/fj.201500058R	http://dx.doi.org/10.1096/fj.201500058R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27251173				2022-12-26	WOS:000382816300014
J	Basudhar, D; Madrona, Y; Yukl, ET; Sivaramakrishnan, S; Nishida, CR; Moenne-Loccoz, P; de Montellano, PRO				Basudhar, Debashree; Madrona, Yarrow; Yukl, Erik T.; Sivaramakrishnan, Santhosh; Nishida, Clinton R.; Moenne-Loccoz, Pierre; de Montellano, Paul R. Ortiz			Distal Hydrogen-bonding Interactions in Ligand Sensing and Signaling by Mycobacterium tuberculosis DosS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONREPLICATING PERSISTENCE; MOLECULAR-DYNAMICS; GAF DOMAIN; HEME; DEVS; SENSOR; PROTEIN; DORMANCY; MACROPHAGES; KINASES	Mycobacterium tuberculosis DosS is critical for the induction of M. tuberculosis dormancy genes in response to nitric oxide (NO), carbon monoxide (CO), or hypoxia. These environmental stimuli, which are sensed by the DosS heme group, result in autophosphorylation of a DosS His residue, followed by phosphotransfer to an Asp residue of the response regulator DosR. To clarify the mechanism of gaseous ligand recognition and signaling, we investigated the hydrogen-bonding interactions of the iron-bound CO and NO ligands by site-directed mutagenesis of Glu-87 and His-89. Autophosphorylation assays and molecular dynamics simulations suggest that Glu-87 has an important role in ligand recognition, whereas His-89 is essential for signal transduction to the kinase domain, a process for which Arg-204 is important. Mutation of Glu-87 to Ala or Gly rendered the protein constitutively active as a kinase, but with lower autophosphorylation activity than the wild-type in the Fe(II) and the Fe(II)-CO states, whereas the E87D mutant had little kinase activity except for the Fe(II)-NO complex. The H89R mutant exhibited attenuated autophosphorylation activity, although the H89A and R204A mutants were inactive as kinases, emphasizing the importance of these residues in communication to the kinase core. Resonance Raman spectroscopy of the wild-type and H89A mutant indicates the mutation does not alter the heme coordination number, spin state, or porphyrin deformation state, but it suggests that interdomain interactions are disrupted by the mutation. Overall, these results confirm the importance of the distal hydrogen-bonding network in ligand recognition and communication to the kinase domain and reveal the sensitivity of the system to subtle differences in the binding of gaseous ligands.	[Basudhar, Debashree; Madrona, Yarrow; Sivaramakrishnan, Santhosh; Nishida, Clinton R.; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Yukl, Erik T.; Moenne-Loccoz, Pierre] Oregon Hlth & Sci Univ, Inst Environm Hlth, Div Environm & Biomol Syst, Portland, OR 97239 USA; [Yukl, Erik T.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	University of California System; University of California San Francisco; Oregon Health & Science University; New Mexico State University	de Montellano, PRO (corresponding author), Univ Calif San Francisco, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu		MOENNE-LOCCOZ, PIERRE/0000-0002-7684-7617	National Institutes of Health [AI074824, GM74785]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AI074824 (to P. R. O. M.) and GM74785 (P. M.-L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Cho HY, 2011, FEBS LETT, V585, P1873, DOI 10.1016/j.febslet.2011.04.050; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Dick T, 2001, J ANTIMICROB CHEMOTH, V47, P117, DOI 10.1093/jac/47.1.117; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Gautam US, 2015, AM J RESP CELL MOL, V52, P708, DOI 10.1165/rcmb.2014-0230OC; Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Ioanoviciu A, 2009, BIOCHEMISTRY-US, V48, P5839, DOI 10.1021/bi802309y; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Regev D, 2012, LAB INVEST, V92, P1541, DOI 10.1038/labinvest.2012.125; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sharma SK, 2006, CHEST, V130, P261, DOI [10.1378/chest.130.1.261, 10.1016/S0012-3692(15)50981-1]; Silva-Gomes S, 2013, INFECT IMMUN, V81, P2536, DOI 10.1128/IAI.00251-13; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne L G, 2001, Methods Mol Med, V54, P247, DOI 10.1385/1-59259-147-7:247; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Yukl ET, 2008, BIOCHEMISTRY-US, V47, P12532, DOI 10.1021/bi801234w; Yukl ET, 2007, BIOCHEMISTRY-US, V46, P9728, DOI 10.1021/bi7008695	30	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16100	16111		10.1074/jbc.M116.724815	http://dx.doi.org/10.1074/jbc.M116.724815			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27235395	Green Published, hybrid			2022-12-26	WOS:000380585400016
J	Harvey, BM; Rana, NA; Moss, H; Leonardi, J; Jafar-Nejad, H; Haltiwanger, RS				Harvey, Beth M.; Rana, Nadia A.; Moss, Hillary; Leonardi, Jessica; Jafar-Nejad, Hamed; Haltiwanger, Robert S.			Mapping Sites of O-Glycosylation and Fringe Elongation on Drosophila Notch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED-N-ACETYLGLUCOSAMINE; LIGAND-BINDING; MOLECULAR-CLONING; PROTEIN O-FUCOSYL-TRANSFERASE-1; EXTRACELLULAR DOMAIN; ALAGILLE-SYNDROME; HUMAN JAGGED1; EGF REPEATS; MUTATIONS; GENE	Glycosylation of the Notch receptor is essential for its activity and serves as an important modulator of signaling. Three major forms of O-glycosylation are predicted to occur at consensus sites within the epidermal growth factor-like repeats in the extracellular domain of the receptor: O-fucosylation, O-glucosylation, and O-GlcNAcylation. We have performed comprehensive mass spectral analyses of these three types of O-glycosylation on Drosophila Notch produced in S2 cells and identified peptides containing all 22 predicted O-fucose sites, all 18 predicted O-glucose sites, and all 18 putative O-GlcNAc sites. Using semiquantitative mass spectral methods, we have evaluated the occupancy and relative amounts of glycans at each site. The majority of the O-fucose sites were modified to high stoichiometries. Upon expression of the beta 3-N-acetylglucosaminyltransferase Fringe with Notch, we observed varying degrees of elongation beyond O-fucose monosaccharide, indicating that Fringe preferentially modifies certain sites more than others. Rumi modified O-glucose sites to high stoichiometries, although elongation of the O-glucose was site-specific. Although the current putative consensus sequence for O-GlcNAcylation predicts 18 O-GlcNAc sites on Notch, we only observed apparent O-GlcNAc modification at five sites. In addition, we performed mass spectral analysis on endogenous Notch purified from Drosophila embryos and found that the glycosylation states were similar to those found on Notch from S2 cells. These data provide foundational information for future studies investigating the mechanisms of how O-glycosylation regulates Notch activity.	[Harvey, Beth M.; Rana, Nadia A.; Moss, Hillary; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Leonardi, Jessica; Jafar-Nejad, Hamed] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Jafar-Nejad, Hamed] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Baylor College of Medicine; Baylor College of Medicine	Haltiwanger, RS (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	rhalti@uga.edu	Moss, Hillary/AAV-4895-2021	Harvey, Beth/0000-0002-9291-5640	Bloomington Drosophila Stock Center (National Institutes of Health Grant) [P40OD018537]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084135, R01GM061126, T32GM008468] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Bloomington Drosophila Stock Center (National Institutes of Health Grant); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Rodrigo Fernandez-Valdivia and Yi-Dong Li for discussions and technical assistance with generation of the Notch<SUP>gt-FH</SUP> transgene. We thank the Bloomington Drosophila Stock Center (National Institutes of Health Grant P40OD018537) for fly stocks. We also thank Spyros Artavanis-Tsakonas and Kazuya Hori for sharing unpublished data indicating that the insertion of epitope tags between EGF repeats and LNR repeats does not disrupt the function of the Drosophila Notch in vivo. We thank the Haltiwanger laboratory for comments on the manuscript.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; Aminkeng F, 2015, CLIN GENET, V88, P532, DOI 10.1111/cge.12681; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1983, P NATL ACAD SCI-BIOL, V80, P1977, DOI 10.1073/pnas.80.7.1977; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cohen I, 2014, EUR J HUM GENET, V22, P374, DOI 10.1038/ejhg.2013.159; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dexter JS, 1914, AM NAT, V48, P712, DOI 10.1086/279446; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; Hambleton S, 2004, STRUCTURE, V12, P2173, DOI 10.1016/j.str.2004.09.012; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kakuda S, 2014, METHODS MOL BIOL, V1187, P209, DOI 10.1007/978-1-4939-1139-4_16; Kamath BM, 2012, J MED GENET, V49, P138, DOI 10.1136/jmedgenet-2011-100544; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; LeBon L, 2014, ELIFE, V3, DOI 10.7554/eLife.02950; Lee TV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003547; Leonardi J, 2014, METHODS MOL BIOL, V1187, P29, DOI 10.1007/978-1-4939-1139-4_3; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Meester JAN, 2015, AM J HUM GENET, V97, P475, DOI 10.1016/j.ajhg.2015.07.015; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062835; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Ogawa M, 2015, J BIOL CHEM, V290, P2137, DOI 10.1074/jbc.M114.598821; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Penton AL, 2012, SEMIN CELL DEV BIOL, V23, P450, DOI 10.1016/j.semcdb.2012.01.010; Perdigoto CN, 2011, DEVELOPMENT, V138, P4585, DOI 10.1242/dev.065292; Ramkumar N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005551; Rana NA, 2011, CURR OPIN STRUC BIOL, V21, P583, DOI 10.1016/j.sbi.2011.08.008; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sethi MK, 2012, J BIOL CHEM, V287, P2739, DOI 10.1074/jbc.M111.302406; Sethi MK, 2010, J BIOL CHEM, V285, P1582, DOI 10.1074/jbc.C109.065409; Shaheen R, 2013, AM J HUM GENET, V92, P598, DOI 10.1016/j.ajhg.2013.02.012; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Southgate L, 2015, CIRC-CARDIOVASC GENE, V8, P572, DOI 10.1161/CIRCGENETICS.115.001086; Stittrich AB, 2014, AM J HUM GENET, V95, P275, DOI 10.1016/j.ajhg.2014.07.011; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Thakurdas SM, 2016, HEPATOLOGY, V63, P550, DOI 10.1002/hep.28024; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; WELSHONS WJ, 1971, GENETICS, V68, P259; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; Xu AG, 2005, J BIOL CHEM, V280, P30158, DOI 10.1074/jbc.M505569200; Xu AG, 2007, J BIOL CHEM, V282, P35153, DOI 10.1074/jbc.M707040200; Yamamoto S, 2012, SCIENCE, V338, P1229, DOI 10.1126/science.1228745	65	46	47	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16348	16360		10.1074/jbc.M116.732537	http://dx.doi.org/10.1074/jbc.M116.732537			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27268051	Green Published, hybrid			2022-12-26	WOS:000380585400038
J	Tossavainen, H; Aitio, O; Hellman, M; Saksela, K; Permi, P				Tossavainen, Helena; Aitio, Olli; Hellman, Maarit; Saksela, Kalle; Permi, Perttu			Structural Basis of the High Affinity Interaction between the Alphavirus Nonstructural Protein-3 (nsP3) and the SH3 Domain of Amphiphysin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C VIRUS NS5A; SIGNAL-TRANSDUCTION; LINEAR MOTIFS; BINDING; RECOGNITION; BIN1; REPLICATION; SPECIFICITY; MEMBRANE; ACTIN	We show that a peptide from Chikungunya virus nsP3 protein spanning residues 1728-1744 binds the amphiphysin-2 (BIN1) Src homology-3 (SH3) domain with an unusually high affinity (K-d 24 nM). Our NMR solution complex structure together with isothermal titration calorimetry data on several related viral and cellular peptide ligands reveal that this exceptional affinity originates from interactions between multiple basic residues in the target peptide and the extensive negatively charged binding surface of amphiphysin-2 SH3. Remarkably, these arginines show no fixed conformation in the complex structure, indicating that a transient or fluctuating polyelectrostatic interaction accounts for this affinity. Thus, via optimization of such dynamic electrostatic forces, viral peptides have evolved a superior binding affinity for amphiphysin-2 SH3 compared with typical cellular ligands, such as dynamin, thereby enabling hijacking of amphiphysin-2 SH3-regulated host cell processes by these viruses. Moreover, our data show that the previously described consensus sequence PXRPXR for amphiphysin SH3 ligands is inaccurate and instead define it as an extended Class II binding motif PXXPXRpXR, where additional positive charges between the two constant arginine residues can give rise to extraordinary high SH3 binding affinity.	[Tossavainen, Helena; Aitio, Olli; Hellman, Maarit; Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, FI-00014 Helsinki, Finland; [Saksela, Kalle] Univ Helsinki, Dept Virol, FI-00014 Helsinki, Finland; [Saksela, Kalle] Helsinki Univ Hosp, FI-00014 Helsinki, Finland; [Permi, Perttu] Univ Jyvaskyla, Nanosci Ctr, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Hellman, Maarit; Permi, Perttu] Univ Jyvaskyla, Nanosci Ctr, Dept Chem, FI-40014 Jyvaskyla, Finland; [Tossavainen, Helena; Aitio, Olli; Hellman, Maarit] Glykos Finland Ltd, FI-00790 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Jyvaskyla; University of Jyvaskyla	Permi, P (corresponding author), Univ Jyvaskyla, POB 35, FI-40014 Jyvaskyla, Finland.	perttu.permi@jyu.fi		Saksela, Kalle/0000-0003-0827-122X				Aitio O, 2012, STRUCTURE, V20, P1692, DOI 10.1016/j.str.2012.07.015; Aitio O, 2010, P NATL ACAD SCI USA, V107, P21743, DOI 10.1073/pnas.1010243107; Aladag A, 2014, J PEPT SCI, V20, P334, DOI 10.1002/psc.2618; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Borg M, 2007, P NATL ACAD SCI USA, V104, P9650, DOI 10.1073/pnas.0702580104; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cestra G, 1999, J BIOL CHEM, V274, P32001, DOI 10.1074/jbc.274.45.32001; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kim S, 2013, J BIOMOL NMR, V55, P249, DOI 10.1007/s10858-013-9706-1; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lopez-Mendez B, 2006, J AM CHEM SOC, V128, P13112, DOI 10.1021/ja061136l; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Moradpour D, 2003, ANTIVIR RES, V60, P103, DOI 10.1016/j.antiviral.2003.08.017; Nanda SK, 2006, GASTROENTEROLOGY, V130, P794, DOI 10.1053/j.gastro.2005.12.030; Neuvonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002383; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Park E, 2009, VIROLOGY, V388, P305, DOI 10.1016/j.virol.2009.03.031; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pineda-Lucena A, 2005, J MOL BIOL, V351, P182, DOI 10.1016/j.jmb.2005.05.046; Prokic I, 2014, J MOL MED, V92, P453, DOI 10.1007/s00109-014-1138-1; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Rouka E, 2015, J BIOL CHEM, V290, P25275, DOI 10.1074/jbc.M115.637207; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; Tuittila M, 2003, J GEN VIROL, V84, P1525, DOI 10.1099/vir.0.18936-0; Via A, 2015, TRENDS BIOCHEM SCI, V40, P36, DOI 10.1016/j.tibs.2014.11.001; Yoshikawa M, 2008, BIOCHEM BIOPH RES CO, V372, P168, DOI 10.1016/j.bbrc.2008.05.027; Zech B, 2003, J GEN VIROL, V84, P555, DOI 10.1099/vir.0.18801-0	39	26	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16307	16317		10.1074/jbc.M116.732412	http://dx.doi.org/10.1074/jbc.M116.732412			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27268056	Green Published, hybrid			2022-12-26	WOS:000380585400034
J	Walworth, AE; Chai, BL; Song, GQ				Walworth, Aaron E.; Chai, Benli; Song, Guo-qing			Transcript Profile of Flowering Regulatory Genes in VcFT-Overexpressing Blueberry Plants	PLOS ONE			English	Article							VACCINIUM-CORYMBOSUM L.; MADS-BOX GENE; MOLECULAR-BASIS; VERNALIZATION; FRUIT; ARABIDOPSIS; GENERATION; REPRESSOR; CEREALS; DOMAIN	In order to identify genetic components in flowering pathways of highbush blueberry (Vaccinium corymbosum L.), a transcriptome reference composed of 254,396 transcripts and 179,853 gene contigs was developed by assembly of 72.7 million reads using Trinity. Using this transcriptome reference and a query of flowering pathway genes of herbaceous plants, we identified potential flowering pathway genes/transcripts of blueberry. Transcriptome analysis of flowering pathway genes was then conducted on leaf tissue samples of transgenic blueberry cv. Aurora ('VcFT-Aurora'), which overexpresses a blueberry FLOWERING LOCUS T-like gene (VcFT). Sixty-one blueberry transcripts of 40 genes showed high similarities to 33 known flowering-related genes of herbaceous plants, of which 17 down-regulated and 16 up-regulated genes were identified in 'VcFT-Aurora'. All down-regulated genes encoded transcription factors/enzymes upstream in the signaling pathway containing VcFT. A blueberry CONSTANS-LIKE 5-like (VcCOL5) gene was down-regulated and associated with five other differentially expressed (DE) genes in the photoperiod-mediated flowering pathway. Three down-regulated genes, i.e., a MADS-AFFECTING FLOWERING 2-like gene (VcMAF2), a MADS-AFFECTING FLOWERING 5-like gene (VcMAF5), and a VERNALIZATION1-like gene (VcVRN1), may function as integrators in place of FLOWERING LOCUS C (FLC) in the vernalization pathway. Because no CONSTAN1-like or FLOWERING LOCUS C-like genes were found in blueberry, VcCOL5 and VcMAF2/VcMAF5 or VRN1 might be the major integrator(s) in the photoperiod-and vernalization-mediated flowering pathway, respectively. The major down-stream genes of VcFT, i.e., SUPPRESSOR of Overexpression of Constans 1-like (VcSOC1), LEAFY-like (VcLFY), APETALA1-like (VcAP1), CAULIFLOWER 1-like (VcCAL1), and FRUITFULL-like (VcFUL) genes were present and showed high similarity to their orthologues in herbaceous plants. Moreover, overexpression of VcFT promoted expression of all of these VcFT downstream genes. These results suggest that VcFT's down-stream genes appear conserved in blueberry.	[Walworth, Aaron E.; Song, Guo-qing] Michigan State Univ, Dept Hort, Plant Biotechnol Resource & Outreach Ctr, E Lansing, MI 48824 USA; [Chai, Benli] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Song, GQ (corresponding author), Michigan State Univ, Dept Hort, Plant Biotechnol Resource & Outreach Ctr, E Lansing, MI 48824 USA.	songg@msu.edu		Walworth, Aaron/0000-0001-7981-9657	Michigan State University, AgBioResearch Project GREEEN	Michigan State University, AgBioResearch Project GREEEN	This work was supported by Michigan State University, AgBioResearch Project GREEEN, URL: http://agbioresearch.msu.edu/project_greeen.	Alexandre CM, 2008, J EXP BOT, V59, P1127, DOI 10.1093/jxb/ern070; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Bian Y, 2014, MOL BREEDING, V34, P675, DOI 10.1007/s11032-014-0066-7; Chavez DJ, 2009, HORTSCIENCE, V44, P1538; Die JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073354; Ehlenfeldt MK, 2001, J AGR FOOD CHEM, V49, P2222, DOI 10.1021/jf0013656; Fan ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09729; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Gupta V, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0046-9; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; Lee J, 2010, J EXP BOT, V61, P2247, DOI 10.1093/jxb/erq098; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Song GQ, 2004, PLANT CELL REP, V23, P475, DOI 10.1007/s00299-004-0842-7; Song GQ, 2015, METHODS MOL BIOL, V1224, P121, DOI 10.1007/978-1-4939-1658-0_11; Song GQ, 2013, PLANT CELL REP, V32, P1819, DOI 10.1007/s00299-013-1495-1; Song GQ, 2013, PLANT CELL REP, V32, P1759, DOI 10.1007/s00299-013-1489-z; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Walworth AE, 2012, MOL BREEDING, V30, P1313, DOI 10.1007/s11032-012-9718-7; Wellmer F, 2010, TRENDS GENET, V26, P519, DOI 10.1016/j.tig.2010.09.001; Wilkie JD, 2008, J EXP BOT, V59, P3215, DOI 10.1093/jxb/ern188; Zamboni A, 2008, IFOREST, V1, P122, DOI 10.3832/ifor0465-0010122; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009	30	26	26	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156993	10.1371/journal.pone.0156993	http://dx.doi.org/10.1371/journal.pone.0156993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271296	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561000057
J	Adkins-Regan, E				Adkins-Regan, Elizabeth			Pairing Behavior of the Monogamous King Quail, Coturnix chinensis	PLOS ONE			English	Article							JAPANESE-QUAIL; PRAIRIE VOLE; PREFERENCES; VASOPRESSIN; MAINTENANCE; EVOLUTION; BOND	Animals with socially monogamous mating systems are valuable for discovering proximate mechanisms of prosocial behavior and close social relationships. Especially powerful are comparisons between related species that differ in monogamous tendency. Birds are the most socially monogamous vertebrates. Thus far most research on mechanisms of pairing has used zebra finches, which do not have a relative with a different mating system, however. The goal of the experiments reported here was to develop a new comparative avian system by studying the pairing behavior of a reportedly strongly monogamous quail, the king quail (Coturnix chinensis), a species in the same clade as the less monogamous Japanese quail (Coturnix japonica), the subject of much prior research. In Experiment 1 male-female pairs of king quail housed together were initially avoidant or aggressive but most rapidly progressed to allopreening and huddling. A separation-reunion paradigm reliably elicited both of these behaviors in males that had cohabited for one week. In Experiment 2 the allopreening and huddling behavior of males in cohabiting pairs was highly selective, and a majority of the males were aggressive toward a familiar female that was not the cohabitation partner. In Experiment 3 males were separated from their female cohabitation partners for 9-10 weeks and then given two-choice tests. All but one male spent more time near an unfamiliar female, which may have reflected aggression and shows recognition of and memory for the past pairing experience. Thus king quail show robust, selective and easy to measure pairing behavior that can be reliably elicited with simple separation-reunion testing procedures. Copulation is rarely seen during tests. The behavior of king quail is a striking contrast to that of Japanese quail, providing a new comparative system for discovering mechanisms of behavior related to close social relationships and monogamy.	[Adkins-Regan, Elizabeth] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA; [Adkins-Regan, Elizabeth] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University; Cornell University	Adkins-Regan, E (corresponding author), Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA.; Adkins-Regan, E (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	er12@cornell.edu			US National Science Foundation [IOS 1146891]	US National Science Foundation(National Science Foundation (NSF))	This work was supported by US National Science Foundation Grant IOS 1146891. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131786; Ball GF, 2010, ILAR J, V51, P310, DOI 10.1093/ilar.51.4.310; Banerjee SB, 2013, EUR J NEUROSCI, V38, P3731, DOI 10.1111/ejn.12378; Baran NM, 2016, FRONTIERS B IN PRESS; Bester-Meredith JK, 1999, HORM BEHAV, V36, P25, DOI 10.1006/hbeh.1999.1522; Black J.M., 1996, PARTNERSHIPS BIRDS S; BLOHOWIAK CC, 1983, BEHAV PROCESS, V8, P255, DOI 10.1016/0376-6357(83)90016-5; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Crowe TM, 2006, CLADISTICS, V22, P495, DOI 10.1111/j.1096-0031.2006.00120.x; Cushing BS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150373; Finseth FR, 2013, J EVOLUTION BIOL, V26, P1875, DOI 10.1111/jeb.12189; Goodson JL, 2013, PSYCHONEUROENDOCRINO, V38, P465, DOI 10.1016/j.psyneuen.2012.12.005; Goodson JL, 2009, SCIENCE, V325, P862, DOI 10.1126/science.1174929; Goodson JL, 1997, CONDOR, V99, P990, DOI 10.2307/1370153; Goodwin, 1982, ESTRILDID FINCHES WO; Hammock EAD, 2006, PHILOS T R SOC B, V361, P2187, DOI 10.1098/rstb.2006.1939; Johnsgard PA, 1988, QUAILS PARTRIDGES FR; Kimball Rebecca T., 2011, International Journal of Evolutionary Biology, V2011, P1, DOI 10.4061/2011/423938; Kingsbury MA, 2014, BEHAV BRAIN RES, V272, P264, DOI 10.1016/j.bbr.2014.06.042; Lack D., 1968, pvii; Le Bot O, 2014, J EXP BIOL, V217, P4184, DOI 10.1242/jeb.108738; Madge S., 2002, PHEASANTS PARTRIDGES; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; NICHOLS CR, 1991, THESIS U BRIT COLUMB; Payne RB., 2010, HDB BIRDS WORLD WEAV, P234; Persaud KN, 2003, ANIM BEHAV, V65, P89, DOI 10.1006/anbe.2002.2057; POTASH LM, 1975, BEHAVIOUR, V54, P153, DOI 10.1163/156853975X00245; Prior NH, 2015, HORM BEHAV, V76, P11, DOI 10.1016/j.yhbeh.2015.04.014; Reichard U. H., 2003, MONOGAMY MATING STRA; Riters LV, 1998, BEHAVIOUR, V135, P551, DOI 10.1163/156853998792897941; Rodriguez-Teijeiro JD, 2003, ETHOLOGY, V109, P291, DOI 10.1046/j.1439-0310.2003.00873.x; SCHLEIDT WM, 1984, Z TIERPSYCHOL, V64, P193; SILCOX AP, 1982, ANIM BEHAV, V30, P1237, DOI 10.1016/S0003-3472(82)80216-9; Smith AS, 2010, HORM BEHAV, V57, P255, DOI 10.1016/j.yhbeh.2009.12.004; Thompson RR, 1998, BRAIN BEHAV EVOLUT, V51, P215; TSUDZUKI M, 1994, POULTRY SCI, V73, P763, DOI 10.3382/ps.0730763; Turner LM, 2010, MOL BIOL EVOL, V27, P1269, DOI 10.1093/molbev/msq013; White DJ, 1999, ANIM BEHAV, V58, P865, DOI 10.1006/anbe.1999.1210; Winkler DW, 2015, BIRD FAMILIES WORLD; Zann RA., 1996, ZEBRA FINCH SYNTHESI	42	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155877	10.1371/journal.pone.0155877	http://dx.doi.org/10.1371/journal.pone.0155877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257681	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700025
J	Bili, M; Cortesero, AM; Mougel, C; Gauthier, JP; Ermel, G; Simon, JC; Outreman, Y; Terrat, S; Maheo, F; Poinsot, D				Bili, Mikael; Cortesero, Anne Marie; Mougel, Christophe; Gauthier, Jean Pierre; Ermel, Gwennola; Simon, Jean Christophe; Outreman, Yannick; Terrat, Sebastien; Maheo, Frederique; Poinsot, Denis			Bacterial Community Diversity Harboured by Interacting Species	PLOS ONE			English	Article							APHID ACYRTHOSIPHON-PISUM; GUT MICROBIOTA; SYMBIOTIC BACTERIA; WOLBACHIA; INSECT; COLEOPTERA; ENDOSYMBIONTS; BEETLE; MICROORGANISMS; TRANSMISSION	All animals are infected by microbial partners that can be passengers or residents and influence many biological traits of their hosts. Even if important factors that structure the composition and abundance of microbial communities within and among host individuals have been recently described, such as diet, developmental stage or phylogeny, few studies have conducted cross-taxonomic comparisons, especially on host species related by trophic relationships. Here, we describe and compare the microbial communities associated with the cabbage root fly Delia radicum and its three major parasitoids: the two staphylinid beetles Aleochara bilineata and A. bipustulata and the hymenopteran parasitoid Trybliographa rapae. For each species, two populations from Western France were sampled and microbial communities were described through culture independent methods (454 pyrosequencing). Each sample harbored at least 59 to 261 different bacterial phylotypes but was strongly dominated by one or two. Microbial communities differed markedly in terms of composition and abundance, being mainly influenced by phylogenetic proximity but also geography to a minor extent. Surprisingly, despite their strong trophic interaction, parasitoids shared a very low proportion of microbial partners with their insect host. Three vertically transmitted symbionts from the genus Wolbachia, Rickettsia, and Spiroplasma were found in this study. Among them, Wolbachia and Spiroplasma were found in both the cabbage fly and at least one of its parasitoids, which could result from horizontal transfers through trophic interactions. Phylogenetic analysis showed that this hypothesis may explain some but not all cases. More work is needed to understand the dynamics of symbiotic associations within trophic network and the effect of these bacterial communities on the fitness of their hosts.	[Bili, Mikael; Cortesero, Anne Marie; Poinsot, Denis] Univ Rennes 1, IGEPP UMR1349, F-35000 Rennes, France; [Outreman, Yannick] Agrocampus Ouest, IGEPP UMR1349, F-35000 Rennes, France; [Mougel, Christophe; Gauthier, Jean Pierre; Simon, Jean Christophe; Maheo, Frederique] INRA, IGEPP UMR1349, F-35000 Rennes, France; [Bili, Mikael; Cortesero, Anne Marie; Poinsot, Denis] Univ Europeenne Bretagne, Rennes, France; [Ermel, Gwennola] Univ Rennes, UMR CNRS Interact Cellulaires & Mol 6026, Rennes, France; [Terrat, Sebastien] Univ Bourgogne, UMR Agroecol 1347, Dijon, France	Universite de Rennes; Institut Agro; Agrocampus Ouest; INRAE; Universite de Bretagne Occidentale; Universite de Rennes; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Poinsot, D (corresponding author), Univ Rennes 1, IGEPP UMR1349, F-35000 Rennes, France.; Poinsot, D (corresponding author), Univ Europeenne Bretagne, Rennes, France.	denis.poinsot@univ-rennes1.fr	Terrat, Sebastien/T-3790-2017; Mougel, Christophe/D-5118-2017; Yannick, OUTREMAN/B-9309-2012	Terrat, Sebastien/0000-0001-5209-6196; Mougel, Christophe/0000-0001-8675-3115; Yannick, OUTREMAN/0000-0002-7337-3049	French Ministry of Research; University of Rennes 1	French Ministry of Research(Ministry of Research, FranceEuropean Commission); University of Rennes 1	This work was supported by the French Ministry of Research: PhD grant to MB and the University of Rennes 1: financed the sequencing costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; Arias-Cordero E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051557; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Bennett DC, 2013, VET MICROBIOL, V166, P304, DOI 10.1016/j.vetmic.2013.05.018; Brucker RM, 2012, TRENDS ECOL EVOL, V27, P443, DOI 10.1016/j.tree.2012.03.011; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Brune A, 2001, BIOL TERMITES MODERN, P439; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chiel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004767; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLHOUN J, 1953, ANN APPL BIOL, V40, P639, DOI 10.1111/j.1744-7348.1953.tb01103.x; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Dedeine F, 2005, HEREDITY, V95, P394, DOI 10.1038/sj.hdy.6800739; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Douglas AE, 2007, TRENDS BIOTECHNOL, V25, P338, DOI 10.1016/j.tibtech.2007.06.003; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Ferrari J, 2004, ECOL ENTOMOL, V29, P60, DOI 10.1111/j.1365-2311.2004.00574.x; Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192; Fukatsu T, 2012, MOL ECOL, V21, P5908, DOI 10.1111/mec.12090; Gehrer L, 2012, BIOL LETTERS, V8, P613, DOI 10.1098/rsbl.2012.0144; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gonella E, 2011, APPL ENVIRON MICROB, V77, P1423, DOI 10.1128/AEM.02121-10; Grunwald S, 2010, SYST APPL MICROBIOL, V33, P25, DOI 10.1016/j.syapm.2009.10.002; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hickman C. S., 2005, INFLUENCE COOPERATIV, P3; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hirsch J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S6; Hongoh Y, 2003, FEMS MICROBIOL ECOL, V44, P231, DOI 10.1016/S0168-6496(03)00026-6; Hongoh Y, 2011, CELL MOL LIFE SCI, V68, P1311, DOI 10.1007/s00018-011-0648-z; Hosokawa T, 2005, FEMS MICROBIOL ECOL, V54, P471, DOI 10.1016/j.femsec.2005.06.002; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Humphreys NJ, 1997, APPL ENVIRON MICROB, V63, P3294, DOI 10.1128/AEM.63.8.3294-3296.1997; Hurst GDD, 2003, CONT T ENT, P177; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Husseneder Claudia, 2010, Open Microbiol J, V4, P53, DOI 10.2174/1874285801004010053; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; Kaltenpoth M, 2006, INT J SYST EVOL MICR, V56, P1403, DOI 10.1099/ijs.0.64117-0; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Kautz S, 2013, PSYCHE J ENTOMOLOGY; Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Le Clec'h W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060232; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Lehman R, 2009, MICROB ECOL, V57, P349, DOI 10.1007/s00248-008-9415-6; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lukasik P, 2013, ECOL LETT, V16, P214, DOI 10.1111/ele.12031; Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369; Maus C, 1998, DEUT ENTOMOL Z, V45, P231, DOI 10.1002/mmnd.19980450209; Maus C, 2001, MOL PHYLOGENET EVOL, V18, P202, DOI 10.1006/mpev.2000.0874; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; MOLAN PC, 1992, BEE WORLD, V73, P5, DOI 10.1080/0005772X.1992.11099109; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Neveu N., 1996, IOBC-WPRS Bulletin, V19, P173; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Moraes APR, 2014, REV BRAS PARASITOL V, V23, P194, DOI 10.1590/S1984-29612014037; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Sasaki-Fukatsu K, 2006, APPL ENVIRON MICROB, V72, P7349, DOI 10.1128/AEM.01429-06; Shelomi Matan, 2013, BMC Research Notes, V6, P0001, DOI 10.1186/1756-0500-6-368; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TANG XR, 2012, PLOS GENET, V8, P47387, DOI DOI 10.1371/JOURNAL.PONE.0036978; Terrat S, 2015, MICROB BIOTECHNOL, V8, P131, DOI 10.1111/1751-7915.12162; Terrat S, 2012, MICROB BIOTECHNOL, V5, P135, DOI 10.1111/j.1751-7915.2011.00307.x; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; VANKEYMEULEN M, 1981, ENTOMOL EXP APPL, V30, P231, DOI 10.1007/BF00347703; Vasanthakumar A, 2008, ENVIRON ENTOMOL, V37, P1344, DOI 10.1603/0046-225X(2008)37[1344:GMOAIS]2.0.CO;2; Wackers FL, 2001, J INSECT PHYSIOL, V47, P1077, DOI 10.1016/S0022-1910(01)00088-9; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; WISHART G., 1956, CANADIAN ENT, V88, P634; WISHART G., 1957, CANADIAN ENT, V89, P510; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Xie JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012149; Xie W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035181; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004	99	24	27	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155392	10.1371/journal.pone.0155392	http://dx.doi.org/10.1371/journal.pone.0155392			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258532	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700014
J	Harhay, MN; Hill, AS; Wang, W; Even-Shoshan, O; Mussell, AS; Bloom, RD; Feldman, HI; Karlawish, JH; Silber, JH; Reese, PP				Harhay, Meera N.; Hill, Alexander S.; Wang, Wei; Even-Shoshan, Orit; Mussell, Adam S.; Bloom, Roy D.; Feldman, Harold I.; Karlawish, Jason H.; Silber, Jeffrey H.; Reese, Peter P.			Measures of Global Health Status on Dialysis Signal Early Rehospitalization Risk after Kidney Transplantation	PLOS ONE			English	Article							EARLY HOSPITAL READMISSION; PHYSICAL FUNCTIONING SCALE; STAGE RENAL-DISEASE; COMORBIDITY INDEXES; 30-DAY READMISSIONS; ADMINISTRATIVE DATA; PREDICTION-MODEL; UNITED-STATES; WAITING TIME; FRAILTY	Background Early rehospitalization (<30 days) after discharge from kidney transplantation (KT) is associated with poor outcomes. We explored summary metrics of pre-transplant health status that may improve the identification of KT recipients at risk for early rehospitalization and mortality after transplant. Materials and Methods We performed a retrospective cohort study of 8,870 adult (>= 18 years) patients on hemodialysis who received KT between 2000 and 2010 at United States transplant centers. We linked Medicare data to United Network for Organ Sharing data and data from a national dialysis provider to examine pre-KT (1) Elixhauser Comorbidity Index, (2) physical function (PF) measured by the Short Form 36 Health Survey, and (3) the number of hospitalizations during the 12 months before KT as potential predictors of early rehospitalization after KT. We also explored whether these metrics are confounders of the known association between early rehospitalization and post-transplant mortality. Results The median age was 52 years (interquartile range [IQR] 41, 60) and 63% were male. 29% were rehospitalized in < 30 days, and 20% died during a median follow-up time of five years (IQR 3.6-6.5). In a multivariable logistic model, kidney recipients with more pre-KT Elixhauser comorbidities (adjusted odds ratio [aOR] 1.09 per comorbidity, 95% Confidence Interval [CI] 1.07-1.11), the poorest pre-KT PF (aOR 1.24, 95% CI 1.08-1.43), or >1 pre-KT hospitalizations (aOR 1.32, 95% CI 1.17-1.49) were more likely to be rehospitalized. All three health status metrics and early rehospitalization were independently associated with post-T mortality in a multivariable Cox model (adjusted hazard ratio for rehospitalization: 1.41, 95% CI 1.28-1.56) Conclusions Pre-transplant metrics of health status, measured by dialysis providers or administrative data, are independently associated with early rehospitalization and mortality risk after KT. Transplant providers may consider utilizing metrics of pre-KT global health status as early signals of vulnerability when transitioning care after KT.	[Harhay, Meera N.] Drexel Univ, Coll Med, Dept Med, Div Nephrol, Philadelphia, PA 19104 USA; [Hill, Alexander S.; Even-Shoshan, Orit; Silber, Jeffrey H.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Wang, Wei] Kaiser Permanente, Dept Surg Outcomes & Anal, San Diego, CA USA; [Mussell, Adam S.; Feldman, Harold I.; Reese, Peter P.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA USA; [Bloom, Roy D.; Feldman, Harold I.; Reese, Peter P.] Univ Penn, Renal Elect & Hypertens Div, Perelman Sch Med, Philadelphia, PA USA; [Karlawish, Jason H.] Univ Penn, Div Geriatr, Perelman Sch Med, Philadelphia, PA USA	Drexel University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Kaiser Permanente; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Harhay, MN (corresponding author), Drexel Univ, Coll Med, Dept Med, Div Nephrol, Philadelphia, PA 19104 USA.	meera.harhay@drexelmed.edu			NIH [F32DK096758-01, K23 DK105207-01, R01-DK090388-01A1]; Development Award in Geriatric Nephrology - American Society of Nephrology; Association of Specialty Professors; John A. Hartford Foundation; Atlantic Philanthropies; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK105207] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Development Award in Geriatric Nephrology - American Society of Nephrology; Association of Specialty Professors; John A. Hartford Foundation; Atlantic Philanthropies; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants F32DK096758-01 and K23 DK105207-01 (Dr. Harhay) and R01-DK090388-01A1 (Drs. Reese, Feldman, Bloom). Dr. Reese's efforts were also supported by a Development Award in Geriatric Nephrology co-sponsored by American Society of Nephrology, the Association of Specialty Professors, John A. Hartford Foundation and the Atlantic Philanthropies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2013, HEMODIAL INT, V17, P50, DOI 10.1111/j.1542-4758.2012.00726.x; Bao YR, 2012, ARCH INTERN MED, V172, P1071, DOI 10.1001/archinternmed.2012.3020; Barcellos FC, 2015, CLIN KIDNEY J, V8, P753, DOI 10.1093/ckj/sfv099; Bureau UNfOSN, OPTN UNOS BOARD APPR; Cook WL, 2008, KIDNEY INT, V73, P1289, DOI 10.1038/ki.2008.62; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DeMarco MAG M.E., 2012, AM J TRANSPLANTA SS3, V12, P27, DOI [10.1111/j.1600-6143.2012.04112.x, DOI 10.1111/J.1600-6143.2012.04112.X]; DeOreo PB, 1997, AM J KIDNEY DIS, V30, P204, DOI 10.1016/S0272-6386(97)90053-6; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Englesbe MJ, 2009, AM J TRANSPLANT, V9, P1108, DOI 10.1111/j.1600-6143.2009.02592.x; Faravardeh A, 2013, TRANSPLANTATION, V96, P1089, DOI 10.1097/TP.0b013e3182a688e5; Friedewald JJ, 2012, ADV CHRONIC KIDNEY D, V19, P252, DOI 10.1053/j.ackd.2012.05.001; Garonzik-Wang JM, 2012, ARCH SURG-CHICAGO, V147, P190, DOI 10.1001/archsurg.2011.1229; Grams ME, 2012, TRANSPLANTATION, V94, P750, DOI 10.1097/TP.0b013e31826205b9; Grams ME, 2012, J AM GERIATR SOC, V60, P1, DOI 10.1111/j.1532-5415.2011.03652.x; Greysen SR, 2015, JAMA INTERN MED, V175, P559, DOI 10.1001/jamainternmed.2014.7756; Group. USC, 2016, MISS DAT SAS 1; HALEY SM, 1994, J CLIN EPIDEMIOL, V47, P671, DOI 10.1016/0895-4356(94)90215-1; Harhay M, 2013, AM J TRANSPLANT, V13, P3164, DOI 10.1111/ajt.12513; Hartmann EL, 2009, CLIN J AM SOC NEPHRO, V4, P588, DOI 10.2215/CJN.03860808; Hasan O, 2010, J GEN INTERN MED, V25, P211, DOI 10.1007/s11606-009-1196-1; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Hummel SL, 2014, MAYO CLIN PROC, V89, P623, DOI 10.1016/j.mayocp.2013.12.018; Jassal SV, 2005, AM J KIDNEY DIS, V46, P136, DOI 10.1053/j.ajkd.2005.03.006; Johansen KL, 2007, J AM SOC NEPHROL, V18, P2960, DOI 10.1681/ASN.2007020221; Joshi S, 2013, TRANSPLANTATION, V95, P309, DOI 10.1097/TP.0b013e31827191d4; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515; Kendall MGaJDG, 1990, RANK CORRELATION MET; Kim JC, 2013, J AM SOC NEPHROL, V24, P337, DOI 10.1681/ASN.2012010047; Kutner NG, 2006, CLIN J AM SOC NEPHRO, V1, P837, DOI 10.2215/CJN.01341005; Kutner NG, 2013, JAMA INTERN MED, V173, P78, DOI 10.1001/2013.jamainternmed.750; Machnicki G, 2009, AM J TRANSPLANT, V9, P494, DOI 10.1111/j.1600-6143.2008.02486.x; Machnicki G, 2011, ARCH MED SCI, V7, P278, DOI 10.5114/aoms.2011.22079; Machnicki G, 2011, SAUDI J KIDNEY DIS T, V22, P24; Massie AB, 2014, AM J TRANSPLANT, V14, P1723, DOI 10.1111/ajt.12777; McAdams-DeMarco MA, 2014, AM J TRANSPLANT, V14, P397, DOI 10.1111/ajt.12563; McAdams-DeMarco MA, 2013, AM J TRANSPLANT, V13, P2091, DOI 10.1111/ajt.12300; McAdams-DeMarco MA, 2012, AM J TRANSPLANT, V12, P3283, DOI 10.1111/j.1600-6143.2012.04285.x; McHorney CA, 1997, J CLIN EPIDEMIOL, V50, P451, DOI 10.1016/S0895-4356(96)00424-6; Meier-Kriesche HU, 2000, KIDNEY INT, V58, P1311, DOI 10.1046/j.1523-1755.2000.00287.x; Meier-Kriesche HU, 2002, TRANSPLANTATION, V74, P1377, DOI 10.1097/00007890-200211270-00005; Merion RM, 2005, JAMA-J AM MED ASSOC, V294, P2726, DOI 10.1001/jama.294.21.2726; Metzger RA, 2003, AM J TRANSPLANT, V3, P114, DOI 10.1034/j.1600-6143.3.s4.11.x; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Painter P, 2013, NEPHROL NURS J, V40, P529; Painter P, 2013, CURR OPIN NEPHROL HY, V22, P615, DOI 10.1097/MNH.0b013e328365b43a; Painter P, 2013, HEMODIAL INT, V17, P41, DOI 10.1111/j.1542-4758.2012.00719.x; Reese PP, 2014, TRANSPLANTATION, V97, P189, DOI 10.1097/TP.0b013e3182a89338; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roshanravan B, 2013, J AM SOC NEPHROL, V24, P822, DOI 10.1681/ASN.2012070702; Roshanravan B, 2012, AM J KIDNEY DIS, V60, P912, DOI 10.1053/j.ajkd.2012.05.017; Schold JD, 2014, J AM SOC NEPHROL, V25, P1617, DOI 10.1681/ASN.2014030235; Segev DL, 2008, J AM SOC NEPHROL, V19, P349, DOI 10.1681/ASN.2007050610; Services CfMM, READM RED PROGR 2012; Shadmi E, 2015, MED CARE, V53, P283, DOI 10.1097/MLR.0000000000000315; Sharabiani MTA, 2012, MED CARE, V50, P1109, DOI 10.1097/MLR.0b013e31825f64d0; Tennankore KK, 2014, J AM SOC NEPHROL, V25, P2113, DOI 10.1681/ASN.2013111180; USRDS U.S. Renal Data System., 2012, USRDS 2012 ANN DAT R; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Vina J, 2012, BRIT J PHARMACOL, V167, P1, DOI 10.1111/j.1476-5381.2012.01970.x; Weinhandl ED, 2009, AM J TRANSPLANT, V9, P506, DOI 10.1111/j.1600-6143.2008.02527.x; Weinhandl ED, 2015, AM J KIDNEY DIS, V65, P98, DOI 10.1053/j.ajkd.2014.06.015; Wolfe RA, 2010, AM J TRANSPLANT, V10, P961, DOI 10.1111/j.1600-6143.2010.03021.x; Wooldridge Jeffrey M., 2012, INTRO ECONOMETRICS M, VFifth; Yan Y, 2005, MED CARE, V43, P1073, DOI 10.1097/01.mlr.0000182477.29129.86	69	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156532	10.1371/journal.pone.0156532	http://dx.doi.org/10.1371/journal.pone.0156532			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257680	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700075
J	Javalkar, P; Prakash, R; Isac, S; Washington, R; Halli, SS				Javalkar, Prakash; Prakash, Ravi; Isac, Shajy; Washington, Reynold; Halli, Shiva S.			An Estimation of Mortality Risks among People Living with HIV in Karnataka State, India: Learnings from an Intensive HIV/AIDS Care and Support Programme	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED INDIVIDUALS; ADHERENCE; SURVIVAL; DEATH; COUNTRIES; OUTCOMES; TRENDS; ADULTS; HAART	Background In Indian context, limited attempts have been made to estimate the mortality risks among people living with HIV (PLHIV). We estimated the rates of mortality among PLHIV covered under an integrated HIV-prevention cum care and support programme implemented in Karnataka state, India, and attempted to identify the key programme components associated with the higher likelihood of their survival. Methods Retrospective programme data of 55,801 PLHIV registered with the Samastha programme implemented in Karnataka state during 2006-11 was used. Kaplan-Meier survival methods were used to estimate the ten years expected survival probabilities and Cox-proportional hazard model was used to examine the factors associated with risk of mortality among PLHIV. We also calculated mortality rates (per 1000 person-year) across selected demographic and clinical parameters. Results Of the total PLHIV registered with the programme, about nine percent died within the 5-years of programme period with an overall death rate of 38 per 1000 person-years. The mortality rate was higher among males, aged 18 and above, among illiterates, and those residing in rural areas. While the presence of co-infections such as Tuberculosis leads to higher mortality rate, adherence to ART was significantly associated with reduction in overall death rate. Cox proportional hazard model revealed that increase in CD4 cell counts and exposure to intensive care and support programme for at least two years can bring significant reduction in risk of death among PLHIV [(hazard ratio: 0.234; CI: 0.211-0.260) & (hazard ratio: 0.062; CI: 0.054-0.071), respectively] even after adjusting the effect of other sociodemographic, economic and health related confounders. Conclusion Study confirms that while residing in rural areas and presence of co-infection significantly increases the mortality risk among PLHIV, adherence to ART and improvement in CD4 counts led to significant reduction in their mortality risk. Longer exposure to the intervention contributed significantly to reduce mortality among PLHIV.	[Javalkar, Prakash; Prakash, Ravi; Isac, Shajy; Washington, Reynold] Karnataka Hlth Promot Trust, Bangalore, Karnataka, India; [Isac, Shajy; Washington, Reynold; Halli, Shiva S.] Univ Manitoba, Winnipeg, MB, Canada	University of Manitoba	Javalkar, P (corresponding author), Karnataka Hlth Promot Trust, Bangalore, Karnataka, India.	prakashj@khpt.org	Prakash, Ravi/ABB-8711-2020; Washington, Reynold/AAD-7447-2020	Javalkar, Prakash/0000-0001-5569-5792; Prakash, Ravi/0000-0003-3715-5789	USAID	USAID(United States Agency for International Development (USAID))	This paper was written as a part of an evaluation of Samastha project funded by USAID and implemented by KHPT. However the project funding does not relates to this manuscript. The views expressed herein are those of the authors and do not necessarily represent the official policy or position of the USAID. We are grateful to the our colleagues of KHPT and University of Manitoba for providing the necessary inputs while preparing this paper. We appreciate the comments of the academic editor and anonymous reviewers for providing valuable suggestions that helped in improving the quality of the paper.	Abaasa AM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-241; Aggarwal Pravesh, 2009, J Assoc Physicians India, V57, P745; Arrivillaga M, 2009, REV PANAM SALUD PUBL, V26, P502, DOI 10.1590/S1020-49892009001200005; Avert, 2013, HIV AIDS IND; Bachani D, 2010, NATL MED J INDIA, V23, P7; Bajpai R. C., 2014, PUBLIC HLTH RES, V4, P31; Banandur P, 2011, SEX TRANSM INFECT, V87, pA340, DOI 10.1136/sextrans-2011-050108.592; Bhattacharjya C, 2015, WORLD J AIDS, V5, P90, DOI [10.4236/wja.2015.52011, DOI 10.4236/WJA.2015.52011]; Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; Cauldbeck MB, 2009, AIDS RES THER, V6, P7, DOI DOI 10.1186/1742-6405-6-7; Chakraborty N, 2008, JPN J INFECT DIS, V61, P49; Chi BH, 2009, INT J EPIDEMIOL, V38, P746, DOI 10.1093/ije/dyp004; Doherty MC, 2000, AIDS, V14, P717, DOI 10.1097/00002030-200004140-00011; Georgia A., 2011, HIV AIDS HAITI ANAL; Ghate Manisha, 2009, Int J Infect Dis, V13, pe1, DOI 10.1016/j.ijid.2008.03.029; Gonzalez MA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-605; Halli SS, 2015, J HIV AIDS IN PRESS; Hambisa Mitiku Teshome, 2013, ISRN AIDS, V2013, P491601, DOI 10.1155/2013/491601; Hosegood V, 2004, AIDS, V18, P663, DOI 10.1097/00002030-200403050-00011; Kee MK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-128; Krentz HB, 2005, HIV MED, V6, P99, DOI 10.1111/j.1468-1293.2005.00271.x; Lifson AR, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-4; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; NACO N, 2012, TECHN REP IND HIV ES; National AIDS Control Organisation (NACO), 2014, NAT AIDS CONTR PROGR; National Health Mission, 2014, COMPR AB CAR PROV MA; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Pandey A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000926; Rai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066860; Raj Y, 2016, INT J STD AIDS, V27, P1257, DOI 10.1177/0956462415612650; Rajagopalan N, 2009, AM J INFECT DIS, V5, P219, DOI 10.3844/ajidsp.2009.219.224; Reda AA, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/574656; Ryavanki SP, 2013, NATL J COMMUNITY MED, P4; Shaboltas AV, 2006, JAIDS-J ACQ IMM DEF, V41, P657; StataCorp, 2015, STAT SOFTW REL 14; Taylor-Smith K, 2010, MALAWI MED J, V22, P49; UNAIDS, 2014, GLOB FACT SHEET; UNAIDS, 2010, UNAIDS REP GLOB AIDS; USAID, 2011, SAM PROJ USAID INDIA; Venkatesh KK, 2012, INDIAN J CANCER, V49, P176, DOI 10.4103/0019-509X.98947; Venkatesh KK, 2010, AIDS PATIENT CARE ST, V24, P795, DOI 10.1089/apc.2010.0153; Washington RG, 2014, ASIA-PAC J PUBLIC HE, V26, P349, DOI 10.1177/1010539514537677; Wood E, 2003, ANN INTERN MED, V139, P810, DOI 10.7326/0003-4819-139-10-200311180-00008	44	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156611	10.1371/journal.pone.0156611	http://dx.doi.org/10.1371/journal.pone.0156611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253974	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700043
J	Modlinska, K; Stryjek, R				Modlinska, Klaudia; Stryjek, Rafal			Food Neophobia in Wild Rats (Rattus norvegicus) Inhabiting a Changeable Environment-A Field Study	PLOS ONE			English	Article							NORWAY RATS; LABORATORY RATS; BEHAVIOR; TASTE; PREFERENCE; EXPOSURE; FLAVOR; STRAIN; SHEEP	Food neophobia is a reaction to novel food observed in many animal species, particularly omnivores, including Rattus norvegicus. A neophobic reaction is typically characterised by avoidance of novel food and the necessity to assess both its potential value and toxicity by the animal. It has been hypothesised that this reaction is not observed in rats inhabiting a changeable environment with a high level of variability with regard to food and food sources. This study was conducted in such changeable conditions and it aims to demonstrate the behaviour of wild rats R. norvegicus in their natural habitat. The rats were studied in a farm setting, and the experimental arena was demarcated by a specially constructed pen which was freely accessible to the rats. At regular intervals, the rats were given new flavour-and smell-altered foods, while their behaviour was video-recorded. The results obtained in the study seem to confirm the hypothesis that rats inhabiting a highly changeable environment do not exhibit food neophobia. The observed reaction to novel food may be connected with a reaction to a novel object to a larger extent than to food neophobia. The value of the results obtained lies primarily in the fact that the study was conducted in the animals' natural habitat, and that it investigated their spontaneous behaviours.	[Modlinska, Klaudia; Stryjek, Rafal] Polish Acad Sci, Inst Psychol, Warsaw, Poland	Polish Academy of Sciences; Institute of Psychology of the Polish Academy of Sciences	Modlinska, K (corresponding author), Polish Acad Sci, Inst Psychol, Warsaw, Poland.	kmodlinska@wp.pl	Pisula, Wojciech/AAR-3618-2020	Pisula, Wojciech/0000-0001-5777-0549; Modlinska, Klaudia/0000-0002-2161-9019; Stryjek, Rafal/0000-0003-3889-9341	National Science Centre (Poland) [UMO-2013/09/B/HS6/03435]	National Science Centre (Poland)	This research project was supported by the National Science Centre (Poland) - grant No. UMO-2013/09/B/HS6/03435.	Addessi Elsa, 2004, Primatologie, V6, P101; BARNETT S.A, 1956, BEHAVIOUR, V9, P24, DOI 10.1163/156853956X00237; Barnett S.A., 2001, STORY RATS THEIR IMP; BARNETT SA, 1958, BRIT J PSYCHOL, V49, P195, DOI 10.1111/j.2044-8295.1958.tb00657.x; Barnett SA, 2009, RAT STUDY BEHAV; Beach FA, 1950, AM PSYCHOL, V5, P115, DOI 10.1037/h0056510; BLANCHARD DC, 1994, AGGRESSIVE BEHAV, V20, P387, DOI 10.1002/1098-2337(1994)20:5&lt;387::AID-AB2480200506&gt;3.0.CO;2-D; BLANCHARD RJ, 1989, J COMP PSYCHOL, V103, P70, DOI 10.1037/0735-7036.103.1.70; BOICE R, 1971, BEHAV RES METH INSTR, V3, P177, DOI 10.3758/BF03208127; Burritt EA, 1997, APPL ANIM BEHAV SCI, V54, P317, DOI 10.1016/S0168-1591(97)00005-1; Calhoun J. B, 1963, ECOLOGY SOCIOLOGY NO; Calisi RM, 2009, HORM BEHAV, V56, P1, DOI 10.1016/j.yhbeh.2009.02.010; CHAPPLE RS, 1987, APPL ANIM BEHAV SCI, V18, P157, DOI 10.1016/0168-1591(87)90189-4; Cheney CD, 1997, APPL ANIM BEHAV SCI, V53, P213, DOI 10.1016/S0168-1591(96)01160-4; COWAN PE, 1977, J COMP PHYSIOL PSYCH, V91, P63, DOI 10.1037/h0077297; Fraga RM, 2005, ORNITOL NEOTROP, V16, P15; Galef BG, 1998, ANIM BEHAV, V56, P1015, DOI 10.1006/anbe.1998.0867; Galef BG, 2003, J COMP PSYCHOL, V117, P96, DOI 10.1037/0735-7036.117.1.96; GALEF BG, 1983, J COMP PSYCHOL, V97, P358, DOI 10.1037/0735-7036.97.4.358; HANKINS WG, 1973, BEHAV BIOL, V8, P407, DOI 10.1016/S0091-6773(73)80081-1; Himmler BT, 2013, J COMP PSYCHOL, V127, P453, DOI 10.1037/a0032187; Inglis IR, 1996, APPL ANIM BEHAV SCI, V47, P175, DOI 10.1016/0168-1591(95)00674-5; JONES RB, 1987, BIRD BEHAV, V7, P78, DOI 10.3727/015613887791918051; KING HELEN DEAN, 1939, AMER ANAT MEMOIR, V17, P1; KRONENBERGER JP, 1985, BEHAV PROCESS, V11, P53, DOI 10.1016/0376-6357(85)90102-0; Launchbaugh KL, 1997, APPL ANIM BEHAV SCI, V54, P327, DOI 10.1016/S0168-1591(96)01194-X; LOCKARD RB, 1968, AM PSYCHOL, V23, P734, DOI 10.1037/h0026726; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; MITCHELL D, 1976, J COMP PHYSIOL PSYCH, V90, P190, DOI 10.1037/h0077196; Modlinska K, 2015, BEHAV PROCESS, V113, P41, DOI 10.1016/j.beproc.2014.12.005; Pisula W., 2015, PSYCHOLOGY, V6, P251, DOI [10.4236/psych.2015.63025, DOI 10.4236/PSYCH.2015.63025]; Pisula W, 2006, ACTA NEUROBIOL EXP, V66, P235; REVUSKY SH, 1967, SCIENCE, V155, P219, DOI 10.1126/science.155.3759.219; RICHTER CP, 1959, AM PSYCHOL, V14, P18, DOI 10.1037/h0043834; Rozin P, 2000, AM BEHAV SCI, V43, P970, DOI 10.1177/0002764200043006006; SHUMAKE SA, 1971, J COMP PHYSIOL PSYCH, V77, P489, DOI 10.1037/h0031900; SIEGEL S., 1956, NONPARAMETRIC STAT B; Stryjek R., 2012, POL PSYCHOL B, V43, P124; Stryjek R, 2016, INT J PEST MANAGE, V62, P158, DOI 10.1080/09670874.2016.1147622; Stryjek R, 2013, LAB ANIMAL, V42, P321, DOI 10.1038/laban.328; Stryjek R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066055; Stryjek R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040642; TAYLOR RH, 1989, NEW ZEAL J ECOL, V12, P23	43	21	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156741	10.1371/journal.pone.0156741	http://dx.doi.org/10.1371/journal.pone.0156741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254150	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700053
J	Nyakundi, DO; Vuko, LAM; Bentley, SJ; Hoppe, H; Blatch, GL; Boshoff, A				Nyakundi, David O.; Vuko, Loyiso A. M.; Bentley, Stephen J.; Hoppe, Heinrich; Blatch, Gregory L.; Boshoff, Aileen			Plasmodium falciparum Hep1 Is Required to Prevent the Self Aggregation of PfHsp70-3	PLOS ONE			English	Article							MITOCHONDRIAL HSP70; ATPASE DOMAIN; PROTEIN ZIM17; CHAPERONE; TRANSLOCATION; LOCALIZATION; IMPORT; MATRIX; BIOGENESIS; DNLZ/HEP	The majority of mitochondrial proteins are encoded in the nucleus and need to be imported from the cytosol into the mitochondria, and molecular chaperones play a key role in the efficient translocation and proper folding of these proteins in the matrix. One such molecular chaperone is the eukaryotic mitochondrial heat shock protein 70 (Hsp70); however, it is prone to self-aggregation and requires the presence of an essential zinc-finger protein, Hsp70-escort protein 1 (Hep1), to maintain its structure and function. PfHsp70-3, the only Hsp70 predicted to localize in the mitochondria of P. falciparum, may also rely on a Hep1 orthologue to prevent self-aggregation. In this study, we identified a putative Hep1 orthologue in P. falciparum and co-expression of PfHsp70-3 and PfHep1 enhanced the solubility of PfHsp70-3. PfHep1 suppressed the thermally induced aggregation of PfHsp70-3 but not the aggregation of malate dehydrogenase or citrate synthase, thus showing specificity for PfHsp70-3. Zinc ions were indeed essential for maintaining the function of PfHep1, as EDTA chelation abrogated its abilities to suppress the aggregation of PfHsp70-3. Soluble and functional PfHsp70-3, acquired by co-expression with PfHep-1, will facilitate the biochemical characterisation of this particular Hsp70 protein and its evaluation as a drug target for the treatment of malaria.	[Nyakundi, David O.; Vuko, Loyiso A. M.; Bentley, Stephen J.; Boshoff, Aileen] Rhodes Univ, Biotechnol Innovat Ctr, ZA-6140 Grahamstown, South Africa; [Hoppe, Heinrich] Rhodes Univ, Dept Biochem & Microbiol, ZA-6140 Grahamstown, South Africa; [Blatch, Gregory L.] Rhodes Univ, Dept Biochem & Microbiol, Biomed Biotechnol Res Unit, ZA-6140 Grahamstown, South Africa; [Blatch, Gregory L.] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic 8001, Australia	Rhodes University; Rhodes University; Rhodes University; Victoria University	Boshoff, A (corresponding author), Rhodes Univ, Biotechnol Innovat Ctr, ZA-6140 Grahamstown, South Africa.	A.Boshoff@ru.ac.za	Blatch, Gregory Lloyd/Q-5900-2019	Blatch, Gregory Lloyd/0000-0003-0778-8577; Hoppe, Heinrich/0000-0003-4409-1955	National Research Foundation (NRF) [87663]; Deutsche Forschungsgemeinschaft (DFG) [LI 402/14-1]; Mwenge Catholic University, Moshi, Tanzania; NRF Doctoral Innovation Scholarship	National Research Foundation (NRF); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Mwenge Catholic University, Moshi, Tanzania; NRF Doctoral Innovation Scholarship	This work was funded by grants from the National Research Foundation (NRF); grant number 87663 and Deutsche Forschungsgemeinschaft (DFG); grant number LI 402/14-1. D.O.N. is the recipient of academic development and training funds from Mwenge Catholic University, Moshi, Tanzania. S.J.B. is the recipient of an NRF Doctoral Innovation Scholarship.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baumann F, 2000, FEBS LETT, V487, P307, DOI 10.1016/S0014-5793(00)02364-4; Biasini M, 2014, NUCL ACIDS RES, V42; Blamowska M, 2010, J BIOL CHEM, V285, P4423, DOI 10.1074/jbc.M109.061697; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Botha M, 2011, CELL STRESS CHAPERON, V16, P389, DOI 10.1007/s12192-010-0250-6; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Buchberger A, 1994, NAT STRUCT BIOL, P195; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Burger Adelle, 2014, Journal of Parasitology Research, P172582, DOI 10.1155/2014/172582; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cockburn IL, 2014, BIOL CHEM, V395, P1353, DOI 10.1515/hsz-2014-0138; Craig EA, PROCNATLACADSCI US, V84, P4156; DeLano W., 2002, CCP4 NEWSL; Dores-Silva PR, 2015, INT J BIOL MACROMOL, V79, P903, DOI 10.1016/j.ijbiomac.2015.05.042; Fraga H, 2013, BBA-GEN SUBJECTS, V1830, P2139, DOI 10.1016/j.bbagen.2012.10.002; Goswami AV, 2010, J BIOL CHEM, V285, P19472, DOI 10.1074/jbc.M110.105957; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; Han WJ, 2001, FEBS LETT, V497, P55, DOI 10.1016/S0014-5793(01)02435-8; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Kabani M, 2008, CURR GENOMICS, V9, P338, DOI 10.2174/138920208785133280; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kluth J, 2012, FEBS LETT, V586, P3071, DOI 10.1016/j.febslet.2012.07.052; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Lee GJ, 1995, METHOD CELL BIOL, V50, P325, DOI 10.1016/S0091-679X(08)61040-7; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lewrenz I, 2013, J BIOL CHEM, V288, P30931, DOI 10.1074/jbc.M113.465997; Matouschek A, 2000, EMBO REP, V1, P404, DOI 10.1093/embo-reports/kvd093; Momose T, 2007, EMBO REP, V8, P664, DOI 10.1038/sj.embor.7400990; Muralidharan V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003488; Njunge JM, 2013, CURR PHARM DESIGN, V19, P387, DOI 10.2174/138161213804143734; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Schilke B, 1996, J CELL BIOL, V134, P603, DOI 10.1083/jcb.134.3.603; Sichting M, 2005, EMBO J, V24, P1046, DOI 10.1038/sj.emboj.7600580; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Toft DO, EXP BIOL MED MAYWOOD, V228, P111; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Vu MT, 2012, PROTEIN SCI, V21, P258, DOI 10.1002/pro.2012; Willmund F, 2008, J BIOL CHEM, V283, P16363, DOI 10.1074/jbc.M708431200; Yamamoto H, 2005, FEBS LETT, V579, P507, DOI 10.1016/j.febslet.2004.12.018; Zhai P, 2008, J BIOL CHEM, V283, P26098, DOI 10.1074/jbc.M803475200; Zhai P, 2011, BIOCHEM BIOPH RES CO, V408, P589, DOI 10.1016/j.bbrc.2011.04.066	53	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156446	10.1371/journal.pone.0156446	http://dx.doi.org/10.1371/journal.pone.0156446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253881	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700031
J	Amir, D; Jordan, MR; Bribiescas, RG				Amir, Dorsa; Jordan, Matthew R.; Bribiescas, Richard G.			A Longitudinal Assessment of Associations between Adolescent Environment, Adversity Perception, and Economic Status on Fertility and Age of Menarche	PLOS ONE			English	Article							LIFE-HISTORY; REPRODUCTIVE STRATEGIES; CHILDHOOD EXPERIENCE; SOCIOECONOMIC-STATUS; PUBERTAL MATURATION; FOOD INSECURITY; GIRLS; MORTALITY; RISK; EVOLUTION	Purpose Perceptions of environmental adversity and access to economic resources in adolescence can theoretically affect the timing of life history transitions and investment in reproductive effort. Here we present evidence of correlations between variables associated with subjective extrinsic mortality, economic status, and reproductive effort in a nationally representative American population of young adults. Methods We used a longitudinal database that sampled American participants (N >= 1,579) at four points during early adolescence and early adulthood to test whether perceptions of environmental adversity and early economic status were associated with reproductive effort. Results We found that subjectively high ratings of environmental danger and low access to economic resources in adolescence were significantly associated with an earlier age of menarche in girls and earlier, more robust fertility in young adulthood. Conclusion While energetics and somatic condition remain as possible sources of variation, the results of this study support the hypothesis that perceptions of adversity early in life and limited access to economic resources are associated with differences in reproductive effort and scheduling. How these factors may covary with energetics and somatic condition merits further investigation.	[Amir, Dorsa; Bribiescas, Richard G.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; [Jordan, Matthew R.] Yale Univ, Dept Psychol, New Haven, CT USA	Yale University; Yale University	Amir, D (corresponding author), Yale Univ, Dept Anthropol, New Haven, CT 06520 USA.	Dorsa.amir@yale.edu		Amir, Dorsa/0000-0003-0255-0228				Belachew T, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-125; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Belsky J, 2012, CURR DIR PSYCHOL SCI, V21, P310, DOI 10.1177/0963721412453588; Belsky J, 2011, J CHILD PSYCHOL PSYC, V52, P619, DOI 10.1111/j.1469-7610.2010.02327.x; Belsky J, 2009, PERSPECT PSYCHOL SCI, V4, P345, DOI 10.1111/j.1745-6924.2009.01136.x; Boynton-Jarrett R, 2013, J ADOLESCENT HEALTH, V52, P241, DOI 10.1016/j.jadohealth.2012.06.006; Brumbach BH, 2009, HUM NATURE-INT BIOS, V20, P25, DOI 10.1007/s12110-009-9059-3; Carey JR, 1998, J GERONTOL A-BIOL, V53, pB245, DOI 10.1093/gerona/53A.4.B245; Charnov Eric L., 1993, P1; Chipman A, 2015, PSYCHONEUROENDOCRINO, V62, P89, DOI 10.1016/j.psyneuen.2015.07.611; Daly M., 1978, SEX EVOLUTION BEHAV; DUNCAN GJ, 1994, CHILD DEV, V65, P296, DOI 10.1111/j.1467-8624.1994.tb00752.x; Ellis BJ, 1999, J PERS SOC PSYCHOL, V77, P387, DOI 10.1037/0022-3514.77.2.387; Ellis BJ, 2003, CHILD DEV, V74, P801, DOI 10.1111/1467-8624.00569; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Ellis BJ, 2007, CHILD DEV, V78, P1799, DOI 10.1111/j.1467-8624.2007.01092.x; Ellis BJ, 2009, HUM NATURE-INT BIOS, V20, P204, DOI 10.1007/s12110-009-9063-7; Ellison PT, 1996, AM J HUM BIOL, V8, P725, DOI 10.1002/(SICI)1520-6300(1996)8:6<725::AID-AJHB4>3.0.CO;2-S; ELLISON PT, 1993, HUM REPROD, V8, P2248, DOI 10.1093/oxfordjournals.humrep.a138015; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Emaus A, 2008, HUM REPROD, V23, P919, DOI 10.1093/humrep/dem432; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; GOLDEN WL, 1981, ACTA GENET MED GEMEL, V30, P91, DOI 10.1017/S000156600000773X; Gordon CM, 1999, PEDIATR CLIN N AM, V46, P519, DOI 10.1016/S0031-3955(05)70135-8; Graber JA, 1997, J AM ACAD CHILD PSY, V36, P1768, DOI 10.1097/00004583-199712000-00026; GRABER JA, 1995, CHILD DEV, V66, P346, DOI 10.1111/j.1467-8624.1995.tb00875.x; Griskevicius V, 2011, J PERS SOC PSYCHOL, V100, P241, DOI 10.1037/a0021082; Harris KM, 2009, NATL LONGITUDINAL ST; Harris KM, 2009, RES DESIGN; James-Todd T, 2010, ANN EPIDEMIOL, V20, P836, DOI 10.1016/j.annepidem.2010.08.006; Jean RT, 2011, AM J EPIDEMIOL, V173, P1203, DOI 10.1093/aje/kwq498; Kaplan H. S., 2005, HDB EVOLUTIONARY PSY, P68, DOI DOI 10.1002/9780470939376.CH2; KAPRIO J, 1995, HUM BIOL, V67, P739; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Khan AD, 1996, AM J HUM BIOL, V8, P717, DOI 10.1002/(SICI)1520-6300(1996)8:6<717::AID-AJHB3>3.0.CO;2-Q; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Kuzawa CW, 2007, AM J HUM BIOL, V19, P654, DOI 10.1002/ajhb.20659; Leitao Raquel Beatriz, 2013, Int J Adolesc Med Health, V25, P55, DOI 10.1515/ijamh-2013-0007; Lipson SF, 1996, HUM REPROD, V11, P2090; Low BS, 2008, CROSS-CULT RES, V42, P201, DOI 10.1177/1069397108317669; Martin JA, 2010, NATL VITAL STAT REP, V61, P1; Mishra GD, 2009, EARLY LIFE CIRCUMSTA; MOFFITT TE, 1992, CHILD DEV, V63, P47, DOI 10.1111/j.1467-8624.1992.tb03594.x; Mpora BO, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-66; Nackers LM, 2013, J NUTR EDUC BEHAV, V45, P780, DOI 10.1016/j.jneb.2013.08.001; Nettle D, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1343; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; Phipps SA, 2006, OBES REV, V7, P5, DOI 10.1111/j.1467-789X.2006.00217.x; Polak M, 1998, P ROY SOC B-BIOL SCI, V265, P2197, DOI 10.1098/rspb.1998.0559; Prebeg Z, 2000, AM J HUM BIOL, V12, P503; Quinlan RJ, 2010, HUM NATURE-INT BIOS, V21, P124, DOI 10.1007/s12110-010-9085-1; Roff Derek A., 1992; Rutherford JN, 2010, AM J HUM BIOL, V22, P310, DOI 10.1002/ajhb.20986; Saez E., 2014, 20625 NBER; Santos-Ruiz A, 2012, PSYCHONEUROENDOCRINO, V37, P1912, DOI 10.1016/j.psyneuen.2012.04.002; Schultz TP, 2005, FERTILITY AND INCOME; Simpson JA, 2012, DEV PSYCHOL, V48, P674, DOI 10.1037/a0027293; Slovic P, 2000, PERCEPTION RISK; Snyder JK, 2011, EVOL HUM BEHAV, V32, P127, DOI 10.1016/j.evolhumbehav.2010.08.007; STEARNS SC, 1977, ANNU REV ECOL SYST, V8, P145, DOI 10.1146/annurev.es.08.110177.001045; Stearns SC, 2010, NAT REV GENET, V11, P611, DOI 10.1038/nrg2831; STJOHN C, 1990, SOC SCI QUART, V71, P152; Trusts PC, 2012, PURSUING AM DREAM EC; Valeggia CR, 2001, FOUND HUM B, P85; Vandell DL, 2010, CHILD DEV, V81, P737, DOI 10.1111/j.1467-8624.2010.01431.x; Wang Xiaofei, 2013, Evolution Medicine and Public Health, P241, DOI 10.1093/emph/eot013; Wattigney WA, 1998, ETHNIC DIS, V9, P181; Wildsmith E, 2006, J MARRIAGE FAM, V68, P491, DOI 10.1111/j.1741-3737.2006.00267.x; WILSON M, 1985, ETHOL SOCIOBIOL, V6, P59, DOI 10.1016/0162-3095(85)90041-X; Yermachenko A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/371583	70	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155883	10.1371/journal.pone.0155883	http://dx.doi.org/10.1371/journal.pone.0155883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27249338	Green Submitted, gold, Green Published			2022-12-26	WOS:000377184700021
J	Broeckling, BE; Watson, RA; Steinwand, B; Bush, DR				Broeckling, Bettina E.; Watson, Ruth A.; Steinwand, Blaire; Bush, Daniel R.			Intronic Sequence Regulates Sugar-Dependent Expression of Arabidopsis thaliana Production of Anthocyanin Pigment-1/MYB75	PLOS ONE			English	Article							ANTHOCYANIN BIOSYNTHETIC-PATHWAY; SUCROSE-INDUCIBLE EXPRESSION; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; SWEET-POTATO; BETA-AMYLASE; GUS GENE; ELEMENTS; PROMOTER; INDUCTION	Sucrose-specific regulation of gene expression is recognized as an important signaling response, distinct from glucose, which serves to modulate plant growth, metabolism, and physiology. The Arabidopsis MYB transcription factor Production of Anthocyanin Pigment-1 (PAP1) plays a key role in anthocyanin biosynthesis and expression of PAP1 is known to be regulated by sucrose. Sucrose treatment of Arabidopsis seedlings led to a 20-fold induction of PAP1 transcript, which represented a 6-fold increase over levels in glucose-treated seedlings. The PAP1 promoter was not sufficient for conferring a sucrose response to a reporter gene and did not correctly report expression of PAP1 in plants. Although we identified 3 putative sucrose response elements in the PAP1 gene, none were found to be necessary for this response. Using deletion analysis, we identified a 90 bp sequence within intron 1 of PAP1 that is necessary for the sucrose response. This sequence was sufficient for conferring a sucrose response to a minimal promoter: luciferase reporter when present in multiple copies upstream of the promoter. This work lays the foundation for dissecting the sucrose signaling pathway of PAP1 and contributes to understanding the interplay between sucrose signaling, anthocyanin biosynthesis, and stress responses.	[Broeckling, Bettina E.; Watson, Ruth A.; Steinwand, Blaire; Bush, Daniel R.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Watson, Ruth A.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Steinwand, Blaire] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	Colorado State University; Colorado State University; University of North Carolina; University of North Carolina Chapel Hill	Bush, DR (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	d.bush@colostate.edu	Bush, Daniel R/AAG-8444-2019	Bush, Daniel/0000-0002-9160-5077				Ainsworth EA, 2011, PLANT PHYSIOL, V155, P157; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Chalker-Scott L, 1999, PHOTOCHEM PHOTOBIOL, V70, P1, DOI 10.1111/j.1751-1097.1999.tb01944.x; Chiou TJ, 1998, P NATL ACAD SCI USA, V95, P4784, DOI 10.1073/pnas.95.8.4784; Choi HI, 2000, J BIOL CHEM, V275, P1723, DOI 10.1074/jbc.275.3.1723; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Comelli RN, 2009, PHYSIOL PLANTARUM, V137, P213, DOI 10.1111/j.1399-3054.2009.01285.x; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; Deyholos MK, 2000, PLANT CELL, V12, P1799, DOI 10.1105/tpc.12.10.1799; FU HY, 1995, PLANT CELL, V7, P1387, DOI 10.1105/tpc.7.9.1387; Geisler M, 2006, PLANT J, V45, P384, DOI 10.1111/j.1365-313X.2005.02634.x; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Gonzali S, 2006, J PLANT RES, V119, P115, DOI 10.1007/s10265-005-0251-1; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; GRIERSON C, 1994, PLANT J, V5, P815, DOI 10.1046/j.1365-313X.1994.5060815.x; Han L, 2015, GENET MOL RES, V14, P4784, DOI 10.4238/2015.May.11.11; Hatier JHB, 2008, J THEOR BIOL, V253, P625, DOI 10.1016/j.jtbi.2008.04.018; Hattori T, 2002, PLANT CELL PHYSIOL, V43, P136, DOI 10.1093/pcp/pcf014; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; ISHIGURO S, 1992, PLANT MOL BIOL, V18, P97, DOI 10.1007/BF00018460; JEFFERSON R, 1990, PLANT MOL BIOL, V14, P995, DOI 10.1007/BF00019396; Jeong SW, 2010, PLANT PHYSIOL, V154, P1514, DOI 10.1104/pp.110.161869; JOHNSON R, 1990, PLANT MOL BIOL, V14, P527, DOI 10.1007/BF00027498; Khoshnoodi J, 1998, PLANT SCI, V135, P183, DOI 10.1016/S0168-9452(98)00093-4; Kim KN, 1999, PLANT PHYSIOL, V121, P225, DOI 10.1104/pp.121.1.225; KIM SR, 1991, PLANT MOL BIOL, V17, P973, DOI 10.1007/BF00037137; Kunz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100312; Kwak MS, 2006, GENE, V366, P87, DOI 10.1016/j.gene.2005.09.021; Li XY, 2002, PLANT SCI, V162, P239, DOI 10.1016/S0168-9452(01)00565-9; Li Y, 2014, MOL PLANT, V7, P570, DOI 10.1093/mp/sst161; Loreti E, 2008, NEW PHYTOL, V179, P1004, DOI 10.1111/j.1469-8137.2008.02511.x; Luo QJ, 2012, PLANT MOL BIOL, V80, P117, DOI 10.1007/s11103-011-9778-9; Maeo K, 2001, PLANT MOL BIOL, V46, P627, DOI 10.1023/A:1010684908364; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; MITA S, 1995, PLANT PHYSIOL, V107, P895, DOI 10.1104/pp.107.3.895; Morikami A, 2005, MOL GENET GENOMICS, V272, P690, DOI 10.1007/s00438-004-1100-y; Mutisya J, 2006, J PLANT PHYSIOL, V163, P770, DOI 10.1016/j.jplph.2005.04.038; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rombauts S, 2003, PLANT PHYSIOL, V132, P1162, DOI 10.1104/pp.102.017715; Rook F, 2003, J EXP BOT, V54, P495, DOI 10.1093/jxb/erg054; Scarpella E, 2005, PLANT CELL PHYSIOL, V46, P1400, DOI 10.1093/pcp/pci153; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; Sheen J, 2014, J PLANT BIOL, V57, P67, DOI 10.1007/s12374-014-0902-7; Shen QX, 1996, PLANT CELL, V8, P1107, DOI 10.1105/tpc.8.7.1107; Shin DH, 2013, BIOCHEM BIOPH RES CO, V430, P634, DOI 10.1016/j.bbrc.2012.11.100; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Sivitz AB, 2008, PLANT PHYSIOL, V147, P92, DOI 10.1104/pp.108.118992; Sivitz AB, 2007, PLANT PHYSIOL, V143, P188, DOI 10.1104/pp.106.089003; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Tang ZJ, 2001, PLANT PHYSIOL, V125, P797, DOI 10.1104/pp.125.2.797; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Tognetti JA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23316; TSUKAYA H, 1991, PLANT PHYSIOL, V97, P1414, DOI 10.1104/pp.97.4.1414; Usadel B, 2008, PLANT PHYSIOL, V146, P1834, DOI 10.1104/pp.107.115592; Vaughn MW, 2002, P NATL ACAD SCI USA, V99, P10876, DOI 10.1073/pnas.172198599; VISSER RGF, 1991, PLANT MOL BIOL, V17, P691, DOI 10.1007/BF00037054; Weiner M, 1995, PCR PRIMER LAB MANUA; Weise A, 2008, PLANT MOL BIOL, V68, P251, DOI 10.1007/s11103-008-9366-9; WENZLER H, 1989, PLANT MOL BIOL, V13, P347, DOI 10.1007/BF00015546; WENZLER HC, 1989, PLANT MOL BIOL, V12, P41, DOI 10.1007/BF00017446; Wind J, 2010, PHYTOCHEMISTRY, V71, P1610, DOI 10.1016/j.phytochem.2010.07.007; YOKOYAMA R, 1994, MOL GEN GENET, V244, P15, DOI 10.1007/BF00280182; Zhang Y, 2014, CURR OPIN PLANT BIOL, V19, P81, DOI 10.1016/j.pbi.2014.05.011; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zourelidou M, 2002, PLANT J, V30, P489, DOI 10.1046/j.1365-313X.2002.01302.x	72	15	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156673	10.1371/journal.pone.0156673	http://dx.doi.org/10.1371/journal.pone.0156673			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248141	Green Published, gold, Green Submitted			2022-12-26	WOS:000377184700064
J	M'ng, JCP; Mehralizadeh, M				M'ng, Jacinta Chan Phooi; Mehralizadeh, Mohammadali			Forecasting East Asian Indices Futures via a Novel Hybrid of Wavelet-PCA Denoising and Artificial Neural Network Models	PLOS ONE			English	Article							STOCK-MARKET; EMERGING MARKETS; COMPLEX NETWORK; TIME-SERIES; PREDICTION; RETURNS; RULE; SELECTION; GA	The motivation behind this research is to innovatively combine new methods like wavelet, principal component analysis (PCA), and artificial neural network (ANN) approaches to analyze trade in today's increasingly difficult and volatile financial futures markets. The main focus of this study is to facilitate forecasting by using an enhanced denoising process on market data, taken as a multivariate signal, in order to deduct the same noise from the open-high-low-close signal of a market. This research offers evidence on the predictive ability and the profitability of abnormal returns of a new hybrid forecasting model using Wavelet-PCA denoising and ANN (named WPCA-NN) on futures contracts of Hong Kong's Hang Seng futures, Japan's NIKKEI 225 futures, Singapore's MSCI futures, South Korea's KOSPI 200 futures, and Taiwan's TAIEX futures from 2005 to 2014. Using a host of technical analysis indicators consisting of RSI, MACD, MACD Signal, Stochastic Fast % K, Stochastic Slow % K, Stochastic % D, and Ultimate Oscillator, empirical results show that the annual mean returns of WPCA-NN are more than the threshold buy-and-hold for the validation, test, and evaluation periods; this is inconsistent with the traditional random walk hypothesis, which insists that mechanical rules cannot outperform the threshold buy-andhold. The findings, however, are consistent with literature that advocates technical analysis.	[M'ng, Jacinta Chan Phooi; Mehralizadeh, Mohammadali] Univ Malaya, Fac Business & Accountancy, Kuala Lumpur 50603, Malaysia	Universiti Malaya	M'ng, JCP (corresponding author), Univ Malaya, Fac Business & Accountancy, Kuala Lumpur 50603, Malaysia.	jacinta@um.edu.my	Chan, Jacinta/ABB-1210-2021	Chan, Jacinta/0000-0002-0083-6014				Aminghafari M, 2006, COMPUT STAT DATA AN, V50, P2381, DOI 10.1016/j.csda.2004.12.010; [Anonymous], 2014, NARX TOOLB US MATLAB; [Anonymous], 2014, LEV MARQ FUNCT US MA; [Anonymous], 2014, WMULDEN FUNCT US MAT; Antoniadis A., 2001, J STAT SOFTW, V6, P1, DOI [10.18637/jss.v006.i06, DOI 10.18637/JSS.V006.I06]; Atsalakis GS, 2009, EXPERT SYST APPL, V36, P5932, DOI 10.1016/j.eswa.2008.07.006; Bahrammirzaee A, 2010, NEURAL COMPUT APPL, V19, P1165, DOI 10.1007/s00521-010-0362-z; Bakshi BR, 1999, J CHEMOMETR, V13, P415, DOI 10.1002/(SICI)1099-128X(199905/08)13:3/4<415::AID-CEM544>3.0.CO;2-8; Boboc I-A, 2013, ALGORITHM TESTING EF; Booth A, 2014, EXPERT SYST APPL, V41, P3651, DOI 10.1016/j.eswa.2013.12.009; Chen AS, 2004, COMPUT OPER RES, V31, P1049, DOI 10.1016/S0305-0548(03)00064-9; Cheng CH, 2010, INFORM SCIENCES, V180, P1610, DOI 10.1016/j.ins.2010.01.014; Chiang T. C., 2001, REV QUANTITATIVE FIN, V17, P301, DOI DOI 10.1023/A:1012296727217; Coronel-Brizio HF, 2007, PHYSICA A, V380, P391, DOI 10.1016/j.physa.2007.02.109; Dempster M. A. H., 2001, Quantitative Finance, V1, P397, DOI 10.1088/1469-7688/1/4/301; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; Dunis CL, 2005, J ASSET MANAG, V6, P168, DOI 10.1057/palgrave.jam.2240174; Enke D, 2005, EXPERT SYST APPL, V29, P927, DOI 10.1016/j.eswa.2005.06.024; ERRUNZA VR, 1994, J PORTFOLIO MANAGE, V20, P82, DOI 10.3905/jpm.1994.82; FAMA EF, 1991, J FINANC, V46, P1575, DOI 10.2307/2328565; Fama EF, 1965, FINANC ANAL J, V21, P55, DOI 10.2469/faj.v51.n1.1861; Fernandez-Rodriguez F, 2000, ECON LETT, V69, P89, DOI 10.1016/S0165-1765(00)00270-6; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Garliauskas A, 1999, SYST MAN CYB 1999 IE; Guo ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101113; Guo ZQ, 2013, SOFT COMPUT, V17, P805, DOI 10.1007/s00500-012-0953-y; Harris L, 2013, FINANC ANAL J, V69, P6; Hassan MR, 2007, EXPERT SYST APPL, V33, P171, DOI 10.1016/j.eswa.2006.04.007; He K, 2014, MATH PROBLEMS ENG, V2014; Hsieh TJ, 2011, APPL SOFT COMPUT, V11, P2510, DOI 10.1016/j.asoc.2010.09.007; Hu Y, 2015, EXPERT SYST APPL, V42, P212, DOI 10.1016/j.eswa.2014.07.059; Huang H, 2009, IEEE T EVOLUT COMPUT, V13, P56, DOI 10.1109/TEVC.2008.911682; Jin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142064; Johnstone I. M., 2011, GAUSSIAN ESTIM UNPUB; KARHUNEN J, 1995, NEURAL NETWORKS, V8, P549, DOI 10.1016/0893-6080(94)00098-7; Karlis D, 2003, COMMUN STAT-THEOR M, V32, P643, DOI 10.1081/STA-120018556; Kim HJ, 2007, APPL SOFT COMPUT, V7, P569, DOI 10.1016/j.asoc.2006.03.004; Kim K, 1998, EXTRACTING TRADING R; Lee SJ, 2010, APPL INTELL, V32, P364, DOI 10.1007/s10489-008-0150-y; LEITCH G, 1991, AM ECON REV, V81, P580; Lertpalangsunti N, 1998, ENG APPL ARTIF INTEL, V11, P549, DOI 10.1016/S0952-1976(98)00013-X; Leung MT, 2000, INT J FORECASTING, V16, P173, DOI 10.1016/S0169-2070(99)00048-5; Li K., 2003, J EMPIR FINANC, V10, P57, DOI DOI 10.1016/S0927-5398(02)00027-0; Lotric U, 2004, NEUROCOMPUTING, V62, P179, DOI 10.1016/j.neucom.2004.02.003; Lotric U, 2005, NEURAL COMPUT APPL, V14, P11, DOI 10.1007/s00521-004-0434-z; MAKRIDAKIS S, 1993, INT J FORECASTING, V9, P527, DOI 10.1016/0169-2070(93)90079-3; McClelland J. L., 1986, PARALLEL DISTRIBUTED, V2; Moazzami M, 2013, APPL ENERG, V101, P489, DOI 10.1016/j.apenergy.2012.06.009; Necula C, 2009, ROM J ECON FORECAST, V10, P118; Ni H, 2009, NEUROCOMPUTING, V72, P2815, DOI 10.1016/j.neucom.2008.09.023; Olson D, 2004, J BANK FINANC, V28, P85, DOI 10.1016/S0378-4266(02)00399-0; Pei-Chann Chang, 2004, Journal of the Chinese Institute of Industrial Engineers, V21, P358, DOI 10.1080/10170660409509416; PESARAN MH, 1994, J FORECASTING, V13, P335, DOI 10.1002/for.3980130402; Pindoriya NM, 2008, IEEE T POWER SYST, V23, P1423, DOI 10.1109/TPWRS.2008.922251; Pukthuanthong K, 2006, FOREIGN EXCHANGE MAR; Quah TS, 1999, EXPERT SYST APPL, V17, P295, DOI 10.1016/S0957-4174(99)00041-X; Ramsey J.B., 1997, J EMPIR FINANC, P341, DOI DOI 10.1016/S0927-5398(96)00013-8; REFENES AN, 1994, NEURAL NETWORKS, V7, P375, DOI 10.1016/0893-6080(94)90030-2; Roman J, 1996, SYST SCI 1996 P 29 H; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; Shafie-khah M, 2011, ENERG CONVERS MANAGE, V52, P2165, DOI 10.1016/j.enconman.2010.10.047; Siegelmann HT, 1997, IEEE T SYST MAN CY B, V27, P208, DOI 10.1109/3477.558801; Taha I, 1997, INT J SMART ENG SYST, V1, P59; Taylor S., 1986, MODELLING FINANCIAL; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; Wang L., 2013, TIME SERIES ANAL MOD, P229; Wang L. P., 2006, DATA MINING COMPUTAT; Xiao Y, 2014, INT J COMPUT INT SYS, V7, P272, DOI 10.1080/18756891.2013.864472; Yao J., 1999, INT J THEOR APPL FIN, V2, P221; YOON YO, 1993, J OPER RES SOC, V44, P51, DOI 10.2307/2584434; ZADEH LA, 1994, MODEL IDENT CONTROL, V15, P191, DOI 10.4173/mic.1994.3.9; Zhang XZ, 2014, NEUROCOMPUTING, V142, P48, DOI 10.1016/j.neucom.2014.01.057; Zhang YD, 2009, EXPERT SYST APPL, V36, P8849, DOI 10.1016/j.eswa.2008.11.028; Zurada J.M., 1992, INTRO ARTIFICIAL NEU	77	17	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156338	10.1371/journal.pone.0156338	http://dx.doi.org/10.1371/journal.pone.0156338			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27248692	Green Published, gold, Green Submitted			2022-12-26	WOS:000377184700036
J	Nagai-Okatani, C; Nagasawa, H; Nagata, S				Nagai-Okatani, Chiaki; Nagasawa, Hiromichi; Nagata, Shinji			Tachykinin-Related Peptides Share a G Protein-Coupled Receptor with Ion Transport Peptide-Like in the Silkworm Bombyx mori	PLOS ONE			English	Article							NEUROPEPTIDE; EXPRESSION; IDENTIFICATION; NEURONS; GENES; CDNA; ITP	Recently, we identified an orphan Bombyx mori neuropeptide G protein-coupled receptor (BNGR)-A24 as an ion transport peptide-like (ITPL) receptor. BNGR-A24 belongs to the same clade as BNGR-A32 and -A33, which were recently identified as natalisin receptors. Since these three BNGRs share high similarities with known receptors for tachykinin-related peptides (TRPs), we examined whether these BNGRs can function as physiological receptors for five endogenous B. mori TRPs (TK-1-5). In a heterologous expression system, BNGR-A24 acted as a receptor for all five TRPs. In contrast, BNGR-A32 responded only to TK-5, and BNGR-A33 did not respond to any of the TRPs. These findings are consistent with recent studies on the ligand preferences for B. mori natalisins. Furthermore, we evaluated whether the binding of ITPL and TRPs to BNGR-A24 is competitive by using a Ca2+ imaging assay. Concomitant addition of a TRP receptor antagonist, spantide I, reduced the responses of BNGR-A24 not only to TK-4 but also to ITPL. The results of a binding assay using fluorescent-labeled BNGR-A24 and ligands demonstrated that the binding of ITPL to BNGR-A24 was inhibited by TK-4 as well as by spantide I, and vice versa. In addition, the ITPL-induced increase in cGMP levels of BNGR-A24-expressing BmN cells was suppressed by the addition of excess TK-4 or spantide I. The intracellular levels of cAMP and cGMP, as second messenger candidates of the TRP signaling, were not altered by the five TRPs, suggesting that these peptides act via different signaling pathways from cAMP and cGMP signaling at least in BmN cells. Taken together, the present findings suggest that ITPL and TRPs are endogenous orthosteric ligands of BNGR-A24 that may activate discrete signaling pathways. This receptor, which shares orthosteric ligands, may constitute an important model for studying ligand-biased signaling.	[Nagai-Okatani, Chiaki; Nagasawa, Hiromichi; Nagata, Shinji] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan; [Nagata, Shinji] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan; [Nagai-Okatani, Chiaki] Natl Inst Adv Ind Sci & Technol, Dept Life Sci & Biotechnol, Tsukuba, Japan; [Nagasawa, Hiromichi] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	University of Tokyo; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Zhejiang University	Nagata, S (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo, Japan.	chiaki-okatani@aist.go.jp; shinjin@edu.k.u-tokyo.ac.jp	Nagai-Okatani, Chiaki/L-2883-2018	Nagai-Okatani, Chiaki/0000-0003-4084-3128	JSPS KAKENHI [22-1424]; MEXT KAKENHI [24580157]; NAITO Foundation; Grants-in-Aid for Scientific Research [15H04609] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NAITO Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the JSPS KAKENHI (Grant-in-Aid for JSPS Fellows [22-1424]) to CN-O (URL: https://www.jsps.go.jp/english/e-grants/) and MEXT KAKENHI (Grant-in-Aid for Scientific Research (C) [24580157]) to SN (URL: https://www.jsps.go.jp/english/e-grants/) and the NAITO Foundation to SN (URL: https://www.naito-f.or.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUDSLEY N, 1992, J EXP BIOL, V173, P261; Audsley N, 2013, PEPTIDES, V41, P74, DOI 10.1016/j.peptides.2012.11.001; Begum K, 2009, INSECT BIOCHEM MOLEC, V39, P717, DOI 10.1016/j.ibmb.2009.08.005; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Dai L, 2007, J COMP NEUROL, V500, P353, DOI 10.1002/cne.21192; Damulewicz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021258; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dircksen H, 2009, J EXP BIOL, V212, P401, DOI 10.1242/jeb.026112; Drexler AL, 2007, CELL TISSUE RES, V329, P391, DOI 10.1007/s00441-007-0391-9; Endo H, 2000, INSECT BIOCHEM MOLEC, V30, P355, DOI 10.1016/S0965-1748(99)00129-0; Fan Y, 2010, INSECT BIOCHEM MOLEC, V40, P581, DOI 10.1016/j.ibmb.2010.05.005; FONAGY A, 1992, BIOSCI BIOTECH BIOCH, V56, P1692, DOI 10.1271/bbb.56.1692; He XB, 2014, BIOCHEMISTRY-US, V53, P6667, DOI 10.1021/bi5007207; Hermann C, 2013, J COMP NEUROL, V521, P367, DOI 10.1002/cne.23178; Jiang HB, 2014, SCI REP-UK, V4, DOI 10.1038/srep06800; Jiang HB, 2013, P NATL ACAD SCI USA, V110, pE3526, DOI 10.1073/pnas.1310676110; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Katayama Hidekazu, 2013, Aqua-Bioscience Monographs, V6, P49; KELLER R, 1992, EXPERIENTIA, V48, P439, DOI 10.1007/BF01928162; Khoury E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00068; Kostenis E, 2005, TRENDS PHARMACOL SCI, V26, P595, DOI 10.1016/j.tips.2005.09.007; LIU XY, 2012, ABSTR APPL ANAL, P40359, DOI DOI 10.1155/2012/; Meredith J, 1996, J EXP BIOL, V199, P1053; Nagai C, 2014, J BIOL CHEM, V289, P32166, DOI 10.1074/jbc.M114.590646; Nagata S, 2011, GEN COMP ENDOCR, V172, P90, DOI 10.1016/j.ygcen.2011.03.004; Nassel D. R., 2013, HDB BIOL ACTIVE PEPT, P315, DOI DOI 10.1016/B978-0-12-385095-9.00044-0; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Poels J, 2004, J NEUROCHEM, V90, P472, DOI 10.1111/j.1471-4159.2004.02506.x; Poels J, 2007, PEPTIDES, V28, P103, DOI 10.1016/j.peptides.2006.06.014; Poels J, 2009, PEPTIDES, V30, P545, DOI 10.1016/j.peptides.2008.10.012; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Satake H, 2013, PROTEIN PEPTIDE LETT, V20, P615, DOI 10.2174/0929866511320060002; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Torfs Herbert, 2002, Invertebrate Neuroscience, V4, P119, DOI 10.1007/s10158-001-0013-2; Van Loy T, 2010, PEPTIDES, V31, P520, DOI 10.1016/j.peptides.2009.09.023; Vanden Broeck J, 1999, ANN NY ACAD SCI, V897, P374, DOI 10.1111/j.1749-6632.1999.tb07907.x; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048	40	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156501	10.1371/journal.pone.0156501	http://dx.doi.org/10.1371/journal.pone.0156501			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248837	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700047
J	Rao, SJ; Meleppattu, S; Pal, JK				Rao, Shilpa J.; Meleppattu, Shimi; Pal, Jayanta K.			A GCN2-Like eIF2 alpha Kinase (LdeK1) of Leishmania donovani and Its Possible Role in Stress Response	PLOS ONE			English	Article							INITIATION FACTOR-2-ALPHA; TRANSLATIONAL CONTROL; GCN2; PHOSPHORYLATION; ACTIVATION; DOMAIN; METACYCLOGENESIS; DIFFERENTIATION; IDENTIFICATION; PROMASTIGOTE	Translation regulation in Leishmania parasites assumes significance particularly because they encounter myriad of stresses during their life cycle. The eukaryotic initiation factor 2 alpha (eIF2 alpha) kinases, the well-known regulators of translation initiation in higher eukaryotes have now been found to control various processes in these protozoan parasites as well. Here, we report on cloning and characterization of a GCN2-like eIF2 alpha kinase from L. donovani and also on its modulation during nutrient starvation. We cloned a GCN2-like kinase from L. donovani, which we named as LdeK1 and validated it to be a functional eIF2 alpha kinase by in vitro kinase assay. LdeK1 was found to be localized in the cytoplasm of the promastigotes with a five-fold higher expression in this stage of the parasite as compared to the axenic amastigotes. Phosphorylation of eIF2 alpha and a G1-arrest was observed in response to nutrient starvation in the wild-type parasites. In contrast, phosphorylation was significantly impaired in a dominant-negative mutant of LdeK1 during this stress with a subsequent failure to bring about a G1-arrest during cell cycle. Thus, LdeK1 is a functional GCN2-like kinase of L. donovani which responds to nutrient starvation by phosphorylating its substrate, eIF2 alpha and a G1-arrest in the cell cycle. Nutrient starvation is encountered by the parasites inside the vector which triggers metacyclogenesis. We therefore propose that global translational regulation by activation of LdeK1 followed by eIF2 alpha phosphorylation and G1-arrest during nutrient starvation in the gut of sandfly vector could be one of the mechanisms to retool the cellular machinery required for metacyclogenesis of Leishmania promastigotes.	[Rao, Shilpa J.; Pal, Jayanta K.] Savitribai Phule Pune Univ, Dept Biotechnol, Cell & Mol Biol Lab, Pune 411007, Maharashtra, India; [Rao, Shilpa J.] Savitribai Phule Pune Univ, Interdisciplinary Sch Hlth Sci, Pune 411007, Maharashtra, India	Savitribai Phule Pune University; Savitribai Phule Pune University	Pal, JK (corresponding author), Savitribai Phule Pune Univ, Dept Biotechnol, Cell & Mol Biol Lab, Pune 411007, Maharashtra, India.	jkpal@unipune.ac.in	Meleppattu, Shimi/AAY-9070-2020	Meleppattu, Shimi/0000-0003-3929-9997; Pal, Jayanta/0000-0003-1840-6458	Department of Science and Technology (DST), Govt. of India (DST PURSE programme); Department Research and Development program of the Savitribai Phule Pune University; Department of Biotechnology, Govt. of India [BT/PR5553/BRB/10/1086/2012]; Council of Scientific and Industrial Research	Department of Science and Technology (DST), Govt. of India (DST PURSE programme); Department Research and Development program of the Savitribai Phule Pune University; Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge the financial supports received from the Department of Science and Technology (DST), Govt. of India (DST PURSE programme), Department Research and Development program of the Savitribai Phule Pune University and Department of Biotechnology, Govt. of India (BT/PR5553/BRB/10/1086/2012) to JKP. SJR and SM thank Department of Biotechnology, Govt. of India, and Council of Scientific and Industrial Research, respectively for their research fellowships. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barak E, 2005, MOL BIOCHEM PARASIT, V141, P99, DOI 10.1016/j.molbiopara.2005.02.004; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BATES PA, 1993, EXP PARASITOL, V76, P412, DOI 10.1006/expr.1993.1050; CHEN JJ, 1989, J BIOL CHEM, V264, P9559; Chow C, 2011, CELL MICROBIOL, V13, P1059, DOI 10.1111/j.1462-5822.2011.01602.x; Cloutier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035085; DASILVA R, 1987, INFECT IMMUN, V55, P2802, DOI 10.1128/IAI.55.11.2802-2806.1987; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Fennell C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-99; Garcia-Barrio M, 2000, EMBO J, V19, P1887, DOI 10.1093/emboj/19.8.1887; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Joyce BR, 2010, P NATL ACAD SCI USA, V107, P17200, DOI 10.1073/pnas.1007610107; Konrad C, 2011, A GCN2 LIKE EUKARYOT, V10, P1403, DOI 10.1128/EC.05117-11; Konrad C, 2014, INT J PARASITOL, V44, P139, DOI 10.1016/j.ijpara.2013.08.005; Lageix S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004326; Lahav T, 2010, MULTIPLE LEVELS GENE, P1, DOI [10.1096/fj.10-157529, DOI 10.1096/FJ.10-157529]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKean PG, 2001, CELL MICROBIOL, V3, P511, DOI 10.1046/j.1462-5822.2001.00135.x; Mohrle JJ, 1997, BIOCHEM J, V328, P677; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; Nameki N, 2004, PROTEIN SCI, V13, P2089, DOI 10.1110/ps.04751804; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Olsen DS, 1998, GENETICS, V149, P1495; Ouakad M, 2007, PARASITOL RES, V101, P473, DOI 10.1007/s00436-007-0491-1; RAMIREZ M, 1992, MOL CELL BIOL, V12, P5801, DOI 10.1128/MCB.12.12.5801; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Saar Y, 1998, MOL BIOCHEM PARASIT, V95, P9, DOI 10.1016/S0166-6851(98)00062-0; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Serafim TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001833; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sood R, 2000, GENETICS, V154, P787; Sreejith RK, 2009, BIOCHEM BIOPH RES CO, V390, P273, DOI 10.1016/j.bbrc.2009.09.106; Sullivan WJ, 2004, BIOCHEM J, V380, P523, DOI 10.1042/BJ20040262; Tonelli RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027904; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK RC, 1990, MOL CELL BIOL, V10, P2820, DOI 10.1128/MCB.10.6.2820; Zhang M, 2012, P NATL ACAD SCI USA, V109, P3956, DOI 10.1073/pnas.1121567109; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808; ZILBERSTEIN D, 1994, ANNU REV MICROBIOL, V48, P449, DOI 10.1146/annurev.mi.48.100194.002313	48	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156032	10.1371/journal.pone.0156032	http://dx.doi.org/10.1371/journal.pone.0156032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248816	gold, Green Submitted, Green Published			2022-12-26	WOS:000377184700027
J	Al-Majedy, YK; Al-Amiery, AA; Kadhum, AAH; Mohamad, AB				Al-Majedy, Yasameen K.; Al-Amiery, Ahmed A.; Kadhum, Abdul Amir H.; Mohamad, Abu Bakar			Antioxidant Activities of 4-Methylumbelliferone Derivatives	PLOS ONE			English	Article							COUMARIN 1,2-BENZOPYRONE; NITRIC-OXIDE; PHASE-II; CIMETIDINE; 3-ARYLCOUMARINS; CARCINOMA; TOXICITY; SERIES	The synthesis of derivatives of 4-Methylumbelliferone (4-MUs), which are structurally interesting antioxidants, was performed in this study. The modification of 4-Methylumbelliferone (4-MU) by different reaction steps was performed to yield the target compounds, the 4-MUs. The 4-MUs were characterized by different spectroscopic techniques (Fourier transform infrared; FT-IR and Nuclear magnetic resonance; NMR) and micro-elemental analysis (CHNS). The in vitro antioxidant activity of the 4-MUs was evaluated in terms of their free radical scavenging activities against 2,2-diphenyl-1-picrylhydrazyl (DPPH), Nitric oxide radical scavenging activity assay, chelating activity and their (FRAP) ferric-reducing antioxidant power, which were compared with a standard antioxidant. Our results reveal that the 4-MUs exhibit excellent radical scavenging activities. The antioxidant mechanisms of the 4-MUs were also studied. Density Function Theory (DFT)-based quantum chemical studies were performed with the basis set at 3-21G. Molecular models of the synthesized compounds were studied to understand the antioxidant activity. The electron levels, namely HOMO (highest occupied molecular orbital) and LUMO (lowest unoccupied molecular orbital), for these synthesized antioxidants were also studied.	[Al-Majedy, Yasameen K.; Al-Amiery, Ahmed A.; Kadhum, Abdul Amir H.] Univ Kebangsaan Malaysia, Dept Chem & Proc Engn, Bangi 43000, Selangor, Malaysia; [Mohamad, Abu Bakar] Univ Kebangsaan Malaysia, Fuel Cell Inst, Bangi 43000, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Al-Amiery, AA (corresponding author), Univ Kebangsaan Malaysia, Dept Chem & Proc Engn, Bangi 43000, Selangor, Malaysia.	dr.ahmed1975@gmail.com	, Abu Bakar Mohamad/J-5638-2014; Almajedy, yasameen Kadhim H./AAX-3695-2021; Kadhum, Abdul Amir/AAB-7234-2021; Al-Amiery, Ahmed/C-1520-2013	, Abu Bakar Mohamad/0000-0001-5135-7956; Kadhum, Abdul Amir/0000-0003-4074-9123; Al-Amiery, Ahmed/0000-0003-1033-4904	Universiti Kebangsaan Malaysia [DIP-2012-02]	Universiti Kebangsaan Malaysia	This study was supported by Universiti Kebangsaan Malaysia under the DIP-2012-02 Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Amiery A.A, 2012, ORG MED CHEM LETT, V2, P1, DOI [DOI 10.1186/2191-2858-2-1, DOI 10.1186/2191-2858-2-4]; Al-Amiery AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132175; Al-Amiery AA, 2013, CHEM NAT COMPD+, V48, P950, DOI 10.1007/s10600-013-0436-0; Al-Amiery AA, 2012, RES CHEM INTERMEDIAT, V38, P559, DOI 10.1007/s11164-011-0371-2; ALAMIERY A, 2013, BIOINORG CHEM APPL, V2013, P1; Benzie IFF, 1999, METHOD ENZYMOL, V299, P15; Chan EWC, 2007, FOOD CHEM, V104, P1586, DOI 10.1016/j.foodchem.2007.03.023; Chang R., 2001, CHEMISTRY, V7th, P253; Chen Y, 1999, J AGR FOOD CHEM, V47, P2226, DOI 10.1021/jf990092f; COX D, 1989, HUM TOXICOL, V8, P501, DOI 10.1177/096032718900800612; DEXEUS FH, 1990, J CLIN ONCOL, V8, P325, DOI 10.1200/JCO.1990.8.2.325; Gocer H, 2011, INT J FOOD SCI NUTR, V62, P821, DOI 10.3109/09637486.2011.585963; GUYER RL, 1989, SCIENCE, V246, P1543, DOI 10.1126/science.2688087; Inati A, 2009, BLOOD REV, V23, pS9, DOI 10.1016/S0268-960X(09)70004-9; Janeiro P, 2013, J ELECTROANAL CHEM, V689, P243, DOI 10.1016/j.jelechem.2012.10.020; Jimenez-Orozco FA, 2001, LUNG CANCER, V34, P185, DOI 10.1016/S0169-5002(01)00263-X; Matos MJ, 2013, BIOORGAN MED CHEM, V21, P3900, DOI 10.1016/j.bmc.2013.04.015; Matos MJ, 2012, CURR TOP MED CHEM, V12, P2210; Kadhum AAH, 2011, INT J MOL SCI, V12, P5747, DOI 10.3390/ijms12095747; Kadhum AAH, 2011, MOLECULES, V16, P6969, DOI 10.3390/molecules16086969; Koncic MZ, 2011, MOLECULES, V16, P6232, DOI 10.3390/molecules16086232; KONTOGHIORGHES GJ, 1995, TOXICOL LETT, V80, P1, DOI 10.1016/0378-4274(95)03415-H; KROL W, 1995, BIOCHEM PHARMACOL, V50, P1031, DOI 10.1016/0006-2952(95)00237-T; Magalhaes LM, 2008, ANAL CHIM ACTA, V613, P1, DOI 10.1016/j.aca.2008.02.047; MARSHALL ME, 1987, J CLIN ONCOL, V5, P862, DOI 10.1200/JCO.1987.5.6.862; MARSHALL ME, 1990, PROSTATE, V17, P95, DOI 10.1002/pros.2990170203; Martins Borges Maria Fernanda, 2009, V4, P23; Matos MJ, 2011, J MED CHEM, V54, P7127, DOI 10.1021/jm200716y; MOHLER JL, 1992, PROSTATE, V20, P123, DOI 10.1002/pros.2990200208; Nath M, 2005, J ORGANOMET CHEM, V690, P134, DOI 10.1016/j.jorganchem.2004.08.043; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Perez C, 2007, QSAR COMB SCI, V26, P368, DOI 10.1002/qsar.200630067; Perez-Cruz F, 2013, J MED CHEM, V56, P6136, DOI 10.1021/jm400546y; Perez-Cruz F, 2012, BIOORG MED CHEM LETT, V22, P5569, DOI 10.1016/j.bmcl.2012.07.013; Reische D.W., 2008, FOOD LIPIDS CHEM NUT, Vthird, P409; Sardari S, 1999, BIOORGAN MED CHEM, V7, P1933, DOI 10.1016/S0968-0896(99)00138-8; THORNES D, 1989, EUR J SURG ONCOL, V15, P431; THORNES RD, 1994, J CANCER RES CLIN, V120, pS32, DOI 10.1007/BF01377122; Vazquez-Rodriguez S, 2013, MEDCHEMCOMM, V4, P993, DOI 10.1039/c3md00025g; Widjaja A, 2008, J CHIN INST CHEM ENG, V39, P413, DOI 10.1016/j.jcice.2008.05.003	40	23	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156625	10.1371/journal.pone.0156625	http://dx.doi.org/10.1371/journal.pone.0156625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243231	gold, Green Submitted, Green Published			2022-12-26	WOS:000377146100057
J	Lefcheck, JS; Marion, SR; Lombana, AV; Orth, RJ				Lefcheck, Jonathan S.; Marion, Scott R.; Lombana, Alfonso V.; Orth, Robert J.			Faunal Communities Are Invariant to Fragmentation in Experimental Seagrass Landscapes	PLOS ONE			English	Article							ZOSTERA-MARINA L; SUBMERGED AQUATIC VEGETATION; RAOS QUADRATIC ENTROPY; LOWER CHESAPEAKE BAY; GULF-OF-MEXICO; HABITAT FRAGMENTATION; SPECIES COOCCURRENCE; PATCH SIZE; DIVERSITY; BEDS	Human-driven habitat fragmentation is cited as one of the most pressing threats facing many coastal ecosystems today. Many experiments have explored the consequences of fragmentation on fauna in one foundational habitat, seagrass beds, but have either surveyed along a gradient of existing patchiness, used artificial materials to mimic a natural bed, or sampled over short timescales. Here, we describe faunal responses to constructed fragmented landscapes varying from 4-400 m(2) in two transplant garden experiments incorporating live eelgrass (Zostera marina L.). In experiments replicated within two subestuaries of the Chesapeake Bay, USA across multiple seasons and non-consecutive years, we comprehensively censused mesopredators and epifaunal communities using complementary quantitative methods. We found that community properties, including abundance, species richness, Simpson and functional diversity, and composition were generally unaffected by the number of patches and the size of the landscape, or the intensity of sampling. Additionally, an index of competition based on species co-occurrences revealed no trends with increasing patch size, contrary to theoretical predictions. We extend conclusions concerning the invariance of animal communities to habitat fragmentation from small-scale observational surveys and artificial experiments to experiments conducted with actual living plants and at more realistic scales. Our findings are likely a consequence of the rapid life histories and high mobility of the organisms common to eelgrass beds, and have implications for both conservation and restoration, suggesting that even small patches can rapidly promote abundant and diverse faunal communities.	[Lefcheck, Jonathan S.; Lombana, Alfonso V.; Orth, Robert J.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA; [Marion, Scott R.] Oregon Dept Fish & Wildlife, Marine Resources Program, Newport, OR 97365 USA	William & Mary; Virginia Institute of Marine Science	Lefcheck, JS (corresponding author), Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA.	jslefche@vims.edu	Lefcheck, Jonathan/H-8768-2019	Lefcheck, Jonathan/0000-0002-8787-1786; Orth, Robert/0000-0003-2491-7430	Virginia Recreational Fishing License Fund; Allied-Signal Foundation; Keith Campbell Foundation for the Environment	Virginia Recreational Fishing License Fund; Allied-Signal Foundation; Keith Campbell Foundation for the Environment	Funding was provided by the grants from the Virginia Recreational Fishing License Fund, as well as private grants from the Allied-Signal Foundation and the Keith Campbell Foundation for the Environment.	ANDERSON G., 1985, BIOL REPORT, V82, P1; [Anonymous], 1973, SHALLOW WATER GAMMAR; [Anonymous], 2006, SEAGRASSES BIOL ECOL, DOI DOI 10.1007/978-1-4020-2983-7; Arponen H, 2012, HYDROBIOLOGIA, V680, P1, DOI 10.1007/s10750-011-0895-x; Auguie B, 2017, GRIDEXTRA MISCELLANE; Azovsky AI, 2011, ECOGRAPHY, V34, P18, DOI 10.1111/j.1600-0587.2010.06288.x; Bell SS, 2001, BIOL CONSERV, V100, P115, DOI 10.1016/S0006-3207(00)00212-3; Best RJ, 2014, ECOLOGY, V95, P775, DOI 10.1890/13-0163.1; Bostrom C, 2006, ESTUAR COAST SHELF S, V68, P383, DOI 10.1016/j.ecss.2006.01.026; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; BROAD AC, 1957, BIOL BULL, V112, P144, DOI 10.2307/1539193; Brooks RA, 2001, J EXP MAR BIOL ECOL, V264, P67, DOI 10.1016/S0022-0981(01)00310-0; CAUSTON D. R, 1988, INTRO VEGETATION ANA; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Connolly RM, 2006, ESTUAR COAST SHELF S, V68, P433, DOI 10.1016/j.ecss.2006.01.023; Douglass JG, 2010, LIMNOL OCEANOGR, V55, P1499, DOI 10.4319/lo.2010.55.4.1499; EDGAR GJ, 1993, OECOLOGIA, V95, P115, DOI 10.1007/BF00649514; EDGAR GJ, 1993, OECOLOGIA, V95, P122, DOI 10.1007/BF00649515; Eggleston DB, 1999, J EXP MAR BIOL ECOL, V236, P107, DOI 10.1016/S0022-0981(98)00192-0; Eggleston DB, 1998, J EXP MAR BIOL ECOL, V223, P111, DOI 10.1016/S0022-0981(97)00154-8; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Fox J., 2011, CAR COMPANION APPL R; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; FREDETTE TJ, 1986, J CRUSTACEAN BIOL, V6, P57, DOI 10.2307/1547931; FREDETTE TJ, 1990, ESTUARIES, V13, P431, DOI 10.2307/1351787; Frost MT, 1999, AQUAT CONSERV, V9, P255, DOI 10.1002/(SICI)1099-0755(199905/06)9:3<255::AID-AQC346>3.0.CO;2-F; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Healey D, 2004, J EXP MAR BIOL ECOL, V313, P155, DOI 10.1016/j.jembe.2004.08.002; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; Hector A, 2010, J ANIM ECOL, V79, P308, DOI 10.1111/j.1365-2656.2009.01634.x; Hirst JA, 2008, ESTUAR COAST SHELF S, V78, P811, DOI 10.1016/j.ecss.2008.02.020; Hovel KA, 2002, MAR ECOL PROG SER, V243, P11, DOI 10.3354/meps243011; Hovel KA, 2001, ECOLOGY, V82, P1814; HOWARD RK, 1985, MAR ECOL PROG SER, V22, P163, DOI 10.3354/meps022163; Jackson EL, 2006, ESTUAR COAST SHELF S, V68, P421, DOI 10.1016/j.ecss.2006.01.024; Johnson MW, 2006, MAR ECOL PROG SER, V306, P233, DOI 10.3354/meps306233; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Laurel BJ, 2003, MAR ECOL PROG SER, V251, P245, DOI 10.3354/meps251245; Lefcheck JS, 2015, ECOLOGY, V96, P2973, DOI 10.1890/14-1977.1; Lefcheck JS, 2015, TOP DOWN VERSUS BUTT; Lefcheck JS, 2015, PEERJ PREPR; Lombana AL, 1999, THESIS; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Macreadie PI, 2009, CONSERV BIOL, V23, P644, DOI 10.1111/j.1523-1739.2008.01130.x; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; Marion SR, 2002, THESIS COLL WILLIAM; Matthews TJ, 2014, DIVERS DISTRIB, V20, P1136, DOI 10.1111/ddi.12227; MCNEILL SE, 1993, J BIOGEOGR, V20, P429, DOI 10.2307/2845591; Merigot B, 2010, ECOLOGY, V91, P1850, DOI 10.1890/09-1387.1; Mills VS, 2009, ESTUAR COAST SHELF S, V81, P123, DOI 10.1016/j.ecss.2008.10.005; Mouchet M, 2008, OIKOS, V117, P794, DOI 10.1111/j.0030-1299.2008.16594.x; Murdy EO, 2013, FISHES CHESAPEAKE BA; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; Nakaoka M, 2001, MAR ECOL-P S Z N I, V22, P379, DOI 10.1046/j.1439-0485.2001.01726.x; NECKLES HA, 1993, OECOLOGIA, V93, P285, DOI 10.1007/BF00317683; NELSON WG, 1982, B MAR SCI, V32, P121; Oksanen J., 2013, R PACKAGE VERSION 23, V2; ORTH RJ, 1986, AQUAT BOT, V24, P335, DOI 10.1016/0304-3770(86)90100-2; ORTH RJ, 1987, MAR ECOL PROG SER, V41, P283, DOI 10.3354/meps041283; ORTH RJ, 1983, SCIENCE, V222, P51, DOI 10.1126/science.222.4619.51; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; ORTH RJ, 1992, SYST ASSOC SPEC VOL, V46, P147; Orth RJ, 1999, AQUAT BOT, V64, P77, DOI 10.1016/S0304-3770(99)00007-8; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Paling E.I., 2009, COAST WETLANDS INTEG, P687; Pavoine S, 2005, THEOR POPUL BIOL, V67, P231, DOI 10.1016/j.tpb.2005.01.004; Pinheiro J, 2015, NLME LINEAR NONLINEA; Podani J, 1999, TAXON, V48, P331, DOI 10.2307/1224438; Pollock LW, 1998, PRACTICAL GUIDE MARI; Smith TM, 2010, J ANIM ECOL, V79, P275, DOI 10.1111/j.1365-2656.2009.01605.x; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; STONER AW, 1980, CONTRIB MAR SCI, V23, P63; STONER AW, 1980, B MAR SCI, V30, P537; Tanner JE, 2005, AUSTRAL ECOL, V30, P210, DOI 10.1111/j.1442-9993.2005.01438.x; Tanner JE, 2003, OIKOS, V100, P517, DOI 10.1034/j.1600-0706.2003.12060.x; Tilman D, 1997, AM NAT, V149, P407, DOI 10.1086/285998; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Ulrich W, 2007, OIKOS, V116, P2053, DOI 10.1111/j.2007.0030-1299.16173.x; vanMontfrans J, 1995, B MAR SCI, V57, P834; Warry FY, 2009, OECOLOGIA, V159, P883, DOI 10.1007/s00442-008-1258-9; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams JA, 2016, J EXP MAR BIOL ECOL, V479, P97, DOI 10.1016/j.jembe.2016.03.008; Wyda JC, 2002, ESTUARIES, V25, P86, DOI 10.1007/BF02696052	87	28	28	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156550	10.1371/journal.pone.0156550	http://dx.doi.org/10.1371/journal.pone.0156550			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244652	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100046
J	Lopez, I; Pineda, C; Munoz, L; Raya, A; Lopez, G; Aguilera-Tejero, E				Lopez, Ignacio; Pineda, Carmen; Munoz, Luis; Raya, Ana; Lopez, Guillermo; Aguilera-Tejero, Escolastico			Chronic Vitamin D Intoxication in Captive Iberian Lynx (Lynx pardinus)	PLOS ONE			English	Article							CHRONIC-RENAL-FAILURE; D TOXICITY; HYPERCALCEMIA; CAT; SECONDARY; CALCIUM	To document the biochemical and pathologic features of vitamin D intoxication in lynx and to characterize mineral metabolism in healthy lynx, blood samples were obtained from 40 captive lynx that had been receiving excessive (approximately 30 times the recommended dose) vitamin D3 in the diet, and from 29 healthy free ranging lynx. Tissue samples (kidney, stomach, lung, heart and aorta) were collected from 13 captive lynx that died as a result of renal disease and from 3 controls. Vitamin D intoxication resulted in renal failure in most lynx (n = 28), and widespread extraskeletal calcification was most severe in the kidneys and less prominent in cardiovascular tissues. Blood minerals and calciotropic hormones in healthy lynx were similar to values reported in domestic cats except for calcitriol which was higher in healthy lynx. Changes in mineral metabolism after vitamin D intoxication included hypercalcemia (12.0 +/- 0.3 mg/dL), hyperphosphatemia (6.3 +/- 0.4 mg/dL), increased plasma calcidiol (381.5 +/- 28.2 ng/mL) and decreased plasma parathyroid hormone (1.2 +/- 0.7 pg/mL). Hypercalcemia and, particularly, hyperphosphatemia were of lower magnitude that what has been previously reported in the course of vitamin D intoxication in other species. However, extraskeletal calcifications were severe. The data suggest that lynx are sensitive to excessive vitamin D and extreme care should be taken when supplementing this vitamin in captive lynx diets.	[Lopez, Ignacio; Pineda, Carmen; Raya, Ana; Aguilera-Tejero, Escolastico] Univ Cordoba, Dept Med & Cirugia Anim, Cordoba, Spain; [Munoz, Luis] Hosp Vet San Francisco La Carolina, Jaen, Spain; [Lopez, Guillermo] Agencia Medio Ambiente & Agua Andalucia, Proyecto Life Iberlince, Seville, Spain	Universidad de Cordoba	Aguilera-Tejero, E (corresponding author), Univ Cordoba, Dept Med & Cirugia Anim, Cordoba, Spain.	eaguilera@uco.es	Pineda, Carmen/AAF-4385-2020; Raya, Ana I/A-9548-2017	Raya, Ana I/0000-0002-4489-9447; Pineda Martos, Carmen Maria/0000-0002-3664-8699	Junta de Andalucia [CTS179]; Iberian lynx conservation LIFE project [LIFE06NAT/E/000209]	Junta de Andalucia(Junta de Andalucia); Iberian lynx conservation LIFE project	The authors received no specific funding for this work. General research funds were provided by Junta de Andalucia CTS179.; The work reported here was supported by Junta de Andalucia (CTS-179). The Andalusian Regional Government of Environment and the Spanish Ministry of Environment facilitated the work at many different levels. Personnel of the Iberian lynx captive breeding program collected all data that helped to identify the origin of the intoxication. The Iberian lynx conservation LIFE project (LIFE06NAT/E/000209) provided the samples of wild individuals. All veterinarians working in any Iberian lynx conservation program worked hard to identify all potential factors underlying the detected renal disease.	Aguilera-Tejero E, 2000, EQUINE VET J, V32, P167, DOI 10.2746/042516400777591552; Araki T, 2011, J CLIN ENDOCR METAB, V96, P3603, DOI 10.1210/jc.2011-1443; Barber PJ, 1998, J SMALL ANIM PRACT, V39, P108, DOI 10.1111/j.1748-5827.1998.tb03613.x; Bas S, 2004, DOMEST ANIM ENDOCRIN, V26, P99, DOI 10.1016/j.domaniend.2003.08.006; Block GA, 2000, CLIN NEPHROL, V54, P318; DeLuca HF, 2011, ARCH BIOCHEM BIOPHYS, V505, P226, DOI 10.1016/j.abb.2010.10.012; Garcia I, 2010, VET J, V183, P201, DOI 10.1016/j.tvjl.2008.10.012; Gerspach C, 2010, J VET INTERN MED, V24, P443, DOI 10.1111/j.1939-1676.2009.0462.x; Harmeyer J, 2004, J STEROID BIOCHEM, V89-90, P595, DOI 10.1016/j.jsbmb.2004.03.034; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Junginger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130573; Klontz KC, 2007, NEW ENGL J MED, V357, P308, DOI 10.1056/NEJMc063341; LEVI M, 1983, J CLIN INVEST, V71, P1624, DOI 10.1172/JCI110918; Liborio AB, 2014, KIDNEY INT, V85, P1247, DOI 10.1038/ki.2013.230; Martinez F, 2013, J ZOO WILDLIFE MED, V44, P845, DOI 10.1638/2011-0165R4.1; Moore FM, 1998, J AM VET MED ASSOC, V193, P1099; Palomares F, 2011, CONSERV BIOL, V25, P4, DOI 10.1111/j.1523-1739.2010.01607.x; Peralta-Ramirez A, 2014, AM J PHYSIOL-RENAL, V306, pF422, DOI 10.1152/ajprenal.00355.2013; PETERSON EN, 1991, J AM VET MED ASSOC, V199, P904; Pineda C, 2012, DOMEST ANIM ENDOCRIN, V42, P256, DOI 10.1016/j.domaniend.2012.01.003; Pineda C, 2013, J FELINE MED SURG, V15, P866, DOI 10.1177/1098612X13478264; SELBY PL, 1995, CLIN ENDOCRINOL, V43, P531, DOI 10.1111/j.1365-2265.1995.tb02916.x; Simon MA, 2012, CONSERV BIOL, V26, P731, DOI 10.1111/j.1523-1739.2012.01871.x; THOMAS JB, 1990, AUST VET J, V67, P274, DOI 10.1111/j.1751-0813.1990.tb07792.x; Tryfonidou MA, 2003, AM J PHYSIOL-ENDOC M, V284, pE505, DOI 10.1152/ajpendo.00236.2002; VIETH R, 1990, BONE MINER, V11, P267, DOI 10.1016/0169-6009(90)90023-9; Wehner A, 2013, J FELINE MED SURG, V15, P730, DOI 10.1177/1098612X12472180; Wimsatt J, 1998, J VET INTERN MED, V12, P42, DOI 10.1111/j.1939-1676.1998.tb00495.x; Zebger-Gong H, 2011, J HYPERTENS, V29, P339, DOI 10.1097/HJH.0b013e328340aa30	29	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156331	10.1371/journal.pone.0156331	http://dx.doi.org/10.1371/journal.pone.0156331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243456	gold, Green Published, Green Submitted			2022-12-26	WOS:000377146100028
J	Liu, XQ; Kiefl, R; Roskopf, C; Tian, F; Huber, RM				Liu, Xiao-qing; Kiefl, Rosemarie; Roskopf, Claudia; Tian, Fei; Huber, Rudolf M.			Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-CELL; METASTASIS; ANGIOGENESIS; TARGETS	In vitro cell-based models of lung cancer are frequently employed to study invasion and the mechanisms behind metastasis. However, these models often study only one cell type with two-dimensional (2D) monolayer cell cultures, which do not accurately reflect the complexity of inflammation in vivo. Here, a three-dimensional (3D) cell co-culture collagen gel model was employed, containing human lung adenocarcinoma cells (HCC), human lung fibroblast cells (MRC-5), and macrophages. Cell culture media and cell images were collected, and matrix metalloproteinase-1 (MMP-1) and vascular endothelial growth factor (VEGF) production was monitored under different cell culture conditions. We found that simulating hypoxia and/or serum starvation conditions induced elevated secretion of VEGF in the 3D co-culture model in vitro, but not MMP-1; the morphology of HCC in the 2D versus the 3D co-culture system was extremely different. MMP-1 and VEGF were secreted at higher levels in mixed cell groups rather than mono-culture groups. Therefore, incorporating lung cancer cells, fibroblasts, and macrophages may better reflect physiological metastasis mechanisms compared to mono-culture systems. Tumour stromal cells, macrophages, and fibroblast cells may promote invasion and metastasis, which also provides a new direction for the design of therapies targeted at destroying the stroma of tumor tissues.	[Liu, Xiao-qing; Kiefl, Rosemarie; Tian, Fei; Huber, Rudolf M.] Univ Munich, Med Klin 5, Div Resp Med & Thorac Oncol, Thorac Oncol Ctr Munich,Comprehens Pneumol Ctr Mu, Munich, Bavaria, Germany; [Liu, Xiao-qing] First Peoples Hosp Lianyungang City, Dept Med Oncol, Lianyungang, Jiangsu, Peoples R China; [Roskopf, Claudia] Univ Munich, Med Klin Innenstadt, Div Hematooncol, Ziemssenstr 1, D-80539 Munich, Bavaria, Germany	University of Munich; University of Munich	Huber, RM (corresponding author), Univ Munich, Med Klin 5, Div Resp Med & Thorac Oncol, Thorac Oncol Ctr Munich,Comprehens Pneumol Ctr Mu, Munich, Bavaria, Germany.	huber@med.uni-muenchen.de	Huber, Rudolf M./L-2464-2019	Huber, Rudolf M./0000-0001-7041-6368				Bhadriraju K, 2002, DRUG DISCOV TODAY, V7, P612, DOI 10.1016/S1359-6446(02)02273-0; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; El-Nikhely N, 2012, EXPERT OPIN INV DRUG, V21, P1107, DOI 10.1517/13543784.2012.693478; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619; International Agency for Research on Cancer W, 2008, GLOB 2008 CANC FACT; Langer CJ, 2010, J CLIN ONCOL, V28, P5311, DOI 10.1200/JCO.2010.28.8126; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; MORIKAWA K, 1988, CANCER RES, V48, P6863; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; Shaked Y, 2009, BBA-REV CANCER, V1796, P1, DOI 10.1016/j.bbcan.2009.07.002; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; TISCHER E, 1989, BIOCHEM BIOPH RES CO, V165, P1198, DOI 10.1016/0006-291X(89)92729-0; Welsh TJ, 2005, J CLIN ONCOL, V23, P8959, DOI 10.1200/JCO.2005.01.4910	20	24	25	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156268	10.1371/journal.pone.0156268	http://dx.doi.org/10.1371/journal.pone.0156268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232698	Green Published, gold, Green Submitted			2022-12-26	WOS:000376883000017
J	Park, J; Kotani, T; Konno, T; Setiawan, J; Kitamura, Y; Imada, S; Usui, Y; Hatano, N; Shinohara, M; Saito, Y; Murata, Y; Matozaki, T				Park, Jung-ha; Kotani, Takenori; Konno, Tasuku; Setiawan, Jajar; Kitamura, Yasuaki; Imada, Shinya; Usui, Yutaro; Hatano, Naoya; Shinohara, Masakazu; Saito, Yasuyuki; Murata, Yoji; Matozaki, Takashi			Promotion of Intestinal Epithelial Cell Turnover by Commensal Bacteria: Role of Short-Chain Fatty Acids	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; STEM-CELLS; SELF-RENEWAL; IN-VITRO; DIFFERENTIATION; MICROBIOTA; RECEPTORS; MARKER; COLON; CRYPT	The life span of intestinal epithelial cells (IECs) is short (3-5 days), and its regulation is thought to be important for homeostasis of the intestinal epithelium. We have now investigated the role of commensal bacteria in regulation of IEC turnover in the small intestine. The proliferative activity of IECs in intestinal crypts as well as the migration of these cells along the crypt-villus axis were markedly attenuated both in germ-free mice and in specific pathogen-free (SPF) mice treated with a mixture of antibiotics, with antibiotics selective for Gram-positive bacteria being most effective in this regard. Oral administration of chloroform- treated feces of SPF mice to germ-free mice resulted in a marked increase in IEC turnover, suggesting that spore-forming Gram-positive bacteria contribute to this effect. Oral administration of short-chain fatty acids (SCFAs) as bacterial fermentation products also restored the turnover of IECs in antibiotic-treated SPF mice as well as promoted the development of intestinal organoids in vitro. Antibiotic treatment reduced the phosphorylation levels of ERK, ribosomal protein S6, and STAT3 in IECs of SPF mice. Our results thus suggest that Gram-positive commensal bacteria are a major determinant of IEC turnover, and that their stimulatory effect is mediated by SCFAs.	[Park, Jung-ha; Kotani, Takenori; Konno, Tasuku; Setiawan, Jajar; Kitamura, Yasuaki; Imada, Shinya; Usui, Yutaro; Saito, Yasuyuki; Murata, Yoji; Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan; [Hatano, Naoya; Shinohara, Masakazu] Kobe Univ, Grad Sch Med, Integrated Ctr Mass Spectrometry, Kobe, Hyogo 657, Japan; [Park, Jung-ha] Dong Eui Univ, Dept Life Sci & Biotechnol, Coll Nat Sci & Human Ecol, Busan, South Korea	Kobe University; Kobe University; Dong-Eui University	Kotani, T; Matozaki, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan.	kotani@med.kobe-u.ac.jp; matozaki@med.kobe-u.ac.jp	Saito, Yasuyuki/AAD-1436-2019; Saito, Yasuyuki/C-2541-2015; Setiawan, Jajar/GLT-9019-2022; Imada, Shinya/GQY-7056-2022	Saito, Yasuyuki/0000-0002-9291-1383; Saito, Yasuyuki/0000-0002-9291-1383; Kotani, Takenori/0000-0001-8571-4210; Murata, Yoji/0000-0002-9576-7030	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23659155, 25114709, 16K08586]; Uehara Memorial Foundation; Institute for Molecular and Cellular Regulation, Gunma University [16036]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Institute for Molecular and Cellular Regulation, Gunma University	This work was supported by a Grant-in-Aid for Challenging Exploratory Research (23659155 to TM), a Grant-in-Aid for Scientific Research on Innovative Areas (25114709 to T. Kotani) and a Grant-in-Aid for Scientific Research (C) (16K08586 to T. Kotani) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan as well as by the Uehara Memorial Foundation (T. Kotani). This work was also supported by the joint research program of the Institute for Molecular and Cellular Regulation, Gunma University (16036 to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS GD, 1963, LAB INVEST, V12, P355; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Dunn SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080516; Faller WJ, 2015, NATURE, V517, P497, DOI 10.1038/nature13896; Feng Y, 2011, GASTROENTEROLOGY, V141, P1003, DOI 10.1053/j.gastro.2011.05.007; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Heuberger J, 2014, P NATL ACAD SCI USA, V111, P3472, DOI 10.1073/pnas.1309342111; Holt PR, 1997, CANCER EPIDEM BIOMAR, V6, P131; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hsieh EA, 2004, J INVEST DERMATOL, V123, P530, DOI 10.1111/j.0022-202X.2004.23303.x; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; JENSEN JE, 1977, J INVEST DERMATOL, V68, P23, DOI 10.1111/1523-1747.ep12485145; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Murata Y, 2015, P NATL ACAD SCI USA, V112, pE4264, DOI 10.1073/pnas.1510167112; Murata Y, 2010, GENES CELLS, V15, P513, DOI 10.1111/j.1365-2443.2010.01398.x; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Puhl NJ, 2012, ANAEROBE, V18, P67, DOI 10.1016/j.anaerobe.2011.12.007; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Sadakata H, 2009, GENES CELLS, V14, P295, DOI 10.1111/j.1365-2443.2008.01270.x; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Solanas G, 2011, EXP CELL RES, V317, P2695, DOI 10.1016/j.yexcr.2011.07.019; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Woodruff-Pak DS, 2010, P NATL ACAD SCI USA, V107, P1624, DOI 10.1073/pnas.0914207107; Yamashita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092904; Zhou Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.588	46	128	133	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156334	10.1371/journal.pone.0156334	http://dx.doi.org/10.1371/journal.pone.0156334			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232601	Green Published, gold			2022-12-26	WOS:000376883000024
J	Liu, T; Zhao, M; Liu, J; He, Z; Zhang, Y; You, H; Huang, J; Lin, X; Feng, XH				Liu, T.; Zhao, M.; Liu, J.; He, Z.; Zhang, Y.; You, H.; Huang, J.; Lin, X.; Feng, X-H			Tumor suppressor bromodomain-containing protein 7 cooperates with Smads to promote transforming growth factor-beta responses	ONCOGENE			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; BRD7 EXPRESSION; TRANSCRIPTIONAL REGULATION; GENE; COACTIVATOR; ACTIVATION; INTERACTS; PATHWAYS; SUBUNIT; BINDS	Smad proteins are central mediators in the canonical transforming growth factor-beta (TGF-beta) signaling pathway in mammalian cells. We report here that bromodomain-ontaining protein 7 (BRD7) functions as a novel transcription coactivator for Smads in TGF-beta signaling. BRD7 forms a TGF-beta inducible complex with Smad3/ 4 through its N-terminal Smad-binding domain. BRD7 simultaneously binds to acetylated histones to promote Smad-chromatin association, and associates with histone acetyltransferase p300 to enhance Smad transcriptional activity. Ectopic expression of BRD7, but not its mutants defective in Smad binding, enhances TGF-beta transcriptional, tumor-suppressing and epithelial-mesenchymal transition responses. Conversely, depletion of BRD7 inhibits TGF-beta responses. Thus, our study provides compelling evidence for a new function of BRD7 in fine-tuning TGF-beta physiological responses.	[Liu, T.; Zhao, M.; Liu, J.; He, Z.; Zhang, Y.; Huang, J.; Feng, X-H] Zhejiang Univ, Life Sci Inst, Hangzhou, Zhejiang, Peoples R China; [Liu, T.; Zhao, M.; Liu, J.; He, Z.; Zhang, Y.; Huang, J.; Feng, X-H] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou, Zhejiang, Peoples R China; [Liu, T.] Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou, Zhejiang, Peoples R China; [Liu, T.] Zhejiang Univ, Sch Med, Program Mol Cell Biol, Hangzhou, Zhejiang, Peoples R China; [You, H.] Coll Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [You, H.] Coll Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Lin, X.; Feng, X-H] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Lin, X.; Feng, X-H] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Baylor College of Medicine; Baylor College of Medicine	Liu, T; Feng, XH (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	liuting518@zju.edu.cn; xfeng@bcm.edu		Liu, Jinquan/0000-0002-5180-5613	NSFC [91540205, 31571447, 31171347]; MOST [2012CB966600, 2015CB553800, 2013CB945303]; NIH [R01GM63773, R01AR053591, R01CA108454, R01DK073932]; Project 111; PhD Programs Foundation of Ministry of Education of China [20110101120152]; Fundamental Research Funds for the Central Universities; NATIONAL CANCER INSTITUTE [R21CA112939, R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER	NSFC(National Natural Science Foundation of China (NSFC)); MOST; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Project 111(Ministry of Education, China - 111 Project); PhD Programs Foundation of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank David Luskutoff for p800 (PAI-1)-luc, Bert Vogelstein for WWP1 (p21)-luc and SBE-luc. We are grateful to the laboratory members for helpful discussion and technical assistance. This research was partly supported by grants from NSFC (91540205, 31571447, 31171347) and MOST (2012CB966600, 2015CB553800, 2013CB945303), NIH (R01GM63773, R01AR053591, R01CA108454, and R01DK073932), Project 111, PhD Programs Foundation of Ministry of Education of China (20110101120152), and the Fundamental Research Funds for the Central Universities.	Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Balasubramanian Anandh, 2015, Asian Pac J Cancer Prev, V16, P1615; Burrows AE, 2010, P NATL ACAD SCI USA, V107, P14280, DOI 10.1073/pnas.1009559107; Chan HM, 2001, J CELL SCI, V114, P2363; Chiu YH, 2014, MOL CELL, V54, P193, DOI 10.1016/j.molcel.2014.02.016; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Derynck R, 2007, TGF BETA FAMILY CELL; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Harte MT, 2010, CANCER RES, V70, P2538, DOI 10.1158/0008-5472.CAN-09-2089; Itoh S, 2000, NUCLEIC ACIDS RES, V28, P4291, DOI 10.1093/nar/28.21.4291; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kikuchi M, 2009, BBA-MOL CELL RES, V1793, P1828, DOI 10.1016/j.bbamcr.2009.11.001; Kim ES, 2004, INT J ONCOL, V25, P1375; LI CY, 1995, J BIOL CHEM, V270, P4971, DOI 10.1074/jbc.270.10.4971; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Liu HY, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-111; Liu HY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-253; Mantovani F, 2010, CELL CYCLE, V9, P2777; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Park YA, 2014, CLIN CANCER RES, V20, P565, DOI 10.1158/1078-0432.CCR-13-1271; Park YA, 2012, GYNECOL ONCOL, V124, P125, DOI 10.1016/j.ygyno.2011.09.026; Peng C, 2006, J CELL BIOCHEM, V97, P882, DOI 10.1002/jcb.20645; Peng C, 2007, MOL CELL BIOCHEM, V303, P141, DOI 10.1007/s11010-007-9466-x; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Wang DG, 2008, CANCER RES, V68, P783, DOI 10.1158/0008-5472.CAN-07-0008; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Wu WJ, 2013, EUR J CLIN INVEST, V43, P131, DOI 10.1111/eci.12024; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu Y, 2015, BEHAV BRAIN RES, V286, P1, DOI 10.1016/j.bbr.2015.02.031; Zhou J, 2004, J CELL PHYSIOL, V200, P89, DOI 10.1002/jcp.20013	39	15	15	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 19	2017	36	3					362	372		10.1038/onc.2016.204	http://dx.doi.org/10.1038/onc.2016.204			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IB	27270427	Green Accepted			2022-12-26	WOS:000394166000006
J	Linke, F; Zaunig, S; Nietert, MM; von Bonin, F; Lutz, S; Dullin, C; Janovska, P; Beissbarth, T; Alves, F; Klapper, W; Bryja, V; Pukrop, T; Trumper, L; Wilting, J; Kube, D				Linke, F.; Zaunig, S.; Nietert, M. M.; von Bonin, F.; Lutz, S.; Dullin, C.; Janovska, P.; Beissbarth, T.; Alves, F.; Klapper, W.; Bryja, V.; Pukrop, T.; Truemper, L.; Wilting, J.; Kube, D.			WNT5A: a motility-promoting factor in Hodgkin lymphoma	ONCOGENE			English	Article							PLANAR CELL POLARITY; REED-STERNBERG CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; BETA-CATENIN; DISHEVELLED PHOSPHORYLATION; GENE-EXPRESSION; BREAST-CANCER; PROLIFERATION; MIGRATION; PATHOGENESIS	Classical Hodgkin lymphoma (cHL) has a typical clinical manifestation, with dissemination involving functionally neighboring lymph nodes. The factors involved in the spread of lymphoma cells are poorly understood. Here we show that cHL cell lines migrate with higher rates compared with non -Hodgkin lymphoma cell lines. cHL cell migration, invasion and adhesion depend on autocrine WNT signaling as revealed by the inhibition of WNT secretion with the porcupine inhibitors Wnt-059/IWP-2, but did not affect cell proliferation. While application of recombinant WNT5A or WNT5A overexpression stimulates cHL cell migration, neither WNT10A, WNT1OB nor WNT16 did so. Time-lapse studies revealed an amoeboid type of cell migration modulated by WNT5A. Reduced migration distances and velocity of cHL cells, as well as altered movement patterns, were observed using porcupine inhibitor or WNT5A antagonist. Knockdown of Frizzled5 and Dishevelled3 disrupted the WNT5A-mediated RHOA activation and cell migration. Overexpression of DVL3-K435M or inhibition of ROCK (Rho-associated protein kinase) by Y-27632/H1152P disrupted cHL cell migration. In addition to these mechanistic insights into the role of WNT5A in vitro, global gene expression data revealed an increased WNT5A expression in primary HL cells in comparison with normal B-cell subsets and other lymphomas. Furthermore, the activity of both porcupine and WNT5A in cHL cells had an impact on lymphoma development in the chick chorionallantoic membrane assay. Massive bleeding of these lymphomas was significantly reduced after inhibition of WNT secretion by Wnt-059. Therefore, a model is proposed where WNT signaling has an important role in regulating tumor-promoting processes.	[Linke, F.; Zaunig, S.; von Bonin, F.; Alves, F.; Pukrop, T.; Truemper, L.; Kube, D.] Georg August Univ Gottingen, Univ Med Ctr, Clin Hematol & Med Oncol, Robert Koch Str 40, D-37075 Gottingen, Germany; [Nietert, M. M.; Beissbarth, T.] Georg August Univ Gottingen, Univ Med Ctr, Dept Med Stat, Gottingen, Germany; [Lutz, S.] Georg August Univ Gottingen, Univ Med Ctr, Inst Pharmacol, Gottingen, Germany; [Dullin, C.; Alves, F.] Georg August Univ Gottingen, Univ Med Ctr, Inst Diagnost & Intervent Radiol, Gottingen, Germany; [Janovska, P.; Bryja, V.] Masaryk Univ, Inst Expt Biol, Fac Sci, Brno, Czech Republic; [Alves, F.] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, Gottingen, Germany; [Klapper, W.] UKSH Campus Kiel, Hematopathol Sect, Kiel, Germany; [Bryja, V.] Acad Sci Czech Republ, Inst Biophys, Dept Cytokinet, Brno, Czech Republic; [Wilting, J.] Georg August Univ Gottingen, Dept Anat & Cell Biol, Univ Med Ctr, Gottingen, Germany; [Pukrop, T.] Univ Hosp Regensburg, Dept Internal Med Hematol & Internal Oncol 3, Regensburg, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Gottingen; Masaryk University Brno; Max Planck Society; University of Kiel; Schleswig Holstein University Hospital; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Gottingen; University of Regensburg	Kube, D (corresponding author), Georg August Univ Gottingen, Univ Med Ctr, Clin Hematol & Med Oncol, Robert Koch Str 40, D-37075 Gottingen, Germany.	dkube@med.uni-goettingen.de	Janovska, Pavlina/AAM-2683-2020; Linke, Franziska/AAD-7600-2022; Bryja, Vítězslav/P-4217-2019; Klapper, Wolfram/S-6314-2016	Linke, Franziska/0000-0002-7005-9687; Bryja, Vítězslav/0000-0002-9136-5085; Dullin, Christian/0000-0003-4297-8077; Nietert, Manuel/0000-0001-5443-7943	Deutsche Forschungsgemeinschaft within the Forschergruppe [Ku 954/12-1, FOR942]	Deutsche Forschungsgemeinschaft within the Forschergruppe(German Research Foundation (DFG))	We thank Moritz Harenberg for evaluating the vascularization of the CAM tumors in a blinded manner. We are very thankful to Mrs S Schwoch, Mrs C Zelent and Mrs S Hellbach for their technical assistance in the histological analysis of the CAM tumors. We kindly acknowledge Dr Aldo Ferrari from the ETH Zurich to provide the sketch on the amoeboid migration type (integrated into Figure 3a). This work was supported by grants of the Deutsche Forschungsgemeinschaft Ku 954/12-1 within the Forschergruppe FOR942.	Aldinucci D, 2008, INT J CANCER, V122, P769, DOI 10.1002/ijc.23119; Aprelikova O, 2013, ONCOGENE, V32, P3246, DOI 10.1038/onc.2012.351; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Bernatik O, 2014, J BIOL CHEM, V289, P23520, DOI 10.1074/jbc.M114.590638; Boll B, 2013, J CLIN ONCOL, V31, P4431, DOI 10.1200/JCO.2013.49.8246; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Bryja V, 2007, J CELL SCI, V120, P586, DOI 10.1242/jcs.03368; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Chiu A, 2007, BLOOD, V109, P729, DOI 10.1182/blood-2006-04-015958; Corrigan PM, 2009, STEM CELLS DEV, V18, P759, DOI 10.1089/scd.2008.0270; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Ekstrom EJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-88; Fhu CW, 2014, BLOOD, V124, P2973, DOI 10.1182/blood-2014-05-576140; Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631; Gentzel M, 2015, MOL BIOL CELL, V26, P966, DOI 10.1091/mbc.E14-06-1089; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Guermazi A, 2001, RADIOGRAPHICS, V21, P161, DOI 10.1148/radiographics.21.1.g01ja02161; Hecht M, 2005, CARCINOGENESIS, V26, P2105, DOI 10.1093/carcin/bgi192; Hopken UE, 2002, BLOOD, V99, P1109, DOI 10.1182/blood.V99.4.1109; Introcaso CE, 2008, J AM ACAD DERMATOL, V58, P295, DOI 10.1016/j.jaad.2005.11.1055; Janz M, 2006, BLOOD, V107, P2536, DOI 10.1182/blood-2005-07-2694; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; Jundt F, 2002, BLOOD, V99, P3398, DOI 10.1182/blood.V99.9.3398; Kafka A, 2014, INT J MOL SCI, V15, P10635, DOI 10.3390/ijms150610635; Kaucka M, 2013, CANCER RES, V73, P1491, DOI 10.1158/0008-5472.CAN-12-1752; Klemm F, 2011, CARCINOGENESIS, V32, P434, DOI 10.1093/carcin/bgq269; Klingenberg M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-339; Kluk MJ, 2013, LAB INVEST, V93, P462, DOI 10.1038/labinvest.2013.7; Koch R, 2014, BLOOD, V123, P2189, DOI 10.1182/blood-2013-08-523886; Kube D, 2001, BLOOD, V98, P762, DOI 10.1182/blood.V98.3.762; Kuppers R, 2012, J CLIN INVEST, V122, P3439, DOI [10.1172/JCI6124.5, 10.1172/JCI61245]; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Long A, 2015, CARCINOGENESIS, V36, P598, DOI 10.1093/carcin/bgv025; Lopez-Giral S, 2004, J LEUKOCYTE BIOL, V76, P462, DOI 10.1189/jlb.1203652; MacDonald BT, 2014, J BIOL CHEM, V289, P18122, DOI 10.1074/jbc.M114.575027; MacMillan CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep06315; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Mayor R, 2014, BIOCHEM J, V457, P19, DOI 10.1042/BJ20131182; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; PALS ST, 1989, IMMUNOL REV, V108, P111, DOI 10.1111/j.1600-065X.1989.tb00015.x; Pals ST, 2007, BLOOD, V110, P3102, DOI 10.1182/blood-2007-05-075176; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Qiang YW, 2005, BLOOD, V106, P1786, DOI 10.1182/blood-2005-01-0049; Qin L, 2015, ONCOTARGET, V6, P10239, DOI 10.18632/oncotarget.3518; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Samarzija I, 2009, BIOCHEM BIOPH RES CO, V386, P449, DOI 10.1016/j.bbrc.2009.06.033; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; Sohlbach K, 2012, LEUKEMIA LYMPHOMA, V53, P996, DOI 10.3109/10428194.2011.634046; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Tiacci E, 2012, BLOOD, V120, P4609, DOI 10.1182/blood-2012-05-428896; van den Berg A, 1999, AM J PATHOL, V154, P1685, DOI 10.1016/S0002-9440(10)65424-7; Vockerodt M, 2001, GENES IMMUN, V2, P433, DOI 10.1038/sj.gene.6363803; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Xargay-Torrent S, 2013, CLIN CANCER RES, V19, P586, DOI 10.1158/1078-0432.CCR-12-1935; Yao LL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/832562; Zepeda-Moreno A, 2014, CELL ADHES MIGR, V5, P215; Zheng B, 2003, BLOOD, V102, P1019, DOI 10.1182/blood-2002-11-3507; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823	63	25	25	1	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 5	2017	36	1					13	23		10.1038/onc.2016.183	http://dx.doi.org/10.1038/onc.2016.183			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK6XJ	27270428				2022-12-26	WOS:000394069100002
J	Chakravarthi, BVSK; Goswami, MT; Pathi, SS; Robinson, AD; Cieslik, M; Chandrashekar, DS; Agarwal, S; Siddiqui, J; Daignault, S; Carskadon, SL; Jing, X; Chinnaiyan, AM; Kunju, LP; Palanisamy, N; Varambally, S				Chakravarthi, B. V. S. K.; Goswami, M. T.; Pathi, S. S.; Robinson, A. D.; Cieslik, M.; Chandrashekar, D. S.; Agarwal, S.; Siddiqui, J.; Daignault, S.; Carskadon, S. L.; Jing, X.; Chinnaiyan, A. M.; Kunju, L. P.; Palanisamy, N.; Varambally, S.			MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer	ONCOGENE			English	Article							POSITIVE COACTIVATOR 4; RNA-POLYMERASE-II; POLO-LIKE KINASES; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; CELL-PROLIFERATION; GASTRIC-CANCER; PC4; ACTIVATION; DNA	MicroRNA-101, a tumor suppressor microRNA (miR), is often downregulated in cancer and is known to target multiple oncogenes. Some of the genes that are negatively regulated by miR-101 expression include histone methyltransferase EZH2 (enhancer of zeste homolog 2), COX2 (cyclooxygenase-2), POMP (proteasome maturation protein), CERS6, STMN1, MCL-1 and ROCK2, among others. In the present study, we show that miR-101 targets transcriptional coactivator SUB1 homolog (Saccharomyces cerevisiae)/PC4 (positive cofactor 4) and regulates its expression. SUB1 is known to have diverse role in vital cell processes such as DNA replication, repair and heterochromatinization. SUB1 is known to modulate transcription and acts as a mediator between the upstream activators and general transcription machinery. Expression profiling in several cancers revealed SUB1 overexpression, suggesting a potential role in tumorigenesis. However, detailed regulation and function of SUB1 has not been elucidated. In this study, we show elevated expression of SUB1 in aggressive prostate cancer. Knockdown of SUB1 in prostate cancer cells resulted in reduced cell proliferation, invasion and migration in vitro, and tumor growth and metastasis in vivo. Gene expression analyses coupled with chromatin immunoprecipitation revealed that SUB1 binds to the promoter regions of several oncogenes such as PLK1 (Polo-like kinase 1), C-MYC, serine-threonine kinase BUB1B and regulates their expression. Additionally, we observed SUB1 downregulated CDKN1B expression. PLK1 knockdown or use of PLK1 inhibitor can mitigate oncogenic function of SUB1 in benign prostate cancer cells. Thus, our study suggests that miR-101 loss results in increased SUB1 expression and subsequent activation of known oncogenes driving prostate cancer progression and metastasis. This study therefore demonstrates functional role of SUB1 in prostate cancer, and identifies its regulation and potential downstream therapeutic targets of SUB1 in prostate cancer.	[Chakravarthi, B. V. S. K.; Goswami, M. T.; Pathi, S. S.; Cieslik, M.; Siddiqui, J.; Carskadon, S. L.; Jing, X.; Chinnaiyan, A. M.; Kunju, L. P.; Palanisamy, N.; Varambally, S.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Chakravarthi, B. V. S. K.; Goswami, M. T.; Pathi, S. S.; Cieslik, M.; Carskadon, S. L.; Jing, X.; Chinnaiyan, A. M.; Kunju, L. P.; Palanisamy, N.; Varambally, S.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Chakravarthi, B. V. S. K.; Robinson, A. D.; Chandrashekar, D. S.; Agarwal, S.; Varambally, S.] Univ Alabama Birmingham, Dept Pathol, Mol & Cellular Pathol, Birmingham, AL 35294 USA; [Daignault, S.] Univ Michigan, Dept Biostat, Ctr Canc Biostat, Ann Arbor, MI 48109 USA; [Chinnaiyan, A. M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Chinnaiyan, A. M.] Univ Michigan, Sch Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Chinnaiyan, A. M.; Palanisamy, N.; Varambally, S.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Varambally, S.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Pathi, S. S.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Carskadon, S. L.; Palanisamy, N.] Henry Ford Hlth Syst, Vattikuti Urol Inst, Dept Urol, Detroit, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Henry Ford Health System; Henry Ford Hospital	Varambally, S (corresponding author), Univ Alabama Birmingham, Dept Pathol, Ctr Comprehens Canc, Mol & Cellular Pathol, Birmingham, AL 35233 USA.	soorya@uab.edu	AGARWAL, SUMIT/I-9349-2019; Palanisamy, Nallasivam/ABC-8844-2020; Daignault-Newton, Stephanie/GYD-6133-2022	AGARWAL, SUMIT/0000-0003-4051-7146; Palanisamy, Nallasivam/0000-0002-0633-9772; Robinson, Alyncia/0000-0002-9369-7665; Varambally, Sooryanarayana/0000-0002-2277-1127	National Institutes of Health [R01CA157845]; University of Michigan Prostate Cancer SPORE Career Development award;  [R01CA154980]; NATIONAL CANCER INSTITUTE [R01CA154980, R01CA157845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Prostate Cancer SPORE Career Development award; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Twani Dhar, Sherin John, Sivakumar Nallasivam, Samuel Lee and Sai Akshaya Hodigere Balasubramanya for their assistance. We also thank the University of Michigan Vector Core for generating lentivirus. This work is supported, in part, by National Institutes of Health R01CA157845. SV is also supported by R01CA154980 and the University of Michigan Prostate Cancer SPORE Career Development award (to SV). Gene expression data has been deposited in the GEO database under accession number GSE74895.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Bargiela-Iparraguirre J, 2014, CELL CYCLE, V13, P3590, DOI 10.4161/15384101.2014.962952; Batta K, 2007, MOL CELL BIOL, V27, P7603, DOI 10.1128/MCB.01064-07; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Chain B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-344; Chakravarthi BVSK, 2014, ONCOTARGET, V5, P6654, DOI 10.18632/oncotarget.2208; Chen L, 2014, J NEUROL SCI, V346, P293, DOI 10.1016/j.jns.2014.09.014; Conesa C, 2010, RNA BIOL, V7, P287, DOI 10.4161/rna.7.3.11491; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Das C, 2010, J MOL BIOL, V397, P1, DOI 10.1016/j.jmb.2009.12.058; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Ferreira PG, 2014, GENOME RES, V24, P212, DOI 10.1101/gr.152132.112; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; GE H, 1994, P NATL ACAD SCI USA, V91, P12691, DOI 10.1073/pnas.91.26.12691; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Gjertsen BT, 2015, LEUKEMIA, V29, P11, DOI 10.1038/leu.2014.222; Goswami MT, 2015, ONCOTARGET, V6, P23445, DOI 10.18632/oncotarget.4352; Haile DT, 1999, J BIOL CHEM, V274, P2113, DOI 10.1074/jbc.274.4.2113; Hammitzsch A, 2015, P NATL ACAD SCI USA, V112, P10768, DOI 10.1073/pnas.1501956112; Henry NL, 1996, J BIOL CHEM, V271, P21842, DOI 10.1074/jbc.271.36.21842; Holloway AF, 2000, J BIOL CHEM, V275, P21668, DOI 10.1074/jbc.M909058199; KAISER K, 1995, EMBO J, V14, P3520, DOI 10.1002/j.1460-2075.1995.tb07358.x; Kannan F, 1999, MOL CELL BIOL, V19, P899; Kershnar E, 1998, J BIOL CHEM, V273, P34444, DOI 10.1074/jbc.273.51.34444; Kim JM, 2015, NUCLEIC ACIDS RES, V43, P8868, DOI 10.1093/nar/gkv874; Kleivi K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-2; Knaus R, 1996, EMBO J, V15, P1933, DOI 10.1002/j.1460-2075.1996.tb00544.x; Kottakis F, 2011, MOL CELL, V43, P285, DOI 10.1016/j.molcel.2011.06.020; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Lada AG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005217; Lee JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122628; Lin CC, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-3725; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Luo L, 2012, MED ONCOL, V29, P1681, DOI 10.1007/s12032-011-0085-8; Luo Y, 1998, MOL CELL BIOL, V18, P3803, DOI 10.1128/MCB.18.7.3803; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Pan ZQ, 1996, J BIOL CHEM, V271, P22111, DOI 10.1074/jbc.271.36.22111; Peng Y, 2012, CANCER GENE THER, V19, P690, DOI 10.1038/cgt.2012.52; Pezuk JA, 2013, CANCER GENE THER, V20, P499, DOI 10.1038/cgt.2013.46; Qian D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.416; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Sato N, 2004, AM J PATHOL, V164, P903, DOI 10.1016/S0002-9440(10)63178-1; Shi CM, 2008, EXP HEMATOL, V36, pS82; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Smith M, 2012, AACR 103 ANN M S, V72; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Suzuki M, 2016, J CLIN INVEST, V126, P254, DOI 10.1172/JCI79775; Tao SL, 2015, AM J CANCER RES, V5, P1878; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang L, 2015, CANCER CELL, V28, P240, DOI 10.1016/j.ccell.2015.07.005; Wang L, 2014, HEPATOLOGY, V59, P1850, DOI 10.1002/hep.26720; Wang R., 2012, MATH PROBL ENG, V2012, P1, DOI DOI 10.1109/IEVC2012.6183284.URL; Wang R, 2012, NEOPLASIA, V14, P905, DOI 10.1593/neo.121192; Werten S, 1998, EMBO J, V17, P5103, DOI 10.1093/emboj/17.17.5103; Wissing MD, 2013, FASEB J, V27, P4279, DOI 10.1096/fj.12-222893; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.380; Yang J, 2015, BIOCHEM BIOPH RES CO, V463, P900, DOI 10.1016/j.bbrc.2015.06.032; Yokoi S, 2002, AM J PATHOL, V161, P207, DOI 10.1016/S0002-9440(10)64172-7; Zhang X, 2015, MOL CELL, V59, P243, DOI 10.1016/j.molcel.2015.05.036; Zheng F, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004873; Zhong L, 2003, GENE, V320, P155, DOI 10.1016/S0378-1119(03)00823-0; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956	75	47	49	1	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 8	2016	35	49					6330	6340		10.1038/onc.2016.164	http://dx.doi.org/10.1038/onc.2016.164			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EF3TJ	27270442	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000390247000006
J	Kopanska, KS; Alcheikh, Y; Staneva, R; Vignjevic, D; Betz, T				Kopanska, Katarzyna S.; Alcheikh, Yara; Staneva, Ralitza; Vignjevic, Danijela; Betz, Timo			Tensile Forces Originating from Cancer Spheroids Facilitate Tumor Invasion	PLOS ONE			English	Article							CELL INVASION; EXTRACELLULAR-MATRIX; RETROGRADE FLOW; COLLAGEN; GROWTH; MOTILITY; DEFORMATION; METASTASIS; MECHANICS; MIGRATION	The mechanical properties of tumors and the tumor environment provide important information for the progression and characterization of cancer. Tumors are surrounded by an extracellular matrix (ECM) dominated by collagen I. The geometrical and mechanical properties of the ECM play an important role for the initial step in the formation of metastasis, presented by the migration of malignant cells towards new settlements as well as the vascular and lymphatic system. The extent of this cell invasion into the ECM is a key medical marker for cancer prognosis. In vivo studies reveal an increased stiffness and different architecture of tumor tissue when compared to its healthy counterparts. The observed parallel collagen organization on the tumor border and radial arrangement at the invasion zone has raised the question about the mechanisms organizing these structures. Here we study the effect of contractile forces originated from model tumor spheroids embedded in a biomimetic collagen I matrix. We show that contractile forces act immediately after seeding and deform the ECM, thus leading to tensile radial forces within the matrix. Relaxation of this tension via cutting the collagen does reduce invasion, showing a mechanical relation between the tensile state of the ECM and invasion. In turn, these results suggest that tensile forces in the ECM facilitate invasion. Furthermore, simultaneous contraction of the ECM and tumor growth leads to the condensation and reorientation of the collagen at the spheroid's surface. We propose a tension-based model to explain the collagen organization and the onset of invasion by forces originating from the tumor.	[Kopanska, Katarzyna S.; Alcheikh, Yara; Betz, Timo] PSL Res Univ, CNRS, UMR 168, Inst Curie, F-75005 Paris, France; [Kopanska, Katarzyna S.; Alcheikh, Yara; Betz, Timo] Univ Paris 06, CNRS, UMR 168, Sorbonne Univ, F-75005 Paris, France; [Kopanska, Katarzyna S.; Alcheikh, Yara; Betz, Timo] CNRS, UMR168, 25 Rue Ulm, F-75248 Paris 05, France; [Kopanska, Katarzyna S.] Zurich Univ Appl Sci, Inst Chem & Biotechnol, Einsiedlerstr 31, CH-8820 Wadenswil, Switzerland; [Staneva, Ralitza; Vignjevic, Danijela] PSL Res Univ, CNRS, UMR 144, Inst Curie, F-75005 Paris, France; [Betz, Timo] Univ Munster, Inst Cell Biol, Ctr Mol Biol Inflammat, D-48149 Munster, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Zurich University of Applied Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Munster	Betz, T (corresponding author), PSL Res Univ, CNRS, UMR 168, Inst Curie, F-75005 Paris, France.; Betz, T (corresponding author), Univ Paris 06, CNRS, UMR 168, Sorbonne Univ, F-75005 Paris, France.; Betz, T (corresponding author), CNRS, UMR168, 25 Rue Ulm, F-75248 Paris 05, France.; Betz, T (corresponding author), Univ Munster, Inst Cell Biol, Ctr Mol Biol Inflammat, D-48149 Munster, Germany.	timo.betz@uni-muenster.de	Betz, Timo/ABF-9946-2021; vignjevic, Danijela Matic/R-5160-2019; Vignjevic, Danijela/L-9721-2017	vignjevic, Danijela Matic/0000-0003-4250-703X; Betz, Timo/0000-0002-1548-0655	program "Investissements d'Avenir" [ANR- JCJC SVSE 5 2011, Labex CelTisPhyBio ANR-10-LBX-0038 ANR-10-IDEX-0001-02 PSL]; Cells-in-Motion Cluster of Excellence, University of Munster, Germany [EXC 1003 - CiM]; Institut Thematique Multi-organismes Cancer - Plan Cancer; Ecole Doctorale Frontieres du Vivant (FdV) - Programme Bettencourt; Fondation pour la Recherche Medicale (FRM) [DGE20111123020]; Cancerople-IdF [2012-2-EML-04-IC-1]; InCA (Cancer National Institute) [2011-1-LABEL-IC-4]; SiRIC@ CNRS-Institut Curie [INCa-DGOS- 4654]; PICT-IBiSA@ CNRS-Institut Curie [INCa-DGOS- 4654]; Nikon Imaging Center@ CNRS-Institut Curie [INCa-DGOS- 4654]	program "Investissements d'Avenir"(French National Research Agency (ANR)); Cells-in-Motion Cluster of Excellence, University of Munster, Germany; Institut Thematique Multi-organismes Cancer - Plan Cancer; Ecole Doctorale Frontieres du Vivant (FdV) - Programme Bettencourt; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Cancerople-IdF; InCA (Cancer National Institute); SiRIC@ CNRS-Institut Curie; PICT-IBiSA@ CNRS-Institut Curie; Nikon Imaging Center@ CNRS-Institut Curie	This work has received support under the program "Investissements d'Avenir" launched by the French Government and implemented by ANR with the references ANR- JCJC SVSE 5 2011 (T.B.) and Labex CelTisPhyBio ANR-10-LBX-0038 ANR-10-IDEX-0001-02 PSL (T.B, K.K. and D.V.), Cells-in-Motion Cluster of Excellence (EXC 1003 - CiM), University of Munster, Germany (T.B.), Institut Thematique Multi-organismes Cancer - Plan Cancer 2014-2019 and Ecole Doctorale Frontieres du Vivant (FdV) - Programme Bettencourt (R.S.). The intravital imaging was supported by the Fondation pour la Recherche Medicale (FRM No DGE20111123020), the Cancerople-IdF (no2012-2-EML-04-IC-1), InCA (Cancer National Institute, no2011-1-LABEL-IC-4), and SiRIC (INCa-DGOS- 4654), PICT-IBiSA and Nikon Imaging Center@ CNRS-Institut Curie.r This work has received support under the program "Investissements d'Avenir" launched by the French Government and implemented by ANR with the references ANR-JCJC SVSE 5 2011 (T.B.) and Labex CelTisPhyBio ANR-10-LBX-0038 ANR-10-IDEX-0001-02 PSL (T.B, K.K. and D.V), Cells-in-Motion Cluster of Excellence (EXC 1003 -CiM), University of Munster, Germany (T.B.), Institut Thematique Multi-organismes Cancer-Plan Cancer 2014-2019 and Ecole Doctorale Frontieres du Vivant (FdV)-Programme Bettencourt (RS). The intravital imaging was supported by the Fondation pour la Recherche Medicale (FRM No GE20111123020), the Cancerople-IdF (no2012-2-EML-04-IC-1), InCA (Cancer National Institute, no2011-1-LABEL-IC-4), and SiRIC (INCa-DGOS- 4654), PICT-IBiSA and Nikon Imaging Center@ CNRS-Institut Curie. We would like to thank Sara Geraldo, Anthony Simon and Vasily Gurchenkov and Marie Irondelle for training and advice.	Alessandri K, 2013, P NATL ACAD SCI USA, V110, P14843, DOI 10.1073/pnas.1309482110; Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108; Betz T, 2009, BIOPHYS J, V96, P5130, DOI 10.1016/j.bpj.2009.03.045; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Carey SP, 2013, CLIN EXP METASTAS, V30, P615, DOI 10.1007/s10585-013-9565-x; Carey SP, 2012, CRIT REV ONCOL HEMAT, V83, P170, DOI 10.1016/j.critrevonc.2011.11.005; Carey SP, 2012, BIOMATERIALS, V33, P4157, DOI 10.1016/j.biomaterials.2012.02.029; Castle JC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-190; Chanrion M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6005; Clark AG, 2015, CURR OPIN CELL BIOL, V36, P13, DOI 10.1016/j.ceb.2015.06.004; Conklin MW, 2012, CELL ADHES MIGR, V6, P249, DOI 10.4161/cam.20567; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Coulson-Thomas VJ, 2011, CELL TISSUE RES, V346, P223, DOI 10.1007/s00441-011-1254-y; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Fang M, 2014, TUMOR BIOL, V35, P2871, DOI 10.1007/s13277-013-1511-7; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Geraldo S, 2013, JOVE-J VIS EXP, DOI 10.3791/50763; Geraldo S, 2012, EUR J CELL BIOL, V91, P930, DOI 10.1016/j.ejcb.2012.07.005; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Gordon VD, 2003, EXP CELL RES, V289, P58, DOI 10.1016/S0014-4827(03)00256-8; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Haeger A, 2014, BBA-GEN SUBJECTS, V1840, P2386, DOI 10.1016/j.bbagen.2014.03.020; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Iordan A, 2010, BIORHEOLOGY, V47, P277, DOI 10.3233/BIR-2010-0575; Kaufman LJ, 2005, BIOPHYS J, V89, P635, DOI 10.1529/biophysj.105.061994; Koch T, 2012, PLOS ONE, V7, DOI [10.1371/Citation, DOI 10.1371/CITATION]; Kopanska KS, 2015, METHOD CELL BIOL, V125, P353, DOI 10.1016/bs.mcb.2014.10.017; Kural MH, 2013, EXP CELL RES, V319, P2447, DOI 10.1016/j.yexcr.2013.06.019; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Luchici A, 2013, MECH COUPLING CYTOSK, P1186; Mierke C, 2013, EUR J CELL BIOL; Mierke CT, 2011, CELL BIOCHEM BIOPHYS, V61, P217, DOI 10.1007/s12013-011-9193-5; Miron-Mendoza M, 2008, MOL BIOL CELL, V19, P2051, DOI 10.1091/mbc.E07-09-0930; Montel F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188102; Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Petroll WM, 2008, DEV DYNAM, V237, P2726, DOI 10.1002/dvdy.21629; Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Sawhney RK, 2002, J CELL BIOL, V157, P1083, DOI 10.1083/jcb.200203069; Shi QM, 2014, P NATL ACAD SCI USA, V111, P658, DOI 10.1073/pnas.1311312110; Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Torzilli PA, 2012, SEMIN CANCER BIOL, V22, P385, DOI 10.1016/j.semcancer.2012.05.002; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; Vallotton P, 2005, MOL BIOL CELL, V16, P1223, DOI 10.1091/mbc.E04-07-0615; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; WEISS P, 1959, REV MOD PHYS, V31, P11, DOI 10.1103/RevModPhys.31.11; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065	57	46	46	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156442	10.1371/journal.pone.0156442	http://dx.doi.org/10.1371/journal.pone.0156442			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271249	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561000015
J	Jang, JY; Choi, YH; Shin, TS; Kim, TH; Shin, KS; Park, HW; Kim, YH; Kim, H; Choi, GJ; Jang, KS; Cha, B; Kim, IS; Myung, EJ; Kim, JC				Jang, Ja Yeong; Choi, Yong Ho; Shin, Teak Soo; Kim, Tae Hoon; Shin, Kee-Sun; Park, Hae Woong; Kim, Young Ho; Kim, Hun; Choi, Gyung Ja; Jang, Kyoung Soo; Cha, Byeongjin; Kim, In Seon; Myung, Eul Jae; Kim, Jin-Cheol			Biological Control of Meloidogyne incognita by Aspergillus niger F22 Producing Oxalic Acid	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; ROOT-KNOT NEMATODES; NEMATOCIDAL ACTIVITY; FORMULATION; STRAIN; BIOCONTROL; EXTRACTION; CULTIVARS; FRUIT; SPP.	Restricted usage of chemical nematicides has led to development of environmentally safe alternatives. A culture filtrate of Aspergillus niger F22 was highly active against Meloidogyne incognita with marked mortality of second-stage juveniles (J2s) and inhibition of egg hatching. The nematicidal component was identified as oxalic acid by organic acid analysis and gas chromatography-mass spectroscopy (GC-MS). Exposure to 2 mmol/L oxalic acid resulted in 100% juvenile mortality at 1 day after treatment and suppressed egg hatching by 95.6% at 7 days after treatment. Oxalic acid showed similar nematicidal activity against M. hapla, but was not highly toxic to Bursaphelenchus xylophilus. The fungus was incubated on solid medium and dried culture was used for preparation of a wettable powder-type (WP) formulation as an active ingredient. Two WP formulations, F22-WP10 (ai 10%) and oxalic acid-WP8 (ai 8%), were prepared using F22 solid culture and oxalic acid. In a field naturally infested with M. incognita, application of a mixture of F22-WP10 + oxalic acid-WP8 at 1,000-and 500-fold dilutions significantly reduced gall formation on the roots of watermelon plants by 58.8 and 70.7%, respectively, compared to the non-treated control. The disease control efficacy of the mixture of F22-WP10 + oxalic acid-WP8 was significantly higher than that of a chemical nematicide, Sunchungtan (ai 30% fosthiazate). These results suggest that A. niger F22 can be used as a microbial nematicide for the control of root-knot nematode disease.	[Jang, Ja Yeong; Kim, In Seon; Kim, Jin-Cheol] Chonnam Natl Univ, Coll Agr & Life Sci, Inst Environm Friendly Agr, Dept Agr Chem, Gwangju, South Korea; [Jang, Ja Yeong; Cha, Byeongjin] Chungbuk Natl Univ, Dept Plant Med, Cheongju, South Korea; [Choi, Yong Ho; Kim, Hun; Choi, Gyung Ja; Jang, Kyoung Soo] Korea Res Inst Chem Technol, Ctr Ecofriendly New Mat, Daejeon, South Korea; [Kim, Tae Hoon; Shin, Kee-Sun; Myung, Eul Jae] Dongbu Farm Hannong Co Ltd, Crop Protect Res Team, Dongbu Adv Res Inst, Nonsan Si, South Korea; [Shin, Kee-Sun] Korea Res Inst Biosci & Biotechnol, Biol Resources Ctr, Daejeon, South Korea; [Park, Hae Woong] World Inst Kimchi, Gwangju, South Korea; [Kim, Young Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Young Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Chonnam National University; Chungbuk National University; Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU); Seoul National University (SNU)	Kim, JC (corresponding author), Chonnam Natl Univ, Coll Agr & Life Sci, Inst Environm Friendly Agr, Dept Agr Chem, Gwangju, South Korea.	kjinc@jnu.ac.kr			Rural Development Administration, Republic of Korea; Dongbu Farm Hannong Company Ltd; Cooperative Research Program for Agricultural Science and Technology Development [PJ01020702]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); Dongbu Farm Hannong Company Ltd; Cooperative Research Program for Agricultural Science and Technology Development	This study was performed with support from the Cooperative Research Program for Agricultural Science and Technology Development (Project PJ01020702), Rural Development Administration, Republic of Korea (http://www.rda.go.kr). The funder provided support in the form of salaries for authors JYJ, YHC, HK, GJC, KSJ, and JCK. Dongbu Farm Hannong Company Ltd provided support in the form of salaries for authors TSS, THK and EJM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Bansal R.K., 2003, Nematologia Mediterranea, V31, P135; Barker TR., 1985, ADV TREATISE MELOIDO, P19; Browning M, 2006, SOIL BIOL BIOCHEM, V38, P401, DOI 10.1016/j.soilbio.2005.05.020; Cabrefiga J, 2014, J APPL MICROBIOL, V117, P1122, DOI 10.1111/jam.12582; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Frisvad JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023496; GADD GM, 1993, NEW PHYTOL, V124, P25, DOI 10.1111/j.1469-8137.1993.tb03796.x; Gasic S., 2013, Pesticidi i Fitomedicina, V28, P97; Glare T, 2012, TRENDS BIOTECHNOL, V30, P250, DOI 10.1016/j.tibtech.2012.01.003; Hu Y, 2013, J AGR FOOD CHEM, V61, P41, DOI 10.1021/jf304314g; Huang WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089717; Hwang SM, 2014, KOREAN J HORTIC SCI, V32, P217, DOI 10.7235/hort.2014.13129; Jain A, 2015, J BASIC MICROB, V55, P601, DOI 10.1002/jobm.201400156; Jayaraj J, 2010, J PLANT INTERACT, V5, P147, DOI 10.1080/17429140903291012; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Khan Z, 2008, BIORESOURCE TECHNOL, V99, P3016, DOI 10.1016/j.biortech.2007.06.031; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lamovsek Janja, 2013, Acta Agriculturae Slovenica, V101, P263, DOI 10.2478/acas-2013-0022; Liu Y, 2006, HELMINTHOLOGIA, V43, P51, DOI 10.2478/s11687-006-0010-4; MANKAU R, 1969, PHYTOPATHOLOGY, V59, P1170; Manzanilla-Lopez Rosa H., 2004, P637, DOI 10.1079/9780851996462.0637; Martinez-Espla A, 2014, J AGR FOOD CHEM, V62, P3432, DOI 10.1021/jf500224g; Mokbel A. A., 2009, Alexandria Journal of Agricultural Research, V54, P199; Nian XG, 2015, PEST MANAG SCI, V71, P1675, DOI 10.1002/ps.3977; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; Nitao JK, 1999, J NEMATOL, V31, P172; OECD, 2001, BRID DIG DIV ISS POL; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Park J, 2014, PLANT PATHOLOGY J, V30, P288, DOI 10.5423/PPJ.OA.02.2014.0013; Ruanpanun P, 2011, WORLD J MICROB BIOT, V27, P1373, DOI 10.1007/s11274-010-0588-z; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schisler DA, 2004, PHYTOPATHOLOGY, V94, P1267, DOI 10.1094/PHYTO.2004.94.11.1267; Scorzetti G, 2002, FEMS YEAST RES, V2, P495, DOI 10.1111/j.1567-1364.2002.tb00117.x; Seo Y, 2014, PLANT PATHOLOGY J, V30, P450, DOI [10.5423/PPJ.NT.07.2014.0062, 10.5423/PPJ.NT.05.2014.0041]; Sikora Richard A., 2005, P319, DOI 10.1079/9780851997278.0319; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vu TT, 2013, PLANT DIS, V97, P1593, DOI 10.1094/PDIS-04-13-0350-RE; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; U.S. Department of Agriculture, 1984, AGR HDB; United States Environmental Protection Agency, 2015, EPA OK OX AC VARR MI, P12; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; Wang Y, US Patent, Patent No. [12/152,788, 12152788]; Wilson MJ, 2013, BIOCONTROL, V58, P715, DOI 10.1007/s10526-013-9511-5; Yanez-Mendizabal V, 2012, J APPL MICROBIOL, V112, P954, DOI 10.1111/j.1365-2672.2012.05258.x; Yu ZT, 1999, CAN J MICROBIOL, V45, P269, DOI 10.1139/cjm-45-3-269; Zheng XL, 2012, FOOD CHEM, V132, P849, DOI 10.1016/j.foodchem.2011.11.049; ZUCKERMAN BM, 1994, J CHEM ECOL, V20, P33, DOI 10.1007/BF02065989	50	46	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156230	10.1371/journal.pone.0156230	http://dx.doi.org/10.1371/journal.pone.0156230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258452	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700044
J	Jang, CH; Piao, YL; Huang, XQ; Yoon, EJ; Park, SH; Lee, K; Zhan, CG; Cho, H				Jang, Chul Ho; Piao, Yu Lan; Huang, Xiaoqin; Yoon, Eun Jeong; Park, So Hee; Lee, Kyoung; Zhan, Chang-Guo; Cho, Hoon			Modeling and Re-Engineering of Azotobacter vinelandii Alginate Lyase to Enhance Its Catalytic Efficiency for Accelerating Biofilm Degradation	PLOS ONE			English	Article							MUCOID PSEUDOMONAS-AERUGINOSA; MOLECULAR-DYNAMICS; BACTERIAL BIOFILMS; CYSTIC-FIBROSIS; CHRONIC WOUNDS; O-ACETYLATION; GENE-CLUSTER; FORCE-FIELD; SEQUENCE; BINDING	Alginate is known to prevent elimination of Pseudomonas aeruginosa biofilms. Alginate lyase (AlgL) might therefore facilitate treatment of Pseudomonas aeruginosa-infected cystic fibrosis patients. However, the catalytic activity of wild-type AlgL is not sufficiently high. Therefore, molecular modeling and site-directed mutagenesis of AlgL might assist in enzyme engineering for therapeutic development. AlgL, isolated from Azotobacter vinelandii, catalyzes depolymerization of alginate via a beta-elimination reaction. AlgL was modeled based on the crystal structure template of Sphingomonas AlgL species A1-III. Based on this computational analysis, AlgL was subjected to site-directed mutagenesis to improve its catalytic activity. The k(cat)/K-m of the K194E mutant showed a nearly 5-fold increase against the acetylated alginate substrate, as compared to the wild-type. Double and triple mutants (K194E/K245D, K245D/K319A, K194E/K245D/E312D, and K194E/K245D/K319A) were also prepared. The most potent mutant was observed to be K194E/K245D/K319A, which has a 10-fold improved k(cat) value (against acetylated alginate) compared to the wild-type enzyme. The antibiofilm effect of both AlgL forms was identified in combination with pipera-cillin/tazobactam (PT) and the disruption effect was significantly higher in mutant AlgL combined with PT than wild-type AlgL. However, for both the wild-type and K194E/K245D/K319A mutant, the use of the AlgL enzyme alone did not show significant antibiofilm effect.	[Jang, Chul Ho] Chonnam Natl Univ, Sch Med, Dept Otolaryngol, Gwangju 501757, South Korea; [Piao, Yu Lan; Yoon, Eun Jeong; Park, So Hee; Cho, Hoon] Chosun Univ, Dept Polymer Sci & Engn, Kwangju 501759, South Korea; [Huang, Xiaoqin; Zhan, Chang-Guo] Univ Kentucky, Coll Pharm, Mol Modeling & Biopharmaceut Ctr, 789 South Limestone St, Lexington, KY 40536 USA; [Huang, Xiaoqin; Zhan, Chang-Guo] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 789 South Limestone St, Lexington, KY 40536 USA; [Lee, Kyoung] Changwon Natl Univ, Dept Microbiol, Chang Won 641773, Kyongnam, South Korea	Chonnam National University; Chosun University; University of Kentucky; University of Kentucky; Changwon National University	Cho, H (corresponding author), Chosun Univ, Dept Polymer Sci & Engn, Kwangju 501759, South Korea.; Zhan, CG (corresponding author), Univ Kentucky, Coll Pharm, Mol Modeling & Biopharmaceut Ctr, 789 South Limestone St, Lexington, KY 40536 USA.; Zhan, CG (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, 789 South Limestone St, Lexington, KY 40536 USA.	zhan@uky.edu; hcho@chosun.ac.kr	Jang, Chul/AAJ-8790-2020	Jang, Chul/0000-0003-4084-2301	Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education; Human Resource Training Program for Regional Innovation and Creativity through the National Research Foundation of Korea [NRF-2014H1C1A1067030]; National Science Foundation (NSF) [CHE-1111761]	Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education; Human Resource Training Program for Regional Innovation and Creativity through the National Research Foundation of Korea(National Research Foundation of Korea); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea)	This work was supported by the Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea (NRF-2014H1C1A1067030), and the National Science Foundation (NSF grant CHE-1111761).; This work was supported in part by the Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea (NRF-2014H1C1A1067030) and the National Science Foundation (NSF grant CHE-1111761).	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; Avila M, 2009, DNA CELL BIOL, V28, P405, DOI 10.1089/dna.2009.0874; BAYER AS, 1992, INFECT IMMUN, V60, P3979, DOI 10.1128/IAI.60.10.3979-3985.1992; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Blackledge MS, 2013, CURR OPIN PHARMACOL, V13, P699, DOI 10.1016/j.coph.2013.07.004; Braman J, 1996, Methods Mol Biol, V57, P31; Case DA, 2012, AMBER 12; Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVIDSON IW, 1977, J GEN MICROBIOL, V98, P603, DOI 10.1099/00221287-98-2-603; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; FRANKLIN MJ, 1993, J BACTERIOL, V175, P5057, DOI 10.1128/JB.175.16.5057-5065.1993; Frederiksen B, 2006, ACTA PAEDIATR, V95, P1070, DOI 10.1080/08035250600752466; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Garcia-Saenz MC, 2000, J CATARACT REFR SURG, V26, P1673, DOI 10.1016/S0886-3350(00)00483-1; GRASDALEN H, 1981, CARBOHYD RES, V89, P179, DOI 10.1016/S0008-6215(00)85243-X; GRASDALEN H, 1983, CARBOHYD RES, V118, P255, DOI 10.1016/0008-6215(83)88053-7; GRISTINA AG, 1985, SCIENCE, V228, P990, DOI 10.1126/science.4001933; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hay ID, 2009, APPL ENVIRON MICROB, V75, P6022, DOI 10.1128/AEM.01078-09; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOIBY N, 1986, ANNU REV MICROBIOL, V40, P29, DOI 10.1146/annurev.mi.40.100186.000333; Huang XQ, 2013, MOL BIOSYST, V9, P3047, DOI 10.1039/c3mb70231f; Huang XQ, 2012, J PHYS CHEM B, V116, P532, DOI 10.1021/jp210579b; Jang CH, 2007, INT J PEDIATR OTORHI, V71, P591, DOI 10.1016/j.ijporl.2006.12.005; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Kotra LP, 2000, ASM NEWS, V66, P675; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; MacDonald LC, 2014, J BIOL CHEM, V289, P18022, DOI 10.1074/jbc.M114.571299; MAI GT, 1993, INFECT IMMUN, V61, P4338, DOI 10.1128/IAI.61.10.4338-4343.1993; Masak J, 2014, FEMS MICROBIOL ECOL, V89, P1, DOI 10.1111/1574-6941.12344; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Nivens DE, 2001, J BACTERIOL, V183, P1047, DOI 10.1128/JB.183.3.1047-1057.2001; Pier GB, 2001, INFECT IMMUN, V69, P1895, DOI 10.1128/IAI.69.3.1895-1901.2001; Rehm BH, 1996, J BACTERIOL, V178, P5884, DOI 10.1128/jb.178.20.5884-5889.1996; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sanderson AR, 2006, LARYNGOSCOPE, V116, P1121, DOI 10.1097/01.mlg.0000221954.05467.54; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trampuz A, 2005, SWISS MED WKLY, V135, P243; Veeranagouda Y, 2011, PROCESS BIOCHEM, V46, P328, DOI 10.1016/j.procbio.2010.09.009; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Wingender J, 2001, METHOD ENZYMOL, V336, P302, DOI 10.1016/S0076-6879(01)36597-7; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Yang L, 2012, FEMS IMMUNOL MED MIC, V65, P146, DOI 10.1111/j.1574-695X.2011.00858.x	51	19	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156197	10.1371/journal.pone.0156197	http://dx.doi.org/10.1371/journal.pone.0156197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253324	gold, Green Published, Green Submitted			2022-12-26	WOS:000377218700016
J	Rade, M; Kononen, M; Marttila, J; Shacklock, M; Vanninen, R; Kankaanpaa, M; Airaksinen, O				Rade, M.; Kononen, M.; Marttila, J.; Shacklock, M.; Vanninen, R.; Kankaanpaa, M.; Airaksinen, O.			In Vivo MRI Measurement of Spinal Cord Displacement in the Thoracolumbar Region of Asymptomatic Subjects with Unilateral and Sham Straight Leg Raise Tests	PLOS ONE			English	Article							RESONANCE-IMAGING MEASUREMENT; INTRARADICULAR BLOOD-FLOW; NERVE ROOT DISPLACEMENT; 2006 YOUNG INVESTIGATOR; LUMBAR DISC HERNIATION; UNEMBALMED CADAVERS; SCIATIC-NERVE; WINNER; MOTION	Background Normal displacement of the conus medullaris with unilateral and bilateral SLR has been quantified and the "principle of linear dependence" has been described. Purpose Explore whether previously recorded movements of conus medullaris with SLRs are i) primarily due to transmission of tensile forces transmitted through the neural tissues during SLR or ii) the result of reciprocal movements between vertebrae and nerves. Study design Controlled radiologic study. Methods Ten asymptomatic volunteers were scanned with a 1.5T magnetic resonance (MR) scanner using T2 weighted spc 3D scanning sequences and a device that permits greater ranges of SLR. Displacement of the conus medullaris during the unilateral and sham SLR was quantified reliably with a randomized procedure. Conus displacement in response to unilateral and sham SLRs was quantified and the results compared. Results The conus displaced caudally in the spinal canal by 3.54 +/- 0.87 mm (mean +/- SD) with unilateral (p <=.001) and proximally by 0.32 +/- 1.6 mm with sham SLR (p <=.542). Pearson correlations were higher than 0.99 for both intra- and inter-observer reliability and the observed power was 1 for unilateral SLRs and 0.054 and 0.149 for left and right sham SLR respectively. Conclusions Four relevant points emerge from the presented data: i) reciprocal movements between the spinal cord and the surrounding vertebrae are likely to occur during SLR in asymptomatic subjects, ii) conus medullaris displacement in the vertebral canal with SLR is primarily due to transmission of tensile forces through the neural tissues, iii) when tensile forces are transmitted through the neural system as in the clinical SLR, the magnitude of conus medullaris displacement prevails over the amount of bone adjustment.	[Rade, M.; Shacklock, M.; Airaksinen, O.] Kuopio Univ Hosp, Dept Phys & Rehabil Med, SF-70210 Kuopio, Finland; [Rade, M.] Josip Juraj Strossmayer Univ Osijek, Fac Med, Orthopaed & Rehabil Hosp Prim Dr Martin Horvat, Rovinj, Croatia; [Kononen, M.; Marttila, J.; Vanninen, R.] Kuopio Univ Hosp, Dept Radiol, SF-70210 Kuopio, Finland; [Shacklock, M.] Neurodynam Solut, Adelaide, SA, Australia; [Kankaanpaa, M.] Tampere Univ Hosp, Dept Phys & Rehabil Med, Tampere, Finland	Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Tampere University; Tampere University Hospital	Rade, M (corresponding author), Kuopio Univ Hosp, Dept Phys & Rehabil Med, SF-70210 Kuopio, Finland.; Rade, M (corresponding author), Josip Juraj Strossmayer Univ Osijek, Fac Med, Orthopaed & Rehabil Hosp Prim Dr Martin Horvat, Rovinj, Croatia.	marinko.rade@kuh.fi	Rade, Marinko/T-1628-2018	Rade, Marinko/0000-0001-7753-7736	Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (Kuopio, Finland) [5960441]	Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (Kuopio, Finland)	The authors acknowledge the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (project 5960441, Kuopio, Finland). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the Research Committee of the Kuopio University Hospital Catchment Area for the State Research Funding (project 5960441, Kuopio, Finland). The authors would here like to thank the medical illustrator Dr. Ivan Barun (ivan.barun@email.t-com.hr) for providing the excellent illustration presented in Fig 6.	Beith ID, 1995, MOVING IN ON PAIN, P194; BREIG A, 1979, Spine, V4, P242, DOI 10.1097/00007632-197905000-00011; Breig A., 1978, ADVERSE MECH TENSION; CHARNLEY J, 1951, LANCET, V260, P186; Coppieters MW, 2015, J ORTHOP SPORT PHYS, V45, P731, DOI 10.2519/jospt.2015.5743; De Beurmann L., 1884, ARCH PHVSIOL NORM PA, V3, P375; FALCONER MA, 1948, J NEUROL NEUROSUR PS, V11, P13, DOI 10.1136/jnnp.11.1.13; Gilbert KK, 2007, SPINE, V32, P1521, DOI 10.1097/BRS.0b013e318067dd72; Gilbert KK, 2007, SPINE, V32, P1513, DOI 10.1097/BRS.0b013e318067dd55; GODDARD MD, 1965, J NEUROL NEUROSUR PS, V28, P12, DOI 10.1136/jnnp.28.1.12; Inman VT, 1942, RADIOLOGY, V38, P669; JONSSON B, 1995, SPINE, V20, P27; Kobayashi S, 2003, SPINE, V28, P1427, DOI 10.1097/00007632-200307010-00014; Kobayashi S, 2003, J NEUROSURG, V99, P298, DOI 10.3171/spi.2003.99.3.0298; Kobayashi S, 2010, SPINE, V35, P2004, DOI 10.1097/BRS.0b013e3181d4164d; PORTER RW, 1990, SPINE, V15, P103, DOI 10.1097/00007632-199002000-00010; Rade M, 2015, SPINE, V40, P935, DOI 10.1097/BRS.0000000000000914; Rade M, 2014, SPINE, V39, P1288, DOI 10.1097/BRS.0000000000000263; Rade M, 2014, SPINE, V39, P1294, DOI 10.1097/BRS.0000000000000264; Shacklock M, 2007, BIOMECHANICS NERVOUS; Sjoqvist O, 1947, ACTA PSYCH NEUROL SU, P290; SMITH SA, 1993, SPINE, V18, P992, DOI 10.1097/00007632-199306150-00007	22	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155927	10.1371/journal.pone.0155927	http://dx.doi.org/10.1371/journal.pone.0155927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253708	Green Submitted, gold, Green Published			2022-12-26	WOS:000377218700012
J	Geva, R; Orr, E				Geva, Ronny; Orr, Edna			Talk the Walk: Does Socio-Cognitive Resource Reallocation Facilitate the Development of Walking?	PLOS ONE			English	Article							CHIMPANZEE; ACQUISITION; BIPEDALISM; ORIGIN; POSTURE; STEP; GAIT	Walking is of interest to psychology, robotics, zoology, neuroscience and medicine. Human's ability to walk on two feet is considered to be one of the defining characteristics of hominoid evolution. Evolutionary science propses that it emerged in response to limited environmental resources; yet the processes supporting its emergence are not fully understood. Developmental psychology research suggests that walking elicits cognitive advancements. We postulate that the relationship between cognitive development and walking is a bi-directional one; and further suggest that the initiation of novel capacities, such as walking, is related to internal socio-cognitive resource reallocation. We shed light on these notions by exploring infants' cognitive and socio-communicative outputs prospectively from 6-18 months of age. Structured bi/tri weekly evaluations of symbolic and verbal development were employed in an urban cohort (N = 9) for 12 months, during the transition from crawling to walking. Results show links between preemptive cognitive changes in socio-communicative output, symbolic-cognitive tool-use processes, and the age of emergence of walking. Plots of use rates of lower symbolic play levels before and after emergence of new skills illustrate reductions in use of previously attained key behaviors prior to emergence of higher symbolic play, language and walking. Further, individual differences in age of walking initiation were strongly related to the degree of reductions in complexity of object-use (r = .832, p < .005), along with increases, counter to the general reduction trend, in skills that serve recruitment of external resources [socio-communication bids before speech (r = -.696, p < .01), and speech bids before walking; r = .729, p < .01)]. Integration of these proactive changes using a computational approach yielded an even stronger link, underscoring internal resource reallocation as a facilitator of walking initiation (r = .901, p < 0.001). These preliminary data suggest that representational capacities, symbolic object use, language and social developments, form an integrated adaptable composite, which possibly enables proactive internal resource reallocation, designed to support the emergence of new developmental milestones, such as walking.	[Geva, Ronny] Bar Ilan Univ, Gonda Multidisciplinary Brain Res Ctr, Dept Psychol, IL-5290002 Ramat Gan, Israel; [Geva, Ronny; Orr, Edna] Bar Ilan Univ, Dev Neuropsychol Lab, IL-5290002 Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Geva, R (corresponding author), Bar Ilan Univ, Gonda Multidisciplinary Brain Res Ctr, Dept Psychol, IL-5290002 Ramat Gan, Israel.; Geva, R (corresponding author), Bar Ilan Univ, Dev Neuropsychol Lab, IL-5290002 Ramat Gan, Israel.	Ronny.Geva@biu.ac.il		Geva, Ronny/0000-0002-5724-2153	National Office of Science, Technology and Space	National Office of Science, Technology and Space	This work was supported by an Infrastructure grant from the National Office of Science, Technology and Space awarded to R.G.; http://most.gov.il/English/Pages/default.aspx. The funder has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2015, NATURE, V521, P426, DOI 10.1038/521426a; Adolph K., 2010, HDB CROSS CULTURAL D; Adolph K. E., 2013, ROAD WALKING WHAT LE, V1, P403, DOI DOI 10.1093/OXFORDHB/9780199958450.013.0015; Adolph KE, 2014, CHILD DEV PERSPECT, V8, P187, DOI 10.1111/cdep.12085; Adolph KE, 2014, CURR DIR PSYCHOL SCI, V23, P60, DOI 10.1177/0963721413498895; Adolph KE, 2011, DEVELOPMENTAL SCIENCE: AN ADVANCED TEXTBOOK, SIXTH EDITION, P241; ADOLPH KE, 2009, LEARNING INFANT MIND, P172; Asada M, 2001, ROBOT AUTON SYST, V37, P185, DOI 10.1016/S0921-8890(01)00157-9; Baldwin DA, 2001, CHILD DEV, V72, P708, DOI 10.1111/1467-8624.00310; Berger SE, 2015, BRIT J DEV PSYCHOL, V33, P106, DOI 10.1111/bjdp.12076; Berger SE, 2014, INFANCY, V19, P117, DOI 10.1111/infa.12042; Berger SE, 2004, INFANCY, V5, P217, DOI 10.1207/s15327078in0502_7; Brand RJ, 2015, INFANCY, V20, P405, DOI 10.1111/infa.12084; BRIL B, 1986, INT J BEHAV DEV, V9, P439, DOI 10.1177/016502548600900403; Carvalho S, 2012, CURR BIOL, V22, pR180, DOI 10.1016/j.cub.2012.01.052; Delisle R, 2015, DABATING HUMANKINDS; Gavrilov Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00286; Harcourt-Smith William E.H., 2007, P1483, DOI 10.1007/978-3-540-33761-4_48; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hoff E., 2014, LANGUAGE DEV; HOPKINS WD, 1993, CURR ANTHROPOL, V34, P786, DOI 10.1086/204224; HREIDARSSON SJ, 1983, CLIN PEDIATR, V22, P248, DOI 10.1177/000992288302200402; Huber N, 2011, INT S SOFTWARE ENG A, P90, DOI DOI 10.1145/1988008.1988021; HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; JABLONSKI NG, 1993, J HUM EVOL, V24, P259, DOI 10.1006/jhev.1993.1021; Karasik LB, 2011, CHILD DEV, V82, P1199, DOI 10.1111/j.1467-8624.2011.01595.x; Karasik LB, 2010, BEHAV BRAIN SCI, V33, P95, DOI 10.1017/S0140525X10000117; Kretch KS, 2013, DEVELOPMENTAL SCI, V16, P336, DOI 10.1111/desc.12045; Kretch KS, 2013, CHILD DEV, V84, P226, DOI 10.1111/j.1467-8624.2012.01842.x; Leavens DA, 2005, CURR DIR PSYCHOL SCI, V14, P185, DOI 10.1111/j.0963-7214.2005.00361.x; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; McCune L., 2008, CHILDREN LEARN LANGU; Nakatsukasa M, 2004, J ANAT, V204, P385, DOI 10.1111/j.0021-8782.2004.00290.x; Orr E, 2015, INFANT BEHAV DEV, V38, P147, DOI 10.1016/j.infbeh.2015.01.002; Rabain-Jamin J., 1993, EARLY DEV PARENTING, V2, P107, DOI DOI 10.1002/EDP.2430020205; Robinson J.T., 1972, EARLY HOMINID POSTUR; Rovee-Collier C, 1999, CURR DIR PSYCHOL SCI, V8, P80, DOI 10.1111/1467-8721.00019; Ryou Jae-Wook, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P430, DOI 10.3758/CABN.4.4.430; Sayers K, 2008, CURR ANTHROPOL, V49, P87, DOI 10.1086/523675; Sherwood CC, 2008, J ANAT, V212, P426, DOI 10.1111/j.1469-7580.2008.00868.x; Shetreat-Klein M, 2014, BRAIN DEV-JPN, V36, P91, DOI 10.1016/j.braindev.2012.02.005; Soska KC, 2010, DEV PSYCHOL, V46, P129, DOI 10.1037/a0014618; Taatgen NA, 2013, PSYCHOL REV, V120, P439, DOI 10.1037/a0033138; THELEN E, 1984, INFANT BEHAV DEV, V7, P479, DOI 10.1016/S0163-6383(84)80007-7; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Thorpe SKS, 2007, SCIENCE, V316, P1328, DOI 10.1126/science.1140799; Visalberghi E, 2009, CURR BIOL, V19, P213, DOI 10.1016/j.cub.2008.11.064; Walle EA, 2014, DEV PSYCHOL, V50, P336, DOI 10.1037/a0033238; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Wuttke J., 2013, LECT NOTES COMPUT SC, V7475, P1, DOI [DOI 10.1007/978-3-642-35813-5_1, 10.1007/978- 3- 642-35813- 5{_}1]; Zelazo PR, 1998, DEV REV, V18, P449, DOI 10.1006/drev.1997.0460	51	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156351	10.1371/journal.pone.0156351	http://dx.doi.org/10.1371/journal.pone.0156351			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27248834	Green Submitted, Green Published, gold			2022-12-26	WOS:000377184700037
J	Hu, XS; Liu, YJ; Wang, YH; Wang, Z; Yu, XL; Wang, B; Zhang, GS; Liu, XF; Hu, ZQ; Zhao, HY; Liu, TX				Hu, Xiang-Shun; Liu, Ying-Jie; Wang, Yu-Han; Wang, Zhe; Yu, Xin-lin; Wang, Bo; Zhang, Gai-Sheng; Liu, Xiao-Feng; Hu, Zu-Qing; Zhao, Hui-Yan; Liu, Tong-Xian			Resistance of Wheat Accessions to the English Grain Aphid Sitobion avenae	PLOS ONE			English	Article							CEREAL APHID; HEMIPTERA APHIDIDAE; GENETIC-STRUCTURE; SPATIAL-DISTRIBUTION; RHOPALOSIPHUM-PADI; WINTER-WHEAT; VARIETIES; POPULATIONS; ANTIBIOSIS; HOMOPTERA	The English grain aphid, Sitobion avenae, is a major pest species of wheat crops; however, certain varieties may have stronger resistance to infestation than others. Here, we investigated 3 classical resistance mechanisms (antixenosis, antibiosis, and tolerance) by 14 wheat varieties/lines to S. avenae under laboratory and field conditions. Under laboratory conditions, alatae given the choice between 2 wheat varieties, strongly discriminated against certain varieties. Specifically, the 'Amigo' variety had the lowest palatability to S. avenae alatae of all varieties. 'Tm' (Triticum monococcum), 'Astron,' 'Xanthus,' 'Ww2730,' and 'Batis' varieties also had lower palatability than other varieties. Thus, these accessions may use antibiosis as the resistant mechanism. In contrast, under field conditions, there were no significant differences in the number of alatae detected on the 14 wheat varieties. One synthetic line (98-10-30, a cross between of Triticum aestivum (var. Chris) and Triticum turgidum (var. durum) hybridization) had low aphid numbers but high yield loss, indicating that it has high antibiosis, but poor tolerance. In comparison, 'Amigo,' 'Xiaoyan22,' and some '186Tm' samples had high aphid numbers but low yield loss rates, indicating they have low antibiosis, but good tolerance. Aphid population size and wheat yield loss rates greatly varied in different fields and years for '98-10-35,' 'Xiaoyan22,' 'Tp,' 'Tam200,' 'PI high,' and other '186Tm' samples, which were hybrid offspring of T. aestivum and wheat related species. Thus, these germplasm should be considered for use in future studies. Overall, S. avenae is best adapted to 'Xinong1376,' because it was the most palatable variety, with the greatest yield loss rates of all 14 wheat varieties. However, individual varieties/lines influenced aphid populations differently in different years. Therefore, we strongly recommend a combination of laboratory and long-term field experiments in targeted planting regions to identify varieties/lines that consistently show high resistance to S. avenae infestation.	[Hu, Xiang-Shun; Wang, Zhe; Yu, Xin-lin; Liu, Xiao-Feng; Hu, Zu-Qing; Zhao, Hui-Yan; Liu, Tong-Xian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Hu, Xiang-Shun; Liu, Ying-Jie; Wang, Yu-Han; Wang, Zhe; Yu, Xin-lin; Wang, Bo; Liu, Xiao-Feng; Hu, Zu-Qing; Zhao, Hui-Yan; Liu, Tong-Xian] Northwest A&F Univ, Key Lab Crop Pest Management Nrothwest Loess Plat, Minist Agr, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Gai-Sheng] Northwest A&F Univ, Coll Agr, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Zhao, HY; Liu, TX (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Zhao, HY; Liu, TX (corresponding author), Northwest A&F Univ, Key Lab Crop Pest Management Nrothwest Loess Plat, Minist Agr, Yangling 712100, Shaanxi, Peoples R China.	zhaohy@nwsuaf.edu.cn; txliu@nwsuaf.edu.cn	Hu, Xiangshun/M-9935-2013		Basic Research Foundation of Northwest AF University [Z222021316, Z109021122]; National Natural Science Foundation of China [31401735]	Basic Research Foundation of Northwest AF University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by the Basic Research Foundation of Northwest A&F University (Z222021316, Z109021122) and the National Natural Science Foundation of China (31401735).	Boeve PJ, 1998, CAN ENTOMOL, V130, P67, DOI 10.4039/Ent13067-1; [蔡凤环 Cai Fenghuan], 2004, [西北农林科技大学学报. 自然科学版, Journal of northwest sci-tech university of agriculture and forestry], V32, P21; Cai QN, 2009, BIOL CONTROL, V49, P134, DOI 10.1016/j.biocontrol.2008.12.009; CAILLAUD CM, 1995, B ENTOMOL RES, V85, P189, DOI 10.1017/S000748530003426X; CAILLAUD CM, 1994, ANN APPL BIOL, V125, P219, DOI 10.1111/j.1744-7348.1994.tb04964.x; Cao H-H, 2014, THESIS NW A F U YANG; CHU H. F., 1961, Acta Entomologica Sinica, V10, P411; Di Pietro JP, 1998, PLANT BREEDING, V117, P407, DOI 10.1111/j.1439-0523.1998.tb01964.x; Ding H-S, 1958, ENTOMOL KNOWLE, V2, P70; Dogimont C, 2010, CR BIOL, V333, P566, DOI 10.1016/j.crvi.2010.04.003; Dong H, 2006, THESIS SHANDONG AGR; DONG QZ, 1987, ACTA ENTOMOL SINICA, V30, P277; Du L.-F., 1999, ACTA BOT BOREALI-OCC, V19, P68; Duan C.X., 2006, J PLANT GENET RESOUR, V7, P297; Fievet V, 2007, AGR FOREST ENTOMOL, V9, P125, DOI 10.1111/j.1461-9563.2007.00331.x; Figueroa CC, 2005, HEREDITY, V95, P24, DOI 10.1038/sj.hdy.6800662; [付晶 FU Jing], 2008, [河北农业大学学报, Journal of Agricultural University of Hebei], V31, P1; Graybosch RA, 1999, PLANT BREEDING, V118, P125, DOI 10.1046/j.1439-0523.1999.118002125.x; Guo Xiao, 2010, Scientia Agricultura Sinica, V43, P2056; HAVLICKOVA H, 1993, J AGRON CROP SCI, V171, P133, DOI 10.1111/j.1439-037X.1993.tb00122.x; Hesler LS, 2005, EUPHYTICA, V143, P153, DOI 10.1007/s10681-005-3060-7; HOLLENHORST MM, 1983, CROP SCI, V23, P91, DOI 10.2135/cropsci1983.0011183X002300010026x; [胡秉芬 HU Bing-fen], 2009, [甘肃农业大学学报, Journal of Gansu Agricultural University], V44, P58; Hu Xiang-Shun, 2014, Chinese Journal of Applied Entomology, V51, P1459, DOI 10.7679/j.issn.2095-1353.2014.170; Hu XS, 2013, J ECON ENTOMOL, V106, P1894, DOI 10.1603/EC13071; Hu Xiang-shun, 2008, Agricultural Sciences in China, V7, P180, DOI 10.1016/S1671-2927(08)60037-1; [胡想顺 Hu Xiangshun], 2011, [植物保护, Plant Protection], V37, P81; Hu XiangShun, 2004, Acta Botanica Boreali-Occidentalia Sinica, V24, P1221; Huang XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122343; Jensen AB, 2008, AGR FOREST ENTOMOL, V10, P279, DOI 10.1111/j.1461-9563.2008.00383.x; Larsson H, 2005, CROP PROT, V24, P397, DOI 10.1016/j.cropro.2004.08.011; Li Feng-Qi, 2013, Plant Science Journal, V31, P228, DOI 10.3724/SP.J.1142.2013.30228; Li FQ, 2013, J ECON ENTOMOL, V106, P1473, DOI 10.1603/EC12327; Li Jun, 2007, Chinese Bulletin of Entomology, V44, P509; Li S-J, 1998, PLANT PROT, V5, P15; Li Su-Juan, 2001, Entomological Knowledge, V38, P355; Li Xian-Qing, 2006, Acta Entomologica Sinica, V49, P963; Liang Hui, 2004, Acta Genetica Sinica, V31, P189; Liu S-Y, 1993, ACTA AGR BOREALI OCC, V3, P76; Liu XL, 2012, THEOR APPL GENET, V124, P287, DOI 10.1007/s00122-011-1704-7; Liu XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106639; Liu XinLun, 2014, Acta Phytophylacica Sinica, V41, P216; Liu XinLun, 2006, Journal of Triticeae Crops, V26, P24; Liu Yong, 2001, Acta Phytophylacica Sinica, V28, P203; Llewellyn KS, 2004, HEREDITY, V93, P143, DOI 10.1038/sj.hdy.6800466; Llewellyn KS, 2003, MOL ECOL, V12, P21, DOI 10.1046/j.1365-294X.2003.01703.x; LOWE HJB, 1984, J AGR SCI, V102, P487, DOI 10.1017/S0021859600042854; Lu Z-Y, 2014, J HEBEI AGR SCI, V3, P24; Luo R-W, 1988, ACTA PHYTOPHYL SIN, V3, P153; [欧行奇 Ou Xingqi], 2005, [麦类作物学报, Journal of triticeae crops], V25, P125; Painter RH, 1951, INSECT RESISTANCE CR; Pan J-X, 2013, THESIS HEBEI U SCI T; Panda N, 1995, HOST PLANT RESISTANC, P448; Papura D, 2003, HEREDITY, V90, P397, DOI 10.1038/sj.hdy.6800262; Peng L-N, 2000, CHINESE J PESTIC SCI, V3, P13; Qi M-W, 1987, J SHANDONG AGR U, V4, P59; Qu F, 2012, J SHANXI AGR SCI, V4, p[386, 392]; Qu H-X, 2004, ACTA AGR BOREALI SIN, V4, P102; Riazuddin, 2004, Pakistan Entomologist, V26, P13; Shi Z., 1999, ACTA AGR BOREALI SIN, V14, P98; Silva AM, 2013, NEOTROP ENTOMOL, V42, P304, DOI 10.1007/s13744-013-0117-5; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Smith CM, 1999, GLOBAL PLANT GENETIC RESOURCES FOR INSECT-RESISTANT CROPS, P25; Sun J-W, 1993, J HENAN AGR SCI, V1, P26; Thackray DJ, 2009, PLANT PATHOL, V58, P186, DOI 10.1111/j.1365-3059.2008.01950.x; Thieme Thomas, 1996, IOBC-WPRS Bulletin, V19, P1; Wang C-P, 2011, J NW A F U NATU SCI, V4, P41; Wang CP, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.9001; Wang M-F, 2011, J HENNAN AGR SCI, V4, P16; Wang Y-M, 1983, J SHANXI AGR SCI, V04, P16; Wei Hui-Ting, 2014, Chinese Journal of Applied Entomology, V51, P1524, DOI 10.7679/j.issn.2095-1353.2014.177; Winder L, 1999, ENTOMOL EXP APPL, V93, P277, DOI 10.1023/A:1003982111689; Wu R., 1996, PLANT PROTECTION TEC, V1, P3; Wu WQ, 2014, ECOL MODEL, V288, P55, DOI 10.1016/j.ecolmodel.2014.05.017; Xie N, 2014, HENAN SCI, V3, P1020; Xin JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109349; Xu LanJie, 2014, Journal of China Agricultural University, V19, P21; Xu LL, 2014, J ORTHOP TRANSL, V2, P1, DOI 10.1016/j.jot.2013.11.002; Xu QiongFang, 2005, Journal of Triticeae Crops, V25, P7; Xu ZH, 2011, J ECON ENTOMOL, V104, P1080, DOI 10.1603/EC10204; Ye S-H, 2012, GRASSLAND TURF, V3, p[78, 83]; Yin Q-Y, 2003, J WHEAT RES, V3, P30; Yu Y, 2008, PLANT CELL TISS ORG, V94, P33, DOI 10.1007/s11240-008-9384-y; Yu Yang, 2006, Yingyong Shengtai Xuebao, V17, P354; Zhang R-L, 1999, ENTOMOL KNOWLE, V3, P135; Zhang X-C, 1985, ACTA PHYTOPHYL SIN, V1, P9; Zhang Z-Y, 2000, ACTA AGR BOREALI SIN, V1, P57; Zhao Z-J, 1996, PLANT PROT, V2, P78; Zheng W-Y, 1999, J WHEAT RES, V1, P1	89	21	22	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156158	10.1371/journal.pone.0156158	http://dx.doi.org/10.1371/journal.pone.0156158			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249206	gold, Green Published, Green Submitted			2022-12-26	WOS:000377184700030
J	Mawrie, D; Kumar, A; Magdalene, D; Bhattacharyya, J; Jaganathan, BG				Mawrie, Darilang; Kumar, Atul; Magdalene, Damaris; Bhattacharyya, Jina; Jaganathan, Bithiah Grace			Mesenchymal Stem Cells from Human Extra Ocular Muscle Harbor Neuroectodermal Differentiation Potential	PLOS ONE			English	Article							EXTRAOCULAR-MUSCLES; NEURAL CREST; BONE-MARROW; PROGENITORS; THERAPY	Mesenchymal stem cells (MSC) have been proposed as suitable candidates for cell therapy for neurological disorderssince they exhibit good neuronal differentiation capacity. However, for better therapeutic outcomes, it is necessary to isolate MSC from a suitable tissue sourcethat posses high neuronal differentiation. In this context, we isolated MSC from extra ocular muscle (EOM) tissue and tested the in vitro neuronal differentiation potential. In the current study, EOM tissue derived MSC were characterized and compared with bone marrow derived MSC. We found that EOM derived MSC proliferated as a monolayer and showed similarities in morphology, growth properties and cell surface marker expression with bone marrow derived MSC and expressed high levels of NES, OCT4, NANOG and SOX2 in its undifferentiated state. They also expressed embryonic cell surface marker SSEA4 and their intracellular mitochondrial distribution pattern was similar to that of multi-potent stem cells. Although EOM derived MSC differentiated readily into adipocytes, osteocytes and chondrocytes, they differentiated more efficiently into neuroectodermal cells. The differentiation into neuroectodermal cellswas confirmed by the expression of neuronal markers NGFR and MAP2B. Thus, EOM derived MSC might be good candidates for stem cell based therapies for treating neurodegenerative diseases.	[Mawrie, Darilang; Kumar, Atul; Jaganathan, Bithiah Grace] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Stem Cell & Canc Biol Lab, Gauhati, Assam, India; [Magdalene, Damaris] Sri Sankaradeva Nethralaya Hosp, Dept Strabismus, Gauhati, Assam, India; [Bhattacharyya, Jina] Gauhati Med Coll & Hosp, Dept Hematol, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Gauhati Medical College & Hospital	Jaganathan, BG (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Stem Cell & Canc Biol Lab, Gauhati, Assam, India.	bithiahgj@iitg.ernet.in		Kumar, Atul/0000-0001-9682-5725	Indian council of Medical Research (ICMR) [5/7/526/2011-RHN]	Indian council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR))	Funded by Indian council of Medical Research (ICMR, No. 5/7/526/2011-RHN). http://www.icmr.nic.in/. ICMR provided seed grant for preliminary studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Himanshu Vyas for performing the preliminary studies. We thank the Central Instrument Facility, Indian Institute of Technology Guwahati (IITG) for performing the FESEM analysis. Primers for calcium channel related genes were kindly provided by Dr. Piruthivi Sukumar (IITG). This project was supported by seed grant from Indian Council of Medical Research (ICMR, No. 5/7/526/2011-RHN) to BGJ and D Magdalene. ICMR did not have any role in designing the experiment, data collection or analysis.	Arrighi N, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.79; BJORK A, 1952, EXPERIENTIA, V8, P226, DOI 10.1007/BF02170722; Bohnsack BL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1030, DOI 10.1001/archophthalmol.2011.75; Boxall SA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/975871; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; De Kock J, 2012, STEM CELLS DEV, V21, P3309, DOI 10.1089/scd.2011.0723; Delfino-Machin M, 2007, DEV DYNAM, V236, P3242, DOI 10.1002/dvdy.21314; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ewart J C, 1894, J Anat Physiol, V28, P342; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hodgkinson CP, 2010, HUM GENE THER, V21, P1513, DOI 10.1089/hum.2010.165; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; KAMINSKI HJ, 1992, ANN NEUROL, V32, P586, DOI 10.1002/ana.410320418; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; KHURANA TS, 1995, J EXP MED, V182, P467, DOI 10.1084/jem.182.2.467; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; McDonald AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086424; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; Olson SD, 2012, MOL NEUROBIOL, V45, P87, DOI 10.1007/s12035-011-8219-8; Pacheco-Pinedo EC, 2009, PHYSIOL GENOMICS, V37, P35, DOI 10.1152/physiolgenomics.00051.2008; Polisetty N, 2008, MOL VIS, V14, P431; Somaiah C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145068; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wang L, 2015, J CLIN INVEST, V125, P796, DOI 10.1172/JCI79220; Wright KW, 2003, PEDIAT OPHTHALMOLOGY, Vxxiii, P1084; Wyse RD, 2014, INT J MOL SCI, V15, P1719, DOI 10.3390/ijms15021719; Zahir T, 2009, STEM CELLS DEV, V18, P1423, DOI 10.1089/scd.2008.0412	32	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156697	10.1371/journal.pone.0156697	http://dx.doi.org/10.1371/journal.pone.0156697			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248788	Green Submitted, Green Published, gold			2022-12-26	WOS:000377184700067
J	Ozono, H; Kamijo, Y; Shimizu, K				Ozono, Hiroki; Kamijo, Yoshio; Shimizu, Kazumi			Institutionalize Reciprocity to Overcome the Public Goods Provision Problem	PLOS ONE			English	Article							COLLECTIVE SANCTIONS; RATIONAL COOPERATION; PRISONERS-DILEMMA; PUNISHMENT; HETEROGENEITY; EVOLUTION; GAMES	Cooperation is fundamental to human societies, and one of the important paths for its emergence and maintenance is reciprocity. In prisoner's dilemma (PD) experiments, reciprocal strategies are often effective at attaining and maintaining high cooperation. In many public goods (PG) games or n-person PD experiments, however, reciprocal strategies are not successful at engendering cooperation. In the present paper, we attribute this difficulty to a coordination problem against free riding among reciprocators: Because it is difficult for the reciprocators to coordinate their behaviors against free riders, this may lead to inequality among players, which will demotivate them from cooperating in future rounds. We propose a new mechanism, institutionalized reciprocity (IR), which refers to embedding the reciprocal strategy as an institution (i.e., institutionalizing the reciprocal strategy). We experimentally demonstrate that IR can prevent groups of reciprocators from falling into coordination failure and achieve high cooperation in PG games. In conclusion, we argue that a natural extension of the present study will be to investigate the possibility of IR to serve as a collective punishment system.	[Ozono, Hiroki] Kagoshima Univ, Fac Law Econ & Humanities, Kagoshima 890, Japan; [Kamijo, Yoshio] Kochi Univ Technol, Sch Econ & Management, Kochi, Japan; [Shimizu, Kazumi] Waseda Univ, Sch Polit Sci & Econ, Tokyo, Japan	Kagoshima University; Kochi University Technology; Waseda University	Shimizu, K (corresponding author), Waseda Univ, Sch Polit Sci & Econ, Tokyo, Japan.	skazumi1961@gmail.com		Shimizu, Kazumi/0000-0003-4860-7007; Kamijo, Yoshio/0000-0002-2184-9594	Japanese Ministry of Education, Culture, Sports, Science and Technology [19046002]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The Grant-in-Aid for Scientific Research on Priority Areas (19046002) provided by the Japanese Ministry of Education, Culture, Sports, Science and Technology, http://www.jsps.go.jp/j-grantsinaid/12_kiban/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We gratefully acknowledge financial support from the Grant-in-Aid for Scientific Research on Priority Areas (19046002) provided by the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Alexander R., 2008, ESSAYS PEDAGOGY; Anderson L. R., 2008, J SOCIO-ECON, V37, P1010, DOI [10.1016/j.socec.2006.12.073, DOI 10.1016/J.SOCEC.2006.12.073, DOI 10.1016/j.socec.2006.12.073]; ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; [Anonymous], 1965, LOGIC COLLECTIVE ACT; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Balliet D, 2011, PSYCHOL BULL, V137, P594, DOI 10.1037/a0023489; Cherry TL, 2005, J ECON BEHAV ORGAN, V57, P357, DOI 10.1016/j.jebo.2003.11.010; COOPER R, 1989, RAND J ECON, V20, P568, DOI 10.2307/2555734; Croson R, 2005, ECON LETT, V87, P95, DOI 10.1016/j.econlet.2004.10.007; Croson RTA, 2007, ECON INQ, V45, P199, DOI 10.1111/j.1465-7295.2006.00006.x; Dal Bo P, 2005, AM ECON REV, V95, P1591; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; De Herdt T., 2003, REV SOC ECON, V61, P183, DOI [10.1080/0034676032000098219, DOI 10.1080/0034676032000098219, 10.1080/]; de Oliveira ACM, 2015, EXP ECON, V18, P116, DOI 10.1007/s10683-014-9412-1; Denant-Boemont L, 2007, ECON THEOR, V33, P145, DOI 10.1007/s00199-007-0212-0; Devetag G, 2007, EXP ECON, V10, P331, DOI 10.1007/s10683-007-9178-9; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Fowler JH, 2005, NATURE, V433, DOI 10.1038/nature03256; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; Gachter S., 2006, DISCUSSION PAPERS U; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Grujic J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00638; HECKATHORN DD, 1988, AM J SOCIOL, V94, P535, DOI 10.1086/229029; HECKATHORN DD, 1990, AM SOCIOL REV, V55, P366, DOI 10.2307/2095762; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Kamijo Y, 2016, EXP ECON, V19, P202, DOI 10.1007/s10683-015-9433-4; KIM O, 1984, PUBLIC CHOICE, V43, P3, DOI 10.1007/BF00137902; KREPS DM, 1982, J ECON THEORY, V27, P245, DOI 10.1016/0022-0531(82)90029-1; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Levinson DJ, 2003, STANFORD LAW REV, V56, P345; Levy DM, 2011, J ECON BEHAV ORGAN, V77, P40, DOI 10.1016/j.jebo.2010.02.018; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Nosenzo D, 2015, EXP ECON, V18, P4, DOI 10.1007/s10683-013-9382-8; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rapoport A, 1996, J ECON BEHAV ORGAN, V30, P173, DOI 10.1016/S0167-2681(96)00856-6; Roberts G, 1998, NATURE, V394, P175, DOI 10.1038/28160; Sherratt TN, 2002, J THEOR BIOL, V215, P47, DOI 10.1006/jtbi.2001.2495; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	43	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0154321	10.1371/journal.pone.0154321	http://dx.doi.org/10.1371/journal.pone.0154321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6KZ	27248493	Green Submitted, Green Published, gold			2022-12-26	WOS:000377184700005
J	Rosignolo, F; Sponziello, M; Durante, C; Puppin, C; Mio, C; Baldan, F; Di Loreto, C; Russo, D; Filetti, S; Damante, G				Rosignolo, Francesca; Sponziello, Marialuisa; Durante, Cosimo; Puppin, Cinzia; Mio, Catia; Baldan, Federica; Di Loreto, Carla; Russo, Diego; Filetti, Sebastiano; Damante, Giuseppe			Expression of PAX8 Target Genes in Papillary Thyroid Carcinoma	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; GLYPICAN-3 EXPRESSION; BREAST-CANCER; CELLS; NGAL; HEDGEHOG; PROTEIN; TUMORS; DIFFERENTIATION; COMBINATION	PAX8 is a thyroid-specific transcription factor whose expression is dysregulated in thyroid cancer. A recent study using a conditional knock-out mouse model identified 58 putative PAX8 target genes. In the present study, we evaluated the expression of 11 of these genes in normal and tumoral thyroid tissues from patients with papillary thyroid cancer (PTC). ATP1B1, GPC3, KCNIP3, and PRLR transcript levels in tumor tissues were significantly lower in PTCs than in NT, whereas LCN2, LGALS1 and SCD1 expression was upregulated in PTC compared with NT. Principal component analysis of the expression of the most markedly dysregulated PAX8 target genes was able to discriminate between PTC and NT. Immunohistochemistry was used to assess levels of proteins encoded by the two most dyregulated PAX8 target genes, LCN2 and GPC3. Interestingly, GPC3 was detectable in all of the NT samples but none of the PTC samples. Collectively, these findings point to significant PTC-associated dysregulation of several PAX8 target genes, supporting the notion that PAX8-regulated molecular cascades play important roles during thyroid tumorigenesis.	[Rosignolo, Francesca; Sponziello, Marialuisa; Durante, Cosimo; Filetti, Sebastiano] Univ Roma La Sapienza, Dept Internal Med & Med Specialties, I-00161 Rome, Italy; [Puppin, Cinzia; Mio, Catia; Baldan, Federica; Di Loreto, Carla; Damante, Giuseppe] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Di Loreto, Carla; Damante, Giuseppe] Univ Hosp S Maria della Misericordia, Dept Oncol, I-33100 Udine, Italy; [Russo, Diego] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy	Sapienza University Rome; University of Udine; Hospital Santa Maria della Misericordia; Magna Graecia University of Catanzaro	Rosignolo, F (corresponding author), Univ Roma La Sapienza, Dept Internal Med & Med Specialties, I-00161 Rome, Italy.	francesca.rosignolo@uniroma1.it	Baldan, Federica/AAK-6349-2021; mio, catia/AAW-1604-2021; Durante, Cosimo/E-4926-2014; Damante, Giuseppe/AAC-5200-2022; Sponziello, Marialuisa/AAK-3530-2020	Baldan, Federica/0000-0003-1164-1316; mio, catia/0000-0002-6245-8266; Durante, Cosimo/0000-0002-1791-5915; Sponziello, Marialuisa/0000-0003-0736-1047; Rosignolo, Francesca/0000-0001-8913-1848; Damante, Giuseppe/0000-0003-2312-4009	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 10296]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2010NFEB9L_003]; Fondazione Umberto Di Mario ONLUS	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondazione Umberto Di Mario ONLUS	This work was supported by a grant to GD from Associazione Italiana per la Ricerca sul Cancro (AIRC) (http://www.airc.it/) (project no IG 10296), by a grant to DR from Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (http://www.miuristruzione.com/miur/)(project no 2010NFEB9L_003), and by the Fondazione Umberto Di Mario ONLUS (http://www.fondazionedimario.org/it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Arturi F, 2001, EUR J ENDOCRINOL, V145, P129, DOI 10.1530/eje.0.1450129; Barresi V, 2012, HISTOL HISTOPATHOL, V27, P329, DOI 10.14670/HH-27.329; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; Capurro MI, 2009, EMBO REP, V10, P901, DOI 10.1038/embor.2009.98; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Damante G, 2001, PROG NUCLEIC ACID RE, V66, P307; di Magliano MP, 2000, P NATL ACAD SCI USA, V97, P13144; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fabbro D, 1998, J MOL ENDOCRINOL, V21, P347, DOI 10.1677/jme.0.0210347; FABBRO D, 1994, CANCER RES, V54, P4744; Filmus J, 2014, MATRIX BIOL, V35, P248, DOI 10.1016/j.matbio.2013.12.007; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hinterseher U, 2014, ENDOCRINE, V45, P439, DOI 10.1007/s12020-013-0015-y; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Kim H, 2003, AM J RESP CELL MOL, V29, P694, DOI 10.1165/rcmb.2003-0061OC; Lacroix L, 2004, EUR J ENDOCRINOL, V151, P367, DOI 10.1530/eje.0.1510367; Lannetti A, 2008, P NATL ACAD SCI USA, V105, P14058, DOI 10.1073/pnas.0710846105; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lippi G, 2014, ADV CLIN CHEM, V64, P179, DOI 10.1016/B978-0-12-800263-6.00004-5; Liu Y, 2015, TUMOR BIOL, V36, P7997, DOI 10.1007/s13277-015-3528-6; Ma H, 2014, POL J PATHOL, V65, P202, DOI 10.5114/PJP.2014.45782; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Marotta P, 2014, MOL CELL ENDOCRINOL, V396, P26, DOI 10.1016/j.mce.2014.08.004; Nettore IC, 2013, J ENDOCRINOL INVEST, V36, P654, DOI 10.3275/8973; Pellizzari L, 1996, BIOCHEM J, V315, P363, DOI 10.1042/bj3150363; Puglisi F, 2000, ANTICANCER RES, V20, P311; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raman P, 2014, NAT REV ENDOCRINOL, V10, P616, DOI 10.1038/nrendo.2014.115; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rodvold JJ, 2012, CANCER LETT, V316, P132, DOI 10.1016/j.canlet.2011.11.002; Ros P, 1999, BIOCHIMIE, V81, P389, DOI 10.1016/S0300-9084(99)80086-8; Rosignolo F, 2015, J ENDOCRINOL INVEST, V38, P1283, DOI 10.1007/s40618-015-0309-4; Ruiz-Morales JM, 2015, TUMOR BIOL, V36, P3601, DOI 10.1007/s13277-014-2997-3; Sponziello M, 2015, ENDOCRINE, V50, P434, DOI 10.1007/s12020-015-0586-x; Sponziello M, 2013, ENDOCRINOLOGY, V154, P3043, DOI 10.1210/en.2013-1028; Tovey S, 2005, CLIN CANCER RES, V11, P4835, DOI 10.1158/1078-0432.CCR-05-0196; Volpe V, 2013, J CLIN ENDOCR METAB, V98, P228, DOI 10.1210/jc.2012-2528; Wang SK, 2014, ADV ANAT PATHOL, V21, P450, DOI 10.1097/PAP.0000000000000043; Wang Y, 2014, GENET MOL RES, V13, P7102, DOI 10.4238/2014.February.21.11; Xiang YY, 2001, ONCOGENE, V20, P7408, DOI 10.1038/sj.onc.1204925; Xu XL, 2012, ENDOCR-RELAT CANCER, V19, P167, DOI 10.1530/ERC-11-0305; Yamanaka K, 2007, ONCOLOGY-BASEL, V73, P389, DOI 10.1159/000136159	44	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156658	10.1371/journal.pone.0156658	http://dx.doi.org/10.1371/journal.pone.0156658			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249794	gold, Green Published, Green Submitted			2022-12-26	WOS:000377184700063
J	Amoras, EDG; Gomes, STM; Freitas, FB; Santana, BB; Ishak, G; de Araujo, MTF; Demachki, S; Conde, SRSD; Ishak, MDG; Ishak, R; Vallinoto, ACR				Graca Amoras, Ednelza da Silva; Monteiro Gomes, Samara Tatielle; Freitas, Felipe Bonfim; Santana, Barbara Brasil; Ishak, Geraldo; Ferreira de Araujo, Marialva Tereza; Demachki, Samia; Souza da Silva Conde, Simone Regina; Guimaraes Ishak, Marluisa de Oliveira; Ishak, Ricardo; Rosario Vallinoto, Antonio Carlos			Intrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV Infection	PLOS ONE			English	Article							REGULATORY T-CELLS; CHRONIC HEPATITIS-C; CHRONIC HBV; LIVER FIBROSIS; APOPTOSIS; LYMPHOCYTES; PROLIFERATION; TRANSAMINASE; TOLERANCE; MECHANISM	This study aimed to evaluate the relative mRNA expression of Fas receptor (FAS), Fas ligand (FASL), and forkhead box protein 3 (FOXP3) in liver biopsy specimens obtained from patients with viral and non-viral chronic hepatitis and correlate their expression with the fibrosis stage. A total of 51 liver biopsy specimens obtained from HBV (n = 6), HCV (n = 28), and non-viral hepatic disease (NVHD) (n = 9) patients and from individuals with normal liver histology (n = 8) (control-CT) were analyzed. Quantifications of the target genes were assessed using qPCR, and liver biopsies according to the METAVIR classification. The mRNA expression levels of FAS and FASL were lower in the CT group compared to the groups of patients. The increase in the mRNA expression of FAS and FASL was correlated with higher levels of inflammation and disease progression, followed by a decline in tissues with cirrhosis, and it was also associated with increased levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Higher mRNA expression of FOXP3 was observed in the HCV and NVHD groups, with the peak observed among patients with cirrhosis. The increased FOXP3 mRNA expression was positively correlated with increased FAS and FASL mRNA expression and the AST and ALT levels in all patients. Conclusions: These results suggest that regardless of the cause, the course of chronic liver disease may be modulated by the analyzed genes and correlated with an increase in regulatory T cells during the liver damage followed by hepatocyte destruction by Fas/FasL system and subsequent non specific lymphocytic infiltrate accumulation.	[Graca Amoras, Ednelza da Silva; Monteiro Gomes, Samara Tatielle; Freitas, Felipe Bonfim; Santana, Barbara Brasil; Guimaraes Ishak, Marluisa de Oliveira; Ishak, Ricardo; Rosario Vallinoto, Antonio Carlos] Fed Univ Para, Inst Biol Sci, Virol Lab, BR-66059 Belem, Para, Brazil; [Ishak, Geraldo] Fed Univ Para, Joao de Barros Barreto Hosp, BR-66059 Belem, Para, Brazil; [Ferreira de Araujo, Marialva Tereza; Demachki, Samia; Souza da Silva Conde, Simone Regina] Fed Univ Para, Sch Med, Inst Hlth Sci, BR-66059 Belem, Para, Brazil; [Souza da Silva Conde, Simone Regina] Holy House Mercy Fdn Para Santa Casa Misericordia, Hepatol Outpatient Serv, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para	Vallinoto, ACR (corresponding author), Fed Univ Para, Inst Biol Sci, Virol Lab, BR-66059 Belem, Para, Brazil.	vallinoto@ufpa.br	Vallinoto, Antonio Carlos/AAL-9501-2020; Gomes, Samara Tatielle Monteiro/GVT-9626-2022	Vallinoto, Antonio Carlos/0000-0003-1135-6507; /0000-0001-7079-4844	Brazilian National Council for Scientific and Technological Development (CNPq); Office of the Dean of Research and Graduate Studies (Pro-Reitoria de Pesquisa e Pos-Graduacao-PROPESP/UFPA)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Office of the Dean of Research and Graduate Studies (Pro-Reitoria de Pesquisa e Pos-Graduacao-PROPESP/UFPA)	This work was partially supported by grants from the Brazilian National Council for Scientific and Technological Development (CNPq), and the Office of the Dean of Research and Graduate Studies (Pro-Reitoria de Pesquisa e Pos-Graduacao-PROPESP/UFPA).	Alatrakchi N, 2009, J VIRAL HEPATITIS, V16, P223, DOI 10.1111/j.1365-2893.2009.01081.x; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Arzberger S, 2010, J VIROL, V84, P11994, DOI 10.1128/JVI.00653-10; Aygun C., 2010, Firat Tip Dergisi, V15, P74; Ayres M, BIOESTAT 2008 5 0 AP; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Bantel H, 2001, HEPATOLOGY, V34, P758, DOI 10.1053/jhep.2001.28229; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Bolacchi F, 2006, CLIN EXP IMMUNOL, V144, P188, DOI 10.1111/j.1365-2249.2006.03048.x; Bortolami M, 2008, J VIRAL HEPATITIS, V15, P515, DOI 10.1111/j.1365-2893.2008.00974.x; Cabrera R, 2004, HEPATOLOGY, V40, P1062, DOI 10.1002/hep.20454; Calabrese F, 2000, HEPATOLOGY, V31, P1153, DOI 10.1053/he.2000.7123; Chaudhary B, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00052; Chung YL, 2003, INT J CANCER, V107, P65, DOI 10.1002/ijc.11303; Ciccaglione AR, 2004, VIRUS RES, V104, P1, DOI 10.1016/j.virusres.2004.02.002; Claassen MAA, 2010, J HEPATOL, V52, P315, DOI 10.1016/j.jhep.2009.12.013; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; CLERMONT RJ, 1967, MEDICINE, V46, P197, DOI 10.1097/00005792-196703000-00012; Conde SRS, 2013, CYTOKINE, V61, P940, DOI 10.1016/j.cyto.2013.01.004; Dunham RM, 2013, J IMMUNOL, V190, P2009, DOI 10.4049/jimmunol.1201937; Ehrmann Jiri Jr., 2000, Pathology and Oncolgy Research, V6, P130; Erhardt A, 2007, HEPATOLOGY, V45, P475, DOI 10.1002/hep.21498; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Fischer R, 2007, WORLD J GASTROENTERO, V13, P4865, DOI 10.3748/wjg.v13.i36.4865; Germanidis G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00207; Amoras EDG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121754; GraphPad Software. Inc, PRISM 2007 DAT AN SO; Guicciardi ME, 2005, GUT, V54, P1024, DOI 10.1136/gut.2004.053850; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hahn CS, 2000, VIROLOGY, V276, P127, DOI 10.1006/viro.2000.0541; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; Karrar A, 2007, GUT, V56, P243, DOI 10.1136/gut.2006.093906; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Lan RY, 2006, HEPATOLOGY, V43, P729, DOI 10.1002/hep.21123; Machida K, 2001, J BIOL CHEM, V276, P12140, DOI 10.1074/jbc.M010137200; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; MEYER DH, 1990, BIOCHEM BIOPH RES CO, V171, P1122, DOI 10.1016/0006-291X(90)90801-S; MITA E, 1994, BIOCHEM BIOPH RES CO, V204, P468, DOI 10.1006/bbrc.1994.2483; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Mossong Joel, 2011, Bull Soc Sci Med Grand Duche Luxemb, P19; Oo YH, 2013, J HEPATOL, V59, P1127, DOI 10.1016/j.jhep.2013.05.034; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Sakaki M, 2008, HEPATOL RES, V38, P354, DOI 10.1111/j.1872-034X.2007.00284.x; Speletas M, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/827565; Stoop JN, 2008, CLIN IMMUNOL, V129, P419, DOI 10.1016/j.clim.2008.07.029; Sturm N, 2010, J HEPATOL, V53, P25, DOI 10.1016/j.jhep.2010.02.024; Ward SM, 2007, J HEPATOL, V47, P316, DOI 10.1016/j.jhep.2007.03.023; Yuen MF, 2003, GUT, V52, P416, DOI 10.1136/gut.52.3.416; Zechini B, 2004, EUR J GASTROEN HEPAT, V16, P891, DOI 10.1097/00042737-200409000-00013; Zekri Abdel-Rahman N, 2011, Comp Hepatol, V10, P4, DOI 10.1186/1476-5926-10-4; Zhu LX, 2004, WORLD J GASTROENTERO, V10, P2972	54	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156604	10.1371/journal.pone.0156604	http://dx.doi.org/10.1371/journal.pone.0156604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243827	Green Published, gold, Green Submitted			2022-12-26	WOS:000377146100052
J	Kao, JK; Wang, SC; Ho, LW; Huang, SW; Chang, SH; Yang, RC; Ke, YY; Wu, CY; Wang, JY; Shieh, JJ				Kao, Jun-Kai; Wang, Shih-Chung; Ho, Li-Wei; Huang, Shi-Wei; Chang, Shu-Hao; Yang, Rei-Cheng; Ke, Yu-Yuan; Wu, Chun-Ying; Wang, Jiu-Yao; Shieh, Jeng-Jer			Chronic Iron Overload Results in Impaired Bacterial Killing of THP-1 Derived Macrophage through the Inhibition of Lysosomal Acidification	PLOS ONE			English	Article							THALASSEMIA MAJOR; CELL-DEATH; IMMUNE-SYSTEM; IN-VITRO; AUTOPHAGY; BIOGENESIS; DEFEROXAMINE; HOMEOSTASIS; ACTIVATION; CHILDREN	Iron is essential for living organisms and the disturbance of iron homeostasis is associated with altered immune function. Additionally, bacterial infections can cause major complications in instances of chronic iron overload, such as patients with transfusion-dependent thalassemia. Monocytes and macrophages play important roles in maintaining systemic iron homoeostasis and in defense against invading pathogens. However, the effect of iron overload on the function of monocytes and macrophages is unclear. We elucidated the effects of chronic iron overload on human monocytic cell line (THP-1) and THP-1 derived macrophages (TDM) by continuously exposing them to high levels of iron (100 mu M) to create I-THP-1 and I-TDM, respectively. Our results show that iron overload did not affect morphology or granularity of I-THP-1, but increased the granularity of I-TDM. Bactericidal assays for non-pathogenic E. coli DH5 alpha, JM109 and pathogenic P. aeruginosa all revealed decreased efficiency with increasing iron concentration in I-TDM. The impaired P. aeruginosa killing ability of human primary monocyte derived macrophages (hMDM) was also found when cells are cultured in iron contained medium. Further studies on the bactericidal activity of I-TDM revealed lysosomal dysfunction associated with the inhibition of lysosomal acidification resulting in increasing lysosomal pH, the impairment of post-translational processing of cathepsins (especially cathepsin D), and decreased autophagic flux. These findings may explain the impaired innate immunity of thalassemic patients with chronic iron overload, suggesting the manipulation of lysosomal function as a novel therapeutic approach.	[Kao, Jun-Kai; Ho, Li-Wei; Shieh, Jeng-Jer] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Kao, Jun-Kai; Wang, Shih-Chung; Ho, Li-Wei; Yang, Rei-Cheng] Changhua Christian Hosp, Childrens Hosp, Dept Pediat, Changhua, Taiwan; [Huang, Shi-Wei; Shieh, Jeng-Jer] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Chang, Shu-Hao] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Ke, Yu-Yuan] Taichung Vet Gen Hosp, Dept Pediat, Taichung, Taiwan; [Wu, Chun-Ying] Taichung Vet Gen Hosp, Div Gastroenterol & Hepatol, Taichung, Taiwan; [Wang, Jiu-Yao] Natl Cheng Kung Univ, Coll Med, Allergy & Clin Immunol Res ACIR Ctr, Tainan 70101, Taiwan; [Wang, Jiu-Yao] China Med Univ, Childrens Hosp, Taichung, Taiwan; [Shieh, Jeng-Jer] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan	National Chung Hsing University; Changhua Christian Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Cheng Kung University; China Medical University Taiwan; National Chung Hsing University	Shieh, JJ (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.; Shieh, JJ (corresponding author), Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan.; Wang, JY (corresponding author), Natl Cheng Kung Univ, Coll Med, Allergy & Clin Immunol Res ACIR Ctr, Tainan 70101, Taiwan.; Wang, JY (corresponding author), China Med Univ, Childrens Hosp, Taichung, Taiwan.; Shieh, JJ (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan.	a122@mail.ncku.edu.tw; shiehjj@vghtc.gov.tw	Shieh, Jeng-Jer/AAX-6903-2020; Wu, Chun-Ying/AAX-5077-2021	Shieh, Jeng-Jer/0000-0001-8412-3603; Wu, Chun-Ying/0000-0001-5053-1801	Chang-hua Christian Hospital [101-CCH-IRP-28]; Taichung Veterans General Hospital [TCVGH-1047307C]; Ministry of Science and Technology, Taiwan [MOST-103-2320-B-005-003, MOST-104-2320-B-005-009-MY3]	Chang-hua Christian Hospital; Taichung Veterans General Hospital; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was funded by Chang-hua Christian Hospital http://www.cch.org.tw/ (101-CCH-IRP-28), recipient: JKK; Taichung Veterans General Hospital http://www.vghtc.gov.tw/home/index.html/ (TCVGH-1047307C), recipient: JJS; The Ministry of Science and Technology, Taiwan https://www.most.gov.tw/ (MOST-103-2320-B-005-003, MOST-104-2320-B-005-009-MY3), recipient: JJS.	Arifin AJ, 2014, MICROBES INFECT, V16, P967, DOI 10.1016/j.micinf.2014.09.003; Baath JS, 2008, RETINA-J RET VIT DIS, V28, P894, DOI 10.1097/IAE.0b013e3181679f67; BALLART IJ, 1986, BLOOD, V67, P105; Boelaert JR, 2007, J INFECT DIS, V195, P1745, DOI 10.1086/518040; BOELAERT JR, 1988, CLIN NEPHROL, V29, P261; Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012; Borgna-Pignatti C, 2011, EXPERT REV HEMATOL, V4, P353, DOI [10.1586/EHM.11.29, 10.1586/ehm.11.29]; CANTINIEAUX B, 1987, EUR J HAEMATOL, V39, P28; Cherayil BJ, 2010, ARCH IMMUNOL THER EX, V58, P407, DOI 10.1007/s00005-010-0095-9; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; Deretic V, 2015, J CLIN INVEST, V125, P75, DOI 10.1172/JCI73945; Doherty CP, 2007, J NUTR, V137, P1341, DOI 10.1093/jn/137.5.1341; Emanuel R, 2014, ARTERIOSCL THROM VAS, V34, P1942, DOI 10.1161/ATVBAHA.114.303342; Ferguson SM, 2015, CURR OPIN CELL BIOL, V35, P59, DOI 10.1016/j.ceb.2015.04.014; Galluzzi L, 2011, EMBO J, V30, P3213, DOI 10.1038/emboj.2011.244; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Gursel O, 2012, J PEDIAT HEMATOL ONC, V34, P630, DOI 10.1097/MPH.0b013e3182707f4d; Ishida JH, 2014, SEMIN DIALYSIS, V27, P26, DOI 10.1111/sdi.12168; Italiani P, 2015, IMMUNE NETW, V15, P167, DOI 10.4110/in.2015.15.4.167; Kenney DL, 2015, NEUROLOGY, V85, P634, DOI 10.1212/WNL.0000000000001860; KESHAV S, 1991, J EXP MED, V174, P1049, DOI 10.1084/jem.174.5.1049; Khan FA, 2007, INT J INFECT DIS, V11, P482, DOI 10.1016/j.ijid.2007.04.007; Komohara Y, 2016, ADV DRUG DELIVER REV, V99, P180, DOI 10.1016/j.addr.2015.11.009; Kontoghiorghes GJ, 2010, HEMOGLOBIN, V34, P227, DOI 10.3109/03630269.2010.483662; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kutukculer N, 1996, PEDIATR HEMAT ONCOL, V13, P239, DOI 10.3109/08880019609030822; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lee DH, 2013, EXP HEMATOL, V41, P539, DOI 10.1016/j.exphem.2013.02.004; Lesic B, 2002, ANTIMICROB AGENTS CH, V46, P1741, DOI 10.1128/AAC.46.6.1741-1745.2002; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Marx JJM, 2002, BEST PRACT RES CL HA, V15, P411, DOI 10.1053/beha.2002.0001; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nairz M, 2015, IMMUNOBIOLOGY, V220, P280, DOI 10.1016/j.imbio.2014.09.010; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Porto G, 2007, WORLD J GASTROENTERO, V13, P4707, DOI 10.3748/wjg.v13.i35.4707; Pullarkat V, 2014, LEUKEMIA RES, V38, P988, DOI 10.1016/j.leukres.2014.06.005; Raiten DJ, 2015, J PEDIATR-US, V167, pS3, DOI 10.1016/j.jpeds.2015.07.013; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Romo MR, 2016, IMMUNOLOGY, V148, P125, DOI 10.1111/imm.12597; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Castrejon-Jimenez NS, 2015, BIOSCI TRENDS, V9, P149, DOI 10.5582/bst.2015.01035; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Taneja R, 2010, INDIAN J OPHTHALMOL, V58, P125, DOI 10.4103/0301-4738.60083; Walker EM, 2000, ANN CLIN LAB SCI, V30, P354; Wiener Edith, 2003, Hematology, V8, P35, DOI 10.1080/1024533031000081414; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yu FF, 2016, TUMOR BIOL, V37, P1427, DOI 10.1007/s13277-015-4516-6; Zhou J, 2013, CELL RES, V23, P508, DOI 10.1038/cr.2013.11	57	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156713	10.1371/journal.pone.0156713	http://dx.doi.org/10.1371/journal.pone.0156713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244448	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100065
J	Kecse-Nagy, C; Szittner, Z; Papp, K; Hegyi, Z; Rovero, P; Migliorini, P; Lorand, V; Homolya, L; Prechl, J				Kecse-Nagy, Csilla; Szittner, Zoltan; Papp, Krisztian; Hegyi, Zoltan; Rovero, Paolo; Migliorini, Paola; Lorand, Veronika; Homolya, Laszlo; Prechl, Jozsef			Characterization of NF-kappa B Reporter U937 Cells and Their Application for the Detection of Inflammatory Immune-Complexes	PLOS ONE			English	Article							FC-GAMMA-RIIA; HIGH-AFFINITY IGG; RHEUMATOID-ARTHRITIS; RECEPTOR EXPRESSION; KEY ROLE; ACTIVATION; AUTOANTIBODIES; INDUCTION; MONOCYTES; MACROPHAGES	Our study tested the hypothesis that immunoglobulins differ in their ability to activate the nuclear factor-kappa B pathway mediated cellular responses. These responses are modulated by several properties of the immune complex, including the ratio of antibody isotypes binding to antigen. Immunoassays allow the measurement of antigen specific antibodies belonging to distinct immunoglobulin classes and subclasses but not the net biological effect of the combination of these antibodies. We set out to develop a biosensor that is suitable for the detection and characterization of antigen specific serum antibodies. We genetically modified the monocytoid U937 cell line carrying Fc receptors with a plasmid encoding NF-kappa B promoter-driven GFP. This clone, U937-NF-kappa B, was characterized with respect to FcR expression and response to solid-phase immunoglobulins. Human IgG3, IgG4 and IgG1 induced GFP production in a time-and dose-dependent manner, in this order of efficacy, while IgG2 triggered no activation at the concentrations tested. IgA elicited no response alone but showed significant synergism with IgG3 and IgG4. We confirmed the importance of activation via Fc gamma RI by direct stimulation with monoclonal antibody and by competition assays. We used citrullinated peptides and serum from rheumatoid arthritis patients to generate immune complexes and to study the activation of U937-NF-kappa B, observing again a synergistic effect between IgG and IgA. Our results show that immunoglobulins have distinct pro-inflammatory potential, and that U937-NF-kappa B is suitable for the estimation of biological effects of immune-complexes, offering insight into monocyte activation and pathogenesis of antibody mediated diseases.	[Kecse-Nagy, Csilla] Eotvos Lorand Univ, Dept Immunol, Pazmany Peter S 1-C, H-1117 Budapest, Hungary; [Szittner, Zoltan; Papp, Krisztian; Prechl, Jozsef] MTA ELTE Immunol Res Grp, Pazmany Peter S 1-C, H-1117 Budapest, Hungary; [Hegyi, Zoltan; Homolya, Laszlo] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Magyar Tudosok Korutja 2, H-1117 Budapest, Hungary; [Rovero, Paolo] Univ Florence, Dept NeuroFarBa, Sect Pharmaceut Sci & Nutraceut, Lab Peptide & Prot Chem & Biol, Via Ugo Schiff 6, I-50019 Sesto Fiorentino, Italy; [Migliorini, Paola] Univ Pisa, Clin Immunol Unit, Dept Clin & Expt Med, Pisa, Italy; [Lorand, Veronika] PTE, Dept Rheumatol & Immunol, Ctr Clin, Pecs, Hungary; [Prechl, Jozsef] Diagnosticum Inc, Res & Dev Lab, Attila Ut 146, H-1047 Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Florence; University of Pisa; University of Pecs	Szittner, Z (corresponding author), MTA ELTE Immunol Res Grp, Pazmany Peter S 1-C, H-1117 Budapest, Hungary.	zoltan.szittner@gmail.com	Rovero, Paolo/AAB-6775-2022; Migliorini, Paola/P-6176-2015; Homolya, Laszlo/N-1154-2016; Prechl, Jozsef/B-2094-2009	Rovero, Paolo/0000-0001-9577-5228; Migliorini, Paola/0000-0001-6433-4964; Homolya, Laszlo/0000-0003-1639-8140; Prechl, Jozsef/0000-0003-3859-4353; Papp, Krisztian/0000-0003-0619-8233	TAMOP by European Social Fund [4.2.1/B-09/1/KMR-2010-0003]; National Research, Development and Innovation Office of Hungary; FACS-ARIA III; European Union [GAPAID-314971, FP7-SME-2012]; OTKA by National Research, Development and Innovation Office of Hungary [109683]; MedInProt Protein Science Research Synergy Program; Diagnosticum Inc.	TAMOP by European Social Fund; National Research, Development and Innovation Office of Hungary; FACS-ARIA III; European Union(European Commission); OTKA by National Research, Development and Innovation Office of Hungary(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MedInProt Protein Science Research Synergy Program; Diagnosticum Inc.	This work was funded by TAMOP (4.2.1/B-09/1/KMR-2010-0003) awarded to Eotvos Lorand University by the European Social Fund (http://ec.europa.eu/esf/main.jsp?catId=384) and National Research, Development and Innovation Office of Hungary (http://nkfih.gov.hu/english) for supporting cell sorting experiments with FACS-ARIA III. This work was also supported by the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement (GAPAID-314971, FP7-SME-2012, http://cordis.europa.eu/project/rcn/105440_en.html), entitled 'Genes and proteins for autoimmunity diagnostics' and OTKA grant (109683) awarded to JP by the National Research, Development and Innovation Office of Hungary (http://nkfih.gov.hu/english). KP was awarded Synergy I. Grant by the MedInProt Protein Science Research Synergy Program (http://medinprot.chem.elte.hu/). The funder (Diagnosticum Inc.) provided support in the form of salaries for authors [JP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abrahams VM, 2000, ARTHRITIS RHEUM-US, V43, P608, DOI 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Anzilotti C, 2007, RHEUMATOLOGY, V46, P1579, DOI 10.1093/rheumatology/kem193; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Badr CE, 2009, MOL IMAGING, V8, P278, DOI 10.2310/7290.2009.00026; Bax M, 2014, SEMIN IMMUNOPATHOL, V36, P313, DOI 10.1007/s00281-014-0429-5; BOLTZNITULESCU G, 1995, J LEUKOCYTE BIOL, V58, P256, DOI 10.1002/jlb.58.2.256; Brandsma AM, 2015, IMMUNOL REV, V268, P74, DOI 10.1111/imr.12332; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Burska A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/545493; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; Dai XL, 2009, BLOOD, V114, P318, DOI 10.1182/blood-2008-10-184457; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; Drechsler Y, 2002, J LEUKOCYTE BIOL, V72, P657; Garcia-Garcia E, 2001, J LEUKOCYTE BIOL, V70, P649; Garcia-Garcia E, 2007, J IMMUNOL, V178, P3048, DOI 10.4049/jimmunol.178.5.3048; Gillis C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00254; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hargreaves CE, 2015, IMMUNOL REV, V268, P6, DOI 10.1111/imr.12341; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Huang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061602; Kwiatkowska K, 2003, J CELL SCI, V116, P537, DOI 10.1242/jcs.00254; Laurent L, 2011, ANN RHEUM DIS, V70, P1052, DOI 10.1136/ard.2010.142091; LegrandPoels S, 1997, BIOCHEM PHARMACOL, V53, P339; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lux A, 2013, J IMMUNOL, V190, P4315, DOI 10.4049/jimmunol.1200501; Magnusson SE, 2014, IMMUNOL LETT, V162, P200, DOI 10.1016/j.imlet.2014.08.016; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; Sanchez-Mejorada G, 1998, J BIOL CHEM, V273, P27610, DOI 10.1074/jbc.273.42.27610; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Sokolove J, 2011, ARTHRITIS RHEUM-US, V63, P53, DOI 10.1002/art.30081; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Swisher JFA, 2014, MABS-AUSTIN, V6, P1377, DOI 10.4161/19420862.2014.975657; Szittner Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072401; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Toes REM, 2015, CURR OPIN RHEUMATOL, V27, P262, DOI 10.1097/BOR.0000000000000166; Torsteinsdottir I, 1999, CLIN EXP IMMUNOL, V115, P554; Valenzuela NM, 2015, AM J TRANSPLANT, V15, P1502, DOI 10.1111/ajt.13174; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; van der Poel CE, 2010, BLOOD, V116, P5327, DOI 10.1182/blood-2010-04-280214; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Vogelpoel LTC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00079; Vogelpoel LTC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6444; Wang R, 2003, HYBRIDOMA HYBRIDOM, V22, P357, DOI 10.1089/153685903771797057; Ward JO, 2001, BLOOD, V98, P3290, DOI 10.1182/blood.V98.12.3290; Yamamoto M, 2014, NAT REV RHEUMATOL, V10, P148, DOI 10.1038/nrrheum.2013.183	53	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156328	10.1371/journal.pone.0156328	http://dx.doi.org/10.1371/journal.pone.0156328			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232500	Green Published, Green Accepted, gold			2022-12-26	WOS:000376883000023
J	Qu, X; Sandmann, T; Frierson, H; Fu, L; Fuentes, E; Walter, K; Okrah, K; Rumpel, C; Moskaluk, C; Lu, S; Wang, Y; Bourgon, R; Penuel, E; Pirzkall, A; Amler, L; Lackner, MR; Tabernero, J; Hampton, GM; Kabbarah, O				Qu, X.; Sandmann, T.; Frierson, H., Jr.; Fu, L.; Fuentes, E.; Walter, K.; Okrah, K.; Rumpel, C.; Moskaluk, C.; Lu, S.; Wang, Y.; Bourgon, R.; Penuel, E.; Pirzkall, A.; Amler, L.; Lackner, M. R.; Tabernero, J.; Hampton, G. M.; Kabbarah, O.			Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter	ONCOGENE			English	Article							DNA METHYLATION; MUTATION STATUS; CETUXIMAB; EPIREGULIN; EXPRESSION; GROWTH; AMPHIREGULIN; KRAS; FLUOROURACIL; BEVACIZUMAB	Key molecular drivers that underlie transformation of colonic epithelium into colorectal adenocarcinoma (CRC) are well described. However, the mechanisms through which clinically targeted pathways are activated during CRC progression have yet to be elucidated. Here, we used an integrative genomics approach to examine CRC progression. We used laser capture microdissection to isolate colonic crypt cells, differentiated surface epithelium, adenomas, carcinomas and metastases, and used gene expression profiling to identify pathways that were differentially expressed between the different cell types. We identified a number of potentially important transcriptional changes in developmental and oncogenic pathways, and noted a marked upregulation of EREG in primary and metastatic cancer cells. We confirmed this pattern of gene expression by in situ hybridization and observed staining consistent with autocrine expression in the tumor cells. Upregulation of EREG during the adenoma-carcinoma transition was associated with demethylation of two key sites within its promoter, and this was accompanied by an increase in the levels of epidermal growth factor receptor (EGFR) phosphorylation, as assessed by reverse-phase protein analysis. In CRC cell lines, we demonstrated that EREG demethylation led to its transcriptional upregulation, higher levels of EGFR phosphorylation, and sensitization to EGFR inhibitors. Low levels of EREG methylation in patients who received cetuximab as part of a phase II study were associated with high expression of the ligand and a favorable response to therapy. Conversely, high levels of promoter methylation and low levels of EREG expression were observed in tumors that progressed after treatment. We also noted an inverse correlation between EREG methylation and expression levels in several other cancers, including those of the head and neck, lung and bladder. Therefore, we propose that upregulation of EREG expression through promoter demethylation might be an important means of activating the EGFR pathway during the genesis of CRC and potentially other cancers.	[Qu, X.; Fu, L.; Walter, K.; Lu, S.; Wang, Y.; Penuel, E.; Amler, L.; Lackner, M. R.; Hampton, G. M.; Kabbarah, O.] Genentech Inc, Oncol Biomarker Dev, 1 DNA Way, San Francisco, CA 94080 USA; [Sandmann, T.; Bourgon, R.] Genentech Inc, Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Frierson, H., Jr.; Rumpel, C.; Moskaluk, C.] Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA USA; [Fuentes, E.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Okrah, K.] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA; [Pirzkall, A.] Genentech Inc, Dept Clin Sci, San Francisco, CA 94080 USA; [Tabernero, J.] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain	Roche Holding; Genentech; Roche Holding; Genentech; University of Virginia; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO)	Hampton, GM; Kabbarah, O (corresponding author), Genentech Inc, Oncol Biomarker Dev, 1 DNA Way, San Francisco, CA 94080 USA.	garreth@gene.com; kabbarao@gene.com	Tabernero, Josep/AAG-5026-2019; Miquel, Josep Maria/AAG-3508-2019	Tabernero, Josep/0000-0002-2495-8139; Sandmann, Thomas/0000-0002-6601-8890; Bourgon, Richard/0000-0002-5890-4374; Wang, Yulei/0000-0002-9057-9786				Akiyama Y, 2003, MOL CELL BIOL, V23, P8429, DOI 10.1128/MCB.23.23.8429-8439.2003; Auf G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-597; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Bourgon R, 2014, CLIN CANCER RES, V20, P2080, DOI 10.1158/1078-0432.CCR-13-3114; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; DeAngelo DJ, 2014, LEUKEMIA RES, V38, P430, DOI 10.1016/j.leukres.2013.10.026; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Gryfe R, 1997, CURR PROB CANCER, V21, P238, DOI 10.1016/S0147-0272(97)80003-7; Hansen AR, 2013, J CLIN ONCOL, V31, P1381, DOI 10.1200/JCO.2012.47.9220; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jonker DJ, 2014, BRIT J CANCER, V110, P648, DOI 10.1038/bjc.2013.753; Jover R, 2011, GASTROENTEROLOGY, V140, P1174, DOI 10.1053/j.gastro.2010.12.035; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kohsaka S, 2014, NEURO-ONCOLOGY, V16, P960, DOI 10.1093/neuonc/not315; Komurasaki T, 2002, GROWTH FACTORS, V20, P61, DOI 10.1080/08977190290024192; Lainey E, 2013, ONCOGENE, V32, P4331, DOI 10.1038/onc.2012.469; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Luo YX, 2014, GASTROENTEROLOGY, V147, P418, DOI 10.1053/j.gastro.2014.04.039; Makky K, 2007, DEV BIOL, V303, P501, DOI 10.1016/j.ydbio.2006.11.030; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; Neufert C, 2013, J CLIN INVEST, V123, P1428, DOI 10.1172/JCI63748; Orre LM, 2013, ONCOGENE, V32, P5531, DOI 10.1038/onc.2013.213; Oshima G, 2012, J CANCER RES CLIN, V138, P491, DOI 10.1007/s00432-011-1127-5; Oving IM, 2002, EUR J CLIN INVEST, V32, P448, DOI 10.1046/j.1365-2362.2002.01004.x; Pasparakis M, 2012, IMMUNOL REV, V246, P346, DOI 10.1111/j.1600-065X.2012.01109.x; Peeters M, 2013, J CLIN ONCOL, V31, P759, DOI 10.1200/JCO.2012.45.1492; Pentheroudakis G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-49; Price TJ, 2011, J CLIN ONCOL, V29, P2675, DOI 10.1200/JCO.2010.34.5520; Rebouissou S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008970; Revillion F, 2008, ANN ONCOL, V19, P73, DOI 10.1093/annonc/mdm431; Riese DJ, 2014, SEMIN CELL DEV BIOL, V28, P49, DOI 10.1016/j.semcdb.2014.03.005; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Seniski GG, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-80; Shen L, 2007, CLIN CANCER RES, V13, P6093, DOI 10.1158/1078-0432.CCR-07-1011; Skeen VR, 2012, CURR PHARM DESIGN, V18, P3874; Sun JZ, 2012, HEMATOL ONCOL, V30, P89, DOI 10.1002/hon.1002; Troiani T, 2013, CLIN CANCER RES, V19, P6751, DOI 10.1158/1078-0432.CCR-13-0423; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walter K, 2012, CLIN CANCER RES, V18, P2360, DOI 10.1158/1078-0432.CCR-11-2635-T; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Watt FM, 2004, TRENDS MOL MED, V10, P577, DOI 10.1016/j.molmed.2004.10.008; Weng WH, 2016, ONCOL REP, V35, P107, DOI 10.3892/or.2015.4336; Yao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078086; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957; Yun J, 2012, LAB INVEST, V92, P1033, DOI 10.1038/labinvest.2012.61; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278	56	44	44	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 15	2016	35	50					6403	6415		10.1038/onc.2016.170	http://dx.doi.org/10.1038/onc.2016.170			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EF3TP	27270421	Green Published, hybrid			2022-12-26	WOS:000390247600005
J	Kilgore, MB; Holland, CK; Jez, JM; Kutchan, TM				Kilgore, Matthew B.; Holland, Cynthia K.; Jez, Joseph M.; Kutchan, Toni M.			Identification of a Noroxomaritidine Reductase with Amaryllidaceae Alkaloid Biosynthesis Related Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRININE-TYPE ALKALOIDS; CRYSTAL-STRUCTURE; STRICTOSIDINE SYNTHASE; SUBSTRATE-BINDING; CHAIN; 5-BETA-REDUCTASE; NORBELLADINE; CATALYSIS; LYCORINE; ENZYME	Amaryllidaceae alkaloids are a large group of plant natural products with over 300 documented structures and diverse biological activities. Several groups of Amaryllidaceae alkaloids including the hemanthamine- and crinine-type alkaloids show promise as anticancer agents. Two reduction reactions are required for the production of these compounds: the reduction of norcraugsodine to norbelladine and the reduction of noroxomaritidine to normaritidine, with the enantiomer of noroxomaritidine dictating whether the derivatives will be the crinine-type or hemanthamine-type. It is also possible for the carbon-carbon double bond of noroxomaritidine to be reduced, forming the precursor for maritinamine or elwesine depending on the enantiomer reduced to an oxomaritinamine product. In this study, a short chain alcohol dehydrogenase/reductase that co-expresses with the previously discovered norbelladine 4'-O-methyltransferase from Narcissus sp. and Galanthus spp. was cloned and expressed in Escherichia coli. Biochemical analyses and x-ray crystallography indicates that this protein functions as a noroxomaritidine reductase that forms oxomaritinamine from noroxomaritidine through a carbon-carbon double bond reduction. The enzyme also reduces norcraugsodine to norbelladine with a 400-fold lower specific activity. These studies identify a missing step in the biosynthesis of this pharmacologically important class of plant natural products.	[Kilgore, Matthew B.; Kutchan, Toni M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Kilgore, Matthew B.; Holland, Cynthia K.; Jez, Joseph M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA	Donald Danforth Plant Science Center; Washington University (WUSTL)	Kutchan, TM (corresponding author), 975 N Warson Rd, St Louis, MO 63132 USA.	tmkutchan@danforthcenter.org	Kutchan, Toni/L-4625-2013	Holland, Cynthia/0000-0001-6099-7998	Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092561] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research under Grant DE-AC02-06CH11357.	Abdel-Halim OB, 2004, J NAT PROD, V67, P1119, DOI 10.1021/np030529k; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banfi L., 2001, ENCY REAGENTS ORGANI; BATTERSBY A, 1961, J AM CHEM SOC, V83, P4098, DOI 10.1021/ja01480a037; BATTERSBY A, 1961, P CHEM SOC LONDON, P243; BOIT HG, 1961, NATURWISSENSCHAFTEN, V48, P406, DOI 10.1007/BF00609105; Brock A, 2008, PLANT J, V54, P388, DOI 10.1111/j.1365-313X.2008.03422.x; Deacon AM, 2000, STRUCT FOLD DES, V8, P453, DOI 10.1016/S0969-2126(00)00128-3; Di Costanzo L, 2008, J BIOL CHEM, V283, P16830, DOI 10.1074/jbc.M801778200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evidente A, 2009, PHYTOCHEM REV, V8, P449, DOI 10.1007/s11101-008-9119-z; FEINSTEIN AI, 1976, J ORG CHEM, V41, P2447, DOI 10.1021/jo00876a020; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; FUGANTI C, 1973, GAZZ CHIM ITAL, V103, P1255; Fuganti C., 1972, J CHEM SOC CHEM COMM, V1972, P237; Gallage NJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5037; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HAMPP N, 1988, PHYTOCHEMISTRY, V27, P3811, DOI 10.1016/0031-9422(88)83023-1; Havelek R, 2014, PHYTOMEDICINE, V21, P479, DOI 10.1016/j.phymed.2013.09.005; He MM, 2015, RSC ADV, V5, P16562, DOI 10.1039/c4ra14666b; Jez JM, 1998, BIOCHEMISTRY-US, V37, P9695, DOI 10.1021/bi980294p; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kilgore M. B., 2015, U. S. patent, Patent No. [WO/2015/196100, 2015196100]; Kilgore MB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00225; Kilgore MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103223; Kries H, 2016, NAT CHEM BIOL, V12, P6, DOI 10.1038/nchembio.1955; KUTCHAN TM, 1994, PHYTOCHEMISTRY, V35, P353, DOI 10.1016/S0031-9422(00)94763-0; Lamoral-Theys D, 2009, J MED CHEM, V52, P6244, DOI 10.1021/jm901031h; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moummou H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-219; PABUCCUOGLU V, 1989, J NAT PROD, V52, P785, DOI 10.1021/np50064a020; Penning TM, 2015, CHEM-BIOL INTERACT, V234, P236, DOI 10.1016/j.cbi.2014.09.024; Reinhardt N, 2014, BIOORG CHEM, V53, P37, DOI 10.1016/j.bioorg.2014.01.004; Samanani N, 2002, J BIOL CHEM, V277, P33878, DOI 10.1074/jbc.M203051200; Stavrinides A, 2015, CHEM BIOL, V22, P336, DOI 10.1016/j.chembiol.2015.02.006; SUHADOLNIK RJ, 1963, BIOCHEM BIOPH RES CO, V11, P208, DOI 10.1016/0006-291X(63)90335-8; Thorn A, 2008, J BIOL CHEM, V283, P17260, DOI 10.1074/jbc.M706185200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Widhalm JR, 2015, MOL PLANT, V8, P83, DOI 10.1016/j.molp.2014.12.001; Wilcock G, 2003, DRUG AGING, V20, P777, DOI 10.2165/00002512-200320100-00006; WILDMAN WC, 1962, P CHEM SOC LONDON, P180; Yamashita A, 1999, BIOCHEMISTRY-US, V38, P7630, DOI 10.1021/bi9825044; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x	44	31	34	4	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16740	16752		10.1074/jbc.M116.717827	http://dx.doi.org/10.1074/jbc.M116.717827			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27252378	Green Published, hybrid			2022-12-26	WOS:000380826700031
J	Bang, YJ; Lee, ZW; Kim, D; Jo, I; Ha, NC; Choi, SH				Bang, Ye-Ji; Lee, Zee-Won; Kim, Dukyun; Jo, Inseong; Ha, Nam-Chul; Choi, Sang Ho			OxyR2 Functions as a Three-state Redox Switch to Tightly Regulate Production of Prx2, a Peroxiredoxin of Vibrio vulnificus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISTINCT CHARACTERISTICS; OXIDATIVE STRESS; EXPRESSION; PEROXIDE; ACTIVATION; MECHANISMS; PROTEIN	The bacterial transcriptional regulator OxyR is known to function as a two-state redox switch. OxyR senses cellular levels of H2O2 via a "sensing cysteine" that switches from the reduced to a disulfide state upon H2O2 exposure, inducing the expression of antioxidant genes. The reduced and disulfide states of OxyR, respectively, bind to extended and compact regions of DNA, where the reduced state blocks and the oxidized state allows transcription and further induces target gene expression by interacting with RNA polymerase. Vibrio vulnificus OxyR2 senses H2O2 with high sensitivity and induces the gene encoding the antioxidant Prx2. In this study, we used mass spectrometry to identify a third redox state of OxyR2, in which the sensing cysteine was overoxidized to S-sulfonated cysteine (Cys-SO3H) by high H2O2 in vitro and in vivo, where the modification deterred the transcription of prx2. The DNA binding preferences of OxyR2(5CA)-C206D, which mimics overoxidized OxyR2, suggested that overoxidized OxyR2 binds to the extended DNA site, masking the -35 region of the prx2 promoter. These combined results demonstrate that OxyR2 functions as a three-state redox switch to tightly regulate the expression of prx2, preventing futile production of Prx2 in cells exposed to high levels of H2O2 sufficient to inactivate Prx2. We further provide evidence that another OxyR homolog, OxyR1, displays similar three-state behavior, inviting further exploration of this phenomenon as a potentially general regulatory mechanism.	[Bang, Ye-Ji; Lee, Zee-Won; Kim, Dukyun; Choi, Sang Ho] Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Seoul 08826, South Korea; [Bang, Ye-Ji; Lee, Zee-Won; Kim, Dukyun; Jo, Inseong; Ha, Nam-Chul; Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea; [Bang, Ye-Ji; Lee, Zee-Won; Kim, Dukyun; Jo, Inseong; Ha, Nam-Chul; Choi, Sang Ho] Seoul Natl Univ, Ctr Food Safety & Toxicol, Seoul 08826, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Seoul 08826, South Korea.; Ha, NC; Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea.; Ha, NC; Choi, SH (corresponding author), Seoul Natl Univ, Ctr Food Safety & Toxicol, Seoul 08826, South Korea.	hanc210@snu.ac.kr; choish@snu.ac.kr	Jo, Inseong/AGY-9957-2022	Choi, Sang Ho/0000-0003-3865-1039; Jo, Inseong/0000-0002-7964-4751; Lee, Zee-Won/0000-0003-0376-1860; Bang, Ye-Ji/0000-0003-4009-0824	Mid-career Researcher Program Grant through the National Research Foundation [2015R1A2A1A13001654]; Ministry of Science, ICT, and Future Planning; RAMP;D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea	Mid-career Researcher Program Grant through the National Research Foundation; Ministry of Science, ICT, and Future Planning; RAMP;D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs, Republic of Korea	This work was supported by Mid-career Researcher Program Grant 2015R1A2A1A13001654 through the National Research Foundation, funded by the Ministry of Science, ICT, and Future Planning (to S. H. C.) and the R&D Convergence Center Support Program of the Ministry of Agriculture, Food, and Rural Affairs (to S. H. C. and N.-C. H.), Republic of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Bang YJ, 2012, J BIOL CHEM, V287, P42516, DOI 10.1074/jbc.M112.421214; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Dong Tao, 2008, P313, DOI 10.1007/978-3-540-74921-9_11; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goo SY, 2006, INFECT IMMUN, V74, P5586, DOI 10.1128/IAI.00171-06; Groitl B, 2014, BBA-PROTEINS PROTEOM, V1844, P1335, DOI 10.1016/j.bbapap.2014.03.007; Heo YJ, 2010, J BACTERIOL, V192, P381, DOI 10.1128/JB.00980-09; Janek K, 2001, RAPID COMMUN MASS SP, V15, P1593, DOI 10.1002/rcm.417; Jo I, 2015, P NATL ACAD SCI USA, V112, P6443, DOI 10.1073/pnas.1424495112; Kim S, 2014, MOL MICROBIOL, V93, P992, DOI 10.1111/mmi.12712; Klauck E, 2012, BACTERIAL REGULATORY NETWORKS, P1; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Lim JG, 2014, J BIOL CHEM, V289, P36263, DOI 10.1074/jbc.M114.611020; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Seo SW, 2015, CELL REP, V12, P1289, DOI 10.1016/j.celrep.2015.07.043; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; TAO K, 1993, MOL MICROBIOL, V7, P859, DOI 10.1111/j.1365-2958.1993.tb01176.x; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Tseng HJ, 2003, INFECT IMMUN, V71, P550, DOI 10.1128/IAI.71.1.550-556.2003; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	26	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16038	16047		10.1074/jbc.M115.710343	http://dx.doi.org/10.1074/jbc.M115.710343			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27268058	hybrid, Green Published			2022-12-26	WOS:000380585400010
J	Rezaei-Ghaleh, N; Kumar, S; Walter, J; Zweckstetter, M				Rezaei-Ghaleh, Nasrollah; Kumar, Sathish; Walter, Jochen; Zweckstetter, Markus			Phosphorylation Interferes with Maturation of Amyloid-beta Fibrillar Structure in the N Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; ALPHA-SYNUCLEIN CLEARANCE; ALZHEIMERS-DISEASE; A-BETA; POSTTRANSLATIONAL MODIFICATIONS; PEPTIDE; PROTEIN; AGGREGATION; TOXICITY; DYNAMICS	Neurodegeneration is characterized by the ubiquitous presence of modifications in protein deposits. Despite their potential significance in the initiation and progression of neurodegenerative diseases, the effects of posttranslational modifications on the molecular properties of protein aggregates are largely unknown. Here, we study the Alzheimer disease-related amyloid-beta (A beta) peptide and investigate how phosphorylation at serine 8 affects the structure of A beta aggregates. Serine 8 is shown to be located in a region of high conformational flexibility in monomeric A beta, which upon phosphorylation undergoes changes in local conformational dynamics. Using hydrogen-deuterium exchange NMR and fluorescence quenching techniques, we demonstrate that A beta phosphorylation at serine 8 causes structural changes in the N-terminal region of A beta aggregates in favor of less compact conformations. Structural changes induced by serine 8 phosphorylation can provide a mechanistic link between phosphorylation and other biological events that involve the N-terminal region of A beta aggregates. Our data therefore support an important role of posttranslational modifications in the structural polymorphism of amyloid aggregates and their modulatory effect on neurodegeneration.	[Rezaei-Ghaleh, Nasrollah; Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, Von Siebold Str 3a, D-37075 Gottingen, Germany; [Rezaei-Ghaleh, Nasrollah; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Fassberg 11, D-37077 Gottingen, Germany; [Kumar, Sathish; Walter, Jochen] Univ Bonn, Dept Neurol, D-53127 Bonn, Germany; [Zweckstetter, Markus] Univ Gottingen, Univ Med Ctr, Dept Neurol, Waldweg 33, D-37073 Gottingen, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; University of Bonn; University of Gottingen	Rezaei-Ghaleh, N; Zweckstetter, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, Von Siebold Str 3a, D-37075 Gottingen, Germany.	nare@nmr.mpibpc.mpg.de; markus.zweckstetter@dzne.de	Wang, Caihong/T-5837-2019; Rezaei-Ghaleh, Nasrollah/B-9443-2008; Walter, Jochen/B-3677-2014; Kumar, Sathish/L-1367-2019	Wang, Caihong/0000-0002-6808-3709; Rezaei-Ghaleh, Nasrollah/0000-0001-6935-6564; Walter, Jochen/0000-0002-4678-2912; Kumar, Sathish/0000-0002-2792-7047; Zweckstetter, Markus/0000-0002-2536-6581				Abelein A, 2014, J BIOL INORG CHEM, V19, P623, DOI 10.1007/s00775-014-1131-8; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Bouter Y, 2013, ACTA NEUROPATHOL, V126, P189, DOI 10.1007/s00401-013-1129-2; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Das AK, 2015, ACS CHEM NEUROSCI, V6, P1290, DOI 10.1021/acschemneuro.5b00074; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; Fandrich M., 2011, TRENDS BIOCHEM SCI, V36, P338; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Goddard T. D, 2007, SPARKY 3; Goncalves S, 2013, MOL NEUROBIOL, V47, P1081, DOI 10.1007/s12035-013-8406-x; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haupt C, 2012, ANGEW CHEM INT EDIT, V51, P1576, DOI 10.1002/anie.201105638; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Hoyer W, 2008, J MOL BIOL, V378, P398, DOI 10.1016/j.jmb.2008.02.040; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Kumar S, 2016, ACTA NEUROPATHOL, V131, P525, DOI 10.1007/s00401-016-1546-0; Kumar S, 2012, J BIOL CHEM, V287, P8641, DOI 10.1074/jbc.M111.279133; Kumar S, 2011, EMBO J, V30, P2255, DOI 10.1038/emboj.2011.138; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Lim KH, 2007, CHEMBIOCHEM, V8, P1251, DOI 10.1002/cbic.200700194; Mahul-Mellier AL, 2014, HUM MOL GENET, V23, P2858, DOI 10.1093/hmg/ddt674; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; Morgado I, 2015, ADV EXP MED BIOL, V855, P67, DOI 10.1007/978-3-319-17344-3_3; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Oueslati A, 2013, P NATL ACAD SCI USA, V110, pE3945, DOI 10.1073/pnas.1309991110; Paleologou KE, 2010, J NEUROSCI, V30, P3184, DOI 10.1523/JNEUROSCI.5922-09.2010; Parthasarathy S, 2011, J AM CHEM SOC, V133, P3390, DOI 10.1021/ja1072178; Qiang W, 2014, BIOCHEMISTRY-US, V53, P7503, DOI 10.1021/bi501003n; Rezaei-Ghaleh N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11359; Rezaei-Ghaleh N, 2014, J AM CHEM SOC, V136, P4913, DOI 10.1021/ja411707y; Rezaei-Ghaleh N, 2011, BIOPHYS J, V101, P1202, DOI 10.1016/j.bpj.2011.06.062; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Russell CL, 2014, J ALZHEIMERS DIS, V41, P345, DOI 10.3233/JAD-132312; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schmid AW, 2013, MOL CELL PROTEOMICS, V12, P3543, DOI 10.1074/mcp.R113.032730; Shao HY, 1999, J MOL BIOL, V285, P755, DOI 10.1006/jmbi.1998.2348; Tenreiro S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00042; Tenreiro S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004302; Thal DR, 2015, ACTA NEUROPATHOL, V129, P167, DOI 10.1007/s00401-014-1375-y; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Upadhaya AR, 2014, BRAIN, V137, P887, DOI 10.1093/brain/awt362; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Williamson MP, 2006, BIOCHEM J, V397, P483, DOI 10.1042/BJ20060293	50	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16059	16067		10.1074/jbc.M116.728956	http://dx.doi.org/10.1074/jbc.M116.728956			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27252381	Green Published, hybrid			2022-12-26	WOS:000380585400012
J	LaMattina, JW; Keul, ND; Reitzer, P; Kapoor, S; Galzerani, F; Koch, DJ; Gouvea, IE; Lanzilotta, WN				LaMattina, Joseph W.; Keul, Nicholas D.; Reitzer, Pierre; Kapoor, Suraj; Galzerani, Felipe; Koch, Daniel J.; Gouvea, Iuri E.; Lanzilotta, William N.			1,2-Propanediol Dehydration in Roseburia inulinivorans STRUCTURAL BASIS FOR SUBSTRATE AND ENANTIOMER SELECTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE FORMATE-LYASE; ESCHERICHIA-COLI PYRUVATE; BENZYLSUCCINATE SYNTHASE; RIBONUCLEOTIDE REDUCTASE; ACTIVATING ENZYME; CRYSTAL-STRUCTURE; MECHANISM; GLYCEROL; 1,3-PROPANEDIOL; CHOLINE	Glycyl radical enzymes (GREs) represent a diverse superfamily of enzymes that utilize a radical mechanism to catalyze difficult, but often essential, chemical reactions. In this work we present the first biochemical and structural data for a GRE-type diol dehydratase from the organism Roseburia inulinivorans (RiDD). Despite high sequence (48% identity) and structural similarity to the GRE-type glycerol dehydratase from Clostridium butyricum, we demonstrate that the RiDD is in fact a diol dehydratase. In addition, the RiDD will utilize both (S)-1,2-propanediol and (R)-1,2-propanediol as a substrate, with an observed preference for the S enantiomer. Based on the new structural information we developed and successfully tested a hypothesis that explains the functional differences we observe.	[LaMattina, Joseph W.; Keul, Nicholas D.; Reitzer, Pierre; Kapoor, Suraj; Lanzilotta, William N.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Galzerani, Felipe; Koch, Daniel J.; Gouvea, Iuri E.] BRASKEM SA, Rua Lemos Moonteiro, BR-05501050 Sao Paulo, SP, Brazil	University System of Georgia; University of Georgia; Braskem	Lanzilotta, WN (corresponding author), Univ Georgia, Dept Biochem, A220B Davison Life Sci Bldg,Green St, Athens, GA 30602 USA.	wlanzilo@bmb.uga.edu		Keul, Nicholas/0000-0002-5302-006X				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Becker A, 1999, NAT STRUCT BIOL, V6, P969; Bharadwaj VS, 2013, J AM CHEM SOC, V135, P12279, DOI 10.1021/ja404842r; Bruender NA, 2015, BIOCHEMISTRY-US, V54, P2903, DOI 10.1021/acs.biochem.5b00210; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CHROMY V, 1974, CLIN CHEM, V20, P1362; Craciun S, 2014, ACS CHEM BIOL, V9, P1408, DOI 10.1021/cb500113p; Craciun S, 2012, P NATL ACAD SCI USA, V109, P21307, DOI 10.1073/pnas.1215689109; Crain AV, 2014, J BIOL CHEM, V289, P5723, DOI 10.1074/jbc.M113.496877; DANIEL R, 1995, J BACTERIOL, V177, P2151, DOI 10.1128/jb.177.8.2151-2156.1995; Demick JM, 2011, BIOCHEMISTRY-US, V50, P440, DOI 10.1021/bi101255e; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feliks M, 2013, J AM CHEM SOC, V135, P14574, DOI 10.1021/ja402379q; Feliks M, 2012, J PHYS CHEM B, V116, P7076, DOI 10.1021/jp301165b; FREY M, 1994, J BIOL CHEM, V269, P12432; Frey PA, 2001, ANNU REV BIOCHEM, V70, P121, DOI 10.1146/annurev.biochem.70.1.121; Funk MA, 2014, P NATL ACAD SCI USA, V111, P10161, DOI 10.1073/pnas.1405983111; Grove TL, 2008, BIOCHEMISTRY-US, V47, P7523, DOI 10.1021/bi8004297; Henshaw TF, 2000, J AM CHEM SOC, V122, P8331, DOI 10.1021/ja002012q; Hioe J, 2011, CHEM-EUR J, V17, P3781, DOI 10.1002/chem.201002620; Jarboe LR, 2011, APPL MICROBIOL BIOT, V89, P249, DOI 10.1007/s00253-010-2912-9; Kalnins G, 2015, J BIOL CHEM, V290, P21732, DOI 10.1074/jbc.M115.670471; KNAPPE J, 1990, FEMS MICROBIOL LETT, V75, P383, DOI 10.1111/j.1574-6968.1990.tb04108.x; KNAPPE J, 1995, METHOD ENZYMOL, V258, P343; KNAPPE J, 1993, BIOCHEM SOC T, V21, P731, DOI 10.1042/bst0210731; Krieger CJ, 2001, J BIOL CHEM, V276, P12924, DOI 10.1074/jbc.M009453200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulzer R, 1998, J BIOL CHEM, V273, P4897, DOI 10.1074/jbc.273.9.4897; LAUE TM, 1986, BIOPHYS J, V49, pA274; Lehtio L, 2002, ACTA CRYSTALLOGR D, V58, P2209, DOI 10.1107/S0907444902016402; Leppanen VM, 1999, ACTA CRYSTALLOGR D, V55, P531, DOI 10.1107/S0907444998011056; Leppanen VM, 1999, STRUCT FOLD DES, V7, P733, DOI 10.1016/S0969-2126(99)80098-7; Li L, 2009, BIOCHEMISTRY-US, V48, P1284, DOI 10.1021/bi801766g; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Martins BM, 2011, J AM CHEM SOC, V133, P14666, DOI 10.1021/ja203344x; Nnyepi MR, 2007, ARCH BIOCHEM BIOPHYS, V459, P1, DOI 10.1016/j.abb.2006.12.024; O'Brien JR, 2004, BIOCHEMISTRY-US, V43, P4635, DOI 10.1021/bi035930k; Ofer A, 2011, J BACTERIOL, V193, P2931, DOI 10.1128/JB.01405-10; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Peng Y, 2010, J BIOL CHEM, V285, P27224, DOI 10.1074/jbc.M109.096875; Pontes H, 2009, J CHROMATOGR SCI, V47, P272, DOI 10.1093/chromsci/47.4.272; Raynaud C, 2003, P NATL ACAD SCI USA, V100, P5010, DOI 10.1073/pnas.0734105100; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06; Selmer T, 2005, BIOL CHEM, V386, P981, DOI 10.1515/BC.2005.114; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; Shibata N, 2003, J BIOL CHEM, V278, P22717, DOI 10.1074/jbc.M301513200; Shisler KA, 2014, ARCH BIOCHEM BIOPHYS, V546, P64, DOI 10.1016/j.abb.2014.01.020; SOTTOCAS.GL, 1971, EXPERIENTIA, V27, P1247, DOI 10.1007/BF02286956; Sulzenbacher G, 2004, J MOL BIOL, V342, P489, DOI 10.1016/j.jmb.2004.07.034; Sun XY, 1996, J BIOL CHEM, V271, P6827, DOI 10.1074/jbc.271.12.6827; SUN XY, 1995, J BIOL CHEM, V270, P2443, DOI 10.1074/jbc.270.6.2443; Toraya T, 2002, CHEM REC, V2, P352, DOI 10.1002/tcr.10035; Toraya T, 2002, SEIKAGAKU, V74, P87; Trivic S, 1998, J ENZYM INHIB, V13, P57, DOI 10.3109/14756369809035827; Yamanishi M, 2012, FEBS J, V279, P793, DOI 10.1111/j.1742-4658.2012.08470.x; Zhuge B, 2010, APPL MICROBIOL BIOT, V87, P2177, DOI 10.1007/s00253-010-2678-0	57	22	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15515	15526		10.1074/jbc.M116.721142	http://dx.doi.org/10.1074/jbc.M116.721142			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27252380	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000380584200009
J	Ameer, S; Gul, IH				Ameer, Shahid; Gul, Iftikhar Hussain			Influence of Reduced Graphene Oxide on Effective Absorption Bandwidth Shift of Hybrid Absorbers	PLOS ONE			English	Article							MICROWAVE-ABSORPTION; NANOPARTICLES; PERMEABILITY	The magnetic nanoparticle composite NiFe2O4 has traditionally been studied for high-frequency microwave absorption with marginal performance towards low-frequency radar bands (particularly L and S bands). Here, NiFe2O4 nanoparticles and nanohybrids using large-diameter graphene oxide (GO) sheets are prepared via solvothermal synthesis for low-frequency wide bandwidth shielding (L and S radar bands). The synthesized materials were characterized using XRD, SEM, FTIR and microwave magneto dielectric spectroscopy. The dimension of these solvothermally synthesized pristine particles and hybrids lies within 30-58 nm. Microwave magneto-dielectric spectroscopy was performed in the low-frequency region in the 1 MHz-3 GHz spectrum. The as-synthesized pristine nanoparticles and hybrids were found to be highly absorbing for microwaves throughout the L and S radar bands (<-10 dB from 1 MHz to 3 GHz). This excellent microwave absorbing property induced by graphene sheet coupling shows application of these materials with absorption bandwidth which is tailored such that these could be used for low frequency. Previously, these were used for high frequency absorptions (typically > 4 GHz) with limited selective bandwidth.	[Ameer, Shahid; Gul, Iftikhar Hussain] Natl Univ Sci & Technol, Sch Chem & Mat Engn, H-12, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Ameer, S (corresponding author), Natl Univ Sci & Technol, Sch Chem & Mat Engn, H-12, Islamabad, Pakistan.	shahidameer@scme.nust.edu.pk						Abbas SM, 2007, J MAGN MAGN MATER, V309, P20, DOI 10.1016/j.jmmm.2006.06.006; Bedre MD., 2012, AM J MAT SCI, V2, P39, DOI DOI 10.5923/J.MATERIALS.20120203.01; Chiou JW, 2012, J PHYS CHEM A; Fang JJ, 2013, J MATER SCI, V48, P8060, DOI 10.1007/s10853-013-7600-6; Fu YS, 2012, IND ENG CHEM RES, V51, P11700, DOI 10.1021/ie301347j; Fu YS, 2012, AICHE J, V58, P3298, DOI 10.1002/aic.13716; Gama AM, 2013, MATER RES-IBERO-AM J, V16, P997, DOI [10.1590/S1516-14392013000500006, 10.1590/S1516-14392013005000077]; Gu X, 2011, CHEM COMMUN, V47, P5337, DOI 10.1039/c0cc05800a; Huang NM, 2011, INT J NANOMED, V6, P3443, DOI 10.2147/IJN.S26812; Kaur R., 2014, INT J ENG RES TECHNO, V3, P160; Kavas H, 2009, CHEM PAP, V63, P450, DOI 10.2478/s11696-009-0034-6; Kooti M, 2013, J MATER SCI TECHNOL, V29, P34, DOI 10.1016/j.jmst.2012.11.016; Li XH, 2015, J MATER CHEM A, V3, P5535, DOI 10.1039/c4ta05718j; Liu PB, 2013, MATER LETT, V112, P117, DOI 10.1016/j.matlet.2013.08.126; Liu PJ, 2015, RSC ADV, V5, P93739, DOI 10.1039/c5ra18668d; MAGUIRE EA, 1976, J AM CERAM SOC, V59, P434, DOI 10.1111/j.1151-2916.1976.tb09512.x; Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368; Micheli D, 2012, INT J MAT SCI, V2, P31; OLMEDO L, 1993, ADV MATER, V5, P373, DOI 10.1002/adma.19930050509; Pardavi-Horvath M, 2000, J MAGN MAGN MATER, V215, P171, DOI 10.1016/S0304-8853(00)00106-2; Petrov VM, 2001, INORG MATER, V37, P135; Qin F, 2012, J APPL PHYS, V111, DOI 10.1063/1.3688435; Qin F, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3678192; Saville, 2005, REV RADAR ABSORBING; Sivakumar P, 2013, J ALLOY COMPD, V563, P6, DOI 10.1016/j.jallcom.2013.02.077; Soo YL, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3544059; Tyagi S, 2012, CERAM INT, V38, P4561, DOI 10.1016/j.ceramint.2012.02.034; Velmurugan K, 2010, MATER RES-IBERO-AM J, V13, P299, DOI 10.1590/S1516-14392010000300005; Vinoy K.J., 1996, RADAR ABSORBING MAT, DOI [10.1007/978-1-4613-0473-9, DOI 10.1007/978-1-4613-0473-9]; Wang C., 2012, APPL PHYS LETT, V100, DOI [DOI 10.1063/1/3678193, 10.1063/ 1.3678193, DOI 10.1063/1.3678193]; Wang ZZ, 2013, J MAGN MAGN MATER, V344, P101, DOI 10.1016/j.jmmm.2013.05.027; Xu HL, 2012, J APPL PHYS, V111, DOI 10.1063/1.3691527; Zhao HT, 2009, PHYSICA B, V404, P69, DOI 10.1016/j.physb.2008.10.006; Zivkovic I, 2012, MICROWAVE ABSORBING; Zong M, 2014, CERAM INT, V40, P6821, DOI 10.1016/j.ceramint.2013.11.145	35	18	18	5	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0153544	10.1371/journal.pone.0153544	http://dx.doi.org/10.1371/journal.pone.0153544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270944	Green Submitted, gold, Green Published			2022-12-26	WOS:000377561000001
J	Abramson, DH; Marr, BP; Francis, JH; Dunkel, IJ; Fabius, AWM; Brodie, SE; Mondesire-Crump, I; Gobin, YP				Abramson, David H.; Marr, Brian P.; Francis, Jasmine H.; Dunkel, Ira J.; Fabius, Armida W. M.; Brodie, Scott E.; Mondesire-Crump, Ijah; Gobin, Y. Pierre			Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy)	PLOS ONE			English	Article							INTRAOCULAR RETINOBLASTOMA; INTRAARTERIAL CHEMOTHERAPY; SUBCONJUNCTIVAL CARBOPLATIN; RETINAL FUNCTION; PHASE-I/II; MELPHALAN; TOPOTECAN; MANAGEMENT; DELIVERY	Objective Report on the 7-year experience with bilateral ophthalmic artery chemosurgery (OAC-Tandem therapy) for bilateral retinoblastoma. Design Retrospective, single institution study. Subjects 120 eyes of 60 children with bilateral retinoblastoma treated since March 2008. Methods Retrospective review of all children treated at Memorial Sloan Kettering with bilateral ophthalmic artery chemosurgery (Melphalan, Carboplatin, Topotecan, Methotrexate) delivered in the same initial session to both naive and previously treated eyes. Main Outcome Measures Ocular survival, metastatic disease, patient survival from metastases, second cancers, systemic adverse effects, need for transfusion of blood products, electroretinogram before and after treatment. Results 116 eyes were salvaged (4 eyes were enucleated: 3 because of progressive disease, 1 family choice). Kaplan Meier ocular survival was 99.2% at one year, 96.9% at 2 and 3 years and 94.9% for years 4 through 7. There were no cases of metastatic disease or metastatic deaths with a mean follow-up of 3.01 years. Two children developed second cancers (both pineoblastoma) and one of them died. Transfusion of blood products was required in 3 cases (4 transfusions), 1.9%. Two children developed fever/neutropenia requiring hospitalization (0.95%). ERGs were improved in 21.6% and unchanged after treatment in 52.5% of cases (increase or decrease of less than 25 mu V). Conclusions Bilateral ophthalmic artery chemosurgery is a safe and effective technique for managing bilateral retinoblastoma-even when eyes are advanced bilaterally, and if both eyes have progressed after systemic chemotherapy. Ocular survival was excellent (94.9% at 8 years), there were no cases of of metastatic disease and no deaths from metastatic disease, but children remain at risk for second cancers. In 21.6% of cases ERG function improved. Despite using chemotherapy in both eyes in the same session, systemic toxicity was low.	[Abramson, David H.; Marr, Brian P.; Francis, Jasmine H.; Fabius, Armida W. M.; Brodie, Scott E.; Mondesire-Crump, Ijah; Gobin, Y. Pierre] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Abramson, David H.; Marr, Brian P.; Francis, Jasmine H.] New York Presbyterian Hosp, Dept Ophthalmol, Weill Cornell Med Coll, New York, NY USA; [Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Dunkel, Ira J.] New York Presbyterian Hosp, Dept Pediat, Weill Cornell Med Coll, New York, NY USA; [Fabius, Armida W. M.] Vrije Univ Amsterdam, Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [Brodie, Scott E.] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Dept Radiol, Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Vrije Universiteit Amsterdam; Icahn School of Medicine at Mount Sinai; Cornell University; NewYork-Presbyterian Hospital	Abramson, DH (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.; Abramson, DH (corresponding author), New York Presbyterian Hosp, Dept Ophthalmol, Weill Cornell Med Coll, New York, NY USA.	abramsod@mskcc.org		Brodie, Scott/0000-0002-3303-4552; Francis, Jasmine/0000-0002-7637-3108	Fund for Ophthalmic Knowledge, Inc, New York; NIH/NCI Cancer Center Support Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Fund for Ophthalmic Knowledge, Inc, New York; NIH/NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Fund for Ophthalmic Knowledge, Inc, New York (No grant number; philanthropic fund) and funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2015, JAMA OPHTHALMOL, V133, P1341, DOI 10.1001/jamaophthalmol.2015.3108; Abramson David H, 2012, Retin Cases Brief Rep, V6, P209, DOI 10.1097/ICB.0b013e318234ccf4; Abramson DH, 2014, ANNU REV MED, V65, P171, DOI 10.1146/annurev-med-061312-123455; Abramson DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034120; Abramson DH, 2011, ARCH OPHTHALMOL-CHIC, V129, P1492, DOI 10.1001/archophthalmol.2011.354; Abramson DH, 2010, BRIT J OPHTHALMOL, V94, P396, DOI 10.1136/bjo.2009.174268; Abramson DH, 2010, ARCH OPHTHALMOL-CHIC, V128, P370, DOI 10.1001/archophthalmol.2010.7; Abramson DH, 1999, OPHTHALMOLOGY, V106, P1947, DOI 10.1016/S0161-6420(99)90406-2; Abramson DH, 2005, INVEST OPHTH VIS SCI, V46, P2684, DOI 10.1167/iovs.04-1462; Abramson DH, 2004, ARCH OPHTHALMOL-CHIC, V122, P1316, DOI 10.1001/archopht.122.9.1316; ABRAMSON DH, 1976, T AM ACAD OPHTHALMOL, V81, pP454; ABRAMSON DH, 1981, ARCH OPHTHALMOL-CHIC, V99, P1761; ABRAMSON DH, 1982, ARCH OPHTHALMOL-CHIC, V100, P1249; Allen S, 2010, PEDIATR BLOOD CANCER, V55, P47, DOI 10.1002/pbc.22467; Brodie SE, 2012, BRIT J OPHTHALMOL, V96, P877, DOI 10.1136/bjophthalmol-2011-301248; Brodie SE, 2009, DOC OPHTHALMOL, V119, P13, DOI 10.1007/s10633-008-9164-3; Carcaboso AM, 2010, INVEST OPHTH VIS SCI, V51, P2126, DOI 10.1167/iovs.09-4050; Chantada GL, 2009, INVEST OPHTH VIS SCI, V50, P1492, DOI 10.1167/iovs.08-2737; De Jong MC, 2015, AM J OPHTHALMOL, V160, P1116, DOI 10.1016/j.ajo.2015.09.009; Dunkel IJ, 2007, PEDIATR BLOOD CANCER, V49, P643, DOI 10.1002/pbc.21163; Dunkel IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108692; Francis JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072441; Francis JH, 2013, DOC OPHTHALMOL, V127, P113, DOI 10.1007/s10633-013-9391-0; Gallie B, 2009, CAN J OPHTHALMOL, V44, P639, DOI [10.3129/i09-229, 10.1139/i09-229]; Grigorovski N, 2014, INT J OPHTHALMOL-CHI, V7, P726, DOI 10.3980/j.issn.2222-3959.2014.04.26; INOMATA M, 1987, JPN J CANCER RES, V78, P858; Liu CY, 2014, DOC OPHTHALMOL, V128, P13, DOI 10.1007/s10633-013-9416-8; Marr BP, 2012, BRIT J OPHTHALMOL, V96, P1300, DOI 10.1136/bjophthalmol-2012-301925; Muen WJ, 2012, OPHTHALMOLOGY, V119, P611, DOI 10.1016/j.ophtha.2011.08.045; Murphree AL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1348, DOI 10.1001/archopht.1996.01100140548005; REESE AB, 1958, ARCH OPHTHALMOL-CHIC, V60, P897; Schaiquevich P, 2014, RETINA-J RET VIT DIS, V34, P1719, DOI 10.1097/IAE.0000000000000253; Schaiquevich P, 2013, PEDIATR BLOOD CANCER, V60, P766, DOI 10.1002/pbc.24356; Schefler AC, 2008, CURR OPIN OPHTHALMOL; Shields CL, 2013, EYE, V27, P253, DOI 10.1038/eye.2012.175; Shields CL, 2014, OPHTHALMOLOGY, V121, P1453, DOI 10.1016/j.ophtha.2014.01.026; Shields CL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1330, DOI 10.1001/archopht.1996.01100140530002; Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013; Taich P, 2014, OPHTHALMOLOGY, V121, P889, DOI 10.1016/j.ophtha.2013.10.045; Van Quill KR, 2005, OPHTHALMOLOGY, V112, P1151, DOI 10.1016/j.ophtha.2004.11.060	41	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156806	10.1371/journal.pone.0156806	http://dx.doi.org/10.1371/journal.pone.0156806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258771	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700134
J	Bing, PF; Xia, W; Wang, L; Zhang, YH; Lei, SF; Deng, FY				Bing, Peng-Fei; Xia, Wei; Wang, Lan; Zhang, Yong-Hong; Lei, Shu-Feng; Deng, Fei-Yan			Common Marker Genes Identified from Various Sample Types for Systemic Lupus Erythematosus	PLOS ONE			English	Article							PERIPHERAL-BLOOD CELLS; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; EXPRESSION; ASSOCIATION; BIOMARKERS; MONOCYTES; RESPONSES; STAT1; GEO	Objective Systemic lupus erythematosus (SLE) is a complex auto-immune disease. Gene expression studies have been conducted to identify SLE-related genes in various types of samples. It is unknown whether there are common marker genes significant for SLE but independent of sample types, which may have potentials for follow-up translational research. The aim of this study is to identify common marker genes across various sample types for SLE. Methods Based on four public microarray gene expression datasets for SLE covering three representative types of blood-born samples (monocyte; peripheral blood mononuclear cell, PBMC; whole blood), we utilized three statistics (fold-change, FC; t-test p value; false discovery rate adjusted p value) to scrutinize genes simultaneously regulated with SLE across various sample types. For common marker genes, we conducted the Gene Ontology enrichment analysis and Protein-Protein Interaction analysis to gain insights into their functions. Results We identified 10 common marker genes associated with SLE (IFI6, IFI27, IFI44L, OAS1, OAS2, EIF2AK2, PLSCR1, STAT1, RNASE2, and GSTO1). Significant up-regulation of IFI6, IFI27, and IFI44L with SLE was observed in all the studied sample types, though the FC was most striking in monocyte, compared with PBMC and whole blood (8.82-251.66 vs. 3.73-74.05 vs. 1.19-1.87). Eight of the above 10 genes, except RNASE2 and GSTO1, interact with each other and with known SLE susceptibility genes, participate in immune response, RNA and protein catabolism, and cell death. Conclusion Our data suggest that there exist common marker genes across various sample types for SLE. The 10 common marker genes, identified herein, deserve follow-up studies to dissert their potentials as diagnostic or therapeutic markers to predict SLE or treatment response.	[Bing, Peng-Fei; Xia, Wei; Wang, Lan; Lei, Shu-Feng; Deng, Fei-Yan] Soochow Univ, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou 215123, Jiangsu, Peoples R China; [Bing, Peng-Fei; Xia, Wei; Wang, Lan; Zhang, Yong-Hong; Lei, Shu-Feng; Deng, Fei-Yan] Soochow Univ, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou 215123, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Deng, FY (corresponding author), Soochow Univ, Sch Publ Hlth, Ctr Genet Epidemiol & Genom, Suzhou 215123, Jiangsu, Peoples R China.; Deng, FY (corresponding author), Soochow Univ, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou 215123, Jiangsu, Peoples R China.	fdeng@suda.edu.cn			Natural Science Foundation of China [81373010, 81541068, 81473046, 31401079, 81401343, 31271336]; Natural Science Foundation of Jiangsu Province [BK20130300]; Startup Fund from Soochow University [Q413900112, Q413900712]; China Postdoctoral Science Foundation [2014M551649]; Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Startup Fund from Soochow University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported by Natural Science Foundation of China (FYD and SFL; 81373010, 81541068, 81473046, 31401079, 81401343 and 31271336; http://www.nsfc.gov.cn/), the Natural Science Foundation of Jiangsu Province (FYD, BK20130300, http://www.jskjjh.gov.cn/), the Startup Fund from Soochow University (SFL, Q413900112; FYD, Q413900712; www.suda.edu.cn), China Postdoctoral Science Foundation (2014M551649), and a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions (FYD and SFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DL, 2014, GENES IMMUN, V15, P347, DOI 10.1038/gene.2014.23; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bovin LF, 2004, IMMUNOL LETT, V93, P217, DOI 10.1016/j.imlet.2004.03.018; Carpintero M F, 2015, DIAGNOSIS RISK STRAT; Chiche L, 2014, ARTHRITIS RHEUMATOL, V66, P1583, DOI 10.1002/art.38628; Dominguez-Gutierrez PR, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4448; Dominguez-Gutierrez PR, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4451; Dominguez-Gutierrez PR, 2014, J CLIN IMMUNOL, V34, P171, DOI 10.1007/s10875-013-9973-3; Feng XB, 2015, CLIN RHEUMATOL, V34, P71, DOI 10.1007/s10067-014-2799-4; Fodil M, 2015, SCAND J RHEUMATOL, V44, P2, DOI 10.3109/03009742.2014.918175; Grammatikos AP, 2014, CLIN IMMUNOL, V150, P192, DOI 10.1016/j.clim.2013.12.002; Grammatikos AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074550; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huang J, 2012, STAT SCI, V27, P481, DOI 10.1214/12-STS392; Huang Jing, 2010, Zhonghua Nei Ke Za Zhi, V49, P45; Huang X, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2475; Ishii T, 2005, DNA RES, V12, P429, DOI 10.1093/dnares/dsi020; Kennedy WP, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2014-000080; Landolt-Marticorena C, 2009, ANN RHEUM DIS, V68, P1440, DOI 10.1136/ard.2008.093146; Lee YH, 2012, MOL BIOL REP, V39, P10627, DOI 10.1007/s11033-012-1952-x; Li Min, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P268; Ma S, 2008, BRIEF BIOINFORM, V9, P392, DOI 10.1093/bib/bbn027; O'Hanlon TP, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3330; Okada Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002455; Ramirez-Ortiz ZG, 2015, NAT IMMUNOL, V16, P495, DOI 10.1038/ni.3143; Raya MA, 2013, J REHABIL RES DEV, V50, P951, DOI 10.1682/JRRD.2012.05.0096; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rodriguez-Pla A, 2014, J IMMUNOL, V192, P5586, DOI 10.4049/jimmunol.1301319; Sanayama Y, 2014, ARTHRITIS RHEUMATOL, V66, P1421, DOI 10.1002/art.38400; Shi XJ, 2014, BRIEF BIOINFORM, V15, P671, DOI 10.1093/bib/bbt044; Tang J, 2008, LUPUS, V17, P805, DOI 10.1177/0961203308089694; Toukap AN, 2007, ARTHRITIS RHEUM-US, V56, P1579, DOI 10.1002/art.22578; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Ye S, 2007, CLIN RHEUMATOL, V26, P186, DOI 10.1007/s10067-006-0260-z	34	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156234	10.1371/journal.pone.0156234	http://dx.doi.org/10.1371/journal.pone.0156234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257790	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700045
J	Cieszanowski, A; Lisowska, A; Dabrowska, M; Korczynski, P; Zukowska, M; Grudzinski, IP; Pacho, R; Rowinski, O; Krenke, R				Cieszanowski, Andrzej; Lisowska, Antonina; Dabrowska, Marta; Korczynski, Piotr; Zukowska, Malgorzata; Grudzinski, Ireneusz P.; Pacho, Ryszard; Rowinski, Olgierd; Krenke, Rafal			MR Imaging of Pulmonary Nodules: Detection Rate and Accuracy of Size Estimation in Comparison to Computed Tomography	PLOS ONE			English	Article							LUNG-CANCER; CT SCANS; POPULATION; SEQUENCE; RISKS	Objective The aims of this study were to assess the sensitivity of various magnetic resonance imaging (MRI) sequences for the diagnosis of pulmonary nodules and to estimate the accuracy of MRI for the measurement of lesion size, as compared to computed tomography (CT). Methods Fifty patients with 113 pulmonary nodules diagnosed by CT underwent lung MRI and CT. MRI studies were performed on 1.5T scanner using the following sequences: T2-TSE, T2-SPIR, T2-STIR, T2-HASTE, T1-VIBE, and T1-out-of-phase. CT and MRI data were analyzed independently by two radiologists. Results The overall sensitivity of MRI for the detection of pulmonary nodules was 80.5% and according to nodule size: 57.1% for nodules <= 4mm, 75% for nodules >4-6mm, 87.5% for nodules >6-8mm and 100% for nodules >8mm. MRI sequences yielded following sensitivities: 69% (T1-VIBE), 54.9% (T2-SPIR), 48.7% (T2-TSE), 48.7% (T1-out-of-phase), 45.1% (T2-STIR), 25.7% (T2-HASTE), respectively. There was very strong agreement between the maximum diameter of pulmonary nodules measured by CT and MRI (mean difference -0.02 mm; 95% CI -1.6-1.57 mm; Bland-Altman analysis). Conclusions MRI yielded high sensitivity for the detection of pulmonary nodules and enabled accurate assessment of their diameter. Therefore it may be considered an alternative to CT for follow-up of some lung lesions. However, due to significant number of false positive diagnoses, it is not ready to replace CT as a tool for lung nodule detection.	[Cieszanowski, Andrzej; Lisowska, Antonina; Zukowska, Malgorzata; Pacho, Ryszard; Rowinski, Olgierd] Med Univ Warsaw, Cent Clin Hosp, Dept Clin Radiol 2, Warsaw, Poland; [Cieszanowski, Andrzej] Maria Sklodowska Curie Mem Canc Ctr, Inst Oncol, Warsaw, Poland; [Dabrowska, Marta; Korczynski, Piotr; Krenke, Rafal] Med Univ Warsaw, Dept Internal Med Pneumonol & Allergol, Warsaw, Poland; [Grudzinski, Ireneusz P.] Med Univ Warsaw, Dept Toxicol, Fac Pharm, Warsaw, Poland	Medical University of Warsaw; Maria Sklodowska-Curie National Research Institute of Oncology; Medical University of Warsaw; Medical University of Warsaw	Cieszanowski, A (corresponding author), Med Univ Warsaw, Cent Clin Hosp, Dept Clin Radiol 2, Warsaw, Poland.; Cieszanowski, A (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Inst Oncol, Warsaw, Poland.	andrzej.cieszanowski@wum.edu.pl		Grudzinski, Ireneusz/0000-0002-6113-1771; Grudzinski, Ireneusz/0000-0002-1485-7529; Dabrowska, Marta/0000-0003-1872-7737				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Albert RH, 2009, AM FAM PHYSICIAN, V80, P827; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Baumann T, 2008, INVEST RADIOL, V43, P359, DOI 10.1097/RLI.0b013e31816901fa; Biederer J, 2012, INSIGHTS IMAGING, V3, P355, DOI 10.1007/s13244-011-0146-8; Biederer J, 2003, RADIOLOGY, V227, P475, DOI 10.1148/radiol.2272020635; Biederer J, 2012, INSIGHTS IMAGING, V3, P373, DOI 10.1007/s13244-011-0142-z; Biederer J, 2008, CANCER IMAGING, V8, P125, DOI 10.1102/1470-7330.2008.0018; Both M, 2005, EUR J RADIOL, V53, P478, DOI 10.1016/j.ejrad.2004.05.007; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Bruegel M, 2007, J MAGN RESON IMAGING, V25, P73, DOI 10.1002/jmri.20824; Choromanska A, 2012, POL J RADIOL, V77, P22, DOI 10.12659/PJR.882967; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Heye T, 2012, ACTA RADIOL, V53, P153, DOI 10.1258/ar.2011.110445; Kersjes W, 1997, EUR RADIOL, V7, P1190, DOI 10.1007/s003300050272; Khan Ali Nawaz, 2011, Avicenna J Med, V1, P39, DOI 10.4103/2231-0770.90915; Luboldt W, 2006, EUR J MED RES, V11, P336; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; McWilliams Annette, 2008, Proc Am Thorac Soc, V5, P900, DOI 10.1513/pats.200809-111QC; McWilliams AM, 2006, J THORAC ONCOL, V1, P61, DOI 10.1097/01243894-200601000-00012; Regier M, 2011, J MED IMAG RADIAT ON, V55, P266, DOI 10.1111/j.1754-9485.2011.02263.x; Rubin GD, 2005, RADIOLOGY, V234, P274, DOI 10.1148/radiol.2341040589; Schroeder T, 2005, AM J ROENTGENOL, V185, P979, DOI 10.2214/AJR.04.0814; Sieren JC, 2010, J MAGN RESON IMAGING, V32, P1353, DOI 10.1002/jmri.22383; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Sommer G, 2014, EUR J RADIOL, V83, P600, DOI 10.1016/j.ejrad.2013.11.012; Stolzmann P, 2013, INVEST RADIOL, V48, P241, DOI 10.1097/RLI.0b013e31826f2de9; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Vogt FM, 2004, AM J ROENTGENOL, V183, P71, DOI 10.2214/ajr.183.1.1830071; Wielputz M, 2012, DIAGN INTERV RADIOL, V18, P344, DOI 10.4261/1305-3825.DIR.5365-11.0; Wu NY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-242; Yi CA, 2007, AM J ROENTGENOL, V189, P386, DOI 10.2214/AJR.07.2082	33	43	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156272	10.1371/journal.pone.0156272	http://dx.doi.org/10.1371/journal.pone.0156272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258047	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700050
J	Khanal, P; Johnsen, L; Axel, AMD; Hansen, PW; Kongsted, AH; Lyckegaard, NB; Nielsen, MO				Khanal, Prabhat; Johnsen, Laerke; Axel, Anne Marie Dixen; Hansen, Pernille Willert; Kongsted, Anna Hauntoft; Lyckegaard, Nette Brinch; Nielsen, Mette Olaf			Long-Term Impacts of Foetal Malnutrition Followed by Early Postnatal Obesity on Fat Distribution Pattern and Metabolic Adaptability in Adult Sheep	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; ADIPOSE-TISSUE; LATE-GESTATION; PRENATAL UNDERNUTRITION; HYPERCALORIC NUTRITION; DIFFERENTIAL IMPACTS; INSULIN ADAPTATIONS; VISCERAL ADIPOSITY; RENAL DYSFUNCTION; OBESOGENIC DIET	We aimed to investigate whether over- versus undernutrition in late foetal life combined with obesity development in early postnatal life have differential implications for fat distribution and metabolic adaptability in adulthood. Twin-pregnant ewes were fed NORM (100% of daily energy and protein requirements), LOW (50% of NORM) or HIGH (150%/110% of energy/protein requirements) diets during the last trimester. Postnatally, twin-lambs received obesogenic (HCHF) or moderate (CONV) diets until 6 months of age, and a moderate (obesity correcting) diet thereafter. At 2(1)/(2) years of age (adulthood), plasma metabolite profiles during fasting, glucose, insulin and propionate (in fed and fasted states) tolerance tests were examined. Organ weights were determined at autopsy. Early obesity development was associated with lack of expansion of perirenal, but not other adipose tissues from adolescence to adulthood, resulting in 10% unit increased proportion of mesenteric of intra-abdominal fat. Prenatal undernutrition had a similar but much less pronounced effect. Across tolerance tests, LOW-HCHF sheep had highest plasma levels of cholesterol, urea-nitrogen, creatinine, and lactate. Sex specific differences were observed, particularly with respect to fat deposition, but direction of responses to early nutrition impacts were similar. However, prenatal undernutrition induced greater metabolic alterations in adult females than males. Foetal undernutrition, but not overnutrition, predisposed for adult hypercholesterolaemia, hyperureaemia, hypercreatinaemia and hyperlactataemia, which became manifested only in combination with early obesity development. Perirenal expandability may play a special role in this context. Differential nutrition recommendations may be advisable for individuals with low versus high birth weights.	[Khanal, Prabhat; Johnsen, Laerke; Axel, Anne Marie Dixen; Hansen, Pernille Willert; Kongsted, Anna Hauntoft; Lyckegaard, Nette Brinch; Nielsen, Mette Olaf] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark	University of Copenhagen	Nielsen, MO (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg, Denmark.	mette.olaf.nielsen@sund.ku.dk	Khanal, Prabhat/AAZ-4444-2021	Khanal, Prabhat/0000-0001-6774-0503; Kongsted, Anna/0000-0003-1959-8308	Danish Council for Strategic Research [09-067124]; Lundbeck Foundation [R167-2013-16124] Funding Source: researchfish	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden)	The study was conducted as part of the research program of the Centre for Fetal Programming (CFP), Denmark. The CFP was supported by the Danish Council for Strategic Research (grant 09-067124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge H, INT J OBES, V35, P325; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Battista MC, 2002, AM J PHYSIOL-ENDOC M, V283, pE124, DOI 10.1152/ajpendo.00004.2001; Bauer R, 2002, ACTA PHYSIOL SCAND, V176, P83, DOI 10.1046/j.1365-201X.2002.01027.x; Bayol SA, BR J NUTR, V98, P843; Buckley AJ, 2005, METABOLISM, V54, P500, DOI 10.1016/j.metabol.2004.11.003; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Cho CE, 2013, INT J OBESITY, V37, P1177, DOI 10.1038/ijo.2012.210; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Dotsch J, 2009, J MOL MED, V87, P841, DOI 10.1007/s00109-009-0507-7; FINCO DR, 1976, J AM VET MED ASSOC, V168, P593; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Gowda S, 2010, N AM J MED SCI, V2, P170; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hou L, 2014, ACTA PHYSIOL, V210, P317, DOI 10.1111/apha.12211; Hou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065452; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Johnsen L, 2013, J ENDOCRINOL, V216, P389, DOI 10.1530/JOE-12-0389; Khanal P, 2015, ACTA PHYSIOL, V213, P519, DOI 10.1111/apha.12391; Khanal P, 2014, ACTA PHYSIOL, V210, P110, DOI 10.1111/apha.12129; Kongsted AH, 2014, ACTA PHYSIOL, V210, P84, DOI 10.1111/apha.12080; Kongsted AH, 2013, J ENDOCRINOL, V219, P159, DOI 10.1530/JOE-13-0099; Lackland DT, 2000, ARCH INTERN MED, V160, P1472, DOI 10.1001/archinte.160.10.1472; Li ZL, 2011, AM J PHYSIOL-RENAL, V301, pF1078, DOI 10.1152/ajprenal.00333.2011; Liu JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034835; MARIN P, 1992, METABOLISM, V41, P1242, DOI 10.1016/0026-0495(92)90016-4; Nielsen MO, 2013, BRIT J NUTR, V109, P2098, DOI 10.1017/S0007114512004199; Nwagwu MO, 2000, BRIT J NUTR, V83, P79, DOI 10.1017/S0007114500000118; Rea DJ, 2006, KIDNEY INT, V70, P1636, DOI 10.1038/sj.ki.5001799; Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200; Sohi G, 2011, MOL ENDOCRINOL, V25, P785, DOI 10.1210/me.2010-0395; Tan CY, 2008, BIOCHEM SOC T, V36, P935, DOI 10.1042/BST0360935; TURLEY SD, 1995, J LIPID RES, V36, P67; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Vikse BE, 2008, J AM SOC NEPHROL, V19, P151, DOI 10.1681/ASN.2007020252; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x; Yates Z, 2009, BRIT J NUTR, V101, P1185, DOI 10.1017/S0007114508066786; Zuo YG, 2008, ANAL SCI, V24, P1589, DOI 10.2116/analsci.24.1589	42	12	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156700	10.1371/journal.pone.0156700	http://dx.doi.org/10.1371/journal.pone.0156700			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257993	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700109
J	Ng, TLM; Karim, R; Tan, YS; Teh, HF; Danial, AD; Ho, LS; Khalid, N; Appleton, DR; Harikrishna, JA				Ng, Theresa Lee Mei; Karim, Rezaul; Tan, Yew Seong; Teh, Huey Fang; Danial, Asma Dazni; Ho, Li Sim; Khalid, Norzulaani; Appleton, David Ross; Harikrishna, Jennifer Ann			Amino Acid and Secondary Metabolite Production in Embryogenic and Non-Embryogenic Callus of Fingerroot Ginger (Boesenbergia rotunda)	PLOS ONE			English	Article							SOMATIC EMBRYOGENESIS; L. MANSF.; CULTURES; DIFFERENTIATION; LOCALIZATION; REGENERATION; FLAVONOIDS; TRYPTOPHAN; GLUTAMINE; TISSUES	Interest in the medicinal properties of secondary metabolites of Boesenbergia rotunda (fingerroot ginger) has led to investigations into tissue culture of this plant. In this study, we profiled its primary and secondary metabolites, as well as hormones of embryogenic and non-embryogenic (dry and watery) callus and shoot base, Ultra Performance Liquid Chromatography-Mass Spectrometry together with histological characterization. Metabolite profiling showed relatively higher levels of glutamine, arginine and lysine in embryogenic callus than in dry and watery calli, while shoot base tissue showed an intermediate level of primary metabolites. For the five secondary metabolites analyzed (ie. panduratin, pinocembrin, pinostrobin, cardamonin and alpinetin), shoot base had the highest concentrations, followed by watery, dry and embryogenic calli. Furthermore, intracellular auxin levels were found to decrease from dry to watery calli, followed by shoot base and finally embryogenic calli. Our morphological observations showed the presence of fibrils on the cell surface of embryogenic callus while diphenylboric acid 2-aminoethylester staining indicated the presence of flavonoids in both dry and embryogenic calli. Periodic acid-Schiff staining showed that shoot base and dry and embryogenic calli contained starch reserves while none were found in watery callus. This study identified several primary metabolites that could be used as markers of embryogenic cells in B. rotunda, while secondary metabolite analysis indicated that biosynthesis pathways of these important metabolites may not be active in callus and embryogenic tissue.	[Ng, Theresa Lee Mei; Karim, Rezaul; Tan, Yew Seong; Khalid, Norzulaani; Harikrishna, Jennifer Ann] Univ Malaya, Ctr Res Biotechnol Agr, Kuala Lumpur 50603, Malaysia; [Ng, Theresa Lee Mei; Karim, Rezaul; Tan, Yew Seong; Khalid, Norzulaani; Harikrishna, Jennifer Ann] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Ng, Theresa Lee Mei; Teh, Huey Fang; Danial, Asma Dazni; Ho, Li Sim; Appleton, David Ross] Univ Putra Malaysia, UPM MTDC Technol Ctr 3, Sime Darby Technol Ctr, 1st Floor Block B, Serdang 43400, Selangor, Malaysia; [Karim, Rezaul] Rajshahi Univ, Fac Life & Earth Sci, Dept Bot, Rajshahi 6205, Bangladesh	Universiti Malaya; Universiti Malaya; Universiti Putra Malaysia; University of Rajshahi	Harikrishna, JA (corresponding author), Univ Malaya, Ctr Res Biotechnol Agr, Kuala Lumpur 50603, Malaysia.; Harikrishna, JA (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia.	jennihari@um.edu.my	Harikrishna, Jennifer Ann/B-2778-2010; KHALID, NORZULAANI/B-9405-2010	Harikrishna, Jennifer Ann/0000-0002-4687-709X; 	High Impact Research Chancellory Grant from the University of Malaya [UM.C/625/1/HIR/MOHE/SCI/19]; Bright Spark Programme of the University of Malaya	High Impact Research Chancellory Grant from the University of Malaya; Bright Spark Programme of the University of Malaya	This work was supported by High Impact Research Chancellory Grant UM.C/625/1/HIR/MOHE/SCI/19 from the University of Malaya. Also, the authors would like to acknowledge Bright Spark Programme of the University of Malaya for supporting Rezaul Karim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by High Impact Research Chancellory Grant UM.C/625/1/HIR/MOHE/SCI/19 from the University of Malaya. We acknowledge colleagues at the Centre for Research in Biotechnology for Agriculture (CEBAR), University of Malaya and at Sime Darby Technology Centre (SDTC) for their kind support and guidance during this research. We thank Ms. Alena Lee Sanusi for editorial assistance and Dr. Melina Ong Abdullah from Malaysian Palm Oil Board (MPOB) for assisting in histology sectioning. A special thank you to Professor Pat Heslop-Harrison, Leicester University, United Kingdom for his considerable input and advice during the study and manuscript preparation. Finally, we would like to acknowledge Bright Spark Programme of the University of Malaya for supporting Rezaul Karim.	Abdelwahab SI, 2011, J ETHNOPHARMACOL, V137, P963, DOI 10.1016/j.jep.2011.07.010; [Anonymous], 2003, J SCI TECHNOL; [Anonymous], MATH PROBL ENG, DOI DOI 10.7873/DATE.2014.232; Bhamarapravati S, 2006, SONGKLANAKARIN J SCI, V28, P157; Buer CS, 2007, PLANT PHYSIOL, V145, P478, DOI 10.1104/pp.107.101824; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Businge E, 2012, TREE PHYSIOL; Chapman A, 2000, CAN J BOT, V78, P816, DOI 10.1139/cjb-78-6-816; Chaudhury R.R., 2001, TRADITIONAL MED ASIA; CHOWDHRY CN, 1993, PLANT CELL TISS ORG, V32, P357, DOI 10.1007/BF00042300; Dubravina GA, 2005, RUSS J PLANT PHYSL+, V52, P672, DOI 10.1007/s11183-005-0100-z; Feirer RP, 1995, SOMATIC EMBRYOGENESI; Gerdakaneh M, 2011, ACTA PHYSIOL PLANT, V33, P1847, DOI 10.1007/s11738-011-0725-9; Guiderdoni E, 1995, BIOTECHNOLOGY AGR FO, V31, P92; Jeyaseelan M., 2005, Indian Journal of Experimental Biology, V43, P555; Jimenez VM, 2001, PLANT CELL TISS ORG, V67, P37, DOI 10.1023/A:1011671310451; Jimenez VM, 2001, PLANT SCI, V160, P247, DOI 10.1016/S0168-9452(00)00382-4; Jing LJ, 2010, J MED PLANTS RES, V4, P27; KAMADA H, 1984, PLANT CELL PHYSIOL, V25, P27; Kirana C, 2007, J NAT MED-TOKYO, V61, P131, DOI 10.1007/s11418-006-0100-0; Thuc LV, 2011, MOL BIOTECHNOL, V48, P156, DOI 10.1007/s12033-010-9356-4; Li QF, 2015, PHYSIOL PLANTARUM, V154, P95, DOI 10.1111/ppl.12276; MALdL Ventosa, 2010, DIFFERENTIAL PROTEOM; MICHALCZUK L, 1992, PLANT PHYSIOL, V100, P1346, DOI 10.1104/pp.100.3.1346; MICHALCZUK L, 1992, PHYTOCHEMISTRY, V31, P1097, DOI 10.1016/0031-9422(92)80241-6; Minocha R, 2004, IN VITRO CELL DEV-PL, V40, P572, DOI 10.1079/IVP2004569; Morikawa T, 2008, CHEM PHARM BULL, V56, P956, DOI 10.1248/cpb.56.956; Muller M, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-37; Naz S, 2008, PAK J BOT, V40, P2525; Neoh BK, 2013, J AGR FOOD CHEM, V61, P1920, DOI 10.1021/jf304561f; Newsholme P, 2003, BRAZ J MED BIOL RES, V36, P153, DOI 10.1590/S0100-879X2003000200002; Nor Azma Yusuf, 2013, Australian Journal of Crop Science, V7, P730; Ogita S, 2001, IN VITRO CELL DEV-PL, V37, P268, DOI 10.1007/s11627-001-0048-4; Palama TL, 2010, BMC PLANT BIOL, V10, P1, DOI 10.1186/1471-2229-10-82; Peer WA, 2001, PLANT PHYSIOL, V126, P536, DOI 10.1104/pp.126.2.536; Policegoudra RS, 2008, FOOD HYDROCOLLOID, V22, P513, DOI 10.1016/j.foodhyd.2007.01.008; Pongtongkam P., 2004, Kasetsart Journal, Natural Sciences, V38, P190; Popielarska M, 2006, ACTA BIOL CRACOV BOT, V48, P97; Poustka F, 2007, PLANT PHYSIOL, V145, P1323, DOI 10.1104/pp.107.105064; RODRIGUEZ R, 1982, HORTSCIENCE, V17, P195; Rodriguez S, 1996, TISSUE CELL, V28, P149, DOI 10.1016/S0040-8166(96)80003-6; Sarath G, 2014, PLANT SCI, V217, P140, DOI 10.1016/j.plantsci.2013.12.012; SUNG ZR, 1979, PLANTA, V145, P339, DOI 10.1007/BF00388358; Takacs EM, 2012, PLANT CELL, V24, P3219, DOI 10.1105/tpc.112.099614; Tan BC, 2015, EVIDENCE BASED COMPL, V2015; Tan E, 2012, EVIDENCE BASED COMPL; Tan SK, 2005, IN VITRO CELL DEV-PL, V41, P757, DOI 10.1079/IVP2005695; Wong SM, 2013, IN VITRO CELL DEV-PL, V49, P665, DOI 10.1007/s11627-013-9570-4; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022992; Yusuf NA, 2012, ACTA PHYSIOL PLANT, P1; Yusuf NA, 2011, J MED PLANTS RES, V5, P2629; ZARATE R, 1994, NEW PHYTOL, V126, P295, DOI 10.1111/j.1469-8137.1994.tb03948.x; ZIMMERMAN JL, 1993, PLANT CELL, V5, P1411, DOI 10.1105/tpc.5.10.1411; Zouine J, 2005, PLANT CELL TISS ORG, V82, P83, DOI 10.1007/s11240-004-6914-0	54	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156714	10.1371/journal.pone.0156714	http://dx.doi.org/10.1371/journal.pone.0156714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258536	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700112
J	Suzuki, K; Tsunoda, H; Omiya, R; Matoba, K; Baba, T; Suzuki, S; Segawa, H; Kumanogoh, A; Iwasaki, K; Hattori, K; Takagi, J				Suzuki, Kei; Tsunoda, Hiroyuki; Omiya, Ryusuke; Matoba, Kyoko; Baba, Takeshi; Suzuki, Sachiyo; Segawa, Hiroaki; Kumanogoh, Atsushi; Iwasaki, Kenji; Hattori, Kunihiro; Takagi, Junichi			Structure of the Plexin Ectodomain Bound by Semaphorin-Mimicking Antibodies	PLOS ONE			English	Article							SECRETED SEMAPHORINS; SYSTEM; CELLS; GENERATION; RECEPTORS; 3A	Semaphorin family proteins act on cells to mediate both repulsive and attractive guidance via binding to plexin family receptors, thereby playing fundamental roles in the morphogenesis and homeostasis of various tissues. Although semaphorin-plexin signaling is implicated in various diseases and is thus a target of intensive research, our mechanistic understanding of how semaphorins activate plexins on the cell surface is limited. Here, we describe unique anti-plexin-A1 antibodies that can induce a collapsed morphology in mouse dendritic cells as efficiently as the semaphorin 3A (Sema3A) ligand. Precise epitope analysis indicates that these "semaphorin-mimicking" antibodies dimerize cell-surface plexin-A1 by binding to the N-terminal sema domain of the plexin at sites away from the interface used by the Sema3A ligand. Structural analysis of plexin-A1 fragments using negative stain electron microscopy further revealed that this agonistic capacity is closely linked to the location and orientation of antibody binding. In addition, the full-length plexin-A1 ectodomain exhibited a highly curved "C" shape, reinforcing the very unusual dimeric receptor conformation of this protein at the cell surface when engaged with Sema3A or agonistic antibodies.	[Suzuki, Kei; Matoba, Kyoko; Iwasaki, Kenji; Takagi, Junichi] Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka 565, Japan; [Tsunoda, Hiroyuki; Omiya, Ryusuke; Baba, Takeshi; Suzuki, Sachiyo; Segawa, Hiroaki; Hattori, Kunihiro] Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan; [Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka, Japan	Osaka University; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Osaka University	Takagi, J (corresponding author), Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka 565, Japan.; Hattori, K (corresponding author), Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan.	hattoriknh@chugai-pharm.co.jp; takagi@protein.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); "Platform for Drug Discovery, Informatics, and Structural Life Science" grant from the MEXT; Chugai Pharmaceutical Co.Ltd.	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Platform for Drug Discovery, Informatics, and Structural Life Science" grant from the MEXT; Chugai Pharmaceutical Co.Ltd.	This work was supported by the Grant-in-Aid for Scientific Research on Innovative Areas (Analysis and Synthesis of Multidimensional Immune Organ Network) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) to JT, and by the "Platform for Drug Discovery, Informatics, and Structural Life Science" grant from the MEXT to JT. The Chugai Pharmaceutical Co.Ltd. provided support in the form of salaries for authors HT, RO, TB, SS, HS, and KH, HT, TB and KH has stocks of Chugai Pharmaceutical Co., Ltd. AK received research grants from Chugai Pharmaceutical Co., Ltd. All funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Barash S, 2002, BIOCHEM BIOPH RES CO, V294, P835, DOI 10.1016/S0006-291X(02)00566-1; Bell CH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001134; Catalano A, 2006, BLOOD, V107, P3321, DOI 10.1182/blood-2005-06-2445; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fujii Y, 2014, PROTEIN EXPRES PURIF, V95, P240, DOI 10.1016/j.pep.2014.01.009; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Hota PK, 2012, CELL MOL LIFE SCI, V69, P3765, DOI 10.1007/s00018-012-1019-0; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Liu HL, 2010, CELL, V142, P749, DOI 10.1016/j.cell.2010.07.040; Liu ZH, 2007, BLOOD, V110, P2408, DOI 10.1182/blood-2007-04-083998; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Montolio M, 2009, CHEM BIOL, V16, P691, DOI 10.1016/j.chembiol.2009.05.006; Nogi T, 2006, EMBO J, V25, P3675, DOI 10.1038/sj.emboj.7601240; Nogi T, 2010, NATURE, V467, P1123, DOI 10.1038/nature09473; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Sangawa T, 2008, HYBRIDOMA, V27, P331, DOI 10.1089/hyb.2008.0027; Scheer JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051817; Seeber S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086184; Siebold C, 2013, SEMIN CELL DEV BIOL, V24, P139, DOI 10.1016/j.semcdb.2012.11.003; Takamatsu H, 2010, NAT IMMUNOL, V11, P594, DOI 10.1038/ni.1885; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang YX, 2013, ELIFE, V2, DOI 10.7554/eLife.01279; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; White AL, 2015, CANCER CELL, V27, P138, DOI 10.1016/j.ccell.2014.11.001; Worzfeld T, 2014, NAT REV DRUG DISCOV, V13, P603, DOI 10.1038/nrd4337; Yamamoto M, 2008, INT IMMUNOL, V20, P413, DOI 10.1093/intimm/dxn006; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023; Zhang L., 2015, PLOS ONE, V10	34	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156719	10.1371/journal.pone.0156719	http://dx.doi.org/10.1371/journal.pone.0156719			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258772	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700114
J	Xu, M; Cheung, CCM; Chow, C; Lun, SWM; Cheung, ST; Lo, KW				Xu, Meng; Cheung, Chartia Ching-Mei; Chow, Chit; Lun, Samantha Wei-Man; Cheung, Siu-Tim; Lo, Kwok-Wai			Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma	PLOS ONE			English	Article							PROLYL ISOMERASE PIN1; TUMOR-SUPPRESSOR; BREAST-CANCER; CELL-DEATH; ESTABLISHMENT; DEGRADATION; EXPRESSION; PHOSPHORYLATION; INHIBITION; ACTIVATION	Background Nasopharyngeal carcinoma (NPC) is a peculiar Epstein Barr virus (EBV)-associated malignancy that is prevalent in South-East Asia. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) isomerizes specific phosphorylated amino acid residues, which makes it an important regulator in cell survival and apoptosis. In this study, we investigated the contribution made by PIN1 in NPC tumorigenesis and PIN1's potential role as a therapeutic target. Methods The expression of PIN1 was examined in a panel of NPC cell lines, xenografts and primary tumors. The functional roles of PIN1 in NPC cells were elucidated by the knockdown and overexpression of PIN1 in in vitro and in vivo nude mice models by siRNA and lenti-viral transfection, respectively. The antitumor effects of the PIN1 inhibitor Juglone in NPC cells were also evaluated. Results We revealed the consistent overexpression of PIN1 in almost all EBV-associated NPC cell lines, xenografts and primary tumors. PIN1 suppression was capable of inhibiting cyclin D1 expression and activating caspase-3 in NPC cells. It positively regulated NPC cell proliferation, colony formation and anchorage-independent growth. The inhibition of PIN1 suppressed tumor growth in vitro and in vivo. Conclusions This study demonstrates the oncogenic role of PIN1 in NPC tumorigenesis, and shows that its overexpression can enhance tumor cell growth via the upregulation of cyclinD1. Our findings inform the development of novel treatments targeting PIN1 for NPC patients.	[Xu, Meng] Sun Yat Sen Univ, Dept Oral Pathol, Guangdong Prov Key Lab Stomatol, Hosp Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Meng; Cheung, Chartia Ching-Mei; Chow, Chit; Lun, Samantha Wei-Man; Lo, Kwok-Wai] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Oncol South China, Shatin, Hong Kong, Peoples R China; [Cheung, Siu-Tim] Chinese Univ Hong Kong, Dept Surg, Shatin, Hong Kong, Peoples R China; [Lo, Kwok-Wai] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Sun Yat Sen University; Chinese University of Hong Kong; Prince of Wales Hospital; State Key Lab Oncology South China; Chinese University of Hong Kong; Chinese University of Hong Kong	Lo, KW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, State Key Lab Oncol South China, Shatin, Hong Kong, Peoples R China.; Lo, KW (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China.	kwlo@cuhk.edu.hk	Cheung, Siu-Tim/C-4238-2009	Cheung, Siu-Tim/0000-0003-2147-315X; Lo, Kwok Wai/0000-0002-3488-6124	Chinese University of Hong Kong; Hong Kong Research Grants Council - GRF [470413, 470312, 471211]; Hong Kong Research Grants Council - CRF [CUHK8/CRF/11R]; Hong Kong Research Grants Council - AoE NPC [AoE/M06/08]; Hong Kong Research Grants Council - Theme-Based Research Scheme [T12-403/11, T12-401/13-R]	Chinese University of Hong Kong(Chinese University of Hong Kong); Hong Kong Research Grants Council - GRF(Hong Kong Research Grants Council); Hong Kong Research Grants Council - CRF(Hong Kong Research Grants Council); Hong Kong Research Grants Council - AoE NPC(Hong Kong Research Grants Council); Hong Kong Research Grants Council - Theme-Based Research Scheme(Hong Kong Research Grants Council)	This study was supported by grant from the Chinese University of Hong Kong (Focus Investigation Scheme-A), and the Hong Kong Research Grants Council - GRF (470413, 470312, 471211), CRF (CUHK8/CRF/11R), AoE NPC (AoE/M06/08), Theme-Based Research Scheme (T12-403/11 and T12-401/13-R).	Aragane Y, 1998, J CELL BIOL, V140, P171, DOI 10.1083/jcb.140.1.171; Ayala G, 2003, CANCER RES, V63, P6244; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; Basu A, 2002, NEOPLASIA, V4, P218, DOI 10.1038/sj.neo.7900233; BUSSON P, 1988, INT J CANCER, V42, P599, DOI 10.1002/ijc.2910420422; Chan ATC, 2011, EUR J CANCER, V47, pS302, DOI 10.1016/S0959-8049(11)70179-4; Chao SH, 2001, NUCLEIC ACIDS RES, V29, P767, DOI 10.1093/nar/29.3.767; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Chung GTY, 2013, J PATHOL, V231, P311, DOI 10.1002/path.4239; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Guito J, 2014, J VIROL, V88, P547, DOI 10.1128/JVI.02877-13; HUANG DP, 1980, INT J CANCER, V26, P127, DOI 10.1002/ijc.2910260202; HUANG DP, 1989, INT J CANCER, V43, P936, DOI 10.1002/ijc.2910430535; Jeong SJ, 2009, BIOCHEM BIOPH RES CO, V381, P294, DOI 10.1016/j.bbrc.2009.02.024; Jin HW, 2011, ONCOL LETT, V2, P1191, DOI 10.3892/ol.2011.392; Kamei H, 1998, CANCER BIOTHER RADIO, V13, P185, DOI 10.1089/cbr.1998.13.185; Khanal P, 2012, ONCOGENE, V31, P3845, DOI 10.1038/onc.2011.548; Kim CJ, 2005, WORLD J GASTROENTERO, V11, P5006, DOI 10.3748/wjg.v11.i32.5006; Kuramochi J, 2006, J SURG ONCOL, V94, P155, DOI 10.1002/jso.20510; Lee KH, 2014, BBA-MOL CELL RES, V1843, P2055, DOI 10.1016/j.bbamcr.2014.06.001; Lim YS, 2011, J VIROL, V85, P8777, DOI 10.1128/JVI.02533-10; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; Lo KW, 2012, SEMIN CANCER BIOL, V22, P79, DOI 10.1016/j.semcancer.2011.12.011; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu Y, 2013, MOL BIOL REP, V40, P3777, DOI 10.1007/s11033-012-2454-6; Man CH, 2012, J PATHOL, V226, P471, DOI 10.1002/path.2997; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Misumi S, 2010, J BIOL CHEM, V285, P25185, DOI 10.1074/jbc.M110.114256; Narita Y, 2013, J VIROL, V87, P2120, DOI 10.1128/JVI.02634-12; Pak MW, 2002, HEAD NECK-J SCI SPEC, V24, P989, DOI 10.1002/hed.10161; Pang RW, 2006, J PATHOL, V210, P19, DOI 10.1002/path.2024; PATHMANATHAN R, 1995, AM J PATHOL, V146, P1355; Paulsen MT, 2005, TOXICOL APPL PHARM, V209, P1, DOI 10.1016/j.taap.2005.03.005; Rajbhandari P, 2012, MOL CELL BIOL, V32, P445, DOI 10.1128/MCB.06073-11; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Spence T, 2016, CHIN CLIN ONCOL, V5, DOI 10.21037/cco.2016.03.09; Tsang CM, 2012, P NATL ACAD SCI USA, V109, pE3473, DOI 10.1073/pnas.1202637109; Tsang YHN, 2013, ONCOGENE, V32, P1488, DOI 10.1038/onc.2012.178; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Watashi K, 2008, J VIROL, V82, P9928, DOI 10.1128/JVI.01017-08; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Zhivotovsky B, 2004, NAT REV MOL CELL BIO, V5, P752, DOI 10.1038/nrm1443; Zhou CX, 2006, ONCOL REP, V16, P505	48	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156833	10.1371/journal.pone.0156833	http://dx.doi.org/10.1371/journal.pone.0156833			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258148	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700142
J	de Stoppelaar, SF; Claushuis, TAM; Schaap, MCL; Hou, BD; van der Poll, T; Nieuwland, R; van't Veer, C				de Stoppelaar, Sacha F.; Claushuis, Theodora A. M.; Schaap, Marianne C. L.; Hou, Baidong; van der Poll, Tom; Nieuwland, Rienk; van't Veer, Cornelis			Toll-Like Receptor Signalling Is Not Involved in Platelet Response to Streptococcus pneumoniae In Vitro or In Vivo	PLOS ONE			English	Article							ACUTE LUNG INJURY; ORGAN DYSFUNCTION; ESCHERICHIA-COLI; ACTIVATION; LIPOPOLYSACCHARIDE; THROMBOCYTOPENIA; SEPSIS; BLOOD; TLR4; INFLAMMATION	Streptococcus (S.) pneumoniae strains vary considerably in their ability to cause invasive disease in humans, which is at least in part determined by the capsular serotype. Platelets have been implicated as sentinel cells in the circulation for host defence. One of their utensils for this function is the expression of Toll-like receptors (TLRs). We here aimed to investigate platelet response to S. pneumoniae and a role for TLRs herein. Platelets were stimulated using four serotypes of S. pneumonia including an unencapsulated mutant strain. In vitro aggregation and flow cytometry assays were performed using blood of healthy volunteers, or blood of TLR knock out and WT mice. For in vivo pneumonia experiments, platelet specific Myd88 knockout (Plt-Myd88(-/-)) mice were used. We found that platelet aggregation was induced by unencapsulated S. pneumoniae only. Whole blood incubation with all S. pneumoniae serotypes tested resulted in platelet degranulation and platelet-leukocyte complex formation. Platelet activation was TLR independent, as responses were not inhibited by TLR blocking antibodies, not induced by TLR agonists and were equally induced in wild-type and Tlr2(-/-), Tlr4(-/-), Tlr2/4(-/-), Tlr9(-/-) and Myd88(-/-) blood. Plt-Myd88(-/-) and control mice displayed no differences in bacterial clearance or immune response to pneumonia by unencapsulated S. pneumoniae. In conclusion, S. pneumoniae activates platelets through a TLR-independent mechanism that is impeded by the bacterial capsule. Additionally, platelet MyD88-dependent TLR signalling is not involved in host defence to unencapsulated S. pneumoniae in vivo.	[de Stoppelaar, Sacha F.; Claushuis, Theodora A. M.; van der Poll, Tom; van't Veer, Cornelis] Univ Amsterdam, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands; [de Stoppelaar, Sacha F.; Claushuis, Theodora A. M.; van der Poll, Tom; van't Veer, Cornelis] Univ Amsterdam, Ctr Expt & Mol Med CEMM, Amsterdam, Netherlands; [Schaap, Marianne C. L.; Nieuwland, Rienk] Univ Amsterdam, Lab Expt & Clin Chem LEKC, Amsterdam, Netherlands; [Hou, Baidong] Inst Biophys, Key Lab Infect & Immun, Beijing, Peoples R China; [van der Poll, Tom] Univ Amsterdam, Div Infect Dis, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Amsterdam	de Stoppelaar, SF (corresponding author), Univ Amsterdam, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands.	s.f.destoppelaar@amc.uva.nl	Nieuwland, Rienk/AAC-9591-2019	Hou, Baidong/0000-0002-0892-0181	AMC PhD Graduate School Scholarship	AMC PhD Graduate School Scholarship	This work was supported by the AMC PhD Graduate School Scholarship to SFS. Landsteiner Foundation for Blood Transfusion Research (LSBR 1351) for TAMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akca S, 2002, CRIT CARE MED, V30, P753, DOI 10.1097/00003246-200204000-00005; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Arman M, 2014, BLOOD, V123, P3166, DOI 10.1182/blood-2013-11-540526; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; BAUGHMAN RP, 1993, CHEST, V104, P1243, DOI 10.1378/chest.104.4.1243; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Blair P, 2009, CIRC RES, V104, P346, DOI 10.1161/CIRCRESAHA.108.185785; Bozza FA, 2009, AM J RESP CELL MOL, V40, P123, DOI 10.1165/rcmb.2008-0241TR; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Claushuis TA, 2016, BLOOD IN PRESS; Cognasse F, 2005, IMMUNOL CELL BIOL, V83, P196, DOI 10.1111/j.1440-1711.2005.01314.x; Cox D, 2011, J THROMB HAEMOST, V9, P1097, DOI 10.1111/j.1538-7836.2011.04264.x; de Stoppelaar SF, 2015, J THROMB HAEMOST, V13, P1709, DOI 10.1111/jth.13048; de Stoppelaar SF, 2014, BLOOD, V124, P3781, DOI 10.1182/blood-2014-05-573915; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; de Stoppelaar SF, 2013, THROMB HAEMOSTASIS, V110, P582, DOI 10.1160/TH13-01-0052; de Vos AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118181; Denes A, 2014, ANN NEUROL, V75, P670, DOI 10.1002/ana.24146; Fung CYE, 2012, BLOOD, V119, P3613, DOI 10.1182/blood-2011-10-386052; Gawaz M, 1997, INTENS CARE MED, V23, P379, DOI 10.1007/s001340050344; Goerge T, 2008, BLOOD, V111, P4958, DOI 10.1182/blood-2007-11-123620; Grommes J, 2012, AM J RESP CRIT CARE, V185, P628, DOI 10.1164/rccm.201108-1533OC; Hamzeh-Cognasse H, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00082; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Iovino F, 2014, INFECT IMMUN, V82, P3555, DOI 10.1128/IAI.00046-14; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kalvegren H, 2010, THROMB HAEMOSTASIS, V103, P398, DOI 10.1160/TH09-07-0442; Keane C, 2010, J THROMB HAEMOST, V8, P2757, DOI 10.1111/j.1538-7836.2010.04093.x; Kerrigan SW, 2010, CELL MOL LIFE SCI, V67, P513, DOI 10.1007/s00018-009-0207-z; Koupenova M, 2015, ARTERIOSCL THROM VAS, V35, P1030, DOI 10.1161/ATVBAHA.114.304954; Kraemer BF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002355; Lammers AJ, 2011, IMMUNOBIOLOGY, V216, P863, DOI 10.1016/j.imbio.2011.02.004; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lin YT, 2012, CURR GENOMICS, V13, P633, DOI 10.2174/138920212803759712; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Montrucchio G, 2003, THROMB HAEMOSTASIS, V90, P872, DOI 10.1160/TH03-02-0085; NIEUWENHUIS HK, 1987, BLOOD, V70, P838; Panigrahi S, 2013, CIRC RES, V112, P103, DOI 10.1161/CIRCRESAHA.112.274241; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Stahl AL, 2006, BLOOD, V108, P167, DOI 10.1182/blood-2005-08-3219; Stark RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041254; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; van den Boogaard F, 2015, CRITICAL CARE MED; van den Boogaard FE, 2015, CRIT CARE MED, V43, pE75, DOI 10.1097/CCM.0000000000000853; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; van 't Veer C, 2011, J BIOL CHEM, V286, P36603, DOI 10.1074/jbc.M110.189126; Ward JR, 2005, THROMB HAEMOSTASIS, V94, P831, DOI 10.1160/TH05-01-0009; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Wunderink RG, 2014, NEW ENGL J MED, V370, P543, DOI 10.1056/NEJMcp1214869; Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; Zhi HY, 2013, BLOOD, V121, P1858, DOI 10.1182/blood-2012-07-443325	62	27	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156977	10.1371/journal.pone.0156977	http://dx.doi.org/10.1371/journal.pone.0156977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253707	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700068
J	Tulloss, EM; Cadenasso, ML				Tulloss, Elise M.; Cadenasso, Mary L.			The Effect of Nitrogen Deposition on Plant Performance and Community Structure: Is It Life Stage Specific?	PLOS ONE			English	Article							QUERCUS-AGRIFOLIA; CRITICAL LOADS; COMPETITION; PATTERNS; NUTRIENT; WATER; ESTABLISHMENT; BIODIVERSITY; GERMINATION; GRASSLANDS	Nitrogen (N) deposition is a key global change factor that is increasing and affecting the structure and function of many ecosystems. To determine the influence of N deposition on specific systems, however, it is crucial to understand the temporal and spatial patterns of deposition as well as the response to that deposition. Response of the receiving plant communities may depend on the life stage-specific performance of individual species. We focus on the California oak savanna because N deposition to this system is complex-characterized by hotspots on the landscape and seasonal pulses. In a greenhouse experiment, we investigated the relative influence of N deposition on plant performance during early growth, peak biomass, and senescent life stages across different soil types, light, and community compositions. To represent the community we used three grass species-a native, naturalized exotic, and invasive exotic. At early growth and peak biomass stages performance was measured as height, and shoot and root biomass, and at the senescent stage as seed production. Simulated N deposition 1) increased shoot biomass and height of the native and, even more so, the naturalized exotic during early growth, 2) positively affected root biomass in all species during peak biomass, and 3) had no influence on seed production at the senescent stage. Alone, N deposition was not a strong driver of plant performance; however, small differences in performance among species in response to N deposition could affect community composition in future years. In particular, if there is a pulse of N deposition during the early growth stage, the naturalized exotic may have a competitive advantage that could result in its spread. Including spatial and temporal heterogeneity in a complex, manipulative experiment provides a clearer picture of not only where N management efforts should be targeted on the landscape, but also when.	[Tulloss, Elise M.; Cadenasso, Mary L.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Tulloss, Elise M.] La Salle High Sch, Yakima, WA USA	University of California System; University of California Davis	Tulloss, EM (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Tulloss, EM (corresponding author), La Salle High Sch, Yakima, WA USA.	emtulloss@ucdavis.edu			Jastro Shields Scholarship from the College of Agriculture and Environmental Sciences, University of California Davis; Department of Plant Sciences, University of California Davis	Jastro Shields Scholarship from the College of Agriculture and Environmental Sciences, University of California Davis; Department of Plant Sciences, University of California Davis(University of California System)	This work was supported by Jastro Shields Scholarship from the College of Agriculture and Environmental Sciences, University of California Davis (EMT); Department of Plant Sciences, University of California Davis (MLC). The authors received no specific funding for this work.	Abraham JK, 2009, HERBACEOUS PLANT ECOLOGY: RECENT ADVANCES IN PLANT ECOLOGY, P81, DOI 10.1007/978-90-481-2798-6_7; Allen-Diaz B, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P313; Arnon DI, 347 U CAL COLL AGR C; Austin AT, 2004, OECOLOGIA, V141, P221, DOI 10.1007/s00442-004-1519-1; Bartolome JW, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P367; BARTOLOME JW, 1979, J ECOL, V67, P273, DOI 10.2307/2259350; Bilbrough CJ, 1997, ECOLOGY, V78, P231; Bobbink R, 1995, WATER AIR SOIL POLL, V85, P2413, DOI 10.1007/BF01186195; Brown CS, 2000, RESTOR ECOL, V8, P10, DOI 10.1046/j.1526-100x.2000.80003.x; CALLAWAY RM, 1991, PLANT SOIL, V137, P209, DOI 10.1007/BF00011199; DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2; Dukes J. S., 2007, CALIFORNIA GRASSLAND, P218; Dupre C, 2010, GLOBAL CHANGE BIOL, V16, P344, DOI 10.1111/j.1365-2486.2009.01982.x; Dyer AR, 1997, ECOL APPL, V7, P484, DOI 10.1890/1051-0761(1997)007[0484:IADCTR]2.0.CO;2; Fenn ME, 2010, J ENVIRON MANAGE, V91, P2404, DOI 10.1016/j.jenvman.2010.07.034; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; Garcia-Palacios P, 2012, J ECOL, V100, P1303, DOI 10.1111/j.1365-2745.2012.02014.x; Going BM, 2009, OECOLOGIA, V159, P839, DOI 10.1007/s00442-008-1264-y; Goldberg DE, 2001, ECOL MONOGR, V71, P423, DOI 10.1890/0012-9615(2001)071[0423:DDIAAP]2.0.CO;2; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Harpole WS., 2007, CALIFORNIA GRASSLAND; Holmes TH, 1996, ANN BOT-LONDON, V78, P233, DOI 10.1006/anbo.1996.0117; HUENNEKE LF, 1990, ECOLOGY, V71, P478, DOI 10.2307/1940302; JACKSON LE, 1988, PLANT SOIL, V110, P9, DOI 10.1007/BF02143533; Jackson LE., 2007, CALIFORNIA GRASSLAND; James JJ, 2011, ECOL APPL, V21, P490, DOI 10.1890/10-0280.1; KELLMAN M, 1979, J ECOL, V67, P565, DOI 10.2307/2259112; Leger EA, 2010, PLANT ECOL, V208, P333, DOI 10.1007/s11258-009-9710-4; MARANON T, 1993, J ECOL, V81, P673, DOI 10.2307/2261665; Marchant R, 2010, CURR OPIN ENV SUST, V2, P101, DOI 10.1016/j.cosust.2010.03.001; Ochoa-Hueso R, 2011, ENVIRON POLLUT, V159, P2265, DOI 10.1016/j.envpol.2010.12.019; Pardo LH, 2011, ECOL APPL, V21, P3049, DOI 10.1890/10-2341.1; PARKER VT, 1982, AM MIDL NAT, V107, P69, DOI 10.2307/2425189; Phoenix GK, 2006, GLOBAL CHANGE BIOL, V12, P470, DOI 10.1111/j.1365-2486.2006.01104.x; Rice KJ, 2000, AM J BOT, V87, P1699, DOI 10.2307/2656747; Scheiner S., 2001, DESIGN ANAL ECOLOGIC; SCHWARTZ SE, 1989, SCIENCE, V243, P753, DOI 10.1126/science.243.4892.753; Smith MD, 2001, INT J PLANT SCI, V162, P785, DOI 10.1086/320774; Sobota DJ, 2013, FRONT ECOL ENVIRON, V11, P82, DOI 10.1890/110216; Stamps RH, 2009, HORTSCIENCE, V44, P239, DOI 10.21273/HORTSCI.44.2.239; Tulloss EM, 2016, PLANT ECOL, V217, P43, DOI 10.1007/s11258-015-0558-5; Tulloss EM, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00440.1; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; USEPA, 2010, EPA454 RES TRIANGL P; Vallano DM, 2012, PLANT ECOL, V213, P1015, DOI 10.1007/s11258-012-0061-1; Weathers KC, 2000, ECOL APPL, V10, P528, DOI 10.1890/1051-0761(2000)010[0528:TEOLFO]2.0.CO;2; Weathers KC, 2001, CONSERV BIOL, V15, P1506, DOI 10.1046/j.1523-1739.2001.01090.x; Weiss SB, 1999, CONSERV BIOL, V13, P1476, DOI 10.1046/j.1523-1739.1999.98468.x; Wigand PE., 2007, CALIFORNIA GRASSLAND, P37; YOUNG JA, 1992, GREAT BASIN NAT, V52, P245	50	13	13	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156685	10.1371/journal.pone.0156685	http://dx.doi.org/10.1371/journal.pone.0156685			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253718	Green Submitted, gold, Green Published			2022-12-26	WOS:000377218700050
J	Urrutia, O; Mendizabal, JA; Insausti, K; Soret, B; Purroy, A; Arana, A				Urrutia, Olaia; Antonio Mendizabal, Jose; Insausti, Kizkitza; Soret, Beatriz; Purroy, Antonio; Arana, Ana			Effects of Addition of Linseed and Marine Algae to the Diet on Adipose Tissue Development, Fatty Acid Profile, Lipogenic Gene Expression, and Meat Quality in Lambs	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; FISH-OIL; RUMEN BIOHYDROGENATION; SEMITENDINOUS MUSCLE; CARCASS COMPOSITION; GROWTH-PERFORMANCE; INTRAMUSCULAR FAT; ENERGY-METABOLISM; LIPID-METABOLISM; FEEDING SYSTEM	This study examined the effect of linseed and algae on growth and carcass parameters, adipocyte cellularity, fatty acid profile and meat quality and gene expression in subcutaneous and intramuscular adipose tissues (AT) in lambs. After weaning, 33 lambs were fed three diets up to 26.7 +/- 0.3 kg: Control diet (barley and soybean); L diet (barley, soybean and 10% linseed) and L-A diet (barley, soybean, 5% linseed and 3.89% algae). Lambs fed L-A diet showed lower average daily gain and greater slaughter age compared to Control and L (P < 0.001). Carcass traits were not affected by L and L-A diets, but a trend towards greater adipocyte diameter was observed in L and L-A in the subcutaneous AT (P = 0.057). Adding either linseed or linseed and algae increased a-linolenic acid and eicosapentaenoic acid contents in both AT (P < 0.001); however, docosahexaenoic acid was increased by L-A (P < 0.001). The n-6/n-3 ratio decreased in L and L-A (P < 0.001). Algae had adverse effects on meat quality, with greater lipid oxidation and reduced ratings for odor and flavor. The expression of lipogenic genes was downregulated in the subcutaneous AT (P < 0.05): acetyl-CoA carboxylase 1 (ACACA) in L and L-A and lipoprotein lipase (LPL) and stearoyl-CoA desaturase (SCD) in L-A. Fatty acid desaturase 1 (FADS1), fatty acid desaturase 2 (FADS2) and fatty acid elongase 5 (ELOVL5) were unaffected. In the subcutaneous AT, supplementing either L or L-A increased peroxisome proliferator-activated receptor gamma (PPARG) and CAAT-enhancer binding protein alpha (CEBPA) (P < 0.05), although it had no effect on sterol regulatory element-binding factor 1 (SREBF1). In the intramuscular AT, expression of ACACA, SCD, FADS1 and FADS2 decreased in L and L-A (P < 0.001) and LPL in L (P < 0.01), but PPARG, CEBPA and SREBF1 were unaffected.	[Urrutia, Olaia; Antonio Mendizabal, Jose; Insausti, Kizkitza; Soret, Beatriz; Purroy, Antonio; Arana, Ana] Univ Publ Navarra, Dept Prod Agr, Escuela Super Ingenieros Agronomos, Pamplona, Spain	Universidad Publica de Navarra	Arana, A (corresponding author), Univ Publ Navarra, Dept Prod Agr, Escuela Super Ingenieros Agronomos, Pamplona, Spain.	aarana@unavarra.es	Urrutia, Olaia/K-8281-2017; Insausti, Kizkitza/AAH-8956-2021; Soret, Beatriz/L-5776-2014; Mendizabal, José Antonio/F-9844-2014	Urrutia, Olaia/0000-0003-4701-4314; Insausti, Kizkitza/0000-0002-3821-814X; Mendizabal, José Antonio/0000-0003-1316-4293; Soret, Beatriz/0000-0001-9214-8595				Anderson BM, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-33; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; ASHES JR, 1992, LIPIDS, V27, P629, DOI 10.1007/BF02536122; Atti N., 2007, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P57; Atti N, 2013, J APPL ANIM RES, V41, P404, DOI 10.1080/09712119.2013.792730; Berthelot V, 2010, MEAT SCI, V84, P114, DOI 10.1016/j.meatsci.2009.08.034; Boeckaert C, 2007, EUR J LIPID SCI TECH, V109, P767, DOI 10.1002/ejlt.200700052; Boque N, 2009, J PHYSIOL BIOCHEM, V65, P387, DOI 10.1007/BF03185934; Brenner R., 1989, R FACTORS INFLUENCIN, VVolume 1989, P45; British Department of Health, 1994, NUTR ASP CARD DIS; Cant JP, 1997, CAN J ANIM SCI, V77, P125, DOI 10.4141/A95-125; COLOMER-ROCHER F., 1988, METODO NORMALIZADO E, P19; Corazzin M, 2013, J ANIM SCI, V91, P405, DOI 10.2527/jas.2011-5057; de la Fuente-Vazquez J, 2014, SPAN J AGRIC RES, V12, P436, DOI 10.5424/sjar/2014122-4639; Dervishi E, 2011, MEAT SCI, V89, P91, DOI 10.1016/j.meatsci.2011.04.003; Dervishi E, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-40; Dodson MV, 2010, INT J BIOL SCI, V6, P691; Duckett SK, 2009, J ANIM SCI, V87, P1120, DOI 10.2527/jas.2008-1420; Ebrahimi M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/194625; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Flint D, 1993, VERTEBRATE ENDOCRINO, P469; Graugnard DE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-142; Griinari JM, 1999, ADVANCES IN CONJUGATED LINOLEIC ACID RESEARCH, VOL 1, P180; Hausman GJ, 2009, J ANIM SCI, V87, P1218, DOI 10.2527/jas.2008-1427; Herdmann A, 2010, ANIMAL, V4, P755, DOI 10.1017/S1751731110000431; Hiller B, 2011, LIPIDS, V46, P557, DOI 10.1007/s11745-011-3571-z; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Hopkins DL, 2014, MEAT SCI, V98, P135, DOI 10.1016/j.meatsci.2014.05.016; Huang FR, 2008, LIVEST SCI, V118, P132, DOI 10.1016/j.livsci.2008.01.002; Jenkins TC, 2008, J ANIM SCI, V86, P397, DOI 10.2527/jas.2007-0588; Jing M, 2013, PROSTAG LEUKOTR ESS, V89, P107, DOI 10.1016/j.plefa.2013.05.006; Juarez M, 2008, MEAT SCI, V79, P203, DOI 10.1016/j.meatsci.2007.08.014; Juarez M, 2010, MEAT SCI, V84, P578, DOI 10.1016/j.meatsci.2009.10.015; Klein CM, 2011, J DAIRY SCI, V94, P4676, DOI 10.3168/jds.2011-4344; Kouba M, 2011, BIOCHIMIE, V93, P13, DOI 10.1016/j.biochi.2010.02.027; Kronberg SL, 2006, LIPIDS, V41, P1059, DOI 10.1007/s11745-006-5056-z; Lourenco M, 2010, ANIMAL, V4, P1008, DOI 10.1017/S175173111000042X; Meale SJ, 2014, J ANIM SCI, V92, P2202, DOI 10.2527/jas.2013-7024; Mendizabal J., 2005, INIA SER GANAD, V3, P251; Mendizabal JA, 2004, SMALL RUMINANT RES, V53, P173, DOI 10.1016/j.smallrumres.2003.09.004; Mendizabal JA, 1997, ANIM SCI, V64, P283, DOI 10.1017/S135772980001585X; Mourot J., 2014, Journees de la Recherche Porcine en France, V46, P55; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Nassu RT, 2011, MEAT SCI, V89, P469, DOI 10.1016/j.meatsci.2011.05.016; Noci F, 2007, J ANIM SCI, V85, P1062, DOI 10.2527/jas.2006-105; Nute GR, 2007, MEAT SCI, V77, P547, DOI 10.1016/j.meatsci.2007.05.003; Overland M, 1996, ACTA AGR SCAND A-AN, V46, P11, DOI 10.1080/09064709609410919; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pickworth CL, 2011, J ANIM SCI, V89, P355, DOI 10.2527/jas.2010-3229; Raes K, 2004, ANIM FEED SCI TECH, V113, P199, DOI 10.1016/j.anifeedsci.2003.09.001; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; ROBELIN J, 1986, LIVEST PROD SCI, V14, P349, DOI 10.1016/0301-6226(86)90014-X; RODBELL M, 1964, J BIOL CHEM, V239, P375; Sardi L, 2006, LIVEST SCI, V103, P95, DOI 10.1016/j.livsci.2006.01.009; Schoonmaker JP, 2004, J ANIM SCI, V82, P137; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; SMITH SB, 1987, J ANIM SCI, V65, P1525, DOI 10.2527/jas1987.6561525x; Sul HS, 2013, BIOCH PHYSL MOL ASPE, P357; TARLADGIS BG, 1960, J AM OIL CHEM SOC, V37, P44, DOI 10.1007/BF02630824; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Urrutia O, 2015, SMALL RUMINANT RES, V123, P204, DOI 10.1016/j.smallrumres.2014.12.008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vatansever L, 2000, ANIM SCI, V71, P471, DOI 10.1017/S135772980005548X; VERNON R G, 1980, Progress in Lipid Research, V19, P23, DOI 10.1016/0163-7827(80)90007-7; Wachira AM, 2002, BRIT J NUTR, V88, P697, DOI 10.1079/BJN2002727; Wachira AM, 2000, J AGR SCI, V135, P419, DOI 10.1017/S0021859699008370; Waters SM, 2009, J ANIM SCI, V87, P244, DOI 10.2527/jas.2008-1005; WHITTINGTON FM, 1986, J SCI FOOD AGR, V37, P753, DOI 10.1002/jsfa.2740370807; Woods VB, 2009, LIVEST SCI, V126, P1, DOI 10.1016/j.livsci.2009.07.002; YIN MC, 1993, J AGR FOOD CHEM, V41, P853, DOI 10.1021/jf00030a002	71	39	43	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156765	10.1371/journal.pone.0156765	http://dx.doi.org/10.1371/journal.pone.0156765			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253325	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700056
J	Flahault, A; Metzger, M; Chasse, JF; Haymann, JP; Boffa, JJ; Flamant, M; Vrtovsnik, F; Houillier, P; Stengel, B; Thervet, E; Pallet, N				Flahault, Adrien; Metzger, Marie; Chasse, Jean-Francois; Haymann, Jean-Philippe; Boffa, Jean-Jacques; Flamant, Martin; Vrtovsnik, Francois; Houillier, Pascal; Stengel, Benedicte; Thervet, Eric; Pallet, Nicolas		NephroTest Study Grp	Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; MUSCLE MASS; URINARY CREATININE; ENZYME-ACTIVITIES; SKELETAL-MUSCLE; BLOOD-PRESSURE; RENAL-FUNCTION; CYSTATIN-C; PHOSPHOKINASE; EXERCISE	Background Serum creatine kinase (sCK) reflects CK activity from striated skeletal muscle. Muscle wasting is a risk factor for mortality in patients with chronic kidney disease (CKD). The aim of this study is to evaluate whether sCK is a predictor of mortality and end-stage renal disease (ESRD) in a CKD population. Methods We included 1801 non-dialysis-dependent CKD patients from the NephroTest cohort. We used time-fixed and time-dependent cause-specific Cox models to estimate hazard ratios (HRs) for the risk of death and for the risk of ESRD associated with gender-specific sCK tertiles. Results Higher sCK level at baseline was associated with a lower age, a higher body mass index, and a higher level of 24 h urinary creatinine excretion, serum albumin and prealbumin (p<0.001). Men, patients of sub-Saharan ancestry, smokers and statin users also experienced a higher level of sCK. In a time-fixed Cox survival model (median follow-up 6.0 years), the lowest gender-specific sCK tertile was associated with a higher risk of death before and after adjustment for confounders (Crude model: hazard ratio (HR) 1.77 (95% CI: 1.34-2.32) compared to the highest tertile; fully-adjusted model: HR 1.37 (95% CI: 1.02-1.86)). Similar results were obtained with a time-dependent Cox model. The sCK level was not associated with the risk of ESRD. Conclusion A low level of sCK is associated with an increased risk of death in a CKD population. sCK levels might reflect muscle mass and nutritional status.	[Flahault, Adrien; Thervet, Eric] Hop Europeen Georges Pompidou, AP HP, Serv Nephrol, Paris, France; [Metzger, Marie; Stengel, Benedicte] INSERM, UMRS 1018, CESP Team Renal & Cardiovasc Epidemiol 5, Villejuif, France; [Chasse, Jean-Francois; Thervet, Eric; Pallet, Nicolas] Paris Descartes Univ, Paris, France; [Chasse, Jean-Francois; Thervet, Eric; Pallet, Nicolas] Sorbonne Paris Cite, Paris, France; [Chasse, Jean-Francois; Pallet, Nicolas] Hop Europeen Georges Pompidou, AP HP, Clin Chem, Paris, France; [Haymann, Jean-Philippe] Univ Paris 06, INSERM, U702, Paris, France; [Haymann, Jean-Philippe] Hop Tenon, AP HP, Serv Explorat Fonct, F-75970 Paris, France; [Boffa, Jean-Jacques] Hop Tenon, AP HP, Serv Nephrol, F-75970 Paris, France; [Flamant, Martin] Hop Bichat Claude Bernard, AP HP, Serv Physiol, F-75877 Paris, France; [Vrtovsnik, Francois] Hop Bichat Claude Bernard, AP HP, Serv Nephrol, F-75877 Paris, France; [Houillier, Pascal] Hop Europeen Georges Pompidou, AP HP, Serv Explorat Fonct, Paris, France; [Flahault, Adrien] Coll France, INSERM, Lab Cent Neuropeptides Regulat Body Fluid Homeost, CIRB,U1050, U114, F-75231 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Pallet, N (corresponding author), Paris Descartes Univ, Paris, France.; Pallet, N (corresponding author), Sorbonne Paris Cite, Paris, France.; Pallet, N (corresponding author), Hop Europeen Georges Pompidou, AP HP, Clin Chem, Paris, France.	npallet@yahoo.fr	Houillier, Pascal/AAD-4903-2019; Stengel, Benedicte/G-5730-2015; Flahault, Adrien/Q-4576-2017; Metzger, Marie/K-9772-2018	Houillier, Pascal/0000-0003-4953-6917; Stengel, Benedicte/0000-0001-9469-0804; Flahault, Adrien/0000-0003-4632-6332; Metzger, Marie/0000-0003-3597-5409; Pallet, Nicolas/0000-0002-8486-3596; Vrtovsnik, Francois/0000-0003-1554-314X	INSERM GIS-IReSP [AO 8113LS TGIR]; French Ministry of Health [AOM 09114]; INSERM [AO 8022LS]; Agence de la Biomedecine [R0 8156LL]; AURA; Roche [2009-152-447G]	INSERM GIS-IReSP; French Ministry of Health; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence de la Biomedecine; AURA; Roche(Roche Holding)	The NephroTest CKD cohort study is supported by the following grants: INSERM GIS-IReSP AO 8113LS TGIR, French Ministry of Health AOM 09114, INSERM AO 8022LS, Agence de la Biomedecine R0 8156LL, AURA and Roche 2009-152-447G.	Amir KA, 2009, AM J MED SCI, V338, P353, DOI 10.1097/MAJ.0b013e3181b1226a; Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Beddhu S, 2009, CLIN J AM SOC NEPHRO, V4, P1901, DOI 10.2215/CJN.01970309; BHATLA B, 1995, ASAIO J, V41, pM442, DOI 10.1097/00002480-199507000-00048; BORGES O, 1989, ACTA PHYSIOL SCAND, V136, P29, DOI 10.1111/j.1748-1716.1989.tb08626.x; Brancaccio P, 2007, BRIT MED BULL, V81-82, P209, DOI 10.1093/bmb/ldm014; Clarkson PM, 2006, MED SCI SPORT EXER, V38, P623, DOI 10.1249/01.mss.0000210192.49210.fc; EPSTEIN Y, 1995, ISRAEL J MED SCI, V31, P698; Fallon KE, 1999, BRIT J SPORT MED, V33, P264, DOI 10.1136/bjsm.33.4.264; Foley RN, 2007, AM J NEPHROL, V27, P279, DOI 10.1159/000101827; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Fu FH, 2002, PERCEPT MOTOR SKILL, V95, P1171, DOI 10.2466/PMS.95.7.1171-1178; HESS JW, 1964, ANN INTERN MED, V61, P1015, DOI 10.7326/0003-4819-61-6-1015; HORDER M, 1991, EUR J CLIN CHEM CLIN, V29, P435; HORTOBAGYI T, 1989, INT J SPORTS MED, V10, P69, DOI 10.1055/s-2007-1024878; Isoyama N, 2014, CLIN J AM SOC NEPHRO, V9, P1720, DOI 10.2215/CJN.10261013; Johnsen SH, 2014, J CLIN HYPERTENS, V16, P820, DOI 10.1111/jch.12422; Johnsen SH, 2011, J HYPERTENS, V29, P36, DOI 10.1097/HJH.0b013e32834068e0; Kaya S, 2014, MIKROBIYOL BUL, V48, P179; Keltz Eran, 2013, Muscles Ligaments Tendons J, V3, P303; Kenney K, 2012, MUSCLE NERVE, V45, P356, DOI 10.1002/mus.22317; KOUTEDAKIS Y, 1993, J SPORT MED PHYS FIT, V33, P252; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Macdonald JH, 2006, NEPHROL DIAL TRANSPL, V21, P3488, DOI 10.1093/ndt/gfl430; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NOAKES TD, 1987, SPORTS MED, V4, P245, DOI 10.2165/00007256-198704040-00003; Proctor DN, 1999, AM J PHYSIOL-ENDOC M, V277, pE489, DOI 10.1152/ajpendo.1999.277.3.E489; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Sowards KJ, 2014, INJURY, V45, P2096, DOI 10.1016/j.injury.2014.09.009; Stollwerck PL, 2011, BURNS, V37, P240, DOI 10.1016/j.burns.2010.09.009; SWAMINATHAN R, 1988, ANN CLIN BIOCHEM, V25, P389, DOI 10.1177/000456328802500411; Tynkevich E, 2015, NEPHROL DIAL TRANSPL, V30, P1386, DOI 10.1093/ndt/gfv047; Tynkevich E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111949; Uchida K, 2002, CLIN CHIM ACTA, V323, P121, DOI 10.1016/S0009-8981(02)00177-8; Wilson FP, 2014, CLIN J AM SOC NEPHRO, V9, P2095, DOI 10.2215/CJN.03790414; WONG ET, 1983, AM J CLIN PATHOL, V79, P582, DOI 10.1093/ajcp/79.5.582	37	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156433	10.1371/journal.pone.0156433	http://dx.doi.org/10.1371/journal.pone.0156433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248151	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700044
J	Lu, JC; Kundrat, M; Shen, C				Lu, Junchang; Kundrat, Martin; Shen, Caizhi			New Material of the Pterosaur Gladocephaloideus Lu et al., 2012 from the Early Cretaceous of Liaoning Province, China, with Comments on Its Systematic Position	PLOS ONE			English	Article							YIXIAN FORMATION; PTERODACTYLOIDEA; BONE	Although there are nine genera of ctenochasmatoids reported from the Jehol Biota, at present each is known from a specimen that has either a skull or a relatively complete postcranial skeleton. A nearly complete juvenile specimen of Gladocephaloideus from the Lower Cretaceous Jiufotang Formation of Sihedang, Lingyuan of Liaoning Province is the most complete ctenochasmatoid preserved to date with a skull and postcranial skeleton. Based on the holotype (IG-CAGS 08-07) and the nearly complete new specimen (JPM 2014-004), the diagnosis of Gladocephaloideus is amended: approximately 50 teeth in total with sharp tips; small nasoantorbital opening, occupying approximately 13% of total skull length; ratio of prenarial rostrum length to skull length approximately 0.63; deep groove along the mid-line of the mandibular symphysis; length to width ratio of the longest cervical vertebra = 4.1; ratio of femur length to tibia length = 0.61; tibia as long as the wing-phalange 1. Phylogenetic analysis recovers Gladocephaloideus within the clade Ctenochasmatidae. Gladocephaloideus has a closer relationship to the Chinese Pterofiltrus rather than to other ctenochasmatid pterosaurs. Microstructure of limb bones implies that JPM 2014-004 represents an early juvenile of Gladocephaloideus jingangshanensis, and that the type specimen is not a fully grown specimen either. We assume that the holotype may equate to the late juvenile or sub-adult developmental stage of Gladocephaloideus.	[Lu, Junchang; Shen, Caizhi] Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China; [Lu, Junchang] Minist Land & Resources, Key Lab Stratig & Paleontol, Beijing, Peoples R China; [Kundrat, Martin] Comenius Univ, Fac Nat Sci, Dept Ecol, Bratislava, Slovakia; [Kundrat, Martin] Safarik Univ, Fac Sci, Ctr Interdisciplinary Biosci, Kosice, Slovakia	Chinese Academy of Geological Sciences; Ministry of Natural Resources of the People's Republic of China; Comenius University Bratislava; University of Pavol Jozef Safarik Kosice	Lu, JC (corresponding author), Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China.; Lu, JC (corresponding author), Minist Land & Resources, Key Lab Stratig & Paleontol, Beijing, Peoples R China.	Lujc2008@126.com	Kundrát, Martin/F-4959-2017	Kundrát, Martin/0000-0001-9361-2273	National Natural Science Foundation of China [41272022]; Fundamental Research Funds for Chinese Academy of Geological Sciences [JB1504]; China Geological Survey [12120114026801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Chinese Academy of Geological Sciences; China Geological Survey(China Geological Survey)	This study was supported by the National Natural Science Foundation of China (No. 41272022), the Fundamental Research Funds for the Chinese Academy of Geological Sciences (No. JB1504), and the project from the China Geological Survey (No. 12120114026801) to Junchang Lu.; We thank Drs. Dale Winkler (Southern Methodist University, Dallas, TX, USA) and David W. E. Hone (Queen Mary University of London, UK) for providing careful comments on the earlier version of the MS. Mr. Zhang Yuqing prepared the specimen. This study was supported by the National Natural Science Foundation of China (No. 41272022), the Fundamental Research Funds for the Chinese Academy of Geological Sciences (No. JB1504), and the project from the China Geological Survey (No. 12120114026801) to Junchang Lu.	Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; Bennett SC, 2003, PALAEONTOLOGY, V46, P185, DOI 10.1111/1475-4983.00293; Chinsamy A, 2008, BIOL LETTERS, V4, P282, DOI 10.1098/rsbl.2008.0004; Francillon-Vieillot H., 1990, P471; Goloboff P, 2008, CLADISTICS, V24, P91; Ji S.-A., 1997, ACT GEOL SIN, V71, P1; Jiang Shun-Xing, 2011, Vertebrata Palasiatica, V49, P172; Jiang SX, 2011, AN ACAD BRAS CIENC, V83, P1243, DOI 10.1590/S0001-37652011000400011; Kaup J, 1834, ISIS, V3, P311; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Liaoning Provincial Institute of Geological Exploration, 2015, EV REP FOSS RE UNPUB; Lu Jun-Chang, 2003, Memoir of the Fukui Prefectural Dinosaur Museum, V2, P153; Lu JC, 2012, ACTA GEOL SIN-ENGL, V86, P287, DOI 10.1111/j.1755-6724.2012.00658.x; Lu JC, 2012, CRETACEOUS RES, V34, P26, DOI 10.1016/j.cretres.2011.09.010; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; PADIAN K, 1995, CR ACAD SCI II, V320, P77; Plieninger F, PALAEONTOLOGICA, V190, P65; Sayao JM, 2000, J VERTEBR PALEONTOL, V20, P67; Steel Lorna, 2008, Zitteliana Reihe B, V28, P109; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Unwin David M., 1995, P69; Wang XL, 2007, CRETACEOUS RES, V28, P245, DOI 10.1016/j.cretres.2006.08.004; Wang Xiaolin, 2006, P665; Wang XL, 2012, NATURWISSENSCHAFTEN, V99, P249, DOI 10.1007/s00114-012-0889-1; Wang XL, 2005, NATURE, V437, P875, DOI 10.1038/nature03982; Zhou CF, 2010, NEUES JAHRB GEOL P-A, V255, P277, DOI 10.1127/0077-7749/2009/0022	27	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0154888	10.1371/journal.pone.0154888	http://dx.doi.org/10.1371/journal.pone.0154888			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249021	Green Published, gold, Green Submitted			2022-12-26	WOS:000377184700008
J	Kumar, AMV; Gupta, D; Kumar, A; Gupta, RS; Kanchar, A; Rao, R; Shastri, S; Suryakanth, MD; Rangaraju, C; Naik, B; Guddemane, DK; Bhat, P; Nair, AS; Harries, AD; Dewan, P				Kumar, Ajay M. V.; Gupta, Devesh; Kumar, Ashok; Gupta, R. S.; Kanchar, Avinash; Rao, Raghuram; Shastri, Suresh; Suryakanth, M. D.; Rangaraju, Chethana; Naik, Balaji; Guddemane, Deepak K.; Bhat, Prashant; Nair, Achuthan Sreenivas; Harries, Anthony David; Dewan, Puneet			HIV Testing among Patients with Presumptive Tuberculosis: How Do We Implement in a Routine Programmatic Setting? Results of a Large Operational Research from India	PLOS ONE			English	Article							SUSPECTS	Background In March 2012, World Health Organization recommended that HIV testing should be offered to all patients with presumptive TB (previously called TB suspects). How this is best implemented and monitored in routine health care settings in India was not known. An operational research was conducted in Karnataka State (South India, population 64 million, accounts for 10% of India's HIV burden), to test processes and learn results and challenges of screening presumptive TB patients for HIV within routine health care settings. Methods In this cross-sectional study conducted between January-March 2012, all presumptive TB patients attending public sector sputum microscopy centres state-wide were offered HIV testing by the laboratory technician, and referred to the nearest public sector HIV counselling and testing services, usually within the same facility. The HIV status of the patients was recorded in the routine TB laboratory form and TB laboratory register. The laboratory register was compiled to obtain the number of presumptive TB patients whose HIV status was ascertained, and the number found HIV positive. Aggregate data on reasons for non-testing were compiled at district level. Results Overall, 115,308 patients with presumptive TB were examined for sputum smear microscopy at 645 microscopy centres state-wide. Of these, HIV status was ascertained for 62,847(55%) among whom 7,559(12%) were HIV-positive, and of these, 3,034(40%) were newly diagnosed. Reasons for non-testing were reported for 37,700(72%) of the 52,461 patients without HIV testing; non-availability of testing services at site of sputum collection was cited by health staff in 54% of respondents. Only 4% of patients opted out of HIV testing. Conclusion Offering HIV testing routinely to presumptive TB patients detected large numbers of previously-undetected instances of HIV infection. Several operational challenges were noted which provide useful lessons for improving uptake of HIV testing in this important group.	[Kumar, Ajay M. V.] Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India; [Gupta, Devesh; Kumar, Ashok; Gupta, R. S.] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India; [Kumar, Ashok; Gupta, R. S.; Kanchar, Avinash; Rao, Raghuram] Govt India, Minist Hlth & Family Welf, Natl AIDS Control Org, New Delhi, India; [Kanchar, Avinash] WHO, CH-1211 Geneva, Switzerland; [Shastri, Suresh; Suryakanth, M. D.] Directorate Hlth Serv, State TB Cell, Bangalore, Karnataka, India; [Rangaraju, Chethana] Karnataka State AIDS Prevent & Control Soc, Bangalore, Karnataka, India; [Naik, Balaji; Guddemane, Deepak K.; Bhat, Prashant; Nair, Achuthan Sreenivas] World Hlth Org Country Off India, New Delhi, India; [Harries, Anthony David] Int Union TB & Lung Dis Union, Paris, France; [Harries, Anthony David] London Sch Hyg & Trop Med, London WC1, England; [Dewan, Puneet] Bill & Melinda Gates Fdn, New Delhi, India	World Health Organization; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Kumar, AMV (corresponding author), Int Union TB & Lung Dis Union, South East Asia Reg Off, New Delhi, India.	akumar@theunion.org	Bhat, Prashant G/H-6696-2012	Bhat, Prashant G/0000-0002-2130-210X; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Nair, Sreenivas/0000-0002-2586-6797	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Achanta S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041378; Adjei A A, 2006, West Afr J Med, V25, P38; Central TB Division, 2005, TECHN OP GUID TUB CO; Central TB Division Ministry of Health and Family Welfare, 2011, REV NAT TB CONTR PRO; Deribew A, 2010, INT J TUBERC LUNG D, V14, P1442; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; Dlodlo RA, 2015, PUBLIC HEALTH ACTION, V5, P217, DOI 10.5588/pha.15.0036; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Joint United Nations Programme on HIV/AIDS, 2014, AMB TREATM TARG HELP, DOI [10.7448/IAS.16.4.18751, DOI 10.7448/IAS.16.4.18751]; Kumar AMV, 2013, PUBLIC HEALTH ACTION, V3, P60, DOI 10.5588/pha.13.0004; Kumar AMV, 2017, J EPIDEMIOL GLOB HEA, V7, P11, DOI 10.1016/j.jegh.2015.12.002; Munthali L, 2006, INT J TUBERC LUNG D, V10, P199; Naik B, 2012, JAIDS-J ACQ IMM DEF, V59, pE72, DOI 10.1097/QAI.0b013e318245c9df; *NAT AIDS CONTR OR, 2013, TECHN REP IND HIV ES; National AIDS Control Organization, 2008, OP GUID INT COUNS TE; National AIDS Control Organization, 2014, GHUL NAB AZ LAUNCH N; National AIDS Control Organization and Central TB Division, 2009, NAT FRAM JOINT HIV T; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Ofice of the Registrar General and Census Commissioner, 2011, 12011 OFF REG GEN CE; Porskrog A, 2011, INT J TUBERC LUNG D, V15, P459, DOI 10.5588/ijtld.10.0353; Srikantiah P, 2007, INT J TUBERC LUNG D, V11, P168; STOP TB Partnership, GLOB PLAN STOP TB 20; UNAIDS, 2015, AIDS CHANG EV MDG6 1; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2012, WHOHTMTB20121; World Health Organization, 2014, WHOHTMTB201408	27	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156487	10.1371/journal.pone.0156487	http://dx.doi.org/10.1371/journal.pone.0156487			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244055	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000377146100042
J	Sagebakken, G; Ahnesjo, I; Kvarnemo, C				Sagebakken, Gry; Ahnesjo, Ingrid; Kvarnemo, Charlotta			Costs and Benefits to Pregnant Male Pipefish Caring for Broods of Different Sizes	PLOS ONE			English	Article							ROLE REVERSED PIPEFISH; FILIAL CANNIBALISM; REPRODUCTIVE SUCCESS; PARENTAL EFFORT; CLUTCH-SIZE; ICTALURUS-PUNCTATUS; CHANNEL CATFISH; MATE CHOICE; SYNGNATHIDAE; CARE	Trade-offs between brood size and offspring size, offspring survival, parental condition or parental survival are classic assumptions in life history biology. A reduction in brood size may lessen these costs of care, but offspring mortality can also result in an energetic gain, if parents are able to utilize the nutrients from the demised young. Males of the broad-nosed pipefish (Syngnathus typhle) care for the offspring by brooding embryos in a brood pouch. Brooding males can absorb nutrients that emanate from embryos, and there is often a reduction in offspring number over the brooding period. In this study, using two experimentally determined brood sizes (partially and fully filled brood pouches), we found that full broods resulted in larger number of developing offspring, despite significantly higher absolute and relative embryo mortality, compared to partial broods. Male survival was also affected by brood size, with males caring for full broods having poorer survival, an effect that together with the reduced embryo survival was found to negate the benefit of large broods. We found that embryo mortality was lower when the brooding males were in good initial condition, that embryos in broods with low embryo mortality weighed more, and surprisingly, that males in higher initial condition had embryos of lower weight. Brood size, however, did not affect embryo weight. Male final condition, but not initial condition, correlated with higher male survival. Taken together, our results show costs and benefits of caring for large brood sizes, where the numerical benefits come with costs in terms of both embryo survival and survival of the brooding father, effects that are often mediated via male condition.	[Sagebakken, Gry; Kvarnemo, Charlotta] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Ahnesjo, Ingrid] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden	University of Gothenburg; Uppsala University	Kvarnemo, C (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	lotta.kvarnemo@bioenv.gu.se			Goteborgs Universitets Marina Forskningscentrum (GMF); Helge Ax:son Johnssons Stiftelse; Radman och Fru Ernst Collianders Stiftelse; Knut och Alice Wallenbergs stiftelse; Wilhelm och Martina Lundgrens Vetenskapsfond; Inez Johanssons stiftelse (Uppsala University); GMF; Swedish Research Council	Goteborgs Universitets Marina Forskningscentrum (GMF); Helge Ax:son Johnssons Stiftelse; Radman och Fru Ernst Collianders Stiftelse; Knut och Alice Wallenbergs stiftelse(Knut & Alice Wallenberg Foundation); Wilhelm och Martina Lundgrens Vetenskapsfond; Inez Johanssons stiftelse (Uppsala University); GMF; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Goteborgs Universitets Marina Forskningscentrum (GMF), Helge Ax:son Johnssons Stiftelse, Radman och Fru Ernst Collianders Stiftelse, Knut och Alice Wallenbergs stiftelse and Wilhelm och Martina Lundgrens Vetenskapsfond to G.S., Inez Johanssons stiftelse (Uppsala University) to I.A. and GMF and the Swedish Research Council to C.K.	AHNESJO I, 1992, J FISH BIOL, V41, P53, DOI 10.1111/j.1095-8649.1992.tb03868.x; AHNESJO I, 1992, FUNCT ECOL, V6, P274, DOI 10.2307/2389517; Ahnesjo I, 1996, BEHAV ECOL SOCIOBIOL, V38, P167, DOI 10.1007/s002650050229; AHNESJO I, 1995, BEHAV ECOL, V6, P229, DOI 10.1093/beheco/6.2.229; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; BERGLUND A, 1986, MAR ECOL PROG SER, V29, P209, DOI 10.3354/meps029209; BERGLUND A, 1986, BEHAV ECOL SOCIOBIOL, V19, P301, DOI 10.1007/BF00300646; BERGLUND A, 1988, OIKOS, V51, P184, DOI 10.2307/3565641; Braga Goncalves I, 2011, J FISH BIOL, V78, P1847, DOI 10.1111/j.1095-8649.2011.02984.x; Braga Goncalves I, 2015, EVOLUTIONARY PUZZLE, V282, DOI [10.1098/rspb.2015.0690, DOI 10.1098/RSPB.2015.0690]; Braga Goncalves I, 2015, J EXP BIOL, V218, P1639, DOI 10.1242/jeb.120907; BROCKELMAN WY, 1975, AM NAT, V109, P677, DOI 10.1086/283037; Brooker RM, 2013, OECOLOGIA, V172, P409, DOI 10.1007/s00442-012-2521-7; CHARNOV EL, 1974, IBIS, V116, P217, DOI 10.1111/j.1474-919X.1974.tb00241.x; CHELLAPPA S, 1989, J FISH BIOL, V35, P275, DOI 10.1111/j.1095-8649.1989.tb02976.x; Christe P, 2012, P ROY SOC B-BIOL SCI, V279, P1142, DOI 10.1098/rspb.2011.1546; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CODY ML, 1966, EVOLUTION, V20, P174, DOI 10.1111/j.1558-5646.1966.tb03353.x; COLEMAN RM, 1985, BEHAV ECOL SOCIOBIOL, V18, P59; Daan S, 1996, J ANIM ECOL, V65, P539, DOI 10.2307/5734; Dufresne F, 1990, BEHAV ECOL, V1, P140, DOI 10.1093/beheco/1.2.140; Elgar M. A., 1992, CANNIBALISM ECOLOGY, P1; Engstrand SM, 2002, FUNCT ECOL, V16, P782, DOI 10.1046/j.1365-2435.2002.00681.x; Gaylord TG, 2000, J WORLD AQUACULT SOC, V31, P326, DOI 10.1111/j.1749-7345.2000.tb00884.x; GODFRAY HCJ, 1991, ANNU REV ECOL SYST, V22, P409, DOI 10.1146/annurev.es.22.110191.002205; Hunt J, 2002, J EVOLUTION BIOL, V15, P57, DOI 10.1046/j.1420-9101.2002.00374.x; Hussey NE, 2009, MAR ECOL PROG SER, V380, P199, DOI 10.3354/meps07918; Ito S, 2010, ENVIRON BIOL FISH, V87, P135, DOI 10.1007/s10641-009-9573-5; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kindsvater HK, 2010, EVOL ECOL RES, V12, P327; Klug H, 2006, EVOLUTION, V60, P2087, DOI 10.1111/j.0014-3820.2006.tb01846.x; Kvarnemo C, 2011, J FISH BIOL, V78, P1725, DOI 10.1111/j.1095-8649.2011.02989.x; Lissaker M, 2003, BEHAV ECOL, V14, P374, DOI 10.1093/beheco/14.3.374; Luo Z, 2009, J APPL ICHTHYOL, V25, P184, DOI 10.1111/j.1439-0426.2009.01216.x; Manica A, 2002, BIOL REV, V77, P261, DOI 10.1017/S1464793101005905; MARCONATO A, 1988, J FISH BIOL, V33, P905, DOI 10.1111/j.1095-8649.1988.tb05539.x; Mock D. W., 1997, EVOLUTION SIBLING RI; MOCK DW, 1995, TRENDS ECOL EVOL, V10, P130, DOI 10.1016/S0169-5347(00)89014-X; Nord A, 2010, FUNCT ECOL, V24, P1031, DOI 10.1111/j.1365-2435.2010.01719.x; Paczolt KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124147; Paczolt KA, 2010, NATURE, V464, P401, DOI 10.1038/nature08861; Partridge C, 2009, BEHAV ECOL SOCIOBIOL, V63, P345, DOI 10.1007/s00265-008-0668-3; PARTRIDGE L, 1991, PHILOS T R SOC B, V332, P3, DOI 10.1098/rstb.1991.0027; Payne AG, 2004, ECOL MODEL, V174, P253, DOI 10.1016/j.ecolmodel.2003.09.026; Payne AG, 2002, P ROY SOC B-BIOL SCI, V269, P2095, DOI 10.1098/rspb.2002.2144; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; RIDGWAY MS, 1989, ETHOLOGY, V80, P47; Ripley JL, 2009, COMP BIOCHEM PHYS A, V154, P98, DOI 10.1016/j.cbpa.2009.05.003; Ripley JL, 2009, J COMP PHYSIOL B, V179, P325, DOI 10.1007/s00360-008-0316-2; Ripley JL, 2006, J EXP BIOL, V209, P1112, DOI 10.1242/jeb.02119; Roff Derek A., 1992; ROHWER S, 1978, AM NAT, V112, P429, DOI 10.1086/283284; ROSENQVIST G, 1995, ANIM BEHAV, V49, P1039, DOI 10.1006/anbe.1995.0133; Roth O, 2011, J EVOLUTION BIOL, V24, P1410, DOI 10.1111/j.1420-9101.2011.02273.x; SABAT AM, 1994, BEHAV ECOL, V5, P195, DOI 10.1093/beheco/5.2.195; Sagebakken G, 2012, THESIS U GOTHENBURG; Sagebakken G, 2011, BEHAV ECOL, V22, P625, DOI 10.1093/beheco/arr023; Sagebakken G, 2010, P ROY SOC B-BIOL SCI, V277, P971, DOI 10.1098/rspb.2009.1767; Sargent Robert Craig, 1992, P38; SMITH C, 1995, REV FISH BIOL FISHER, V5, P7, DOI 10.1007/BF01103363; Sommer S, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-39; Stearns S.C., 1992, pi; SVENSSON I, 1988, J ANIM ECOL, V57, P929, DOI 10.2307/5102; TRIVERS RL, 1974, AM ZOOL, V14, P249; VINCENT A, 1994, BEHAV ECOL SOCIOBIOL, V34, P435, DOI 10.1007/s002650050060; Vincent ACJ, 1995, ENVIRON BIOL FISH, V44, P347, DOI 10.1007/BF00008250; Watanabe S, 2002, ENVIRON BIOL FISH, V65, P319, DOI 10.1023/A:1020510422509; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson AB, 2001, J HERED, V92, P159, DOI 10.1093/jhered/92.2.159; Wolfe RK, 1998, J GREAT LAKES RES, V24, P731; Wootton R.J., 1998, ECOLOGY TELEOST FISH	71	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156484	10.1371/journal.pone.0156484	http://dx.doi.org/10.1371/journal.pone.0156484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243937	gold, Green Published, Green Submitted			2022-12-26	WOS:000377146100041
J	Man-Kupisinska, A; Michalski, M; Maciejewska, A; Swierzko, AS; Cedzynski, M; Lugowski, C; Lukasiewicz, J				Man-Kupisinska, Aleksandra; Michalski, Mateusz; Maciejewska, Anna; Swierzko, Anna S.; Cedzynski, Maciej; Lugowski, Czeslaw; Lukasiewicz, Jolanta			A New Ligand-Based Method for Purifying Active Human Plasma-Derived Ficolin-3 Complexes Supports the Phenomenon of Crosstalk between Pattern-Recognition Molecules and Immunoglobulins	PLOS ONE			English	Article							MANNAN-BINDING LECTIN; H-FICOLIN; COMPLEMENT ACTIVATION; PATHWAY ACTIVATION; HAFNIA-ALVEI; SERINE-PROTEASE; HAKATA ANTIGEN; CORE OLIGOSACCHARIDE; HUMAN SERUM; PURIFICATION	Despite recombinant protein technology development, proteins isolated from natural sources remain important for structure and activity determination. Ficolins represent a class of proteins that are difficult to isolate. To date, three methods for purifying ficolin-3 from plasma/serum have been proposed, defined by most critical step: (i) hydroxyapatite absorption chromatography (ii) N-acetylated human serum albumin affinity chromatography and (iii) anti-ficolin-3 monoclonal antibody-based affinity chromatography. We present a new protocol for purifying ficolin-3 complexes from human plasma that is based on an exclusive ligand: the O-specific polysaccharide of Hafnia alvei PCM 1200 LPS (O-PS 1200). The protocol includes (i) poly(ethylene glycol) precipitation; (ii) yeast and L-fucose incubation, for depletion of mannose-binding lectin; (iii) affinity chromatography using O-PS 1200-Sepharose; (iv) size-exclusion chromatography. Application of this protocol yielded average 2.2 mg of ficolin-3 preparation free of mannose-binding lectin (MBL), ficolin-1 and -2 from 500 ml of plasma. The protein was complexed with MBL-associated serine proteases (MASPs) and was able to activate the complement in vitro. In-process monitoring of MBL, ficolins, and total protein content revealed the presence of difficult-to-remove immunoglobulin G, M and A, in some extent in agreement with recent findings suggesting crosstalk between IgG and ficolin-3. We demonstrated that recombinant ficolin-3 interacts with IgG and IgM in a concentration-dependent manner. Although this association does not appear to influence ficolin-3-ligand interactions in vitro, it may have numerous consequences in vivo. Thus our purification procedure provides Ig-ficolin-3/MASP complexes that might be useful for gaining further insight into the crosstalk and biological activity of ficolin-3.	[Man-Kupisinska, Aleksandra; Maciejewska, Anna; Lugowski, Czeslaw; Lukasiewicz, Jolanta] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, Wroclaw, Poland; [Michalski, Mateusz; Swierzko, Anna S.; Cedzynski, Maciej] Polish Acad Sci, Inst Med Biol, Lab Immunobiol Infect, Lodz, Poland; [Michalski, Mateusz] Univ Lodz, Inst Microbiol Immunol & Biotechnol, PL-90131 Lodz, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Lodz	Lukasiewicz, J (corresponding author), Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Immunochem, Wroclaw, Poland.	jolanta.lukasiewicz@iitd.pan.wroc.pl		Lugowski, Czeslaw/0000-0002-2336-0530; Cedzynski, Maciej/0000-0002-4486-9256; Maciejewska, Anna/0000-0003-4057-2997; Lukasiewicz, Jolanta/0000-0001-8081-7261	Polish Ministry of Science and Higher Education [N40108432/1944]; National Science Centre [2012/07/N/NZ6/04115, 2015/16/T/NZ6/00412]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre(National Science Centre, Poland)	This research was supported by The Polish Ministry of Science and Higher Education grant N40108432/1944 to JL, http://www.nauka.gov.pl/en/, and by the National Science Centre grant 2012/07/N/NZ6/04115 to AMK, https://www.ncn.gov.pl/?language=en. MM is the recipient of fellowship for PhD students from the National Science Center, 2015/16/T/NZ6/00412, https://www.ncn.gov.pl/?language=en. Publication supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018, http://know.wroc.pl/?lang=en.	ABDELAKHER M, 1951, J AM CHEM SOC, V73, P4691, DOI 10.1021/ja01154a061; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Bartlomiejczyk MA, 2014, CLIN EXP IMMUNOL, V178, P310, DOI 10.1111/cei.12416; Bidula S, 2015, IMMUNOLOGY, V146, P281, DOI 10.1111/imm.12501; Breen KA, 2014, BLOOD COAGUL FIBRIN, V25, P644, DOI 10.1097/MBC.0000000000000060; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Cedzynski M, 2004, CLIN EXP IMMUNOL, V136, P304, DOI 10.1111/j.1365-2249.2004.02453.x; Cestari ID, 2009, MOL IMMUNOL, V47, P426, DOI 10.1016/j.molimm.2009.08.030; Degn SE, 2013, J IMMUNOL, V191, P1334, DOI 10.4049/jimmunol.1300780; Degn SE, 2012, J IMMUNOL, V189, P3957, DOI 10.4049/jimmunol.1201736; Endo Y, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/105891; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; Evans-Osses I, 2010, BIOCHEM BIOPH RES CO, V395, P382, DOI 10.1016/j.bbrc.2010.04.025; Faro J, 2008, CLIN EXP IMMUNOL, V151, P275, DOI 10.1111/j.1365-2249.2007.03538.x; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; GHUYSEN JM, 1963, BIOCHEMISTRY-US, V2, P1110, DOI 10.1021/bi00905a035; Gout E, 2010, J BIOL CHEM, V285, P6612, DOI 10.1074/jbc.M109.065854; Hein E, 2013, MOL IMMUNOL, V56, P406, DOI 10.1016/j.molimm.2013.05.233; Hein E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015443; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; JACHYMEK W, 1994, CARBOHYD RES, V251, P327, DOI 10.1016/0008-6215(94)84295-7; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Kilpatrick DC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/138797; Kjaer TR, 2011, J LEUKOCYTE BIOL, V90, P425, DOI 10.1189/jlb.0411201; Le Y, 1998, FEBS LETT, V425, P367, DOI 10.1016/S0014-5793(98)00267-1; Le Y, 1997, J IMMUNOL METHODS, V204, P43, DOI 10.1016/S0022-1759(97)00029-X; Lei XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07824; Ma YG, 2004, J BIOL CHEM, V279, P25307, DOI 10.1074/jbc.M400701200; Matsushita M, 1996, J BIOL CHEM, V271, P2448, DOI 10.1074/jbc.271.5.2448; MATSUSHITA M, 1995, IMMUNOBIOLOGY, V194, P443, DOI 10.1016/S0171-2985(11)80110-5; Matsushita M, 2002, IMMUNOBIOLOGY, V205, P490, DOI 10.1078/0171-2985-00149; Matsushita M, 2014, METHODS MOL BIOL, V1100, P141, DOI 10.1007/978-1-62703-724-2_12; Matsushita M, 2013, ARCH IMMUNOL THER EX, V61, P273, DOI 10.1007/s00005-013-0229-y; Matsushita M, 2013, MOL IMMUNOL, V55, P22, DOI 10.1016/j.molimm.2012.08.017; Michalski M, 2015, IMMUNOBIOLOGY, V220, P711, DOI 10.1016/j.imbio.2015.01.003; Michalski M, 2015, IMMUNOBIOLOGY, V220, P117, DOI 10.1016/j.imbio.2014.08.012; Michalski M, 2012, IMMUNOBIOLOGY, V217, P730, DOI 10.1016/j.imbio.2011.12.004; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Niedziela T, 2006, BIOCHEMISTRY-US, V45, P10422, DOI 10.1021/bi0607709; Panda S, 2014, SCI REP-UK, V4, DOI 10.1038/srep03675; Panda S, 2013, EMBO J, V32, P2905, DOI 10.1038/emboj.2013.199; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Petersson C, 1997, EUR J BIOCHEM, V244, P580, DOI 10.1111/j.1432-1033.1997.00580.x; PORATH J, 1967, NATURE, V215, P1491, DOI 10.1038/2151491a0; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Presanis JS, 2003, BIOCHEM SOC T, V31, P748, DOI 10.1042/BST0310748; Sahagun-Ruiz A, 2015, IMMUNOBIOLOGY, V220, P1177, DOI 10.1016/j.imbio.2015.06.001; SHEEHAN JC, 1961, J ORG CHEM, V26, P2525, DOI 10.1021/jo01351a600; Swierzko A, 2012, GLYCOBIOLOGY, V22, P267, DOI 10.1093/glycob/cwr119; Szala A, 2013, CANCER IMMUNOL IMMUN, V62, P1411, DOI 10.1007/s00262-013-1445-3; Tan SM, 1996, BIOCHEM J, V319, P329, DOI 10.1042/bj3190329; Thiel S, 2009, ADV EXP MED BIOL, V653, P58; Tsujimura M, 2001, CLIN DIAGN LAB IMMUN, V8, P454, DOI 10.1128/CDLI.8.2.454-459.2001; Vassal-Stermann E, 2014, J IMMUNOL, V193, P5699, DOI 10.4049/jimmunol.1400127; Verma A, 2012, J IMMUNOL, V189, P2478, DOI 10.4049/jimmunol.1103786; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; YAE Y, 1991, BIOCHIM BIOPHYS ACTA, V1078, P369, DOI 10.1016/0167-4838(91)90158-V; Zacho RM, 2012, J BIOL CHEM, V287, P8071, DOI 10.1074/jbc.M111.301044	59	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156691	10.1371/journal.pone.0156691	http://dx.doi.org/10.1371/journal.pone.0156691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232184	Green Published, gold, Green Submitted			2022-12-26	WOS:000376883000053
J	Low, JKK; Webb, SR; Silva, APG; Saathoff, H; Ryan, DP; Torrado, M; Brofelth, M; Parker, BL; Shepherd, NE; Mackay, JP				Low, Jason K. K.; Webb, Sarah R.; Silva, Ana P. G.; Saathoff, Hinnerk; Ryan, Daniel P.; Torrado, Mario; Brofelth, Mattias; Parker, Benjamin L.; Shepherd, Nicholas E.; Mackay, Joel P.			CHD4 Is a Peripheral Component of the Nucleosome Remodeling and Deacetylase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NURD COMPLEX; CHROMATIN REMODELER; STRUCTURAL-ANALYSIS; MI-2/NURD COMPLEX; SOMATIC-CELLS; STEM-CELLS; ARCHITECTURE; BINDING; MBD3/NURD; INSIGHTS	Chromatin remodeling enzymes act to dynamically regulate gene accessibility. In many cases, these enzymes function as large multicomponent complexes that in general comprise a central ATP-dependent Snf2 family helicase that is decorated with a variable number of regulatory subunits. The nucleosome remodeling and deacetylase (NuRD) complex, which is essential for normal development in higher organisms, is one such macromolecular machine. The NuRD complex comprises similar to 10 subunits, including the histone deacetylases 1 and 2 (HDAC1 and HDAC2), and is defined by the presence of a CHD family remodeling enzyme, most commonly CHD4 (chromodomain helicase DNA-binding protein 4). The existing paradigm holds that CHD4 acts as the central hub upon which the complex is built. We show here that this paradigm does not, in fact, hold and that CHD4 is a peripheral component of the NuRD complex. A complex lacking CHD4 that has HDAC activity can exist as a stable species. The addition of recombinant CHD4 to this nucleosome deacetylase complex reconstitutes a NuRD complex with nucleosome remodeling activity. These data contribute to our understanding of the architecture of the NuRD complex.	[Low, Jason K. K.; Webb, Sarah R.; Silva, Ana P. G.; Saathoff, Hinnerk; Torrado, Mario; Brofelth, Mattias; Parker, Benjamin L.; Shepherd, Nicholas E.; Mackay, Joel P.] Univ Sydney, Sch Life & Environm Sci, Bldg G08, Sydney, NSW 2006, Australia; [Ryan, Daniel P.] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, Acton, ACT 2601, Australia; [Webb, Sarah R.] Francis Crick Inst, Mill Hill Lab, Mill Hill, London, England	University of Sydney; Australian National University; John Curtin School of Medical Research	Mackay, JP (corresponding author), Univ Sydney, Sch Life & Environm Sci, Bldg G08, Sydney, NSW 2006, Australia.; Shepherd, NE (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	n.shepherd@imb.uq.edu.au; joel.mackay@sydney.edu.au	Mackay, Joel P/D-6834-2011	Mackay, Joel P/0000-0001-7508-8033; Low, Jason/0000-0003-0862-0012; Brofelth, Mattias/0000-0003-1187-4005; Ryan, Daniel/0000-0001-9842-2620	Australian Research Council [DE120102857]; National Health and Medical Research Council [APP1012161, 1063301, 571099]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Grant DE120102857 and National Health and Medical Research Council Grants APP1012161, 1063301, and 571099. The authors declare that they have no conflicts of interest with the contents of this article.	Alkhatib SG, 2011, FEBS LETT, V585, P3197, DOI 10.1016/j.febslet.2011.09.003; Alqarni SSM, 2014, J BIOL CHEM, V289, P21844, DOI 10.1074/jbc.M114.558940; Armache KJ, 2011, SCIENCE, V334, P977, DOI 10.1126/science.1210915; Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Brownlee PM, 2012, BIOCHEM SOC T, V40, P364, DOI 10.1042/BST20110754; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Desai MA, 2015, NUCLEIC ACIDS RES, V43, P3100, DOI 10.1093/nar/gkv168; dos Santos RL, 2014, CELL STEM CELL, V15, P102, DOI 10.1016/j.stem.2014.04.019; Gao ZG, 2010, EMBO J, V29, P457, DOI 10.1038/emboj.2009.368; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; Gnanapragasam MN, 2011, P NATL ACAD SCI USA, V108, P7487, DOI 10.1073/pnas.1015341108; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Kloet SL, 2015, FEBS J, V282, P1774, DOI 10.1111/febs.12972; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lazarev AV, 2009, ELECTROPHORESIS, V30, P966, DOI 10.1002/elps.200800474; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Leschziner AE, 2005, STRUCTURE, V13, P267, DOI 10.1016/j.str.2004.12.008; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Li X, 2009, BLOOD, V114, P5464, DOI 10.1182/blood-2009-06-227777; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P1026, DOI 10.1038/nsmb.2648; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; Nguyen VQ, 2013, CELL, V154, P1220, DOI 10.1016/j.cell.2013.08.018; O'Shaughnessy A, 2013, BIOCHEM SOC T, V41, P777, DOI 10.1042/BST20130027; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Saathoff H, 2015, BIOORGAN MED CHEM, V23, P960, DOI 10.1016/j.bmc.2015.01.023; Silva APG, 2016, J BIOL CHEM, V291, P924, DOI 10.1074/jbc.M115.683227; Sims JK, 2011, CELL, V144, P626, DOI 10.1016/j.cell.2011.02.019; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Sparmann A, 2013, EMBO J, V32, P1598, DOI 10.1038/emboj.2013.93; Spruijt CG, 2010, MOL BIOSYST, V6, P1700, DOI 10.1039/c004108d; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun YE, 2014, DEV CELL, V30, P9, DOI 10.1016/j.devcel.2014.06.028; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Torchy MP, 2015, CELL MOL LIFE SCI, V72, P2491, DOI 10.1007/s00018-015-1880-8; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Yadon AN, 2011, CELL, V144, P454, DOI 10.1016/j.cell.2011.01.019; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808	56	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15853	15866		10.1074/jbc.M115.707018	http://dx.doi.org/10.1074/jbc.M115.707018			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27235397	hybrid, Green Published			2022-12-26	WOS:000380584200037
J	Schon, C; Paquet-Durand, F; Michalakis, S				Schoen, Christian; Paquet-Durand, Francois; Michalakis, Stylianos			Ca(v)1.4 L-Type Calcium Channels Contribute to Calpain Activation in Degenerating Photoreceptors of rd1 Mice	PLOS ONE			English	Article							D-CIS-DILTIAZEM; RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; RIBBON SYNAPSES; CNG CHANNELS; MOUSE; RESCUE; BLOCKER; INHIBITORS; SUBUNIT	Retinitis pigmentosa is an inherited blinding disorder characterized by progressive degeneration and loss of photoreceptors. The exact mechanism of degeneration and cell death of photoreceptors is not known, but is thought to involve disturbed Ca2+-signaling. Ca2+ can enter the photoreceptor cell via outer segment cyclic nucleotide-gated (CNG) channels or synaptic Ca(v)1.4 L-type voltage-gated calcium channels (VGCC). Previously, we have shown that genetic ablation of the Cngb1 gene encoding the B subunit of the rod CNG channel delays the fast progressing degeneration in the rd1 mutant mouse model of retinitis pigmentosa. In this study, we crossbred rd1 mice with the Cacna1f-deficient mouse lacking the Ca(v)1.4 alpha 1 subunit of the L-type VGCC. Longitudinal in vivo examinations of photoreceptor layer thickness by optical coherence tomography revealed a significant, but not sustained delay of retinal degeneration in Cacna1f x rd1 double mutant mice compared to rd1 mice. This was accompanied by a reduction of TUNEL positive cells in the early phase of rod degeneration. Remarkably, Cacna1f x rd1 double mutant mice displayed a strong decrease in the activation of the Ca2+-dependent protease calpain during photoreceptor loss. Our results show that genetic deletion of the synaptic Ca-v 1.4 L-type VGCCs impairs calpain activation and leads to a short-term preservation of photoreceptors in the rd1 mouse.	[Schoen, Christian; Michalakis, Stylianos] Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, Dept Pharm, Ctr Drug Res, Munich, Germany; [Paquet-Durand, Francois] Univ Tubingen, Ctr Ophthalmol, Div Ocular Neurodegenerat, Inst Ophthalm Res, Schleichstr 4-3, D-72076 Tubingen, Germany	University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Michalakis, S (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, Dept Pharm, Ctr Drug Res, Munich, Germany.; Paquet-Durand, F (corresponding author), Univ Tubingen, Ctr Ophthalmol, Div Ocular Neurodegenerat, Inst Ophthalm Res, Schleichstr 4-3, D-72076 Tubingen, Germany.	francois.paquet-durand@klinikum.uni-tuebingen.de; stylianos.michalakis@cup.lmu.de	Michalakis, Stylianos/M-4677-2019; Michalakis, Stylianos/W-2094-2018; Paquet-Durand, Francois/G-6709-2015	Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238; Paquet-Durand, Francois/0000-0001-7355-5742	Deutsche Forschungsgemeinschaft (DFG) [EXC114]; Tistou and Charlotte Kerstan Foundation (RD-CURE)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Tistou and Charlotte Kerstan Foundation (RD-CURE)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, EXC114, http://www.dfg.de/) and the Tistou and Charlotte Kerstan Foundation (RD-CURE, http://www.kerstanstiftung.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Barabas P, 2010, ADV EXP MED BIOL, V664, P491, DOI 10.1007/978-1-4419-1399-9_56; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Biel M, 2007, MOL NEUROBIOL, V35, P266, DOI 10.1007/s12035-007-0025-y; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Bush RA, 2000, INVEST OPHTH VIS SCI, V41, P2697; Fox DA, 1999, ANN NY ACAD SCI, V893, P282, DOI 10.1111/j.1749-6632.1999.tb07837.x; Frasson M, 1999, NAT MED, V5, P1183, DOI 10.1038/13508; Katiyar R, 2015, INVEST OPHTH VIS SCI, V56, P2312, DOI 10.1167/iovs.15-16654; Keeler CE, 1924, P NATL ACAD SCI USA, V10, P329, DOI 10.1073/pnas.10.7.329; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; Liu XN, 2013, CHANNELS, V7, P514, DOI 10.4161/chan.26376; Mercer AJ, 2011, VISUAL NEUROSCI, V28, P453, DOI 10.1017/S0952523811000356; Michalakis S, 2014, HUM MOL GENET, V23, P1538, DOI 10.1093/hmg/ddt541; Nakazawa M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/585729; Nakazawa M, 2011, OPHTHALMOLOGICA, V225, P120, DOI 10.1159/000320500; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Paquet-Durand F, 2010, J NEUROCHEM, V115, P930, DOI 10.1111/j.1471-4159.2010.06983.x; Pawlyk BS, 2002, INVEST OPHTH VIS SCI, V43, P1912; Pearce-Kelling SE, 2001, MOL VIS, V7, P42; Read DS, 2002, EXP EYE RES, V75, P415, DOI 10.1006/exer.2002.2034; Regus-Leidig H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086769; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Schon C, 2016, HUM MOL GENET, V25, P1165, DOI 10.1093/hmg/ddv639; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Striessnig Jorg, 2014, Wiley Interdiscip Rev Membr Transp Signal, V3, P15; Zabouri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063853	30	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156974	10.1371/journal.pone.0156974	http://dx.doi.org/10.1371/journal.pone.0156974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270916	gold, Green Published, Green Submitted			2022-12-26	WOS:000377561000054
J	Turgeon, K; Kramer, DL				Turgeon, Katrine; Kramer, Donald L.			Immigration Rates during Population Density Reduction in a Coral Reef Fish	PLOS ONE			English	Article							TERRITORIAL DAMSELFISH; CONSPECIFIC-ATTRACTION; DEPENDENT DISPERSAL; BEHAVIORAL ECOLOGY; LARVAL SETTLEMENT; MODEL SELECTION; MARINE RESERVE; LOCAL DYNAMICS; RECRUITMENT; PATTERNS	Although the importance of density-dependent dispersal has been recognized in theory, few empirical studies have examined how immigration changes over a wide range of densities. In a replicated experiment using a novel approach allowing within-site comparison, we examined changes in immigration rate following the gradual removal of territorial damselfish from a limited area within a much larger patch of continuous habitat. In all sites, immigration occurred at intermediate densities but did not occur before the start of removals and only rarely as density approached zero. In the combined data and in 5 of 7 sites, the number of immigrants was a hump-shaped function of density. This is the first experimental evidence for hump-shaped, density-dependent immigration. This pattern may be more widespread than previously recognized because studies over more limited density ranges have identified positive density dependence at low densities and negative density dependence at high densities. Positive density dependence at low density can arise from limits to the number of potential immigrants and from behavioral preferences for settling near conspecifics. Negative density dependence at high density can arise from competition for resources, especially high quality territories. The potential for non-linear effects of local density on immigration needs to be recognized for robust predictions of conservation reserve function, harvest impacts, pest control, and the dynamics of fragmented populations.	[Turgeon, Katrine; Kramer, Donald L.] McGill Univ, Dept Biol, 1205 Docteur Penfield Ave, Montreal, PQ H3A 1B1, Canada	McGill University	Turgeon, K (corresponding author), McGill Univ, Dept Biol, 1205 Docteur Penfield Ave, Montreal, PQ H3A 1B1, Canada.	katrine.turgeon@mail.mcgill.ca	Kramer, Donald L/E-9058-2011; Turgeon, Katrine/K-9980-2019	Turgeon, Katrine/0000-0002-2528-130X	Natural Sciences and Engineering Research Council (NSERC); Fonds Quebec de Recherche sur la Nature et les Technologies (FQRNT) [97423]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebec de Recherche sur la Nature et les Technologies (FQRNT)	Funded by Natural Sciences and Engineering Research Council (NSERC) Discovery grants to DLK (http://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=285204, http://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=388214). Natural Sciences and Engineering Research Council (NSERC) Strategic Grant to DLK (P.I.; Michael Jenkin, York University) (http://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=364899), Natural Sciences and Engineering Research Council (NSERC) postgraduate scholarship to KT (http://www.nserc-crsng.gc.ca/aseoro/Details-Detailles_eng.asp?id=370685), and Fonds Quebec de Recherche sur la Nature et les Technologies (FQRNT) (http://www.frqnt.gouv.qc.ca/en/bourses-et-subventions/consulter-lesprogrammes- remplir-une-demande/bourse/programs-of-scholarships-of-2supndsup-and-3suprdsup-cycles-o7unxnhm1432651694011 Number: 97423, concours B2, comite 02A, 2004-2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Adams ES, 2001, ANNU REV ECOL SYST, V32, P277, DOI 10.1146/annurev.ecolsys.32.081501.114034; Ahlering MA, 2010, CONDOR, V112, P252, DOI 10.1525/cond.2010.090239; Anderson TW, 2007, MAR ECOL PROG SER, V350, P109, DOI 10.3354/meps07135; Baird TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041819; BARTELS PJ, 1984, BEHAVIOUR, V91, P312, DOI 10.1163/156853984X00137; Bolker B., 2012, BBMLE TOOLS GEN MAXI; Bolker B, 2008, ECOLOGICAL MODELS DA; BOOTH DJ, 1992, J EXP MAR BIOL ECOL, V155, P85, DOI 10.1016/0022-0981(92)90029-A; BOUTIN S, 1985, CAN J ZOOL, V63, P106, DOI 10.1139/z85-019; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Brett MT, 2004, OIKOS, V105, P647, DOI 10.1111/j.0030-1299.2004.12777.x; Bullock JM, 2002, DISPERSAL ECOLOGY, pxv; BURKE RD, 1986, B MAR SCI, V39, P323; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CHABOT R, 1988, MAR BIOL, V97, P45, DOI 10.1007/BF00391244; Cheney KL, 2003, J EXP MAR BIOL ECOL, V287, P1, DOI 10.1016/S0022-0981(02)00500-2; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Clobert J, 2001, DISPERSAL; Danchin Etienne, 2001, P243; DAVIES NB, 1978, ANIM BEHAV, V26, P138, DOI 10.1016/0003-3472(78)90013-1; Detto T, 2010, AM NAT, V175, pE119, DOI 10.1086/651588; Doligez B, 2004, J ANIM ECOL, V73, P75, DOI 10.1111/j.1365-2656.2004.00782.x; Donahue MJ, 2006, OECOLOGIA, V149, P33, DOI 10.1007/s00442-006-0419-y; Efford M, 2000, WILDLIFE RES, V27, P117, DOI 10.1071/WR99005; Eggleston DB, 2008, MAR ECOL PROG SER, V371, P213, DOI 10.3354/meps07699; FORRESTER GE, 1995, OECOLOGIA, V103, P275, DOI 10.1007/BF00328615; FOSTER SA, 1987, OIKOS, V50, P153, DOI 10.2307/3565995; FOSTER SA, 1985, ANIM BEHAV, V33, P782, DOI 10.1016/S0003-3472(85)80011-7; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; GRANT JWA, 1990, CAN J FISH AQUAT SCI, V47, P1724, DOI 10.1139/f90-197; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heg D, 2000, BEHAVIOUR, V137, P473, DOI 10.1163/156853900502187; Herrando-Perez S, 2012, OECOLOGIA, V170, P585, DOI 10.1007/s00442-012-2347-3; HESTBECK JB, 1982, OIKOS, V39, P157, DOI 10.2307/3544480; Hixon Mark A., 2002, P303, DOI 10.1016/B978-012615185-5/50018-9; ITZKOWITZ M, 1978, BEHAVIOUR, V65, P125, DOI 10.1163/156853978X00233; JONES GP, 1987, J EXP MAR BIOL ECOL, V114, P169; KARINO K, 1993, J ETHOL, V11, P99, DOI 10.1007/BF02350043; Komdeur J, 2001, BEHAV ECOL, V12, P706, DOI 10.1093/beheco/12.6.706; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; KREBS J R, 1971, Ecology (Washington D C), V52, P2, DOI 10.2307/1934734; Kritzer Jacob P., 2006, P31, DOI 10.1016/B978-012088781-1/50005-4; Lambin X, 2001, DISPERSAL, P111; LARSEN KW, 1995, CAN J ZOOL, V73, P1115, DOI 10.1139/z95-133; Lloyd-Smith JO, 2010, J THEOR BIOL, V265, P160, DOI 10.1016/j.jtbi.2010.03.032; Loe LE, 2009, P ROY SOC B-BIOL SCI, V276, P2581, DOI 10.1098/rspb.2009.0224; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; McDougall PT, 2007, BEHAV ECOL, V18, P53, DOI 10.1093/beheco/arl055; Meadows DW, 2001, BEHAVIOUR, V138, P1085, DOI 10.1163/156853901753287154; Mihoub JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027453; NEWTON I, 1992, BIOL REV, V67, P129, DOI 10.1111/j.1469-185X.1992.tb01017.x; Novaro AJ, 2000, CONSERV BIOL, V14, P713, DOI 10.1046/j.1523-1739.2000.98452.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; ROBERTSON DR, 1986, ECOLOGY, V67, P1372, DOI 10.2307/1938693; ROBERTSON DR, 1995, OECOLOGIA, V103, P180, DOI 10.1007/BF00329078; ROBERTSON DR, 1979, ENVIRON BIOL FISH, V4, P125, DOI 10.1007/BF00005448; ROBERTSON DR, 1976, ECOLOGY, V57, P1208, DOI 10.2307/1935045; ROBERTSON DR, 1993, MAR ECOL PROG SER, V94, P105, DOI 10.3354/meps094105; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Russ Garry R., 2002, P421, DOI 10.1016/B978-012615185-5/50024-4; Saether BE, 1999, P ROY SOC B-BIOL SCI, V266, P113, DOI 10.1098/rspb.1999.0610; SALE PF, 1979, OECOLOGIA, V42, P159, DOI 10.1007/BF00344855; Schaub M, 2013, ECOLOGY, V94, P1828, DOI 10.1890/12-1395.1; Schmitt RJ, 1996, MAR FRESHWATER RES, V47, P449, DOI 10.1071/MF9960449; Serrano D, 2004, ECOLOGY, V85, P3438, DOI 10.1890/04-0463; Stamps Judy A., 2001, P230; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; STIMSON JS, 1990, ENVIRON BIOL FISH, V29, P1, DOI 10.1007/BF00000563; SWEATMAN HPA, 1985, ECOL MONOGR, V55, P469, DOI 10.2307/2937132; Travis JMJ, 2012, METHODS ECOL EVOL, V3, P628, DOI 10.1111/j.2041-210X.2012.00193.x; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; Turgeon K, 2012, J ANIM ECOL, V81, P1161, DOI 10.1111/j.1365-2656.2012.01990.x; Turgeon K, 2010, ECOLOGY, V91, P3332, DOI 10.1890/09-2015.1; Tuyttens FAM, 2000, J ANIM ECOL, V69, P567, DOI 10.1046/j.1365-2656.2000.00419.x; Waser PM, 2006, MOL ECOL, V15, P1929, DOI 10.1111/j.1365-294X.2006.02893.x; WELLINGTON GM, 1988, AM NAT, V131, P588, DOI 10.1086/284808; Wilson AG, 2008, J AVIAN BIOL, V39, P341, DOI 10.1111/j.0908-8857.2008.04239.x; Wilson J, 2002, OECOLOGIA, V130, P205, DOI 10.1007/s004420100784; Wood S., MIXED GAM COMPUTATIO; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wood SN, 2002, ECOL MODEL, V157, P157, DOI 10.1016/S0304-3800(02)00193-X; Wormald CL, 2013, ECOL APPL, V23, P365, DOI 10.1890/12-0790.1	89	2	2	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156417	10.1371/journal.pone.0156417	http://dx.doi.org/10.1371/journal.pone.0156417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271081	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561000014
J	Aouar, B; Kovarova, D; Letard, S; Font-Haro, A; Florentin, J; Weber, J; Durantel, D; Chaperot, L; Plumas, J; Trejbalova, K; Hejnar, J; Nunes, JA; Olive, D; Dubreuil, P; Hirsch, I; Stranska, R				Aouar, Besma; Kovarova, Denisa; Letard, Sebastien; Font-Haro, Albert; Florentin, Jonathan; Weber, Jan; Durantel, David; Chaperot, Laurence; Plumas, Joel; Trejbalova, Katerina; Hejnar, Jiri; Nunes, Jacques A.; Olive, Daniel; Dubreuil, Patrice; Hirsch, Ivan; Stranska, Ruzena			Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							HEPATITIS-C VIRUS; B-VIRUS; ALPHA; INTERFERON; SECRETION; RESPONSES	Crosslinking of regulatory immunoreceptors (RR), such as BDCA-2 (CD303) or ILT7 (CD85g), of plasmacytoid dendritic cells (pDCs) efficiently suppresses production of type-I interferon (IFN)-alpha/beta and other cytokines in response to Toll-like receptor (TLR) 7/9 ligands. This cytokine-inhibitory pathway is mediated by spleen tyrosine kinase (Syk) associated with the ITAM-containing adapter of RR. Here we demonstrate by pharmacological targeting of Syk that in addition to the negative regulation of TLR7/9 signaling via RR, Syk also positively regulates the TLR7/9 pathway in human pDCs. Novel highly specific Syk inhibitor AB8779 suppressed IFN-alpha, TNF-alpha and IL-6 production induced by TLR7/9 agonists in primary pDCs and in the pDC cell line GEN2.2. Triggering of TLR9 or RR signaling induced a differential kinetics of phosphorylation at Y352 and Y525/526 of Syk and a differential sensitivity to AB8779. Consistent with the different roles of Syk in TLR7/9 and RR signaling, a concentration of AB8779 insufficient to block TLR7/9 signaling still released the block of IFN-alpha production triggered via the RR pathway, including that induced by hepatitis B and C viruses. Thus, pharmacological targeting of Syk partially restored the main pDC function-IFN-alpha production. Opposing roles of Syk in TLR7/9 and RR pathways may regulate the innate immune response to weaken inflammation reaction.	[Aouar, Besma; Kovarova, Denisa; Letard, Sebastien; Florentin, Jonathan; Nunes, Jacques A.; Olive, Daniel; Dubreuil, Patrice; Hirsch, Ivan; Stranska, Ruzena] Ctr Rech Cancerol Marseille, Inserm U1068, Marseille, France; [Aouar, Besma; Kovarova, Denisa; Letard, Sebastien; Florentin, Jonathan; Nunes, Jacques A.; Olive, Daniel; Dubreuil, Patrice; Hirsch, Ivan; Stranska, Ruzena] CNRS, UMR7258, Marseille, France; [Aouar, Besma; Kovarova, Denisa; Letard, Sebastien; Florentin, Jonathan; Nunes, Jacques A.; Olive, Daniel; Dubreuil, Patrice; Hirsch, Ivan; Stranska, Ruzena] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Aouar, Besma; Kovarova, Denisa; Letard, Sebastien; Florentin, Jonathan; Nunes, Jacques A.; Olive, Daniel; Dubreuil, Patrice; Hirsch, Ivan; Stranska, Ruzena] Aix Marseille Univ, UM105, Marseille, France; [Kovarova, Denisa; Font-Haro, Albert; Trejbalova, Katerina; Hejnar, Jiri; Hirsch, Ivan] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic; [Kovarova, Denisa; Font-Haro, Albert; Hirsch, Ivan] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic; [Letard, Sebastien] AB Sci, Paris, France; [Font-Haro, Albert; Weber, Jan; Hirsch, Ivan] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic; [Durantel, David] Ctr Rech Cancerol Lyon, Inserm U1052, CNRS UMR5286, Lyon, France; [Chaperot, Laurence; Plumas, Joel] Univ Grenoble Alpes, UJF, INSERM U823, EFS Rhone Alpes, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Hirsch, I; Stranska, R (corresponding author), Ctr Rech Cancerol Marseille, Inserm U1068, Marseille, France.; Hirsch, I; Stranska, R (corresponding author), CNRS, UMR7258, Marseille, France.; Hirsch, I; Stranska, R (corresponding author), Inst J Paoli I Calmettes, F-13009 Marseille, France.; Hirsch, I; Stranska, R (corresponding author), Aix Marseille Univ, UM105, Marseille, France.; Hirsch, I (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic.; Hirsch, I (corresponding author), Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic.; Hirsch, I (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Prague, Czech Republic.	ivan.hirsch@inserm.fr; ruzena.stranska@kuleuven.be	Dubreuil, Patrice/V-4816-2019; Durantel, David/I-4639-2018; chaperot, laurence/N-2927-2013; Weber, Jan/B-5405-2013; Hirsch, Ivan/J-7726-2015; Font Haro, Albert/N-9267-2017; NUNES, Jacques A/F-4952-2013; dubreuil, patrice/F-5346-2011; Trejbalova, Katerina/G-4394-2014	Dubreuil, Patrice/0000-0003-1155-1150; Durantel, David/0000-0002-9226-3419; chaperot, laurence/0000-0002-1479-9410; Weber, Jan/0000-0002-2799-7352; Hirsch, Ivan/0000-0003-1701-1438; Font Haro, Albert/0000-0002-2568-3309; NUNES, Jacques A/0000-0003-4865-0400; dubreuil, patrice/0000-0003-1155-1150; LETARD, Sebastien/0000-0002-6508-7376	Grantova agentura Ceske republiky (Czech Science Foundation) [14-32547S]; Fondation ARC pour la Recherche sur le Cancer [PJA 20131200304]; Fondation pour la Recherche Medicale [SPF20121226309]; BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]; Ligue contre le cancer; Algerian Ministry of Higher Education and Research; Franco-Algerian Cooperation; AB Science	Grantova agentura Ceske republiky (Czech Science Foundation); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University from the European Regional Development Fund; Ligue contre le cancer(Ligue nationale contre le cancer); Algerian Ministry of Higher Education and Research; Franco-Algerian Cooperation; AB Science	Grantova agentura Ceske republiky (Czech Science Foundation) 14-32547S (http://gacr.cz/) DK AFH KT JH IH. Fondation ARC pour la Recherche sur le Cancer, PJA 20131200304, (http://www.fondation-arc.org/) BA JAN DO IH RS. Fondation pour la Recherche Medicale, SPF20121226309, (http://www.frm.org/) RS. BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" (CZ.1.05/1.1.00/02.0109), from the European Regional Development Fund (http://www.biocev.eu/) IH. Ligue contre le cancer (http://www.ligue-cancer.net/) BA. Algerian Ministry of Higher Education and Research, and Franco-Algerian Cooperation BA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SL is an employee of AB Science. AB Science provided support in the form of salary for author SL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Cao W, 2007, PLOS BIOL, V5, P2190, DOI 10.1371/journal.pbio.0050248; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Carsetti L, 2009, CELL SIGNAL, V21, P1187, DOI 10.1016/j.cellsig.2009.03.007; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Dental C, 2012, J VIROL, V86, P1090, DOI 10.1128/JVI.05444-11; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Firaguay G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286pl3; Florentin J, 2012, BLOOD, V120, P4544, DOI 10.1182/blood-2012-02-413286; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Glitzner E, 2014, SPECIFIC ROLES DENDR, DOI 10.15252/emmm.201404114; Gondois-Rey F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004319; Hirsch I, 2010, TRENDS IMMUNOL, V31, P391, DOI 10.1016/j.it.2010.07.004; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Luangsay S, 2015, J HEPATOL, V63, P1314, DOI 10.1016/j.jhep.2015.07.014; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Rao S, 2013, J BIOL CHEM, V288, P12448, DOI 10.1074/jbc.M113.454405; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Shiina M, 2008, HEPATOLOGY, V47, P385, DOI 10.1002/hep.21996; Sisirak V, 2012, CANCER RES, V72, P5188, DOI 10.1158/0008-5472.CAN-11-3468; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Vincent IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026315; Woltman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015324; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	27	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156063	10.1371/journal.pone.0156063	http://dx.doi.org/10.1371/journal.pone.0156063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258042	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700030
J	Buss, LW; Buss, ED; Anderson, CP; Power, M; Zinter, J				Buss, Leo W.; Buss, Evan D.; Anderson, Christopher P.; Power, Michael; Zinter, Joseph			Control of Hydroid Colony Form by Surface Heterogeneity	PLOS ONE			English	Article							PODOCORYNE-CARNEA; HYDRACTINIID HYDROIDS; CELL MOVEMENTS; GROWTH; DIFFERENTIATION; PHYSIOLOGY; DYNAMICS; FLEXUOSA; STOLONS; BIOLOGY	The colonial hydroid Podocoryna carnea grows adherent to surfaces progressing along them by a motile stolon tip. We here ask whether the stolon tip grows preferentially within grooves etched in silicon wafers. In a series of pilot experiments, we varied the dimensions of grooves and found that stolons did not utilize grooves with a width: depth of 5: 5 mu m or 10: 10 mu m, occasionally followed grooves 25: 25 mu m in size, and preferentially grew within grooves of a width: depth of 50: 50 mu m and 100: 50 mu m. We then grew colonies in grids, with fixed 50: 50 mu m width: depth channels intersecting at 90 degrees every 950, 700, 450, or 150 mu m. We find that stolons grew within grooves early in colony ontogeny, but remained restricted to them only in the grid pattern with channel intersections every 150 mu m. Finally, we created a grid in the shape of the Yale Y logo, with channels of 50: 50 mu m width: depth and intersections every 100 mu m. The resulting colonies conformed to that of the logo. Our findings demonstrate that stolons respond to surface heterogeneity and that surface etching can be used to fabricate microfluidic circuits comprised of hydroid perisarc.	[Buss, Leo W.; Buss, Evan D.; Anderson, Christopher P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Buss, Leo W.] Smithsonian Marine Stn, Ft Pierce, FL USA; [Power, Michael] Yale Univ, Sch Engn & Appl Sci, New Haven, CT USA; [Zinter, Joseph] Yale Univ, Ctr Engn Design & Innovat, New Haven, CT USA	Yale University; Smithsonian Institution; Smithsonian National Museum of Natural History; Yale University; Yale University	Buss, LW (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA.; Buss, LW (corresponding author), Smithsonian Marine Stn, Ft Pierce, FL USA.	leo.buss@yale.edu						Beloussov L.V., 1973, Publications Seto Mar Biol Lab, V20, P315; BELOUSSOV LV, 1989, J EXP ZOOL, V249, P258, DOI 10.1002/jez.1402490304; BELOUSSOV LV, 1972, J EMBRYOL EXP MORPH, V27, P317; Blackstone NW, 1999, J EXP BIOL, V202, P3541; Blackstone NW, 1998, J EXP BIOL, V201, P2821; Blackstone NW, 2005, J EXP BIOL, V208, P383, DOI 10.1242/jeb.01394; Blackstone NW, 2004, INVERTEBR BIOL, V123, P43; Blackstone NW, 2003, J EXP BIOL, V206, P651, DOI 10.1242/jeb.00138; Blackstone NW, 2001, J EXP BIOL, V204, P1845; Blackstone NW, 1996, BIOL BULL, V190, P56, DOI 10.2307/1542675; BLACKSTONE NW, 1991, BIOL BULL, V180, P394, DOI 10.2307/1542340; BOARDMAN RS, 1973, ANIMAL COLONIES; BRAVERMAN M, 1974, AM ZOOL, V14, P673; BRAVERMAN M, 1971, J MORPHOL, V135, P131, DOI 10.1002/jmor.1051350202; BRAVERMAN M, 1968, J MORPHOL, V126, P95, DOI 10.1002/jmor.1051260106; Braverman M, 1966, CNIDARIA THEIR EVOLU, P169; Braverman M, 1974, ANN REV OCEANOGRAPHY, V12, P129; BRAVERMAN MH, 1963, J EMBRYOL EXP MORPH, V11, P239; BRAVERMAN MH, 1962, SCIENCE, V135, P310, DOI 10.1126/science.135.3500.310; Brown C. H., 1975, STRUCTURAL MAT ANIMA; Bumann D, 2008, INVERTEBR BIOL, V127, P368, DOI 10.1111/j.1744-7410.2008.00135.x; Buss LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136814; Buss LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072221; BUSS LW, 1991, PHILOS T ROY SOC B, V332, P49, DOI 10.1098/rstb.1991.0032; BUSS LW, 1984, BIOL BULL, V167, P139, DOI 10.2307/1541343; Buss LW, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P3; BUSS LW, 1988, ECOLOGY, V69, P646, DOI 10.2307/1941013; Cairns SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021670; CHAPMAN D M, 1969, Tissue and Cell, V1, P619, DOI 10.1016/S0040-8166(69)80036-4; DONALDSON S, 1974, AM ZOOL, V14, P735; Dudgeon S, 1999, BIOL BULL, V196, P1, DOI 10.2307/1543161; Dudgeon SR, 2011, ADV MAR BIOL, V59, P107, DOI 10.1016/B978-0-12-385536-7.00003-0; Dudgeon SR, 1996, AM NAT, V147, P667, DOI 10.1086/285874; Franssila S, 2010, INTRO MICROFABRICATI; HALE LJ, 1960, Q J MICROSC SCI, V101, P339; HALE LJ, 1964, J EMBRYOL EXP MORPH, V12, P517; Harmata KL, 2011, PHYSIOL BIOCHEM ZOOL, V84, P481, DOI 10.1086/661952; Jackson J. B. C., 1985, POPULATION BIOL EVOL; Jansen HV, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/3/033001; Kern W, 1993, HDB SEMICONDUCTOR CL; Knight D. P., 1970, Tissue Cell, V2, P467, DOI 10.1016/S0040-8166(70)80045-3; KNIGHT DP, 1968, NATURE, V218, P585, DOI 10.1038/218584a0; KNIGHT DP, 1971, TISSUE CELL, V3, P57, DOI 10.1016/S0040-8166(71)80030-7; Kosevich I. A., 2006, Russian Journal of Developmental Biology, V37, P90, DOI 10.1134/S1062360406020056; LARWOOD G, 1979, BIOL SYSTEMATICS COL; MARCUM BA, 1978, TISSUE CELL, V10, P113, DOI 10.1016/0040-8166(78)90010-1; MCFADDEN CS, 1984, BIOL BULL, V166, P54, DOI 10.2307/1541430; Moreau WM, 2012, SEMICONDUCTOR LITHOG; Nicotra ML, 2005, BIOL BULL-US, V208, P157, DOI 10.2307/3593147; TARDENT P, 1983, MECH AGEING DEV, V21, P257, DOI 10.1016/0047-6374(83)90045-3; Thomas MB, 1991, SCOPIC ANATOMY INVER, P91; Tidball J.G., 1984, BIOL INTEGUMENT, P69; WYTTENBACH CR, 1973, J EXP ZOOL, V186, P79, DOI 10.1002/jez.1401860111; WYTTENBACH CR, 1968, J EXP ZOOL, V167, P333, DOI 10.1002/jez.1401670306; WYTTENBACH CR, 1974, AM ZOOL, V14, P699; YUND PO, 1987, ECOLOGY, V68, P971, DOI 10.2307/1938368; YUND PO, 1991, EVOLUTION, V45, P1564, DOI 10.1111/j.1558-5646.1991.tb02663.x	57	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156249	10.1371/journal.pone.0156249	http://dx.doi.org/10.1371/journal.pone.0156249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257948	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700047
J	Bwire, G; Mwesawina, M; Baluku, Y; Kanyanda, SSE; Orach, CG				Bwire, Godfrey; Mwesawina, Maurice; Baluku, Yosia; Kanyanda, Setiala S. E.; Orach, Christopher Garimoi			Cross-Border Cholera Outbreaks in Sub-Saharan Africa, the Mystery behind the Silent Illness: What Needs to Be Done?	PLOS ONE			English	Article							EPIDEMIC	Introduction Cross-border cholera outbreaks are a major public health problem in Sub-Saharan Africa contributing to the high annual reported cholera cases and deaths. These outbreaks affect all categories of people and are challenging to prevent and control. This article describes lessons learnt during the cross-border cholera outbreak control in Eastern and Southern Africa sub-regions using the case of Uganda-DRC and Malawi-Mozambique borders and makes recommendations for future outbreak prevention and control. Materials and Methods We reviewed weekly surveillance data, outbreak response reports and documented experiences on the management of the most recent cross-border cholera outbreaks in Eastern and Southern Africa sub-regions, namely in Uganda and Malawi respectively. Uganda-Democratic Republic of Congo and Malawi-Mozambique borders were selected because the countries sharing these borders reported high cholera disease burden to WHO. Results A total of 603 cross-border cholera cases with 5 deaths were recorded in Malawi and Uganda in 2015. Uganda recorded 118 cases with 2 deaths and CFR of 1.7%. The under-fives and school going children were the most affected age groups contributing 24.2% and 36.4% of all patients seen along Malawi-Mozambique and Uganda-DRC borders, respectively. These outbreaks lasted for over 3 months and spread to new areas leading to 60 cases with 3 deaths, CRF of 5%, and 102 cases 0 deaths in Malawi and Uganda, respectively. Factors contributing to these outbreaks were: poor sanitation and hygiene, use of contaminated water, floods and rampant cross- border movements. The outbreak control efforts mainly involved unilateral measures implemented by only one of the affected countries. Conclusions Cross-border cholera outbreaks contribute to the high annual reported cholera burden in Sub-Saharan Africa yet they remain silent, marginalized and poorly identified by cholera actors (governments and international agencies). The under-fives and the school going children were the most affected age groups. To successfully prevent and control these outbreaks, guidelines and strategies should be reviewed to assign clear roles and responsibilities to cholera actors on collaboration, prevention, detection, monitoring and control of these epidemics.	[Bwire, Godfrey] Minist Hlth Uganda, Control Diarrheal Dis Unit, Kampala, Uganda; [Mwesawina, Maurice; Kanyanda, Setiala S. E.] Minist Hlth Malawi, Lilongwe, Malawi; [Baluku, Yosia] Bwera Hosp, Minist Hlth Uganda, Kasese, Uganda; [Orach, Christopher Garimoi] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	Makerere University	Bwire, G (corresponding author), Minist Hlth Uganda, Control Diarrheal Dis Unit, Kampala, Uganda.	cddmoh@yahoo.com	Bwire, Godfrey/J-7715-2019	Bwire, Godfrey/0000-0002-8376-2857	Ministry of Health of Malawi; Ministry of Health of Uganda	Ministry of Health of Malawi; Ministry of Health of Uganda	Data collection for this study was supported by the ministries of Health of Malawi and Uganda as part of the routine outbreak surveillance and response activities.	Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Bhattacharya S, 2009, SCIENCE, V324, P885, DOI 10.1126/science.1173890; Bradley M, 1996, T ROY SOC TROP MED H, V90, P378, DOI 10.1016/S0035-9203(96)90512-X; Coalition for Cholera Prevention and Control, 2013, COMPR INT STRAT PREV; Gaffga NH, 2007, AM J TROP MED HYG, V77, P705, DOI 10.4269/ajtmh.2007.77.705; GLASS RI, 1991, LANCET, V338, P791, DOI 10.1016/0140-6736(91)90673-D; Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Kasolo F, 2013, BIOSECUR BIOTERROR, V11, P163, DOI 10.1089/bsp.2013.0032; Mengel MA, 2014, T ROY SOC TROP MED H, V108, P391, DOI 10.1093/trstmh/tru077; Mengel MA, 2014, CURR TOP MICROBIOL, V379, P117, DOI 10.1007/82_2014_369; Msyamboza KP, 2014, J INFECT DEV COUNTR, V8, P720, DOI 10.3855/jidc.3506; Naidoo A, 2002, J R SOC PROMO HEALTH, V122, P89, DOI 10.1177/146642400212200209; Okeke IN, 2012, EMERG INFECT DIS, P362; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2010, WHO POS PAP; WHO, 2013, IHR NEWS        1220; WHO, 2013, CHOL SIT WHO AFR REG; WHO, 2013, OR CHOL VACC STOCKP; WHO, 2011, CHOL MECH CONTR PREV, V7, P13; World Health Organization, 2012, OB OV, P1; World Health Organization (WHO), 2016, INT HLTH REG 2005	24	30	31	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156674	10.1371/journal.pone.0156674	http://dx.doi.org/10.1371/journal.pone.0156674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258124	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700101
J	Herencia, C; Diaz-Tocados, JM; Jurado, L; de Oca, AM; Rodriguez-Ortiz, ME; Martin-Alonso, C; Martinez-Moreno, JM; Vergara, N; Rodriguez, M; Almaden, Y; Munoz-Castaneda, JR				Herencia, Carmen; Miguel Diaz-Tocados, Juan; Jurado, Lidia; Montes de Oca, Addy; Encarnacion Rodriguez-Ortiz, Maria; Martin-Alonso, Carmen; Martinez-Moreno, Julio M.; Vergara, Noemi; Rodriguez, Mariano; Almaden, Yolanda; Munoz-Castaneda, Juan R.			Procaine Inhibits Osteo/Odontogenesis through Wnt/beta-Catenin Inactivation	PLOS ONE			English	Article							DIFFERENTIATION; SCLEROSTIN; PERIODONTITIS	Introduction Periodontitis is a complex pathology characterized by the loss of alveolar bone. The causes and the mechanisms that promote this bone resorption still remain unknown. The knowledge of the critical regulators involved in the alteration of alveolar bone homeostasis is of great importance for developing molecular therapies. Procaine is an anesthetic drug with demethylant properties, mainly used by dentists in oral surgeries. The inhibitor role of Wnt signaling of procaine was described in vitro in colon cancer cells. Methods In this work we evaluated the role of procaine (1 uM) in osteo/odontogenesis of rat bone marrow mesenchymal stem cells. Similarly, the mechanisms whereby procaine achieves these effects were also studied. Results Procaine administration led to a drastic decrease of calcium content, alkaline phosphatase activity, alizarin red staining and an increase in the expression of Matrix Gla Protein. With respect to osteo/odontogenic markers, procaine decreased early and mature osteo/odontogenic markers. In parallel, procaine inhibited canonical Wnt/beta-catenin pathway, observing a loss of nuclear beta-catenin, a decrease in Lrp5 and Frizzled 3, a significant increase of sclerostin and Gsk3 beta and an increase of phosphorylated beta-catenin. The combination of osteo/odontogenic stimuli and Lithium Chloride decreased mRNA expression of Gsk3 beta, recovered by Procaine. Furthermore it was proved that Procaine alone dose dependently increases the expression of Gsk3 beta and beta-catenin phosphorylation. These effects of procaine were also observed on mature osteoblast. Interestingly, at this concentration of procaine no demethylant effects were observed. Conclusions Our results demonstrated that procaine administration drastically reduced the mineralization and osteo/odontogenesis of bone marrow mesenchymal stem cells inhibiting Wnt/beta-catenin pathway through the increase of Gsk3 beta expression and beta-catenin phosphorylation.	[Herencia, Carmen; Miguel Diaz-Tocados, Juan; Jurado, Lidia; Montes de Oca, Addy; Martin-Alonso, Carmen; Martinez-Moreno, Julio M.; Vergara, Noemi; Rodriguez, Mariano; Munoz-Castaneda, Juan R.] Univ Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, Serv Nefrol, Cordoba, Spain; [Encarnacion Rodriguez-Ortiz, Maria] REDinREN, Fdn Jimenez Diaz, Nephrol Lab, Madrid, Spain; [Almaden, Yolanda] REDinREN, Lipids & Atherosclerosis Unit, CIBEROBN, Hosp Univ Reina Sofia,IMIBIC, Cordoba, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Munoz-Castaneda, JR (corresponding author), Univ Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hosp Univ Reina Sofia, Serv Nefrol, Cordoba, Spain.	juanr.munoz.exts@juntadeandalucia.es	Muñoz-Castañeda, Juan R./AFQ-3443-2022; Herencia, Carmen/AAA-6843-2020; Tocados, Juan Miguel Díaz/I-8254-2018; Martínez, Julio Manuel/AAA-6724-2020	Martínez, Julio Manuel/0000-0002-1945-5078; Munoz-Castaneda, Juan R/0000-0002-9341-0724; Rodriguez, Mariano/0000-0002-9380-6614; Diaz Tocados, Juan Miguel/0000-0001-5192-5212	Consejeria de Economia, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia) [P09-CTS-05205]; Consejeria de Salud (Junta de Andalucia) [SAS111221]; Instituto de Salud Carlos III [FIS PI11/02055]; Nicolas Monardes Programm from Consejeria de Salud from Junta de Andalucia, Spain	Consejeria de Economia, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia); Consejeria de Salud (Junta de Andalucia)(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Nicolas Monardes Programm from Consejeria de Salud from Junta de Andalucia, Spain(Junta de Andalucia)	This study was supported by grants from Consejeria de Economia, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia: P09-CTS-05205), Consejeria de Salud (Junta de Andalucia: SAS111221) and Instituto de Salud Carlos III (FIS PI11/02055). JRM-C and YA are supported by Nicolas Monardes Programm from Consejeria de Salud from Junta de Andalucia, Spain.; The authors deny any potential conflict of interest related to this study and they have no financial affiliations. This study was supported by grants from Consejeria de Economia, Ciencia y Empresa, Junta de Andalucia (Proyecto de Excelencia: P09-CTS-05205), Consejeria de Salud ( Junta de Andalucia: SAS111221) and Instituto de Salud Carlos III (FIS PI11/02055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JR. M-C and YA are supported by Nicolas Monardes Program from Consejeria de Salud from Junta de Andalucia, Spain. Authors state no conflicts of interest.	Abbayya K, 2015, N AM J MED SCI, V7, P241, DOI 10.4103/1947-2714.159325; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Galli C, 2011, J PERIODONTAL RES, V46, P397, DOI 10.1111/j.1600-0765.2011.01354.x; Gambardella A, 2011, J BONE MINER RES, V26, P811, DOI 10.1002/jbmr.266; Gao Z, 2009, ONCOL REP, V22, P1479, DOI 10.3892/or_00000590; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Kaipatur NR, 2008, J DENT RES, V87, P839, DOI 10.1177/154405910808700907; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Kucher U, 2014, INT J ORAL SCI, V6, P70, DOI 10.1038/ijos.2014.12; Lee SI, 2014, J DENT RES, V93, P678, DOI 10.1177/0022034514535214; Lim WH, 2015, J PERIODONTOL, V86, P319, DOI 10.1902/jop.2014.140286; Lim WH, 2014, AM J ORTHOD DENTOFAC, V146, P337, DOI 10.1016/j.ajodo.2014.05.027; de Oca AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089525; de Oca AM, 2010, J BONE MINER RES, V25, P1996, DOI 10.1002/jbmr.93; Napimoga MH, 2014, J CLIN PERIODONTOL, V41, P550, DOI 10.1111/jcpe.12245; Pihlstrom BL, 2014, J AM DENT ASSOC, V145, P1208, DOI 10.14219/jada.2014.112; Qiang YW, 2008, BONE, V42, P669, DOI 10.1016/j.bone.2007.12.006; Ren YS, 2015, FASEB J, V29, P2702, DOI 10.1096/fj.14-265496; Rogers CL, 2001, J EXP BIOL, V204, P2657; Shan TF, 2015, CELL BIOL INT, V39, P35, DOI 10.1002/cbin.10340; Singh N, 2009, CHEMMEDCHEM, V4, P792, DOI 10.1002/cmdc.200900017; Taut AD, 2013, J BONE MINER RES, V28, P2347, DOI 10.1002/jbmr.1984; Villar-Garea A, 2003, CANCER RES, V63, P4984; Yamaguchi Akira, 2010, Clin Calcium, V20, P1669, DOI CliCa101116691676; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071	26	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156788	10.1371/journal.pone.0156788	http://dx.doi.org/10.1371/journal.pone.0156788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257912	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700127
J	Hentze, K; Thonfeld, F; Menz, G				Hentze, Konrad; Thonfeld, Frank; Menz, Gunter			Evaluating Crop Area Mapping from MODIS Time-Series as an Assessment Tool for Zimbabwe's "Fast Track Land Reform Programme"	PLOS ONE			English	Article							RANDOM FOREST CLASSIFIER; MONITORING VEGETATION; SOUTHERN AFRICA; COVER; PHENOLOGY; RESETTLEMENT; DEGRADATION; LANDSCAPES; ECOSYSTEM; SUPPORT	Moderate Resolution Imaging Spectroradiometer (MODIS) data forms the basis for numerous land use and land cover (LULC) mapping and analysis frameworks at regional scale. Compared to other satellite sensors, the spatial, temporal and spectral specifications of MODIS are considered as highly suitable for LULC classifications which support many different aspects of social, environmental and developmental research. The LULC mapping of this study was carried out in the context of the development of an evaluation approach for Zimbabwe's land reform program. Within the discourse about the success of this program, a lack of spatially explicit methods to produce objective data, such as on the extent of agricultural area, is apparent. We therefore assessed the suitability of moderate spatial and high temporal resolution imagery and phenological parameters to retrieve regional figures about the extent of cropland area in former freehold tenure in a series of 13 years from 2001-2013. Time-series data was processed with TIMESAT and was stratified according to agro-ecological potential zoning of Zimbabwe. Random Forest (RF) classifications were used to produce annual binary crop/non crop maps which were evaluated with high spatial resolution data from other satellite sensors. We assessed the cropland products in former freehold tenure in terms of classification accuracy, inter-annual comparability and heterogeneity. Although general LULC patterns were depicted in classification results and an overall accuracy of over 80% was achieved, user accuracies for rainfed agriculture were limited to below 65%. We conclude that phenological analysis has to be treated with caution when rainfed agriculture and grassland in semi-humid tropical regions have to be separated based on MODIS spectral data and phenological parameters. Because classification results significantly underestimate redistributed commercial farmland in Zimbabwe, we argue that the method cannot be used to produce spatial information on land-use which could be linked to tenure change. Hence capabilities of moderate resolution data are limited to assess Zimbabwe's land reform. To make use of the unquestionable potential of MODIS time-series analysis, we propose an analysis of plant productivity which allows to link annual growth and production of vegetation to ownership after Zimbabwe's land reform.	[Hentze, Konrad; Thonfeld, Frank; Menz, Gunter] Univ Bonn, Dept Geog, Remote Sensing Res Grp, Bonn, Germany; [Thonfeld, Frank; Menz, Gunter] Univ Bonn, Ctr Remote Sensing Land Surfaces, Bonn, Germany	University of Bonn; University of Bonn	Hentze, K (corresponding author), Univ Bonn, Dept Geog, Remote Sensing Res Grp, Bonn, Germany.	k.hentze@geographie.uni-bonn.de		Thonfeld, Frank/0000-0002-3371-7206				Alcantara C, 2012, REMOTE SENS ENVIRON, V124, P334, DOI 10.1016/j.rse.2012.05.019; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Battrick B, 2005, GLOBAL EARTH OBSERVA; Brown Molly E., 2008, FAMINE EARLY WARNING; Chaumba J, 2003, J MOD AFR STUD, V41, P533, DOI 10.1017/S0022278X03004397; Chen J, 2004, REMOTE SENS ENVIRON, V91, P332, DOI 10.1016/j.rse.2004.03.014; Cliffe L, 2011, J PEASANT STUD, V38, P907, DOI 10.1080/03066150.2011.643387; Cousins B, 2010, J PEASANT STUD, V37, P31, DOI 10.1080/03066150903498739; Deininger K, 2004, WORLD DEV, V32, P1697, DOI 10.1016/j.worlddev.2004.06.006; Dubovyk O, 2013, ERDKUNDE, V67, P167, DOI 10.3112/erdkunde.2013.02.05; Eklundh L., 2012, TIMESAT 3 1 SOFTWARE; European Commision Joint Research Centre, 2016, GLOB LAND COV 2000 P; FAO, 2006, FERT US CROP ZIMB; FORMAN RTT, 1995, LANDSCAPE ECOL, V10, P133, DOI 10.1007/BF00133027; Fraser A, 2008, GEOGR REV, V98, P309, DOI 10.1111/j.1931-0846.2008.tb00303.x; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Fritz S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046213; Fritz S, 2010, INT J REMOTE SENS, V31, P2237, DOI 10.1080/01431160902946598; Funk C, 2009, REMOTE SENS ENVIRON, V113, P115, DOI 10.1016/j.rse.2008.08.015; Garcia-Mora TJ, 2012, INT J DIGIT EARTH, V5, P63, DOI 10.1080/17538947.2011.565080; Gstraunthaler T, 2011, Q J AUSTRIAN EC, V14, P311; Hanlon Joseph, 2013, ZIMBABWE TAKES BACK; Hentze K, 2015, LAND-BASEL, V4, P355, DOI 10.3390/land4020355; Herold M, 2008, REMOTE SENS ENVIRON, V112, P2538, DOI 10.1016/j.rse.2007.11.013; IUSS W.G.W, 2006, WORLD REF BAS SOIL R; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Kuri F, 2014, INT J APPL EARTH OBS, V33, P39, DOI 10.1016/j.jag.2014.04.021; Lhermitte S, 2011, REMOTE SENS ENVIRON, V115, P3129, DOI 10.1016/j.rse.2011.06.020; Lobell DB, 2004, REMOTE SENS ENVIRON, V93, P412, DOI 10.1016/j.rse.2004.08.002; Lotsch A., 2003, International Journal of Remote Sensing, V24, P1997, DOI 10.1080/01431160210154858; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Lunetta RS, 2010, INT J APPL EARTH OBS, V12, P81, DOI 10.1016/j.jag.2009.11.005; Maguranyanga C, 2015, J INDIAN SOC REMOTE, V43, P79, DOI 10.1007/s12524-014-0395-3; Matavire MS, 2015, T R SOC S AFR, V70, P1, DOI [10.1080/0035919X.2015.1017865, DOI 10.1080/0035919X.2015.1017865]; Matsa M., 2011, ETHIOP J ENV STUD MA, V4, P88, DOI [10.4314/ejesm.v4i2.10, DOI 10.4314/EJESM.V4I2.10]; Mlambo Alois S., 2014, HIST ZIMBABWE; Moody A, 1995, LANDSCAPE ECOL, V10, P363, DOI 10.1007/BF00130213; Nuding MA, 1999, NATURRESSOURCEN NUTZ; Olivieri F, 2008, AM J PHYS ANTHROPOL, V136, P214, DOI 10.1002/ajpa.20797; Owens T, 2003, ECON DEV CULT CHANGE, V51, P337, DOI 10.1086/346113; Pal M, 2005, INT J REMOTE SENS, V26, P217, DOI 10.1080/01431160412331269698; Pal M, 2005, INT J REMOTE SENS, V26, P1007, DOI 10.1080/01431160512331314083; PALMER R, 1990, AFR AFFAIRS, V89, P163, DOI 10.1093/oxfordjournals.afraf.a098283; Pan ZK, 2015, INT J APPL EARTH OBS, V34, P188, DOI 10.1016/j.jag.2014.08.011; Petit C, 2001, INT J REMOTE SENS, V22, P3435, DOI 10.1080/01431160010006881; Pittman K, 2010, REMOTE SENS-BASEL, V2, P1844, DOI 10.3390/rs2071844; Potts D., 2012, HDB LAND WATER GRABS, P24; Prince SD, 2009, REMOTE SENS ENVIRON, V113, P1046, DOI 10.1016/j.rse.2009.01.016; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Saura S, 2004, LANDSCAPE ECOL, V19, P197, DOI 10.1023/B:LAND.0000021724.60785.65; Scoones I., 2014, DEBATING ZIMBABWES L; Senf C, 2012, INT GEOSCI REMOTE SE, P6733, DOI 10.1109/IGARSS.2012.6352560; Sibanda M, 2012, INT J REMOTE SENS, V33, P4841, DOI 10.1080/01431161.2011.635715; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; TUCKER CJ, 1980, PHOTOGRAMM ENG REM S, V46, P657; van der Linden S, 2015, REMOTE SENS-BASEL, V7, P11249, DOI 10.3390/rs70911249; van Straaten H. P., 2002, ROCKS CROPS AGROMINE; Vina A, 2004, AGRON J, V96, P1139, DOI 10.2134/agronj2004.1139; Vincent V, AGR SURVEY SO RHOD 1; Vintrou E, 2012, INT J APPL EARTH OBS, V14, P83, DOI 10.1016/j.jag.2011.06.010; Wardlow BD, 2008, REMOTE SENS ENVIRON, V112, P1096, DOI 10.1016/j.rse.2007.07.019; Wessels KJ, 2004, REMOTE SENS ENVIRON, V92, P67, DOI 10.1016/j.rse.2004.05.002; Wessels KJ, 2004, REMOTE SENS ENVIRON, V91, P47, DOI 10.1016/j.rse.2004.02.005; Wessels KJ, 2009, INFLUENCE COMPOSITE; *Wild H., 1967, VEGETATION MAP FLORA; Woodcock CE, 1994, PHOTOGRAMM ENG REMOT, P60; Zhang XY, 2003, REMOTE SENS ENVIRON, V84, P471, DOI 10.1016/S0034-4257(02)00135-9; Zimbabwe National Statistics Agency, 2014, FACTS FIG 2014	68	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156630	10.1371/journal.pone.0156630	http://dx.doi.org/10.1371/journal.pone.0156630			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253327	gold, Green Published, Green Submitted			2022-12-26	WOS:000377218700046
J	Sabir, H; Osredkar, D; Maes, E; Wood, T; Thoresen, M				Sabir, Hemmen; Osredkar, Damjan; Maes, Elke; Wood, Thomas; Thoresen, Marianne			Xenon Combined with Therapeutic Hypothermia Is Not Neuroprotective after Severe Hypoxia-Ischemia in Neonatal Rats	PLOS ONE			English	Article							BRAIN-INJURY; HYPOXIA/ISCHEMIA; INHIBITION; ANESTHESIA; ASPHYXIA; RECEPTOR; MODELS; DAMAGE; DEATH	Background Therapeutic hypothermia (TH) is standard treatment following perinatal asphyxia in newborn infants. Experimentally, TH is neuroprotective after moderate hypoxia-ischemia (HI) in seven-day-old (P7) rats. However, TH is not neuroprotective after severe HI. After a moderate HI insult in newborn brain injury models, the anesthetic gas xenon (Xe) doubles TH neuroprotection. The aim of this study was to examine whether combining Xe and TH is neuroprotective as applied in a P7 rat model of severe HI. Design/Methods 120 P7 rat pups underwent a severe HI insult; unilateral carotid artery ligation followed by hypoxia (8% O-2 for 150min at experimental normothermia (NT-37: T-rectal 37 degrees C). Surviving pups were randomised to immediate NT-37 for 5h (n = 36), immediate TH-32: T-rectal 32 degrees C for 5h (n = 25) or immediate TH-32 plus 50% inhaled Xe for 5h (n = 24). Pups were sacrificed after one week of survival. Relative area loss of the ligated hemisphere was measured, and neurons in the subventricular zone of this injured hemisphere were counted, to quantify brain damage. Results Following the HI insult, median (interquartile range, IQR) hemispheric brain area loss was similar in all groups: 63.5% (55.5-75.0) for NT-37 group, 65.0%(57.0-65.0) for TH-32 group, and 66.5% (59.0-72.0) for TH-32+Xe50% group (not significant). Correspondingly, there was no difference in neuronal cell count (NeuN marker) in the subventricular zone across the three treatment groups. Conclusions Immediate therapeutic hypothermia with or without additional 50% inhaled Xe, does not provide neuroprotection one week after severe HI brain injury in the P7 neonatal rat. This model aims to mimic the clinical situation in severely asphyxiated neonates and treatment these newborns remains an ongoing challenge.	[Sabir, Hemmen; Osredkar, Damjan; Maes, Elke; Wood, Thomas; Thoresen, Marianne] Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway; [Sabir, Hemmen] Univ Dusseldorf, Dept Gen Pediat Neonatol & Pediat Cardiol, Dusseldorf, Germany; [Thoresen, Marianne] Univ Bristol, St Michaels Hosp, Sch Clin Sci, Bristol, Avon, England	University of Oslo; Heinrich Heine University Dusseldorf; University of Bristol	Thoresen, M (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway.; Thoresen, M (corresponding author), Univ Bristol, St Michaels Hosp, Sch Clin Sci, Bristol, Avon, England.	marianne.thoresen@medisin.uio.no	Osredkar, Damjan/M-3739-2019; Wood, Tommy/AAC-8252-2019; Osredkar, Damjan/B-6293-2011; Wood, Thomas/GWZ-2481-2022	Osredkar, Damjan/0000-0002-2188-420X; Wood, Tommy/0000-0002-1130-2720; Osredkar, Damjan/0000-0002-2188-420X; Wood, Thomas/0000-0001-8962-8571	Sport Aiding Medical Research for Kids (SPARKS, UK); Norwegian Research Council (NFR); Laerdal Foundation for Acute Medicine; Deutscher Akademischer Austauschdienst (DAAD); Sparks Charity [05BTL01, 14BTL01] Funding Source: researchfish	Sport Aiding Medical Research for Kids (SPARKS, UK); Norwegian Research Council (NFR)(Research Council of Norway); Laerdal Foundation for Acute Medicine; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Sparks Charity	This study was funded by Sport Aiding Medical Research for Kids (SPARKS, UK), Norwegian Research Council (NFR), The Laerdal Foundation for Acute Medicine, and Deutscher Akademischer Austauschdienst (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; Chakkarapani E, 2013, J CEREBR BLOOD F MET, V33, P1752, DOI 10.1038/jcbfm.2013.123; Chakkarapani E, 2010, ANN NEUROL, V68, P330, DOI 10.1002/ana.22016; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; Dingley J, 2014, PEDIATRICS, V133, P809, DOI 10.1542/peds.2013-0787; Faulkner S, 2011, ANN NEUROL, V70, P133, DOI 10.1002/ana.22387; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Gunn AJ, 1999, PEDIATR RES, V46, P274, DOI 10.1203/00006450-199909000-00005; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Hobbs C, 2008, STROKE, V39, P1307, DOI 10.1161/STROKEAHA.107.499822; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Laitio R, 2016, JAMA-J AM MED ASSOC, V315, P1120, DOI 10.1001/jama.2016.1933; Liu X, 2015, PEDIATR RES, V77, P779, DOI 10.1038/pr.2015.49; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Mallard C, 2015, STROKE, V46, P3006, DOI 10.1161/STROKEAHA.115.007776; Neukirchen M, 2012, BRIT J ANAESTH, V109, P887, DOI 10.1093/bja/aes303; Osredkar D, 2014, RESUSCITATION, V85, P567, DOI 10.1016/j.resuscitation.2013.12.006; Palmer GC, 2000, AMINO ACIDS, V19, P151, DOI 10.1007/s007260070043; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Romanko MJ, 2007, J NEUROCHEM, V103, P1121, DOI 10.1111/j.1471-4159.2007.04820.x; Sabir H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109845; Sabir H, 2013, ANESTHESIOLOGY, V119, P345, DOI 10.1097/ALN.0b013e318294934d; Sabir H, 2012, STROKE, V43, P3364, DOI 10.1161/STROKEAHA.112.674481; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; Tooley JR, 2003, ANN NEUROL, V53, P65, DOI 10.1002/ana.10402; Wood T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23430	30	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156759	10.1371/journal.pone.0156759	http://dx.doi.org/10.1371/journal.pone.0156759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253085	gold, Green Published, Green Submitted			2022-12-26	WOS:000377218700055
J	Wu, XG; Shi, Y; Yan, DW; Li, XS; Yan, PX; Gao, XY; Zhang, YE; Yu, L; Ren, CC; Li, GX; Yan, LP; Teng, QY; Li, ZJ				Wu, Xiaogang; Shi, Ying; Yan, Dawei; Li, Xuesong; Yan, Pixi; Gao, Xuyuan; Zhang, Yuee; Yu, Lei; Ren, Chaochao; Li, Guoxin; Yan, Liping; Teng, Qiaoyang; Li, Zejun			Development of a PCR-Based Reverse Genetics System for an Attenuated Duck Tembusu Virus Strain	PLOS ONE			English	Article							JAPANESE-ENCEPHALITIS-VIRUS; INFECTIOUS CDNA-CLONE; FULL-LENGTH CDNA; WEST NILE VIRUS; POLYMERASE-CHAIN-REACTION; COMPLETE GENOME SEQUENCE; EGG-DROP SYNDROME; CAPSID PROTEIN; FEVER VIRUS; IN-VITRO	The infectious disease caused by the duck Tembusu virus (DTMUV) has resulted in massive economic losses to the Chinese duck industry in China since 2010. Research on the molecular basis of DTMUV pathogenicity has been hampered by the lack of a reliable reverse genetics system for this virus. Here we developed a PCR-based reverse genetics system with high fidelity for the attenuated DTMUV strain FX2010-180P. The rescued virus was characterized by using both indirect immunofluorescence assays (IFA) and whole genome sequencing. The rescued virus (rFX2010-180P) grew to similar titers as compared with the wild-type virus in DF-1 cells, and had similar replication and immunogenicity properties in ducks. To determine whether exogenous proteins could be expressed from DTMUV, both an internal ribosomal entry site (IRES) and the enhanced green fluorescent protein (eGFP) gene were introduced between the NS5 gene and the 3' non-coding sequence of FX2010-180P. A recombinant DTMUV expressing eGFP was rescued, but eGFP expression was unstable after 4 passages in DF-1 cells due to a deletion of 1,294 nucleotides. The establishment of a reliable reverse genetics system for FX2010-180P provides a foundation for future studies of DTMUV.	[Li, Zejun] Chinese Acad Agr Sci, Dept Avian Infect Dis, Shanghai Vet Res Inst, Shanghai, Peoples R China; Chinese Acad Agr Sci, Innovat Team Pathogen Ecol Res Anim Influenza Vir, Shanghai Vet Res Inst, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Li, ZJ (corresponding author), Chinese Acad Agr Sci, Dept Avian Infect Dis, Shanghai Vet Res Inst, Shanghai, Peoples R China.	lizejun@shvri.ac.cn	Wu, Xiaogang/N-8920-2018	Wu, Xiaogang/0000-0002-7552-5616	National Natural Science Foundation of China [31172332, 31472205, 31402150]; Shanghai Science and Technology Program for Agriculture [2012-2-6]; "Innovation Action Plan" Key Basic Research Project of Shanghai Science and Technology Commission [12JC1410600]; "Innovation Action Plan" Key Scientific and Technological Projects in the Field of Modern Agriculture of Shanghai Science and Technology Commission [13391901601]; Special Fund for Central Nonprofit Research Institutes Fundamental Research [2011JB02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Program for Agriculture; "Innovation Action Plan" Key Basic Research Project of Shanghai Science and Technology Commission; "Innovation Action Plan" Key Scientific and Technological Projects in the Field of Modern Agriculture of Shanghai Science and Technology Commission; Special Fund for Central Nonprofit Research Institutes Fundamental Research	This study was supported by the National Natural Science Foundation of China (no. 31172332, 31472205 and 31402150), the Shanghai Science and Technology Program for Agriculture (no. 2012-2-6), the "Innovation Action Plan" Key Basic Research Project of Shanghai Science and Technology Commission (no. 12JC1410600), the "Innovation Action Plan" Key Scientific and Technological Projects in the Field of Modern Agriculture of Shanghai Science and Technology Commission (no. 13391901601), and the Special Fund for Central Nonprofit Research Institutes Fundamental Research (no. 2011JB02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaldo MC, 2010, J VIROL, V84, P3699, DOI 10.1128/JVI.02255-09; Cameron-Wilson CL, 2002, J MOL MICROB BIOTECH, V4, P127; Campbell MS, 2000, VIROLOGY, V269, P225, DOI 10.1006/viro.2000.0220; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Chen H, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1128/GEN0MEA.00789-13; Forns X, 1997, P NATL ACAD SCI USA, V94, P13909, DOI 10.1073/pnas.94.25.13909; Huang XM, 2013, RES VET SCI, V94, P774, DOI 10.1016/j.rvsc.2012.11.014; Jiang XH, 2011, VACCINE, V29, P1248, DOI 10.1016/j.vaccine.2010.11.079; Kawaguchi Yasushi, 2004, Uirusu, V54, P255, DOI 10.2222/jsv.54.255; LAI CJ, 1991, P NATL ACAD SCI USA, V88, P5139, DOI 10.1073/pnas.88.12.5139; Li GX, 2014, VIROLOGY, V450, P233, DOI 10.1016/j.virol.2013.12.028; Li LL, 2012, VIRUS GENES, V45, P105, DOI 10.1007/s11262-012-0753-6; Li S, 2013, VIRUS RES, V171, P238, DOI 10.1016/j.virusres.2012.10.019; Li XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053026; Liu M, 2012, J CLIN MICROBIOL, V50, P2807, DOI 10.1128/JCM.00655-12; Liu PP, 2012, J GEN VIROL, V93, P2158, DOI 10.1099/vir.0.043554-0; Maeda A, 2009, VIRUS RES, V144, P35, DOI 10.1016/j.virusres.2009.03.021; McElroy KL, 2005, J GEN VIROL, V86, P1747, DOI 10.1099/vir.0.80746-0; Miyanishi M, 2002, ARCH VIROL, V147, P1141, DOI 10.1007/s00705-002-0798-2; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; Qiu J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018106, DOI 10.1371/JOURNAL.PONE.0018106]; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992; Tang Y, 2015, TRANSBOUND EMERG DIS, V62, P209, DOI 10.1111/tbed.12111; Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P193, DOI 10.1111/tbed.12085; Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P152, DOI 10.1111/j.1865-1682.2012.01328.x; Tang Y, 2012, TRANSBOUND EMERG DIS, V59, P336, DOI 10.1111/j.1865-1682.2011.01275.x; Wan CH, 2012, J VIROL, V86, P10912, DOI 10.1128/JVI.01582-12; YAMSHCHIKOV VF, 1994, GENE, V149, P193, DOI 10.1016/0378-1119(94)90150-3; YAMSHCHIKOV VF, 1994, J VIROL, V68, P5765, DOI 10.1128/JVI.68.9.5765-5771.1994; Yan LP, 2012, J VIROL METHODS, V182, P50, DOI 10.1016/j.jviromet.2012.03.007; Yan LP, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-464; Yan PX, 2011, VIROLOGY, V417, P1, DOI 10.1016/j.virol.2011.06.003; Yoshii K, 2011, VIRUS RES, V155, P61, DOI 10.1016/j.virusres.2010.08.023; Yun SI, 2003, J VIROL, V77, P6450, DOI 10.1128/JVI.77.11.6450-6465.2003; Yun T, 2012, VET MICROBIOL, V157, P311, DOI 10.1016/j.vetmic.2012.01.013; Yun T, 2012, J VIROL, V86, P3406, DOI 10.1128/JVI.07132-11; Zhang FQ, 2001, J VIROL METHODS, V96, P171, DOI 10.1016/S0166-0934(01)00331-7; Zhao ZJ, 2005, J GEN VIROL, V86, P2209, DOI 10.1099/vir.0.80638-0; Zhu W, 2007, VIRUS RES, V126, P226, DOI 10.1016/j.virusres.2007.03.004	41	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156579	10.1371/journal.pone.0156579	http://dx.doi.org/10.1371/journal.pone.0156579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248497	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700055
J	Ali, I; Ramage, H; Boehm, D; Dirk, LMA; Sakane, N; Hanada, K; Pagans, S; Kaehlcke, K; Aull, K; Weinberger, L; Trievel, R; Schnoelzer, M; Kamada, M; Houtz, R; Ott, M				Ali, Ibraheem; Ramage, Holly; Boehm, Daniela; Dirk, Lynnette M. A.; Sakane, Naoki; Hanada, Kazuki; Pagans, Sara; Kaehlcke, Katrin; Aull, Katherine; Weinberger, Leor; Trievel, Raymond; Schnoelzer, Martina; Kamada, Masafumi; Houtz, Robert; Ott, Melanie			The HIV-1 Tat Protein Is Monomethylated at Lysine 71 by the Lysine Methyltransferase KMT7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CYCLIN T1; TRANSCRIPTIONAL ACTIVITY; STRUCTURAL BASIS; IN-VITRO; METHYLATION; TRANSACTIVATION; RNA; REGION; LATENCY; CURE	The HIV-1 transactivator protein Tat is a critical regulator of HIV transcription primarily enabling efficient elongation of viral transcripts. Its interactions with RNA and various host factors are regulated by ordered, transient post-translational modifications. Here, we report a novel Tat modification, monomethylationatlysine-71 (K71). We found that Lys-71 monomethylation (K71me) is catalyzed by KMT7, a methyltransferase that also targets lysine 51 (K51) in Tat. Using mass spectrometry, in vitro enzymology, and modification-specific antibodies, we found that KMT7 monomethylates both Lys-71 and Lys-51 in Tat. K71me is important for full Tat transactivation, as KMT7 knockdown impaired the transcriptional activity of wild type (WT) Tat but not a Tat K71R mutant. These findings underscore the role of KMT7 as an important monomethyltransferase regulating HIV transcription through Tat.	[Ali, Ibraheem; Ramage, Holly; Boehm, Daniela; Sakane, Naoki; Pagans, Sara; Kaehlcke, Katrin; Aull, Katherine; Weinberger, Leor; Ott, Melanie] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Ali, Ibraheem; Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Aull, Katherine; Weinberger, Leor] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Dirk, Lynnette M. A.; Houtz, Robert] Univ Kentucky, Dept Hort, Lexington, KY 40508 USA; [Sakane, Naoki; Hanada, Kazuki; Kamada, Masafumi] JT Inc, Pharmaceut Frontier Res Lab, Yokohama, Kanagawa 2360004, Japan; [Trievel, Raymond] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Schnoelzer, Martina] German Canc Res Ctr, D-69121 Heidelberg, Germany	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Kentucky; University of Michigan System; University of Michigan; Helmholtz Association; German Cancer Research Center (DKFZ)	Ott, M (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.; Ott, M (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA.	mott@gladstone.ucsf.edu	Pagans, Sara/G-3407-2015	Pagans, Sara/0000-0003-0772-6982; Hanada, Kazuki/0000-0001-7554-107X; Aull, Katherine/0000-0003-4289-1342; Ali, Ibraheem/0000-0003-3945-2701; Ramage, Holly/0000-0002-0390-6786	University of California San Francisco; Gladstone Institute of Virology and Immunology Center for AIDS Research; JT Pharma, Gladstone Institutes, CA AIDS Research Program; National Institutes of Health [R01AI083139, U19AI096113, T32IA7334-26, P30AI027763]; California HIV/AIDS Research Program (CHRP) [ID F13-GI-316]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109593, T32AI060537, P30AI027763, U19AI096113, R01AI083139, T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067547] Funding Source: NIH RePORTER	University of California San Francisco(University of California System); Gladstone Institute of Virology and Immunology Center for AIDS Research; JT Pharma, Gladstone Institutes, CA AIDS Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California HIV/AIDS Research Program (CHRP); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of California San Francisco, Gladstone Institute of Virology and Immunology Center for AIDS Research, a collaboration with JT Pharma, Gladstone Institutes, CA AIDS Research Program, and Grants R01AI083139, U19AI096113, T32IA7334-26, and P30AI027763 from the National Institutes of Health, and Grant ID F13-GI-316 from the California HIV/AIDS Research Program (CHRP). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Bruner KM, 2015, TRENDS MICROBIOL, V23, P192, DOI 10.1016/j.tim.2015.01.013; Campbell GR, 2004, J BIOL CHEM, V279, P48197, DOI 10.1074/jbc.M406195200; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Dahabieh MS, 2015, ANNU REV MED, V66, P407, DOI 10.1146/annurev-med-092112-152941; Del Rizzo PA, 2011, EPIGENETICS-US, V6, P1059, DOI 10.4161/epi.6.9.16069; Dhayalan A, 2011, CHEM BIOL, V18, P111, DOI 10.1016/j.chembiol.2010.11.014; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Endo-Munoz L, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-17; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; GARCIA JA, 1989, EMBO J, V8, P765, DOI 10.1002/j.1460-2075.1989.tb03437.x; HOUTZ RL, 1991, PLANT PHYSIOL, V97, P913, DOI 10.1104/pp.97.3.913; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; LORET EP, 1992, P NATL ACAD SCI USA, V89, P9734, DOI 10.1073/pnas.89.20.9734; Masatsugu T, 2009, BIOCHEM BIOPH RES CO, V381, P22, DOI 10.1016/j.bbrc.2009.01.185; Mbonye U, 2014, VIROLOGY, V454, P328, DOI 10.1016/j.virol.2014.02.008; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pagans S, 2011, METHODS, V53, P91, DOI 10.1016/j.ymeth.2010.07.001; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Rambaut A., 2015, HIV SEQUENCE COMPEND; Razooky BS, 2015, CELL, V160, P990, DOI 10.1016/j.cell.2015.02.009; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; SELBY MJ, 1989, GENE DEV, V3, P547, DOI 10.1101/gad.3.4.547; Singh A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.38; Sivakumaran H, 2009, J VIROL, V83, P11694, DOI 10.1128/JVI.00499-09; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Taube R, 2000, J VIROL, V74, P892, DOI 10.1128/JVI.74.2.892-898.2000; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yang XZ, 1997, P NATL ACAD SCI USA, V94, P12331, DOI 10.1073/pnas.94.23.12331; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	40	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16240	16248		10.1074/jbc.M116.735415	http://dx.doi.org/10.1074/jbc.M116.735415			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27235396	Green Published, hybrid			2022-12-26	WOS:000380585400028
J	Kang, HS; Takeda, Y; Jeon, K; Jetten, AM				Kang, Hong Soon; Takeda, Yukimasa; Jeon, Kilsoo; Jetten, Anton M.			The Spatiotemporal Pattern of Glis3 Expression Indicates a Regulatory Function in Bipotent and Endocrine Progenitors during Early Pancreatic Development and in Beta, PP and Ductal Cells	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; NEONATAL DIABETES-MELLITUS; ZINC-FINGER PROTEINS; PHYSIOLOGICAL FUNCTIONS; LINEAGE DETERMINANTS; ADULT PANCREAS; NEUROGENIN 3; TRANSCRIPTION; GENE; LOCI	The transcription factor Glis-similar 3 (Glis3) has been implicated in the development of neonatal, type 1 and type 2 diabetes. In this study, we examined the spatiotemporal expression of Glis3 protein during embryonic and neonatal pancreas development as well as its function in PP cells. To obtain greater insights into the functions of Glis3 in pancreas development, we examined the spatiotemporal expression of Glis3 protein in a knockin mouse strain expressing a Glis3-EGFP fusion protein. Immunohistochemistry showed that Glis3-EGFP was not detectable during early pancreatic development (E11.5 and E12.5) and at E13.5 and 15.5 was not expressed in Ptf1a(+) cells in the tip domains indicating that Glis3 is not expressed in multipotent pancreatic progenitors. Glis3 was first detectable at E13.5 in the nucleus of bipotent progenitors in the trunk domains, where it co-localized with Sox9, Hnf6, and Pdx1. It remained expressed in preductal and Ngn3(+) endocrine progenitors and at later stages becomes restricted to the nucleus of pancreatic beta and PP cells as well as ductal cells. Glis3-deficiency greatly reduced, whereas exogenous Glis3, induced Ppy expression, as reported for insulin. Collectively, our study demonstrates that Glis3 protein exhibits a temporal and cell type-specific pattern of expression during embryonic and neonatal pancreas development that is consistent with a regulatory role for Glis3 in promoting endocrine progenitor generation, regulating insulin and Ppy expression in beta and PP cells, respectively, and duct morphogenesis.	[Kang, Hong Soon; Takeda, Yukimasa; Jeon, Kilsoo; Jetten, Anton M.] NIEHS, Cell Biol Grp, Immun Inflammat & Dis Lab, Div Intramural Res,NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jetten, AM (corresponding author), NIEHS, Cell Biol Grp, Immun Inflammat & Dis Lab, Div Intramural Res,NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	jetten@niehs.nih.gov	Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445	National Institute of Environmental Health Sciences, National Institutes of Health [Z01-ES-100485]; Intramural Research Program of the National Institute of Environmental Health Sciences, the National Institutes of Health [Z01-ES-100485]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100485, Z01ES100485] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural Research Program of the National Institute of Environmental Health Sciences, the National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by National Institute of Environmental Health Sciences, National Institutes of Health Z01-ES-100485.; This research was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences, the National Institutes of Health [Z01-ES-100485]. The authors thank Laura Miller DeGraff for her excellent assistance with managing the mouse colonies.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Ames L., 2012, PLOS ONE, V7, DOI [10.13713ournal.pone.0052026, DOI 10.1371/JOURNAL.PONE.0052026]; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beak JY, 2008, NUCLEIC ACIDS RES, V36, P1690, DOI 10.1093/nar/gkn009; Benitez C. M., 2012, COLD SPRING HARBOR P, V4; Boesgaard TW, 2010, DIABETOLOGIA, V53, P1647, DOI 10.1007/s00125-010-1753-5; Carolan PJ, 2013, CURR OPIN ENDOCRINOL, V20, P1, DOI 10.1097/MED.0b013e32835bc380; De Vas MG, 2015, DEVELOPMENT, V142, P871, DOI 10.1242/dev.110759; Dimitri P, 2011, EUR J ENDOCRINOL, V164, P437, DOI 10.1530/EJE-10-0893; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Happe H, 2011, BBA-MOL BASIS DIS, V1812, P1249, DOI 10.1016/j.bbadis.2011.05.005; Hashimoto H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006299; Henseleit KD, 2005, DEVELOPMENT, V132, P3139, DOI 10.1242/dev.01875; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015542; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kang HS, 2010, HISTOL HISTOPATHOL, V25, P1481, DOI 10.14670/HH-25.1481; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Kim YS, 2012, MOL CELLS, V34, P193, DOI 10.1007/s10059-012-0109-z; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Kopp JL, 2011, CELL CYCLE, V10, P1921, DOI 10.4161/cc.10.12.16010; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Lichti-Kaiser K, 2012, VITAM HORM, V88, P141, DOI 10.1016/B978-0-12-394622-5.00007-9; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Pierreux CE, 2006, GASTROENTEROLOGY, V130, P532, DOI 10.1053/j.gastro.2005.12.005; Puri S, 2015, CELL STEM CELL, V16, P18, DOI 10.1016/j.stem.2014.11.001; Rieck S, 2012, SEMIN CELL DEV BIOL, V23, P673, DOI 10.1016/j.semcdb.2012.06.005; Sakai K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076317; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Seymour PA, 2011, DIABETES, V60, P364, DOI 10.2337/db10-1068; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Stanger BZ, 2013, GASTROENTEROLOGY, V144, P1170, DOI 10.1053/j.gastro.2013.01.074; Takeda Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004331; Watanabe N, 2009, FEBS LETT, V583, P2108, DOI 10.1016/j.febslet.2009.05.039; Yang Y, 2011, DIABETOLOGIA, V54, P2595, DOI 10.1007/s00125-011-2255-9; Yang YS, 2013, EMBO MOL MED, V5, P92, DOI 10.1002/emmm.201201398; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; ZeRuth GT, 2013, MOL ENDOCRINOL, V27, P1692, DOI 10.1210/me.2013-1117; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	46	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157138	10.1371/journal.pone.0157138	http://dx.doi.org/10.1371/journal.pone.0157138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270601	gold, Green Submitted, Green Published			2022-12-26	WOS:000377561000067
J	Kumar, KLS; Tangadpalliwar, SR; Desai, A; Singh, VK; Jere, A				Kumar, Konda Leela Sarath; Tangadpalliwar, Sujit R.; Desai, Aarti; Singh, Vivek K.; Jere, Abhay			Integrated Computational Solution for Predicting Skin Sensitization Potential of Molecules	PLOS ONE			English	Article							ADVERSE OUTCOME PATHWAY; ALLERGIC CONTACT-DERMATITIS; LYMPH-NODE DATA; IN-VITRO; FORCE FIELD; READ-ACROSS; QSAR MODELS; MECHANISMS; SYSTEMS; CLASSIFICATION	Introduction Skin sensitization forms a major toxicological endpoint for dermatology and cosmetic products. Recent ban on animal testing for cosmetics demands for alternative methods. We developed an integrated computational solution (SkinSense) that offers a robust solution and addresses the limitations of existing computational tools i.e. high false positive rate and/or limited coverage. Results The key components of our solution include: QSAR models selected from a combinatorial set, similarity information and literature-derived sub-structure patterns of known skin protein reactive groups. Its prediction performance on a challenge set of molecules showed accuracy = 75.32%, CCR = 74.36%, sensitivity = 70.00% and specificity = 78.72%, which is better than several existing tools including VEGA (accuracy = 45.00% and CCR = 54.17% with 'High' reliability scoring), DEREK (accuracy = 72.73% and CCR = 71.44%) and TOPKAT (accuracy = 60.00% and CCR = 61.67%). Although, TIMES-SS showed higher predictive power (accuracy = 90.00% and CCR = 92.86%), the coverage was very low (only 10 out of 77 molecules were predicted reliably). Conclusions Owing to improved prediction performance and coverage, our solution can serve as a useful expert system towards Integrated Approaches to Testing and Assessment for skin sensitization. It would be invaluable to cosmetic/dermatology industry for pre-screening their molecules, and reducing time, cost and animal testing.	[Kumar, Konda Leela Sarath; Tangadpalliwar, Sujit R.; Desai, Aarti; Singh, Vivek K.; Jere, Abhay] Persistent Syst Ltd, LABS, Pune, Maharashtra, India; [Kumar, Konda Leela Sarath; Tangadpalliwar, Sujit R.] Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat, Vaishali, Bihar, India	National Institute of Pharmaceutical Education & Research (NIPER)	Jere, A (corresponding author), Persistent Syst Ltd, LABS, Pune, Maharashtra, India.	abhay_jere@persistent.com		Konda, Leela Sarath Kumar/0000-0001-9877-5039				Alves VM, 2015, TOXICOL APPL PHARM, V284, P262, DOI [10.1016/j.taap.2014.12.013, 10.1016/j.taap.2014.12.014]; Anderson Stacey E, 2011, J Allergy (Cairo), V2011, P424203, DOI 10.1155/2011/424203; [Anonymous], 2010, VLIFEMDS MOLECULAR D; [Anonymous], 2012, TEST NO 109 DENS LIQ, DOI DOI 10.1787/9789264123298-EN; Aptula AO, 2006, CHEM RES TOXICOL, V19, P1097, DOI 10.1021/tx0601004; Bauch C, 2012, REGUL TOXICOL PHARM, V63, P489, DOI 10.1016/j.yrtph.2012.05.013; Blum LC, 2011, J COMPUT AID MOL DES, V25, P637, DOI 10.1007/s10822-011-9436-y; Bruce CL, 2007, J CHEM INF MODEL, V47, P219, DOI 10.1021/ci600332j; Chaudhry Q, 2010, CHEM CENT J, V4, DOI 10.1186/1752-153X-4-S1-S5; Chipinda I., 2011, J ALLERGY, V2011, DOI DOI 10.1155/2011/839682; Cronin M T, 1994, SAR QSAR Environ Res, V2, P159, DOI 10.1080/10629369408029901; Divkovic M, 2005, CONTACT DERMATITIS, V53, P189, DOI 10.1111/j.0105-1873.2005.00683.x; Dudek AZ, 2006, COMB CHEM HIGH T SCR, V9, P213, DOI 10.2174/138620706776055539; Emter R, 2013, TOXICOL IN VITRO, V27, P2225, DOI 10.1016/j.tiv.2013.09.009; Emter R, 2010, TOXICOL APPL PHARM, V245, P281, DOI 10.1016/j.taap.2010.03.009; Enoch SJ, 2008, SAR QSAR ENVIRON RES, V19, P555, DOI 10.1080/10629360802348985; Enoch SJ, 2009, QSAR COMB SCI, V28, P696, DOI 10.1002/qsar.200960011; Enslein K, 1997, FOOD CHEM TOXICOL, V35, P1091, DOI 10.1016/S0278-6915(97)87277-8; EU. REGULATION (EC), 2006, OFFICIAL JOURNAL OF; Garg P, 2015, MOL DIVERS, V19, P163, DOI 10.1007/s11030-014-9562-2; Gerberick GF, 2005, DERMATITIS, V16, P157, DOI 10.2310/6620.2005.05040; Greene N, 2002, ADV DRUG DELIVER REV, V54, P417, DOI 10.1016/S0169-409X(02)00012-1; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Heller S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-7; Hewitt M, 2010, REPROD TOXICOL, V30, P147, DOI 10.1016/j.reprotox.2009.12.003; Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399; Johnson M. A., 1990, CONCEPTS APPL MOL SI; Karlberg AT, 2008, CHEM RES TOXICOL, V21, P53, DOI 10.1021/tx7002239; Kern PS, 2010, DERMATITIS, V21, P8, DOI 10.2310/6620.2009.09038; Kimber I, 2001, TOXICOL SCI, V59, P198, DOI 10.1093/toxsci/59.2.198; Li SQ, 2005, J CHEM INF MODEL, V45, P952, DOI 10.1021/ci050049u; Low Y, 2011, CHEM RES TOXICOL, V24, P1251, DOI 10.1021/tx200148a; MacKay C, 2013, ALTEX-ALTERN ANIM EX, V30, P473, DOI 10.14573/altex.2013.4.473; Magee PS, 2000, QUANT STRUCT-ACT REL, V19, P356, DOI 10.1002/1521-3838(200010)19:4<356::AID-QSAR356>3.0.CO;2-I; Nantasenamat C, 2014, CHEM PAP, V68, P697, DOI 10.2478/s11696-013-0498-2; Natsch A, 2013, J APPL TOXICOL, V33, P1337, DOI 10.1002/jat.2868; Natsch A, 2009, TOXICOL SCI, V107, P106, DOI 10.1093/toxsci/kfn204; Nukada Y, 2013, TOXICOL IN VITRO, V27, P609, DOI 10.1016/j.tiv.2012.11.006; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-5; Patlewicz G, 2007, SAR QSAR ENVIRON RES, V18, P515, DOI 10.1080/10629360701427872; Patlewicz G, 2008, JRC SCI TECH REP EUR, P23225; Patlewicz G, 2008, QSAR COMB SCI, V27, P60, DOI 10.1002/qsar.200710067; Patlewicz G, 2014, REGUL TOXICOL PHARM, V69, P529, DOI 10.1016/j.yrtph.2014.06.001; Piroird C, 2015, TOXICOL IN VITRO, V29, P901, DOI 10.1016/j.tiv.2015.03.009; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Ren YY, 2006, ANAL CHIM ACTA, V572, P272, DOI 10.1016/j.aca.2006.05.027; Roberts DW, 2007, CHEM RES TOXICOL, V20, P1321, DOI 10.1021/tx700169w; Roberts DW, 2007, CHEM RES TOXICOL, V20, P44, DOI 10.1021/tx060121y; Rodford R, 2003, ENVIRON TOXICOL CHEM, V22, P1855, DOI 10.1897/01-438; Ruet Rossignol Martine, 2005, Altern Lab Anim, V33 Suppl 1, P19; Ryan D, 2011, WAO WHITE BOOK ALLER, P5; Sakaguchi H, 2007, TOXICOL LETT, V172, pS93, DOI 10.1016/j.toxlet.2007.05.257; Schlede E, 2003, TOXICOLOGY, V193, P219, DOI 10.1016/S0300-483X(03)00266-X; Singla Deepak, 2011, BMC Pharmacology, V11, P5, DOI 10.1186/1471-2210-11-5; Teubner W, 2013, REGUL TOXICOL PHARM, V67, P468, DOI 10.1016/j.yrtph.2013.09.007; Tou J., 1977, PATTERN RECOGNITION; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; van der Veen JW, 2014, CRIT REV TOXICOL, V44, P590, DOI 10.3109/10408444.2014.925425; Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x; Yao XJ, 2004, J CHEM INF COMP SCI, V44, P1257, DOI 10.1021/ci049965i; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0155419	10.1371/journal.pone.0155419	http://dx.doi.org/10.1371/journal.pone.0155419			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271321	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561000003
J	Minlikeeva, AN; Browne, RW; Ochs-Balcom, HM; Marian, C; Shields, PG; Trevisan, M; Krishnan, S; Modali, R; Seddon, M; Lehman, T; Freudenheim, JL				Minlikeeva, Albina N.; Browne, Richard W.; Ochs-Balcom, Heather M.; Marian, Catalin; Shields, Peter G.; Trevisan, Maurizio; Krishnan, Shiva; Modali, Ramakrishna; Seddon, Michael; Lehman, Teresa; Freudenheim, Jo L.			Single-Nucleotide Polymorphisms and Markers of Oxidative Stress in Healthy Women	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; BREAST-CANCER RISK; ANTIOXIDANT STATUS; LIPID-PEROXIDATION; GENERAL-POPULATION; DAMAGE; ASSOCIATION; BIOMARKERS; CATALASE; LUNG	Purpose There is accumulating evidence that oxidative stress is an important contributor to carcinogenesis. We hypothesized that genetic variation in genes involved in maintaining antioxidant/oxidant balance would be associated with overall oxidative stress. Methods We examined associations between single nucleotide polymorphisms (SNPs) in MnSOD, GSTP1, GSTM1, GPX1, GPX3, and CAT genes and thiobarbituric acid-reactive substances (TBARS), a blood biomarker of oxidative damage, in healthy white women randomly selected from Western New York (n = 1402). We used general linear models to calculate age-adjusted geometric means of TBARS across the variants. We also examined the associations within strata of menopausal status. Results For MnSOD, being heterozygous was associated with lower geometric means of TBARS (less oxidative stress), 1.28 mg/dL, compared to homozygous T-allele or homozygous Callele, 1.35 mg/dL, and 1.31 mg/dL correspondingly (p for trend = 0.01). This difference remained among postmenopausal women, 1.40 mg/dL for TT, 1.32 mg/dL for TC, and 1.34mg/dL for CC (p for trend 0.015); it was attenuated among premenopausal women. SNPs in the other genes examined (GSTP1, GSTM1, GPX1, GPX3, and CAT) were not associated with TBARS. Conclusions Our findings suggest that genetic variation in MnSOD gene may be associated with oxidative status, particularly among postmenopausal women.	[Minlikeeva, Albina N.; Ochs-Balcom, Heather M.; Freudenheim, Jo L.] Univ Buffalo, Dept Epidemiol & Environm Hlth, Buffalo, NY USA; [Browne, Richard W.] Univ Buffalo, Dept Biotech & Clin Lab Sci, Buffalo, NY USA; [Marian, Catalin; Shields, Peter G.; Krishnan, Shiva] Ohio State Univ, Ctr Comprehens Canc, Div Canc Prevent & Control, Columbus, OH 43210 USA; [Marian, Catalin] Victor Babes Univ Med & Pharm, Timisoara, Romania; [Trevisan, Maurizio] CUNY City Coll, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA; [Modali, Ramakrishna; Seddon, Michael; Lehman, Teresa] BioServe Biotechnol Ltd, Beltsville, MD USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Victor Babes University of Medicine & Pharmacy, Timisoara; City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education	Minlikeeva, AN (corresponding author), Univ Buffalo, Dept Epidemiol & Environm Hlth, Buffalo, NY USA.	albinami@buffalo.edu; jfreuden@buffalo.edu	Marian, Catalin/P-2885-2019; Ochs-Balcom, Heather M/F-3500-2012	Marian, Catalin/0000-0002-7749-1384; Freudenheim, Jo/0000-0002-9301-0499	U.S. Army Medical Research [DAMD170010417, DAMD179616202]; National Institute on Alcohol Abuse and Alcoholism [P50-AA09802]; BioServe Biotechnologies Ltd.; NATIONAL CANCER INSTITUTE [R25CA113951] Funding Source: NIH RePORTER	U.S. Army Medical Research(United States Department of DefenseUS Army Research Laboratory (ARL)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); BioServe Biotechnologies Ltd.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The following grants provided funding for the study: U.S. Army Medical Research (http://mrmc.amedd.army.mil/) Grant DAMD170010417 (to JF); U.S. Army Medical Research (http://mrmc.amedd.army.mil/) Grant DAMD179616202 (to PS, CM, SK, and JF); National Institute on Alcohol Abuse and Alcoholism (http://www.niaaa.nih.gov/) Grant P50-AA09802 (to RB, HOB, MT, and JF). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder, BioServe Biotechnologies Ltd., synthesized primers that were used for genotyping of the SNPs and provided support in the form of salaries for authors RM, MS, and TL for the laboratory analyses. BioServe did not have any additional role in the study design, data collection and analysis, decision to publish. The co-authors were involved in review and approval of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ambrosone CB, 2000, ANTIOXID REDOX SIGN, V2, P903, DOI 10.1089/ars.2000.2.4-903; Andersen HR, 1997, CLIN CHEM, V43, P562; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Bastaki M, 2006, PHARMACOGENET GENOM, V16, P279, DOI 10.1097/01.fpc.0000199498.08725.9c; Battisti V, 2011, BIOMED PHARMACOTHER, V65, P516, DOI 10.1016/j.biopha.2011.06.003; Bonner MR, 2005, CANCER EPIDEM BIOMAR, V14, P53; Cai QY, 2004, BREAST CANCER RES, V6, pR647, DOI 10.1186/bcr929; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Forsberg L, 2001, FREE RADICAL BIO MED, V30, P500, DOI 10.1016/S0891-5849(00)00487-1; Gonenc A, 2001, J CLIN PHARM THER, V26, P141, DOI 10.1046/j.1365-2710.2001.00334.x; Halliwell B., 2007, FREE RADICALS BIOL M; Hamanishi T, 2004, DIABETES, V53, P2455, DOI 10.2337/diabetes.53.9.2455; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hiroi S, 1999, BIOCHEM BIOPH RES CO, V261, P332, DOI 10.1006/bbrc.1999.1036; Hong YC, 2002, TOXICOL LETT, V129, P255, DOI 10.1016/S0378-4274(02)00014-0; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Kalkan G, 2014, ARCH DERMATOL RES, V306, P253, DOI 10.1007/s00403-013-1427-5; Kang D, 2007, CANCER EPIDEM BIOMAR, V16, P1581, DOI 10.1158/1055-9965.EPI-07-0160; Kariz S, 2012, DIABETES RES CLIN PR, V98, P144, DOI 10.1016/j.diabres.2012.07.003; Khanzode SS, 2004, FREE RADICAL RES, V38, P81, DOI 10.1080/01411590310001637066; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Lee KH, 2010, CANCER EPIDEM BIOMAR, V19, P877, DOI 10.1158/1055-9965.EPI-09-1098; Li YL, 2013, ENVIRON RES, V121, P31, DOI 10.1016/j.envres.2012.10.003; Mayne ST, 2003, J NUTR, V133, p933S, DOI 10.1093/jn/133.3.933S; Mitrunen K, 2001, CARCINOGENESIS, V22, P827, DOI 10.1093/carcin/22.5.827; Moore LE, 2005, CANCER EPIDEM BIOMAR, V14, P1823, DOI 10.1158/1055-9965.EPI-05-0037; Ochs-Balcom HM, 2005, AM J EPIDEMIOL, V162, P1137, DOI 10.1093/aje/kwi339; Pansini F, 2005, CURR PHARM DESIGN, V11, P2063, DOI 10.2174/1381612054065819; Platek ME, 2010, BREAST CANCER RES TR, V121, P453, DOI 10.1007/s10549-009-0587-7; Quick SK, 2008, CANCER EPIDEM BIOMAR, V17, P1082, DOI 10.1158/1055-9965.EPI-07-2755; Ratnasinghe D, 2000, CANCER RES, V60, P6381; Samir M, 1999, CLIN OTOLARYNGOL, V24, P232, DOI 10.1046/j.1365-2273.1999.00249.x; Sanchez-Rodriguez MA, 2012, MENOPAUSE, V19, P361, DOI 10.1097/gme.0b013e318229977d; Sener DE, 2007, CELL BIOCHEM FUNCT, V25, P377, DOI 10.1027/cbf.1308; Slanger TE, 2006, CANCER CAUSE CONTROL, V17, P1025, DOI 10.1007/s10552-006-0043-5; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/00008571-200303000-00004; Trevisan M, 2001, AM J EPIDEMIOL, V154, P348, DOI 10.1093/aje/154.4.348; Wang SM, 2009, EUR J CANCER, V45, P2874, DOI 10.1016/j.ejca.2009.04.024; Wei BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046982; Wu K, 2013, MOL BIOL REP, V40, P687, DOI 10.1007/s11033-012-2109-7; ZIMNIAK P, 1994, EUR J BIOCHEM, V224, P893, DOI 10.1111/j.1432-1033.1994.00893.x	42	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156450	10.1371/journal.pone.0156450	http://dx.doi.org/10.1371/journal.pone.0156450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271305	Green Published, gold			2022-12-26	WOS:000377561000016
J	Rose, JA; Wanner, N; Cheong, HI; Queisser, K; Barrett, P; Park, M; Hite, C; Prasad, SVN; Erzurum, S; Asosingh, K				Rose, Jonathan A.; Wanner, Nicholas; Cheong, Hoi I.; Queisser, Kimberly; Barrett, Patrick; Park, Margaret; Hite, Corrine; Prasad, Sathyamangla V. Naga; Erzurum, Serpil; Asosingh, Kewal			Flow Cytometric Quantification of Peripheral Blood Cell beta-Adrenergic Receptor Density and Urinary Endothelial Cell-Derived Microparticles in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							FAILING HUMAN HEART; CIRCULATING MICROPARTICLES; EXTRACELLULAR VESICLES; LYMPHOCYTES; MARKER; KINASE	Pulmonary arterial hypertension (PAH) is a heterogeneous disease characterized by severe angiogenic remodeling of the pulmonary artery wall and right ventricular hypertrophy. Thus, there is an increasing need for novel biomarkers to dissect disease heterogeneity, and predict treatment response. Although beta-adrenergic receptor (beta AR) dysfunction is well documented in left heart disease while endothelial cell-derived microparticles (Ec-MPs) are established biomarkers of angiogenic remodeling, methods for easy large clinical cohort analysis of these biomarkers are currently absent. Here we describe flow cytometric methods for quantification of beta AR density on circulating white blood cells (WBC) and Ec-MPs in urine samples that can be used as potential biomarkers of right heart failure in PAH. Biotinylated beta-blocker alprenolol was synthesized and validated as a beta AR specific probe that was combined with immunophenotyping to quantify beta AR density in circulating WBC subsets. Ec-MPs obtained from urine samples were stained for annexin-V and CD144, and analyzed by a micro flow cytometer. Flow cytometric detection of alprenolol showed that beta AR density was decreased in most WBC subsets in PAH samples compared to healthy controls. EcMPs in urine was increased in PAH compared to controls. Furthermore, there was a direct correlation between Ec-MPs and Tricuspid annular plane systolic excursion (TAPSE) in PAH patients. Therefore, flow cytometric quantification of peripheral blood cell beta AR density and urinary Ec-MPs may be useful as potential biomarkers of right ventricular function in PAH.	[Rose, Jonathan A.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Wanner, Nicholas; Cheong, Hoi I.; Queisser, Kimberly; Park, Margaret; Hite, Corrine; Erzurum, Serpil; Asosingh, Kewal] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA; [Barrett, Patrick] Cleveland Clin, Lerner Res Inst, Flow Cytometry Core, Cleveland, OH 44106 USA; [Prasad, Sathyamangla V. Naga] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Erzurum, Serpil] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Asosingh, K (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44106 USA.	asosink@ccf.org			National Institutes of Health [HL081064, HL60917, HL115008, M01 RR018390]; American Thoracic Society/Pulmonary Association Research grant [PH-07-003]; Cleveland Clinic Research Program Committee Pilot Grant (RPC) [2014-1045]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR018390] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060917, P01HL081064, R01HL115008, R37HL060917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Thoracic Society/Pulmonary Association Research grant; Cleveland Clinic Research Program Committee Pilot Grant (RPC); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL081064 (SE), HL60917 (SE), HL115008 (SE) and M01 RR018390 (SE) from the National Institutes of Health, American Thoracic Society/Pulmonary Association Research grant (PH-07-003 (KA)), and Cleveland Clinic Research Program Committee Pilot Grant (RPC# 2014-1045 (JR)).; We sincerely appreciate Marybeth Boyle, Laura Peterson, Dr. Suzy Comhair and Michelle Koo's assistance in collecting patients samples and clinical data. Kewal Asosingh is a Scholar of the International Society for Advancement of Cytometry (ISAC). This work was supported by grants HL081064, HL60917, HL115008 and M01 RR018390 from the National Institutes of Health, American Thoracic Society/Pulmonary Association Research grant (PH-07-003), and Cleveland Clinic Research Program Committee Pilot Grant (RPC# 2014-1045).	Amabile N, 2008, AM J RESP CRIT CARE, V177, P1268, DOI 10.1164/rccm.200710-1458OC; Asosingh K, 2012, BLOOD, V120, P1218, DOI 10.1182/blood-2012-03-419275; Barteneva NS, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-23; Bernal-Mizrachi L, 2003, AM HEART J, V145, P962, DOI 10.1016/S0002-8703(03)00103-0; Boulanger CM, 2006, HYPERTENSION, V48, P180, DOI 10.1161/01.HYP.0000231507.00962.b5; Bretelle F, 2003, THROMB HAEMOSTASIS, V89, P486, DOI 10.1055/s-0037-1613378; BRISTOW MR, 1992, J CLIN INVEST, V89, P803, DOI 10.1172/JCI115659; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; BRODDE OE, 1986, SCIENCE, V231, P1584, DOI 10.1126/science.3006250; Brodsky SV, 2004, AM J PHYSIOL-HEART C, V286, pH1910, DOI 10.1152/ajpheart.01172.2003; Bull TM, 2003, THROMB HAEMOSTASIS, V90, P698, DOI 10.1160/TH03-04-0251; Chow S, 2005, CYTOM PART A, V67A, P4, DOI 10.1002/cyto.a.20167; Chow Sue, 2008, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0927s46; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; COLUCCI WS, 1981, NEW ENGL J MED, V305, P185, DOI 10.1056/NEJM198107233050402; Curtis AM, 2013, VASC MED, V18, P204, DOI 10.1177/1358863X13499773; Erdbrugger U, 2016, CYTOM PART A, V89A, P123, DOI 10.1002/cyto.a.22795; Fan XL, 2009, PROG NAT SCI-MATER, V19, P17, DOI 10.1016/j.pnsc.2008.10.001; Farha S, 2011, BLOOD, V117, P3485, DOI 10.1182/blood-2010-09-306357; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Haeck MLA, 2015, HEART, V101, P311, DOI 10.1136/heartjnl-2011-301386; Hargett LA, 2013, PULM CIRC, V3, P329, DOI 10.4103/2045-8932.114760; Hata JA, 2006, J CARD FAIL, V12, P360, DOI 10.1016/j.cardfail.2006.02.011; Inglis HC, 2015, CYTOM PART A, V87A, P1052, DOI 10.1002/cyto.a.22649; Jimenez JJ, 2003, BRIT J HAEMATOL, V123, P896, DOI 10.1046/j.1365-2141.2003.04716.x; KURIYAMA H, 1982, AM J PHYSIOL, V243, pH641, DOI 10.1152/ajpheart.1982.243.5.H641; Lanzola E, 2013, PULM CIRC, V3, P781, DOI 10.1086/674769; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Martinez MC, 2011, CIRC RES, V109, P110, DOI 10.1161/CIRCRESAHA.110.233049; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; MEIER KE, 1983, BIOCHIM BIOPHYS ACTA, V761, P257, DOI 10.1016/0304-4165(83)90074-0; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Mezentsev A, 2005, AM J PHYSIOL-HEART C, V289, pH1106, DOI 10.1152/ajpheart.00265.2005; Naga Prasad S V, 2001, Trends Genet, V17, pS44, DOI 10.1016/S0168-9525(01)02487-8; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Smadja DM, 2010, EUR RESPIR J, V36, P1284, DOI 10.1183/09031936.00130809; Tonelli AR, 2013, AM J RESP CRIT CARE, V188, P365, DOI 10.1164/rccm.201209-1640OC; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; van der Pol E, 2014, NANO LETT, V14, P6195, DOI 10.1021/nl503371p; WILLIAMS LT, 1976, J CLIN INVEST, V57, P149, DOI 10.1172/JCI108254; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yan LH, 2011, DEV GROWTH DIFFER, V53, P772, DOI 10.1111/j.1440-169X.2011.01284.x; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066	44	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156940	10.1371/journal.pone.0156940	http://dx.doi.org/10.1371/journal.pone.0156940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270458	Green Submitted, gold, Green Published			2022-12-26	WOS:000377561000052
J	Kim, JK; Lee, SH; Lee, SY; Kim, EK; Kwon, JE; Seo, HB; Lee, HH; Lee, BI; Park, SH; Cho, ML				Kim, Jae-kyung; Lee, Seung Hoon; Lee, Seon-Young; Kim, Eun-Kyung; Kwon, Jeong-Eun; Seo, Hyeon-Beom; Lee, Han Hee; Lee, Bo-In; Park, Sung-Hwan; Cho, Mi-La			Grim19 Attenuates DSS Induced Colitis in an Animal Model	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; STAT3; GRIM-19; MICE; INHIBITION; ENTEROCOLITIS; MACROPHAGES; ARTHRITIS; PATHWAY	DSS induced colitis is a chronic inflammatory disease characterized by inflammation in the gastrointestinal tract, which destabilizes the gut and induces an uncontrolled immune response. Although DSS induced colitis is generally thought to develop as a result of an abnormally active intestinal immune system, its pathogenesis remains unclear. Gene associated with retinoid interferon induced mortality (Grim) 19 is an endogenous specific inhibitor of STAT3, which regulates the expression of proinflammatory cytokines. In this study, we investigated the influence of GRIM19 in a DSS induced colitis mouse model. We hypothesized that Grim19 would ameliorate DSS induced colitis by altering STAT3 activity and intestinal inflammation. Grim19 ameliorated DSS induced colitis severity and protected intestinal tissue. The expression of STAT3 and proinflammatory cytokines such as IL-1 beta and TNF-alpha in colon and lymph nodes was decreased significantly by Grim19. Moreover, DSS induced colitis progression in a Grim19 transgenic mouse line was inhibited in association with a reduction in STAT3 and IL-17 expression. These results suggest that Grim19 attenuates DSS induced colitis by suppressing the excessive inflammatory response mediated by STAT3 activation.	[Kim, Jae-kyung; Lee, Seung Hoon; Lee, Seon-Young; Kim, Eun-Kyung; Kwon, Jeong-Eun; Seo, Hyeon-Beom; Park, Sung-Hwan; Cho, Mi-La] Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, 222 Banpo Daero, Seoul 137701, South Korea; [Kim, Jae-kyung; Lee, Seung Hoon; Lee, Seon-Young; Kim, Eun-Kyung; Kwon, Jeong-Eun; Seo, Hyeon-Beom; Cho, Mi-La] Catholic Univ Korea, Catholic Res Inst Med Sci, Lab Immune Network, 222 Banpo Daero, Seoul 137701, South Korea; [Lee, Han Hee; Lee, Bo-In] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Gastroenterl, Seoul, South Korea; [Park, Sung-Hwan] Catholic Univ Korea, Dept Internal Med, Div Rheumatol, Seoul 137040, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Cho, ML (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Rheumatism Res Ctr, 222 Banpo Daero, Seoul 137701, South Korea.; Cho, ML (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Lab Immune Network, 222 Banpo Daero, Seoul 137701, South Korea.	iammila@catholic.ac.kr	Lee, Han Hee/AAB-7987-2022		Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C1062]; Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [HI14C3417, HI13C0016]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (https://www.khidi.or.kr/) (HI15C1062). This study was also supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (HI14C3417); and a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0016).	Alonzi T, 2004, CYTOKINE, V26, P45, DOI 10.1016/j.cyto.2003.12.002; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Barnich N, 2005, J BIOL CHEM, V280, P19021, DOI 10.1074/jbc.M413776200; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Cenit MC, 2010, GENES IMMUN, V11, P264, DOI 10.1038/gene.2010.10; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Dalmasso G, 2006, GASTROENTEROLOGY, V131, P1812, DOI 10.1053/j.gastro.2006.10.001; Ekchariyawat P, 2013, INNATE IMMUN-LONDON, V19, P655, DOI 10.1177/1753425913479149; Fitzpatrick LR, 2013, INT REV IMMUNOL, V32, P544, DOI 10.3109/08830185.2013.821118; Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040; Kalakonda S, 2013, P NATL ACAD SCI USA, V110, pE4213, DOI 10.1073/pnas.1303760110; Lee S, 2015, INT J NANOMED, V10, P3, DOI 10.2147/IJN.S91389; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Mitsuyama K, 2007, ANTICANCER RES, V27, P3749; Moon YM, 2014, ARTHRITIS RHEUMATOL, V66, P569, DOI 10.1002/art.38267; Okamoto T, 2010, MOL CANCER THER, V9, P2333, DOI 10.1158/1535-7163.MCT-09-1147; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Rogler G, 2010, BEST PRACT RES CL GA, V24, P157, DOI 10.1016/j.bpg.2009.10.011; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Sugimoto K, 2008, WORLD J GASTROENTERO, V14, P5110, DOI 10.3748/wjg.14.5110; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Vuitton L, 2013, CURR DRUG TARGETS, V14, P1385, DOI 10.2174/13894501113149990160; Yan JW, 2014, EXPERT OPIN THER TAR, V18, P29, DOI 10.1517/14728222.2013.843669; Yan S, 2013, ONCOTARGET, V4, P433, DOI 10.18632/oncotarget.930; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang J, 2003, P NATL ACAD SCI USA, V100, P9342, DOI 10.1073/pnas.1633516100; Zhang JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109625	29	11	11	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155853	10.1371/journal.pone.0155853	http://dx.doi.org/10.1371/journal.pone.0155853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258062	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700021
J	Mech, LD; Barber-Meyer, SM; Erb, J				Mech, L. David; Barber-Meyer, Shannon M.; Erb, John			Wolf (Canis lupus) Generation Time and Proportion of Current Breeding Females by Age	PLOS ONE			English	Article							REPRODUCTIVE ACTIVITY; GRAY WOLVES; WILD; GUIDELINES; ECOLOGY; SIZE; PACK	Information is sparse about aspects of female wolf (Canis lupus) breeding in the wild, including age of first reproduction, mean age of primiparity, generation time, and proportion of each age that breeds in any given year. We studied these subjects in 86 wolves (113 captures) in the Superior National Forest (SNF), Minnesota (MN), during 1972-2013 where wolves were legally protected for most of the period, and in 159 harvested wolves from throughout MN wolf range during 2012-2014. Breeding status of SNF wolves were assessed via nipple measurements, and wolves from throughout MN wolf range, by placental scars. In the SNF, proportions of currently breeding females (those breeding in the year sampled) ranged from 19% at age 2 to 80% at age 5, and from throughout wolf range, from 33% at age 2 to 100% at age 7. Excluding pups and yearlings, only 33% to 36% of SNF females and 58% of females from throughout MN wolf range bred in any given year. Generation time for SNF wolves was 4.3 years and for MN wolf range, 4.7 years. These findings will be useful in modeling wolf population dynamics and in wolf genetic and dog-domestication studies.	[Mech, L. David; Barber-Meyer, Shannon M.] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA; [Erb, John] Minnesota Dept Nat Resources, Grand Rapids, MI USA; [Mech, L. David] Raptor Ctr, 1920 Fitch Ave, St Paul, MN USA; [Barber-Meyer, Shannon M.] US Geol Survey, 1393 Highway 169, Ely, MN USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Mech, LD (corresponding author), US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA.; Mech, LD (corresponding author), Raptor Ctr, 1920 Fitch Ave, St Paul, MN USA.	mechx002@umn.edu		Barber-Meyer, Shannon/0000-0002-3048-2616	US Geological Survey; Minnesota Dept. of Natural Resources	US Geological Survey(United States Geological Survey); Minnesota Dept. of Natural Resources	This work was funded by US Geological Survey to LDM SMB; Minnesota Dept. of Natural Resources to JE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber-Meyer SM, 2015, NORTHEAST NAT, V22, P652, DOI 10.1656/045.022.0402; BOERTJE RD, 1992, CAN J ZOOL, V70, P2441, DOI 10.1139/z92-328; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Cook R.D., 1999, RESPONSE TRANSFORMAT, DOI DOI 10.1002/9780470316948; Creel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012918; Erb J, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P49, DOI 10.1007/978-0-387-85952-1_4; FRENZEL L D, 1974, Naturaliste Canadien (Quebec), V101, P467; Fritts SH, 1992, USFWS RESOURCE PUBL, P1; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GASAWAY WC, 1983, WILDLIFE MONOGR, P1; Gipson PS, 2000, J WILDLIFE MANAGE, V64, P752, DOI 10.2307/3802745; Gude JA, 2012, J WILDLIFE MANAGE, V76, P108, DOI 10.1002/jwmg.201; Hedrick PW, 2014, CONSERV GENET, V15, P1111, DOI 10.1007/s10592-014-0604-1; Hillis TL, 1996, CAN J ZOOL, V74, P2211, DOI 10.1139/z96-251; Hillis TL, 1990, THESIS LAURENTIAN U; Jochle W, 1997, REPROD DOMEST ANIM, V32, P183, DOI 10.1111/j.1439-0531.1997.tb01280.x; Kreeger Terry J., 2003, P192; Landon DB, 1998, J WILDLIFE MANAGE, V62, P674, DOI 10.2307/3802343; McNay ME, 2006, J MAMMAL, V87, P85, DOI 10.1644/05-MAMM-A-057R1.1; Mech LD, 2006, J WILDLIFE MANAGE, V70, P1481, DOI 10.2193/0022-541X(2006)70[1481:EASOWI]2.0.CO;2; Mech L.D, 1974, P 11 INT C GAM BIOL, P315; Mech LD, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P15, DOI 10.1007/978-0-387-85952-1_2; Mech LD, 2006, J MAMMAL, V87, P80, DOI 10.1644/05-MAMM-F-212R1.1; MECH LD, 1993, AM MIDL NAT, V129, P266, DOI 10.2307/2426507; MECH LD, 1987, J MAMMAL, V68, P871, DOI 10.2307/1381570; Mech LD., 1998, WOLVES DENALI; MEDJO DC, 1976, J MAMMAL, V57, P406, DOI 10.2307/1379708; Mlot C, 2013, SCIENCE, V340, P919, DOI 10.1126/science.340.6135.919; Olson SF, 1938, ECOLOGY, V19, P168, DOI 10.2307/1930384; PACKARD JM, 1992, CAN J ZOOL, V70, P1269, DOI 10.1139/z92-177; PETERSON RO, 1984, J WILDLIFE MANAGE, P1; Pimlott DH, 1969, 87 ONT DEP LANDS FOR, P1; RAUSCH RA, 1967, AM ZOOL, V7, P253; SEAL US, 1979, BIOL REPROD, V21, P1057, DOI 10.1095/biolreprod21.5.1057; Sikes RS, 2012, BIOSCIENCE, V62, P830, DOI 10.1525/bio.2012.62.9.9; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Skoglund P, 2015, CURR BIOL, V25, P1515, DOI 10.1016/j.cub.2015.04.019; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Stahler DR, 2013, J ANIM ECOL, V82, P222, DOI 10.1111/j.1365-2656.2012.02039.x; STENLUND MILTON H., 1955, TECH BULL MINNESOTA DEPT CONSERV, V4, P1; van Ballenberghe V., 1975, Wildlife Monogr, VNo. 43, P1; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; ZIMEN E, 1976, Z TIERPSYCHOL, V40, P300	43	25	25	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156682	10.1371/journal.pone.0156682	http://dx.doi.org/10.1371/journal.pone.0156682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258193	Green Published, gold			2022-12-26	WOS:000377369700102
J	Zhu, HM; Liu, J; Cui, CC; Song, YJ; Ge, HT; Hu, LY; Li, Q; Jin, YP; Zhang, Y				Zhu, Hongmei; Liu, Jun; Cui, Chenchen; Song, Yujie; Ge, Hengtao; Hu, Linyong; Li, Qian; Jin, Yaping; Zhang, Yong			Targeting Human alpha-Lactalbumin Gene Insertion into the Goat beta-Lactoglobulin Locus by TALEN-Mediated Homologous Recombination	PLOS ONE			English	Article							HUMAN-MILK; PROTEINS; DESIGN	Special value of goat milk in human nutrition and well being is associated with medical problems of food allergies which are caused by milk proteins such as beta-lactoglobulin (BLG). Here, we employed transcription activator-like effector nuclease (TALEN)-assisted homologous recombination in goat fibroblasts to introduce human alpha-lactalbumin (hLA) genes into goat BLG locus. TALEN-mediated targeting enabled isolation of colonies with mono-and bi-allelic transgene integration in up to 10.1% and 1.1%, respectively, after selection. Specifically, BLG mRNA levels were gradually decreasing in both mo- and bi-allelic goat mammary epithelial cells (GMECs) while hLA demonstrated expression in GMECs in vitro. Gene-targeted fibroblast cells were efficiently used in somatic cell nuclear transfer, resulting in production of hLA knock-in goats directing down-regulated BLG expression and abundant hLA secretion in animal milk. Our findings provide valuable background for animal milk optimization and expedited development for agriculture and biomedicine.	[Zhu, Hongmei; Liu, Jun; Cui, Chenchen; Song, Yujie; Ge, Hengtao; Hu, Linyong; Li, Qian; Jin, Yaping; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Zhu, Hongmei; Liu, Jun; Cui, Chenchen; Song, Yujie; Ge, Hengtao; Hu, Linyong; Li, Qian; Jin, Yaping; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Jin, YP; Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.; Jin, YP; Zhang, Y (corresponding author), Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China.	yapingjin@163.com; zhangyong1956@nwsuaf.edu.cn	Cui, Chenchen/AAJ-1061-2020		China National Program for Transgenic Animal [2014ZX08008-004]; National High Technology Research and Development Program of China [2011AA100303]	China National Program for Transgenic Animal; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work is financially supported by the China National Program for Transgenic Animal (2014ZX08008-004) and the National High Technology Research and Development Program of China (2011AA100303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Leung S, 2006, ALLERGY, V61, P1358, DOI 10.1111/j.1398-9995.2006.01193.x; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Brew K, 2013, ADV DAIRY CHEM, V4th, P261, DOI [DOI 10.1007/978-1-4614-4714-6_8, 10.1007/978-1-4614-4714-6_8]; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chatterton DEW, 2006, INT DAIRY J, V16, P1229, DOI 10.1016/j.idairyj.2006.06.001; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Cui C, 2015, SCI REP-UK, V5, DOI 10.1038/srep10482; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; del Val G, 1999, J ALLERGY CLIN IMMUN, V103, P690, DOI 10.1016/S0091-6749(99)70244-7; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Feng XJ, 2015, TRANSGENIC RES, V24, P73, DOI 10.1007/s11248-014-9818-8; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gao Q, 2007, STEM CELLS, V25, P3085, DOI 10.1634/stemcells.2007-0478; Haenlein GFW, 2004, SMALL RUMINANT RES, V51, P155, DOI 10.1016/j.smallrumres.2003.08.010; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Hursel R, 2010, BRIT J NUTR, V103, P775, DOI 10.1017/S0007114509992352; Kasparek P, 2014, FEBS LETT, V588, P3982, DOI 10.1016/j.febslet.2014.09.014; Kehoe JJ, 2014, FOOD HYDROCOLLOID, V34, P217, DOI 10.1016/j.foodhyd.2012.09.009; Lantinga-van Leeuwen IS, 2006, GENESIS, V44, P225, DOI 10.1002/dvg.20207; Liu J, 2013, ANTIBACTERIAL ACTIVI; Liu X, 2013, NATURE COMMUNICATION, V4; Lonnerdal B, 2014, AM J CLIN NUTR, V99, p712S, DOI 10.3945/ajcn.113.071993; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Moghaddassi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089631; Papapetrou EP, 2016, MOL THERAPY; Park Y, 2012, 1 AS DAIR GOAT C; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Puthia M, 2014, GUT, V63, P131, DOI 10.1136/gutjnl-2012-303715; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Sharma S, 2001, J CHROMATOGR B, V756, P183, DOI 10.1016/S0378-4347(01)00107-4; Spencer WJ, 2010, PEDIATR RES, V68, P490, DOI 10.1203/PDR.0b013e3181f70f21; STACEY A, 1995, P NATL ACAD SCI USA, V92, P2835, DOI 10.1073/pnas.92.7.2835; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Wheeler MB, 2003, J ANIM SCI, V81, P32; Wu HB, 2015, P NATL ACAD SCI USA, V112, pE1530, DOI 10.1073/pnas.1421587112; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153; Zhu Lihua Julie, 2015, [Frontiers in Biology, 生物学前沿], V10, P289	41	9	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156636	10.1371/journal.pone.0156636	http://dx.doi.org/10.1371/journal.pone.0156636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258157	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700093
J	Brownlow, A; Onoufriou, J; Bishop, A; Davison, N; Thompson, D				Brownlow, Andrew; Onoufriou, Joseph; Bishop, Amanda; Davison, Nicholas; Thompson, Dave			Corkscrew Seals: Grey Seal (Halichoerus grypus) Infanticide and Cannibalism May Indicate the Cause of Spiral Lacerations in Seals	PLOS ONE			English	Article							GRAY SEALS; POSTWEANING FAST; PHOCA-VITULINA; SABLE-ISLAND; POPULATION; BEHAVIOR; PUPS; MOVEMENTS; MORTALITY; DURATION	Large numbers of dead seals with characteristic spiral lesions have been washing ashore around the North Atlantic over the past two decades. Interactions with ship propellers and shark predation have been suggested as the likely causal mechanisms. However, new evidence points towards a more likely candidate: grey seal predation. An adult male grey seal was observed and recorded catching, killing and eating five weaned grey seal pups over a period of one week on the Isle of May, Scotland. A further 9 carcasses found in the same area exhibited similar injuries. Post mortem analysis of lesions indicated the wound characteristics were similar to each other and in 12 of the 14 carcasses analysed, were indistinguishable from carcasses previously attributed to propeller interaction. We therefore propose that most of the seal carcasses displaying spiral lacerations in the UK are caused by grey seal predation. Cases in other locations should be re-evaluated using the scoring system presented here to identify whether grey seal predation is a major cause of mortality in phocid seals.	[Brownlow, Andrew; Davison, Nicholas] SAC Vet Serv Drummondhill, Scottish Marine Anim Stranding Scheme, Stratherrick Rd, Inverness 1V2 4JZ, Scotland; [Onoufriou, Joseph; Thompson, Dave] Univ St Andrews, Sea Mammal Res Unit, St Andrews KY16 8LB, Fife, Scotland; [Bishop, Amanda] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	Scottish Agricultural College; University of St Andrews; Durham University	Onoufriou, J (corresponding author), Univ St Andrews, Sea Mammal Res Unit, St Andrews KY16 8LB, Fife, Scotland.	jo26@st-andrews.ac.uk	Brownlow, Andrew C/P-6593-2018; Brownlow, Andrew/ABA-4653-2020	Brownlow, Andrew/0000-0001-9885-7480; Thompson, David/0000-0003-1546-2876; Davison, Nicholas/0000-0001-7286-1836	Marine Scotland [MMS001/11]; National Capability funding from the Natural Environment Research Council [SMRU1001]; Natural Environment Research Council [smru10001] Funding Source: researchfish	Marine Scotland; National Capability funding from the Natural Environment Research Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by Marine Scotland (http://www.gov.scot/Topics/marine/Publications/TopicSheets/MSScience, project: MMS001/11) and additionally supported by National Capability funding from the Natural Environment Research Council (http://www.nerc.ac.uk/) to the Sea Mammal Research Unit (grant no. SMRU1001).	[Anonymous], 1998, CAN COOOPERATIVE WIL, V5, P6; ARNBOM T, 1993, CAN J ZOOL, V71, P1772, DOI 10.1139/z93-252; BEDARD C, 1993, MAR MAMMAL SCI, V9, P421, DOI 10.1111/j.1748-7692.1993.tb00474.x; Bennett KA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P911, DOI 10.1086/656925; Bexton S, 2012, AQUAT MAMM, V38, P229, DOI 10.1578/AM.38.3.2012.229; Bishop A, 2016, AQUAT MAMM; Bonner W., 1972, OCEANGR MAR BIOL ANN, V10, P461; BOWEN WD, 1992, J ZOOL, V227, P607, DOI 10.1111/j.1469-7998.1992.tb04418.x; Boyle D, 2009, CCWWW104; Boyle D, 2011, CCWWW111; Crocker DE, 2012, PHYSIOL BIOCHEM ZOOL, V85, P11, DOI 10.1086/663634; FEDAK MA, 1982, J ZOOL, V198, P473, DOI 10.1111/jzo.1982.198.4.473; Gaydos Joseph K., 2005, Northwestern Naturalist, V86, P150, DOI 10.1898/1051-1733(2005)086[0150:SSKOHS]2.0.CO;2; Haelters J, 2015, AQUAT MAMM, V41, P351, DOI 10.1578/AM.41.3.2015.351; Haelters J, 2012, AQUAT MAMM, V38, P343, DOI 10.1578/AM.38.4.2012.343; Hall AJ, 2007, MAR MAMMAL SCI, V23, P650, DOI 10.1111/j.1748-7692.2007.00132.x; HAMMOND PS, 1994, J APPL ECOL, V31, P340, DOI 10.2307/2404548; Hanson N, 2015, AQUAT CONSERV MAR FR; Jauniaux T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108993; KRUUK H, 1972, J ZOOL, V166, P233, DOI 10.1111/j.1469-7998.1972.tb04087.x; Leopold M, 2015, P R SOC B, V282; Lidgard DC, 2001, J ZOOL SOC LONDON, V255; Lonergan M, 2007, J ZOOL, V271, P261, DOI 10.1111/j.1469-7998.2007.00311.x; Lucas Z, 2000, J ZOOL, V252, P405, DOI 10.1017/S0952836900000157; Lucas Zoe N., 2010, Proceedings of the Nova Scotian Institute of Science, V45, P64; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; MILLER FL, 1985, CAN J ZOOL, V63, P295, DOI 10.1139/z85-045; Noren SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P269, DOI 10.1086/528777; Onoufriou J, 2014, MMS00111; PRIME JH, 1990, J APPL ECOL, V27, P435, DOI 10.2307/2404292; REILLY JJ, 1991, AM J PHYSIOL, V260, pR267, DOI 10.1152/ajpregu.1991.260.2.R267; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SCOS, 2015, SCI ADV MATT REL MAN; SOLHEIM R, 1984, ANN ZOOL FENN, V21, P301; Sundqvist AK, 2008, CONSERV GENET, V9, P1275, DOI 10.1007/s10592-007-9454-4; Thompson D, 2005, J APPL ECOL, V42, P638, DOI 10.1111/j.1365-2664.2005.01025.x; THOMPSON D, 1991, J ZOOL, V224, P223, DOI 10.1111/j.1469-7998.1991.tb04801.x; Thompson D, 2010, MMS00111; THOMPSON PM, 1990, J APPL ECOL, V27, P924, DOI 10.2307/2404387; TRIGGS GS, 1991, J ZOOL, V225, P449, DOI 10.1111/j.1469-7998.1991.tb03828.x; Twiss S, 1994, J ZOOL SOC LONDON, V233; van Bleijswijk JDL, 2014, MAR ECOL PROG SER, V513, P277, DOI 10.3354/meps11004; van Neer A, 2015, J SEA RES, V97, P1, DOI 10.1016/j.seares.2014.11.006	43	24	24	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156464	10.1371/journal.pone.0156464	http://dx.doi.org/10.1371/journal.pone.0156464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254025	gold, Green Published, Green Accepted			2022-12-26	WOS:000377218700032
J	Liang, D; Wang, TF; Rotgans, BA; McManus, DP; Cummins, SF				Liang, Di; Wang, Tianfang; Rotgans, Bronwyn A.; McManus, Donald P.; Cummins, Scott F.			Ionotropic Receptors Identified within the Tentacle of the Freshwater Snail Biomphalaria glabrata, an Intermediate Host of Schistosoma mansoni	PLOS ONE			English	Article							PROTEIN; NEURONS; KAINATE; PRAZIQUANTEL; EVOLUTION; AFRICA; GENOME	Biomphalaria glabrata (B. glabrata) is an air-breathing aquatic mollusc found in freshwater habitats across the Western Hemisphere. It is most well-known for its recognized capacity to act as a major intermediate host for Schistosoma mansoni, the human blood fluke parasite. Ionotropic receptors (IRs), a variant family of the ionotropic glutamate receptors (iGluR), have an evolutionary ancient function in detecting odors to initiate chemosensory signaling. In this study, we applied an array of methods towards the goal of identifying IR-like family members in B. glabrata, ultimately revealing two types, the iGluR and IR. Sequence alignment showed that three ligand-binding residues are conserved in most Biomphalaria iGluR sequences, while the IRs did exhibit a variable pattern, lacking some or all known glutamate-interactingresidues, supporting their distinct classification from the iGluRs. We show that B. glabrata contains 7 putative IRs, some of which are expressed within its chemosensory organs. To further investigate a role for the more ancient IR25a type in chemoreception, we tested its spatial distribution pattern within the snail cephalic tentacle by in situ hybridization. The presence of IR25a within presumptive sensory neurons supports a role for this receptor in olfactory processing, contributing to our understanding of the molecular pathways that are involved in Biomphalaria olfactory processing.	[Liang, Di; Wang, Tianfang; Rotgans, Bronwyn A.; Cummins, Scott F.] Univ Sunshine Coast, Fac Sci Hlth & Educ, Maroochydore, Qld 4558, Australia; [McManus, Donald P.] QIMR Berghofer Med Res Inst, Mol Parasitol Lab, Brisbane, Qld 4006, Australia	University of the Sunshine Coast; QIMR Berghofer Medical Research Institute	Cummins, SF (corresponding author), Univ Sunshine Coast, Fac Sci Hlth & Educ, Maroochydore, Qld 4558, Australia.	scummins@usc.edu.au	McManus, Don/AAC-5394-2020; Wang, Tianfang/GRO-0844-2022; Wang, Tianfang/AAG-4290-2020; Wang, Tianfang/L-5192-2016; Cummins, Scott/I-6420-2016	McManus, Don/0000-0001-6443-1449; Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Cummins, Scott/0000-0002-1454-2076	Australian Research Council [FT110100990]; Australian Government	Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	This work was supported by the Australian Research Council (Future Fellowship, FT110100990 to SFC). This research was undertaken with the assistance of resources from the National Computational Infrastructure (NCI), which is supported by the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertin CB, 2015, NATURE, V524, P220, DOI 10.1038/nature14668; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bonfardin VDJ, 2010, J NEUROSCI, V30, P985, DOI 10.1523/JNEUROSCI.3389-09.2010; Case D. A., 2014, AMBER 14; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Corey EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060551; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Cummins SF, 2007, GENOMICS, V90, P110, DOI 10.1016/j.ygeno.2007.03.020; Danso-Appiah A, 2002, TRENDS PARASITOL, V18, P125, DOI 10.1016/S1471-4922(01)02209-7; Derby CD, 1997, J EXP BIOL, V200, P2073; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Groh-Lunow Katrin C, 2014, Front Cell Neurosci, V8, P448, DOI 10.3389/fncel.2014.00448; Hollins B, 2003, J COMP NEUROL, V455, P125, DOI 10.1002/cne.10489; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Mayer ML, 2004, ANNU REV PHYSIOL, V66, P161, DOI 10.1146/annurev.physiol.66.050802.084104; Melman SD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000504; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; Pravin S, 2012, J COMP PHYSIOL A, V198, P669, DOI 10.1007/s00359-012-0738-x; Rodriguez-Moreno A, 2007, J NEUROCHEM, V103, P2121, DOI 10.1111/j.1471-4159.2007.04924.x; Rota-Stabelli O, 2013, CURR BIOL, V23, P392, DOI 10.1016/j.cub.2013.01.026; Shaham S, 2010, NAT REV NEUROSCI, V11, P212, DOI 10.1038/nrn2740; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stepanyan R, 2004, CHEM SENSES, V29, P179, DOI 10.1093/chemse/bjh023; Tadesse T, 2011, DEV NEUROBIOL, V71, P316, DOI 10.1002/dneu.20862; Tikhonov D B, 2009, Neurosci Behav Physiol, V39, P763, DOI 10.1007/s11055-009-9195-6; Tuchina O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096430; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	34	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156380	10.1371/journal.pone.0156380	http://dx.doi.org/10.1371/journal.pone.0156380			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253696	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700022
J	Yip, EC; Berner-Aharon, N; Smith, DR; Lubin, Y				Yip, Eric C.; Berner-Aharon, Na'ama; Smith, Deborah R.; Lubin, Yael			Coy Males and Seductive Females in the Sexually Cannibalistic Colonial Spider, Cyrtophora citricola	PLOS ONE			English	Article							MALE MATE CHOICE; CONDITIONAL MONOGYNY; SPERM COMPETITION; SIZE DIMORPHISM; EVOLUTION; SELECTION; ARANEAE; PREFERENCE; POLYANDRY; SACRIFICE	The abundance of sperm relative to eggs selects for males that maximize their number of mates and for females that choose high quality males. However, in many species, males exercise mate choice, even when they invest little in their offspring. Sexual cannibalism may promote male choosiness by limiting the number of females a male can inseminate and by biasing the sex ratio toward females because, while females can reenter the mating pool, cannibalized males cannot. These effects may be insufficient for male choosiness to evolve, however, if males face low sequential encounter rates with females. We hypothesized that sexual cannibalism should facilitate the evolution of male choosiness in group living species because a male is likely to encounter multiple receptive females simultaneously. We tested this hypothesis in a colonial orb-weaving spider, Cyrtophora citricola, with a high rate of sexual cannibalism. We tested whether mated females would mate with multiple males, and thereby shift the operational sex ratio toward females. We also investigated whether either sex chooses mates based on nutritional state and age, and whether males choose females based on reproductive state. We found that females are readily polyandrous and exhibit no mate choice related to male feeding or age. Males courted more often when the male was older and the female was younger, and males copulated more often with well-fed females. The data show that males are choosier than females for the traits we measured, supporting our hypothesis that group living and sexual cannibalism may together promote the evolution of male mate choice.	[Yip, Eric C.; Berner-Aharon, Na'ama; Lubin, Yael] Ben Gurion Univ Negev, Mitrani Dept Desert Ecol, Swiss Inst Dryland Environm & Energy Res, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel; [Smith, Deborah R.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	Ben Gurion University; University of Kansas	Yip, EC (corresponding author), Ben Gurion Univ Negev, Mitrani Dept Desert Ecol, Swiss Inst Dryland Environm & Energy Res, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel.	ecy7@cornell.edu	Smith, Deborah/V-1676-2019; Lubin, Yael D/F-1382-2012	Smith, Deborah/0000-0002-2581-5009; Lubin, Yael D/0000-0003-3876-1668; Yip, Eric/0000-0002-3543-3717	U.S.-Israel Binational Science Foundation [2010178]; Jacob Blaustein Center for Scientific Cooperation; Kreitman School for Advanced Graduate Studies	U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Jacob Blaustein Center for Scientific Cooperation; Kreitman School for Advanced Graduate Studies	The study was funded by the U.S.-Israel Binational Science Foundation, grant #2010178. Additional funding to ECY was provided by the Jacob Blaustein Center for Scientific Cooperation and the Kreitman School for Advanced Graduate Studies.	Aisenberg A, 2007, BEHAV ECOL SOCIOBIOL, V62, P29, DOI 10.1007/s00265-007-0435-x; Andrade MCB, 2005, INTEGR COMP BIOL, V45, P838, DOI 10.1093/icb/45.5.838; Andrade MCB, 1996, SCIENCE, V271, P70, DOI 10.1126/science.271.5245.70; Andrade MCB, 2003, BEHAV ECOL, V14, P531, DOI 10.1093/beheco/arg015; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Barry KL, 2010, ANIM BEHAV, V80, P163, DOI 10.1016/j.anbehav.2010.04.020; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Berner-Aharon N., 2013, THESIS BEN GURION U; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; BUCHLI HHR, 1969, AM ZOOL, V9, P175; Darwin C., 1871, P423; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Elgar MA, 1996, BEHAV ECOL, V7, P195, DOI 10.1093/beheco/7.2.195; Elgar MA, 2003, AUST J ZOOL, V51, P357, DOI 10.1071/ZO02079; Elgar MA, 2004, ADV STUD BEHAV, V34, P135, DOI 10.1016/S0065-3454(04)34004-0; Elgar Mark A., 1992, P128; Fromhage L, 2005, EVOLUTION, V59, P1400; Fromhage L, 2012, ECOL EVOL, V2, P2572, DOI 10.1002/ece3.372; Gaskett AC, 2007, BIOL REV, V82, P26, DOI 10.1111/j.1469-185X.2006.00002.x; HARRINGTON DP, 1982, BIOMETRIKA, V69, P553, DOI 10.2307/2335991; Huber BA, 2005, BIOL REV, V80, P363, DOI 10.1017/S1464793104006700; JENNI DA, 1972, AUK, V89, P743, DOI 10.2307/4084107; Kasumovic MM, 2007, BEHAV ECOL, V18, P189, DOI 10.1093/beheco/arl072; Kokko H, 2005, EVOLUTION, V59, P1876; Kokko H, 2003, TRENDS ECOL EVOL, V18, P103, DOI 10.1016/S0169-5347(03)00009-0; Kvarnemo C, 2000, J EVOLUTION BIOL, V13, P882, DOI 10.1046/j.1420-9101.2000.00228.x; Rao D, 2010, ISR J ECOL EVOL, V56, P21, DOI 10.1560/IJEE.56.1.21; RIECHERT SE, 1995, ANIM BEHAV, V49, P715, DOI 10.1016/0003-3472(95)80204-5; Roth O, 2011, J EVOLUTION BIOL, V24, P1410, DOI 10.1111/j.1420-9101.2011.02273.x; RYPSTRA AL, 1979, BEHAV ECOL SOCIOBIOL, V5, P291, DOI 10.1007/BF00293677; Scharer L, 2012, TRENDS ECOL EVOL, V27, P260, DOI 10.1016/j.tree.2011.12.006; Schneider J., 2015, CRYPTIC FEMALE CHOIC, P55; Schneider JM, 2001, BEHAV ECOL, V12, P547, DOI 10.1093/beheco/12.5.547; Schneider Jutta, 2011, P215; Schneider J, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P441, DOI 10.1007/978-3-642-02624-9_15; Schneider JM, 2016, ETHOLOGY, V122, P257, DOI 10.1111/eth.12466; Schulte KF, 2010, ANIM BEHAV, V80, P699, DOI 10.1016/j.anbehav.2010.07.005; Schulz S, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P110, DOI 10.1017/CBO9780511542664.005; SINGER F, 1995, BEHAV ECOL SOCIOBIOL, V36, P313, DOI 10.1007/BF00167792; Snow LSE, 2005, P ROY SOC B-BIOL SCI, V272, P1139, DOI 10.1098/rspb.2005.3088; South SH, 2012, EVOLUTION, V66, P3722, DOI 10.1111/j.1558-5646.2012.01716.x; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Uetz George W., 1997, P458; Uhl G, 2010, GENETICA, V138, P75, DOI 10.1007/s10709-009-9388-5; Vollrath F., 1987, P357; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Welke KW, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-7; Wilgers DJ, 2012, BEHAV ECOL SOCIOBIOL, V66, P29, DOI 10.1007/s00265-011-1248-5; Yip EC, 2016, BIOL J LINN SOC, V118, P410, DOI 10.1111/bij.12730; Zimmer SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031389	51	7	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155433	10.1371/journal.pone.0155433	http://dx.doi.org/10.1371/journal.pone.0155433			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249787	Green Submitted, Green Published, gold			2022-12-26	WOS:000377184700013
J	Di Tullio, JC; Gandra, TBR; Zerbini, AN; Secchi, ER				Di Tullio, Juliana Couto; Gandra, Tiago B. R.; Zerbini, Alexandre N.; Secchi, Eduardo R.			Diversity and Distribution Patterns of Cetaceans in the Subtropical Southwestern Atlantic Outer Continental Shelf and Slope	PLOS ONE			English	Article							WHALES MEGAPTERA-NOVAEANGLIAE; GULF-OF-CALIFORNIA; RELATIVE ABUNDANCE; BETA-DIVERSITY; SOUTHERN; HABITAT; BRAZIL; DOLPHINS; DENSITY; WATERS	Temporal and spatial patterns of cetacean diversity and distribution were investigated through eight ship-based surveys carried out during spring and autumn between 2009 and 2014 on the outer continental shelf (similar to 150m) and slope (1500m) off southeastern and southern Brazil (similar to 23 degrees S to similar to 34 degrees S). The survey area was divided into southeast and south areas according to their oceanographic characteristics. Twenty-one species were observed in 503 sightings. The overall number of species was similar between the two areas, though it was higher in the spring in the south area. Five species were dominant and diversity varied more seasonally than spatially. ANOVA and kernel analyses showed that overall cetacean densities were higher in spring compared to autumn. Physeter macrocephalus, the most frequent species, concentrated throughout the south area at depths over 1000m in both seasons. Despite the overlapped occurrence at a broader scale, small delphinids presented latitudinal and in-offshore gradients as well as seasonal variation in distribution patterns, which could indicate habitat partitioning between some species. Delphinus delphis was only recorded in the south and its density decreased in areas where the presence of Stenella frontalis increased, mainly beyond the 250m isobath. Densities of S. longirostris and S. attenuata increased in lower latitudes and beyond the shelf break. The large delphinids Tursiops truncatus and Globicephala melas formed mixed groups in many occasions and were observed along the study area around depths of 500m. Grampus griseus was twice as frequent in the south area and densities increased in waters deeper than 600m. As expected, densities of both small and large migratory whales were higher during spring, over the continental slope, in the southeast area. The results presented here provided strong evidence on the importance of the outer continental shelf and slope to a diverse community of cetaceans occurring in the subtropical Southwestern Atlantic.	[Di Tullio, Juliana Couto; Secchi, Eduardo R.] Univ Fed Rio Grande, Inst Oceanog, Lab Ecol & Conservacao Megafauna Marinha ECOMEGA, Rio Grande, RS, Brazil; [Gandra, Tiago B. R.] Inst Fed Educ Ciencia & Tecnol Rio Grande Sul IFR, Lab Geotecnol & Meio Ambiente GEOMA, Rio Grande, RS, Brazil; [Zerbini, Alexandre N.] Cascadia Res Collect, Olympia, WA USA; [Zerbini, Alexandre N.] NOAA, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Zerbini, Alexandre N.] Inst Aqualie, R Dr Paulo Japiassu Coelho 714-206, Juiz De Fora, MG, Brazil	Universidade Federal do Rio Grande; National Oceanic Atmospheric Admin (NOAA) - USA	Di Tullio, JC (corresponding author), Univ Fed Rio Grande, Inst Oceanog, Lab Ecol & Conservacao Megafauna Marinha ECOMEGA, Rio Grande, RS, Brazil.	ditullio.juliana@gmail.com	Gandra, Tiago/AAC-1457-2020; Secchi, Eduardo R./ABF-1191-2020; Zerbini, Alexandre/ABH-3916-2020	Gandra, Tiago/0000-0002-7165-770X; Secchi, Eduardo R./0000-0001-9087-9909; Zerbini, Alexandre/0000-0002-9776-6605	Chevron Brasil Upstrem Frade Ltda; BG Group, Brasil; National Counsel of Technological and Scientific Development (CNPq) [143263/2011-0, PQ 307843/2014-0]; CNPq [610012/2011-8]	Chevron Brasil Upstrem Frade Ltda; BG Group, Brasil; National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project was mostly funded by Chevron Brasil Upstrem Frade Ltda. Additional funding was provided by BG Group, Brasil. The Brazilian Inter-Ministerial Commission for the Resources of the Sea (CIRM) supplied diesel for the ship for all surveys. The National Counsel of Technological and Scientific Development (CNPq) provided a scholarship to JCDT (Process 143263/2011-0) and a research fellowship to ERS (PQ 307843/2014-0). This study is a contribution of the Research Group "Ecologia e Conservacao da Megafauna Marinha-EcoMega/CNPq" and the Brazilian National Institute of Science and Technology - INCT-Mar COI funded by CNPq Grant Number 610012/2011-8. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all researchers and students from the Federal University of Rio Grande-FURG and many other institutions who helped collecting the data at sea and especially F Abdala, M Bassoi, F Castro, PF Fruet, R Genoves, J Prado and E Seyboth. We also thank the crew of FURG's R/V "Atlantico Sul" for helping us in all onboard activities. A Andriolo, S Botta, L Fidelix, G Miranda, M Pinho, S Weigert, and the personnel of the Fleet Division provided logistical support. L Dalla Rosa, V Tavano, LS Madureira, A Azevedo and the anonymous referees provided useful suggestions to improve the manuscript. We dedicate this study to the late skipper of the R/V "Atlantico Sul" Mr. Homero Poujeaux Alvariz for his lifetime dedication to our research vessel. This study is a contribution of the Research Group "Ecologia e Conservacao da Megafauna Marinha-EcoMega/CNPq" and the Brazilian National Institute of Science and Technology - INCT-Mar COI funded by CNPq Grant Number 610012/2011-8.	Mandiola M. Agustina, 2015, Mastozool. neotrop., V22, P397; Andriolo A, 2010, ZOOLOGIA-CURITIBA, V27, P741, DOI 10.1590/S1984-46702010000500011; [Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Azzellino A, 2012, OCEAN COAST MANAGE, V67, P63, DOI 10.1016/j.ocecoaman.2012.05.024; Baines Mick E., 2014, Journal of Cetacean Research and Management, V14, P57; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Barlow J, 2007, FISH B-NOAA, V105, P509; Bastida R, 2007, MAMIFEROS ACUATICOS; Baumgartner MF, 2001, FISH B-NOAA, V99, P219; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Braga ES, 2008, CONT SHELF RES, V28, P1649, DOI 10.1016/j.csr.2007.06.018; BRANDINI FP, 1990, HYDROBIOLOGIA, V196, P111, DOI 10.1007/BF00006105; Campbell GS, 2015, DEEP-SEA RES PT II, V112, P143, DOI 10.1016/j.dsr2.2014.10.008; Campos EJD, 2000, GEOPHYS RES LETT, V27, P751, DOI 10.1029/1999GL010502; Chen Y., 2012, MULTIPLE SITE BIODIV; CLARKE MR, 1980, MAR BIOL, V59, P235, DOI 10.1007/BF00404746; Cords M., 2014, PRIMATES CETACEANS F, P409, DOI DOI 10.1007/978-4-431-54523-1_21; Dalla Rosa L, 2007, J MAR BIOL ASSOC UK, V87, P135, DOI 10.1017/S0025315407054306; Danilewicz Daniel, 2013, Marine Biodiversity Records, V6, pe6, DOI 10.1017/S1755267212000929; Davis RW, 2002, DEEP-SEA RES PT I, V49, P121, DOI 10.1016/S0967-0637(01)00035-8; de Mahiques MM, 2004, CONT SHELF RES, V24, P1685, DOI 10.1016/j.csr.2004.05.013; de Vivo M, 2011, BIOTA NEOTROP, V11, P111, DOI 10.1590/S1676-06032011000500007; do Amaral KB, 2015, J EXP MAR BIOL ECOL, V472, P166, DOI 10.1016/j.jembe.2015.07.013; Doksaeter L, 2008, DEEP-SEA RES PT II, V55, P243, DOI 10.1016/j.dsr2.2007.09.009; dos Santos RA, 2002, B MAR SCI, V71, P753; dos Santos RA, 2001, FISH RES, V52, P99; Edwards EF, 2015, MAMMAL REV, V45, P197, DOI 10.1111/mam.12048; Fertl D, 2003, MAMMAL REV, V33, P253, DOI 10.1046/j.1365-2907.2003.00033.x; Fox J., 2015, COMPANION APPL REGRE; Fruet PF, 2014, CONSERV GENET, V15, P879, DOI 10.1007/s10592-014-0586-z; Gill PC, 2015, J WILDLIFE MANAGE, V79, P672, DOI 10.1002/jwmg.867; Goncalves LR, 2016, J MAR BIOL ASSOC UK, V96, P943, DOI 10.1017/S0025315415001812; Haimovici M, 2014, FISH RES, V152, P1, DOI 10.1016/j.fishres.2013.09.007; Haimovici M, 2009, LAT AM J AQUAT RES, V37, P395, DOI 10.3856/vol37-issue3-fulltext-10; HARRISON S, 1992, J ANIM ECOL, V61, P151, DOI 10.2307/5518; Hiby A.R., 1989, Reports of the International Whaling Commission Special Issue, P47; Jaquet N, 2002, MAR BIOL, V141, P591, DOI 10.1007/s00227-002-0839-0; Jefferson TA, 2014, MAMMAL REV, V44, P56, DOI 10.1111/mam.12008; Knoppers B., 2010, BIOL MARINHA, P529; Lodi L, 2014, MAR ECOL-EVOL PERSP, V35, P516, DOI 10.1111/maec.12108; Macleod K, 2004, MAR ECOL PROG SER, V277, P263, DOI 10.3354/meps277263; Madureira LASP, 2005, SERIE DOCUMENTOS REV; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martins AS, 2005, J MAR BIOL ASSOC UK, V85, P1223, DOI 10.1017/S002531540501235X; Moller OO, 2008, CONT SHELF RES, V28, P1607, DOI 10.1016/j.csr.2008.03.012; Moreno IB, 2005, MAR ECOL PROG SER, V300, P229, DOI 10.3354/meps300229; Muelbert JH, 2008, CONT SHELF RES, V28, P1662, DOI 10.1016/j.csr.2007.08.011; Nino-Torres C, 2014, MAR MAMMAL SCI, V30, P1748; Obe RO, 2011, POSTGIS IN ACTION, P492; Oksanen J, 2015, COMMUNITY ECOLOGY PA; Ott PH, 2013, MAMIFEROS RIO GRANDE, P457; Parente Cristiano Leite, 2007, Biota Neotrop., V7, P0, DOI 10.1590/S1676-06032007000100007; Pastene LA, 2015, REV BIOL MAR OCEANOG, V50, P453, DOI 10.4067/S0718-19572015000400005; Pinedo M. C., 2002, Journal of Cetacean Research and Management, V4, P323; Piola A. R., 2000, Journal of Geophysical Research, V105, P6565, DOI 10.1029/1999JC000300; Piola AR, 2008, CONT SHELF RES, V28, P1639, DOI 10.1016/j.csr.2008.03.013; Pirotta E, 2011, MAR ECOL PROG SER, V436, P257, DOI 10.3354/meps09236; Prado JHF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146339; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; Ripley B, 2015, SUPPORT FUNCTIONS DA; Salvadeo CJ, 2011, CIENC MAR, V37, P215, DOI 10.7773/cm.v37i2.1840; Secchi Eduardo R., 1998, Aquatic Mammals, V24, P117; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Signorini S, 2006, J GEO RES, V33; Springer AM, 1999, PROG OCEANOGR, V43, P443, DOI 10.1016/S0079-6611(99)00014-2; Tavares M, 2010, MAMMAL REV, V40, P40, DOI 10.1111/j.1365-2907.2009.00154.x; Thomas PO, 2016, MAR MAMMAL SCI, V32, P682, DOI 10.1111/mms.12281; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Tynan CT, 2005, DEEP-SEA RES PT II, V52, P145, DOI 10.1016/j.dsr2.2004.09.024; VINOGRADOV M, 1981, ANAL MARINE ECOSYSTE; Whitehead H, 2010, MAR ECOL PROG SER, V408, P1, DOI 10.3354/meps08619; Wickham H., 2014, IMPLEMENTATION GRAMM; WILSON MV, 1984, J ECOL, V72, P1055, DOI 10.2307/2259551; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; WOLDA H, 1983, OECOLOGIA, V58, P290, DOI 10.1007/BF00385226; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Zerbini A N, 2004, SERIE DOCUMENTOS REV, P40; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295; Zerbini Alexandre N., 1997, Report of the International Whaling Commission, V47, P407; Zerbini Alexandre N., 2011, Journal of Cetacean Research and Management, P113; Zerbini Alexandre N., 1996, Report of the International Whaling Commission, V46, P333	82	33	36	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155841	10.1371/journal.pone.0155841	http://dx.doi.org/10.1371/journal.pone.0155841			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243455	Green Published, gold, Green Submitted			2022-12-26	WOS:000377146100008
J	Habener, A; Chowdhury, A; Echtermeyer, F; Lichtinghagen, R; Theilmeier, G; Herzog, C				Habener, Anika; Chowdhury, Arpita; Echtermeyer, Frank; Lichtinghagen, Ralf; Theilmeier, Gregor; Herzog, Christine			MitoNEET Protects HL-1 Cardiomyocytes from Oxidative Stress Mediated Apoptosis in an In Vitro Model of Hypoxia and Reoxygenation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; GLUTATHIONE-REDUCTASE INHIBITION; MITOCHONDRIAL-MEMBRANE PROTEIN; IRON-SULFUR CLUSTERS; CARDIAC MYOCYTES; FREE-RADICALS; RAT-HEART; GENERATION; PIOGLITAZONE; ANTIOXIDANTS	The iron-sulfur cluster containing protein mitoNEET is known to modulate the oxidative capacity of cardiac mitochondria but its function during myocardial reperfusion injury after transient ischemia is unknown. The purpose of this study was to analyze the impact of mitoNEET on oxidative stress induced cell death and its relation to the glutathione-redox system in cardiomyocytes in an in vitro model of hypoxia and reoxygenation (H/R). Our results show that siRNA knockdown (KD) of mitoNEET caused an 1.9-fold increase in H/R induced apoptosis compared to H/R control while overexpression of mitoNEET caused a 53% decrease in apoptosis. Necrosis was not affected. Apoptosis of both, mitoNEET-KD and control cells was diminished to comparable levels by using the antioxidants Tiron and glutathione compound glutathione reduced ethyl ester (GSH-MEE), indicating that mitoNEETdependent apoptosis is mediated by oxidative stress. The interplay between mitoNEET and glutathione redox system was assessed by treating cardiomyocytes with 2-acetylamino-3-[4-(2-acetylamino-2-carboxyethylsulfanylthio-carbonylamino) phenylthiocarbamoylsulfanyl] propionic acid (2-AAPA), known to effectively inhibit glutathione reductase (GSR) and to decrease the GSH/GSSG ratio. Surprisingly, inhibition of GSR-activity to 20% by 2-AAPA decreased apoptosis of control and mitoNEET-KD cells to 23% and 25% respectively, while at the same time mitoNEET-protein was increased 4-fold. This effect on mitoNEET-protein was not accessible by mitoNEET-KD but was reversed by GSH-MEE. In conclusion we show that mitoNEET protects cardiomyocytes from oxidative stress-induced apoptosis during H/R. Inhibition of GSH-recycling, GSR-activity by 2-AAPA increased mitoNEET-protein, accompanied by reduced apoptosis. Addition of GSH reversed these effects suggesting that mitoNEET can in part compensate for imbalances in the antioxidative glutathione-system and therefore could serve as a potential therapeutic approach for the oxidatively stressed myocardium.	[Habener, Anika; Chowdhury, Arpita; Echtermeyer, Frank; Theilmeier, Gregor; Herzog, Christine] Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany; [Habener, Anika] Hannover Med Sch, Dept Pediat Pneumol Allergol & Neonatol, Hannover, Germany; [Chowdhury, Arpita] Univ Med Ctr Gottingen, Dept Cellular Biochem, Gottingen, Germany; [Lichtinghagen, Ralf] Hannover Med Sch, Inst Clin Chem, Hannover, Germany; [Theilmeier, Gregor] Carl von Ossietzky Univ Oldenburg, Fac Med & Hlth Sci, Dept Hlth Serv Sci, D-26111 Oldenburg, Germany	Hannover Medical School; Hannover Medical School; University of Gottingen; Hannover Medical School; Carl von Ossietzky Universitat Oldenburg	Herzog, C (corresponding author), Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany.	herzog.christine@mh-hannover.de		Chowdhury, Arpita/0000-0001-5025-0268	Deutsche Forschungsgemeinschaft (DFG) [Th667/6-1, 7-1, KFO136, TP12]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, grant numbers: Th667/6-1 and 7-1; KFO136, TP12 (GT and CH)). The funders had no role in study design, data collection, analysis and interpretation, decision to publish, or preparation of the manuscript.	AMBROSIO G, 1993, J BIOL CHEM, V268, P18532; Andersen AD, 2009, AM J PHYSIOL-CELL PH, V296, pC1227, DOI 10.1152/ajpcell.00370.2008; ANDERSON ME, 1989, ANAL BIOCHEM, V183, P16, DOI 10.1016/0003-2697(89)90164-4; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Belka C, 2006, ONCOGENE, V25, P969, DOI 10.1038/sj.onc.1209175; Carlson DL, 2002, AM J PHYSIOL-HEART C, V282, pH1907, DOI 10.1152/ajpheart.00393.2001; Chang NC, 2010, EMBO J, V29, P606, DOI 10.1038/emboj.2009.369; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Dicus MM, 2010, J AM CHEM SOC, V132, P2037, DOI 10.1021/ja909359g; Du Y, 2005, LIFE SCI, V77, P2770, DOI 10.1016/j.lfs.2005.03.027; Dwivedi VK, 2006, J ENZYM INHIB MED CH, V21, P43, DOI 10.1080/14756360500286070; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; Fiedler B, 2006, J BIOL CHEM, V281, P32831, DOI 10.1074/jbc.M603416200; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Grieve DJ, 2003, EUR HEART J, V24, P2161, DOI 10.1016/j.ehj.2003.10.015; Hunter RL, 2008, NEUROSCI LETT, V432, P198, DOI 10.1016/j.neulet.2007.12.019; Jiao XY, 2009, J PHARMACOL EXP THER, V328, P777, DOI 10.1124/jpet.108.144352; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kevin LG, 2005, ANESTH ANALG, V101, P1275, DOI 10.1213/01.ANE.0000180999.81013.D0; Kitta K, 2001, FREE RADICAL BIO MED, V31, P902, DOI 10.1016/S0891-5849(01)00663-3; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Landry AP, 2015, FREE RADICAL BIO MED, V81, P119, DOI 10.1016/j.freeradbiomed.2015.01.017; Lievre V, 2001, NEUROSCIENCE, V105, P287, DOI 10.1016/S0306-4522(01)00189-0; Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104; Logan SJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0471-z; MIZUI T, 1992, AM J PHYSIOL, V262, pH313, DOI 10.1152/ajpheart.1992.262.2.H313; Paddock ML, 2007, P NATL ACAD SCI USA, V104, P14342, DOI 10.1073/pnas.0707189104; Park JW, 1997, LIFE SCI, V60, P2207, DOI 10.1016/S0024-3205(97)00236-1; Rozanski GJ, 2002, AM J PHYSIOL-HEART C, V282, pH2346, DOI 10.1152/ajpheart.00894.2001; Sadhu SS, 2013, J ENZYM INHIB MED CH, V28, P456, DOI 10.3109/14756366.2011.649267; Seefeldt T, 2009, J BIOL CHEM, V284, P2729, DOI 10.1074/jbc.M802683200; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Tavazzi B, 1998, FREE RADICAL RES, V28, P25, DOI 10.3109/10715769809097873; Venardos KM, 2007, CURR MED CHEM, V14, P1539, DOI 10.2174/092986707780831078; Webster KA, 1999, J CLIN INVEST, V104, P239; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; Wiley SE, 2013, EMBO MOL MED, V5, P904, DOI 10.1002/emmm.201201429; Xie JS, 2014, FREE RADICAL BIO MED, V70, P214, DOI 10.1016/j.freeradbiomed.2014.02.022; Yang HJ, 2009, TOXICOL MECH METHOD, V19, P66, DOI 10.1080/15376510802428583; Yuan ZK, 2010, MOL CELL ENDOCRINOL, V325, P1, DOI 10.1016/j.mce.2010.04.013; Zhao Y, 2009, FREE RADICAL BIO MED, V47, P176, DOI 10.1016/j.freeradbiomed.2009.04.022; Zhao Y, 2009, ARCH BIOCHEM BIOPHYS, V485, P56, DOI 10.1016/j.abb.2009.03.001	46	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156054	10.1371/journal.pone.0156054	http://dx.doi.org/10.1371/journal.pone.0156054			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243905	Green Submitted, Green Published, gold			2022-12-26	WOS:000377146100012
J	Lee, CY; Song, H; Park, CW; Chung, YH; Kim, JS; Park, JC				Lee, Chae Young; Song, Hankyeol; Park, Chan Woo; Chung, Yong Hyun; Kim, Jin Sung; Park, Justin C.			Optimization of Proton CT Detector System and Image Reconstruction Algorithm for On-Line Proton Therapy	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RESOLUTION	The purposes of this study were to optimize a proton computed tomography system (pCT) for proton range verification and to confirm the pCT image reconstruction algorithm based on projection images generated with optimized parameters. For this purpose, we developed a new pCT scanner using the Geometry and Tracking (GEANT) 4.9.6 simulation toolkit. GEANT4 simulations were performed to optimize the geometric parameters representing the detector thickness and the distance between the detectors for pCT. The system consisted of four silicon strip detectors for particle tracking and a calorimeter to measure the residual energies of the individual protons. The optimized pCT system design was then adjusted to ensure that the solution to a CS-based convex optimization problem would converge to yield the desired pCT images after a reasonable number of iterative corrections. In particular, we used a total variation-based formulation that has been useful in exploiting prior knowledge about the minimal variations of proton attenuation characteristics in the human body. Examinations performed using our CS algorithm showed that high-quality pCT images could be reconstructed using sets of 72 projections within 20 iterations and without any streaks or noise, which can be caused by under-sampling and proton starvation. Moreover, the images yielded by this CS algorithm were found to be of higher quality than those obtained using other reconstruction algorithms. The optimized pCT scanner system demonstrated the potential to perform high-quality pCT during on-line image-guided proton therapy, without increasing the imaging dose, by applying our CS based proton CT reconstruction algorithm. Further, we make our optimized detector system and CS-based proton CT reconstruction algorithm potentially useful in on-line proton therapy.	[Lee, Chae Young; Song, Hankyeol; Park, Chan Woo; Chung, Yong Hyun] Yonsei Univ, Dept Radiol Sci, Wonju, South Korea; [Kim, Jin Sung] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea; [Park, Justin C.] Univ Florida, Dept Radiat Oncol, Gainesville, FL USA	Yonsei University; Yonsei University; Yonsei University Health System; State University System of Florida; University of Florida	Chung, YH (corresponding author), Yonsei Univ, Dept Radiol Sci, Wonju, South Korea.; Kim, JS (corresponding author), Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea.	ychung@yonsei.ac.kr; jinsung@yuhs.ac		Kim, Jin Sung/0000-0003-1415-6471	Nuclear Safety Research Program through the Korea Radiation Safety Foundation (KORSAFe); Nuclear Safety and Security Commission (NSSC), Republic of Korea [1402015]	Nuclear Safety Research Program through the Korea Radiation Safety Foundation (KORSAFe); Nuclear Safety and Security Commission (NSSC), Republic of Korea	This work was supported by the Nuclear Safety Research Program through the Korea Radiation Safety Foundation (KORSAFe) and the Nuclear Safety and Security Commission (NSSC), Republic of Korea (Grant No. 1402015).	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Anderson HH, 1977, STOPPING RANGES IONS, P3; Berger M. J., 2010, ESTAR PSTAR ASTAR CO; Bichsel H., 1972, AM I PHYS HDB, V42, P8; Choi K, 2010, MED PHYS, V37, P5113, DOI 10.1118/1.3481510; Chung K, 2015, RADIAT ONCOL J, V33, P337, DOI 10.3857/roj.2015.33.4.337; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Li TF, 2006, MED PHYS, V33, P699, DOI 10.1118/1.2171507; Sadrozinski HFW, 2004, IEEE T NUCL SCI, V51, P3, DOI 10.1109/TNS.2003.823044; Schaffner B, 1998, PHYS MED BIOL, V43, P1579, DOI 10.1088/0031-9155/43/6/016; SCHNEIDER U, 1994, MED PHYS, V21, P1657, DOI 10.1118/1.597212; Schulte RW, 2005, MED PHYS, V32, P1035, DOI 10.1118/1.1884906; SLATER JM, 1992, INT J RADIAT ONCOL, V22, P383, DOI 10.1016/0360-3016(92)90058-P; Williams DC, 2004, PHYS MED BIOL, V49, P2899, DOI 10.1088/0031-9155/49/13/010; Zhang J, 2013, P IEEE INT S CIRC SY, P2135	16	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156226	10.1371/journal.pone.0156226	http://dx.doi.org/10.1371/journal.pone.0156226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243822	Green Published, gold, Green Submitted			2022-12-26	WOS:000377146100021
J	Gerchen, JF; Reichert, SJ; Rohr, JT; Dieterich, C; Kloas, W; Stock, M				Gerchen, Joern F.; Reichert, Samuel J.; Roehr, Johannes T.; Dieterich, Christoph; Kloas, Werner; Stoeck, Matthias			A Single Transcriptome of a Green Toad (Bufo viridis) Yields Candidate Genes for Sex Determination and -Differentiation and Non-Anonymous Population Genetic Markers	PLOS ONE			English	Article							MICROSATELLITE LOCI; WIDE-RANGE; CHROMOSOMES; EVOLUTION; GENOME; AMPLIFICATION; AMPHIBIA; SUBGROUP; SEQUENCE; UTILITY	Large genome size, including immense repetitive and non-coding fractions, still present challenges for capacity, bioinformatics and thus affordability of whole genome sequencing in most amphibians. Here, we test the performance of a single transcriptome to understand whether it can provide a cost-efficient resource for species with large unknown genomes. Using RNA from six different tissues from a single Palearctic green toad ( Bufo viridis) specimen and Hiseq2000, we obtained 22,5 Mio reads and publish >100,000 unigene sequences. To evaluate efficacy and quality, we first use this data to identify green toad specific candidate genes, known from other vertebrates for their role in sex determination and differentiation. Of a list of 37 genes, the transcriptome yielded 32 ( 87%), many of which providing the first such data for this non-model anuran species. However, for many of these genes, only fragments could be retrieved. In order to allow also applications to population genetics, we further used the transcriptome for the targeted development of 21 non-anonymous microsatellites and tested them in genetic families and backcrosses. Eleven markers were specifically developed to be located on the B. viridis sex chromosomes; for eight markers we can indeed demonstrate sex-specific transmission in genetic families. Depending on phylogenetic distance, several markers, which are sex-linked in green toads, show high cross-amplification success across the anuran phylogeny, involving nine systematic anuran families. Our data support the view that single transcriptome sequencing (based on multiple tissues) provides a reliable genomic resource and cost-efficient method for non-model amphibian species with large genome size and, despite limitations, should be considered as long as genome sequencing remains unaffordable for most species.	[Gerchen, Joern F.; Reichert, Samuel J.; Kloas, Werner; Stoeck, Matthias] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecophysiol & Aquaculture, Berlin, Germany; [Roehr, Johannes T.] Leibniz Inst Res Evolut & Biodivers, Berlin, Germany; [Roehr, Johannes T.] Free Univ Berlin, Dept Math & Comp Sci, Berlin, Germany; [Dieterich, Christoph] Max Planck Inst Biol Ageing, Cologne, Germany; [Gerchen, Joern F.] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin; Max Planck Society; University of Lausanne	Stock, M (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Ecophysiol & Aquaculture, Berlin, Germany.	matthias.stoeck@igb-berlin.de	Dieterich, Christoph/ABF-8459-2021; Stöck, Matthias/E-7245-2014	Stöck, Matthias/0000-0003-4888-8371	DFG [STO493/2-2, STO493/3-1]; Leibniz Association	DFG(German Research Foundation (DFG)); Leibniz Association	This work was funded by DFG, STO493/2-2, STO493/3-1, Open Access Fund of the Leibniz Association.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auguie B, 2017, GRIDEXTRA MISCELLANE; Betto-Colliard C, 2015, HEREDITY, V114, P300, DOI 10.1038/hdy.2014.100; Brelsford A, 2013, EVOLUTION, V67, P2434, DOI 10.1111/evo.12151; Carreras-Carbonell J, 2007, CONSERV GENET, V9, P181; Colliard C, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-232; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dawson DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-176; Doyle JM, 2013, GENOME, V56, P407, DOI 10.1139/gen-2013-0056; Dufresnes C, 2014, HEREDITY, V113, P9, DOI 10.1038/hdy.2014.26; Dufresnes C, 2014, MOL ECOL RESOUR, V14, P716, DOI 10.1111/1755-0998.12215; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Foote AD, 2015, NAT GENET, V47, P272, DOI 10.1038/ng.3198; Glenn TC, 1996, MOL BIOL EVOL, V13, P1151, DOI 10.1093/oxfordjournals.molbev.a025678; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Gregory TR, 2015, ANIMAL GENOME SIZE D; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Hendrix R, 2010, MOL ECOL RESOUR, V10, P1038, DOI 10.1111/j.1755-0998.2010.02861.x; James-Zorn C, 2015, GENESIS, V53, P486, DOI 10.1002/dvg.22873; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Mesak F, 2014, FRONTIERS ECOLOGY EV, V2; MIURA I, 1995, CHROMOSOMA, V103, P567, DOI 10.1007/BF00355322; Nair Abhilash, 2012, BMC Research Notes, V5, P389, DOI 10.1186/1756-0500-5-389; Primmer CR, 1996, MOL ECOL, V5, P365, DOI 10.1046/j.1365-294X.1996.00092.x; Primmer CR, 2005, J AVIAN BIOL, V36, P348; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Singhal S, 2013, MOL ECOL RESOUR, V13, P403, DOI 10.1111/1755-0998.12077; Stock M, 2013, J EVOLUTION BIOL, V26, P674, DOI 10.1111/jeb.12086; Stock M, 2011, J EVOLUTION BIOL, V24, P1064, DOI 10.1111/j.1420-9101.2011.02239.x; Stock M, 2006, MOL PHYLOGENET EVOL, V41, P663, DOI 10.1016/j.ympev.2006.05.026; Sun YB, 2015, P NATL ACAD SCI USA, V112, pE1257, DOI 10.1073/pnas.1501764112; Tamschick S, 2014, CYTOGENET GENOME RES, V144, P315, DOI 10.1159/000380841; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	37	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156419	10.1371/journal.pone.0156419	http://dx.doi.org/10.1371/journal.pone.0156419			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232626	Green Published, gold, Green Submitted			2022-12-26	WOS:000376883000032
J	Lei, L; Yu, XF; Chen, B; Chen, ZH; Wang, XJ				Lei, Lei; Yu, Xingfei; Chen, Bo; Chen, Zhanhong; Wang, Xiaojia			Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study	PLOS ONE			English	Article							DUCTAL CARCINOMA; PURE; MEDULLARY; FEATURES	Background Mucinous breast carcinoma (MC) is a special type of breast cancer that presents with a large amount of extracellular mucin. MC comprises approximately 4% of all invasive breast cancers. This type of tumor has a better prognosis and higher incidence in peri-and postmenopausal patients. Pathologically, there are two main subtypes of MC: pure and mixed. In this study, we describe 10 years of experience with MC at the Zhejiang Cancer Hospital in China, specifically, clinical data, histological findings and immunohistochemical features. Methods We identified MC patients who were diagnosed as operable and completed clinical treatment from January 2001 to January 2011. The clinicopathological data included the age at diagnosis, tumor size, TNM stage, presence and number of lymph node (LN) metastases, estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2) status and p53 expression. If the tumor was defined as mixed mucinous carcinoma (MMC), IHC was performed on a non-mucinous part, such as invasive ductal and lobular cancer. We evaluated the clinical characteristics of all MC patients using chi-square, one-way ANOVA and LSD tests. We also studied the correlations between all of the clinical parameters and LN metastasis in a binary logistic regression analysis. We used ten consecutive years of data that were collected at Zhejiang Cancer Hospital. Results We identified 48 cases of pure mucinous carcinoma (PMC) and 77 cases of MMC. The 48 PMC cases consisted of 38 PMC-A and 10 PMC-B subtypes. The MMCs were divided into two groups, those with partial mixed mucinous breast carcinoma (pMMC, 58 cases) and those with main mixed mucinous breast carcinoma (mMMC, 19 cases). pMMC was defined by tumors with less than 50% mucinous components, while mMMC was defined by tumors where the mucinous component accounted for 50% to 90% of the tumor. No significant differences in the clinicopathological characteristics were noted between the patients with PMC-A and those with PMC-B. The tumor size was larger in the mMMC than PMC cases (44.84 mm vs. 30.06 mm, p = 0.021). The number of positive LN metastases was greater in pMMC than PMC patients (p = 0.024). The clinical stages were significantly different among the three groups, with the pMMC group having more stage III-IV patients than the other two groups (p = 0.005). The incidence of LN metastasis was also higher in the pMMC cases (pMMC vs. mMMC and PMC, 50% vs. 31.58% and 18.75%, p = 0.003). The PMC patients had much lower p53 expression than the other two groups (PMC vs. pMMC and mMMC, 27.08% vs. 55.17% and 57.89%, p = 0.007). The tumor size (>30mm), p53 expression and less proportion of the mucinous component are associated with risk of LN metastasis. Conclusion Based on the results of this study, we conclude that the tumor size, status of LN metastasis, clinical stage, and p53 mutation rate may differ between MMC and PMC patients. The tumor size (>30mm), p53 mutation and less proportion of the mucinous component should be considered risk factors of LN metastasis in MC patients.	[Lei, Lei; Chen, Zhanhong; Wang, Xiaojia] Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Yu, Xingfei] Zhejiang Canc Hosp, Dept Breast Tumor Surg, Hangzhou, Zhejiang, Peoples R China; [Chen, Bo] Zhejiang Canc Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Wang, XJ (corresponding author), Zhejiang Canc Hosp, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China.	wangxj@zjcc.org.cn			Zhejiang Province Medical Science Fund Project of China [2015KYB052]; Zhejiang Province Medical Science Research Foundation of China [2015PYA001, 2009A030, 2008B022]	Zhejiang Province Medical Science Fund Project of China; Zhejiang Province Medical Science Research Foundation of China	This work was funded by the Zhejiang Province Medical Science Fund Project of China (No. 2015KYB052) and the Zhejiang Province Medical Science Research Foundation of China (Nos. 2015PYA001, 2009A030, and 2008B022).	Aljarrah Adil, 2013, Oman Med J, V28, P350, DOI 10.5001/omj.2013.100; Anderson WF, 2004, CANCER EPIDEM BIOMAR, V13, P1128; ANDRE S, 1995, J SURG ONCOL, V58, P162, DOI 10.1002/jso.2930580305; Bae SY, 2011, J BREAST CANCER, V14, P308, DOI 10.4048/jbc.2011.14.4.308; Barkley CR, 2008, AM J SURG, V196, P549, DOI 10.1016/j.amjsurg.2008.06.013; Cao AY, 2012, ANN SURG ONCOL, V19, P3019, DOI 10.1245/s10434-012-2322-6; CAPELLA C, 1980, HISTOPATHOLOGY, V4, P613, DOI 10.1111/j.1365-2559.1980.tb02957.x; Cyrta J, 2013, CYTOPATHOLOGY, V24, P377, DOI 10.1111/cyt.12016; Dhillon R, 2006, CLIN RADIOL, V61, P423, DOI 10.1016/j.crad.2005.10.008; Di Saverio S, 2008, BREAST CANCER RES TR, V111, P541, DOI 10.1007/s10549-007-9809-z; Diab SG, 1999, J CLIN ONCOL, V17, P1442, DOI 10.1200/JCO.1999.17.5.1442; Dumitru Adrian, 2015, Maedica (Bucur), V10, P14; Erhan Y, 2009, ACTA CHIR BELG, V109, P204; Hanagiri T, 2010, INT SURG, V95, P126; Karan B, 2012, DIAGN INTERV RADIOL, V18, P270, DOI 10.4261/1305-3825.DIR.4454-11.2; Kashiwagi S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-481; KOMAKI K, 1988, CANCER, V61, P989, DOI 10.1002/1097-0142(19880301)61:5<989::AID-CNCR2820610522>3.0.CO;2-E; Lakhani SR, 2012, WHO CLASSIFICATION T, V4; Laucirica R, 2011, ARCH PATHOL LAB MED, V135, P1533, DOI 10.5858/arpa.2010-0652-CP; Li Christopher I., 2010, Hormones & Cancer, V1, P156, DOI 10.1007/s12672-010-0016-8; Li CI, 2005, BRIT J CANCER, V93, P1046, DOI 10.1038/sj.bjc.6602787; Morand C, 2009, CYTOM PART B-CLIN CY, V76B, P56, DOI 10.1002/cyto.b.20436; Park S, 2010, J KOREAN MED SCI, V25, P361, DOI 10.3346/jkms.2010.25.3.361; Ranade A, 2010, J CLIN PATHOL, V63, P1043, DOI 10.1136/jcp.2010.082495; Reimer T, 2008, BREAST CARE, V3, P190, DOI 10.1159/000136826; Sas-Korczynska B, 2014, WSPOLCZESNA ONKOL, V18, P120, DOI 10.5114/wo.2014.42727; Tan JZY, 2013, J MED IMAG RADIAT ON, V57, P25, DOI 10.1111/1754-9485.12006; Thurman SA, 2004, INT J RADIAT ONCOL, V59, P152, DOI 10.1016/j.ijrobp.2003.10.029; Vo T, 2007, AM J SURG, V194, P527, DOI 10.1016/j.amjsurg.2007.06.012	29	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155132	10.1371/journal.pone.0155132	http://dx.doi.org/10.1371/journal.pone.0155132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232881	Green Published, gold, Green Submitted			2022-12-26	WOS:000376883000002
J	Abe, M; Hasegawa, Y; Oku, M; Sawada, Y; Tanaka, E; Sakai, Y; Miyoshi, H				Abe, Masato; Hasegawa, Yui; Oku, Masahide; Sawada, Yoshiki; Tanaka, Eriko; Sakai, Yasuyoshi; Miyoshi, Hideto			Mechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae Tafazzin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; BARTH-SYNDROME; CYTOCHROME-C; YEAST; GENE; TRANSACYLATION; PHOSPHOLIPIDS; PHOSPHATASE; MEMBRANES; SYNTHASE	Remodeling of the acyl chains of cardiolipin (CL) is responsible for final molecular composition of mature CL after de novo CL synthesis in mitochondria. Yeast Saccharomyces cerevisiae undergoes tafazzin-mediated CL remodeling, in which tafazzin serves as a transacylase from phospholipids to monolyso-CL (MLCL). In light of the diversity of the acyl compositions of mature CL between different organisms, the mechanism underlying tafazzin-mediated transacylation remains to be elucidated. We investigated the mechanism responsible for transacylation using purified S. cerevisiae tafazzin with liposomes composed of various sets of acyl donors and acceptors. The results revealed that tafazzin efficiently catalyzes transacylation in liposomal membranes with highly ordered lipid bilayer structure. Tafazzin elicited unique acyl chain specificity against phosphatidylcholine (PC) as follows: linoleoyl (18:2) > oleoyl (18:1) = palmitoleoyl (16:1) >> palmitoyl (16:0). In these reactions, tafazzin selectively removed the sn-2 acyl chain of PC and transferred it into the sn-1 and sn-2 positions of MLCL isomers at equivalent rates. We demonstrated for the first time that MLCL and dilyso-CL have inherent abilities to function as an acyl donor to monolyso-PC and acyl acceptor from PC, respectively. Furthermore, a Barth syndrome-associated tafazzin mutant (H77Q) was shown to completely lack the catalytic activity in our assay. It is difficult to reconcile the present results with the so-called thermodynamic remodeling hypothesis, which premises that tafazzin reacylates MLCL by unsaturated acyl chains only in disordered non-bilayer lipid domain. The acyl specificity of tafazzin may be one of the factors that determine the acyl composition of mature CLin S. cerevisiae mitochondria.	[Abe, Masato; Hasegawa, Yui; Oku, Masahide; Sawada, Yoshiki; Tanaka, Eriko; Sakai, Yasuyoshi; Miyoshi, Hideto] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Miyoshi, H (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	miyoshi@kais.kyoto-u.ac.jp	Oku, Masahide/AAW-4752-2021; Oku, Masahide/R-9389-2019	Oku, Masahide/0000-0001-5991-6281; Oku, Masahide/0000-0001-5991-6281	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [16K07689] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the Kyoto University Nano Technology Hub in the "Nanotechnology Platform Project," which is sponsored by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, for allowing us access to the dynamic light scattering particle-size analyzer (ELSZ-2Plus, Otsuka Electronic).	Abe M, 2015, TETRAHEDRON LETT, V56, P2258, DOI 10.1016/j.tetlet.2015.03.056; Abe M, 2011, BIOCHEMISTRY-US, V50, P8383, DOI 10.1021/bi2010202; Abe M, 2010, TETRAHEDRON LETT, V51, P2071, DOI 10.1016/j.tetlet.2010.02.071; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Butterworth PJ, 2012, CARBOHYD POLYM, V87, P2189, DOI 10.1016/j.carbpol.2011.10.048; Cao JS, 2004, J BIOL CHEM, V279, P31727, DOI 10.1074/jbc.M402930200; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Claypool SM, 2011, J CELL BIOL, V192, P447, DOI 10.1083/jcb.201008177; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Epand RM, 2015, BBA-BIOMEMBRANES, V1848, P220, DOI 10.1016/j.bbamem.2014.05.004; Gallet PF, 1997, BIOCHEM J, V324, P627, DOI 10.1042/bj3240627; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Hatch GM, 2004, BIOCHEM CELL BIOL, V82, P99, DOI 10.1139/o03-074; Jiang GW, 2006, J ORG CHEM, V71, P934, DOI 10.1021/jo051894e; KELLY BL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P144, DOI 10.1016/0005-2760(90)90181-V; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Lu YW, 2016, HUM MOL GENET, V25, P1754, DOI 10.1093/hmg/ddw046; Malhotra A, 2009, BBA-MOL CELL BIOL L, V1791, P314, DOI 10.1016/j.bbalip.2009.01.004; Minkler PE, 2010, J LIPID RES, V51, P856, DOI 10.1194/jlr.D002857; Nakano M, 2009, J PHYS CHEM B, V113, P6745, DOI 10.1021/jp900913w; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Oswald M, 2016, INT J PHARMACEUT, V497, P293, DOI 10.1016/j.ijpharm.2015.11.014; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Rosseto R, 2007, J ORG CHEM, V72, P1691, DOI 10.1021/jo062352f; RYTOMAA M, 1995, J BIOL CHEM, V270, P3197, DOI 10.1074/jbc.270.7.3197; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shintou K, 2007, BIOPHYS J, V93, P3900, DOI 10.1529/biophysj.107.108399; Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Valianpour F, 2005, J LIPID RES, V46, P1182, DOI 10.1194/jlr.M500056-JLR200; Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yamashita S, 2014, LIPIDS, V49, P1261, DOI 10.1007/s11745-014-3957-9; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007	50	23	25	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15491	15502		10.1074/jbc.M116.718510	http://dx.doi.org/10.1074/jbc.M116.718510			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27268057	Green Published, hybrid			2022-12-26	WOS:000380584200007
J	Gupta, GK; Agrawal, T; Rai, V; Del Core, MG; Hunter, WJ; Agrawal, DK				Gupta, Gaurav K.; Agrawal, Tanupriya; Rai, Vikrant; Del Core, Michael G.; Hunter, William J., III; Agrawal, Devendra K.			Vitamin D Supplementation Reduces Intimal Hyperplasia and Restenosis following Coronary Intervention in Atherosclerotic Swine	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; SIROLIMUS-ELUTING STENT; SMOOTH-MUSCLE-CELLS; ARTERY-DISEASE; D DEFICIENCY; BALLOON ANGIOPLASTY; CARDIOVASCULAR-DISEASE; DENDRITIC CELLS; 1,25-DIHYDROXYVITAMIN D-3; HEART-DISEASE	Vitamin D is a fat-soluble steroid hormone that activates vitamin D receptor to regulate multiple downstream signaling pathways and transcription of various target genes. There is an association between vitamin D deficiency and increased risk for cardiovascular disease. However, most of the studies are observational and associative in nature with limited data on clinical application. Thus, there is a need for more prospective randomized controlled studies to determine whether or not vitamin D supplementation provides cardiovascular protection. In this study, we examined the effects of the deficiency and supplementation of vitamin D on coronary restenosis following coronary intervention in atherosclerotic Yucatan microswine. Twelve Yucatan microswine were fed vitamin D-deficient (n = 4) or -sufficient (n = 8) high cholesterol diet for 6-months followed by coronary intervention. Post-intervention, swine in the vitamin D-sufficient high cholesterol diet group received daily oral supplementation of either 1,000 IU (n = 4) or 3,000 IU (n = 4) vitamin D3. Six months later, optical coherence tomography (OCT) was performed to monitor the development of intimal hyperplasia and restenosis. Animals were euthanized to isolate arteries for histomorphometric and immunohistochemical studies. Animals had graded levels of serum 25(OH)D; vitamin D-deficient (15.33 +/- 1.45 ng/ml), vitamin D-sufficient + 1,000 IU oral vitamin D post-intervention (32.27 +/- 1.20 ng/ml), and vitamin D-sufficient + 3,000 IU oral vitamin D post-intervention (51.00 +/- 3.47 ng/ml). Findings from the OCT and histomorphometric studies showed a decrease in intimal hyperplasia and restenosis in vitamin D-supplemented compared to vitamin D-deficient swine. Vitamin D supplementation significantly decreased serum levels of TNF-alpha and IFN-gamma, upregulated serum levels of IL-10, and had no effect on serum IL-6 levels. These findings suggest that vitamin D supplementation limits neointimal formation following coronary intervention in atherosclerotic swine and provide the support for vitamin D supplementation to protect against the development of coronary restenosis.	[Gupta, Gaurav K.; Agrawal, Tanupriya; Rai, Vikrant; Del Core, Michael G.; Hunter, William J., III; Agrawal, Devendra K.] Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE USA	Creighton University	Agrawal, DK (corresponding author), Creighton Univ, Sch Med, Dept Clin & Translat Sci, Omaha, NE USA.	dkagr@creighton.edu	Rai, Vikrant/J-3680-2019; Agrawal, Devendra/GLR-3925-2022	Rai, Vikrant/0000-0001-6286-2341; Agrawal, Devendra/0000-0001-5445-0013; Agrawal, Tanupriya/0000-0002-7649-2828	National Institutes of Health from the Office of the Dietary Supplements [R01HL112597, R01HL116042]; National Institutes of Health; National Heart, Lung and Blood Institute (NHLBI)	National Institutes of Health from the Office of the Dietary Supplements; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by research grants from the National Institutes of Health award numbers R01HL112597 and R01HL116042 from the Office of the Dietary Supplements and the Director, National Institutes of Health (OD) and the National Heart, Lung and Blood Institute (NHLBI) to DKA. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Bagchi AK, 2013, CYTOKINE, V61, P304, DOI 10.1016/j.cyto.2012.10.013; Battes LC, 2014, ATHEROSCLEROSIS, V236, P18, DOI 10.1016/j.atherosclerosis.2014.06.010; Bostick RM, 1999, AM J EPIDEMIOL, V149, P151, DOI 10.1093/oxfordjournals.aje.a009781; BRENNAN A, 1987, IMMUNOLOGY, V61, P457; Canning MO, 2001, EUR J ENDOCRINOL, V145, P351, DOI 10.1530/eje.0.1450351; Carrelli AL, 2011, STROKE, V42, P2240, DOI 10.1161/STROKEAHA.110.608539; Chen WR, 2014, HEART LUNG CIRC, V23, P314, DOI 10.1016/j.hlc.2013.08.012; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Ford ES, 2005, DIABETES CARE, V28, P1228, DOI 10.2337/diacare.28.5.1228; Guagliumi G, 2003, CIRCULATION, V107, P1340, DOI 10.1161/01.CIR.0000062700.42060.6F; Gupta GK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042789; Gupta GK, 2012, EXP MOL PATHOL, V93, P82, DOI 10.1016/j.yexmp.2012.04.006; Gupta GK, 2011, EXP MOL PATHOL, V91, P346, DOI 10.1016/j.yexmp.2011.04.004; Hathcock JN, 2007, AM J CLIN NUTR, V85, P6, DOI 10.1093/ajcn/85.1.6; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2006, DIABETES CARE, V29, P2244, DOI 10.2337/dc06-0946; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Jordan NJ, 1997, BRIT J PHARMACOL, V122, P749, DOI 10.1038/sj.bjp.0701433; Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6; Kranzhofer R, 1996, CIRC RES, V79, P286, DOI 10.1161/01.RES.79.2.286; LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Michos ED, 2008, CURR OPIN CLIN NUTR, V11, P7, DOI 10.1097/MCO.0b013e3282f2f4dd; MITSUMATA M, 1993, AM J PHYSIOL, V265, pH3, DOI 10.1152/ajpheart.1993.265.1.H3; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; NOBUYOSHI M, 1988, J AM COLL CARDIOL, V12, P616, DOI 10.1016/S0735-1097(88)80046-9; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Pilz S, 2009, NAT REV CARDIOL, V6, P621, DOI 10.1038/nrcardio.2009.135; Profumo E, 2007, ATHEROSCLEROSIS, V191, P340, DOI 10.1016/j.atherosclerosis.2006.03.030; Rao VH, 2016, ATHEROSCLEROSIS, V248, P160, DOI 10.1016/j.atherosclerosis.2016.03.021; REITMAN JS, 1982, ATHEROSCLEROSIS, V43, P119, DOI 10.1016/0021-9150(82)90104-6; RUPPRECHT HJ, 1990, CATHETER CARDIO DIAG, V19, P151, DOI 10.1002/ccd.1810190302; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; SCHWARTZ RS, 1990, CIRCULATION, V82, P2190, DOI 10.1161/01.CIR.82.6.2190; SCHWARTZ RS, 1992, J AM COLL CARDIOL, V20, P1284, DOI 10.1016/0735-1097(92)90389-5; Seker T, 2014, J CLIN LAB ANAL, V28, P52, DOI 10.1002/jcla.21643; SERRUYS PW, 1993, AM HEART J, V126, P1243, DOI 10.1016/0002-8703(93)90689-7; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; STEELE PM, 1985, CIRC RES, V57, P105, DOI 10.1161/01.RES.57.1.105; Thorand B, 2011, DIABETES CARE, V34, P2320, DOI 10.2337/dc11-0775; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Verdoia M, 2014, EUR J CLIN INVEST, V44, P634, DOI 10.1111/eci.12281; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Zittermann A, 2005, BRIT J NUTR, V94, P483, DOI 10.1079/BJN20051544; Zittermann A, 1998, EUR J CLIN NUTR, V52, P501, DOI 10.1038/sj.ejcn.1600591	48	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156857	10.1371/journal.pone.0156857	http://dx.doi.org/10.1371/journal.pone.0156857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271180	gold, Green Submitted, Green Published			2022-12-26	WOS:000377560200022
J	Jackson, JW; Singh, MV; Singh, VB; Jones, LD; Davidson, GA; Ture, S; Morrell, CN; Schifitto, G; Maggirwar, SB				Jackson, Joseph W.; Singh, Meera V.; Singh, Vir B.; Jones, Letitia D.; Davidson, Gregory A.; Ture, Sara; Morrell, Craig N.; Schifitto, Giovanni; Maggirwar, Sanjay B.			Novel Antiplatelet Activity of Minocycline Involves Inhibition of MLK3-p38 Mitogen Activated Protein Kinase Axis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; P38 MAP KINASE; PLATELET-DERIVED CD40L; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; RANDOMIZED-TRIAL; HIV-INFECTION; UP-REGULATION; MOUSE MODEL; IN-VIVO	Platelets play an essential role in hemostasis and wound healing by facilitating thrombus formation at sites of injury. Platelets also mediate inflammation and contain several pro-inflammatory molecules including cytokines and chemokines that mediate leukocyte recruitment and activation. Not surprisingly, platelet dysfunction is known to contribute to several inflammatory disorders. Antiplatelet therapies, such as aspirin, adenosine diphosphate (ADP) antagonists, glycoprotein IIb/IIIa (GPIIb/IIIa) inhibitors, and anticoagulants such as warfarin, dampen platelet activity at the risk of unwarranted bleeding. Thus, the development of drugs that reduce platelet-mediated inflammation without interfering with thrombus formation is of importance to combat platelet-associated disorders. We have shown here for the first time that the tetracycline antibiotic, minocycline, administered to HIV-infected individuals reduces plasma levels of soluble CD40L and platelet factor 4 levels, host molecules predominately released by platelets. Minocycline reduced the activation of isolated platelets in the presence of the potent platelet activator, thrombin, as measured by ELISA and flow cytometry. Platelet degranulation was reduced upon exposure to minocycline as shown by mepacrine retention and flow cytometry. However, minocycline had no effect on spreading, aggregation, GPIIb/IIIa activation, or in vivo thrombus formation. Lastly, immunoblot analysis suggests that the antiplatelet activity of minocycline is likely mediated by inhibition of mixed lineage kinase 3 (MLK3)-p38 MAPK signaling axis and loss of p38 activity. Our findings provide a better understanding of platelet biology and a novel repurposing of an established antibiotic, minocycline, to specifically reduce platelet granule release without affecting thrombosis, which may yield insights in generating novel, specific antiplatelet therapies.	[Jackson, Joseph W.; Singh, Meera V.; Singh, Vir B.; Jones, Letitia D.; Davidson, Gregory A.; Maggirwar, Sanjay B.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Ture, Sara; Morrell, Craig N.] Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Schifitto, Giovanni] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Maggirwar, SB (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	Sanjay_Maggirwar@URMC.Rochester.edu		Jackson, Joseph/0000-0002-3826-2749; Jones, Letitia/0000-0002-1889-5629	National Institutes of Health, USA [R01 NS066801, R01 HL128155, T32AI049815, R01 NS054578-08S1]; University of Rochester Center for AIDS Research (CFAR) through an NIH grant [P30 AI078498]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066801] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Center for AIDS Research (CFAR) through an NIH grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health, USA: R01 NS066801 and R01 HL128155 (to SBM) and T32AI049815 and R01 NS054578-08S1 (to JWJ). This publication was also made possible through core services and support from the University of Rochester Center for AIDS Research (CFAR) through an NIH grant: P30 AI078498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam F, 2008, J THROMB HAEMOST, V6, P2007, DOI 10.1111/j.1538-7836.2008.03169.x; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161/01.CIR.0000028962.04520.01; Barber SA, 2004, AM J PATHOL, V164, P355, DOI 10.1016/S0002-9440(10)63125-2; Begonja AJ, 2007, BLOOD, V109, P616, DOI 10.1182/blood-2006-07-038158; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Brancho D, 2005, MOL CELL BIOL, V25, P3670, DOI 10.1128/MCB.25.9.3670-3681.2005; Canault M, 2010, BLOOD, V115, P1835, DOI 10.1182/blood-2009-03-211706; Capodanno D, 2013, J THROMB HAEMOST, V11, P316, DOI 10.1111/jth.12219; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Combes V, 2006, INT J PARASITOL, V36, P541, DOI 10.1016/j.ijpara.2006.02.005; Cuello AC, 2010, NEURODEGENER DIS, V7, P96, DOI 10.1159/000285514; Davidson DC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-144; Davidson DC, 2011, J IMMUNOL, V186, P584, DOI 10.4049/jimmunol.1001911; DiCenzo R, 2008, ANTIMICROB AGENTS CH, V52, P3035, DOI 10.1128/AAC.00194-08; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Follstaedt SC, 2008, J NEUROVIROL, V14, P376, DOI 10.1080/13550280802199898; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Garrido-Mesa N, 2013, BRIT J PHARMACOL, V169, P337, DOI 10.1111/bph.12139; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Goubran HA, 2014, SEMIN ONCOL, V41, P359, DOI 10.1053/j.seminoncol.2014.04.006; Gowert NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090523; Gresele P, 2012, ANTIPLATELET AGENTS, Vxii; Harrington RA, 2003, CIRCULATION, V108, pE45, DOI 10.1161/01.CIR.0000083142.13956.D6; Haynes BF, 2006, NAT MED, V12, P1351, DOI 10.1038/nm1206-1351; Hottz ED, 2014, J IMMUNOL, V193, P1864, DOI 10.4049/jimmunol.1400091; Ishikawa M, 2005, CIRCULATION, V111, P1690, DOI 10.1161/01.CIR.0000160349.42665.0C; Jackson SP, 2009, J THROMB HAEMOST, V7, P17, DOI 10.1111/j.1538-7836.2009.03401.x; Jackson SP, 2003, NAT REV DRUG DISCOV, V2, P775, DOI 10.1038/nrd1198; KRAMER RM, 1995, J BIOL CHEM, V270, P27395, DOI 10.1074/jbc.270.46.27395; Kuliopulos A, 2004, THROMB HAEMOSTASIS, V92, P1387, DOI 10.1160/TH04-03-0187; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Lindl KA, 2010, J NEUROIMMUNE PHARM, V5, P294, DOI 10.1007/s11481-010-9205-z; Manolis Antonis S., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P203, DOI 10.2174/1568016054368188; Mayne E, 2012, JAIDS-J ACQ IMM DEF, V59, P340, DOI 10.1097/QAI.0b013e3182439355; Metz LM, 2009, MULT SCLER, V15, P1183, DOI 10.1177/1352458509106779; Michelson AD, 2007, PLATELETS, Vxlii; Murata Y, 2008, STROKE, V39, P3372, DOI 10.1161/STROKEAHA.108.514026; Nakasujja N, 2013, NEUROLOGY, V80, P196, DOI 10.1212/WNL.0b013e31827b9121; Neidecker M, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-14; O'Brien JJ, 2008, BLOOD, V112, P4051, DOI 10.1182/blood-2008-05-158535; O'Brien M, 2013, JAIDS-J ACQ IMM DEF, V63, P280, DOI 10.1097/QAI.0b013e31828a292c; Ombrello C, 2010, J CARDIOVASC TRANSL, V3, P538, DOI 10.1007/s12265-010-9213-7; Rahman M, 2009, ANN SURG, V250, P783, DOI 10.1097/SLA.0b013e3181bd95b7; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Robinson M, 2000, BRIT J HAEMATOL, V108, P859, DOI 10.1046/j.1365-2141.2000.01939.x; Rondina MT, 2013, CIRC RES, V112, P1506, DOI 10.1161/CIRCRESAHA.113.300512; SAIVIN S, 1988, CLIN PHARMACOKINET, V15, P355, DOI 10.2165/00003088-198815060-00001; Singh M, 2014, IMMUNOLOGY, V142, P562, DOI 10.1111/imm.12246; Sitia G, 2012, P NATL ACAD SCI USA, V109, pE2165, DOI 10.1073/pnas.1209182109; Steele RW, 2012, OCHSNER J, V12, P202; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Sui Z, 2006, J IMMUNOL, V177, P702, DOI 10.4049/jimmunol.177.1.702; Thushara RM, 2014, BIOL PLATELET APOPTO; von Hundelshausen P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00294; Wachtman LM, 2007, ARCH NEUROL-CHICAGO, V64, P1264, DOI 10.1001/archneur.64.9.1264; Wang CX, 2003, BRAIN RES, V963, P327, DOI 10.1016/S0006-8993(02)04045-3; Yeung J, 2012, J BLOOD MED, V3, P33, DOI 10.2147/JBM.S25421; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Zabad RK, 2007, MULT SCLER, V13, P517, DOI 10.1177/1352458506070319; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003	61	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157115	10.1371/journal.pone.0157115	http://dx.doi.org/10.1371/journal.pone.0157115			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270236	Green Published, gold, Green Submitted			2022-12-26	WOS:000377560200032
J	Bucher, EH; Stein, AF				Bucher, Enrique H.; Stein, Ariel F.			Large Salt Dust Storms Follow a 30-Year Rainfall Cycle in the Mar Chiquita Lake (Cordoba, Argentina)	PLOS ONE			English	Article							SEA; CALIFORNIA	Starting in 2006, a new source of intense salt dust storms developed in Mar Chiquita (Cordoba, Argentina), the largest saline lake in South America. Storms originate from vastmudflats left by a 30-year expansion-retreat cycle of the lake due to changes in the regional rainfall regime. The annual frequency of salt dust storms correlated with the size of the salt mudflats. Events were restricted to the coldest months, and reached up to 800 km from the source. Occurrence of dust storms was associated with specific surface colors and textures easily identifiable in satellite images. High-emission surfaces were characterized by the presence of sodium sulfate hydrous/anhydrous crystals (mirabilite and thenardite), and a superficial and variable water table, which may result in the periodic development of a characteristic "fluffy" surface derived from salt precipitation-dissolution processes. HYSPLIT model simulation estimates a deposition maximum near the sources (of about 2.5 kg/ha/yr), and a decreasing trend from the emission area outwards, except for the relative secondary maximum modeled over the mountain ranges in southern Bolivia and northern Argentina due to an orographic effect. The 2009 total deposition of salt dust generated in Mar Chiquita was estimated at 6.5 million tons.	[Bucher, Enrique H.] Univ Nacl Cordoba, CONICET, Inst Diversidad & Ecol Anim, Rondeau 798, RA-5000 Cordoba, Argentina; [Bucher, Enrique H.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Zool Aplicada, Rondeau 798, RA-5000 Cordoba, Argentina; [Stein, Ariel F.] NOAA, Air Resources Lab, R ARL, NCWCP, Room 4205,5830 Univ Res Court, College Pk, MD 20740 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; National Oceanic Atmospheric Admin (NOAA) - USA	Bucher, EH (corresponding author), Univ Nacl Cordoba, CONICET, Inst Diversidad & Ecol Anim, Rondeau 798, RA-5000 Cordoba, Argentina.; Bucher, EH (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Zool Aplicada, Rondeau 798, RA-5000 Cordoba, Argentina.	buchereh@gmail.com	Stein, Ariel/ABE-7423-2021; Stein, Ariel F/L-9724-2014	Stein, Ariel/0000-0002-9560-9198; Stein, Ariel F/0000-0002-9560-9198; Bucher, Enrique H./0000-0001-8152-1104	NASA/HQ	NASA/HQ	We acknowledge the use of Rapid Response imagery from the Land, Atmosphere Near realtime Capability for EOS (LANCE) system operated by the NASA/GSFC/Earth Science Data and Information System (ESDIS) with funding provided by NASA/HQ. We are also grateful to the Municipality of Miramar, Cordoba, Argentina for providing research infrastructure in Mar Chiquita, and also thank Fantine Ngan for help with the HYSPLIT graphics.	Abuduwaili J, 2010, J ARID LAND, V2, P144, DOI 10.3724/SP.J.1227.2010.00144; Bucher E., 2006, BANADOS RIO DULCE LA, P79; Bucher EH., 2006, BANADOS RIO DULCE LA; Buck BJ, 2011, SOIL SCI SOC AM J, V75, P1971, DOI 10.2136/sssaj2011.0049; Draxier RR, 1998, AUST METEOROL MAG, V47, P295; Draxler RR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013167; Escudero M, 2011, ATMOS RES, V99, P518, DOI 10.1016/j.atmosres.2010.12.002; Escudero M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006395; Frank H., 1912, B DEP GEN CULTURA GA, V6, P87; GAIERO D, 2013, J GEOPHYS RES-ATMOS, V118, P1, DOI DOI 10.1002/JGRD.50036; Gasso S, 2010, ATMOS CHEM PHYS, V10, P8287, DOI 10.5194/acp-10-8287-2010; Ginoux P, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000388; Kanamitsu M, 1989, WEA FORECASTING, p[4, 335], DOI [10.1175/1520-0434(1989)004&LT;0335:DOTNGD&GT;2.0.CO;2, DOI 10.1175/1520-0434(1989)004<0335:D0TNGD>2.0.C0;2, 10.1175/1520-0434(1989)0042.0.CO;2]; King J, 2011, AEOLIAN RES, V3, P67, DOI 10.1016/j.aeolia.2011.03.005; Krohling DM, 1999, QUATERN INT, V57-8, P149, DOI 10.1016/S1040-6182(98)00056-1; Micklin P, 2007, ANNU REV EARTH PL SC, V35, P47, DOI 10.1146/annurev.earth.35.031306.140120; NASA Observatory, 2008, DUST STORM AR SEA; Piovano E.L., 2006, BANADOS RIO DULCE LA, P37; Reynolds R., 2009, NATURAL RESOURCES EN, V15, P18; Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1; Stein AF, 2011, WEATHER FORECAST, V26, P236, DOI 10.1175/WAF-D-10-05044.1; Troin M, 2010, J HYDROL, V393, P233, DOI 10.1016/j.jhydrol.2010.08.019; Wang YQ, 2011, ATMOS ENVIRON, V45, P6368, DOI 10.1016/j.atmosenv.2011.08.035	23	23	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156672	10.1371/journal.pone.0156672	http://dx.doi.org/10.1371/journal.pone.0156672			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258088	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700100
J	Huang, BN; Gomez-Rodriguez, J; Preite, S; Garrett, LJ; Harper, UL; Schwartzberg, PL				Huang, Bonnie; Gomez-Rodriguez, Julio; Preite, Silvia; Garrett, Lisa J.; Harper, Ursula L.; Schwartzberg, Pamela L.			CRISPR-Mediated Triple Knockout of SLAMF1, SLAMF5 and SLAMF6 Supports Positive Signaling Roles in NKT Cell Development	PLOS ONE			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; CONTROLS T-CELL; HUMORAL IMMUNITY; NEGATIVE REGULATION; FAMILY RECEPTORS; GENE-PRODUCT; ADAPTER SAP; B-CELLS; MICE; DIFFERENTIATION	The SLAM family receptors contribute to diverse aspects of lymphocyte biology and signal via the small adaptor molecule SAP. Mutations affecting SAP lead to X-linked lymphoproliferative syndrome Type 1, a severe immunodysregulation characterized by fulminant mononucleosis, dysgammaglobulinemia, and lymphoproliferation/lymphomas. Patients and mice having mutations affecting SAP also lack germinal centers due to a defect in T:B cell interactions and are devoid of invariant NKT (iNKT) cells. However, which and how SLAM family members contribute to these phenotypes remains uncertain. Three SLAM family members: SLAMF1, SLAMF5 and SLAMF6, are highly expressed on T follicular helper cells and germinal center B cells. SLAMF1 and SLAMF6 are also implicated in iNKT development. Although individual receptor knockout mice have limited iNKT and germinal center phenotypes compared to SAP knockout mice, the generation of multi-receptor knockout mice has been challenging, due to the genomic linkage of the genes encoding SLAM family members. Here, we used Cas9/CRISPR-based mutagenesis to generate mutations simultaneously in Slamf1, Slamf5 and Slamf6. Genetic disruption of all three receptors in triple-knockout mice (TKO) did not grossly affect conventional T or B cell development and led to mild defects in germinal center formation post-immunization. However, the TKO worsened defects in iNKT cells development seen in SLAMF6 single gene-targeted mice, supporting data on positive signaling and potential redundancy between these receptors.	[Huang, Bonnie; Gomez-Rodriguez, Julio; Preite, Silvia; Schwartzberg, Pamela L.] NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA; [Garrett, Lisa J.] NHGRI, Embryon Stem Cell & Transgen Mouse Core, Bethesda, MD 20892 USA; [Harper, Ursula L.] NHGRI, Genom Core, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Schwartzberg, PL (corresponding author), NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA.	pams@mail.nih.gov			National Human Genome Research Institute [HG000123, HG200349]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200346, ZIAHG000123, ZICHG200349] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by intramural funding from the National Human Genome Research Institute (HG000123 and HG200349).	Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Behringer R, 2014, MANIPULATING MOUSE E, P814; Booth C, 2011, BLOOD, V117, P53, DOI 10.1182/blood-2010-06-284935; Cannons JL, 2006, J EXP MED, V203, P1551, DOI 10.1084/jem.20052097; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Cannons JL, 2010, J IMMUNOL, V185, P2819, DOI 10.4049/jimmunol.0902182; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Chan AY, 2006, CURR OPIN IMMUNOL, V18, P656, DOI 10.1016/j.coi.2006.09.010; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; De Calisto J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00186; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Dutta M, 2013, J IMMUNOL, V190, P2121, DOI 10.4049/jimmunol.1202145; Dutta M, 2012, J IMMUNOL, V188, P3031, DOI 10.4049/jimmunol.1103226; Eissmann P, 2005, BLOOD, V105, P4722, DOI 10.1182/blood-2004-09-3796; Gomez-Rodriguez J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10857; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Harada Y, 2012, IMMUNITY, V36, P188, DOI 10.1016/j.immuni.2012.02.002; Hislop AD, 2010, BLOOD, V116, P3249, DOI 10.1182/blood-2009-09-238832; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Kraft K, 2015, CELL REP, V10, P833, DOI 10.1016/j.celrep.2015.01.016; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; McCausland MM, 2007, J IMMUNOL, V178, P817, DOI 10.4049/jimmunol.178.2.817; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; Palendira U, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001187; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Preite S, 2015, EUR J IMMUNOL, V45, P3010, DOI 10.1002/eji.201545920; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Roncagalli R, 2005, NAT IMMUNOL, V6, P1002, DOI 10.1038/ni1242; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Sidorenko SP, 2003, NAT IMMUNOL, V4, P19, DOI 10.1038/ni0103-19; Snow AL, 2009, J CLIN INVEST, V119, P2976, DOI 10.1172/JCI39518; Sood R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057239; Tangye SG, 2014, J CLIN IMMUNOL, V34, P772, DOI 10.1007/s10875-014-0083-7; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang NH, 2004, J EXP MED, V199, P1255, DOI 10.1084/jem.20031835; Wang N, 2006, AM J RESP CELL MOL, V35, P206, DOI 10.1165/rcmb.2005-0294OC; Wang NH, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00158; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713; Wu N, 2016, CURR OPIN IMMUNOL, V38, P45, DOI 10.1016/j.coi.2015.11.003; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017	52	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156072	10.1371/journal.pone.0156072	http://dx.doi.org/10.1371/journal.pone.0156072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258160	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700033
J	Kot, W; Kilstrup, M; Vogensen, FK; Hammer, K				Kot, Witold; Kilstrup, Mogens; Vogensen, Finn K.; Hammer, Karin			Clear Plaque Mutants of Lactococcal Phage TP901-1	PLOS ONE			English	Article							BACTERIOPHAGE TP901-1; ESCHERICHIA-COLI; TEMPERATE BACTERIOPHAGE; GENETIC SWITCH; CI REPRESSOR; LACTIS; DNA; PROTEIN; MUTATIONS; PHI-LC3	We report a method for obtaining turbid plaques of the lactococcal bacteriophage TP901-1 and its derivative TP901-BC1034. We have further used the method to isolate clear plaque mutants of this phage. Analysis of 8 such mutants that were unable to lysogenize the host included whole genome resequencing. Four of the mutants had different mutations in structural genes with no relation to the genetic switch. However all 8 mutants had a mutation in the cl repressor gene region. Three of these were located in the promoter and Shine-Dalgarno sequences and five in the N-terminal part of the encoded Cl protein involved in the DNA binding. The conclusion is that cl is the only gene involved in clear plaque formation i.e. the Cl protein is the determining factor for the lysogenic pathway and its maintenance in the lactococcal phage TP901-1.	[Kot, Witold] Aarhus Univ, Dept Environm Sci, Frederiksborgvej 399, DK-4000 Roskilde, Denmark; [Kilstrup, Mogens; Hammer, Karin] Tech Univ Denmark, Dept Syst Biol, Matemat Torvet Bldg 301, DK-2800 Lyngby, Denmark; [Vogensen, Finn K.] Univ Copenhagen, Dept Food Sci, Rolighedsvej 26, DK-1958 Frederiksberg C, Denmark	Aarhus University; Technical University of Denmark; University of Copenhagen	Kot, W (corresponding author), Aarhus Univ, Dept Environm Sci, Frederiksborgvej 399, DK-4000 Roskilde, Denmark.; Hammer, K (corresponding author), Tech Univ Denmark, Dept Syst Biol, Matemat Torvet Bldg 301, DK-2800 Lyngby, Denmark.	wk@envs.au.dk; kha@bio.dtu.dk	Kot, Witold/N-3747-2017; Kot, Witold/M-2170-2014; Kilstrup, Mogens/AAV-2030-2021	Kot, Witold/0000-0002-0188-4587; Kot, Witold/0000-0002-0188-4587; Kilstrup, Mogens/0000-0002-3900-723X	Danish Council for Independent Research [4093-00198, 0602-02271B, 4002-00107, DFF-4002-00107]; University of Copenhagen; Danish Council for Independent Research grant (PHAGEMID) [4093-00198]; Danish Council for Independent Research grant (MetaPhageLAB) [0602-02271B]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); University of Copenhagen; Danish Council for Independent Research grant (PHAGEMID); Danish Council for Independent Research grant (MetaPhageLAB)	This work was supported by the Danish Council for Independent Research (http://ufm.dk/en/research-andinnovation/councils-and-commissions/the-danish-council-for-independent-research) grant 4093-00198 (received by WK), used to cover cost of data generation and analysis; and the Danish Council for Independent Research (http://ufm.dk/en/researchandinnovation/councils-and-commissions/the-danishcouncil-for-independent-research) grant 0602-02271B (received by FKV), used to cover cost of data generation and analysis. Grant 4002-00107 from Danish Council for Independent Research received by Dr. Leila Lo Leggio, at the Chemical Department, University of Copenhagen is acknowledged for sponsoring materials for cloning and enzyme activity assays. Dr. Leila Lo Leggio had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Danish Council for Independent Research grants 4093-00198 (PHAGEMID), 0602-02271B (MetaPhageLAB) and DFF-4002-00107. We thank Lars H. Hansen from the Department of Environmental Science, Aarhus University for providing sequencing facilities. We thank Bashir Aideh from Department of Food Science, University of Copenhagen for his technical support. Marzanna Pulka-Amin and Lise Sorensen from Department of Systems Biology, The Technical University of Denmark, are also thanked for their technical support.	Blatny JM, 2001, MOL GENET GENOMICS, V265, P189, DOI 10.1007/s004380000407; BRAUN V, 1989, J GEN MICROBIOL, V135, P2551; Brondsted L, 2001, VIROLOGY, V283, P93, DOI 10.1006/viro.2001.0871; Brondsted L, 1999, APPL ENVIRON MICROB, V65, P752; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Frandsen KH, 2013, BIOCHEMISTRY-US, V52, P6892, DOI 10.1021/bi400439y; HOYT MA, 1982, CELL, V31, P565, DOI 10.1016/0092-8674(82)90312-9; JENSEN PR, 1993, APPL ENVIRON MICROB, V59, P4363, DOI 10.1128/AEM.59.12.4363-4366.1993; KAISER AD, 1957, VIROLOGY, V3, P42, DOI 10.1016/0042-6822(57)90022-3; Koch B, 1997, APPL ENVIRON MICROB, V63, P2439, DOI 10.1128/AEM.63.6.2439-2441.1997; KUMAR A, 1993, J MOL BIOL, V232, P406, DOI 10.1006/jmbi.1993.1400; Lildballe DL, 2008, J MOL BIOL, V384, P9, DOI 10.1016/j.jmb.2008.09.014; LILLEHAUG D, 1991, APPL ENVIRON MICROB, V57, P3206, DOI 10.1128/AEM.57.11.3206-3211.1991; Madsen PL, 1999, J BACTERIOL, V181, P7430, DOI 10.1128/JB.181.24.7430-7438.1999; Nanda AM, 2015, J BACTERIOL, V197, P410, DOI 10.1128/JB.02230-14; Pedersen M, 2008, J MOL BIOL, V376, P983, DOI 10.1016/j.jmb.2007.12.022; Pedersen M, 2010, J BACTERIOL, V192, P2102, DOI 10.1128/JB.01387-09; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; Russell DW, 1989, MOL CLONING LAB MANU, V1; Shimada T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090447; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Vegge CS, 2006, APPL ENVIRON MICROB, V72, P6815, DOI 10.1128/AEM.01033-06; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005	23	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155233	10.1371/journal.pone.0155233	http://dx.doi.org/10.1371/journal.pone.0155233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258092	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700011
J	Kunogi, H; Yamaguchi, N; Terao, Y; Sasai, K				Kunogi, Hiroaki; Yamaguchi, Nanae; Terao, Yasuhisa; Sasai, Keisuke			Kidney-Sparing Methods for Extended-Field Intensity-Modulated Radiotherapy (EF-IMRT) in Cervical Carcinoma Treatment	PLOS ONE			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; RADIATION-THERAPY; LYMPH-NODES; CONCURRENT CISPLATIN; CANCER; CHEMOTHERAPY; WOMEN	Coplanar extended-field intensity-modulated radiation therapy (EF-IMRT) targeting the whole-pelvic and para-aortic lymph nodes in patients with advanced cervical cancer results in impaired creatinine clearance. An improvement in renal function cannot be expected unless low-dose (approximately 10 Gy) kidney exposure is reduced. The dosimetric method should be considered during EF-IMRT planning to further reduce low-dose exposure to the kidneys. To assess the usefulness of non-coplanar EF-IMRT with kidney-avoiding beams to spare the kidneys during cervical carcinoma treatment in dosimetric analysis between non-coplanar and coplanar EF-IMRT, we compared the doses of the target organ and organs at risk, including the kidney, in 10 consecutive patients. To estimate the influence of EFRT on renal dysfunction, creatinine clearance values after treatment were also examined in 18 consecutive patients. Of these 18 patients, 10 patients who were included in the dosimetric analysis underwent extended field radiation therapy (EFRT) with concurrent chemotherapy, and eight patients underwent whole-pelvis radiation therapy with concurrent chemotherapy to treat cervical carcinoma between April 2012 and March 2015 at our institution. In the dosimetric analysis, non-coplanar EF-IMRT was effective at reducing low-dose (approximately 10 Gy) exposure to the kidneys, thus maintaining target coverage and sparing other organs at risk, such as the small bowel, rectum, and bladder, compared with coplanar EF-IMRT. Renal function in all 10 patients who underwent EFRT, including coplanar EF-IMRT (with kidney irradiation), was low after treatment, and differed significantly from that of the eight patients who underwent WPRT (no kidney irradiation) 6 months after the first day of treatment (P = 0.005). In conclusion, non-coplanar EF-IMRT should be considered in patients with advanced cervical cancer, particularly in patients with a long life expectancy or with pre-existing renal dysfunction.	[Kunogi, Hiroaki; Yamaguchi, Nanae; Sasai, Keisuke] Juntendo Univ, Dept Radiat Oncol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan; [Terao, Yasuhisa] Juntendo Univ, Dept Gynecol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan	Juntendo University; Juntendo University	Kunogi, H (corresponding author), Juntendo Univ, Dept Radiat Oncol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	hkunogi@juntendo.ac.jp	TERAO, YASUHISA/AAH-6307-2019					Beriwal S, 2007, INT J RADIAT ONCOL, V68, P166, DOI 10.1016/j.ijrobp.2006.12.023; Beriwal S, 2006, GYNECOL ONCOL, V102, P195, DOI 10.1016/j.ygyno.2006.01.062; BERMAN ML, 1984, GYNECOL ONCOL, V19, P8, DOI 10.1016/0090-8258(84)90151-3; Dunlop A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120141; Egeler R M, 1999, Semin Urol Oncol, V17, P55; Gay HA, 2012, INT J RADIAT ONCOL, V83, pE353, DOI 10.1016/j.ijrobp.2012.01.023; Gerszten K, 2006, GYNECOL ONCOL, V102, P182, DOI 10.1016/j.ygyno.2005.12.044; Jabbour SK, 2014, PRACT RADIAT ONCOL, V4, P82, DOI 10.1016/j.prro.2013.06.004; Jung J, 2014, ANTICANCER RES, V34, P4361; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS10, DOI 10.1016/j.ijrobp.2009.07.1754; Mundt AJ, 2003, INT J RADIAT ONCOL, V56, P1354, DOI 10.1016/S0360-3016(03)00325-0; Mundt AJ, 2001, GYNECOL ONCOL, V82, P456, DOI 10.1006/gyno.2001.6250; Murakami N, 2014, ANTICANCER RES, V34, P5091; Orlandi E, 2014, RADIOTHER ONCOL, V113, P260, DOI 10.1016/j.radonc.2014.11.024; ROTMAN M, 1995, JAMA-J AM MED ASSOC, V274, P387, DOI 10.1001/jama.274.5.387; Toita T, 2010, JPN J CLIN ONCOL, V40, P456, DOI 10.1093/jjco/hyp191; Varia MA, 1998, INT J RADIAT ONCOL, V42, P1015, DOI 10.1016/S0360-3016(98)00267-3; Varlotto JM, 2006, AM J CLIN ONCOL-CANC, V29, P281, DOI 10.1097/01.coc.0000217828.95729.b5; Wersall PJ, 2005, RADIOTHER ONCOL, V77, P88, DOI 10.1016/j.radonc.2005.03.022; Zhang GY, 2014, J GYNECOL ONCOL, V25, P14, DOI 10.3802/jgo.2014.25.1.14	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156623	10.1371/journal.pone.0156623	http://dx.doi.org/10.1371/journal.pone.0156623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258030	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700090
J	Petito, A; Altamura, M; Iuso, S; Padalino, FA; Sessa, F; D'Andrea, G; Margaglione, M; Bellomo, A				Petito, Annamaria; Altamura, Mario; Iuso, Salvatore; Padalino, Flavia A.; Sessa, Francesco; D'Andrea, Giovanna; Margaglione, Maurizio; Bellomo, Antonello			The Relationship between Personality Traits, the 5HTT Polymorphisms, and the Occurrence of Anxiety and Depressive Symptoms in Elite Athletes	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; STRESSFUL LIFE EVENTS; ALLELIC VARIATION; 5-HTTLPR; METAANALYSIS; ASSOCIATION; NEUROTICISM; PREVALENCE; SPORT; ADOLESCENTS	The purpose of this study was to determine the relationship between personality, the serotonin transporter (5HTT) polymorphisms and the occurrence of anxiety and depressive symptoms in elite athletes. 133 healthy participants completed the NEO Five-Factor Inventory (NEO-FFI). The mood states were assessed using the Profile of Mood States (POMS) questionnaire. The athlete's mental skills were assessed through the Sport Performance Psychological Inventory (IPPS-48). The occurrence of psychiatric and personality disorders was assessed using the Clinical Interview for DSM-IV Disorders. A polymerase chain reaction was employed to identify genotypes at the 5HTTLPR polymorphism. The 5HTTLPR s/s genotype was associated with both neuroticism (p<0.001) and tension/anxiety symptoms according to the POMS (p<0.02), cognitive anxiety and emotional arousal control according to the IPPS-48 (p<0.01). Significant correlations were proved between neuroticism and symptoms of anxiety and depression (p<0.05). Neuroticism mediates the association between the 5HTTLPR polymorphism and symptoms of cognitive anxiety and emotional arousal control (p<0.05). These results suggest a significant interaction between the 5HTTLPR polymorphism, neuroticism and sport related stress that predict adverse mental health outcomes in athletes. Identification of homogeneous groups of athletes having predispositions to anxiety and depressive symptoms may help to implement early prevention programs.	[Petito, Annamaria; Altamura, Mario; Iuso, Salvatore; Padalino, Flavia A.; Bellomo, Antonello] Univ Foggia, Psychiat Unit, Dept Clin & Expt Med, Foggia, Italy; [Sessa, Francesco; D'Andrea, Giovanna; Margaglione, Maurizio] Univ Foggia, Med Genet, Dept Clin & Expt Med, Foggia, Italy	University of Foggia; University of Foggia	Altamura, M (corresponding author), Univ Foggia, Psychiat Unit, Dept Clin & Expt Med, Foggia, Italy.	m_altamura@virgilio.it	Sessa, Francesco/G-1754-2018	Sessa, Francesco/0000-0003-0357-8791; MARGAGLIONE, MAURIZIO/0000-0001-5627-9221				Bar KJ, 2013, EUR ARCH PSY CLIN N, V263, pS205, DOI 10.1007/s00406-013-0458-4; Barnhofer T, 2010, BEHAV RES THER, V48, P275, DOI 10.1016/j.brat.2009.12.005; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; Broshek DK, 2005, CLIN SPORT MED, V24, P663, DOI 10.1016/j.csm.2005.04.005; Brummett BH, 2008, BEHAV GENET, V38, P34, DOI 10.1007/s10519-007-9172-1; Burke TA, 2006, INT J STROKE, V1, P208, DOI 10.1111/j.1747-4949.2006.00060.x; Carron A. V., 1998, GROUP DYNAMICS SPORT, V2nd; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Clarke H, 2010, PSYCHOL MED, V40, P1767, DOI 10.1017/S0033291710000516; Costa Jr PT, 1989, NEO PIINEO FFI MAN S; Culverhouse RC, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-304; Dale GA, 1996, SPORT PSYCHOL, V10, P307, DOI 10.1123/tsp.10.4.307; Eccles JS, 1999, J ADOLESCENT RES, V14, P10, DOI 10.1177/0743558499141003; First MB, 2003, SCID 2 STRUCTURED CL; First MB, 2000, SCID 1 STRUCTURED CL; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Fredricks JA, 2002, J ADOLESCENT RES, V17, P68, DOI 10.1177/0743558402171004; Gill EL, 2008, SOC WORK, V53, P85, DOI 10.1093/sw/53.1.85; Gonda X, 2005, J AFFECT DISORDERS, V87, P291, DOI 10.1016/j.jad.2005.05.007; Gotlib IH, 2008, BIOL PSYCHIAT, V63, P847, DOI 10.1016/j.biopsych.2007.10.008; GOULD D, 1993, J SPORT EXERCISE PSY, V15, P134, DOI 10.1123/jsep.15.2.134; Gouttebarge V, 2015, OCCUP MED-OXFORD, V65, P190, DOI 10.1093/occmed/kqu202; Hansen DM, 2003, J RES ADOLESCENCE, V13, P25, DOI 10.1111/1532-7795.1301006; Hansen Hans C, 2003, Pain Physician, V6, P179; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hauser J, 2003, EUR PSYCHIAT, V18, P129, DOI 10.1016/S0924-9338(03)00026-9; Heils A, 1996, J NEUROCHEM, V66, P2621; Hutchinson JG, 2007, PERS INDIV DIFFER, V42, P1367, DOI 10.1016/j.paid.2006.10.014; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kendler KS, 2005, ARCH GEN PSYCHIAT, V62, P529, DOI 10.1001/archpsyc.62.5.529; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Leonardo ED, 2006, ANNU REV PSYCHOL, V57, P117, DOI 10.1146/annurev.psych.57.102904.190118; LESCH KP, 1994, J NEURAL TRANSM-GEN, V95, P157, DOI 10.1007/BF01276434; Lieben CKJ, 2004, NEUROCHEM INT, V44, P9, DOI 10.1016/S0197-0186(03)00102-5; Maloney JL, 2000, CHILD DEV, V71, P502, DOI 10.1111/1467-8624.00160; McNair D.M., 1971, MANUAL PROFILES MOOD; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Minelli A, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-50; Ming QS, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-142; Mossner R, 2001, MOL PSYCHIATR, V6, P350, DOI 10.1038/sj.mp.4000849; Munafo MR, 2006, NEUROPSYCHOBIOLOGY, V53, P1, DOI 10.1159/000089915; Munafo MR, 2004, PERS INDIV DIFFER, V37, P621, DOI 10.1016/j.paid.2003.09.031; Nixdorf I., 2015, Advances in Physical Education, V5, P255, DOI 10.4236/ape.2015.54030; Nixdorf I, 2013, J CLIN SPORT PSYCHOL, V7, P313, DOI 10.1123/jcsp.7.4.313; OCONNOR PJ, 1989, PSYCHONEUROENDOCRINO, V14, P303, DOI 10.1016/0306-4530(89)90032-2; Oo KZ, 2016, AUST NZ J PSYCHIAT; Ormel J, 2004, ARCH GEN PSYCHIAT, V61, P387, DOI 10.1001/archpsyc.61.4.387; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Piedmont RL, 1991, J PERS SOC PSYCHOL, V60, P630, DOI DOI 10.1037/0022-3514.60.4.630; Proctor SL, 2010, J CLIN SPORT PSYCHOL, V4, P204, DOI 10.1123/jcsp.4.3.204; Puente-Diaz R, 2005, J SOC PSYCHOL, V145, P429, DOI 10.3200/SOCP.145.4.429-446; PUFFER JC, 1992, CLIN SPORT MED, V11, P327; PULVER A, 1995, EUR J PERSONALITY, V9, P109, DOI 10.1002/per.2410090205; Richman EL, 2000, PSYCHOL WOMEN QUART, V24, P189, DOI 10.1111/j.1471-6402.2000.tb00200.x; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Robazza C, 2009, GIORNALE ITALIANO PS, V4, P14, DOI DOI 10.1007/S40279-016-0492-2; Rolland JP, 1998, J PERS ASSESS, V71, P269, DOI 10.1207/s15327752jpa7102_13; Schinka JA, 2004, MOL PSYCHIATR, V9, P197, DOI 10.1038/sj.mp.4001405; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; SMOLL FL, 1989, J APPL SOC PSYCHOL, V19, P1522, DOI 10.1111/j.1559-1816.1989.tb01462.x; Snow A., 1994, Journal of Sport Behavior, V17, P207; Spirrison CL, 1998, PSYCHOL REP, V83, P263, DOI 10.2466/PR0.83.5.263-274; Storch E. A., 2005, J SPORT BEHAV, V28, P86; Weinberg R.S., 2003, FDN SPORT EXERCISE P; Williams J. M., 2006, APPL SPORT PSYCHOL P, V5th, P285; Wolanin A, 2015, CURR SPORT MED REP, V14, P56, DOI 10.1249/JSR.0000000000000123; Yang JZ, 2007, CLIN J SPORT MED, V17, P481, DOI 10.1097/JSM.0b013e31815aed6b	70	53	53	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156601	10.1371/journal.pone.0156601	http://dx.doi.org/10.1371/journal.pone.0156601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257942	Green Published, gold			2022-12-26	WOS:000377369700087
J	Adams, SV; Ceballos, R; Newcomb, PA				Adams, Scott V.; Ceballos, Rachel; Newcomb, Polly A.			Quality of Life and Mortality of Long-Term Colorectal Cancer Survivors in the Seattle Colorectal Cancer Family Registry	PLOS ONE			English	Article							FORM HEALTH SURVEY; POSTTRAUMATIC GROWTH; COLON-CANCER; OLDER-ADULTS; POPULATION; DIAGNOSIS; ASSOCIATIONS; OUTCOMES; PREDICT; 1-YEAR	Background and Aim Because most colorectal cancer patients survive beyond five years, understanding quality of life among these long-term survivors is essential to providing comprehensive survivor care. We sought to identify personal characteristics associated with reported quality of life in colorectal cancer survivors, and sub-groups of survivors potentially vulnerable to very low quality of life. Methods We assessed quality of life using the Veterans RAND 12-item Health Survey within a population-based sample of 1,021 colorectal cancer survivors in the Seattle Colorectal Cancer Family Registry, approximately 5 years post-diagnosis. In this case-only study, mean physical component summary scores and mental component summary scores were examined with linear regression. To identify survivors with substantially reduced ability to complete daily tasks, logistic regression was used to estimate odds ratios for "very low" summary scores, defined as a score in the lowest decile of the reference US population. All cases were followed for vital status following QoL assessment, and mortality was analyzed with Cox proportional hazards regression. Results Lower mean physical component summary score was associated with older age, female sex, obesity, smoking, and diabetes or other co-morbidity; lower mean mental component summary score was associated with younger age and female sex. Higher odds of very low physical component summary score was associated with older age, obesity, less education, smoking, co-morbidities, and later stage at diagnosis; smoking was associated with higher odds of very low mental component summary score. A very low physical component score was associated with higher risk of mortality (hazard ratio (95% confidence interval): 3.97 (2.95-5.34)). Conclusions Our results suggest that identifiable sub-groups of survivors are vulnerable to very low physical components of quality of life, decrements that may represent meaningful impairment in completing everyday tasks and are associated with higher risk of death.	[Adams, Scott V.; Ceballos, Rachel; Newcomb, Polly A.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA	Fred Hutchinson Cancer Center	Newcomb, PA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	pnewcomb@fhcrc.org			National Cancer Institute, National Institutes of Health [UM1 CA167551]; Colorectal Cancer Family Registry Cohort infrastructure [U01CA074794]; Seattle Colorectal Cancer Family Registry;  [K05 CA152715]; NATIONAL CANCER INSTITUTE [K05CA152715, U24CA074794, U01CA074794, UM1CA167551] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Colorectal Cancer Family Registry Cohort infrastructure; Seattle Colorectal Cancer Family Registry; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, National Institutes of Health grant UM1 CA167551 to R.M. Haile to support the Colorectal Cancer Family Registry Cohort infrastructure, grant U01CA074794 to P.A. Newcomb to support the Seattle Colorectal Cancer Family Registry, and grant K05 CA152715 to P.A. Newcomb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt V, 2004, J CLIN ONCOL, V22, P4829, DOI 10.1200/JCO.2004.02.018; Brown DS, 2015, PREV SCI, V16, P21, DOI 10.1007/s11121-013-0437-z; Buffart LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036164; Coghill AE, 2011, GUT, V60, P491, DOI 10.1136/gut.2010.221143; Diouf M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-69; Dominick KL, 2002, AGING CLIN EXP RES, V14, P499, DOI 10.1007/BF03327351; Efficace F, 2006, EUR J CANCER, V42, P42, DOI 10.1016/j.ejca.2005.07.025; Fournier E, 2016, DIGEST LIVER DIS, V48, P87, DOI 10.1016/j.dld.2015.09.006; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gotay CC, 2008, J CLIN ONCOL, V26, P1355, DOI 10.1200/JCO.2007.13.3439; Harding S, 2014, PEERJ, V2, DOI 10.7717/peerj.256; Jansen L, 2011, BRIT J CANCER, V105, P1158, DOI 10.1038/bjc.2011.335; Jansen L, 2010, EUR J CANCER, V46, P2879, DOI 10.1016/j.ejca.2010.06.010; Jansen L, 2011, J CLIN ONCOL, V29, P3263, DOI 10.1200/JCO.2010.31.4013; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Jones D, 2001, J Ambul Care Manage, V24, P68; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; Kochanek Kenneth D, 2015, Natl Vital Stat Rep, V63, P1; Kroenke CH, 2008, AM J PUBLIC HEALTH, V98, P2085, DOI 10.2105/AJPH.2007.114041; Montazeri A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-102; Mosher CE, 2009, CANCER-AM CANCER SOC, V115, P4001, DOI 10.1002/cncr.24436; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Phipps AI, 2011, CANCER-AM CANCER SOC, V117, P4948, DOI 10.1002/cncr.26114; Ramsey SD, 2002, AM J GASTROENTEROL, V97, P1228, DOI 10.1111/j.1572-0241.2002.05694.x; Rodriguez JL, 2015, AM J PREV MED, V49, pS518, DOI 10.1016/j.amepre.2015.08.007; Sapp AL, 2003, CANCER-AM CANCER SOC, V98, P1749, DOI 10.1002/cncr.11717; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Sharma A, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/269510; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Soerjomataram I, 2012, CANCER CAUSE CONTROL, V23, P1421, DOI 10.1007/s10552-012-0010-2; Thraen-Borowski KM, 2013, J CANCER SURVIV, V7, P369, DOI 10.1007/s11764-013-0277-7; Trentham-Dietz A, 2003, ONCOLOGIST, V8, P342, DOI 10.1634/theoncologist.8-4-342; Tsai SY, 2007, EUR J EPIDEMIOL, V22, P19, DOI 10.1007/s10654-006-9092-z; Ul-Haq Z, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1197; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Ware JE, 2001, QUAL LIFE RES, V10, P405, DOI 10.1023/A:1012588218728; Weaver KE, 2012, CANCER EPIDEM BIOMAR, V21, P2108, DOI 10.1158/1055-9965.EPI-12-0740; Wong CKH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-337; Yost KJ, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-66; Yost KJ, 2005, J CLIN EPIDEMIOL, V58, P1241, DOI 10.1016/j.jclinepi.2005.07.008	42	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156534	10.1371/journal.pone.0156534	http://dx.doi.org/10.1371/journal.pone.0156534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253385	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700038
J	Storsve, AB; Fjell, AM; Yendiki, A; Walhovd, KB				Storsve, Andreas B.; Fjell, Anders M.; Yendiki, Anastasia; Walhovd, Kristine B.			Longitudinal Changes in White Matter Tract Integrity across the Adult Lifespan and Its Relation to Cortical Thinning	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; OLDER-ADULTS; BRAIN ATROPHY; IN-VIVO; MRI; MICROSTRUCTURE; THICKNESS; TRAJECTORIES	A causal link between decreases in white matter (WM) integrity and cortical degeneration is assumed, but there is scarce knowledge on the relationship between these changes across the adult human lifespan. We investigated changes in thickness throughout the cortical mantle and WM tract integrity derived from T1 and diffusion weighted magnetic resonance imaging (MRI) scans in 201 healthy adults aged 23-87 years over a mean interval of 3.6 years. Fractional anisotropy (FA), mean (MD), radial (RD) and axial (AD) diffusivity changes were calculated for forceps minor and major and eight major white matter tracts in each hemisphere by use of a novel automated longitudinal tractography constrained by underlying anatomy (TRACULA) approach. We hypothesized that increasing MD and decreasing FA across tracts would relate to cortical thinning, with some anatomical specificity. WM integrity decreased across tracts non-uniformly, with mean annual percentage decreases ranging from 0.20 in the Inferior Longitudinal Fasciculus to 0.65 in the Superior Longitudinal Fasciculus. For most tracts, greater MD increases and FA decreases related to more cortical thinning, in areas in part overlapping with but also outside the projected tract endings. The findings indicate a combination of global and tract-specific relationships between WM integrity and cortical thinning.	[Storsve, Andreas B.; Fjell, Anders M.; Walhovd, Kristine B.] Univ Oslo, Dept Psychol, Res Grp Lifespan Changes Brain & Cognit, N-0373 Oslo, Norway; [Fjell, Anders M.; Walhovd, Kristine B.] Oslo Univ Hosp, Unit Neuropsychol, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Yendiki, Anastasia] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA; [Yendiki, Anastasia] Harvard Univ, Sch Med, Boston, MA USA	University of Oslo; University of Oslo; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Storsve, AB (corresponding author), Univ Oslo, Dept Psychol, Res Grp Lifespan Changes Brain & Cognit, N-0373 Oslo, Norway.	a.b.storsve@psykologi.uio.no		Storsve, Andreas B/0000-0001-6807-8638; Yendiki, Anastasia/0000-0003-1386-3828	Department of Psychology, University of Oslo; Norwegian Research Council; European Research Council [313440, 283634]; US-Norway Fulbright Foundation; National Institute for Biomedical Imaging and Bioengineering [R00-EB008129, R01-EB006758]; National Institutes of Health Blueprint for Neuroscience Research [5U01-MH093765]; National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health [P41EB015896]; NIH Shared Instrumentation Grants [S10RR023401, S10RR019307, S10RR019254, S10RR023043]	Department of Psychology, University of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); European Research Council(European Research Council (ERC)European Commission); US-Norway Fulbright Foundation; National Institute for Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institutes of Health Blueprint for Neuroscience Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH Shared Instrumentation Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Department of Psychology, University of Oslo (A.B.S., K.B.W.), the Norwegian Research Council (to K.B.W., A.M.F.), the European Research Council's Starting Grant scheme (Grant 313440 to K.B.W. and Grant 283634 to A.M.F.), the US-Norway Fulbright Foundation (to A.B.S.), the National Institute for Biomedical Imaging and Bioengineering (R00-EB008129, R01-EB006758) (to A.Y.) and the National Institutes of Health Blueprint for Neuroscience Research (5U01-MH093765) (to A.Y.), part of the multi-institutional Human Connectome Project. Additional resources were provided by the Center for Functional Neuroimaging Technologies, P41EB015896, a P41 Biotechnology Resource Grant supported by the National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health (to A.Y.). This work also involved the use of instrumentation supported by the NIH Shared Instrumentation Grants S10RR023401, S10RR019307, S10RR019254, S10RR023043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2011, RADIOLOGY, V258, P853, DOI 10.1148/radiol.10101284; Amlien IK, 2014, NEUROSCIENCE, V276, P206, DOI 10.1016/j.neuroscience.2014.02.017; Barrick TR, 2010, NEUROIMAGE, V51, P565, DOI 10.1016/j.neuroimage.2010.02.033; Bartzokis G, 2012, BIOL PSYCHIAT, V72, P1026, DOI 10.1016/j.biopsych.2012.07.010; Beck A.T., 1987, BECK DEPRESSION INVE; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bender AR, 2016, NEUROIMAGE, V131, P193, DOI 10.1016/j.neuroimage.2015.10.085; Benner T, 2011, MAGN RESON MED, V66, P154, DOI 10.1002/mrm.22837; Bennett IJ, 2014, NEUROSCIENCE, V276, P187, DOI 10.1016/j.neuroscience.2013.11.026; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bodini B, 2009, HUM BRAIN MAPP, V30, P2852, DOI 10.1002/hbm.20713; Bosch B, 2012, NEUROBIOL AGING, V33, P61, DOI 10.1016/j.neurobiolaging.2010.02.004; Brouwer RM, 2014, NEUROIMAGE, V100, P676, DOI 10.1016/j.neuroimage.2014.04.072; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; Callaghan MF, 2014, NEUROBIOL AGING, V35, P1862, DOI 10.1016/j.neurobiolaging.2014.02.008; Chetelat G, 2013, NEUROIMAGE, V76, P167, DOI 10.1016/j.neuroimage.2013.03.009; Colby JB, 2011, NEUROIMAGE, V54, P25, DOI 10.1016/j.neuroimage.2010.08.014; Collins-Praino LE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0083-0; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Ehrlich S, 2014, SCHIZOPHRENIA BULL, V40, P665, DOI 10.1093/schbul/sbt056; Esiri MM, 2007, J PATHOL, V211, P181, DOI 10.1002/path.2089; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2013, J NEUROSCI, V33, P8237, DOI 10.1523/JNEUROSCI.5506-12.2013; Fjell AM, 2010, NEUROIMAGE, V50, P1376, DOI 10.1016/j.neuroimage.2010.01.061; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forkel SJ, 2014, CORTEX, V56, P73, DOI 10.1016/j.cortex.2012.09.005; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P1205, DOI 10.1097/NEN.0b013e31818fc72f; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson MA, 2015, BRAIN STRUCT FUNCT, V220, P2705, DOI 10.1007/s00429-014-0822-9; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kucyi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035589; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Li YO, 2012, HUM BRAIN MAPP, V33, P1431, DOI 10.1002/hbm.21292; Lovden M, 2013, HUM BRAIN MAPP, V34, P1386, DOI 10.1002/hbm.21518; Mailhard P, 2013, AM J NEURORADIOL, V34, P54, DOI 10.3174/ajnr.A3146; Mesulam M, 2012, NEUROIMAGE, V62, P2182, DOI 10.1016/j.neuroimage.2011.12.033; Narr KL, 2007, CEREB CORTEX, V17, P2163, DOI 10.1093/cercor/bhl125; Navas-Sanchez FJ, 2014, HUM BRAIN MAPP, V35, P2619, DOI 10.1002/hbm.22355; Penke L, 2010, J NEUROSCI, V30, P7569, DOI 10.1523/JNEUROSCI.1553-10.2010; Peters A, 1998, CEREB CORTEX, V8, P295, DOI 10.1093/cercor/8.4.295; Pfefferbaum A, 2013, NEUROIMAGE, V65, P176, DOI 10.1016/j.neuroimage.2012.10.008; Phillips OR, 2011, HUM BRAIN MAPP, V32, P1788, DOI 10.1002/hbm.21147; Ramcharitar J, 2013, NEUROBIOL AGING, V34, P1815, DOI 10.1016/j.neurobiolaging.2013.01.007; RAZ N, 2001, AGEING AND THE BRAIN; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Resnick SM, 2003, J NEUROSCI, V23, P3295; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Schnack HG, 2015, CEREB CORTEX, V25, P1608, DOI 10.1093/cercor/bht357; Sexton CE, 2014, J NEUROSCI, V34, P15425, DOI 10.1523/JNEUROSCI.0203-14.2014; Sexton CE, 2014, NEUROLOGY, V83, P967, DOI 10.1212/WNL.0000000000000774; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Storsve AB, 2014, J NEUROSCI, V34, P8488, DOI 10.1523/JNEUROSCI.0391-14.2014; Sullivan EV, 2010, NEUROPSYCHOLOGIA, V48, P4155, DOI 10.1016/j.neuropsychologia.2010.10.023; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Thompson WK, 2011, NEUROIMAGE, V57, P1, DOI 10.1016/j.neuroimage.2010.11.092; Vergani F, 2014, CORTEX, V56, P145, DOI 10.1016/j.cortex.2014.03.002; Walhovd KB, 2014, NEUROBIOL AGING, V35, P1055, DOI 10.1016/j.neurobiolaging.2013.11.011; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Westlye LT, 2010, NEUROIMAGE, V52, P172, DOI 10.1016/j.neuroimage.2010.03.056; Yap QJ, 2013, J NEURAL TRANSM, V120, P1369, DOI 10.1007/s00702-013-0971-7; Yendiki A, 2016, NEUROIMAGE, V127, P277, DOI 10.1016/j.neuroimage.2015.12.003; Yendiki A, 2014, NEUROIMAGE, V88, P79, DOI 10.1016/j.neuroimage.2013.11.027; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023	89	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156770	10.1371/journal.pone.0156770	http://dx.doi.org/10.1371/journal.pone.0156770			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253393	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700057
J	Adler, FR; Liou, TG				Adler, Frederick R.; Liou, Theodore G.			The Dynamics of Disease Progression in Cystic Fibrosis	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; FORCED EXPIRATORY VOLUME; PSEUDOMONAS-AERUGINOSA; LUNG-FUNCTION; BACTERIAL COMMUNITIES; YOUNG-CHILDREN; FEV1 DECLINE; INFECTION; SURVIVAL; MODEL	In cystic fibrosis, statistical models have been more successful in predicting mortality than the time course of clinical status. We develop a system of partial differential equations that simultaneously track mortality and patient status, with all model parameters estimated from the extensive and carefully maintained database from the Cystic Fibrosis Foundation. Cystic fibrosis is an autosomal recessive disease that leads to loss of lung function, most commonly assessed using the Forced Expiratory Volume in 1 second (FEV1%). This loss results from inflammation secondary to chronic bacterial infections, particularly Pseudomonas aeruginosa, methicillin-sensitive Staphylococcus aureus (MSSA) and members of the virulent Burkholderia complex. The model tracks FEV1% and carriage of these three bacteria over the course of a patient's life. Analysis of patient state changes from year to year reveals four feedback loops: a damaging positive feedback loop between P. aeruginosa carriage and lower FEV1%, negative feedback loops between P. aeruginosa and MSSA and between P. aeruginosa and Burkholderia, and a protective positive feedback loop between MSSA carriage and higher FEV1%. The partial differential equations built from this data analysis accurately capture the life-long progression of the disease, quantify the key role of high annual FEV1% variability in reducing survivorship, the relative unimportance of short-term bacterial interactions for long-term survival, and the potential benefits of eradicating the most harmful bacteria.	[Adler, Frederick R.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Adler, Frederick R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Liou, Theodore G.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Adler, FR (corresponding author), Univ Utah, Dept Math, Salt Lake City, UT 84112 USA.; Adler, FR (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	adler@math.utah.edu	Liou, Theodore/AAI-3667-2021	Liou, Theodore/0000-0003-0121-4847	21st Century Science Initiative Grant, James S. McDonnell Foundation; Cystic Fibrosis Foundation [LIOU14P0]; Ben B. and Iris M. Margolis Family Foundation of Utah; National Institutes of Health [R01HL125520]; 21st Century Science Initiative Grant from the James S McDonnell Foundation; Ben B and Iris M Margolis Family Foundation of Utah; NIH/NHLBI [R01HL125520]; Cystic Fibrosis Foundation (Bethesda, MD, USA) [LIOU14P0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125520] Funding Source: NIH RePORTER	21st Century Science Initiative Grant, James S. McDonnell Foundation; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Ben B. and Iris M. Margolis Family Foundation of Utah; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 21st Century Science Initiative Grant from the James S McDonnell Foundation; Ben B and Iris M Margolis Family Foundation of Utah; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation (Bethesda, MD, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by 21st Century Science Initiative Grant, James S. McDonnell Foundation (https://www.jsmf.org/) (to F.R.A.). This work was also supported by Cystic Fibrosis Foundation, LIOU14P0 (https://www.cff.org/); Ben B. and Iris M. Margolis Family Foundation of Utah; and National Institutes of Health, R01HL125520 (www.nih.gov) (to T.G.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a 21st Century Science Initiative Grant from the James S McDonnell Foundation (to F.R.A.), and by research grants from the Cystic Fibrosis Foundation, LIOU14P0, (Bethesda, MD, USA), the Ben B and Iris M Margolis Family Foundation of Utah and the NIH/NHLBI, R01HL125520 (to T.G.L.). Opinions expressed in this manuscript by the authors do not necessarily state or reflect those of the NIH, the NHLBI, or the Margolis or CF Foundations.	Aaron SD, 2015, J CLIN EPIDEMIOL, V68, P1336, DOI 10.1016/j.jclinepi.2014.12.010; Aaron SD, 2010, JAMA-J AM MED ASSOC, V304, P2145, DOI 10.1001/jama.2010.1665; Ahlgren HG, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0062-7; Ashish A, 2013, J CYST FIBROS, V12, P790, DOI 10.1016/j.jcf.2013.04.003; Barrett J, 2014, J R STAT SOC B, V67, P860; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Cystic Fibrosis Foundation, 2012, CYST FIBR FDN PAT RE; Dasenbrook EC, 2008, AM J RESP CRIT CARE, V178, P814, DOI 10.1164/rccm.200802-327OC; Dasenbrook EC, 2010, JAMA-J AM MED ASSOC, V303, P2386, DOI 10.1001/jama.2010.791; Dayananda PWA, 2004, MATH BIOSCI, V190, P113, DOI 10.1016/j.mbs.2004.04.001; Diggle P, 2009, CH CRC HANDB MOD STA, P349; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HOLMES EE, 1994, ECOLOGY, V75, P17, DOI 10.2307/1939378; Horsley A, 2015, RESPIROLOGY, V20, P33, DOI 10.1111/resp.12382; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Knapp EA, 2016, ANN AM THORAC SOC, V13, P1173, DOI 10.1513/AnnalsATS.201511-781OC; Konstan MW, 2007, J PEDIATR-US, V151, P134, DOI 10.1016/j.jpeds.2007.03.006; Konstan Michael W, 2009, J Cyst Fibros, V8 Suppl 1, pS15, DOI 10.1016/S1569-1993(09)60006-0; Levy H, 2008, PEDIATR PULM, V43, P463, DOI 10.1002/ppul.20794; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Liou TG, 2005, AM J RESP CRIT CARE, V171, P1053, DOI 10.1164/rccm.200407-900OC; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; LiPuma JJ, 2001, AM J RESP CRIT CARE, V164, P92, DOI 10.1164/ajrccm.164.1.2011153; Madec Y, 2004, MATH BIOSCI, V189, P131, DOI 10.1016/j.mbs.2004.02.001; Marvig RL, 2015, NAT GENET, V47, P57, DOI 10.1038/ng.3148; Mayer-Hamblett N, 2014, AM J RESP CRIT CARE, V190, P289, DOI 10.1164/rccm.201404-0681OC; Merion RM, 2003, LIVER TRANSPLANT, V9, P12, DOI 10.1053/jlts.2003.50009; Miller M, 2013, THORAX, V68, P294, DOI 10.1136/thoraxjnl-2012-202838; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Parkins MD, 2015, J CYST FIBROS, V14, P293, DOI 10.1016/j.jcf.2015.03.012; Prisman EZ, 2011, STAT MED, V30, P3038, DOI 10.1002/sim.4329; R Development Core Team, 2012, R LANG ENV STAT COMP; Razvi S, 2009, CHEST, V136, P1554, DOI 10.1378/chest.09-0132; Rosenfeld M, 2012, J CYST FIBROS, V11, P446, DOI 10.1016/j.jcf.2012.04.003; Schluchter MD, 2002, STAT MED, V21, P1271, DOI 10.1002/sim.1104; Stanbrook MB, 2004, CHEST, V125, P150, DOI 10.1378/chest.125.1.150; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Stutman HR, 2002, J PEDIATR-US, V140, P299, DOI 10.1067/mpd.2002.121930; Szczesniak RD, 2013, ANN EPIDEMIOL, V23, P771, DOI 10.1016/j.annepidem.2013.08.009; Taylor-Robinson D, 2012, THORAX, V67, P860, DOI 10.1136/thoraxjnl-2011-200953; Traverse CC, 2013, P NATL ACAD SCI USA, V110, pE250, DOI 10.1073/pnas.1207025110; Tsiatis AA, 2004, STAT SINICA, V14, P809; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Zemanick ET, 2014, PEDIAT PULMONOL, V13, P542; Zhao J, 2014, SCI REPORTS, V4; Zhu L, 2011, STAT MED, V30, P2435, DOI 10.1002/sim.4294	52	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156752	10.1371/journal.pone.0156752	http://dx.doi.org/10.1371/journal.pone.0156752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248696	Green Submitted, Green Published, gold			2022-12-26	WOS:000377184700076
J	Fournier, D; de Biseau, JC; De Laet, S; Lenoir, A; Passera, L; Aron, S				Fournier, Denis; de Biseau, Jean-Christophe; De laet, Sophie; Lenoir, Alain; Passera, Luc; Aron, Serge			Social Structure and Genetic Distance Mediate Nestmate Recognition and Aggressiveness in the Facultative Polygynous Ant Pheidole pallidula	PLOS ONE			English	Article							DIRECT BEHAVIORAL EVIDENCE; DEAR-ENEMY PHENOMENON; QUEEN NUMBER; COLONY SIZE; INTRASPECIFIC AGGRESSION; CHEMICAL RECOGNITION; CAMPONOTUS-FELLAH; MATE RECOGNITION; KIN RECOGNITION; ARGENTINE ANT	In social insects, the evolutionary stability of cooperation depends on the privileged relationships between individuals of the social group, which is facilitated by the recognition of relatives. Nestmate recognition is based on genetically determined cues and/or environmentally derived chemical components present on the cuticle of individuals. Here, we studied nestmate recognition in the ant Pheidole pallidula, a species where both single-queen (monogyne) and multiple-queen (polygyne) colonies co-occur in the same population. We combined geographical, genetic and chemical analyses to disentangle the factors influencing the level of intraspecific aggressiveness. We show that encounters between workers from neighbouring colonies (i.e., nests less than 5 m away) are on average less aggressive than those between workers from more distant colonies. Aggressive behaviour is associated with the level of genetic difference: workers from monogyne colonies are more aggressive than workers from polygyne colonies, and the intensity of aggressiveness is positively associated with the genetic distance between colonies. Since the genetic distance is correlated with the spatial distance between pairs of colonies, the lower level of aggression toward neighbours may result from their higher relatedness. In contrast, the analysis of overall cuticular hydrocarbon profiles shows that aggressive behaviour is associated neither with the chemical diversity of colonies, nor with the chemical distances between them. When considering methyl-branched alkanes only, however, chemical distances differed between monogyne and polygyne colonies and were significantly associated with aggressiveness. Altogether, these results show that the social structure of colonies and the genetic distances between colonies are two major factors influencing the intensity of agonistic behaviours in the ant P. pallidula.	[Fournier, Denis; de Biseau, Jean-Christophe; De laet, Sophie; Aron, Serge] Univ Libre Bruxelles, Evolutionary Biol & Ecol, CP 160-12,Ave FD Roosevelt 50, B-1050 Brussels, Belgium; [Lenoir, Alain] Univ Tours, IRBI, UMR CNRS 7261, Parc Grandmont, F-37200 Tours, France; [Passera, Luc] Univ Toulouse 3, UMR 5169, Ctr Rech Cognit Anim, F-31062 Toulouse, France	Universite Libre de Bruxelles; Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Fournier, D (corresponding author), Univ Libre Bruxelles, Evolutionary Biol & Ecol, CP 160-12,Ave FD Roosevelt 50, B-1050 Brussels, Belgium.	Denis.Fournier@ulb.ac.be	Fournier, Denis/EZX-2474-2022	Fournier, Denis/0000-0003-4094-0390	Belgian FRS-FNRS (Fonds National pour la Recherche Scientifique) [FRFC 2.4516.11]; Universite libre de Bruxelles (ARC)	Belgian FRS-FNRS (Fonds National pour la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS); Universite libre de Bruxelles (ARC)	This work was funded by the Belgian FRS-FNRS (Fonds National pour la Recherche Scientifique, FRFC 2.4516.11) and Universite libre de Bruxelles (ARC 2010-2015 #5).	Abbot P, 2011, NATURE, V471, pE1, DOI [10.1038/nature09831, 10.1038/nature09835]; AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; Aron S, 1999, ETHOL ECOL EVOL, V11, P209, DOI 10.1080/08927014.1999.9522824; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bagneres AG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P75, DOI 10.1017/CBO9780511711909.006; Bargum K, 2007, J EVOLUTION BIOL, V20, P1351, DOI 10.1111/j.1420-9101.2007.01345.x; Beye M, 1998, BEHAV ECOL SOCIOBIOL, V43, P67, DOI 10.1007/s002650050467; Beye M, 1997, INSECT SOC, V44, P49, DOI 10.1007/s000400050022; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Bontpart H, 1964, THESIS U TOULOUSE; Boulay R, 2014, J EVOLUTION BIOL, V27, P2856, DOI 10.1111/jeb.12515; Boulay R, 2000, ANIM BEHAV, V59, P1127, DOI 10.1006/anbe.2000.1408; Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Bourke AFG, 2011, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780199231157.001.0001; Breed MD, 1987, KIN RECOGNITION ANIM, P209; Buczkowski G, 2005, J CHEM ECOL, V31, P829, DOI 10.1007/s10886-005-3547-7; Cahan SH, 2002, OIKOS, V96, P206, DOI 10.1034/j.1600-0706.2002.960202.x; Chapuisat M, 2004, EVOLUTION, V58, P1064, DOI 10.1111/j.0014-3820.2004.tb00440.x; Chirino MG, 2012, ANN ENTOMOL SOC AM, V105, P740, DOI 10.1603/AN11073; Cronin AL, 2013, ANNU REV ENTOMOL, V58, P37, DOI 10.1146/annurev-ento-120811-153643; CROSLAND MWJ, 1990, ANIM BEHAV, V39, P413, DOI 10.1016/S0003-3472(05)80404-X; Crozier R.H., 1996, EVOLUTION SOCIAL INS; D'Ettorre P, 2006, ANIM BEHAV, V71, P773, DOI 10.1016/j.anbehav.2005.05.014; d'Ettorre P, 2010, ANT ECOLOGY, P194; Dalecky A, 2005, BIOL J LINN SOC, V86, P133, DOI 10.1111/j.1095-8312.2005.00524.x; DESLIPPE RJ, 1995, ECOLOGY, V76, P375, DOI 10.2307/1941196; Dimarco RD, 2010, BEHAV ECOL, V21, P304, DOI 10.1093/beheco/arp190; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Foitzik S, 2007, ANIM BEHAV, V73, P999, DOI 10.1016/j.anbehav.2006.07.017; Fournier D, 2003, EVOLUTION, V57, P1336, DOI 10.1111/j.0014-3820.2003.tb00341.x; Fournier D, 2002, MOL ECOL, V11, P1805, DOI 10.1046/j.1365-294X.2002.01573.x; Fournier D, 2004, THESIS U LIBRE BRUXE; Fournier D, 2009, MOL ECOL, V18, P186, DOI 10.1111/j.1365-294X.2008.04018.x; Fournier D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031480; Frizzi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137919; Furst MA, 2012, P ROY SOC B-BIOL SCI, V279, P516, DOI 10.1098/rspb.2011.0581; Goudet J, 1996, GENETICS, V144, P1933; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Greene MJ, 2007, J EXP BIOL, V210, P897, DOI 10.1242/jeb.02706; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Hamidi R, 2012, EUR J ENTOMOL, V109, P95, DOI 10.14411/eje.2012.012; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hefetz Abraham, 2007, Myrmecological News, V10, P59; Helantera H, 2011, BEHAV ECOL, V22, P710, DOI 10.1093/beheco/arr037; Herbers Joan M., 1993, P262; HOLLDOBLER B, 1977, NATURWISSENSCHAFTEN, V64, P8, DOI 10.1007/BF00439886; Holldobler B., 1990, pi; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; KELLER L, 1989, ANIM BEHAV, V37, P733, DOI 10.1016/0003-3472(89)90059-6; KELLER L, 1995, TRENDS ECOL EVOL, V10, P355, DOI 10.1016/S0169-5347(00)89133-8; Keller L., 1993, QUEEN NUMBER SOCIALI; Keller Laurent, 1993, P16; Krasnec MO, 2013, J CHEM ECOL, V39, P59, DOI 10.1007/s10886-012-0227-2; Lach L., 2009, ANT ECOLOGY; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Langen TA, 2000, BEHAV ECOL SOCIOBIOL, V48, P285, DOI 10.1007/s002650000223; Lenoir A, 2001, PHYSIOL ENTOMOL, V26, P275, DOI 10.1046/j.0307-6962.2001.00244.x; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Martin SJ, 2009, INSECT SOC, V56, P375, DOI 10.1007/s00040-009-0035-z; Martin SJ, 2008, J CHEM ECOL, V34, P1072, DOI 10.1007/s10886-008-9482-7; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; Martin SJ, 2012, BEHAV GENET, V42, P323, DOI 10.1007/s10519-011-9503-0; Martin SJ, 2009, J CHEM ECOL, V35, P368, DOI 10.1007/s10886-009-9612-x; Mateo JM, 2003, J MAMMAL, V84, P1163, DOI 10.1644/BLe-011; MOREL L, 1990, ANN ENTOMOL SOC AM, V83, P642, DOI 10.1093/aesa/83.3.642; Nei M., 1987, MOL EVOLUTIONARY GEN; Nonacs Peter, 1993, P110; NOWBAHARI E, 1990, BIOCHEM SYST ECOL, V18, P63, DOI 10.1016/0305-1978(90)90036-F; Passera L, 1967, VIE MILIEU, V1, P189; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pedersen J.S., 1997, P157; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; R Core Team, 2021, R LANGUAGE ENV STAT; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REEVE HK, 1989, AM NAT, V133, P407, DOI 10.1086/284926; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosset H, 2007, ANIM BEHAV, V74, P951, DOI 10.1016/j.anbehav.2006.11.028; Roulston TH, 2003, INSECT SOC, V50, P151, DOI 10.1007/s00040-003-0624-1; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saar Maya, 2014, Frontiers in Ecology and Evolution, V2, P13; Sambrook J., 2001, MOL CLONING LAB MANU; Silva AR, 2015, J APPL STAT, V42, P1984, DOI 10.1080/02664763.2015.1014894; Singer TL, 1998, AM ZOOL, V38, P394; Sobotnik J, 2012, SCIENCE, V337, P436, DOI 10.1126/science.1219129; Sokal R. H., 1995, BIOMETRY PRINCIPLES; SOROKER V, 1995, J CHEM ECOL, V21, P365, DOI 10.1007/BF02036724; Starks PT, 1998, ETHOLOGY, V104, P573, DOI 10.1111/j.1439-0310.1998.tb00092.x; STUART RJ, 1988, P NATL ACAD SCI USA, V85, P4572, DOI 10.1073/pnas.85.12.4572; STUART RJ, 1991, ANIM BEHAV, V42, P277, DOI 10.1016/S0003-3472(05)80559-7; Stuart RJ, 2000, BEHAV ECOL, V11, P676, DOI 10.1093/beheco/11.6.676; Suarez AV, 2002, ANIM BEHAV, V64, P697, DOI 10.1006/anbe.2002.4011; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; Thurin N, 2008, ANIM BEHAV, V75, P1023, DOI 10.1016/j.anbehav.2007.08.013; Tripet F, 2006, INSECT SOC, V53, P127, DOI 10.1007/s00040-005-0846-5; Tsutsui ND, 2003, P NATL ACAD SCI USA, V100, P1078, DOI 10.1073/pnas.0234412100; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vander Meer RK, 2002, BEHAV ECOL SOCIOBIOL, V51, P122, DOI 10.1007/s002650100417; Vander Meer Robert K., 1998, P79; VIENNE C, 1995, INSECT SOC, V42, P267, DOI 10.1007/BF01240421; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; West SA, 2010, SCIENCE, V327, P1341, DOI 10.1126/science.1178332; YDENBERG RC, 1988, ANIM BEHAV, V36, P343, DOI 10.1016/S0003-3472(88)80004-6; Zar J.H., 1996, BIOSTAT ANAL; Zinck L, 2008, ENTOMOL EXP APPL, V126, P211, DOI 10.1111/j.1570-7458.2007.00654.x	109	10	10	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156440	10.1371/journal.pone.0156440	http://dx.doi.org/10.1371/journal.pone.0156440			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243627	Green Submitted, Green Published, gold			2022-12-26	WOS:000377146100039
J	Smith, GR; Xie, L; Schwartz, R				Smith, Gregory R.; Xie, Lu; Schwartz, Russell			Modeling Effects of RNA on Capsid Assembly Pathways via Coarse-Grained Stochastic Simulation	PLOS ONE			English	Article							SINGLE-STRANDED RNA; PROTEIN-PROTEIN INTERACTIONS; VIRUS; GENOME; BINDING; SUFFICIENT; NUCLEATION; MOLECULES; MECHANISM; KINETICS	The environment of a living cell is vastly different from that of an in vitro reaction system, an issue that presents great challenges to the use of in vitro models, or computer simulations based on them, for understanding biochemistry in vivo. Virus capsids make an excellent model system for such questions because they typically have few distinct components, making them amenable to in vitro and modeling studies, yet their assembly can involve complex networks of possible reactions that cannot be resolved in detail by any current experimental technology. We previously fit kinetic simulation parameters to bulk in vitro assembly data to yield a close match between simulated and real data, and then used the simulations to study features of assembly that cannot be monitored experimentally. The present work seeks to project how assembly in these simulations fit to in vitro data would be altered by computationally adding features of the cellular environment to the system, specifically the presence of nucleic acid about which many capsids assemble. The major challenge of such work is computational: simulating fine-scale assembly pathways on the scale and in the parameter domains of real viruses is far too computationally costly to allow for explicit models of nucleic acid interaction. We bypass that limitation by applying analytical models of nucleic acid effects to adjust kinetic rate parameters learned from in vitro data to see how these adjustments, singly or in combination, might affect fine-scale assembly progress. The resulting simulations exhibit surprising behavioral complexity, with distinct effects often acting synergistically to drive efficient assembly and alter pathways relative to the in vitro model. The work demonstrates how computer simulations can help us understand how assembly might differ between the in vitro and in vivo environments and what features of the cellular environment account for these differences.	[Smith, Gregory R.; Schwartz, Russell] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Xie, Lu] Joint Carnegie Mellon Univ Pittsburgh, PhD Program Computat Biol, Pittsburgh, PA USA; [Xie, Lu; Schwartz, Russell] Carnegie Mellon Univ, Computat Biol Dept, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Schwartz, R (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.; Schwartz, R (corresponding author), Carnegie Mellon Univ, Computat Biol Dept, Pittsburgh, PA 15213 USA.	russells@andrew.cmu.edu	Schwartz, Russell/A-1998-2016	Schwartz, Russell/0000-0002-4970-2252; Smith, Gregory/0000-0003-0112-6134	United States National Institutes of Health [R01AI076318, R01CA140214]; Computational Biology Department, Carnegie Mellon University	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Computational Biology Department, Carnegie Mellon University	This work was supported by United States National Institutes of Health awards R01AI076318 (to L.X., G.S., and R.S.) and R01CA140214 (to R.S.), and the Computational Biology Department, Carnegie Mellon University (to L.X.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelescu DG, 2008, EUR PHYS J E, V25, P323, DOI 10.1140/epje/i2007-10301-6; Angelescu DG, 2007, J PHYS CHEM B, V111, P8477, DOI 10.1021/jp068384o; Baschek JE, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-22; Belyi VA, 2006, P NATL ACAD SCI USA, V103, P17174, DOI 10.1073/pnas.0608311103; Cadena-Nava RD, 2012, J VIROL, V86, P3318, DOI 10.1128/JVI.06566-11; Ceres P, 2002, BIOCHEMISTRY-US, V41, P11525, DOI 10.1021/bi0261645; Chen B, 2011, BIOPHYS J, V100, P3035, DOI 10.1016/j.bpj.2011.05.025; Chen H, 2012, P NATL ACAD SCI USA, V109, P799, DOI 10.1073/pnas.1119057109; Colby R.H., 2003, POLYM PHYS; Comas-Garcia M, 2012, J VIROL, V86, P12271, DOI 10.1128/JVI.01695-12; Dykeman EC, 2014, P NATL ACAD SCI USA, V111, P5361, DOI 10.1073/pnas.1319479111; Dykeman EC, 2013, J MOL BIOL, V425, P3235, DOI 10.1016/j.jmb.2013.06.005; Dykeman EC, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022717; Elrad OM, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/045003; Erdemci-Tandogan G, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032707; Flory PJ, 1942, J CHEM PHYS, V10, P51, DOI 10.1063/1.1723621; Fox JM, 1998, VIROLOGY, V244, P212, DOI 10.1006/viro.1998.9107; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Grime JMA, 2012, BIOPHYS J, V103, P1774, DOI 10.1016/j.bpj.2012.09.007; Hagan MF, 2006, BIOPHYS J, V91, P42, DOI 10.1529/biophysj.105.076851; Hagan MF, 2010, BIOPHYS J, V98, P1065, DOI 10.1016/j.bpj.2009.11.023; Hemberg M, 2006, BIOPHYS J, V90, P3029, DOI 10.1529/biophysj.105.076737; Jamalyaria F, 2005, J COMPUT PHYS, V204, P100, DOI 10.1016/j.jcp.2004.10.004; Johnston IG, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/10/104101; Jones SA, 2014, J VIROL, V88, P1564, DOI 10.1128/JVI.02852-13; Kegel WK, 2004, BIOPHYS J, V86, P3905, DOI 10.1529/biophysj.104.040055; Kler S, 2012, J AM CHEM SOC, V134, P8823, DOI 10.1021/ja2110703; Krishna V, 2010, BIOPHYS J, V98, P18, DOI 10.1016/j.bpj.2009.09.049; Kumar MS, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/045005; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Misra N, 2008, COMPUT MATH METHOD M, V9, P277, DOI 10.1080/17486700802168379; Moisant P, 2010, BIOPHYS J, V99, P1350, DOI 10.1016/j.bpj.2010.06.030; Morales L, 2013, J VIROL, V87, P11579, DOI 10.1128/JVI.01836-13; Morozov AY, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3212694; Murakami S, 2012, J VIROL, V86, P4034, DOI 10.1128/JVI.06700-11; Nguyen HD, 2007, NANO LETT, V7, P338, DOI 10.1021/nl062449h; Nikolaitchik OA, 2014, J VIROL, V88, P4040, DOI 10.1128/JVI.03745-13; Perlmutter JD, 2014, J MOL BIOL, V426, P3148, DOI 10.1016/j.jmb.2014.07.004; Perlmutter JD, 2013, ELIFE, V2, DOI 10.7554/eLife.00632; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; Rapaport DC, 1999, COMPUT PHYS COMMUN, V121, P231, DOI 10.1016/S0010-4655(99)00319-7; Sakaue T, 2006, MACROMOLECULES, V39, P2621, DOI 10.1021/ma0514424; Schwartz R, 1998, BIOPHYS J, V75, P2626, DOI 10.1016/S0006-3495(98)77708-2; Siber A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051919; Siber A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051915; Smith GR, 2014, BIOPHYS J, V106, P310, DOI 10.1016/j.bpj.2013.11.022; Stockley PG, 2013, J BIOL PHYS, V39, P277, DOI 10.1007/s10867-013-9313-0; Strobl G., 2007, PHYS POLYM CONCEPTS; Sweeney B, 2008, BIOPHYS J, V94, P772, DOI 10.1529/biophysj.107.107284; Ting CL, 2011, P NATL ACAD SCI USA, V108, P16986, DOI 10.1073/pnas.1109307108; Tsiang M, 2012, BIOCHEMISTRY-US, V51, P4416, DOI 10.1021/bi300052h; van der Schoot P, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061928; van der Schoot P, 2013, J BIOL PHYS, V39, P289, DOI 10.1007/s10867-013-9307-y; Venter PA, 2005, J VIROL, V79, P6239, DOI 10.1128/JVI.79.10.6239-6248.2005; Wang JCY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002919; Xie L, 2012, BIOPHYS J, V103, P1545, DOI 10.1016/j.bpj.2012.08.057; Zandi R, 2006, BIOPHYS J, V90, P1939, DOI 10.1529/biophysj.105.072975; Zandi R, 2009, BIOPHYS J, V96, P9, DOI 10.1529/biophysj.108.137489; Zeng YY, 2012, J STRUCT BIOL, V180, P110, DOI 10.1016/j.jsb.2012.06.008; Zhang TQ, 2005, Proceedings of the 2005 Winter Simulation Conference, Vols 1-4, P2223; Zhang TQ, 2006, BIOPHYS J, V90, P57, DOI 10.1529/biophysj.105.072207; Zlotnick A, 2000, VIROLOGY, V277, P450, DOI 10.1006/viro.2000.0619; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a; Zlotnick A, 2003, VIROLOGY, V315, P269, DOI 10.1016/S0042-6822(03)00586-5; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473	65	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156547	10.1371/journal.pone.0156547	http://dx.doi.org/10.1371/journal.pone.0156547			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244559	Green Published, gold, Green Submitted			2022-12-26	WOS:000377146100045
J	Anigilaje, EA; Aderibigbe, SA; Adeoti, AO; Nweke, NO				Anigilaje, Emmanuel A.; Aderibigbe, Sunday A.; Adeoti, Adekunle O.; Nweke, Nnamdi O.			Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; COHORT; EPIDEMIOLOGY; REINFECTION; RELAPSE; DISEASE; IMPACT; HAART	Introduction In Nigeria, there is a dearth of pediatric data on the risk factors associated with tuberculosis (TB), before and after antiretroviral therapy (ART). Methodology A retrospective observational cohort study, between October 2010 and December 2013, at the Federal Medical Centre, Makurdi, Nigeria. TB was noted among children less than 15 years of age at ART enrolment (prevalent TB-PrevTB), within 6 months (early incident tuberculosis-EITB) and after 6 months (late incident tuberculosis-LITB) of a 12-month follow-up on ART. Potential risk factors for PrevTB and incident TB were assessed using the multivariate logistic and Cox regression models respectively. Results Among 368 HIV-1 infected children, PrevTB was diagnosed in 73 children (19.8%). Twenty-eight EITB cases were diagnosed among 278 children over 132 person-years (py) with an EITB rate of 21.2/100 py. Twelve LITB cases were seen among 224 children over 221.9 py with a LITB rate of 5.4/100 py. A significant reduction in the incidence rates of TB was found over time (75%, p < 0.001). Young age of children (12-35 months, aOR; 24, 95% CI; 4.1-146.6, p < 0.001; 36-59 months, aOR; 21, 95% CI; 4.0-114.3, p < 0.001); history of TB in children (aOR; 29, 95% CI; 7.3-119.4, P < 0.001); severe immunosuppression (aOR; 38, 95% CI; 12-123.2, p < 0.001); oropharyngeal candidiasis (aOR; 3.3, 95% CI; 1.4-8.0, p = 0.009) and sepsis (aOR; 3.2, 95% CI; 1.0-9.6, p = 0.043) increased the risk of PrevTB. Urban residency was protective against EITB (aHR; 0.1, 95% CI; 0.0-0.4, p = 0.001). Virological failure (aHR; 4.7, 95% CI; 1.3-16.5, p < 0.001) and sepsis (aHR; 26, 95% CI; 5.3-131.9, p < 0.001) increased the risk of LITB. Conclusions In our cohort of HIV-infected children, a significant reduction in cases of incident TB was seen following a 12-month use of ART. After ART initiation, TB screening should be optimized among children of rural residency, children with sepsis, and those with poor virological response to ART.	[Anigilaje, Emmanuel A.; Nweke, Nnamdi O.] Fed Med Ctr, Dept Paediat, Makurdi, Benue State, Nigeria; [Aderibigbe, Sunday A.] Univ Ilorin, Dept Community Med, Ilorin, Kwara State, Nigeria; [Adeoti, Adekunle O.] Ekiti State Univ Teaching Hosp, Dept Med, Ado Ekiti, Ekiti State, Nigeria; [Anigilaje, Emmanuel A.] Univ Abuja, Coll Hlth Sci, Dept Paediat, Abuja, Nigeria	University of Ilorin	Anigilaje, EA (corresponding author), Fed Med Ctr, Dept Paediat, Makurdi, Benue State, Nigeria.; Anigilaje, EA (corresponding author), Univ Abuja, Coll Hlth Sci, Dept Paediat, Abuja, Nigeria.	demolaanigilaje@yahoo.co.uk			US Department of Health and Human Services, Health Resources and Services Administration [U51HA02522]; CDC through AIDS Preventive Initiative Nigeria-APIN [PS001058]	US Department of Health and Human Services, Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); CDC through AIDS Preventive Initiative Nigeria-APIN	This work was funded in part by the US Department of Health and Human Services, Health Resources and Services Administration (U51HA02522) and CDC through AIDS Preventive Initiative Nigeria-APIN-(PS001058).	Agbaji O., 2013, Journal of AIDS and Clinical Research, V4, P222; Akanbi MO, 2013, AIDS RES HUM RETROV, V29, P931, DOI [10.1089/aid.2012.0231, 10.1089/AID.2012.0231]; Anigilaje EA, 2014, HIV AIDS-RES PALLIAT, V6, P127, DOI 10.2147/HIV.S64964; [Anonymous], 2010, NAT TUB LEPR CONTR P; [Anonymous], 2009, INT J HLTH RES; [Anonymous], 1995, PHYS STAT US INT ANT; [Anonymous], 2006, J INFECT DIS; Ayalaw GS, 2015, INCIDENCE PREDICTORS; Bakeera-Kitaka S, 2011, INT J TUBERC LUNG D, V15, P1082, DOI 10.5588/ijtld.10.0538; Braitstein P, 2009, PEDIATR INFECT DIS J, V28, P626, DOI 10.1097/INF.0b013e31819665c5; Bugaje M. A., 2006, Annals of African Medicine, V5, P73; Cohen JM, 2008, HIV MED, V9, P277, DOI 10.1111/j.1468-1293.2008.00559.x; Coovadia HM, 1998, INT J TUBERC LUNG D, V2, P844; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Crampin AC, 2010, AIDS, V24, P417, DOI 10.1097/QAD.0b013e32832f51cf; Daniel OJ, 2005, NIGER J PEADIAT, V32, P83; Daniels R, 2011, J ANTIMICROB CHEMOTH, V66, pII11, DOI 10.1093/jac/dkq515; Edmonds A, 2009, INT J EPIDEMIOL, V38, P1612, DOI 10.1093/ije/dyp208; Federal Ministry of Health, 2007, NAT GUID PAED HIV AI; Federal Ministry of Health, 2010, NAT GUID PAED HIV AI; Graham SM, 2001, INT J TUBERC LUNG D, V5, P12; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; International Union against Tuberculosis and Lung Disease, 2010, DESK GUIDE DIAGNOSIS; Jensen J, 2012, PEDIATR INFECT DIS J, V31, P278, DOI 10.1097/INF.0b013e318239e268; Joint United Nations Programme on HIV/ AIDS, 2013 PROGR REP GLOB; Kouakoussui A, 2004, Paediatr Respir Rev, V5, P311, DOI 10.1016/j.prrv.2004.07.008; Li N, 2013, AIDS, V27, P1273, DOI 10.1097/QAD.0b013e32835ecb24; Martinson NA, 2009, INT J TUBERC LUNG D, V13, P862; Moreira J, 2015, CLIN RES HIV AIDS, V2, P1021; Mu WW, 2014, AIDS CARE, V26, P1127, DOI 10.1080/09540121.2014.882492; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Nelson LJ, 2004, PEDIATRICS, V114, P333, DOI 10.1542/peds.114.2.333; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Ogunbosi BO, 2011, ITAL J PEDIATR, V37, DOI 10.1186/1824-7288-37-29; Okechukwu AA, 2011, NIGER J CLIN PRACT, V14, P206, DOI 10.4103/1119-3077.84018; Oladokun RE, 2014, CLIN RES INFECT DIS, V1, P1007; Otu AA, 2013, ANN TROP MED PUBLIC, V6, P491, DOI 10.4103/1755-6783.133685; Palme IB, 2002, PEDIATR INFECT DIS J, V21, P1053, DOI 10.1097/00006454-200211000-00016; Saharia KK, 2013, CELL, V155, P505, DOI 10.1016/j.cell.2013.09.045; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Ugochukwu E F, 2006, West Afr J Med, V25, P10; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Venturini E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S5; Walters E, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-1; World Health Organization, 2011, ANTHR PERS COMP VERS; World Health Organization, 2021, 10 THREATS GLOB HLTH	49	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156177	10.1371/journal.pone.0156177	http://dx.doi.org/10.1371/journal.pone.0156177			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232185	gold, Green Published, Green Submitted			2022-12-26	WOS:000376883000013
J	Jang, HS; Hong, YJ; Choi, HW; Song, H; Byun, SJ; Uhm, SJ; Seo, HG; Do, JT				Jang, Hyun Sik; Hong, Yean Ju; Choi, Hyun Woo; Song, Hyuk; Byun, Sung June; Uhm, Sang Jun; Seo, Han Geuk; Do, Jeong Tae			Changes in Parthenogenetic Imprinting Patterns during Reprogramming by Cell Fusion	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NUCLEAR TRANSFER; SOMATIC-CELLS; MOUSE EMBRYOS; HYBRID-CELLS; GENERATION; EXPRESSION; CULTURE; MICE; LINE	Differentiated somatic cells can be reprogrammed into the pluripotent state by cell-cell fusion. In the pluripotent state, reprogrammed cells may then self-renew and differentiate into all three germ layers. Fusion-induced reprogramming also epigenetically modifies the somatic cell genome through DNA demethylation, X chromosome reactivation, and histone modification. In this study, we investigated whether fusion with embryonic stem cells (ESCs) also reprograms genomic imprinting patterns in somatic cells. In particular, we examined imprinting changes in parthenogenetic neural stem cells fused with biparental ESCs, as well as in biparental neural stem cells fused with parthenogenetic ESCs. The resulting hybrid cells expressed the pluripotency markers Oct4 and Nanog. In addition, methylation of several imprinted genes except Peg3 was comparable between hybrid cells and ESCs. This finding indicates that reprogramming by cell fusion does not necessarily reverse the status of all imprinted genes to the state of pluripotent fusion partner.	[Jang, Hyun Sik; Hong, Yean Ju; Choi, Hyun Woo; Song, Hyuk; Seo, Han Geuk; Do, Jeong Tae] Konkuk Univ, Coll Anim Biosci & Technol, Dept Anim Biotechnol, Seoul, South Korea; [Byun, Sung June] Rural Dev Adm, Natl Inst Anim Sci, Anim Biotechnol Div, Suwon, South Korea; [Uhm, Sang Jun] Sangji Youngseo Coll, Dept Anim Sci & Biotechnol, Wonju, South Korea	Konkuk University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Do, JT (corresponding author), Konkuk Univ, Coll Anim Biosci & Technol, Dept Anim Biotechnol, Seoul, South Korea.	dojt@konkuk.ac.kr		Do, Jeong Tae/0000-0001-6721-1441	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2015R1A5A1009701]; Next-Generation BioGreen 21 Program - Rural Development Administration, Republic of Korea [PJ01133802]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Next-Generation BioGreen 21 Program - Rural Development Administration, Republic of Korea	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (grant no. 2015R1A5A1009701); and the Next-Generation BioGreen 21 Program (grant no. PJ01133802) funded by the Rural Development Administration, Republic of Korea.	Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Choi HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021367; Do JT, 2006, STEM CELL REV, V2, P257, DOI 10.1007/BF02698052; Do JT, 2009, STEM CELLS, V27, P2962, DOI 10.1002/stem.233; Do JT, 2008, STEM CELLS, V26, P2821, DOI 10.1634/stemcells.2008-0482; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Jelinic P, 2007, J PATHOL, V211, P261, DOI 10.1002/path.2116; Kaffer CR, 2000, GENE DEV, V14, P1908; Khosla S, 2001, HUM REPROD UPDATE, V7, P419, DOI 10.1093/humupd/7.4.419; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sumer H, 2010, STEM CELLS DEV, V19, P239, DOI 10.1089/scd.2009.0142; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	23	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156491	10.1371/journal.pone.0156491	http://dx.doi.org/10.1371/journal.pone.0156491			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232503	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000039
J	Nguyen, MT; Krupa, M; Koo, BK; Song, JA; Vu, TTT; Do, BH; Nguyen, AN; Seo, T; Yoo, J; Jeong, B; Jin, J; Lee, KJ; Oh, HB; Choe, H				Minh Tan Nguyen; Krupa, Martin; Koo, Bon-Kyung; Song, Jung-A; Thu Trang Thi Vu; Do, Bich Hang; Anh Ngoc Nguyen; Seo, Taewook; Yoo, Jiwon; Jeong, Boram; Jin, Jonghwa; Lee, Kyung Jin; Oh, Heung-Bum; Choe, Han			Prokaryotic Soluble Overexpression and Purification of Human VEGF165 by Fusion to a Maltose Binding Protein Tag	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ESCHERICHIA-COLI; TUMOR ANGIOGENESIS; INCLUSION-BODIES; EXPRESSION; CELLS; DIFFERENTIATION; OPTIMIZATION; FACTOR(165); SOLUBILITY	Human vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis and plays a central role in the process of tumor growth and metastatic dissemination. Escherichia coli is one of the most common expression systems used for the production of recombinant proteins; however, expression of human VEGF in E. coli has proven difficult because the E. coli-expressed VEGF tends to be misfolded and forms inclusion bodies, resulting in poor solubility. In this study, we successfully produced semi-preparative amounts of soluble bioactive human VEGF165 (hVEGF). We created seven N-terminal fusion tag constructs with hexahistidine (His6), thioredoxin (Trx), glutathione S-transferase (GST), maltose-binding protein (MBP), N-utilization substance protein A (NusA), human protein disulfide isomerase (PDI), and the b'a' domain of PDI (PDIb'a'), and tested each construct for soluble overexpression in E. coli. We found that at 18o C, 92.8% of the MBP-tagged hVEGF to be soluble and that this tag significantly increased the protein's solubility. We successfully purified 0.8 mg of pure hVEGF per 500 mL cell culture. The purified hVEGF is stable after tag cleavage, contains very low levels of endotoxin, and is 97.6% pure. Using an Flk1(+) mesodermal precursor cell (MPC) differentiation assay, we show that the purified hVEGF is not only bioactive but has similar bioactivity to hVEGF produced in mammalian cells. Previous reports on producing hVEGF in E. coli have all been based on refolding of the protein from inclusion bodies. To our knowledge, this is the first report on successfully expressing and purifying soluble hVEGF in E. coli.	[Minh Tan Nguyen; Krupa, Martin; Koo, Bon-Kyung; Song, Jung-A; Thu Trang Thi Vu; Do, Bich Hang; Anh Ngoc Nguyen; Seo, Taewook; Yoo, Jiwon; Jeong, Boram; Choe, Han] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Physiol, Seoul 05505, South Korea; [Minh Tan Nguyen; Krupa, Martin; Koo, Bon-Kyung; Song, Jung-A; Thu Trang Thi Vu; Do, Bich Hang; Anh Ngoc Nguyen; Seo, Taewook; Yoo, Jiwon; Jeong, Boram; Choe, Han] Univ Ulsan, Coll Med, Asan Med Ctr, Biomed Inst Technol, Seoul 05505, South Korea; [Jin, Jonghwa] Osong Med Innovat Fdn, New Drug Dev Ctr, Div Drug Screening & Evaluat, Chungbuk 363951, South Korea; [Lee, Kyung Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med,Asan Inst Life Sci, Seoul 05505, South Korea; [Oh, Heung-Bum] Univ Ulsan, Coll Med, Dept Lab Med, Seoul 05505, South Korea; [Oh, Heung-Bum] Asan Med Ctr, Seoul 05505, South Korea	University of Ulsan; University of Ulsan; Osong Medical Innovation Foundation; University of Ulsan; University of Ulsan	Choe, H (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Physiol, Seoul 05505, South Korea.; Choe, H (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Biomed Inst Technol, Seoul 05505, South Korea.	hchoe@ulsan.ac.kr	Hang, Bich/AAI-6230-2021; Nguyen, Minh Tan/AAH-7865-2019	Hang, Bich/0000-0002-8951-175X; 	Medical Research Center Program [2008-0062286]; National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2015K1A4A3046807]; Asan Institute for Life Sciences, Seoul, Korea [2015219]	Medical Research Center Program; National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; Asan Institute for Life Sciences, Seoul, Korea	This work was supported by Medical Research Center Program (2008-0062286) and a grant (2015K1A4A3046807) through the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, and a grant (2015219) from the Asan Institute for Life Sciences, Seoul, Korea.	Bach H, 2001, J MOL BIOL, V312, P79, DOI 10.1006/jmbi.2001.4914; Bornhorst JA, 2000, METHOD ENZYMOL, V326, P245; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Carlevaro MF, 2000, J CELL SCI, V113, P59; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chung ND, 2014, ENZYME MICROB TECH, V63, P58, DOI 10.1016/j.enzmictec.2014.05.007; Costa S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00063; Cothran A, 2011, BIOTECHNOL PROGR, V27, P1273, DOI 10.1002/btpr.642; Do BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089906; Drake Christopher J., 2003, Birth Defects Research, V69, P73, DOI 10.1002/bdrc.10003; El-Sheikh A, 2002, CANCER RES, V62, P7118; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; Fox JD, 2001, PROTEIN SCI, V10, P622, DOI 10.1110/ps.45201; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Han M, 2009, BIOTECHNOL LETT, V31, P1677, DOI 10.1007/s10529-009-0060-z; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Jiang XN, 2003, J HISTOCHEM CYTOCHEM, V51, P1393, DOI 10.1177/002215540305101101; Joo HJ, 2012, BLOOD, V120, P2733, DOI 10.1182/blood-2012-04-421610; Kang W, 2013, PROTEIN EXPRES PURIF, V87, P55, DOI 10.1016/j.pep.2012.10.004; Kang WK, 2013, J BIOTECHNOL, V164, P441, DOI 10.1016/j.jbiotec.2013.02.004; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Keswani SG, 2013, WOUND REPAIR REGEN, V21, P554, DOI 10.1111/wrr.12065; Kiriakidis S, 2003, J CELL SCI, V116, P665, DOI 10.1242/jcs.00286; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Lebendiker M, 2014, FEBS LETT, V588, P236, DOI 10.1016/j.febslet.2013.10.044; Lee GY, 2006, PROTEIN EXPRES PURIF, V46, P503, DOI 10.1016/j.pep.2005.09.023; Lee IL, 2011, PROTEIN EXPRES PURIF, V76, P54, DOI 10.1016/j.pep.2010.08.014; Lee SB, 2008, J MICROBIOL BIOTECHN, V18, P183; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Nguyen MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089038; MOHANRAJ D, 1995, GROWTH FACTORS, V12, P17, DOI 10.3109/08977199509003210; Park C, 2007, J MOL BIOL, V368, P1426, DOI 10.1016/j.jmb.2007.02.091; PERETZ D, 1992, BIOCHEM BIOPH RES CO, V182, P1340, DOI 10.1016/0006-291X(92)91880-Y; Pizarro SA, 2010, PROTEIN EXPRES PURIF, V72, P184, DOI 10.1016/j.pep.2010.03.007; Pryor KD, 1997, PROTEIN EXPRES PURIF, V10, P309, DOI 10.1006/prep.1997.0759; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Song JA, 2013, PLOS ONE, V8, DOI [DOI 10.1371/J0URNAL.P0NE.0083781, 10.1371/journal.pone.0083781]; Song JA, 2013, APPL BIOCHEM BIOTECH, V170, P67, DOI 10.1007/s12010-013-0140-3; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Vu TTT, 2014, TOXICON, V92, P157, DOI 10.1016/j.toxicon.2014.10.017; Woolard J, 2009, MICROCIRCULATION, V16, P572, DOI 10.1080/10739680902997333; Wu XF, 2004, J BIOTECHNOL, V111, P253, DOI 10.1016/j.jbiotec.2004.04.016; Zanier K, 2007, PROTEIN EXPRES PURIF, V51, P59, DOI 10.1016/j.pep.2006.07.029; Zou JP, 2009, AFR J BIOTECHNOL, V8, P2362	46	16	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156296	10.1371/journal.pone.0156296	http://dx.doi.org/10.1371/journal.pone.0156296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27231876	Green Published, gold			2022-12-26	WOS:000376883000020
J	Wallen, MP; Gomersall, SR; Keating, SE; Wisloff, U; Coombes, JS				Wallen, Matthew P.; Gomersall, Sjaan R.; Keating, Shelley E.; Wisloff, Ulrik; Coombes, Jeff S.			Accuracy of Heart Rate Watches: Implications for Weight Management	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; WEARABLE DEVICES; SKIN TYPE; VALIDITY; HEALTH; VALIDATION; ADULTS	Background Wrist-worn monitors claim to provide accurate measures of heart rate and energy expenditure. People wishing to lose weight use these devices to monitor energy balance, however the accuracy of these devices to measure such parameters has not been established. Aim To determine the accuracy of four wrist-worn devices (Apple Watch, Fitbit Charge HR, Samsung Gear S and Mio Alpha) to measure heart rate and energy expenditure at rest and during exercise. Methods Twenty-two healthy volunteers (50% female; aged 24 +/- 5.6 years) completed similar to 1-hr protocols involving supine and seated rest, walking and running on a treadmill and cycling on an ergometer. Data from the devices collected during the protocol were compared with reference methods: electrocardiography (heart rate) and indirect calorimetry (energy expenditure). Results None of the devices performed significantly better overall, however heart rate was consistently more accurate than energy expenditure across all four devices. Correlations between the devices and reference methods were moderate to strong for heart rate (0.67-0.95 [0.35 to 0.98]) and weak to strong for energy expenditure (0.16-0.86 [-0.25 to 0.95]). All devices underestimated both outcomes compared to reference methods. The percentage error for heart rate was small across the devices (range: 1-9%) but greater for energy expenditure (9-43%). Similarly, limits of agreement were considerably narrower for heart rate (ranging from -27.3 to 13.1 bpm) than energy expenditure (ranging from -266.7 to 65.7 kcals) across devices. Conclusion These devices accurately measure heart rate. However, estimates of energy expenditure are poor and would have implications for people using these devices for weight loss.	[Wallen, Matthew P.; Gomersall, Sjaan R.; Keating, Shelley E.; Coombes, Jeff S.] Univ Queensland, Ctr Res Exercise Phys Act & Hlth CRExPAH, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia; [Wisloff, Ulrik] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway	University of Queensland; Norwegian University of Science & Technology (NTNU)	Coombes, JS (corresponding author), Univ Queensland, Ctr Res Exercise Phys Act & Hlth CRExPAH, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia.	jcoombes@uq.edu.au	Coombes, Jeff/F-1764-2010; Wallen, Matthew/AAY-1989-2020; Gomersall, Sjaan/J-9665-2013; Keating, Shelley E/P-2520-2015	Coombes, Jeff/0000-0002-6990-3596; Wallen, Matthew/0000-0002-2201-7933; Gomersall, Sjaan/0000-0001-6808-0180; Keating, Shelley E/0000-0001-5357-2721; Wisloff, Ulrik/0000-0002-7211-3587	Coca Cola [2014002786]	Coca Cola	The principal investigator on the study (Coombes) received an unrestricted grant from Coca Cola that was used to partially fund this study (Research Master Number 2014002786, http://transparency.coca-colajourney.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2015, FORECAST UNIT SALES; [Anonymous], 2014, CCS INSIGHT; Brown R, 2005, EUR J ORTHODONT, V27, P286, DOI 10.1093/ejo/cjh078; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Dannecker KL, 2013, MED SCI SPORT EXER, V45, P2105, DOI 10.1249/MSS.0b013e318299d2eb; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; Fallow BA, 2013, J CLIN MONIT COMPUT, V27, P313, DOI 10.1007/s10877-013-9436-7; Ferguson T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0201-9; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Keytel LR, 2005, J SPORT SCI, V23, P289, DOI 10.1080/02640410470001730089; Lee JM, 2014, MED SCI SPORT EXER, V46, P1840, DOI 10.1249/MSS.0000000000000287; Luke A, 1997, MED SCI SPORT EXER, V29, P144, DOI 10.1097/00005768-199701000-00021; Mann T, 2013, SPORTS MED, V43, P613, DOI 10.1007/s40279-013-0045-x; Parak J, 2014, IEEE ENG MED BIO, P3670, DOI 10.1109/EMBC.2014.6944419; Patel MS, 2015, JAMA-J AM MED ASSOC, V313, P459, DOI 10.1001/jama.2014.14781; Sasaki JE, 2015, J PHYS ACT HEALTH, V12, P149, DOI 10.1123/jpah.2012-0495; Spierer David K., 2015, Journal of Medical Engineering & Technology, V39, P264, DOI 10.3109/03091902.2015.1047536; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	19	172	176	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0154420	10.1371/journal.pone.0154420	http://dx.doi.org/10.1371/journal.pone.0154420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232714	Green Published, gold, Green Submitted			2022-12-26	WOS:000376883000001
J	Le Moing, AG; Seferian, AM; Moraux, A; Annoussamy, M; Dorveaux, E; Gasnier, E; Hogrel, JY; Voit, T; Vissiere, D; Servais, L				Le Moing, Anne-Gaelle; Seferian, Andreea Mihaela; Moraux, Amelie; Annoussamy, Melanie; Dorveaux, Eric; Gasnier, Erwan; Hogrel, Jean-Yves; Voit, Thomas; Vissiere, David; Servais, Laurent			A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment	PLOS ONE			English	Article							DAILY PHYSICAL-ACTIVITY; NEUROMUSCULAR DISEASE; CALIBRATION METHODOLOGY; ATTITUDE ESTIMATION; PARKINSONS-DISEASE; ACCELEROMETRY DATA; EPILEPSY PATIENTS; MOTOR FUNCTION; UPPER LIMBS; CHILDREN	Measurement of muscle strength and activity of upper limbs of non-ambulant patients with neuromuscular diseases is a major challenge. ActiMyo (R) is an innovative device that uses magneto-inertial sensors to record angular velocities and linear accelerations that can be used over long periods of time in the home environment. The device was designed to insure long-term stability and good signal to noise ratio, even for very weak movements. In order to determine relevant and pertinent clinical variables with potential for use as outcome measures in clinical trials or to guide therapy decisions, we performed a pilot study in non-ambulant neuromuscular patients. We report here data from seven Duchenne Muscular Dystrophy (DMD) patients (mean age 18.5 +/- 5.5 years) collected in a clinical setting. Patients were assessed while wearing the device during performance of validated tasks (MoviPlate, Box and Block test and Minnesota test) and tasks mimicking daily living. The ActiMyo (R) sensors were placed on the wrists during all the tests. Software designed for use with the device computed several variables to qualify and quantify muscular activity in the non-ambulant subjects. Four variables representative of upper limb activity were studied: the rotation rate, the ratio of the vertical component in the overall acceleration, the hand elevation rate, and an estimate of the power of the upper limb. The correlations between clinical data and physical activity and the ActiMyo (R) movement parameters were analyzed. The mean of the rotation rate and mean of the elevation rate appeared promising since these variables had the best reliability scores and correlations with task scores. Parameters could be computed even in a patient with a Brooke functional score of 6. The variables chosen are good candidates as potential outcome measures in non-ambulant patients with Duchenne Muscular Dystrophy and use of the ActiMyo (R) is currently being explored in home environment.	[Le Moing, Anne-Gaelle; Seferian, Andreea Mihaela; Moraux, Amelie; Annoussamy, Melanie; Gasnier, Erwan; Hogrel, Jean-Yves; Voit, Thomas; Servais, Laurent] Grp Hosp La Pitie Salpetriere, Inst Myol, Paris, France; [Le Moing, Anne-Gaelle] Ctr Hosp Univ Amiens Picardie, Grp Rech Anal Multimodale Fonct Cerebrale, Serv Neurol Pediat, Amiens, France; [Dorveaux, Eric; Vissiere, David] SYSNAV, Vernon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Servais, L (corresponding author), Grp Hosp La Pitie Salpetriere, Inst Myol, Paris, France.	l.servais@institut-myologie.org	Servais, Laurent/AAL-7384-2020; Dorveaux, Eric/ABE-9144-2021	Dorveaux, Eric/0000-0003-1606-6461; Hogrel, Jean-Yves/0000-0003-0045-7505; Servais, Laurent/0000-0001-9270-4061	Institute of Myology	Institute of Myology	The PreActi study was entirely funded by Institute of Myology, AIM. Eric Dorveaux and David Vissiere are employed by the commercial company SYSNAV. SYSNAV provided support in the form of salaries for authors ED and DV and provided the prototype used for the study and the operating system on a collaboration agreement, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; [Anonymous], PLOS CURR; Bartels B, 2011, J REHABIL MED, V43, P770, DOI 10.2340/16501977-0841; Becq G, 2011, COMPUT BIOL MED, V41, P46, DOI 10.1016/j.compbiomed.2010.11.005; Berard C, 2006, REV NEUROL-FRANCE, V162, P485; BROOKE MH, 1981, MUSCLE NERVE, V4, P186, DOI 10.1002/mus.880040304; Carpinella I, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-67; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Clanchy KM, 2011, EUR J APPL PHYSIOL, V111, P2951, DOI 10.1007/s00421-011-1915-2; Connolly AM, 2015, MUSCLE NERVE, V51, P522, DOI 10.1002/mus.24346; Crassidis JL, 2007, J GUID CONTROL DYNAM, V30, P12, DOI 10.2514/1.22452; Dash D, 2012, EPILEPTIC DISORD, V14, P290, DOI 10.1684/epd.2012.0529; Dencker M, 2008, CLIN PHYSIOL FUNCT I, V28, P133, DOI 10.1111/j.1475-097X.2008.00788.x; Dorveaux E, 2009, IEEE DECIS CONTR P, P8296, DOI 10.1109/CDC.2009.5399503; El-Gohary M, 2014, SENSORS-BASEL, V14, P356, DOI 10.3390/s140100356; El-Zayat BF, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-72; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Escolar DM, 2001, MUSCLE NERVE, V24, P787, DOI 10.1002/mus.1070; Foster CC, 2008, IEEE T AERO ELEC SYS, V44, P1070, DOI 10.1109/TAES.2008.4655364; Ganea R, 2012, J CHILD NEUROL, V27, P30, DOI 10.1177/0883073811413581; Glanzman AM, 2010, NEUROMUSCULAR DISORD, V20, P155, DOI 10.1016/j.nmd.2009.11.014; GLOSS DS, 1982, PERCEPT MOTOR SKILL, V55, P527, DOI 10.2466/pms.1982.55.2.527; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Gorter JW, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/329284; Grimpampi E, 2013, GAIT POSTURE, V38, P523, DOI 10.1016/j.gaitpost.2013.01.031; Grootenhuis MA, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-31; Hamel T, 2006, IEEE INT CONF ROBOT, P2170; HILLER LB, 1992, ARCH PHYS MED REHAB, V73, P527; Hogrel JY, 2016, NEUROLOGY, V86, P1022, DOI 10.1212/WNL.0000000000002464; Jeannet PY, 2011, EUR J PAEDIATR NEURO, V15, P40, DOI 10.1016/j.ejpn.2010.07.002; Kurillo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045341; Lan KC, 2013, SENSORS-BASEL, V13, P4781, DOI 10.3390/s130404781; LORD JP, 1987, ARCH PHYS MED REHAB, V68, P8; Lowes LP, 2015, MUSCLE NERVE, V52, P356, DOI 10.1002/mus.24557; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; Main M, 2003, EUR J PAEDIATR NEURO, V7, P155, DOI 10.1016/S1090-3798(03)00060-6; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Mattar FL, 2008, NEUROMUSCULAR DISORD, V18, P193, DOI 10.1016/j.nmd.2007.11.004; Mayhew A, 2013, DEV MED CHILD NEUROL, V55, P1038, DOI 10.1111/dmcn.12213; Mazzone ES, 2012, DEV MED CHILD NEUROL, V54, P879, DOI 10.1111/j.1469-8749.2012.04345.x; McDonald CM, 2005, ARCH PHYS MED REHAB, V86, P793, DOI 10.1016/j.apmr.2004.10.011; McDonald CM, 2002, AM J PHYS MED REHAB, V81, pS108, DOI 10.1097/00002060-200211001-00012; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nijsen TME, 2007, IEEE T BIO-MED ENG, V54, P2073, DOI 10.1109/TBME.2007.895114; Nijsen TME, 2010, IEEE T INF TECHNOL B, V14, P1197, DOI 10.1109/TITB.2010.2058123; Paulis WD, 2011, GAIT POSTURE, V33, P185, DOI 10.1016/j.gaitpost.2010.10.094; Penta M, 1998, ARCH PHYS MED REHAB, V79, P1038, DOI 10.1016/S0003-9993(98)90167-8; Prahm KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114273; Ricci L, 2014, SENSORS-BASEL, V14, P1057, DOI 10.3390/s140101057; Santoso F, 2015, PHYSIOL MEAS, V36, DOI 10.1088/0967-3334/36/10/R53; Schoeppe S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2053-2; Schulc E, 2011, EPILEPSY RES, V95, P173, DOI 10.1016/j.eplepsyres.2011.02.010; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121799; Seferian AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113999; Servais L, 2013, NEUROMUSCULAR DISORD, V23, P139, DOI 10.1016/j.nmd.2012.10.022; Sosnoff JJ, 2010, MULT SCLER J, V16, P868, DOI 10.1177/1352458510373111; Taffoni F, 2014, IEEE ENG MED BIO, P3638, DOI 10.1109/EMBC.2014.6944411; Van de Vel A, 2013, EPILEPSY BEHAV, V26, P118, DOI 10.1016/j.yebeh.2012.10.006; Vincent KA, 2007, NEUROLOGY, V68, P1051, DOI 10.1212/01.wnl.0000257819.47628.41; Vissiere D, 2007, CONTR C ECC 2007 EUR, P2853; Voit T, 2014, LANCET NEUROL, V13, P987, DOI 10.1016/S1474-4422(14)70195-4; Zampieri C, 2011, PARKINSONISM RELAT D, V17, P277, DOI 10.1016/j.parkreldis.2010.08.001; Zimetbaum P, 2010, CIRCULATION, V122, P1629, DOI 10.1161/CIRCULATIONAHA.109.925610	68	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156696	10.1371/journal.pone.0156696	http://dx.doi.org/10.1371/journal.pone.0156696			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271157	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000032
J	Zuiderveen, GH; Padder, BA; Kamfwa, K; Song, QJ; Kelly, JD				Zuiderveen, Grady H.; Padder, Bilal A.; Kamfwa, Kelvin; Song, Qijian; Kelly, James D.			Genome-Wide Association Study of Anthracnose Resistance in Andean Beans (Phaseolus vulgaris)	PLOS ONE			English	Article							COLLETOTRICHUM-LINDEMUTHIANUM; DISEASE-RESISTANCE; CONDITIONING RESISTANCE; MOLECULAR MARKERS; COMMON; GENES; LOCUS; RACES; IDENTIFICATION; INHERITANCE	Anthracnose is a seed-borne disease of common bean (Phaseolus vulgaris L.) caused by the fungus Colletotrichum lindemuthianum, and the pathogen is cosmopolitan in distribution. The objectives of this study were to identify new sources of anthracnose resistance in a diverse panel of 230 Andean beans comprised of multiple seed types and market classes from the Americas, Africa, and Europe, and explore the genetic basis of this resistance using genome-wide association mapping analysis (GWAS). Twenty-eight of the 230 lines tested were resistant to six out of the eight races screened, but only one cultivar Uyole98 was resistant to all eight races (7, 39, 55, 65, 73, 109, 2047, and 3481) included in the study. Outputs from the GWAS indicated major quantitative trait loci (QTL) for resistance on chromosomes, Pv01, Pv02, and Pv04 and two minor QTL on Pv10 and Pv11. Candidate genes associated with the significant SNPs were detected on all five chromosomes. An independent QTL study was conducted to confirm the physical location of the Co-1 locus identified on Pv01 in an F-4:6 recombinant inbred line (RIL) population. Resistance was determined to be conditioned by the single dominant gene Co-1 that mapped between 50.16 and 50.30 Mb on Pv01, and an InDel marker (NDSU_IND_1_50.2219) tightly linked to the gene was developed. The information reported will provide breeders with new and diverse sources of resistance and genomic regions to target in the development of anthrac-nose resistance in Andean beans.	[Zuiderveen, Grady H.; Padder, Bilal A.; Kamfwa, Kelvin; Kelly, James D.] Michigan State Univ, Dept Plant Soil & Microbial Sci, 1066 Bogue St, E Lansing, MI 48824 USA; [Song, Qijian] USDA ARS, Soybean Genom & Improvement Lab, BARC, 10300 Baltimore Ave, Beltsville, MD 20705 USA; [Zuiderveen, Grady H.] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA; [Padder, Bilal A.] Sher E Kashmir Univ Agr Sci & Technol Kashmir, Srinagar 191121, Jammu & Kashmir, India; [Kamfwa, Kelvin] Univ Zambia, Dept Plant Sci, Sch Agr Sci, POB 32379,Great East Rd, Lusaka, Zambia	Michigan State University; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir); University of Zambia	Kelly, JD (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, 1066 Bogue St, E Lansing, MI 48824 USA.	kellyj@msu.edu		Padder, Bilal A/0000-0001-8842-2432	Feed the Future Innovation Lab for Collaborative Research on Grain Legumes by the Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development [EDH-A-00-07-00005-00]	Feed the Future Innovation Lab for Collaborative Research on Grain Legumes by the Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development(United States Agency for International Development (USAID))	Research was supported by the Feed the Future Innovation Lab for Collaborative Research on Grain Legumes by the Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development, under the terms of Cooperative Agreement No. EDH-A-00-07-00005-00. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the U.S. Agency for International Development or the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balardin RS, 1997, PHYTOPATHOLOGY, V87, P1184, DOI 10.1094/PHYTO.1997.87.12.1184; Balardin RS, 1998, J AM SOC HORTIC SCI, V123, P1038, DOI 10.21273/JASHS.123.6.1038; Bello MH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-903; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Burt AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139450; Campa A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-115; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Cichy KA, 2015, CROP SCI, V55, P2149, DOI 10.2135/cropsci2014.09.0653; Coelho RT., 2013, ANN REP BEAN IMPROV, V56, P43; Coimbra GK, 2014 CON C BRAZ; Collazo C., 2006, BIOTECNOL APL, V23, P1; Creusot F, 1999, GENOME, V42, P254, DOI 10.1139/gen-42-2-254; Delledonne M, P NAT ACAD SCI, V20-98, P13454; Doyle J. J., 1987, PHYTOCHEM B, P11; DRIJFHOUT E, 1989, PLANT PATHOL, V38, P391, DOI 10.1111/j.1365-3059.1989.tb02158.x; Ferreira J.J., 2013, TRANSLATIONAL GENOMI, VI, P151, DOI DOI 10.1002/9781118728475.CH9; Fivawo NC, 2011, TANZANIA J NAT APPL, V2, P337; Geffroy V, 1999, MOL PLANT MICROBE IN, V12, P774, DOI 10.1094/MPMI.1999.12.9.774; Geffroy V, 2000, MOL PLANT MICROBE IN, V13, P287, DOI 10.1094/MPMI.2000.13.3.287; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Gepts Paul, 2008, V1, P113; Gon?alves AMO., 2010, ANN REP BEAN IMPROV, V53, P220; Goncalves-Vidigal MC, 2013, THEOR APPL GENET, V126, P2245, DOI 10.1007/s00122-013-2131-8; Goncalves-Vidigal MC, 2009, CROP SCI, V49, P133, DOI 10.2135/cropsci2008.01.0004; Goncalves-Vidigal MC, 2008, PLANT BREEDING, V127, P592, DOI 10.1111/j.1439-0523.2008.01530.x; Goncalves-Vidigal MC, 2006, EUPHYTICA, V151, P411, DOI 10.1007/s10681-006-9164-x; Goncalves-Vidigal MC, 2012, PLANT BREEDING, V131, P423, DOI 10.1111/j.1439-0523.2011.01939.x; Goncalves-Vidigal MC, 2011, THEOR APPL GENET, V122, P893, DOI 10.1007/s00122-010-1496-1; Gonzalez AM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00141; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; GUZMAN P, 1979, TURRIALBA, V29, P65; Kamfwa K, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.09.0059; KELLY JD, 1994, PLANT DIS, V78, P892, DOI 10.1094/PD-78-0892; Kelly JD, 2004, HORTSCIENCE, V39, P1196, DOI 10.21273/HORTSCI.39.6.1196; Kelly JD, 1998, CROP SCI, V38, P280; Kelly JD, 2001, CROP SCI, V41, P1647, DOI 10.2135/cropsci2001.4151647x; Lacanallo G. F., 2015, Australian Journal of Crop Science, V9, P394; Lopez CE, 2003, PHYTOPATHOLOGY, V93, P88, DOI 10.1094/PHYTO.2003.93.1.88; Melotto M, 2000, EUPHYTICA, V116, P143, DOI 10.1023/A:1004005001049; Melotto M, 2004, THEOR APPL GENET, V109, P690, DOI 10.1007/s00122-004-1697-6; Melotto M, 2000, COLLETOTRICHUM, P346; Mendoza A, 2001, PLANT DIS, V85, P252, DOI 10.1094/PDIS.2001.85.3.252; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Meziadi C, 2016, PLANT SCI, V242, P351, DOI 10.1016/j.plantsci.2015.09.006; Moghaddam SM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00185; Oblessuc PR, 2015, THEOR APPL GENET, V128, P1193, DOI 10.1007/s00122-015-2500-6; Oblessuc PR, 2014, MOL BREEDING, V34, P1313, DOI 10.1007/s11032-014-0118-z; Pastor-Corrales M.A., 1989, BEAN PRODUCTION PROB, P77; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Richard MMS, 2014, THEOR APPL GENET, V127, P1653, DOI 10.1007/s00122-014-2328-5; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Song QJ, 2015, G3-GENES GENOM GENET, V5, P2285, DOI 10.1534/g3.115.020594; Sousa L. L., 2014, Australian Journal of Crop Science, V8, P317; Sousa LL, 2015, CROP SCI, V55, P1900, DOI 10.2135/cropsci2014.09.0604; Trabanco N, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.10.0079; Valentini G, 2015, ANN REP BEAN IMPROV, V58, P21; Vallejo VA, 2003, ANN REP BEAN IMPROV, V44, P121; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Vazin MA, 2014, ANN REPT BEAN IMPROV, V57, P161; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang S., WINDOWS QTL CARTOGRA; Young RA, 1996, ANN REP BEAN IMPROV, V39, P296; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	65	75	76	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156391	10.1371/journal.pone.0156391	http://dx.doi.org/10.1371/journal.pone.0156391			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270627	gold, Green Published, Green Submitted			2022-12-26	WOS:000377560200008
J	Altiok, EI; Browne, S; Khuc, E; Moran, EP; Qiu, FF; Zhou, KL; Santiago-Ortiz, JL; Ma, JX; Chan, MF; Healy, KE				Altiok, Eda I.; Browne, Shane; Khuc, Emily; Moran, Elizabeth P.; Qiu, Fangfang; Zhou, Kelu; Santiago-Ortiz, Jorge L.; Ma, Jian-xing; Chan, Matilda F.; Healy, Kevin E.			sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; INTRAVITREAL DRUG-DELIVERY; DIABETIC-RETINOPATHY; EXTRACELLULAR DOMAIN; VASCULAR-DISEASE; EYE DISEASE; PHARMACOKINETICS; RANIBIZUMAB; VITRO	Current anti-VEGF drugs for patients with diabetic retinopathy suffer from short residence time in the vitreous of the eye. In order to maintain biologically effective doses of drug for inhibiting retinal neovascularization, patients are required to receive regular monthly injections of drug, which often results in low patient compliance and progression of the disease. To improve the intravitreal residence time of anti-VEGF drugs, we have synthesized multivalent bioconjugates of an anti-VEGF protein, soluble fms-like tyrosine kinase-1 (sFlt) that is covalently grafted to chains of hyaluronic acid (HyA), conjugates that are termed mvsFlt. Using a mouse corneal angiogenesis assay, we demonstrate that covalent conjugation to HyA chains does not decrease the bioactivity of sFlt and that mvsFlt is equivalent to sFlt at inhibiting corneal angiogenesis. In a rat vitreous model, we observed that mvsFlt had significantly increased intravitreal residence time compared to the unconjugated sFlt after 2 days. The calculated intravitreal half-lives for sFlt and mvsFlt were 3.3 and 35 hours, respectively. Furthermore, we show that mvsFlt is more effective than the unconjugated form at inhibiting retinal neovascularization in an oxygen-induced retinopathy model, an effect that is most likely due to the longer half-life of mvsFlt in the vitreous. Taken together, our results indicate that conjugation of sFlt to HyA does not affect its affinity for VEGF and this conjugation significantly improves drug half-life. These in vivo results suggest that our strategy of multivalent conjugation could substantially improve upon drug half-life, and thus the efficacy of currently available drugs that are used in diseases such as diabetic retinopathy, thereby improving patient quality of life.	[Altiok, Eda I.; Browne, Shane; Healy, Kevin E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Browne, Shane] Natl Univ Ireland Galway, Ctr Res Med Devices CURAM, Galway, Ireland; [Khuc, Emily; Chan, Matilda F.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Moran, Elizabeth P.; Qiu, Fangfang; Zhou, Kelu; Ma, Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Dept Physiol, Oklahoma City, OK USA; [Santiago-Ortiz, Jorge L.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Healy, Kevin E.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Ollscoil na Gaillimhe-University of Galway; University of California System; University of California San Francisco; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Healy, KE (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.; Healy, KE (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.	kehealy@berkeley.edu	Qiu, Fangfang/GLT-3181-2022; Qiu, Fangfang/GLT-3151-2022	Qiu, Fangfang/0000-0002-3584-0275; Qiu, Fangfang/0000-0002-3584-0275; Pearsall, Elizabeth/0000-0003-1013-6238; Browne, Shane/0000-0002-1005-1712; Santiago-Ortiz, Jorge/0000-0003-4560-9963	NIH; NATIONAL EYE INSTITUTE [R01EY022739, P30EY002162] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was carried out with NIH funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrishami M, 2009, RETINA-J RET VIT DIS, V29, P699, DOI 10.1097/IAE.0b013e3181a2f42a; Akula JD, 2010, DOC OPHTHALMOL, V120, P41, DOI 10.1007/s10633-009-9198-1; Altiok EI, 2016, BIOMATERIALS, V93, P95, DOI 10.1016/j.biomaterials.2016.03.017; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P2179, DOI 10.1016/j.ophtha.2007.09.012; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017; Barleon B, 1997, J BIOL CHEM, V272, P10382; Bochot A, 2012, J CONTROL RELEASE, V161, P628, DOI 10.1016/j.jconrel.2012.01.019; Boulton M, 1998, BRIT J OPHTHALMOL, V82, P561, DOI 10.1136/bjo.82.5.561; Boyer DS, 2014, OPHTHALMOLOGY; Chan MF, 2013, J CELL SCI, V126, P3948, DOI [10.1242/jcs.28033, 10.1242/jcs.128033]; Cohen SY, 2013, RETINA-J RET VIT DIS, V33, P474, DOI 10.1097/IAE.0b013e31827b6324; Conway A, 2013, NAT NANOTECHNOL, V8, P831, DOI [10.1038/nnano.2013.205, 10.1038/NNANO.2013.205]; del Amo EM, 2008, DRUG DISCOV TODAY, V13, P135, DOI 10.1016/j.drudis.2007.11.002; Drolet DW, 2000, PHARMACEUT RES, V17, P1503, DOI 10.1023/A:1007657109012; ENGERMAN RL, 1989, DIABETES, V38, P1203, DOI 10.2337/diabetes.38.10.1203; Fishburn S. C., 2010, J PHARM SCI, V97, P4167; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Gaudreault J, 2005, INVEST OPHTH VIS SCI, V46, P726, DOI 10.1167/iovs.04-0601; Han BW, 2015, TISSUE ENG PT A, V21, P2366, DOI [10.1089/ten.TEA.2014.0281, 10.1089/ten.tea.2014.0281]; Hornof M, 2005, EUR J PHARM BIOPHARM, V60, P207, DOI 10.1016/j.ejpb.2005.01.009; Ito TK, 2009, BLOOD, V113, P2363, DOI 10.1182/blood-2008-08-172742; Kane FE, 2008, EXPERT OPIN DRUG DEL, V5, P1039, DOI [10.1517/17425247.5.9.1039, 10.1517/17425247.5.9.1039 ]; Lee SS, 2009, OPHTHALMIC RES, V41, P124, DOI 10.1159/000209665; Maurice D, 2001, J OCUL PHARMACOL TH, V17, P393, DOI 10.1089/108076801753162807; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Mohammad DA, 2007, ANN PHARMACOTHER, V41, P449, DOI 10.1345/aph.1H540; Moradi A, 2013, WORLD J DIABETES, V4, P303, DOI 10.4239/wjd.v4.i6.303; Necas J, 2008, VET MED-CZECH, V53, P397, DOI 10.17221/1930-VETMED; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Oh EJ, 2011, BIOMATERIALS, V32, P3115, DOI 10.1016/j.biomaterials.2011.01.003; Oh EJ, 2009, BIOMATERIALS, V30, P6026, DOI 10.1016/j.biomaterials.2009.07.024; Pagliarini S, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/857148; RICCI B, 1990, DOC OPHTHALMOL, V74, P171, DOI 10.1007/BF02482606; Sahoo SK, 2008, DRUG DISCOV TODAY, V13, P144, DOI 10.1016/j.drudis.2007.10.021; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; Stewart MW, 2012, RETINA-J RET VIT DIS, V32, P434, DOI 10.1097/IAE.0B013E31822C290F; STEWART MW, 2011, EYE REPORTS, V1, P5; Tan LE, 2011, INVEST OPHTH VIS SCI, V52, P1111, DOI 10.1167/iovs.10-5813; Tanaka K, 1997, JPN J CANCER RES, V88, P867, DOI 10.1111/j.1349-7006.1997.tb00463.x; URTTI A, 1993, SURV OPHTHALMOL, V37, P435, DOI 10.1016/0039-6257(93)90141-S; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wall ST, 2008, BIOCONJUGATE CHEM, V19, P806, DOI 10.1021/bc700265k; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5	48	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155990	10.1371/journal.pone.0155990	http://dx.doi.org/10.1371/journal.pone.0155990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257918	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700027
J	Baek, SH; Lee, SW; Kim, SW; Ahn, SY; Yu, MY; Kim, KI; Chin, HJ; Na, KY; Chae, DW; Kim, S				Baek, Seon Ha; Lee, Sung Woo; Kim, Sun-Wook; Ahn, Shin Young; Yu, Mi-Yeon; Kim, Kwang-Il; Chin, Ho Jun; Na, Ki Young; Chae, Dong-Wan; Kim, Sejoong			Frailty as a Predictor of Acute Kidney Injury in Hospitalized Elderly Patients: A Single Center, Retrospective Cohort Study	PLOS ONE			English	Article							OLDER-ADULTS; MORTALITY; OUTCOMES; POPULATION; DIALYSIS; RISK	Background Elderly patients have an increased risk for acute kidney injury (AKI). However, few studies have reported on predictors for AKI in geriatric patients. Therefore, we aimed at determining the effect of frailty as a predictor of AKI. Methods We retrospectively enrolled 533 hospitalized elderly patients (aged >= 65 years) who had their creatinine levels measured (>= 1 measurement) during admission for a period of 1 year (2013) and conducted a comprehensive geriatric assessment (CGA) within 1 year before the index hospitalization. We examined five variables (activity of daily living [ADL] and instrumental ADL dependence, dementia, nutrition, and polypharmacy) from CGA. We categorized the patients into 3 groups according to the tertile of aggregate frailty scores: Group 1, score 1-2; Group 2, score 3-4; Group 3, score 5-8). Results Fifty-four patients (10.1%) developed AKI (median duration, 4 days). The frailest group (Group 3) showed an increased risk of AKI as compared to Group 1, (hazard ratio [HR] = 3.536, P = 0.002). We found that discriminatory accuracy for AKI improved with the addition of the tertile of aggregate frailty score to covariates (area under the receiver operator characteristics curves [AUROC] 0.641, AUROC 0.739, P = 0.004). Forty-six patients (8.6%) were transferred to nursing facilities and 477 patients (89.5%) were discharged home. The overall 90-day and 1-year mortality for elderly inpatients were 7.9% and 26.3%. The frailest group also demonstrated an increased risk of discharge to nursing facilities, and 90-day and 1-year mortality as compared to Group 1, independent of AKI severity (nursing facilities: odd ratio = 4.843, P = 0.002; 90-day mortality: HR = 6.555, P = 0.002; 1-year mortality: HR = 3.249, P = 0.001). Conclusions We found that frailty may independently predict the development of AKI and adverse outcomes in geriatric inpatients.	[Baek, Seon Ha; Lee, Sung Woo; Kim, Sun-Wook; Ahn, Shin Young; Yu, Mi-Yeon; Kim, Kwang-Il; Chin, Ho Jun; Na, Ki Young; Chae, Dong-Wan; Kim, Sejoong] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea	Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	sejoong2@snu.ac.kr	Kim, Kwang-il/D-8024-2012; Yu, Mi-Yeon/ABB-7937-2021; Kim, Kwang-il/AAP-7315-2021; Kim, Sejoong/J-5356-2015	Kim, Kwang-il/0000-0002-6658-047X; Kim, Kwang-il/0000-0002-6658-047X; Kim, Sejoong/0000-0002-7238-9962				Bac JN, 2004, J PSYCHOSOM RES, V57, P297, DOI 10.1016/j.jpsychores.2004.01.004; Basic D, 2015, J AGING HEALTH, V27, P670, DOI 10.1177/0898264314558202; Bien B, 2015, J NUTR HEALTH AGING, V19, P481, DOI 10.1007/s12603-014-0570-9; Choi JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075583; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Coca SG, 2010, AM J KIDNEY DIS, V56, P122, DOI 10.1053/j.ajkd.2009.12.034; Dent E, 2014, AGE AGEING, V43, P477, DOI 10.1093/ageing/aft181; Druml W, 2010, INTENS CARE MED, V36, P1221, DOI 10.1007/s00134-010-1844-2; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gaudreau JD, 2005, J PAIN SYMPTOM MANAG, V29, P368, DOI 10.1016/j.jpainsymman.2004.07.009; Han SS, 2014, TOHOKU J EXP MED, V232, P177, DOI 10.1620/tjem.232.177; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hilmer SN, 2011, BRIT J CLIN PHARMACO, V71, P224, DOI 10.1111/j.1365-2125.2010.03825.x; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Jang HR, 2015, NAT REV NEPHROL, V11, P88, DOI 10.1038/nrneph.2014.180; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; Kim SW, 2014, JAMA SURG, V149, P633, DOI 10.1001/jamasurg.2014.241; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Lee DH, 2010, CIRCULATION, V121, P973, DOI 10.1161/CIRCULATIONAHA.108.841437; Lee DY, 2002, J AM GERIATR SOC, V50, P1233, DOI 10.1046/j.1532-5415.2002.50310.x; Leng SX, 2007, J AM GERIATR SOC, V55, P864, DOI 10.1111/j.1532-5415.2007.01186.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MAHONEY F I, 1965, Md State Med J, V14, P61; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; McGregor TL, 2016, AM J KIDNEY DIS, V67, P384, DOI 10.1053/j.ajkd.2015.07.019; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Odden MC, 2009, J GERONTOL A-BIOL, V64, P370, DOI 10.1093/gerona/gln037; Qu T, 2009, CYTOKINE, V46, P319, DOI 10.1016/j.cyto.2009.02.015; Rosner MH, 2013, CLIN GERIATR MED, V29, P565, DOI 10.1016/j.cger.2013.05.001; Schmitt R, 2008, AM J KIDNEY DIS, V52, P262, DOI 10.1053/j.ajkd.2008.03.005; Varrier M, 2014, CURR OPIN NEPHROL HY, V23, P560, DOI 10.1097/MNH.0000000000000061; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x	37	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156444	10.1371/journal.pone.0156444	http://dx.doi.org/10.1371/journal.pone.0156444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257823	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700066
J	Genolini, C; Ecochard, R; Benghezal, M; Driss, T; Andrieu, S; Subtil, F				Genolini, Christophe; Ecochard, Rene; Benghezal, Mamoun; Driss, Tarak; Andrieu, Sandrine; Subtil, Fabien			kmlShape: An Efficient Method to Cluster Longitudinal Data (Time-Series) According to Their Shapes	PLOS ONE			English	Article							ALGORITHM; MODEL; CLASSIFICATION; REGISTRATION; TRAJECTORIES; ALIGNMENT; EUROPE; KML3D; CYCLE	Background Longitudinal data are data in which each variable is measured repeatedly over time. One possibility for the analysis of such data is to cluster them. The majority of clustering methods group together individual that have close trajectories at given time points. These methods group trajectories that are locally close but not necessarily those that have similar shapes. However, in several circumstances, the progress of a phenomenon may be more important than the moment at which it occurs. One would thus like to achieve a partitioning where each group gathers individuals whose trajectories have similar shapes whatever the time lag between them. Method In this article, we present a longitudinal data partitioning algorithm based on the shapes of the trajectories rather than on classical distances. Because this algorithm is time consuming, we propose as well two data simplification procedures that make it applicable to high dimensional datasets. Results In an application to Alzheimer disease, this algorithm revealed a "rapid decline" patient group that was not found by the classical methods. In another application to the feminine menstrual cycle, the algorithm showed, contrarily to the current literature, that the luteinizing hormone presents two peaks in an important proportion of women (22%).	[Genolini, Christophe; Benghezal, Mamoun; Andrieu, Sandrine] Univ Toulouse 3, Inserm UMR 1027, F-31062 Toulouse, France; [Genolini, Christophe; Driss, Tarak] Univ Paris Ouest Nanterre La Def, UFR STAPS, CeRSM EA 2931, Nanterre, France; [Ecochard, Rene; Subtil, Fabien] Univ Lyon 1, Serv Biostat, F-69622 Villeurbanne, France; [Ecochard, Rene; Subtil, Fabien] CNRS, UMR5558, Equipe Biotatist Sante, Lab Biometrie & Biol Evolut, Villeurbanne, France; [Andrieu, Sandrine] CHU Toulouse, Dept Epidemiol & Publ Hlth, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Paris Nanterre; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; CHU de Toulouse	Genolini, C (corresponding author), Univ Toulouse 3, Inserm UMR 1027, F-31062 Toulouse, France.; Genolini, C (corresponding author), Univ Paris Ouest Nanterre La Def, UFR STAPS, CeRSM EA 2931, Nanterre, France.	christophe.genolini@u-paris10.fr	DRISS, Tarak/AAR-2823-2020; ANDRIEU, Sandrine/G-1343-2018	DRISS, Tarak/0000-0001-6109-7393; ANDRIEU, Sandrine/0000-0002-1142-770X	Agence National de la Recherche grant [IDoL: ANR-12-BSV1-0036]	Agence National de la Recherche grant(French National Research Agency (ANR))	This research was funded by the Agence National de la Recherche grant IDoL: ANR-12-BSV1-0036 (CG received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was founded by the ANR grant IDoL: ANR-12-BSV1-0036.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al-Naymat G., 2009, AUSTRALASIAN DATA MI, V101, P117, DOI DOI 10.1007/s10115-004-0154-9; Alliende ME, 2002, FERTIL STERIL, V78, P90, DOI 10.1016/S0015-0282(02)03167-9; ALT H, 1995, INT J COMPUT GEOM AP, V5, P75, DOI 10.1142/S0218195995000064; [Anonymous], 1973, PATTERN CLASSIFICATI; Berndt D.J., 1994, P 3 INT C KNOWL DAT, P359; Bolstad WM., 2007, INTRO BAYESIAN STAT, DOI [10.1002/9780470181188, DOI 10.1002/9780470181188]; Buchin K, 2011, COMP GEOM-THEOR APPL, V44, P465, DOI 10.1016/j.comgeo.2011.05.004; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Cao H, 2006, VLDB J, V15, P211, DOI 10.1007/s00778-005-0163-7; CELEUX G, 1992, COMPUT STAT DATA AN, V14, P315, DOI 10.1016/0167-9473(92)90042-E; Chen L., 2005, P 2005 ACM SIGMOD IN, P491, DOI DOI 10.1145/1066157.1066213; Chen Y, 2015, THE UCR TIME SERIES; Chiou JM, 2007, J ROY STAT SOC B, V69, P679, DOI 10.1111/j.1467-9868.2007.00605.x; Chudova D., 2003, P 9 ACM SIGKDD INT C, P79, DOI DOI 10.1145/956755.956763; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dimeglio C, 2014, COMPUT STAT DATA AN, V70, P373, DOI 10.1016/j.csda.2013.09.030; Direito A, 2013, FERTIL STERIL, V99, P279, DOI 10.1016/j.fertnstert.2012.08.047; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Douglas D.H., 1973, CARTOGRAPHICA INT J, V10, P112, DOI [10.3138/FM57-6770-U75U-7727, DOI 10.3138/FM57-6770-U75U-7727]; Ecochard R, 2006, STAT METHODS MED RES, V15, P141, DOI 10.1191/0962280206sm436oa; Ecochard R, 2001, BRIT J OBSTET GYNAEC, V108, P822, DOI 10.1111/j.1471-0528.2001.00194.x; Ecochard R, 2000, HUM REPROD, V15, P752, DOI 10.1093/humrep/15.4.752; Elsensohn MH, 2013, STAT METHODS MED RES; Engels JM, 2003, J CLIN EPIDEMIOL, V56, P968, DOI 10.1016/S0895-4356(03)00170-7; Everitt B. S., 2001, CLUSTER ANAL; Frechet M., 1906, REND CIRC MATEM PALE, V22, P1, DOI [DOI 10.1007/BF03018603, 10.1007/BF03018603]; Gaffney S. J., 2004, NIPS, P473; Garcia-Escudero LA, 2005, J CLASSIF, V22, P185, DOI 10.1007/s00357-005-0013-8; Genolini C, 2013, COMPUT METH PROG BIO, V109, P104, DOI 10.1016/j.cmpb.2012.08.016; Genolini C, 2013, OPEN J STAT, V3, P26, DOI [DOI 10.4236/OJS.2013.34A004, 10.4236/ojs.2013.34A004]; Genolini C, 2015, COMPUTER ME IN PRESS, P1; Genolini C, 2015, J STAT SOFTW, V65, P1, DOI 10.18637/jss.v065.i04; Genolini C, 2010, COMPUTATION STAT, V25, P317, DOI 10.1007/s00180-009-0178-4; Gudmundsson J, 2009, COMP GEOM-THEOR APPL, V42, P825, DOI 10.1016/j.comgeo.2009.02.002; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; James GM, 2007, ANN APPL STAT, V1, P480, DOI 10.1214/07-AOAS127; James GM, 2003, J AM STAT ASSOC, V98, P397, DOI 10.1198/016214503000189; Kadous MW, 1999, MACHINE LEARNING, PROCEEDINGS, P454; Kaziska D, 2007, J AM STAT ASSOC, V102, P1114, DOI 10.1198/016214507000000464; Keogh E, 2001, 2001 IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P289, DOI 10.1109/ICDM.2001.989531; Keogh E, 2005, KNOWL INF SYST, V7, P358, DOI 10.1007/s10115-004-0154-9; Khan SS, 2004, PATTERN RECOGN LETT, V25, P1293, DOI 10.1016/j.patrec.2004.04.007; Lee J.-G., 2007, P 2007 ACM SIGMOD IN, P593, DOI DOI 10.1145/1247480.1247546; Liu XL, 2009, COMPUT STAT DATA AN, V53, P1361, DOI 10.1016/j.csda.2008.11.019; Luan YH, 2003, BIOINFORMATICS, V19, P474, DOI 10.1093/bioinformatics/btg014; Lucero JC, 1997, J SPEECH LANG HEAR R, V40, P1111, DOI 10.1044/jslhr.4005.1111; Mackelprang RD, 2012, J INFECT DIS, V206, P1299, DOI 10.1093/infdis/jis480; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Magidson J., 2002, CAN J MARKET RES, V20, P37, DOI DOI 10.1017/CBO9780511499531.004; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Muthen B, 1999, BIOMETRICS, V55, P463, DOI 10.1111/j.0006-341X.1999.00463.x; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Panagiotakis C, 2012, IEEE T KNOWL DATA EN, V24, P1328, DOI 10.1109/TKDE.2011.39; Patriarca M, 2013, FDAKMA CLUSTERING AL; Pena JM, 1999, PATTERN RECOGN LETT, V20, P1027, DOI 10.1016/S0167-8655(99)00069-0; Pingault JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062594; Pingault JB, 2011, AM J PSYCHIAT, V168, P1164, DOI 10.1176/appi.ajp.2011.10121732; Ramer U., 1972, COMPUT GRAPH-UK, V1, P244, DOI [DOI 10.1016/S0146-664X(72)80017-0, 10.1016/S0146-664X(72)80017-0]; Ramsay J, 1998, SPRINGER SERIES STAT; Ramsay JO, 1998, J ROY STAT SOC B, V60, P351, DOI 10.1111/1467-9868.00129; Ranciere F, 2013, ALLERGY, V68, P1158, DOI 10.1111/all.12208; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ray S., 1999, P 4 INT C ADV PATTER, P137; Redmond SJ, 2007, PATTERN RECOGN LETT, V28, P965, DOI 10.1016/j.patrec.2007.01.001; Reynish E, 2007, NEUROEPIDEMIOLOGY, V29, P29, DOI 10.1159/000108915; Roverso D., 2000, 3 ANS INT TOP M NUCL, V20, P1; Sangalli LM, 2010, COMPUT STAT DATA AN, V54, P1219, DOI 10.1016/j.csda.2009.12.008; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shim Y, 2006, INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE FOR MODELLING, CONTROL & AUTOMATION JOINTLY WITH INTERNATIONAL CONFERENCE ON INTELLIGENT AGENTS, WEB TECHNOLOGIES & INTERNET COMMERCE, VOL 1, PROCEEDINGS, P199; Steinley D, 2007, J CLASSIF, V24, P99, DOI 10.1007/s00357-007-0003-0; Tarpey T, 2003, J CLASSIF, V20, P93, DOI 10.1007/s00357-003-0007-3; Tarpey T, 2007, COMPUTATION STAT, V22, P71, DOI 10.1007/s00180-007-0022-7; Twisk J, 2002, J CLIN EPIDEMIOL, V55, P329, DOI 10.1016/S0895-4356(01)00476-0; Vellas B, 2012, CURR ALZHEIMER RES, V9, P902, DOI 10.2174/156720512803251066; Vlachos M, 2002, PROC INT CONF DATA, P673, DOI 10.1109/ICDE.2002.994784	78	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0150738	10.1371/journal.pone.0150738	http://dx.doi.org/10.1371/journal.pone.0150738			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258355	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700003
J	Martinez-Biarge, M; Groenendaal, F; Kersbergen, KJ; Benders, MJNL; Foti, F; Cowan, FM; de Vries, LS				Martinez-Biarge, Miriam; Groenendaal, Floris; Kersbergen, Karina J.; Benders, Manon J. N. L.; Foti, Francesca; Cowan, Frances M.; de Vries, Linda S.			MRI Based Preterm White Matter Injury Classification: The Importance of Sequential Imaging in Determining Severity of Injury	PLOS ONE			English	Article							CYSTIC PERIVENTRICULAR LEUKOMALACIA; PREMATURE NEWBORNS; CEREBRAL-PALSY; INFANTS; ULTRASOUND; DIAGNOSIS; BRAIN; SPECTRUM; TIME	Background The evolution of non-hemorrhagic white matter injury (WMI) based on sequential magnetic resonance imaging (MRI) has not been well studied. Our aim was to describe sequential MRI findings in preterm infants with non-hemorrhagic WMI and to develop an MRI classification system for preterm WMI based on these findings. Methods Eighty-two preterm infants (gestation <= 35 weeks) were retrospectively included. WMI was diagnosed and classified based on sequential cranial ultrasound (cUS) and confirmed on MRI. Results 138 MRIs were obtained at three time-points: early (<2 weeks; n = 32), mid (2-6 weeks; n = 30) and term equivalent age (TEA; n = 76). 63 infants (77%) had 2 MRIs during the neonatal period. WMI was non-cystic in 35 and cystic in 47 infants. In infants with cystic-WMI early MRI showed extensive restricted diffusion abnormalities, cysts were already present in 3 infants; mid MRI showed focal or extensive cysts, without acute diffusion changes. A significant reduction in the size and/or extent of the cysts was observed in 32% of the infants between early/mid and TEA MRI. In 4/9 infants previously seen focal cysts were no longer identified at TEA. All infants with cystic WMI showed >= 2 additional findings at TEA: significant reduction in WM volume, mild-moderate irregular ventriculomegaly, several areas of increased signal intensity on T1-weighted-images, abnormal myelination of the PLIC, small thalami. Conclusion In infants with extensive WM cysts at 2-6 weeks, cysts may be reduced in number or may even no longer be seen at TEA. A single MRI at TEA, without taking sequential cUS data and pre-TEA MRI findings into account, may underestimate the extent of WMI; based on these results we propose a new MRI classification for preterm non-hemorrhagic WMI.	[Martinez-Biarge, Miriam; Foti, Francesca; Cowan, Frances M.] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England; [Groenendaal, Floris; Kersbergen, Karina J.; Benders, Manon J. N. L.; de Vries, Linda S.] UMCU, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands	Imperial College London; Unilever; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	de Vries, LS (corresponding author), UMCU, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands.	l.s.devries@umcutrecht.nl	de Vries, Linda S/AAB-6454-2021; Martinez-Biarge, Miriam/HCH-8730-2022; Groenendaal, Floris/P-6872-2019	Groenendaal, Floris/0000-0002-9284-1637	Wilhelmina Research Fund [OZF2008-19]	Wilhelmina Research Fund	This study includes infants from a study funded by the Wilhelmina Research Fund, OZF2008-19 (KJ Kersbergen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; BANKER BQ, 1962, ARCH NEUROL-CHICAGO, V7, P386, DOI 10.1001/archneur.1962.04210050022004; Bozzao A, 2003, EUR RADIOL, V13, P1571, DOI 10.1007/s00330-002-1815-2; Cornette LG, 2002, ARCH DIS CHILD-FETAL, V86, P171, DOI 10.1136/fn.86.3.F171; Counsell SJ, 2003, PEDIATRICS, V112, P1, DOI 10.1542/peds.112.1.1; de Bruine FT, 2011, RADIOLOGY, V261, P899, DOI 10.1148/radiol.11110797; De Vries LS, 2004, J PEDIATR-US, V144, P815, DOI 10.1016/j.jpeds.2004.03.034; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Gano D, 2015, J PEDIATR-US, V166, P39, DOI 10.1016/j.jpeds.2014.09.009; Hamrick SEG, 2004, J PEDIATR-US, V145, P593, DOI 10.1016/j.jpeds.2004.05.042; Hintz SR, 2015, PEDIATRICS, V135, pE32, DOI 10.1542/peds.2014-0898; Inder T, 1999, J PEDIATR-US, V134, P631, DOI 10.1016/S0022-3476(99)70251-9; Kersbergen KJ, 2011, ARCH DIS CHILD-FETAL, V96, pF404, DOI 10.1136/adc.2010.201129; Kersbergen KJ, 2015, J PEDIATR-US, V167, P260, DOI 10.1016/j.jpeds.2015.05.013; Kersbergen KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108904; Kidokoro H, 2013, AM J NEURORADIOL, V34, P2208, DOI 10.3174/ajnr.A3521; Kidokoro H, 2008, NEUROPEDIATRICS, V39, P233, DOI 10.1055/s-0028-1103274; Miller SP, 2003, AM J NEURORADIOL, V24, P1661; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Pierrat V, 2001, ARCH DIS CHILD-FETAL, V84, pF151, DOI 10.1136/fn.84.3.F151; Sarkar S, 2015, AM J PERINAT, V32, P973, DOI 10.1055/s-0035-1545666; van Haastert IC, 2011, J PEDIATR-US, V159, P86, DOI 10.1016/j.jpeds.2010.12.053; Verboon-Maciolek MA, 2012, J PEDIATR-US, V160, P165, DOI 10.1016/j.jpeds.2011.08.053; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792	24	34	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156245	10.1371/journal.pone.0156245	http://dx.doi.org/10.1371/journal.pone.0156245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257863	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700046
J	Martinez-Crego, B; Arteaga, P; Tomas, F; Santos, R				Martinez-Crego, Begona; Arteaga, Pedro; Tomas, Fiona; Santos, Rui			The Role of Seagrass Traits in Mediating Zostera noltei Vulnerability to Mesograzers	PLOS ONE			English	Article							FRESH-WATER MACROPHYTES; CHEMICAL DEFENSES; MARINE HERBIVORES; INTRASPECIFIC VARIATION; NUTRIENT AVAILABILITY; FEEDING PREFERENCES; PLANT TRAITS; FOOD CHOICE; RESISTANCE; TEMPERATE	Understanding how intra-specific differences in plant traits mediate vulnerability to herbivores of relevant habitat-forming plants is vital to attain a better knowledge on the drivers of the structure and functioning of ecosystems. Such studies, however, are rare in seagrass-mesograzer systems despite the increasingly recognized relevance of mesograzers as seagrass consumers. We investigated the role and potential trade-offs of multiple leaf traits in mediating the vulnerability of the seagrass Zostera noltei to different mesograzer species, the amphipod Gammarus insensibilis and the isopod Idotea chelipes. We worked with plants from two different meadows for which contrasting chemical and structural traits were expected based on previous information. We found that plants with high vulnerability to mesograzers (i.e. those preferred and subjected to higher rates of leaf area loss) had not only higher nitrogen content and lower C:N, fibre, and phenolics, but also tender and thinner leaves. No trade-offs between chemical and structural traits of the seagrass were detected, as they were positively correlated. When leaf physical structure was removed using agar-reconstituted food, amphipod preference towards high-susceptibility plants disappeared; thus indicating that structural rather than chemical traits mediated the feeding preference. Removal of plant structure reduced the size of isopod preference to less than half, indicating a stronger contribution of structural traits (>50%) but combined with chemical/nutritional traits in mediating the preference. We then hypothesized that the high environmental nutrient levels recorded in the meadow exhibiting high susceptibility modulate the differences observed between meadows in seagrass traits. To test this hypothesis, we exposed low-vulnerability shoots to eutrophic nutrient levels in a 6-week enrichment experiment. Nutrient enrichment increased Z. noltei nitrogen content and lowered C:N, fibre, and phenolics, but had no effect on structural traits. Overall, our findings help to better understand the trait-mediated seagrass susceptibility to mesograzers and reinforce the increasingly recognized role of structural defences against herbivory.	[Martinez-Crego, Begona; Arteaga, Pedro; Santos, Rui] Ctr Marine Sci CCMAR, Faro, Portugal; [Tomas, Fiona] Mediterranean Inst Adv Studies IMEDEA CSIC, Esporles, Balearic Island, Spain; [Tomas, Fiona] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Oregon State University	Martinez-Crego, B (corresponding author), Ctr Marine Sci CCMAR, Faro, Portugal.	bmcrego@ualg.pt	Martínez-Crego, Begoña/J-4090-2013; Santos, Rui O P/B-4168-2008; Tomas, Fiona/G-3713-2010	Martínez-Crego, Begoña/0000-0002-9051-6961; Santos, Rui O P/0000-0002-7861-4366; Tomas, Fiona/0000-0001-8682-2504	European Regional Development Fund through the COMPETE; Portuguese funds through the FCT project [PEst-C/MAR/LA0015/2011]; FCT post-doctoral fellowship [SFRH/BPD/75307/2010]; COST Action (EU-FP7 program) [ES0906]	European Regional Development Fund through the COMPETE; Portuguese funds through the FCT project; FCT post-doctoral fellowship; COST Action (EU-FP7 program)	This research was partially supported by the European Regional Development Fund through the COMPETE and by Portuguese funds through the FCT project PEst-C/MAR/LA0015/2011 (Fundacao para a Ciencia e a Tecnologia). Mesocosm facilities were provided by ASSEMBLE (EU-FP7 program). BMC was supported by an FCT post-doctoral fellowship (SFRH/BPD/75307/2010). PA was granted with a short-term scientific mission of the COST Action ES0906 (EU-FP7 program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, OIKOS, V89, P493, DOI 10.1034/j.1600-0706.2000.890308.x; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Amsler CD, 2006, ADV BOT RES, V43, P1, DOI 10.1016/S0065-2296(05)43001-3; Arnold TM, 2003, OIKOS, V100, P406, DOI 10.1034/j.1600-0706.2003.11680.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Bailey JK, 2004, ECOLOGY, V85, P603, DOI 10.1890/03-3049; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Berenbaum MR, 2008, PLANT PHYSIOL, V146, P804, DOI 10.1104/pp.107.113472; Best RJ, 2012, MAR ECOL PROG SER, V456, P29, DOI 10.3354/meps09678; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Bolser RC, 1996, ECOLOGY, V77, P2269, DOI 10.2307/2265730; Bolser RC, 1998, J CHEM ECOL, V24, P1639, DOI 10.1023/A:1020816511924; Cabaco S, 2008, ESTUAR COAST SHELF S, V78, P1, DOI 10.1016/j.ecss.2007.11.005; Cardenas RE, 2014, J ECOL, V102, P939, DOI 10.1111/1365-2745.12255; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Carr LA, 2014, MAR ECOL PROG SER, V508, P117, DOI 10.3354/meps10855; Carvalho S, 2006, CAH BIOL MAR, V47, P321; Cebrian J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004929; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cronin G, 2003, OECOLOGIA, V137, P32, DOI 10.1007/s00442-003-1315-3; Cronin G, 1996, OIKOS, V77, P93, DOI 10.2307/3545589; Cronin G, 2002, J CRUSTACEAN BIOL, V22, P708, DOI 10.1651/0278-0372(2002)022[0708:CFPFFM]2.0.CO;2; Cronin G, 1996, ECOLOGY, V77, P1531, DOI 10.2307/2265549; Cruz-Rivera E, 2000, OECOLOGIA, V123, P252, DOI 10.1007/s004420051012; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; Cruz-Rivera E, 2013, MAR ECOL PROG SER, V490, P69, DOI 10.3354/meps10429; de los Santos CB, 2013, MAR BIOL, V160, P1083, DOI 10.1007/s00227-012-2159-3; de los Santos CB, 2012, MAR ECOL PROG SER, V458, P89, DOI 10.3354/meps09757; DUFFY JE, 1991, ECOLOGY, V72, P1286, DOI 10.2307/1941102; DUFFY JE, 1990, BIOSCIENCE, V40, P368, DOI 10.2307/1311214; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Eklof JS, 2008, ESTUAR COAST SHELF S, V79, P569, DOI 10.1016/j.ecss.2008.05.005; Fredriksen S, 2004, SARSIA, V89, P218, DOI 10.1080/00364820410005593; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Green E.P., 2003, WORLD ATLAS SEAGRASS; GROENENDIJK AM, 1984, NETH J SEA RES, V18, P384, DOI 10.1016/0077-7579(84)90011-5; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; HAY ME, 1990, ECOLOGY, V71, P733, DOI 10.2307/1940326; HAY ME, 1987, ECOLOGY, V68, P1567, DOI 10.2307/1939849; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Heithaus MR, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00028; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hughes AR, 2009, FRONT ECOL ENVIRON, V7, P242, DOI 10.1890/080041; Hulme PE, 1996, J ECOL, V84, P609, DOI 10.2307/2261482; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Kempel A, 2015, ECOLOGY, V96, P2923, DOI 10.1890/14-2125.1; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; La Nafie YA, 2013, J EXP MAR BIOL ECOL, V446, P186, DOI 10.1016/j.jembe.2013.05.020; La Nafie YA, 2012, LIMNOL OCEANOGR, V57, P1664, DOI 10.4319/lo.2012.57.6.1664; Lamberti-Raverot B, 2012, J EXP BOT, V63, P6115, DOI 10.1093/jxb/ers268; Lanyon JM, 2006, J ZOOL, V270, P277, DOI 10.1111/j.1469-7998.2006.00135.x; Lewis LS, 2012, ECOLOGY, V93, P2746, DOI 10.1890/12-0038.1; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; Mariani S, 1999, MAR ECOL PROG SER, V189, P295, DOI 10.3354/meps189295; Martinez-Crego B, 2014, BIOGEOSCIENCES, V11, P7237, DOI 10.5194/bg-11-7237-2014; Martinez-Crego B, 2008, MAR ECOL PROG SER, V361, P93, DOI 10.3354/meps07358; Martinez-Crego B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141219; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Maxwell PS, 2014, J ECOL, V102, P54, DOI 10.1111/1365-2745.12167; Moles AT, 2013, NEW PHYTOL, V198, P252, DOI 10.1111/nph.12116; Molis M, 2010, J PHYCOL, V46, P76, DOI 10.1111/j.1529-8817.2009.00787.x; Morrison WE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017227; da Silva DM, 2011, PLANT ECOL, V212, P181, DOI 10.1007/s11258-010-9813-y; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Paul VJ, 2004, NAT PROD REP, V21, P189, DOI 10.1039/b302334f; Pennings SC, 1998, ECOLOGY, V79, P1968; Peralta G, 2002, J EXP MAR BIOL ECOL, V269, P9, DOI 10.1016/S0022-0981(01)00393-8; Perez-Harguindeguy N, 2003, AUSTRAL ECOL, V28, P642, DOI 10.1046/j.1442-9993.2003.01321.x; POORE AGB, 1994, MAR ECOL PROG SER, V107, P113, DOI 10.3354/meps107113; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Prado P, 2011, MAR ECOL PROG SER, V429, P45, DOI 10.3354/meps09076; Prado P, 2010, MAR ECOL PROG SER, V409, P229, DOI 10.3354/meps08585; Prusak AC, 2005, J CHEM ECOL, V31, P1145, DOI 10.1007/s10886-005-4253-1; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; Read J, 2009, ANN BOT-LONDON, V103, P757, DOI 10.1093/aob/mcn246; Reynolds LK, 2012, MAR ECOL PROG SER, V451, P107, DOI 10.3354/meps09569; Rudgers JA, 2006, J ECOL, V94, P1249, DOI 10.1111/j.1365-2745.2006.01161.x; Sanson G, 2006, AM J BOT, V93, P1531, DOI 10.3732/ajb.93.10.1531; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Steele L, 2012, MAR ECOL PROG SER, V466, P81, DOI 10.3354/meps09921; STEWARD JL, 1988, OIKOS, V53, P79, DOI 10.2307/3565666; Targett NM, 1998, J PHYCOL, V34, P195, DOI 10.1046/j.1529-8817.1998.340195.x; Taylor RB, 2003, OECOLOGIA, V136, P412, DOI 10.1007/s00442-003-1280-x; Tomas F, 2011, ECOLOGY, V92, P1807, DOI 10.1890/10-2095.1; Tomas F, 2015, GLOBAL CHANGE BIOL, V21, P4021, DOI 10.1111/gcb.13024; Twigg LE, 1996, OECOLOGIA, V108, P21, DOI 10.1007/BF00333210; Van Alstyne KL, 1999, J PHYCOL, V35, P483, DOI 10.1046/j.1529-8817.1999.3530483.x; Verges A, 2007, OECOLOGIA, V151, P675, DOI 10.1007/s00442-006-0606-x; Verges A, 2011, OECOLOGIA, V166, P381, DOI 10.1007/s00442-010-1830-y; Viejo RM, 2003, MAR BIOL, V142, P1229, DOI 10.1007/s00227-002-0994-3; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wise MJ, 2008, ECOLOGY, V89, P3275, DOI 10.1890/08-0277.1; Wright W, 1996, BIOL REV, V71, P401, DOI 10.1111/j.1469-185X.1996.tb01280.x; Zimmerman RC, 2001, MAR ECOL PROG SER, V218, P127, DOI 10.3354/meps218127	100	22	22	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156848	10.1371/journal.pone.0156848	http://dx.doi.org/10.1371/journal.pone.0156848			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257679	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700145
J	Matsuo, R; Ago, T; Hata, J; Wakisaka, Y; Kuroda, J; Kuwashiro, T; Kitazono, T; Kamouchi, M				Matsuo, Ryu; Ago, Tetsuro; Hata, Jun; Wakisaka, Yoshinobu; Kuroda, Junya; Kuwashiro, Takahiro; Kitazono, Takanari; Kamouchi, Masahiro		Fukuoka Stroke Registry Investigat	Plasma C-Reactive Protein and Clinical Outcomes after Acute Ischemic Stroke: A Prospective Observational Study	PLOS ONE			English	Article							PHOSPHOLIPASE A(2); RISK; INFLAMMATION; DISEASE; INCREASES; PROGNOSIS; MORTALITY; PREDICT; EVENTS	Background and Purpose Although plasma C-reactive protein (CRP) is elevated in response to inflammation caused by brain infarction, the association of CRP with clinical outcomes after acute ischemic stroke remains uncertain. This study examined whether plasma high-sensitivity CRP (hsCRP) levels at onset were associated with clinical outcomes after acute ischemic stroke independent of conventional risk factors and acute infections after stroke. Methods We prospectively included 3653 patients with first-ever ischemic stroke who had been functionally independent and were hospitalized within 24 h of onset. Plasma hsCRP levels were measured on admission and categorized into quartiles. The association between hsCRP levels and clinical outcomes, including neurological improvement, neurological deterioration, and poor functional outcome (modified Rankin scale >= 3 at 3 months), were investigated using a logistic regression analysis. Results Higher hsCRP levels were significantly associated with unfavorable outcomes after adjusting for age, sex, baseline National Institutes of Health Stroke Scale score, stroke subtype, conventional risk factors, intravenous thrombolysis and endovascular therapy, and acute infections during hospitalization (multivariate-adjusted odds ratios [95% confidence interval] in the highest quartile versus the lowest quartile as a reference: 0.80 [0.65-0.97] for neurological improvement, 1.72 [1.26-2.34] for neurological deterioration, and 2.03 [1.55-2.67] for a poor functional outcome). These associations were unchanged after excluding patients with infectious diseases occurring during hospitalization, or those with stroke recurrence or death. These trends were similar irrespective of stroke subtypes or baseline stroke severity, but more marked in patients aged <70 years (P-heterogeneity = 0.001). Conclusions High plasma hsCRP is independently associated with unfavorable clinical outcomes after acute ischemic stroke.	[Matsuo, Ryu; Ago, Tetsuro; Wakisaka, Yoshinobu; Kuroda, Junya; Kuwashiro, Takahiro; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Matsuo, Ryu; Kamouchi, Masahiro] Kyushu Univ, Dept Hlth Care Adm & Management, Grad Sch Med Sci, Fukuoka 812, Japan; [Hata, Jun; Wakisaka, Yoshinobu; Kitazono, Takanari; Kamouchi, Masahiro] Kyushu Univ, Ctr Cohort Studies, Grad Sch Med Sci, Fukuoka 812, Japan; [Kuwashiro, Takahiro] Kyushu Med Ctr, Natl Hosp Org, Dept Cerebrovasc Med & Neurol, Cerebrovasc Ctr, Fukuoka, Japan; [Kuwashiro, Takahiro] Kyushu Med Ctr, Natl Hosp Org, Clin Res Inst, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University	Kamouchi, M (corresponding author), Kyushu Univ, Dept Hlth Care Adm & Management, Grad Sch Med Sci, Fukuoka 812, Japan.; Kamouchi, M (corresponding author), Kyushu Univ, Ctr Cohort Studies, Grad Sch Med Sci, Fukuoka 812, Japan.	kamouchi@hcam.med.kyushu-u.ac.jp		Ago, Tetsuro/0000-0003-4560-6594	Japan Society for the Promotion of Science (JSPS) KAKENHI from the Japanese Ministry of Education, Culture, Sports, Science and Technology [26293158, 15K08849]; Japan Agency for Medical Research and Development, AMED; Grants-in-Aid for Scientific Research [15K08849] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 26293158 to MK and 15K08849 to RM from the Japanese Ministry of Education, Culture, Sports, Science and Technology and the Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus to MK from Japan Agency for Medical Research and Development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Arenillas JF, 2003, STROKE, V34, P2463, DOI 10.1161/01.STR.0000089920.93927.A7; Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; Christensen H, 2004, CEREBROVASC DIS, V18, P214, DOI 10.1159/000079944; Cucchiara BL, 2009, STROKE, V40, P2332, DOI 10.1161/STROKEAHA.109.553545; Di Napoli M, 2005, STROKE, V36, P1316, DOI 10.1161/01.STR.0000165929.78756.ed; Di Napoli M, 2002, STROKE, V33, P1763, DOI 10.1161/01.STR.0000019124.54361.08; Di Napoli M, 2001, STROKE, V32, P133, DOI 10.1161/01.STR.32.1.133; Di Napoli M, 2001, STROKE, V32, P917, DOI 10.1161/01.STR.32.4.917; Di Napoli M, 2011, EXPERT REV CARDIOVAS, V9, P1565, DOI [10.1586/erc.11.159, 10.1586/ERC.11.159]; Elkind MSV, 2006, ARCH INTERN MED, V166, P2073, DOI 10.1001/archinte.166.19.2073; Gill R, 2004, J CEREBR BLOOD F MET, V24, P1214, DOI 10.1097/01.WCB.0000136517.61642.99; Kamouchi M, 2011, STROKE, V42, P2788, DOI 10.1161/STROKEAHA.111.617415; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kumai Y, 2012, NEUROLOGY, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; Lane T, 2014, CIRC RES, V114, P672, DOI 10.1161/CIRCRESAHA.114.302770; Luna JM, 2014, STROKE, V45, P979, DOI 10.1161/STROKEAHA.113.002289; Makita S, 2009, ATHEROSCLEROSIS, V204, P234, DOI 10.1016/j.atherosclerosis.2008.07.040; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Montaner J, 2006, STROKE, V37, P1205, DOI 10.1161/01.STR.0000217744.89208.4e; Muir KW, 1999, STROKE, V30, P981, DOI 10.1161/01.STR.30.5.981; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Shinohara Y, 2008, INT J STROKE, V3, P55, DOI 10.1111/j.1747-4949.2008.00178.x; Song IU, 2010, EUR NEUROL, V64, P304, DOI 10.1159/000321415; Song IU, 2009, CEREBROVASC DIS, V28, P545, DOI 10.1159/000247597; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Toyoda K, 2009, STROKE, V40, P2585, DOI 10.1161/STROKEAHA.108.543587; Verma S, 2003, AM J PHYSIOL-REG I, V285, pR1253, DOI 10.1152/ajpregu.00170.2003; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wakugawa Y, 2006, STROKE, V37, P27, DOI 10.1161/01.STR.0000194958.88216.87; Welsh P, 2009, CEREBROVASC DIS, V27, P247, DOI 10.1159/000196823; Winbeck K, 2002, STROKE, V33, P2459, DOI 10.1161/01.STR.0000029828.51413.82; Yong M, 2008, STROKE, V39, P2749, DOI 10.1161/STROKEAHA.108.514307	37	39	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156790	10.1371/journal.pone.0156790	http://dx.doi.org/10.1371/journal.pone.0156790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258004	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700129
J	Navas, JF; Vilar-Lopez, R; Perales, JC; Steward, T; Fernandez-Aranda, F; Verdejo-Garcia, A				Navas, Juan F.; Vilar-Lopez, Raquel; Perales, Jose C.; Steward, Trevor; Fernandez-Aranda, Fernando; Verdejo-Garcia, Antonio			Altered Decision-Making under Risk in Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; GAMBLING TASK; SENSITIVITY; REWARD; IMPULSIVITY; BEHAVIORS; DEFICITS	Background The negative consequences of energy dense foods are well known, yet people increasingly make unhealthy food choices leading to obesity (i.e., risky decisions). The aims of this study were: [1] to compare performance in decision-making tasks under risk and under ambiguity between individuals with obesity, overweight and normal weight; [2] to examine the associations between body mass index (BMI) and decision-making, and the degree to which these associations are modulated by reward sensitivity. Methods Seventy-nine adults were recruited and classified in three groups according to their BMI: obesity, overweight and normal-weight. Groups were similar in terms of age, education and socio-economic status, and were screened for comorbid medical and mental health conditions. Decision-making under risk was measured via the Wheel of Fortune Task (WoFT) and decision-making under ambiguity via the Iowa Gambling Task (IGT). Reward sensitivity was indicated by the Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ). Results Individuals with obesity made riskier choices in the WoFT, specifically in choices with an expected value close to zero and in the propensity to risk index. No differences were found in IGT performance or SPSRQ scores. BMI was associated with risk-taking (WoFT performance), independently of reward sensitivity. Conclusions Obesity is linked to a propensity to make risky decisions in experimental conditions analogous to everyday food choices.	[Navas, Juan F.; Perales, Jose C.] Univ Granada, Dept Expt Psychol, Granada, Spain; [Navas, Juan F.; Vilar-Lopez, Raquel; Perales, Jose C.; Verdejo-Garcia, Antonio] Univ Granada, Red Trastornos Adict, Granada, Spain; [Navas, Juan F.; Vilar-Lopez, Raquel; Perales, Jose C.; Verdejo-Garcia, Antonio] Univ Granada, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain; [Vilar-Lopez, Raquel] Univ Granada, Dept Personal Assessment & Psychol Treatment, Granada, Spain; [Steward, Trevor; Fernandez-Aranda, Fernando] Bellvitge Univ Hosp IDIBELL, Dept Psychiat, Barcelona, Spain; [Steward, Trevor; Fernandez-Aranda, Fernando] ISCIII, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Barcelona, Spain; [Verdejo-Garcia, Antonio] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Verdejo-Garcia, Antonio] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic 3004, Australia	University of Granada; University of Granada; University of Granada; University of Granada; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Monash University; Monash University	Verdejo-Garcia, A (corresponding author), Univ Granada, Red Trastornos Adict, Granada, Spain.; Verdejo-Garcia, A (corresponding author), Univ Granada, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain.; Verdejo-Garcia, A (corresponding author), Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia.; Verdejo-Garcia, A (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic 3004, Australia.	Antonio.verdejo@monash.edu	FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Verdejo-Garcia, Antonio/AAV-1147-2021; Vilar-López, Raquel/I-7847-2016; Fernandez-Aranda, Fernando/L-9762-2014; Navas, Juan/AAD-3302-2019; Steward, Trevor/K-7469-2015	FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Verdejo-Garcia, Antonio/0000-0001-8874-9339; Vilar-López, Raquel/0000-0001-9639-0143; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Perales, Jose C./0000-0001-5163-8811; Steward, Trevor/0000-0003-3116-8175; Navas, Juan. F./0000-0002-9521-6642	Andalusian Council of Innovation, Science and Industry [HUM-6635]; Instituto de Salud Carlos III [FIS PI14/00290]; FEDER funds; Ian Potter Foundation; Spanish Ministry of Education, Culture and Sports, FPU Program [FP13/00669]; Spanish Ministry of Economy and Competitiveness [PSI2013-45055]	Andalusian Council of Innovation, Science and Industry; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER funds(European Commission); Ian Potter Foundation; Spanish Ministry of Education, Culture and Sports, FPU Program; Spanish Ministry of Economy and Competitiveness(Spanish Government)	Research was funded by grants HUM-6635 (NEUROECOBE) from the Andalusian Council of Innovation, Science and Industry; RETICS from the Instituto de Salud Carlos III and co-funded by FEDER funds -a way to build Europe-; and "Translational discovery laboratory for brain mechanisms of food choice and obesity" from the Ian Potter Foundation to AVG. JFN was funded by a predoctoral fellowship of the Spanish Ministry of Education, Culture and Sports, FPU Program, (FP13/00669). JCP was funded by grant PSI2013-45055 (G-BRAIN) from the Spanish Ministry of Economy and Competitiveness. TS and FFA were funded by grants FIS PI14/00290; and CIBERobn from the Instituto de Salud Carlos III and co-funded by FEDER funds-a way to build Europe-.	Anderson LR, 2008, J HEALTH ECON, V27, P1260, DOI 10.1016/j.jhealeco.2008.05.011; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Brand M, 2005, NEUROPSYCHOLOGY, V19, P267, DOI 10.1037/0894-4105.19.3.267; Brogan A, 2010, J INT NEUROPSYCH SOC, V16, P711, DOI 10.1017/S1355617710000354; Chamberlain SR, 2015, CNS SPECTRUMS, V20, P500, DOI 10.1017/S1092852914000625; Clark L, 2012, PSYCHOPHYSIOLOGY, V49, P1436, DOI 10.1111/j.1469-8986.2012.01454.x; Danner UN, 2012, EUR EAT DISORD REV, V20, pe56, DOI 10.1002/erv.1098; Davis C, 2008, APPETITE, V50, P43, DOI 10.1016/j.appet.2007.05.007; Davis C, 2007, PERS INDIV DIFFER, V42, P279, DOI 10.1016/j.paid.2006.07.006; Davis C, 2010, APPETITE, V54, P208, DOI 10.1016/j.appet.2009.11.002; Delgado-Rico E, 2013, OBESITY, V21, P1662, DOI 10.1002/oby.20375; Emrich TE, 2014, APPL PHYSIOL NUTR ME, V39, P417, DOI 10.1139/apnm-2013-0304; Fagundo AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043382; Figner B, 2011, CURR DIR PSYCHOL SCI, V20, P211, DOI 10.1177/0963721411415790; Fitzpatrick S, 2013, NEUROPSYCHOL REV, V23, P138, DOI 10.1007/s11065-013-9224-7; Franken IHA, 2005, PERS INDIV DIFFER, V39, P991, DOI 10.1016/j.paid.2005.04.004; GRAY JA, 1990, COGNITION EMOTION, V4, P269, DOI 10.1080/02699939008410799; Koritzky G, 2014, OBESITY, V22, P1904, DOI 10.1002/oby.20770; Koritzky G, 2012, APPETITE, V59, P289, DOI 10.1016/j.appet.2012.05.020; Stice E, 2011, J NEUROSCI, V31, P4360, DOI 10.1523/JNEUROSCI.6604-10.2011; Studer B, 2011, COGN AFFECT BEHAV NE, V11, P144, DOI 10.3758/s13415-011-0025-2; Svaldi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133534; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Vainik U, 2013, NEUROSCI BIOBEHAV R, V37, P279, DOI 10.1016/j.neubiorev.2012.11.008; Verbeken S, 2013, INT J OBESITY, P1; Volkow ND, 2013, BIOL PSYCHIAT, V73, P811, DOI 10.1016/j.biopsych.2012.12.020; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zald DH, 2009, ANN BEHAV MED, V38, pS18, DOI 10.1007/s12160-009-9117-4	29	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155600	10.1371/journal.pone.0155600	http://dx.doi.org/10.1371/journal.pone.0155600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257888	gold, Green Published			2022-12-26	WOS:000377369700017
J	Robinson, NJ; Majewska, R; Lazo-Wasem, EA; Nel, R; Paladino, FV; Rojas, L; Zardus, JD; Pinou, T				Robinson, Nathan J.; Majewska, Roksana; Lazo-Wasem, Eric A.; Nel, Ronel; Paladino, Frank V.; Rojas, Lourdes; Zardus, John D.; Pinou, Theodora			Epibiotic Diatoms Are Universally Present on All Sea Turtle Species	PLOS ONE			English	Article							CHELONIA-MYDAS; CARETTA-CARETTA; MARINE TURTLES; BACILLARIOPHYTA; SKIN; GENERA	The macro-epibiotic communities of sea turtles have been subject to growing interest in recent years, yet their micro-epibiotic counterparts are almost entirely unknown. Here, we provide the first evidence that diatoms are epibionts for all seven extant species of sea turtle. Using Scanning Electron Microscopy, we inspected superficial carapace or skin samples from a single representative of each turtle species. We distinguished 18 diatom taxa from these seven individuals, with each sea turtle species hosting at least two diatom taxa. We recommend that future research is undertaken to confirm whether diatom communities vary between sea turtle species and whether these diatom taxa are facultative or obligate commensals.	[Robinson, Nathan J.; Paladino, Frank V.] Leatherback Trust, Goldring Gund Marine Biol Stn, Playa Grande, Guanacaste, Costa Rica; [Robinson, Nathan J.; Paladino, Frank V.] Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46805 USA; [Majewska, Roksana] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, BioNEM Lab, Catanzaro, Italy; [Lazo-Wasem, Eric A.; Rojas, Lourdes] Yale Univ, Peabody Museum Nat Hist, Div Invertebrate Zool, New Haven, CT USA; [Nel, Ronel] Nelson Mandela Metropolitan Univ, Inst Coastal & Marine Res, Port Elizabeth, South Africa; [Zardus, John D.] The Citadel, Dept Biol, 171 Moultrie St, Charleston, SC 29407 USA; [Pinou, Theodora] Western Connecticut State Univ, Dept Biol & Environm Sci, Danbury, CT USA	Purdue University System; Indiana University Purdue University Fort Wayne; Magna Graecia University of Catanzaro; Yale University; Nelson Mandela University; Connecticut State University System; Western Connecticut State University	Robinson, NJ (corresponding author), Leatherback Trust, Goldring Gund Marine Biol Stn, Playa Grande, Guanacaste, Costa Rica.; Robinson, NJ (corresponding author), Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46805 USA.	nathan@leatherback.org	Zardus, John/V-4470-2019; Robinson, Nathan/AAE-4717-2019; Majewska, Roksana/P-1280-2015	Robinson, Nathan/0000-0001-7384-3576; Majewska, Roksana/0000-0003-2681-4304; Paladino, Frank V./0000-0002-6452-0086	WCSU-AAUP [241290]	WCSU-AAUP	This study was funded by a WCSU-AAUP grant (#241290) to Theodora Pinou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bunkley-Williams L, 2008, COMP PARASITOL, V75, P263, DOI 10.1654/4252.1; Denys Luc, 1997, Diatom Research, V12, P1; Frankovich TA, 2015, PHYTOTAXA, V234, P227, DOI 10.11646/phytotaxa.234.3.3; Frankovich TA, 2015, PHYTOTAXA, V204, P33, DOI 10.11646/phytotaxa.204.1.3; Frenguelli J., 1958, I ANTARTICO ARGENTIN, V5; Frick MG, 2013, CRC MAR BIOL SER, P399; Frick Michael G., 1998, Herpetological Review, V29, P211; GIFFEN MH, 1970, BOT MAR, V13, P87; Greenblatt RJ, 2004, VIROLOGY, V321, P101, DOI 10.1016/j.virol.2003.12.026; Grunow A., 1860, VERHANDLUNGEN KAISER, V10, P503; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Hazrin-Chong NH, 2012, J MICROBIOL METH, V90, P96, DOI 10.1016/j.mimet.2012.04.014; Holmes R.W., 1989, OTSUCHI MARINE RES C, V15, P15; Holmes Robert W., 1993, Bulletin of the National Science Museum Series B (Botany), V19, P1; HOLMES RW, 1985, BRIT PHYCOL J, V20, P43, DOI 10.1080/00071618500650061; Hustedt F., 1958, DSCH ANTARKT EXPED 1, P103; Lazo-Wasem EA, 2011, B PEABODY MUS NAT HI, V52, P221, DOI 10.3374/014.052.0203; Majewska R, 2015, PHYTOTAXA, V233, P236, DOI 10.11646/phytotaxa.233.3.2; Majewska R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130351; Pfaller JB, 2014, MAR BIOL, V161, P2167, DOI 10.1007/s00227-014-2498-3; Reich KJ, 2010, MAR BIOL, V157, P113, DOI 10.1007/s00227-009-1300-4; Robinson NJ, J MAR BIOL ASSOC UK, DOI [10.1017/S0025315416000734, DOI 10.1017/S0025315416000734]; Round F. E., 1990, DIATOMS BIOL MORPHOL; Senties A, 1999, B MAR SCI, V64, P185; Wahl M, 1999, MAR ECOL PROG SER, V187, P59, DOI 10.3354/meps187059; Wetzel CE, 2012, DIATOM RES, V27, P1, DOI 10.1080/0269249X.2011.642498; Witkowski A., 2000, ICONOGRAPHIA DIATOMO, V7, P1	27	35	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157011	10.1371/journal.pone.0157011	http://dx.doi.org/10.1371/journal.pone.0157011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257972	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700168
J	Sarker, PK; Kapuscinski, AR; Lanois, AJ; Livesey, ED; Bernhard, KP; Coley, ML				Sarker, Pallab K.; Kapuscinski, Anne R.; Lanois, Alison J.; Livesey, Erin D.; Bernhard, Katie P.; Coley, Mariah L.			Towards Sustainable Aquafeeds: Complete Substitution of Fish Oil with Marine Microalga Schizochytrium sp Improves Growth and Fatty Acid Deposition in Juvenile Nile Tilapia (Oreochromis niloticus)	PLOS ONE			English	Article							X-O-AUREUS; DOCOSAHEXAENOIC ACID; IMMUNE FUNCTION; DIETARY LIPIDS; HYBRID TILAPIA; REPLACEMENT; PROTEIN; QUALITY; MEAL; METABOLISM	We conducted a 84-day nutritional feeding experiment with dried whole cells of DHA-rich marine microalga Schizochytrium sp. (Sc) to determine the optimum level of fish-oil substitution (partial or complete) for maximum growth of Nile tilapia. When we fully replaced fish oil with Schizochytrium (Sc100 diet), we found significantly higher weight gain and protein efficiency ratio (PER), and lower (improved) feed conversion ratio (FCR) and feed intake compared to a control diet containing fish oil (Sc0); and no significant change in SGR and survival rate among all diets. The Sc100 diet had the highest contents of 22:6n3 DHA, led to the highest DHA content in fillets, and consequently led to the highest DHA: EPA ratios in tilapia fillets. Schizochytrium sp. is a high quality candidate for complete substitution of fish oil in juvenile Nile tilapia feeds, providing an innovative means to formulate and optimize the composition of tilapia juvenile feed while simultaneously raising feed efficiency of tilapia aquaculture and to further develop environmentally and socially sustainable aquafeeds. Results show that replacing fish oil with DHA-rich marine Sc improves the deposition of n3 LC PUFA levels in tilapia fillet. These results support further studies to lower Schizochytrium production costs and to combine different marine microalgae to replace fish oil and fishmeal into aquafeeds.	[Sarker, Pallab K.; Kapuscinski, Anne R.; Lanois, Alison J.; Livesey, Erin D.; Bernhard, Katie P.; Coley, Mariah L.] Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA; [Coley, Mariah L.] Univ Calif Davis, Sustainable Agr Res & Educ Program, One Shields Ave, Davis, CA 95616 USA	Dartmouth College; University of California System; University of California Davis	Sarker, PK (corresponding author), Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA.	Pallab.K.Sarker@dartmouth.edu		Bernhard, Katie P./0000-0002-4121-7850	Sherman Fairchild Distinguished Professorship in Sustainability Science; Dean of the Faculty of Arts and Sciences, Dartmouth College	Sherman Fairchild Distinguished Professorship in Sustainability Science; Dean of the Faculty of Arts and Sciences, Dartmouth College	This research was supported by the Sherman Fairchild Distinguished Professorship in Sustainability Science (to ARK) and the Dean of the Faculty of Arts and Sciences, Dartmouth College.	Association of Official Analytical Chemists, 1995, OFFICIAL METHODS ANA, V1; Barrows F, 2010, FUTURE AQUAFEEDS, P15; Brasky TM, 2011, AM J EPIDEMIOL, V173, P1429, DOI 10.1093/aje/kwr027; Bureau DP, 2008, J WORLD AQUACULT SOC, V39, P1, DOI 10.1111/j.1749-7345.2007.00146.x; Chauton MS, 2015, AQUACULTURE, V436, P95, DOI 10.1016/j.aquaculture.2014.10.038; FAO, 2022, BLUE TRANSFORMATION, DOI [DOI 10.4060/CC0461EN, 10.4060/cc0461en]; FAO (Food and Agriculture Organization of the United Nations), 2012, STAT WORLD FISH AQ S; Glencross B, 2011, AQUACULT NUTR, V17, pE536, DOI 10.1111/j.1365-2095.2010.00795.x; Glencross BD, 2001, AQUACULT NUTR, V7, P101, DOI 10.1046/j.1365-2095.2001.00158.x; Gross M, 2015, APPL MICROBIOL BIOT, V99, P5781, DOI 10.1007/s00253-015-6736-5; Hall SJ., 2011, BLUE FRONTIERS MANAG; Hemaiswarya S, 2011, WORLD J MICROB BIOT, V27, P1737, DOI 10.1007/s11274-010-0632-z; Huang CH, 1998, COMP BIOCHEM PHYS B, V120, P331, DOI 10.1016/S0305-0491(98)10022-6; Hussein E. E., 2012, AQUAC RES, V44, P937; Karapanagiotidis IT, 2007, LIPIDS, V42, P547, DOI 10.1007/s11745-007-3057-1; Kousoulaki K, 2016, AQUACULTURE, V451, P47, DOI 10.1016/j.aquaculture.2015.08.027; Menoyo D, 2005, J ANIM SCI, V83, P2853; Menoyo D, 2004, BRIT J NUTR, V92, P41, DOI 10.1079/BJN20041165; Mourente G, 2007, BRIT J NUTR, V98, P770, DOI 10.1017/S000711450773461X; Nauroth JM, 2010, LIPIDS, V45, P375, DOI 10.1007/s11745-010-3406-3; Ng W.K., 2005, GLOB AQUACULT AD OCT, P60; Ng WK, 2009, FOOD CHEM, V113, P1041, DOI 10.1016/j.foodchem.2008.08.060; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Peet M, 2005, DRUGS, V65, P1051, DOI 10.2165/00003495-200565080-00002; Raghukumar S, 2008, MAR BIOTECHNOL, V10, P631, DOI 10.1007/s10126-008-9135-4; Ryckebosch E., 2012, Lipid Technology, V24, P128, DOI 10.1002/lite.201200197; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Sarker PK, 2016, AQUACULT NUTR, V22, P109, DOI 10.1111/anu.12230; Sarker PK, 2013, REV AQUACULT, V5, P199, DOI 10.1111/raq.12013; SHIAU SY, 1990, AQUACULTURE, V86, P401, DOI 10.1016/0044-8486(90)90328-K; Suloma A., 2008, 8 INT S TIL AQ CAIR, P921; Tacon AGJ., 2011, DEMAND SUPPLY FEED I; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; TAKEUCHI T, 1983, B JPN SOC SCI FISH, V49, P1127; Thompson KR, 2012, N AM J AQUACULT, V74, P365, DOI 10.1080/15222055.2012.675999; Trushenski JT, 2009, N AM J AQUACULT, V71, P242, DOI 10.1577/A08-051.1; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Vechklang K, 2011, AQUACULT NUTR, V17, P685, DOI 10.1111/j.1365-2095.2011.00870.x; Walker DA, 2009, J APPL PHYCOL, V21, P509, DOI 10.1007/s10811-009-9446-5; Weaver KL, 2008, J AM DIET ASSOC, V108, P1178, DOI 10.1016/j.jada.2008.04.023; White R.L., 2015, IND BIOTECHNOL, V11, P213, DOI [DOI 10.1089/IND.2015.0006, 10.1089/ind.2015.0006]; Yokoyama Rinka, 2007, Mycoscience, V48, P199, DOI 10.1007/s10267-006-0362-0; YONES AM, 2013, MERIT RES J FOOD SCI, V1, P9	43	110	116	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156684	10.1371/journal.pone.0156684	http://dx.doi.org/10.1371/journal.pone.0156684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258552	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700104
J	Bang, OY; Chung, JW; Cha, J; Lee, MJ; Yeon, JY; Ki, CS; Jeon, P; Kim, JS; Hong, SC				Bang, Oh Young; Chung, Jong-Won; Cha, Jihoon; Lee, Mi Ji; Yeon, Je Young; Ki, Chang-Seok; Jeon, Pyoung; Kim, Jong-Soo; Hong, Seung Chyul			A Polymorphism in RNF213 Is a Susceptibility Gene for Intracranial Atherosclerosis	PLOS ONE			English	Article							MOYAMOYA-DISEASE; ISCHEMIC-STROKE; RISK-FACTORS; VARIANT; C.14576G-GREATER-THAN-A; POPULATION; DIFFERENCE; CAVEOLIN-1; ETHNICITY	Background Both intracranial atherosclerotic stenosis (ICAS) and moyamoya disease (MMD) are prevalent in Asians. We hypothesized that the Ring Finger protein 213 gene polymorphism (RNF213), a susceptibility locus for MMD in East Asians, is also a susceptibility gene for ICAS in patients whose diagnosis had been confirmed by conventional angiography (absence of basal collaterals) and high-resolution MRI (HR-MRI, presence of plaque). Methods We analyzed 532 consecutive patients with ischemic events in the middle cerebral artery (MCA) distribution and relevant stenotic lesion on the distal internal carotid artery or proximal MCA, but no demonstrable carotid or cardiac embolism sources. Additional angiography was performed on 370 (69.5%) patients and HR-MRI on 283 (53.2%) patients. Results Based on angiographic and HR-MRI findings, 234 patients were diagnosed with ICAS and 288 with MMD. The RNF213 variant was observed in 50 (21.4%) ICAS patients and in 119 (69.1%) MMD patients. The variant was observed in 25.2% of patients with HR-MRI-confirmed ICAS. Similarly, 15.8% of ICAS patients in whom MMD was excluded by angiography had this variant. Among the ICAS patients, RNF213 variant carriers were younger and more likely to have a family history of MMD than non-carriers were. Multivariate testing showed that only the age of ICAS onset was independently associated with the RNF213 variant (odds ratio, 0.97; 95% CI, 0.944-0.99). Conclusions RNF213 is a susceptibility gene not only for MMD but also for ICAS in East Asians. Further studies are needed on RNF213 variants in ICAS patients outside East Asian populations.	[Bang, Oh Young; Chung, Jong-Won; Lee, Mi Ji] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Cha, Jihoon; Jeon, Pyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Yeon, Je Young; Kim, Jong-Soo; Hong, Seung Chyul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Ki, Chang-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Bang, OY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	ohyoung.bang@samsung.com	ki, cs/O-5931-2014; Ki, Chang-Seok/G-7559-2014	Ki, Chang-Seok/0000-0001-7679-8731; Lee, Mi Ji/0000-0003-1364-1969; Yeon, Je Young/0000-0003-4603-8103; Chung, Jong-Won/0000-0002-9200-8899	Korean Healthcare Technology R&D Project, Ministry of Health Welfare [HI14C15310000]	Korean Healthcare Technology R&D Project, Ministry of Health Welfare	This study was supported by the Korean Healthcare Technology R&D Project, Ministry of Health & Welfare (HI14C15310000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang OY, 2016, J STROKE, V18, P12, DOI 10.5853/jos.2015.01760; Bang OY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130663; Bang OY, 2014, J STROKE, V16, P27, DOI 10.5853/jos.2014.16.1.27; Bang OY, 2009, J NEUROL SCI, V284, P40, DOI 10.1016/j.jns.2009.03.033; Boden-Albala B, 2008, STROKE, V39, P30, DOI 10.1161/STROKEAHA.107.496588; Bower RS, 2013, STROKE, V44, P1997, DOI 10.1161/STROKEAHA.111.000307; Cecchi AC, 2014, STROKE, V45, P3200, DOI 10.1161/STROKEAHA.114.006244; Chang SH, 2009, AM J PATHOL, V175, P1768, DOI 10.2353/ajpath.2009.090171; Forouhi NG, 2006, ATHEROSCLEROSIS SUPP, V7, P11, DOI 10.1016/j.atherosclerosissup.2006.01.003; Fra AM, 1999, GENOMICS, V56, P355, DOI 10.1006/geno.1998.5723; Frank PG, 2003, ARTERIOSCL THROM VAS, V23, P1161, DOI 10.1161/01.ATV.0000070546.16946.3A; Fujimura M, 2014, J STROKE, V16, P65, DOI 10.5853/jos.2014.16.2.65; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kim SJ, 2013, J STROKE, V15, P27, DOI 10.5853/jos.2013.15.1.27; Kim SJ, 2010, STROKE, V41, P173, DOI 10.1161/STROKEAHA.109.562264; Kim YJ, 2013, EUR J NEUROL, V20, P1311, DOI 10.1111/ene.12202; Kleinloog R, 2012, J NEUROL NEUROSUR PS, V83, P531, DOI 10.1136/jnnp-2011-301387; Koizumi A, 2013, ENVIRON HEALTH PREV, V18, P121, DOI 10.1007/s12199-012-0299-1; Li H, 2011, STROKE, V42, P1138, DOI 10.1161/STROKEAHA.110.608471; Liu J, 2002, J BIOL CHEM, V277, P10661, DOI 10.1074/jbc.M110354200; Liu WY, 2012, NEUROL MED-CHIR, V52, P299, DOI 10.2176/nmc.52.299; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Ma JP, 2013, NEUROL INDIA, V61, P35, DOI 10.4103/0028-3886.107927; Mak W, 2005, MED HYPOTHESES, V65, P637, DOI 10.1016/j.mehy.2005.05.017; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Miyawaki S, 2013, STROKE, V44, P2894, DOI 10.1161/STROKEAHA.113.002477; Miyawaki S, 2012, STROKE, V43, P3371, DOI 10.1161/STROKEAHA.112.663864; Ryoo S, 2015, STROKE; Ryoo S, 2014, STROKE, V45, P2457, DOI 10.1161/STROKEAHA.114.004761; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Shi ZH, 2014, INT J STROKE, V9, P735, DOI 10.1111/ijs.12177; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Wu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048179	34	36	39	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156607	10.1371/journal.pone.0156607	http://dx.doi.org/10.1371/journal.pone.0156607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253870	Green Submitted, gold, Green Published			2022-12-26	WOS:000377218700042
J	Martz, F; Vuosku, J; Ovaskainen, A; Stark, S; Rautio, P				Martz, Francoise; Vuosku, Jaana; Ovaskainen, Anu; Stark, Sari; Rautio, Pasi			The Snow Must Go On: Ground Ice Encasement, Snow Compaction and Absence of Snow Differently Cause Soil Hypoxia, CO2 Accumulation and Tree Seedling Damage in Boreal Forest	PLOS ONE			English	Article							CARBON-DIOXIDE; ROOT-GROWTH; NITROGEN MINERALIZATION; MICROBIAL ACTIVITY; FROZEN SOIL; FROST; TEMPERATURE; RESPONSES; PHYSIOLOGY; RESPIRATION	At high latitudes, the climate has warmed at twice the rate of the global average with most changes observed in autumn, winter and spring. Increasing winter temperatures and wide temperature fluctuations are leading to more frequent rain-on-snow events and freeze-thaw cycles causing snow compaction and formation of ice layers in the snowpack, thus creating ice encasement (IE). By decreasing the snowpack insulation capacity and restricting soil-atmosphere gas exchange, modification of the snow properties may lead to colder soil but also to hypoxia and accumulation of trace gases in the subnivean environment. To test the effects of these overwintering conditions changes on plant winter survival and growth, we established a snow manipulation experiment in a coniferous forest in Northern Finland with Norway spruce and Scots pine seedlings. In addition to ambient conditions and prevention of IE, we applied three snow manipulation levels: IE created by artificial rain-on-snow events, snow compaction and complete snow removal. Snow removal led to deeper soil frost during winter, but no clear effect of IE or snow compaction done in early winter was observed on soil temperature. Hypoxia and accumulation of CO2 were highest in the IE plots but, more importantly, the duration of CO2 concentration above 5% was 17 days in IE plots compared to 0 days in ambient plots. IE was the most damaging winter condition for both species, decreasing the proportion of healthy seedlings by 47% for spruce and 76% for pine compared to ambient conditions. Seedlings in all three treatments tended to grow less than seedlings in ambient conditions but only IE had a significant effect on spruce growth. Our results demonstrate a negative impact of winter climate change on boreal forest regeneration and productivity. Changing snow conditions may thus partially mitigate the positive effect of increasing growing season temperatures on boreal forest productivity.	[Martz, Francoise; Vuosku, Jaana; Ovaskainen, Anu; Stark, Sari; Rautio, Pasi] Nat Resources Inst Finland Luke, Rovaniemi, Finland; [Stark, Sari] Univ Lapland, Arctic Ctr, Rovaniemi, Finland	Natural Resources Institute Finland (Luke); University of Lapland	Martz, F (corresponding author), Nat Resources Inst Finland Luke, Rovaniemi, Finland.	francoise.martz@luke.fi	Stark, Sari/L-4440-2013; Martz, Francoise/C-6354-2017; Rautio, Pasi/A-6595-2013	Rautio, Pasi/0000-0003-0559-7531; Martz, Francoise/0000-0002-5693-4529	Suomen akatemia [267092]; Suomen Kulttuurirahasto, Lapin Rahasto [40121486, 2010-2011]	Suomen akatemia; Suomen Kulttuurirahasto, Lapin Rahasto	This work was supported by Suomen akatemia (www.aka.fi, decision 267092, to PR): complete project funding (field experiment implementation, material collection, data analysis, preparation of manuscript) and Suomen Kulttuurirahasto, Lapin Rahasto (www.skr.fi, grant 40121486, 2010-2011, to FM): running a pilot field experiment, material collection and data analysis.	Al-Traboulsi M, 2013, PLANT SOIL, V365, P267, DOI 10.1007/s11104-012-1390-5; Alvarez-Uria P, 2007, FUNCT ECOL, V21, P211, DOI 10.1111/j.1365-2435.2007.01231.x; Barbeito I, 2012, ECOLOGY, V93, P389, DOI 10.1890/11-0384.1; Bergjord AK, 2008, EUR J AGRON, V28, P321, DOI 10.1016/j.eja.2007.10.002; Bjerke JW, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/095007; Bottcher K, 2014, REMOTE SENS ENVIRON, V140, P625, DOI 10.1016/j.rse.2013.09.022; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Castonguay Y, 2009, CROP SCI, V49, P671, DOI 10.2135/cropsci2008.08.0484; CHOMBA BM, 1993, TREE PHYSIOL, V13, P351, DOI 10.1093/treephys/13.4.351; CLEIN JS, 1995, SOIL BIOL BIOCHEM, V27, P1231, DOI 10.1016/0038-0717(95)00044-F; Comerford DP, 2013, OECOLOGIA, V171, P261, DOI 10.1007/s00442-012-2393-x; Crawford RMM, 1996, J EXP BOT, V47, P145, DOI 10.1093/jxb/47.2.145; Crawford RMM, 2003, CAN J BOT, V81, P1224, DOI [10.1139/B03-127, 10.1139/b03-127]; Decker KLM, 2003, SOIL SCI SOC AM J, V67, P1234, DOI 10.2136/sssaj2003.1234; Drescher M, 2013, OIKOS, V122, P541, DOI 10.1111/j.1600-0706.2012.20642.x; FREY W, 1983, ARCTIC ALPINE RES, V15, P241, DOI 10.2307/1550925; Gaul D, 2008, J PLANT NUTR SOIL SC, V171, P690, DOI 10.1002/jpln.200700284; Gonzelez-Meller MA, 2004, ANN BOT-LONDON, V94, P647, DOI 10.1093/aob/mch189; Greenway H, 2006, ANN BOT-LONDON, V98, P9, DOI 10.1093/aob/mcl076; Gudleifsson BE, 2009, PLANT COLD HARDINESS: FROM THE LABORATORY TO THE FIELD, P163, DOI 10.1079/9781845935139.0163; Gudleifsson BE, 2014, METHODS MOL BIOL, V1166, P225, DOI 10.1007/978-1-4939-0844-8_17; Hardy JP, 2001, BIOGEOCHEMISTRY, V56, P151, DOI 10.1023/A:1013036803050; Heiskanen J., 2015, Journal of Forest Science (Prague), V61, P35, DOI 10.17221/97/2014-JFS; Hoglind M, 2010, GRASS FORAGE SCI, V65, P431, DOI 10.1111/j.1365-2494.2010.00762.x; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Kammann C, 2001, EUR J SOIL SCI, V52, P297, DOI 10.1046/j.1365-2389.2001.00380.x; Krasowski MJ, 2001, TREE PHYSIOL SER, V1, P253; KRASOWSKI MJ, 1995, WATER AIR SOIL POLL, V82, P133, DOI 10.1007/BF01182827; Kruger M, 2011, INT J GREENH GAS CON, V5, P1093, DOI 10.1016/j.ijggc.2011.05.002; Liston GE, 2011, J CLIMATE, V24, P5691, DOI 10.1175/JCLI-D-11-00081.1; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Mikkonen S, 2015, STOCH ENV RES RISK A, V29, P1521, DOI 10.1007/s00477-014-0992-2; Musselman RC, 2005, ARCT ANTARCT ALP RES, V37, P527, DOI 10.1657/1523-0430(2005)037[0527:TTDOCD]2.0.CO;2; Pirinen P., 2012, REPORTS-BASEL; Preece C, 2013, ENVIRON EXP BOT, V85, P7, DOI 10.1016/j.envexpbot.2012.06.003; Preece C, 2012, PHYSIOL PLANTARUM, V146, P460, DOI 10.1111/j.1399-3054.2012.01640.x; QI JE, 1994, NEW PHYTOL, V128, P435, DOI 10.1111/j.1469-8137.1994.tb02989.x; Rasmus S, 2004, ANN GLACIOL, V38, P238, DOI 10.3189/172756404781814843; Repo T, 2005, TREE PHYSIOL, V25, P1053, DOI 10.1093/treephys/25.8.1053; Repo T, 2008, TREE PHYSIOL, V28, P1583, DOI 10.1093/treephys/28.10.1583; Repo T, 2014, FOREST ECOL MANAG, V313, P112, DOI 10.1016/j.foreco.2013.11.002; Repo T, 2011, ENVIRON EXP BOT, V72, P387, DOI 10.1016/j.envexpbot.2011.04.014; RICARD J, 1976, FIELD ASSEMBLED FROS; Rixen C, 2008, ARCT ANTARCT ALP RES, V40, P568, DOI 10.1657/1523-0430(07-044)[RIXEN]2.0.CO;2; Schimel JP, 2004, SOIL BIOL BIOCHEM, V36, P217, DOI 10.1016/j.soilbio.2003.09.008; Schrader J, 2004, PLANT J, V40, P173, DOI 10.1111/j.1365-313X.2004.02199.x; Smith KL, 2013, ENRGY PROCED, V37, P791, DOI 10.1016/j.egypro.2013.05.169; SOLOMON DK, 1987, WATER RESOUR RES, V23, P2257, DOI 10.1029/WR023i012p02257; Sullivan BW, 2012, ARCT ANTARCT ALP RES, V44, P247, DOI 10.1657/1938-4246-44.2.247; Sutinen ML, 1996, CAN J FOREST RES, V26, P1602, DOI 10.1139/x26-180; Sutinen ML, 2000, FOREST ECOL MANAG, V135, P217, DOI 10.1016/S0378-1127(00)00312-1; Sutinen R, 2009, ARCT ANTARCT ALP RES, V41, P373, DOI 10.1657/1938-4246-41.3.373; Sutinen S, 2014, BOREAL ENVIRON RES, V19, P281; Tierney GL, 2001, BIOGEOCHEMISTRY, V56, P175, DOI 10.1023/A:1013072519889; Varhola A, 2010, J HYDROL, V392, P219, DOI 10.1016/j.jhydrol.2010.08.009; Voesenek LACJ, 2015, NEW PHYTOL, V206, P57, DOI 10.1111/nph.13209; Wang D, 2012, OECOLOGIA, V169, P1, DOI 10.1007/s00442-011-2172-0; WILLIAMS BL, 1995, COMMUN SOIL SCI PLAN, V26, P91, DOI 10.1080/00103629509369283; Yanai Y, 2011, SOIL BIOL BIOCHEM, V43, P1779, DOI 10.1016/j.soilbio.2010.06.009; Ylitalo E, 2013, STAT YB FORESTRY	60	19	19	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156620	10.1371/journal.pone.0156620	http://dx.doi.org/10.1371/journal.pone.0156620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254100	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700044
J	Wehrendt, DP; Carmona, F; Wusener, AEG; Gonzalez, A; Martinez, JML; Arregui, CO				Wehrendt, Diana P.; Carmona, Fernando; Gonzalez Wusener, Ana E.; Gonzalez, Angela; Lazaro Martinez, Juan M.; Arregui, Carlos O.			P120-Catenin Regulates Early Trafficking Stages of the N-Cadherin Precursor Complex	PLOS ONE			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; P120 CATENIN; ENDOPLASMIC-RETICULUM; EXTRACELLULAR DOMAIN; CLASSICAL CADHERINS; CYTOPLASMIC DOMAIN; EPITHELIAL-CELLS; PLASMA-MEMBRANE; AMPA RECEPTORS; ALPHA-SNAP	It is well established that binding of p120 catenin to the cytoplasmic domain of surface cadherin prevents cadherin endocytosis and degradation, contributing to cell-cell adhesion. In the present work we show that p120 catenin bound to the N-cadherin precursor, contributes to its anterograde movement from the endoplasmic reticulum (ER) to the Golgi complex. In HeLa cells, depletion of p120 expression, or blocking its binding to N-cadherin, increased the accumulation of the precursor in the ER, while it decreased the localization of mature N-cadherin at intercellular junctions. Reconstitution experiments in p120-deficient SW48 cells with all three major isoforms of p120 (1, 3 and 4) had similar capacity to promote the processing of the N-cadherin precursor to the mature form, and its localization at cell-cell junctions. P120 catenin and protein tyrosine phosphatase PTP1B facilitated the recruitment of the N-ethylmaleimide sensitive factor (NSF), an ATPase involved in vesicular trafficking, to the N-cadherin precursor complex. Dominant negative NSF E329Q impaired N-cadherin trafficking, maturation and localization at cell-cell junctions. Our results uncover a new role for p120 catenin bound to the N-cadherin precursor ensuring its trafficking through the biosynthetic pathway towards the cell surface.	[Wehrendt, Diana P.; Carmona, Fernando; Gonzalez Wusener, Ana E.; Gonzalez, Angela; Arregui, Carlos O.] Univ San Martin, IIB INTECH, Inst Invest Biotecnol, San Martin, Argentina; [Lazaro Martinez, Juan M.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Organ, Caba, Argentina	University of Buenos Aires	Arregui, CO (corresponding author), Univ San Martin, IIB INTECH, Inst Invest Biotecnol, San Martin, Argentina.	carregui@iib.unsam.edu.ar	Lázaro-Martínez, Juan/AAE-5709-2020; Martinez, Juan/GXM-4393-2022	Lázaro-Martínez, Juan/0000-0002-7189-6874; Arregui, Carlos/0000-0003-0704-3321	Agencia Nacional de Promocion Cientifica y Tecnologica [PICTs 1363, 2129]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funding was provided by Agencia Nacional de Promocion Cientifica y Tecnologica, http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt (PICTs 1363 and 2129), to COA; and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), http://www.conicet.gov.ar, to COA, DPW and JMLM.	Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Arregui C, 2000, J CELL BIOL, V149, P1263, DOI 10.1083/jcb.149.6.1263; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Coppolino MG, 2001, J BIOL CHEM, V276, P4772, DOI 10.1074/jbc.M007792200; Curtis MW, 2008, CELL COMMUN ADHES, V15, P365, DOI 10.1080/15419060802460748; Dalal S, 2004, MOL BIOL CELL, V15, P637, DOI 10.1091/mbc.E03-02-0097; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Giraudo CG, 1999, BIOCHEM J, V342, P633, DOI 10.1042/0264-6021:3420633; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Heisler FF, 2014, P NATL ACAD SCI USA, V111, P5030, DOI 10.1073/pnas.1304301111; Hernandez MV, 2010, MOL BIOL CELL, V21, P1387, DOI 10.1091/mbc.E09-10-0880; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Koch AW, 2004, STRUCTURE, V12, P793, DOI 10.1016/j.str.2004.02.034; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Kowalczyk AP, 2004, CURR OPIN CELL BIOL, V16, P522, DOI 10.1016/j.ceb.2004.07.001; Lazaro-Martinez JM, 2015, MACROMOLECULES, V48, P1115, DOI 10.1021/ma5023082; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Miyashita Y, 2007, J CELL SCI, V120, P4395, DOI 10.1242/jcs.03489; Mo YY, 1996, CANCER RES, V56, P2633; Nakamura T, 2010, J BIOL CHEM, V285, P16145, DOI 10.1074/jbc.M109.081315; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Naydenov NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034320; Naydenov NG, 2012, J BIOL CHEM, V287, P5928, DOI 10.1074/jbc.M111.278358; Ohkubo T, 1999, J BIOL CHEM, V274, P21409, DOI 10.1074/jbc.274.30.21409; Ozawa M, 2002, J BIOL CHEM, V277, P19600, DOI 10.1074/jbc.M202029200; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; Peter F, 1998, J CELL SCI, V111, P2625; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Posthaus H, 1998, FEBS LETT, V438, P306, DOI 10.1016/S0014-5793(98)01330-1; Reynolds AB, 1996, EXP CELL RES, V225, P328, DOI 10.1006/excr.1996.0183; Roczniak-Ferguson A, 2003, J CELL SCI, V116, P4201, DOI 10.1242/jcs.00724; Sangwan V, 2011, J BIOL CHEM, V286, P45000, DOI 10.1074/jbc.M111.270934; Shi L, 2014, J BIOL CHEM, V289, P8432, DOI 10.1074/jbc.M113.517466; SHORE EM, 1991, J BIOL CHEM, V266, P19672; Silverman JB, 2007, J NEUROSCI, V27, P8505, DOI 10.1523/JNEUROSCI.1395-07.2007; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Troyanovsky RB, 2011, MOL BIOL CELL, V22, P4247, DOI 10.1091/mbc.E11-03-0250; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Wu J, 1998, HYBRIDOMA, V17, P175, DOI 10.1089/hyb.1998.17.175; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Zarelli VEP, 2009, J BIOL CHEM, V284, P10491, DOI 10.1074/jbc.M807614200; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	59	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156758	10.1371/journal.pone.0156758	http://dx.doi.org/10.1371/journal.pone.0156758			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254316	Green Published, gold			2022-12-26	WOS:000377218700054
J	Zhang, CL; Guo, L; Chu, X; Shen, LM; Guo, YY; Dong, HL; Mao, JF; van der Veen, S				Zhang, Chuanling; Guo, Liang; Chu, Xu; Shen, Limeng; Guo, Yuanyu; Dong, Huali; Mao, Jianfeng; van der Veen, Stijn			Presence of the Panton-Valentine Leukocidin Genes in Methicillin-Resistant Staphylococcus aureus Is Associated with Severity and Clinical Outcome of Hospital-Acquired Pneumonia in a Single Center Study in China	PLOS ONE			English	Article							NECROTIZING PNEUMONIA; COMMUNITY; STRAINS; INFECTIONS; VIRULENCE; SEQUENCE; USA300	The Panton-Valentine leukocidin (PVL) genes of methicillin-resistant Staphylococcus aureus (MRSA) have previously been associated with severe infections. Here, the impact of the PVL genes on severity of disease and clinical outcome of patients with hospital-acquired pneumonia (HAP) or ventilator-associated pneumonia (VAP) due to MRSA was investigated in a single center observational study in a hospital in China. HAP due to MRSA was diagnosed in 100 patients and 13 of the patients were PVL positive, while VAP was diagnosed in 5 patients and 2 were PVL positive. The PVL positive patient group showed a significantly higher Acute Physiology and Chronic Health Evaluation (APACHE) II score (14.3 +/- 7.8 vs. 10.1 +/- 4.7, P = 0.005) and significantly more patients with CRP levels >80 mg/L (8/15 vs. 12/90, P = 0.006) or WBC counts >15x10(9)/L (7/15 vs. 12/90, P = 0.006), indicating that the severity of disease is affected by the presence of the PVL genes. The outcome of the study was defined by 30-day mortality. Four (27%) of the PVL positive patients and four (4%) of the PVL negative patients died within 30 days (P = 0.01, Fisher exact test). Kaplan-Meier survival curves were generated for the PVL positive and PVL negative patient groups, which differed significantly (P = 0.003). Among the patients that died, the mean interval between diagnosis and death was shorter for the PVL positive patients (9.3 +/- 5.6 vs. 40.8 +/- 6.6 days, P = 0.013). Further analysis within the HAP and VAP patient groups showed that the presence of PVL in MRSA impacted the severity of disease and clinical outcome of HAP, but for VAP the number of patients included in the study was too low. In conclusion, in this single center study in a Chinese hospital the presence of the PVL genes in MRSA impacted the severity of disease and clinical outcome in patients with HAP due to MRSA.	[Zhang, Chuanling; Chu, Xu; Shen, Limeng; Guo, Yuanyu; Dong, Huali; Mao, Jianfeng] Zhejiang Xiaoshan Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Guo, Liang] Zhejiang Xiaoshan Hosp, Intens Care Unit, Hangzhou, Zhejiang, Peoples R China; [van der Veen, Stijn] Zhejiang Univ, Sch Med, Dept Microbiol & Parasitol, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	van der Veen, S (corresponding author), Zhejiang Univ, Sch Med, Dept Microbiol & Parasitol, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.	stijnvanderveen@zju.edu.cn		van der Veen, Stijn/0000-0002-8176-391X	Zhejiang Medical and Health Science and Technology Project [2012KYB171]; Major Science and Technology Programs of Xiaoshan in Hangzhou [2013314]	Zhejiang Medical and Health Science and Technology Project; Major Science and Technology Programs of Xiaoshan in Hangzhou	This work was supported by the Zhejiang Medical and Health Science and Technology Project [2012KYB171] and the Major Science and Technology Programs of Xiaoshan in Hangzhou [2013314]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chen BJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1032-7; Chen FJ, 2014, ANTIMICROB AGENTS CH, V58, P1047, DOI 10.1128/AAC.02045-13; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096255; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dumitrescu O, 2007, ANTIMICROB AGENTS CH, V51, P1515, DOI 10.1128/AAC.01201-06; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Haque NZ, 2012, J CLIN MICROBIOL, V50, P1640, DOI 10.1128/JCM.06701-11; Hota B, 2011, CLIN INFECT DIS, V53, P757, DOI 10.1093/cid/cir472; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070602; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Peyrani P, 2011, CLIN INFECT DIS, V53, P766, DOI 10.1093/cid/cir541; Sharma-Kuinkel BK, 2012, J CLIN MICROBIOL, V50, P848, DOI 10.1128/JCM.06219-11; Song JH, 2011, J ANTIMICROB CHEMOTH, V66, P1061, DOI 10.1093/jac/dkr024; Tacconelli E, 2009, CURR OPIN PULM MED, V15, P218, DOI 10.1097/MCP.0b013e3283292666; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	23	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156704	10.1371/journal.pone.0156704	http://dx.doi.org/10.1371/journal.pone.0156704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249225	Green Published, gold, Green Submitted			2022-12-26	WOS:000377184700071
J	Seo, MG; Lee, SH; VanBik, D; Ouh, IO; Yun, SH; Choi, E; Park, YS; Lee, SE; Kim, JW; Cho, GJ; Kwon, OD; Kwak, D				Seo, Min-Goo; Lee, Seung-Hun; VanBik, Dorene; Ouh, In-Ohk; Yun, Sun-Hee; Choi, Eunsang; Park, Yong-Soo; Lee, Sang-Eun; Kim, Jong Wan; Cho, Gil-Jae; Kwon, Oh-Deog; Kwak, Dongmi			Detection and Genotyping of Coxiella burnetii and Coxiella-Like Bacteria in Horses in South Korea	PLOS ONE			English	Article							Q-FEVER; INFECTION; TICKS; TRANSMISSION	Coxiella burnetii and Coxiella-like bacteria (CLB) are genetically and ecologically distinct despite some genetic similarities. Furthermore, CLB are exceptionally diverse and widespread in ticks, but rarely detected in domestic animals. Since Coxiella bacteria can be transmitted from infected horses by inhalation or by coming in contact with ticks during activities such as horseback riding, it is necessary to study their prevalence. To the best of our knowledge, this is the first large-scale nationwide investigation of the prevalence of C. burnetii and CLB among horses reared in South Korea. Of 816 blood samples collected between 2007 and 2013, 11 (1.3%) were identified as C. burnetii by ELISA, and six (0.7%) as CLB by 16S rRNA sequencing. While a sequence from Jeju Island was similar (97.9-100%) to those within clade B, five sequences obtained from the northern region were categorized into a new clade, indicating the sequence diversity of the genus Coxiella. Studies until date had detected CLB only in ticks; here, we describe their detection in mammals. Given their zoonotic potential, strategic monitoring and appropriate control programs for Coxiella species need to be established.	[Seo, Min-Goo; Lee, Seung-Hun; VanBik, Dorene; Cho, Gil-Jae; Kwon, Oh-Deog; Kwak, Dongmi] Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea; [Seo, Min-Goo; Ouh, In-Ohk; Kim, Jong Wan] Anim & Plant Quarantine Agcy, Gimcheon, South Korea; [Yun, Sun-Hee] Inst Publ Hlth & Environm, Div Vet Serv Lab, Inchon, South Korea; [Choi, Eunsang] Smile Equine Clin, Busan, South Korea; [Park, Yong-Soo] Korea Natl Coll Agr & Fisheries, Dept Horse Ind, Jeonju, South Korea; [Lee, Sang-Eun] Korea Natl Inst Hlth, Div Malaria & Parasit Dis, Cheongju, South Korea; [Kwak, Dongmi] Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea	Kyungpook National University; Animal & Plant Quarantine Agency; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Kyungpook National University	Kwak, D (corresponding author), Kyungpook Natl Univ, Coll Vet Med, Daegu, South Korea.; Kwak, D (corresponding author), Kyungpook Natl Univ, Cardiovasc Res Inst, Daegu, South Korea.	dmkwak@knu.ac.kr		Seo, Min-Goo/0000-0003-1752-5105	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2013102]; Smile Equine Clinic	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education; Smile Equine Clinic	This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant No. NRF-2013R1A1A2013102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Smile Equine Clinic provided support in the form of salary for author EC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Acland HM., 1993, EQUINE REPROD, P554; [Anonymous], 1959, ADV VET SCI; [Anonymous], 2015, DANSK VETERINAERTIDS; Dantas-Torres F, 2015, INT J PARASITOL-PAR, V4, P452, DOI 10.1016/j.ijppaw.2015.07.001; Duron O, 2015, TRENDS PARASITOL, V31, P536, DOI 10.1016/j.pt.2015.06.014; Duron O, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004892; Duron O, 2014, TICKS TICK-BORNE DIS, V5, P557, DOI 10.1016/j.ttbdis.2014.04.003; EKLUND CM, 1947, PUBLIC HEALTH REP, V62, P1413, DOI 10.2307/4586287; Georgiev M, 2013, EURO SURVEILL, V18; Jung BY, 2014, VET MICROBIOL, V173, P152, DOI 10.1016/j.vetmic.2014.06.029; Kirkan S, 2008, TURK J VET ANIM SCI, V32, P215; 우인옥, 2013, [Korean Journal of Veterinary Service, 한국가축위생학회지], V36, P243; Leon A, 2012, PREV VET MED, V104, P179, DOI 10.1016/j.prevetmed.2011.11.001; Marenzoni ML, 2013, VET MICROBIOL, V167, P662, DOI 10.1016/j.vetmic.2013.09.027; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Meredith AL, 2015, TRANSBOUND EMERG DIS, V62, P639, DOI 10.1111/tbed.12211; Ministry of Agriculture, 2015, REP FACT FIND SURV H; Nett RJ, 2012, CASE REP INFECT DIS, V2012, DOI 10.1155/2012/916142; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; Pan L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002231; Racic I, 2014, VET MICROBIOL, V173, P340, DOI 10.1016/j.vetmic.2014.08.016; Roest HIJ, 2013, EMERG INFECT DIS, V19, P834, DOI 10.3201/eid1905.121489; Rolain JM, 2005, CLIN INFECT DIS, V40, P82, DOI 10.1086/426440; Runge M, 2012, PRAKT TIERARZT, V93, P220; Shin GW, 2014, J VET MED SCI, V76, P1069, DOI 10.1292/jvms.13-0575; Shivaprasad HL, 2008, AVIAN DIS, V52, P426, DOI 10.1637/8192-120707-Reg; SKERMAN VBD, 1980, INT J SYST BACTERIOL, V30, P225, DOI 10.1099/00207713-30-1-225; Smith TA, 2015, GENOME BIOL EVOL, V7, P831, DOI 10.1093/gbe/evv016; Tan CK, 2000, DIS AQUAT ORGAN, V41, P115, DOI 10.3354/dao041115; Thrusfield M, 2005, VET EPIDEMIOLOGY, VThird, P228; Tozer SJ, 2014, ZOONOSES PUBLIC HLTH, V61, P105, DOI 10.1111/zph.12051; Vapniarsky N, 2012, VET PATHOL, V49, P717, DOI 10.1177/0300985811409251; Woc-Colburn AM, 2008, VET PATHOL, V45, P247, DOI 10.1354/vp.45-2-247; Zhong JM, 2012, ADV EXP MED BIOL, V984, P365, DOI 10.1007/978-94-007-4315-1_18	34	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156710	10.1371/journal.pone.0156710	http://dx.doi.org/10.1371/journal.pone.0156710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244230	Green Published, gold			2022-12-26	WOS:000377146100064
J	Thompson, GL; Kao-Kniffin, J				Thompson, Grant L.; Kao-Kniffin, Jenny			Diversity Enhances NPP, N Retention, and Soil Microbial Diversity in Experimental Urban Grassland Assemblages	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; 16S RIBOSOMAL-RNA; PLANT DIVERSITY; ECOSYSTEM MULTIFUNCTIONALITY; COMMUNITY STRUCTURE; SPECIES-DIVERSITY; BIODIVERSITY LOSS; UNITED-STATES; NITROGEN; CARBON	Urban grasslands, landscapes dominated by turfgrasses for aesthetic or recreational groundcovers, are rapidly expanding in the United States and globally. These managed ecosystems are often less diverse than the natural or agricultural lands they replace, leading to potential losses in ecosystem functioning. Research in non-urban systems has provided evidence for increases in multiple ecosystem functions associated with greater plant diversity. To test if biodiversity-ecosystem function findings are applicable to urban grasslands, we examined the effect of plant species and genotypic diversity on three ecosystem functions, using grassland assemblages of increasing diversity that were grown within a controlled environment facility. We found positive effects of plant diversity on reduced nitrate leaching and plant productivity. Soil microbial diversity (Mean Shannon Diversity, H') of bacteria and fungi were also enhanced in multi-species plantings, suggesting that moderate increments in plant diversity influence the composition of soil biota. The results from this study indicate that plant diversity impacts multiple functions that are important in urban ecosystems; therefore, further tests of urban grassland biodiversity should be examined in situ to determine the feasibility of manipulating plant diversity as an explicit landscape design and function trait.	[Thompson, Grant L.; Kao-Kniffin, Jenny] Cornell Univ, Sch Integrat Plant Sci, Hort Sect, Ithaca, NY 14853 USA	Cornell University	Kao-Kniffin, J (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Hort Sect, Ithaca, NY 14853 USA.	jtk57@cornell.edu	Thompson, Grant/AAH-2241-2021	Thompson, Grant/0000-0002-6818-2176	National Science Foundation (NSF) Integrated Graduate Education and Research Training (IGERT) grant [1069193]	National Science Foundation (NSF) Integrated Graduate Education and Research Training (IGERT) grant(National Science Foundation (NSF))	The work for this project was supported by a fellowship from the National Science Foundation (NSF) Integrated Graduate Education and Research Training (IGERT) grant #1069193 in Cross-Scale Biogeochemistry and Climate at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dan Vandam, Jeremie Blum, Dani Park, Princess Swan, and the staff of Ken Post Lab Greenhouses for their assistance in the greenhouse, Carri Marchner for help with the LECO CN Analyzer, Marty Petrovic and Jeff Barlow for the use of the SEAL autoanalyzer, the Cornell Statistical Consulting Unit for statistical consultation, Frank Rossi and Laurie Drink-water for comments on the manuscript, and Kevin Panke-Buisse, Sarah Carver, Juana Munoz-Ucros for assistance throughout the project. The work for this project was supported by a fellowship from the National Science Foundation (NSF) Integrated Graduate Education and Research Training (IGERT) grant #1069193 in Cross-Scale Biogeochemistry and Climate at Cornell University. We would also like to thank the journal editorial staff and two anonymous reviewers for guidance in the preparation of this manuscript.	Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barthe CA, 1995, WATERSHED PROTECTION, V2, P239; Berthrong S.T., 2013, MICROB ECOL, P1; Bertin C, 2007, P NATL ACAD SCI USA, V104, P16964, DOI 10.1073/pnas.0707198104; Blackwood CB, 2007, APPL ENVIRON MICROB, V73, P5276, DOI 10.1128/AEM.00514-07; Bormann F. H., 2001, REDESIGNING AM LAWN; Bremer DJ, 2015, HORTTECHNOLOGY, V25, P90, DOI 10.21273/HORTTECH.25.1.90; Bureau UC, 2011, 2010 CENS BRIEFS; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cardinale BJ, 2013, ECOLOGY; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Clark CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052821; Clegg CD, 2003, FEMS MICROBIOL ECOL, V43, P263, DOI 10.1111/j.1574-6941.2003.tb01066.x; Duran J, 2013, GLOBA CHANG BIOL; GOLD AJ, 1990, J SOIL WATER CONSERV, V45, P305; Groffman PM, 2009, J ENVIRON QUAL, V38, P1848, DOI 10.2134/jeq2008.0521; Guillard K, 2004, J ENVIRON QUAL, V33, P1822, DOI 10.2134/jeq2004.1822; Ho CY, 1997, PLANT CELL REP, V16, P797, DOI 10.1007/s002990050323; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hooper DU, 1998, ECOLOGY, V79, P704, DOI 10.1890/0012-9658(1998)079[0704:TROCAC]2.0.CO;2; Jantz P, 2005, ENVIRON MANAGE, V36, P808, DOI 10.1007/s00267-004-0315-3; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Klaus VH, 2013, RESTOR ECOL, V21, P665, DOI 10.1111/rec.12051; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Lundholm J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009677; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; McCarty L.B., 2011, BEST GOLF COURSE MAN; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Mueller KE, 2013, GLOBAL CHANGE BIOL, V19, P1249, DOI 10.1111/gcb.12096; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Pasari JR, 2013, P NATL ACAD SCI USA, V110, P10219, DOI 10.1073/pnas.1220333110; Pouyat RV, 2006, J ENVIRON QUAL, V35, P1566, DOI 10.2134/jeq2005.0215; Pouyat Richard V., 2009, Urban Ecosystems, V12, P45, DOI 10.1007/s11252-008-0059-6; Qian YL, 2002, AGRON J, V94, P930; Raciti SM, 2008, ECOL APPL, V18, P1615, DOI 10.1890/07-1062.1; Raciti SM, 2011, J ENVIRON QUAL, V40, P1932, DOI 10.2134/jeq2011.0107; Raciti SM, 2011, ECOSYSTEMS, V14, P287, DOI 10.1007/s10021-010-9409-3; Robbins P, 2003, LAND USE POLICY, V20, P181, DOI 10.1016/S0264-8377(03)00006-1; Scherer-Lorenzen M, 2003, ECOLOGY, V84, P1539, DOI 10.1890/0012-9658(2003)084[1539:TROPDA]2.0.CO;2; Schimel J. P., 2005, Biological diversity and function in soils, P171, DOI 10.1017/CBO9780511541926.011; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Townsend-Small A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041675; Turgeon A.J., 2005, TURFGRASS MANAGEMENT, V7th ed.; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Webster G, 2002, APPL ENVIRON MICROB, V68, P20, DOI 10.1128/AEM.68.1.20-30.2002; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yao HY, 2006, APPL SOIL ECOL, V34, P209, DOI 10.1016/j.apsoil.2006.01.009; Zhang Y, 2013, J ENV QUAL	60	15	15	4	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155986	10.1371/journal.pone.0155986	http://dx.doi.org/10.1371/journal.pone.0155986			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243768	gold, Green Published			2022-12-26	WOS:000377146100010
J	Fang, JY; Wang, HY; Bai, J; Zhang, QY; Li, YF; Liu, F; Jiang, P				Fang, Jianyu; Wang, Haiyan; Bai, Juan; Zhang, Qiaoya; Li, Yufeng; Liu, Fei; Jiang, Ping			Monkey Viperin Restricts Porcine Reproductive and Respiratory Syndrome Virus Replication	PLOS ONE			English	Article							ANTIVIRAL PROTEIN VIPERIN; INTERFERON-INDUCIBLE PROTEIN; AMPHIPATHIC ALPHA-HELIX; WEST NILE VIRUS; MARC-145 CELLS; ENDOPLASMIC-RETICULUM; HUMAN CYTOMEGALOVIRUS; ENCEPHALITIS-VIRUS; LIPID RAFTS; GENE-EXPRESSION	Porcine reproductive and respiratory syndrome virus (PRRSV) is an important pathogen which causes huge economic damage globally in the swine industry. Current vaccination strategies provide only limited protection against PRRSV infection. Viperin is an interferon (IFN) stimulated protein that inhibits some virus infections via IFN-dependent or IFN-independent pathways. However, the role of viperin in PRRSV infection is not well understood. In this study, we cloned the full-length monkey viperin (mViperin) complementary DNA (cDNA) from IFN-alpha-treated African green monkey Marc-145 cells. It was found that the mViperin is up-regulated following PRRSV infection in Marc-145 cells along with elevated IRF-1 gene levels. IFN-alpha induced mViperin expression in a dose-and time-dependent manner and strongly inhibits PRRSV replication in Marc-145 cells. Overexpression of mViperin suppresses PRRSV replication by blocking the early steps of PRRSV entry and genome replication and translation but not inhibiting assembly and release. And mViperin co-localized with PRRSV GP5 and N protein, but only interacted with N protein in distinct cytoplasmic loci. Furthermore, it was found that the 13-16 amino acids of mViperin were essential for inhibiting PRRSV replication, by disrupting the distribution of mViperin protein from the granular distribution to a homogeneous distribution in the cytoplasm. These results could be helpful in the future development of novel antiviral therapies against PRRSV infection.	[Fang, Jianyu; Wang, Haiyan; Bai, Juan; Zhang, Qiaoya; Li, Yufeng; Liu, Fei; Jiang, Ping] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China; [Jiang, Ping] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Nanjing Agricultural University	Jiang, P (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China.; Jiang, P (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	jiangp@njau.edu.cn			National Natural Science Foundation [31230071]; Ministry of Education, China [2012009711004]; Ministry of Agriculture [CARS-36]; priority academic program development of Jiangsu higher education institutions (PAPD)	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education, China(Ministry of Education, China); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); priority academic program development of Jiangsu higher education institutions (PAPD)	This work was mainly supported by the National Natural Science Foundation (31230071) and grant from the Ministry of Education, China (2012009711004), and for PRRSV immunology, a grant from the Ministry of Agriculture (CARS-36) for swine disease controlling techniques, and the priority academic program development of Jiangsu higher education institutions (PAPD).	Albina E, 1997, VET MICROBIOL, V55, P309, DOI 10.1016/S0378-1135(96)01322-3; Buddaert W, 1998, ADV EXP MED BIOL, V440, P461; Carlton-Smith C, 2012, J VIROL, V86, P11548, DOI 10.1128/JVI.01773-12; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chan YL, 2008, J VIROL, V82, P10455, DOI 10.1128/JVI.00438-08; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; DeFilippis VR, 2006, J VIROL, V80, P1032, DOI 10.1128/JVI.80.2.1032-1037.2006; Dokland T, 2010, VIRUS RES, V154, P86, DOI 10.1016/j.virusres.2010.07.029; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Gao JM, 2014, VET MICROBIOL, V174, P409, DOI 10.1016/j.vetmic.2014.09.030; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Hinson ER, 2010, J IMMUNOL, V184, P5723, DOI 10.4049/jimmunol.0903752; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Huang L, 2011, BIOCHEM BIOPH RES CO, V414, P545, DOI 10.1016/j.bbrc.2011.09.109; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jiang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059229; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Jumat MR, 2015, ANTIVIR RES, V114, P11, DOI 10.1016/j.antiviral.2014.11.007; Kappes MA, 2015, VIROLOGY, V479, P475, DOI 10.1016/j.virol.2015.02.012; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kim Y, 2015, VIROLOGY, V484, P181, DOI 10.1016/j.virol.2015.06.007; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Li C, 2013, ANTIVIR RES, V100, P487, DOI 10.1016/j.antiviral.2013.09.002; Li YH, 2014, P NATL ACAD SCI USA, V111, pE2172, DOI 10.1073/pnas.1321930111; Lim ES, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-55; Mattijssen S, 2012, MICROBES INFECT, V14, P419, DOI 10.1016/j.micinf.2011.11.015; McGillivary G, 2013, J INNATE IMMUN, V5, P60, DOI 10.1159/000342473; MEULENBERG JJM, 1993, J GEN VIROL, V74, P1697, DOI 10.1099/0022-1317-74-8-1697; Miller LC, 2004, ARCH VIROL, V149, P2453, DOI 10.1007/s00705-004-0377-9; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Sen Tan K, 2012, J GEN VIROL, V93, P1269, DOI 10.1099/vir.0.040824-0; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Shi CX, 2015, ARCH MICROBIOL, V197, P503, DOI 10.1007/s00203-015-1088-1; Snijder EJ, 2003, J VIROL, V77, P97, DOI 10.1128/JVI.77.1.97-104.2003; Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264; Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11; Tang YD, 2014, J VIROL, V88, P12296, DOI 10.1128/JVI.01379-14; Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120; Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241; van der Meer Y, 1998, J VIROL, V72, P6689, DOI 10.1128/JVI.72.8.6689-6698.1998; Van Gorp H, 2010, J VIROL, V84, P3101, DOI 10.1128/JVI.02093-09; Veit M, 2014, VIRUS RES, V194, P16, DOI 10.1016/j.virusres.2014.09.010; Wang B, 2015, PLACENTA, V36, P667, DOI 10.1016/j.placenta.2015.03.002; Wang HY, 2016, J INTERF CYTOK RES, V36, P129, DOI 10.1089/jir.2015.0077; Wang R, 2013, J VIROL, V87, P5219, DOI 10.1128/JVI.02643-12; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wissink EHJ, 2005, J VIROL, V79, P12495, DOI 10.1128/JVI.79.19.12495-12506.2005; Yamamoto A, 1996, J CELL SCI, V109, P1727; Yang Q, 2015, VIROLOGY, V484, P170, DOI 10.1016/j.virol.2015.06.005; Yun SI, 2013, J MICROBIOL, V51, P711, DOI 10.1007/s12275-013-3431-z; Zhang LL, 2013, ANTIVIR RES, V99, P197, DOI 10.1016/j.antiviral.2013.06.004; Zhang YG, 2007, J VIROL, V81, P11246, DOI 10.1128/JVI.01282-07	64	22	29	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156513	10.1371/journal.pone.0156513	http://dx.doi.org/10.1371/journal.pone.0156513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232627	gold, Green Submitted, Green Published			2022-12-26	WOS:000376883000040
J	Iden, M; Fye, S; Li, KG; Chowdhury, T; Ramchandran, R; Rader, JS				Iden, Marissa; Fye, Samantha; Li, Keguo; Chowdhury, Tamjid; Ramchandran, Ramani; Rader, Janet S.			The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; C-MYC ONCOGENE; UTERINE CERVIX; INCREASED EXPRESSION; TUMOR OXYGENATION; NUCLEOLIN; TRANSLOCATION; PROLIFERATION; AMPLIFICATION; TRANSCRIPTION	The plasmacytoma variant translocation 1 gene (PVT1) is an lncRNA that has been designated as an oncogene due to its contribution to the phenotype of multiple cancers. Although the mechanism by which PVT1 influences disease processes has been studied in multiple cancer types, its role in cervical tumorigenesis remains unknown. Thus, the present study was designed to investigate the role of PVT1 in cervical cancer in vitro and in vivo. PVT1 expression was measured by quantitative PCR (qPCR) in 121 invasive cervical carcinoma (ICC) samples, 30 normal cervix samples, and cervical cell lines. Functional assays were carried out using both siRNA and LNA-mediated knockdown to examine PVT1' s effects on cervical cancer cell proliferation, migration and invasion, apoptosis, and cisplatin resistance. Our results demonstrate that PVT1 expression is significantly increased in ICC tissue versus normal cervix and that higher expression of PVT1 correlates with poorer overall survival. In cervical cancer cell lines, PVT1 knockdown resulted in significantly decreased cell proliferation, migration and invasion, while apoptosis and cisplatin cytotoxicity were significantly increased in these cells. Finally, we show that PVT1 expression is augmented in response to hypoxia and immune response stimulation and that this lncRNA associates with the multifunctional and stress-responsive protein, Nucleolin. Collectively, our results provide strong evidence for an oncogenic role of PVT1 in cervical cancer and lend insight into potential mechanisms by which PVT1 overexpression helps drive cervical carcinogenesis.	[Iden, Marissa; Fye, Samantha; Li, Keguo; Chowdhury, Tamjid; Ramchandran, Ramani; Rader, Janet S.] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Rader, JS (corresponding author), Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA.	jrader@mcw.edu	Ogunwobi, Olorunseun/F-3172-2010	Iden, Marissa/0000-0003-3383-1751	Women's Health Research Program at the Medical College of Wisconsin	Women's Health Research Program at the Medical College of Wisconsin	This work was supported by the Women's Health Research Program at the Medical College of Wisconsin (http://obgyn.mcw.edu/research/whrp/). The funders had no role in any part of preparation of this manuscript.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; Berger CM, 2015, BIOCHIMIE, V113, P78, DOI 10.1016/j.biochi.2015.03.023; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman MH, 2012, J HEPATOL, V56, P877, DOI 10.1016/j.jhep.2011.10.022; CORY S, 1985, EMBO J, V4, P675, DOI 10.1002/j.1460-2075.1985.tb03682.x; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Daniely Y, 2002, MOL CELL BIOL, V22, P6014, DOI 10.1128/MCB.22.16.6014-6022.2002; Ding CF, 2015, ONCOL LETT, V9, P955, DOI 10.3892/ol.2014.2730; Ding J, 2014, ONCOTARGETS THER, V7, P1625, DOI 10.2147/OTT.S68854; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Fyles AW, 1998, RADIOTHER ONCOL, V48, P149, DOI 10.1016/S0167-8140(98)00044-9; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ginisty H, 1999, J CELL SCI, V112, P761; GRAHAM M, 1986, EMBO J, V5, P2845, DOI 10.1002/j.1460-2075.1986.tb04578.x; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; HOCKEL M, 1993, GYNECOL ONCOL, V51, P141, DOI 10.1006/gyno.1993.1262; Huang C, 2015, MINERVA MED, V106, P143; HUPPI K, 1994, INT J CANCER, V59, P848, DOI 10.1002/ijc.2910590623; Iden M, 2014, ANN M AM ASS CANC RE; Kong R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0355-8; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Paci P, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-83; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Riquelme E, 2014, J THORAC ONCOL, V9, P998, DOI 10.1097/JTO.0000000000000202; Rofstad EK, 2000, BRIT J CANCER, V83, P354, DOI 10.1054/bjoc.2000.1266; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; SHTIVELMAN E, 1990, MOL CELL BIOL, V10, P1835, DOI 10.1128/MCB.10.4.1835; Sundfor K, 2000, RADIOTHER ONCOL, V54, P101, DOI 10.1016/S0167-8140(99)00175-9; Takahashi Y, 2014, BRIT J CANCER, V110, P164, DOI 10.1038/bjc.2013.698; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Tuteja R, 1998, CRIT REV BIOCHEM MOL, V33, P407, DOI 10.1080/10409239891204260; Wang F, 2014, HEPATOLOGY, V60, P1278, DOI 10.1002/hep.27239; WEBB E, 1984, NATURE, V312, P777, DOI 10.1038/312777a0; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Yang YR, 2014, INT J CLIN EXP PATHO, V7, P6929; Zhang X.-w., 2015, BIOCH BIOPHYS RES CO; Zhao Y, 2009, J ZHEJIANG UNIV-SC B, V10, P404, DOI 10.1631/jzus.B0820293; Zhou Q., 2015, TUMOUR BIOL	47	124	129	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156274	10.1371/journal.pone.0156274	http://dx.doi.org/10.1371/journal.pone.0156274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232880	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000018
J	Kroger, H; Fritzell, J; Hoffmann, R				Kroger, Hannes; Fritzell, Johan; Hoffmann, Rasmus			The Association of Levels of and Decline in Grip Strength in Old Age with Trajectories of Life Course Occupational Position	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; SOCIOECONOMIC POSITION; MUSCLE STRENGTH; SOCIAL-CLASS; LONGITUDINAL DATA; CHILDHOOD HEALTH; DROP-OUT; LONG ARM; MEN; COHORT	Background The study of the influence of life course occupational position (OP) on health in old age demands analysis of time patterns in both OP and health. We study associations between life course time patterns of OP and decline in grip strength in old age. Methods We analyze 5 waves from the Survey of Health Ageing and Retirement in Europe (n = 5108, ages 65-90). We use a pattern-mixture latent growth model to predict the level and decline in grip strength in old age by trajectory of life course OP. We extend and generalize the structured regression approach to establish the explanatory power of different life course models for both the level and decline of grip strength. Results Grip strength declined linearly by 0.70 kg (95% CI -0.74;-0.66) for men and 0.42 kg (95% CI -0.45;-0.39) for women per year. The level of men's grip strength can best be explained by a critical period during midlife, with those exposed to low OP during this period having 1.67 kg (95% CI -2.33;-1.00) less grip strength. These differences remain constant over age. For women, no association between OP and levels of or decline in grip strength was found. Conclusions Men's OP in midlife seems to be a critical period for the level of grip strength in old age. Inequalities remain constant over age. The integration of the structured regression approach and latent growth modelling offers new possibilities for life course epidemiology.	[Kroger, Hannes; Hoffmann, Rasmus] European Univ Inst, Florence, Italy; [Fritzell, Johan] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Fritzell, Johan] Stockholm Univ, S-10691 Stockholm, Sweden	European University Institute; Karolinska Institutet; Stockholm University	Kroger, H (corresponding author), European Univ Inst, Florence, Italy.	hannes.kroger@eui.eu	Kröger, Hannes/AAI-3799-2021	Fritzell, Johan/0000-0003-0496-3085; Kroger, Hannes/0000-0003-1576-5519; Hoffmann, Rasmus/0000-0002-9007-3144	European Research Council (ERC) [ERC: 313532]; NordForsk [74637]; European Commission [QLK6-CT-2001-00360]; European Commission (SHARE-I3) [RII-CT-2006-062193]; European Commission (COMPARE) [CIT5- CT-2005-028857]; European Commission (SHARELIFE) [CIT4-CT-2006-028812]; European Commission (SHARE-PREP) [211909]; European Commission (SHARE-LEAP) [227822]; European Commission (SHARE M4) [261982]; U.S. National Institute on Aging [U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, R21 AG025169, Y1-AG-4553-01, IAG BSR06-11, OGHA 04-064]; German Ministry of Education and Research; NATIONAL INSTITUTE ON AGING [R21AG025169, P01AG005842] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)European Commission); NordForsk; European Commission(European CommissionEuropean Commission Joint Research Centre); European Commission (SHARE-I3)(European Commission); European Commission (COMPARE)(European Commission); European Commission (SHARELIFE)(European Commission); European Commission (SHARE-PREP)(European Commission); European Commission (SHARE-LEAP)(European Commission); European Commission (SHARE M4); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the European Research Council (ERC): [ERC: 313532] (https://erc.europa.eu/) and NordForsk [74637] (http://www.nordforsk.org/). The SHARE data collection has been primarily funded by the European Commission through the 5th Framework Programme (project QLK6-CT-2001-00360 in the thematic programme Quality of Life), through the 6th Framework Programme (projects SHARE-I3, RII-CT-2006-062193, COMPARE, CIT5- CT-2005-028857, and SHARELIFE, CIT4-CT-2006-028812) and through the 7th Framework Programme (SHARE-PREP, No 211909, SHARE-LEAP, No 227822 and SHARE M4, No 261982). Additional funding from the U.S. National Institute on Aging (U01 AG09740-13S2, P01 AG005842, P01 AG08291, P30 AG12815, R21 AG025169, Y1-AG-4553-01, IAG BSR06-11 and OGHA 04-064), and the German Ministry of Education and Research, as well as from various national sources, is gratefully acknowledged (see www.share-project.org for a full list of funding institutions). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alomari MA, 2010, EUR J APPL PHYSIOL, V109, P803, DOI 10.1007/s00421-010-1367-0; Andersen-Ranberg K, 2009, EUR J AGEING, V6, P227, DOI 10.1007/s10433-009-0128-6; Bartley M., 2004, HLTH INEQUALITY INTR; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Birnie K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015564; Blane D, 2007, REV EPIDEMIOL SANTE, V55, P31, DOI 10.1016/j.respe.2006.12.004; Blane D, 2001, SOC SCI MED, V52, P959, DOI 10.1016/S0277-9536(00)00188-X; Borsch-Supan A, 2013, INT J EPIDEMIOL, V42, P992, DOI 10.1093/ije/dyt088; Borsch-Supan A, 2011, SHARELIFE METHODOL, V5; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; CLEMENT FJ, 1974, J GERONTOL, V29, P423, DOI 10.1093/geronj/29.4.423; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Corna LM, 2013, ADV LIFE COURSE RES, V18, P150, DOI 10.1016/j.alcr.2013.01.002; den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008; Dex S., 1995, B SOCIOLOGICAL METHO, V49, P58, DOI [10.1177/075910639504900105, DOI 10.1177/075910639504900105]; Diggle P, 2007, J R STAT SOC C-APPL, V56, P499, DOI 10.1111/j.1467-9876.2007.00590.x; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Enders CK, 2011, PSYCHOL METHODS, V16, P1, DOI 10.1037/a0022640; ERA P, 1992, EUR J APPL PHYSIOL O, V64, P84, DOI 10.1007/BF00376446; ERIKSON R, 1984, SOCIOLOGY, V18, P500, DOI 10.1177/0038038584018004003; Fatouros IG, 2005, BRIT J SPORT MED, V39, P776, DOI 10.1136/bjsm.2005.019117; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Fritzell J, 2007, HLTH INEQUALITIES WE, P67; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Gunther CM, 2008, J HAND SURG-AM, V33A, P558, DOI 10.1016/j.jhsa.2008.01.008; Gustafsson PE, 2012, EUR J PUBLIC HEALTH, V22, P322, DOI 10.1093/eurpub/ckr061; Haas S, 2008, SOC SCI MED, V66, P849, DOI 10.1016/j.socscimed.2007.11.004; Hairi FM, 2010, J EPIDEMIOL COMMUN H, V64, P829, DOI 10.1136/jech.2009.088476; Hallqvist J, 2004, SOC SCI MED, V58, P1555, DOI 10.1016/S0277-9536(03)00344-7; Havari E, 2015, EUR J POPUL, V31, P233, DOI 10.1007/s10680-014-9332-y; Hayward MD, 2004, DEMOGRAPHY, V41, P87, DOI 10.1353/dem.2004.0005; Heraclides A, 2010, J EPIDEMIOL COMMUN H, V64, P714, DOI 10.1136/jech.2009.087692; Hoffmann R, 2011, J GERONTOL B-PSYCHOL, V66, P374, DOI 10.1093/geronb/gbr014; Hogan JW, 2004, STAT MED, V23, P1455, DOI 10.1002/sim.1728; Hurst L, 2013, AM J PUBLIC HEALTH, V103, P1641, DOI 10.2105/AJPH.2013.301240; International Standard Classification of Occupations, 1990, ISCO88 ILO; Jann B, 2007, STATA J, V7, P227, DOI 10.1177/1536867X0700700207; Jones AM, 2006, J R STAT SOC A STAT, V169, P543, DOI 10.1111/j.1467-985X.2006.00399.x; Kapetanakis VV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114289; Kim DH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059316, 10.1371/journal.pone.0070684]; Kok A, 2016, J EPIDEMIOL IN PRESS; Kroger H, 2015, STATA J, V15, P155, DOI 10.1177/1536867X1501500110; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kuh D, 2002, AM J EPIDEMIOL, V156, P627, DOI 10.1093/aje/kwf099; Kuh D, 1997, LIFE COURSE APPROACH TO CHRONIC DISEASE EPIDEMIOLOGY, P3; Liang J, 2002, J GERONTOL B-PSYCHOL, V57, pS294, DOI 10.1093/geronb/57.5.S294; Martin-Ruiz C, 2014, LIFE COURSE APPROACH, P177; McDonough P, 2005, SOC SCI MED, V61, P1795, DOI 10.1016/j.socscimed.2005.03.021; Mishra G, 2009, INT J EPIDEMIOL, V38, P528, DOI 10.1093/ije/dyn229; Mishra GD, 2013, EUR J EPIDEMIOL, V28, P139, DOI 10.1007/s10654-013-9777-z; de Quadros LDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136886; Murray ET, 2011, J GERONTOL A-BIOL, V66, P1350, DOI 10.1093/gerona/glr139; Niedzwiedz CL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-628; Nybo H, 2001, J AM GERIATR SOC, V49, P601, DOI 10.1046/j.1532-5415.2001.49121.x; NYGARD CH, 1988, INT ARCH OCC ENV HEA, V60, P291, DOI 10.1007/BF00378476; Ostbye T, 2011, INT J EPIDEMIOL, V40, P240, DOI 10.1093/ije/dyq142; Otero-Rodriguez A, 2011, J EPIDEMIOL COMMUN H, V65, P964, DOI 10.1136/jech.2010.113555; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Russo A, 2006, OCCUP ENVIRON MED, V63, P438, DOI 10.1136/oem.2005.023549; Sacker A, 2011, J EPIDEMIOL COMMUN H, V65, P130, DOI 10.1136/jech.2009.091199; Sasaki H, 2007, AM J MED, V120, P337, DOI 10.1016/j.amjmed.2006.04.018; Sayer AA, 2004, J GERONTOL A-BIOL, V59, P930, DOI 10.1093/gerona/59.9.M930; Schibye B, 2001, APPL ERGON, V32, P425, DOI 10.1016/S0003-6870(01)00034-5; Smith ADAC, 2015, EPIDEMIOLOGY, V26, P719, DOI 10.1097/EDE.0000000000000348; Solga H, 2001, QUAL QUANT, V35, P291, DOI 10.1023/A:1010387414959; Sovio U, 2013, EUR J PREV CARDIOL, V20, P844, DOI 10.1177/2047487312446136; Starr JM, 2011, AGE AGEING, V40, P749, DOI 10.1093/ageing/afr070; Sterba SK, 2014, STRUCT EQU MODELING, V21, P630, DOI 10.1080/10705511.2014.919828; Syddall H, 2003, AGE AGEING, V32, P650, DOI 10.1093/ageing/afg111; Toraman NF, 2005, BRIT J SPORT MED, V39, P561, DOI 10.1136/bjsm.2004.015420; Torssander J, 2010, EUR SOCIOL REV, V26, P465, DOI 10.1093/esr/jcp034; Vermeulen J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-33; Willson AE, 2007, AM J SOCIOL, V112, P1886, DOI 10.1086/512712	75	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155954	10.1371/journal.pone.0155954	http://dx.doi.org/10.1371/journal.pone.0155954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232696	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000009
J	Parang, B; Bradley, AM; Mittal, MK; Short, SP; Thompson, JJ; Barrett, CW; Naik, RD; Bilotta, AJ; Washington, MK; Revetta, FL; Smith, JJ; Chen, X; Wilson, KT; Hiebert, SW; Williams, CS				Parang, B.; Bradley, A. M.; Mittal, M. K.; Short, S. P.; Thompson, J. J.; Barrett, C. W.; Naik, R. D.; Bilotta, A. J.; Washington, M. K.; Revetta, F. L.; Smith, J. J.; Chen, X.; Wilson, K. T.; Hiebert, S. W.; Williams, C. S.			Myeloid translocation genes differentially regulate colorectal cancer programs	ONCOGENE			English	Article							INTESTINAL TUMORIGENESIS; COLON-CANCER; CELL-PROLIFERATION; APC(MIN/+) MICE; NOTCH; COLITIS; APC; ACTIVATION; NEOPLASIA; CARCINOMA	Myeloid translocation genes (MTGs), originally identified as chromosomal translocations in acute myelogenous leukemia, are transcriptional corepressors that regulate hematopoietic stem cell programs. Analysis of The Cancer Genome Atlas (TCGA) database revealed that MTGs were mutated in epithelial malignancy and suggested that loss of function might promote tumorigenesis. Genetic deletion of MTGR1 and MTG16 in the mouse has revealed unexpected and unique roles within the intestinal epithelium. Mtgr1(-/-) mice have progressive depletion of all intestinal secretory cells, and Mtg16(-/-) mice have a decrease in goblet cells. Furthermore, both Mtgr1(-/-) and Mtg16(-/-) mice have increased intestinal epithelial cell proliferation. We thus hypothesized that loss of MTGR1 or MTG16 would modify Apc(1638/+)-dependent intestinal tumorigenesis. Mtgr1(-/-) mice, but not Mtg16(-/-) mice, had a 10-fold increase in tumor multiplicity. This was associated with more advanced dysplasia, including progression to invasive adenocarcinoma, and augmented intratumoral proliferation. Analysis of chromatin immunoprecipitation sequencing data sets for MTGR1 and MTG16 targets indicated that MTGR1 can regulate Wnt and Notch signaling. In support of this, immunohistochemistry and gene expression analysis revealed that both Wnt and Notch signaling pathways were hyperactive in Mtgr1(-/-) tumors. Furthermore, in human colorectal cancer (CRC) samples MTGR1 was downregulated at both the transcript and protein level. Overall our data indicates that MTGR1 has a contextdependent effect on intestinal tumorigenesis.	[Parang, B.; Bradley, A. M.; Mittal, M. K.; Short, S. P.; Thompson, J. J.; Barrett, C. W.; Naik, R. D.; Bilotta, A. J.; Wilson, K. T.; Williams, C. S.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol, 2231 Garland Ave,1065D MRB-IV, Nashville, TN 37235 USA; [Parang, B.; Bradley, A. M.; Mittal, M. K.; Short, S. P.; Thompson, J. J.; Barrett, C. W.; Wilson, K. T.; Williams, C. S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, 2231 Garland Ave,1065D MRB-IV, Nashville, TN 37235 USA; [Washington, M. K.; Revetta, F. L.] Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Smith, J. J.] Div Surg Oncol, Dept Surg, Nashville, TN USA; [Chen, X.] Dept Biostat, Nashville, TN USA; [Wilson, K. T.; Hiebert, S. W.; Williams, C. S.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Wilson, K. T.; Williams, C. S.] Vet Affairs Tennessee Valley Hlth Care Syst, Nashville, TN USA; [Hiebert, S. W.] Dept Biochem, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Williams, CS (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol, 2231 Garland Ave,1065D MRB-IV, Nashville, TN 37235 USA.; Williams, CS (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, 2231 Garland Ave,1065D MRB-IV, Nashville, TN 37235 USA.	christopher.williams@vanderbilt.edu	Williams, Christopher/W-3524-2019; Smith, Jesse Joshua/AAN-5440-2020	Williams, Christopher/0000-0002-1541-579X; Smith, Jesse Joshua/0000-0003-2538-5456; Short, Sarah/0000-0001-9606-7370	National Institutes of Health [K08DK080221, R01DK099204, P50CA095103, 1F30DK096718, 1F31 CA167920, T32 GM07347]; Office of Medical Research, Department of Veterans Affairs [1I01BX001426]; ACS-RSG [116552]; NIH [UL1TR000445];  [R01AT004821];  [P30DK058404]; NATIONAL CANCER INSTITUTE [F31CA167920, P50CA095103, R01CA190612, P01CA116087, R01CA178030] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099204, F30DK096718, P30DK058404, K08DK080221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453, I01BX001426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); ACS-RSG(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank the members of the Williams lab, and Karie Ballard for help in revising and proofreading the manuscript. We also thank Dr R Daniel Beauchamp, David Bader and Barbara Fingleton for their advice and counsel in preparing the manuscript. This work was supported by the National Institutes of Health Grants K08DK080221, R01DK099204 (to CSW), P50CA095103 (to MKW), 1F30DK096718 (to BP), 1F31 CA167920 (to CWB), T32 GM07347 (NIH/NIGMS) (to BP), Merit Review Grant from the Office of Medical Research, Department of Veterans Affairs 1I01BX001426 (to CSW), ACS-RSG 116552 (to CSW), R01AT004821 (to KTW), P30DK058404 (Vanderbilt Digestive Disease Research Center), NIH Grant UL1TR000445 (Vanderbilt CTSA). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	American Cancer Society, 2010, CANC FACTS FIG 2010; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barrett CW, 2011, CANCER RES, V71, P1302, DOI 10.1158/0008-5472.CAN-10-3317; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Calabi F, 2001, MOL CELL BIOL, V21, P5658, DOI 10.1128/MCB.21.16.5658-5666.2001; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chyla BJ, 2008, MOL CELL BIOL, V28, P6234, DOI 10.1128/MCB.00404-08; Dahl JA, 2007, FRONT BIOSCI-LANDMRK, V12, P4925, DOI 10.2741/2438; Davis JN, 2003, GENE, V303, P1, DOI 10.1016/S0378-1119(02)01172-1; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Garg P, 2010, CANCER RES, V70, P792, DOI 10.1158/0008-5472.CAN-09-3166; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Katoh M, 2007, INT J ONCOL, V30, P247; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Kochetkova M, 2002, CANCER RES, V62, P4599; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Li Y, 2014, ONCOGENE, V33, P369, DOI 10.1038/onc.2012.581; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Martinez JA, 2006, GASTROENTEROLOGY, V131, P579, DOI 10.1053/j.gastro.2006.06.009; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Moore AC, 2008, MOL CELL BIOL, V28, P977, DOI 10.1128/MCB.01242-07; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Parang B, 2015, FASEB J, V29, P786, DOI 10.1096/fj.14-254284; Peignon G, 2011, GUT, V60, P166, DOI 10.1136/gut.2009.204719; Poindexter SV, 2015, AM J PHYSIOL-GASTR L, V308, pG562, DOI 10.1152/ajpgi.00253.2014; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Silverman KA, 2002, GENOME RES, V12, P88, DOI 10.1101/gr.206002; Sinnamon MJ, 2008, INT J EXP PATHOL, V89, P466, DOI 10.1111/j.1365-2613.2008.00621.x; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Weyden L, 2008, ONCOGENE, V27, P4503; Williams CS, 2013, GUT, V62, P1446, DOI 10.1136/gutjnl-2011-301439; Williams CS, 2011, J CLIN INVEST, V121, P4056, DOI 10.1172/JCI44228; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598; Zecchini V, 2005, GENE DEV, V19, P1686, DOI 10.1101/gad.341705	48	8	9	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 8	2016	35	49					6341	6349		10.1038/onc.2016.167	http://dx.doi.org/10.1038/onc.2016.167			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EF3TJ	27270437	Green Accepted			2022-12-26	WOS:000390247000007
J	Gopalakrishna, KN; Boyd, K; Yadav, RP; Artemyev, NO				Gopalakrishna, Kota N.; Boyd, Kimberly; Yadav, Ravi P.; Artemyev, Nikolai O.			Aryl Hydrocarbon Receptor-interacting Protein-like 1 Is an Obligate Chaperone of Phosphodiesterase 6 and Is Assisted by the gamma-Subunit of Its Client	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; CYCLIC-GMP PHOSPHODIESTERASE; ROD CGMP-PHOSPHODIESTERASE; BETA-SUBUNIT; RETINAL DEGENERATION; NONSENSE MUTATION; AIPL1; GENE; MOUSE; DOMAIN	Phosphodiesterase 6 (PDE6) is the effector enzyme in the phototransduction cascade and is critical for the health of both rod and cone photoreceptors. Its dysfunction, caused by mutations in either the enzyme itself or AIPL1 (aryl hydrocarbon receptor-interacting protein-like 1), leads to retinal diseases culminating in blindness. Progress in research on PDE6 and AIPL1 has been severely hampered by failure to express functional PDE6 in a heterologous expression system. Here, we demonstrated that AIPL1 is an obligate chaperone of PDE6 and that it enables low yield functional folding of cone PDE6C in cultured cells. We further show that the AIPL1-mediated production of folded PDE6C is markedly elevated in the presence of the inhibitory P gamma-subunit of PDE6. As illustrated in this study, a simple and sensitive system in which AIPL1 and P gamma are co-expressed with PDE6 represents an effective tool for probing structure-function relationships of AIPL1 and reliably establishing the pathogenicity of its variants.	[Gopalakrishna, Kota N.; Boyd, Kimberly; Yadav, Ravi P.; Artemyev, Nikolai O.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Artemyev, Nikolai O.] Univ Iowa, Carver Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Artemyev, NO (corresponding author), Dept Mol Physiol & Biophys, 5-532 Bowen Sci Bldg,51 Newton Rd, Iowa City, IA 52242 USA.	nikolai-artemyev@uiowa.edu		Artemyev, Nikolai/0000-0002-5266-6854; Yadav, Ravi Prakash/0000-0002-6243-8388	National Institutes of Health [EY-10843]; NATIONAL EYE INSTITUTE [R01EY010843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant EY-10843 (to N. O. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ANANT JS, 1992, J BIOL CHEM, V267, P687; Arshavsky Vadim Y, 2014, Cell Logist, V4, pe29390; Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; BAEHR W, 1979, J BIOL CHEM, V254, P1669; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; Bellingham J, 2015, INVEST OPHTH VIS SCI, V56, P7784, DOI 10.1167/iovs.15-18092; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Cahill KB, 2012, J BIOL CHEM, V287, P41406, DOI 10.1074/jbc.M112.389189; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Cheguru P, 2015, MOL CELL NEUROSCI, V64, P1, DOI 10.1016/j.mcn.2014.10.007; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dhamaraj S, 2004, ARCH OPHTHALMOL-CHIC, V122, P1029, DOI 10.1001/archopht.122.7.1029; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; Dvir L, 2010, AM J HUM GENET, V87, P258, DOI 10.1016/j.ajhg.2010.06.016; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Galvin JA, 2005, RETINA-J RET VIT DIS, V25, P919, DOI 10.1097/00006982-200510000-00016; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; Granovsky AE, 1998, J BIOL CHEM, V273, P24485, DOI 10.1074/jbc.273.38.24485; Grau T, 2011, HUM MOL GENET, V20, P719, DOI 10.1093/hmg/ddq517; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; Kirschman LT, 2010, HUM MOL GENET, V19, P1076, DOI 10.1093/hmg/ddp571; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; Kohl S, 2012, AM J HUM GENET, V91, P527, DOI 10.1016/j.ajhg.2012.07.006; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Majumder A, 2015, J NEUROSCI, V35, P9225, DOI 10.1523/JNEUROSCI.3563-14.2015; Majumder A, 2013, J BIOL CHEM, V288, P21320, DOI 10.1074/jbc.M113.476242; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Morgan RML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053339; Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015; Muradov H, 2009, J BIOL CHEM, V284, P32662, DOI 10.1074/jbc.M109.049916; OYCHINNIKOV YA, 1986, FEBS LETT, V204, P288; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; QIN N, 1994, J BIOL CHEM, V269, P3265; Ramamurthy V, 2004, P NATL ACAD SCI USA, V101, P13897, DOI 10.1073/pnas.0404197101; Schwartz ML, 2006, ADV EXP MED BIOL, V572, P89; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Skiba NP, 2000, J BIOL CHEM, V275, P32716, DOI 10.1074/jbc.C000413200; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tan MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032330; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Trivellin G, 2011, J ENDOCRINOL, V210, P137, DOI 10.1530/JOE-11-0054; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; van der Spuy J, 2006, ADV EXP MED BIOL, V572, P471; Yadav RP, 2015, J NEUROCHEM, V135, P165, DOI 10.1111/jnc.13223; Zeng-Elmore X, 2014, J MOL BIOL, V426, P3713, DOI 10.1016/j.jmb.2014.07.033; Zhang ZX, 2015, J BIOL CHEM, V290, P12833, DOI 10.1074/jbc.M115.647636	57	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16282	16291		10.1074/jbc.M116.737593	http://dx.doi.org/10.1074/jbc.M116.737593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27268253	Green Published, hybrid			2022-12-26	WOS:000380585400032
J	Peck, BCE; Sincavage, J; Feinstein, S; Mah, AT; Simmons, JG; Lund, PK; Sethupathy, P				Peck, Bailey C. E.; Sincavage, John; Feinstein, Sydney; Mah, Amanda T.; Simmons, James G.; Lund, P. Kay; Sethupathy, Praveen			miR-30 Family Controls Proliferation and Differentiation of Intestinal Epithelial Cell Models by Directing a Broad Gene Expression Program That Includes SOX9 and the Ubiquitin Ligase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; TRANSCRIPTION FACTOR; SUCRASE-ISOMALTASE; CACO-2; MICRORNAS; TARGETS; POPULATIONS; SUPPRESSES; REGULATORS; INHIBITION	Proliferation and differentiation of intestinal epithelial cells (IECs) occur in part through precise regulation of key transcription factors, such as SOX9. MicroRNAs (miRNAs) have emerged as prominent fine-tuners of transcription factor expression and activity. We hypothesized that miRNAs, in part through the regulation of SOX9, may mediate IEC homeostasis. Bioinformatic analyses of the SOX9 3'-UTR revealed highly conserved target sites for nine different miRNAs. Of these, only the miR-30 family members were both robustly and variably expressed across functionally distinct cell types of the murine jejunal epithelium. Inhibition of miR-30 using complementary locked nucleic acids (LNA30bcd) in both human IECs and human colorectal adenocarcinoma-derived Caco-2 cells resulted in significant up-regulation of SOX9 mRNA but, interestingly, significant down-regulation of SOX9 protein. To gain mechanistic insight into this non-intuitive finding, we performed RNA sequencing on LNA30bcd-treated human IECs and found 2440 significantly increased genes and 2651 significantly decreased genes across three time points. The up-regulated genes are highly enriched for both predicted miR-30 targets, as well as genes in the ubiquitin-proteasome pathway. Chemical suppression of the proteasome rescued the effect of LNA30bcd on SOX9 protein levels, indicating that the regulation of SOX9 protein by miR-30 is largely indirect through the proteasome pathway. Inhibition of the miR-30 family led to significantly reduced IEC proliferation and a dramatic increase in markers of enterocyte differentiation. This in-depth analysis of a complexm iRNA regulatory program in intestinal epithelial cell models provides novel evidence that the miR-30 family likely plays an important role in IEC homeostasis.	[Peck, Bailey C. E.; Lund, P. Kay; Sethupathy, Praveen] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Sincavage, John; Feinstein, Sydney; Sethupathy, Praveen] Univ N Carolina, Dept Genet, 5091 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA; [Mah, Amanda T.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Mah, Amanda T.; Simmons, James G.; Lund, P. Kay] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Sethupathy, Praveen] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sethupathy, P (corresponding author), Univ N Carolina, Dept Genet, 5091 Genet Med Bldg,120 Mason Farm Rd, Chapel Hill, NC 27599 USA.	praveen_sethupathy@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022	Peck, Bailey/0000-0002-4316-0966	University of North Carolina Genetics and Molecular Biology Training Grant through the NIGMS, National Institutes of Health [T32GM007092]; University of North Carolina Initiative to Maximize Student Diversity (IMSD) Diversity Fellowship Award through NIGMS, National Institutes of Health Grant [5R25GM55336]; NIDDK/National Institutes of Health Grants [F31DK105747, 5R00DK091318, P30DK056350]; American Diabetes Association [1-16-ACE-47]; NATIONAL CANCER INSTITUTE [F31CA165891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK105747, R00DK091318, P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055336, T32GM007092] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER	University of North Carolina Genetics and Molecular Biology Training Grant through the NIGMS, National Institutes of Health; University of North Carolina Initiative to Maximize Student Diversity (IMSD) Diversity Fellowship Award through NIGMS, National Institutes of Health Grant; NIDDK/National Institutes of Health Grants; American Diabetes Association(American Diabetes Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by University of North Carolina Genetics and Molecular Biology Training Grant T32GM007092 (to B. C. E. P.) through the NIGMS, National Institutes of Health; by the University of North Carolina Initiative to Maximize Student Diversity (IMSD) Diversity Fellowship Award (to B. C. E. P.) through NIGMS, National Institutes of Health Grant 5R25GM55336; NIDDK/National Institutes of Health Grants F31DK105747 (to B. C. E. P.), 5R00DK091318 (to P. S.), and P30DK056350 (to P. S.); and American Diabetes Association Grant 1-16-ACE-47 (to P. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Andres SF, 2013, J CELL SCI, V126, P5645, DOI 10.1242/jcs.132985; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baran-Gale J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073240; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Belo J, 2013, STEM CELLS DEV, V22, P2935, DOI 10.1089/scd.2013.0106; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; BriskeAnderson MJ, 1997, P SOC EXP BIOL MED, V214, P248; Chang TJ, 2016, CELL PROLIFERAT, V49, P207, DOI 10.1111/cpr.12246; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chivukula RR, 2014, CELL, V157, P1104, DOI 10.1016/j.cell.2014.03.055; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Dynoodt P, 2013, INT J ONCOL, V42, P1443, DOI 10.3892/ijo.2013.1823; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gil-Zamorano J, 2014, J NUTR, V144, P575, DOI 10.3945/jn.113.189050; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guess MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118229; Hattori T, 2013, J BIOL CHEM, V288, P35138, DOI 10.1074/jbc.M113.486795; He P, 2015, INT J CLIN EXP MED, V8, P6510; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Kanai Y, 2005, J BIOCHEM, V138, P13, DOI 10.1093/jb/mvi098; Kurtz CL, 2014, DIABETES, V63, P3141, DOI 10.2337/db13-1015; Lee S, 2014, STEM CELLS DEV, V23, P1798, DOI 10.1089/scd.2013.0609; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu SR, 2016, CELL HOST MICROBE, V19, P32, DOI 10.1016/j.chom.2015.12.005; Mah AT, 2014, ENDOCRINOLOGY, V155, P3302, DOI 10.1210/en.2014-1112; Martinez-Sanchez A, 2012, J BIOL CHEM, V287, P916, DOI 10.1074/jbc.M111.302430; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Mologni L, 2010, CANCER RES, V70, P7253, DOI 10.1158/0008-5472.CAN-10-1108; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Mustata RC, 2011, EMBO REP, V12, P558, DOI 10.1038/embor.2011.52; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Nunn A.C, 2012, THESIS U COLL LONDON, P1; Peck BCE, 2015, INFLAMM BOWEL DIS, V21, P2178, DOI 10.1097/MIB.0000000000000478; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roche KC, 2015, GASTROENTEROLOGY, V149, P1553, DOI 10.1053/j.gastro.2015.07.004; Rockich BE, 2013, P NATL ACAD SCI USA, V110, pE4456, DOI 10.1073/pnas.1311847110; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; She ZY, 2015, EUR J CELL BIOL, V94, P547, DOI 10.1016/j.ejcb.2015.08.002; Shi ZC, 2013, AM J PHYSIOL-GASTR L, V305, pG74, DOI 10.1152/ajpgi.00086.2013; Su WL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.23; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; VANBEERS EH, 1995, BIOCHEM J, V308, P769, DOI 10.1042/bj3080769; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wu TT, 2012, J BIOL CHEM, V287, P7503, DOI 10.1074/jbc.M111.292722; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Ye DM, 2011, GASTROENTEROLOGY, V141, P1323, DOI 10.1053/j.gastro.2011.07.005; Yu CC, 2013, CANCER RES, V73, P3425, DOI 10.1158/0008-5472.CAN-12-3840; Zhang YQ, 2012, FEBS LETT, V586, P4362, DOI 10.1016/j.febslet.2012.10.053; ZWEIBAUM A, 1983, INT J CANCER, V32, P407, DOI 10.1002/ijc.2910320403	60	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					15975	15984		10.1074/jbc.M116.733733	http://dx.doi.org/10.1074/jbc.M116.733733			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27261459	Green Published, hybrid			2022-12-26	WOS:000380585400005
J	Bilgic, HB; Karagenc, T; Bakirci, S; Shiels, B; Tait, A; Kinnaird, J; Eren, H; Weir, W				Bilgic, Huseyin Bilgin; Karagenc, Tulin; Bakirci, Serkan; Shiels, Brian; Tait, Andrew; Kinnaird, Jane; Eren, Hasan; Weir, William			Identification and Analysis of Immunodominant Antigens for ELISA-Based Detection of Theileria annulata	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; PIROPLASM SURFACE-ANTIGEN; TROPICAL THEILERIOSIS; MULTIPLEX PCR; INFECTION; DIAGNOSIS; DIVERSITY; PROTEIN; CATTLE; IMMUNITY	Tropical or Mediterranean theileriosis, caused by the protozoan parasite Theileria annulata, remains an economically important bovine disease in North Africa, Southern Europe, India, the Middle East and Asia. The disease affects mainly exotic cattle and imposes serious constraints upon livestock production and breed improvement programmes. While microscopic and molecular methods exist which are capable of detecting T. annulata during acute infection, the identification of animals in the carrier state is more challenging. Serological tests, which detect antibodies that react against parasite-encoded antigens, should ideally have the potential to identify carrier animals with very high levels of sensitivity and specificity. However, assays developed to date have suffered from a lack of sensitivity and/or specificity and it is, therefore, necessary to identify novel parasite antigens, which can be developed for this purpose. In the present study, genes encoding predicted antigens were bioinformatically identified in the T. annulata genome. These proteins, together with a panel of previously described antigens, were assessed by western blot analysis for immunoreactivity, and this revealed that four novel candidates and five previously described antigens were recognised by immune bovine serum. Using a combination of immunoprecipitation and mass spectrophotometric analysis, an immunodominant protein (encoded by TA15705) was identified as Ta9, a previously defined T cell antigen. Western blotting revealed another of the five proteins in the Ta9 family, TA15710, also to be an immunodominant protein. However, validation by Enzyme-Linked Immunosorbent Assay indicated that due to either allelic polymorphism or differential immune responses of individual hosts, none of the novel candidates can be considered ideal for routine detection of T. annulata-infected/carrier animals.	[Bilgic, Huseyin Bilgin; Karagenc, Tulin; Bakirci, Serkan; Eren, Hasan] Adnan Menderes Univ, Dept Parasitol, Fac Vet Med, TR-09016 Isikli Mevki, Aydin, Turkey; [Shiels, Brian; Tait, Andrew; Kinnaird, Jane; Weir, William] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland	Adnan Menderes University; University of Glasgow	Bilgic, HB (corresponding author), Adnan Menderes Univ, Dept Parasitol, Fac Vet Med, TR-09016 Isikli Mevki, Aydin, Turkey.	huseyin_bilgic@yahoo.com	Bilgic, Huseyin Bilgin/AAH-4568-2019; BAKIRCI, Serkan/ABD-1433-2020	BAKIRCI, Serkan/0000-0002-6033-2205; Weir, William/0000-0001-8648-666X; Shiels, Brian/0000-0001-7595-2514	Wellcome Trust Foundation [075820/A/04/Z]; University of Adnan Menderes, Scientific Research Programs [VFT-06006]	Wellcome Trust Foundation(Wellcome Trust); University of Adnan Menderes, Scientific Research Programs(Adnan Menderes University)	This work was supported by the Wellcome Trust Foundation (www.wellcome.ac.uk/funding/) (Ref: 075820/A/04/Z, AT BS TK) and the University of Adnan Menderes, Scientific Research Programs (http://idari.adu.edu.tr/bap/) (Project no. VFT-06006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED JS, 1988, ZBL BAKT-INT J MED M, V267, P425; Al-Hosary Amira A.T., 2015, Journal of Parasitology Research, P787812, DOI 10.1155/2015/787812; Ali AM, 2008, ANN NY ACAD SCI, V1149, P218, DOI 10.1196/annals.1428.025; Bakheit M. A., 2007, Parassitologia (Rome), V49, P53; Bakheit MA, 2004, PARASITOL RES, V92, P299, DOI 10.1007/s00436-003-1055-7; Beniwal RK, 1997, TROP ANIM HEALTH PRO, V29, p109S, DOI 10.1007/BF02632947; BENMILED L, 1994, PARASITOLOGY, V108, P51, DOI 10.1017/S0031182000078513; Betton JM, 2004, BIOCHIMIE, V86, P601, DOI 10.1016/j.biochi.2004.07.004; Bhatia V, 2004, INFECT IMMUN, V72, P6245, DOI 10.1128/IAI.72.11.6245-6254.2004; Bilgic HB, 2013, EXP PARASITOL, V133, P222, DOI 10.1016/j.exppara.2012.11.005; Bilgic HB, 2010, VET PARASITOL, V174, P341, DOI 10.1016/j.vetpar.2010.08.025; Boulter N, 2000, ADV PARASIT, V44, P41; BREWER S, 1990, J MOL BIOL, V216, P883, DOI 10.1016/S0022-2836(99)80008-4; Brown C.G.D., 1987, P230; Chen JH, 2014, J PROTEOMICS, V98, P289, DOI 10.1016/j.jprot.2014.01.010; DEKOK JB, 1993, EXP APPL ACAROL, V17, P839, DOI 10.1007/BF00225857; DICKSON J, 1993, MOL BIOCHEM PARASIT, V57, P55, DOI 10.1016/0166-6851(93)90243-Q; dOliveira C, 1997, VACCINE, V15, P1796, DOI 10.1016/S0264-410X(97)00197-7; DOLIVEIRA C, 1995, J CLIN MICROBIOL, V33, P2665, DOI 10.1128/JCM.33.10.2665-2669.1995; EDWARDS MC, 1994, PCR METH APPL, V3, pS65; Gharbi M, 2006, VET PARASITOL, V137, P231, DOI 10.1016/j.vetpar.2006.01.015; Ghoneim AM, 2014, ACTA PARASITOL, V59, P85, DOI 10.2478/s11686-014-0211-9; GLASCODINE J, 1990, MOL BIOCHEM PARASIT, V40, P105, DOI 10.1016/0166-6851(90)90084-Y; Goto Y, 2007, INFECT IMMUN, V75, P846, DOI 10.1128/IAI.01205-06; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Gray MA, 1981, IN VITRO NEUTRALIZAT, P127; GREINER M, 1995, J IMMUNOL METHODS, V185, P145, DOI 10.1016/0022-1759(95)00078-O; Gubbels JM, 1999, J CLIN MICROBIOL, V37, P1782, DOI 10.1128/JCM.37.6.1782-1789.1999; Gubbels MJ, 2000, CLIN DIAGN LAB IMMUN, V7, P404, DOI 10.1128/CDLI.7.3.404-411.2000; Gubbels MJ, 2000, MOL BIOCHEM PARASIT, V110, P23, DOI 10.1016/S0166-6851(00)00253-X; Ilhan T, 1999, THESIS U EDINBURGH; Irvin A. D., 1987, Immune responses in parasitic infections: immunology, immunopathology, and immunoprophylaxis. Volume III: Protozoa, P223; Jongejan F., 1994, EUR UN 3 COORD M TRO, P59; KACHANI M, 1992, VET IMMUNOL IMMUNOP, V34, P221, DOI 10.1016/0165-2427(92)90166-N; Katzer F, 1998, ANN NY ACAD SCI, V849, P96, DOI 10.1111/j.1749-6632.1998.tb11039.x; KILTZ HH, 1986, RES VET SCI, V40, P197, DOI 10.1016/S0034-5288(18)30512-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leemans I, 1999, VET PARASITOL, V82, P193, DOI 10.1016/S0304-4017(99)00014-X; Limenitakis J, 2011, FEBS LETT, V585, P1579, DOI 10.1016/j.febslet.2011.05.002; Machugh ND, 2008, PARASITE IMMUNOL, V30, P385, DOI 10.1111/j.1365-3024.2008.01038.x; MacHugh ND, 2011, INFECT IMMUN, V79, P2059, DOI 10.1128/IAI.01285-10; Martin-Sanchez J, 1999, PARASITOL RES, V85, P243, DOI 10.1007/s004360050541; Matita G, 1994, STAGE SPECIFIC DIAGN; MINAMI T, 1983, RES VET SCI, V35, P334, DOI 10.1016/S0034-5288(18)32029-0; Miranda JPG, 2006, ANN NY ACAD SCI, V1081, P468, DOI 10.1196/annals.1373.067; Mohamed AM, 2012, VET PARASITOL, V186, P486, DOI 10.1016/j.vetpar.2011.11.028; NEITZ W. O., 1957, ONDERSTEPOORT JOUR VET RES, V27, P275; Oura CAL, 2004, PARASITOLOGY, V129, P27, DOI 10.1017/S003118200400513X; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pieszko MWW, 2015, PLOS NEGL TROP DIS, V14; PRESTON PM, 1985, PARASITE IMMUNOL, V7, P301, DOI 10.1111/j.1365-3024.1985.tb00078.x; Rajendran C., 2014, Journal of Parasitic Diseases, V38, P41, DOI 10.1007/s12639-012-0183-3; Renneker S, 2008, TRANSBOUND EMERG DIS, V55, P249, DOI 10.1111/j.1865-1682.2008.01036.x; ROBINSON PM, 1982, TROP ANIM HEALTH PRO, V14, P3, DOI 10.1007/BF02281092; Salih DA, 2008, TRANSBOUND EMERG DIS, V55, P238, DOI 10.1111/j.1865-1682.2008.01033.x; Salih DEA, 2005, PARASITOL RES, V97, P302, DOI 10.1007/s00436-005-1431-6; Santos M, 2013, TICKS TICK-BORNE DIS, V4, P72, DOI 10.1016/j.ttbdis.2012.07.006; Schnittger L, 2002, MOL BIOCHEM PARASIT, V120, P247, DOI 10.1016/S0166-6851(02)00013-0; Schnittger L, 2000, PARASITOL RES, V86, P444, DOI 10.1007/s004360050692; Seitzer U, 2008, TRANSBOUND EMERG DIS, V55, P244, DOI 10.1111/j.1865-1682.2008.01030.x; Seitzer U, 2008, VACCINE, V26, pG24, DOI 10.1016/j.vaccine.2008.10.039; Seitzer U, 2007, PARASITOL RES, V101, pS217, DOI 10.1007/s00436-007-0685-6; Shayan P, 1998, ANN NY ACAD SCI, V849, P88, DOI 10.1111/j.1749-6632.1998.tb11038.x; SHIELS B, 1989, MOL BIOCHEM PARASIT, V34, P209, DOI 10.1016/0166-6851(89)90049-2; SHIELS BR, 1995, MOL BIOCHEM PARASIT, V72, P149, DOI 10.1016/0166-6851(95)00074-B; SHIELS BR, 1986, PARASITE IMMUNOL, V8, P69, DOI 10.1111/j.1365-3024.1986.tb00834.x; Shiels Brian R., 1994, Molecular and Cellular Differentiation, V2, P101; Towbin H., 1990, P NATL ACAD SCI USA, P4350; UILENBERG G, 1995, VET PARASITOL, V57, P19, DOI 10.1016/0304-4017(94)03107-8; Van Regenmortel MHV, 2006, J MOL RECOGNIT, V19, P183, DOI 10.1002/jmr.768; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Weir W, 2006, GENOMIC POPULATION G; Weir W, 2007, MOL BIOCHEM PARASIT, V154, P170, DOI 10.1016/j.molbiopara.2007.04.015; Weir W, 2011, INT J PARASITOL, V41, P193, DOI 10.1016/j.ijpara.2010.08.004; WILLIAMSON S, 1989, P NATL ACAD SCI USA, V86, P4639, DOI 10.1073/pnas.86.12.4639; Williamson S, 1994, 3 EUR UN COORD M TRO; Williamson SM, 1988, THEILERIA ANNULATA S	78	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156645	10.1371/journal.pone.0156645	http://dx.doi.org/10.1371/journal.pone.0156645			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270235	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000377561000026
J	Jehi, SE; Nanavaty, V; Li, BB				Jehi, Sanaa E.; Nanavaty, Vishal; Li, Bibo			Trypanosoma brucei TIF2 and TRF Suppress VSG Switching Using Overlapping and Independent Mechanisms	PLOS ONE			English	Article							GENE-EXPRESSION SITES; ANTIGENIC VARIATION; HOMOLOGOUS RECOMBINATION; TELOMERE LENGTH; END; REPLICATION; ROLES; IDENTIFICATION; DEGRADATION; POLYMERASE	Trypanosoma brucei causes debilitating human African trypanosomiasis and evades the host's immune response by regularly switching its major surface antigen, VSG, which is expressed exclusively from subtelomeric loci. We previously showed that two interacting telomere proteins, TbTRF and TbTIF2, are essential for cell proliferation and suppress VSG switching by inhibiting DNA recombination events involving the whole active VSG expression site. We now find that TbTIF2 stabilizes TbTRF protein levels by inhibiting their degradation by the 26S proteasome, indicating that decreased TbTRF protein levels in TbTIF2-depleted cells contribute to more frequent VSG switching and eventual cell growth arrest. Surprisingly, although TbTIF2 depletion leads to more subtelomeric DNA double strand breaks (DSBs) that are both potent VSG switching inducers and detrimental to cell viability, TbTRF depletion does not increase the amount of DSBs inside subtelomeric VSG expression sites. Furthermore, expressing an ectopic allele of F2H-TbTRF in TbTIF2 RNAi cells allowed cells to maintain normal TbTRF protein levels for a longer frame of time. This resulted in a mildly better cell growth and partially suppressed the phenotype of increased VSG switching frequency but did not suppress the phenotype of more subtelomeric DSBs in TbTIF2-depleted cells. Therefore, TbTIF2 depletion has two parallel effects: decreased TbTRF protein levels and increased subtelomeric DSBs, both resulting in an acute increased VSG switching frequency and eventual cell growth arrest.	[Jehi, Sanaa E.; Nanavaty, Vishal; Li, Bibo] Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA; [Li, Bibo] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Li, Bibo] Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA; [Li, Bibo] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Jehi, Sanaa E.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University System of Ohio; Cleveland State University; Rockefeller University; Cleveland Clinic Foundation; Case Western Reserve University; Scripps Research Institute	Li, BB (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA.; Li, BB (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.; Li, BB (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Immunol, Cleveland, OH 44106 USA.; Li, BB (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	b.li37@csuohio.edu		Nanavaty, Vishal/0000-0001-7946-8076	National Institute of Allergy and Infectious Diseases [AI066095]; Cleveland State University Faculty Research and Development; Center for Gene Regulation in Health and Disease at Cleveland State University research fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066095] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cleveland State University Faculty Research and Development; Center for Gene Regulation in Health and Disease at Cleveland State University research fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institute of Allergy and Infectious Diseases, R01 grant (AI066095), https://www.niaid.nih.gov/Pages/default.aspx, PI: Li; Cleveland State University 2010 Faculty Research and Development, http://www.csuohio.edu/, PI: Li; The Center for Gene Regulation in Health and Disease at Cleveland State University research fund, https://www.csuohio.edu/grhd/grhd, PI: Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2001, MOL BIOCHEM PARASIT, V113, P79, DOI 10.1016/S0166-6851(00)00388-1; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Benmerzouga I, 2013, MOL MICROBIOL, V87, P196, DOI 10.1111/mmi.12093; BERNARDS A, 1983, NATURE, V303, P592, DOI 10.1038/303592a0; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Berriman M, 2002, MOL BIOCHEM PARASIT, V122, P131, DOI 10.1016/S0166-6851(02)00092-0; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Boothroyd CE, 2009, NATURE, V459, P278, DOI 10.1038/nature07982; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Burton P, 2007, EUKARYOT CELL, V6, P1773, DOI 10.1128/EC.00212-07; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Conway C, 2002, MOL MICROBIOL, V45, P1687, DOI 10.1046/j.1365-2958.2002.03122.x; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1982, NATURE, V299, P451, DOI 10.1038/299451a0; Dreesen O, 2007, NAT REV MICROBIOL, V5, P70, DOI 10.1038/nrmicro1577; Dreesen O, 2006, EUKARYOT CELL, V5, P2114, DOI 10.1128/EC.00059-06; Glover L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003260; Glover L, 2012, MOL BIOCHEM PARASIT, V183, P78, DOI 10.1016/j.molbiopara.2012.01.008; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Hartley CL, 2008, MOL MICROBIOL, V68, P1237, DOI 10.1111/j.1365-2958.2008.06230.x; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; Holthausen JT, 2010, DNA REPAIR, V9, P1264, DOI 10.1016/j.dnarep.2010.09.014; Hovel-Miner GA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002900; Huang L, 1999, MOL BIOCHEM PARASIT, V102, P211, DOI 10.1016/S0166-6851(99)00096-1; Jehi SE, 2014, NUCLEIC ACIDS RES, V42, P12899, DOI 10.1093/nar/gku942; Jehi SE, 2014, CELL RES, V24, P870, DOI 10.1038/cr.2014.60; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Kim H.T., 2010, INT C 2 COMP ENG TEC, V6, pV6, DOI DOI 10.1371/J0URNAL.PPAT.1000992; Kim HY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Lee TH, 2006, J BIOL CHEM, V281, P759, DOI 10.1074/jbc.M509855200; Li B, 2005, MOL CELL BIOL, V25, P5011, DOI 10.1128/MCB.25.12.5011-5021.2005; Li BB, 2015, EUKARYOT CELL, V14, P196, DOI 10.1128/EC.00207-14; Li Z, 2007, J CELL SCI, V120, P3883, DOI 10.1242/jcs.007955; Li ZY, 2002, J BIOL CHEM, V277, P15486, DOI 10.1074/jbc.M109029200; McCulloch R, 1999, GENE DEV, V13, P2875, DOI 10.1101/gad.13.21.2875; Melville SE, 2000, MOL BIOCHEM PARASIT, V111, P261, DOI 10.1016/S0166-6851(00)00316-9; Murnane JP, 2006, DNA REPAIR, V5, P1082, DOI 10.1016/j.dnarep.2006.05.030; MYLER PJ, 1984, CELL, V39, P203, DOI 10.1016/0092-8674(84)90206-X; Pandya UM, 2013, NUCLEIC ACIDS RES, V41, P7673, DOI 10.1093/nar/gkt562; Proudfoot C, 2005, NUCLEIC ACIDS RES, V33, P6906, DOI 10.1093/nar/gki996; Robinson NP, 1999, MOL CELL BIOL, V19, P5839; Rudenko G, 1996, MOL BIOCHEM PARASIT, V80, P65, DOI 10.1016/0166-6851(96)02669-2; RUDENKO G, 1989, EMBO J, V8, P2633, DOI 10.1002/j.1460-2075.1989.tb08403.x; Sandhu R, 2013, CELL RES, V23, P537, DOI 10.1038/cr.2013.35; Sandhu R, 2011, JOVE-J VIS EXP, DOI 10.3791/1959; Sarbajna S, 2014, TRENDS BIOCHEM SCI, V39, P409, DOI 10.1016/j.tibs.2014.07.003; SCHOLLER JK, 1989, MOL BIOCHEM PARASIT, V35, P11, DOI 10.1016/0166-6851(89)90137-0; Neto JLS, 2007, BIOCHEM BIOPH RES CO, V358, P417, DOI 10.1016/j.bbrc.2007.04.144; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Stewart JA, 2012, MUTAT RES-FUND MOL M, V730, P12, DOI 10.1016/j.mrfmmm.2011.08.011; Valdes J, 1996, NUCLEIC ACIDS RES, V24, P1809, DOI 10.1093/nar/24.10.1809; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Wei Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073869; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODS A, 1989, J CELL SCI, V93, P491; Yang XF, 2009, CELL, V137, P99, DOI 10.1016/j.cell.2009.01.037; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zhao WX, 2015, MOL CELL, V59, P176, DOI 10.1016/j.molcel.2015.05.032	64	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156746	10.1371/journal.pone.0156746	http://dx.doi.org/10.1371/journal.pone.0156746			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258069	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700120
J	Matsunami, M; Igawa, T; Michimae, H; Miura, T; Nishimura, K				Matsunami, Masatoshi; Igawa, Takeshi; Michimae, Hirofumi; Miura, Toru; Nishimura, Kinya			Population Structure and Evolution after Speciation of the Hokkaido Salamander (Hynobius retardatus)	PLOS ONE			English	Article							DNA CONTROL REGION; BEAR URSUS-ARCTOS; MITOCHONDRIAL-DNA; TOKYOENSIS AMPHIBIA; LANDSCAPE GENETICS; CAUDATA; JAPAN; SOFTWARE; DIFFERENTIATION; PHYLOGEOGRAPHY	The Hokkaido salamander (Hynobius retardatus) is endemic to Hokkaido Island, Japan, and shows intriguing flexible phenotypic plasticity and regional morphological diversity. However, to date, allozymes and partial mitochondria DNA sequences have provided only an outline of its demographic histories and the pattern of its genetic diversification. To understand the finer details of the population structure of this species and its evolution since speciation, we genotyped five regional populations by using 12 recently developed microsatellite polymorphic markers. We found a clear population structure with low gene flow among the five populations, but a close genetic relationship between the Teshio and Kitami populations. Our demographic analysis suggested that Teshio and Erimo had the largest effective population sizes among the five populations. These findings regarding the population structure and demography of H. retardatus improve our understanding of the faunal phylogeography on Hokkaido Island and also provide fundamental genetic information that will be useful for future studies.	[Matsunami, Masatoshi; Miura, Toru] Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido 0600810, Japan; [Igawa, Takeshi] Hiroshima Univ, Grad Sch Int Dev & Cooperat, Higashihiroshima 724, Japan; [Michimae, Hirofumi] Kitasato Univ, Sch Pharm, Dept Clin Med Biostat, Tokyo 1088641, Japan; [Nishimura, Kinya] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	Hokkaido University; Hiroshima University; Kitasato University; Hokkaido University	Matsunami, M (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Lab Ecol Genet, Sapporo, Hokkaido 0600810, Japan.	mmatsunami@ees.hokudai.ac.jp	Igawa, Takeshi/E-2881-2014; Miura, Toru/P-2456-2019; Matsunami, Masatoshi/AAB-3878-2021	Igawa, Takeshi/0000-0001-6880-6180; Miura, Toru/0000-0002-7456-4402; Matsunami, Masatoshi/0000-0003-4109-2493	KAKENHI [23247004, 16K18613]; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [16K18613] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a KAKENHI Grant-in-Aid for Scientific Research (A) (23247004) to K.N. and a KAKENHI Grand-in-Aid for Young Scientists (B) (16K18613) to M.M. from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma N, 2013, ZOOL SCI, V30, P7, DOI 10.2108/zsj.30.7; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chen MY, 2015, MOL PHYLOGENET EVOL, V83, P1, DOI 10.1016/j.ympev.2014.10.010; Donovan MF, 2000, EVOLUTION, V54, P1449, DOI 10.1554/0014-3820(2000)054[1449:BOTSUS]2.0.CO;2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Giordano AR, 2007, MOL ECOL, V16, P1625, DOI 10.1111/j.1365-294X.2006.03223.x; Hirata D, 2013, MOL BIOL EVOL, V30, P1644, DOI 10.1093/molbev/mst077; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Igawa T, 2013, HEREDITY, V110, P46, DOI 10.1038/hdy.2012.59; Iwami T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001084; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Japan Association for Quaternary Research, 1987, QUAT MAPS JAP PLUS E; Kawai K, 2013, ZOOL SCI, V30, P642, DOI 10.2108/zsj.30.642; Kono H, 1933, KONCHU, V7, P86; Matsuhashi T, 1999, MOL BIOL EVOL, V16, P676, DOI 10.1093/oxfordjournals.molbev.a026150; Matsui M, 2000, COMP BIOCHEM PHYS B, V125, P115, DOI 10.1016/S0305-0491(99)00154-6; MATSUI M, 1992, ZOOL SCI, V9, P193; Matsui M, 2001, COMP BIOCHEM PHYS B, V130, P181, DOI 10.1016/S1096-4959(01)00424-9; Matsui M., 1996, NATURAL HIST AMPHIBI; Matsui M, 2007, MOL PHYLOGENET EVOL, V44, P204, DOI 10.1016/j.ympev.2006.11.031; Matsunami M, 2015, CURR HERPETOL, V34, P177, DOI 10.5358/hsj.34.177; Matsunami M, 2015, MOL ECOL, V24, P3064, DOI 10.1111/mec.13228; Michimae H, 2002, EVOLUTION, V56, P2029; Michimae H, 2009, OECOLOGIA, V160, P601, DOI 10.1007/s00442-009-1319-8; Murphy MA, 2010, MOL ECOL, V19, P3634, DOI 10.1111/j.1365-294X.2010.04723.x; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nishikawa K, 2001, HERPETOLOGICA, V57, P281; Ohshima K, 1990, QUATERNARY RES, V29, P193, DOI DOI 10.4116/JAQUA.29.193; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sakamoto M, 2009, ZOOL SCI, V26, P35, DOI 10.2108/zsj.26.35; Sakata N, 2005, INT J DEV BIOL, V49, P417, DOI 10.1387/ijdb.041916ns; Sasaki M., 1924, J COLL AGR HOKKAIDO, V15, P1; Steinfartz S, 2000, MOL ECOL, V9, P397, DOI 10.1046/j.1365-294x.2000.00870.x; Sugawara H, 2015, CURR HERPETOL, V34, P1, DOI 10.5358/hsj.34.1; Suzuki H, 2004, GENES GENET SYST, V79, P165, DOI 10.1266/ggs.79.165; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tominaga A, 2003, ZOOL SCI, V20, P1467, DOI 10.2108/zsj.20.1467; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WAKAHARA M, 1995, ZOOL SCI, V12, P467, DOI 10.2108/zsj.12.467; Wakahara M, 1997, ZOOL SCI, V14, P893, DOI 10.2108/zsj.14.893; Weisrock DW, 2013, ZOOTAXA, V3626, P77, DOI 10.11646/zootaxa.3626.1.3; Wilson GA, 2003, GENETICS, V163, P1177; Yamane Akihiro, 2010, Current Herpetology, V29, P79, DOI 10.3105/018.029.0203; Zhang P, 2006, P NATL ACAD SCI USA, V103, P7360, DOI 10.1073/pnas.0602325103; Zheng YC, 2011, MOL BIOL EVOL, V28, P2521, DOI 10.1093/molbev/msr072	53	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156815	10.1371/journal.pone.0156815	http://dx.doi.org/10.1371/journal.pone.0156815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257807	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700136
J	Sun, XH; Zhang, JY				Sun, Xiaohan; Zhang, Junying			Dysfunctional miRNA-Mediated Regulation in Chromophobe Renal Cell Carcinoma	PLOS ONE			English	Article							CANCER; KIDNEY; GENES; EXPRESSION; PROGNOSIS	Past research on pathogenesis of a complex disease suggests that differentially expressed message RNAs (mRNAs) can be noted as biomarkers of a disease. However, significant miRNA-mediated regulation change might also be more deep underlying cause of a disease. In this study, a miRNA-mediated regulation module is defined based on GO terms (Gene Ontology terms) from which dysfunctional modules are identified as the suspected cause of a disease. A miRNA-mediated regulation module contains mRNAs annotated to a GO term and MicroRNAs (miRNAs) which regulate the mRNAs. Based on the miRNA-mediated regulation coefficients estimated from the expression profiles of the mRNA and the miRNAs, a SW (single regulation-weight) value is then designed to evaluate the miRNA-mediated regulation change of an mRNA, and the modules with significantly differential SW values are thus identified as dysfunctional modules. The approach is applied to Chromophobe renal cell carcinoma and it identifies 70 dysfunctional miRNA-mediated regulation modules from initial 4381 modules. The identified dysfunctional modules are detected to be comprehensive reflection of chromophobe renal cell carcinoma. The proposed approach suggests that accumulated alteration in miRNA-mediated regulation might cause functional alterations, which further cause a disease. Moreover, this approach can also be used to identify diffentially miRNA-mediated regulated mRNAs showing more comprehensive underlying association with a disease than differentially expressed mRNAs.	[Sun, Xiaohan; Zhang, Junying] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China; [Sun, Xiaohan] Weinan Normal Univ, Coll Math & Informat Sci, Weinan, Shaanxi, Peoples R China	Xidian University; Weinan Normal University	Zhang, JY (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China.	jyzhang@mail.xidian.edu.cn		Sun, Xiaohan/0000-0003-0336-3053	Natural Science Foundation of China [61571341, 61201312, 91530113]; Research Fund for the Doctoral Program of Higher Education of China [20130203110017]; Fundamental Research Funds for the Central Universities of China [BDY171416, JB140306]; Scientific research plan projects of Shaanxi Education Department [14JK1249]; Subject Fund for Shaanxi Province of China [14SXZD014]; research plan projects of Weinan Normal University [16YKP002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Scientific research plan projects of Shaanxi Education Department; Subject Fund for Shaanxi Province of China; research plan projects of Weinan Normal University	This work was supported by the Natural Science Foundation of China under Grants [61571341, 61201312, 91530113], Research Fund for the Doctoral Program of Higher Education of China [20130203110017], the Fundamental Research Funds for the Central Universities of China [BDY171416, JB140306], Scientific research plan projects of Shaanxi Education Department [14JK1249], the Subject Fund for Shaanxi Province of China [14SXZD014] and the research plan projects of Weinan Normal University [16YKP002].	Barrera-Vilarmau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021413; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Chang I, 2013, MOL CANCER THER, V12, P1049, DOI 10.1158/1535-7163.MCT-12-1187; Ge YZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10328; Gerlinger M, 2012, J PATHOL, V227, P146, DOI 10.1002/path.4006; Gillies L, 2009, CELL SIGNAL, V21, P675, DOI 10.1016/j.cellsig.2009.01.023; Hirata H, 2007, CLIN CANCER RES, V13, P4123, DOI 10.1158/1078-0432.CCR-07-0609; Huang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043441; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kennedy JC, 2016, SEMIN CELL DEV BIOL, V52, P47, DOI 10.1016/j.semcdb.2016.02.014; Kleftogiannis D, 2013, J BIOMED INFORM, V46, P563, DOI 10.1016/j.jbi.2013.02.002; Linehan WM, 2009, CANCER-AM CANCER SOC, V115, P2252, DOI 10.1002/cncr.24230; Liou Louis S, 2004, BMC Urol, V4, P9, DOI 10.1186/1471-2490-4-9; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; More Vijay R, 2012, Comp Hepatol, V11, P1, DOI 10.1186/1476-5926-11-1; Nair N, 2013, MOL CELL BIOCHEM, V376, P33, DOI 10.1007/s11010-012-1546-x; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Oparina NY, 2013, RUSS J GENET+, V49, P707, DOI 10.1134/S1022795413050104; Peiris-John R, 2006, EXPOSURE ACETYLCHOLI; SAWILOWSKY SS, 1992, PSYCHOL BULL, V111, P352, DOI 10.1037/0033-2909.111.2.352; Saxena M, 1998, J BIOL CHEM, V273, P15340, DOI 10.1074/jbc.273.25.15340; Srikanth MS, 2005, OBES SURG, V15, P1165, DOI 10.1381/0960892055002185; Tabatabaeifar M, 2009, PEDIATR NEPHROL, V24, P2361, DOI 10.1007/s00467-009-1287-6; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Wolf I, 2002, MOL CELL BIOL, V22, P231, DOI 10.1128/MCB.22.1.231-244.2002; Xiao Y, 2013, NEURO-ONCOLOGY, V15, P818, DOI 10.1093/neuonc/not018; Yamazaki K, 2003, ONCOGENE, V22, P847, DOI 10.1038/sj.onc.1206153; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Zheng H, 2013, INT J MOL SCI, V14, P8179, DOI 10.3390/ijms14048179	29	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156324	10.1371/journal.pone.0156324	http://dx.doi.org/10.1371/journal.pone.0156324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258182	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700053
J	Thomas, RC; Cowley, PM; Singh, A; Myagmar, BE; Swigart, PM; Baker, AJ; Simpson, PC				Thomas, R. Croft, Jr.; Cowley, Patrick M.; Singh, Abhishek; Myagmar, Bat-Erdene; Swigart, Philip M.; Baker, Anthony J.; Simpson, Paul C.			The Alpha-1A Adrenergic Receptor in the Rabbit Heart	PLOS ONE			English	Article							RIGHT-VENTRICULAR MYOCARDIUM; ALPHA-1-ADRENERGIC RECEPTORS; SELECTIVE ANTAGONIST; CARDIAC MYOCYTES; IN-VIVO; SUBTYPE; FAILURE; ALPHA(1D)-ADRENOCEPTORS; STIMULATION; ALPHA(1B)	The alpha-1A-adrenergic receptor (AR) subtype is associated with cardioprotective signaling in the mouse and human heart. The rabbit is useful for cardiac disease modeling, but data on the alpha-1A in the rabbit heart are limited. Our objective was to test for expression and function of the alpha-1A in rabbit heart. By quantitative real-time reverse transcription PCR (qPCR) on mRNA from ventricular myocardium of adult male New Zealand White rabbits, the alpha-1B was 99% of total alpha-1-AR mRNA, with <1% alpha-1A and alpha-1D, whereas alpha-1A mRNA was over 50% of total in brain and liver. Saturation radioligand binding identified similar to 4 fmol total alpha-1-ARs per mg myocardial protein, with 17% alpha-1A by competition with the selective antagonist 5-methylurapidil. The alpha-1D was not detected by competition with BMY-7378, indicating that 83% of alpha-1-ARs were alpha-1B. In isolated left ventricle and right ventricle, the selective alpha-1A agonist A61603 stimulated a negative inotropic effect, versus a positive inotropic effect with the nonselective alpha-1-agonist phenylephrine and the beta-agonist isoproterenol. Blood pressure assay in conscious rabbits using an indwelling aortic telemeter showed that A61603 by bolus intravenous dosing increased mean arterial pressure by 20 mm Hg at 0.14 mu g/kg, 10-fold lower than norepinephrine, and chronic A61603 infusion by iPRECIO programmable micro Infusion pump did not increase BP at 22 mu g/kg/d. A myocardial slice model useful in human myocardium and an anthracycline cardiotoxicity model useful in mouse were both problematic in rabbit. We conclude that alpha-1A mRNA is very low in rabbit heart, but the receptor is present by binding and mediates a negative inotropic response. Expression and function of the alpha-1A in rabbit heart differ from mouse and human, but the vasopressor response is similar to mouse.	[Thomas, R. Croft, Jr.; Cowley, Patrick M.; Singh, Abhishek; Myagmar, Bat-Erdene; Swigart, Philip M.; Baker, Anthony J.; Simpson, Paul C.] VA Med Ctr, Dept Med, Div Cardiol, San Francisco, CA USA; [Thomas, R. Croft, Jr.; Cowley, Patrick M.; Singh, Abhishek; Myagmar, Bat-Erdene; Swigart, Philip M.; Baker, Anthony J.; Simpson, Paul C.] VA Med Ctr, Res Serv, San Francisco, CA USA; [Thomas, R. Croft, Jr.; Cowley, Patrick M.; Singh, Abhishek; Myagmar, Bat-Erdene; Baker, Anthony J.; Simpson, Paul C.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Thomas, R. Croft, Jr.; Cowley, Patrick M.; Singh, Abhishek; Myagmar, Bat-Erdene; Baker, Anthony J.; Simpson, Paul C.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Singh, Abhishek] Temple Univ, Philadelphia, PA 19122 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Simpson, PC (corresponding author), VA Med Ctr, Dept Med, Div Cardiol, San Francisco, CA USA.; Simpson, PC (corresponding author), VA Med Ctr, Res Serv, San Francisco, CA USA.; Simpson, PC (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA USA.; Simpson, PC (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA.	paul.simpson@ucsf.edu			Department of Veterans Affairs [BX001970]; National Institutes of Health [HL31113, 5T32HL007731]; Western States Affiliate of the American Heart Association; Veterans Affairs [I01BX000740] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Western States Affiliate of the American Heart Association(American Heart Association); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by: Department of Veterans Affairs (PCS, BX001970, AJB); National Institutes of Health (PCS, HL31113; AS, 5T32HL007731); and Western States Affiliate of the American Heart Association (AJB, B-EM, RCT, PMC).	Cowley PM, 2015, AM J PHYSIOL-HEART C, V309, pH888, DOI 10.1152/ajpheart.00042.2015; Dash R, 2011, MAGN RESON MED, V66, P1152, DOI 10.1002/mrm.22876; ENDOH M, 1992, N-S ARCH PHARMACOL, V345, P578; GOETZ AS, 1995, EUR J PHARMACOL, V272, pR5, DOI 10.1016/0014-2999(94)00751-R; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Jensen BC, 2014, J CARDIOVASC PHARM, V63, P291, DOI 10.1097/FJC.0000000000000032; Jensen BC, 2011, J MOL CELL CARDIOL, V51, P518, DOI 10.1016/j.yjmcc.2010.11.014; Jensen BC, 2009, CIRC-HEART FAIL, V2, P654, DOI 10.1161/CIRCHEARTFAILURE.108.846212; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Klimtova I, 2002, HUM EXP TOXICOL, V21, P649, DOI 10.1191/0960327102ht311oa; KNEPPER SM, 1995, J PHARMACOL EXP THER, V274, P97; KOHI M, 1993, EUR J PHARMACOL, V250, P95, DOI 10.1016/0014-2999(93)90625-R; Methven L, 2009, BRIT J PHARMACOL, V158, P1663, DOI 10.1111/j.1476-5381.2009.00462.x; Miyamoto S, 1997, LIFE SCI, V60, P2069, DOI 10.1016/S0024-3205(97)00194-X; Nagashima M, 1996, AM J PHYSIOL-HEART C, V271, pH1423, DOI 10.1152/ajpheart.1996.271.4.H1423; O'Connell TD, 2014, PHARMACOL REV, V66, P308, DOI 10.1124/pr.112.007203; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piao H, 2000, EUR J PHARMACOL, V396, P9, DOI 10.1016/S0014-2999(00)00171-0; Pogwizd Steven M, 2008, Drug Discov Today Dis Models, V5, P185, DOI 10.1016/j.ddmod.2009.02.001; Rokosh DG, 2002, P NATL ACAD SCI USA, V99, P9474, DOI 10.1073/pnas.132552699; Rokosh DG, 1996, J BIOL CHEM, V271, P5839, DOI 10.1074/jbc.271.10.5839; Simunek T, 2004, EUR J HEART FAIL, V6, P377, DOI 10.1016/j.ejheart.2003.05.003; Sterba M, 2011, J MOL CELL CARDIOL, V50, P849, DOI 10.1016/j.yjmcc.2011.01.018; Tanoue A, 2002, HYPERTENSION, V40, P101, DOI 10.1161/01.HYP.0000022062.70639.1C; Thomas R Croft, 2016, JACC Basic Transl Sci, V1, P155; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang GY, 2006, AM J PHYSIOL-HEART C, V291, pH2013, DOI 10.1152/ajpheart.00167.2006; Yang HT, 1996, EUR J PHARMACOL, V312, P281, DOI 10.1016/0014-2999(96)00442-6	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155238	10.1371/journal.pone.0155238	http://dx.doi.org/10.1371/journal.pone.0155238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258143	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700012
J	Thomsson, O; Sjunnesson, Y; Magnusson, U; Eliasson-Selling, L; Wallenbeck, A; Bergqvist, AS				Thomsson, Ola; Sjunnesson, Ylva; Magnusson, Ulf; Eliasson-Selling, Lena; Wallenbeck, Anna; Bergqvist, Ann-Sofi			Consequences for Piglet Performance of Group Housing Lactating Sows at One, Two, or Three Weeks Post-Farrowing	PLOS ONE			English	Article							MATERNAL-BEHAVIOR; NURSING BEHAVIOR; SURVIVAL; PIGS; MORTALITY; QUALITY; WEIGHTS	Housing lactating sows with piglets in a multi-suckling pen from around 14 days post-farrowing is common practice in Swedish organic piglet production. However, nursing-suckling interaction is less frequent in multi-suckling pens than in individual farrowing pens, thus affecting piglet performance, e.g., piglet growth. Moreover, piglet mortality is higher in systems using multi-suckling pens. Three management routines whereby lactating sows with piglets were moved from individual farrowing pens to multi-suckling pens at one, two, or three weeks post-farrowing were compared in terms of nursing-suckling interaction and piglet performance. Correlations between nursing-suckling interaction, piglet performance, and piglet mortality were also examined. In total, 43 Yorkshire sows with piglets were included in the study. Nursing-suckling interaction and all piglet performance parameters except piglet mortality did not differ between management routines. Piglet mortality in the individual farrowing pens did not differ between management routines, but piglet mortality in the multi-suckling pen was lower (P<0.05) when piglets were group housed at three weeks compared with one week post-farrowing. Overall piglet mortality was positively correlated with mortality in the multi-suckling pen for piglets group housed at one week (r = 0.61: P<0.05) and at two weeks post-farrowing (r = 0.62: P<0.05) but not for piglets group housed at three weeks post-farrowing. In conclusion, overall piglet mortality could be reduced if sows and piglets are group housed at three weeks post-farrowing and piglet survival the first week post-farrowing is improved.	[Thomsson, Ola; Sjunnesson, Ylva; Magnusson, Ulf; Bergqvist, Ann-Sofi] Swedish Univ Agr Sci, SLU, Dept Clin Sci, Div Reprod, Uppsala, Sweden; [Eliasson-Selling, Lena] Farm & Anim Hlth, Uppsala, Sweden; [Wallenbeck, Anna] Swedish Univ Agr Sci, SLU, Dept Anim Breeding & Genet, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Bergqvist, AS (corresponding author), Swedish Univ Agr Sci, SLU, Dept Clin Sci, Div Reprod, Uppsala, Sweden.	ann-sofi.bergqvist@slu.se	Eliasson-Selling, Lena/AAX-9805-2021; Sjunnesson, Ylva/AAN-6152-2020	Sjunnesson, Ylva/0000-0003-4500-5123; Thomsson, Ola/0000-0002-6065-7923; Magnusson, Ulf/0000-0002-7087-6820; Wallenbeck, Anna/0000-0001-8012-2849	Swedish Research Council; Swedish University of Agricultural Sciences; Farm and Animal Health, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish University of Agricultural Sciences; Farm and Animal Health, Sweden	Funding for this study was provided by the Swedish Research Council for environment, agricultural sciences and spatial planning (UM) (http://proj.formas.se/detail.asp?arendeid=24161&sprak=2&x=230&y=0 Reg.no 2010-1895). The Swedish University of Agricultural Sciences provided funding in the form of salary for Ylva Sjunnesson (YS), Ulf Magnusson (UM), Anna Wallenbeck (AW) and Ann-Sofi Bergqvist (ASB). The Farm and Animal Health, Sweden provided funding in the form of salary for Lena Eliasson-Selling (LES). The funders had no role in study design, data collection, and -analysis, decision to publish or preparation of the manuscript but decided that if the data was published it had to be with Open Access.	ALGERS B, 1990, APPL ANIM BEHAV SCI, V26, P143, DOI 10.1016/0168-1591(90)90094-T; Alonso-Spilsbury M, 2007, J ANIM VET ADV, V6, P76; Andersen IL, 2005, APPL ANIM BEHAV SCI, V93, P229, DOI 10.1016/j.applanim.2004.11.015; Baxter EM, 2008, THERIOGENOLOGY, V69, P773, DOI 10.1016/j.theriogenology.2007.12.007; BOE K, 1993, APPL ANIM BEHAV SCI, V35, P327, DOI 10.1016/0168-1591(93)90084-3; Dybjaer L, 2001, ACTA AGR SCAND A-AN, V51, P134, DOI 10.1080/090647001750193477; EDWARDS SA, 1994, VET REC, V135, P324, DOI 10.1136/vr.135.14.324; Edwards SA, 2002, LIVEST PROD SCI, V78, P3, DOI 10.1016/S0301-6226(02)00180-X; EEC CR, 2007, OFFICIAL J EUROPEAN, P1; Hessel EF, 2006, J ANIM SCI, V84, P2847, DOI 10.2527/jas.2005-606; Hulten F, 1997, ACTA VET SCAND, V38, P119; Lindgren Y, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-33; Milligan BN, 2002, LIVEST PROD SCI, V76, P181, DOI 10.1016/S0301-6226(02)00012-X; Oostindjer M, 2011, APPL ANIM BEHAV SCI, V134, P31, DOI 10.1016/j.applanim.2011.06.011; Pajor EA, 2002, APPL ANIM BEHAV SCI, V76, P267, DOI 10.1016/S0168-1591(02)00010-2; Pedersen ML, 2011, LIVEST SCI, V140, P253, DOI 10.1016/j.livsci.2011.04.001; Silerova J, 2006, APPL ANIM BEHAV SCI, V101, P167, DOI 10.1016/j.applanim.2006.01.002; Su G, 2007, J ANIM SCI, V85, P1385, DOI 10.2527/jas.2006-631; THOMPSON BK, 1986, CAN J ANIM SCI, V66, P361, DOI 10.4141/cjas86-037; Thomsson O, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0101-7; Valros AE, 2002, APPL ANIM BEHAV SCI, V76, P93, DOI 10.1016/S0168-1591(02)00006-0; Vasdal G, 2012, LIVEST SCI, V146, P91, DOI 10.1016/j.livsci.2012.02.005; Wallenbeck A, 2008, LIVEST SCI, V116, P216, DOI 10.1016/j.livsci.2007.10.008; Wallenbeck A, 2009, ACTA AGR SCAND A-AN, V59, P181, DOI 10.1080/09064700903307824; Weary DM, 2002, APPL ANIM BEHAV SCI, V76, P279, DOI 10.1016/S0168-1591(02)00011-4; Wulbers-Mindermann M, 2002, LIVEST PROD SCI, V73, P285, DOI 10.1016/S0301-6226(01)00257-3	26	8	9	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156581	10.1371/journal.pone.0156581	http://dx.doi.org/10.1371/journal.pone.0156581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258149	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700083
J	Wei, JZ; Liang, GM; Wang, BJ; Zhong, F; Chen, L; Khaing, MM; Zhang, J; Guo, YY; Wu, KM; Tabashnik, BE				Wei, Jizhen; Liang, Gemei; Wang, Bingjie; Zhong, Feng; Chen, Lin; Khaing, Myint Myint; Zhang, Jie; Guo, Yuyuan; Wu, Kongming; Tabashnik, Bruce E.			Activation of Bt Protoxin Cry1Ac in Resistant and Susceptible Cotton Bollworm	PLOS ONE			English	Article							FIELD-EVOLVED RESISTANCE; BACILLUS-THURINGIENSIS TOXINS; INSECT RESISTANCE; LEPIDOPTERA-NOCTUIDAE; HELICOVERPA-ARMIGERA; QUANTITATIVE-ANALYSIS; CROSS-RESISTANCE; PEST RESISTANCE; MAIZE; CROPS	Crystalline (Cry) proteins from Bacillus thuringiensis (Bt) are used extensively for insect control in sprays and transgenic plants, but their efficacy is reduced by evolution of resistance in pests. Here we evaluated reduced activation of Cry1Ac protoxin as a potential mechanism of resistance in the invasive pest Helicoverpa armigera. Based on the concentration killing 50% of larvae (LC50) for a laboratory-selected resistant strain (LF120) divided by the LC50 for its susceptible parent strain (LF), the resistance ratio was 1600 for Cry1Ac protoxin and 1200 for trypsin-activated Cry1Ac toxin. The high level of resistance to activated toxin as well as to protoxin indicates reduced activation of protoxin is not a major mechanism of resistance to Cry1Ac in LF120. For both insect strains, treatment with either the trypsin inhibitor N-a-tosyl-L-lysine chloromethyl ketone (TLCK) or the chymotrypsin inhibitor N-a-tosyl-L-phenylalanine chloromethyl ketone (TPCK) did not significantly affect the LC50 of Cry1Ac protoxin. Enzyme activity was higher for LF than LF120 for trypsin-like proteases, but did not differ between strains for chymotrypsin-like proteases. The results here are consistent with previous reports indicating that reduced activation of protoxin is generally not a major mechanism of resistance to Bt proteins.	[Wei, Jizhen; Liang, Gemei; Wang, Bingjie; Zhong, Feng; Chen, Lin; Khaing, Myint Myint; Zhang, Jie; Guo, Yuyuan; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Tabashnik, Bruce E.] Univ Arizona, Inst BIO5, Tucson, AZ 85721 USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Arizona; University of Arizona	Liang, GM; Guo, YY (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	gmliang@ippcaas.cn; yyguo@ippcaas.cn			Key Project for Breeding Genetically Modified Organisms [2016ZX08011-002]; National Natural Science Foundation of China [31321004]	Key Project for Breeding Genetically Modified Organisms; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Key Project for Breeding Genetically Modified Organisms (2016ZX08011-002) and the National Natural Science Foundation of China (No. 31321004).	Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; An JJ, 2015, PEST MANAG SCI, V71, P377, DOI 10.1002/ps.3807; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budatha M, 2008, BIOTECHNOL LETT, V30, P305, DOI 10.1007/s10529-007-9539-7; Cao GC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05629; Cao GC, 2013, J ECON ENTOMOL, V106, P2514, DOI 10.1603/EC13301; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; Chen WC, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/462929; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; Downes SJ, 2015, HELICOVERPA RESISTAN; Edgerton MD, 2012, NAT BIOTECHNOL, V30, P493, DOI 10.1038/nbt.2259; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; GASSMANN AJ, 2014, P NATL ACAD SCI USA, V111, P5141, DOI DOI 10.1073/pnas.1317179111; GILL SS, 1992, ANNU REV ENTOMOL, V37, P615, DOI 10.1146/annurev.en.37.010192.003151; Gomez I, 2014, BIOCHEM J, V459, P383, DOI 10.1042/BJ20131408; Gonzalez-Cabrera J, 2013, INSECT BIOCHEM MOLEC, V43, P635, DOI 10.1016/j.ibmb.2013.04.001; Herrero S, 2001, APPL ENVIRON MICROB, V67, P1085, DOI 10.1128/AEM.67.3.1085-1089.2001; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jin L, 2015, NAT BIOTECHNOL, V33, P169, DOI 10.1038/nbt.3100; Jin L, 2013, EVOL APPL, V6, P1222, DOI 10.1111/eva.12099; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119618; LeOra Software, 2003, POLOPLUS US GUID PRO; Li HR, 2005, INSECT BIOCHEM MOLEC, V35, P847, DOI 10.1016/j.ibmb.2005.03.004; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Liu CX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07219; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Nicolia A, 2014, CRIT REV BIOTECHNOL, V34, P77, DOI 10.3109/07388551.2013.823595; Oppert B, 1997, J BIOL CHEM, V272, P23473, DOI 10.1074/jbc.272.38.23473; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Rajagopal R, 2009, BIOCHEM J, V419, P309, DOI 10.1042/BJ20081152; Rasband WS., 1997, IMAGEJ VERSION 1 46, P1997, DOI U. S. National Institutes of Health; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Hernandez-Rodriguez CS, 2008, APPL ENVIRON MICROB, V74, P7654, DOI 10.1128/AEM.01373-08; Sayyed AH, 2001, APPL ENVIRON MICROB, V67, P4372, DOI 10.1128/AEM.67.9.4372-4373.2001; SPSS Inc. Released, 2009, PASW STAT WIND VERS; Swiatkiewicz S, 2014, ANIM FEED SCI TECH, V198, P1, DOI 10.1016/j.anifeedsci.2014.09.009; Tabashnik BE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15107; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Van den Berg J, 2013, CROP PROT, V54, P154, DOI 10.1016/j.cropro.2013.08.010; Wang CZ., 1986, ACTA LOGICA SINICA, V1, P7; Wang GJ, 2006, APPL MICROBIOL BIOT, V72, P924, DOI 10.1007/s00253-006-0390-x; Welch KL, 2015, J INVERTEBR PATHOL, V132, P149, DOI 10.1016/j.jip.2015.10.003; Wu KM, 2005, PEST MANAG SCI, V61, P491, DOI 10.1002/ps.999; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; Xiao YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06184; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109	53	18	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156560	10.1371/journal.pone.0156560	http://dx.doi.org/10.1371/journal.pone.0156560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257885	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700077
J	Yang, SS; Jin, LH; Park, SH; Kim, MS; Kim, YJ; Choi, BH; Lee, CT; Park, SR; Min, BH				Yang, Soon Sim; Jin, Long Hao; Park, Sang-Hyug; Kim, Moon Suk; Kim, Young Jick; Choi, Byung Hyune; Lee, Chun Tek; Park, So Ra; Min, Byoung-Hyun			Extracellular Matrix (ECM) Multilayer Membrane as a Sustained Releasing Growth Factor Delivery System for rhTGF-beta(3) in Articular Cartilage Repair	PLOS ONE			English	Article							BONE-MARROW STIMULATION; MESENCHYMAL STEM-CELLS; FACTOR-BETA; IN-VIVO; POLYELECTROLYTE MULTILAYERS; SEQUENTIAL RELEASE; THICKNESS DEFECTS; TGF-BETA; IGF-I; SCAFFOLDS	Recombinant human transforming growth factor beta-3 (rhTGF-beta(3)) is a key regulator of chondrogenesis in stem cells and cartilage formation. We have developed a novel drug delivery system that continuously releases rhTGF-beta(3) using a multilayered extracellular matrix (ECM) membrane. We hypothesize that the sustained release of rhTGF-beta(3) could activate stem cells and result in enhanced repair of cartilage defects. The properties and efficacy of the ECM multilayer-based delivery system (EMLDS) are investigated using rhTGF-beta(3) as a candidate drug. The bioactivity of the released rhTGF-beta(3) was evaluated through chondrogenic differentiation of mesenchymal stem cells (MSCs) using western blot and circular dichroism (CD) analyses in vitro. The cartilage reparability was evaluated through implanting EMLDS with endogenous and exogenous MSC in both in vivo and ex vivo models, respectively. In the results, the sustained release of rhTGF-beta(3) was clearly observed over a prolonged period of time in vitro and the released rhTGF-beta(3) maintained its structural stability and biological activity. Successful cartilage repair was also demonstrated when rabbit MSCs were treated with rhTGF-beta(3)-loaded EMLDS ((+) rhTGF-beta(3) EMLDS) in an in vivo model and when rabbit chondrocytes and MSCs were treated in ex vivo models. Therefore, the multilayer ECM membrane could be a useful drug delivery system for cartilage repair.	[Yang, Soon Sim; Kim, Moon Suk; Min, Byoung-Hyun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Jin, Long Hao; Min, Byoung-Hyun] Ajou Univ, Sch Med, Dept Orthoped Surg, Suwon 441749, South Korea; [Park, Sang-Hyug] Pukyong Natl Univ, Dept Biomed Engn, Busan, South Korea; [Kim, Young Jick; Min, Byoung-Hyun] Ajou Univ, Med Ctr, Cell Therapy Ctr, Suwon 441749, South Korea; [Choi, Byung Hyune] Inha Univ, Coll Med, Div Biomed & Bioengn Sci, Inchon, South Korea; [Lee, Chun Tek] Lee Chun Tek Orthoped Specialty Hosp, Suwon, South Korea; [Park, So Ra] Inha Univ, Coll Med, Dept Physiol, Inchon, South Korea	Ajou University; Ajou University; Pukyong National University; Ajou University; Inha University; Inha University	Min, BH (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.; Min, BH (corresponding author), Ajou Univ, Sch Med, Dept Orthoped Surg, Suwon 441749, South Korea.; Min, BH (corresponding author), Ajou Univ, Med Ctr, Cell Therapy Ctr, Suwon 441749, South Korea.	bhmin@ajou.ac.kr			Ministry of Science, ICT & Future Planning, Republic of Korea [NRF-2013R1A1A1011040]	Ministry of Science, ICT & Future Planning, Republic of Korea(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by a grant from the Ministry of Science, ICT & Future Planning (NRF-2013R1A1A1011040), Republic of Korea. There is no other potential conflict of interest relevant to this article.	Abarrategi A, 2008, BIOMACROMOLECULES, V9, P711, DOI 10.1021/bm701049g; Anraku Y, 2009, J BONE MINER METAB, V27, P272, DOI 10.1007/s00774-009-0038-x; BH M, 2013, J ORTHOPAEDIC RES; Cai DZ, 2007, CHINESE MED J-PEKING, V120, P197, DOI 10.1097/00029330-200702010-00005; Catelas I, 2008, TISSUE ENG PART C-ME; Cui JH, 2007, TISSUE ENG, V13, P351, DOI 10.1089/ten.2006.0080; Derynck R, 1997, BIOCHIM BIOPHYS ACTA, V1333, P105; Dierich A, 2007, ADV MATER, V19, P693, DOI 10.1002/adma.200601271; Gillogly SD, 2005, ORTHOP CLIN N AM, V36, P433, DOI 10.1016/j.ocl.2005.06.005; Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007; Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346; Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS171; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004; Jin CZ, 2007, TISSUE ENG, V13, P693, DOI 10.1089/ten.2006.0184; Jin CZ, 2011, TISSUE ENG PT A, V17, P3057, DOI [10.1089/ten.tea.2010.0605, 10.1089/ten.TEA.2010.0605]; Jin LH, 2011, OSTEOARTHR CARTILAGE, V19, P1440, DOI 10.1016/j.joca.2011.07.012; Jung Y, 2009, BIOMATERIALS, V30, P4657, DOI 10.1016/j.biomaterials.2009.05.034; Karlsson AJ, 2010, BIOMACROMOLECULES, V11, P2321, DOI 10.1021/bm100424s; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kim JM, 2012, TISSUE ENG REGEN MED, V9, P175, DOI 10.1007/s13770-012-0175-5; Kittitheeranun P, 2010, LANGMUIR, V26, P6869, DOI 10.1021/la1003676; Kuo AC, 2006, OSTEOARTHR CARTILAGE, V14, P1126, DOI 10.1016/j.joca.2006.04.004; LaPorta TF, 2012, ORTHOP CLIN N AM, V43, P245, DOI 10.1016/j.ocl.2012.02.002; Li TZ, 2012, ADV FUNCT MATER, V22, P4292, DOI 10.1002/adfm.201102695; Mao ZW, 2005, BIOCONJUGATE CHEM, V16, P1316, DOI 10.1021/bc049755b; Mierisch CM, 2002, ARTHROSCOPY, V18, P892, DOI 10.1053/jars.2002.36117; Miura Y, 2002, J BONE JOINT SURG AM, V84A, P793, DOI 10.2106/00004623-200205000-00015; Mueller-Rath R, 2007, BIO-MED MATER ENG, V17, P357; Park JS, 2008, TRANSPLANTATION, V85, P589, DOI 10.1097/TP.0b013e3181639b3a; Pavlukhina S, 2011, ADV DRUG DELIVER REV, V63, P822, DOI 10.1016/j.addr.2011.03.017; Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802; Shah NJ, 2011, BIOMATERIALS; SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009; Sohier J, 2007, INT J PHARMACEUT, V332, P80, DOI 10.1016/j.ijpharm.2006.09.037; Solheim E, 2010, KNEE SURG SPORT TR A, V18, P504, DOI 10.1007/s00167-009-0974-y; Steinbrech DS, 2000, PLAST RECONSTR SURG, V105, P2028, DOI 10.1097/00006534-200005000-00018; Strobel C, 2011, J CONTROL RELEASE, V156, P37, DOI 10.1016/j.jconrel.2011.07.006; Vinardell T, 2009, ANN BIOMED ENG, V37, P2556, DOI 10.1007/s10439-009-9791-1; Wang L, 2009, LANGMUIR, V25, P7990, DOI 10.1021/la9004664; Wang Y, 2008, CHEM MATER, V20, P848, DOI 10.1021/cm7024813; Wells RG, 1997, J BIOL CHEM, V272, P11444; Yang HS, 2011, TISSUE ENG PT A, V17, P1809, DOI 10.1089/ten.tea.2010.0540	43	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156292	10.1371/journal.pone.0156292	http://dx.doi.org/10.1371/journal.pone.0156292			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258120	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700052
J	Uzan, VRM; Lengert, AV; Boldrini, E; Penna, V; Scapulatempo-Neto, C; Scrideli, CA; Filho, APD; Cavalcante, CEB; de Oliveira, CZ; Lopes, LF; Vidal, DO				Maciel Uzan, Vanessa Regina; Lengert, Andre van Helvoort; Boldrini, Erica; Penna, Valter; Scapulatempo-Neto, Cristovam; Scrideli, Carlos Alberto; de Moraes Filho, Alberto Paiva; Bezerra Cavalcante, Carlos Eduardo; de Oliveira, Cleyton Zanardo; Lopes, Luiz Fernando; Vidal, Daniel Onofre			High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients	PLOS ONE			English	Article							LONG NONCODING RNA; HIGH-GRADE OSTEOSARCOMA; CELL-PROLIFERATION; CANCER; EXTREMITIES; METASTASIS; GENE; CHEMOTHERAPY; APOPTOSIS	Osteosarcoma (OS) is the most common primary bone cancer in childhood. OS is an aggressive disease, and metastatic patients evolve with very poor clinical outcomes. Genetically, OSs are extremely complex tumors, and the related metastatic process is not well understood in terms of the biology of the disease. In this context, long non-coding RNAs (lncRNAs) have emerged as an important class of gene expression regulators that play key roles in the invasion and metastasis of several human tumors. Here, we evaluated the expression of HULC, which is an lncRNA that is associated with the tumor metastatic process, and assessed its potential role as a prognostic marker in OS. HULC expression was evaluated in primary OS samples using real-time RT-PCR. HULC expression status was determined by receiver operating characteristic (ROC) analysis, and its association with survival was assessed using the Kaplan-Meier method. The HULC expression level was not significantly associated with the clinicopathological characteristics of the OS patients. However, our data demonstrated that higher levels of expression of HULC were associated with lower survival rates in OS patients, both in terms of overall and event-free survival. Elevated HULC expression was associated with poor clinical outcomes among the OS patients, which suggests that HULC could be a potential prognostic biomarker in OS.	[Maciel Uzan, Vanessa Regina; Lengert, Andre van Helvoort; Scapulatempo-Neto, Cristovam; Vidal, Daniel Onofre] Barretos Canc Hosp, Mol Oncol Res Ctr, Pediat Oncol Lab, Barretos, SP, Brazil; [Boldrini, Erica; Lopes, Luiz Fernando] Barretos Childrens Canc Hosp, Barretos, SP, Brazil; [Penna, Valter] Barretos Canc Hosp, Dept Orthoped Surg, Barretos, SP, Brazil; [Scapulatempo-Neto, Cristovam] Barretos Canc Hosp, Dept Pathol, Barretos, SP, Brazil; [Scrideli, Carlos Alberto] Univ Sao Paulo, Med Sch Ribeirao Preto, Dept Pediat, BR-14049 Ribeirao Preto, SP, Brazil; [de Moraes Filho, Alberto Paiva; de Oliveira, Cleyton Zanardo] Barretos Canc Hosp, Dept Radiol, Barretos, SP, Brazil; [Bezerra Cavalcante, Carlos Eduardo] Barretos Childrens Canc Hosp, Dept Radiol, Barretos, SP, Brazil; [de Oliveira, Cleyton Zanardo] Barretos Canc Hosp, Ctr Res Support NAP, Barretos, SP, Brazil	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Universidade de Sao Paulo; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos	Vidal, DO (corresponding author), Barretos Canc Hosp, Mol Oncol Res Ctr, Pediat Oncol Lab, Barretos, SP, Brazil.; Lopes, LF (corresponding author), Barretos Childrens Canc Hosp, Barretos, SP, Brazil.	lf.lopes@yahoo.com; daniel.vidal@hcancerbarretos.com.br	van Helvoort Lengert, André/AAU-1140-2021; Scrideli, Carlos/D-7618-2012; Lopes, Luiz Fernando/L-5513-2016; Vidal, Daniel/C-7203-2012	van Helvoort Lengert, André/0000-0002-3632-343X; Scrideli, Carlos/0000-0001-6618-789X; Lopes, Luiz Fernando/0000-0001-9737-9245; Vidal, Daniel/0000-0003-2117-3640; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579	Barretos Cancer Hospital	Barretos Cancer Hospital	The author(s) received an internal research funding (PAIP) from Barretos Cancer Hospital for this work.	Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; Bacci G, 2008, J SURG ONCOL, V98, P415, DOI 10.1002/jso.21140; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Briccoli A, 2010, SURG ONCOL, V19, P193, DOI 10.1016/j.suronc.2009.05.002; Chen LL, 2010, WIRES RNA, V1, P2, DOI 10.1002/wrna.5; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Fellenberg J, 2007, MODERN PATHOL, V20, P1085, DOI 10.1038/modpathol.3800937; Fu XQ, 2006, DNA CELL BIOL, V25, P135, DOI 10.1089/dna.2006.25.135; Guo FJ, 2010, ACTA BIOCH BIOPH SIN, V42, P224, DOI 10.1093/abbs/gmq008; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Harting Matthew T, 2006, Semin Pediatr Surg, V15, P25, DOI 10.1053/j.sempedsurg.2005.11.005; Iacoangeli A, 2004, CARCINOGENESIS, V25, P2125, DOI 10.1093/carcin/bgh228; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; Matouk IJ, 2009, EUR J GASTROEN HEPAT, V21, P688, DOI 10.1097/MEG.0b013e328306a3a2; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Peng W, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0346-4; Petrilli AS, 2006, J CLIN ONCOL, V24, P1161, DOI 10.1200/JCO.2005.03.5352; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sun XH, 2015, INT J CLIN EXP PATHO, V8, P2994; Tesser-Gamba F, 2012, HUM PATHOL, V43, P994, DOI 10.1016/j.humpath.2011.08.003; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Xie H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/136106; Zhang Q, 2013, ASIAN PAC J CANCER P, V14, P2311, DOI 10.7314/APJCP.2013.14.4.2311; Zhao Y, 2014, ONCOL REP, V31, P358, DOI 10.3892/or.2013.2850	29	53	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156774	10.1371/journal.pone.0156774	http://dx.doi.org/10.1371/journal.pone.0156774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253450	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700058
J	Voisin, S; Guilherme, JPFL; Yan, X; Pushkarev, VP; Cieszczyk, P; Massidda, M; Calo, CM; Dyatlov, DA; Kolupaev, VA; Pushkareva, YE; Maciejewska, A; Sawczuk, M; Lancha, AH; Artioli, GG; Eynon, N				Voisin, Sarah; Guilherme, Joao Paulo F. L.; Yan, Xu; Pushkarev, Vladimir P.; Cieszczyk, Pawel; Massidda, Myosotis; Calo, Carla M.; Dyatlov, Dmitry A.; Kolupaev, Vitaliy A.; Pushkareva, Yuliya E.; Maciejewska, Agnieszka; Sawczuk, Marek; Lancha, Antonio H., Jr.; Artioli, Guilherme G.; Eynon, Nir			ACVR1B rs2854464 Is Associated with Sprint/Power Athletic Status in a Large Cohort of Europeans but Not Brazilians	PLOS ONE			English	Article							MYOSTATIN PATHWAY GENES; GROWTH-FACTOR-BETA; SKELETAL-MUSCLE; PERFORMANCE; STRENGTH; SPORTS; VARIANTS; ANCESTRY; LINKAGE; POWER	Skeletal muscle strength and mass, major contributors to sprint/power athletic performance, are influenced by genetics. However, to date, only a handful of genetic variants have been associated with sprint/power performance. The ACVR1B A allele (rs rs2854464) has previously been associated with increased muscle-strength in non-athletic cohort. However, no follow-up and/or replications studies have since been conducted. Therefore, the aim of the present study was to compare the genotype distribution of ACVR1B rs2854464 between endurance athletes (E), sprint/power (S/P) athletes, mixed athletes (M), and non-athletic control participants in 1672 athletes (endurance athletes, n = 482; sprint/power athletes, n = 578; mixed athletes, n = 498) and 1089 controls (C) of both European Caucasians (Italian, Polish and Russians) and Brazilians. We have also compared the genotype distribution according to the athlete's level of competition (elite vs. sub-elite). DNA extraction and genotyping were performed using various methods. Fisher's exact test (adjusted for multiple comparisons) was used to test whether the genotype distribution of rs2854464 (AA, AG and GG) differs between groups. The A allele was overrepresented in S/P athletes compared with C in the Caucasian sample (adjusted p = 0.048), whereas there were no differences in genotype distribution between E athletes and C, in neither the Brazilian nor the Caucasian samples (adjusted p > 0.05). When comparing all Caucasian athletes regardless of their sporting discipline to C, we found that the A allele was overrepresented in athletes compared to C (adjusted p = 0.024). This association was even more pronounced when only elite-level athletes were considered (adjusted p = 0.00017). In conclusion, in a relatively large cohort of athletes from Europe and South America we have shown that the ACVR1B rs2854464 A allele is associated with sprint/power performance in Caucasians but not in Brazilian athletes. This reinforces the notion that phenotype-genotype associations may be ethnicity-dependent.	[Voisin, Sarah] INRA, Biol Dev & Reprod UMR1198, F-78350 Jouy En Josas, France; [Voisin, Sarah; Yan, Xu; Eynon, Nir] Victoria Univ, ISEAL, Melbourne, Vic, Australia; [Guilherme, Joao Paulo F. L.; Lancha, Antonio H., Jr.; Artioli, Guilherme G.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Pushkarev, Vladimir P.] Fed Med Biol Agcy Russia, Lab Radiat Genet, Urals Res Ctr Radiat Med, Chelyabinsk, Russia; [Cieszczyk, Pawel] Acad Phys Educ & Sport, Dept Tourism & Recreat, Gdansk, Poland; [Massidda, Myosotis; Calo, Carla M.] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy; [Dyatlov, Dmitry A.; Kolupaev, Vitaliy A.] Ural State Univ Phys Culture, Chelyabinsk, Russia; [Pushkareva, Yuliya E.] South Ural State Med Univ, Chelyabinsk, Russia; [Cieszczyk, Pawel; Maciejewska, Agnieszka; Sawczuk, Marek] Univ Szczecin, Dept Phys Culture & Hlth Promot, PL-70453 Szczecin, Poland; [Pushkarev, Vladimir P.] Chelyabinsk State Univ, Dept Radiat Biol, Chelyabinsk, Russia	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Victoria University; Universidade de Sao Paulo; Gdansk University of Physical Education & Sport; University of Cagliari; South Ural State Medical University; University of Szczecin; Chelyabinsk State University	Eynon, N (corresponding author), Victoria Univ, ISEAL, Melbourne, Vic, Australia.	Nir.Eynon@vu.edu.au	Guilherme, João Paulo L. F./C-3490-2017; Artioli, Guilherme Giannini/K-5925-2013; Cieszczyk, Pawel/AFK-4645-2022; Massidda, Myosotis/AAD-7934-2021; Cieszczyk, Pawel/AAG-3328-2022; Lancha, Antonio Herbert/C-9130-2012; Sawczuk, Marek/S-3609-2017; Yan, Xu/T-1427-2019	Guilherme, João Paulo L. F./0000-0001-9165-973X; Artioli, Guilherme Giannini/0000-0001-8463-2213; Cieszczyk, Pawel/0000-0002-7735-7580; Massidda, Myosotis/0000-0001-5726-4435; Cieszczyk, Pawel/0000-0002-7735-7580; Lancha, Antonio Herbert/0000-0003-2128-1182; Yan, Xu/0000-0001-8547-4210; Eynon, Nir/0000-0003-4046-8276; Maciejewska-Skrendo, Agnieszka/0000-0003-4587-2411; Sawczuk, Marek/0000-0002-5730-5249; Voisin, Sarah/0000-0002-4074-7083	FAPESP [12/22516-6]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was partly funded by FAPESP (grant #12/22516-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was partly funded by FAPESP (grant #12/22516-6).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005; Chen JL, 2015, MOL THER, V23, P434, DOI 10.1038/mt.2014.221; Costa AM, 2012, SPORTS MED, V42, P449, DOI 10.2165/11650560-000000000-00000; Elliott B, 2012, ACTA PHYSIOL, V205, P324, DOI 10.1111/j.1748-1716.2012.02423.x; Eynon N, 2009, INT J SPORTS MED, V30, P888, DOI 10.1055/s-0029-1238291; Eynon N, 2013, SPORTS MED, V43, P803, DOI 10.1007/s40279-013-0059-4; Eynon N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043132; Eynon N, 2011, J PHYSIOL-LONDON, V589, P3063, DOI 10.1113/jphysiol.2011.207035; He ZH, 2015, SCAND J MED SCI SPOR, V25, P184, DOI 10.1111/sms.12188; Huygens W, 2005, PHYSIOL GENOMICS, V22, P390, DOI 10.1152/physiolgenomics.00010.2005; Huygens W, 2004, PHYSIOL GENOMICS, V17, P264, DOI 10.1152/physiolgenomics.00224.2003; Kehdy FSG, 2015, P NATL ACAD SCI USA, V112, P8696, DOI 10.1073/pnas.1504447112; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Lins TC, 2011, J EPIDEMIOL, V21, P240, DOI 10.2188/jea.JE20100164; Massidda M, 2016, J STRENGTH COND RES, V30, P1171, DOI 10.1519/JSC.0000000000001176; Papadimitriou ID, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2462-3; Peeters MW, 2009, MED SPORT SCI, V54, P28, DOI 10.1159/000235695; Pimenta JR, 2006, HUM HERED, V62, P190, DOI 10.1159/000096872; Pitsiladis Y, 2013, BRIT J SPORT MED, V47, P550, DOI 10.1136/bjsports-2013-092400; Pitsiladis YP, 2016, PHYSIOL GENOMICS, V48, P183, DOI 10.1152/physiolgenomics.00105.2015; Puthucheary Z, 2011, SPORTS MED, V41, P433, DOI 10.2165/11588720-000000000-00000; Ratzliff ADH, 2001, NEUROSCIENCE, V103, P337, DOI 10.1016/S0306-4522(01)00013-6; Ruiz JR, 2010, J APPL PHYSIOL, V108, P561, DOI 10.1152/japplphysiol.01242.2009; Sawczuk M, 2015, J SCI MED SPORT, V18, P114, DOI 10.1016/j.jsams.2013.12.008; Slater G, 2011, J SPORT SCI, V29, pS67, DOI 10.1080/02640414.2011.574722; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Voisin S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-382; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Webborn N, 2015, BRIT J SPORT MED, V49, P1486, DOI 10.1136/bjsports-2015-095343; Windelinckx A, 2011, EUR J HUM GENET, V19, P208, DOI 10.1038/ejhg.2010.173; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	33	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156316	10.1371/journal.pone.0156316	http://dx.doi.org/10.1371/journal.pone.0156316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253421	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000377218700020
J	Wei, QG; Feng, SW; Lu, ZW				Wei, Qingguo; Feng, Siwei; Lu, Zongwu			Stimulus Specificity of Brain-Computer Interfaces Based on Code Modulation Visual Evoked Potentials	PLOS ONE			English	Article							CANONICAL CORRELATION-ANALYSIS; FREQUENCY; CORTEX; SIZE; COMMUNICATION	A brain-computer interface (BCI) based on code modulated visual evoked potentials (c-VEP) is among the fastest BCIs that have ever been reported, but it has not yet been given a thorough study. In this study, a pseudorandom binary M sequence and its time lag sequences are utilized for modulation of different stimuli and template matching is adopted as the method for target recognition. Five experiments were devised to investigate the effect of stimulus specificity on target recognition and we made an effort to find the optimal stimulus parameters for size, color and proximity of the stimuli, length of modulation sequence and its lag between two adjacent stimuli. By changing the values of these parameters and measuring classification accuracy of the c-VEP BCI, an optimal value of each parameter can be attained. Experimental results of ten subjects showed that stimulus size of visual angle 3.8 degrees, white, spatial proximity of visual angle 4.8 degrees center to center apart, modulation sequence of length 63 bits and the lag of 4 bits between adjacent stimuli yield individually superior performance. These findings provide a basis for determining stimulus presentation of a high-performance c-VEP based BCI system.	[Wei, Qingguo; Feng, Siwei; Lu, Zongwu] Nanchang Univ, Sch Informat Engn, Dept Elect Engn, Nanchang 330029, Peoples R China	Nanchang University	Wei, QG (corresponding author), Nanchang Univ, Sch Informat Engn, Dept Elect Engn, Nanchang 330029, Peoples R China.	wqg07@163.com			National Natural Science Foundation of China [61365013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant 61365013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminaka D, 2015, IEEE ENG MED BIO, P1906, DOI 10.1109/EMBC.2015.7318755; Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Bin GY, 2009, IEEE COMPUT INTELL M, V4, P22, DOI 10.1109/MCI.2009.934562; Bin GY, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046002; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; CAMPBELL FW, 1970, J PHYSIOL-LONDON, V207, P635, DOI 10.1113/jphysiol.1970.sp009085; Cao T, 2012, IEEE ENG MED BIO, P1819, DOI 10.1109/EMBC.2012.6346304; Chen XG, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046008; COPENHAVER RM, 1964, INVEST OPHTH VISUAL, V3, P665; Dawoud NN, 2012, P INT MULT ENG COMP, VI; DOW BM, 1981, EXP BRAIN RES, V44, P213; Duszyk A, 2014, PLOS ONE, V11, P1; Friman O, 2001, MAGNET RESON MED, V45, P323, DOI 10.1002/1522-2594(200102)45:2<323::AID-MRM1041>3.0.CO;2-#; Gao SK, 2014, IEEE T BIO-MED ENG, V61, P1436, DOI 10.1109/TBME.2014.2300164; Hubel David H, 1995, EYE BRAIN VISION, P6; Jain AK, 1998, SIGNAL PROCESS, V71, P109, DOI 10.1016/S0165-1684(98)00139-X; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Kastner S, 2001, J NEUROPHYSIOL, V86, P1398, DOI 10.1152/jn.2001.86.3.1398; Lin ZL, 2006, IEEE T BIO-MED ENG, V53, P2610, DOI 10.1109/TBME.2006.886577; Nakanishi M, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714500191; Nezamfar H, 2011, INT J IMAG SYST TECH, V21, P139, DOI 10.1002/ima.20288; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; REGAN D, 1966, NATURE, V210, P1056, DOI 10.1038/2101056a0; Regan David, 2000, HUMAN PERCEPTION OBJ; Spuler M, 2012, P 20 EUR S ART NEUR, P103, DOI [10.13140/2.1.2186.7526, DOI 10.13140/2.1.2186.7526]; Spuler M, 2012, ONLINE ADAPTATION C, V7, P1; Sutter E. E., 1984, Proceedings of the Symposium on Biosensors (Cat. No. 84CH2068-5), P95; SUTTER EE, 1992, J MICROCOMPUT APPL, V15, P31, DOI 10.1016/0745-7138(92)90045-7; Thielen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133797; Volosyak I, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036020; Waytowich NR, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/036006; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu MP, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026001; Yin EW, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026012; Yuan P, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046006; Zhu Danhua, 2010, Comput Intell Neurosci, P702357, DOI 10.1155/2010/702357	37	22	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156416	10.1371/journal.pone.0156416	http://dx.doi.org/10.1371/journal.pone.0156416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243454	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100038
J	Hwang, IH; Park, J; Kim, JM; Kim, SI; Choi, JS; Lee, KB; Yun, SH; Lee, MG; Park, SJ; Jang, IS				Hwang, In-Hu; Park, Junsoo; Kim, Jung Min; Kim, Seung Il; Choi, Jong-Soon; Lee, Kyung-Bok; Yun, Sung Ho; Lee, Min-Goo; Park, Soo Jung; Jang, Ik-Soon			Tetraspanin-2 promotes glucotoxic apoptosis by regulating the JNK/-catenin signaling pathway in human pancreatic cells	FASEB JOURNAL			English	Article						Bax; glucose toxicity; TSPAN2	THIOREDOXIN-INTERACTING PROTEIN; WNT; PHOSPHORYLATION; TRANSCRIPTION; GSK3-BETA; MECHANISM; SURVIVAL; BAX	Diabetes mellitus is a complex and heterogeneous disease, which has -cell dysfunction at its core. Glucotoxicity affects pancreatic islets, causing -cell apoptosis. However, the role of JNK/-catenin signaling in glucotoxic -cell apoptosis is not well understood. Recently, we identified tetraspanin-2 (TSPAN2) protein as a proapoptotic -cell factor induced by glucose, suggesting that TSPAN2 might contribute to pancreatic -cell glucotoxicity. To investigate the effects of glucose concentration on TSPAN2 expression and apoptosis, we used reverted immortalized RNAKT-15 human pancreatic cells. High TSPAN2 levels up-regulated phosphorylated (p) JNK and induced apoptosis. p-JNK enhanced the phosphorylation of -catenin and Dickkopf-1 (Dkk1). Dkk1 knockdown by small interfering (si)RNA up-regulated nuclear -catenin, suggesting that it is a JNK/-catenin-dependent pathway. siRNA-mediated TSPAN2 depletion in RNAKT-15 cells increased nuclear -catenin. This decreased BCL2-associated X protein (Bax) activation, leading to marked protection against high glucose-induced apoptosis. Bax subfamily proteins induced apoptosis through caspase-3. Thus, TSPAN2 might have induced Bax translocation and caspase-3 activation in pancreatic cells, thereby promoting the apoptosis of RNAKT-15 cells by regulating the JNK/-catenin pathway in response to high glucose concentrations. Targeting TSPAN2 could be a potential therapeutic strategy to treat glucose toxicity-induced -cell failure.Hwang, I.-H., Park, J., Kim, J. M., Kim, S. I., Choi, J.-S., Lee, K.-B., Yun, S. H., Lee, M.-G., Park, S. J., Jang, I.-S. Tetraspanin-2 promotes glucotoxic apoptosis by regulating the JNK/-catenin signaling pathway in human pancreatic cells.	[Hwang, In-Hu; Lee, Min-Goo] Korea Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Park, Junsoo] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea; [Kim, Jung Min] Daejeon Univ, Daejeon Oriental Hosp, NAR Ctr Inc, Daejeon, South Korea; [Kim, Seung Il; Choi, Jong-Soon; Lee, Kyung-Bok; Yun, Sung Ho; Jang, Ik-Soon] Korea Basic Sci Inst, Div Bioconvergence, Daejeon 305333, South Korea; [Park, Soo Jung] Sangji Univ, Coll Korean Med, Wonju 220702, South Korea	Korea University; Korea University Medicine (KU Medicine); Yonsei University; Daejeon University; Korea Basic Science Institute (KBSI); Sangji University	Jang, IS (corresponding author), Korea Basic Sci Inst, Div Bioconvergence, Daejeon 305333, South Korea.; Park, SJ (corresponding author), Sangji Univ, Coll Korean Med, Wonju 220702, South Korea.	taorgi@hanmail.net; jangiksn@kbsi.re.kr		Lee, Kyung-Bok/0000-0003-1495-3462; Kim, Jung Min/0000-0001-6319-0217	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01058744, 2014R1A1A2058114]; Korea Basic Science Institute [D36403]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Korea Basic Science Institute	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by Ministry of Education Grants 2015R1D1A1A01058744 and 2014R1A1A2058114, and supported by Korea Basic Science Institute Grant D36403. Author contributions: I.-H. Hwang and J. Park performed the experiments, including cell culture, Western blot analyses, and confocal microscopy, and analyzed the data; J. M. Kim and S. I. Kim performed microarray and Gene Ontology analyses; J.-S. Choi, K.-B. Lee, S. H. Yun, and M.-G. Lee supported the experiments and prepared the figures; and S. J. Park and I.-S. Jang conceived and designed the experiments, contributed reagents, sourced materials, provided analysis tools, and wrote the paper. The authors declare no conflicts of interest.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006640; Hu D, 2008, CARCINOGENESIS, V29, P2317, DOI 10.1093/carcin/bgn239; Kang BPS, 2003, AM J PHYSIOL-RENAL, V284, pF455, DOI 10.1152/ajprenal.00137.2002; Khera T, 2006, LAB INVEST, V86, P566, DOI 10.1038/labinvest.3700418; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Sinha D, 2005, AM J PHYSIOL-RENAL, V288, pF703, DOI 10.1152/ajprenal.00189.2004; Todd SC, 1998, BBA-GENE STRUCT EXPR, V1399, P101, DOI 10.1016/S0167-4781(98)00087-6; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008	24	11	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3107	3116		10.1096/fj.201600240RR	http://dx.doi.org/10.1096/fj.201600240RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27247127	hybrid, Green Published			2022-12-26	WOS:000382816300011
J	Denomme, MM; McCallie, BR; Parks, JC; Schoolcraft, WB; Katz-Jaffe, MG				Denomme, Michelle M.; McCallie, Blair R.; Parks, Jason C.; Schoolcraft, William B.; Katz-Jaffe, Mandy G.			Epigenetic Dysregulation Observed in Monosomy Blastocysts Further Compromises Developmental Potential	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; BECKWITH-WIEDEMANN-SYNDROME; IN-SITU HYBRIDIZATION; UNIPARENTAL DISOMY; DNA METHYLATION; HUMAN EMBRYOS; PRADER-WILLI; ANEUPLOIDY; MOSAICISM; GENE	Epigenetic mechanisms such as DNA methylation regulate genomic imprinting and account for the distinct non-equivalence of the parental genomes in the embryo. Chromosomal aneuploidy, a major cause of infertility, distorts this highly regulated disparity by the presence or absence of chromosomes. The implantation potential of monosomy embryos is negligible compared to their trisomy counterparts, yet the cause for this is unknown. This study investigated the impact of chromosomal aneuploidy on strict epigenetically regulated domains, specifically imprinting control regions present on aneuploid chromosomes. Donated cryopreserved human IVF blastocysts of transferable quality, including trisomy 15, trisomy 11, monosomy 15, monosomy 11, and donor oocyte control blastocysts were examined individually for DNA methylation profiles by bisulfite mutagenesis and sequencing analysis of two maternally methylated imprinting control regions (ICRs), SNRPN (15q11.2) and KCNQ1OT1 (11p15.5), and one paternally methylated imprinting control region, H19 (11p15.5). Imprinted genes within the regions were also evaluated for transcript abundance by RT-qPCR. Overall, statistically significant hypermethylated and hypomethylated ICRs were found in both the trisomy and monosomy blastocysts compared to controls, restricted only to the chromosome affected by the aneuploidy. Increased expression was observed for maternally-expressed imprinted genes in trisomy blastocysts, while a decreased expression was observed for both maternally-and paternally-expressed imprinted genes in monosomy blastocysts. This epigenetic dysregulation and altered monoallelic expression observed at imprinting control regions in aneuploid IVF embryos supports euploid embryo transfer during infertility treatments, and may specifically highlight an explanation for the compromised implantation potential in monosomy embryos.	[Denomme, Michelle M.; McCallie, Blair R.; Parks, Jason C.; Katz-Jaffe, Mandy G.] Fertil Labs Colorado, Lone Tree, CO USA; [Schoolcraft, William B.; Katz-Jaffe, Mandy G.] Colorado Ctr Reprod Med, Lone Tree, CO USA		Katz-Jaffe, MG (corresponding author), Fertil Labs Colorado, Lone Tree, CO USA.; Katz-Jaffe, MG (corresponding author), Colorado Ctr Reprod Med, Lone Tree, CO USA.	MKatz-Jaffe@ColoCRM.com						Alfarawati S, 2011, FERTIL STERIL, V95, P520, DOI 10.1016/j.fertnstert.2010.04.003; Berteaux N, 2005, J BIOL CHEM, V280, P29625, DOI 10.1074/jbc.M504033200; Chen SL, 2010, FERTIL STERIL, V94, P2356, DOI 10.1016/j.fertnstert.2010.01.120; Choufani S, 2010, AM J MED GENET C, V154C, P343, DOI 10.1002/ajmg.c.30267; Cooper WN, 2005, EUR J HUM GENET, V13, P1025, DOI 10.1038/sj.ejhg.5201463; Davidsson J, 2014, EPIGENOMICS-UK, V6, P45, DOI 10.2217/epi.13.78; Davidsson J, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-18; DELHANTY JDA, 1993, HUM MOL GENET, V2, P1183, DOI 10.1093/hmg/2.8.1183; Denomme MM, 2012, JOVE-J VIS EXP, DOI 10.3791/4046; Denomme MM, 2012, REPRODUCTION, V144, P393, DOI 10.1530/REP-12-0237; Fragouli E, 2006, HUM REPROD, V21, P2319, DOI 10.1093/humrep/del157; Fragouli E, 2009, REPROD BIOMED ONLINE, V19, P228, DOI 10.1016/S1472-6483(10)60078-8; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Geuns E, 2003, HUM MOL GENET, V12, P2873, DOI 10.1093/hmg/ddg315; Geuns E, 2007, EUR J HUM GENET, V15, P352, DOI 10.1038/sj.ejhg.5201759; Gueye NA, 2014, FERTIL STERIL, V101, P232, DOI 10.1016/j.fertnstert.2013.08.051; Haas O. A., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P239; Hassold T, 2007, HUM MOL GENET, V16, pR203, DOI 10.1093/hmg/ddm243; Herrera LA, 2008, CURR GENOMICS, V9, P43, DOI 10.2174/138920208783884883; Horsthemke B, 1997, J CELL PHYSIOL, V173, P237, DOI 10.1002/(SICI)1097-4652(199711)173:2<237::AID-JCP28>3.0.CO;2-B; Horsthemke B, 2014, J PATHOL, V232, P485, DOI 10.1002/path.4326; Ibala-Romdhane S, 2011, EUR J HUM GENET, V19, P1138, DOI 10.1038/ejhg.2011.99; Iwarsson E, 1999, HUM GENET, V104, P376, DOI 10.1007/s004390050971; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KAMIGUCHI Y, 1993, HUM GENET, V90, P533; Khoueiry R, 2013, ZYGOTE, V21, P129, DOI 10.1017/S0967199411000694; Lim JH, 2015, PLACENTA, V36, P322, DOI 10.1016/j.placenta.2014.12.020; McCallie BR, 2014, J ASSIST REPROD GEN, V31, P913, DOI 10.1007/s10815-014-0235-y; McCallie BR PJ, 2014, 70 AM SOC REPR MED A; McCoy RC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005601; MUNNE S, 1993, HUM REPROD, V8, P2185, DOI 10.1093/oxfordjournals.humrep.a138001; Munne S, 2016, FERTIL STERIL, V105, P1146, DOI 10.1016/j.fertnstert.2016.01.016; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Parks JC, 2011, FERTIL STERIL, V95, P1367, DOI 10.1016/j.fertnstert.2010.08.009; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Prawitt D, 2005, P NATL ACAD SCI USA, V102, P4085, DOI 10.1073/pnas.0500037102; Rabinowitz M, 2012, FERTIL STERIL, V97, P395, DOI 10.1016/j.fertnstert.2011.11.034; Robinson WP, 2000, BIOESSAYS, V22, P452; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Rodriguez-Purata J, 2015, FERTIL STERIL, V104, P1460, DOI 10.1016/j.fertnstert.2015.08.007; Sailani MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135555; Schoolcraft WB, 2010, FERTIL STERIL, V94, P1700, DOI [10.1016/itertnstert2009.10.015, DOI 10.1016/ITERTNSTERT.2009.10.015]; Shi XY, 2014, REPROD SCI, V21, P978, DOI 10.1177/1933719113519173; Shuman C, 1993, BECKWITH WIEDEMANN S; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Templado C, 2011, CYTOGENET GENOME RES, V133, P91, DOI 10.1159/000323795; Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590; Viana J, 2014, EPIGENETICS-US, V9, P587, DOI 10.4161/epi.27806; Weksberg R, 2005, AM J MED GENET C, V137C, P12, DOI 10.1002/ajmg.c.30058; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; White CR, 2015, SCI REP-UK, V5, DOI 10.1038/srep17311; Wilton L, 2003, FERTIL STERIL, V80, P860, DOI 10.1016/S0015-0282(03)01162-2; Yang ZH, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-24	54	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156980	10.1371/journal.pone.0156980	http://dx.doi.org/10.1371/journal.pone.0156980			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271036	Green Published, Green Submitted, gold			2022-12-26	WOS:000377561000055
J	Auranen, K; Syrjanen, R; Leino, T; Kilpi, T				Auranen, Kari; Syrjanen, Ritva; Leino, Tuija; Kilpi, Terhi			New Pneumococcal Carriage Acquired in Association with Acute Respiratory Infection Is Prone to Cause Otitis Media	PLOS ONE			English	Article							INFLUENZA-A VIRUS; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; CHILDREN; DISEASE; COLONIZATION; ACQUISITION; RESISTANCE; BACTERIAL; FAMILIES	For considering vaccine-prevention of pneumococcal acute otitis media (PncAOM), relationships between pneumococcal carriage, respiratory infection and PncAOM need to be understood. We analyzed nasopharyngeal samples collected from 329 unvaccinated Finnish children aged 2-24 months at scheduled visits and at visits during respiratory infection in 1994-97. We assessed temporal associations of respiratory infection with pneumococcal acquisition and whether PncAOM hazard depends on the relative timing of acquisition and the infection onset. The data comprised 607 person-years of risk-time for acquisition, 245 person-months of concurrent respiratory infection and carriage, and 119 episodes of PncAOM. The acquisition hazard was 3-fold in the month preceding respiratory sickness (hazard ratio, HR 3.5, 90% credible interval CI 2.9, 4.1) as compared to acquisition in healthy children. Moreover, the PncAOM hazard was markedly higher (HR 3.7, 90% CI 2.4, 5.3) during the first month of carriage acquired around the acute phase of respiratory infection (between 1 month before and 1 week after the sickness onset), as compared to carriage acquired later during sickness. The high proportion (76%) of PncAOM events occurring within 1 month of acquisition was due to frequent acquisition being associated with respiratory infection as well as the susceptibility of such acquisition to cause otitis media.	[Auranen, Kari; Syrjanen, Ritva; Leino, Tuija; Kilpi, Terhi] Natl Inst Hlth & Welf, Dept Hlth Protect, Mannerheimintie 166, Helsinki 00300, Finland; [Auranen, Kari] Univ Turku, Dept Math & Stat, Turku 20014, Finland; [Syrjanen, Ritva] Natl Inst Hlth & Welf, Dept Hlth Protect, Finn Medi I, Biokatu 6, Tampere 33520, Finland	Finland National Institute for Health & Welfare; University of Turku; Finland National Institute for Health & Welfare	Auranen, K (corresponding author), Natl Inst Hlth & Welf, Dept Hlth Protect, Mannerheimintie 166, Helsinki 00300, Finland.; Auranen, K (corresponding author), Univ Turku, Dept Math & Stat, Turku 20014, Finland.	kari.auranen@thl.fi			Pasteur Merieux Connaught; Wyeth-Lederle Vaccines and Pediatrics	Pasteur Merieux Connaught; Wyeth-Lederle Vaccines and Pediatrics	The FinOM studies were supported by Merck & Co., Inc., Pasteur Merieux Connaught and Wyeth-Lederle Vaccines and Pediatrics. These funders had no role in study design, analysis, decision to publish, or preparation of the current manuscript.	Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; ABRAMSON JS, 1982, INFECT IMMUN, V36, P289, DOI 10.1128/IAI.36.1.289-296.1982; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Chonmaitree T, 2000, PEDIATR INFECT DIS J, V19, P258, DOI 10.1097/00006454-200003000-00020; Ciftci E, 2000, PEDIATR INT, V42, P552, DOI 10.1046/j.1442-200x.2000.01269.x; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P331, DOI 10.1016/S0928-8244(98)00153-9; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; FADEN H, 1990, PEDIATR INFECT DIS J, V9, P623; FADEN H, 1991, ANN OTO RHINOL LARYN, V100, P612, DOI 10.1177/000348949110000802; GIEBINK GS, 1980, ANN OTO RHINOL LARYN, V89, P339, DOI 10.1177/00034894800890S380; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; Heikkinen T, 2003, CLIN MICROBIOL REV, V16, P230, DOI 10.1128/CMR.16.2.230-241.2003; Hoa M, 2009, ANN OTO RHINOL LARYN, V118, P292, DOI 10.1177/000348940911800410; Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06; Hoti F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-102; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Kilpi T, 2001, PEDIATR INFECT DIS J, V20, P654, DOI 10.1097/00006454-200107000-00004; Lipsitch M, 2012, EPIDEMIOLOGY, V23, P510, DOI 10.1097/EDE.0b013e31824f2f32; MASTERS PL, 1958, BMJ-BRIT MED J, V1, P1200, DOI 10.1136/bmj.1.5081.1200; MASTRO TD, 1993, PEDIATR INFECT DIS J, V12, P824, DOI 10.1097/00006454-199310000-00006; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; McCullers JA, 2010, J INFECT DIS, V202, P1287, DOI 10.1086/656333; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; MOGDASY MC, 1992, PEDIATR INFECT DIS J, V11, P648; Novales MGM, 1997, ARCH MED RES, V28, P559; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Ruohola A, 2013, J INFECTION, V66, P247, DOI 10.1016/j.jinf.2012.12.002; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Sleeman KL, 2005, PEDIATR INFECT DIS J, V24, P121, DOI 10.1097/01.inf.0000151030.10159.b1; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Syrjanen RK, 2006, PEDIATR INFECT DIS J, V25, P1032, DOI 10.1097/01.inf.0000241097.37428.1d; Syrjanen RK, 2005, PEDIATR INFECT DIS J, V24, P801, DOI 10.1097/01.inf.0000178072.83531.4f; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Tong HH, 2000, ANN OTO RHINOL LARYN, V109, P1021, DOI 10.1177/000348940010901106	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156343	10.1371/journal.pone.0156343	http://dx.doi.org/10.1371/journal.pone.0156343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257789	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700055
J	Li, C; Zou, XH; Zhang, CY; Shao, QH; Liu, J; Liu, B; Li, HY; Zhao, T				Li, Cong; Zou, Xiaohua; Zhang, Chunyu; Shao, Qinghao; Liu, Jun; Liu, Bin; Li, Hongyu; Zhao, Tao			OsLBD3-7 Overexpression Induced Adaxially Rolled Leaves in Rice	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; BULLIFORM CELLS; GENE FAMILY; LEAF; BOUNDARIES; ARABIDOPSIS; PROTEIN; EXPRESSION; DEFINES; FATE	Appropriate leaf rolling enhances erect-leaf habits and photosynthetic efficiency, which consequently improves grain yield. Here, we reported the novel lateral organ boundaries domain (LBD) gene OsLBD3-7, which is involved in the regulation of leaf rolling. OsLBD3-7 works as a transcription activator and its protein is located on the plasma membrane and in the nucleus. Overexpression of OsLBD3-7 leads to narrow and adaxially rolled leaves. Microscopy of flag leaf cross-sections indicated that overexpression of OsLBD3-7 led to a decrease in both bulliform cell size and number. Transcriptional analysis showed that key genes that had been reported to be negative regulators of bulliform cell development were up-regulated in transgenic plants. These results indicated that OsLBD3-7 might acts as an upstream regulatory gene of bulliform cell development to regulate leaf rolling, which will give more insights on the leaf rolling regulation mechanism.	[Li, Cong; Zhang, Chunyu; Liu, Jun; Liu, Bin; Li, Hongyu; Zhao, Tao] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Zou, Xiaohua] Shanghai Acad Agr Sci, Forestry & Fruit Tree Res Inst, Shanghai Key Lab Protected Hort Technol, Shanghai 201403, Peoples R China; [Shao, Qinghao] Jinan Licheng 2 High Sch, Jinan 250104, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Shanghai Academy of Agricultural Sciences	Li, HY; Zhao, T (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China.	lihongyu@caas.cn; zhaotao02@caas.cn	Zhang, Chun-yu/HDP-5776-2022	Zhao, Tao/0000-0002-5641-8161	National Natural Science Foundation of China [31571758]; CAAS Innovation Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAAS Innovation Program	This work is supported by the National Natural Science Foundation of China (31571758 to TZ) and the CAAS Innovation Program.	Alvarez JM, 2008, BRAZ ARCH BIOL TECHN, V51, P113, DOI 10.1590/S1516-89132008000100014; Becraft PW, 2002, DEVELOPMENT, V129, P5217; Chen XF, 2013, J EXP BOT, V64, P4895, DOI 10.1093/jxb/ert278; Coudert Y, 2013, MOL BIOL EVOL, V30, P569, DOI 10.1093/molbev/mss250; Fang LK, 2012, PLANT BIOTECHNOL J, V10, P524, DOI 10.1111/j.1467-7652.2012.00679.x; Govaerts YM, 1996, APPL OPTICS, V35, P6585, DOI 10.1364/AO.35.006585; Hibara K, 2009, DEV BIOL, V334, P345, DOI 10.1016/j.ydbio.2009.07.042; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hu J, 2010, PLANT MOL BIOL, V73, P283, DOI 10.1007/s11103-010-9614-7; Husbands A, 2007, NUCLEIC ACIDS RES, V35, P6663, DOI 10.1093/nar/gkm775; Li L, 2010, MOL PLANT, V3, P807, DOI 10.1093/mp/ssq022; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Ma Y, 2009, J PLANT BIOL, V52, P374, DOI 10.1007/s12374-009-9048-4; Majer C, 2011, TRENDS PLANT SCI, V16, P47, DOI 10.1016/j.tplants.2010.09.009; Matsumura Y, 2009, PLANT J, V58, P525, DOI 10.1111/j.1365-313X.2009.03797.x; Meng YY, 2013, PLANT CELL, V25, P4405, DOI 10.1105/tpc.113.116590; Ohashi M, 2015, PLANT CELL PHYSIOL, V56, P769, DOI 10.1093/pcp/pcv005; Shi ZY, 2007, PLANTA, V226, P99, DOI 10.1007/s00425-006-0472-0; Shuai B, 2002, PLANT PHYSIOL, V129, P747, DOI 10.1104/pp.010926; Steffen A, 1994, PLANT J, V5, P421; Xiang JJ, 2012, PLANT PHYSIOL, V159, P1488, DOI 10.1104/pp.112.199968; Yan S, 2008, PLANT MOL BIOL, V68, P239, DOI 10.1007/s11103-008-9365-x; Yang CH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-158; Yang Y, 2006, MOL PHYLOGENET EVOL, V39, P248, DOI 10.1016/j.ympev.2005.09.016; Zhang GH, 2009, PLANT CELL, V21, P719, DOI 10.1105/tpc.108.061457; Zhao T, 2015, SCI CHINA LIFE SCI, V58, P1160, DOI 10.1007/s11427-015-4937-x; Zou LP, 2011, PLANT PHYSIOL, V156, P1589, DOI 10.1104/pp.111.176016	27	15	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156413	10.1371/journal.pone.0156413	http://dx.doi.org/10.1371/journal.pone.0156413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258066	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700061
J	Liu, WJ; Li, YC; Kou, GH; Lo, CF				Liu, Wang-Jing; Li, Yi-Chieh; Kou, Guang-Hsiung; Lo, Chu-Fang			Laminin Receptor in Shrimp Is a Cellular Attachment Receptor for White Spot Syndrome Virus	PLOS ONE			English	Article							CHITIN-BINDING PROTEIN; WSSV INFECTION; LITOPENAEUS VANNAMEI; TOPOLOGY PREDICTION; ENVELOPE PROTEINS; PENAEUS-MONODON; CAPSID PROTEINS; BETA-INTEGRIN; IDENTIFICATION; ENTRY	White spot syndrome virus (WSSV, genus Whispovirus, family Nimaviridae) is causing huge economic losses in global shrimp farming, but there is no effective control. Shrimp cell laminin receptor (Lamr) may have a role in WSSV infection. The objective was to characterize interactions between Penaeus monodon Lamr (PmLamr) and WSSV structural proteins. In this study, PmLamr interacted with nine WSSV structural proteins (based on yeast two-hybrid screening), of which one (VP31) was characterized. Protein pull-down assay confirmed the interaction between PmLamr and VP31; the latter was an envelope protein exposed outside the WSSV virion (based on membrane topology assays). Furthermore, similar to mammalian Lamr, there were two major protein bands in shrimp cells. Cellular localization assay demonstrated VP31 co-localized with PmLamr on transfected cells. Enzyme-link immunosorbent assay (ELISA) and competitive ELISA demonstrated binding of VP31 on PmLamr was dose-dependent; however, addition of WSSV virion competed for binding affinity. Furthermore, based on an in vivo neutralization assay, both VP31 and PmLamr delayed mortality in shrimp challenged with WSSV. We concluded Lamr was an important receptor for WSSV infection and the viral envelope protein VP31 may have a role in host cell recognition and binding. These data contributed to elucidating pathogenesis of WSSV infection and may help in controlling this disease.	[Liu, Wang-Jing; Li, Yi-Chieh] Univ Taipei, Coll Sci, Dept Earth & Life Sci, Taipei, Taiwan; [Kou, Guang-Hsiung] Natl Taiwan Univ, Coll Life Sci, Dept Life Sci, Taipei 10764, Taiwan; [Lo, Chu-Fang] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 701, Taiwan	University of Taipei; National Taiwan University; National Cheng Kung University	Liu, WJ (corresponding author), Univ Taipei, Coll Sci, Dept Earth & Life Sci, Taipei, Taiwan.	liuwjing@utaipei.edu.tw	Lo, Chu-Fang/G-3088-2014	Lo, Chu-Fang/0000-0001-5136-8129	Ministry of Science and Technology, R.O.C [MOST 104-2311-B-845-001]	Ministry of Science and Technology, R.O.C	This investigation was supported financially by the Ministry of Science and Technology, R.O.C (https://www.most.gov.tw/) under grant no. MOST 104-2311-B-845-001. WJL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Ardini E, 1997, J BIOL CHEM, V272, P2342; Busayarat N, 2011, FISH SHELLFISH IMMUN, V31, P66, DOI 10.1016/j.fsi.2011.03.007; CASTRONOVO V, 1993, INVAS METAST, V13, P1; Charoensapsri W, 2015, DEV COMP IMMUNOL, V51, P39, DOI 10.1016/j.dci.2015.02.012; Chen JN, 2015, J VIROL, V89, P4894, DOI 10.1128/JVI.00019-15; Chen LL, 2007, DIS AQUAT ORGAN, V74, P171, DOI 10.3354/dao074171; DiGiacomo V, 2015, BIOL REV; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Huang HT, 2015, FISH SHELLFISH IMMUN, V46, P305, DOI 10.1016/j.fsi.2015.06.034; Huang HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033216; Huang PY, 2014, J GEN VIROL, V95, P1799, DOI 10.1099/vir.0.064782-0; Kang ST, 2009, VIROLOGY, V387, P353, DOI 10.1016/j.virol.2009.02.012; Kielian M, 2010, VIRUSES-BASEL, V2, P796, DOI 10.3390/v2040796; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leu JH, 2008, DEV COMP IMMUNOL, V32, P121, DOI 10.1016/j.dci.2007.05.005; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Li L, 2005, VIROLOGY, V340, P125, DOI 10.1016/j.virol.2005.06.007; Li LJ, 2006, ARCH VIROL, V151, P1309, DOI 10.1007/s00705-005-0719-2; Li L, 2011, ARCH VIROL, V156, P1317, DOI 10.1007/s00705-011-0984-1; Liang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-144; Liu WJ, 2007, J VIROL, V81, P1461, DOI 10.1128/JVI.01880-06; Liu WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085779; Lo C.-F., 2005, DIS ASIAN AQUACULTUR, P421; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Senapin S, 2006, VIRUS RES, V122, P69, DOI 10.1016/j.virusres.2006.06.013; Senapin S, 2010, FISH SHELLFISH IMMUN, V29, P422, DOI 10.1016/j.fsi.2010.04.022; Sritunyalucksana K, 2006, J VIROL, V80, P10734, DOI 10.1128/JVI.00349-06; Tsai JM, 2006, J VIROL, V80, P3021, DOI 10.1128/JVI.80.6.3021-3029.2006; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Vlak JM, 2005, 8 REP INT COMM TAX V, P187; Xie XX, 2005, VIROLOGY, V336, P93, DOI 10.1016/j.virol.2005.03.011; Zhang JY, 2014, J BIOSCIENCES, V39, P381, DOI 10.1007/s12038-014-9418-z	36	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156375	10.1371/journal.pone.0156375	http://dx.doi.org/10.1371/journal.pone.0156375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257954	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700057
J	Michel, G; Ferrua, B; Munro, P; Boyer, L; Mathal, N; Gillet, D; Marty, P; Lemichez, E				Michel, Gregory; Ferrua, Bernard; Munro, Patrick; Boyer, Laurent; Mathal, Nassim; Gillet, Daniel; Marty, Pierre; Lemichez, Emmanuel			Immunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantum	PLOS ONE			English	Article							PROTEASOMAL DEGRADATION; BACTERIAL TOXINS; BALB/C MICE; GTPASES; ADJUVANTS; ANTIGENS; IMMUNITY; UPDATE	There is a need to develop new effective immunoadjuvants for prophylactic or therapeutic vaccines against intracellular pathogens. The activation of Rho GTPases by bacterial cytotoxic necrotizing factor 1 (CNF1) elicits humoral protective responses against protein antigens. Here, we set out to investigate whether CNF1 activity initiates humoral immunity against co-administered parasite antigens and anti-microbial immune signaling. We report that co-administration of wild-type (WT) CNF1 with Leishmania (L.) promastigote antigens at the nasal mucosa triggered prophylactic and curative vaccine responses against this parasite. Vaccination of the mucosa with promastigote lysate antigens combined with WT CNF1 conferred protection against high inoculum L. infantum infection, which reached 82% in the spleen. Immune parameter analysis by antigen recall indicated robust T-helper (Th) 1 polarization of immune memory cells, with high IL-2 and IFN-gamma. production combined with decreased IL-4 production. Additionally, we explored the curative effect of WT CNF1 on previously infected animals. We observed that PL combined with WT CNF1, but not the inactive C866S mutant CNF1 (mCNF1), induced a 58% decrease in the parasite burden in the spleen.	[Michel, Gregory; Ferrua, Bernard; Munro, Patrick; Boyer, Laurent; Marty, Pierre; Lemichez, Emmanuel] Fac Med Nice, INSERM, Team Microbial Toxins Host Pathogen Interact, U1065,Ctr Mediterraneen Med Mol,Equipe Labellisee, U210, F-06034 Nice, France; [Michel, Gregory; Ferrua, Bernard; Munro, Patrick; Boyer, Laurent; Marty, Pierre; Lemichez, Emmanuel] Univ Nice Sophia Antipolis, Fac Med, F-06189 Nice, France; [Michel, Gregory; Marty, Pierre] CHU Nice, Lab Parasitol Mycol, F-06202 Nice, France; [Mathal, Nassim; Gillet, Daniel] Paris Saclay Univ, LabEx LERMIT, CEA, iBiTecS,SIMOPRO, Gif Sur Yvette, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CEA; UDICE-French Research Universities; Universite Paris Saclay	Michel, G; Lemichez, E (corresponding author), Fac Med Nice, INSERM, Team Microbial Toxins Host Pathogen Interact, U1065,Ctr Mediterraneen Med Mol,Equipe Labellisee, U210, F-06034 Nice, France.; Michel, G; Lemichez, E (corresponding author), Univ Nice Sophia Antipolis, Fac Med, F-06189 Nice, France.; Michel, G (corresponding author), CHU Nice, Lab Parasitol Mycol, F-06202 Nice, France.	gmichel@unice.fr; lemichez@unice.fr	Lemichez, Emmanuel/G-3559-2013; Michel, Grégory/M-4124-2018; Marty, Pierre/P-6228-2016; Boyer, laurent/F-8921-2015; BOYER, Laurent/AAH-4543-2021; Gillet, Daniel/C-5592-2008; Munro, Patrick/A-6579-2009	Lemichez, Emmanuel/0000-0001-9080-7761; Michel, Grégory/0000-0002-6902-7514; Boyer, laurent/0000-0002-1375-1706; BOYER, Laurent/0000-0002-1375-1706; Gillet, Daniel/0000-0003-0477-3599; Munro, Patrick/0000-0003-4283-4671	Groupe d'Action Contre la Leishmaniose (GACL); INSERM; Fondation Infectiopole Sud; Agence Nationale de la Recherche [ANR 11BSV3 004 01, ANR-10-LABEX-33]; "Investments for the Future" LABEX SIGNALIFE [ANR-11-LABX-0028-01]; C3M; DGA; joint ministerial program of RD	Groupe d'Action Contre la Leishmaniose (GACL); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation Infectiopole Sud; Agence Nationale de la Recherche(French National Research Agency (ANR)); "Investments for the Future" LABEX SIGNALIFE; C3M; DGA; joint ministerial program of RD	This work was supported by the Groupe d'Action Contre la Leishmaniose (GACL), by institutional funding from INSERM, grants from the Fondation Infectiopole Sud, the Agence Nationale de la Recherche (ANR 11BSV3 004 01), the "Investments for the Future" LABEX SIGNALIFE ANR-11-LABX-0028-01 and the C3M animal facility. NM was supported by DGA and the joint ministerial program of R&D against CBRNE threats. SIMOPRO is a member of the laboratory of Excellence LERMIT supported by the grant from the Agence Nationale de la Recherche (ANR-10-LABEX-33).	Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; Das A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00099; Diabate M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004732; Doye A, 2006, METHOD ENZYMOL, V406, P447, DOI 10.1016/S0076-6879(06)06033-2; Fernandes AP, 2012, CURR OPIN MICROBIOL, V15, P476, DOI 10.1016/j.mib.2012.05.002; Ferrua B, 2006, VACCINE, V24, P589, DOI 10.1016/j.vaccine.2005.08.057; Ferrua B, 2001, J IMMUNOASS IMMUNOCH, V22, P165, DOI 10.1081/IAS-100103227; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Holmgren J, 2005, IMMUNOL LETT, V97, P181, DOI 10.1016/j.imlet.2004.11.009; Keestra AM, 2013, NATURE, V496, P233, DOI 10.1038/nature12025; Lemesre JL, 2005, VACCINE, V23, P2825, DOI 10.1016/j.vaccine.2004.11.061; Lemichez E, 2013, EXP CELL RES, V319, P2329, DOI 10.1016/j.yexcr.2013.04.021; Lemonnier M, 2007, FEMS MICROBIOL REV, V31, P515, DOI 10.1111/j.1574-6976.2007.00078.x; Marty P, 2007, ANN TROP MED PARASIT, V101, P563, DOI 10.1179/136485907X229121; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Mettouchi Amel, 2012, Small GTPases, V3, P102, DOI 10.4161/sgtp.19221; Michel G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001323; Munro P, 2005, VACCINE, V23, P2551, DOI 10.1016/j.vaccine.2004.11.042; Munro P, 2004, J BIOL CHEM, V279, P35849, DOI 10.1074/jbc.M401580200; Munro P, 2007, VACCINE, V25, P8702, DOI 10.1016/j.vaccine.2007.10.024; Nagill R, 2011, INT IMMUNOPHARMACOL, V11, P1464, DOI 10.1016/j.intimp.2011.05.008; Reis AB, 2010, TRENDS PARASITOL, V26, P341, DOI 10.1016/j.pt.2010.04.005; Roberts MTM, 2005, INFECT IMMUN, V73, P7620, DOI 10.1128/IAI.73.11.7620-7628.2005; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Stuart LM, 2013, NAT REV IMMUNOL, V13, P199, DOI 10.1038/nri3398; Sundar S, 2015, EXPERT OPIN PHARMACO, V16, P237, DOI 10.1517/14656566.2015.973850; Zamboni DS, 2015, IMMUNOL REV, V265, P156, DOI 10.1111/imr.12291	27	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156363	10.1371/journal.pone.0156363	http://dx.doi.org/10.1371/journal.pone.0156363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257862	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700056
J	Hao, YA; Dietrich, CH; Dai, W				Hao, Yanan; Dietrich, Christopher H.; Dai, Wu			Structure and Sensilla of the Mouthparts of the Spotted Lanternfly Lycorma delicatula (Hemiptera: Fulgoromorpha: Fulgoridae), a Polyphagous Invasive Planthopper	PLOS ONE			English	Article							EXTERNAL MORPHOLOGY; STYLET PENETRATION; DIGESTIVE ENZYMES; HOMOPTERA; ULTRASTRUCTURE; DELPHACIDAE; INSECTA; MIRIDAE; PARTS; PLANT	Mouthparts are among the most important sensory and feeding structures in insects and comparative morphological study may help explain differences in feeding behavior and diet breadth among species. The spotted lanternfly Lycorma delicatula (White) (Hemiptera: Fulgoromorpha: Fulgoridae) is a polyphagous agricultural pest originating in China, recently established and becoming widespread in Korea, and more recently introduced into eastern North America. It causes severe economic damage by sucking phloem sap and the sugary excrement produced by nymphs and adults serves as a medium for sooty mold. To facilitate future study of feeding mechanisms in this insect, the fine-structural morphology of mouthparts focusing on the distribution of sensilla located on the labium in adult L. delicatula was observed using a scanning electron microscope. The mouthparts consist of a small cone-shaped labrum, a tubular labium and a stylet fascicle consisting of two inner interlocked maxillary stylets partially surrounded by two shorter mandibular stylets similar to those found in other hemipteran insects. The five-segmented labium is unusual (most other Fulgoromorpha have four segments) and is provided with several types of sensilla and cuticular processes situated on the apex of its distal labial segment. In general, nine types of sensilla were found on the mouthparts. Six types of sensilla and four types of cuticular processes are present on sensory fields of the labial apex. The proposed taxonomic and functional significance of the sensilla are discussed. Morphological similarities in the interlocking mechanism of the stylets suggest a relationship between Fulgoromorpha and Heteroptera.	[Hao, Yanan; Dai, Wu] Northwest A&F Univ, Minist Educ, Entomol Museum, Key Lab Plant Protect Resources & Pest Integrated, Yangling, Shaanxi, Peoples R China; [Dietrich, Christopher H.] Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Urbana, IL 61801 USA	Northwest A&F University - China; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Dai, W (corresponding author), Northwest A&F Univ, Minist Educ, Entomol Museum, Key Lab Plant Protect Resources & Pest Integrated, Yangling, Shaanxi, Peoples R China.	daiwu@nwsuaf.edu.cn	Dietrich, Chris/A-9169-2016	Dietrich, Chris/0000-0003-4005-4305	National Natural Science Foundation of China [31572306, 31272343, 30970385]; Chinese Universities Scientific Fund [YQ2013010]; West Light Foundation of the Chinese Academy of Sciences [2012DF06]; U.S. National Science Foundation [DEB 1239788]; Division Of Environmental Biology [1239788] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Universities Scientific Fund; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Natural Science Foundation of China (Nos. 31572306, 31272343, 30970385,), the Chinese Universities Scientific Fund (YQ2013010)" and the West Light Foundation of the Chinese Academy of Sciences (2012DF06) to Wu Dai; U.S. National Science Foundation grant DEB 1239788 to Christopher H. Dietrich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; Anderson WG, 2006, J ECON ENTOMOL, V99, P212, DOI 10.1603/0022-0493(2006)099[0212:CBHBMM]2.0.CO;2; BACKUS EA, 1983, J MORPHOL, V176, P3, DOI 10.1002/jmor.1051760102; Barringer L., 2014, PEST ALERT SPOTTED L; Boyd DW, 2003, ANN ENTOMOL SOC AM, V96, P667, DOI 10.1603/0013-8746(2003)096[0667:DEASMO]2.0.CO;2; Boyd DW, 2002, ANN ENTOMOL SOC AM, V95, P395, DOI 10.1603/0013-8746(2002)095[0395:DEASMO]2.0.CO;2; Brozek Jolanta, 2006, Polskie Pismo Entomologiczne, V75, P239; Brozek Jolanta, 2006, Polskie Pismo Entomologiczne, V75, P255; Brozek Jolanta, 2004, Polskie Pismo Entomologiczne, V73, P79; Brozek J, 2013, ZOOMORPHOLOGY, V132, P403, DOI 10.1007/s00435-013-0195-2; Brozek J, 2013, ZOOMORPHOLOGY, V132, P33, DOI 10.1007/s00435-012-0174-z; Brozek Jolanta, 2010, Zootaxa, V2476, P39; Brozek Jolanta, 2007, P35; Chapman R.F., 1995, P101; Cobben RH, 1987, P 6 AUCH M TUR IT 8, P81; Cobben RH, 1978, EVOLUTIONARY TRENDS, P65; Cohen AC, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P563; Dai W, 2014, MICRON, V56, P8, DOI 10.1016/j.micron.2013.09.005; Ding JQ, 2006, BIOCONTROL SCI TECHN, V16, P547, DOI 10.1080/09583150500531909; Emelyanov A.F., 1987, Trudy Vsesoyuznogo Entomologicheskogo Obshchestva, V69, P19; Forbes A.R., 1977, P83; FOSTER S, 1983, CELL TISSUE RES, V230, P353; Freeman TP, 2001, ANN ENTOMOL SOC AM, V94, P761, DOI 10.1603/0013-8746(2001)094[0761:SPBBAH]2.0.CO;2; Freeman TP, 2000, MICROSC MICROANAL S2, V6, P876; Garzo E, 2012, ARTHROPOD STRUCT DEV, V41, P79, DOI 10.1016/j.asd.2011.07.005; Gullan PJ, 2005, INSECTS OUTLINE ENTO, P86; Han Jung Min, 2008, Entomological Research, V38, P281, DOI 10.1111/j.1748-5967.2008.00188.x; Herczek A, 2001, ACTA ENTOMOL SINICA, V7, P19; Hunter WB, 1996, INT J INSECT MORPHOL, V25, P295, DOI 10.1016/0020-7322(95)00002-X; Kim H, 2013, J ASIA-PAC ENTOMOL, V16, P503, DOI 10.1016/j.aspen.2013.07.003; Kim IK, 2011, J ASIA-PAC ENTOMOL, V14, P213, DOI 10.1016/j.aspen.2011.01.004; Kim S. S., 2005, LUCANUS, V5, P9; Kramer S, 1950, ILLINOIS BIOL MONOGR, V20, pi, DOI 10.5962/bhl.title.50340; Krenn Harald W., 2007, Arthropod Systematics & Phylogeny, V65, P7; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Lee Jeong-Eun, 2009, Korean Journal of Applied Entomology, V48, P467; Leopold RA, 2003, ARTHROPOD STRUCT DEV, V32, P189, DOI 10.1016/S1467-8039(03)00047-1; Liang AP, 2005, J ENTOMOL SCI, V40, P428, DOI 10.18474/0749-8004-40.4.428; Liang XM, 2013, ARTHROPOD STRUCT DEV, V42, P495, DOI 10.1016/j.asd.2013.08.002; Lieu KOV, 1934, YB BUREAU ENTOMOLOGY, P1; Liu G., 1939, PSYCHE, V46, P23, DOI DOI 10.1155/1939/74632; Mora R, 2001, ANN ENTOMOL SOC AM, V94, P438, DOI 10.1603/0013-8746(2001)094[0438:EMOTOH]2.0.CO;2; Park Ji-Doo, 2009, Korean Journal of Applied Entomology, V48, P53; Qadri M. A. H., 1959, P237; Rani Pathipati Usha, 2005, International Journal of Tropical Insect Science, V25, P198, DOI 10.1079/IJT200577; RANI PU, 1995, INT J INSECT MORPHOL, V24, P119, DOI 10.1016/0020-7322(94)00020-Q; ROSELL RC, 1995, INT J INSECT MORPHOL, V24, P297, DOI 10.1016/0020-7322(94)00026-M; RUTTNER F, 1978, APIDOLOGIE, V9, P363, DOI 10.1051/apido:19780408; Sogawa K., 1977, The rice brown planthopper., P95; TAVELLA L, 1993, B ZOOL, V60, P33, DOI 10.1080/11250009309355788; Uzest M, 2010, ARTHROPOD STRUCT DEV, V39, P221, DOI 10.1016/j.asd.2010.02.005; Wang RR, 2013, MICRON, V44, P261, DOI 10.1016/j.micron.2012.07.003; Wang RR, 2012, MICROSC RES TECHNIQ, V75, P1659, DOI 10.1002/jemt.22113; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Wheeler AG, 2001, BIOL PLANT BUGS HEMI, P147; Wiesenborn WD, 2004, J KANSAS ENTOMOL SOC, V77, P152, DOI 10.2317/0307.28.1; Xiao G.R., 1992, FOREST INSECTS CHINA, V2nd eds; Zhao LQ, 2010, MICRON, V41, P754, DOI 10.1016/j.micron.2010.06.001	58	15	16	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156640	10.1371/journal.pone.0156640	http://dx.doi.org/10.1371/journal.pone.0156640			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253390	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700047
J	Sosulski, A; Horn, H; Zhang, LH; Coletti, C; Vathipadiekal, V; Castro, CM; Birrer, MJ; Nagano, O; Saya, H; Lage, K; Donahoe, PK; Pepin, D				Sosulski, Amanda; Horn, Heiko; Zhang, Lihua; Coletti, Caroline; Vathipadiekal, Vinod; Castro, Cesar M.; Birrer, Michael J.; Nagano, Osamu; Saya, Hideyuki; Lage, Kasper; Donahoe, Patricia K.; Pepin, David			CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis	PLOS ONE			English	Article							FAVORABLE PROGNOSIS; ADHESION MOLECULE; E-CADHERIN; EXPRESSION; CELLS; SPECTRUM; RESISTANCE; VIMENTIN; CLEAVAGE; SURVIVAL	CD44 is a transmembrane hyaluronic acid receptor gene that encodes over 100 different tissue-specific protein isoforms. The most ubiquitous, CD44 standard, has been used as a cancer stem cell marker in ovarian and other cancers. Expression of the epithelial CD44 variant containing exons v8-10 (CD44v8-10) has been associated with more chemoresistant and metastatic tumors in gastrointestinal and breast cancers, but its role in ovarian cancer is unknown; we therefore investigated its use as a prognostic marker in this disease. The gene expression profiles of 254 tumor samples from The Cancer Genome Atlas RNAseqV2 were analyzed for the presence of CD44 isoforms. A trend for longer survival was observed in patients with high expression of CD44 isoforms that include exons v8-10. Immunohistochemical (IHC) analysis of tumors for presence of CD44v8-10 was performed on an independent cohort of 210 patients with high-grade serous ovarian cancer using a tumor tissue microarray. Patient stratification based on software analysis of staining revealed a statistically significant increase in survival in patients with the highest levels of transmembrane protein expression (top 10 or 20%) compared to those with the lowest expression (bottom 10 and 20%) (p = 0.0181, p = 0.0262 respectively). Expression of CD44v8-10 in primary ovarian cancer cell lines was correlated with a predominantly epithelial phenotype characterized by high expression of epithelial markers and low expression of mesenchymal markers by qPCR, Western blot, and IHC. Conversely, detection of proteolytically cleaved and soluble extracellular domain of CD44v8-10 in patient ascites samples was correlated with significantly worse prognosis (p<0.05). Therefore, presence of transmembrane CD44v8-10 on the surface of primary tumor cells may be a marker of a highly epithelial tumor with better prognosis while enzymatic cleavage of CD44v8-10, as detected by presence of the soluble extracellular domain in ascites fluid, may be indicative of a more metastatic disease and worse prognosis.	[Sosulski, Amanda; Horn, Heiko; Zhang, Lihua; Coletti, Caroline; Lage, Kasper; Donahoe, Patricia K.; Pepin, David] Massachusetts Gen Hosp, Dept Surg, Pediat Surg Res Labs, Boston, MA 02114 USA; [Sosulski, Amanda; Zhang, Lihua; Coletti, Caroline; Donahoe, Patricia K.; Pepin, David] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Horn, Heiko; Lage, Kasper; Donahoe, Patricia K.; Pepin, David] Broad Inst, Cambridge, MA USA; [Vathipadiekal, Vinod; Castro, Cesar M.; Birrer, Michael J.] Massachusetts Gen Hosp, Dept Med, Gynecol Oncol, Boston, MA 02114 USA; [Vathipadiekal, Vinod; Castro, Cesar M.; Birrer, Michael J.] Harvard Univ, Sch Med, Boston, MA USA; [Nagano, Osamu; Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat,Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan; [Nagano, Osamu; Saya, Hideyuki] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Tokyo, Japan	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Keio University; Japan Science & Technology Agency (JST)	Pepin, D (corresponding author), Massachusetts Gen Hosp, Dept Surg, Pediat Surg Res Labs, Boston, MA 02114 USA.; Pepin, D (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.; Pepin, D (corresponding author), Broad Inst, Cambridge, MA USA.	dpepin@mgh.harvard.edu	Nagano, Osamu/J-5874-2013; Saya, Hideyuki/J-4325-2013	Nagano, Osamu/0000-0002-7630-142X; Horn, Heiko/0000-0003-4898-0557; Saya, Hideyuki/0000-0001-6610-1902				Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Behrens J, 1994, Cancer Treat Res, V71, P251; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Carduner L, 2014, CLIN EXP METASTAS, V31, P675, DOI 10.1007/s10585-014-9658-1; Davidson B, 2015, HUM PATHOL, V46, P1, DOI 10.1016/j.humpath.2014.10.004; Ha TU, 2000, J BIOL CHEM, V275, P37101, DOI 10.1074/jbc.M005701200; Handra-Luca A, 2011, BRIT J CANCER, V104, P1296, DOI 10.1038/bjc.2011.93; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Ishii H, 2014, J BIOL CHEM, V289, P27386, DOI 10.1074/jbc.M114.589432; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Kaufhold S, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0062-0; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Lau WM, 2014, CANCER RES, V74, P2630, DOI 10.1158/0008-5472.CAN-13-2309; Lockhart MS, 2001, ONCOL REP, V8, P145; Masuko K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029728; Meirelles K, 2012, P NATL ACAD SCI USA, V109, P2358, DOI 10.1073/pnas.1120733109; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; Okamoto I, 1999, ONCOGENE, V18, P1435, DOI 10.1038/sj.onc.1202447; Pepin D, 2015, P NATL ACAD SCI USA, V112, pE4418, DOI 10.1073/pnas.1510604112; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rodriguez-Rodriguez L, 2003, MED ONCOL, V20, P255, DOI 10.1385/MO:20:3:255; Shi J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-182; Sillanpaa S, 2003, CLIN CANCER RES, V9, P5318; SLIUTZ G, 1995, BRIT J CANCER, V72, P1494, DOI 10.1038/bjc.1995.535; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Wang YC, 2012, AM J PATHOL, V180, P1159, DOI 10.1016/j.ajpath.2011.11.015; Wei W, 2013, J CLIN INVEST, V123, P4435, DOI 10.1172/JCI70625; Woopen H, 2014, J GYNECOL ONCOL, V25, P221, DOI 10.3802/jgo.2014.25.3.221; Zeilstra J, 2014, ONCOGENE, V33, P665, DOI 10.1038/onc.2012.611	33	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156595	10.1371/journal.pone.0156595	http://dx.doi.org/10.1371/journal.pone.0156595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253518	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700040
J	Nagamine, T; Sako, Y				Nagamine, Toshihiro; Sako, Yasushi			A Role for the Anti-Viral Host Defense Mechanism in the Phylogenetic Divergence in Baculovirus Evolution	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; BM-N CELLS; BOMBYX-MORI; ABORTIVE INFECTION; RANGE EXPANSION; RIBOSOMAL-RNA; P143; IE1; GENE; IDENTIFICATION	Although phylogenic analysis often suggests co-evolutionary relationships between viruses and host organisms, few examples have been reported at the microevolutionary level. Here, we show a possible example in which a species-specific anti-viral response may drive phylogenic divergence in insect virus evolution. Two baculoviruses, Autographa californica multiple nucleopolyhedrovirus (AcMNPV) and Bombyx mori nucleopolyhedrovirus (BmNPV), have a high degree of DNA sequence similarity, but exhibit non-overlapping host specificity. In our study of their host-range determination, we found that BmNPV replication in B. mori cells was prevented by AcMNPV-P143 (AcP143), but not BmNPV-P143 (BmP143) or a hybrid P143 protein from a host-range expanded phenotype. This suggests that AcMNPV resistance in B. mori cells depends on AcP143 recognition and that BmNPV uses BmP143 to escapes this recognition. Based on these data, we propose an insectbaculovirus co-evolution scenario in which an ancestor of silkworms exploited an AcMNPVresistant mechanism; AcMNPV counteracted this resistance via P143 mutations, resulting in the birth of BmNPV.	[Nagamine, Toshihiro; Sako, Yasushi] RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	RIKEN	Nagamine, T (corresponding author), RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tnaga@riken.jp	Sako, Yasushi/B-3253-2015	Sako, Yasushi/0000-0002-5707-5455	Japan Society for the Promotion of Science (JSPS) [26292173]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid (26292173) from the Japan Society for the Promotion of Science (JSPS: http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaud O, 1998, J GEN VIROL, V79, P931, DOI 10.1099/0022-1317-79-4-931; Blissard GW, 2000, FAMILY BACULOVIRIDAE, P195; Clarke TE, 2003, J VIROL, V77, P2227, DOI 10.1128/JVI.77.3.2227-2232.2003; CROIZIER G, 1994, P NATL ACAD SCI USA, V91, P48, DOI 10.1073/pnas.91.1.48; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; Hamajima R, 2015, VIROLOGY, V485, P244, DOI 10.1016/j.virol.2015.08.008; Hamajima R, 2013, J GEN VIROL, V94, P2102, DOI 10.1099/vir.0.053645-0; Herniou EA, 2004, J VIROL, V78, P3244, DOI 10.1128/JVI.78.7.3244-3251.2004; Iwanaga M, 2009, J INVERTEBR PATHOL, V101, P124, DOI 10.1016/j.jip.2009.05.004; KAMITA SG, 1993, J VIROL, V67, P455, DOI 10.1128/JVI.67.1.455-463.1993; KAMITA SG, 1993, J VIROL, V67, P6239, DOI 10.1128/JVI.67.10.6239-6245.1993; Kamita SG, 1997, GENE, V190, P173, DOI 10.1016/S0378-1119(96)00671-3; Kamita SG, 1996, J VIROL, V70, P6244, DOI 10.1128/JVI.70.9.6244-6250.1996; Kawasaki Y, 2004, J GEN VIROL, V85, P3575, DOI 10.1099/vir.0.80418-0; KONDO A, 1991, J VIROL, V65, P3625, DOI 10.1128/JVI.65.7.3625-3632.1991; MAEDA S, 1993, J VIROL, V67, P6234, DOI 10.1128/JVI.67.10.6234-6238.1993; Nagamine T, 2005, J VIROL, V79, P39, DOI 10.1128/JVI.79.1.39-46.2005; Nagamine T, 2006, VIROLOGY, V352, P400, DOI 10.1016/j.virol.2006.04.034; Nagamine T, 2011, VIROLOGY, V417, P188, DOI 10.1016/j.virol.2011.06.001; SMITH GE, 1978, VIROLOGY, V89, P517, DOI 10.1016/0042-6822(78)90193-9; Theze J, 2011, P NATL ACAD SCI USA, V108, P15931, DOI 10.1073/pnas.1105580108; Xu YP, 2012, J GEN VIROL, V93, P2480, DOI 10.1099/vir.0.043836-0	22	8	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156394	10.1371/journal.pone.0156394	http://dx.doi.org/10.1371/journal.pone.0156394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244571	gold, Green Submitted, Green Published			2022-12-26	WOS:000377146100036
J	Mabb, AM; Simon, JM; King, IF; Lee, HM; An, LK; Philpot, BD; Zylka, MJ				Mabb, Angela M.; Simon, Jeremy M.; King, Ian F.; Lee, Hyeong-Min; An, Lin-Kun; Philpot, Benjamin D.; Zylka, Mark J.			Topoisomerase 1 Regulates Gene Expression in Neurons through Cleavage Complex-Dependent and -Independent Mechanisms	PLOS ONE			English	Article							CELL-CYCLE ARREST; I INHIBITORS; SPINOCEREBELLAR ATAXIA; BREAK REPAIR; DNA; TRANSCRIPTION; AUTISM; UBE3A; MUTATIONS; DISRUPTION	Topoisomerase 1 (TOP1) inhibitors, including camptothecin and topotecan, covalently trap TOP1 on DNA, creating cleavage complexes (cc's) that must be resolved before gene transcription and DNA replication can proceed. We previously found that topotecan reduces the expression of long (>100 kb) genes and unsilences the paternal allele of Ube3a in neurons. Here, we sought to evaluate overlap between TOP1cc-dependent and -independent gene regulation in neurons. To do this, we utilized Top1 conditional knockout mice, Top1 knockdown, the CRISPR-Cas9 system to delete Top1, TOP1 catalytic inhibitors that do not generate TOP1cc's, and a TOP1 mutation (T718A) that stabilizes TOP1cc's. We found that topotecan treatment significantly alters the expression of many more genes, including long neuronal genes, immediate early genes, and paternal Ube3a, when compared to Top1 deletion. Our data show that topotecan has a stronger effect on neuronal transcription than Top1 deletion, and identifies TOP1cc-dependent and -independent contributions to gene expression.	[Mabb, Angela M.; Simon, Jeremy M.; King, Ian F.; Lee, Hyeong-Min; Philpot, Benjamin D.; Zylka, Mark J.] Univ N Carolina, Dept Cell Biol & Physiol, UNC Neurosci Ctr, Carolina Inst Dev Disabil, Chapel Hill, NC USA; [Mabb, Angela M.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA; [An, Lin-Kun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University System of Georgia; Georgia State University; Sun Yat Sen University	Philpot, BD; Zylka, MJ (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, UNC Neurosci Ctr, Carolina Inst Dev Disabil, Chapel Hill, NC USA.	bphilpot@med.unc.edu; zylka@med.unc.edu	, PEP-MX Core/AGV-4051-2022; Lee, HM/D-2777-2011; Lee, HM/ABC-2680-2020; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Lee, HM/0000-0002-9381-3611; Lee, HM/0000-0002-9381-3611; Mabb, Angela/0000-0002-3000-8690; King, Ian/0000-0003-3405-9767	Angelman Syndrome Foundation; National Institute of Environmental Health Sciences [DP1ES024088]; National Institute of Child Health and Human Development [5T32HD040127, P30NS045892, P30HD03110]; National Institute of Neurological Disorders and Stroke; National Natural Science Foundation of China [8137357]; Joseph E. Wagstaff Postdoctoral Research Fellowship from Angelman Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003110, U54HD079124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES024088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	Angelman Syndrome Foundation; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joseph E. Wagstaff Postdoctoral Research Fellowship from Angelman Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to B.D.P. and M.J.Z. from the Angelman Syndrome Foundation (http://www.angelman.org/), National Institute of Environmental Health Sciences (DP1ES024088; M.J.Z.), National Institute of Child Health and Human Development (5T32HD040127; B.L.P.), National Institute of Neurological Disorders and Stroke and National Institute of Child Health and Human Development (P30NS045892; P30HD03110, J.M.S.), and by the National Natural Science Foundation of China (No. 8137357) to L.K.A. A.M.M. was supported by the Joseph E. Wagstaff Postdoctoral Research Fellowship from the Angelman Syndrome Foundation. The confocal imaging core was funded by grants from National Institute of Neurological Disorders and Stroke and National Institute of Child Health and Human Development (P30NS045892; P30HD03110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashour ME, 2015, NAT REV CANCER, V15, P137, DOI 10.1038/nrc3892; Cheng Y, 2008, BIOORGAN MED CHEM, V16, P4617, DOI 10.1016/j.bmc.2008.02.036; Cristini A, 2015, NUCL ACIDS RES; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Fiorani P, 1999, MOL PHARMACOL, V56, P1105, DOI 10.1124/mol.56.6.1105; Gabel HW, 2015, NATURE, V522, P89, DOI 10.1038/nature14319; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Huang HS, 2012, NATURE, V481, P185, DOI 10.1038/nature10726; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Katyal S, 2014, NAT NEUROSCI, V17, P813, DOI 10.1038/nn.3715; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Mabb AM, 2014, P NATL ACAD SCI US; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Meng LY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004039; Morham SG, 1996, MOL CELL BIOL, V16, P6804; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng SY, 2013, TRENDS GENET, V29, P461, DOI 10.1016/j.tig.2013.03.002; Noor A, 2015, HUM MUTAT, V36, P689, DOI 10.1002/humu.22800; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Patel AG, 2016, NUCLEIC ACIDS RES, V44, P2816, DOI 10.1093/nar/gkw109; Pearson BL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11173; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Powell WT, 2013, P NATL ACAD SCI USA, V110, P13938, DOI 10.1073/pnas.1305426110; Puc J, 2015, CELL, V160, P367, DOI 10.1016/j.cell.2014.12.023; Rougeulle C, 1998, NAT GENET, V19, P15, DOI 10.1038/ng0598-15; Rudenko A, 2014, NEUROPHARMACOLOGY, V80, P70, DOI 10.1016/j.neuropharm.2014.01.043; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Schroer RJ, 1998, AM J MED GENET, V76, P327, DOI 10.1002/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Solier S, 2013, CANCER RES, V73, P4830, DOI 10.1158/0008-5472.CAN-12-3504; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Sugino K, 2014, J NEUROSCI, V34, P12877, DOI 10.1523/JNEUROSCI.2674-14.2014; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; TSAO YP, 1989, CELL, V56, P111, DOI 10.1016/0092-8674(89)90989-6; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; Wu N, 2010, BIOCHEMISTRY-US, V49, P10131, DOI 10.1021/bi1009419; Yi JJ, 2015, CELL, V162, P795, DOI 10.1016/j.cell.2015.06.045; Yu LM, 2015, EUR J MED CHEM, V101, P525, DOI 10.1016/j.ejmech.2015.07.007; ZHANG H, 1988, P NATL ACAD SCI USA, V85, P1060, DOI 10.1073/pnas.85.4.1060; Zylka MJ, 2015, NEURON, V86, P353, DOI 10.1016/j.neuron.2015.03.059	52	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156439	10.1371/journal.pone.0156439	http://dx.doi.org/10.1371/journal.pone.0156439			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27231886	Green Submitted, Green Published, gold			2022-12-26	WOS:000376883000036
J	Barcomb, K; Hell, JW; Benke, TA; Bayer, KU				Barcomb, Kelsey; Hell, Johannes W.; Benke, Tim A.; Bayer, K. Ulrich			The CaMKII/GluN2B Protein Interaction Maintains Synaptic Strength	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; KINASE-II; CAMKII INHIBITOR; DUPLICATE GENES; NR2B SUBUNIT; PKM-ZETA; LTP; PLASTICITY; MECHANISM	Learning, memory, and cognition are thought to require normal long-term potentiation (LTP) of synaptic strength, which in turn requires binding of the Ca2+/calmodulin-dependent protein kinase II (CaMKII) to the NMDA-type glutamate receptor (NMDAR) subunit GluN2B. For LTP induction, many additional required players are known. Here we tested the hypothesis that CaMKII/GluN2B binding also mediates the more elusive maintenance of synaptic strength. Intriguingly, the CaMKII inhibitor tatCN21 reduces synaptic strength only at high concentrations necessary for CaMKII/NMDAR disruption (20 mu M) but not at lower concentrations sufficient for kinase inhibition (5 mu M). However, increased concentration also causes unrelated effects. Thus, to distinguish between correlation and causality, we used a pharmacogenetic approach. In a mouse with a mutant NMDARGluN2B subunit that is CaMKII binding-incompetent, any tatCN21 effects that are specific to the CaMKII/GluN2B interaction should be abolished, and any remaining tatCN21 effects have to be nonspecific (i.e. mediated by other targets). The results showed that the persistent reduction of synaptic strength by transient application of 20 mu M tatCN21 had a non-specific presynaptic component (on fiber volley amplitude) that was unrelated to the CaMKII/GluN2B interaction or CaMKII activity. However, the remaining component of the persistent tatCN21 effect was almost completely abolished in the GluN2B mutant mouse. These results highlight the requirement for stringent pharmacogenetic approaches to separate specific on-target effects from nonspecific off-target effects. Importantly, they also demonstrate that the CaMKII/GluN2B interaction is required not only for normal LTP induction but also for the maintenance of synaptic strength.	[Barcomb, Kelsey; Bayer, K. Ulrich] Univ Colorado Denver, Sch Med, Neurol Sect, Dept Pharmacol, Aurora, CO 80045 USA; [Benke, Tim A.] Univ Colorado Denver, Sch Med, Neurol Sect, Dept Pediat, Aurora, CO 80045 USA; [Hell, Johannes W.] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA; [Barcomb, Kelsey] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Davis; Brown University	Bayer, KU (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Mail Stop 8303,RC1-North,12800 E 19th Ave, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu	Hell, Johannes W./P-5085-2019	Barcomb, Kelsey/0000-0002-4050-0566	National Institute of Health [F31NS083298, P30NS048154, R01NS078792, R01NS076577, R21DA036300, R01NS081248]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS083298, R01NS081248, R01NS076577, P30NS048154, R01NS080851, R01NS078792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA036300] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health Grants F31NS083298 (to K. B.), P30NS048154 (University of Colorado Center grant), R01NS078792 (to J. W. H.), R01NS076577 (to T. A. B.), and R21DA036300 and R01NS081248 (to K. U. B.). The University of Colorado holds the patent rights for tatCN21, its derivatives, and its uses (PCT/US08/077934 ''Compositions and Methods for Improved CaMKII Inhibitors and Uses Thereof"). K. U. B. is the owner of Neurexus Therapeutics, LLC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bogard AS, 2015, MOL PHARMACOL, V88, P728, DOI 10.1124/mol.115.099457; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Granger AJ, 2013, NATURE, V493, P495, DOI 10.1038/nature11775; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Kim S, 2015, P NATL ACAD SCI USA, V112, P3122, DOI 10.1073/pnas.1417498112; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shonesy BC, 2014, PROG MOL BIOL TRANSL, V122, P61, DOI 10.1016/B978-0-12-420170-5.00003-9; Stein Ivar S, 2014, F1000Res, V3, P193, DOI 10.12688/f1000research.4660.1; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tao-Cheng JH, 2013, NEUROSCIENCE, V244, P188, DOI 10.1016/j.neuroscience.2013.03.063; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Volk LJ, 2013, NATURE, V493, P420, DOI 10.1038/nature11802; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Yao YD, 2008, J NEUROSCI, V28, P7820, DOI 10.1523/JNEUROSCI.0223-08.2008	32	45	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16082	16089		10.1074/jbc.M116.734822	http://dx.doi.org/10.1074/jbc.M116.734822			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27246855	Green Published, hybrid			2022-12-26	WOS:000380585400014
J	Bhardwaj, A; Srivastava, SK; Singh, S; Tyagi, N; Arora, S; Carter, JE; Khushman, M; Singh, AP				Bhardwaj, Arun; Srivastava, Sanjeev K.; Singh, Seema; Tyagi, Nikhil; Arora, Sumit; Carter, James E.; Khushman, Moh'd; Singh, Ajay P.			MYB Promotes Desmoplasia in Pancreatic Cancer through Direct Transcriptional Up-regulation and Cooperative Action of Sonic Hedgehog and Adrenomedullin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYB; MESENCHYMAL TRANSITION; INDUCE FIBROSIS; TUMOR-GROWTH; CELLS; ACTIVATION; EXPRESSION; HYPOXIA; DIFFERENTIATION; PROLIFERATION	Extensive desmoplasia is a prominent pathological characteristic of pancreatic cancer (PC) that not only impacts tumor development, but therapeutic outcome as well. Recently, we demonstrated a novel role of MYB, an oncogenic transcription factor, in PC growth and metastasis. Here we studied its effect on pancreatic tumor histopathology and associated molecular and biological mechanisms. Tumor-xenografts derived from orthotopic-inoculation of MYB-overexpressing PC cells exhibited far-greater desmoplasia in histological analyses compared with those derived from MYB-silenced PC cells. These findings were further confirmed by immunostaining of tumor-xenograft sections with collagen-I, fibronectin (major extracellular-matrix proteins), and alpha-SMA (well-characterized marker of myofibroblasts or activated pancreatic stellate cells (PSCs)). Likewise, MYB-overexpressing PC cells provided significantly greater growth benefit to PSCs in a co-culture system as compared with the MYB-silenced cells. Interrogation of deep-sequencing data from MYB-overexpressing versus-silenced PC cells identified Sonic-hedgehog (SHH) and Adrenomedullin (ADM) as two differentially-expressed genes among others, which encode for secretory ligands involved in tumor-stromal cross-talk. In-silico analyses predicted putative MYB-binding sites in SHH and ADM promoters, which was later confirmed by chromatin-immunoprecipitation. A cooperative role of SHH and ADM in growth promotion of PSCs was confirmed in co-culture by using their specific-inhibitors and exogenous recombinant-proteins. Importantly, while SHH acted exclusively in a paracrine fashion on PSCs and influenced the growth of PC cells only indirectly, ADM could directly impact the growth of both PC cells and PSCs. In summary, we identified MYB as novel regulator of pancreatic tumor desmoplasia, which is suggestive of its diverse roles in PC pathobiology.	[Bhardwaj, Arun; Srivastava, Sanjeev K.; Singh, Seema; Tyagi, Nikhil; Arora, Sumit; Singh, Ajay P.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Springhill Ave, Mobile, AL 36604 USA; [Khushman, Moh'd] Univ S Alabama, Mitchell Canc Inst, Dept Interdisciplinary Clin Oncol, Mobile, AL 36604 USA; [Singh, Seema; Singh, Ajay P.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Carter, James E.] Univ S Alabama, Coll Med, Dept Pathol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama	Singh, AP (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Springhill Ave, Mobile, AL 36604 USA.	asingh@health.southalabama.edu	Singh, Ajay/AAF-4414-2020	Singh, Ajay/0000-0003-3492-6330	National Institutes of Health/NCI [CA167137, CA175772, CA185490]; USAMCI; NATIONAL CANCER INSTITUTE [R21CA167137, R01CA175772, U01CA185490] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); USAMCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from National Institutes of Health/NCI Grants CA167137, CA175772, and CA185490 (to A. P. S.) and the USAMCI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggarwal G, 2012, GASTROENTEROLOGY, V143, P1510, DOI 10.1053/j.gastro.2012.08.044; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bhardwaj A, 2014, BRIT J CANCER, V110, P2000, DOI 10.1038/bjc.2014.141; Bhardwaj A, 2014, ONCOTARGET, V5, P11490, DOI 10.18632/oncotarget.2571; Biroccio A, 2001, AM J PATHOL, V158, P1289, DOI 10.1016/S0002-9440(10)64080-1; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Duan WX, 2014, CURR CANCER DRUG TAR, V14, P446, DOI 10.2174/1568009614666140402105101; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; Greco C, 2001, ANTICANCER RES, V21, P3185; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jagadeeshan S, 2015, ONCOGENE, V34, P455, DOI 10.1038/onc.2013.576; Keleg S, 2007, INT J CANCER, V121, P21, DOI 10.1002/ijc.22596; Kikuta K, 2010, BIOCHEM BIOPH RES CO, V403, P380, DOI 10.1016/j.bbrc.2010.11.040; Kumar S, 2015, ONCOGENE, V34, P2052, DOI 10.1038/onc.2014.154; Larrayoz IM, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0339-2; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Masamune A, 2008, AM J PHYSIOL-GASTR L, V295, pG709, DOI 10.1152/ajpgi.90356.2008; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ramachandran V, 2007, CANCER RES, V67, P2666, DOI 10.1158/0008-5472.CAN-06-3362; Ramachandran V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007502; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Sakurai T, 2011, PANCREATOLOGY, V11, P7, DOI 10.1159/000323478; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; Spivak-Kroizman TR, 2013, CANCER RES, V73, P3235, DOI 10.1158/0008-5472.CAN-11-1433; Srivastava SK, 2015, BRIT J CANCER, V113, P1694, DOI 10.1038/bjc.2015.400; Srivastava SK, 2012, CARCINOGENESIS, V33, P1149, DOI 10.1093/carcin/bgs134; Wallrapp C, 1997, CANCER RES, V57, P3135	38	14	14	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16263	16270		10.1074/jbc.M116.732651	http://dx.doi.org/10.1074/jbc.M116.732651			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27246849	Green Published, hybrid			2022-12-26	WOS:000380585400030
J	Kirchgesner, J; Beaugerie, L; Carrat, F; Sokol, H; Cosnes, J; Schwarzinger, M				Kirchgesner, Julien; Beaugerie, Laurent; Carrat, Fabrice; Sokol, Harry; Cosnes, Jacques; Schwarzinger, Michael		BERENICE Study Grp	Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; POPULATION-BASED COHORT; TERM NET SURVIVAL; COLORECTAL NEOPLASIA; NATURAL-HISTORY; CO-TREATMENT; INFLIXIMAB; ADALIMUMAB; AZATHIOPRINE; IMMUNOMODULATORS	Objective Long-term treatment with thiopurines is associated with a decreased risk of Crohn's disease (CD) flare but an increased risk of various cancers depending on gender, age, and presence of extensive colitis. We evaluated risks and benefits of withdrawing thiopurines in patients with CD in prolonged remission. Methods We developed a Markov model assessing risks and benefits of withdrawing thiopurines compared to continuing thiopurines in a lifetime horizon. The model was stratified by age (35 and 65 years old at thiopurine withdrawal), gender and presence of extensive colitis. Parameter estimates were taken from French cohorts and hospital databases, cancer and death national registries and published literature. Life expectancy, rates of relapse, serious adverse events, and causes-of-death were evaluated. Results In patients without extensive colitis, continuing thiopurines increased life expectancy up to 0.03 years for 35 year-old men and women but decreased life expectancy down to 0.07 years for 65 year-old men and women. Withdrawal strategy became the preferred strategy at 40.6 years for men, and 45.7 years for women without extensive colitis. In patients with extensive colitis, continuation strategy was the preferred strategy regardless of age. Risk-benefit analysis was not modified by duration of CD activity. Conclusions Factors determining life expectancy associated with withdrawal or continuation of thiopurines in patients with CD and in sustained clinical remission vary substantially according to gender, age and presence of extensive colitis. Individual decisions to continue or withdraw thiopurines in patients with CD in sustained remission should take into account these parameters.	[Kirchgesner, Julien; Beaugerie, Laurent; Sokol, Harry; Cosnes, Jacques] Hop St Antoine, Dept Gastroenterol, AP HP, F-75571 Paris, France; [Kirchgesner, Julien; Carrat, Fabrice] INSERM, UMR S 1136, Paris, France; [Kirchgesner, Julien; Carrat, Fabrice] Univ Paris 06, Paris, France; [Beaugerie, Laurent] Univ Paris 06, INSERM, ERL 1057, UMRS 7203, Paris, France; [Beaugerie, Laurent] Univ Paris 06, GRC UPMC 03, Paris, France; [Carrat, Fabrice] Hop St Antoine, Dept Publ Hlth, AP HP, F-75571 Paris, France; [Schwarzinger, Michael] Translat Hlth Econ Network, Paris, France; [Schwarzinger, Michael] INSERM, UMR 1137, Infect, Antimicrobials,Modelizat,Evolut IAME, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Kirchgesner, J (corresponding author), Hop St Antoine, Dept Gastroenterol, AP HP, F-75571 Paris, France.; Kirchgesner, J (corresponding author), INSERM, UMR S 1136, Paris, France.; Kirchgesner, J (corresponding author), Univ Paris 06, Paris, France.	julien.kirchgesner@gmx.com	sokol, harry/ABA-8991-2020; Carrat, Fabrice/AAU-8480-2020; Kirchgesner, Julien/ABA-1398-2021; Sokol, Harry/E-2290-2019; Schwarzinger, Michael/F-7367-2011	sokol, harry/0000-0002-2914-1822; Carrat, Fabrice/0000-0002-8672-7918; Sokol, Harry/0000-0002-2914-1822; Schwarzinger, Michael/0000-0002-0573-6856; Kirchgesner, Julien/0000-0002-2314-9284	French National Agency for Medicines and Health Products Safety (Agence Nationale de Securite du Medicament (ANSM))	French National Agency for Medicines and Health Products Safety (Agence Nationale de Securite du Medicament (ANSM))	The BERENICE project is supported by grants from the French National Agency for Medicines and Health Products Safety (Agence Nationale de Securite du Medicament (ANSM)).	Ariyaratnam J, 2014, AM J GASTROENTEROL, V109, P163, DOI 10.1038/ajg.2013.451; ATIH. Agence technique de l'information sur l'hospitalisation, 2015, PROGR MED SYST INF P; Beaugerie L, 2013, GASTROENTEROLOGY, V145, P166, DOI 10.1053/j.gastro.2013.03.044; Beaugerie L, 2009, LANCET, V374, P1617, DOI 10.1016/S0140-6736(09)61302-7; Benchimol EI, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006792.pub2; Bewtra M, 2015, AM J GASTROENTEROL, V110, P1675, DOI 10.1038/ajg.2015.321; Binder-Foucard F., 2013, TUMEURS SOLIDES 1, V122; Bourrier A, 2016, ALIMENT PHARM THER, V43, P252, DOI 10.1111/apt.13466; Buisson A, 2012, ALIMENT PHARM THER, V35, P625, DOI 10.1111/j.1365-2036.2012.05002.x; Burmester GR, 2013, ANN RHEUM DIS, V72, P517, DOI 10.1136/annrheumdis-2011-201244; CepiDc INSERM, 2015, CTR EP CAUS MED DEC; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Dignass A, 2010, J CROHNS COLITIS, V4, P28, DOI 10.1016/j.crohns.2009.12.002; Eshuis EJ, 2013, INFLAMM BOWEL DIS, V19, P1622, DOI 10.1097/MIB.0b013e318281f4c4; Fidder H, 2009, GUT, V58, P501, DOI 10.1136/gut.2008.163642; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P1783, DOI 10.1111/j.1572-0241.2008.01848.x; Gordillo J, 2015, J CROHNS COLITIS, V9, P1063, DOI 10.1093/ecco-jcc/jjv145; Gordon M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010233.pub2; Horne R, 2009, INFLAMM BOWEL DIS, V15, P837, DOI 10.1002/ibd.20846; Jess T, 2014, CLIN GASTROENTEROL H, V12, P1793, DOI 10.1016/j.cgh.2014.05.019; Jooste V, 2013, INT J CANCER, V132, P2370, DOI 10.1002/ijc.27857; Katz L, 2012, INFLAMM BOWEL DIS, V18, P2026, DOI 10.1002/ibd.22902; Kotlyar DS, 2015, CLIN GASTROENTEROL H, V13, P847, DOI 10.1016/j.cgh.2014.05.015; Lemann M, 2005, GASTROENTEROLOGY, V128, P1812, DOI 10.1053/j.gastro.2005.03.031; Lewis JD, 2008, AM J GASTROENTEROL, V103, P1428, DOI 10.1111/j.1572-0241.2008.01836.x; Lopez A, 2014, CLIN GASTROENTEROL H, V12, P1324, DOI 10.1016/j.cgh.2014.02.026; Monnereau A, 2013, ST MAURICE FRA I VEI, P88; Monnereau A, 2013, INT J CANCER, V132, P2378, DOI 10.1002/ijc.27889; Peters CP, 2014, J CROHNS COLITIS, V8, P866, DOI 10.1016/j.crohns.2014.01.012; Peyrin-Biroulet L, 2012, AM J GASTROENTEROL, V107, P1693, DOI 10.1038/ajg.2012.298; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; Rahier JF, 2009, J CROHNS COLITIS, V3, P47, DOI 10.1016/j.crohns.2009.02.010; Reenaers C, 2012, ALIMENT PHARM THER, V36, P1040, DOI 10.1111/apt.12076; Regueiro M, 2009, GASTROENTEROLOGY, V136, P441, DOI 10.1053/j.gastro.2008.10.051; Sandborn WJ, 2011, INFLAMM BOWEL DIS, V17, P141, DOI 10.1002/ibd.21328; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Savarino E, 2013, AM J GASTROENTEROL, V108, P1731, DOI 10.1038/ajg.2013.287; Singh S, 2014, CLIN GASTROENTEROL H, V12, P210, DOI 10.1016/j.cgh.2013.04.033; Sokol H, 2010, GUT, V59, P1363, DOI 10.1136/gut.2010.212712; Tang DH, 2013, INFLAMM BOWEL DIS, V19, P2673, DOI 10.1097/MIB.0b013e3182916046; Targownik LE, 2013, AM J GASTROENTEROL, V108, P1835, DOI 10.1038/ajg.2013.294; Torres J, 2015, GASTROENTEROLOGY, V149, P1, DOI 10.1053/j.gastro.2015.08.055; Toruner M, 2008, GASTROENTEROLOGY, V134, P929, DOI 10.1053/j.gastro.2008.01.012; Treton X, 2009, CLIN GASTROENTEROL H, V7, P80, DOI 10.1016/j.cgh.2008.08.028; Vilien M, 2004, ALIMENT PHARM THER, V19, P1147, DOI 10.1111/j.1365-2036.2004.01944.x; Wolters FL, 2006, GUT, V55, P510, DOI 10.1136/gut.2005.072793	46	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157191	10.1371/journal.pone.0157191	http://dx.doi.org/10.1371/journal.pone.0157191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271176	Green Published, gold, Green Submitted			2022-12-26	WOS:000377560200034
J	Ahmed, T; Vafaei, A; Auais, M; Guralnik, J; Zunzunegui, MV				Ahmed, Tamer; Vafaei, Afshin; Auais, Mohammad; Guralnik, Jack; Zunzunegui, Maria Victoria			Gender Roles and Physical Function in Older Adults: Cross-Sectional Analysis of the International Mobility in Aging Study (IMIAS)	PLOS ONE			English	Article							LOWER-EXTREMITY FUNCTION; ACUTE CORONARY SYNDROME; PSYCHOLOGICAL ANDROGYNY; SUBSEQUENT DISABILITY; PERFORMANCE-MEASURES; GENERAL-POPULATION; ROLE ATTITUDES; AGE; HEALTH; LIFE	Objectives To examine the relationships between physical function and gender-stereotyped traits and whether these relationships are modified by sex or social context. Methods A total of 1995 community-dwelling older adults from the International Mobility in Aging Study (IMIAS) aged 65 to 74 years were recruited in Natal (Brazil), Manizales (Colombia), Tirana (Albania), Kingston (Ontario, Canada), and Saint-Hyacinthe (Quebec, Canada). We performed a cross-sectional analysis. Study outcomes were mobility disability, defined as having difficulty in walking 400 meters without assistance or climbing a flight of stairs without resting, and low physical performance, defined as a score < 8 on the Short Physical Performance Battery. The 12-item Bem Sex Role Inventory (BSRI) was used to classify participants into four gender roles (Masculine, Feminine, Androgynous, and Undifferentiated) using site-specific medians of femininity and masculinity as cut-off points. Poisson regression models were used to estimate prevalence rate ratios (PRR) of mobility disability and poor physical performance according to gender roles. Results In models adjusted for sex, marital status, education, income, and research site, when comparing to the androgynous role, we found higher prevalence of mobility disability and poor physical performance among participants endorsing the feminine role (PRR = 1.20, 95% confidence interval (CI) 1.03-1.39 and PRR = 1.37, CI 1.01-1.88, respectively) or the undifferentiated role (PRR = 1.23, 95% CI 1.07-1.42 and PRR = 1.58, CI 1.18-2.12, respectively). Participants classified as masculine did not differ from androgynous participants in prevalence rates of mobility disability or low physical performance. None of the multiplicative interactions by sex and research site were significant. Conclusion Feminine and undifferentiated gender roles are independent risk factors for mobility disability and low physical performance in older adults. Longitudinal research is needed to assess the mediation pathways through which gender-stereotyped traits influence functional limitations and to investigate the longitudinal nature of these relationships.	[Ahmed, Tamer; Zunzunegui, Maria Victoria] Univ Montreal, Dept Med Sociale & Prevent, Montreal, PQ, Canada; [Vafaei, Afshin; Auais, Mohammad] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Guralnik, Jack] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Div Gerontol, Baltimore, MD 21201 USA	Universite de Montreal; Queens University - Canada; University System of Maryland; University of Maryland Baltimore	Ahmed, T (corresponding author), Univ Montreal, Dept Med Sociale & Prevent, Montreal, PQ, Canada.	tis.ahmed@umontreal.ca		Ahmed, Tamer/0000-0002-5708-0270; Zunzunegui, Maria-Victoria/0000-0003-0827-2804	Canadian Institutes of Health [AAM 108751]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by The Canadian Institutes of Health, grant number AAM 108751. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahacic K, 2000, AGING-CLIN EXP RES, V12, P190, DOI 10.1007/BF03339836; Ahmed T, 2016, CANADIAN J IN PRESS; Alabas OA, 2012, EUR J PAIN, V16, P1211, DOI 10.1002/j.1532-2149.2012.00121.x; Alvarado BE, 2007, J AGING HEALTH, V19, P1004, DOI 10.1177/0898264307308618; Bannerman E, 2002, PUBLIC HEALTH NUTR, V5, P655, DOI 10.1079/PHN2002336; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Beland F, 1999, AGE AGEING, V28, P153, DOI 10.1093/ageing/28.2.153; Bem S. L., 1981, J PERS SOC PSYCHOL; BEM SL, 1974, J CONSULT CLIN PSYCH, V42, P155, DOI 10.1037/h0036215; BEM SL, 1977, J CONSULT CLIN PSYCH, V45, P196, DOI 10.1037//0022-006X.45.2.196; Bentley JP, 2013, QUAL LIFE RES, V22, P1621, DOI 10.1007/s11136-012-0315-3; Bolzendahl CI, 2004, SOC FORCES, V83, P759, DOI 10.1353/sof.2005.0005; Campbell C., 2005, J PAIN, V6, pS60; Carver LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076356; Chant Sylvia H., 2003, GENDER LATIN AM; CIHR, 2010, GEND SEX HLTH RES GU; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Crompton R, 2005, BRIT J SOCIOL, V56, P601, DOI 10.1111/j.1468-4446.2005.00085.x; de Yebenes MJG, 2003, INT J GERIATR PSYCH, V18, P925, DOI 10.1002/gps.947; Doulougou B, 2016, J HUM HYPERTENS, V30, P112, DOI 10.1038/jhh.2015.30; Gomez JF, 2013, COLOMB MEDICA, V44, P165; Forlani C, 2014, AM J GERIAT PSYCHIAT, V22, P370, DOI 10.1016/j.jagp.2012.08.015; Freire AN, 2012, J AGING HEALTH, V24, P863, DOI 10.1177/0898264312438551; Gale-Ross R, 2009, CAN J AGING, V28, P135, DOI 10.1017/S0714980809090187; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gomez F, 2009, J AM GERIATR SOC, V57, P1692, DOI 10.1111/j.1532-5415.2009.02341.x; Guallar-Castillon P, 2007, OBESITY, V15, P233, DOI 10.1038/oby.2007.532; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1989, J GERONTOL, V44, pM141, DOI 10.1093/geronj/44.5.M141; GURALNIK JM, 1993, AM J EPIDEMIOL, V137, P845, DOI 10.1093/oxfordjournals.aje.a116746; Health Canada, 2000, HLTH CAN GEND BAS AN; Helliwell B, 2001, INT PSYCHOGERIATR, V13, P49, DOI 10.1017/S1041610202007986; Ho SC, 1997, J GERONTOL A-BIOL, V52, pM356, DOI 10.1093/gerona/52A.6.M356; Hunt K, 2007, INT J EPIDEMIOL, V36, P612, DOI 10.1093/ije/dym022; Hunt K, 2006, SOC PSYCH PSYCH EPID, V41, P641, DOI 10.1007/s00127-006-0074-y; IBGE FIBDGEE, 1987, SER EST RETR; Juster RP, 2012, GENDER MED, V9, P511, DOI 10.1016/j.genm.2012.10.008; Kada Olivia, 2010, REV PSYCHOL, V17, P97; Keeler E, 2010, J GERONTOL A-BIOL, V65, P727, DOI 10.1093/gerona/glq029; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; LACKEY PN, 1989, SEX ROLES, V20, P271, DOI 10.1007/BF00287724; Leveille SG, 2000, J GERONTOL B-PSYCHOL, V55, pS41; Leveille SG, 2000, AGING-CLIN EXP RES, V12, P106, DOI 10.1007/BF03339897; Leveille SG, 2002, J GEN INTERN MED, V17, P766, DOI 10.1046/j.1525-1497.2002.20229.x; Marks JL, 2009, SEX ROLES, V61, P221, DOI 10.1007/s11199-009-9619-3; Mateo M., 1991, INVESTIGACIONES PSIC, V9, P95; Mechakra-Tahiri SD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-598; Melzer D, 2004, J GERONTOL A-BIOL, V59, P1295, DOI 10.1093/gerona/59.12.1295; Merrill SS, 1997, J GERONTOL A-BIOL, V52, pM19, DOI 10.1093/gerona/52A.1.M19; Miluka J, 2009, ED MIGRATION LABOR M; Miszkurka M, 2012, GLOB PUBLIC HEALTH, V7, P495, DOI 10.1080/17441692.2011.630676; Mori M, 2002, Arch Womens Ment Health, V5, P161, DOI 10.1007/s00737-002-0148-0; NAGI SZAN, 1976, THE MILBANK MEMORIAL, V54, P439; Newman AB, 2001, EPIDEMIOL REV, V23, P343, DOI 10.1093/oxfordjournals.epirev.a000810; Onadja Y, 2013, ARCH GERONTOL GERIAT, V57, P311, DOI 10.1016/j.archger.2013.06.007; Pelletier R, 2016, J AM COLL CARDIOL, V67, P127, DOI 10.1016/j.jacc.2015.10.067; Pelletier R, 2015, PSYCHOSOM MED, V77, P517, DOI 10.1097/PSY.0000000000000186; Pirkle CM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-293; Price EC, 2018, AM J MENS HEALTH, V12, P19, DOI 10.1177/1557988315619676; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Sarnhult V., 2014, GENDER POWER IMAGES; Schwartz S, 1999, AM J PUBLIC HEALTH, V89, P1175, DOI 10.2105/AJPH.89.8.1175; Seidel D, 2011, AGE AGEING, V40, P463, DOI 10.1093/ageing/afr054; Shimonaka Y, 1996, INT J AGING HUM DEV, V42, P173, DOI 10.2190/UMWD-64W7-3M2K-2MKJ; Shumway-Cook A, 2005, J AM GERIATR SOC, V53, P1217, DOI 10.1111/j.1532-5415.2005.53372.x; Silova I, 2004, COMP EDUC REV, V48, P417, DOI 10.1086/423358; Sinnott JD, 1986, SEX ROLES AGING THEO; Siren A, 2009, TOP GERIATR REHABIL, V25, P3; Stecklov G, 2010, DEMOGRAPHY, V47, P935, DOI 10.1007/BF03213734; Tilvis RS, 1997, ARCH GERONTOL GERIAT, V25, P311, DOI 10.1016/S0167-4943(97)00024-1; Urwin M, 1998, ANN RHEUM DIS, V57, P649, DOI 10.1136/ard.57.11.649; Vafaei A, 2014, ARCH GERONTOLOGY GER; Vafaei A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146867; Webber SC, 2010, GERONTOLOGIST, V50, P443, DOI 10.1093/geront/gnq013; Wilkie R, 2007, ARTHRIT RHEUM-ARTHR, V57, P1381, DOI 10.1002/art.23083; Wong R, 2006, J AGING HEALTH, V18, P157, DOI 10.1177/0898264305285655; Zunzunegui MV, 2015, ARCH GERONTOL GERIAT, V61, P140, DOI 10.1016/j.archger.2015.06.005	78	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156828	10.1371/journal.pone.0156828	http://dx.doi.org/10.1371/journal.pone.0156828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258050	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700140
J	Canioni, D; Michot, JM; Rabiega, P; Molina, TJ; Charlotte, F; Lazure, T; Davi, F; Settegrana, C; Berger, F; Alric, L; Cacoub, P; Terrier, B; Suarez, F; Sibon, D; Dupuis, J; Feray, C; Tilly, H; Pol, S; Fischer, BD; Roulland, S; Thieblemont, C; Leblond, V; Carrat, F; Hermine, O; Besson, C				Canioni, Danielle; Michot, Jean-Marie; Rabiega, Pascaline; Molina, Thierry J.; Charlotte, Frederic; Lazure, Thierry; Davi, Frederic; Settegrana, Catherine; Berger, Francoise; Alric, Laurent; Cacoub, Patrice; Terrier, Benjamin; Suarez, Felipe; Sibon, David; Dupuis, Jehan; Feray, Cyrille; Tilly, Herve; Pol, Stanislas; Fischer, Benedicte Deau; Roulland, Sandrine; Thieblemont, Catherine; Leblond, Veronique; Carrat, Fabrice; Hermine, Olivier; Besson, Caroline		Natl ANRS HC13 LymphoC Study	In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas	PLOS ONE			English	Article							VIRUS-INFECTION; MONOCYTES	Hepatitis C Virus (HCV) infection is associated with the B-cell non-Hodgkin lymphomas (NHL), preferentially marginal zone lymphomas (MZL) and diffuse large B-cell lymphomas (DLBCL). While chronic antigenic stimulation is a main determinant of lymphomagenesis in marginal zone lymphomas (MZL), a putative role of HCV infection of B-cells is supported by in vitro studies. We performed a pathological study within the "ANRS HC-13 LymphoC" observational study focusing on in situ expression of the oncogenic HCV non structural 3 (NS3) protein. Lympho-C study enrolled 116 HCV-positive patients with B-NHL of which 86 histological samples were collected for centralized review. Main histological subtypes were DLBCL (36%) and MZL (34%). Almost half of DLBCL (12/26) were transformed from underlying small B-cell lymphomas. NS3 immunostaining was found positive in 17 of 37 tested samples (46%). There was a striking association between NS3 detection and presence of high grade lymphoma features: 12 out of 14 DLBCL were NS3+ compared to only 4 out of 14 MZL (p = 0.006). Moreover, 2 among the 4 NS3+ MZL were enriched in large cells. Remarkably, this study supports a new mechanism of transformation with a direct oncogenic role of HCV proteins in the occurrence of high-grade B lymphomas.	[Canioni, Danielle; Molina, Thierry J.] Paris Descartes Univ, Hop Necker, AP HP, Dept Pathol,Sorbonne Paris Cite, Paris, France; [Michot, Jean-Marie] Inst Gustave Roussy, Dept Hematol & Drug Dev, F-94805 Villejuif, France; [Rabiega, Pascaline; Carrat, Fabrice] Univ Paris 06, INSERM, UMR S1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France; [Charlotte, Frederic] Univ Paris 06, Hop Pitie Salpetriere, Dept Pathol, Paris, France; [Lazure, Thierry] Univ Paris 11, Dept Pathol, Hop Bicetre, AP HP, Le Kremlin Bicetre, France; [Davi, Frederic; Settegrana, Catherine] Univ Paris 06, Hop Pitie Salpetriere, AP HP, Dept Biol Hematol, Paris, France; [Berger, Francoise] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Hop Lyon Sud, Dept Pathol, Lyon, France; [Alric, Laurent] Univ Toulouse 3, Dept Internal Med & Digest Dis, UMR 152, IRD,Hop Purpan, F-31062 Toulouse, France; [Cacoub, Patrice; Terrier, Benjamin] Univ Paris 06, Hop Pitie Salpetriere, AP HP, Dept Internal Med,INSERM,UMR S 959,CNRS,UMR 7211, Paris, France; [Suarez, Felipe; Sibon, David; Hermine, Olivier] Univ Paris 05, Hop Necker, AP HP, Dept Adult Hematol, Paris, France; [Suarez, Felipe; Sibon, David; Hermine, Olivier] Univ Sorbonne Paris Cite, Imagine Inst, INSERM, U1163,CNRS,ERL 8254, Paris, France; [Dupuis, Jehan] Paris 12 Est Creteil Univ, Dept Lymphoid Malignancies & Clin Hematol, Hop Henri Mondor, AP HP, Creteil, France; [Feray, Cyrille] Univ Nantes, Hop Nantes, Dept Hepatol, Nantes, France; [Tilly, Herve] Univ Rouen, Ctr Henri Becquerel, Dept Hematol, Rouen, France; [Pol, Stanislas] Univ Paris 05, Hop Cochin, AP HP, Dept Hepatol,INSERM,U1016, Paris, France; [Fischer, Benedicte Deau] Paris Descartes Univ, Hop Cochin, AP HP, Dept Hematol, Paris, France; [Roulland, Sandrine] Aix Marseille Univ, Ctr Immunol Marseille Luminy, INSERM, U1104,CNRS,UMR7280, Marseille, France; [Thieblemont, Catherine] Univ Paris 07, Hop St Louis, AP HP, Dept Hematooncol,INSERM,U728, Paris, France; [Leblond, Veronique] Univ Paris 06, Dept Clin Hematol, Paris, France; [Besson, Caroline] Univ Paris 11, Dept Internal Med & Clin Immunol Biol Immunol & H, Hop Bicetre, AP HP,INSERM,U1184, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Lyon; CHU de Toulouse; Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Nantes Universite; CHU de Nantes; UNICANCER; Centre Henri Becquerel; Universite de Rouen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Canioni, D (corresponding author), Paris Descartes Univ, Hop Necker, AP HP, Dept Pathol,Sorbonne Paris Cite, Paris, France.; Hermine, O (corresponding author), Univ Paris 05, Hop Necker, AP HP, Dept Adult Hematol, Paris, France.; Hermine, O (corresponding author), Univ Sorbonne Paris Cite, Imagine Inst, INSERM, U1163,CNRS,ERL 8254, Paris, France.; Besson, C (corresponding author), Univ Paris 11, Dept Internal Med & Clin Immunol Biol Immunol & H, Hop Bicetre, AP HP,INSERM,U1184, Le Kremlin Bicetre, France.	danielle.canioni@aphp.fr; ohermine@gmail.com; caroline.besson@bct.aphp.fr	Besson, Caroline/H-4648-2018; Hermine, Olivier/Q-7072-2018; Michot, Jean-Marie/AAC-3028-2022; Molina, Thierry/ABA-5214-2020; Sibon, David/AAX-5243-2020; roulland, sandrine/H-9843-2014; Thieblemont, Catherine/AAZ-8423-2020; Carrat, Fabrice/AAU-8480-2020; Feray, Cyrille/S-2559-2018	Besson, Caroline/0000-0003-4364-7173; Michot, Jean-Marie/0000-0003-3482-3331; Molina, Thierry/0000-0002-3929-9754; Sibon, David/0000-0002-9205-625X; roulland, sandrine/0000-0003-2187-1959; Thieblemont, Catherine/0000-0002-9941-2448; Carrat, Fabrice/0000-0002-8672-7918; Hermine, Olivier/0000-0003-2574-3874; Cacoub, Patrice/0000-0002-6727-4992; Charlotte, Frederic/0000-0003-2803-6606; DEAU FISCHER, Benedicte/0000-0002-7468-5466	Inserm-ANRS (Institut national de la sante et de la recherche medicale - France Recherche Nord&Sud SIDA-HIV Hepatites) Paris, France	Inserm-ANRS (Institut national de la sante et de la recherche medicale - France Recherche Nord&Sud SIDA-HIV Hepatites) Paris, France	This research has been funded by Inserm-ANRS (Institut national de la sante et de la recherche medicale - France Recherche Nord&Sud SIDA-HIV Hepatites) 101, rue de Tolbiac, 75013 Paris, France. Grant LymphoC-HC13. http://www.anrs.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaini L, 2004, CANCER, V100, P107, DOI 10.1002/cncr.11893; Dai B, 2016, ONCOGENE, V35, P2979, DOI 10.1038/onc.2015.364; Ducoulombier D, 2004, HEPATOLOGY, V39, P817, DOI 10.1002/hep.20087; Engels EA, 2004, INT J CANCER, V111, P76, DOI 10.1002/ijc.20021; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hermine O, 2002, NEW ENGL J MED, V347, P89, DOI 10.1056/NEJMoa013376; Machida K, 2010, J IMMUNOL, V185, P6985, DOI 10.4049/jimmunol.1000618; Michot JM, 2015, AM J HEMATOL, V90, P197, DOI 10.1002/ajh.23889; Nieters A, 2006, GASTROENTEROLOGY, V131, P1879, DOI 10.1053/j.gastro.2006.09.019; Peveling-Oberhag J, 2013, J HEPATOL, V59, P169, DOI 10.1016/j.jhep.2013.03.018; Swerdlow SH, 2008, WHO CLASSIFICATION T; Takeshita M, 2006, HISTOPATHOLOGY, V48, P189, DOI 10.1111/j.1365-2559.2005.02311.x; Takeshita M, 2005, HUM PATHOL, V36, P878, DOI 10.1016/j.humpath.2005.06.005; Tsutsumi Yutaka, 2011, Adv Hematol, V2011, P717951, DOI 10.1155/2011/717951	14	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156384	10.1371/journal.pone.0156384	http://dx.doi.org/10.1371/journal.pone.0156384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257992	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700058
J	Khateb, M; Fourier, N; Barnea-Yizhar, O; Ram, S; Kovalev, E; Azriel, A; Rand, U; Nakayama, M; Hauser, H; Gepstein, L; Levi, B				Khateb, Mamduh; Fourier, Nitsan; Barnea-Yizhar, Ofer; Ram, Sigal; Kovalev, Ekaterina; Azriel, Aviva; Rand, Ulfert; Nakayama, Manabu; Hauser, Hansjorg; Gepstein, Lior; Levi, Ben-Zion			The Third Intron of the Interferon Regulatory Factor-8 Is an Initiator of Repressed Chromatin Restricting Its Expression in Non-Immune Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; TARGET GENES; ADENOSINE DIALDEHYDE; GENOME BROWSER; MACROPHAGES; IRF-8; DNA; ELEMENTS; DYNAMICS; DIFFERENTIATION	Interferon Regulatory Factor-8 (IRF-8) serves as a key factor in the hierarchical differentiation towards monocyte/dendritic cell lineages. While much insight has been accumulated into the mechanisms essential for its hematopoietic specific expression, the mode of restricting IRF-8 expression in non-hematopoietic cells is still unknown. Here we show that the repression of IRF-8 expression in restrictive cells is mediated by its 3rd intron. Removal of this intron alleviates the repression of Bacterial Artificial Chromosome (BAC) IRF-8 reporter gene in these cells. Fine deletion analysis points to conserved regions within this intron mediating its restricted expression. Further, the intron alone selectively initiates gene silencing only in expression-restrictive cells. Characterization of this intron's properties points to its role as an initiator of sustainable gene silencing inducing chromatin condensation with suppressive histone modifications. This intronic element cannot silence episomal transgene expression underlining a strict chromatin-dependent silencing mechanism. We validated this chromatin-state specificity of IRF-8 intron upon in-vitro differentiation of induced pluripotent stem cells (iPSCs) into cardiomyocytes. Taken together, the IRF-8 3rd intron is sufficient and necessary to initiate gene silencing in non-hematopoietic cells, highlighting its role as a nucleation core for repressed chromatin during differentiation.	[Khateb, Mamduh; Fourier, Nitsan; Barnea-Yizhar, Ofer; Ram, Sigal; Azriel, Aviva; Levi, Ben-Zion] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Haifa, Israel; [Kovalev, Ekaterina; Gepstein, Lior] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Kovalev, Ekaterina; Gepstein, Lior] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Rand, Ulfert; Hauser, Hansjorg] Helmholtz Ctr Infect Res, Dept Gene Regulat & Differentiat, Braunschweig, Germany; [Nakayama, Manabu] Kazusa DNA Res Inst, Dev Technol Dept, Kazusa Kamatari, Kazusa, Japan	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Kazusa DNA Research Institute	Levi, B (corresponding author), Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Haifa, Israel.	blevi@technion.ac.il		Rand, Ulfert/0000-0002-5946-4921	Israel Science Foundation [121/10, 224/15]	Israel Science Foundation(Israel Science Foundation)	This research was funded by The Israel Science Foundation [grant numbers121/10, 224/15 to BZL.; We acknowledge the contribution of past members of the Levi's laboratory, Mr. Ron Shalom and Mrs. Revital Schick for their valuable contributions at the early stages of this project. We are grateful for the technical support and valuable input of Dr. Irit Huber, Dr. Limor Zwi-Dantsis, and Dr. Amira Gepstein from Dr. Lior Gepstein lab. This research was funded by The Israel Science Foundation [grant numbers121/10, 224/15 to B.Z.L]. B.Z.L. is an incumbent of the Lily and Silvian Marcus Chair in Life Sciences, Technion.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alter-Koltunoff M, 2003, J BIOL CHEM, V278, P44025, DOI 10.1074/jbc.M307954200; Apostolou E, 2013, NATURE, V502, P462, DOI 10.1038/nature12749; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; BARTEL RL, 1984, MOL PHARMACOL, V25, P418; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Burchert A, 2004, BLOOD, V103, P3480, DOI 10.1182/blood-2003-08-2970; Campos EI, 2014, TRENDS CELL BIOL, V24, P664, DOI 10.1016/j.tcb.2014.08.004; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chorev Michal, 2012, Frontiers in Genetics, V3, P55, DOI 10.3389/fgene.2012.00055; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Dror N, 2007, MOL IMMUNOL, V44, P338, DOI 10.1016/j.molimm.2006.02.026; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frengen E, 1999, GENOMICS, V58, P250, DOI 10.1006/geno.1998.5693; Gaunitz F, 2005, HEPATOLOGY, V41, P1225, DOI 10.1002/hep.20710; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; JEONG SW, 1994, NUCLEIC ACIDS RES, V22, P370, DOI 10.1093/nar/22.3.370; JOHNSON BA, 1993, J BIOL CHEM, V268, P6174; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Li KK, 2012, MED RES REV, V32, P815, DOI 10.1002/mrr.20228; Makinde TO, 2011, AM J RESP CELL MOL, V44, P384, DOI 10.1165/rcmb.2009-0330OC; Martinez-Garcia E, 2010, NAT GENET, V42, P100, DOI 10.1038/ng0210-100; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Sparwasser T, 2007, IMMUNOLOGY, V121, P308, DOI 10.1111/j.1365-2567.2007.02605.x; Suzuki E, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1280; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; TOURMENTE S, 1993, INSECT BIOCHEM MOLEC, V23, P137, DOI 10.1016/0965-1748(93)90092-7; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8; Yankulov K, 2013, BIOCHEM CELL BIOL, V91, P6, DOI 10.1139/bcb-2012-0048; Zwi-Dantsis L, 2011, TISSUE ENG PT A, V17, P1027, DOI 10.1089/ten.TEA.2010.0235	53	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156812	10.1371/journal.pone.0156812	http://dx.doi.org/10.1371/journal.pone.0156812			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257682	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700135
J	Kwasniewska, J; Jaskowiak, J				Kwasniewska, Jolanta; Jaskowiak, Joanna			Transcriptional Activity of rRNA Genes in Barley Cells after Mutagenic Treatment	PLOS ONE			English	Article							ROOT-TIP CELLS; ALLIUM-CEPA L; PLANT-CELLS; ARABIDOPSIS-THALIANA; MALEIC HYDRAZIDE; NUCLEOLUS; INTERPHASE; SEQUENCES; GROWTH; BODIES	In the present study, the combination of the micronucleus test with analysis of the activity of the rRNA genes in mutagen-treated Hordeum vulgare (barley) by maleic hydrazide (MH) cells was performed. Simultaneously fluorescence in situ hybridization (FISH) with 25S rDNA as probes and an analysis of the transcriptional activity of 35S rRNA genes with silver staining were performed. The results showed that transcriptional activity is always maintained in the micronuclei although they are eliminated during the next cell cycle. The analysis of the transcriptional activity was extended to barley nuclei. MH influenced the fusion of the nucleoli in barley nuclei. The silver staining enabled detection of the nuclear bodies which arose after MH treatment. The results confirmed the usefulness of cytogenetic techniques in the characterization of micronuclei. Similar analyses can be now extended to other abiotic stresses to study the response of plant cells to the environment.	[Kwasniewska, Jolanta; Jaskowiak, Joanna] Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland	University of Silesia in Katowice	Kwasniewska, J (corresponding author), Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland.	jolanta.kwasniewska@us.edu.pl	Kwasniewska, Jolanta/ABF-1547-2020	Kwasniewska, Jolanta/0000-0002-8965-8727				BARLOW PW, 1983, PROTOPLASMA, V118, P104, DOI 10.1007/BF01293066; BARLOW PW, 1983, PROTOPLASMA, V115, P1, DOI 10.1007/BF01293574; DOLEZEL J, 1989, STAIN TECHNOL, V64, P9, DOI 10.3109/10520298909108037; GABARA B, 1995, PLANT SCI, V111, P153, DOI 10.1016/0168-9452(95)04244-O; GUERRERO F, 1989, PROTOPLASMA, V152, P96, DOI 10.1007/BF01323067; Hasterok R, 2000, FOLIA HISTOCHEM CYTO, V38, P181; Hasterok Robert, 2000, Journal of Applied Genetics, V41, P1; HIZUME M, 1980, STAIN TECHNOL, V55, P87; Hubbel HR, 1985, BIOTECH HISTOCHEM, V60, P285; Jabee Farha, 2008, Turkish Journal of Botany, V32, P337; Jiang W, 2000, B ENVIRON CONTAM TOX, V65, P786, DOI 10.1007/s001280000191; Jiang Z, 2014, INT J MOL SCI, V15, P13406, DOI 10.3390/ijms150813406; Juchimiuk J, 2007, J APPL GENET, V48, P99, DOI 10.1007/BF03194666; Juchimiuk-Kwasniewska J, 2011, J APPL GENET, V52, P23, DOI 10.1007/s13353-010-0017-x; LEITCH IJ, 1993, GENOME, V36, P517, DOI 10.1139/g93-071; MALUSZYNSKA J, 1991, PLANT J, V1, P159, DOI 10.1111/j.1365-313X.1991.00159.x; Maluszynska J, 1998, RRNA GENES THEIR DIS, P75; Qin R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-225; ROGERS SO, 1987, PLANT MOL BIOL, V9, P509, DOI 10.1007/BF00015882; UNFRIED I, 1990, NUCLEIC ACIDS RES, V18, P4011, DOI 10.1093/nar/18.13.4011; WILLIAMS LM, 1983, PROTOPLASMA, V118, P95, DOI 10.1007/BF01293065	21	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156865	10.1371/journal.pone.0156865	http://dx.doi.org/10.1371/journal.pone.0156865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257817	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700146
J	Tomiyama, Y; Fujita, K; Nishiguchi, KM; Tokashiki, N; Daigaku, R; Tabata, K; Sugano, E; Tomita, H; Nakazawa, T				Tomiyama, Yusuke; Fujita, Kosuke; Nishiguchi, Koji M.; Tokashiki, Naoyuki; Daigaku, Reiko; Tabata, Kitako; Sugano, Eriko; Tomita, Hiroshi; Nakazawa, Toru			Measurement of Electroretinograms and Visually Evoked Potentials in Awake Moving Mice	PLOS ONE			English	Article							KETAMINE-XYLAZINE ANESTHESIA; OPEN-ANGLE GLAUCOMA; OSCILLATORY POTENTIALS; PHOTORECEPTOR FUNCTION; DARK-ADAPTATION; DIABETIC-RATS; RETINOPATHY; RETINA; PREMATURITY; DYSFUNCTION	The development of new treatments for intractable retinal diseases requires reliable functional assessment tools for animal models. In vivo measurements of neural activity within visual pathways, including electroretinogram (ERG) and visually evoked potential (VEP) recordings, are commonly used for such purposes. In mice, the ERG and VEPs are usually recorded under general anesthesia, a state that may alter sensory transduction and neurotransmission, but seldom in awake freely moving mice. Therefore, it remains unknown whether the electrophysiological assessment of anesthetized mice accurately reflects the physiological function of the visual pathway. Herein, we describe a novel method to record the ERG and VEPs simultaneously in freely moving mice by immobilizing the head using a custom-built restraining device and placing a rotatable cylinder underneath to allow free running or walking during recording. Injection of the commonly used anesthetic mixture xylazine plus ketamine increased and delayed ERG oscillatory potentials by an average of 67.5% and 36.3%, respectively, compared to unanesthetized mice, while having minimal effects on the a-wave and b-wave. Similarly, components of the VEP were enhanced and delayed by up to 300.2% and 39.3%, respectively, in anesthetized mice. Our method for electrophysiological recording in conscious mice is a sensitive and robust means to assess visual function. It uses a conventional electrophysiological recording system and a simple platform that can be built in any laboratory at low cost. Measurements using this method provide objective indices of mouse visual function with high precision and stability, unaffected by anesthetics.	[Tomiyama, Yusuke; Tokashiki, Naoyuki; Daigaku, Reiko; Nakazawa, Toru] Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Fujita, Kosuke; Nakazawa, Toru] Tohoku Univ, Dept Retinal Dis Control, Grad Sch Med, Sendai, Miyagi 980, Japan; [Nishiguchi, Koji M.; Nakazawa, Toru] Tohoku Univ, Dept Adv Ophthalm Med, Grad Sch Med, Sendai, Miyagi 980, Japan; [Tabata, Kitako; Sugano, Eriko; Tomita, Hiroshi] Iwate Univ, Fac Engn, Lab Visual Neurosci, Dept Chem & Bioengn,Grad Sch Engn, Morioka, Iwate 020, Japan	Tohoku University; Tohoku University; Tohoku University; Iwate University	Nishiguchi, KM (corresponding author), Tohoku Univ, Dept Adv Ophthalm Med, Grad Sch Med, Sendai, Miyagi 980, Japan.	nishiguchi@oph.med.tohoku.ac.jp	Tomita, Hiroshi/O-2135-2018	Tomita, Hiroshi/0000-0003-1051-2301	KAKENHI [26893018]; Japan Agency for Medical Research and Development [15lm0103007j0004]; SENJU Pharmaceutical Co., Ltd	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); SENJU Pharmaceutical Co., Ltd	This work was supported in part by KAKENHI Grants-in-Aid for Scientific Research Activity start-up (26893018; KMN; https://www.jsps.go.jp/english/index.html) and Translational Research Network program from the Japan Agency for Medical Research and Development (15lm0103007j0004; HT; http://www.amed.go.jp/en/). This study was also supported by SENJU Pharmaceutical Co., Ltd (TN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer AU, 2001, EXP EYE RES, V72, P667, DOI 10.1006/exer.2001.1004; Bergman S A, 1999, Anesth Prog, V46, P10; CALDERONE L, 1986, EXP EYE RES, V42, P331, DOI 10.1016/0014-4835(86)90026-6; Charng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074172; Dong CJ, 2004, VISUAL NEUROSCI, V21, P533, DOI 10.1017/S0952523804214043; Ferreri G, 2002, OPHTHALMOLOGICA, V216, P22, DOI 10.1159/000048292; Fulton AB, 1996, J OPT SOC AM A, V13, P566, DOI 10.1364/JOSAA.13.000566; GREENE SA, 1988, J VET PHARMACOL THER, V11, P295, DOI 10.1111/j.1365-2885.1988.tb00189.x; Guarino Irene, 2004, Neural Plasticity, V11, P241, DOI 10.1155/NP.2004.241; Hancock HA, 2004, INVEST OPHTH VIS SCI, V45, P1002, DOI 10.1167/iovs.03-1080; HARA A, 1994, DOC OPHTHALMOL, V88, P39, DOI 10.1007/BF01203700; Hart CYT, 2001, AM J PHYSIOL-HEART C, V281, pH1938, DOI 10.1152/ajpheart.2001.281.5.H1938; Holopigian K, 2000, J GLAUCOMA, V9, P163; IMAI R, 1990, Journal of Toxicological Sciences, V15, P263; IMRIE MM, 1990, BRIT J ANAESTH, V64, P346, DOI 10.1093/bja/64.3.346; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Kohzaki K, 2008, INVEST OPHTH VIS SCI, V49, P3595, DOI 10.1167/iovs.08-1679; Kurihara T, 2008, DIABETES, V57, P2191, DOI 10.2337/db07-1281; Layton CJ, 2007, GRAEF ARCH CLIN EXP, V245, P1335, DOI 10.1007/s00417-006-0506-0; Lei H, 2001, BRAIN RES, V913, P174, DOI 10.1016/S0006-8993(01)02786-X; Liu K, 2006, INVEST OPHTH VIS SCI, V47, P2639, DOI 10.1167/iovs.06-0016; Lopez L, 2002, BEHAV BRAIN RES, V131, P105, DOI 10.1016/S0166-4328(01)00351-5; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; Nair G, 2011, DOC OPHTHALMOL, V122, P163, DOI 10.1007/s10633-011-9271-4; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; SATO S, 1982, J PHARMACOL METHOD, V8, P173; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; SEBEL PS, 1986, BRIT J ANAESTH, V58, P580, DOI 10.1093/bja/58.6.580; Szabo-Salfay O, 2001, BRAIN RES BULL, V56, P7, DOI 10.1016/S0361-9230(01)00585-8; Tremblay F, 2003, DOC OPHTHALMOL, V107, P271, DOI 10.1023/B:DOOP.0000005336.08147.fc; Valjakka A, 2007, GRAEF ARCH CLIN EXP, V245, P1199, DOI 10.1007/s00417-006-0519-8; Wang JS, 2014, J NEUROSCI, V34, P11212, DOI 10.1523/JNEUROSCI.1245-14.2014; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Xue YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep17616; YONEMURA D, 1962, ARCH OPHTHALMOL-CHIC, V68, P19	35	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156927	10.1371/journal.pone.0156927	http://dx.doi.org/10.1371/journal.pone.0156927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257864	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700157
J	Saha, P; San Yeoh, B; Singh, R; Chandrasekar, B; Vemula, PK; Haribabu, B; Vijay-Kumar, M; Jala, VR				Saha, Piu; San Yeoh, Beng; Singh, Rajbir; Chandrasekar, Bhargavi; Vemula, Praveen Kumar; Haribabu, Bodduluri; Vijay-Kumar, Matam; Jala, Venkatakrishna R.			Gut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme Peroxidases	PLOS ONE			English	Article							PUNICA-GRANATUM L.; COMMENSAL BACTERIA; PROSTATE-CANCER; POMEGRANATE; MYELOPEROXIDASE; HEALTH; MECHANISMS; HOST; BIOAVAILABILITY; CONSUMPTION	Numerous studies signify that diets rich in phytochemicals offer many beneficial functions specifically during pathologic conditions, yet their effects are often not uniform due to inter-individual variation. The host indigenous gut microbiota and their modifications of dietary phytochemicals have emerged as factors that greatly influence the efficacy of phytoceutical-based intervention. Here, we investigated the biological activities of one such active microbial metabolite, Urolithin A (UA or 3,8-dihydroxybenzo[c]chromen-6-one), which is derived from the ellagic acid (EA). Our study demonstrates that UA potently inhibits heme peroxidases i.e. myeloperoxidase (MPO) and lactoperoxidase (LPO) when compared to the parent compound EA. In addition, chrome azurol S (CAS) assay suggests that EA, but not UA, is capable of binding to Fe3+, due to its catechol-like structure, although its modest heme peroxidase inhibitory activity is abrogated upon Fe3+-binding. Interestingly, UA-mediated MPO and LPO inhibition can be prevented by innate immune protein human NGAL or its murine ortholog lipocalin 2 (Lcn2), implying the complex nature of host innate immunity-microbiota interactions. Spectral analysis indicates that UA inhibits heme peroxidase-catalyzed reaction by reverting the peroxidase back to its inactive native state. In support of these in vitro results, UA significantly reduced phorbol myristate acetate (PMA)-induced superoxide generation in neutrophils, however, EA failed to block the superoxide generation. Treatment with UA significantly reduced PMA-induced mouse ear edema and MPO activity compared to EA treated mice. Collectively, our results demonstrate that microbiota-mediated conversion of EA to UA is advantageous to both host and microbiota i.e. UA-mediated inhibition of pro-oxidant enzymes reduce tissue inflammation, mitigate non-specific killing of gut bacteria, and abrogate iron-binding property of EA, thus providing a competitive edge to the microbiota in acquiring limiting nutrient iron and thrive in the gut.	[Saha, Piu; San Yeoh, Beng; Vijay-Kumar, Matam] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Vijay-Kumar, Matam] Penn State Univ, Med Ctr, Dept Med, Hershey, PA USA; [Singh, Rajbir; Haribabu, Bodduluri; Jala, Venkatakrishna R.] Univ Louisville, James Graham Brown Canc Ctr, Dept Microbiol & Immunol, Louisville, KY 40292 USA; [Chandrasekar, Bhargavi; Vemula, Praveen Kumar] Inst Stem Cell Biol & Regenerat Med InStem, Bangalore, Karnataka, India; [Vemula, Praveen Kumar] Govt India, Dept Biotechnol, New Delhi, India	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Louisville; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Department of Biotechnology (DBT) India	Jala, VR (corresponding author), Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA.	mvk13@psu.edu; jvrao001@louisville.edu	Bodduluri, Haribabu/A-2584-2010; Singh, Rajbir/AAT-4666-2020; Jala, Venkatakrishna R/K-7255-2018; Vijay-Kumar, Matam/Q-8988-2019	Bodduluri, Haribabu/0000-0002-8261-3294; Singh, Rajbir/0000-0002-2307-2360; Jala, Venkatakrishna R/0000-0002-4206-7305; 	Dept. Microbiology and Immunology and JGBCC, University of Louisville, Louisville, KY	Dept. Microbiology and Immunology and JGBCC, University of Louisville, Louisville, KY	The studies were supported by a pilot grant to VRJ from Dept. Microbiology and Immunology and JGBCC, University of Louisville, Louisville, KY.	Alasalvar C, 2015, BRIT J NUTR, V113, pS68, DOI 10.1017/S0007114514003729; Andreasen AS, 2010, BRIT J NUTR, V104, P1831, DOI 10.1017/S0007114510002874; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arthur JC, 2011, INFLAMM BOWEL DIS, V17, P396, DOI 10.1002/ibd.21354; Banihani S, 2013, NUTR RES, V33, P341, DOI 10.1016/j.nutres.2013.03.003; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Belkaid Y, 2013, NAT IMMUNOL, V14, P646, DOI 10.1038/ni.2604; Bell C, 2008, J PHARM PHARMACOL, V60, P139, DOI 10.1211/jpp.60.2.0001; Bensalem S, 2014, J ETHNOPHARMACOL, V154, P361, DOI 10.1016/j.jep.2014.03.070; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; Candela M, 2011, CRIT REV MICROBIOL, V37, P1, DOI 10.3109/1040841X.2010.501760; Capeillere-Blandin C, 1998, BIOCHEM J, V336, P395, DOI 10.1042/bj3360395; Espin JC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/270418; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Cerda B, 2005, J AGR FOOD CHEM, V53, P5571, DOI 10.1021/jf050384i; Cerda B, 2004, EUR J NUTR, V43, P205, DOI 10.1007/s00394-004-0461-7; Cerda B, 2003, EUR J NUTR, V42, P18, DOI 10.1007/s00394-003-0396-4; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Choi HS, 2006, J IMMUNOASS IMMUNOCH, V27, P31, DOI 10.1080/15321810500403722; Chung HC, 2010, CURR OPIN IMMUNOL, V22, P455, DOI 10.1016/j.coi.2010.06.008; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; Espin JC, 2007, J AGR FOOD CHEM, V55, P10476, DOI 10.1021/jf0723864; Feng BS, 2009, N AM J MED SCI, V1, P200, DOI 10.4297/najms.2009.4200; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Girish C, 2008, FUND CLIN PHARMACOL, V22, P623, DOI 10.1111/j.1472-8206.2008.00618.x; Gonzalez-Sarrias A, 2015, J FUNCT FOODS, V19, P225, DOI 10.1016/j.jff.2015.09.019; Gonzalez-Sarrias A, 2010, MOL NUTR FOOD RES, V54, P311, DOI 10.1002/mnfr.200900152; Griswold DE, 1998, INFLAMM RES, V47, P56, DOI 10.1007/s000110050270; Guinane CM, 2013, THER ADV GASTROENTER, V6, P295, DOI 10.1177/1756283X13482996; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Heber D, 2008, CANCER LETT, V269, P262, DOI 10.1016/j.canlet.2008.03.043; HEINECKE JW, 1993, J CLIN INVEST, V91, P2866, DOI 10.1172/JCI116531; Ishimoto H, 2011, BIOORG MED CHEM LETT, V21, P5901, DOI 10.1016/j.bmcl.2011.07.086; Jurenka J, 2008, ALTERN MED REV, V13, P128; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Larrosa M, 2010, J NUTR BIOCHEM, V21, P717, DOI 10.1016/j.jnutbio.2009.04.012; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; McFarlin BK, 2009, BRIT J NUTR, V102, P54, DOI 10.1017/S0007114508159001; Mertens-Talcott SU, 2006, J AGR FOOD CHEM, V54, P8956, DOI 10.1021/jf061674h; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Odobasic D, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2349817; Oikonomou KA, 2012, J GASTROENTEROL, V47, P519, DOI 10.1007/s00535-011-0516-5; PAYNE SM, 1994, METHOD ENZYMOL, V235, P329; Perron NR, 2009, CELL BIOCHEM BIOPHYS, V53, P75, DOI 10.1007/s12013-009-9043-x; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; San Yeoh B, 2016, AM J PATHOL, V186, P912, DOI 10.1016/j.ajpath.2015.12.004; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Seeram NP, 2007, J AGR FOOD CHEM, V55, P7732, DOI 10.1021/jf071303g; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Selma MV, 2014, FOOD FUNCT, V5, P1779, DOI [10.1039/C4FO00092G, 10.1039/c4fo00092g]; Singh V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8113; Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393; Swamydas M, 2013, JOVE-J VIS EXP, DOI 10.3791/50586; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Tomkovich S, 2016, IMMUNOLOGY, V147, P1, DOI 10.1111/imm.12538; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026; Vyas U, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/872716; Xu KZY, 2009, J ETHNOPHARMACOL, V123, P280, DOI 10.1016/j.jep.2009.03.035; Zhang Hong-Mei, 2014, Cancer Biology Medicine, V11, P92, DOI 10.7497/j.issn.2095-3941.2014.02.004	73	77	79	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156811	10.1371/journal.pone.0156811	http://dx.doi.org/10.1371/journal.pone.0156811			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254317	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700064
J	Chu, TJ; Yeniterzi, S; Yatsenko, SA; Dunkel, M; Shaw, PA; Bunce, KD; Peters, DG				Chu, Tianjiao; Yeniterzi, Suveyda; Yatsenko, Svetlana A.; Dunkel, Mary; Shaw, Patricia A.; Bunce, Kimberly D.; Peters, David G.			High Levels of Sample-to-Sample Variation Confound Data Analysis for Non-Invasive Prenatal Screening of Fetal Microdeletions	PLOS ONE			English	Article							AMNIOCENTESIS; DNA; DIAGNOSIS; ANXIETY; TRIAL	Our goal was to test the hypothesis that inter-individual genomic copy number variation in control samples is a confounding factor in the non-invasive prenatal detection of fetal microdeletions via the sequence-based analysis of maternal plasma DNA. The database of genomic variants (DGV) was used to determine the "Genomic Variants Frequency" (GVF) for each 50kb region in the human genome. Whole genome sequencing of fifteen karyotypically normal maternal plasma and six CVS DNA controls samples was performed. The coefficient of variation of relative read counts (cv.RTC) for these samples was determined for each 50kb region. Maternal plasma from two pregnancies affected with a chromosome 5p microdeletion was also sequenced, and analyzed using the GCREM algorithm. We found strong correlation between high variance in read counts and GVF amongst controls. Consequently we were unable to confirm the presence of the microdeletion via sequencing of maternal plasma samples obtained from two sequential affected pregnancies. Caution should be exercised when performing NIPT for microdeletions. It is vital to develop our understanding of the factors that impact the sensitivity and specificity of these approaches. In particular, benign copy number variation amongst controls is a major confounder, and their effects should be corrected bioinformatically.	[Chu, Tianjiao; Yeniterzi, Suveyda; Yatsenko, Svetlana A.; Peters, David G.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Chu, Tianjiao; Yeniterzi, Suveyda; Yatsenko, Svetlana A.; Dunkel, Mary; Shaw, Patricia A.; Bunce, Kimberly D.; Peters, David G.] Magee Womens Res Inst, Ctr Fetal Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Peters, DG (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA.; Peters, DG (corresponding author), Magee Womens Res Inst, Ctr Fetal Med, Pittsburgh, PA USA.	dgp6@pitt.edu	Peters, David/AAD-4629-2019		Magee-Womens Research Institute and Foundation (MWRIF); NIH [R01 HD068578]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068578] Funding Source: NIH RePORTER	Magee-Womens Research Institute and Foundation (MWRIF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Magee-Womens Research Institute and Foundation (MWRIF) and the NIH (R01 HD068578) (both to DGP).	Chim SSC, 2005, P NATL ACAD SCI USA, V102, P14753, DOI 10.1073/pnas.0503335102; Chu TJ, 2014, PRENATAL DIAG, V34, P469, DOI 10.1002/pd.4331; Chu TJ, 2010, PRENATAL DIAG, V30, P1226, DOI 10.1002/pd.2656; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Gupta AK, 2004, CLIN CHEM, V50, P2187, DOI 10.1373/clinchem.2004.040196; Hertling-Schaal E, 2001, Gynecol Obstet Fertil, V29, P440, DOI 10.1016/S1297-9589(01)00158-8; Hewison J, 2007, BJOG-INT J OBSTET GY, V114, P462, DOI 10.1111/j.1471-0528.2007.01276.x; Hewison J, 2006, HEALTH TECHNOL ASSES, V10, P1; Hillman SC, 2011, ULTRASOUND OBST GYN, V37, P6, DOI 10.1002/uog.7754; Jensen TJ, 2012, CLIN CHEM, V58, P1148, DOI 10.1373/clinchem.2011.180794; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Mujezinovic F, 2007, OBSTET GYNECOL, V110, P687, DOI 10.1097/01.AOG.0000278820.54029.e3; Odibo AO, 2008, OBSTET GYNECOL, V111, P589, DOI 10.1097/AOG.0b013e318162eb53; Orozco AE, 2006, ANN NY ACAD SCI, V1075, P57, DOI 10.1196/annals.1368.007; Orozco AF, 2008, AM J PATHOL, V173, P1595, DOI 10.2353/ajpath.2008.080414; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Peters D, 2011, NEW ENGL J MED, V365, P1847, DOI 10.1056/NEJMc1106975; Shaffer LG, 2012, PRENATAL DIAG, V32, P976, DOI 10.1002/pd.3945; Srinivasan A, 2013, AM J HUM GENET, V92, P167, DOI 10.1016/j.ajhg.2012.12.006; TABOR A, 1986, LANCET, V1, P1287; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; Yu SCY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060968	24	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0153182	10.1371/journal.pone.0153182	http://dx.doi.org/10.1371/journal.pone.0153182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249650	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000377184700003
J	Lo, YL; Pan, WH; Hsu, WL; Chien, YC; Chen, JY; Hsu, MM; Lou, PJ; Chen, IH; Hildesheim, A; Chen, CJ				Lo, Yen-Li; Pan, Wen-Harn; Hsu, Wan-Lun; Chien, Yin-Chu; Chen, Jen-Yang; Hsu, Mow-Ming; Lou, Pei-Jen; Chen, I-How; Hildesheim, Allan; Chen, Chien-Jen			Partial Least Square Discriminant Analysis Discovered a Dietary Pattern Inversely Associated with Nasopharyngeal Carcinoma Risk	PLOS ONE			English	Article							PRESERVED FOODS; LOW-CHOLESTEROL; NUTRIENT INTAKE; HEART-DISEASE; CHINESE DIET; CANCER; CONSUMPTION; TAIWAN; VIRUS; FISH	Evidence on the association between dietary component, dietary pattern and nasopharyngeal carcinoma (NPC) is scarce. A major challenge is the high degree of correlation among dietary constituents. We aimed to identify dietary pattern associated with NPC and to illustrate the dose-response relationship between the identified dietary pattern scores and the risk of NPC. Taking advantage of a matched NPC case-control study, data from a total of 319 incident cases and 319 matched controls were analyzed. Dietary pattern was derived employing partial least square discriminant analysis (PLS-DA) performed on energy-adjusted food frequencies derived from a 66-item food-frequency questionnaire. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated with multiple conditional logistic regression models, linking pattern scores and NPC risk. A high score of the PLS-DA derived pattern was characterized by high intakes of fruits, milk, fresh fish, vegetables, tea, and eggs ordered by loading values. We observed that one unit increase in the scores was associated with a significantly lower risk of NPC (ORadj = 0.73, 95% CI = 0.60-0.88) after controlling for potential confounders. Similar results were observed among Epstein-Barr virus seropositive subjects. An NPC protective diet is indicated with more phytonutrient-rich plant foods (fruits, vegetables), milk, other protein-rich foods (in particular fresh fish and eggs), and tea. This information may be used to design potential dietary regimen for NPC prevention.	[Lo, Yen-Li; Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Hsu, Wan-Lun; Chien, Yin-Chu; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Chen, Jen-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Chunan, Taiwan; [Chen, Jen-Yang] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei, Taiwan; [Hsu, Mow-Ming; Lou, Pei-Jen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Hsu, Mow-Ming; Lou, Pei-Jen] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chen, I-How] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Chen, I-How] Chang Gung Univ, Taoyuan, Taiwan; [Hildesheim, Allan] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Chen, Chien-Jen] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Taiwan University	Pan, WH (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Chen, CJ (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.; Chen, CJ (corresponding author), Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan.	pan@ibms.sinica.edu.tw; chencj@gate.sinica.edu.tw	Chen, Chien-Jen/N-4723-2019; Pan, Wen-Harn/F-9972-2010	Pan, Wen-Harn/0000-0001-9136-0658; LOU, PEI-JEN/0000-0002-3383-8593	National Institutes of Health, USA; Institute of Biomedical Sciences, Academia Sinica, Taiwan; NATIONAL CANCER INSTITUTE [ZIACP010211] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Biomedical Sciences, Academia Sinica, Taiwan(Academia Sinica - Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported from the intramural funds from the National Institutes of Health, USA and from Institute of Biomedical Sciences, Academia Sinica, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RW, 1998, INT J CANCER, V77, P228, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;228::AID-IJC11&gt;3.0.CO;2-7; Benn M, 2011, JNCI-J NATL CANCER I, V103, P508, DOI 10.1093/jnci/djr008; Bidoli E, 2013, NUTR CANCER, V65, P1157, DOI 10.1080/01635581.2013.828088; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen CJ, 2002, JPN J CLIN ONCOL, V32, pS66, DOI 10.1093/jjco/hye138; Chen DL, 1997, CANCER LETT, V117, P17, DOI 10.1016/S0304-3835(97)00182-1; CHEN JY, 1987, J MED VIROL, V23, P11, DOI 10.1002/jmv.1890230103; Cheng YJ, 1999, CANCER CAUSE CONTROL, V10, P201, DOI 10.1023/A:1008893109257; Chow KC, 1997, CANCER EPIDEM BIOMAR, V6, P363; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; DiBello JR, 2008, AM J EPIDEMIOL, V168, P1433, DOI 10.1093/aje/kwn274; Edefonti V, 2015, BRIT J CANCER, V112, P446, DOI 10.1038/bjc.2014.611; Farrow DC, 1998, INT J CANCER, V78, P675, DOI 10.1002/(SICI)1097-0215(19981209)78:6&lt;675::AID-IJC2&gt;3.0.CO;2-J; Feng BJ, 2007, INT J CANCER, V121, P1550, DOI 10.1002/ijc.22813; Fernandez E, 1999, AM J CLIN NUTR, V70, P85; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Hildesheim A, 1997, J NATL CANCER I, V89, P1207, DOI 10.1093/jnci/89.16.1207; Hildesheim A, 2001, CANCER EPIDEM BIOMAR, V10, P1145; Hoffmann K, 2004, AM J EPIDEMIOL, V159, P935, DOI 10.1093/aje/kwh134; Hsu C, 2006, CANCER EPIDEM BIOMAR, V15, P856, DOI 10.1158/1055-9965.EPI-05-0821; Hsu WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041779; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hu J, 2012, ANN ONCOL, V23, P491, DOI 10.1093/annonc/mdr155; Huang YC, 2011, ASIA PAC J CLIN NUTR, V20, P134; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kampman E, 2007, FOOD NUTR PHYS ACT P; Key TJ, 2002, LANCET, V360, P861, DOI 10.1016/S0140-6736(02)09958-0; Laouamri S, 2001, REV EPIDEMIOL SANTE, V49, P145; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; LEE HP, 1994, INT J CANCER, V59, P585, DOI 10.1002/ijc.2910590502; LEE MMS, 1992, INT J EPIDEMIOL, V21, P922, DOI 10.1093/ije/21.5.922; Liu MY, 1997, J MED VIROL, V52, P262, DOI 10.1002/(SICI)1096-9071(199707)52:3&lt;262::AID-JMV5&gt;3.0.CO;2-0; Nago N, 2011, J EPIDEMIOL, V21, P67, DOI 10.2188/jea.JE20100065; PAN WH, 1992, INT J EPIDEMIOL, V21, P929, DOI 10.1093/ije/21.5.929; Pan WH, 1991, CHOLESTEROL AND FIBE, V16, P1; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Polesel J, 2012, BRIT J CANCER, V107, P1580, DOI 10.1038/bjc.2012.413; Polesel J, 2013, CANCER CAUSE CONTROL, V24, P1157, DOI 10.1007/s10552-013-0195-z; Qin LQ, 2007, ASIA PAC J CLIN NUTR, V16, P467; Ruan Hong-Lian, 2010, Front Med China, V4, P448, DOI 10.1007/s11684-010-0280-6; Salehi M, 2013, NUTR REV, V71, P257, DOI 10.1111/nure.12028; Simko V, 2014, BRATISL MED J, V115, P59, DOI 10.4149/BLL_2014_013; Ward MH, 2000, INT J CANCER, V86, P603, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;603::AID-IJC1&gt;3.0.CO;2-H; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; YU MC, 1989, INT J CANCER, V43, P1077, DOI 10.1002/ijc.2910430621; YU MC, 1988, CANCER RES, V48, P1954; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; ZHENG YM, 1994, BRIT J CANCER, V69, P508, DOI 10.1038/bjc.1994.92	50	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155892	10.1371/journal.pone.0155892	http://dx.doi.org/10.1371/journal.pone.0155892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249558	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700022
J	Eisenmann, P; Fry, B; Holyoake, C; Coughran, D; Nicol, S; Nash, SB				Eisenmann, Pascale; Fry, Brian; Holyoake, Carly; Coughran, Douglas; Nicol, Steve; Nash, Susan Bengtson			Isotopic Evidence of a Wide Spectrum of Feeding Strategies in Southern Hemisphere Humpback Whale Baleen Records	PLOS ONE			English	Article							CARBON STABLE-ISOTOPES; FOOD-WEB STRUCTURE; MEGAPTERA-NOVAEANGLIAE; ORGANOCHLORINE BURDENS; OCEAN ACIDIFICATION; TROPHIC POSITION; WEST-COAST; NITROGEN; MIGRATION; KRILL	Our current understanding of Southern hemisphere humpback whale (Megaptera novaeangliae) ecology assumes high-fidelity feeding on Antarctic krill in Antarctic waters during summer, followed by fasting during their annual migration to and from equatorial breeding grounds. An increase in the number of reported departures from this feeding/fasting model suggests that the current model may be oversimplified or, alternatively, undergoing contemporary change. Information about the feeding and fasting cycles of the two Australian breeding populations of humpback whales were obtained through stable isotope analysis of baleen plates from stranded adult individuals. Comparison of isotope profiles showed that individuals from the West Australian breeding population strongly adhered to the classical feeding model. By contrast, East Australian population individuals demonstrated greater heterogeneity in their feeding. On a spectrum from exclusive Antarctic feeding to exclusive feeding in temperate waters, three different strategies were assigned and discussed: classical feeders, supplemental feeders, and temperate zone feeders. Diversity in the inter-annual feeding strategies of humpback whales demonstrates the feeding plasticity of the species, but could also be indicative of changing dynamics within the Antarctic sea-ice ecosystem. This study presents the first investigation of trophodynamics in Southern hemisphere humpback whales derived from baleen plates, and further provides the first estimates of baleen plate elongation rates in the species.	[Eisenmann, Pascale; Nash, Susan Bengtson] Griffith Univ, Environm Futures Res Inst, Brisbane, Qld 4111, Australia; [Fry, Brian] Griffith Univ, Australian Rivers Inst, Brisbane, Qld 4111, Australia; [Holyoake, Carly] Murdoch Univ, Perth, WA 6150, Australia; [Coughran, Douglas] Dept Pk & Wildlife, Kensington, WA 6151, Australia; [Nicol, Steve] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas 7000, Australia	Griffith University; Griffith University; Murdoch University; University of Tasmania	Eisenmann, P (corresponding author), Griffith Univ, Environm Futures Res Inst, Brisbane, Qld 4111, Australia.	pascale.eisenmann@griffithuni.edu.au	Nash, Susan Bengtson/I-3942-2015; Bengtson Nash, Susan/GMX-4611-2022	Nash, Susan Bengtson/0000-0001-5928-0850; Bengtson Nash, Susan/0000-0001-5928-0850	Pacific Life Ocean Foundation; Griffith University (GUPRS); Griffith University (GUIPRS)	Pacific Life Ocean Foundation; Griffith University (GUPRS); Griffith University (GUIPRS)	This work was funded by a Pacific Life Ocean Foundation Grant (https://www.oceanfdn.org/partnerships/foundation/pacific-life-foundation) awarded to SBN and Pascale Eisenmann acknowledges two Griffith University (https://www.griffith.edu.au) post-graduate (GUPRS) and international (GUIPRS) scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo J, 2013, EVIDENCE SPATIAL STR; Aguilar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092288; ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Ayliffe LK, 2004, OECOLOGIA, V139, P11, DOI 10.1007/s00442-003-1479-x; Barendse J, 2010, AFR J MAR SCI, V32, P1, DOI 10.2989/18142321003714203; Barendse J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081238; Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bengtson Nash S, 2014, MOBILISATION PERSIST; Bentaleb I, 2011, MAR ECOL PROG SER, V438, P285, DOI 10.3354/meps09269; Best PB, 1996, MAR BIOL, V124, P483, DOI 10.1007/BF00351030; Borrell A, 2012, RAPID COMMUN MASS SP, V26, P1596, DOI 10.1002/rcm.6267; Bowes RE, 2014, FRESHWATER BIOL, V59, P1926, DOI 10.1111/fwb.12396; Bruce E, 2014, APPL GEOGR, V54, P83, DOI 10.1016/j.apgeog.2014.06.014; Caraveo-Patino J, 2005, HYDROBIOLOGIA, V539, P99, DOI 10.1007/s10750-004-3370-0; Caraveo-Patino J, 2007, HYDROBIOLOGIA, V586, P17, DOI 10.1007/s10750-006-0477-5; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Cherel Y, 2008, MAR BIOL, V154, P813, DOI 10.1007/s00227-008-0974-3; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Christiansen F, 2013, FUNCT ECOL; Constantine R, 2014, MAR BIOL, V161, P1087, DOI 10.1007/s00227-014-2401-2; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Danilewicz Daniel, 2009, Marine Biodiversity Records, V2, pe88, DOI 10.1017/S1755267209000943; Davenport SR, 2002, CAN J FISH AQUAT SCI, V59, P514, DOI 10.1139/F02-031; Alves LCPD, 2009, MAR MAMMAL SCI, V25, P416, DOI 10.1111/j.1748-7692.2008.00249.x; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Doucett RR, 1999, CAN J FISH AQUAT SCI, V56, P2172, DOI 10.1139/cjfas-56-11-2172; FINDLAY KP, 1995, S AFR J MARINE SCI, V15, P279; Flores H, 2012, MAR ECOL PROG SER, V458, P1, DOI 10.3354/meps09831; FRY B, 1981, FISH B-NOAA, V79, P337; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Fry B, 2003, ESTUARIES, V26, P82, DOI 10.1007/BF02691696; Fry B, 1999, B MAR SCI, V65, P419; Gales N, 2009, J CETACEAN RES MANAG; Garrigue C, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150489; Gascon V, 2005, ANTARCTIC KRILL CASE; Germain LR, 2013, MAR ECOL PROG SER, V482, P265, DOI 10.3354/meps10257; Gomez-Campos E, 2011, RAPID COMMUN MASS SP, V25, P1343, DOI 10.1002/rcm.4999; Hall-Aspland SA, 2005, OECOLOGIA, V143, P143, DOI 10.1007/s00442-004-1783-0; Harris BP, 2014, J PLANKTON RES; Hobson KA, 1998, CAN J FISH AQUAT SCI, V55, P2601, DOI 10.1139/cjfas-55-12-2601; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hodum PJ, 2000, MAR ECOL PROG SER, V198, P273, DOI 10.3354/meps198273; Kawaguchi S, 2013, NAT CLIM CHANGE, V3, DOI 10.1038/NCLIMATE1937; Kawamura A., 1994, REP INT WHALING COMM, P261; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Lubetkin SC, 2008, CAN J ZOOL, V86, P525, DOI 10.1139/Z08-028; Matthews CJD, 2015, MAR ECOL PROG SER, V522, P269, DOI 10.3354/meps11145; McMahon KW, 2015, OECOLOGIA, P1; Miller CA, 2011, MAR ECOL PROG SER, V438, P267, DOI 10.3354/meps09174; Murase H, 2002, POLAR BIOL, V25, P135, DOI 10.1007/s003000100321; Nash SB, 2014, AQUAT TOXICOL, V155, P207, DOI 10.1016/j.aquatox.2014.06.021; Nash SMB, 2013, ENVIRON SCI TECHNOL, V47, P9404, DOI 10.1021/es401441n; Nielsen JM, 2015, OECOLOGIA, V178, P631, DOI 10.1007/s00442-015-3305-7; O'Driscoll RL, 1998, DEEP-SEA RES PT II, V45, P1295, DOI 10.1016/S0967-0645(98)00035-6; Owen K, 2016, POLAR BIOL, P1; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Popp BN, 2007, TERR ECOL SER, V1, P173; Ratnarajah L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114067; Schell D.M., 1989, Ecological Studies, V68, P260; SCHELL DM, 1989, MAR BIOL, V103, P433, DOI 10.1007/BF00399575; Seminoff JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037403; Stamation Kasey A., 2007, Aquatic Mammals, V33, P165, DOI 10.1578/AM.33.2.2007.165; Stevick PT, 2011, BIOL LETTERS, V7, P299, DOI 10.1098/rsbl.2010.0717; Stockin Karen A., 2005, Aquatic Mammals, V31, P120, DOI 10.1578/AM.31.1.2005.120; STONE GS, 1990, NATURE, V346, P705, DOI 10.1038/346705a0; Swart PK, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041397; Trull TW, 2008, DEEP-SEA RES PT II, V55, P820, DOI 10.1016/j.dsr2.2007.12.035; WADA E, 1987, DEEP-SEA RES, V34, P829, DOI 10.1016/0198-0149(87)90039-2; Waugh CA, 2012, ORGANOHALOGEN COMPOU, V74, P919; Waugh CA, 2012, MAR ECOL PROG SER, V471, P271, DOI 10.3354/meps10059; Wei GJ, 2009, GEOCHIM COSMOCHIM AC, V73, P2332, DOI 10.1016/j.gca.2009.02.009; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; YOUNG JW, 1993, MAR BIOL, V116, P9, DOI 10.1007/BF00350726; Zerbini AN, 2010, MAR BIOL, V157, P1225, DOI 10.1007/s00227-010-1403-y	79	47	47	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156698	10.1371/journal.pone.0156698	http://dx.doi.org/10.1371/journal.pone.0156698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244081	Green Published, gold			2022-12-26	WOS:000377146100063
J	De Cian, MC; Pauper, E; Bandiera, R; Vidal, VPI; Sacco, S; Gregoire, EP; Chassot, AA; Panzolini, C; Wilhelm, D; Pailhoux, E; Youssef, SA; de Bruin, A; Teerds, K; Schedl, A; Gillot, I; Chaboissier, MC				De Cian, M-C; Pauper, E.; Bandiera, R.; Vidal, V. P. I.; Sacco, S.; Gregoire, E. P.; Chassot, A-A; Panzolini, C.; Wilhelm, D.; Pailhoux, E.; Youssef, S. A.; de Bruin, A.; Teerds, K.; Schedl, A.; Gillot, I.; Chaboissier, M-C			Amplification of R-spondin1 signaling induces granulosa cell fate defects and cancers in mouse adult ovary	ONCOGENE			English	Article							BETA-CATENIN; FOLLICULAR DEVELOPMENT; SERTOLI-CELLS; DIFFERENTIATION; RSPO1; SPECIFICATION; DISRUPTION; EXPRESSION; CADHERINS; ATRESIA	R-spondin1 is a secreted regulator of WNT signaling, involved in both embryonic development and homeostasis of adult organs. It can have a dual role, acting either as a mitogen or as a tumor suppressor. During ovarian development, Rspo1 is a key factor required for sex determination and differentiation of the follicular cell progenitors, but is downregulated after birth. In human, increased RSPO1 expression is associated with ovarian carcinomas, but it is not clear whether it is a cause or a consequence of the tumorigenic process. To address the role of Rspo1 expression in adult ovaries, we generated an Rspol gain-of-function mouse model. Females were hypofertile and exhibited various ovarian defects, ranging from cysts to ovarian tumors. Detailed phenotypical characterization showed anomalies in the ovulation process. Although follicles responded to initial follicle-stimulating hormone stimulation and developed normally until the pre-ovulatory stage, they did not progress any further. Although non-ovulated oocytes degenerated, the surrounding follicular cells did not begin atresia. RSPO1-induced expression not only promotes canonical WNT signaling but also alters granulosa cell fate decisions by maintaining epithelial-like traits in these cells. This prevents follicle cells from undergoing apoptosis, leading to the accumulation of granulosa cell tumors that reactivates the epithelial program from their progenitors. Taken together, our data demonstrate that activation of RSPO1 is sufficient in promoting ovarian tumors and thus supports a direct involvement of this gene in the commencement of ovarian cancers.	[De Cian, M-C; Pauper, E.; Vidal, V. P. I.; Sacco, S.; Gregoire, E. P.; Chassot, A-A; Panzolini, C.; Schedl, A.; Gillot, I.; Chaboissier, M-C] Univ Nice Sophia Antipolis, iBV, CNRS, INSERM, Nice, France; [De Cian, M-C] Univ Corte, EA 7310, Corte, France; [Bandiera, R.] Univ Cambridge, Wellcome Trust Med Res Council Cambridge Stem Cel, Cambridge CB2 1TN, England; [Wilhelm, D.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic, Australia; [Pailhoux, E.] Univ Paris Saclay, INRA, UMR BDR, ENVA, Jouy En Josas, France; [Youssef, S. A.; de Bruin, A.] Univ Utrecht, Fac Vet Med, Dutch Mol Pathol Ctr, Dept Pathobiol, Utrecht, Netherlands; [de Bruin, A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Div Mol Genet, Groningen, Netherlands; [Teerds, K.] Wageningen Univ, Dept Human & Anim Physiol, Wageningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Cambridge; University of Melbourne; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Utrecht University; University of Groningen; Wageningen University & Research	Gillot, I; Chaboissier, MC (corresponding author), Univ Nice Sophia Antipolis, iBV, UFR Sci, Parc Valrose,28 Ave Valrose, F-06108 Nice 2, France.	gillot@unice.fr; marie-christine.chaboissier@unice.fr	Wilhelm, Dagmar/B-6915-2009; vidal, valerie/S-2597-2019; de Bruin, Alain/AAL-9195-2020; Schedl, Andreas/F-8823-2015; CHABOISSIER, Marie-Christine/F-6166-2019; Chassot, Anne-Amandine/O-2102-2016; CHABOISSIER, Marie-Christine/AAZ-5905-2021; Teerds, Katja/H-7580-2019; Grégoire, Elodie P./CAG-7541-2022; Schedl, Andreas/GOP-3427-2022; Vidal, Valerie/M-1477-2018	Wilhelm, Dagmar/0000-0002-7757-4075; Schedl, Andreas/0000-0001-9380-7396; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; Chassot, Anne-Amandine/0000-0003-1242-9456; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; Teerds, Katja/0000-0002-0930-1198; Grégoire, Elodie P./0000-0001-7614-4754; 	Fondation ARC pour la Recherche sur le Cancer [PJA 20131200236]; Agence Nationale de la Recherche [ANR-09-GENM-009-03, ANR-11-LABX-0028-01]; INRA; Ligue Nationale contre le Cancer	Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); INRA; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	We thank Mireille Cutajar-Bossert for her work and management of funding and also Fariba Jianmotamedi, Aurelie Charlet and Beatrice Polo for their punctual help in this work. We are thankful to Walter Birchmeier (Berlin, Germany) for the Axin2<SUP>+/LacZ</SUP> mice and Ken Morohashi (Fukuoka, Japan) for the SF1 antibody. We thank Aitana Perea-Gomez for critical reading of the manuscript. This work was supported by grants from the Fondation ARC pour la Recherche sur le Cancer (PJA 20131200236) and Agence Nationale de la Recherche (ANR-09-GENM-009-03 and ANR-11-LABX-0028-01). EP was supported by a fellowship from INRA and Ligue Nationale contre le Cancer.	Ahima RS, 1997, J CLIN INVEST, V99, P391, DOI 10.1172/JCI119172; Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Auguste A, 2011, SEX DEV, V5, P304, DOI 10.1159/000334517; Bandiera R, 2013, DEV CELL, V27, P5, DOI 10.1016/j.devcel.2013.09.003; Bingham NC, 2006, GENESIS, V44, P419, DOI 10.1002/dvg.20231; Boerboom D, 2006, CANCER RES, V66, P1964, DOI 10.1158/0008-5472.CAN-05-3493; Boerboom D, 2005, CANCER RES, V65, P9206, DOI 10.1158/0008-5472.CAN-05-1024; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Chassot AA, 2012, DEVELOPMENT, V139, P4461, DOI 10.1242/dev.078972; Chidgey M, 2007, BRIT J CANCER, V96, P1783, DOI 10.1038/sj.bjc.6603808; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Fan HY, 2010, MOL ENDOCRINOL, V24, P1529, DOI 10.1210/me.2010-0141; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hatano O, 1996, GENES CELLS, V1, P663, DOI 10.1046/j.1365-2443.1996.00254.x; Hirshfield AN, 1997, ENVIRON MOL MUTAGEN, V29, P10; Huang CCJ, 2010, ENDOCRINOLOGY, V151, P1119, DOI 10.1210/en.2009-0814; Jamieson S, 2012, ENDOCR REV, V33, P109, DOI 10.1210/er.2011-0014; Karl J, 1998, DEV BIOL, V203, P323, DOI 10.1006/dbio.1998.9068; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kim AC, 2008, DEVELOPMENT, V135, P2593, DOI 10.1242/dev.021493; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kuchenbaecker KB, 2015, NAT GENET, V47, P164, DOI 10.1038/ng.3185; Liu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7934; Liu Z. H., 2015, HIGHWAY, V2015, P1, DOI DOI 10.1016/J.FUPR0C.2015.01.025; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Maatouk DM, 2013, DEV BIOL, V383, P295, DOI 10.1016/j.ydbio.2013.08.026; Maeda O, 2004, ONCOGENE, V23, P964, DOI 10.1038/sj.onc.1207254; Makrigiannakis A, 1999, AM J PATHOL, V154, P1391, DOI 10.1016/S0002-9440(10)65393-X; Mork L, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095208; Mullany LK, 2012, ENDOCRINOLOGY, V153, P1585, DOI 10.1210/en.2011-2121; Ng A, 2014, NAT CELL BIOL, V16, P745, DOI 10.1038/ncb3000; OSMAN P, 1985, J REPROD FERTIL, V73, P261, DOI 10.1530/jrf.0.0730261; Pan HJ, 2014, ENDOCRINOLOGY, V155, P3624, DOI 10.1210/en.2013-2183; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Rastetter RH, 2014, DEV BIOL, V394, P242, DOI 10.1016/j.ydbio.2014.08.013; Rocha AS, 2015, CELL REP, V13, P1757, DOI 10.1016/j.celrep.2015.10.049; Rowlands TM, 2000, REV REPROD, V5, P53; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sun XF, 2014, FASEB J, V28, P2380, DOI 10.1096/fj.13-248344; Svingen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052620; Tomaselli S, 2008, HUM MUTAT, V29, P220, DOI 10.1002/humu.20665; Tomaselli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016366; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Zheng WJ, 2014, HUM MOL GENET, V23, P920, DOI 10.1093/hmg/ddt486	48	15	15	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2017	36	2					208	218		10.1038/onc.2016.191	http://dx.doi.org/10.1038/onc.2016.191			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK5AA	27270435	Green Published, hybrid			2022-12-26	WOS:000393938100006
J	Zhen, Y; Fang, W; Zhao, M; Luo, R; Liu, Y; Fu, Q; Chen, Y; Cheng, C; Zhang, Y; Liu, Z				Zhen, Y.; Fang, W.; Zhao, M.; Luo, R.; Liu, Y.; Fu, Q.; Chen, Y.; Cheng, C.; Zhang, Y.; Liu, Z.			miR-374a-CCND 1-pPI3KJAKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER CELLS; LUNG-CANCER; CYCLE PROGRESSION; GENE-EXPRESSION; DOWN-REGULATION; OVARIAN-CANCER; C-MYC; PROLIFERATION; PROMOTES	miR-374a has been reported to function as an oncogene during tumor pathogenesis. In this study, miR-374a is observed to reduce nasopharyngeal carcinoma (NPC) cell proliferation, migration, invasion, metastasis and cisplatin (DDP) resistance in vitro and in vivo. Mechanistic analyses indicate that miR-374a directly targets CCND1 to inactivate pPI3K/pAKT/c-JUN forming a negative feedback loop, as well as suppressing downstream signals related to cell cycle progression and epithelial mesenchymal transition (EMT). Interestingly, we also observed that miR-374a direct targeting of CCND1 is modulated by tumor suppressor PDCD4 via suppressing pPl3K/pAICT/c-JUN signaling. In clinical specimens, miR-374a was positively and negatively correlated with expression of PDCD4 and CCND1, respectively. Our studies are the first to demonstrate that the miR-374a-CCND1-pPl3K/AKT-c-JUN feedback loop induced by PDCD4 supresses NPC cell growth, metastasis and chemotherapy resistance.	[Zhen, Y.; Fang, W.; Luo, R.] Southern Med Univ, TCM Integrated Hosp, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Zhen, Y.] Guangdong Med Univ, Affiliated Hosp, Inst Resp Dis, Zhanjiang, Peoples R China; [Zhen, Y.; Fang, W.; Zhao, M.; Liu, Y.; Fu, Q.; Chen, Y.; Cheng, C.; Liu, Z.] Southern Med Univ, Canc Res Inst, Guangzhou 510515, Guangdong, Peoples R China; [Zhang, Y.; Liu, Z.] Guangzhou Med Univ, Sch Basic Med, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangdong Medical University; Southern Medical University - China; Guangzhou Medical University	Fang, W; Liu, Z (corresponding author), Southern Med Univ, Canc Res Inst, Guangzhou 510515, Guangdong, Peoples R China.	fangweiyi1975@163.com; narcissus_jane@163.com			National Nature Science Fund of China [81372184, 81401906]; Outstanding Young Teacher Training Project of Colleges and Universities in Guangdong Province [Yq2013136]; Guangdong Province Education Foundation [2014KTSCX107]; Yangcheng Scholar Research Projects from Universities of Guangzhou [12A011D]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Outstanding Young Teacher Training Project of Colleges and Universities in Guangdong Province; Guangdong Province Education Foundation; Yangcheng Scholar Research Projects from Universities of Guangzhou	This study was supported by National Nature Science Fund of China (No. 81372184 and No. 81401906) (http://www.nsfc.gov.cn), the Outstanding Young Teacher Training Project of Colleges and Universities in Guangdong Province (No. Yq2013136), Guangdong Province Education Foundation (No. 2014KTSCX107), and Yangcheng Scholar Research Projects from Universities of Guangzhou (No. 12A011D). We are also grateful to Dr Douglas E Linn (Brigham & Women's Hospital, Boston, MA, USA) for critical reading of the manuscript.	Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Bu PC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7879; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Cai LM, 2015, ONCOGENE, V34, P2156, DOI 10.1038/onc.2014.341; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; JIANG W, 1993, ONCOGENE, V8, P3447; Ju XM, 2014, CANCER RES, V74, P508, DOI 10.1158/0008-5472.CAN-13-1313; Keklikoglou I, 2015, ONCOGENE, V34, P4867, DOI 10.1038/onc.2014.408; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lei K, 2008, ONCOGENE, V27, P4877, DOI 10.1038/onc.2008.132; Li JY, 2013, ASIAN PAC J CANCER P, V14, P1715, DOI 10.7314/APJCP.2013.14.3.1715; Liao HZ, 2015, ONCOTARGET, V6, P8914, DOI 10.18632/oncotarget.3563; Lin KT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6917; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Mihailovich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9725; Miko E, 2009, EXP LUNG RES, V35, P646, DOI 10.3109/01902140902822312; Miow QH, 2015, ONCOGENE, V34, P1899, DOI 10.1038/onc.2014.136; Que T, 2015, ONCOGENE, V34, P4952, DOI 10.1038/onc.2014.419; Sorokin AV, 2013, ONCOGENE, V32, P3130, DOI 10.1038/onc.2012.327; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Vosa U, 2011, GENE CHROMOSOME CANC, V50, P812, DOI 10.1002/gcc.20902; Walsh AM, 2015, MOL CANCER RES, V13, P1227, DOI 10.1158/1541-7786.MCR-14-0183-T; Wang H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.122; Wang Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.186; Wu AB, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-38; Ye Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2489; Yu X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.153; Zhang PJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6671; Zhao MY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11309; Zhen Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.376; Zhong ZJ, 2010, CANCER RES, V70, P2105, DOI 10.1158/0008-5472.CAN-08-1108; Zhou Y, 2015, ONCOTARGET, V6, P10350, DOI 10.18632/oncotarget.3585	37	79	85	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2017	36	2					275	285		10.1038/onc.2016.201	http://dx.doi.org/10.1038/onc.2016.201			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK5AA	27270423				2022-12-26	WOS:000393938100012
J	Beck, D; Zobel, J; Barber, R; Evans, S; Lezina, L; Allchin, RL; Blades, M; Elliott, R; Lord, CJ; Ashworth, A; Porter, ACG; Wagner, SD				Beck, Daniel; Zobel, Jenny; Barber, Ruth; Evans, Sian; Lezina, Larissa; Allchin, Rebecca L.; Blades, Matthew; Elliott, Richard; Lord, Christopher J.; Ashworth, Alan; Porter, Andrew C. G.; Wagner, Simon D.			Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMINAL-CENTER FORMATION; NEGATIVE AUTOREGULATION; TRANSCRIPTION FACTOR; SIGNAL TRANSDUCER; DOWN-REGULATION; IN-VITRO; BCL6; DIFFERENTIATION; REPRESSION; EXPRESSION	We demonstrate the usefulness of synthetic lethal screening of a conditionally BCL6-deficient Burkitt lymphoma cell line, DG75-AB7, with a library of small molecules to determine survival pathways suppressed by BCL6 and suggest mechanism-based treatments for lymphoma. Lestaurtinib, a JAK2 inhibitor and one of the hits from the screen, repressed survival of BCL6-deficient cells in vitro and reduced growth and proliferation of xenografts in vivo. BCL6 deficiency in DG75-AB7 induced JAK2 mRNA and protein expression and STAT3 phosphorylation. Surface IL10RA was elevated by BCL6 deficiency, and blockade of IL10RA repressed STAT3 phosphorylation. Therefore, we define an IL10RA/JAK2/STAT3 pathway each component of which is repressed by BCL6. We also show for the first time that JAK2 is a direct BCL6 target gene; BCL6 bound to the JAK2 promoter in vitro and was enriched by ChIP-seq. The place of JAK2 inhibitors in the treatment of diffuse large B-cell lymphoma has not been defined; we suggest that JAK2 inhibitors might be most effective in poor prognosis ABC-DLBCL, which shows higher levels of IL10RA, JAK2, and STAT3 but lower levels of BCL6 than GC-DLBCL and might be usefully combined with novel approaches such as inhibition of IL10RA.	[Beck, Daniel; Barber, Ruth; Evans, Sian; Lezina, Larissa; Allchin, Rebecca L.; Wagner, Simon D.] Univ Leicester, Ernest & Helen Scott Haematol Res Inst, Dept Canc Studies, Lancaster Rd, Lancaster LE1 7HB, England; [Barber, Ruth] Univ Leicester, Leicester Diagnost & Drug Dev Ctr LD3, Lancaster Rd, Lancaster LE1 7HB, England; [Zobel, Jenny; Porter, Andrew C. G.] Imperial Coll London, Dept Haematol, Hammersmith Campus,Du Cane Rd, London W12 0NN, England; [Blades, Matthew] Univ Leicester, Bioinformat & Biostat Anal Support Hub B BASH, Leicester LE1 9HN, Leics, England; [Elliott, Richard; Lord, Christopher J.; Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England	University of Leicester; University of Leicester; Imperial College London; University of Leicester; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Wagner, SD (corresponding author), Univ Leicester, Dept Canc Studies, Rm 104,Hodgkin Bldg,Lancaster Rd, Leicester LE1 7HB, Leics, England.	sw227@le.ac.uk	Lord, Christopher/AAX-7130-2021; Lezina, Larissa/AAO-3574-2020; Allchin, Rebecca/HDO-5629-2022; Lord, Christopher/B-3295-2012	Lord, Christopher/0000-0002-3226-0515	Leukemia and Lymphoma Research; Gordon Piller Leukaemia and Lymphoma Research PhD Studentship; University of Leicester; Ernest and Helen Scott Hematology Research Institute; Cancer Research UK [14276] Funding Source: researchfish; Medical Research Council [MC_PC_14117] Funding Source: researchfish; MRC [MC_PC_14117] Funding Source: UKRI	Leukemia and Lymphoma Research; Gordon Piller Leukaemia and Lymphoma Research PhD Studentship; University of Leicester; Ernest and Helen Scott Hematology Research Institute; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from Leukemia and Lymphoma Research (to S. D. W.). The authors declare that they have no conflicts of interest with the contents of this article.r A Gordon Piller Leukaemia and Lymphoma Research PhD Studentship to S. D. W. and A. C. G. P. supported J. Z.r Supported by a University of Leicester Ph.D. Studentship.r Supported by a Clinical Research Fellowship from the Ernest and Helen Scott Hematology Research Institute.	Beguelin W, 2015, LEUKEMIA, V29, P1684, DOI 10.1038/leu.2015.57; Cerchietti LC, 2010, J CLIN INVEST, V120, P4569, DOI 10.1172/JCI42869; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Cerchietti LC, 2009, BLOOD, V113, P3397, DOI 10.1182/blood-2008-07-168773; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Derenzini E, 2013, EXPERT OPIN INV DRUG, V22, P775, DOI 10.1517/13543784.2013.775244; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Gupta M, 2012, BLOOD, V119, P2844, DOI 10.1182/blood-2011-10-388538; HAMMERSCHMIDT W, 1989, NATURE, V340, P393, DOI 10.1038/340393a0; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li ZP, 2005, J IMMUNOL, V174, P205, DOI 10.4049/jimmunol.174.1.205; Maier S, 2005, J VIROL, V79, P8784, DOI 10.1128/JVI.79.14.8784-8792.2005; Mottok A, 2009, BLOOD, V114, P4503, DOI 10.1182/blood-2009-06-225839; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Niu HF, 2003, J EXP MED, V198, P211, DOI 10.1084/jem.20021395; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; OFFIT K, 1994, NEW ENGL J MED, V331, P74, DOI 10.1056/NEJM199407143310202; Papadopoulou V, 2010, BIOCHEM J, V427, P541, DOI 10.1042/BJ20091578; Parekh S, 2007, BLOOD, V110, P2067, DOI 10.1182/blood-2007-01-069575; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Wang X, 2002, P NATL ACAD SCI USA, V99, P15018, DOI 10.1073/pnas.232581199; Witzig TE, 2013, LEUKEMIA LYMPHOMA, V54, P397, DOI 10.3109/10428194.2012.708931; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Younes A, 2012, J CLIN ONCOL, V30, P4161, DOI 10.1200/JCO.2012.42.5223; Yu RYL, 2005, BLOOD, V105, P1777, DOI 10.1182/blood-2004-08-3171; Zhou T, 2014, LEUKEMIA, V28, P471, DOI 10.1038/leu.2013.299	50	8	9	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16686	16698		10.1074/jbc.M116.736868	http://dx.doi.org/10.1074/jbc.M116.736868			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27268052	hybrid, Green Published			2022-12-26	WOS:000380826700026
J	Gartung, A; Zhao, JW; Chen, S; Mottillo, E; VanHecke, GC; Ahn, YH; Maddipati, KR; Sorokin, A; Granneman, J; Lee, MJ				Gartung, Allison; Zhao, Jiawei; Chen, Simon; Mottillo, Emilio; VanHecke, Garrett C.; Ahn, Young-Hoon; Maddipati, Krishna Rao; Sorokin, Andrey; Granneman, James; Lee, Menq-Jer			Characterization of Eicosanoids Produced by Adipocyte Lipolysis IMPLICATION OF CYCLOOXYGENASE-2 IN ADIPOSE INFLAMMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; HORMONE-SENSITIVE LIPASE; ADIPOSE-TISSUE; FATTY-ACIDS; OBESITY; INFLAMMATION; EXPRESSION; CYCLOOXYGENASE-2; PATHWAY; AXIS	Excessive adipocyte lipolysis generates lipid mediators and triggers inflammation in adipose tissue. However, the specific roles of lipolysis-generated mediators in adipose inflammation remain to be elucidated. In the present study, cultured 3T3-L1 adipocytes were treated with isoproterenol to activate lipolysis and the fatty acyl lipidome of released lipids was determined by using LC-MS/MS. We observed that beta-adrenergic activation elevated levels of approximately fifty lipid species, including metabolites of cyclooxygenases, lipoxygenases, epoxygenases, and other sources. Moreover, we found that beta-adrenergic activation induced cyclooxygenase 2 (COX-2), not COX-1, expression in a manner that depended on activation of hormone-sensitive lipase (HSL) in cultured adipocytes and in the epididymal white adipose tissue (EWAT) of C57BL/6 mice. We found that lipolysis activates the JNK/NF kappa B signaling pathway and inhibition of the JNK/NF kappa B axis abrogated the lipolysis-stimulated COX-2 expression. In addition, pharmacological inhibition of COX-2 activity diminished levels of COX-2 metabolites during lipolytic activation. Inhibition of COX-2 abrogated the induction of CCL2/MCP-1 expression by beta-adrenergic activation and prevented recruitment of macrophage/monocyte to adipose tissue. Collectively, our data indicate that excessive adipocyte lipolysis activates the JNK/NF-kappa B pathway leading to the up-regulation of COX-2 expression and recruitment of inflammatory macrophages.	[Gartung, Allison; Zhao, Jiawei; Chen, Simon; Maddipati, Krishna Rao; Lee, Menq-Jer] Wayne State Univ, Bioact Lipid Res Program, Detroit, MI 48202 USA; [Gartung, Allison; Zhao, Jiawei; Chen, Simon; Mottillo, Emilio; Maddipati, Krishna Rao; Lee, Menq-Jer] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [VanHecke, Garrett C.; Ahn, Young-Hoon] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Granneman, James] Wayne State Univ, Ctr Integrat Metab & Endocrine Res, Detroit, MI 48202 USA; [Granneman, James] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Lee, Menq-Jer] Wayne State Univ, Cardiovasc Res Inst, Detroit, MI 48202 USA; [Lee, Menq-Jer] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48202 USA; [Sorokin, Andrey] Med Coll Wisconsin, Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Medical College of Wisconsin	Lee, MJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, 541 East Canfield Ave,Scott Hall 9215, Detroit, MI 48201 USA.	menqjer.lee@wayne.edu	Maddipati, Krishna Rao/H-3569-2019; Maddipati, Krishna Rao/G-1859-2011	Maddipati, Krishna Rao/0000-0003-1445-791X; Maddipati, Krishna Rao/0000-0003-1445-791X; Sorokin, Andrey/0000-0002-5660-0190	Department of Defense Grant [W81XWH-14-1-0346]; Wayne State University; National Institutes of Health [DK-076229, DK-062292, CA-182114]; NATIONAL CANCER INSTITUTE [R03CA182114] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R56DK062292, R01DK062292] Funding Source: NIH RePORTER	Department of Defense Grant(United States Department of Defense); Wayne State University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Department of Defense Grant W81XWH-14-1-0346, a funding support of Wayne State University (to M. L.), and National Institutes of Health Grants DK-076229, DK-062292 (to J. G. G.) and CA-182114 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackerman WE, 2008, BIOL REPROD, V78, P68, DOI 10.1095/biolreprod.107.061663; Ahn G, 2013, BBA-GEN SUBJECTS, V1830, P2820, DOI 10.1016/j.bbagen.2012.12.008; Al-Shabrawey M, 2011, DIABETES, V60, P614, DOI 10.2337/db10-0008; Alhouayek M, 2014, TRENDS PHARMACOL SCI, V35, P284, DOI 10.1016/j.tips.2014.03.001; Andersson CX, 2008, DIABETES-METAB RES, V24, P595, DOI 10.1002/dmrr.889; Bezaire V, 2009, P NUTR SOC, V68, P350, DOI 10.1017/S0029665109990279; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Claus TH, 2005, J PHARMACOL EXP THER, V315, P1396, DOI 10.1124/jpet.105.086926; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Das Arghya, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P23; Eckel RH, 2004, CIRCULATION, V110, P2968, DOI 10.1161/01.CIR.0000140086.88453.9A; Engeland A, 2003, AM J EPIDEMIOL, V157, P517, DOI 10.1093/aje/kwf219; Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006; Fain JN, 2000, PROSTAG OTH LIPID M, V62, P343, DOI 10.1016/S0090-6980(00)00088-5; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Garcia-Alonso V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153751; Gomez I, 2013, PROSTAG LEUKOTR ESS, V89, P55, DOI 10.1016/j.plefa.2013.04.004; Hellmann J, 2013, J IMMUNOL, V191, P1383, DOI 10.4049/jimmunol.1203369; Henrichot E, 2005, ARTERIOSCL THROM VAS, V25, P2594, DOI 10.1161/01.ATV.0000188508.40052.35; Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307; HO MK, 1982, J IMMUNOL, V128, P1221; Hsieh PS, 2010, EUR J CLIN INVEST, V40, P164, DOI 10.1111/j.1365-2362.2009.02239.x; Kaltschmidt B, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-16; Kawahara K., 2015, BBA-MOL CELL BIOL L, V1851, P414, DOI [10.1016/j.bbalip.2014.07.008, DOI 10.1016/J.BBALIP.2014.07.008]; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Krishnamoorthy S, 2010, EXP CELL RES, V316, P1706, DOI 10.1016/j.yexcr.2010.03.005; Kuo WW, 2013, INT J CARDIOL, V168, P270, DOI 10.1016/j.ijcard.2012.09.080; Largo R, 2004, ANN RHEUM DIS, V63, P1197, DOI 10.1136/ard.2003.011163; Lee YH, 2014, BBA-MOL BASIS DIS, V1842, P358, DOI 10.1016/j.bbadis.2013.05.011; Lim JW, 2001, LAB INVEST, V81, P349, DOI 10.1038/labinvest.3780243; Lowe DB, 2004, BIOORG MED CHEM LETT, V14, P3155, DOI 10.1016/j.bmcl.2004.04.015; Maddipati KR, 2014, FASEB J, V28, P4835, DOI 10.1096/fj.14-254383; Maddipati KR, 2011, PROSTAG OTH LIPID M, V94, P59, DOI 10.1016/j.prostaglandins.2011.01.003; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Mottillo EP, 2011, AM J PHYSIOL-ENDOC M, V301, pE122, DOI 10.1152/ajpendo.00039.2011; Mottillo EP, 2010, BBA-MOL CELL BIOL L, V1801, P1048, DOI 10.1016/j.bbalip.2010.04.012; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shantsila E, 2009, ARTERIOSCL THROM VAS, V29, P1433, DOI 10.1161/ATVBAHA.108.180513; Torres R, 2015, MOL IMMUNOL, V63, P61, DOI 10.1016/j.molimm.2014.03.007; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Vona-Davis L, 2013, J MAMMARY GLAND BIOL, V18, P291, DOI 10.1007/s10911-013-9299-z; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195; Zahner G, 2009, BIOCHEM J, V422, P563, DOI 10.1042/BJ20090420; Zhang WL, 2014, J BIOL CHEM, V289, P32178, DOI 10.1074/jbc.M114.601096; Zhang WL, 2013, J BIOL CHEM, V288, P32126, DOI 10.1074/jbc.M113.495218; Zhou H, 2015, MOL MED REP, V11, P4327, DOI 10.3892/mmr.2015.3289	50	27	28	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16001	16010		10.1074/jbc.M116.725937	http://dx.doi.org/10.1074/jbc.M116.725937			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27246851	hybrid, Green Published			2022-12-26	WOS:000380585400007
J	Llopis-Torregrosa, V; Ferri-Blazquez, A; Adam-Artigues, A; Deffontaines, E; van Heusden, GPH; Yenush, L				Llopis-Torregrosa, Vicent; Ferri-Blazquez, Alba; Adam-Artigues, Anna; Deffontaines, Emilie; van Heusden, G. Paul H.; Yenush, Lynne			Regulation of the Yeast Hxt6 Hexose Transporter by the Rod1 alpha-Arrestin, the Snf1 Protein Kinase, and the Bmh2 14-3-3 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; UBIQUITIN-LIGASE; MULTIVESICULAR BODY; PHEROMONE RESPONSE; CELL-SURFACE; COMPLEX; ENDOCYTOSIS; TRAFFICKING; PERMEASE; SWITCH	Cell viability requires adaptation to changing environmental conditions. Ubiquitin-mediated endocytosis plays a crucial role in this process, because it provides a mechanism to remove transport proteins from the membrane. Arrestin-related trafficking proteins are important regulators of the endocytic pathway in yeast, facilitating selective ubiquitylation of target proteins by the E3 ubiquitin ligase, Rsp5. Specifically, Rodl (Art4) has been reported to regulate the endocytosis of both the Hxtl, Hxt3, and Hxt6 glucose transporters and the Jen1 lactate transporter. Also, the AMP kinase homologue, Snfl, and 14-3-3 proteins have been shown to regulate Jenl via Rodl. Here, we further characterized the role of Rodl, Snfl, and 14-3-3 in the signal transduction route involved in the endocytic regulation of the Hxt6 high affinity glucose transporter by showing that Sal interacts specifically with Rodl and Rog3 (Art7), that the interaction between the Bmh2 and several arrestin-related trafficking proteins may be modulated by carbon source, and that both the 14-3-3 protein Bmh2 and the Snfl regulatory domain interact with the arrestin-like domain containing the N -terminal half of Rodl (amino acids 1-395). Finally, using both co-immunoprecipitation and bimolecular fluorescence complementation, we demonstrated the interaction of Rodl with Hxt6 and showed that the localization of the Rodl-Hxt6 complex at the plasma membrane is affected by carbon source and is reduced upon overexpression of SNF1 and BMH2.	[Llopis-Torregrosa, Vicent; Ferri-Blazquez, Alba; Adam-Artigues, Anna; Deffontaines, Emilie; Yenush, Lynne] Univ Politecn Valencia, IBMCP, CSIC, E-46022 Valencia, Spain; [van Heusden, G. Paul H.] Leiden Univ, Inst Biol, Sect Mol & Dev Genet, Sylviusweg 72, NL-2333 BE Leiden, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Leiden University; Leiden University - Excl LUMC	Yenush, L (corresponding author), Univ Politecn Valencia, IBMCP, CSIC, E-46022 Valencia, Spain.; Yenush, L (corresponding author), Inst Biol Mol & Celular Plantas, C Vera S-N, Valencia 46022, Spain.	lynne@ibmcp.upv.es	Yenush, Lynne/J-8815-2014; van Heusden, Paul/S-3495-2017; Llopis, Vicent/AAW-2467-2021	Yenush, Lynne/0000-0001-8589-7002; van Heusden, Paul/0000-0002-6422-8034; Llopis, Vicent/0000-0003-1041-9676; ADAM-ARTIGUES, ANNA/0000-0002-4257-8535; Ferri-Blazquez, Alba/0000-0002-4533-5117	Ministerio de Economia y Competitividad (Madrid, Spain) [BFU2011-30197-C03-03]; Netherlands Organization for Scientific Research-Earth and Life Sciences [826.09.006]; Polytechnic University of Valencia	Ministerio de Economia y Competitividad (Madrid, Spain); Netherlands Organization for Scientific Research-Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); Polytechnic University of Valencia	This work was supported by Grant BFU2011-30197-C03-03 from the Ministerio de Economia y Competitividad (Madrid, Spain) and in part by Netherlands Organization for Scientific Research-Earth and Life Sciences Grant 826.09.006. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a predoctoral fellowship from the Polytechnic University of Valencia.	Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Alvaro CG, 2016, GENETICS, V203, P299, DOI 10.1534/genetics.115.186122; Alvaro CG, 2014, MOL CELL BIOL, V34, P2660, DOI 10.1128/MCB.00230-14; Andres AM, 2011, FEBS LETT, V585, P1223, DOI 10.1016/j.febslet.2011.03.042; Aubry L, 2013, PROG MOL BIOL TRANSL, V118, P21, DOI 10.1016/B978-0-12-394440-5.00002-4; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Becuwe M, 2014, ELIFE, V3, DOI 10.7554/eLife.03307; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; GAXIOLA R, 1992, EMBO J, V11, P3157, DOI 10.1002/j.1460-2075.1992.tb05392.x; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jiang R, 1996, GENE DEV, V10, P3105, DOI 10.1101/gad.10.24.3105; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Mayordomo I, 2003, FEBS LETT, V544, P160, DOI 10.1016/S0014-5793(03)00498-8; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Mulet JM, 2013, CURR GENET, V59, P207, DOI 10.1007/s00294-013-0401-2; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; O'Donnell AF, 2015, MOL CELL BIOL, V35, P939, DOI 10.1128/MCB.01183-14; O'Donnell AF, 2013, J BIOL CHEM, V288, P24063, DOI 10.1074/jbc.M113.478511; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Patwari P, 2009, J BIOL CHEM, V284, P24996, DOI 10.1074/jbc.M109.018093; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; Sanz P, 2000, GENETICS, V154, P99; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; Shinoda J, 2007, BIOCHEM BIOPH RES CO, V364, P258, DOI 10.1016/j.bbrc.2007.09.134; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yenush L, 2005, MOL CELL BIOL, V25, P8683, DOI 10.1128/MCB.25.19.8683-8692.2005; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515; ZONNEVELD BJM, 1986, J MICROBIOL METH, V4, P287, DOI 10.1016/0167-7012(86)90040-0	42	33	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	2016	291	29					14973	14985		10.1074/jbc.M116.733923	http://dx.doi.org/10.1074/jbc.M116.733923			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2GZ	27261460	Green Published, hybrid			2022-12-26	WOS:000380583200010
J	Wright, CJ; Zeeman, H; Biezaitis, V				Wright, Courtney J.; Zeeman, Heidi; Biezaitis, Valda			Holistic Practice in Traumatic Brain Injury Rehabilitation: Perspectives of Health Practitioners	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE REHABILITATION; CARE PERSPECTIVES; SELF-AWARENESS; DISABILITY; TRANSITION; OUTCOMES; ADULTS; MODEL; PROFESSIONALS	Given that the literature suggests there are various (and often contradictory) interpretations of holistic practice in brain injury rehabilitation and multiple complexities in its implementation (including complex setting, discipline, and client-base factors), this study aimed to examine the experiences of practitioners in their conceptualization and delivery of holistic practice in their respective settings. Nineteen health practitioners purposively sampled from an extensive Brain Injury Network in Queensland, Australia participated in individual interviews. A systematic text analysis process using Leximancer qualitative analysis program was undertaken, followed by manual thematic analysis to develop overarching themes. The findings from this study have identified several items for future inter-professional development that will not only benefit the practitioners working in brain injury rehabilitation settings, but the patients and their families as well.	[Wright, Courtney J.; Zeeman, Heidi] Griffith Univ, Menzies Hlth Inst Queensland, Sch Human Serv & Social Work, Meadowbrook, Qld 4131, Australia; [Wright, Courtney J.; Zeeman, Heidi] Griffith Univ, RECOVER Injury Res Ctr, Meadowbrook, Qld 4131, Australia; [Biezaitis, Valda] Mater Childrens Hosp, ROBIN Team, South Brisbane, Qld, Australia; [Biezaitis, Valda] Mater Res, Improving Treatment Dis, South Brisbane, Qld, Australia	Griffith University; Griffith University; Mater Research	Wright, CJ (corresponding author), Griffith Univ, Menzies Hlth Inst Queensland, Sch Human Serv & Social Work, Meadowbrook, Qld 4131, Australia.; Wright, CJ (corresponding author), Griffith Univ, RECOVER Injury Res Ctr, Meadowbrook, Qld 4131, Australia.	Courtney.wright@griffith.edu.au		Wright, Courtney/0000-0003-4735-4378	Mater Children's Hospital	Mater Children's Hospital	The authors are grateful to the Mater Children's Hospital and the Brain Injury Network team led by Dr. Ron Hazelton, who supported this study throughout. Many thanks in particular, to the participants of the study who gave so generously of their time. Special thanks are also extended to Dr. Valda Biezaitis for her willingness and enthusiasm to engage in research as a practicing clinician.	Allan Chris M, 2006, J Interprof Care, V20, P235, DOI 10.1080/13561820600718139; Australian Institute of Health and Welfare, 2008, AUSTR HLTH 2008; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Ben-Yishay Y, 2011, HDB HOLISTIC NEUROPS; Ben-Yishay Y., 1990, COGNITIVE REMEDIATIO; Bolderston A, 2012, J MED IMAGING RADIAT, V43, P66, DOI 10.1016/j.jmir.2011.12.002; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Breen LJ, 2011, DISABIL REHABIL, V33, P862, DOI 10.3109/09638288.2010.520799; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Cattelani R, 2010, NEUROPSYCHOL REV, V20, P52, DOI 10.1007/s11065-009-9125-y; Cerniauskaite M, 2011, DISABIL REHABIL, V33, P281, DOI 10.3109/09638288.2010.529235; Charleswell C, 2015, J EPIDEMIOL COMMUN H, V69, P290, DOI 10.1136/jech-2014-204239; Chittiboina Prashant, 2013, Pathophysiology, V20, P15, DOI 10.1016/j.pathophys.2012.02.004; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Dalton C, 2012, CLIN REHABIL, V26, P165, DOI 10.1177/0269215511405230; Dion GR, 2014, J VOICE, V28, P88, DOI 10.1016/j.jvoice.2013.08.005; Engel George L, 2012, Psychodyn Psychiatry, V40, P377, DOI 10.1037/h0089260; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Flick U., 2019, INTRO QUALITATIVE RE, V6th; Fossey E, 2002, AUST NZ J PSYCHIAT, V36, P717, DOI 10.1046/j.1440-1614.2002.01100.x; Gerring JP, 2012, J NEUROTRAUM, V29, P621, DOI 10.1089/neu.2011.2234; Gibbins S, 2015, QUAL HEALTH RES, V25, P763, DOI 10.1177/1049732315580105; Goldstein K., 1939, ORG HOLISTIC APPROAC; Guion L.A., 2011, TRIANGULATION ESTABL, V2011, P3; Gzil F, 2007, DISABIL REHABIL, V29, P1616, DOI 10.1080/09638280701618620; Haboubi NHJ, 2003, DISABIL REHABIL, V25, P291, DOI 10.1080/0963828021000031188; Hall Pippa, 2005, J Interprof Care, V19 Suppl 1, P188; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Heinemann AW, 2005, REHABIL PSYCHOL, V50, P6, DOI 10.1037/0090-5550.50.1.6; Helps Y. L., 2008, INJURY RES STAT SERI, V45; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Huber JG, 2010, DISABIL REHABIL, V32, P1955, DOI 10.3109/09638281003797414; Jenesick V, 2000, HDB QUALITATIVE RES; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kontos PC, 2012, QUAL HEALTH RES, V22, P1612, DOI 10.1177/1049732312458370; Koskinen S, 2011, DISABIL REHABIL, V33, P2464, DOI 10.3109/09638288.2011.574776; Kuipers P, 2014, J INTERPROF CARE, V28, P246, DOI 10.3109/13561820.2013.821601; Kuipers P, 2009, DISABIL REHABIL, V31, P144, DOI 10.1080/01674820701817938; Kurowski BG, 2011, PM&R, V3, P836, DOI 10.1016/j.pmrj.2011.05.016; Leonardi M, 2009, DISABIL REHABIL, V31, pS83, DOI 10.3109/09638280903317948; Leplege A, 2007, DISABIL REHABIL, V29, P1555, DOI 10.1080/09638280701618661; Lexell J, 2007, J HEAD TRAUMA REHAB, V22, P229, DOI 10.1097/01.HTR.0000281838.00344.03; Lyons AC., 2006, HLTH PSYCHOL CRITICA; Malec JF, 2006, BRAIN INJURY, V20, P227, DOI 10.1080/02699050500488124; McDougall J, 2010, DEV NEUROREHABIL, V13, P204, DOI 10.3109/17518421003620525; McEvoy Liz, 2008, Nurse Educ Pract, V8, P412, DOI 10.1016/j.nepr.2008.02.002; McHugh J C, 2007, Ir Med J, V100, P518; McMillan SS, 2013, MED CARE RES REV, V70, P567, DOI 10.1177/1077558713496318; Merriam S. B., 2009, QUALITATIVE RES GUID; Moos R, 1979, HLTH PSYCHOL HDB; Nicassio PM., 1995, MANAGING CHRONIC ILL; PETRIE HG, 1976, J AESTHET EDUC, V10, P29, DOI 10.2307/3332007; Ponsford J., 2013, TRAUMATIC BRAIN INJU, V2nd ed; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 1997, J INT NEUROPSYCH SOC, V3, P497, DOI 10.1017/S1355617797004979; Prigatano GP, 1999, REHABILITATION ADULT; Rahman B, 2013, NEUROPSYCHOL REHABIL, V23, P501, DOI 10.1080/09602011.2013.787938; RAND Corporation, 2012, LAB FORC REENTR ISS; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Rowe H, 1996, J Nurs Manag, V4, P93, DOI 10.1046/j.1365-2834.1996.01946.x; SCHWARTZ MA, 1985, PERSPECT BIOL MED, V28, P331; Silberg T, 2015, BRAIN INJURY, V29, P481, DOI 10.3109/02699052.2014.984758; Smith AE, 2006, BEHAV RES METHODS, V38, P262, DOI 10.3758/BF03192778; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Svestkova O, 2010, DISABIL REHABIL, V32, pS68, DOI 10.3109/09638288.2010.511690; Tate DG, 2003, AM PSYCHOL, V58, P289, DOI 10.1037/0003-066X.58.4.289; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, BRAIN INJURY, V23, P51, DOI 10.1080/02699050802635257; Turner BJ, 2008, DISABIL REHABIL, V30, P1153, DOI 10.1080/09638280701532854; WHO, 2001, WHO INT CLASS FUNCT; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Wilkinson-Meyers L, 2010, SOC SCI MED, V71, P1882, DOI 10.1016/j.socscimed.2010.08.019; Williams J, 2011, DISABIL REHABIL, V33, P423, DOI 10.3109/09638288.2010.498555; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]; Wilmot S, 2007, HEALTH CARE ANAL, V15, P59, DOI 10.1007/s10728-006-0032-6; Wilson BA, 2002, NEUROPSYCHOL REHABIL, V12, P97, DOI 10.1080/09602010244000020; Wilson BA, 1997, J INT NEUROPSYCH SOC, V3, P487, DOI 10.1017/S1355617797004876; Wood RLL, 2013, BRAIN INJURY, V27, P253, DOI 10.3109/02699052.2012.743181; Yates PJ, 2003, NEUROPSYCHOL REHABIL, V13, P291, DOI 10.1080/09602010244000408; Young NL, 2009, PHYS OCCUP THER PEDI, V29, P345, DOI 10.3109/01942630903245994; Young NL, 2005, DISABIL REHABIL, V27, P1455, DOI 10.1080/00222930500218946	89	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156826	10.1371/journal.pone.0156826	http://dx.doi.org/10.1371/journal.pone.0156826			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1SU	27270604	Green Published, gold, Green Submitted			2022-12-26	WOS:000377560200019
J	Eriksen, AHM; Andersen, RF; Nielsen, BS; Sorensen, FB; Appelt, AL; Jakobsen, A; Hansen, TF				Eriksen, Anne Haahr Mellergaard; Andersen, Rikke Fredslund; Nielsen, Boye Schnack; Sorensen, Flemming Brandt; Appelt, Ane Lindegaard; Jakobsen, Anders; Hansen, Torben Frostrup			Intratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer	PLOS ONE			English	Article							NEOADJUVANT CHEMORADIATION; RELATIVE QUANTIFICATION; REFERENCE GENES; COLON; CHEMORADIOTHERAPY; IDENTIFICATION; BIOMARKERS	Introduction An increasing number of studies have investigated microRNAs (miRNAs) as potential markers of diagnosis, treatment and prognosis. So far, agreement between studies has been minimal, which may in part be explained by intratumoral heterogeneity of miRNA expression. The aim of the present study was to assess the heterogeneity of a panel of selected miRNAs in rectal cancer, using two different technical approaches. Materials and Methods The expression of the investigated miRNAs was analysed by real- time quantitative polymerase chain reaction (RT-qPCR) and in situ hybridization (ISH) in tumour specimens from 27 patients with T3-4 rectal cancer. From each tumour, tissue from three different luminal localisations was examined. Inter- and intra-patient variability was assessed by calculating intra-class correlation coefficients (ICCs). Correlations between RT-qPCR and ISH were evaluated using Spearman's correlation. Results ICCsingle (one sample from each patient) was higher than 50% for miRNA-21 and miRNA-31. For miRNA-125b, miRNA-145, and miRNA-630, ICCsingle was lower than 50%. The ICCmean (mean of three samples from each patient) was higher than 50% for miRNA-21(RT-qPCR and ISH), miRNA-125b (RT-qPCR and ISH), miRNA-145 (ISH), miRNA-630 (RT-qPCR), and miRNA-31 (RT-qPCR). For miRNA-145 (RT-qPCR) and miRNA-630 (ISH), ICCmean was lower than 50%. Spearman correlation coefficients, comparing results obtained by RT-qPCR and ISH, respectively, ranged from 0.084 to 0.325 for the mean value from each patient, and from -0.085 to 0.515 in the section including the deepest part of the tumour. Conclusion Intratumoral heterogeneity may influence the measurement of miRNA expression and consequently the number of samples needed for representative estimates. Our findings with two different methods suggest that one sample is sufficient for adequate assessment of miRNA-21 and miRNA-31, whereas more samples would improve the assessment of miRNA-125b, miRNA-145, and miRNA-630. Interestingly, we found a poor correlation between the expression estimates obtained by RT-qPCR and ISH, respectively.	[Eriksen, Anne Haahr Mellergaard; Andersen, Rikke Fredslund; Sorensen, Flemming Brandt; Appelt, Ane Lindegaard; Jakobsen, Anders; Hansen, Torben Frostrup] Vejle Hosp, Danish Colorectal Canc Ctr South, Vejle, Denmark; [Eriksen, Anne Haahr Mellergaard; Andersen, Rikke Fredslund; Sorensen, Flemming Brandt; Jakobsen, Anders; Hansen, Torben Frostrup] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Nielsen, Boye Schnack] Bioneer AS, Horsholm, Denmark; [Appelt, Ane Lindegaard] Univ Copenhagen, Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark	University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Bioneer A/S; Rigshospitalet; University of Copenhagen	Eriksen, AHM (corresponding author), Vejle Hosp, Danish Colorectal Canc Ctr South, Vejle, Denmark.; Eriksen, AHM (corresponding author), Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark.	anne.haahr.mellergaard@rsyd.dk	Andersen, Rikke/GRS-3064-2022; Hansen, Torben Frøstrup/K-5583-2019	Hansen, Torben Frøstrup/0000-0001-7476-671X; Jakobsen, Anders/0000-0003-2110-2615; Appelt, Ane L/0000-0003-2792-9218; Eriksen, Anne Haahr Mellergaard/0000-0003-0134-3374; Andersen, Rikke Fredslund/0000-0002-5894-7745; Sorensen, Flemming Brandt/0000-0002-5446-1035	Agency of Research and Innovation	Agency of Research and Innovation	The project expenses regarding research materials were covered by Vejle Hospital Research Council. The funder did not provide support in the form of salaries for authors. The Agency of Research and Innovation provided funding for BSN (Bioneer A/S). The funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2010, CLIN CHIM ACTA, V411, P1181, DOI 10.1016/j.cca.2010.05.002; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Drebber U, 2011, INT J ONCOL, V39, P409, DOI 10.3892/ijo.2011.1036; Eriksen AHM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150593; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HEPPNER GH, 1984, CANCER RES, V44, P2259; Jorgensen S, 2010, METHODS, V52, P375, DOI 10.1016/j.ymeth.2010.07.002; Kheirelseid EAH, 2013, INT J COLORECTAL DIS, V28, P247, DOI 10.1007/s00384-012-1549-9; Knudsen KN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140503; Kuremsky JG, 2009, INT J RADIAT ONCOL, V74, P673, DOI 10.1016/j.ijrobp.2009.03.003; Laurila EM, 2013, GENES CHROMOSOMES CA; Li T, 2013, WORLD J GASTROENTERO, V19, P5615, DOI 10.3748/wjg.v19.i34.5615; Lim SH, 2015, CRIT REV ONCOL HEMAT, V96, P67, DOI 10.1016/j.critrevonc.2015.05.003; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Peveling-Oberhag J, 2014, TRANSL ONCOL, V7, P672, DOI 10.1016/j.tranon.2014.09.003; Raychaudhuri M, 2012, J MOL DIAGN, V14, P376, DOI 10.1016/j.jmoldx.2012.01.016; Scarpati GD, 2012, INT J RADIAT ONCOL, V83, P1113, DOI 10.1016/j.ijrobp.2011.09.030; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Svoboda M, 2008, INT J ONCOL, V33, P541, DOI 10.3892/ijo_00000038; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009	27	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156919	10.1371/journal.pone.0156919	http://dx.doi.org/10.1371/journal.pone.0156919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258547	gold, Green Published			2022-12-26	WOS:000377369700154
J	Kim, KH; Choi, SH; Park, SH				Kim, Ki Hwan; Choi, Seung Hong; Park, Sung-Hong			Feasibility of Quantifying Arterial Cerebral Blood Volume Using Multiphase Alternate Ascending/Descending Directional Navigation (ALADDIN)	PLOS ONE			English	Article							STATE FREE PRECESSION; VASCULAR-SPACE-OCCUPANCY; TRANSIT-TIME CHANGES; SPIN-LABELING MRI; FLOW-VELOCITY; HUMAN BRAIN; PART 1; PERFUSION; QUANTIFICATION; CONTRAST	Arterial cerebral blood volume (aCBV) is associated with many physiologic and pathologic conditions. Recently, multiphase balanced steady state free precession (bSSFP) readout was introduced to measure labeled blood signals in the arterial compartment, based on the fact that signal difference between labeled and unlabeled blood decreases with the number of RF pulses that is affected by blood velocity. In this study, we evaluated the feasibility of a new 2D inter-slice bSSFP-based arterial spin labeling (ASL) technique termed, alternate ascending/descending directional navigation (ALADDIN), to quantify aCBV using multiphase acquisition in six healthy subjects. A new kinetic model considering bSSFP RF perturbations was proposed to describe the multiphase data and thus to quantify aCBV. Since the inter-slice time delay (TD) and gap affected the distribution of labeled blood spins in the arterial and tissue compartments, we performed the experiments with two TDs (0 and 500 ms) and two gaps (300% and 450% of slice thickness) to evaluate their roles in quantifying aCBV. Comparison studies using our technique and an existing method termed arterial volume using arterial spin tagging (AVAST) were also separately performed in five subjects. At 300% gap or 500-ms TD, significant tissue perfusion signals were demonstrated, while tissue perfusion signals were minimized and arterial signals were maximized at 450% gap and 0-ms TD. ALADDIN has an advantage of visualizing bi-directional flow effects (ascending/descending) in a single experiment. Labeling efficiency (alpha) of inter-slice blood flow effects could be measured in the superior sagittal sinus (SSS) (20.8 +/- 3.7%.) and was used for aCBV quantification. As a result of fitting to the proposed model, aCBV values in gray matter (1.4-2.3 mL/100 mL) were in good agreement with those from literature. Our technique showed high correlation with AVAST, especially when arterial signals were accentuated (i.e., when TD = 0 ms) (r = 0.53). The bi-directional perfusion imaging with multiphase ALADDIN approach can be an alternative to existing techniques for quantification of aCBV.	[Kim, Ki Hwan; Park, Sung-Hong] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Park, Sung-Hong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST)	Park, SH (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea.; Park, SH (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea.	sunghongpark@kaist.ac.kr	Park, Sung-Hong/B-3393-2012	Park, Sung-Hong/0000-0002-1731-0668	National Research Foundation of Korea [2013R1A1A1061759]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare of South Korea [HI16C1111]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare of South Korea	This work was supported by National Research Foundation of Korea (2013R1A1A1061759) and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare of South Korea (HI16C1111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Bieri O, 2013, J MAGN RESON IMAGING, V38, P2, DOI 10.1002/jmri.24163; Bodurka J, 2002, MAGNET RESON MED, V47, P1052, DOI 10.1002/mrm.10159; Brookes MJ, 2007, MAGN RESON MED, V58, P41, DOI 10.1002/mrm.21199; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Buxton RB, 2012, NEUROIMAGE, V62, P953, DOI 10.1016/j.neuroimage.2012.01.012; Calamante F, 1999, J CEREBR BLOOD F MET, V19, P701, DOI 10.1097/00004647-199907000-00001; Carr JP, 2007, MAGN RESON MED, V58, P281, DOI 10.1002/mrm.21317; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; Donahue MJ, 2006, NMR BIOMED, V19, P1043, DOI 10.1002/nbm.1075; Donahue MJ, 2010, J CEREBR BLOOD F MET, V30, P1329, DOI 10.1038/jcbfm.2010.16; Duong TQ, 2000, MAGNET RESON MED, V43, P393, DOI 10.1002/(SICI)1522-2594(200003)43:3<393::AID-MRM11>3.0.CO;2-K; Francis ST, 2008, MAGN RESON MED, V59, P316, DOI 10.1002/mrm.21442; Gonzalez-At JB, 2000, MAGNET RESON MED, V43, P739, DOI 10.1002/(SICI)1522-2594(200005)43:5<739::AID-MRM17>3.0.CO;2-2; Han PK, 2016, NMR BIOMED, V29, P264, DOI 10.1002/nbm.3463; Han PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140560; Hargreaves BA, 2001, MAGNET RESON MED, V46, P149, DOI 10.1002/mrm.1170; Helenius J, 2003, ACTA RADIOL, V44, P538, DOI 10.1034/j.1600-0455.2003.00104.x; Hua J, 2011, NMR BIOMED, V24, P1313, DOI 10.1002/nbm.1693; Hua J, 2011, MAGN RESON MED, V66, P40, DOI 10.1002/mrm.22775; Ibaraki M, 2007, J CEREBR BLOOD F MET, V27, P404, DOI 10.1038/sj.jcbfm.9600337; IVANOV KP, 1981, MICROVASC RES, V22, P143, DOI 10.1016/0026-2862(81)90084-4; Jahanian H, 2015, MAGN RESON MED, V73, P1053, DOI 10.1002/mrm.25220; JORDAN JE, 1994, JMRI-J MAGN RESON IM, V4, P25, DOI 10.1002/jmri.1880040108; Kim T, 2005, MAGNET RESON MED, V54, P333, DOI 10.1002/mrm.20550; Kim T, 2007, J CEREBR BLOOD F MET, V27, P1235, DOI 10.1038/sj.jcbfm.9600429; Kim T, 2011, J CEREBR BLOOD F MET, V31, P1211, DOI 10.1038/jcbfm.2010.226; KOBARI M, 1984, J CEREBR BLOOD F MET, V4, P110, DOI 10.1038/jcbfm.1984.15; Krieger SN, 2012, J CEREBR BLOOD F MET, V32, P1618, DOI 10.1038/jcbfm.2012.63; Liu TT, 2007, J INT NEUROPSYCH SOC, V13, P517, DOI 10.1017/S1355617707070646; Lu HZ, 2005, MAGN RESON MED, V54, P1403, DOI 10.1002/mrm.20705; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Martirosian P, 2004, MAGNET RESON MED, V51, P353, DOI 10.1002/mrm.10709; Park SH, 2015, KOREAN J RADIOL, V16, P550, DOI 10.3348/kjr.2015.16.3.550; Park SH, 2013, MAGN RESON IMAGING, V31, P1044, DOI 10.1016/j.mri.2013.03.024; Park SH, 2012, MAGN RESON MED, V68, P1600, DOI 10.1002/mrm.24169; Park SH, 2011, MAGN RESON MED, V65, P1578, DOI 10.1002/mrm.22580; Park SH, 2011, MAGN RESON MED, V65, P1702, DOI 10.1002/mrm.22568; Parkes LM, 2005, J MAGN RESON IMAGING, V22, P732, DOI 10.1002/jmri.20456; Petersen ET, 2006, MAGN RESON MED, V55, P219, DOI 10.1002/mrm.20784; Qin Q, 2014, NMR BIOMED, V27, P116, DOI 10.1002/nbm.3040; Scheffler K, 2003, EUR RADIOL, V13, P2409, DOI 10.1007/s00330-003-1957-x; Scheffler K, 2003, MAGNET RESON MED, V49, P781, DOI 10.1002/mrm.10421; WILLIAMS DM, 1987, INVEST RADIOL, V22, P642, DOI 10.1097/00004424-198708000-00005; Yan LR, 2012, MAGN RESON MED, V68, P130, DOI 10.1002/mrm.23218; Zhao JM, 2007, MAGN RESON MED, V58, P592, DOI 10.1002/mrm.21342; Ziegelitz D, 2009, MAGN RESON MED, V62, P56, DOI 10.1002/mrm.21975	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156687	10.1371/journal.pone.0156687	http://dx.doi.org/10.1371/journal.pone.0156687			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257674	gold, Green Submitted, Green Published			2022-12-26	WOS:000377369700105
J	Sariyer, IK; Sariyer, R; Otte, J; Gordon, J				Sariyer, Ilker Kudret; Sariyer, Rahsan; Otte, Jessica; Gordon, Jennifer			Pur-Alpha Induces JCV Gene Expression and Viral Replication by Suppressing SRSF1 in Glial Cells	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SINGLE-STRANDED-DNA; LARGE T-ANTIGEN; BINDING-PROTEIN; BETA-CATENIN; ANTIRETROVIRAL THERAPY; ASSOCIATION; AIDS; RNA; NATALIZUMAB	Objective PML is a rare and fatal demyelinating disease of the CNS caused by the human polyomavirus, JC virus (JCV), which occurs in AIDS patients and those on immunosuppressive monoclonal antibody therapies (mAbs). We sought to identify mechanisms that could stimulate reactivation of JCV in a cell culture model system and targeted pathways which could affect early gene transcription and JCV T-antigen production, which are key steps of the viral life cycle for blocking reactivation of JCV. Two important regulatory partners we have previously identified for T-antigen include Pur-alpha and SRSF1 (SF2/ASF). SRSF1, an alternative splicing factor, is a potential regulator of JCV whose overexpression in glial cells strongly suppresses viral gene expression and replication. Pur-alpha has been most extensively characterized as a sequence-specific DNA-and RNA-binding protein which directs both viral gene transcription and mRNA translation, and is a potent inducer of the JCV early promoter through binding to T-antigen. Methods and Results Pur-alpha and SRSF1 both act directly as transcriptional regulators of the JCV promoter and here we have observed that Pur-alpha is capable of ameliorating SRSF1-mediated suppression of JCV gene expression and viral replication. Interestingly, Pur-alpha exerted its effect by suppressing SRSF1 at both the protein and mRNA levels in glial cells suggesting this effect can occur independent of T-antigen. Pur-alpha and SRSF1 were both localized to oligodendrocyte inclusion bodies by immunohistochemistry in brain sections from patients with HIV-1 associated PML. Interestingly, inclusion bodies were typically positive for either Pur-alpha or SRSF1, though some cells appeared to be positive for both proteins. Conclusions Taken together, these results indicate the presence of an antagonistic interaction between these two proteins in regulating of JCV gene expression and viral replication and suggests that they play an important role during viral reactivation leading to development of PML.	[Sariyer, Ilker Kudret; Sariyer, Rahsan; Otte, Jessica; Gordon, Jennifer] Temple Univ, Dept Neurosci, Ctr Neurovirol, Lewis Katz Sch Med, 3500 North Broad St,7th Floor, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sariyer, IK (corresponding author), Temple Univ, Dept Neurosci, Ctr Neurovirol, Lewis Katz Sch Med, 3500 North Broad St,7th Floor, Philadelphia, PA 19140 USA.	isariyer@temple.edu	Sariyer, Ilker/AAE-7677-2020		National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI101192, R21NS081447, P30MH092177]; Comprehensive NeuroAIDS Center (CNAC NIMH) at the Lewis Katz School of Medicine at Temple University [P30MH092177]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081447] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Comprehensive NeuroAIDS Center (CNAC NIMH) at the Lewis Katz School of Medicine at Temple University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI101192, R21NS081447 and P30MH092177. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Dr. Susan Morgello at the Manhattan HIV Brain Bank of the NNTC for sharing AIDS-PML tissue sections. Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award numbers R01AI101192 and R21NS081447. This study utilized services offered by core facilities of the Comprehensive NeuroAIDS Center (CNAC NIMH Grant Number P30MH092177) at the Lewis Katz School of Medicine at Temple University. The funding organizations played no role in the design of the study, in the collection, analysis, and interpretation of the data and in the decision to submit the manuscript for publication.	Atzeni F, 2013, AUTOIMMUN REV, V12, P575, DOI 10.1016/j.autrev.2012.10.020; Beltrami S, 2014, J NEUROVIROL, V20, P137, DOI 10.1007/s13365-013-0222-6; Beltrami S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053447; Bhattacharyya R, 2007, ONCOGENE, V26, P7628, DOI 10.1038/sj.onc.1210576; Brew BJ, 2010, NAT REV NEUROL, V6, P667, DOI 10.1038/nrneurol.2010.164; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Chang CF, 1996, J VIROL, V70, P4150, DOI 10.1128/JVI.70.6.4150-4156.1996; CHEN NN, 1995, J VIROL, V69, P5843, DOI 10.1128/JVI.69.9.5843-5848.1995; Clifford DB, 1999, NEUROLOGY, V52, P623, DOI 10.1212/WNL.52.3.623; Craigie M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0426-x; Enam S, 2002, CANCER RES, V62, P7093; Gallia GL, 1998, J BIOL CHEM, V273, P32662, DOI 10.1074/jbc.273.49.32662; Gallia GL, 1999, J CELL BIOCHEM, V74, P334, DOI 10.1002/(SICI)1097-4644(19990901)74:3<334::AID-JCB3>3.0.CO;2-O; Gallia GL, 2001, J CELL BIOCHEM, V83, P355, DOI 10.1002/jcb.1247; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Gan DD, 2004, ONCOGENE, V23, P483, DOI 10.1038/sj.onc.1207018; Gasnault J, 1999, J NEUROVIROL, V5, P421, DOI 10.3109/13550289909029483; Gualco E, 2010, CELL DEATH DIFFER, V17, P439, DOI 10.1038/cdd.2009.146; Johnson EM, 2003, ANTICANCER RES, V23, P2093; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; JOHNSON EM, 1995, J BIOL CHEM, V270, P24352, DOI 10.1074/jbc.270.41.24352; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Krachmarov CP, 1996, P NATL ACAD SCI USA, V93, P14112, DOI 10.1073/pnas.93.24.14112; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; LASHGARI MS, 1989, VIROLOGY, V170, P292, DOI 10.1016/0042-6822(89)90381-4; Miralles P, 1998, AIDS, V12, P2467, DOI 10.1097/00002030-199818000-00016; Mishra M, 2013, J CELL PHYSIOL, V228, P65, DOI 10.1002/jcp.24105; Moulton VR, 2014, J BIOL CHEM, V289, P4126, DOI 10.1074/jbc.M113.518662; Safak M, 1999, J VIROL, V73, P10146, DOI 10.1128/JVI.73.12.10146-10157.1999; Sariyer IK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045000; Sariyer IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014630; Sariyer R, 2016, J NEUROVIROL; Tassie JM, 1999, AIDS, V13, P1881, DOI 10.1097/00002030-199910010-00010; Uleri E, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-147; Uleri Elena, 2011, Genes Cancer, V2, P728, DOI 10.1177/1947601911424578; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Vugmeyster Y, 2004, CLIN IMMUNOL, V113, P38, DOI 10.1016/j.clim.2004.06.001; White MK, 2009, CELL CYCLE, V8, P414, DOI 10.4161/cc.8.3.7585; Wollebo HS, 2011, J NEUROIMMUNOL, V233, P46, DOI 10.1016/j.jneuroim.2010.11.013; Wuthrich C, 2006, J NEUROVIROL, V12, P116, DOI 10.1080/13550280600716604	41	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156819	10.1371/journal.pone.0156819	http://dx.doi.org/10.1371/journal.pone.0156819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257867	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700137
J	Tsai, CL; Yeh, WB				Tsai, Cheng-Lung; Yeh, Wen-Bin			Subspecific Differentiation Events of Montane Stag Beetles (Coleoptera, Lucanidae) Endemic to Formosa Island	PLOS ONE			English	Article							ARC-CONTINENT COLLISION; SPECIES DELIMITATION; POPULATION-STRUCTURE; MOLECULAR-IDENTIFICATION; NEOTROPICAL BIODIVERSITY; GENUS TETTIGETTALNA; WASPS HYMENOPTERA; GENETIC DIVERSITY; SIZE VARIATION; PHYLOGEOGRAPHY	Taxonomic debates have been carrying on for decades over Formosan stag beetles, which consist of a high proportion of endemic species and subspecies featuring morphological variations associated with local adaptation. With the influence of periodical Pleistocene glaciations and the presence of several mountain ranges, the genetic differentiation and taxonomic recognition, within this medium-size island, of two endemic subspecies for each of four montane stag beetles, i.e. Lucanus ogakii, L. kanoi, Prismognathus davidis, and Neolucanus doro, has been an appealing issue. Based on monophyletic lineages and population structure, possible divergent scenarios have been proposed to clarify the subspecific status for each of the above mentioned stag beetles. Phylogenetic inferences based on COI+16S rDNA+28S rDNA of 240 Formosan lucanids have confirmed most species are monophyletic groups; and the intraspecific (<2%) and interspecific (>2%) genetic distances of the two mitochondrial genes could be applied concordantly for taxonomic identification. On account of Bayesian-based species delimitation, geographic distribution, population structure, and sequence divergences, the subspecific status for L. ogakii, L. kanoi, and Pri. davidis are congruent with their geographic distribution in this island; and the calibration time based on the mitochondrial genes shows the subspecific split events occurred 0.7-1 million years ago. In addition, a more complicated scenario, i. e. genetic differentiation including introgression/hybridization events, might have occurred among L. ogakii, L. kanoi, and L. maculifemoratus. The geological effects of mountain hindrance accompanied by periodical glaciations could have been vital in leading to the geographical subspecific differentiation of these montane stag beetles.	[Tsai, Cheng-Lung; Yeh, Wen-Bin] Natl Chung Hsing Univ, Dept Entomol, Taichung 40227, Taiwan	National Chung Hsing University	Yeh, WB (corresponding author), Natl Chung Hsing Univ, Dept Entomol, Taichung 40227, Taiwan.	wbyeh@nchu.edu.tw						Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Alvarez S, 2016, J AVIAN BIOL, V47, P335, DOI 10.1111/jav.00814; Andersen JJ, 2012, J MAMMAL, V93, P1195, DOI 10.1644/11-MAMM-A-341.3; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blois JL, 2008, J BIOGEOGR, V35, P602, DOI 10.1111/j.1365-2699.2007.01836.x; Cheng HL, 2005, ZOOL STUD, V44, P329; Cheng YP, 2005, MOL ECOL, V14, P2075, DOI 10.1111/j.1365-294X.2005.02567.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dumas P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122407; Ellison AM, 2004, AM J BOT, V91, P1930, DOI 10.3732/ajb.91.11.1930; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fujita H., 2010, LUCANID BEETLES WORL; Germain JF, 2013, B ENTOMOL RES, V103, P354, DOI 10.1017/S000748531200079X; Goka Kouichi, 2004, Global Environmental Research, V8, P67; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamback PA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-92; Harvey DJ, 2006, PHYSIOL ENTOMOL, V31, P218, DOI 10.1111/j.1365-3032.2006.00509.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hidalgo-Galiana A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0187-y; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hosoya T, 2005, ZOOL SCI, V22, P1305, DOI 10.2108/zsj.22.1305; Hsu YF, 2013, BUTTERFLIES TAIWAN; Huang CW, 2014, ZOOKEYS, P31, DOI 10.3897/zookeys.445.7778; Huang CY, 1997, TECTONOPHYSICS, V281, P31, DOI 10.1016/S0040-1951(97)00157-1; Huang H, 2013, STAG BEETLES CHINA; Huang H, 2010, STAG BEETLES CHINA; Huang Hao, 2012, Zootaxa, V3255, P1; Huang JP, 2010, MOL PHYLOGENET EVOL, V57, P1149, DOI 10.1016/j.ympev.2010.10.012; Huang S, 2001, MOL ECOL, V10, P2669, DOI 10.1046/j.0962-1083.2001.01395.x; Huang SC, 2005, J PLANT RES, V118, P1, DOI 10.1007/s10265-004-0185-z; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Jang-Liaw NH, 2008, ZOOL SCI, V25, P68, DOI 10.2108/zsj.25.68; Kawano K, 2000, ANN ENTOMOL SOC AM, V93, P198, DOI 10.1603/0013-8746(2000)093[0198:GAAITS]2.0.CO;2; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Kozak KM, 2015, SYST BIOL, V64, P505, DOI 10.1093/sysbio/syv007; Krajcik M., 2001, LUCANIDAE WORLD CA 1; Kuo HC, 2014, MOL ECOL, V23, P3566, DOI 10.1111/mec.12838; Lai JS, 2008, HERPETOLOGICA, V64, P63, DOI 10.1655/06-065.1; Le Ru BP, 2014, INVERTEBR SYST, V28, P451, DOI 10.1071/IS13062; Lee CF, 2016, ZOOKEYS, P23, DOI 10.3897/zookeys.568.7125; Legendre P, 2004, AUST NZ J STAT, V46, P615, DOI 10.1111/j.1467-842X.2004.00357.x; Li HY, 2010, J ASIA-PAC ENTOMOL, V13, P267, DOI 10.1016/j.aspen.2010.05.002; Li HY, 2004, TAIWANESE STAG BEETL; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021506; Lin CP, 2011, CONSERV GENET, V12, P337, DOI 10.1007/s10592-009-9996-8; Lin HD, 2008, J FISH BIOL, V72, P2011, DOI 10.1111/j.1095-8649.2008.01836.x; Lin HD, 2012, MOL PHYLOGENET EVOL, V62, P251, DOI 10.1016/j.ympev.2011.09.022; Lin Jgun Sian, 2003, Formosan Entomologist, V23, P353; Lin SC, 2014, ODONATOLOGICA, V43, P51; Linares MC, 2009, MOL PHYLOGENET EVOL, V50, P485, DOI 10.1016/j.ympev.2008.11.008; Mashkaryan V, 2013, AMPHIBIA-REPTILIA, V34, P337, DOI 10.1163/15685381-00002895; Mendes R, 2014, EUR J ENTOMOL, V111, P429, DOI 10.14411/eje.2014.054; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mizunuma T, 1994, LUCANID BEETLES WORL; Ng PKL, 2010, ZOOL STUD, V49, P544; Nunes VL, 2014, MOL ECOL RESOUR, V14, P27, DOI 10.1111/1755-0998.12158; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pramual P, 2014, MOL ECOL RESOUR, V14, P262, DOI 10.1111/1755-0998.12174; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2014, ZOOTAXA, V3794, P108, DOI 10.11646/zootaxa.3794.1.4; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2009, TRACER V1 5 MCMC TRA; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schwarzfeld MD, 2015, MOL PHYLOGENET EVOL, V93, P234, DOI 10.1016/j.ympev.2015.08.003; Shih HT, 2007, ZOOL SCI, V24, P57, DOI 10.2108/zsj.24.57; Shih HT, 2006, J BIOGEOGR, V33, P980, DOI 10.1111/j.1365-2699.2006.01472.x; Shirozu T, 1992, LEPIDOPTERA TAIWAN 2, V1, P136; Smith MA, 2013, MOL ECOL RESOUR, V13, P168, DOI 10.1111/1755-0998.12038; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatsuta H, 2004, BIOL J LINN SOC, V81, P219, DOI 10.1111/j.1095-8312.2003.00279.x; Tatsuta H, 2001, ANN ENTOMOL SOC AM, V94, P462, DOI 10.1603/0013-8746(2001)094[0462:APOHAG]2.0.CO;2; TENG LS, 1990, TECTONOPHYSICS, V183, P57, DOI 10.1016/0040-1951(90)90188-E; Toussaint EFA, 2015, MOL PHYLOGENET EVOL, V91, P194, DOI 10.1016/j.ympev.2015.05.015; Tsai CL, 2014, MOL PHYLOGENET EVOL, V78, P245, DOI 10.1016/j.ympev.2014.05.004; Tseng SP, 2015, MOL PHYLOGENET EVOL, V90, P164, DOI 10.1016/j.ympev.2015.04.022; Waldrop E, 2016, J BIOGEOGR, V43, P1116, DOI 10.1111/jbi.12680; Wang LJ., 2000, DRAGONFLIES TAIWAN; Wang TY, 2007, ZOOL STUD, V46, P547; Ward PS, 2005, SYST ENTOMOL, V30, P310, DOI 10.1111/j.1365-3113.2004.00281.x; Weng YM, 2016, ECOL EVOL, V6, P2061, DOI 10.1002/ece3.2006; Weng YM, 2016, ZOOKEYS IN PRESS; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wild AL, 2008, MOL PHYLOGENET EVOL, V48, P877, DOI 10.1016/j.ympev.2008.05.023; Williams PH, 2012, SYST BIODIVERS, V10, P21, DOI 10.1080/14772000.2012.664574; Williams PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123437; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406; Wirta H, 2009, BIOL J LINN SOC, V96, P942, DOI 10.1111/j.1095-8312.2008.01156.x; Wu SP, 2016, ZOOKEYS, P121, DOI 10.3897/zookeys.557.6131; Yeh WB, 2004, ANN ENTOMOL SOC AM, V97, P613, DOI 10.1603/0013-8746(2004)097[0613:GDOLAC]2.0.CO;2; Yu TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098029; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhang LX, 2014, BIOCHEM GENET, V52, P38, DOI 10.1007/s10528-013-9626-5	108	8	8	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156600	10.1371/journal.pone.0156600	http://dx.doi.org/10.1371/journal.pone.0156600			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257861	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700086
J	Cherif, M; Granados, M; Duffy, S; Robert, P; Pequin, B; Mohit, V; McKindsey, CW; Archambault, P; Myrand, B; Lovejoy, C; Tremblay, R; Plourde, S; Fussmann, GF				Cherif, Mehdi; Granados, Monica; Duffy, Sean; Robert, Pauline; Pequin, Berangere; Mohit, Vani; McKindsey, Christopher W.; Archambault, Philippe; Myrand, Bruno; Lovejoy, Connie; Tremblay, Rejean; Plourde, Stephane; Fussmann, Gregor F.			Potential for Local Fertilization: A Benthocosm Test of Long-Term and Short-Term Effects of Mussel Excretion on the Plankton	PLOS ONE			English	Article							DE-LA-MADELEINE; MYTILUS-EDULIS; MAGDALEN ISLANDS; BIOGEOCHEMICAL FLUXES; ECOSYSTEM APPROACH; SHELLFISH CULTURE; WATER-COLUMN; RAFT CULTURE; ST-LAWRENCE; FOOD-WEB	Mussel aquaculture has expanded worldwide and it is important to assess its impact on the water column and the planktonic food web to determine the sustainability of farming practices. Mussel farming may affect the planktonic food web indirectly by excreting bioavailable nutrients in the water column (a short-term effect) or by increasing nutrient effluxes from bio-deposit-enriched sediments (a long-term effect). We tested both of these indirect effects in a lagoon by using plankton-enclosing benthocosms that were placed on the bottom of a shallow lagoon either inside of a mussel farm or at reference sites with no history of aquaculture. At each site, half of the benthocosms were enriched with seawater that had held mussels (excretion treatment), the other half received non-enriched seawater as a control treatment. We monitored nutrients ([PO43-] and [NH4+]), dissolved oxygen and plankton components (bacteria, the phytoplankton and the zooplankton) over 5 days. We found a significant relationship between long-term accumulation of mussel biodeposits in sediments, water-column nutrient concentrations and plankton growth. Effects of mussel excretion were not detected, too weak to be significant given the spatial and temporal variability observed in the lagoon. Effects of mussels on the water column are thus likely to be coupled to benthic processes in such semi-enclosed water bodies.	[Cherif, Mehdi] Umea Univ, Inst Ekol Miljo & Geovetenskap, SE-90187 Umea, Sweden; [Granados, Monica; Duffy, Sean; Fussmann, Gregor F.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Robert, Pauline; Archambault, Philippe; Tremblay, Rejean] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ G5L 3A1, Canada; [Pequin, Berangere; Mohit, Vani; Lovejoy, Connie] Univ Laval, Dept Biol, Quebec City, PQ G1V0A6, Canada; [McKindsey, Christopher W.; Plourde, Stephane] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Mont Joli, PQ G5H 3Z4, Canada; [Myrand, Bruno] Merinov, Cap Aux Meules, PQ G4T 1B3, Canada; [Archambault, Philippe] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	Umea University; McGill University; University of Quebec; Laval University; Fisheries & Oceans Canada; Stanford University	Cherif, M (corresponding author), Umea Univ, Inst Ekol Miljo & Geovetenskap, Linnaeus Vag 6, SE-90187 Umea, Sweden.	mehdi.cherif@umu.se	Lovejoy, Connie/A-3756-2008; McKindsey, Chris/AAH-6773-2020; Cherif, Mehdi/B-2598-2013; Tremblay, Rejean/A-4971-2013	Lovejoy, Connie/0000-0001-8027-2281; Cherif, Mehdi/0000-0003-0107-9374; Tremblay, Rejean/0000-0003-2590-8915; Fussmann, Gregor/0000-0001-9576-0122; Granados, Monica/0000-0002-6750-9341; McKindsey, Chris/0000-0002-3026-6454	Natural Sciences and Engineering Research Council of Canada [365217-08, STPGP 365217]; Fisheries and Oceans Canada; Ministere de l'agriculture, des pecheries et de l'alimentation du Quebec; Ressources Aquatique Quebec; Societe de developpement de l'industrie maricole inc.; Reseau Aquaculture Quebec	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fisheries and Oceans Canada; Ministere de l'agriculture, des pecheries et de l'alimentation du Quebec; Ressources Aquatique Quebec; Societe de developpement de l'industrie maricole inc.; Reseau Aquaculture Quebec	This research was supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) with a Strategic Project Grant 365217-08 to G.F., P.A., C.L. and R.T. The authors are also grateful for generous financial and in-kind support by Fisheries and Oceans Canada (http://www.dfo-mpo.gc.ca); Ministere de l'agriculture, des pecheries et de l'alimentation du Quebec (http://www.mapaq.gouv.qc.ca/fr/Pages/Accueil.aspx); Ressources Aquatique Quebec (http://raq.uqar.ca/index.php/fr/); Societe de developpement de l'industrie maricole inc. (http://www.sodim.org). Special thanks to the authors' industrial partner, M. Fournier and Moules de culture des Iles inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the divers, Simon Bourgeois and Frederic Hartog, without whom no experiment would have been possible. We thank them also for granting the publication of the picture in Fig 2. We acknowledge support from the Natural Science and Engineering Research Council of Canada through Strategic Project Grant STPGP 365217. We are also grateful for the generous financial and in-kind support by Fisheries and Oceans Canada; Ministere de l'agriculture, des pecheries et de l'alimentation du Quebec; Reseau Aquaculture Quebec; and the Societe de developpement de l'industrie maricole inc. Special thanks to our industrial partner, M. Fournier and Moules de culture des Iles inc. We acknowledge the contribution of anonymous reviewers and editors in the improvement of the earlier versions of the manuscript.	BAUDINET D, 1990, HYDROBIOLOGIA, V207, P187, DOI 10.1007/BF00041456; Belzile C, 2008, J MARINE SYST, V74, P946, DOI 10.1016/j.jmarsys.2007.12.010; BLACKFORD BL, 1978, J PHYS OCEANOGR, V8, P653, DOI 10.1175/1520-0485(1978)008<0653:WDICIT>2.0.CO;2; Callier MD, 2008, AQUACULTURE, V278, P77, DOI 10.1016/j.aquaculture.2008.03.026; Callier MD, 2009, MAR POLLUT BULL, V58, P1544, DOI 10.1016/j.marpolbul.2009.05.010; Carlsson MS, 2009, J SHELLFISH RES, V28, P791, DOI 10.2983/035.028.0408; Cranford PJ, 2009, AQUACULTURE, V292, P189, DOI 10.1016/j.aquaculture.2009.04.039; Danovaro R, 2004, MAR POLLUT BULL, V49, P325, DOI 10.1016/j.marpolbul.2004.02.038; Davenport J, 2000, MAR ECOL PROG SER, V198, P131, DOI 10.3354/meps198131; FAO, 2014, THE STATE OF WORLD F; Filgueira R, 2015, MAR ECOL PROG SER, V518, P281, DOI 10.3354/meps11048; Frojan M, 2014, MAR ECOL PROG SER, V498, P43, DOI 10.3354/meps10612; Gosling E, 2003, BIVALVE MOLLUSCS BIO; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Grant J, 1996, J EXP MAR BIOL ECOL, V200, P239, DOI 10.1016/S0022-0981(96)02660-3; Grasshoff K, 1999, METHODS OF SEAWATER; Guyondet T, 2005, J MARINE SYST, V58, P35, DOI 10.1016/j.jmarsys.2005.05.004; Guyondet T, 2008, ESTUAR COAST SHELF S, V77, P396, DOI 10.1016/j.ecss.2007.10.009; Guyondet T, 2010, J SEA RES, V64, P341, DOI 10.1016/j.seares.2010.05.003; Holmer M, 2008, AQUACULTURE IN THE E; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Jeffrey SW, 1997, PHYTOPLANKTON PIGMEN, P597; Jiang WM, 2005, AQUACULTURE, V244, P171, DOI 10.1016/j.aquaculture.2004.11.050; Koutitonski VG, 2006, TEMPS DE RENOUVELLEM; Koutitonsky VG, 2002, ESTUAR COAST SHELF S, V54, P833, DOI 10.1006/ecss.2001.0860; Lachance AA, 2008, AQUAT BIOL, V2, P119, DOI 10.3354/ab00041; Lehane C, 2006, ESTUAR COAST SHELF S, V67, P645, DOI 10.1016/j.ecss.2005.12.015; Lindahl O, 2009, HYDROBIOLOGIA, V629, P59, DOI 10.1007/s10750-009-9771-3; Maar M, 2008, AQUAT BIOL, V4, P127, DOI 10.3354/ab00125; McKindsey CW, 2011, CAN J ZOOL, V89, P622, DOI [10.1139/Z11-037, 10.1139/z11-037]; Mohit V, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv038; Mohit V, 2014, APPL ENVIRON MICROB, V80, P2071, DOI 10.1128/AEM.02916-13; Nielsen TG, 2007, MAR ECOL PROG SER, V339, P185, DOI 10.3354/meps339185; NUSCH E. A., 1980, ERGEBN LIMNOL, V14, P14; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Pequin B, 2015, THESIS; Petersen JK, 2008, AQUAT BIOL, V4, P113, DOI 10.3354/ab00124; Porter ET, 2004, MAR ECOL PROG SER, V271, P43, DOI 10.3354/meps271043; Richard M, 2007, CAN J FISH AQUAT SCI, V64, P1491, DOI 10.1139/F07-116; Rinaldi A, 2014, ESTUAR COAST SHELF S, V144, P89, DOI 10.1016/j.ecss.2014.04.013; Sara G, 2007, WATER RES, V41, P3187, DOI 10.1016/j.watres.2007.05.013; Shuntov VP, 2013, RUSS J MAR BIOL+, V39, P455, DOI 10.1134/S1063074013070055; Smaal AC, 2002, HYDROBIOLOGIA, V484, P89, DOI 10.1023/A:1021352904712; Sommer U, 2001, EXPERIMENTAL SYSTEMS; Souchu P, 1991, ATMOS RES, V26, P543, DOI 10.1016/0169-8095(91)90043-V; Trottet A, 2008, J EXP MAR BIOL ECOL, V365, P103, DOI 10.1016/j.jembe.2008.08.001; Wahl M, 2016, MAR FRESHWATER RES, V67, P25, DOI 10.1071/MF14154; Walker TR, 2014, AQUACULTURE, V433, P450, DOI 10.1016/j.aquaculture.2014.07.006; Weise AM, 2009, AQUACULTURE, V288, P239, DOI 10.1016/j.aquaculture.2008.12.001	49	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156411	10.1371/journal.pone.0156411	http://dx.doi.org/10.1371/journal.pone.0156411			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249793	Green Published, gold			2022-12-26	WOS:000377184700042
J	Milewska, A; Kaminski, K; Ciejka, J; Kosowicz, K; Zeglen, S; Wojarski, J; Nowakowska, M; Szczubialka, K; Pyrc, K				Milewska, Aleksandra; Kaminski, Kamil; Ciejka, Justyna; Kosowicz, Katarzyna; Zeglen, Slawomir; Wojarski, Jacek; Nowakowska, Maria; Szczubialka, Krzysztof; Pyrc, Krzysztof			HTCC: Broad Range Inhibitor of Coronavirus Entry	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; ANTIBACTERIAL ACTIVITY; CHITOSAN; NL63; VIRUS; HKU1; CARRAGEENAN; PNEUMONIA; PATHOGENS; MATRICES	To date, six human coronaviruses have been known, all of which are associated with respiratory infections in humans. With the exception of the highly pathogenic SARS and MERS coronaviruses, human coronaviruses (HCoV-NL63, HCoV-OC43, HCoV-229E, and HCoV-HKU1) circulate worldwide and typically cause the common cold. In most cases, infection with these viruses does not lead to severe disease, although acute infections in infants, the elderly, and immunocompromised patients may progress to severe disease requiring hospitalization. Importantly, no drugs against human coronaviruses exist, and only supportive therapy is available. Previously, we proposed the cationically modified chitosan, N-(2-hydroxypropyl)-3-trimethylammonium chitosan chloride (HTCC), and its hydrophobically-modified derivative (HM-HTCC) as potent inhibitors of the coronavirus HCoV-NL63. Here, we show that HTCC inhibits interaction of a virus with its receptor and thus blocks the entry. Further, we demonstrate that HTCC polymers with different degrees of substitution act as effective inhibitors of all low-pathogenic human coronaviruses.	[Milewska, Aleksandra; Kosowicz, Katarzyna; Pyrc, Krzysztof] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Milewska, Aleksandra; Ciejka, Justyna; Kosowicz, Katarzyna; Pyrc, Krzysztof] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland; [Kaminski, Kamil; Nowakowska, Maria; Szczubialka, Krzysztof] Jagiellonian Univ, Fac Chem, PL-30060 Krakow, Poland; [Zeglen, Slawomir; Wojarski, Jacek] Silesian Ctr Heart Dis, Dept Cardiac Surg & Transplantol, PL-41800 Zabrze, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University; Silesian Center for Heart Diseases	Pyrc, K (corresponding author), Jagiellonian Univ, Fac Chem, Ingardena 3, PL-30060 Krakow, Poland.	szczubia@chemia.uj.edu.pl; k.a.pyrc@uj.edu.pl	Szczubiałka, Krzysztof/D-4728-2016; Ciejka, Justyna/AAL-4155-2020; Owczarek, Katarzyna/AAL-6245-2021; Kaminski, Kamil/AAJ-9650-2020	Szczubiałka, Krzysztof/0000-0001-6612-1102; Owczarek, Katarzyna/0000-0002-2166-4688; Kaminski, Kamil/0000-0002-7421-6758; Pyrc, Krzysztof/0000-0002-3867-7688; Wojarski, Jacek/0000-0001-7724-8213; Ciejka, Justyna/0000-0003-2532-3386	Unilab LP (Rockville, MD, USA) [20850]; LIDER grant from the National Centre for Research and Development [Lider/27/55/L-2/10/2011]; National Science Center [UMO-657 2012/07/E/ NZ6/01712, UMO-2012/07/N/NZ6/02955]; European Union [POIG.02.01.00-12-064/08]; Ministry of Science and Higher Education of the Republic of Poland	Unilab LP (Rockville, MD, USA); LIDER grant from the National Centre for Research and Development; National Science Center(National Science Centre, Poland); European Union(European Commission); Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the grant "Evaluation of anticoronal compounds" from the Unilab LP (966 Hungford Dr. Ste. 3B, Rockville, MD 20850, USA) (KS and KP), by the LIDER grant from the National Centre for Research and Development (Lider/27/55/L-2/10/2011) (KP), and by grants from the National Science Center (UMO-657 2012/07/E/ NZ6/01712 and UMO-2012/07/N/NZ6/02955) (KP and AM, respectively). KP would like to acknowledge networking contribution by the COST Action CM1407 "Challenging organic syntheses inspired by nature - from natural products chemistry to drug discovery". The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No: POIG.02.01.00-12-064/08 - "Molecular biotechnology for health"). Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a partner of the Leading National Research Center supported by the Ministry of Science and Higher Education of the Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LY, 2004, BIOMATERIALS, V25, P3725, DOI 10.1016/j.biomaterials.2003.09.100; Cho J, 2006, BIOMACROMOLECULES, V7, P3548, DOI 10.1021/bm068002k; Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7; Choi BK, 2001, INT J ANTIMICROB AG, V18, P553, DOI 10.1016/S0924-8579(01)00434-4; Chung YC, 2003, BIORESOURCE TECHNOL, V88, P179, DOI 10.1016/S0960-8524(03)00002-6; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Fields BN, 2013, FIELDS VIROLOGY; Grassauer A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-107; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Ikinci G, 2002, INT J PHARM, V235, P121, DOI 10.1016/S0378-5173(01)00974-7; Kaminski K, 2010, J MED CHEM, V53, P4141, DOI 10.1021/jm1001666; Kim MS, 2002, NEUROSCI LETT, V321, P105, DOI 10.1016/S0304-3940(02)00066-6; Leibbrandt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014320; Milewska A, 2014, J VIROL, V88, P13221, DOI 10.1128/JVI.02078-14; Milewska A, 2013, ANTIVIR RES, V97, P112, DOI 10.1016/j.antiviral.2012.11.006; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Pyrc K, 2006, J MOL BIOL, V364, P964, DOI 10.1016/j.jmb.2006.09.074; Pyrc K, 2007, J VIROL, V81, P3051, DOI 10.1128/JVI.01466-06; Pyrc K, 2010, J VIROL, V84, P11255, DOI 10.1128/JVI.00947-10; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sarasam AR, 2008, J MATER SCI-MATER M, V19, P1083, DOI 10.1007/s10856-007-3072-z; Song S, 2009, IMMUNOPHARM IMMUNOT, V31, P202, DOI 10.1080/08923970802629593; Stadler K, 2003, NAT REV MICROBIOL, V1, P209, DOI 10.1038/nrmicro775; Tsujimoto K, 2010, INT J MOL MED, V25, P433, DOI 10.3892/ijmm_00000362; van der Hoek L, 2005, PLOS MED, V2, P764, DOI 10.1371/journal.pmed.0020240; Viswanathan K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002332; Wang W, 2011, ANTIVIR RES, V92, P237, DOI 10.1016/j.antiviral.2011.08.010; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yeh MY, 2016, EXP THER MED, V11, P1300, DOI 10.3892/etm.2016.3057; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zeng LT, 2008, CARBOHYD POLYM, V71, P435, DOI 10.1016/j.carbpol.2007.06.016; ZHIRNOV OP, 1990, VIROLOGY, V176, P274, DOI 10.1016/0042-6822(90)90253-N	32	45	48	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156552	10.1371/journal.pone.0156552	http://dx.doi.org/10.1371/journal.pone.0156552			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249425	Green Published, gold, Green Submitted			2022-12-26	WOS:000377184700051
J	Karamyan, A; Dunser, MW; Wiebe, DJ; Pilz, G; Wipfler, P; Chroust, V; Novak, HF; Hauer, L; Trinka, E; Sellner, J				Karamyan, Anush; Duenser, Martin W.; Wiebe, Douglas J.; Pilz, Georg; Wipfler, Peter; Chroust, Vaclav; Novak, Helmut F.; Hauer, Larissa; Trinka, Eugen; Sellner, Johann			Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study	PLOS ONE			English	Article							ILL PATIENTS; MORTALITY; MULTICENTER; ADMISSION; COST	Background Over the course of multiple sclerosis (MS) several conditions may arise that require critical care. We aimed to study the reasons for admission and outcome in patients with MS admitted to a neuro-intensive care unit (NICU). Methods We retrospectively searched the electronic charts of a 9-bedded NICU in a tertiary hospital for patients with a diagnosis of multiple sclerosis (MS) from 1993-2015, and matched them to NICU controls without MS based on age and gender. Conditional logistic regression was used to compare admission causes, Charlson's Comorbidity Index, indicators of disease severity, and survival between MS and non-MS patients. Results We identified 61 MS patients and 181 non-MS controls. Respiratory dysfunction was the most frequent reason for NICU admission among MS patients (34.4%), having infectious context as a rule. In a matched analysis, after adjusting for co-morbidities and immunosuppressive medications, patients with MS were more likely to be admitted to the NICU because of respiratory dysfunction (OR = 7.86, 95% CI 3.02-20.42, p<0.001), non-respiratory infections (OR = 3.71, 95% CI 1.29-10.68, p = 0.02), had a higher rate of multiple NICU admissions (OR = 2.53, 95% CI 1.05-6.05, p = 0.04) than non-MS patients. Mortality after NICU admission at a median follow-up time of 1 year was higher in MS than control patients (adjusted OR = 4.21, 95% CI 1.49-11.85, p = 0.04). Conclusion The most common reason for NICU admission in MS patients was respiratory dysfunction due to infection. Compared to non-MS patients, critically ill MS patients had a higher NICU re-admission rate, and a higher mortality.	[Karamyan, Anush; Pilz, Georg; Wipfler, Peter; Chroust, Vaclav; Novak, Helmut F.; Trinka, Eugen; Sellner, Johann] Paracelsus Med Univ, Dept Neurol, Christian Doppler Med Ctr, Salzburg, Austria; [Karamyan, Anush; Pilz, Georg; Wipfler, Peter; Chroust, Vaclav; Novak, Helmut F.; Trinka, Eugen; Sellner, Johann] Ctr Cognit Neurosci, Salzburg, Austria; [Duenser, Martin W.] Univ Hosp Salzburg, Dept Anesthesiol Perioperat & Gen Intens Care Med, Salzburg, Austria; [Duenser, Martin W.] Paracelsus Med Univ, Salzburg, Austria; [Wiebe, Douglas J.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hauer, Larissa] Paracelsus Med Univ, Dept Psychiat, Christian Doppler Med Ctr, Salzburg, Austria; [Sellner, Johann] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, D-80290 Munich, Germany	Paracelsus Private Medical University; Paracelsus Private Medical University; University of Pennsylvania; Pennsylvania Medicine; Paracelsus Private Medical University; Technical University of Munich	Sellner, J (corresponding author), Paracelsus Med Univ, Dept Neurol, Christian Doppler Med Ctr, Salzburg, Austria.; Sellner, J (corresponding author), Ctr Cognit Neurosci, Salzburg, Austria.; Sellner, J (corresponding author), Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, D-80290 Munich, Germany.	j.sellner@salk.at	Selllner, Johann/AAB-1263-2019; Wiebe, Douglas J/Q-1168-2017	Pilz, Georg/0000-0001-8764-2628; Wipfler, Peter/0000-0003-4982-4855; Trinka, Eugen/0000-0002-5950-2692	Merck; Paracelsus Medical University; Bayer; Biogen-Idec; Novartis; Genzyme	Merck(Merck & Company); Paracelsus Medical University; Bayer(Bayer AG); Biogen-Idec(Biogen); Novartis(Novartis); Genzyme(Sanofi-AventisGenzyme Corporation)	This study was in part supported by an unrestricted grant from Merck. JS has received research funding from the Paracelsus Medical University, Bayer, Biogen-Idec, Merck and Novartis, has acted as paid consultant to Novartis and Genzyme, and has received speakers' honoraria from Biogen-Idec, Ever Neuropharma, Genzyme, Novartis and Teva-Ratiopharm. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman Gabriel, 2013, J Med Econ, V16, P639, DOI 10.3111/13696998.2013.778268; Bernal-Macias S, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2015-000122; Brinkman S, 2013, CRIT CARE MED, V41, P1229, DOI 10.1097/CCM.0b013e31827ca4e1; Broessner G, 2007, CRIT CARE MED, V35, P2025, DOI 10.1097/01.ccm.0000281449.07719.2b; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Findling O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121856; Finkielman JD, 2004, CRIT CARE MED, V32, P1161, DOI 10.1097/01.CCM.0000126151.56590.99; Goodin DS, 2014, HAND CLINIC, V122, P231, DOI 10.1016/B978-0-444-52001-2.00010-8; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lalmohamed A, 2012, EUR J NEUROL, V19, P1007, DOI 10.1111/j.1468-1331.2012.03668.x; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Marrie RA, 2015, NEUROLOGY, V85, P240, DOI 10.1212/WNL.0000000000001718; Marrie RA, 2014, NEUROLOGY, V82, P2112, DOI 10.1212/WNL.0000000000000495; Metnitz PGH, 2003, INTENS CARE MED, V29, P241, DOI 10.1007/s00134-002-1584-z; Miranda DR, 1996, CRIT CARE MED, V24, P64, DOI 10.1097/00003246-199601000-00012; Montgomery S, 2013, EUR J NEUROL, V20, P1153, DOI 10.1111/ene.12130; Nardone R, 2015, J SPINAL CORD MED, V13, P1; Orton SM, 2006, LANCET NEUROL, V5, P932, DOI 10.1016/S1474-4422(06)70581-6; Scalfari A, 2013, NEUROLOGY, V81, P184, DOI 10.1212/WNL.0b013e31829a3388; Sellner J, 2011, AUTOIMMUN REV, V10, P495, DOI 10.1016/j.autrev.2011.02.006; Tzelepis GE, 2015, RESP MED, V109, P671, DOI 10.1016/j.rmed.2015.01.018; Vezzani A, 2011, GENDER MED, V8, P32, DOI 10.1016/j.genm.2010.11.011; Williamson EM, 2015, CNS DRUGS, V29, P229, DOI 10.1007/s40263-015-0226-2	23	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155795	10.1371/journal.pone.0155795	http://dx.doi.org/10.1371/journal.pone.0155795			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244560	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100006
J	Zhang, GH; Zhang, HF; Yu, HXY; Zhao, Z; Yang, J; Zhang, MZ; Zhang, MY				Zhang, Guohong; Zhang, Huifang; Yu, Hongxuyang; Zhao, Zheng; Yang, Jie; Zhang, Mianzhi; Zhang, Minying			Hypothetical Rectal Microbicide Acceptability and Factors Influencing It among Men Who Have Sex with Men in Tianjin, China	PLOS ONE			English	Article							RECEPTIVE ANAL INTERCOURSE; INTIMATE PARTNER VIOLENCE; URBAN US WOMEN; VAGINAL MICROBICIDE; HIV-INFECTION; CLINICAL-TRIALS; RISK BEHAVIORS; PRODUCTS; HEALTH; GEL	Objectives To measure potential acceptability of rectal microbicides and to explore factors likely to affect their acceptability among men who have sex with men (MSM). Methods Cross-sectional and retrospective surveys were conducted in this study. A questionnaire and a scale were used to measure the acceptability score for physical and functional characteristics of hypothetical rectal microbicides. We also evaluated the involvement of other factors such as sexual behaviors, social context, etc. Results MSMs we interviewed showed a high acceptability to rectal microbicides, indicated by the mean acceptability score of 2.92 (SD, 0.54, scale of 1-4). The results also suggested that microbicides were preferred in a cream form that can moisten and lubricate the rectum, prevent HIV infection and go unnoticed by their partners. Multivariate analysis showed that the microbicides acceptability varied significantly by education level (beta = 0.135; P = 0.028), having casual partners (beta = 0.174; P = 0.007), frequency of lubricant use (beta = 0.134; P = 0.031), history of HIV test (beta = 0.129; P = 0.036), willingness to use lubricant (beta = 0.126; P = 0.045), locus of control by partners regarding STI infection (beta = 0.168; P = 0.009). Conclusions A positive response to rectal microbicides among MSMs was found in our study, suggesting that rectal microbicides might have a potential market in MSMs and they might play an important role in HIV/STIs prevention as a supplement. Further studies may be considered to combine the acceptability study with clinical research together to understand the true feelings of MSMs when they use the products.	[Zhang, Guohong; Zhang, Huifang; Yu, Hongxuyang; Zhang, Minying] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Zhao, Zheng; Yang, Jie] Shenlan MSM Community Org, Tianjin, Peoples R China; [Zhang, Mianzhi] Tianjin Publ Secur Hosp, Tianjin, Peoples R China	Nankai University	Zhang, MY (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.	zhangminying@nankai.edu.cn	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022	Yu, Hongxuyang/0000-0003-0700-7937	Scientific Research Foundation of Nankai University [J02006]	Scientific Research Foundation of Nankai University	The work was funded by Scientific Research Foundation of Nankai University (J02006).	Abdulai MA, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-40; Baral S, 2013, AIDS BEHAV, V17, pS60, DOI 10.1007/s10461-012-0202-5; Bentley ME, 2004, AM J PUBLIC HEALTH, V94, P1159, DOI 10.2105/AJPH.94.7.1159; Carballo-Dieguez A, 2008, SEX TRANSM INFECT, V84, P483, DOI 10.1136/sti.2008.030478; Carballo-Dieguez A, 2000, AM J PUBLIC HEALTH, V90, P1117, DOI 10.2105/AJPH.90.7.1117; Carballo-Dieguez A, 2008, AIDS BEHAV, V12, P860, DOI 10.1007/s10461-007-9301-0; Carballo-Dieguez A, 2007, SEX TRANSM DIS, V34, P224, DOI 10.1097/01.olq.0000233715.59239.83; Coetzee N, 2001, AIDS, V15, P1837, DOI 10.1097/00002030-200109280-00013; Coggins C, 2000, REPROD HEALTH MATTER, V8, P132, DOI 10.1016/S0968-8080(00)90015-6; Davis A, 2015, SEX TRANSM DIS, V42, P387, DOI 10.1097/OLQ.0000000000000302; Dunkle KL, 2013, SEX TRANSM DIS, V40, P362, DOI 10.1097/OLQ.0b013e318283d2af; Fleck F, 2004, B WORLD HEALTH ORGAN, V82, P393; Giguere R, 2015, J SEX RES, P1; Green G, 2001, SOC SCI MED, V52, P585, DOI 10.1016/S0277-9536(00)00162-3; Grulich AE, 2010, INT J EPIDEMIOL, V39, P1064, DOI 10.1093/ije/dyq101; Guo XT, 2016, J MED VIROL, V88, P1098, DOI 10.1002/jmv.24439; Guo XT, 2016, MICROBES INFECT, V18, P148, DOI 10.1016/j.micinf.2015.10.004; Hammett TM, 2000, SEX TRANSM DIS, V27, P119, DOI 10.1097/00007435-200002000-00011; Han L, 2011, CHIN J DIS CONTROL P, V15, P560; Han L, 2009, J WOMENS HEALTH, V18, P1377, DOI 10.1089/jwh.2008.1239; Hart GJ, 2005, SEX TRANSM INFECT, V81, P367, DOI 10.1136/sti.2004.013995; Hoffman S, 2010, ARCH SEX BEHAV, V39, P748, DOI 10.1007/s10508-009-9509-3; Jones DL, 2008, SEX TRANSM DIS, V35, P147, DOI 10.1097/OLQ.0b013e3181574dbf; Kinsler JJ, 2010, INT J STD AIDS, V21, P567, DOI 10.1258/ijsa.2010.010134; Kinsler JJ, 2012, AIDS BEHAV, V16, P1436, DOI 10.1007/s10461-011-0045-5; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Li L, 2013, J ANTIMICROB CHEMOTH, V68, P573, DOI 10.1093/jac/dks458; Lu L, 2013, MICROBES INFECT, V15, P506, DOI 10.1016/j.micinf.2013.03.003; Mantell JE, 2005, SOC SCI MED, V60, P319, DOI 10.1016/j.socscimed.2004.05.011; Marks G., 2000, AIDS BEHAV, V4, P279, DOI DOI 10.1023/A:1009572919712; McGowan I, 2012, CURR OPIN HIV AIDS, V7, P526, DOI 10.1097/COH.0b013e3283582bc2; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Morrow KM, 2008, AIDS BEHAV, V12, P272, DOI 10.1007/s10461-007-9266-z; Newman PA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18476; Peinado Jesus, 2013, J Int Assoc Provid AIDS Care, V12, P278, DOI 10.1177/1545109712473650; Rader M, 2001, AIDS EDUC PREV, V13, P149, DOI 10.1521/aeap.13.2.149.19735; Robertson Angela M, 2013, Glob Public Health, V8, P619, DOI 10.1080/17441692.2012.762412; Sakondhavat Chuanchom, 2001, Journal of the Medical Association of Thailand, V84, P973; Severy LJ, 2005, J SOC ISSUES, V61, P45, DOI 10.1111/j.0022-4537.2005.00393.x; Stadler J, 2011, CULT HEALTH SEX, V13, P31, DOI 10.1080/13691058.2010.511270; Stone A, 2006, LANCET, V368, P431, DOI 10.1016/S0140-6736(06)69131-9; Tanner A, 2009, J SEX RES, V46, P15, DOI 10.1080/00224490802398407; Tolley EE, 2006, AM J PUBLIC HEALTH, V96, P79, DOI 10.2105/AJPH.2004.043471; [涂晓雯 Tu Xiaowen], 2010, [生殖与避孕, Reproduction and Contraception], V30, P696; Turner G, 1999, HEALTH EDUC RES, V14, P235, DOI 10.1093/her/14.2.235; Ventuneac A, 2010, AIDS BEHAV, V14, P618, DOI 10.1007/s10461-009-9611-5; Verguet S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015501; Wang Y, 2008, SEX TRANSM DIS, V35, P102, DOI 10.1097/OLQ.0b013e31814b8546; Weeks MR, 2004, SEX TRANSM DIS, V31, P682, DOI 10.1097/01.olq.0000143113.04524.a5; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6	50	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156561	10.1371/journal.pone.0156561	http://dx.doi.org/10.1371/journal.pone.0156561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN5XX	27243457	gold, Green Submitted, Green Published			2022-12-26	WOS:000377146100048
J	Radreau, P; Porcherot, M; Ramiere, C; Mouzannar, K; Lotteau, V; Andre, P				Radreau, Pauline; Porcherot, Marine; Ramiere, Christophe; Mouzannar, Karim; Lotteau, Vincent; Andre, Patrice			Reciprocal regulation of farnesoid X receptor activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes	FASEB JOURNAL			English	Article						cccDNA; bile salt; nuclear receptor; FXR agonist	NUCLEAR RECEPTORS; OBETICHOLIC ACID; NATURAL-HISTORY; CCCDNA FUNCTION; FXR-ALPHA; AUTOPHAGY; TRANSCRIPTION; INFECTION; MINICHROMOSOME; PGC-1-ALPHA	Hepatitis B virus (HBV) and bile salt metabolism seem tightly connected. HBV enters hepatocytes by binding to sodium taurocholate cotransporting polypeptide (NTCP), the genome of which contains 2 active farnesoid X receptor (FXR) response elements that participate in HBV transcriptional activity. We investigated in differentiated HepaRG cells and in primary human hepatocytes (PHHs) effects of FXR activation on HBV replication and of infection on the FXR pathway. In HepaRG cells, FXR agonists (6-ethyl chenodeoxycholic acid and GW4064), but no antagonist, and an FXR-unrelated bile salt inhibited viral mRNA, DNA, and protein production (IC50, 0.1-0.5 M) and reduced covalently closed circular DNA pool size. These effects were independent of the NTCP inhibitor cyclosporine-A, which suggests inhibition occurred at a postentry step. Similar results were obtained in PHHs with GW4064. Infection of these cells increased expression of FXR and modified expression of FXR-regulated genes SHP, APOA1, NTCP, CYP7A1, and CYP8B1 with a more pronounced effect in PHHs than in HepaRG cells. FXR agonists reversed all but one of the HBV-induced FXR gene profile modifications. HBV replication and FXR regulation seem to be interdependent, and altered bile salt metabolism homeostasis might contribute to the persistence of HBV infection.Radreau, P., Porcherot, M., Ramiere, C., Mouzannar, K., Lotteau, V., Andre, P. Reciprocal regulation of farnesoid X receptor activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes.	[Radreau, Pauline; Porcherot, Marine; Ramiere, Christophe; Mouzannar, Karim; Lotteau, Vincent; Andre, Patrice] CNRS, INSERM, Ctr Int Rech Infectiol, UMR 5308,U1111, Lyon, France; [Radreau, Pauline; Porcherot, Marine; Ramiere, Christophe; Mouzannar, Karim; Lotteau, Vincent; Andre, Patrice] Ecole Normale Super Lyon, Lyon, France; [Radreau, Pauline; Porcherot, Marine; Ramiere, Christophe; Mouzannar, Karim; Lotteau, Vincent; Andre, Patrice] Univ Lyon 1, Villeurbanne, France; [Radreau, Pauline; Porcherot, Marine; Ramiere, Christophe; Mouzannar, Karim; Lotteau, Vincent; Andre, Patrice] Univ Lyon, Lyon, France; [Ramiere, Christophe; Andre, Patrice] Hosp Civils Lyon, Hop Croix Rousse, Virol Lab, Lyon, France; [Radreau, Pauline; Porcherot, Marine] EnyoPharma, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Andre, P (corresponding author), INSERM, Ctr Int Rech Infectiol, U1111, 21 Ave Tony Garnier, F-69007 Lyon, France.	patrice.andre@inserm.fr	Sharma, Ashwani/AAK-3879-2020; Ramière, Christophe/M-8083-2014; André, Patrice/M-8139-2014; lotteau, vincent/M-8143-2014	Sharma, Ashwani/0000-0001-9835-1973; Ramière, Christophe/0000-0002-1981-7155; André, Patrice/0000-0002-5834-7395; Lotteau, Vincent/0000-0003-0997-3282	Agence Nationale de Recherche sur le Sida et les Hepatites [2AO 2013, 1AO 2015]; Finovi, FP7 EC Network SCRTox [266753]; EnyoPharma	Agence Nationale de Recherche sur le Sida et les Hepatites; Finovi, FP7 EC Network SCRTox; EnyoPharma	The authors thank Stephane Joly (EnyoPharma, Lyon, France) for technical assistance and expertise. This work was funded, in part, by grants from the Agence Nationale de Recherche sur le Sida et les Hepatites (2AO 2013 and 1AO 2015), Finovi, FP7 EC Network SCR&Tox (Grant Agreement 266753), and EnyoPharma. V.L. and P.A. are cofounders of EnyoPharma, Lyon. Author contributions: V. Lotteau and P. Andre designed research, analyzed data and wrote the manuscript; P. Radreau and M. Porcherot performed the experiments, analyzed data and contributed to the manuscript writing; and C. Ramiere and K. Mouzannar contributed reagents and experiments.	Bar-Yishay I, 2011, LIVER INT, V31, P282, DOI 10.1111/j.1478-3231.2010.02423.x; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Bock CT, 2001, J MOL BIOL, V307, P183, DOI 10.1006/jmbi.2000.4481; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Curtil C, 2014, FASEB J, V28, P1454, DOI 10.1096/fj.13-236372; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003722; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Mao Y, 2011, BIOCHEM BIOPH RES CO, V415, P68, DOI 10.1016/j.bbrc.2011.10.013; Mudaliar S, 2013, GASTROENTEROLOGY, V145, P574, DOI 10.1053/j.gastro.2013.05.042; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; Oehler N, 2014, HEPATOLOGY, V60, P1483, DOI 10.1002/hep.27159; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Parent R, 2004, GASTROENTEROLOGY, V126, P1147, DOI 10.1053/j.gastro.2004.01.002; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Rabe B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000563; Ramiere C, 2008, J VIROL, V82, P10832, DOI 10.1128/JVI.00883-08; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Shlomai A, 2006, P NATL ACAD SCI USA, V103, P16003, DOI 10.1073/pnas.0607837103; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Urban S, 2010, J HEPATOL, V52, P282, DOI 10.1016/j.jhep.2009.10.031; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	33	23	24	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3146	3154		10.1096/fj.201500134	http://dx.doi.org/10.1096/fj.201500134			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27251172				2022-12-26	WOS:000382816300015
J	Colella, S; Falcini, F; Rinaldi, E; Sammartino, M; Santoleri, R				Colella, Simone; Falcini, Federico; Rinaldi, Eleonora; Sammartino, Michela; Santoleri, Rosalia			Mediterranean Ocean Colour Chlorophyll Trends	PLOS ONE			English	Article							A CONCENTRATION; COASTAL WATERS; TIME-SERIES; VARIABILITY; EUTROPHICATION; SEA; PRODUCTIVITY; EGYPT; NORTH; SEASONALITY	In being at the base of the marine food web, phytoplankton is particularly important for marine ecosystem functioning (e.g., biodiversity). Strong anthropization, over-exploitation of natural resources, and climate change affect the natural amount of phytoplankton and, therefore, represent a continuous threat to the biodiversity in marine waters. In particular, a concerning risks for coastal waters is the increase in nutrient inputs of terrestrial/anthropogenic origin that can lead to undesirable modifications of phytoplankton concentration (i.e., eutrophication). Monitoring chlorophyll (Chl) concentration, which is a proxy of phytoplankton biomass, is an efficient tool for recording and understanding the response of the marine ecosystem to human pressures and thus for detecting eutrophication. Here, we compute Chl trends over the Mediterranean Sea by using satellite data, also highlighting the fact that remote sensing may represent an efficient and reliable solution to synoptically control the "good environmental status" (i.e., the Marine Directive to achieve Good Environmental Status of EU marine waters by 2020) and to assess the application of international regulations and environmental directives. Our methodology includes the use of an ad hoc regional (i.e., Mediterranean) algorithm for Chl concentration retrieval, also accounting for the difference between offshore (i.e., Case I) and coastal (i.e., Case II) waters. We apply the Mann-Kendall test and the Sens's method for trend estimation to the Chl concentration de-seasonalized monthly time series, as obtained from the X-11 technique. We also provide a preliminary analysis of some particular trends by evaluating their associated inter-annual variability. The high spatial resolution of our approach allows a clear identification of intense trends in those coastal waters that are affected by river outflows. We do not attempt to attribute the observed trends to specific anthropogenic events. However, the trends that we document are consistent with the findings of several previous studies.	[Colella, Simone; Falcini, Federico; Rinaldi, Eleonora; Sammartino, Michela; Santoleri, Rosalia] CNR ISAC, Via Fosso del Cavaliere 100, I-00133 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR)	Santoleri, R (corresponding author), CNR ISAC, Via Fosso del Cavaliere 100, I-00133 Rome, Italy.	r.santoleri@isac.cnr.it		Falcini, Federico/0000-0001-8105-2491; COLELLA, SIMONE/0000-0002-7727-7353	RITMARE - Italian Research Ministry (MIUR) Projects; EU Project EMODNET MedSea checkpoint [MARE/2012/1]; EU Project MyOceanFO - Pre-Operational Marine Service Continuity in Transition towards Copernicus [210129802]	RITMARE - Italian Research Ministry (MIUR) Projects; EU Project EMODNET MedSea checkpoint; EU Project MyOceanFO - Pre-Operational Marine Service Continuity in Transition towards Copernicus	This work was supported by the RITMARE - Italian Research Ministry (MIUR) Projects, and the EU Projects EMODNET MedSea checkpoint (#MARE/2012/1; www.emodnet-mediterranean.eu) and MyOceanFO - Pre-Operational Marine Service Continuity in Transition towards Copernicus (#210129802; marine.copernicus.eu). All authors have no competing financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz OIA, 2006, J HYDROL, V319, P282, DOI 10.1016/j.jhydrol.2005.06.039; Barale V, 2008, REMOTE SENS ENVIRON, V112, P3300, DOI 10.1016/j.rse.2007.10.014; Beaulieu C, 2013, BIOGEOSCIENCES, V10, P2711, DOI 10.5194/bg-10-2711-2013; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Berthon J-F, 2002, SEAWIFS POSTLAUNCH T, V20, P1; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Brown CW, 2014, DEEP-SEA RES PT I, V90, P166, DOI 10.1016/j.dsr.2014.05.009; Bulut H, 2008, INT J NATURAL ENG SC, V1, P115; Coppini G., 2013, INT J GEOSCI, V4, P927, DOI [DOI 10.4236/IJG.2013.46087, 10.4236/ijg.2013.46087]; Cozzi S, 2011, CONT SHELF RES, V31, P1881, DOI 10.1016/j.csr.2011.08.010; CULLEN JJ, 1982, CAN J FISH AQUAT SCI, V39, P791, DOI 10.1139/f82-108; D'Alimonte D, 2003, IEEE T GEOSCI REMOTE, V41, P2833, DOI 10.1109/TGRS.2003.818020; D'Alimonte D, 2003, IEEE T GEOSCI REMOTE, V41, P2861, DOI 10.1109/TGRS.2003.817682; Dagum E. B., 1980, 12564E STAT CAN; Deyab Mohamed Ali Ibraheem, 2015, Journal of Coastal Life Medicine, V3, P113, DOI 10.12980/JCLM.3.2015JCLM-2014-0097; Djakovac T, 2012, ESTUAR COAST SHELF S, V115, P25, DOI 10.1016/j.ecss.2012.03.029; Dorgham MM, 2004, OCEANOLOGIA, V46, P25; *EEA, 2005, 7 EEA; *EEA, 2005, 1 EEA; Ferreira JG, 2011, ESTUAR COAST SHELF S, V93, P117, DOI 10.1016/j.ecss.2011.03.014; Findley DF, 1998, J BUS ECON STAT, V16, P127, DOI 10.2307/1392565; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Giani M, 2012, ESTUAR COAST SHELF S, V115, P1, DOI 10.1016/j.ecss.2012.08.023; Gohin F, 2008, REMOTE SENS ENVIRON, V112, P3329, DOI 10.1016/j.rse.2008.02.014; Gregg WW, 2014, J GEOPHYS RES-OCEANS, V119, P5921, DOI 10.1002/2014JC010158; Gregg WW, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021808; Henson SA, 2010, BIOGEOSCIENCES, V7, P621, DOI 10.5194/bg-7-621-2010; HIRSCH RM, 1982, WATER RESOUR RES, V18, P107, DOI 10.1029/WR018i001p00107; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN; Karageorgis AP, 2005, REG ENVIRON CHANGE, V5, P138, DOI 10.1007/s10113-004-0078-7; Kendall M., 1938, NATURE, V142, P402, DOI [10.2307/2280246, DOI 10.2307/2280246]; Khairy HM, 2014, REV BIOL MAR OCEANOG, V49, P267, DOI 10.4067/S0718-19572014000200007; KROM MD, 1991, LIMNOL OCEANOGR, V36, P424, DOI 10.4319/lo.1991.36.3.0424; Lavender S, 2013, REMOTE SENSING APPL, P12; Loisel H, 2014, REMOTE SENS ENVIRON, V150, P218, DOI 10.1016/j.rse.2014.05.006; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Markovic M, 2001, UN ENV PROGRAMME DIV; Marsaleix P, 1998, J MARINE SYST, V14, P99, DOI 10.1016/S0924-7963(97)00011-0; Melin F, 2011, PROG OCEANOGR, V91, P229, DOI 10.1016/j.pocean.2010.12.001; Melin F, 2000, INTEGRATED TOOL SEAW; MOREL A, 1977, LIMNOL OCEANOGR, V22, P709, DOI 10.4319/lo.1977.22.4.0709; Nikolaidis NP, 2009, ECOL MODEL, V220, P383, DOI 10.1016/j.ecolmodel.2008.10.003; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Pezzulli S, 2005, J CLIMATE, V18, P71, DOI 10.1175/JCLI-3256.1; Rinaldi E, 2012, THESIS U BOLOGNA ITA; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Rudnick DL, 2003, DEEP-SEA RES PT I, V50, P691, DOI 10.1016/S0967-0637(03)00053-0; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Shiskin J., 1978, SEASONAL ANAL EC TIM, P97; Smith SV, 2003, BIOSCIENCE, V53, P235, DOI 10.1641/0006-3568(2003)053[0235:HHATDO]2.0.CO;2; Solidoro C, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004838; Tsiaras KP, 2014, J SEA RES, V86, P97, DOI 10.1016/j.seares.2013.11.007; *UNEP MAP PAP, 2001, WHIT PAP COAST ZON M; Vantrepotte V, 2011, DEEP-SEA RES PT I, V58, P429, DOI 10.1016/j.dsr.2011.02.003; Vantrepotte V, 2009, ICES J MAR SCI, V66, P1547, DOI 10.1093/icesjms/fsp107; Volpe G, 2007, REMOTE SENS ENVIRON, V107, P625, DOI 10.1016/j.rse.2006.10.017; Volpe G, 2012, OCEAN SCI, V8, P869, DOI 10.5194/os-8-869-2012; Wunsch C, 1999, B AM METEOROL SOC, V80, P245, DOI 10.1175/1520-0477(1999)080<0245:TIOSCR>2.0.CO;2; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7; Zanchettin D, 2008, CLIMATIC CHANGE, V89, P411, DOI 10.1007/s10584-008-9395-z	61	73	75	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155756	10.1371/journal.pone.0155756	http://dx.doi.org/10.1371/journal.pone.0155756			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258025	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700020
J	Jaber, AAS; Khan, AH; Sulaiman, SAS; Ahmad, N; Anaam, MS				Jaber, Ammar Ali Saleh; Khan, Amer Hayat; Sulaiman, Syed Azhar Syed; Ahmad, Nafees; Anaam, Mohamed Saif			Evaluation of Health-Related Quality of Life among Tuberculosis Patients in Two Cities in Yemen	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SF-36; DIAGNOSIS; MANAGEMENT; GENDER; SCORES; IMPACT	Background The health-related quality of life (HRQoL) of Tuberculosis (TB) patients is important because it directly influences the outcome of TB patients in several aspects. The current study aims to evaluate and to find the factors influencing the HRQoL of TB patients in two major TB-prevalent cities (Taiz and Alhodidah) in Yemen. Methods A prospective study was conducted, and all TB patients meeting the HRQoL criteria were asked to complete the HRQoL SF-36 survey. The records of TB patients were examined for disease confirmation, and a follow-up was consequently performed for patients during treatment between March 2013 and February 2014 in Taiz and Alhodidah Cities. HRQol scores were calculated by using QM scoring software version 4.5, in which the physical component score (PCS) and mental component score (MCS) were obtained. The scores obtained between 47-53 normal based score (NBS) were considered equivalent to the US normal score. Low scores indicate the poor health situation of TB patients Results A total of 243 TB patients enrolled in the study at the beginning of the treatment. A total of 235 and 197 TB patients completed the questionnaire at the end of the intensive phase (I. P.) and continuation phase (C.P.), respectively. The final dropout rate was 16.2%. The mean PCS and MCS scores at the beginning of treatment were low, thus showing the poor health situation of TB patients. The mean PCS scores at the beginning of treatment, end of I.P., and end of treatment were (36.1), (44.9), and (48), respectively. Moreover, the mean MCS score at the beginning of treatment, end of I.P., and end of treatment were (35.1), (42.2), and (44.3), respectively. The result shows that significant increases are observed at the end of I. P. for PCS and MCS because of the treatment and slight changes at the end of C.P. Despite this finding, the MCS score remains below the normal range (47), thus indicating a significant risk of depression among TB patients. Furthermore, general linear repeated measure ANOVA was performed for selected variables, to examine the changes of PCS and MCS over time. It was found that Alhodiah city, chewing khat habit, stigmatization, and duration of treatment more than six months were greatly associated with low mean MCS score of TB patient, indicating great risk of depression which may result in poor treatment outcome. Conclusion TB patients in Yemen were found to have poor QoL, with a significant likelihood of depression. Highly risk depression was found among TB patients in Alhodiah city, khat chewers, stigmatization and having a duration of treatment more than 6 months. Therefore, additional efforts should be made to improve their QoL because it may affect the final clinical outcome of patients.	[Jaber, Ammar Ali Saleh; Khan, Amer Hayat; Sulaiman, Syed Azhar Syed; Ahmad, Nafees; Anaam, Mohamed Saif] USM, Sch Pharmaceut Sci, Dept Clin Pharm, George Town, Malaysia	Universiti Sains Malaysia	Jaber, AAS (corresponding author), USM, Sch Pharmaceut Sci, Dept Clin Pharm, George Town, Malaysia.	amarali2014015@gmail.com	Khan, Amer Hayat/O-5310-2018	Khan, Amer Hayat/0000-0003-4802-6181; Syed Sulaiman, Syed Azhar/0000-0002-0775-859X; Khan, Amer Hayat/0000-0001-6079-0567; Jaber, Ammar/0000-0003-0411-1923				Aggarwal AN, 2013, INT J TUBERC LUNG D, V17, P947, DOI 10.5588/ijtld.12.0299; Al-Akhali A, 2007, INT J TUBERC LUNG D, V11, P1328; Al-Hebshi NN, 2005, ADDICT BIOL, V10, P299, DOI 10.1080/13556210500353020; Al-Qahtani MF, 2014, J TAIBAH UNIV MED SC, V9, P311, DOI 10.1016/j.jtumed.2014.04.005; Al-Sharafi BA, 2015, CLIN MED INSIGHTS-EN, V8, P47, DOI 10.4137/CMED.S26045; Ali AA, 2006, J ORAL PATHOL MED, V35, P81, DOI 10.1111/j.1600-0714.2006.00362.x; Anaam MS, 2013, J PHARM HEALTH SERV, V4, P115, DOI 10.1111/jphs.12012; Atif M, 2015, PUBLIC HEALTH, V129, P777, DOI 10.1016/j.puhe.2015.04.010; Atif M, 2014, VALUE HEALTH, V17, pA778, DOI 10.1016/j.jval.2014.08.361; Atif M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-19; Atif M, 2013, QUAL LIFE RES, V22, P1955, DOI 10.1007/s11136-012-0337-x; Babikako HM, 2010, HEALTH QUAL LIFE OUT, V8, P1, DOI 10.1186/1477-7525-8-93; Bauer M, 2013, QUAL LIFE RES, V22, P2213, DOI 10.1007/s11136-012-0329-x; Bauer M, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0250-4; Brown J, 2015, INT J INFECT DIS, V32, P68, DOI 10.1016/j.ijid.2014.12.045; Budweiser S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-92; Chamla D, 2004, INT J TUBERC LUNG D, V8, P1100; Chan-Yeung M., 2003, Hong Kong Medical Journal, V9, P263; Chang B, 2004, QUAL LIFE RES, V13, P1633, DOI 10.1007/s11136-004-0374-1; Coates A, 1997, EUR J CANCER, V33, P1025, DOI 10.1016/S0959-8049(97)00049-X; Cronberg T, 2015, JAMA NEUROL, V72, P634, DOI 10.1001/jamaneurol.2015.0169; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000443; Daiffallah Ali A., 2015, AM J HLTH RES, V3, P91; Demiral Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-247; Dhuria M., 2009, ASIA PACIFIC J PUBLI; Dion MJ, 2004, QUAL LIFE RES, V13, P653, DOI 10.1023/B:QURE.0000021320.89524.64; Dujaili JA, 2015, INT J INFECT DIS, V31, P4, DOI 10.1016/j.ijid.2014.12.004; Duyan V, 2005, INT J TUBERC LUNG D, V9, P1361; Granich R, 2005, INT J TUBERC LUNG D, V9, P590; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Hart PD., 2015, WORLD J PREV MED, V3, P17, DOI DOI 10.12691/JPM-3-2-1; Hassan NA, 2002, SAUDI MED J, V23, P850; Hemingway H, 1997, AM J PUBLIC HEALTH, V87, P1484, DOI 10.2105/AJPH.87.9.1484; Julie P, 2002, SPSS SURVIVAL MANUAL; Kakhki AD, 2015, TUBERC RESPIR DIS, V78, P309, DOI 10.4046/trd.2015.78.4.309; Khan A, 2000, SOC SCI MED, V50, P247, DOI 10.1016/S0277-9536(99)00279-8; Knight SJ, 2007, CANCER, V109, P1769, DOI 10.1002/cncr.22597; Kruijshaar ME, 2010, INT J TUBERC LUNG D, V14, P296; Lam CLK, 2005, J CLIN EPIDEMIOL, V58, P815, DOI 10.1016/j.jclinepi.2004.12.008; Long NH, 2001, HEALTH POLICY, V58, P69, DOI 10.1016/S0168-8510(01)00143-9; Long Q, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-202; Loosman WL, 2015, NEPHROL DIAL TRANSPL, V30, P1170, DOI 10.1093/ndt/gfv066; Mamani Mojgan, 2014, Oman Med J, V29, P102, DOI 10.5001/omj.2014.25; Marra CA, 2004, HEALTH QUAL LIFE OUT, V2, P1, DOI DOI 10.1186/1477-7525-2-58; Marra CA, 2008, CHEST, V133, P396, DOI 10.1378/chest.07-1494; Mitlin Diana, 2004, UNDERSTANDING URBAN; Montazeri A, 2005, QUAL LIFE RES, V14, P875, DOI 10.1007/s11136-004-1014-5; Muniyandi M, 2007, INT J TUBERC LUNG D, V11, P887; Organization WH, 2013, YEM WHO STAT PROF; Organization WH, 20132013 WHO; Othman GQ, 2011, AFR J PHARM PHARMACO, V5, P547; Pappa E, 2005, QUAL LIFE RES, V14, P1433, DOI 10.1007/s11136-004-6014-y; Peck M, 2013, BURNS, V39, P1054, DOI 10.1016/j.burns.2013.04.010; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; Ritu K, 2015, INT J HLTH SCI RES I, V5, P357; Sajid MS, 2008, INT J HEALTH CARE Q, V21, P365, DOI 10.1108/09526860810880162; Shalaeva O, 2003, PROBLEMY TUBERKULEZA, P7; Tadesse S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152900; Unalan Demet, 2008, Indian J Tuberc, V55, P127; Vinaccia S, 2007, AN PSICOL-SPAIN, V23, P245; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; Ware JE, 2008, USERS MANUAL SF 36V2	62	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156258	10.1371/journal.pone.0156258	http://dx.doi.org/10.1371/journal.pone.0156258			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257990	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700048
J	Kanaya, M; Shibuya, K; Hirochika, R; Kanemoto, M; Ohashi, K; Okada, M; Wagatsuma, Y; Cho, Y; Kojima, H; Teshima, T; Imamura, M; Sakamaki, H; Shibuya, A				Kanaya, Minoru; Shibuya, Kazuko; Hirochika, Rei; Kanemoto, Miyoko; Ohashi, Kazuteru; Okada, Masafumi; Wagatsuma, Yukiko; Cho, Yukiko; Kojima, Hiroshi; Teshima, Takanori; Imamura, Masahiro; Sakamaki, Hisashi; Shibuya, Akira			Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease	PLOS ONE			English	Article							PVR CD155; LIGANDS; CELLS; DIFFERENTIATION; INJURY	Acute graft-versus-host disease (aGVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Because diagnosis of aGVHD is exclusively based on clinical symptoms and pathological findings, reliable and noninvasive laboratory tests for accurate diagnosis are required. An activating immunoreceptor, DNAM-1 (CD226), is expressed on T cells and natural killer cells and is involved in the development of aGVHD. Here, we identified a soluble form of DNAM-1 (sDNAM-1) in human sera. In retrospective univariate and multivariate analyses of allo-HSCT patients (n = 71) at a single center, cumulative incidences of all grade (grade I-IV) and sgrade II-IV aGVHD in patients with high maximal serum levels of sDNAM-1 (>= 30 pM) in the 7 days before allo-HSCT were significantly higher than those in patients with low maximal serum levels of sDNAM-1 (<30 pM) in the same period. However, sDNAM-1 was not associated with other known allo-HSCT complications. Our data suggest that sDNAM-1 is potentially a unique candidate as a predictive biomarker for the development of aGVHD.	[Kanaya, Minoru; Shibuya, Kazuko; Hirochika, Rei; Cho, Yukiko; Shibuya, Akira] Univ Tsukuba, Fac Med, Dept Immunol, Ibaraki, Japan; [Kanaya, Minoru; Teshima, Takanori; Imamura, Masahiro] Hokkaido Univ, Grad Sch Med, Dept Hematol, Sapporo, Hokkaido, Japan; [Kanemoto, Miyoko; Ohashi, Kazuteru; Sakamaki, Hisashi] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Okada, Masafumi; Wagatsuma, Yukiko] Univ Tsukuba, Dept Clin Trial & Clin Epidemiol, Ibaraki, Japan; [Cho, Yukiko; Kojima, Hiroshi] Ibaraki Cent Hosp, Dept Clin Oncol, Ibaraki, Japan; [Kojima, Hiroshi] Univ Tsukuba Hosp, Ibaraki Clin Educ & Training Ctr, Ibaraki, Japan; [Shibuya, Akira] Univ Tsukuba, Life Sci Ctr, TARA, Ibaraki, Japan; [Shibuya, Akira] Univ Tsukuba, CREST, Japan Sci & Technol Agcy, Ibaraki, Japan; [Okada, Masafumi] Univ Tokyo, Univ Hosp Med Informat Network Ctr, Tokyo, Japan; [Imamura, Masahiro] Sapporo Hokuyu Hosp, Dept Hematol, Sapporo, Hokkaido, Japan	University of Tsukuba; Hokkaido University; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tokyo	Shibuya, A (corresponding author), Univ Tsukuba, Fac Med, Dept Immunol, Ibaraki, Japan.; Shibuya, A (corresponding author), Univ Tsukuba, Life Sci Ctr, TARA, Ibaraki, Japan.; Shibuya, A (corresponding author), Univ Tsukuba, CREST, Japan Sci & Technol Agcy, Ibaraki, Japan.	ashibuya@md.tsukuba.ac.jp	Wagatsuma, Yukiko/AAE-5881-2020; Kanaya, Minoru/AAE-7446-2020	Wagatsuma, Yukiko/0000-0002-8056-9998; teshima, takanori/0000-0002-0941-271X; Kanaya, Minoru/0000-0002-0035-8657	Ministry of Education, Culture, Sports, Science and Technology, Japan; Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan	This work was supported in part by grants provided by the Ministry of Education, Culture, Sports, Science and Technology, Japan and the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan.; We thank the members of the Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital for serum sampling, the members of CREIL Center, University of Tsukuba for data management, Satoko Mitsuishi and Yuka Nomura (University of Tsukuba) for secretarial assistance, and Mizuha Kosugi-Kanaya (Hokkaido University, Sapporo) for helpful discussions. This work was supported in part by grants provided by the Ministry of Education, Culture, Sports, Science and Technology, Japan and the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan.	Ando M, 2010, BONE MARROW TRANSPL, V45, P1427, DOI 10.1038/bmt.2009.377; Ayano M, 2015, J IMMUNOL, V195, P892, DOI 10.4049/jimmunol.1403046; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Ferrara JLM, 2011, BLOOD, V118, P6702, DOI 10.1182/blood-2011-08-375006; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Harris AC, 2013, BRIT J HAEMATOL, V160, P288, DOI 10.1111/bjh.12142; Harris AC, 2012, BLOOD, V119, P2960, DOI 10.1182/blood-2011-10-387357; Hattori K, 1997, BLOOD, V90, P542, DOI 10.1182/blood.V90.2.542.542_542_548; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Jankovic D, 2013, J EXP MED, V210, P1899, DOI 10.1084/jem.20130084; Koyama M, 2013, BLOOD, V121, P3511, DOI 10.1182/blood-2012-07-444026; Luft T, 2011, BLOOD, V118, P1685, DOI 10.1182/blood-2011-02-334821; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Martinez C, 2011, HAEMATOL-HEMATOL J, V96, P1249, DOI 10.3324/haematol.2011.050534; McDonald GB, 2015, BLOOD, V126, P113, DOI 10.1182/blood-2015-03-636753; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; Nakai K, 2005, LEUKEMIA, V19, P396, DOI 10.1038/sj.leu.2403640; Paczesny S, 2013, BLOOD, V121, P585, DOI 10.1182/blood-2012-08-355990; Paczesny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000406; Paczesny S, 2009, BLOOD, V113, P273, DOI 10.1182/blood-2008-07-167098; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sato M, 2013, BONE MARROW TRANSPL, V48, P698, DOI 10.1038/bmt.2012.193; Seth S, 2011, P NATL ACAD SCI USA, V108, pE32, DOI 10.1073/pnas.1017969108; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Soriani A, 2009, BLOOD, V113, P3503, DOI 10.1182/blood-2008-08-173914; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Vander Lugt MT, 2013, NEW ENGL J MED, V369, P529, DOI 10.1056/NEJMoa1213299; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Xiao B, 2013, BLOOD, V122, P3365, DOI 10.1182/blood-2013-06-510586	32	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0154173	10.1371/journal.pone.0154173	http://dx.doi.org/10.1371/journal.pone.0154173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257974	gold, Green Submitted, Green Published			2022-12-26	WOS:000377369700008
J	Lee, H; Um, SJ; Kim, YS; Kim, DK; Jang, AS; Choi, HS; Kim, YH; Kim, TE; Yoo, KH; Jung, KS				Lee, Heock; Um, Soo-Jung; Kim, Yun Seong; Kim, Deog Kyeom; Jang, An Soo; Choi, Hye Sook; Kim, Yee Hyung; Kim, Tae Eun; Yoo, Kwang Ha; Jung, Ki-Suck			Association of the Neutrophil-to-Lymphocyte Ratio with Lung Function and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							INFLAMMATORY BIOMARKERS; COPD; VALIDATION	Background The ratio of neutrophils to lymphocytes (NLR) is a widely available marker of inflammation. Several types of inflammatory cells and mediators have been found to be involved in the progression of chronic obstructive pulmonary disease (COPD). We sought to evaluate the association of the NLR with severity of airflow limitation and disease exacerbations in a COPD population. Methods We analyzed 885 patients from the Korean COPD Subtype Study cohort that recruited subjects with COPD from 44 referral hospitals. We determined the relationship of NLR levels to severity of lung function using a linear regression model. In addition, we analyzed the experiences of COPD exacerbation according to the NLR quartiles. Results NLR levels were inversely associated with severity of airflow limitation as measured by FEV1% predicted and absolute values after adjustments for age, gender, body mass index, pack-years of smoking, and the use of inhaled corticosteroid (P<0.001, respectively). In the multivariate binary regression model, the NLR 4th quartile (vs. 1st quartile) was found to be a significant predictor of exacerbations during 1-year follow-up (OR = 2.05, 95% CI = 1.03 to 4.06, P = 0.041). Adding an NLR to FEV1 significantly improved prediction for exacerbations during 1-year follow-up as measured by the net reclassification improvement (NRI = 7.8%, P = 0.032) and the integrated discrimination improvement (IDI = 0.014, P = 0.021). Conclusions The NLR showed a significant inverse relationship to airflow limitation and was a prognostic marker for future exacerbations in patients with COPD.	[Lee, Heock; Um, Soo-Jung] Dong A Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Kim, Yun Seong] Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea; [Kim, Deog Kyeom] Seoul Natl Univ, Coll Med, Dept Internal Med, SMG SNU Boramae Med Ctr, Seoul 151, South Korea; [Jang, An Soo] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Bucheon, South Korea; [Choi, Hye Sook] Dongguk Univ, Gyeongju Hosp, Dept Internal Med, Gyeongju, South Korea; [Kim, Yee Hyung] Kyung Hee Univ, Gangdong Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Tae Eun] Konkuk Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yoo, Kwang Ha] Konkuk Univ, Coll Med, Dept Clin Pharmacol, Seoul, South Korea; [Jung, Ki-Suck] Hallym Univ, Coll Med, Dept Internal Med, Anyang, South Korea	Dong A University; Pusan National University; Seoul National University (SNU); Seoul National University Hospital; Soonchunhyang University; Dongguk University; Kyung Hee University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; Hallym University	Um, SJ (corresponding author), Dong A Univ, Coll Med, Dept Internal Med, Busan, South Korea.	sjum@dau.ac.kr	Jung, Ki-Suck/AAN-2473-2021		Dong-A University	Dong-A University	This study was supported by research funds from Dong-A University.	Agusti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037483; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Birring SS, 2002, AM J RESP CRIT CARE, V166, P1078, DOI 10.1164/rccm.200203-245OC; Celli BR, 2012, AM J RESP CRIT CARE, V185, P1065, DOI 10.1164/rccm.201110-1792OC; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dahl M, 2007, AM J RESP CRIT CARE, V175, P250, DOI 10.1164/rccm.200605-713OC; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; Furutate R, 2016, INTERNAL MED, V55, P223, DOI 10.2169/internalmedicine.55.5772; Global Initiative for Chronic Obstructive Lung Disease, 2015, GLOB STRAT DIAGN MAN; Gray RD, 2010, J CYST FIBROS, V9, P193, DOI 10.1016/j.jcf.2010.01.005; Gunay E, 2014, INFLAMMATION, V37, P374, DOI 10.1007/s10753-013-9749-1; Han YC, 2013, KOREAN CIRC J, V43, P93, DOI 10.4070/kcj.2013.43.2.93; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; MacNee William, 2005, Proc Am Thorac Soc, V2, P258, DOI 10.1513/pats.200504-045SR; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Meguro M, 2007, CHEST, V132, P456, DOI 10.1378/chest.06-0702; Milara J, 2012, RESPIRATION, V83, P147, DOI 10.1159/000332834; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Sorensen AK, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0064-5; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; Taylan M, 2017, CLIN RESPIR J, V11, P311, DOI 10.1111/crj.12336; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Thomsen M, 2013, JAMA-J AM MED ASSOC, V309, P2353, DOI 10.1001/jama.2013.5732; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; Walter RE, 2008, CHEST, V133, P19, DOI 10.1378/chest.07-0058; Yoon NB, 2013, ANN LAB MED, V33, P105, DOI 10.3343/alm.2013.33.2.105	28	45	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156511	10.1371/journal.pone.0156511	http://dx.doi.org/10.1371/journal.pone.0156511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258044	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700070
J	Lombardi, F; Belmonti, S; Fabbiani, M; Morandi, M; Rossetti, B; Tordini, G; Cauda, R; De Luca, A; Di Giambenedetto, S; Montagnani, F				Lombardi, Francesca; Belmonti, Simone; Fabbiani, Massimiliano; Morandi, Matteo; Rossetti, Barbara; Tordini, Giacinta; Cauda, Roberto; De Luca, Andrea; Di Giambenedetto, Simona; Montagnani, Francesca			Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY-VIRUS-INFECTION; SEROLOGICAL RESPONSE; ANTIBODY-RESPONSES; RANDOMIZED-TRIAL; DISEASE; CHILDREN; ERA; INDIVIDUALS; ADOLESCENTS	Objectives Definition of the optimal pneumococcal vaccine strategy in HIV-infected adults is still under evaluation. We aimed to compare immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine (PCV13) versus the 23-valent polysaccharide vaccine (PPSV23) in HIV-infected adults. Methods We performed a pilot, prospective controlled study enrolling HIV-infected pneumococcal vaccine-naive outpatients, aged 18-65 years with CD4 counts >= 200 cells/mu L. Eligible subjects were recruited into two parallel groups: group 1 (n = 50) received two doses of PCV13 eight weeks apart, and group 2 (n = 50) received one dose of PPSV23, as part of their standard of care. Anti-pneumococcal capsular polysaccharide immunoglobulin G concentrations were quantified by ELISA at baseline, 8, 24 and 48 weeks. Clinical and viroimmunological follow-up was performed at the same time points. Unvaccinated, age-atched HIV-negative adults (n = 100) were also enrolled as baseline controls. Results Pre-vaccination specific IgG titers for each pneumococcal antigen did not differ between study groups but they were constantly lower than those from the HIV-negative controls. After immunization, significant increases in IgG titers were observed in both study groups at each time point compared to baseline, but response to serotype 3 was blunted in group 1. Antibody titers for each antigen did not differ between study groups at week 48. Overall, the proportion of subjects achieving seroprotection and seroconversion to all serotypes was comparable between groups. A marked decrease in IgG levels over time was observed with both vaccines. No relevant adverse reactions were reported in either group. Conclusions In this population with favorable immune profile, no relevant differences were observed in immunogenicity between PCV13 and PPSV23. Both vaccines were safe and well tolerated.	[Lombardi, Francesca; Belmonti, Simone; Fabbiani, Massimiliano; Cauda, Roberto; Di Giambenedetto, Simona] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, Largo Agostino Gemelli 8, I-00168 Rome, Italy; [Morandi, Matteo; Tordini, Giacinta; De Luca, Andrea; Montagnani, Francesca] Univ Siena, Dept Med Biotechnol, Viale Bracci 16, Siena, Italy; [Rossetti, Barbara; De Luca, Andrea; Montagnani, Francesca] Hosp Dept Specialized & Internal Med, Univ Div Infect Dis, Viale Bracci 16, Siena, Italy; [Fabbiani, Massimiliano] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy	Catholic University of the Sacred Heart; University of Siena; San Gerardo Hospital; University of Milano-Bicocca	Montagnani, F (corresponding author), Univ Siena, Dept Med Biotechnol, Viale Bracci 16, Siena, Italy.; Montagnani, F (corresponding author), Hosp Dept Specialized & Internal Med, Univ Div Infect Dis, Viale Bracci 16, Siena, Italy.	francesca.montagnani@unisi.it	Rossetti, Barbara/AAA-5989-2019; Montagnani, Francesca/R-3334-2016; Fabbiani, Massimiliano/K-8842-2016; digiambenedetto, simona/AAL-4429-2020; Belmonti, Simone/N-7746-2018; De Luca, Andrea/G-8810-2011; Lombardi, Francesca/ABC-7379-2020	Montagnani, Francesca/0000-0002-2267-1337; Fabbiani, Massimiliano/0000-0002-1343-812X; De Luca, Andrea/0000-0002-9561-9193; Lombardi, Francesca/0000-0001-5757-8346; CAUDA, Roberto/0000-0002-1498-4229	Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR) [2011-004518-40]	Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	The study was funded by the Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR) through a PRIN 2009 project to FM (EudraCT number 2011-004518-40). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abzug MJ, 2006, PEDIATR INFECT DIS J, V25, P920, DOI 10.1097/01.inf.0000237830.33228.c3; Ahmed F, 1996, J INFECT DIS, V173, P83, DOI 10.1093/infdis/173.1.83; Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; [Anonymous], 2014, CADTH RAPID RESPONSE; Bamford A, 2014, AIDS, V28, P2033, DOI 10.1097/QAD.0000000000000385; Belmonti Simone, 2016, J Immunoassay Immunochem, V37, P189, DOI 10.1080/15321819.2015.1106949; Bhorat AE, 2015, AIDS, V29, P1345, DOI 10.1097/QAD.0000000000000689; *CDC, 1989, MMWR-MORBID MORTAL W, V38, P73; *CDC, 1989, MMWR-MORBID MORTAL W, V38, P64; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; European Medicine Agency ( EMA), REVENAR13 SUMM PROD; Falco V, 2006, VACCINE, V24, P2567, DOI 10.1016/j.vaccine.2005.12.021; Feikin DR, 2001, VACCINE, V20, P545, DOI 10.1016/S0264-410X(01)00347-4; Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; Gebo KA, 1996, J INFECT DIS, V173, P857, DOI 10.1093/infdis/173.4.857; Girden E. R., 1992, SAGE U PAPER SERIES, V07-084; Glesby MJ, 2015, J INFECT DIS, V212, P18, DOI 10.1093/infdis/jiu631; Goldblatt D, 2011, CLIN VACCINE IMMUNOL, V18, P1728, DOI 10.1128/CVI.05252-11; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Ho YL, 2013, VACCINE, V31, P4047, DOI 10.1016/j.vaccine.2013.04.065; Hung CC, 2010, HIV MED, V11, P54, DOI 10.1111/j.1468-1293.2009.00744.x; Jordano Q, 2004, CLIN INFECT DIS, V38, P1623, DOI 10.1086/420933; Klugman KP, 2007, CURR OPIN INFECT DIS, V20, P11, DOI 10.1097/QCO.0b013e328012c5f1; Kourtis AP, 2010, JAIDS-J ACQ IMM DEF, V55, P128, DOI 10.1097/QAI.0b013e3181e8ed15; Lu CL, 2014, VACCINE, V32, P1031, DOI 10.1016/j.vaccine.2014.01.009; MASCARTLEMONE F, 1995, J INFECT DIS, V172, P1253, DOI 10.1093/infdis/172.5.1253; McEllistrem MC, 2002, J INFECT DIS, V185, P1364, DOI 10.1086/339882; Munoz-Almagro C, 2013, CURR INFECT DIS REP, V15, P184, DOI 10.1007/s11908-013-0326-4; Nunes MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027929; Nuorti J. P., 2010, Morbidity and Mortality Weekly Report, V59, P1102; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Rubin LG, 2014, CLIN INFECT DIS, V58, pE44, DOI [10.1093/cid/cit816, 10.1093/cid/cit684]; Thanee C, 2011, VACCINE, V29, P5886, DOI 10.1016/j.vaccine.2011.06.072; Vila-Corcoles A, 2013, DRUG AGING, V30, P263, DOI 10.1007/s40266-013-0060-5; WHO, 2005, WHO TECHN REP SER, V927; WHO Pneumococcal Serology Reference Laboratories, MMWR MORB MORTAL WKL	38	16	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156523	10.1371/journal.pone.0156523	http://dx.doi.org/10.1371/journal.pone.0156523			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258647	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700074
J	Meng, LH; Wang, RH; Zhu, BZ; Zhu, HL; Luo, YB; Fu, DQ				Meng, Lan-Huan; Wang, Rui-Heng; Zhu, Ben-Zhong; Zhu, Hong-Liang; Luo, Yun-Bo; Fu, Da-Qi			Efficient Virus-Induced Gene Silencing in Solanum rostratum	PLOS ONE			English	Article							TOBACCO RATTLE VIRUS; BIOSYNTHESIS; TOMATO	Solanum rostratum is a "super weed" that grows fast, is widespread, and produces the toxin solanine, which is harmful to both humans and other animals. To our knowledge, no study has focused on its molecular biology owing to the lack of available transgenic methods and sequence information for S. rostratum. Virus-induced gene silencing (VIGS) is a powerful tool for the study of gene function in plants; therefore, in the present study, we aimed to establish tobacco rattle virus (TRV)-derived VIGS in S. rostratum. The genes for phytoene desaturase (PDS) and Chlorophyll H subunit (ChlH) of magnesium protoporphyrin chelatase were cloned from S. rostratum and used as reporters of gene silencing. It was shown that high-efficiency VIGS can be achieved in the leaves, flowers, and fruit of S. rostratum. Moreover, based on our comparison of three different types of infection methods, true leaf infection was found to be more efficient than cotyledon and sprout infiltration in long-term VIGS in multiple plant organs. In conclusion, the VIGS technology and tomato genomic sequences can be used in the future to study gene function in S. rostratum.	[Meng, Lan-Huan; Wang, Rui-Heng; Zhu, Ben-Zhong; Zhu, Hong-Liang; Luo, Yun-Bo; Fu, Da-Qi] China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Biotechnol, 17 Qinghua Donglu Rd, Beijing 100083, Peoples R China	China Agricultural University	Fu, DQ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Biotechnol, 17 Qinghua Donglu Rd, Beijing 100083, Peoples R China.	daqifu@cau.edu.cn			National Natural Science Foundation of China [31000925, 31571898]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31000925, 31571898).; We would like to thank Dr. S.P. Dinesh-Kumar (University of California, Davis) for providing the pTRV1 and pTRV2 vectors. This work was supported by grants from the National Natural Science Foundation of China (31571898). We also would like to thank Editage [http://www.editage.cn/english-editing/] for English language editing.	Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Brigneti G, 2004, PLANT J, V39, P264, DOI 10.1111/j.1365-313X.2004.02122.x; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Chung E, 2004, MOL CELLS, V17, P377; Dinesh-Kumar SP, 2003, METH MOL B, V236, P287; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Hao Li-Juan, 2014, Zhongguo Zhong Yao Za Zhi, V39, P2034; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; Hiriart JB, 2002, PLANT MOL BIOL, V50, P213, DOI 10.1023/A:1016000627231; Kaloshian Isgouhi, 2007, Methods Mol Biol, V354, P173; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Liu HP, 2012, J INTEGR PLANT BIOL, V54, P422, DOI 10.1111/j.1744-7909.2012.01102.x; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Ryu CM, 2004, PLANT J, V40, P322, DOI 10.1111/j.1365-313X.2004.02211.x; Spitzer B, 2007, PLANT PHYSIOL, V145, P1241, DOI 10.1104/pp.107.105916; Vallejo-Marin M, 2013, PLANT BIOLOGY, V15, P948, DOI 10.1111/j.1438-8677.2012.00715.x; Walker CJ, 1997, BIOCHEM J, V327, P321; Yan HX, 2012, PLANT CELL REP, V31, P1713, DOI 10.1007/s00299-012-1285-1; Zhang CQ, 2006, VIROLOGY, V344, P401, DOI 10.1016/j.virol.2005.08.046; Zhao JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079807	22	5	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156228	10.1371/journal.pone.0156228	http://dx.doi.org/10.1371/journal.pone.0156228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258320	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700043
J	Carmello, JC; Alves, F; Basso, FG; Costa, CAD; Bagnato, VS; Mima, EGD; Pavarina, AC				Carmello, Juliana Cabrini; Alves, Fernanda; Basso, Fernanda G.; de Souza Costa, Carlos Alberto; Bagnato, Vanderlei Salvador; de Oliveira Mima, Ewerton Garcia; Pavarina, Ana Claudia			Treatment of Oral Candidiasis Using Photodithazine (R)-Mediated Photodynamic Therapy In Vivo	PLOS ONE			English	Article							LEVEL LASER IRRADIATION; MURINE MODEL; ALBICANS; INACTIVATION; SUSCEPTIBILITY; EPIDEMIOLOGY; FLUCONAZOLE; NYSTATIN; ADHESION; GROWTH	This study evaluated the effectiveness of antimicrobial photodynamic therapy (aPDT) in the treatment of oral candidiasis in a murine model using Photodithazine (R) (PDZ). This model of oral candidiasis was developed to allow the monitoring of the infection and the establishment of the aPDT treatment. Six-week-old female mice were immunosuppressed and inoculated with C. albicans to induce oral candidiasis. PDZ-mediated aPDT and nystatin treatment were carried out for 5 consecutive days with one application per day. The macroscopic evaluation of oral lesions was performed. After each treatment, the tongue was swabbed to recover C. albicans cells. Viable colonies were quantified and the number of CFU/ml determined. The animals were sacrificed 24 hours and 7 days after treatment and the tongues were surgically removed for histological analysis and analysis of inflammatory cytokines expression (IL-1, TNF-alpha and IL-6) by RT-qPCR. Data were analyzed by two-way ANOVA. PDZ-mediated aPDT was as effective as Nystatin (NYS group) in the inactivation of C. albicans, reducing 3 and 3.2 logs(10) respectively, 24 h after treatment (p<0.05). Animals underwent PDZ-mediated aPDT showed complete remission of oral lesions, while animals treated with NYS presented partial remission of oral lesions in both periods assessed. Histological evaluation revealed mild inflammatory infiltrate in the groups treated with aPDT and NYS in both periods assessed. The aPDT induced the TNF-alpha expression when compared with the control (P-L-) (p<0.05), 24 h and 7 days after treatment. In summary, the murine model developed here was able to mimic the infection and PDZ-mediated aPDT was effective to treat mice with oral candidiasis.	[Carmello, Juliana Cabrini; Alves, Fernanda; de Oliveira Mima, Ewerton Garcia; Pavarina, Ana Claudia] UNESP Univ Estadual Paulista, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Araraquara, SP, Brazil; [Basso, Fernanda G.; de Souza Costa, Carlos Alberto] UNESP Univ Estadual Paulista, Araraquara Dent Sch, Dept Physiol & Pathol, Araraquara, SP, Brazil; [Bagnato, Vanderlei Salvador] Univ Sao Paulo, Phys Inst Sao Carlos, Sao Carlos, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo	Pavarina, AC (corresponding author), UNESP Univ Estadual Paulista, Araraquara Dent Sch, Dept Dent Mat & Prosthodont, Araraquara, SP, Brazil.	pavarina@foar.unesp.br	Mima, Ewerton/X-5176-2019; Pavarina, Ana Claudia/J-8640-2013; Mima, Ewerton/F-9496-2014; Bagnato, Vanderlei S/C-3133-2012; Alves, Fernanda/AAJ-3470-2020; Carmello, Juliana Cabrini/J-8305-2016; de Souza Costa, Carlos Alberto/C-6799-2012	Mima, Ewerton/0000-0002-9575-7625; Mima, Ewerton/0000-0002-9575-7625; de Souza Costa, Carlos Alberto/0000-0002-7455-6867; Pavarina, Ana Claudia/0000-0002-9231-1994; INCT de Optica Basica e Aplicada as Ciencias da Vida (CNPq), CePOF (FAPESP)/0000-0002-6403-4037; Bagnato, Vanderlei Salvador/0000-0003-4833-239X; Cabrini Carmello, Juliana/0000-0002-5285-0571	Sao Paulo Research Foundation (FAPESP) [2012/17468-2]; Centro de Pesquisa, Inovacao e Difusao (CEPID) [2013/07276-1]; Fundacao para o Desenvolvimento da UNESP-FUNDUNESP-PROINTER (PROPe/CDC)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centro de Pesquisa, Inovacao e Difusao (CEPID); Fundacao para o Desenvolvimento da UNESP-FUNDUNESP-PROINTER (PROPe/CDC)	This work was supported by the Sao Paulo Research Foundation (FAPESP), grants number 2012/17468-2 (http://www.bv.fapesp.br/pt/pesquisa/?sort=-data_inicio&q2=% 28id_pesquisador_exact%3A179294%29+AND+%28%28bolsa_exact%3A%22Bolsas+no+Brasil%22+AND+situacao_exact%3A%22Conclu%C3%ADdos%22%29%29) to JCC, Centro de Pesquisa, Inovacao e Difusao (CEPID), grants number 2013/07276-1 (http://www.bv.fapesp.br/pt/auxilios/58564/cepof-centro-de-pesquisa-em-optica-e-fotonica/ ACP) and Fundacao para o Desenvolvimento da UNESP-FUNDUNESP-PROINTER (PROPe/CDC) to ACP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpan A, 2002, POSTGRAD MED J, V78, P455, DOI 10.1136/pmj.78.922.455; Blignaut E, 1999, SADJ, V54, P605; Blomgren J, 1998, ACTA ODONTOL SCAND, V56, P202, DOI 10.1080/00016359850142790; Costa ACBP, 2012, OR SURG OR MED OR PA, V114, P67, DOI 10.1016/j.oooo.2012.02.002; Brackett CM, 2011, PHOTOCH PHOTOBIO SCI, V10, P649, DOI 10.1039/c0pp00354a; Brandis A, 2005, PHOTOCHEM PHOTOBIOL, V81, P983, DOI 10.1562/2004-12-01-RA-389R1.1; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Camargo MR, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-98; Carmello JC, 2015, PHOTOCH PHOTOBIO SCI, V14, P1319, DOI 10.1039/c4pp00368c; Quishida CCC, 2015, LASER MED SCI, V30, P685, DOI 10.1007/s10103-013-1397-z; Darwazeh AMG, 1997, J ORAL PATHOL MED, V26, P233, DOI 10.1111/j.1600-0714.1997.tb01229.x; Mima EGD, 2010, ORAL SURG ORAL MED O, V109, P392, DOI 10.1016/j.tripleo.2009.10.006; Demidova TN, 2004, INT J IMMUNOPATH PH, V17, P245, DOI 10.1177/039463200401700304; Donnelly RF, 2008, MICROBIOL RES, V163, P1, DOI 10.1016/j.micres.2007.08.001; Dovigo LN, 2013, BIOFOULING, V29, P1057, DOI 10.1080/08927014.2013.827668; Dovigo LN, 2013, MED MYCOL, V51, P243, DOI 10.3109/13693786.2012.714081; Dovigo LN, 2011, MYCOSES, V54, P123, DOI 10.1111/j.1439-0507.2009.01769.x; Eggimann P, 2003, LANCET INFECT DIS, V3, P685, DOI 10.1016/S1473-3099(03)00801-6; Engelmann M., 2007, J BIOENERG BIOMEMBR, V39, P175, DOI DOI 10.1007/S10863-007-9075-0; Firczuk M, 2011, PHOTOCH PHOTOBIO SCI, V10, P653, DOI 10.1039/c0pp00308e; Gavish L, 2004, LASER SURG MED, V35, P369, DOI 10.1002/lsm.20108; Gollnick SO, 2003, BRIT J CANCER, V88, P1772, DOI 10.1038/sj.bjc.6600864; Gollnick SO, 1997, CANCER RES, V57, P3904; Hu WP, 2007, J INVEST DERMATOL, V127, P2048, DOI 10.1038/sj.jid.5700826; Jonker MA, 2010, J TRAUMA, V69, P843, DOI 10.1097/TA.0b013e3181c45284; Junqueira JC, 2009, LASER MED SCI, V24, P877, DOI 10.1007/s10103-009-0673-4; KABBUR MB, 1995, COMP HAEMATOL INT, V5, P47, DOI 10.1007/BF00214490; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Kong EF, 2015, INFECT IMMUN, V83, P604, DOI 10.1128/IAI.02843-14; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Lambrechts SAG, 2005, ANTIMICROB AGENTS CH, V49, P2026, DOI 10.1128/AAC.49.5.2026-2034.2005; Lushchak, 2001, COMP BIOCH PHYSL C, V153, P175, DOI DOI 10.1016/J.CBPC.2010.10.004; Mima EG, 2012, CLIN MICROBIOL INFEC, V18, pE380, DOI 10.1111/j.1469-0691.2012.03933.x; Monfrecola G, 2004, PHOTOCH PHOTOBIO SCI, V3, P419, DOI 10.1039/b315629j; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ogawa Y, 2006, J INVEST DERMATOL, V126, P349, DOI 10.1038/sj.jid.5700081; Park H, 2014, VIRULENCE, V5, P625, DOI 10.4161/viru.29699; Pires L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085431; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Seneviratne CJ, 2009, ARCH ORAL BIOL, V54, P1052, DOI 10.1016/j.archoralbio.2009.08.002; Shao Lu-Cheng, 2007, Yaoxue Xuebao, V42, P1129; Soares BM, 2009, J PHOTOCH PHOTOBIO B, V94, P65, DOI 10.1016/j.jphotobiol.2008.07.013; Sorgo AG, 2013, FEMS MICROBIOL LETT, V338, P10, DOI 10.1111/1574-6968.12049; Stadler I, 2000, LASER SURG MED, V27, P255, DOI 10.1002/1096-9101(2000)27:3<255::AID-LSM7>3.0.CO;2-L; Strakhovskaya M. G., 2002, Mikrobiologiya, V71, P345; Strakhovskaya M G, 2002, Dokl Biochem Biophys, V384, P155, DOI 10.1023/A:1016072130789; Tafur J, 2008, PHOTOMED LASER SURG, V26, P323, DOI 10.1089/pho.2007.2184; Takakura N, 2003, MICROBIOL IMMUNOL, V47, P321, DOI 10.1111/j.1348-0421.2003.tb03403.x; Teichert MC, 2002, ORAL SURG ORAL MED O, V93, P155, DOI 10.1067/moe.2002.120051; Totti Marilda Aparecida Gonçalves, 2004, Braz. oral res., V18, P202, DOI 10.1590/S1806-83242004000300005	52	39	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156947	10.1371/journal.pone.0156947	http://dx.doi.org/10.1371/journal.pone.0156947			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253525	gold, Green Published, Green Submitted			2022-12-26	WOS:000377218700067
J	Freund, P; Porpaczy, EA; Le, T; Gruber, M; Pausz, C; Staber, P; Jager, U; Vanura, K				Freund, Patricia; Porpaczy, Edit A.; Trang Le; Gruber, Michaela; Pausz, Clemens; Staber, Philipp; Jaeger, Ulrich; Vanura, Katrina			Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MANTLE CELL LYMPHOMA; TYROSINE KINASE INHIBITOR; HUMAN BREAST-CARCINOMA; CB2 RECEPTOR; GROWTH-INHIBITION; OPIOID RECEPTORS; IMMUNE-SYSTEM; MARGINAL ZONE; CROSS-TALK	The cannabinoid receptors 1 and 2 (CNR1&2) are overexpressed in a variety of malignant diseases and cannabinoids can have noteworthy impact on tumor cell viability and tumor growth. Patients diagnosed with chronic lymphocytic leukemia (CLL) present with very heterogeneous disease characteristics translating into highly differential risk properties. To meet the urgent need for refinement in risk stratification at diagnosis and the search for novel therapies we studied CNR expression and response to cannabinoid treatment in CLL. Expression levels of CNR1&2 were determined in 107 CLL patients by real-time PCR and analyzed with regard to prognostic markers and survival. Cell viability of primary CLL cells was determined in suspension and co-culture after incubation in increasing cannabinoid concentrations under normal and reduced serum conditions and in combination with fludarabine. Impact of cannabinoids on migration of CLL cells towards CXCL12 was determined in transwell plates. We found CNR1&2 to be overexpressed in CLL compared to healthy B-cells. Discriminating between high and low expressing subgroups, only high CNR1 expression was associated with two established high risk markers and conferred significantly shorter overall and treatment free survival. Viability of CLL primary cells was reduced in a dose dependent fashion upon incubation with cannabinoids, however, healthy cells were similarly affected. Under serum reduced conditions, no significant differences were observed within suspension and co-culture, respectively, however, the feeder layer contributed significantly to the survival of CLL cells compared to suspension culture conditions. No significant differences were observed when treating CLL cells with cannabinoids in combination with fludarabine. Interestingly, biologic activity of cannabinoids was independent of both CNR1&2 expression. Finally, we did not observe an inhibition of CXCL12-induced migration by cannabinoids. In contrast to other tumor entities, our data suggest a limited usability of cannabinoids for CLL therapy. Nonetheless, we could define CNR1 mRNA expression as novel prognostic marker.	[Freund, Patricia; Porpaczy, Edit A.; Trang Le; Gruber, Michaela; Pausz, Clemens; Staber, Philipp; Jaeger, Ulrich; Vanura, Katrina] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Med 1, Vienna, Austria	Medical University of Vienna	Vanura, K (corresponding author), Med Univ Vienna, Div Hematol & Hemostaseol, Dept Med 1, Vienna, Austria.	katrina.vanura@meduniwien.ac.at	Vanura, Katrina/AAG-1236-2021; Staber, Philipp Bernhard/ADK-1536-2022	Vanura, Katrina/0000-0002-2217-4998; Staber, Philipp Bernhard/0000-0001-6729-7708	Herzfelder'sche Familienstiftung	Herzfelder'sche Familienstiftung	This work was supported by a grant of the Herzfelder'sche Familienstiftung to KV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almestrand S, 2015, PEERJ, V3, DOI 10.7717/peerj.1056; Atwood BK, 2010, BRIT J PHARMACOL, V160, P467, DOI 10.1111/j.1476-5381.2010.00729.x; Balakrishnan K, 2013, INVEST NEW DRUG, V31, P1384, DOI 10.1007/s10637-013-0002-4; Basu S, 2011, J IMMUNOL, V187, P5720, DOI 10.4049/jimmunol.1102195; Benz AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081675; Bojesen IN, 2003, J LIPID RES, V44, P1790, DOI 10.1194/jlr.M300170-JLR200; Burger JA, 2010, SEMIN CANCER BIOL, V20, P424, DOI 10.1016/j.semcancer.2010.09.005; Cao Y, 2015, LEUKEMIA, V29, P169, DOI 10.1038/leu.2014.187; Costa B, 2004, BRIT J PHARMACOL, V143, P247, DOI 10.1038/sj.bjp.0705920; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; Duncan M, 2013, AM J PHYSIOL-REG I, V305, pR224, DOI 10.1152/ajpregu.00104.2013; Engel MA, 2010, J PHYSIOL PHARMACOL, V61, P89; Farsandaj N, 2012, J ENVIRON PATHOL TOX, V31, P377, DOI 10.1615/JEnvironPatholToxicolOncol.2013005859; Flygare J, 2005, FEBS LETT, V579, P6885, DOI 10.1016/j.febslet.2005.11.020; Fogli S, 2006, FEBS LETT, V580, P1733, DOI 10.1016/j.febslet.2006.02.024; Fowler CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015205; Gallotta D, 2010, BIOCHEM PHARMACOL, V80, P370, DOI 10.1016/j.bcp.2010.04.023; Gentilini D, 2010, FERTIL STERIL, V93, P2588, DOI 10.1016/j.fertnstert.2010.02.006; Ghosh S, 2006, MOL IMMUNOL, V43, P2169, DOI 10.1016/j.molimm.2006.01.005; Graham ES, 2010, INT J IMMUNOPATH PH, V23, P25, DOI 10.1177/039463201002300103; Grimsey NL, 2008, J NEUROSCI METH, V171, P78, DOI 10.1016/j.jneumeth.2008.02.014; Guida M, 2010, ENDOCRINOLOGY, V151, P921, DOI 10.1210/en.2009-0883; Gustafsson K, 2008, INT J CANCER, V123, P1025, DOI 10.1002/ijc.23584; Gustafsson K, 2006, MOL PHARMACOL, V70, P1612, DOI 10.1124/mol.106.025981; Gustafsson SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023003; Gustafsson SB, 2009, CANCER CHEMOTH PHARM, V63, P691, DOI 10.1007/s00280-008-0788-5; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; He F, 2007, MOL PHARMACOL, V72, P1289, DOI 10.1124/mol.107.036566; Hoellenriegel J, 2014, BLOOD, V123, P1032, DOI 10.1182/blood-2013-03-493924; Jones JA, 2014, BLOOD, V123, P1455, DOI 10.1182/blood-2013-09-453092; Jorda MA, 2002, BLOOD, V99, P2786; Jung CK, 2013, ONCOL LETT, V5, P870, DOI 10.3892/ol.2012.1081; Kapur A, 2009, J BIOL CHEM, V284, P29817, DOI 10.1074/jbc.M109.050187; Kathmann M, 2006, N-S ARCH PHARMACOL, V372, P354, DOI 10.1007/s00210-006-0033-x; Kishimoto S, 2005, J BIOCHEM, V137, P217, DOI 10.1093/jb/mvi021; Kishimoto S, 2006, INT ARCH ALLERGY IMM, V140, P3, DOI 10.1159/000092704; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Ligresti A, 2006, J PHARMACOL EXP THER, V318, P1375, DOI 10.1124/jpet.106.105247; Liu YJ, 2013, J BIOL CHEM, V288, P13551, DOI 10.1074/jbc.M113.453811; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcu JP, 2010, MOL CANCER THER, V9, P180, DOI 10.1158/1535-7163.MCT-09-0407; Martinez-Martinez Esther, 2015, Oncoscience, V2, P131; Massi P, 2004, J PHARMACOL EXP THER, V308, P838, DOI 10.1124/jpet.103.061002; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McDougall JJ, 2008, BRIT J PHARMACOL, V153, P358, DOI 10.1038/sj.bjp.0707565; McKallip RJ, 2002, BLOOD, V100, P627, DOI 10.1182/blood-2002-01-0098; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Mohle R, 2001, ANN NY ACAD SCI, V938, P26; Montecucco F, 2008, AM J PHYSIOL-HEART C, V294, pH1145, DOI 10.1152/ajpheart.01328.2007; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Nasser MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023901; Nulent TJWK, 2013, BRIT J ORAL MAX SURG, V51, P604, DOI 10.1016/j.bjoms.2013.03.015; Olea-Herrero N, 2009, BRIT J CANCER, V101, P940, DOI 10.1038/sj.bjc.6605248; Ortega-Alvaro A, 2011, NEUROPSYCHOPHARMACOL, V36, P1489, DOI 10.1038/npp.2011.34; Patil M, 2011, NEUROPHARMACOLOGY, V61, P778, DOI 10.1016/j.neuropharm.2011.05.024; Patinkin D, 2008, EUR J PHARMACOL, V595, P1, DOI 10.1016/j.ejphar.2008.05.002; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Perez-Gomez E, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv077; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Piszcz J A, 2007, Exp Oncol, V29, P221; Pourkhalili N, 2013, TOXICOL MECH METHOD, V23, P120, DOI 10.3109/15376516.2012.730559; Powles T, 2005, BLOOD, V105, P1214, DOI 10.1182/blood-2004-03-1182; Preet A, 2011, CANCER PREV RES, V4, P65, DOI 10.1158/1940-6207.CAPR-10-0181; Puente XS, 2013, NAT GENET, V45, P229, DOI 10.1038/ng.2556; Quiroga MP, 2009, BLOOD, V114, P1029, DOI 10.1182/blood-2009-03-212837; Ramer R, 2015, INT REV CEL MOL BIO, V314, P43, DOI 10.1016/bs.ircmb.2014.10.005; Rayman N, 2007, LEUKEMIA LYMPHOMA, V48, P1389, DOI 10.1080/10428190701377030; Rayman N, 2011, EUR J HAEMATOL, V86, P466, DOI 10.1111/j.1600-0609.2011.01596.x; Richardson SJ, 2007, LEUKEMIA LYMPHOMA, V48, P1855, DOI 10.1080/10428190701534465; Rodriguez-Arias M, 2013, NEUROPHARMACOLOGY, V75, P172, DOI 10.1016/j.neuropharm.2013.07.013; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Saez TMM, 2014, J NEUROCHEM, V129, P637, DOI 10.1111/jnc.12636; Schuh A, 2012, BLOOD, V120, P4191, DOI 10.1182/blood-2012-05-433540; Seely KA, 2012, NEUROPHARMACOLOGY, V63, P905, DOI 10.1016/j.neuropharm.2012.06.046; Shrivastava A, 2011, MOL CANCER THER, V10, P1161, DOI 10.1158/1535-7163.MCT-10-1100; Song ZH, 2000, J PHARMACOL EXP THER, V294, P204; Stamatopoulos B, 2012, HAEMATOL-HEMATOL J, V97, P608, DOI 10.3324/haematol.2011.052779; Suarez-Pinilla P, 2014, BRAIN BEHAV IMMUN, V40, P269, DOI 10.1016/j.bbi.2014.01.018; TANG JL, 1993, INT J IMMUNOPHARMACO, V15, P665, DOI 10.1016/0192-0561(93)90139-P; Tanikawa T, 2011, BIOL PHARM BULL, V34, P1090, DOI 10.1248/bpb.34.1090; Taylor L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10682; Theocharis S, 2015, TUMOUR BIOL IN PRESS; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Velasco G, 2012, NAT REV CANCER, V12, P436, DOI 10.1038/nrc3247; Wasik AM, 2015, CELL CYCLE, V14, P291, DOI 10.1080/15384101.2015.1006536; Wasik Agata M, 2014, Oncoscience, V1, P550; Wasik AM, 2011, SEMIN CANCER BIOL, V21, P313, DOI 10.1016/j.semcancer.2011.10.004; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Xie HR, 2012, J BIOL CHEM, V287, P32288, DOI 10.1074/jbc.M112.381145; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014	92	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156693	10.1371/journal.pone.0156693	http://dx.doi.org/10.1371/journal.pone.0156693			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248492	Green Submitted, Green Published, gold			2022-12-26	WOS:000377184700065
J	Gilmore, JM; Sardiu, ME; Groppe, BD; Thornton, JL; Liu, XY; Dayebgadoh, G; Banks, CA; Slaughter, BD; Unruh, JR; Workman, JL; Florens, L; Washburn, MP				Gilmore, Joshua M.; Sardiu, Mihaela E.; Groppe, Brad D.; Thornton, Janet L.; Liu, Xingyu; Dayebgadoh, Gerald; Banks, Charles A.; Slaughter, Brian D.; Unruh, Jay R.; Workman, Jerry L.; Florens, Laurence; Washburn, Michael P.			WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage	PLOS ONE			English	Article							SHOTGUN PROTEOMICS; UBIQUITIN LIGASE; REPAIR; TECHNOLOGY; ABUNDANCE; PEPTIDES; STRESS; CELLS; GENE; HP1	Proteins that respond to DNA damage play critical roles in normal and diseased states in human biology. Studies have suggested that the S. cerevisiae protein CMR1/YDL156w is associated with histones and is possibly associated with DNA repair and replication processes. Through a quantitative proteomic analysis of affinity purifications here we show that the human homologue of this protein, WDR76, shares multiple protein associations with the histones H2A, H2B, and H4. Furthermore, our quantitative proteomic analysis of WDR76 associated proteins demonstrated links to proteins in the DNA damage response like PARP1 and XRCC5 and heterochromatin related proteins like CBX1, CBX3, and CBX5. Co-immunoprecipitation studies validated these interactions. Next, quantitative imaging studies demonstrated that WDR76 was recruited to laser induced DNA damage immediately after induction, and we compared the recruitment of WDR76 to laser induced DNA damage to known DNA damage proteins like PARP1, XRCC5, and RPA1. In addition, WDR76 co-localizes to puncta with the heterochromatin proteins CBX1 and CBX5, which are also recruited to DNA damage but much less intensely than WDR76. This work demonstrates the chromatin and DNA damage protein associations of WDR76 and demonstrates the rapid response of WDR76 to laser induced DNA damage.	[Gilmore, Joshua M.; Sardiu, Mihaela E.; Groppe, Brad D.; Thornton, Janet L.; Liu, Xingyu; Dayebgadoh, Gerald; Banks, Charles A.; Slaughter, Brian D.; Unruh, Jay R.; Workman, Jerry L.; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Gilmore, Joshua M.] Boehringer Ingelheim Vetmed, St Joseph, MO 64506 USA; [Groppe, Brad D.] Thermo Fisher Sci, Waltham, MA 02451 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Boehringer Ingelheim; Thermo Fisher Scientific	Washburn, MP (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.; Washburn, MP (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	mpw@stowers.org		Unruh, Jay/0000-0003-3077-4990; Florens, Laurence/0000-0002-9310-6650; Banks, Charles/0000-0002-0404-2940; Washburn, Michael/0000-0001-7568-2585	Stowers Institute for Medical Research	Stowers Institute for Medical Research	This work was supported by the Stowers Institute for Medical Research.; This work was solely supported by the Stowers Institute for Medical Research. JMG is now an employee of Boeheringer Ingelheim Vetmedica and BDG is now an employee of Thermo Fisher Scientific. All of JMG's and BDG's contributions to this work was carried out when they were members of the Stowers Institute for Medical Research. Neither Boerheringer Ingelheim Vetmedica nor Thermo Fisher Scientific provided any resources for this project. H2A-Halo, H2B-Halo, H4-Halo with the tag on the C-terminus of each protein was a gift from Marie Schwinn of Promega.	AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; Abu-Jamous B, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0990; Banks CAS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08530; Choi DH, 2012, J MICROBIOL, V50, P112, DOI 10.1007/s12275-012-1597-4; Choi H, 2008, MOL CELL PROTEOMICS, V7, P2373, DOI 10.1074/mcp.M800203-MCP200; Daniels DL, 2012, J PROTEOME RES, V11, P564, DOI 10.1021/pr200459c; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Dinant C, 2009, MOL CELL BIOL, V29, P6335, DOI 10.1128/MCB.01048-09; EDWARDS MJ, 1980, NATURE, V287, P745, DOI 10.1038/287745a0; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gallina I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7533; Gilmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011544; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jones JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148897; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Lum PY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01236; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Sardiu ME, 2015, EMBO REP, V16, P116, DOI 10.15252/embr.201439403; Sardiu ME, 2014, MOL CELL PROTEOMICS, V13, P3114, DOI 10.1074/mcp.M113.037127; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stagge F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078745; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Trautlein D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp932; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weems JC, 2015, J BIOL CHEM, V290, P15030, DOI 10.1074/jbc.M114.632794; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	32	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155492	10.1371/journal.pone.0155492	http://dx.doi.org/10.1371/journal.pone.0155492			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248496	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700015
J	Goral, A; Bieganowski, P; Prus, W; Krzemien-Ojak, L; Kadziolka, B; Fabczak, H; Filipek, A				Goral, Agnieszka; Bieganowski, Pawel; Prus, Wiktor; Krzemien-Ojak, Lucja; Kadziolka, Beata; Fabczak, Hanna; Filipek, Anna			Calcyclin Binding Protein/Siah-1 Interacting Protein Is a Hsp90 Binding Chaperone	PLOS ONE			English	Article							HEAT-SHOCK; POSTTRANSLATIONAL MODIFICATIONS; TERMINAL DOMAIN; SGT1; HEAT-SHOCK-PROTEIN-90; DIMERIZATION; CACYBP/SIP; EXPRESSION; NOVOBIOCIN; COMPLEXES	The Hsp90 chaperone activity is tightly regulated by interaction with many co-chaperones. Since CacyBP/SIP shares some sequence homology with a known Hsp90 co-chaperone, Sgt1, in this work we performed a set of experiments in order to verify whether CacyBP/SIP can interact with Hsp90. By applying the immunoprecipitation assay we have found that CacyBP/SIP binds to Hsp90 and that the middle (M) domain of Hsp90 is responsible for this binding. Furthermore, the proximity ligation assay (PLA) performed on HEp-2 cells has shown that the CacyBP/SIP-Hsp90 complexes are mainly localized in the cytoplasm of these cells. Using purified proteins and applying an ELISA we have shown that Hsp90 interacts directly with CacyBP/SIP and that the latter protein does not compete with Sgt1 for the binding to Hsp90. Moreover, inhibitors of Hsp90 do not perturb CacyBP/SIP-Hsp90 binding. Luciferase renaturation assay and citrate synthase aggregation assay with the use of recombinant proteins have revealed that CacyBP/SIP exhibits chaperone properties. Also, CacyBP/SIP-3xFLAG expression in HEp-2 cells results in the appearance of more basic Hsp90 forms in 2D electrophoresis, which may indicate that CacyBP/SIP dephosphorylates Hsp90. Altogether, the obtained results suggest that CacyBP/SIP is involved in regulation of the Hsp90 chaperone machinery.	[Goral, Agnieszka; Prus, Wiktor; Krzemien-Ojak, Lucja; Kadziolka, Beata; Fabczak, Hanna; Filipek, Anna] Nencki Inst Expt Biol PAS, Warsaw, Poland; [Bieganowski, Pawel] Mossakowski Med Res Ctr PAS, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences	Filipek, A (corresponding author), Nencki Inst Expt Biol PAS, Warsaw, Poland.	a.filipek@nencki.gov.pl	Bieganowski, Pawel/ABC-8554-2021; Kądziołka, Beata/J-1231-2016; Prus, Wiktor/T-8317-2017; Fabczak, Hanna/R-4095-2016	Bieganowski, Pawel/0000-0002-1169-4517; Kądziołka, Beata/0000-0002-9229-440X; Prus, Wiktor/0000-0002-2665-5545; Fabczak, Hanna/0000-0001-6661-4599; Filipek, Anna/0000-0001-9484-9555; Goral, Agnieszka/0000-0002-7324-9718	National Science Centre [2014/15/N/NZ3/04493, 2011/03/B/NZ1/00595, NN303 818640]; statutory funds from Nencki Institute of Experimental Biology	National Science Centre(National Science Centre, Poland); statutory funds from Nencki Institute of Experimental Biology	This work was supported by grants from the National Science Centre: 2014/15/N/NZ3/04493 to AG, 2011/03/B/NZ1/00595 to AF and NN303 818640 to PB, and by statutory funds from the Nencki Institute of Experimental Biology.; Authors would like to thank to Prof. K. Kitagawa (University of British Columbia, Vancouver, Canada) for a generous gift of the pDEST17-hSGT1B plasmid and to Prof. W. Lesniak for a critical reading of the manuscript. This work was supported by grants from the National Science Centre: 2014/15/N/NZ3/04493 to AG, 2011/03/B/NZ1/00595 to AF and NN303 818640 to PB, and by statutory funds from the Nencki Institute of Experimental Biology. We are also grateful to the staff of the Laboratory of Imaging Tissue Structure and Function of the Nencki Institute for skillful technical help.	Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Bhattacharya S, 2005, BIOCHEMISTRY-US, V44, P9462, DOI 10.1021/bi0502689; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Cloutier P, 2013, BBA-GENE REGUL MECH, V1829, P443, DOI 10.1016/j.bbagrm.2013.02.010; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Filipek A, 1996, BIOCHEM J, V320, P585, DOI 10.1042/bj3200585; Filipek A, 2002, J BIOL CHEM, V277, P28848, DOI 10.1074/jbc.M203602200; Gano JJ, 2010, MOL CELL PROTEOMICS, V9, P255, DOI 10.1074/mcp.M900261-MCP200; Kadota Y, 2010, TRENDS BIOCHEM SCI, V35, P199, DOI 10.1016/j.tibs.2009.12.005; Kadota Y, 2008, EMBO REP, V9, P1209, DOI 10.1038/embor.2008.185; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kilanczyk E, 2011, BIOCHEM BIOPH RES CO, V404, P179, DOI 10.1016/j.bbrc.2010.11.088; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Koga F, 2009, ANTICANCER RES, V29, P797; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Lianos GD, 2015, CANCER LETT, V360, P114, DOI 10.1016/j.canlet.2015.02.026; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Mollapour M, 2012, BBA-MOL CELL RES, V1823, P648, DOI 10.1016/j.bbamcr.2011.07.018; Nowotny M, 2003, J BIOL CHEM, V278, P26923, DOI 10.1074/jbc.M211518200; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Schneider G, 2011, AMINO ACIDS, V41, P773, DOI 10.1007/s00726-010-0498-2; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Scroggins BT, 2007, EXPERT OPIN DRUG DIS, V2, P1403, DOI 10.1517/17460441.2.10.1403; Splechowicz M, 2007, BIOCHEM BIOPH RES CO, V357, P1148, DOI 10.1016/j.bbrc.2007.04.073; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Tatokoro M, 2015, EXCLI J, V14, P48, DOI 10.17179/excli2015-586; Topolska-Wos AM, 2016, BBA-GEN SUBJECTS, V1860, P79, DOI 10.1016/j.bbagen.2015.10.012; Topolska-Wos AM, 2015, FASEB J, V29, P1711, DOI 10.1096/fj.14-264770; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Wasik U, 2013, NEUROBIOL AGING, V34, P1380, DOI 10.1016/j.neurobiolaging.2012.11.007; Zabka M, 2008, BIOCHEM BIOPH RES CO, V370, P179, DOI 10.1016/j.bbrc.2008.03.055; Zhai HH, 2008, J HISTOCHEM CYTOCHEM, V56, P765, DOI 10.1369/jhc.2008.950519; Zurawska A, 2010, BBA-MOL CELL RES, V1803, P575, DOI 10.1016/j.bbamcr.2010.03.002	42	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156507	10.1371/journal.pone.0156507	http://dx.doi.org/10.1371/journal.pone.0156507			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249023	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700048
J	Ihlow, F; Courant, J; Secondi, J; Herrel, A; Rebelo, R; Measey, GJ; Lillo, F; De Villiers, FA; Vogt, S; De Busschere, C; Backeljau, T; Rodder, D				Ihlow, Flora; Courant, Julien; Secondi, Jean; Herrel, Anthony; Rebelo, Rui; Measey, G. John; Lillo, Francesco; De Villiers, F. Andre; Vogt, Solveig; De Busschere, Charlotte; Backeljau, Thierry; Rodder, Dennis			Impacts of Climate Change on the Global Invasion Potential of the African Clawed Frog Xenopus laevis	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BIOLOGICAL INVASIONS; EXTREME WEATHER; DISTRIBUTIONS; FUTURE; BIODIVERSITY; EXTINCTION; SCENARIOS; PIPIDAE; PHYLOGEOGRAPHY	By altering or eliminating delicate ecological relationships, non-indigenous species are considered a major threat to biodiversity, as well as a driver of environmental change. Global climate change affects ecosystems and ecological communities, leading to changes in the phenology, geographic ranges, or population abundance of several species. Thus, predicting the impacts of global climate change on the current and future distribution of invasive species is an important subject in macroecological studies. The African clawed frog (Xenopus laevis), native to South Africa, possesses a strong invasion potential and populations have become established in numerous countries across four continents. The global invasion potential of X. laevis was assessed using correlative species distribution models (SDMs). SDMs were computed based on a comprehensive set of occurrence records covering South Africa, North America, South America and Europe and a set of nine environmental predictors. Models were built using both a maximum entropy model and an ensemble approach integrating eight algorithms. The future occurrence probabilities for X. laevis were subsequently computed using bioclimatic variables for 2070 following four different IPCC scenarios. Despite minor differences between the statistical approaches, both SDMs predict the future potential distribution of X. laevis, on a global scale, to decrease across all climate change scenarios. On a continental scale, both SDMs predict decreasing potential distributions in the species' native range in South Africa, as well as in the invaded areas in North and South America, and in Australia where the species has not been introduced. In contrast, both SDMs predict the potential range size to expand in Europe. Our results suggest that all probability classes will be equally affected by climate change. New regional conditions may promote new invasions or the spread of established invasive populations, especially in France and Great Britain.	[Ihlow, Flora; Vogt, Solveig; Rodder, Dennis] Zoolog Forsch Museum Alexander Koenig, Herpetol Sect, Bonn, Germany; [Courant, Julien; Herrel, Anthony] UMR7179 CNRS MNHN, Paris, France; [Secondi, Jean] Univ Lyon 1, UMR CNRS LEHNA 5023, F-69365 Lyon, France; [Secondi, Jean] Univ Angers, UMR CNRS LETG LEESA 6554, Angers, France; [Rebelo, Rui] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes, Lisbon, Portugal; [Measey, G. John; De Villiers, F. Andre] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, Private Bag X1, ZA-7602 Stellenbosch, South Africa; [Lillo, Francesco] Univ Palermo, Dipartimento Sci & Tecnol Biol Chim & Farmaceut, Palermo, Italy; [De Busschere, Charlotte; Backeljau, Thierry] Royal Belgian Inst Nat Sci, Brussels, Belgium; [De Busschere, Charlotte; Backeljau, Thierry] Univ Antwerp, B-2020 Antwerp, Belgium	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite d'Angers; Universidade de Lisboa; Stellenbosch University; University of Palermo; Royal Belgian Institute of Natural Sciences; University of Antwerp	Ihlow, F (corresponding author), Zoolog Forsch Museum Alexander Koenig, Herpetol Sect, Bonn, Germany.	F.Ihlow@ZFMK.de	Herrel, Anthony/C-3712-2013; Rebelo, Rui/D-7054-2013; Rödder, Dennis/AAT-8644-2021; Measey, John/F-2028-2010	Herrel, Anthony/0000-0003-0991-4434; Rebelo, Rui/0000-0003-2544-1470; Rödder, Dennis/0000-0002-6108-1639; Measey, John/0000-0001-9939-7615; Courant, Julien/0000-0002-1946-5444; Secondi, Jean/0000-0001-8130-1195; Ihlow, Flora/0000-0002-0460-4210	biodiversa project "Invasive biology of Xenopus laevis in Europe: ecology, impact and predictive models"; Deutsche Forschungsgemeinschaft (DFG) [RO 4520/3-1]; Leibniz Association	biodiversa project "Invasive biology of Xenopus laevis in Europe: ecology, impact and predictive models"; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Leibniz Association	This research was funded by biodiversa (http://www.biodiversa.org/, project title: "Invasive biology of Xenopus laevis in Europe: ecology, impact and predictive models," grant recipients: AH, RR, TB, DR) and the Deutsche Forschungsgemeinschaft (http://www.dfg.de/, DFG RO 4520/3-1, grant recipient: DR). The publication of this article was funded by the Open Access fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly David D., 2003, International Journal of Plant Sciences, V164, pS165, DOI 10.1086/368401; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Amaral P, 2012, HERPETOL J, V22, P187; BALINSKY B I, 1969, Zoologica Africana, V4, P37; Balint M, 2011, NAT CLIM CHANGE, V1, P313, DOI 10.1038/NCLIMATE1191; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Beebee TJ., 2009, NATURE, V374, P219; Bertelsmeier C, 2015, BIODIVERS CONSERV, V24, P117, DOI 10.1007/s10531-014-0794-3; Blaustein AR, 2001, CONSERV BIOL, V15, P1804, DOI 10.1046/j.1523-1739.2001.00307.x; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Clavero M, 2006, ECOL APPL, V16, P2313, DOI 10.1890/1051-0761(2006)016[2313:HDAIRO]2.0.CO;2; Corn P. S., 2005, Animal Biodiversity and Conservation, V28, P59; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Crayon JJ, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P522; De Busschere C, 2016, PEERJ, V4, DOI 10.7717/peerj.1659; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Faraone FP, 2008, AMPHIBIA-REPTILIA, V29, P405, DOI 10.1163/156853808785112075; Ficetola GF, 2010, GLOBAL CHANGE BIOL, V16, P528, DOI 10.1111/j.1365-2486.2009.01957.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Fouquet A, 2001, ZAMENIS, V6, P10; Fouquet A, 2006, ANIM BIOL, V56, P95, DOI 10.1163/157075606775904722; Furman BLS, 2015, MOL ECOL, V24, P909, DOI 10.1111/mec.13076; Harrison PA, 2006, ENVIRON SCI POLICY, V9, P116, DOI 10.1016/j.envsci.2005.11.003; Herrel A, 2014, HERPETOL J, V24, P103; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Ihlow F, 2012, GLOBAL CHANGE BIOL, V18, P1520, DOI 10.1111/j.1365-2486.2011.02623.x; Kolbe JJ, 2010, ECOL APPL, V20, P2273, DOI 10.1890/09-1973.1; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; Lillo F, 2013, ITAL J ZOOL, V80, P566, DOI 10.1080/11250003.2013.847502; Lillo Francesco, 2005, Herpetozoa, V18, P63; Lillo F, 2011, BIOL INVASIONS, V13, P1533, DOI 10.1007/s10530-010-9911-8; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobos G, 2005, BIODIVERS CONSERV, V14, P429, DOI 10.1007/s10531-004-6403-0; Lobos G, 2002, HERPETOL J, V12, P163; Lobos G, 2014, STUD NEOTROP FAUNA E, V49, P50, DOI 10.1080/01650521.2014.912865; Lobos G, 2013, STUD NEOTROP FAUNA E, V48, P1, DOI 10.1080/01650521.2012.746050; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lodge DM, 2001, FUTURE SCENARIOS GLO, P277; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MCCOID M J, 1980, Bulletin Southern California Academy of Sciences, V79, P82; MCCOID MJ, 1995, CALIF FISH GAME, V81, P39; MCCOID MJ, 1985, CALIF FISH GAME, V71, P245; McNeely JA, 2001, GLOBAL STRATEGY INVA; McNeely JA, 2006, EUPHYTICA, V148, P5, DOI 10.1007/s10681-006-5937-5; Measey GJ, 2012, BIOL INVASIONS, V14, P2255, DOI 10.1007/s10530-012-0227-8; Measey GJ, 2003, AMPHIBIA-REPTILIA, V24, P321, DOI 10.1163/156853803322440781; Measey GJ, 1998, HERPETOL J, V8, P23; Meyerson LA, 2002, BIOSCIENCE, V52, P593, DOI 10.1641/0006-3568(2002)052[0593:BMTACA]2.0.CO;2; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Miller D, 2004, FERTIL STERIL, V81, P954, DOI 10.1016/j.fertnstert.2003.09.051; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; *NAT INV SPEC COUN, 2001, M INV SPEC CHALL NAT; Nori J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025718; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pounds JA, 2001, NATURE, V410, P639, DOI 10.1038/35070683; Pyke CR, 2008, CONSERV BIOL, V22, P585, DOI 10.1111/j.1523-1739.2008.00956.x; R Development Core Team, R LANG ENV STAT COMP; Ramirez Villejas J., 2010, 1 INT CTR TROP AGR C; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Rebelo R, 2010, BIOL INVASIONS, V12, P3383, DOI 10.1007/s10530-010-9757-0; Rocchini D, 2011, PROG PHYS GEOG, V35, P211, DOI 10.1177/0309133311399491; Rowland EL, 2011, ENVIRON MANAGE, V47, P322, DOI 10.1007/s00267-010-9608-x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Sutherst RW, 1996, CONSERV BIOL, V10, P294, DOI 10.1046/j.1523-1739.1996.10010294.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2013, ECOL LETT, V16, P94, DOI 10.1111/ele.12104; Thuiller Wilfried, 2007, V193, P197; Tinsley R.C., 1996, Symposia of the Zoological Society of London, V68, P81; Tinsley RC, 2015, BIOL INVASIONS, V17, P3183, DOI 10.1007/s10530-015-0944-x; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; van Sittert Lance, 2016, Transactions of the Royal Society of South Africa, V71, P157, DOI 10.1080/0035919X.2016.1158747; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Villiers De, 2016, THESIS STELLENBOSCH; VilO M., 2007, TERRESTRIAL ECOSYSTE, P93, DOI DOI 10.1007/978-3-540-32730-1_8; Vogel G, 2008, SCIENCE, V319, P1472, DOI 10.1126/science.319.5869.1472a; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x	103	39	39	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0154869	10.1371/journal.pone.0154869	http://dx.doi.org/10.1371/journal.pone.0154869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248830	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700007
J	Fernandez-Egea, E; Vertes, PE; Flint, SM; Turner, L; Mustafa, S; Hatton, A; Smith, KGC; Lyons, PA; Bullmore, ET				Fernandez-Egea, Emilio; Vertes, Petra E.; Flint, Shaun M.; Turner, Lorinda; Mustafa, Syed; Hatton, Alex; Smith, Kenneth G. C.; Lyons, Paul A.; Bullmore, Edward T.			Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; HUMAN IMMUNOLOGY PROJECT; T-CELLS; DENDRITIC CELLS; DOPAMINE; LYMPHOCYTES; PSYCHOSIS; PHARMACOLOGY; EXPRESSION; CLOZAPINE	Background Hypothetically, psychotic disorders could be caused or conditioned by immunological mechanisms. If so, one might expect there to be peripheral immune system phenotypes that are measurable in blood cells as biomarkers of psychotic states. Methods We used multi-parameter flow cytometry of venous blood to quantify and determine the activation state of 73 immune cell subsets for 18 patients with chronic schizophrenia (17 treated with clozapine), and 18 healthy volunteers matched for age, sex, BMI and smoking. We used multivariate methods (partial least squares) to reduce dimensionality and define populations of differentially co-expressed cell counts in the cases compared to controls. Results Schizophrenia cases had increased relative numbers of NK cells, naive B cells, CXCR5(+) memory T cells and classical monocytes; and decreased numbers of dendritic cells (DC), HLA-DR+ regulatory T-cells (Tregs), and CD4(+) memory T cells. Likewise, within the patient group, more severe negative and cognitive symptoms were associated with decreased relative numbers of dendritic cells, HLA-DR+ Tregs, and CD4(+) memory T cells. Motivated by the importance of central nervous system dopamine signalling for psychosis, we measured dopamine receptor gene expression in separated CD4(+) cells. Expression of the dopamine D3 (DRD3) receptor was significantly increased in clozapine-treated schizophrenia and covaried significantly with differentiated T cell classes in the CD4(+) lineage. Conclusions Peripheral immune cell populations and dopaminergic signalling are disrupted in clozapine-treated schizophrenia. Immuno-phenotypes may provide peripherally accessible and mechanistically specific biomarkers of residual cognitive and negative symptoms in this treatment-resistant subgroup of patients.	[Fernandez-Egea, Emilio; Turner, Lorinda; Smith, Kenneth G. C.; Bullmore, Edward T.] Cambridge Univ Hosp NHS Fdn Trust, NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Fernandez-Egea, Emilio; Turner, Lorinda; Smith, Kenneth G. C.; Bullmore, Edward T.] Univ Cambridge, Cambridge, England; [Fernandez-Egea, Emilio; Vertes, Petra E.; Mustafa, Syed; Bullmore, Edward T.] Univ Cambridge, Dept Psychiat, Behav & Clin Neurosci Inst, Cambridge, England; [Fernandez-Egea, Emilio] Ctr Invest Biomed Red Salud Mental CIBERSAM, G04, Barcelona, Spain; [Fernandez-Egea, Emilio; Bullmore, Edward T.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Flint, Shaun M.; Turner, Lorinda; Hatton, Alex; Smith, Kenneth G. C.; Lyons, Paul A.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England; [Flint, Shaun M.; Turner, Lorinda; Hatton, Alex; Smith, Kenneth G. C.; Lyons, Paul A.] Univ Cambridge, Cambridge Inst Med Res, Sch Clin Med, Cambridge, England; [Bullmore, Edward T.] GlaxoSmithKline, ImmunoPsychiat Alternat Discovery & Dev, Pharmaceut R&D, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Cambridge; University of Cambridge; GlaxoSmithKline	Bullmore, ET (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, NIHR Cambridge Biomed Res Ctr, Cambridge, England.; Bullmore, ET (corresponding author), Univ Cambridge, Cambridge, England.; Bullmore, ET (corresponding author), Univ Cambridge, Dept Psychiat, Behav & Clin Neurosci Inst, Cambridge, England.; Bullmore, ET (corresponding author), Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England.; Bullmore, ET (corresponding author), GlaxoSmithKline, ImmunoPsychiat Alternat Discovery & Dev, Pharmaceut R&D, Cambridge, England.	etb23@cam.ac.uk	Bullmore, Ed/C-1706-2012	Bullmore, Ed/0000-0002-8955-8283; Turner, Lorinda/0000-0001-9032-1796; Vertes, Petra E./0000-0002-0992-3210; Fernandez-Egea, Emilio/0000-0003-4128-8955; Smith, Kenneth/0000-0003-3829-4326	NIHR Cambridge Biomedical Research Centre; NIHR Clinical Research Network: Eastern; Medical Research Council (MRC) Bioinformatics Fellowship [MR/K020706/1]; MRC [MR/L019027/1]; Wellcome Trust; Translational Medicine and Therapeutics clinical research training program in the University of Cambridge; Wellcome Trust Strategic Award [079895]; NARSAD Young investigator Award; GlaxoSmithKline (GSK); Medical Research Council [G1000183B, G0001354, G1000183, MR/K020706/1, MR/L019027/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10051] Funding Source: researchfish; MRC [G1000183, MR/K020706/1] Funding Source: UKRI	NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Clinical Research Network: Eastern; Medical Research Council (MRC) Bioinformatics Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Translational Medicine and Therapeutics clinical research training program in the University of Cambridge; Wellcome Trust Strategic Award(Wellcome Trust); NARSAD Young investigator Award(NARSAD); GlaxoSmithKline (GSK)(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the NIHR Cambridge Biomedical Research Centre and the NIHR Clinical Research Network: Eastern. PEV is supported by a Medical Research Council (MRC) Bioinformatics Fellowship (grant no. MR/K020706/1). The Behavioural & Clinical Neuroscience Institute is supported by the MRC and the Wellcome Trust. SMF is supported by the Translational Medicine and Therapeutics clinical research training program in the University of Cambridge; and SMF, KGCS and PAL are supported by the MRC (MR/L019027/1). The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award (079895). EFE was supported in part by 2009 NARSAD Young investigator Award. The authors acknowledge the NIHR Cambridge Bioresource for recruitment of healthy volunteers and clozapine clinic patients and staff members. GlaxoSmithKline (GSK) provided support in the form of salary for ETB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of ETB as an author of this paper is articulated in the 'author contributions' section.	Abdi Herve, 2013, Methods Mol Biol, V930, P549, DOI 10.1007/978-1-62703-059-5_23; Barkus EJ, 2006, PSYCHOPATHOLOGY, V39, P175, DOI 10.1159/000092678; Beumer W, 2012, J LEUKOCYTE BIOL, V92, P959, DOI 10.1189/jlb.0212100; Boneberg EM, 2006, J NEUROIMMUNOL, V173, P180, DOI 10.1016/j.jneuroim.2005.11.018; Brito-Melo GEA, 2012, J PSYCHIATR RES, V46, P738, DOI 10.1016/j.jpsychires.2012.03.004; Brusic V, 2014, NAT BIOTECHNOL, V32, P146, DOI 10.1038/nbt.2777; Bullmore ET, 2014, BIOL PSYCHIAT, V75, P260, DOI 10.1016/j.biopsych.2013.12.006; Carter CS, 2014, BIOL PSYCHIAT, V75, P258, DOI 10.1016/j.biopsych.2013.10.023; Cazzullo CL, 1998, SCHIZOPHR RES, V31, P49, DOI 10.1016/S0920-9964(97)00153-9; Chen ML, 2013, IMMUNOPHARM IMMUNOT, V35, P573, DOI 10.3109/08923973.2013.828744; Chen ML, 2012, IMMUNOPHARM IMMUNOT, V34, P686, DOI 10.3109/08923973.2011.651535; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Craddock RM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000692; Drexhage RC, 2011, INT J NEUROPSYCHOPH, V14, P746, DOI 10.1017/S1461145710001653; Drexhage RC, 2010, INT J NEUROPSYCHOPH, V13, P1369, DOI 10.1017/S1461145710000799; Ersche KD, 2011, PSYCHOPHARMACOLOGY, V214, P779, DOI 10.1007/s00213-010-2087-1; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Fillman SG, 2013, MOL PSYCHIATR, V18, P206, DOI 10.1038/mp.2012.110; Haro JM, 2003, ACTA PSYCHIAT SCAND, V107, P16, DOI 10.1034/j.1600-0447.107.s416.5.x; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Ilani T, 2001, P NATL ACAD SCI USA, V98, P625, DOI 10.1073/pnas.021535398; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Keefe RSE, 2004, SCHIZOPHR RES, V68, P283, DOI 10.1016/j.schres.2003.09.011; Kipnis J, 2012, NAT REV IMMUNOL, V12, P662, DOI 10.1038/nri3280; Kwak Y T, 2001, BMC Med Genet, V2, P3, DOI 10.1186/1471-2350-2-3; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Maino K, 2007, PSYCHIAT RES, V152, P173, DOI 10.1016/j.psychres.2006.06.004; Miller BJ, 2013, BIOL PSYCHIAT, V73, P993, DOI 10.1016/j.biopsych.2012.09.007; Miller BJ, 2013, PROG NEURO-PSYCHOPH, V42, P92, DOI 10.1016/j.pnpbp.2012.03.010; Miyamoto S, 2012, MOL PSYCHIATR, V17, P1206, DOI 10.1038/mp.2012.47; Nagai Y, 1996, NEUROLOGY, V46, P791, DOI 10.1212/WNL.46.3.791; Nakajima S, 2013, EUR NEUROPSYCHOPHARM, V23, P799, DOI 10.1016/j.euroneuro.2013.05.006; National Institute for Health and Care Excellence (NICE), 2014, PSYCH SCHIZ AD, P1; O'Sullivan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104430; Olsson Eric, 2015, Prim Care Companion CNS Disord, V17, DOI 10.4088/PCC.14m01704; Pacheco Rodrigo, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P65; Pacheco R, 2009, J NEUROIMMUNOL, V216, P8, DOI 10.1016/j.jneuroim.2009.07.018; Prado C, 2012, J IMMUNOL, V188, P3062, DOI 10.4049/jimmunol.1103096; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roge R, 2012, SCHIZOPHR RES, V140, P204, DOI 10.1016/j.schres.2012.06.020; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Schofield PN, 2010, SCIENCE, V330, P592, DOI 10.1126/science.1191506; Sperner-Unterweger B, 1999, SCHIZOPHR RES, V38, P61, DOI 10.1016/S0920-9964(98)00175-3; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steiner J, 2012, BRAIN BEHAV IMMUN, V26, P564, DOI 10.1016/j.bbi.2012.01.018; Steiner J, 2010, EUR ARCH PSY CLIN N, V260, P509, DOI 10.1007/s00406-010-0098-x; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Tourjman V, 2013, SCHIZOPHR RES, V151, P43, DOI 10.1016/j.schres.2013.10.011; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Urhan-Kucuk M, 2011, MOL BIOL REP, V38, P2569, DOI 10.1007/s11033-010-0396-4; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; WHO, 2011, INT STAT CLASS DIS R	52	48	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155631	10.1371/journal.pone.0155631	http://dx.doi.org/10.1371/journal.pone.0155631			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244229	Green Submitted, Green Published, gold			2022-12-26	WOS:000377146100004
J	Mitra, A; Guevremont, G; Timofeeva, E				Mitra, Arojit; Guevremont, Genevieve; Timofeeva, Elena			Stress and Sucrose Intake Modulate Neuronal Activity in the Anterior Hypothalamic Area in Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; LATERAL SEPTUM; FOOD-INTAKE; GLUTAMATE-DECARBOXYLASE; INSITU HYBRIDIZATION; PREFRONTAL CORTEX; RESTRAINT STRESS; FOOTSHOCK STRESS; LICKING ACTIVITY	The anterior hypothalamic area (AHA) is an important integrative relay structure for a variety of autonomic, endocrine, and behavioral responses including feeding behavior and response to stress. However, changes in the activity of the AHA neurons during stress and feeding in freely moving rats are not clear. The present study investigated the firing rate and burst activity of neurons in the central nucleus of the AHA (cAHA) during sucrose intake in non-stressful conditions and after acute stress in freely behaving rats. Rats were implanted with micro-electrodes into the cAHA, and extracellular multi-unit activity was recorded during 1-h access to 10% sucrose in non-stressful conditions or after acute foot shock stress. Acute stress significantly reduced sucrose intake, total sucrose lick number, and lick frequency in licking clusters, and increased inter-lick intervals. At the cluster start (CS) of sucrose licking, the cAHA neurons increased (CS-excited, 20% of the recorded neurons), decreased (CS-inhibited, 42% of the neurons) or did not change (CS-nonresponsive, 38% of the neurons) their firing rate. Stress resulted in a significant increase in the firing rate of the CS-inhibited neurons by decreasing inter-spike intervals within the burst firing of these neurons. This increase in the stress-induced firing rate of the CS-inhibited neurons was accompanied by a disruption of the correlation between the firing rate of CS-inhibited and CS-nonresponsive neurons that was observed in non-stressful conditions. Stress did not affect the firing rate of the CS-excited and CS-nonresponsive neurons. However, stress changed the pattern of burst firing of the CS-excited and CS-nonresponsive neurons by decreasing and increasing the burst number in the CS-excited and CS-nonresponsive neurons, respectively. These results suggest that the cAHA neurons integrate the signals related to stress and intake of palatable food and play a role in the stress-and eating-related circuitry.	[Mitra, Arojit; Guevremont, Genevieve; Timofeeva, Elena] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Dept Psychiat & Neurosci,Fac Med, Quebec City, PQ G1V 0A6, Canada	Laval University	Timofeeva, E (corresponding author), Univ Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Dept Psychiat & Neurosci,Fac Med, Quebec City, PQ G1V 0A6, Canada.	Elena.Timofeeva@fmed.ulaval.ca	Mitra, Arojit/AGE-5058-2022	MITRA, AROJIT/0000-0002-4026-4057	Canadian Institutes of Health Research [102659]; Natural Sciences and Engineering Research Council of Canada [327597]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number 102659 (grant received by ET); and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), grant number 327597 (grant received by ET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE JW, 1991, BRAIN RES, V543, P123; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Anthony TE, 2014, CELL, V156, P522, DOI 10.1016/j.cell.2013.12.040; Bali A, 2015, REV NEUROSCI; Bali B, 2005, NEUROSCI LETT, V380, P60, DOI 10.1016/j.neulet.2005.01.014; BERRIDGE KC, 1995, NEUROSCI BIOBEHAV R, V19, P121, DOI 10.1016/0149-7634(94)00026-W; Berthoud HR, 2011, PHYSIOL BEHAV, V104, P29, DOI 10.1016/j.physbeh.2011.04.051; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; BOURQUE CW, 1991, BRAIN RES, V540, P349, DOI 10.1016/0006-8993(91)90535-4; Calvez J, 2015, GENES BRAIN BEHAV, V14, P550, DOI 10.1111/gbb.12236; Chen L, 2009, PROG NAT SCI-MATER, V19, P229, DOI 10.1016/j.pnsc.2008.05.027; Christiansen AM, 2011, STRESS, V14, P205, DOI 10.3109/10253890.2010.531331; Christiansen AM, 2011, PHYSIOL BEHAV, V103, P111, DOI 10.1016/j.physbeh.2011.01.015; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Constantin S, 2013, J NEUROSCI, V33, P9394, DOI 10.1523/JNEUROSCI.0533-13.2013; Constantin S, 2012, ENDOCRINOLOGY, V153, P3758, DOI 10.1210/en.2012-1126; Cooper SJ, 2005, APPETITE, V44, P133, DOI 10.1016/j.appet.2005.01.003; Cottone P, 2007, NEUROPSYCHOPHARMACOL, V32, P1069, DOI 10.1038/sj.npp.1301229; Cottone P, 2012, NEUROPSYCHOPHARMACOL, V37, P2593, DOI 10.1038/npp.2012.89; DAVIS JD, 1990, AM J PHYSIOL, V259, pR1228, DOI 10.1152/ajpregu.1990.259.6.R1228; DAVIS JD, 1992, BEHAV NEUROSCI, V106, P217, DOI 10.1037/0735-7044.106.1.217; DAVIS JD, 1993, AM J PHYSIOL, V264, pR97, DOI 10.1152/ajpregu.1993.264.1.R97; DYBALL REJ, 1991, J NEUROENDOCRINOL, V3, P383, DOI 10.1111/j.1365-2826.1991.tb00291.x; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; FALLON JH, 1986, J COMP NEUROL, V249, P293, DOI 10.1002/cne.902490302; FERRIS CF, 1990, J COMP NEUROL, V293, P476, DOI 10.1002/cne.902930310; Foster MT, 2009, ENDOCRINOLOGY, V150, P2325, DOI 10.1210/en.2008-1426; FUCHS SAG, 1985, BRAIN RES, V330, P93, DOI 10.1016/0006-8993(85)90010-1; Gavrilov Yu V, 2008, Neurosci Behav Physiol, V38, P87, DOI 10.1007/s11055-008-0012-4; Gerstner W, 1997, P NATL ACAD SCI USA, V94, P12740, DOI 10.1073/pnas.94.24.12740; GIRARD CL, 1986, CAN J PHYSIOL PHARM, V64, P406, DOI 10.1139/y86-065; HARLAN RE, 1987, J COMP NEUROL, V258, P159, DOI 10.1002/cne.902580202; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Herbison AE, 2011, J NEUROENDOCRINOL, V23, P557, DOI 10.1111/j.1365-2826.2011.02145.x; Higgs S, 2004, PROG NEURO-PSYCHOPH, V28, P405, DOI 10.1016/j.pnpbp.2003.11.003; Homayoun H, 2006, CEREB CORTEX, V16, P93, DOI 10.1093/cercor/bhi087; Homayoun L, 2005, J NEUROPHYSIOL, V93, P1989, DOI 10.1152/jn.00875.2004; IMAKI T, 1993, BRAIN RES, V616, P114, DOI 10.1016/0006-8993(93)90199-W; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; JOHANSSON O, 1984, NEUROSCIENCE, V13, P265, DOI 10.1016/0306-4522(84)90233-1; KANT GJ, 1983, LIFE SCI, V33, P2657; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kim MS, 2000, DIABETES, V49, P177, DOI 10.2337/diabetes.49.2.177; Kim U, 1998, J NEUROSCI, V18, P9500; Kinzig KP, 2008, PHYSIOL BEHAV, V95, P108, DOI 10.1016/j.physbeh.2008.04.026; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Kubo T, 2001, BRAIN RES BULL, V56, P569, DOI 10.1016/S0361-9230(01)00729-8; LAMMERS JHCM, 1988, BRAIN RES, V449, P311, DOI 10.1016/0006-8993(88)91046-3; LAMMERS JHCM, 1988, BRAIN RES, V449, P294, DOI 10.1016/0006-8993(88)91045-1; LARSEN PJ, 1992, J COMP NEUROL, V316, P287, DOI 10.1002/cne.903160304; Lee K, 2010, J NEUROSCI, V30, P6214, DOI 10.1523/JNEUROSCI.6156-09.2010; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Li CY, 2007, J PHYSIOL-LONDON, V581, P221, DOI 10.1113/jphysiol.2006.123810; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Martin J, 2010, AM J PHYSIOL-REG I, V298, pR1383, DOI 10.1152/ajpregu.00371.2009; MCCARTY R, 1978, PHYSIOL BEHAV, V21, P567, DOI 10.1016/0031-9384(78)90132-4; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Miller BR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00026; Mitra A, 2011, NEUROSCIENCE, V192, P459, DOI 10.1016/j.neuroscience.2011.06.033; Mitra A, 2015, EUR J NEUROSCI, V41, P420, DOI 10.1111/ejn.12798; Mitra A, 2014, BEHAV BRAIN RES, V273, P82, DOI 10.1016/j.bbr.2014.07.035; OKAMURA H, 1990, NEUROSCIENCE, V39, P675, DOI 10.1016/0306-4522(90)90252-Y; Orsetti M, 2007, NEUROPSYCHOPHARMACOL, V32, P1783, DOI 10.1038/sj.npp.1301291; Ossipov MH, 2010, J CLIN INVEST, V120, P3779, DOI 10.1172/JCI43766; Patel SM, 2008, EUR J PHARMACOL, V601, P106, DOI 10.1016/j.ejphar.2008.10.059; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pecoraro N, 2004, ENDOCRINOLOGY, V145, P3754, DOI 10.1210/en.2004-0305; RHODES CH, 1981, J COMP NEUROL, V198, P45, DOI 10.1002/cne.901980106; Richard D., 2009, ENCY NEUROSCIENCE, P1035; RISOLD PY, 1994, J COMP NEUROL, V348, P1, DOI 10.1002/cne.903480102; Rossier MF, 2003, J STEROID BIOCHEM, V85, P383, DOI 10.1016/S0960-0760(03)00201-2; SAKANAKA M, 1989, BRAIN RES, V479, P205, DOI 10.1016/0006-8993(89)91621-1; SAPER CB, 1978, J COMP NEUROL, V182, P575, DOI 10.1002/cne.901820402; Sawchenko PE, 2000, PROG BRAIN RES, V122, P61; Sawchenko PE, 1996, PROG BRAIN RES, V107, P201; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; Shin SY, 2011, KOREAN J PHYSIOL PHA, V15, P163, DOI 10.4196/kjpp.2011.15.3.163; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; SKOFITSCH G, 1985, PEPTIDES, V6, P509, DOI 10.1016/0196-9781(85)90118-4; Spector AC, 1998, BEHAV NEUROSCI, V112, P678, DOI 10.1037/0735-7044.112.3.678; Stanley BG, 2011, PHYSIOL BEHAV, V104, P40, DOI 10.1016/j.physbeh.2011.04.046; Tabarean IV, 2005, NEUROSCIENCE, V135, P433, DOI 10.1016/j.neuroscience.2005.06.053; Timofeeva E., 2014, BRAIN DISORD THER, V3, P121; Turenius CI, 2009, BRAIN RES, V1283, P65, DOI 10.1016/j.brainres.2009.05.064; Ulrich-Lai YM, 2007, ENDOCRINOLOGY, V148, P1823, DOI 10.1210/en.2006-1241; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Wichmann T, 2006, J NEUROPHYSIOL, V95, P2120, DOI 10.1152/jn.01013.2005	89	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156563	10.1371/journal.pone.0156563	http://dx.doi.org/10.1371/journal.pone.0156563			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243579	Green Submitted, Green Published, gold			2022-12-26	WOS:000377146100049
J	Silva-O'Hare, J; de Oliveira, IS; Klevorn, T; Almeida, VA; Oliveira, GGS; Atta, AM; de Freitas, LAR; Dos-Santos, WLC				Silva-O'Hare, Joselli; de Oliveira, Isabela Silva; Klevorn, Thais; Almeida, Valter A.; Oliveira, Geraldo G. S.; Atta, Ajax M.; de Freitas, Luiz Antonio R.; dos-Santos, Washington L. C.			Disruption of Splenic Lymphoid Tissue and Plasmacytosis in Canine Visceral Leishmaniasis: Changes in Homing and Survival of Plasma Cells	PLOS ONE			English	Article							PERIPHERAL-BLOOD; B-CELLS; SPLEEN; INFECTION; CHAGASI; DOGS; ARCHITECTURE; ACTIVATION; EXPRESSION; AUTOIMMUNE	Visceral leishmaniasis (VL) is a disease caused by Leishmania infantum, which is transmitted by phlebotomine sandflies. Dogs are the main urban reservoir of this parasite and the disease presents similar characteristics in both humans and dogs. In this paper, we investigated the potential pathways involved in plasma cell replacement of normal cell populations in the spleen, with respect to disease severity in dogs from an endemic area for visceral leishmaniasis. To this end, canine spleen samples were grouped into three categories: TYPE1SC- (non-infected dogs or without active infection with organized white pulp), TYPE1SC+ (infected dogs with organized white pulp) or TYPE3SC+ (infected animals with disorganized white pulp). We analyzed the distribution of different plasma cell isotypes (IgA, IgG and IgM) in the spleen. The expression of cytokines and chemokines involved in plasma cell homing and survival were assessed by real time RT-PCR. Polyclonal B cell activation and hypergammaglobulinemia were also evaluated. The proportion of animals with moderate or intense plasmacytosis was higher in the TYPE3SC+ group than in the other groups (Fisher test, P<0.05). This was mainly due to a higher density of IgG+ plasma cells in the red pulp of this group. The albumin/globulin ratio was lower in the TYPE3SC+ animals than in the TYPE1SC- or TYPE1SC+ animals, which evidences VL-associated dysproteinemia. Interestingly, TYPE3SC+ animals showed increased expression of the BAFF and APRIL cytokines, as well as chemokine CXCL12. Aberrant expression of BAFF, APRIL and CXCL12, together with amplified extrafollicular B cell activation, lead to plasma cell homing and the extended survival of these cells in the splenic red pulp compartment. These changes in the distribution of immunocompetent cells in the spleen may contribute to the progression of VL, and impair the spleen's ability to protect against blood borne pathogens.	[Silva-O'Hare, Joselli; Klevorn, Thais; Almeida, Valter A.; Oliveira, Geraldo G. S.; de Freitas, Luiz Antonio R.; dos-Santos, Washington L. C.] Fundacao Oswaldo Cruz BA, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil; [de Oliveira, Isabela Silva; Atta, Ajax M.] Univ Fed Bahia, Fac Farm, Salvador, BA, Brazil; [de Freitas, Luiz Antonio R.] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal da Bahia	Dos-Santos, WLC (corresponding author), Fundacao Oswaldo Cruz BA, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.	wluis@bahia.fiocruz.br	dos-Santos, Washington LC/AAO-4649-2021; de Sá Oliveira, Geraldo Gileno/AAO-4099-2021	dos-Santos, Washington LC/0000-0002-5075-1254; de Sá Oliveira, Geraldo Gileno/0000-0001-6065-6480; Almeida, Valter/0000-0001-8380-3391	Fundacao de Amparo a Pesquisa do Estado da Bahia [PET0053/2013]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) AUXPE-CAPES-FAPESB [23038.006718/2013-19]; Fundacao Oswaldo Cruz (Fiocruz)-CNPq PROEP [400905/2013-2]; CNPq	Fundacao de Amparo a Pesquisa do Estado da Bahia; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) AUXPE-CAPES-FAPESB(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Cruz (Fiocruz)-CNPq PROEP; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado da Bahia (Fapesb.http://www.fapesb.ba.gov.br) grant no. PET0053/2013, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes. http://www.capes.gov.br/) AUXPE-CAPES-FAPESB 2072/2013/PROCESSO #23038.006718/2013-19 and Fundacao Oswaldo Cruz (Fiocruz. http://portal.fiocruz.br/pt-br)-CNPq PROEP grant 400905/2013-2. WLCS received a scholarship from CNPq (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade Z, 1956, REV ASSOC MED BRAS, V5, P413; Belnoue E, 2012, J IMMUNOL, V188, P1283, DOI 10.4049/jimmunol.1103169; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Camacho AT, 2002, B SOC PATHOL EXOT, V95, P17; Carvalho LJM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-59; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Cavalcanti AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123009; Chu VT, 2013, IMMUNOL REV, V251, P177, DOI 10.1111/imr.12011; Chu VT, 2009, ARTHRITIS RHEUM-US, V60, P2083, DOI 10.1002/art.24628; DOnofrio G, 2015, MORPHOLOGY OF BLOOD DISORDERS, 2ND EDITION, P1; Dos-Santos WLC, 2008, VET IMMUNOL IMMUNOP, V123, P251, DOI 10.1016/j.vetimm.2008.02.004; Ellyard JI, 2005, EUR J IMMUNOL, V35, P699, DOI 10.1002/eji.200425442; Engwerda CR, 2002, AM J PATHOL, V161, P429, DOI 10.1016/S0002-9440(10)64199-5; de Lima VMF, 2012, VET PARASITOL, V184, P147, DOI 10.1016/j.vetpar.2011.08.024; GALVAOCASTRO B, 1984, CLIN EXP IMMUNOL, V56, P58; Goto Y, 2014, AM J TROP MED HYG, V91, P912, DOI 10.4269/ajtmh.14-0260; Hansen K, 2001, PEDIATR DEVEL PATHOL, V4, P105, DOI 10.1007/s100240010145; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1; Jourdan M, 2014, LEUKEMIA, V28, P1647, DOI 10.1038/leu.2014.61; KEENAN CM, 1984, VET PATHOL, V21, P80, DOI 10.1177/030098588402100114; Kemming G, 2004, EUR SURG RES, V36, P198, DOI 10.1159/000078853; Kirkwood BR, 2003, ESSENTIAL MED STAT; LESTER SJ, 1995, CAN VET J, V36, P444; Lima IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087742; Mahevas M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00494; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Ministerio da Saude do Brasil S, 2006, MANUAL DE VIGILANCIA; O'Connell TX, 2005, AM FAM PHYSICIAN, V71, P105; Paranhos-Silva M, 2003, VET PARASITOL, V114, P97, DOI 10.1016/S0304-4017(03)00132-8; Peeters D, 2005, J COMP PATHOL, V132, P283, DOI 10.1016/j.jcpa.2004.11.002; Santana CC, 2008, PARASITE IMMUNOL, V30, P515, DOI 10.1111/j.1365-3024.2008.01051.x; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Shrestha R, 2014, J NEUROPSYCH CLIN N, V26, pE53, DOI 10.1176/appi.neuropsych.13030057; Silva JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029103; Solca MD, 2012, VET PARASITOL, V184, P133, DOI 10.1016/j.vetpar.2011.08.026; Steiniger B, 1999, MICROANATOMY FUNCTIO; Tagariello G, 2014, BLOOD TRANSFUS-ITALY, V12, P428, DOI 10.2450/2014.0242-13; Tangye SG, 2011, TRENDS IMMUNOL, V32, P595, DOI 10.1016/j.it.2011.09.001; Rodrigues CAT, 2009, VET IMMUNOL IMMUNOP, V127, P382, DOI 10.1016/j.vetimm.2008.10.324; Urban BC, 2005, INFECT IMMUN, V73, P1986, DOI 10.1128/IAI.73.4.1986-1994.2005; VERESS B, 1983, BRIT J EXP PATHOL, V64, P505; VERESS B, 1977, IMMUNOLOGY, V33, P605	44	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156733	10.1371/journal.pone.0156733	http://dx.doi.org/10.1371/journal.pone.0156733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243459	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100068
J	Wells, E; Wolfe, MK; Murray, A; Lantagne, D				Wells, Emma; Wolfe, Marlene K.; Murray, Anna; Lantagne, Daniele			Accuracy, Precision, Ease-Of-Use, and Cost of Methods to Test Ebola-Relevant Chlorine Solutions	PLOS ONE			English	Article								To prevent transmission in Ebola Virus Disease (EVD) outbreaks, it is recommended to disinfect living things (hands and people) with 0.05% chlorine solution and non-living things (surfaces, personal protective equipment, dead bodies) with 0.5% chlorine solution. In the current West African EVD outbreak, these solutions (manufactured from calcium hypochlorite (HTH), sodium dichloroisocyanurate (NaDCC), and sodium hypochlorite (NaOCl)) have been widely used in both Ebola Treatment Unit and community settings. To ensure solution quality, testing is necessary, however test method appropriateness for these Ebola-relevant concentrations has not previously been evaluated. We identified fourteen commercially-available methods to test Ebola-relevant chlorine solution concentrations, including two titration methods, four DPD dilution methods, and six test strips. We assessed these methods by: 1) determining accuracy and precision by measuring in quintuplicate five different 0.05% and 0.5% chlorine solutions manufactured from NaDCC, HTH, and NaOCl; 2) conducting volunteer testing to assess ease-of-use; and, 3) determining costs. Accuracy was greatest in titration methods (reference-12.4% error compared to reference method), then DPD dilution methods (2.4-19% error), then test strips (5.2-48% error); precision followed this same trend. Two methods had an accuracy of <10% error across all five chlorine solutions with good precision: Hach digital titration for 0.05% and 0.5% solutions (recommended for contexts with trained personnel and financial resources), and Serim test strips for 0.05% solutions (recommended for contexts where rapid, inexpensive, and low-training burden testing is needed). Measurement error from test methods not including pH adjustment varied significantly across the five chlorine solutions, which had pH values 5-11. Volunteers found test strip easiest and titration hardest; costs per 100 tests were $14-37 for test strips and $33-609 for titration. Given the ease-of-use and cost benefits of test strips, we recommend further development of test strips robust to pH variation and appropriate for Ebola-relevant chlorine solution concentrations.	[Wells, Emma; Wolfe, Marlene K.; Murray, Anna; Lantagne, Daniele] Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA	Tufts University	Wells, E (corresponding author), Tufts Univ, Dept Civil & Environm Engn, Medford, MA 02155 USA.	emmafayewells@gmail.com		Murray, Anna/0000-0003-0909-2012	United States Agency for International Development, Office of Foreign Disaster Assistance [AID-OFDA-A-15-00026]; National Science Foundation [0966093]	United States Agency for International Development, Office of Foreign Disaster Assistance(United States Agency for International Development (USAID)); National Science Foundation(National Science Foundation (NSF))	This study was funded by a grant from the United States Agency for International Development, Office of Foreign Disaster Assistance (AID-OFDA-A-15-00026). MW was supported by the National Science Foundation (grant 0966093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders were provided a final version of the manuscript before submission, and had no comments.	[Anonymous], 2014, WHO REP EB VIR DIS E, P1; [Anonymous], HAND HYG W AFR GEN N; [Anonymous], 2013, HACH DIGITAL TITRATO; [Anonymous], 2014, EBOLA CAN FREE RESID; [Anonymous], 2008, D202289 ASTM; [Anonymous], 2012, STANDARD METHODS EXA; [Anonymous], EB EB VIR DIS SIGNS; Bender DF, 1978, COMP METHODS DETERMI; Centers for Disease Control and Prevention, EB VIR DIS DISTR MAP; Centers for Disease Control and Prevention, EB EB VIR DIS TRANSM; Committee NRC (US) SDW, 1980, DIS DRINK WAT; Current Technology of Chlorine Analysis for Water and Wastewater. Hach Company, 2002, 17 HACH CO; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Ebola KnowledgePoint Forum, EB KNOWLEDGEPOINT FO; Ebola Thomson P., 2007, TOR MED FRONT; Emmanueal Jorge N Babacar, 2015, ASSESSMENT RECOMMEND; Henze M, 2008, BIOLOGICAL WASTEWATER TREATMENT: PRINCIPLES, MODELLING AND DESIGN, P1; Murray A, 2015, J WATER HEALTH, V13, P79, DOI 10.2166/wh.2014.195; Paessler S, 2013, ANNU REV PATHOL-MECH, V8, P411, DOI 10.1146/annurev-pathol-020712-164041; Preparing and Measuring High Chlorine Concentration Solutions for Disinfection. United States Army Public Health Command, 2014, 130341114 US ARM PUB; Quick Robert, 2015, COMMUNICATION; Rutala WA, 2004, CLIN INFECT DIS, V39, P702, DOI 10.1086/423182; Sterk E, MED SANS FRONTIERES; Walker J., 2014, DECONTAMINATION HOSP; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization, EB VIR DIS	26	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0152442	10.1371/journal.pone.0152442	http://dx.doi.org/10.1371/journal.pone.0152442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243817	Green Submitted, gold, Green Published			2022-12-26	WOS:000377146100001
J	Sun, H; He, L; Wu, H; Pan, F; Wu, X; Zhao, J; Hu, Z; Sekhar, C; Li, H; Zheng, L; Chen, H; Shen, BH; Guo, Z				Sun, H.; He, L.; Wu, H.; Pan, F.; Wu, X.; Zhao, J.; Hu, Z.; Sekhar, C.; Li, H.; Zheng, L.; Chen, H.; Shen, B. H.; Guo, Z.			The FEN1 L209P mutation interferes with long-patch base excision repair and induces cellular transformation	ONCOGENE			English	Article							DNA-POLYMERASE-BETA; STRAND BREAK REPAIR; HUMAN FLAP ENDONUCLEASE-1; LUNG-CANCER; MUTANT MICE; SACCHAROMYCES-CEREVISIAE; REPLICATION STRESS; TUMOR PROGRESSION; ESCHERICHIA-COLI; MAMMALIAN-CELLS	Flap endonuclease-1 (FEN1) is a multifunctional, structure-specific nuclease that has a critical role in maintaining human genome stability. FEN1 mutations have been detected in human cancer specimens and have been suggested to cause genomic instability and cancer predisposition. However, the exact relationship between FEN1 deficiency and cancer susceptibility remains unclear. In the current work, we report a novel colorectal cancer-associated FEN1 mutation, L209P. This mutant protein lacks the FEN, exonuclease (EXO) and gap endonuclease (GEN) activities of FEN1 but retains DNA-binding affinity. The L209P FEN1 variant interferes with the function of the wild-type FEN1 enzyme in a dominant-negative manner and impairs long-patch base excision repair in vitro and in vivo. Expression of L209P FEN1 sensitizes cells to DNA damage, resulting in endogenous genomic instability and cellular transformation, as well as tumor growth in a mouse xenograft model. These data indicate that human cancer associated genetic alterations in the FEN1 gene can contribute substantially to cancer development.	[Sun, H.; He, L.; Wu, H.; Pan, F.; Zhao, J.; Hu, Z.; Sekhar, C.; Guo, Z.] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 Wenyuan Rd, Nanjing 210023, Jiangsu, Peoples R China; [Wu, X.] Southeast Univ, Affiliated Hosp 2, Hosp Nanjing 2, Nanjing, Jiangsu, Peoples R China; [Li, H.; Zheng, L.; Shen, B. H.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Li, H.; Zheng, L.; Shen, B. H.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, Duarte, CA USA; [Chen, H.] Shanghai Jiao Tong Univ, RenJi Hosp, Sch Med, Div Gastroenterol & Hepatol, Shanghai 200001, Peoples R China	Nanjing Normal University; Southeast University - China; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Shanghai Jiao Tong University	Guo, Z (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, 1 Wenyuan Rd, Nanjing 210023, Jiangsu, Peoples R China.; Shen, BH (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA.; Chen, H (corresponding author), Shanghai Jiao Tong Univ, RenJi Hosp, Sch Med, Div Gastroenterol & Hepatol, Shanghai 200001, Peoples R China.	chenhaoyan@gmail.com; bshen@coh.org; guozgang@gmail.com		k, chandrasekhar/0000-0002-6900-9447; Shen, Binghui/0000-0002-4408-407X	Ministry of Science and Technology of China [2013CB911600]; National Natural Science Foundation of China [31271449]; Jiangsu Provincial Natural Science Foundation [BK20130044, BK20130061, BK2011783]; Research Fund for the Doctoral Program of Higher Education of China (RFDP) [20133207110005]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-13-0868]; Priority Academic Program Development Award for Jiangsu Higher Education Institutions; NIH [RO1 CA085344]; NCI-designated cancer center [P30 CA033572]; NATIONAL CANCER INSTITUTE [R01CA085344, R01CA073764, P30CA033572] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Research Fund for the Doctoral Program of Higher Education of China (RFDP)(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Priority Academic Program Development Award for Jiangsu Higher Education Institutions; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI-designated cancer center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported by Ministry of Science and Technology of China (2013CB911600), National Natural Science Foundation of China (31271449), Jiangsu Provincial Natural Science Foundation (BK20130044, BK20130061, BK2011783), The Research Fund for the Doctoral Program of Higher Education of China (RFDP) (20133207110005), The Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-13-0868) and the Priority Academic Program Development Award for Jiangsu Higher Education Institutions. The work was also partially supported by an NIH grant RO1 CA085344 to BHS and NCI-designated cancer center support grant P30 CA033572. We also thank Dr Nancy Linford for her professional editing of the manuscript.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Bajpayee M, 2002, MUTAT RES-GEN TOX EN, V520, P83, DOI 10.1016/S1383-5718(02)00175-4; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bose R, 2013, CANCER DISCOV, V3, P224, DOI 10.1158/2159-8290.CD-12-0349; Chang JS, 2009, CARCINOGENESIS, V30, P78, DOI 10.1093/carcin/bgn261; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chung L, 2015, ONCOGENE, V34, P902, DOI 10.1038/onc.2014.19; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004; Dianova II, 2001, BIOCHEMISTRY-US, V40, P12639, DOI 10.1021/bi011117i; Du JA, 2010, ACTA BIOCH BIOPH SIN, V42, P839, DOI 10.1093/abbs/gmq095; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Figueroa JD, 2007, HUM GENET, V121, P233, DOI 10.1007/s00439-006-0294-y; Frank G, 1998, J BIOL CHEM, V273, P33064, DOI 10.1074/jbc.273.49.33064; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gao J, 2015, APPL BIOCHEM BIOTECH, V176, P454, DOI 10.1007/s12010-015-1587-1; Gary R, 1999, J BIOL CHEM, V274, P4354, DOI 10.1074/jbc.274.7.4354; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Goode EL, 2002, CANCER EPIDEM BIOMAR, V11, P1513; Guo Z, 2012, COCHRANE DB SYST REV, V5, P1; Guo ZG, 2008, MOL CELL BIOL, V28, P4310, DOI 10.1128/MCB.00200-08; Guo ZG, 2008, J MOL BIOL, V377, P679, DOI 10.1016/j.jmb.2007.10.074; Guo ZG, 2009, NUCLEIC ACIDS RES, V37, P3431, DOI 10.1093/nar/gkp201; Henneke G, 2003, ONCOGENE, V22, P4301, DOI 10.1038/sj.onc.1206606; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hosfield DJ, 1998, J BIOL CHEM, V273, P27154, DOI 10.1074/jbc.273.42.27154; Hosfield DJ, 1998, CELL, V95, P135, DOI 10.1016/S0092-8674(00)81789-4; Ivancsits S, 2002, MUTAT RES-GEN TOX EN, V519, P1, DOI 10.1016/S1383-5718(02)00109-2; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Ling CF, 2015, WORLD J MICROB BIOT, V31, P681, DOI 10.1007/s11274-015-1804-7; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Pascucci B, 2005, NUCLEIC ACIDS RES, V33, P280, DOI 10.1093/nar/gki168; Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Qiu JZ, 2004, J BIOL CHEM, V279, P24394, DOI 10.1074/jbc.M401464200; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Sato M, 2003, ONCOGENE, V22, P7243, DOI 10.1038/sj.onc.1206977; Sattler U, 2003, EMBO REP, V4, P363, DOI 10.1038/sj.embor.embor796; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; SINGH NP, 1991, MUTAT RES, V252, P289, DOI 10.1016/0165-1161(91)90008-V; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Soza S, 2009, MOL CELL BIOL, V29, P2032, DOI 10.1128/MCB.01730-08; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Tishkoff DX, 1997, CELL, V88, P253, DOI 10.1016/S0092-8674(00)81846-2; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wang YX, 2005, NAT GENET, V37, P750, DOI 10.1038/ng1587; Wu ZX, 2012, MUTAT RES-FUND MOL M, V731, P85, DOI 10.1016/j.mrfmmm.2011.11.009; Xu H, 2011, ONCOGENE, V30, P1072, DOI 10.1038/onc.2010.482; Yamada Y, 2005, ANN NY ACAD SCI, V1049, P9, DOI 10.1196/annals.1334.002; Yang M, 2009, HUM MUTAT, V30, P1320, DOI 10.1002/humu.21060; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103; Zhang B, 2014, NAT GENET, V46, P533, DOI 10.1038/ng.2985; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zheng L, 2007, MOL CELL BIOL, V27, P3176, DOI 10.1128/MCB.01652-06; Zheng L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1825; Zheng L, 2011, CELL RES, V21, P1052, DOI 10.1038/cr.2011.35; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884	83	24	26	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2017	36	2					194	207		10.1038/onc.2016.188	http://dx.doi.org/10.1038/onc.2016.188			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK5AA	27270424	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000393938100005
J	Rohrig, F; Vorlova, S; Hoffmann, H; Wartenberg, M; Escorcia, FE; Keller, S; Tenspoldel, M; Weigand, I; Gatzner, S; Manova, K; Penack, O; Scheinberg, DA; Rosenwald, A; Ergun, S; Granot, Z; Henke, E				Roehrig, F.; Vorlova, S.; Hoffmann, H.; Wartenberg, M.; Escorcia, F. E.; Keller, S.; Tenspoldel, M.; Weigand, I.; Gaetzner, S.; Manova, K.; Penack, O.; Scheinberg, D. A.; Rosenwald, A.; Erguen, S.; Granot, Z.; Henke, E.			VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors	ONCOGENE			English	Article							FACTOR RECEPTOR-2 BLOCKADE; LYSYL OXIDASE; GROWTH-FACTOR; ANTITUMOR-ACTIVITY; VASCULAR NORMALIZATION; BLOOD-VESSELS; IN-VIVO; BEVACIZUMAB; IMPROVES; BIODISTRIBUTION	The inadequate transport of drugs into the tumor tissue caused by its abnormal vasculature is a major obstacle to the treatment of cancer. Anti-vascular endothelial growth factor (anti-VEGF) drugs can cause phenotypic alteration and maturation of the tumor's vasculature. However, whether this consistently improves delivery and subsequent response to therapy is still controversial. Clinical results indicate that not all patients benefit from antiangiogenic treatment, necessitating the development of criteria to predict the effect of these agents in individual tumors. We demonstrate that, in anti-VEGF-refractory murine tumors, vascular changes after VEGF ablation result in reduced delivery leading to therapeutic failure. In these tumors, the impaired response after anti-VEGF treatment is directly linked to strong deposition of fibrillar extracellular matrix (ECM) components and high expression of lysyl oxidases. The resulting condensed, highly crosslinked ECM impeded drug permeation, protecting tumor cells from exposure to small-molecule drugs. The reduced vascular density after anti-VEGF treatment further decreased delivery in these tumors, an effect not compensated by the improved vessel quality. Pharmacological inhibition of lysyl oxidases improved drug delivery in various tumor models and reversed the negative effect of VEGF ablation on drug delivery and therapeutic response in anti-VEGF-resistant tumors. In conclusion, the vascular changes after anti-VEGF therapy can have a context-dependent negative impact on overall therapeutic efficacy. A determining factor is the tumor ECM, which strongly influences the effect of anti-VEGF therapy. Our results reveal the prospect to revert a possible negative effect and to potentiate responsiveness to antiangiogenic therapy by concomitantly targeting ECM-modifying enzymes.	[Roehrig, F.; Hoffmann, H.; Keller, S.; Tenspoldel, M.; Weigand, I.; Erguen, S.; Henke, E.] Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany; [Roehrig, F.; Vorlova, S.; Hoffmann, H.; Gaetzner, S.; Henke, E.] Univ Klinikum Wurzburg, Inst Expt Biomed, Wurzburg, Germany; [Roehrig, F.; Hoffmann, H.; Henke, E.] Univ Wurzburg, Grad Sch Life Sci, Wurzburg, Germany; [Wartenberg, M.; Rosenwald, A.] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Wartenberg, M.; Rosenwald, A.] CCCMF, Wurzburg, Germany; [Escorcia, F. E.; Scheinberg, D. A.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA; [Manova, K.] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, 1275 York Ave, New York, NY 10021 USA; [Penack, O.] Univ Klinikum Charite, Med Klin Schwerpunkt Hamatol Onkol & Tumorimmunol, Berlin, Germany; [Granot, Z.] Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, Jerusalem, Israel; [Granot, Z.] Hebrew Univ Jerusalem, Hadassah Med Sch, Jerusalem, Israel	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hebrew University of Jerusalem	Henke, E (corresponding author), Univ Wurzburg, Inst Anat & Cell Biol, Koellikerstr 6, D-97070 Wurzburg, Germany.	erik.henke@uni-wuerzburg.de	Escorcia, Freddy E/GVS-4521-2022; Henke, Erik/AAG-7053-2020; Penack, Olaf/L-1068-2016	Henke, Erik/0000-0003-2380-2682; Wartenberg, Martin/0000-0002-5378-3825; Penack, Olaf/0000-0003-4876-802X; Rohrig, Florian/0000-0002-6879-7883; Escorcia, Freddy E/0000-0002-0727-3242	Deutsche Forschungsgemeinschaft (DFG) [HE3565/1-1, HE3565/2-1, HE3565/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank Robert Benezra (Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center) for helpful discussion; Thomas Jarchau (Institute for clinical Biochemistry and Pathobiochemistry, Univeritatsklinikum Wurzburg) for a thorough correction of the manuscript; and Afshar Barlas, Mesruh Turkekul (Molecular Cytology Core facility, Memorial Sloan-Kettering Cancer Center) and Oliver Reinhardt (Biology Master Course, Universitat Wurzburg) for help with experiments. Funding was provided by the Deutsche Forschungsgemeinschaft (DFG Grant Nos. HE3565/1-1, HE3565/2-1 and HE3565/3-1 to EH).	Arjaans M, 2013, CANCER RES, V73, P3347, DOI 10.1158/0008-5472.CAN-12-3518; Baker AM, 2013, CANCER RES, V73, P583, DOI 10.1158/0008-5472.CAN-12-2447; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Cesca M, 2009, NEOPLASIA, V11, P1155, DOI 10.1593/neo.09866; Chung AS, 2013, NAT MED, V19, P1114, DOI 10.1038/nm.3291; Constantinidou A, 2013, EXPERT REV ANTICANC, V13, P211, DOI [10.1586/ERA.12.161, 10.1586/era.12.161]; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; DUNN JF, 1995, MAGN RESON MED, V34, P515, DOI 10.1002/mrm.1910340405; Eisinger-Mathason TSK, 2013, CANCER DISCOV, V3, P1190, DOI 10.1158/2159-8290.CD-13-0118; Erler JT, 2006, CANCER RES, V66, P10238, DOI 10.1158/0008-5472.CAN-06-3197; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Escorcia FE, 2010, CANCER RES, V70, P9277, DOI 10.1158/0008-5472.CAN-10-2029; Feres EJ, 1995, J BIOL CHEM, V270, P30797, DOI 10.1074/jbc.270.51.30797; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Gangloff A, 2005, J NUCL MED, V46, P1866; Hansen-Algenstaedt N, 2000, CANCER RES, V60, P4556; Heskamp S, 2013, INT J CANCER, V133, P307, DOI 10.1002/ijc.28046; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kato Y, 2006, MAGN RESON MED, V55, P755, DOI 10.1002/mrm.20831; Kesner AL, 2007, J NUCL MED, V48, P2021, DOI 10.2967/jnumed.107.045716; Kim S, 2012, MOL VIS, V18, P265; Kratz F., 2011, DRUG DELIVERY ONCOLO, V1, pLIX; Krishnamachary B, 2003, CANCER RES, V63, P1138; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lin KY, 2008, TRANSL ONCOL, V1, P84, DOI 10.1593/tlo.08118; Liu JQ, 2012, P NATL ACAD SCI USA, V109, P16618, DOI 10.1073/pnas.1117610109; Lorenzo E, 2002, J BIOL CHEM, V277, P10883, DOI 10.1074/jbc.M107442200; McKee TD, 2006, CANCER RES, V66, P2509, DOI 10.1158/0008-5472.CAN-05-2242; Memon AA, 2009, CANCER RES, V69, P873, DOI 10.1158/0008-5472.CAN-08-3118; Mendenhall WM, 2009, AM J CLIN ONCOL-CANC, V32, P436, DOI 10.1097/COC.0b013e318173a54f; Minko T, 2000, PHARMACEUT RES, V17, P505, DOI 10.1023/A:1007500412442; Phillips PG, 2011, ANTICANCER RES, V31, P411; Primeau AJ, 2005, CLIN CANCER RES, V11, P8782, DOI 10.1158/1078-0432.CCR-05-1664; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Rapisarda A, 2009, MOL CANCER THER, V8, P1867, DOI 10.1158/1535-7163.MCT-09-0274; Rodriguez HM, 2010, J BIOL CHEM, V285, P20964, DOI 10.1074/jbc.M109.094136; Sandhu JK, 2000, J NATL CANCER I, V92, P1429, DOI 10.1093/jnci/92.17.1429; Singh M, 2010, NAT BIOTECHNOL, V28, P585, DOI 10.1038/nbt.1640; Staffhorst RWHM, 2008, ANTI-CANCER DRUG, V19, P721, DOI 10.1097/CAD.0b013e328304355f; Stylianopoulos T, 2013, P NATL ACAD SCI USA, V110, P18632, DOI 10.1073/pnas.1318415110; TEICHER BA, 1990, SCIENCE, V247, P1457, DOI 10.1126/science.2108497; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Turley RS, 2012, CLIN CANCER RES, V18, P3328, DOI 10.1158/1078-0432.CCR-11-3000; Van der Veldt AAM, 2012, CANCER CELL, V21, P82, DOI 10.1016/j.ccr.2011.11.023; Wilgus ML, 2011, CANCER-AM CANCER SOC, V117, P2186, DOI 10.1002/cncr.25768; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988; WILMARTH KR, 1992, J TOXICOL ENV HEALTH, V37, P411, DOI 10.1080/15287399209531680; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Xie J, 2012, INT ORTHOP, V36, P207, DOI 10.1007/s00264-011-1261-3	55	17	20	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 5	2017	36	1					1	12		10.1038/onc.2016.182	http://dx.doi.org/10.1038/onc.2016.182			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK6XJ	27270432	Green Published, hybrid			2022-12-26	WOS:000394069100001
J	Sharma, P; Kuehn, MR				Sharma, P.; Kuehn, M. R.			SENP1-modulated sumoylation regulates retinoblastoma protein (RB) and Lamin A/C interaction and stabilization	ONCOGENE			English	Article							TUMOR-SUPPRESSOR PROTEIN; A-TYPE LAMINS; PROSTATE-CANCER; SUMO; MUTATIONS; SENP1; MECHANISMS; PATHWAY; GENE; PROLIFERATION	The retinoblastoma tumor suppressor protein (RB) plays a critical role in cell proliferation and differentiation and its inactivation is a frequent underlying factor in tumorigenesis. While the regulation of RB function by phosphorylation is well studied, proteasome-mediated RB protein degradation is emerging as an important regulatory mechanism. Although our understanding of RB turnover is currently limited, there is evidence that the nuclear lamina filament protein Lamin A/C protects RB from proteasomal degradation. Here we show that SUMO1 conjugation of RB and Lamin A/C is modulated by the SUMO protease SENP1 and that sumoylation of both proteins is required for their interaction. Importantly, this SUMO1-dependent complex protects both RB and Lamin A/C from proteasomal turnover.	[Sharma, P.; Kuehn, M. R.] NCI, NIH, Frederick, MD 21701 USA; [Sharma, P.] NHGRI, Undiagnosed Dis Program, UDP Translat Lab, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Kuehn, MR (corresponding author), NCI, NIH, Frederick, MD 21701 USA.	mkuehn@mail.nih.gov	Sharma, Prashant/ABH-1968-2021		Intramural Research Program of the National Cancer Institute, National Institutes of Health	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Stefano Campaner (IIT, Milan) for discussions, and Alessandra Mazzoni (AIRC, Milan), Shyam Sharan (NCI, Frederick), Sushil Rane (NIDDK, Bethesda) and Tom Misteli (NCI, Bethesda) for comments on the manuscript. This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Bawa-Khalfe T, 2010, J BIOL CHEM, V285, P25859, DOI 10.1074/jbc.M110.134874; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Burdelski C, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1555-8; Butin-Israeli V, 2012, TRENDS GENET, V28, P464, DOI 10.1016/j.tig.2012.06.001; Cao HN, 2003, J HUM GENET, V48, P271, DOI 10.1007/s10038-003-0025-3; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dechat T, 2010, COLD SH Q B, V75, P533, DOI 10.1101/sqb.2010.75.018; Dechat T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000547; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Ezhevsky SA, 2001, MOL CELL BIOL, V21, P4773, DOI 10.1128/MCB.21.14.4773-4784.2001; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huang W., 2012, EVID-BASED COMPL ALT, V2012, P1, DOI DOI 10.1155/2012/910520; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jiao W, 2006, J BIOL CHEM, V281, P38098, DOI 10.1074/jbc.M605271200; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kennedy BK, 2014, ADV EXP MED BIOL, V773, P127, DOI 10.1007/978-1-4899-8032-8_6; Ledl A, 2005, ONCOGENE, V24, P3810, DOI 10.1038/sj.onc.1208539; Li T, 2013, UROL ONCOL-SEMIN ORI, V31, P1539, DOI 10.1016/j.urolonc.2012.03.007; Ma CC, 2014, TUMOR BIOL, V35, P12729, DOI 10.1007/s13277-014-2598-1; Macdonald James I, 2012, Genes Cancer, V3, P619, DOI 10.1177/1947601912473305; Maraldi NM, 2011, J CELL BIOCHEM, V112, P979, DOI 10.1002/jcb.22992; Marji J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011132; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Mu JW, 2014, CHINESE MED J-PEKING, V127, P4060, DOI 10.3760/cma.j.issn.0366-6999.20141013; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; Nitta RT, 2006, MOL CELL BIOL, V26, P5360, DOI 10.1128/MCB.02464-05; Pekovic V, 2007, J CELL BIOL, V176, P163, DOI 10.1083/jcb.200606139; Schreiber KH, 2013, CELL, V152, P1365, DOI 10.1016/j.cell.2013.02.015; Sharma P, 2013, CELL REP, V3, P1640, DOI 10.1016/j.celrep.2013.04.016; Sharma P, 2010, J CELL SCI, V123, P1227, DOI 10.1242/jcs.060160; Simon DN, 2013, MOL BIOL CELL, V24, P342, DOI 10.1091/mbc.E12-07-0527; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Van Berlo JH, 2005, HUM MOL GENET, V14, P2839, DOI 10.1093/hmg/ddi316; Wang C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/328707; Wang J, 2001, ONCOGENE, V20, P4740, DOI 10.1038/sj.onc.1204655; Wang Q., 2013, POWERTECH POWERTECH, P1; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Xu Y, 2011, CANCER LETT, V309, P78, DOI 10.1016/j.canlet.2011.05.019; Xu Z, 2009, ANTIOXID REDOX SIGN, V11, P1453, DOI [10.1089/ars.2008.2182, 10.1089/ARS.2008.2182]; Yamaguchi T, 2005, MOL CELL BIOL, V25, P5171, DOI 10.1128/MCB.25.12.5171-5182.2005; Yan XM, 2016, BIOTECHNOL APPL BIOC, V63, P435, DOI 10.1002/bab.1375; Ying HQ, 2006, CELL CYCLE, V5, P506, DOI 10.4161/cc.5.5.2515; Zhang YQ, 2008, J CELL BIOL, V182, P35, DOI 10.1083/jcb.200712124	52	15	16	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 15	2016	35	50					6429	6438		10.1038/onc.2016.177	http://dx.doi.org/10.1038/onc.2016.177			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EF3TP	27270425				2022-12-26	WOS:000390247600007
J	Balsorano, P; Romagnoli, S; Evans, SK; Ricci, Z; De Gaudio, AR				Balsorano, Paolo; Romagnoli, Stefano; Evans, Samuel Kagan; Ricci, Zaccaria; De Gaudio, Angelo Raffaele			Urinary Strong Ion Difference as a Marker of Renal Dysfunction. A Retrospective Analysis	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CRITICALLY-ILL PATIENTS; BIOMARKERS; AKI; BLOOD; TIME; RISK	Introduction The kidneys play a crucial role in the regulation of electrolytes and acid-base homeostasis. Urinary Strong Ion Difference (SIDu = NaU + KU-ClU) represents an important aspect of renal acid-base regulation. We evaluated the role of SIDu as a marker of renal dysfunction in critically ill patients. Materials and Methods Patients admitted to the Medical Intensive Care Unit with a diagnosis of AKI for whom concomitant urinary samples available for SIDu calculation were retrospectively reviewed and staged according to KDIGO criteria for 3 days from inclusion. Patients were classified as Recovered (R-AKI) or Persistent-AKI (P-AKI) whether they exited KDIGO criteria within the 3-day observation period or not. A control group with normal renal function and normal serum acid-base and electrolytes was prospectively recruited in order to identify reference SIDu values. Results One-hundred-and-forty-three patients with a diagnosis of AKI were included: 77 with R-AKI, and 66 with P-AKI. Thirty-six controls were recruited. Patients with P-AKI had more severe renal dysfunction and higher mortality than patients with R-AKI (SCr 2.23(IQR: 1.68-3.45) and 1.81(IQR1.5-2.5) mg/dl respectively, p<0.001; 24-h UO 1297(950) and 2100(1094) ml respectively, p = 0.003); 30-d mortality, 39% and 13% respectively; p<0.001). SIDu significantly differed between groups, with rising values from controls to P-AKI groups (16.4(12), 30(24) and 47.3(21.5) mEq/l respectively, p<0.001). Discussion SIDu may be a simple and inexpensive tool in AKI patients' evaluation. Further research is needed to evaluate the ability of SIDu to identify patients with renal dysfunction before derangements in serum creatinine or urine output are observed.	[Balsorano, Paolo; Romagnoli, Stefano; De Gaudio, Angelo Raffaele] Univ Florence, Dept Hlth Sci, Sect Anaesthesiol Intens Care & Pain Med, Florence, Italy; [Evans, Samuel Kagan] Rhode Isl Hosp, Dept Pulm & Crit Care Med, Providence, RI USA; [Ricci, Zaccaria] Bambino Gesu Pediat Hosp, IRCCS, Dept Cardiol & Cardiac Surg, Pediat Cardiac Intens Care Unit, Rome, Italy	University of Florence; Lifespan Health Rhode Island; Rhode Island Hospital; IRCCS Bambino Gesu	Balsorano, P (corresponding author), Univ Florence, Dept Hlth Sci, Sect Anaesthesiol Intens Care & Pain Med, Florence, Italy.	paolobal84@gmail.com	Balsorano, Paolo/AAG-3245-2019; Ricci, Zaccaria/J-2944-2012	ricci, zaccaria/0000-0001-8916-0569				Bagshaw SM, 2006, AM J KIDNEY DIS, V48, P695, DOI 10.1053/j.ajkd.2006.07.017; Bagshaw SM, 2010, CAN J ANESTH, V57, P985, DOI 10.1007/s12630-010-9375-4; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Cruz DN, 2009, CRIT CARE, V13, DOI 10.1186/cc7759; de Geus HRH, 2012, CLIN KIDNEY J, V5, P102, DOI 10.1093/ckj/sfs008; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Gattinoni L, 2006, CRIT CARE, V10, DOI 10.1186/cc4890; GOLDSTEIN MB, 1986, AM J MED SCI, V292, P198, DOI 10.1097/00000441-198610000-00003; Hall IE, 2011, CLIN J AM SOC NEPHRO, V6, P2740, DOI 10.2215/CJN.04960511; Honore PM, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-24; Kellum JA, 2000, CRIT CARE, V4, P6, DOI 10.1186/cc644; Koyner JL, 2010, CLIN J AM SOC NEPHRO, V5, P2154, DOI 10.2215/CJN.00740110; Maciel Alexandre Toledo, 2013, Rev. bras. ter. intensiva, V25, P184, DOI 10.5935/0103-507X.20130032; Maciel AT, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-31; Masevicius FD, 2010, CRIT CARE RESUSC, V12, P248; Masevicius Fabio Daniel, 2013, Rev. bras. ter. intensiva, V25, P197, DOI 10.5935/0103-507X.20130035; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Moviat M, 2012, J CRIT CARE, V27, P255, DOI 10.1016/j.jcrc.2011.05.028; Ronco C, 2013, CRIT CARE, V17, DOI 10.1186/cc12488; Ronco C, 2012, CRIT CARE, V16, DOI 10.1186/cc11240; SARTORIUS OW, 1949, J CLIN INVEST, V28, P423; Sood MM, 2014, J CRIT CARE, V29, P711, DOI 10.1016/j.jcrc.2014.04.003; STEWART PA, 1983, CAN J PHYSIOL PHARM, V61, P1444, DOI 10.1139/y83-207; Zazzeron L, 2013, CRITICAL CARE, V17, pP415	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156941	10.1371/journal.pone.0156941	http://dx.doi.org/10.1371/journal.pone.0156941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258049	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700161
J	Chand, RP; Kumar, AS; Anuj, K; Vishnupriya, S; Reddy, BM				Chand, Rayabarapu Pranav; Kumar, Arramraju Sreenivas; Anuj, Kapadia; Vishnupriya, Satti; Reddy, Battini Mohan			Distinct Patterns of Association of Variants at 11q23.3 Chromosomal Region with Coronary Artery Disease and Dyslipidemia in the Population of Andhra Pradesh, India	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MULTILOCUS GENOTYPE DATA; HEART-DISEASE; GENE-CLUSTER; LIPID LEVELS; SUSCEPTIBILITY; RISK; LOCI; HAPLOTYPES; BIOMARKERS	In our attempt to comprehensively understand the nature of association of variants at 11q23.3 apolipoprotein gene cluster region, we genotyped a prioritized set of 96 informative SNPs using Fluidigm customized SNP genotyping platform in a sample of 508 coronary artery disease (CAD) cases and 516 controls. We found 12 SNPs as significantly associated with CAD at P < 0.05, albeit only four (rs2849165, rs17440396, rs6589566 and rs633389) of these remained significant after Benjamin Hochberg correction. Of the four, while rs6589566 confers risk to CAD, the other three SNPs reduce risk for the disease. Interaction of variants that belong to regulatory genes BUD13 and ZPR1 with APOA5-APOA4 intergenic variants is also observed to significantly increase the risk towards CAD. Further, ROC analysis of the risk scores of the 12 significant SNPs suggests that our study has substantial power to confer these genetic variants as predictors of risk for CAD, as illustrated by AUC (0.763; 95% CI: 0.729-0.798, p = <0.0001). On the other hand, the protective SNPs of CAD are associated with elevated Low Density Lipoprotein Cholesterol and Total Cholesterol levels, hence with dyslipidemia, in our sample of controls, which may suggest distinct effects of the variants at 11q23.3 chromosomal region towards CAD and dyslipidemia. It may be necessary to replicate these findings in the independent and ethnically heterogeneous Indian samples in order to establish this as an Indian pattern. However, only functional analysis of the significant variants identified in our study can provide more precise understanding of the mechanisms involved in the contrasting nature of their effects in manifesting dyslipidemia and CAD.	[Chand, Rayabarapu Pranav; Reddy, Battini Mohan] Indian Stat Inst, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India; [Kumar, Arramraju Sreenivas; Anuj, Kapadia] Care Hosp, Dept Cardiol, Hyderabad, Andhra Pradesh, India; [Vishnupriya, Satti] Osmania Univ, Dept Genet, Hyderabad 500007, Andhra Pradesh, India	Indian Statistical Institute; Osmania University	Reddy, BM (corresponding author), Indian Stat Inst, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India.	bmrisi@gmail.com			Indian Statistical Institute	Indian Statistical Institute	This work was supported by in-house funding from the Indian Statistical Institute. No specific grant number, etc., is applicable.	Aruna M, 2011, HUM REPROD, V26, P765, DOI 10.1093/humrep/der024; AshokKumar M, 2010, MOL BIOL REP, V37, P521, DOI 10.1007/s11033-009-9728-7; Aung LHH, 2014, J CELL MOL MED, V18, P1417, DOI 10.1111/jcmm.12291; Bhanushali AA, 2010, J COMMUN GENET, V1, P139, DOI 10.1007/s12687-010-0025-x; Braun TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037056; Chandra K Sarat, 2014, Indian Heart J, V66 Suppl 3, pS1, DOI 10.1016/j.ihj.2014.12.001; Chhabra S, 2005, DIS MARKERS, V21, P169, DOI 10.1155/2005/195078; Dasgupta S, 2012, GENE, V503, P140, DOI 10.1016/j.gene.2012.04.060; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Drenos F, 2009, HUM MOL GENET, V18, P2305, DOI 10.1093/hmg/ddp159; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Falush D, 2003, GENETICS, V164, P1567; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gangwani L, 2006, J BIOL CHEM, V281, P40330, DOI 10.1074/jbc.M608165200; Henkhaus Rebecca S, 2011, Indian J Hum Genet, V17, P194, DOI 10.4103/0971-6866.92103; Joshi SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096808; Jyothi KU, 2015, META GENE, V5, P9, DOI 10.1016/j.mgene.2015.05.001; Kraja AT, 2011, DIABETES, V60, P1329, DOI 10.2337/db10-1011; Kumar BAV, 2014, INT J SCI STUDY, V2, P73; Misra A, 2004, J Assoc Physicians India, V52, P137; Moreno-Luna R, 2007, J CLIN ENDOCR METAB, V92, P2280, DOI 10.1210/jc.2006-1802; Olivier M, 2004, GENOMICS, V83, P912, DOI 10.1016/j.ygeno.2003.11.016; Pranavchand R, 2013, J POSTGRAD MED, V59, P30, DOI 10.4103/0022-3859.109492; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUMAN GENETICS, V81; Reddy BM, 2005, HUM BIOL, V77, P803, DOI 10.1353/hub.2006.0018; ROSS R, 1977, AM J PATHOL, V86, P675; Sachdeva A, 2009, AM HEART J, V157, P111, DOI 10.1016/j.ahj.2008.08.010; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Saxena R, 2013, DIABETES, V62, P1746, DOI 10.2337/db12-1077; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sekhri T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005346; Shanker J, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-33; Tabassum R, 2013, DIABETES, V62, P977, DOI 10.2337/db12-0406; Walia GK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101688; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wang J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-561; Willer C, 2013, NAT GENET, V45, P1, DOI DOI 10.1038/ng.2519; Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26; Yamada Y, 2007, GENOMICS, V90, P551, DOI 10.1016/j.ygeno.2007.08.001; Yin RX, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-140	41	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0153720	10.1371/journal.pone.0153720	http://dx.doi.org/10.1371/journal.pone.0153720			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257688	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700005
J	Pfister, R; Lee, S; Kuhr, K; Baer, F; Fehske, W; Hoepp, HW; Baldus, S; Michels, G				Pfister, Roman; Lee, Samuel; Kuhr, Kathrin; Baer, Frank; Fehske, Wolfgang; Hoepp, Hans-Wilhelm; Baldus, Stephan; Michels, Guido			Impact of the Type of First Medical Contact within a Guideline-Conform ST-Elevation Myocardial Infarction Network: A Prospective Observational Registry Study	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME; PRIMARY ANGIOPLASTY; PRIMARY PCI; MORTALITY; STRATEGIES; OUTCOMES; IMPLEMENTATION; ASSOCIATION; MANAGEMENT	Aims The impact of type of first medical contact (FMC) in the setting of a guideline conform metropolitan ST-elevation myocardial infarction (STEMI) network providing obligatory primary percutaneous coronary intervention (PCI) is unclear. Methods and Results 3,312 patients were prospectively included between 2006 and 2012 into a registry accompanying the "Cologne Infarction Model" STEMI network, with 68.4% primarily presenting to emergency medical service (EMS), 17.6% to non-PCI-capable hospitals, and 14.0% to PCI-capable hospitals. Median contact-to-balloon time differed significantly by FMC with 89 minutes (IQR 72-115) for EMS, 107 minutes (IQR 85-148) for non-PCI- and 65 minutes (IQR 48-91) for PCI-capable hospitals (p < 0.001). TIMI-flow grade III and in-hospital mortality were 75.7% and 10.4% in EMS, 70.3% and 8.6% in non-PCI-capable hospital and 84.4% and 5.6% in PCI-capable hospital presenters, respectively (p both < 0.01). The association of FMC with in-hospital mortality was not significant after adjustment for baseline characteristics, but risk of TIMI-flow grade < III remained significantly increased in patients presenting to non-PCI-capable hospitals. Conclusion Despite differences in treatment delay by type of FMC in-hospital mortality did not differ significantly. The increased risk of TIMI-flow grade < III in patients presenting to non PCI-capable hospitals needs further study.	[Pfister, Roman; Lee, Samuel; Hoepp, Hans-Wilhelm; Baldus, Stephan; Michels, Guido] Univ Cologne, Dept Internal Med 3, D-50931 Cologne, Germany; [Kuhr, Kathrin] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany; [Baer, Frank] St Antonius Hosp, Cologne, Germany; [Fehske, Wolfgang] St Vinzenz Hosp, Cologne, Germany	University of Cologne; University of Cologne; Saint Antonius Hospital	Pfister, R (corresponding author), Univ Cologne, Dept Internal Med 3, D-50931 Cologne, Germany.	roman.pfister@uk-koeln.de	Baer, Frank M/AAI-8957-2021	Lee, Samuel/0000-0001-6768-7079	KIM registered association	KIM registered association	The KIM registry is funded by the KIM registered association (http://www.koelner-infarktmodell.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bradley EH, 2006, NEW ENGL J MED, V355, P2308, DOI 10.1056/NEJMsa063117; Bray JE, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001927; Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Flesch M, 2008, CIRC-CARDIOVASC INTE, V1, P95, DOI 10.1161/CIRCINTERVENTIONS.108.768176; Flynn A, 2010, ARCH INTERN MED, V170, P1842, DOI 10.1001/archinternmed.2010.381; Garberich RF, 2014, CIRCULATION, V129, P1225, DOI 10.1161/CIRCULATIONAHA.113.005568; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Huber K, 2014, EUR HEART J, V35, P1526, DOI 10.1093/eurheartj/ehu125; Kalla K, 2006, CIRCULATION, V113, P2398, DOI 10.1161/CIRCULATIONAHA.105.586198; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Koul S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000486; Le May MR, 2008, NEW ENGL J MED, V358, P231, DOI 10.1056/NEJMoa073102; Liebetrau C, 2011, CLIN RES CARDIOL, V100, P217, DOI 10.1007/s00392-010-0231-x; Mathews R, 2011, CIRCULATION, V124, P154, DOI 10.1161/CIRCULATIONAHA.110.002345; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Pinto DS, 2011, CIRCULATION, V124, P2512, DOI 10.1161/CIRCULATIONAHA.111.018549; Scholz KH, 2012, JACC-CARDIOVASC INTE, V5, P848, DOI 10.1016/j.jcin.2012.04.012; Schoos MM, 2012, EUR HEART J-ACUTE CA, V1, P200, DOI 10.1177/2048872612455143; Silvain J, 2012, ARCH CARDIOVASC DIS, V105, P639, DOI 10.1016/j.acvd.2012.07.007; So DYF, 2006, AM J CARDIOL, V97, P458, DOI 10.1016/j.amjcard.2005.08.069; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Tartan Z, 2008, NUTR METAB CARDIOVAS, V18, P441, DOI 10.1016/j.numecd.2007.02.015; Thilo C, 2013, CLIN RES CARDIOL, V102, P905, DOI 10.1007/s00392-013-0608-8; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Tsao NW, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.02.012; Wang TY, 2011, JAMA-J AM MED ASSOC, V305, P2540, DOI 10.1001/jama.2011.862; Wilson BH, 2013, JACC-CARDIOVASC INTE, V6, P1064, DOI 10.1016/j.jcin.2013.05.018; Windecker S, 2013, LANCET, V382, P644, DOI 10.1016/S0140-6736(13)61452-X; Zijistra F, 2002, EUR HEART J, V23, P550, DOI 10.1053/euhj.2001.2901	32	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156769	10.1371/journal.pone.0156769	http://dx.doi.org/10.1371/journal.pone.0156769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258655	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700124
J	Schick, T; Altay, L; Viehweger, E; Hoyng, CB; den Hollander, AI; Felsch, M; Fauser, S				Schick, Tina; Altay, Lebriz; Viehweger, Eva; Hoyng, Carel B.; den Hollander, Anneke I.; Felsch, Moritz; Fauser, Sascha			Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; POLYMORPHISMS; ASSOCIATION; PREVALENCE; PREDICTION; VARIANTS; DRUSEN; GENES; TWIN	Background Age-related macular degeneration (AMD) is a common disease causing visual impairment and blindness. Various gene variants are strongly associated with late stage AMD, but little is known about the genetics of early forms of the disease. This study evaluated associations of genetic factors and different AMD stages depending on unilateral and bilateral disease severity. Methods In this case-control study, participants were assigned to nine AMD severity stages based on the characteristics of each eye. 18 single nucleotide polymorphisms (SNPs) were geno-typed and attempted to correlate with AMD severity stages by uni- and multivariate logistic regression analyses and trend analyses. Area under the receiver operating characteristic curves (AUC) were calculated. Results Of 3444 individuals 1673 were controls, 379 had early AMD, 333 had intermediate AMD and 989 showed late AMD stages. With increasing severity of disease and bilateralism more SNPs with significant associations were found. Odds ratios, especially for the main risk polymorphisms in ARMS2 (rs10490924) and CFH (rs1061170), gained with increasing disease severity and bilateralism (exemplarily: rs1061170: unilateral early AMD: OR = 1.18; bilateral early AMD: OR = 1.20; unilateral intermediate AMD: OR = 1.28; bilateral intermediate AMD: OR = 1.39, unilateral geographic atrophy (GA): OR = 1.50; bilateral GA: OR = 1.71). Trend analyses showed p<0.0001 for ARMS2 (rs10490924) and for CFH (rs1061170), respectively. AUC of risk models for various AMD severity stages was lowest for unilateral early AMD (AUC = 0.629) and showed higher values in more severely and bilaterally affected individuals being highest for late AMD with GA in one eye and neovascular AMD in the other eye (AUC = 0.957). Conclusion The association of known genetic risk factors with AMD became stronger with increasing disease severity, which also led to an increasing discriminative ability of AMD cases and controls. Genetic predisposition was also associated with the disease severity of the fellow-eye, highlighting the importance of both eyes in AMD patients.	[Schick, Tina; Altay, Lebriz; Viehweger, Eva; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Felsch, Moritz] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany; [Hoyng, Carel B.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands	University of Cologne; University of Cologne; Radboud University Nijmegen	Fauser, S (corresponding author), Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany.	sascha.fauser@gmail.com	Hollander, Anneke den/N-4911-2014					Ardeljan D, 2013, EUR J HUM GENET, V21, P1152, DOI 10.1038/ejhg.2013.14; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Buitendijk GHS, 2013, OPHTHALMOLOGY, V120, P2644, DOI 10.1016/j.ophtha.2013.07.053; Chakravarthy U, 2013, OPHTHALMOLOGY, V120, P342, DOI 10.1016/j.ophtha.2012.08.004; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Delcourt C, 2011, INVEST OPHTH VIS SCI, V52, P5955, DOI 10.1167/iovs.10-6235; Dietzel M, 2014, GRAEF ARCH CLIN EXP, V252, P1273, DOI 10.1007/s00417-014-2690-7; Farwick A, 2009, EYE, V23, P2238, DOI 10.1038/eye.2008.426; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Grassmann F, 2015, EUR J PHARM BIOPHARM, V95, P194, DOI 10.1016/j.ejpb.2015.04.039; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; Hawkins JR, 2002, HUM MUTAT, V19, P543, DOI 10.1002/humu.10060; Hermann M, 2012, ACTA OPHTHALMOL, V90, pe500, DOI 10.1111/j.1755-3768.2011.02347.x; Holliday EG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082305, 10.1371/journal.pone.0053830]; Ng TK, 2008, INVEST OPHTH VIS SCI, V49, P3312, DOI 10.1167/iovs.07-1517; Ristau T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093459; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2015, INVEST OPHTH VIS SCI, V56, P2192, DOI 10.1167/iovs.14-15841; Seddon JM, 2009, INVEST OPHTH VIS SCI, V50, P2044, DOI 10.1167/iovs.08-3064; Wang YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15711; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070	25	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156778	10.1371/journal.pone.0156778	http://dx.doi.org/10.1371/journal.pone.0156778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257685	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700125
J	Wei, WD; Jiang, JJ; Liang, H; Gao, L; Liang, BY; Huang, JG; Zang, N; Liao, YY; Yu, J; Lai, JZ; Qin, FX; Su, JM; Ye, L; Chen, H				Wei, Wudi; Jiang, Junjun; Liang, Hao; Gao, Lian; Liang, Bingyu; Huang, Jiegang; Zang, Ning; Liao, Yanyan; Yu, Jun; Lai, Jingzhen; Qin, Fengxiang; Su, Jinming; Ye, Li; Chen, Hui			Application of a Combined Model with Autoregressive Integrated Moving Average (ARIMA) and Generalized Regression Neural Network (GRNN) in Forecasting Hepatitis Incidence in Heng County, China	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SPRING FESTIVAL; RENAL SYNDROME; VIRUS; TRANSMISSION; PREDICTION; RISK	Background Hepatitis is a serious public health problem with increasing cases and property damage in Heng County. It is necessary to develop a model to predict the hepatitis epidemic that could be useful for preventing this disease. Methods The autoregressive integrated moving average (ARIMA) model and the generalized regression neural network (GRNN) model were used to fit the incidence data from the Heng County CDC (Center for Disease Control and Prevention) from January 2005 to December 2012. Then, the ARIMA-GRNN hybrid model was developed. The incidence data from January 2013 to December 2013 were used to validate the models. Several parameters, including mean absolute error (MAE), root mean square error (RMSE), mean absolute percentage error (MAPE) and mean square error (MSE), were used to compare the performance among the three models. Results The morbidity of hepatitis from Jan 2005 to Dec 2012 has seasonal variation and slightly rising trend. The ARIMA(0,1,2)(1,1,1)(12) model was the most appropriate one with the residual test showing a white noise sequence. The smoothing factor of the basic GRNN model and the combined model was 1.8 and 0.07, respectively. The four parameters of the hybrid model were lower than those of the two single models in the validation. The parameters values of the GRNN model were the lowest in the fitting of the three models. Conclusions The hybrid ARIMA-GRNN model showed better hepatitis incidence forecasting in Heng County than the single ARIMA model and the basic GRNN model. It is a potential decision-supportive tool for controlling hepatitis in Heng County.	[Wei, Wudi; Jiang, Junjun; Liang, Hao; Liang, Bingyu; Huang, Jiegang; Zang, Ning; Liao, Yanyan; Yu, Jun; Lai, Jingzhen; Qin, Fengxiang; Su, Jinming; Ye, Li] Guangxi Med Univ, Sch Publ Hlth, Guangxi Key Lab AIDS Prevent & Treatment, Nanning 530021, Guangxi, Peoples R China; [Wei, Wudi; Jiang, Junjun; Liang, Hao; Liang, Bingyu; Huang, Jiegang; Zang, Ning; Liao, Yanyan; Yu, Jun; Lai, Jingzhen; Qin, Fengxiang; Su, Jinming; Ye, Li] Guangxi Med Univ, Sch Publ Hlth, Guangxi Univ Key Lab Prevent & Control Highly Pre, Nanning 530021, Guangxi, Peoples R China; [Gao, Lian] Ctr Dis Control & Prevent, Heng Cty 530300, Guangxi, Peoples R China; [Liang, Hao; Zang, Ning; Liao, Yanyan; Ye, Li] Guangxi Med Univ, Guangxi Collaborat Innovat Ctr Biomed, Guangxi Med Res Ctr, Nanning 530021, Guangxi, Peoples R China; [Chen, Hui] Guangxi Med Univ, Geriatr Digest Dept Internal Med, Affiliated Hosp 1, Nanning 530021, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Chinese Center for Disease Control & Prevention; Guangxi Medical University; Guangxi Medical University	Ye, L (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Guangxi Key Lab AIDS Prevent & Treatment, Nanning 530021, Guangxi, Peoples R China.; Ye, L (corresponding author), Guangxi Med Univ, Sch Publ Hlth, Guangxi Univ Key Lab Prevent & Control Highly Pre, Nanning 530021, Guangxi, Peoples R China.; Ye, L (corresponding author), Guangxi Med Univ, Guangxi Collaborat Innovat Ctr Biomed, Guangxi Med Res Ctr, Nanning 530021, Guangxi, Peoples R China.	yeli@gxmu.edu.cn; chenhui680804@163.com	Jiang, Junjun/AAH-9095-2020	Wei, Wudi/0000-0001-6703-4529	National Natural Science Foundation of China [81271851, 31360033, 81460511, 81460305]; Guangxi scientific research and technology development program fund [14124003-1]; Guangxi Natural Science Foundation [2013GXNSFCB019004]; Scientific Research Foundation of the Higher Education Institutions of Guangxi Province, China [YB2014062, 2013ZD012]; Guangxi Universities "100-Talent" Program, Guangxi, China; Guangxi Universities Innovation Research Team and Outstanding Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi scientific research and technology development program fund; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Scientific Research Foundation of the Higher Education Institutions of Guangxi Province, China; Guangxi Universities "100-Talent" Program, Guangxi, China; Guangxi Universities Innovation Research Team and Outstanding Scholar Program	The study was supported by National Natural Science Foundation of China (81271851, 31360033, 81460511, and 81460305), Guangxi scientific research and technology development program fund (Gui Ke Gong NO.14124003-1), Guangxi Natural Science Foundation (2013GXNSFCB019004), Scientific Research Foundation of the Higher Education Institutions of Guangxi Province, China (YB2014062, 2013ZD012), Guangxi Universities "100-Talent" Program, Guangxi, China (to LY), and Guangxi Universities Innovation Research Team and Outstanding Scholar Program (to LY).	Box G. E. P., 1994, J MARKETING RES, V14; BuHamra S, 2003, APPL MATH MODEL, V27, P805, DOI 10.1016/S0307-904X(03)00079-9; Cao SY, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-56; Claeskens G, 2008, MODEL SELECTION MODE, P561; Dai X, 2013, EMERG INFECT DIS, V19, P1528, DOI 10.3201/eid1909.130013; Faruk DO, 2010, ENG APPL ARTIF INTEL, V23, P586, DOI 10.1016/j.engappai.2009.09.015; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Guo ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101113; Haider S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144490; Han Qin, 2012, Modern Preventive Medicine, V39, P1337; Han YN, 2009, J INT MED RES, V37, P1952, DOI 10.1177/147323000903700633; Hou LQ, 2014, CHRONIC PATHEMATHOL, V15, P344; Hu J, 2016, COMPUT BIOL CHEM, V60, P59, DOI 10.1016/j.compbiolchem.2015.11.007; Jiang ZhiHua, 2015, China Tropical Medicine, V15, P1057; Jing H, 2014, ENVIRON POLLUT, V192, P204, DOI 10.1016/j.envpol.2014.06.003; Kong SF, 2015, SCI TOTAL ENVIRON, V520, P59, DOI [10.1016/j.scitotenv.2015.03.001, 10.1016/j.scitote]; Leung MT, 2009, INTELL SYST ACCOUNT, V16, P257, DOI 10.1002/isaf.308; Leung MT, 2000, FORECASTING EXCHANGE; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Li WM, 2008, NEURAL COMPUT APPL, V17, P441, DOI 10.1007/s00521-007-0131-9; Liao GY., 2015, AGR ARCHAEOL, V03, P225; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; Longatti A, 2015, VIRUSES-BASEL, V7, P6707, DOI 10.3390/v7122967; Lu MF, 2012, CHINESE PRIMARY HLTH, V26, P49; Lu YH, 2013, EPIDEMIOL INFECT, V141, P2403, DOI 10.1017/S0950268813000113; Mou HX, 2009, HEILONGJIANG MED PHA, V32, P94; Naghibi SA, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-015-5049-6; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; Ozyildirim BM, 2013, NEURAL NETWORKS, V39, P18, DOI 10.1016/j.neunet.2012.12.001; Purwanto, 2012, APPL INTELL, V37, P511, DOI 10.1007/s10489-012-0344-1; Qina G, 1997, CANC LETT, V121, P203; Sharma N, 2015, J THROID RES, V2015, DOI 10.1155/2015/517173; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Tang XY, 2009, CHINESE J HLTH STAT, P114; Walker CM, 2015, CURR OPIN VIROL, V11, P7, DOI 10.1016/j.coviro.2015.01.003; Wang Dingming, 2015, J Med Case Rep, V9, P109, DOI 10.1186/s13256-015-0580-1; Wang YJ, 2006, CHINESE J VECTOR BIO, V17, P333; Wu J, 2013, GENET TEST MOL BIOMA, V17, P595, DOI 10.1089/gtmb.2013.0031; Yu LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098241; Zhang G, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, DOI 10.1371/journal.pone.0080969]; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; [张国良 Zhang Guoliang], 2013, [中国卫生统计, Chinese Journal of Health Statistics], V30, P480; Zhao N, 1994, ZHONGHUA LIU XING BI, V15; Zhao P, 2016, CONTEMP CLIN TRIALS, V47, P85, DOI 10.1016/j.cct.2015.12.012; Zheng YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116832; Zhu FC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087154	47	45	51	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156768	10.1371/journal.pone.0156768	http://dx.doi.org/10.1371/journal.pone.0156768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258555	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700123
J	Takeuchi, T; Yamada, L; Shinzato, C; Sawada, H; Satoh, N				Takeuchi, Takeshi; Yamada, Lixy; Shinzato, Chuya; Sawada, Hitoshi; Satoh, Noriyuki			Stepwise Evolution of Coral Biomineralization Revealed with Genome-Wide Proteomics and Transcriptomics	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SKELETAL MATRIX PROTEINS; CELL-CELL ADHESION; ORGANIC MATRIX; CALICOBLASTIC EPITHELIUM; SOLUBLE-PROTEIN; E-CADHERIN; DOMAIN; ACID; IDENTIFICATION	Despite the importance of stony corals in many research fields related to global issues, such as marine ecology, climate change, paleoclimatogy, and metazoan evolution, very little is known about the evolutionary origin of coral skeleton formation. In order to investigate the evolution of coral biomineralization, we have identified skeletal organic matrix proteins (SOMPs) in the skeletal proteome of the scleractinian coral, Acropora digitifera, for which large genomic and transcriptomic datasets are available. Scrupulous gene annotation was conducted based on comparisons of functional domain structures among metazoans. We found that SOMPs include not only coral-specific proteins, but also protein families that are widely conserved among cnidarians and other metazoans. We also identified several conserved transmembrane proteins in the skeletal proteome. Gene expression analysis revealed that expression of these conserved genes continues throughout development. Therefore, these genes are involved not only skeleton formation, but also in basic cellular functions, such as cell-cell interaction and signaling. On the other hand, genes encoding coral-specific proteins, including extracellular matrix domain-containing proteins, galaxins, and acidic proteins, were prominently expressed in post-settlement stages, indicating their role in skeleton formation. Taken together, the process of coral skeleton formation is hypothesized as: 1) formation of initial extracellular matrix between epithelial cells and substrate, employing pre-existing transmembrane proteins; 2) additional extracellular matrix formation using novel proteins that have emerged by domain shuffling and rapid molecular evolution and; 3) calcification controlled by coral-specific SOMPs.	[Takeuchi, Takeshi; Shinzato, Chuya; Satoh, Noriyuki] Grad Univ, Okinawa Inst Sci & Technol, Marine Genom Unit, Onna, Okinawa 9040495, Japan; [Yamada, Lixy; Sawada, Hitoshi] Nagoya Univ, Grad Sch Sci, Sugashima Marine Biol Lab, Toba 5170004, Japan	Okinawa Institute of Science & Technology Graduate University; Nagoya University	Takeuchi, T (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Marine Genom Unit, Onna, Okinawa 9040495, Japan.	t.takeuchi@oist.jp	Satoh, Nori/C-4123-2009	Satoh, Nori/0000-0002-4480-3572; Shinzato, Chuya/0000-0001-7843-3381	Japan Society for the Promotion of Science KAKENHI [24241071, 25660172]; Canon Foundation; OIST Graduate University	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Canon Foundation(Canon Foundation); OIST Graduate University	Japan Society for the Promotion of Science KAKENHI (https://www.jsps.go.jp/english/index.html, 24241071 and 25660172) and The Canon Foundation (http://www.canonfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge generous support from OIST Graduate University for the Marine Genomics Unit. We thank Dr. Steven D. Aird for editing the manuscript.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Araki Y, 2012, EUKARYOT CELL, V11, P638, DOI 10.1128/EC.00028-12; Barneah O, 2002, INVERTEBR BIOL, V121, P81; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chen HJ, 2010, J NUTR, V140, P1728, DOI 10.3945/jn.109.117531; Clode PL, 2003, PROTOPLASMA, V220, P153, DOI 10.1007/s00709-002-0046-3; Clode PL, 2002, TISSUE CELL, V34, P187, DOI 10.1016/S0040-8166(02)00031-9; CONSTANTZ B, 1988, J EXP ZOOL, V248, P253, DOI 10.1002/jez.1402480302; Cuif JP, 2003, GEOCHIM COSMOCHIM AC, V67, P75, DOI 10.1016/S0016-7037(02)01041-4; Cuif JP, 1999, COMP BIOCHEM PHYS A, V123, P269, DOI 10.1016/S1095-6433(99)00059-8; Desseyn JL, 2008, GENE, V410, P215, DOI 10.1016/j.gene.2007.12.014; Domart-Coulon I, 2004, J EXP MAR BIOL ECOL, V309, P199, DOI 10.1016/j.jembe.2004.03.021; Drake Jeana L., 2014, Elementa-Science of the Anthropocene, V2, P000026, DOI 10.12952/journal.elementa.000026; Drake JL, 2013, P NATL ACAD SCI USA, V110, pE2147, DOI 10.1073/pnas.1304591110; Drake JL, 2013, P NATL ACAD SCI USA, V110, P3788, DOI 10.1073/pnas.1301419110; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fukuda I, 2003, BIOCHEM BIOPH RES CO, V304, P11, DOI 10.1016/S0006-291X(03)00527-8; Ganot P, 2015, MOL BIOL EVOL, V32, P44, DOI 10.1093/molbev/msu265; Gautret P, 1997, FACIES, V36, P189, DOI 10.1007/BF02536884; Gilis M, 2014, J MORPHOL, V275, P1349, DOI 10.1002/jmor.20307; Goffredo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022338; Goldberg WM, 2001, TISSUE CELL, V33, P376, DOI 10.1054/tice.2001.0191; Goldberg WM, 2001, TISSUE CELL, V33, P388, DOI 10.1054/tice.2001.0192; GORSKI JP, 1992, CALCIFIED TISSUE INT, V50, P391, DOI 10.1007/BF00296767; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gunaratne HJ, 2007, BMC GENOMICS, P8; HARE PE, 1963, SCIENCE, V139, P216, DOI 10.1126/science.139.3551.216; Hayakawa H, 2007, ZOOL SCI, V24, P249, DOI 10.2108/zsj.24.249; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Hughes J, 1999, HUM MOL GENET, V8, P543, DOI 10.1093/hmg/8.3.543; Hulpiau P, 2011, MOL BIOL EVOL, V28, P647, DOI 10.1093/molbev/msq233; ISA Y, 1987, COMP BIOCHEM PHYS B, V87, P507, DOI 10.1016/0305-0491(87)90045-9; ISA Y, 1986, MAR BIOL, V93, P91, DOI 10.1007/BF00428658; Isowa Y, 2012, J MOL EVOL, V75, P11, DOI 10.1007/s00239-012-9514-3; Jell J.S., 1980, Acta Palaeontologica Polonica, V25, P311; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Kawasaki K, 2007, CELLS TISSUES ORGANS, V186, P7, DOI 10.1159/000102678; Kawasaki K, 2009, ANNU REV GENET, V43, P119, DOI 10.1146/annurev-genet-102108-134242; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Knowlton Nancy, 2010, P65, DOI 10.1002/9781444325508.ch4; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; LETISSIER MDA, 1988, MAR BIOL, V98, P493, DOI 10.1007/BF00391540; Lowenstam HA, 1989, BIOMINERALIZATION; Magie CR, 2008, BIOL BULL-US, V214, P218, DOI 10.2307/25470665; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; Mann S, 2001, BIOMINERALIZATION; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Massa T, 2014, P NATL ACAD SCI USA, V111, P12728, DOI 10.1073/pnas.1408621111; McCrea PD, 2010, J CELL SCI, V123, P637, DOI 10.1242/jcs.039842; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Mengerink KJ, 2002, J BIOL CHEM, V277, P943, DOI 10.1074/jbc.M109673200; MITTERER RM, 1978, B MAR SCI, V28, P173; Miyamoto H, 2013, ZOOL SCI, V30, P801, DOI 10.2108/zsj.30.801; Muscatine L, 1997, CORAL REEFS, V16, P205, DOI 10.1007/s003380050075; Musci G, 1996, BIOMETALS, V9, P66, DOI 10.1007/BF00188092; Oda H, 2011, J CELL BIOL, V193, P1137, DOI 10.1083/jcb.201008173; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Puverel S, 2005, CORAL REEFS, V24, P149, DOI 10.1007/s00338-004-0456-0; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Ramos-Silva P, 2013, MOL BIOL EVOL, V30, P2099, DOI 10.1093/molbev/mst109; Ramos-Silva P, 2013, P NATL ACAD SCI USA, V110, pE2144, DOI 10.1073/pnas.1303657110; Reyes-Bermudez A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-178; Sarashina Isao, 2006, Paleontological Research, V10, P311; Shikina S, 2013, ENDOCRINOLOGY, V154, P3447, DOI 10.1210/en.2013-1086; Shinzato C, 2008, BMC EVOL BIOL, P8; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Stanley SM, 2006, PALAEOGEOGR PALAEOCL, V232, P214, DOI 10.1016/j.palaeo.2005.12.010; Stanton R.J. Jr, 1987, Facies, V16, P157, DOI 10.1007/BF02536751; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Tambutte E, 2007, CORAL REEFS, V26, P517, DOI 10.1007/s00338-007-0263-5; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; VANDERMEULEN JH, 1973, MAR BIOL, V23, P47, DOI 10.1007/BF00394111; Vashchenko G, 2013, NUTRIENTS, V5, P2289, DOI 10.3390/nu5072289; Vasin A, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.574bcb0f133fe52835911abc4e296141; Vergnes L, 2013, CELL METAB, V17, P916, DOI 10.1016/j.cmet.2013.04.007; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEINER S, 1975, SCIENCE, V190, P987, DOI 10.1126/science.1188379; Wilson JM, 1997, J CELL BIOL, V136, P319, DOI 10.1083/jcb.136.2.319; Yamada L, 2009, J BIOL CHEM, V284, P9402, DOI 10.1074/jbc.M809672200; Yonezawa N, 2003, BIOCHEM BIOPH RES CO, V307, P877, DOI 10.1016/S0006-291X(03)01297-X	96	46	46	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156424	10.1371/journal.pone.0156424	http://dx.doi.org/10.1371/journal.pone.0156424			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253604	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700029
J	Tweedie, D; Fukui, K; Li, YZ; Yu, QS; Barak, S; Tamargo, IA; Rubovitch, V; Holloway, HW; Lehrmann, E; Wood, WH; Zhang, YQ; Becker, KG; Perez, E; Van Praag, H; Luo, Y; Hoffer, BJ; Becker, RE; Pick, CG; Greig, NH				Tweedie, David; Fukui, Koji; Li, Yazhou; Yu, Qian-sheng; Barak, Shani; Tamargo, Ian A.; Rubovitch, Vardit; Holloway, Harold W.; Lehrmann, Elin; Wood, William H., III; Zhang, Yongqing; Becker, Kevin G.; Perez, Evelyn; Van Praag, Henriette; Luo, Yu; Hoffer, Barry J.; Becker, Robert E.; Pick, Chaim G.; Greig, Nigel H.			Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms	PLOS ONE			English	Article							OBJECT RECOGNITION MEMORY; FLUID-PERCUSSION INJURY; HEAD-INJURY; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; OXIDATIVE STRESS; ACETYLCHOLINESTERASE INHIBITION; GENE-EXPRESSION; RISK-FACTOR; CELL-DEATH	Traumatic brain injury (TBI), often caused by a concussive impact to the head, affects an estimated 1.7 million Americans annually. With no approved drugs, its pharmacological treatment represents a significant and currently unmet medical need. In our prior development of the anti-cholinesterase compound phenserine for the treatment of neurodegenerative disorders, we recognized that it also possesses non-cholinergic actions with clinical potential. Here, we demonstrate neuroprotective actions of phenserine in neuronal cultures challenged with oxidative stress and glutamate excitotoxicity, two insults of relevance to TBI. These actions translated into amelioration of spatial and visual memory impairments in a mouse model of closed head mild TBI (mTBI) two days following cessation of clinically translatable dosing with phenserine (2.5 and 5.0 mg/kg BID x 5 days initiated post mTBI) in the absence of anti-cholinesterase activity. mTBI elevated levels of thiobarbituric acid reactive substances (TBARS), a marker of oxidative stress. Phenserine counteracted this by augmenting homeostatic mechanisms to mitigate oxidative stress, including superoxide dismutase [SOD] 1 and 2, and glutathione peroxidase [GPx], the activity and protein levels of which were measured by specific assays. Microarray analysis of hippocampal gene expression established that large numbers of genes were exclusively regulated by each individual treatment with a substantial number of them co-regulated between groups. Molecular pathways associated with lipid peroxidation were found to be regulated by mTBI, and treatment of mTBI animals with phenserine effectively reversed injury-induced regulations in the 'Blalock Alzheimer's Disease Up' pathway. Together these data suggest that multiple phenserine-associated actions underpin this compound's ability to ameliorate cognitive deficits caused by mTBI, and support the further evaluation of the compound as a therapeutic for TBI.	[Tweedie, David; Fukui, Koji; Li, Yazhou; Yu, Qian-sheng; Tamargo, Ian A.; Holloway, Harold W.; Becker, Robert E.; Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Fukui, Koji] Shibaura Inst Technol, Div Biosci & Engn, Saitama 3378570, Japan; [Barak, Shani; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Lehrmann, Elin; Wood, William H., III; Zhang, Yongqing; Becker, Kevin G.] NIA, Lab Genet & Genom, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Perez, Evelyn] NIA, Lab Behav Neurosci, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Van Praag, Henriette] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Luo, Yu; Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Becker, Robert E.] 7123 Pinebrook Rd, Park City, UT 84098 USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Shibaura Institute of Technology; Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Case Western Reserve University; Tel Aviv University	Greig, NH (corresponding author), NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	greign@mail.nih.gov	Fukui, Koji/I-7067-2019	Fukui, Koji/0000-0003-2748-3228; Lehrmann, Elin/0000-0002-9869-9475; van Praag, Henriette/0000-0002-5727-434X; Luo, Yu/0000-0002-7939-5505; Holloway, Courtney Jean/0000-0003-3661-1957	Intramural Research Program of the National Institute on Aging, National Institutes of Health; Ari and Regine Aprijaskis Fund, at Tel-Aviv University; Israel Science Foundation [108/09]; NATIONAL INSTITUTE ON AGING [ZICAG000616, ZIAAG000311, ZIAAG000328] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ari and Regine Aprijaskis Fund, at Tel-Aviv University; Israel Science Foundation(Israel Science Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, (ii) the Ari and Regine Aprijaskis Fund, at Tel-Aviv University, and (iii) a grant from the Israel Science Foundation, grant number 108/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, (ii) the Ari and Regine Aprijaskis Fund, at Tel-Aviv University, and (iii) a grant from the Israel Science Foundation, grant number 108/09.	AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Allen TGJ, 2006, J NEUROSCI, V26, P1588, DOI 10.1523/JNEUROSCI.3979-05.2006; [Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Araujo JA, 2011, J ALZHEIMERS DIS, V26, P143, DOI 10.3233/JAD-2011-110005; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barger SW, 2004, FRONT BIOSCI-LANDMRK, V9, P3286, DOI 10.2741/1481; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; Boyajyan A, 2015, RECENT ADV DNA GENE; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Chen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099818; Chuah YML, 2004, BRAIN COGNITION, V56, P304, DOI 10.1016/j.bandc.2004.08.002; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cox CD, 2008, J NEUROTRAUM, V25, P1355, DOI 10.1089/neu.2008.0671; Crepaldi L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003699; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Dixon CE, 1979, EXP NEUROL, V146, P479; Djordjevic J, 2016, CURR ALZHEIMER RES; Donat CK, 2008, BRAIN RES, V1246, P167, DOI 10.1016/j.brainres.2008.09.059; Donat CK, 2007, BRAIN INJURY, V21, P1031, DOI 10.1080/02699050701630359; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Dumas JA, 2011, PHARMACOL BIOCHEM BE, V99, P254, DOI 10.1016/j.pbb.2011.02.022; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Greig NH, 2000, ACTA NEUROL SCAND, V102, P74, DOI 10.1034/j.1600-0404.2000.00311.x; Greig Nigel H., 2005, Current Alzheimer Research, V2, P483, DOI 10.2174/156720505774330564; Hendrickx A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099467; HEPPNER F, 1958, Monatsschr Unfallheilkd Versicherungsmed, V61, P257; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; IKARI H, 1995, NEUROREPORT, V6, P481, DOI 10.1097/00001756-199502000-00019; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jenkner FL, 1954, NERVENARZT, V25, P77; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Klein BD, 2004, EPILEPSY RES, V62, P13, DOI 10.1016/j.eplepsyres.2004.06.007; Lahiri DK, 2003, J ALZHEIMERS DIS, V5, P81, DOI 10.3233/JAD-2003-5203; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; LECHNER H, 1963, Wien Klin Wochenschr, V75, ppassim; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058752; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054887; Lusardi TA, 2009, CURR NEUROPHARMACOL, V7, P228, DOI 10.2174/157015909789152137; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; METZ B, 1971, J NEUROSURG, V35, P523, DOI 10.3171/jns.1971.35.5.0523; Mikkilineni S, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/142372; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Ostberg A, 2011, NEUROLOGY, V76, P1046, DOI 10.1212/WNL.0b013e318211c1c4; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Parsons CG, 2013, NEUROTOX RES, V24, P358, DOI 10.1007/s12640-013-9398-z; Perry E, 1999, TRENDS NEUROSCI, V22, P273, DOI 10.1016/S0166-2236(98)01361-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pike BR, 1997, J NEUROTRAUM, V14, P897, DOI 10.1089/neu.1997.14.897; Pilipovic K, 2011, NEUROCHEM RES, V36, P913, DOI 10.1007/s11064-011-0424-3; Poole NA, 2008, BRAIN INJURY, V22, P519, DOI 10.1080/02699050802132495; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reale M, 2014, CURR ALZHEIMER RES, V11, P608, DOI 10.2174/1567205010666131212113218; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; RUGE D, 1954, J NEUROSURG, V11, P77, DOI 10.3171/jns.1954.11.1.0077; Ruszkiewicz J, 2015, NEUROCHEM INT, V88, P66, DOI 10.1016/j.neuint.2014.12.012; SACHS E, 1957, J NEUROSURG, V14, P22, DOI 10.3171/jns.1957.14.1.0022; SAIJA A, 1988, BRAIN RES, V452, P303, DOI 10.1016/0006-8993(88)90034-0; Salmond CH, 2005, J NEUROTRAUM, V22, P613, DOI 10.1089/neu.2005.22.613; Sambamurti K, 2002, NEUROMOL MED, V1, P1, DOI 10.1385/NMM:1:1:1; Saso L, 2014, CURR DRUG TARGETS, V15, P1177, DOI 10.2174/1389450115666141024113925; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Scarr E, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00055; Schliebs R, 2006, J NEURAL TRANSM, V113, P1625, DOI 10.1007/s00702-006-0579-2; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Scremin OU, 2012, J NEUROTRAUM, V29, P2457, DOI 10.1089/neu.2012.2465; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; TOWER DB, 1949, CAN J RES E, V27, P105, DOI 10.1139/cjr49e-016; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Wang XD, 1999, NEUROSCI LETT, V272, P21, DOI 10.1016/S0304-3940(99)00567-4; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yu QS, 2001, J MED CHEM, V44, P4062, DOI 10.1021/jm010080x; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	127	32	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156493	10.1371/journal.pone.0156493	http://dx.doi.org/10.1371/journal.pone.0156493			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254111	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700033
J	Uchitomi, H; Ogawa, K; Orimo, S; Wada, Y; Miyake, Y				Uchitomi, Hirotaka; Ogawa, Ken-ichiro; Orimo, Satoshi; Wada, Yoshiaki; Miyake, Yoshihiro			Effect of Interpersonal Interaction on Festinating Gait Rehabilitation in Patients with Parkinson's Disease	PLOS ONE			English	Article							RHYTHMIC AUDITORY-STIMULATION; FRACTAL DYNAMICS; MOVEMENT; SYNCHRONIZATION; IMPAIRMENT; MECHANISM; SPEECH	Although human walking gait rhythms are generated by native individual gait dynamics, these gait dynamics change during interactions between humans. A typical phenomenon is synchronization of gait rhythms during cooperative walking. Our previous research revealed that fluctuation characteristics in stride interval of subjects with Parkinson's disease changed from random to 1/f fluctuation as fractal characteristics during cooperative walking with the gait assist system Walk-Mate, which emulates a human interaction using interactive rhythmic cues. Moreover, gait dynamics were relearned through Walk-Mate gait training. However, the system's clinical efficacy was unclear because the previous studies did not focus on specific gait rhythm disorder symptoms. Therefore, this study aimed to evaluate the effect of Walk-Mate on festinating gait among subjects with Parkinson's disease. Three within-subject experimental conditions were used: (1) preinteraction condition, (2) interaction condition, and (3) postinteraction condition. The only difference between conditions was the interactive rhythmic cues generated by Walk-Mate. Because subjects with festinating gait gradually and involuntarily decreased their stride interval, the regression slope of stride interval as an index of severity of preinteraction festinating gait was elevated. The regression slope in the interaction condition was more gradual than during the preinteraction condition, indicating that the interactive rhythmic cues contributed to relieving festinating gait and stabilizing gait dynamics. Moreover, the gradual regression slope was carried over to the postinteraction condition, indicating that subjects with festinating gait have the potential to relearn stable gait dynamics. These results suggest that disordered gait dynamics are clinically restored through interactive rhythmic cues and that Walk-Mate may have the potential to assist therapists in more effective rehabilitation.	[Uchitomi, Hirotaka; Ogawa, Ken-ichiro; Miyake, Yoshihiro] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan; [Orimo, Satoshi] Kanto Cent Hosp, Dept Neurol, Setagaya Ku, Tokyo, Japan; [Wada, Yoshiaki] Nissan Tamagawa Hosp, Dept Rehabil, Setagaya Ku, Tokyo, Japan	Tokyo Institute of Technology	Uchitomi, H (corresponding author), Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 227, Japan.	uchitomi@myk.dis.titech.ac.jp						Brown P, 1996, BALANCE POSTURE GAIT, P156; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Coelho M, 2014, NONMOTOR SYMPTOMS PA, P45; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; CONDON WS, 1974, SCIENCE, V183, P99, DOI 10.1126/science.183.4120.99; Fahn S., 1987, RECENT DEV PARKINSON, P153; Giladi N, 2001, PARKINSONISM RELAT D, V7, P135, DOI 10.1016/S1353-8020(00)00030-4; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Grahn JA, 2009, CORTEX, V45, P54, DOI 10.1016/j.cortex.2008.01.005; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 1996, J APPL PHYSIOL, V80, P1448, DOI 10.1152/jappl.1996.80.5.1448; Herman T, 2005, GAIT POSTURE, V21, P178, DOI 10.1016/j.gaitpost.2004.01.014; Hoehn MM, 1998, NEUROLOGY, V50, P318, DOI 10.1212/WNL.50.2.318; Hove MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032600; MATARAZZO JD, 1964, PSYCHOTHER-THEOR RES, V1, P54, DOI 10.1037/h0088571; MATES J, 1994, BIOL CYBERN, V70, P463, DOI 10.1007/BF00203239; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Miyake Y, 2004, ACTA NEUROBIOL EXP, V64, P415; Miyake Y., 1994, Proceedings. 3rd IEEE International Workshop on Robot and Human Communication. RO-MAN '94 Nagoya (Cat. No.94TH0679-1), P118, DOI 10.1109/ROMAN.1994.365945; Miyake Y, 1997, IEEE SYS MAN CYBERN, P293, DOI 10.1109/ICSMC.1997.625765; Miyake Y., 2002, T SOC INSTRUMENT CON, VE-2, P195; Miyake Y, 2009, IEEE T ROBOT, V25, P638, DOI 10.1109/TRO.2009.2020350; Muto T, 2002, P 2002 IEEE INT C SY, P1; Muto T, 2007, 2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, VOLS 1-4, P1240, DOI 10.1109/ICCME.2007.4381942; Muto T, 2011, J ADV COMPUT INTELL, V15, P534, DOI 10.20965/jaciii.2011.p0534; Muto T, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-58; Nagaoka Chika, 2007, CONVERSATIONAL INFOR, P331; Orlovsky GN, 1999, NEURAL CONTROL IOCOM; Ota L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112952; Parkinson J., 1817, ASSAY SHAKING PALSY; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Scafetta N, 2009, CHAOS, V19, DOI 10.1063/1.3143035; Schwartze M, 2011, BEHAV BRAIN RES, V216, P685, DOI 10.1016/j.bbr.2010.09.015; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Takano K, 2007, NEUROSCI LETT, V417, P196, DOI 10.1016/j.neulet.2007.02.044; Takenaka T, 2006, ADV ENG INFORM, V20, P321, DOI 10.1016/j.aei.2006.01.004; Thaut MH, 2010, MUSIC PERCEPT, V27, P263, DOI 10.1525/MP.2010.27.4.263; Uchitomi H, 2012, BIOMEDICAL ENG COGNI, P38; Uchitomi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072176; Zhao YJ, 2010, MOVEMENT DISORD, V25, P710, DOI 10.1002/mds.22875; Zivotofsky AZ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-28	45	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155540	10.1371/journal.pone.0155540	http://dx.doi.org/10.1371/journal.pone.0155540			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253376	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700007
J	Xu, CM; Zhang, ZQ; Cui, KD; Zhao, YH; Han, JK; Liu, F; Mu, W				Xu, Chunmei; Zhang, Zhengqun; Cui, Kaidi; Zhao, Yunhe; Han, Jingkun; Liu, Feng; Mu, Wei			Effects of Sublethal Concentrations of Cyantraniliprole on the Development, Fecundity and Nutritional Physiology of the Black Cutworm Agrotis ipsilon ( Lepidoptera: Noctuidae)	PLOS ONE			English	Article							ANTHRANILIC DIAMIDE INSECTICIDE; SPODOPTERA-LITURA LEPIDOPTERA; ASIAN CORN-BORER; ENZYME-ACTIVITIES; LIFE TABLE; FAT-BODY; CHLORANTRANILIPROLE; RESISTANCE; HEMOLYMPH; TOXICITY	To better understand the sublethal effects of cyantraniliprole on the black cutworm Agrotis ipsilon (Lepidoptera: Noctuidae), several studies were carried out to investigate sublethal effects on development stages, population parameters, feeding indices and nutrient content of A. ipsilon. The result of a bioassay showed that cyantraniliprole had high toxicity against A. ipsilon fourth-instar larvae with an LC50 of 0.354 mu g.g(-1) using an artificial diet. Compared with controls, sublethal doses of cyantraniliprole at LC5, LC20 and LC40 levels prolonged larval and pupal duration and extended mean generation time and total preovipositional period. In addition, survival rate, reproductive value, intrinsic and finite rates of increase and net reproduction rate declined significantly. Meanwhile, cyantraniliprole had markedly anti-feedant effects; decreased the relative growth rate (RGR), the relative consumption rate (RCR), the efficiency of conversion of ingested food (ECI), the efficiency of conversion of digested food (ECD); and increased the approximate digestibility (AD) significantly. This phenomenon contributed to the decrease of nutrient contents, including lipids, protein and carbohydrates, to the point that insufficient energy was available for normal growth. Therefore, sublethal concentrations of cyantraniliprole decreased growth speed and reduced population reproduction of A. ipsilon. This result provides information useful in integrated pest management (IPM) programs for A. ipsilon.	[Xu, Chunmei; Cui, Kaidi; Zhao, Yunhe; Han, Jingkun; Liu, Feng; Mu, Wei] Shandong Agr Univ, Coll Plant Protect, Shandong Prov Key Lab Biol Vegetable Dis & Insect, Tai An 271018, Shandong, Peoples R China; [Zhang, Zhengqun] Shandong Agr Univ, Coll Hort Sci & Engn, Tai An 271018, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Mu, W (corresponding author), Shandong Agr Univ, Coll Plant Protect, Shandong Prov Key Lab Biol Vegetable Dis & Insect, Tai An 271018, Shandong, Peoples R China.	muwei@sdau.edu.cn	liu, feng/D-2803-2017; Zhang, Zhengqun/AAW-8239-2020	liu, feng/0000-0002-0271-3632; 	National Natural Science Foundation of China [31572040, 31501651]; Modern Agricultural Industry Technology System of Shandong Province [SDAIT-01-02-09]; Natural Science Foundation of Shangdong Province [ZR2015CQ017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agricultural Industry Technology System of Shandong Province; Natural Science Foundation of Shangdong Province	"This work was supported by the National Natural Science Foundation of China, award number 31572040 to Feng Liu and award number 31501651 to Zhengqun Zhang, the Modern Agricultural Industry Technology System of Shandong Province, award number SDAIT-01-02-09 to Wei Mu, and the Natural Science Foundation of Shangdong Province, award number ZR2015CQ017 to Zhengqun Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Akca I, 2015, J ECON ENTOMOL, V108, P1466, DOI 10.1093/jee/tov187; Akkopru EP, 2015, J ECON ENTOMOL, V108, P378, DOI 10.1093/jee/tov011; [Anonymous], 1925, J ECON ENTOMOL; Bielza P, 2015, PEST MANAG SCI, V71, P1068, DOI 10.1002/ps.3886; Binning RR, 2015, PEST MANAG SCI, V71, P601, DOI 10.1002/ps.3901; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Chi H, 2015, TWOSEX MSCHART COMPU; Cohen E, 2006, PESTIC BIOCHEM PHYS, V85, P21, DOI 10.1016/j.pestbp.2005.09.002; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Du JunHui, 2013, Acta Phytophylacica Sinica, V40, P266; Etebari K, 2007, PESTIC BIOCHEM PHYS, V88, P14, DOI 10.1016/j.pestbp.2006.08.005; Gravalos C, 2015, PEST MANAG SCI, V71, P1030, DOI 10.1002/ps.3885; Han WS, 2012, PEST MANAG SCI, V68, P1184, DOI 10.1002/ps.3282; Hannig GT, 2009, PEST MANAG SCI, V65, P969, DOI 10.1002/ps.1781; Hardke JT, 2011, FLA ENTOMOL, V94, P272, DOI 10.1653/024.094.0221; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; Huang Yu-Bing, 2012, Insect Science, V19, P263, DOI 10.1111/j.1744-7917.2011.01424.x; Ioriatti C, 2009, PEST MANAG SCI, V65, P717, DOI 10.1002/ps.1744; Jansen BJM, 2004, NAT PROD REP, V21, P449, DOI 10.1039/b311170a; Khosravi Roya, 2010, Journal of Plant Protection Research, V50, P423, DOI 10.2478/v10045-010-0071-8; Knight AL, 2007, PEST MANAG SCI, V63, P180, DOI 10.1002/ps.1318; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; Lai TC, 2011, PEST MANAG SCI, V67, P1468, DOI 10.1002/ps.2201; Lai TC, 2011, J PEST SCI, V84, P381, DOI 10.1007/s10340-011-0366-1; Liu ZL, 2008, PESTIC BIOCHEM PHYS, V91, P122, DOI 10.1016/j.pestbp.2008.03.003; Murillo AC, 2015, PEST MANAG SCI, V71, P752, DOI 10.1002/ps.3847; Nath BS, 2000, PESTIC BIOCHEM PHYS, V68, P127, DOI 10.1006/pest.2000.2509; Nath BS, 1997, ECOTOX ENVIRON SAFE, V36, P169, DOI 10.1006/eesa.1996.1504; Nathan SS, 2006, PESTIC BIOCHEM PHYS, V84, P98, DOI 10.1016/j.pestbp.2005.05.006; Nathan SS, 2005, PHYTOPARASITICA, V33, P187, DOI 10.1007/BF03029978; Perveen F, 2000, ANN ENTOMOL SOC AM, V93, P1131, DOI 10.1603/0013-8746(2000)093[1131:EOSDOC]2.0.CO;2; Rehan A, 2015, NEOTROP ENTOMOL, V44, P513, DOI 10.1007/s13744-015-0306-5; Enriquez CLR, 2010, J ECON ENTOMOL, V103, P662, DOI 10.1603/EC09244; ROE JH, 1954, J BIOL CHEM, V208, P889; Sang Song, 2014, Journal of South China Agricultural University, V35, P64; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; Schoonhoven L. M., 2005, Insect-plant biology; Song YueQin, 2013, Acta Entomologica Sinica, V56, P446; STOYENOFF JL, 1994, OECOLOGIA, V97, P158, DOI 10.1007/BF00323145; Tang QL, 2015, J ECON ENTOMOL, V108, P2720, DOI 10.1093/jee/tov221; Tiwari S, 2013, PEST MANAG SCI, V69, P1066, DOI 10.1002/ps.3468; Tuan SJ, 2016, J ECON ENTOMOL, V109, P13, DOI 10.1093/jee/tov265; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Yin XH, 2009, J ECON ENTOMOL, V102, P357, DOI 10.1603/029.102.0146; Yu H., 2015, ACTA ENTOMOL SINICA, V6; Yu JZ, 2013, BIOL CONTROL, V64, P1, DOI 10.1016/j.biocontrol.2012.10.002; Yu WeiLi, 2012, Acta Phytophylacica Sinica, V39, P277; Zhang RM, 2015, PEST MANAG SCI, V71, P250, DOI 10.1002/ps.3791; Zhang YJ, Patent No. [No 200810112399, 200810112399]; Zhao YH, 2016, PESTIC BIOCHEM PHYS, V129, P49, DOI 10.1016/j.pestbp.2015.10.017	52	42	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156555	10.1371/journal.pone.0156555	http://dx.doi.org/10.1371/journal.pone.0156555			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249654	Green Submitted, gold, Green Published			2022-12-26	WOS:000377184700052
J	Banerjee, A; Chakraborty, S; Chakraborty, A; Chakrabarti, S; Ray, K				Banerjee, Antara; Chakraborty, Subhadip; Chakraborty, Abhijit; Chakrabarti, Saikat; Ray, Kunal			Functional and Structural Analyses of CYP1B1 Variants Linked to Congenital and Adult-Onset Glaucoma to Investigate the Molecular Basis of These Diseases	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CYTOCHROME P4501B1 CYP1B1; MUTATION SPECTRUM; JAPANESE PATIENTS; INDIAN PATIENTS; GENE-MUTATIONS; HAPLOTYPE BACKGROUNDS; ESSENTIAL DYNAMICS; PROTEIN DYNAMICS; EYE DEVELOPMENT	Glaucoma, the leading cause of irreversible blindness, appears in various forms. Mutations in CYP1B1 result in primary congenital glaucoma (PCG) by an autosomal recessive mode of inheritance while it acts as a modifier locus for primary open angle glaucoma (POAG). We investigated the molecular basis of the variable phenotypes resulting from the defects in CYP1B1 by using subclones of 23 CYP1B1 mutants reported in glaucoma patients, in a cell based system by measuring the dual activity of the enzyme to metabolize both retinol and 17 beta-estradiol. Most variants linked to POAG showed low steroid metabolism while null or very high retinol metabolism was observed in variants identified in PCG. We examined the translational turnover rates of mutant proteins after the addition of cycloheximide and observed that the levels of enzyme activity mostly corroborated the translational turnover rate. We performed extensive normal mode analysis and molecular-dynamics-simulations-based structural analyses and observed significant variation of fluctuation in certain segmental parts of the mutant proteins, especially at the B-C and F-G loops, which were previously shown to affect the dynamic behavior and ligand entry/ exit properties of the cytochrome P450 family of proteins. Our molecular study corroborates the structural analysis, and suggests that the pathologic state of the carrier of CYP1B1 mutations is determined by the allelic state of the gene. To our knowledge, this is the first attempt to dissect biological activities of CYP1B1 for correlation with congenital and adult onset glaucomas.	[Banerjee, Antara; Chakraborty, Subhadip; Ray, Kunal] Indian Inst Chem Biol, CSIR, Mol & Human Genet Div, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Chakraborty, Abhijit; Chakrabarti, Saikat] Indian Inst Chem Biol, CSIR, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Ray, Kunal] Acad Sci & Innovat Res AcSIR, Cent Rd Res Inst, Delhi Mathura Rd, New Delhi 110025, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Road Research Institute (CRRI)	Ray, K (corresponding author), Indian Inst Chem Biol, CSIR, Mol & Human Genet Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.; Chakrabarti, S (corresponding author), Indian Inst Chem Biol, CSIR, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.; Ray, K (corresponding author), Acad Sci & Innovat Res AcSIR, Cent Rd Res Inst, Delhi Mathura Rd, New Delhi 110025, India.	saikat@iicb.res.in; kunalray@acsir.res.in			Council of Scientific and Industrial Research (CSIR), Government of India [CM-0016, MLP-0016, SIP-007, BSC-0121]; CSIR Network project GENESIS [BSC0121]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); CSIR Network project GENESIS	The Council of Scientific and Industrial Research (CSIR), Government of India supported the study through funding grants CM-0016, MLP-0016, SIP-007 to KR and BSC-0121 to SC, http://www.csir.res.in. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Ananya Ray-Soni for critically proofreading the manuscript to improve the language and grammar of the manuscript. We also thank CSIR-IICB for providing infrastructural support and CSIR Network project GENESIS (BSC0121) for financial support.	Abu-Amero KK, 2011, MOL VIS, V17, P2911; Achary MS, 2006, BIOPHYS J, V91, P4329, DOI 10.1529/biophysj.106.085498; Acharya M, 2006, MOL VIS, V12, P399; Acharya M, 2008, J GENET, V87, P265, DOI 10.1007/s12041-008-0041-3; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amadei A, 1999, PROTEINS, V35, P283, DOI 10.1002/(SICI)1097-0134(19990515)35:3<283::AID-PROT2>3.0.CO;2-R; Amini A. M NM, 2005, IRAN J SCI TECHNOL A, V29, P1; [Anonymous], 1984, J CHEM PHYS, V81, P511; [Anonymous], 1984, CANONICAL DYNAMICS E, V31, P1695; Azmanov DN, 2011, EUR J HUM GENET, V19, P326, DOI 10.1038/ejhg.2010.181; Bagiyeva S, 2007, MOL VIS, V13, P1458; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Bayat B, 2008, MOL VIS, V14, P508; Bejjani BA, 1998, AM J HUM GENET, V62, P325, DOI 10.1086/301725; Bejjani BA, 2000, HUM MOL GENET, V9, P367, DOI 10.1093/hmg/9.3.367; Belmouden A, 2002, CLIN GENET, V62, P334, DOI 10.1034/j.1399-0004.2002.620415.x; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bhattacharjee A, 2008, MOL VIS, V14, P841; Campos-Mollo E, 2009, MOL VIS, V15, P417; Chakrabarti S, 2006, INVEST OPHTH VIS SCI, V47, P43, DOI 10.1167/iovs.05-0912; Chakrabarti S, 2007, INVEST OPHTH VIS SCI, V48, P5439, DOI 10.1167/iovs.07-0629; Chakrabarti Subhabrata, 2003, Hum Genet, V113, P556; Chavarria-Soley G, 2006, MOL VIS, V12, P523; Chen YH, 2008, ARCH OPHTHALMOL-CHIC, V126, P1443, DOI 10.1001/archopht.126.10.1443; Chitsazian F, 2007, J MOL DIAGN, V9, P382, DOI 10.2353/jmoldx.2007.060157; Chouldhary D, 2008, PHARMACOGENET GENOM, V18, P665, DOI 10.1097/FPC.0b013e3282ff5a36; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Colomb E, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9197; Cvekl A, 2009, EXP EYE RES, V89, P280, DOI 10.1016/j.exer.2009.04.012; Duester G, 2009, CHEM-BIOL INTERACT, V178, P178, DOI 10.1016/j.cbi.2008.09.004; El-Gayar S, 2009, MOL VIS, V15, P1325; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Firasat S, 2008, MOL VIS, V14, P2002; Fuse N, 2010, JPN J OPHTHALMOL, V54, P1, DOI 10.1007/s10384-009-0769-1; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; HAYWARD S, 1995, PROTEINS, V23, P177, DOI 10.1002/prot.340230207; HAYWARD S, 1995, ANNU REV PHYS CHEM, V46, P223, DOI 10.1146/annurev.pc.46.100195.001255; Hayward Steven, 2008, V443, P89, DOI 10.1007/978-1-59745-177-2_5; Hess B, 1997, J COMPUTATIONAL CHEM; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hilal L, 2010, MOL VIS, V16, P1215; Hollander David A, 2006, Trans Am Ophthalmol Soc, V104, P183; Hollander DA, 2006, AM J OPHTHALMOL, V142, P993, DOI 10.1016/j.ajo.2006.07.054; Jansson I, 2001, PHARMACOGENETICS, V11, P793, DOI 10.1097/00008571-200112000-00007; Kakiuchi-Matsumoto T, 2001, AM J OPHTHALMOL, V131, P345, DOI 10.1016/S0002-9394(00)00808-4; Kim HJ, 2011, MOL VIS, V17, P2093; Kitao A, 1998, PROTEINS, V33, P496, DOI 10.1002/(SICI)1097-0134(19981201)33:4<496::AID-PROT4>3.3.CO;2-T; Kumar A, 2007, MOL VIS, V13, P667; Li DN, 2000, PHARMACOGENETICS, V10, P343, DOI 10.1097/00008571-200006000-00008; Li N, 2011, EXP EYE RES, V93, P572, DOI 10.1016/j.exer.2011.07.009; LIEHR JG, 1986, J BIOL CHEM, V261, P6865; Lopez-Garrido MP, 2010, CLIN GENET, V77, P70, DOI 10.1111/j.1399-0004.2009.01284.x; Lopez-Garrido MP, 2009, CLIN GENET, V76, P552, DOI 10.1111/j.1399-0004.2009.01242.x; Lopez-Garrido MP, 2006, MOL VIS, V12, P748; Lopez-Garrido MP, 2013, OPHTHALMOLOGY, V120, P716, DOI 10.1016/j.ophtha.2012.09.016; Maden M, 2001, POSTGRAD MED J, V77, P489, DOI 10.1136/pmj.77.910.489; Maihofner C, 2001, INVEST OPHTH VIS SCI, V42, P2616; Mashima Y, 2001, INVEST OPHTH VIS SCI, V42, P2211; Melki R, 2004, J MED GENET, V41, P647, DOI 10.1136/jmg.2004.020024; Michels-Rautenstrauss KG, 2001, J GLAUCOMA, V10, P354, DOI 10.1097/00061198-200108000-00017; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mookherjee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045077; Ng SK, 2014, CLIN EXP OPHTHALMOL, V42, P25, DOI 10.1111/ceo.12234; Ohtake Y, 2003, BRIT J OPHTHALMOL, V87, P302, DOI 10.1136/bjo.87.3.302; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Panicker SG, 2002, INVEST OPHTH VIS SCI, V43, P1358; Panicker SG, 2004, INVEST OPHTH VIS SCI, V45, P1149, DOI 10.1167/iovs.03-0404; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Pasutto F, 2010, INVEST OPHTH VIS SCI, V51, P249, DOI 10.1167/iovs.09-3880; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plasilova M, 1999, J MED GENET, V36, P290; Reddy ABM, 2004, MOL VIS, V10, P696; Reddy ABM, 2003, INVEST OPHTH VIS SCI, V44, P4200, DOI 10.1167/iovs.02-0945; Scheetz TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058657; Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420; Sena DF, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010777; Sivadorai P, 2008, CLIN GENET, V74, P82, DOI 10.1111/j.1399-0004.2008.01024.x; Skopalik J, 2008, J PHYS CHEM B, V112, P8165, DOI 10.1021/jp800311c; Stoilov I, 1998, AM J HUM GENET, V62, P573, DOI 10.1086/301764; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; Stoilov IR, 2002, INVEST OPHTH VIS SCI, V43, P1820; Su CC, 2012, EYE, V26, P1369, DOI 10.1038/eye.2012.159; Suri F, 2009, OPHTHALMOLOGY, V116, P2101, DOI 10.1016/j.ophtha.2009.04.045; Suri F, 2008, MOL VIS, V14, P2349; Tanwar M, 2009, MOL VIS, V15, P1200; Vasiliou V, 2008, ANNU REV PHARMACOL, V48, P333, DOI 10.1146/annurev.pharmtox.48.061807.154729; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vincent AL, 2002, AM J HUM GENET, V70, P448, DOI 10.1086/338709; Yu XF, 2013, BIOTECHNOL APPL BIOC, V60, P134, DOI 10.1002/bab.1074; Zenteno JC, 2008, J GLAUCOMA, V17, P189, DOI 10.1097/IJG.0b013e31815678c3	96	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156252	10.1371/journal.pone.0156252	http://dx.doi.org/10.1371/journal.pone.0156252			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243976	Green Submitted, Green Published, gold			2022-12-26	WOS:000377146100022
J	Li, D; Du, XLL; Ren, YH; Liu, PJ; Li, ST; Yang, J; Lv, M; Chen, L; Wang, X; Li, EX; Yang, J; Yi, M				Li, Dan; Du, Xianglin L.; Ren, Yinghong; Liu, Peijun; Li, Shuting; Yang, Jiao; Lv, Meng; Chen, Ling; Wang, Xin; Li, Enxiao; Yang, Jin; Yi, Min			Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer	PLOS ONE			English	Article							FACTOR-RECEPTOR GENE; RACIAL-DIFFERENCES; ASIAN/PACIFIC ISLANDER; PROGNOSTIC-FACTORS; DISPARITIES; MUTATIONS; ASSOCIATION; VETERANS; REGISTRY; ACCESS	Ethnic disparities in lung and bronchial cancer diagnoses and disease-specific survival (DSS) rates in the United States are well known. However, few studies have specifically assessed these differences in Asian subgroups. The primary objectives of the retrospective analysis described herein were to identify any significant differences in clinicopathologic features, treatment, and survival rate between Asian lung cancer patients and lung cancer patients in other broad ethnic groups in the United States and to determine the reasons for these differences among subgroups of Asian patients with lung or bronchial cancer. We searched the Surveillance, Epidemiology, and End Results Program database to identify patients diagnosed with lung or bronchial cancer from 1990 to 2012. Differences in clinicopathologic features, treatment, and DSS rate in four broad ethnic groups and eight Asian subgroups were compared. The study population consisted of 849,088 patients, 5.2% of whom were of Asian descent. Female Asian patients had the lowest lung and bronchial cancer incidence rates, whereas male black patients had the highest rates. Asian patients had the best 5-year DSS rate. In our Asian subgroup analysis, Indian/Pakistani patients had the best 5-year DSS rate, whereas Hawaiian/Pacific Islander patients had the worst 5-year DSS rates. We found the differences in DSS rate among the four broad ethnic groups and eight Asian subgroups when we grouped patients by age and disease stage, as well. Asian patients had better DSS rates than those in the other three broad ethnic groups in almost every age and disease-stage group, especially in older patients and those with advanced-stage disease. In conclusion, we found that clinicopathologic features and treatment of lung and bronchial cancer differ by ethnicity in the United States, and the differences impact survival in each ethnic group.	[Li, Dan; Li, Shuting; Yang, Jiao; Lv, Meng; Chen, Ling; Wang, Xin; Li, Enxiao; Yang, Jin; Yi, Min] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian 710049, Shaanxi, Peoples R China; [Li, Dan] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Resp & Crit Care Med, Xian 710049, Shaanxi, Peoples R China; [Du, Xianglin L.] Univ Texas Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Ren, Yinghong] Shangluo Cent Hosp, Dept Internal Med, Shangluo, Shaanxi, Peoples R China; [Liu, Peijun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Translat Med, Xian 710049, Shaanxi, Peoples R China; [Yi, Min] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Xi'an Jiaotong University; University of Texas System; UTMD Anderson Cancer Center	Yang, J; Yi, M (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Oncol, Xian 710049, Shaanxi, Peoples R China.; Yi, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA.	yangjin@mail.xjtu.edu.cn; myi@mdanderson.org	Yi, Min/J-8963-2017	Yi, Min/0000-0001-8662-6546				Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Cetin Karynsa, 2011, Clin Epidemiol, V3, P139, DOI 10.2147/CLEP.S17191; Chang ET, 2009, CANCER EPIDEM BIOMAR, V18, P2248, DOI 10.1158/1055-9965.EPI-09-0332; Chen SL, 2008, AM J SURG, V196, P495, DOI 10.1016/j.amjsurg.2008.06.018; Ferketich AK, 2013, CANCER-AM CANCER SOC, V119, P847, DOI 10.1002/cncr.27824; Finlay GA, 2002, CHEST, V122, P1938, DOI 10.1378/chest.122.6.1938; Gadgeel SM, 2003, CANCER METAST REV, V22, P39, DOI 10.1023/A:1022207917249; Ganti AK, 2014, CLIN LUNG CANCER, V15, P152, DOI 10.1016/j.cllc.2013.11.004; Gomez SL, 2011, CANCER EPIDEM BIOMAR, V20, P545, DOI 10.1158/1055-9965.EPI-10-0965; Hamid MS, 2015, J CANCER EPIDEMIOL, V2015, DOI 10.1155/2015/269304; Holford TR, 2014, AM J PREV MED, V46, pE31, DOI 10.1016/j.amepre.2013.10.022; Ignatius SH, 2009, J THORAC ONCOL, V4, P1083, DOI 10.1097/JTO.0b013e3181b27b15; Jemal A, 2013, JNCI-J NATL CANCER I, V105, P175, DOI 10.1093/jnci/djs491; Kim HJ, 2013, ONCOL LETT, V5, P271, DOI 10.3892/ol.2012.950; Leggett MD, 2008, ANN SURG ONCOL, V15, P2493, DOI 10.1245/s10434-008-0022-z; Martinez SR, 2008, CANCER-AM CANCER SOC, V112, P1162, DOI 10.1002/cncr.23261; Meza R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121323; Mulligan CR, 2006, CANCER EPIDEM BIOMAR, V15, P25, DOI 10.1158/1055-9965.EPI-05-0537; Nimako K, 2013, EUR J CANCER CARE, V22, P79, DOI 10.1111/j.1365-2354.2012.01373.x; Ou SHI, 2008, CANCER-AM CANCER SOC, V112, P2011, DOI 10.1002/cncr.23397; Ou SHI, 2007, CANCER-AM CANCER SOC, V110, P1532, DOI 10.1002/cncr.22938; Ou SI, 2008, J CLIN ONCOL, V26; Ou SHI, 2008, J THORAC ONCOL, V3, P216, DOI 10.1097/JTO.0b013e318164545d; Schwartz AG, 2009, J THORAC ONCOL, V4, P1195, DOI 10.1097/JTO.0b013e3181b244ef; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tomizawa Y, 2005, CLIN CANCER RES, V11, P6816, DOI 10.1158/1078-0432.CCR-05-0441; Trinh QD, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv054; Williams CD, 2013, J CLIN ONCOL, V31, P475, DOI 10.1200/JCO.2012.44.1170; Wisnivesky JP, 2005, AM J RESP CRIT CARE, V171, P1158, DOI 10.1164/rccm.200411-1475OC; Wu YL, 2007, J THORAC ONCOL, V2, P430, DOI 10.1097/01.JTO.0000268677.87496.4c; Yang R, 2010, CANCER-AM CANCER SOC, V116, P2437, DOI 10.1002/cncr.24986; Yoshino I, 2002, SURGERY, V131, pS242, DOI 10.1067/msy.2002.119796; Zell JA, 2008, CANCER, V112, P136, DOI 10.1002/cncr.23146; Zheng L, 2012, CANCER EPIDEM BIOMAR, V21, P1841, DOI 10.1158/1055-9965.EPI-12-0560	35	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156617	10.1371/journal.pone.0156617	http://dx.doi.org/10.1371/journal.pone.0156617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244238	Green Submitted, Green Published, gold			2022-12-26	WOS:000377146100055
J	Rivera, J; Canals, M; Lastras, G; Hermida, N; Amblas, D; Arrese, B; Martin-Sosa, P; Acosta, J				Rivera, Jesus; Canals, Miquel; Lastras, Galderic; Hermida, Nuria; Amblas, David; Arrese, Beatriz; Martin-Sosa, Pablo; Acosta, Juan			Morphometry of Concepcion Bank: Evidence of Geological and Biological Processes on a Large Volcanic Seamount of the Canary Islands Seamount Province	PLOS ONE			English	Article							EL HIERRO; GLOBAL DISTRIBUTION; CONTINENTAL-MARGIN; ROCKALL TROUGH; NORTH FLANK; EVOLUTION; HISTORY; ORIGIN; FLOW; DEEP	Concepcion Bank is the largest seamount in the Canary Islands Seamount Province (CISP), an oceanic area off NW Africa including 16 main seamounts, the Canaries archipelago and the Selvagens subarchipelago. The Bank is located 90 km northeast of Lanzarote Island and has been identified as a candidate Marine Protected Area (MPA) to be included in the Natura 2000 network. A compilation of complementary datasets consisting of multibeam bathymetry, TOPAS seismic reflection profiles, side scan sonar sonographs, Remotely Operated Vehicle video records and seafloor samples allowed describing in detail and ground truthing the submarine landforms and bioconstructions exhibited by the bank. The Concepcion Bank presently rises up to 2,433 m above the adjacent seafloor and exhibits two main domains: an extensive summit plateau and steep flanks. The sub-round summit plateau is 50km by 45 km and ranges from 158 to 1,485 m depth. The steep flanks that bound it descend to depths ranging between 1,700 and 2,500 m and define a seamount base that is 66km by 53 km. This morphology is the result of constructive and erosive processes involving different time scales, volumes of material and rates of change. The volcanic emplacement phase probably lasted 25-30 million years and was likely responsible for most of the 2,730 km(3) of material that presently form the seamount. Subsequently, marine abrasion and, possibly, subaerial erosion modulated by global sea level oscillations, levelled the formerly emerging seamount summit plateau, in particular its shallower (<400 m), flatter (<0.5 degrees) eastern half. Subsidence associated to the crustal cooling that followed the emplacement phase further contributed the current depth range of the seamount. The deeper and steeper (2.3 degrees) western half of Concepcion Bank may result from tectonic tilting normal to a NNE-SSW fracture line. This fracture may still be expressed on the seafloor surface at some scarps detected on the seamount's summit. Sediment waves and cold-water coral (CWC) mounds on the bank summit plateau are the youngest features contributing to its final shaping, and may be indicative of internal wave effects. Numerous submarine canyons generally less than 10 km in length are incised on the bank's flanks. The most developed, hierarchized canyon system runs southwest of the bank, where it merges with other canyons coming from the southern bulges attached to some sections of the seamount flanks. These bulges are postulated as having an intrusive origin, as no major headwall landslide scars have been detected and their role as deposition areas for the submarine canyons seems to be minor. The results presented document how geological processes in the past and recent to subrecent oceanographic conditions and associated active processes determined the current physiography, morphology and sedimentary patterns of Concepcion Bank, including the development and decline of CWC mounds The setting of the seamount in the regional crustal structure is also discussed.	[Rivera, Jesus; Hermida, Nuria; Arrese, Beatriz; Acosta, Juan] Inst Espanol Oceanog, Corazon Maria 8, E-28002 Madrid, Spain; [Canals, Miquel; Lastras, Galderic; Amblas, David] Univ Barcelona, GRC Geociencies Marines, E-08028 Barcelona, Spain; [Martin-Sosa, Pablo] Inst Espanol Oceanog, Via Espaldon,Parcela 8, E-38180 Santa Cruz De Tenerife, Spain	Spanish Institute of Oceanography; University of Barcelona; Spanish Institute of Oceanography	Rivera, J (corresponding author), Inst Espanol Oceanog, Corazon Maria 8, E-28002 Madrid, Spain.	jesus.rivera@md.ieo.es	Rivera, Jesus/I-8926-2016; Canals, Miquel/F-4922-2013; Lastras, Galderic/A-6487-2013	Rivera, Jesus/0000-0002-9766-7105; Canals, Miquel/0000-0001-5267-7601; Lastras, Galderic/0000-0002-8756-3855; Hermida, Nuria/0000-0001-7841-7197	EU [07/NAT/E000732]; EC [603418]; Generalitat de Catalunya [2014 SGR 1068]	EU(European Commission); EC(European CommissionEuropean Commission Joint Research Centre); Generalitat de Catalunya(Generalitat de Catalunya)	The data used in this article has been gathered in the scope of Life+ INDEMARES Project (07/NAT/E000732) funded by the EU. The coordination of the project was carried out by Fundacion Biodiversidad from the Spanish Ministry of Agriculture, Food and Environment. The technical and scientific work was led by the Instituto Espanol de Oceanografia. The involvement of UB researchers in the analysis of the dataset was made possible by the EC funded research project MIDAS (GA n. 603418). Generalitat de Catalunya supported GRC Geociencies Marines through grant 2014 SGR 1068.	Acosta J, 2005, MAR GEOPHYS RES, V26, P77, DOI 10.1007/s11001-005-4766-6; Acosta J, 2005, GEOPHYSICS CANARY IS, P41, DOI DOI 10.1007/S11001-004-1161-7; Adams EW, 2000, J SEDIMENT RES, V70, P814, DOI 10.1306/2DC4093A-0E47-11D7-8643000102C1865D; Anguita F, 2000, J VOLCANOL GEOTH RES, V103, P1, DOI 10.1016/S0377-0273(00)00195-5; ANGUITA F, 1975, EARTH PLANET SC LETT, V27, P11, DOI 10.1016/0012-821X(75)90155-7; Aristegui J, 2009, PROG OCEANOGR, V83, P33, DOI 10.1016/j.pocean.2009.07.031; BALLARD RD, 1979, J GEOPHYS RES, V84, P5407, DOI 10.1029/JB084iB10p05407; Biescas B, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033971; Boehlert GW, 2013, AM GEOPHYS UNION GEO, V43, P319; BOSSHARD E, 1970, J GEOPHYS RES, V75, P4901, DOI 10.1029/JB075i026p04901; Carbo A, 2005, GEOPHYSICS CANARY IS, P113; Carracedo JC, 1998, GEOL MAG, V135, P591, DOI 10.1017/S0016756898001447; CHAPMAN DC, 1992, GEOPHYS ASTRO FLUID, V64, P31, DOI 10.1080/03091929208228084; Clague DA, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2011GC003791; Clark MR, 2011, OCEAN COAST MANAGE, V54, P19, DOI 10.1016/j.ocecoaman.2010.10.006; Clark MR, 2006, UNEP WCMC BIODIVERS; Clouard V, 2001, GEOLOGY, V29, P695, DOI 10.1130/0091-7613(2001)029<0695:HMPHAF>2.0.CO;2; Correa TBS, 2012, MAR GEOL, V326, P14, DOI 10.1016/j.margeo.2012.06.008; CRAIG CH, 1988, J GEOPHYS RES-SOLID, V93, P10408, DOI 10.1029/JB093iB09p10408; Danobeitia J.J., 1988, REV SOC GEOL ESPANA, V1, P143; Danobeitia JJ, 1989, ESTUDIO MEDIANTE SIS; DICKSON RR, 1985, PROG OCEANOGR, V14, P103, DOI 10.1016/0079-6611(85)90008-4; EPP D, 1989, NATURE, V337, P254, DOI 10.1038/337254a0; FavalliM M, 2005, B VOLCANOL, V68, P157, DOI 10.1007/s00445-005-0429-3; Freiwald A, 2004, UNEP WCMC CAMB UK, V84; Gee MJR, 2001, MAR GEOL, V177, P271, DOI 10.1016/S0025-3227(01)00153-0; Geldmacher J, 2005, EARTH PLANET SC LETT, V237, P85, DOI 10.1016/j.epsl.2005.04.037; Geldmacher J, 2001, J VOLCANOL GEOTH RES, V111, P55, DOI 10.1016/S0377-0273(01)00220-7; Gregg TKP, 1996, GEOLOGY, V24, P981, DOI 10.1130/0091-7613(1996)024<0981:SLFIAM>2.3.CO;2; Grosse P, 2012, GEOMORPHOLOGY, V136, P114, DOI 10.1016/j.geomorph.2011.06.001; Guillou H, 1996, J VOLCANOL GEOTH RES, V73, P141, DOI 10.1016/0377-0273(96)00021-2; Harris RN, 2004, GEOLOGY, V32, P725, DOI 10.1130/G20387.1; Heezen B.C., 1959, GEOLOGICAL SOC AM SP, DOI DOI 10.1130/SPE65-P1; Hernandez-Guerra A, 2001, SCI MAR, V65, P177, DOI 10.3989/scimar.2001.65s1177; Hernandez-Guerra A, 2007, SCI MAR, V65; Hinz K, 1982, GEOLOGY NW AFRICAN C, P34, DOI [DOI 10.1007/978-3-642-68409-8_, DOI 10.1007/978-3-642-68409-8_3]; Hobson R., 2019, SPATIAL ANAL GEOMORP, P221; Howe JA, 2006, MAR PETROL GEOL, V23, P165, DOI 10.1016/j.marpetgeo.2005.08.003; IEO, 2013, PROYECT LIFE INDEMAR; IHO, 2008, STAND UND FEAT NAM G; Jackson J.A., 2005, GLOSSARY GEOLOGY; King SD, 2000, SCIENCE, V290, P1137, DOI 10.1126/science.290.5494.1137; Klugel A, 2011, GEOLOGY, V39, P855, DOI 10.1130/G32006.1; Knoll M, 2002, DEEP-SEA RES PT II, V49, P3427, DOI 10.1016/S0967-0645(02)00105-4; Kuhlmann H, 2004, MAR GEOL, V207, P209, DOI 10.1016/j.margeo.2004.03.017; Lancelot Y, 1980, DEEP SEA DRILLING PR; Leichter JJ, 1998, MAR ECOL PROG SER, V166, P83, DOI 10.3354/meps166083; Machin F, 2006, PROG OCEANOGR, V70, P416, DOI 10.1016/j.pocean.2006.03.019; Mason E, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006665; Masson DG, 1996, GEOLOGY, V24, P231, DOI 10.1130/0091-7613(1996)024<0231:CCOTVI>2.3.CO;2; Masson DG, 2002, EARTH-SCI REV, V57, P1, DOI 10.1016/S0012-8252(01)00069-1; Mienis F, 2007, DEEP-SEA RES PT I, V54, P1655, DOI 10.1016/j.dsr.2007.05.013; MITTELSTAEDT E, 1991, PROG OCEANOGR, V26, P307, DOI 10.1016/0079-6611(91)90011-A; Morato T, 2010, OCEANOGRAPHY, V23, P190, DOI 10.5670/oceanog.2010.71; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; Neumann E, 2005, AGU SPRING M; Pelegri JL, 2006, PROG OCEANOGR, V70, P366, DOI 10.1016/j.pocean.2006.03.018; Pitcher TJ., 2008, SEAMOUNTS ECOLOGY FI; Pomar L, 2012, EARTH-SCI REV, V111, P56, DOI 10.1016/j.earscirev.2011.12.005; Quevedo-Gonzalez L, 2012, CARACTERISTICAS SEDI; Richardson PL, 2000, PROG OCEANOGR, V45, P209, DOI 10.1016/S0079-6611(99)00053-1; RICHARDSON PL, 1991, DYNAM ATMOS OCEANS, V15, P241, DOI 10.1016/0377-0265(91)90022-8; Rivera J, 2013, GEOLOGY, V41, P355, DOI 10.1130/G33863.1; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts JM, 2005, CORAL REEFS, V24, P654, DOI 10.1007/s00338-005-0049-6; Roden GI, 1987, GEOPHYS MONOGR SER, V43, P335, DOI DOI 10.1029/GM043P0335; Rowden AA, 2005, NEW ZEAL J MAR FRESH, V39, P1039, DOI 10.1080/00288330.2005.9517374; Schmidt R, 2000, SEAMOUNTS ISLAND BUI; SCHMINCKE HU, 1973, GEOL SOC AM BULL, V84, P633, DOI 10.1130/0016-7606(1973)84<633:MEATRI>2.0.CO;2; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; SMITH DK, 1992, J GEOPHYS RES-SOL EA, V97, P1645, DOI 10.1029/91JB02507; Staudigel H, 2010, OCEANOGRAPHY, V23, P20, DOI 10.5670/oceanog.2010.85; Staudigel H, 2010, OCEANOGRAPHY, V23, P58, DOI 10.5670/oceanog.2010.62; Svensen H, 2003, GEO-MAR LETT, V23, P351, DOI 10.1007/s00367-003-0141-2; TOMCZAK M JR, 1981, Progress in Oceanography, V10, P173, DOI 10.1016/0079-6611(81)90011-2; UCHUPI E, 1976, AAPG BULL, V60, P809; UNEP World Conservation Monitoring Center & Census of Marine Life on Seamounts Program Data Analysis Working Group, 2006, SEAM DEEP SEA COR FI; Urgeles R, 1999, J GEOPHYS RES-SOL EA, V104, P25331, DOI 10.1029/1999JB900243; Urgeles R, 1997, J GEOPHYS RES-SOL EA, V102, P20305, DOI 10.1029/97JB00649; Van den Bogaard P., 2013, SCI REP, P3; VOGT PR, 1984, J GEOPHYS RES, V89, P1085, DOI 10.1029/JB089iB13p11085; Watts AB, 1995, J GEOPHYS RES-SOL EA, V100, P24487, DOI 10.1029/95JB02630; Watts AB, 2001, B VOLCANOL, V63, P8; Weigel W., 1978, Marine Geophysical Researches, V3, P381, DOI 10.1007/BF00347674; Weigel W., 1982, GEOLOGY NW AFRICAN C, P132, DOI [10.1007/978-3-642-68409-8_8, DOI 10.1007/978-3-642-68409-8_8]; Wessel P, 2010, OCEANOGRAPHY, V23, P24, DOI 10.5670/oceanog.2010.60; White M, 2004, OASIS REP CONTRACT; WILSON JT, 1963, CAN J PHYS, V41, P863, DOI 10.1139/p63-094; Yesson C, 2011, DEEP-SEA RES PT I, V58, P442, DOI 10.1016/j.dsr.2011.02.004	89	13	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156337	10.1371/journal.pone.0156337	http://dx.doi.org/10.1371/journal.pone.0156337			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243626	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100029
J	Elshikha, AS; Lu, YQ; Chen, MJ; Akbar, M; Zeumer, L; Ritter, A; Elghamry, H; Mahdi, MA; Morel, L; Song, SH				Elshikha, Ahmed S.; Lu, Yuanqing; Chen, Mong-Jen; Akbar, Mohammad; Zeumer, Leilani; Ritter, Andrea; Elghamry, Hanaa; Mahdi, Mahmoud A.; Morel, Laurence; Song, Sihong			Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus	PLOS ONE			English	Article							I INTERFERON; IMMUNE TOLERANCE; MICE; ERYTHEMATOSUS; THERAPY; DISEASE; ALPHA(1)-ANTITRYPSIN; AUTOIMMUNITY; EXPRESSION; LIPOPOLYSACCHARIDE	Systemic lupus erythematosus (SLE) is an autoimmune disorder with a worldwide distribution and considerable mortality and morbidity. Although the pathogenesis of this disease remains elusive, over-reactive dendritic cells (DCs) play a critical role in the disease development. It has been shown that human alpha-1 antitrypsin (hAAT) has protective effects in type 1 diabetes and rheumatoid arthritis mouse models. In the present study, we tested the effect of AAT on DC differentiation and functions, as well as its protective effect in a lupus-prone mouse model. We showed that hAAT treatment significantly inhibited LPS (TLR4 agonist) and CpG (TLR9 agonist) -induced bone-marrow (BM)-derived conventional and plasmacytoid DC (cDC and pDC) activation and reduced the production of inflammatory cytokines including IFN-I, TNF-alpha and IL-1 beta. In MRL/lpr mice, hAAT treatment significantly reduced BM-derived DC differentiation, serum autoantibody levels, and importantly attenuated renal pathology. Our results for the first time demonstrate that hAAT inhibits DC activation and function, and it also attenuates autoimmunity and renal damage in the MRL/lpr lupus model. These results imply that hAAT has a therapeutic potential for the treatment of SLE in humans.	[Elshikha, Ahmed S.; Lu, Yuanqing; Chen, Mong-Jen; Akbar, Mohammad; Ritter, Andrea; Song, Sihong] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA; [Zeumer, Leilani; Morel, Laurence] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA; [Elshikha, Ahmed S.; Elghamry, Hanaa; Mahdi, Mahmoud A.] Zagazig Univ, Dept Pharmaceut, Zagazig, Sharkia, Egypt	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Egyptian Knowledge Bank (EKB); Zagazig University	Song, SH (corresponding author), Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA.	shsong@ufl.edu	Elghamry, Hanaa/AGR-0035-2022	Elghamry, Hanaa/0000-0002-4917-2570	University of Florida; Grifols Inc [62632]; Egypt Government Scholarship	University of Florida(University of Florida); Grifols Inc; Egypt Government Scholarship	This study was supported in part by grants from University of Florida, Grifols Inc (62632). Ahmed S. Elshikha was supported by an Egypt Government Scholarship.	Andersson LIM, 2008, HUM IMMUNOL, V69, P625, DOI 10.1016/j.humimm.2008.07.010; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bergin DA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007116; Bergin DA, 2010, J CLIN INVEST, V120, P4236, DOI 10.1172/JCI41196; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Carreno LJ, 2009, IMMUNOLOGY, V128, P334, DOI 10.1111/j.1365-2567.2009.03138.x; Chen MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138184; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Colonna L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1911; Ewald SE, 2011, CURR OPIN IMMUNOL, V23, P3, DOI 10.1016/j.coi.2010.11.006; Finke D, 2009, AUTOIMMUNITY, V42, P349, DOI 10.1080/08916930902831829; Grimstein C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-21; Grimstein C, 2010, J GENE MED, V12, P35, DOI 10.1002/jgm.1409; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Henry JY, 2013, IMMUNOLOGY, V139, P377, DOI 10.1111/imm.12087; Hoshino K, 1999, J IMMUNOL, V162, P3749; Huang HH, 2004, INT J CANCER, V112, P1042, DOI 10.1002/ijc.20494; Iwata Y, 2009, J RHEUMATOL, V36, P306, DOI 10.3899/jrheum.080318; Janciauskiene S, 2004, BIOCHEM BIOPH RES CO, V321, P592, DOI 10.1016/j.bbrc.2004.06.123; Janciauskiene SM, 2007, J BIOL CHEM, V282, P8573, DOI 10.1074/jbc.M607976200; Kikawada E, 2003, J IMMUNOL, V170, P3915, DOI 10.4049/jimmunol.170.7.3915; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lewis EC, 2005, P NATL ACAD SCI USA, V102, P12153, DOI 10.1073/pnas.0505579102; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Liu B, 2006, J IMMUNOL, V177, P6880, DOI 10.4049/jimmunol.177.10.6880; Lu YQ, 2006, HUM GENE THER, V17, P625, DOI 10.1089/hum.2006.17.625; Ma H, 2010, DIABETOLOGIA, V53, P2198, DOI 10.1007/s00125-010-1829-2; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Marcondes AM, 2014, BLOOD; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; Nickerson KM, 2013, J IMMUNOL, V190, P3889, DOI 10.4049/jimmunol.1203525; Ozeri E, 2012, J IMMUNOL, V189, P146, DOI 10.4049/jimmunol.1101340; Mackern-Oberti JP, 2015, AUTOIMMUN REV, V14, P127, DOI 10.1016/j.autrev.2014.10.010; Pascual V, 2003, CURR OPIN RHEUMATOL, V15, P548, DOI 10.1097/00002281-200309000-00005; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Petrache I, 2009, BIOL-TARGETS THER, V3, P193; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; Rowland SL, 2014, J EXP MED, V211, P1977, DOI 10.1084/jem.20132620; Sang A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102151; Scott JL, 2015, J IMMUNOL; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Song S, 2004, GENE THER, V11, P181, DOI 10.1038/sj.gt.3302156; Sriram U, 2007, J IMMUNOL, V179, P6446, DOI 10.4049/jimmunol.179.10.6446; Sriram U, 2012, J IMMUNOL, V189, P80, DOI 10.4049/jimmunol.1101686; Tawara I, 2012, P NATL ACAD SCI USA, V109, P564, DOI 10.1073/pnas.1117665109; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; THEOFILOPOULOS AN, 1981, IMMUNOL REV, V55, P179, DOI 10.1111/j.1600-065X.1981.tb00343.x; Wan SG, 2008, ARTHRITIS RHEUM, V58, P1741, DOI 10.1002/art.23515; Wan SG, 2007, J IMMUNOL, V178, P271, DOI 10.4049/jimmunol.178.1.271; Xie J, 2014, GENET MOL RES, V13, P1251, DOI 10.4238/2014.February.27.10; Zhang B, 2007, DIABETES, V56, P1316, DOI 10.2337/db06-1273; Zhu JK, 2005, J CLIN INVEST, V115, P1869, DOI 10.1172/JCI23049	56	29	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156583	10.1371/journal.pone.0156583	http://dx.doi.org/10.1371/journal.pone.0156583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232337	Green Published, gold, Green Submitted			2022-12-26	WOS:000376883000046
J	Kim, JE; Shin, JS; Moon, JH; Hong, SW; Jung, DJ; Kim, JH; Hwang, IY; Shin, YJ; Gong, EY; Lee, DH; Kim, SM; Lee, EY; Kim, YS; Kim, D; Hur, D; Kim, TW; Kim, KP; Jin, DH; Lee, WJ				Kim, J-E; Shin, J-S; Moon, J-H; Hong, S-W; Jung, D-J; Kim, J. H.; Hwang, I-Y; Shin, Y. J.; Gong, E-Y; Lee, D. H.; Kim, S-M; Lee, E. Y.; Kim, Y. S.; Kim, D.; Hur, D.; Kim, T. W.; Kim, K-p; Jin, D-H; Lee, W-J			Foxp3 is a key downstream regulator of p53-mediated cellular senescence	ONCOGENE			English	Article							HUMAN-DIPLOID CELLS; DNA-DAMAGE; REPLICATIVE SENESCENCE; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; ONCOGENIC RAS; MUTANT P53; LIFE-SPAN; CANCER; EXPRESSION	The downstream events and target genes of p53 in the process of senescence are not fully understood. Here, we report a novel function of the forkhead transcription factor Foxp3, which is a key player in mediating T-cell inhibitory functions, in p53-mediated cellular senescence. The overexpression of Foxp3 in mouse embryonic fibroblasts (MEFs) accelerates senescence, whereas Foxp3 knockdown leads to escape from p53-mediated senescence in p53-expressing MEFs. Consistent with these results, Foxp3 expression resulted in the induction of senescence in epithelial cancer cells, including MCF7 and HCT116 cells. Foxp3 overexpression also increased the intracellular levels of reactive oxygen species (ROS). The ROS inhibitor N-acetyl-L-cysteine rescued cells from Foxp3-expression-induced senescence. Furthermore, the elevated ROS levels that accompanied Foxp3 overexpression were paralleled by an increase in p21 expression. Knockdown of p21 in Foxp3-expressing MEFs abrogated the Foxp3-dependent increase in ROS levels, indicating that Foxp3 acts through the induction of p21 and the subsequent ROS elevation to trigger senescence. Collectively, these results suggest that Foxp3 is a downstream target of p53 that is sufficient to induce p21 expression, ROS production and p53-mediated senescence.	[Kim, J-E; Jung, D-J; Lee, W-J] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Kim, J-E; Jung, D-J; Lee, W-J] Seoul Natl Univ, Coll Med, Tumor Immun Med Res Ctr, Seoul, South Korea; [Shin, J-S; Moon, J-H; Hong, S-W; Kim, J. H.; Hwang, I-Y; Shin, Y. J.; Gong, E-Y; Lee, D. H.; Kim, S-M; Lee, E. Y.; Kim, T. W.; Kim, K-p; Jin, D-H] Asan Inst Life Sci, Asan Med Ctr, Innovat Canc Res, Seoul, South Korea; [Shin, J-S; Moon, J-H; Hong, S-W; Kim, J. H.; Hwang, I-Y; Shin, Y. J.; Gong, E-Y; Lee, D. H.; Kim, S-M; Lee, E. Y.; Kim, T. W.; Kim, K-p; Jin, D-H] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea; [Kim, Y. S.; Kim, D.; Hur, D.] Inje Univ, Coll Med, Dept Anat, Busan, South Korea; [Kim, Y. S.; Kim, D.; Hur, D.] Inje Univ, Coll Med, Res Ctr Tumor Immunol, Busan, South Korea; [Jin, D-H] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Inje University; Inje University; University of Ulsan; Asan Medical Center	Kim, KP (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea.; Jin, DH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea.	kkp1122@amc.seoul.kr; inno183@amc.seoul.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2013233]; National Research Foundation of Korea (NRF) grant - Korean government (MEST), Seoul, Republic of Korea [NRF-2013R1A2A2A01067394]; Korea Government (Ministry of Education, Science and Technology) [NRF-2010355-000062]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); National Research Foundation of Korea (NRF) grant - Korean government (MEST), Seoul, Republic of Korea(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); Korea Government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by grants from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2013233), and the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (NRF-2013R1A2A2A01067394), Seoul, Republic of Korea. The National Research Foundation of Korea Grant funded by the Korea Government (Ministry of Education, Science and Technology) (NRF-2010355-000062).	Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; BOND JA, 1994, ONCOGENE, V9, P1885; BOND JA, 1995, CANCER RES, V55, P2404; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Grimmig T, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24521; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Inoue T, 2009, CANCER SCI, V100, P1275, DOI 10.1111/j.1349-7006.2009.01166.x; Jung DJ, 2010, J BIOL CHEM, V285, P7995, DOI 10.1074/jbc.M109.047985; Jung MS, 2004, J BIOL CHEM, V279, P17765, DOI 10.1074/jbc.M305015200; Jung MS, 2001, ONCOGENE, V20, P5818, DOI 10.1038/sj.onc.1204748; Kim HJ, 2009, CELLS TISSUES ORGANS, V190, P1, DOI 10.1159/000153041; Ladoire S, 2011, BREAST CANCER RES TR, V125, P65, DOI 10.1007/s10549-010-0831-1; Le Bras S, 2006, J CLIN INVEST, V116, P1473, DOI 10.1172/JCI28880; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Liu RH, 2009, CANCER RES, V69, P2252, DOI 10.1158/0008-5472.CAN-08-3717; Ma GF, 2014, BRIT J CANCER, V110, P1552, DOI 10.1038/bjc.2014.47; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Sreeramaneni R, 2005, MOL CELL BIOL, V25, P220, DOI 10.1128/MCB.25.1.220-232.2005; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; Thaler S, 2009, CANCER RES, V69, P1748, DOI 10.1158/0008-5472.CAN-08-1377; VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Winerdal ME, 2011, BJU INT, V108, P1672, DOI 10.1111/j.1464-410X.2010.10020.x; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06; Zuo T, 2007, J CLIN INVEST, V117, P3765, DOI 10.1172/JCI32538; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	36	16	16	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2017	36	2					219	230		10.1038/onc.2016.193	http://dx.doi.org/10.1038/onc.2016.193			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK5AA	27238838				2022-12-26	WOS:000393938100007
J	Obinata, D; Takayama, K; Fujiwara, K; Suzuki, T; Tsutsumi, S; Fukuda, N; Nagase, H; Fujimura, T; Urano, T; Homma, Y; Aburatani, H; Takahashi, S; Inoue, S				Obinata, D.; Takayama, K.; Fujiwara, K.; Suzuki, T.; Tsutsumi, S.; Fukuda, N.; Nagase, H.; Fujimura, T.; Urano, T.; Homma, Y.; Aburatani, H.; Takahashi, S.; Inoue, S.			Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth	ONCOGENE			English	Article							PYRROLE-IMIDAZOLE POLYAMIDE; ACYL-COA SYNTHETASE-5; GENE-EXPRESSION; TRANSCRIPTION FACTORS; DNA; PROGRESSION; IDENTIFICATION; SUPPRESSION; RECOGNITION; NETWORK	Androgen receptor (AR) functions as a ligand-dependent transcription factor to regulate its downstream signaling for prostate cancer progression. AR complex formation by multiple transcription factors is important for enhancer activity and transcriptional regulation. However, the significance of such collaborative transcription factors has not been fully understood. In this study, we show that Oct1, an AR collaborative factor, coordinates genome-wide AR signaling for prostate cancer growth. Using global analysis by chromatin immunoprecipitation sequencing (ChIP-seq), we found that Oct1 is recruited to AR-binding enhancer/promoter regions and facilitates androgen signaling. Moreover, a major target of AR/Oct1 complex, acyl-CoA synthetase 3 (ACSL3), contributes to tumor growth in nude mice, and its high expression is associated with poor prognosis in prostate cancer patients. Next, we examined the therapeutic effects of pyrrole-imidazole polyamides that target the Oct1-binding sequence identified in the center of the ACSL3 AR-binding site. We observed that treatment with Oct1 polyamide severely blocked the Oct1 binding at the ACSL3 enhancer responsible for its transcriptional activity and ACSL3 induction. In addition, Oct1 polyamides suppressed castration-resistant tumor growth and specifically repressed global Oct1 chromatin association and androgen signaling in prostate cancer cells, with few nonspecific effects on basal promoter activity. Thus, targeting Oct1 binding could be a novel therapeutic strategy for AR-activated castration-resistant prostate cancer.	[Obinata, D.; Takayama, K.; Urano, T.; Inoue, S.] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Tokyo, Japan; [Obinata, D.; Takahashi, S.] Nihon Univ, Sch Med, Dept Urol, Tokyo, Japan; [Takayama, K.; Urano, T.; Inoue, S.] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan; [Takayama, K.; Inoue, S.] Tokyo Metropolitan Inst Gerontol, Dept Funct Biogerontr, Tokyo, Japan; [Fujiwara, K.] Nihon Univ, Sch Med, Dept Med, Div Gen Med, Tokyo, Japan; [Suzuki, T.] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi, Japan; [Tsutsumi, S.; Aburatani, H.] Univ Tokyo, RCAST, Genome Sci Div, Tokyo, Japan; [Fukuda, N.] Nihon Univ, Sch Med, Dept Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan; [Nagase, H.] Chiba Canc Ctr, Res Inst, Lab Canc Genet, Chiba, Japan; [Fujimura, T.; Homma, Y.] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo, Japan; [Inoue, S.] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Saitama, Japan	University of Tokyo; Nihon University; University of Tokyo; Tokyo Metropolitan Institute of Gerontology; Nihon University; Tohoku University; University of Tokyo; Nihon University; Chiba Cancer Center; University of Tokyo; Saitama Medical University	Inoue, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo 1138655, Japan.	sinoue@tmig.or.jp	Urano, Tomohiko/AFS-9574-2022; Takayama, Kenichi/AAK-9238-2020	Fukuda, Noboru/0000-0003-0098-054X; Nagase, Hiroki/0000-0002-3992-5399	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science (JSPS), Japan [15K15353, 15K15581, 25293214, 15K10610]; MHLW, Japan; Nihon University Medical Alumni Association; Japanese Urological Association; Advanced Research for Medical Products Mining Program, NIBIO, Japan; Takeda Science Foundation; Mochida Memorial Research Foundation, Japan; Grants-in-Aid for Scientific Research [25112001, 16K09796] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MHLW, Japan; Nihon University Medical Alumni Association; Japanese Urological Association(Japanese Urological Association); Advanced Research for Medical Products Mining Program, NIBIO, Japan; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Research Foundation, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N Sasaki, T Oishi, S Takada, A Ito and E Sakamoto for technical assistance. This work was supported by grants of the Cell Innovation Program (SI) and P-Direct (SI) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; by Grants-in-Aid for SI (no. 15K15353), KT (no. 15K15581), TU (no. 25293214) and ST (no. 15K10610) from the Japan Society for the Promotion of Science (JSPS), Japan; by Grants-in-Aid (SI) from the MHLW, Japan; by the 2010 Research Grant of the 60th Anniversary Memorial Fund (DO) from Nihon University Medical Alumni Association; by the Young Researcher Promotion Grant (DO) from The Japanese Urological Association; by the Advanced Research for Medical Products Mining Program (SI), NIBIO, Japan; by grants from Takeda Science Foundation (SI and KT), by a grant from Mochida Memorial Research Foundation (KT), Japan.	Attard G, 2008, BRIT J CANCER, V99, P314, DOI 10.1038/sj.bjc.6604472; Barfeld SJ, 2014, ENDOCR-RELAT CANCER, V21, pT57, DOI 10.1530/ERC-13-0515; Bu SY, 2009, J BIOL CHEM, V284, P30474, DOI 10.1074/jbc.M109.036665; Chang YS, 2011, J CELL BIOCHEM, V112, P881, DOI 10.1002/jcb.22996; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Dervan PB, 2003, CURR OPIN STRUC BIOL, V13, P284, DOI 10.1016/S0959-440X(03)00081-2; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Gassler N, 2005, J PATHOL, V207, P295, DOI 10.1002/path.1831; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; He B, 2014, P NATL ACAD SCI USA, V111, P18261, DOI 10.1073/pnas.1421415111; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Jariwala U, 2009, PROSTATE, V69, P392, DOI 10.1002/pros.20893; Jin Y, 2015, EMBO MOL MED, V7, P315, DOI 10.15252/emmm.201404181; Kim JY, 2014, MOL CELL, V54, P613, DOI 10.1016/j.molcel.2014.03.043; Maloberti PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015540; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matsuda H, 2011, KIDNEY INT, V79, P46, DOI 10.1038/ki.2010.330; Minekura H, 2001, GENE, V278, P185, DOI 10.1016/S0378-1119(01)00714-4; Monaco ME, 2010, TRANSL ONCOL, V3, P91, DOI 10.1593/tlo.09202; Murty MSRC, 2004, BIOL PHARM BULL, V27, P468, DOI 10.1248/bpb.27.468; Nagashima T, 2009, BIOL PHARM BULL, V32, P921, DOI 10.1248/bpb.32.921; Nickols NG, 2007, P NATL ACAD SCI USA, V104, P10418, DOI 10.1073/pnas.0704217104; Obinata D, 2012, INT J CANCER, V130, P1021, DOI 10.1002/ijc.26043; Raskatov JA, 2012, P NATL ACAD SCI USA, V109, P16041, DOI 10.1073/pnas.1214267109; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Takayama K, 2007, ONCOGENE, V26, P4453, DOI 10.1038/sj.onc.1210229; Takayama K, 2015, ONCOTARGET, V6, P2263, DOI 10.18632/oncotarget.2949; Takayama K, 2014, MOL ENDOCRINOL, V28, P2012, DOI 10.1210/me.2014-1171; Takayama K, 2014, CANCER RES, V74, P6542, DOI 10.1158/0008-5472.CAN-14-1030; Takayama K, 2013, INT J UROL, V20, P756, DOI 10.1111/iju.12146; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; VERRIJZER CP, 1993, BIOCHIM BIOPHYS ACTA, V1173, P1, DOI 10.1016/0167-4781(93)90237-8; Wang G, 2006, ONCOGENE, V25, P7311, DOI 10.1038/sj.onc.1209715; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang XF, 2010, CANCER SCI, V101, P759, DOI 10.1111/j.1349-7006.2009.01435.x; Wu MH, 2011, INT J MOL MED, V27, P655, DOI 10.3892/ijmm.2011.624; Yamashita Y, 2000, ONCOGENE, V19, P5919, DOI 10.1038/sj.onc.1203981; Yang F, 2013, P NATL ACAD SCI USA, V110, P1863, DOI 10.1073/pnas.1222035110; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao HJ, 2005, PROSTATE, V63, P187, DOI 10.1002/pros.20158	47	29	29	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 8	2016	35	49					6350	6358		10.1038/onc.2016.171	http://dx.doi.org/10.1038/onc.2016.171			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EF3TJ	27270436				2022-12-26	WOS:000390247000008
J	Rajpurohit, YS; Bihani, SC; Waldor, MK; Misra, HS				Rajpurohit, Yogendra S.; Bihani, Subhash C.; Waldor, Matthew K.; Misra, Hari S.			Phosphorylation of Deinococcus radiodurans RecA Regulates Its Activity and May Contribute to Radioresistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-STRAND EXCHANGE; EXTREME RADIORESISTANCE; PROTEIN-KINASE; IONIZING-RADIATION; RESISTANCE; BINDING; REPAIR; ATP; DAMAGE; RECOMBINATION	Deinococcus radiodurans has a remarkable capacity to survive exposure to extreme levels of radiation that cause hundreds of DNA double strand breaks (DSBs). DSB repair in this bacterium depends on its recombinase A protein (DrRecA). DrRecA plays a pivotal role in both extended synthesis-dependent strand annealing and slow crossover events of DSB repair during the organism's recovery from DNA damage. The mechanisms that control DrRecA activity during the D. radiodurans response to gamma radiation exposure are unknown. Here, we show that DrRecA undergoes phosphorylation at Tyr-77 and Thr-318 by a DNA damage-responsive serine threonine/tyrosine protein kinase (RqkA). Phosphorylation modifies the activity of DrRecA in several ways, including increasing its affinity for dsDNA and its preference for dATP over ATP. Strand exchange reactions catalyzed by phosphorylated versus unphosphorylated DrRecA also differ. In silico analysis of DrRecA structure support the idea that phosphorylation can modulate crucial functions of this protein. Collectively, our findings suggest that phosphorylation of DrRecA enables the recombinase to selectively use abundant dsDNA substrate present during post-irradiation recovery for efficient DSB repair, thereby promoting the extraordinary radioresistance of D. radiodurans.	[Rajpurohit, Yogendra S.; Misra, Hari S.] Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India; [Bihani, Subhash C.] Bhabha Atom Res Ctr, Div Solid State Phys, Bombay 400085, Maharashtra, India; [Waldor, Matthew K.] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Waldor, Matthew K.] Harvard Med Sch, Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Misra, HS (corresponding author), Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India.	hsmisra@barc.gov.in	Bihani, Subhash Chandra/G-1255-2010	Bihani, Subhash Chandra/0000-0002-0724-4919; Misra, Hari/0000-0002-9349-1229; Waldor, Matthew/0000-0003-1843-7000	Fulbright-Nehru senior research fellowship grant from United States-India Education Foundation (USIEF); J. William Fulbright foreign scholarship Board	Fulbright-Nehru senior research fellowship grant from United States-India Education Foundation (USIEF); J. William Fulbright foreign scholarship Board	Recipient of a Fulbright-Nehru senior research fellowship grant from the United States-India Education Foundation (USIEF) and the J. William Fulbright foreign scholarship Board. To whom correspondence should be addressed: Molecular Biology Division, Bhabha Atomic Research Centre, Mumbai-400 085, India. Tel.: 91-22-25595417; Fax: 91-22-25505151; E-mail: hsmisra@barc.gov.in.	Aihara H, 1997, J MOL BIOL, V274, P213, DOI 10.1006/jmbi.1997.1403; Battista JR, 2001, CRYOBIOLOGY, V43, P133, DOI 10.1006/cryo.2001.2357; Bidnenko V, 2013, MOL MICROBIOL, V88, P921, DOI 10.1111/mmi.12233; Buxbaum E, 1999, EUR J BIOCHEM, V265, P64, DOI 10.1046/j.1432-1327.1999.00644.x; Charaka VK, 2012, J BACTERIOL, V194, P5739, DOI 10.1128/JB.00610-12; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Das AD, 2011, MICROBIOL-SGM, V157, P2196, DOI 10.1099/mic.0.040436-0; Datta S, 2003, PROTEINS, V50, P474, DOI 10.1002/prot.10315; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; Flott S, 2011, EMBO REP, V12, P833, DOI 10.1038/embor.2011.127; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; GUTMAN PD, 1994, GENE, V141, P31, DOI 10.1016/0378-1119(94)90124-4; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jers C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014653; Kamble VA, 2010, DNA REPAIR, V9, P488, DOI 10.1016/j.dnarep.2010.01.012; KIM JI, 1992, J BIOL CHEM, V267, P16444; Kim JI, 2002, P NATL ACAD SCI USA, V99, P7917, DOI 10.1073/pnas.122218499; Kim JI, 2002, J BACTERIOL, V184, P1649, DOI 10.1128/JB.184.6.1649-1660.2002; Kim SH, 2014, J AM CHEM SOC, V136, P14796, DOI 10.1021/ja506363y; Kota S, 2010, BIOCHEM J, V431, P149, DOI 10.1042/BJ20100446; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Mazin AV, 1998, EMBO J, V17, P1161, DOI 10.1093/emboj/17.4.1161; Mijakovic I, 2006, NUCLEIC ACIDS RES, V34, P1588, DOI 10.1093/nar/gkj514; Misra HS, 2013, CURR SCI INDIA, V104, P194; Misra HS, 2006, MOL MICROBIOL, V59, P1308, DOI 10.1111/j.1365-2958.2005.05005.x; Narumi I, 2001, J BACTERIOL, V183, P6951, DOI 10.1128/JB.183.23.6951-6956.2001; Nayak S, 1999, J BIOL CHEM, V274, P25979, DOI 10.1074/jbc.274.37.25979; Nishi H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00270; Rajan R, 2004, J MOL BIOL, V344, P951, DOI 10.1016/j.jmb.2004.09.087; Rajpurohit YS, 2013, INT J BIOCHEM CELL B, V45, P2541, DOI 10.1016/j.biocel.2013.08.011; Rajpurohit YS, 2010, MOL MICROBIOL, V77, P1470, DOI 10.1111/j.1365-2958.2010.07301.x; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; Schafer M, 2000, PHOTOCHEM PHOTOBIOL, V71, P514, DOI 10.1562/0031-8655(2000)071<0514:SSOPIT>2.0.CO;2; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shi L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00538; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	46	23	23	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16672	16685		10.1074/jbc.M116.736389	http://dx.doi.org/10.1074/jbc.M116.736389			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27255712	Green Published, hybrid			2022-12-26	WOS:000380826700025
J	Alvarez-Zaldiernas, C; Lu, J; Zheng, YJ; Yang, HQ; Blasi, J; Solsona, C; Holmgren, A				Alvarez-Zaldiernas, Cristina; Lu, Jun; Zheng, Yujuan; Yang, Hongqian; Blasi, Juan; Solsona, Carles; Holmgren, Arne			Cellular Redox Systems Impact the Aggregation of Cu,Zn Superoxide Dismutase Linked to Familial Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ALS (Lou Gehrig disease); reduction-oxidation (redox); oxidative stress; protein aggregation; thiol; thioredoxin; cysteine 111; SOD1; glutaredoxin; glutathione	MUTANT CU,ZN-SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE 1; MOTOR-NEURON INJURY; DISULFIDE BOND; TRANSGENIC MICE; MOUSE MODEL; WILD-TYPE; KEY ROLE; SOD1; ALS	Protein misfolding is implicated in neurodegenerative diseases such as ALS, where mutations of superoxide dismutase 1 (SOD1) account for about 20% of the inherited mutations. Human SOD1 (hSOD1) contains four cysteines, including Cys(57) and Cys(146), which have been linked to protein stability and folding via forming a disulfide bond, and Cys(6) and Cys(111) as free thiols. But the roles of the cellular oxidation-reduction (redox) environment in SOD1 folding and aggregation are not well understood. Here we explore the effects of cellular redox systems on the aggregation of hSOD1 proteins. We found that the known hSOD1 mutations G93A and A4V increased the capability of the thioredoxin and glutaredoxin systems to reduce hSOD1 compared with wild-type hSOD1. Treatment with inhibitors of these redox systems resulted in an increase of hSOD1 aggregates in the cytoplasm of cells transfected with mutants but not in cells transfected with wild-type hSOD1 or those containing a secondary C111G mutation. This aggregation may be coupled to changes in the redox state of the G93A and A4V mutants upon mild oxidative stress. These results strongly suggest that the thioredoxin and glutaredoxin systems are the key regulators for hSOD1 aggregation and may play critical roles in the pathogenesis of ALS.	[Alvarez-Zaldiernas, Cristina; Lu, Jun; Zheng, Yujuan; Yang, Hongqian; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Alvarez-Zaldiernas, Cristina; Blasi, Juan; Solsona, Carles] Univ Barcelona, Fac Med, Dept Pathol & Expt Therapeut, Campus Bellvitge,Feixa Llarga S-N, Barcelona 08907, Spain; [Alvarez-Zaldiernas, Cristina; Blasi, Juan; Solsona, Carles] Bellvitge Biomed Res Inst, Gran Via Hospitalet 199-203, Barcelona 08908, Spain	Karolinska Institutet; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Solsona, C (corresponding author), Univ Barcelona, Fac Med, Dept Pathol & Expt Therapeut, Campus Bellvitge,Feixa Llarga S-N, Barcelona 08907, Spain.; Lu, J (corresponding author), Southwest Univ, Sch Pharmaceut Sci, Chongqing 400715, Peoples R China.; Holmgren, A (corresponding author), Karolinska Inst, Div Biochem, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	junlu@swu.edu.cn; solsona@ub.edu; arne.holmgren@ki.se	Lu, Jun/E-9701-2017	Lu, Jun/0000-0002-1699-8835	Swedish Cancer Society [961]; Swedish Research Council Medicine [13X-3529]; K&A Wallenberg Foundation; Karolinska Institutet and Boehringer Ingelheim Fonds; Spanish Ministry of Economy and Competitiveness [SAF2014-56811R]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council Medicine(Swedish Research Council); K&A Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Karolinska Institutet and Boehringer Ingelheim Fonds; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Swedish Cancer Society (961), the Swedish Research Council Medicine (13X-3529), the K&A Wallenberg Foundation, grants from Karolinska Institutet and Boehringer Ingelheim Fonds, and Grant SAF2014-56811R from the Spanish Ministry of Economy and Competitiveness. The authors declare that they have no conflicts of interest with the contents of this article.	Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bouldin SD, 2012, BIOCHEM J, V446, P59, DOI 10.1042/BJ20120075; Cardoso RMF, 2002, J MOL BIOL, V324, P247, DOI 10.1016/S0022-2836(02)01090-2; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; CATZ SD, 1995, FREE RADICAL BIO MED, V19, P741, DOI 10.1016/0891-5849(95)00065-6; Chattopadhyay M, 2015, J BIOL CHEM, V290, P30624, DOI 10.1074/jbc.M115.666503; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Du YT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392225; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Ferri A, 2010, HUM MOL GENET, V19, P4529, DOI 10.1093/hmg/ddq383; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Goodall Emily F., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010854; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Kato S, 2004, ACTA NEUROPATHOL, V107, P149, DOI 10.1007/s00401-003-0791-1; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Lee JK, 2013, P NATL ACAD SCI USA, V110, P12066, DOI 10.1073/pnas.1300894110; Liu HB, 2000, BIOCHEMISTRY-US, V39, P8125, DOI 10.1021/bi000846f; Lu J, 2014, ANTIOXID REDOX SIGN, V21, P457, DOI 10.1089/ars.2014.5849; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; Mitchell J, 2009, FREE RADICAL BIO MED, V46, P202, DOI 10.1016/j.freeradbiomed.2008.09.041; Nagano S, 2015, HUM MOL GENET, V24, P3427, DOI 10.1093/hmg/ddv093; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Ogawa M, 2015, BIOCHEM BIOPH RES CO, V463, P1196, DOI 10.1016/j.bbrc.2015.06.084; Prudencio M, 2012, J NEUROCHEM, V121, P475, DOI 10.1111/j.1471-4159.2012.07690.x; Redler RL, 2011, BIOCHEMISTRY-US, V50, P7057, DOI 10.1021/bi200614y; Roberts BLT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047838; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Solsona C, 2014, J BIOL CHEM, V289, P26722, DOI 10.1074/jbc.M114.565333; Tiwari A, 2005, J BIOL CHEM, V280, P29771, DOI 10.1074/jbc.M504039200; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Tiwari A, 2005, NEURODEGENER DIS, V2, P115, DOI 10.1159/000089616; Tiwari A, 2009, J BIOL CHEM, V284, P27746, DOI 10.1074/jbc.M109.043729; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200	57	17	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17197	17208		10.1074/jbc.M115.708230	http://dx.doi.org/10.1074/jbc.M115.708230			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27261461	hybrid, Green Published			2022-12-26	WOS:000382643800023
J	Kurczab, R; Canale, V; Zajdel, P; Bojarski, AJ				Kurczab, Rafal; Canale, Vittorio; Zajdel, Pawel; Bojarski, Andrzej J.			An Algorithm to Identify Target-Selective Ligands - A Case Study of 5-HT7/5-HT1A Receptor Selectivity	PLOS ONE			English	Article							SEROTONIN 5-HT7 RECEPTOR; MACHINE LEARNING-METHODS; FREE-ENERGY CALCULATIONS; ACID AMIDE FRAGMENTS; SUBTYPE SELECTIVITY; BIOLOGICAL-ACTIVITY; IN-VIVO; ANTAGONISTS; BINDING; MODELS	A computational procedure to search for selective ligands for structurally related protein targets was developed and verified for serotonergic 5-HT7/5-HT1A receptor ligands. Starting from a set of compounds with annotated activity at both targets (grouped into four classes according to their activity: selective toward each target, not-selective and not-selective but active) and with an additional set of decoys (prepared using DUD methodology), the SVM (Support Vector Machines) models were constructed using a selective subset as positive examples and four remaining classes as negative training examples. Based on these four component models, the consensus classifier was then constructed using a data fusion approach. The combination of two approaches of data representation (molecular fingerprints vs. structural interaction fingerprints), different training set sizes and selection of the best SVM component models for consensus model generation, were evaluated to determine the optimal settings for the developed algorithm. The results showed that consensus models with molecular fingerprints, a larger training set and the selection of component models based on MCC maximization provided the best predictive performance.	[Kurczab, Rafal; Bojarski, Andrzej J.] Polish Acad Sci, Inst Pharmacol, Dept Med Chem, 12 Smetna St, PL-31343 Krakow, Poland; [Canale, Vittorio; Zajdel, Pawel] Jagiellonian Univ, Coll Med, Dept Med Chem, 9 Med St, PL-30688 Krakow, Poland	Polish Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University	Kurczab, R (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Med Chem, 12 Smetna St, PL-31343 Krakow, Poland.	kurczab@if-pan.krakow.pl	Bojarski, Andrzej/GSO-0213-2022; Kurczab, Rafał/AAD-4526-2020	Kurczab, Rafał/0000-0002-9555-3905; Bojarski, Andrzej/0000-0003-1417-6333; Zajdel, Pawel/0000-0002-6192-8721; Canale, Vittorio/0000-0001-7940-9500	Polish-Norwegian Research Programme [Pol-Nor/198887/73/2013]; National Science Center [DEC-2012/05/B/N27/03076]	Polish-Norwegian Research Programme; National Science Center(National Science Centre, Poland)	The study was partially supported by the Polish-Norwegian Research Programme operated by the National Centre for Research and Development under the Norwegian Financial Mechanism 2009-2014 in the frame of Project PLATFORMex (Pol-Nor/198887/73/2013) and by the National Science Center grant no. DEC-2012/05/B/N27/03076.	Abbas AI, 2009, PSYCHOPHARMACOLOGY, V205, P119, DOI 10.1007/s00213-009-1521-8; Alvarsson J, 2014, J CHEM INF MODEL, V54, P2647, DOI 10.1021/ci500361u; [Anonymous], 2015, SMALL MOL DRUG DISC; [Anonymous], 2015, SCHROD REL 2015 4 EP; [Anonymous], 2015, SCHRODINGER RELEASE; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bonaventure P, 2002, J PHARMACOL EXP THER, V302, P240, DOI 10.1124/jpet.302.1.240; Bonaventure P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020210; Canale V, 2015, EUR J MED CHEM, V92, P202, DOI 10.1016/j.ejmech.2014.12.041; Canale V, 2014, EUR J MED CHEM, V78, P10, DOI 10.1016/j.ejmech.2014.03.005; Chuaqui C, 2005, J MED CHEM, V48, P121, DOI 10.1021/jm049312t; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costa L, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00065; Di Pilato P, 2014, REV NEUROSCIENCE, V25, P401, DOI 10.1515/revneuro-2014-0009; Fang L, 2008, J CHEM INF MODEL, V48, P2030, DOI 10.1021/ci800104s; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Hiroaki Y, 2015, PACKAGE ENRICHVS; Huang YY, 2013, J CHEM INF MODEL, V53, P3044, DOI 10.1021/ci400458z; Ishibashi T, 2010, J PHARMACOL EXP THER, V334, P171, DOI 10.1124/jpet.110.167346; Kalliokoski T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061007; Klekota J, 2008, BIOINFORMATICS, V24, P2518, DOI 10.1093/bioinformatics/btn479; Kurczab R, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-32; Kurczab R, 2010, BIOORG MED CHEM LETT, V20, P2465, DOI 10.1016/j.bmcl.2010.03.012; Leopoldo M, 2010, EXPERT OPIN THERP PA, V20, P739; Leopoldo M, 2007, J MED CHEM, V50, P4214, DOI 10.1021/jm070487n; Lovell PJ, 2000, J MED CHEM, V43, P342, DOI 10.1021/jm991151j; Ma C, 2013, J CHEM INF MODEL, V53, P11, DOI 10.1021/ci3003914; Medina RA, 2014, J MED CHEM, V57, P6879, DOI 10.1021/jm500880c; Medina RA, 2009, J MED CHEM, V52, P2384, DOI 10.1021/jm8014553; Mordalski S, 2011, BIOORG MED CHEM LETT, V21, P6816, DOI 10.1016/j.bmcl.2011.09.027; Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e; Naumenko VS, 2014, CNS NEUROSCI THER, V20, P582, DOI 10.1111/cns.12247; Neill JC, 2010, PHARMACOL THERAPEUT, V128, P419, DOI 10.1016/j.pharmthera.2010.07.004; Nikiforuk A, 2015, CNS DRUGS, V29, P265, DOI 10.1007/s40263-015-0236-0; Nikiforuk A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066695; Ning X, 2012, J CHEM INF MODEL, V52, P38, DOI 10.1021/ci200346b; Perez-Garcia GS, 2005, BEHAV BRAIN RES, V163, P136, DOI 10.1016/j.bbr.2005.04.014; R Core Team, 2018, R LANG ENV STAT COMP; Renner U, 2012, J CELL SCI, V125, P2486, DOI 10.1242/jcs.101337; Ruocco LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083003; Sabbah DA, 2012, J CHEM INF MODEL, V52, P3213, DOI 10.1021/ci3003057; Salerno L, 2014, EUR J MED CHEM, V85, P716, DOI 10.1016/j.ejmech.2014.08.023; Sciabola S, 2008, J CHEM INF MODEL, V48, P1851, DOI 10.1021/ci800138n; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smusz S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-17; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Viguier F, 2013, EUR J PHARMACOL, V716, P8, DOI 10.1016/j.ejphar.2013.01.074; Volk B, 2008, J MED CHEM, V51, P2522, DOI 10.1021/jm070279v; Wang Q, 2010, J CHEM INF MODEL, V50, P1970, DOI 10.1021/ci1002747; Wang XS, 2008, J CHEM INF MODEL, V48, P997, DOI 10.1021/ci700404c; Warszycki D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084510; Wassermann AM, 2009, J CHEM INF MODEL, V49, P582, DOI 10.1021/ci800441c; Willett P, 2006, QSAR COMB SCI, V25, P1143, DOI 10.1002/qsar.200610084; Witek J, 2014, BIOORG MED CHEM LETT, V24, P580, DOI 10.1016/j.bmcl.2013.12.017; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zajdel P, 2015, MEDCHEMCOMM, V6, P1272, DOI 10.1039/c5md00166h; Zajdel P, 2012, EUR J MED CHEM, V56, P348, DOI 10.1016/j.ejmech.2012.07.043; Zajdel P, 2011, BIOORGAN MED CHEM, V19, P6750, DOI 10.1016/j.bmc.2011.09.044; Zajdel P, 2009, BIOORG MED CHEM LETT, V19, P4827, DOI 10.1016/j.bmcl.2009.06.038	61	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156986	10.1371/journal.pone.0156986	http://dx.doi.org/10.1371/journal.pone.0156986			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271158	Green Published, gold, Green Submitted			2022-12-26	WOS:000377561000056
J	Huang, YC; Kuo, YH; Huang, YH; Chen, CS; Ho, DR; Shi, CS				Huang, Yun-Ching; Kuo, Yi-Hung; Huang, Yan-Hua; Chen, Chih-Shou; Ho, Dong-Ru; Shi, Chung-Sheng			The Effects of Adipose-Derived Stem Cells in a Rat Model of Tobacco-Associated Erectile Dysfunction	PLOS ONE			English	Article							CIGARETTE-SMOKING; OXIDATIVE STRESS; BLADDER; PLASMA; TISSUE	Tobacco use is associated with erectile dysfunction (ED) via a number of mechanisms including vascular injury and oxidative stress in corporal tissue. Adipose derived stem cells (ADSC) have been shown to ameliorate vascular/corporal injury and oxidative stress by releasing cytokines, growth factors and antioxidants. We assessed the therapeutic effects of intracavernous injection of ADSC in a rat model of tobacco-associated ED. Thirty male rats were used in this study. Ten rats exposed to room air only served as negative controls. The remaining 20 rats were passively exposed to cigarette smoke (CS) for 12 weeks. At the 12-week time point, ADSC were isolated from paragonadal fat in all rats. Amongst the 20 CS exposed rats, 10 each were assigned to one of the two following conditions: (i) injection of phosphate buffered saline (PBS) into the corpora cavernosa (CS+PBS); or (ii) injection of autologous ADSC in PBS into the corpora cavernosa (CS+ADSC). Negative control animals received PBS injection into the corpora cavernosa (normal rats [NR] + PBS). After injections all rats were returned to their previous air versus CS exposure state. Twenty-eight days after injection, all rats were placed in a metabolic cage for 24-hour urine collection to be testing for markers of oxidative stress. After 24-hour urine collection all 30 rats also underwent erectile function testing via intracavernous pressure (ICP) testing and were then sacrificed. Corporal tissues were obtained for histological assessment and Western blotting. Mean body weight was significantly lower in CS-exposed rats than in control animals. Mean ICP, ICP /mean arterial pressure ratio, serum nitric oxide level were significantly lower in the CS+PBS group compared to the NR+PBS and CS+ADSC groups. Urine markers for oxidative stress were significantly higher in the CS+PBS group compared to the NR+PBS and CS+ADSC groups. Mean expression of corporal nNOS and histological markers for endothelial and smooth muscle cells was significantly lower, and tissue apoptotic index significantly higher, in the CS+PBS group compared to the NR+PBS and CS+ADSC groups. Our findings confirm that chronic tobacco exposure causes ultrastructural damage to the corporal tissue and increases systemic oxidative stress states. Treatment with ADSC ameliorates these adverse effects and holds promise as a potential therapy for tobacco-related ED.	[Huang, Yun-Ching; Chen, Chih-Shou; Ho, Dong-Ru; Shi, Chung-Sheng] Chang Gung Mem Hosp, Dept Surg, Div Urol, Chiayi, Taiwan; [Huang, Yun-Ching; Shi, Chung-Sheng] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Kuo, Yi-Hung] Chang Gung Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Chiayi, Taiwan; [Huang, Yan-Hua] Calif State Univ, Coll Profess Studies, Sch Hlth & Human Serv, Dept Occupat Therapy, Dominguez Hills, Carson, CA USA	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Shi, CS (corresponding author), Chang Gung Mem Hosp, Dept Surg, Div Urol, Chiayi, Taiwan.; Shi, CS (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	csshi@mail.cgu.edu.tw	huang, yan/GWM-4747-2022	Chen, Chih-Shou/0000-0002-5785-2373; Ho, Dong-Ru/0000-0002-1805-0538; Shi, Chung-Sheng/0000-0002-5548-7675	National Science Council, Taiwan [MOST 103-2314-B-182A-104]; Chang Gung Medical Foundation, Taiwan [CMRPG6E0351]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Medical Foundation, Taiwan	YCH and CSS received a grant from National Science Council, Taiwan (MOST 103-2314-B-182A-104) and Chang Gung Medical Foundation, Taiwan (CMRPG6E0351). All the funding or sources of support received during this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwaal A, 2015, ADV DRUG DELIVER REV, V82-83, P137, DOI 10.1016/j.addr.2014.11.012; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bivalacqua TJ, 2009, J UROLOGY, V181, P899, DOI 10.1016/j.juro.2008.10.062; Bonafede R, 2016, EXP CELL RES, V340, P150, DOI 10.1016/j.yexcr.2015.12.009; Cao SY, 2014, J SEX MED, V11, P2376, DOI 10.1111/jsm.12641; Chae SY, 2004, BIOMATERIALS, V25, P843, DOI 10.1016/S0142-9612(03)00605-7; Chiou CC, 2003, CLIN CHIM ACTA, V334, P87, DOI 10.1016/S0009-8981(03)00191-8; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Erdelmeier I, 1998, CHEM RES TOXICOL, V11, P1184, DOI 10.1021/tx970180z; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; Huang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140728; Huang YC, 2010, J SEX MED, V7, P1391, DOI 10.1111/j.1743-6109.2009.01697.x; Huang YC, 2010, J UROLOGY, V183, P1232, DOI 10.1016/j.juro.2009.11.012; Hwang TIS, 2010, J SEX MED, V7, P2817, DOI 10.1111/j.1743-6109.2010.01837.x; Imamura M, 2007, AM J PHYSIOL-REG I, V293, pR2081, DOI 10.1152/ajpregu.00406.2007; Kaiser J, 2010, SCIENCE, V329, P1132, DOI 10.1126/science.329.5996.1132; Kleinman KP, 2000, J CLIN EPIDEMIOL, V53, P71, DOI 10.1016/S0895-4356(99)00150-X; Lin G, 2008, STEM CELLS DEV, V17, P1053, DOI 10.1089/scd.2008.0117; Lin WY, 2011, BJU INT, V107, P1839, DOI 10.1111/j.1464-410X.2010.09597.x; Lue TF, 2000, NEW ENGL J MED, V342, P1802, DOI 10.1056/NEJM200006153422407; MANNINO DM, 1994, AM J EPIDEMIOL, V140, P1003, DOI 10.1093/oxfordjournals.aje.a117189; Mobley David, 2015, Rev Urol, V17, P220; Montorsi F, 2010, J SEX MED, V7, P3572, DOI 10.1111/j.1743-6109.2010.02062.x; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pan F, 2015, MOL MED REP, V12, P3725, DOI 10.3892/mmr.2015.3847; Rosen RC, 2003, AM J CARDIOL, V92, p9M, DOI 10.1016/S0002-9149(03)00824-5; Singhal SS, 2015, TOXICOL APPL PHARM, V289, P361, DOI 10.1016/j.taap.2015.10.006; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tostes RC, 2008, J SEX MED, V5, P1284, DOI 10.1111/j.1743-6109.2008.00804.x; Wang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118951; Ypsilantis P, 2013, NICOTINE TOB RES, V15, P206, DOI 10.1093/ntr/nts113	36	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156725	10.1371/journal.pone.0156725	http://dx.doi.org/10.1371/journal.pone.0156725			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257818	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700116
J	Jeong, JH; Resop, JP; Mueller, ND; Fleisher, DH; Yun, K; Butler, EE; Timlin, DJ; Shim, KM; Gerber, JS; Reddy, VR; Kim, SH				Jeong, Jig Han; Resop, Jonathan P.; Mueller, Nathaniel D.; Fleisher, David H.; Yun, Kyungdahm; Butler, Ethan E.; Timlin, Dennis J.; Shim, Kyo-Moon; Gerber, James S.; Reddy, Vangimalla R.; Kim, Soo-Hyung			Random Forests for Global and Regional Crop Yield Predictions	PLOS ONE			English	Article							RANGE SHIFTS; CORN YIELDS; REGRESSION; CLASSIFICATION; TEMPERATURE; MODELS; RESPONSES; BIOMASS	Accurate predictions of crop yield are critical for developing effective agricultural and food policies at the regional and global scales. We evaluated a machine-learning method, Random Forests (RF), for its ability to predict crop yield responses to climate and biophysical variables at global and regional scales in wheat, maize, and potato in comparison with multiple linear regressions (MLR) serving as a benchmark. We used crop yield data from various sources and regions for model training and testing: 1) gridded global wheat grain yield, 2) maize grain yield from US counties over thirty years, and 3) potato tuber and maize silage yield from the northeastern seaboard region. RF was found highly capable of predicting crop yields and outperformed MLR benchmarks in all performance statistics that were compared. For example, the root mean square errors (RMSE) ranged between 6 and 14% of the average observed yield with RF models in all test cases whereas these values ranged from 14% to 49% for MLR models. Our results show that RF is an effective and versatile machine-learning method for crop yield predictions at regional and global scales for its high accuracy and precision, ease of use, and utility in data analysis. RF may result in a loss of accuracy when predicting the extreme ends or responses beyond the boundaries of the training data.	[Jeong, Jig Han; Yun, Kyungdahm; Kim, Soo-Hyung] Univ Washington, Sch Environm & Forest Sci, Coll Environm, Box 354115, Seattle, WA 98195 USA; [Resop, Jonathan P.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Resop, Jonathan P.; Fleisher, David H.; Timlin, Dennis J.; Reddy, Vangimalla R.] USDA ARS, Crop Syst & Global Change Lab, Beltsville, MD 20705 USA; [Mueller, Nathaniel D.] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA; [Mueller, Nathaniel D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Butler, Ethan E.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Shim, Kyo-Moon] RDA, Climate Change & Agroecol Div, Natl Inst Agr Sci, Suwon, South Korea; [Gerber, James S.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA	University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); Harvard University; Harvard University; University of Minnesota System; University of Minnesota Twin Cities; Rural Development Administration (RDA), Republic of Korea; University of Minnesota System; University of Minnesota Twin Cities	Kim, SH (corresponding author), Univ Washington, Sch Environm & Forest Sci, Coll Environm, Box 354115, Seattle, WA 98195 USA.	soohkim@uw.edu	Resop, Jonathan Patrick/AAH-5537-2019; Kim, Soo-Hyung/A-3012-2009; Butler, Ethan/AAG-2034-2019; Mueller, Nathan D/E-5864-2010	Resop, Jonathan Patrick/0000-0002-9534-2518; Kim, Soo-Hyung/0000-0003-3879-4080; Mueller, Nathan D/0000-0003-1857-5104; Fleisher, Dave/0000-0002-0631-3986; Gerber, James/0000-0002-6890-0481; Timlin, Dennis/0000-0003-4883-4664	Cooperative Research Program for Agricultural Science and Technology Development, Rural Development Administration, Republic of Korea [PJ01000707]; University of Washington [58-1265-1-074]; USDA-ARS [58-1265-1-074]; USDA-ARS Headquarters Postdoctoral Research Associate Program; USDA-NIFA-AFRI [2011-68004-30057]; USDA AFRI fellowship [2016-67012-25208]; NSF Hydrological Sciences grant [1521210]; Packard Foundation; NERC [NE/M021327/1] Funding Source: UKRI; Directorate For Geosciences [1540195] Funding Source: National Science Foundation; Natural Environment Research Council [NE/M021327/1] Funding Source: researchfish	Cooperative Research Program for Agricultural Science and Technology Development, Rural Development Administration, Republic of Korea; University of Washington(University of Washington); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-ARS Headquarters Postdoctoral Research Associate Program(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-NIFA-AFRI(United States Department of Agriculture (USDA)); USDA AFRI fellowship; NSF Hydrological Sciences grant; Packard Foundation(The David & Lucile Packard Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by a Cooperative Research Program for Agricultural Science and Technology Development (Project No. PJ01000707), Rural Development Administration, Republic of Korea (SHK; KMS). Additional support was provided in part by a Specific Cooperative Agreement: 58-1265-1-074 between University of Washington and USDA-ARS (SHK; VRR), the USDA-ARS Headquarters Postdoctoral Research Associate Program (DHF), the USDA-NIFA-AFRI Grant no. 2011-68004-30057: Enhancing Food Security of Underserved Populations in the Northeast through Sustainable Regional Food Systems (DHF), the USDA AFRI fellowship 2016-67012-25208 (NDM), the NSF Hydrological Sciences grant 1521210 (NDM), and the Packard Foundation (EEB).	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Butler EE, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034009; Butler EE, 2013, NAT CLIM CHANGE, V3, P68, DOI [10.1038/NCLIMATE1585, 10.1038/nclimate1585]; CARLSON RE, 1990, J PROD AGRIC, V3, P293, DOI 10.2134/jpa1990.0293; Chen XW, 2005, BIOINFORMATICS, V21, P4394, DOI 10.1093/bioinformatics/bti721; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; ESRI, 2011, ARCGIS DESKT REL 10; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Fukuda S, 2013, AGR WATER MANAGE, V116, P142, DOI 10.1016/j.agwat.2012.07.003; Gromping U, 2009, AM STAT, V63, P308, DOI 10.1198/tast.2009.08199; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hutchinson M.F., 2004, ANUSPLIN VERSION 4 3; Kim SH, 2012, AGRON J, V104, P1523, DOI 10.2134/agronj2011.0321; Krause P., 2005, ADV GEOSCI, V5, P89, DOI [10.5194/adgeo-5-89-2005, DOI 10.5194/ADGEO-5-89-2005, DOI 10.5194/ADGE0-5-89-2005]; Kucharik CJ, 2005, EARTH INTERACT, V9, DOI 10.1175/EI098.1; Landau S, 2000, AGR FOREST METEOROL, V101, P151, DOI 10.1016/S0168-1923(99)00166-5; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Lobell DB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034007; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Mutanga O, 2012, INT J APPL EARTH OBS, V18, P399, DOI 10.1016/j.jag.2012.03.012; NASS, 2011, 2010 CROPL DAT LAYER; NASS, 2015, CENS AGR; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; R Core Team, 2021, R LANGUAGE ENV STAT; Resop JP, 2014, AGRON J, V106, P43, DOI 10.2134/agronj2013.0277; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Segal M.R., 2004, INT C BIOINF, DOI DOI 10.2307/2404188; Sheehy JE, 2006, FIELD CROP RES, V98, P151, DOI 10.1016/j.fcr.2006.01.001; Svetnik V, 2004, LECT NOTES COMPUT SC, V3077, P334; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; United States Department of Agriculture National Agricultural Statistics Service (NASS), 2009, CENS AGR; Venables WN., 2002, MODERN APPL STAT S, V4; Villareal R, 1985, S WHEATS MOR TROP EN; Vincenzi S, 2011, ECOL MODEL, V222, P1471, DOI 10.1016/j.ecolmodel.2011.02.007; Wallach D, 2014, WORKING WITH DYNAMIC CROP MODELS: METHODS, TOOLS AND EXAMPLES FOR AGRICULTURE AND ENVIRONMENT, 2ND EDITION, P1, DOI 10.1016/C2011-0-06987-9; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]	49	183	188	17	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156571	10.1371/journal.pone.0156571	http://dx.doi.org/10.1371/journal.pone.0156571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257967	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700078
J	Kim, H; Lee, KI; Jang, M; Namkoong, S; Park, R; Ju, H; Choi, I; Oh, WK; Park, J				Kim, Hyunju; Lee, Kang Il; Jang, Minsu; Namkoong, Sim; Park, Rackhyun; Ju, Hyunwoo; Choi, Inho; Oh, Won Keun; Park, Junsoo			Conessine Interferes with Oxidative Stress-Induced C2C12 Myoblast Cell Death through Inhibition of Autophagic Flux	PLOS ONE			English	Article							DOUBLE-EDGED-SWORD; ALKALOID CONESSINE; SKELETAL-MUSCLES; CANCER-THERAPY; PROTEIN; ANTAGONISTS; DISEASE	Conessine, a steroidal alkaloid isolated from Holarrhena floribunda, has anti-malarial activity and interacts with the histamine H3 receptor. However, the cellular effects of conessine are poorly understood. Accordingly, we evaluated the involvement of conessine in the regulation of autophagy. We searched natural compounds that modulate autophagy, and conessine was identified as an inhibitor of autophagic flux. Conessine treatment induced the formation of autophagosomes, and p62, an autophagic adapter, accumulated in the autophagosomes. Reactive oxygen species such as hydrogen peroxide (H2O2) result in muscle cell death by inducing excessive autophagic flux. Treatment with conessine inhibited H2O2-induced autophagic flux in C2C12 myoblast cells and also interfered with cell death. Our results indicate that conessine has the potential effect to inhibit muscle cell death by interfering with autophagic flux.	[Kim, Hyunju; Lee, Kang Il; Jang, Minsu; Namkoong, Sim; Park, Rackhyun; Ju, Hyunwoo; Choi, Inho; Park, Junsoo] Yonsei Univ, Div Biol Sci & Technol, Wonju 26493, South Korea; [Oh, Won Keun] Seoul Natl Univ, Coll Pharm, Korea Bioact Nat Mat Bank, Seoul 08826, South Korea	Yonsei University; Seoul National University (SNU)	Park, J (corresponding author), Yonsei Univ, Div Biol Sci & Technol, Wonju 26493, South Korea.	junsoo@yonsei.ac.kr		Park, Junsoo/0000-0002-2355-6760; Oh, Won Keun/0000-0003-0761-3064	Leading Space Core Technology Development Program through the NRF - Ministry of Science, ICT & Future Planning [2013M1A3A3A02042433]	Leading Space Core Technology Development Program through the NRF - Ministry of Science, ICT & Future Planning	This study was supported by a grant from the Leading Space Core Technology Development Program through the NRF funded by the Ministry of Science, ICT & Future Planning (2013M1A3A3A02042433) (http://www.nrf.re.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Dua VK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-194; Kesidou E, 2013, NEURAL REGEN RES, V8, P2275, DOI 10.3969/j.issn.1673-5374.2013.24.007; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lee KI, 2015, BIOCHEM BIOPH RES CO, V462, P402, DOI 10.1016/j.bbrc.2015.04.145; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Namkoong S, 2015, AUTOPHAGY, V11, P756, DOI 10.1080/15548627.2015.1034412; Pan T, 2009, NEUROSCIENCE, V164, P541, DOI 10.1016/j.neuroscience.2009.08.014; Paris R., 1951, GAZ MED FR, P79; Rahman M, 2014, ANTIOXID REDOX SIGN, V20, P443, DOI 10.1089/ars.2013.5410; Ryu HW, 2014, DNA CELL BIOL, V33, P128, DOI 10.1089/dna.2013.2089; Ryu HW, 2013, BIOCHEM BIOPH RES CO, V433, P121, DOI 10.1016/j.bbrc.2013.02.053; Santora VJ, 2008, BIOORG MED CHEM LETT, V18, P1490, DOI 10.1016/j.bmcl.2007.12.059; Seo G, 2011, FREE RADICAL RES, V45, P389, DOI 10.3109/10715762.2010.535530; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Yoon JH, 2012, MOL BIOL REP, V39, P1087, DOI 10.1007/s11033-011-0835-x; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zhao C, 2008, J MED CHEM, V51, P5423, DOI 10.1021/jm8003625; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zirihi GN, 2005, BIOORG MED CHEM LETT, V15, P2637, DOI 10.1016/j.bmcl.2005.03.021	24	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157096	10.1371/journal.pone.0157096	http://dx.doi.org/10.1371/journal.pone.0157096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257813	gold, Green Submitted, Green Published			2022-12-26	WOS:000377369700176
J	Larkin, DJ; Jacobi, SK; Hipp, AL; Kramer, AT				Larkin, Daniel J.; Jacobi, Sarah K.; Hipp, Andrew L.; Kramer, Andrea T.			Keeping All the PIECES: Phylogenetically Informed Ex Situ Conservation of Endangered Species	PLOS ONE			English	Article							PLANT CONSERVATION; FOREST MANAGEMENT; DIVERSITY; ECOLOGY; EXTINCTION; PATTERNS; THREAT	Ex situ conservation in germplasm and living collections is a major focus of global plant conservation strategies. Prioritizing species for ex situ collection is a necessary component of this effort for which sound strategies are needed. Phylogenetic considerations can play an important role in prioritization. Collections that are more phylogenetically diverse are likely to encompass more ecological and trait variation, and thus provide stronger conservation insurance and richer resources for future restoration efforts. However, phylogenetic criteria need to be weighed against other, potentially competing objectives. We used ex situ collection and threat rank data for North American angiosperms to investigate gaps in ex situ coverage and phylogenetic diversity of collections and to develop a flexible framework for prioritizing species across multiple objectives. We found that ex situ coverage of 18,766 North American angiosperm taxa was low with respect to the most vulnerable taxa: just 43% of vulnerable to critically imperiled taxa were in ex situ collections, far short of a year-2020 goal of 75%. In addition, species held in ex situ collections were phylogenetically clustered (P < 0.001), i.e., collections comprised less phylogenetic diversity than would be expected had species been drawn at random. These patterns support incorporating phylogenetic considerations into ex situ prioritization in a manner balanced with other criteria, such as vulnerability. To meet this need, we present the 'PIECES' index (Phylogenetically Informed Ex situ Conservation of Endangered Species). PIECES integrates phylogenetic considerations into a flexible framework for prioritizing species across competing objectives using multi-criteria decision analysis. Applying PIECES to prioritizing ex situ conservation of North American angiosperms, we show strong return on investment across multiple objectives, some of which are negatively correlated with each other. A spreadsheet-based decision support tool for North American angiosperms is provided; this tool can be customized to align with different conservation objectives.	[Larkin, Daniel J.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Larkin, Daniel J.; Jacobi, Sarah K.; Kramer, Andrea T.] Chicago Bot Garden, Plant Sci & Conservat, Glencoe, IL USA; [Hipp, Andrew L.] Morton Arboretum, Herbarium, Lisle, IL USA; [Hipp, Andrew L.] Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA	University of Minnesota System; University of Minnesota Twin Cities; Field Museum of Natural History (Chicago)	Larkin, DJ (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.; Larkin, DJ (corresponding author), Chicago Bot Garden, Plant Sci & Conservat, Glencoe, IL USA.	djlarkin@umn.edu	Kramer, Andrea T/K-8427-2017	Kramer, Andrea T/0000-0002-0956-0157; Larkin, Daniel/0000-0001-6378-0495	National Science Foundation (US) Division of Environmental Biology [DEB-1354426, DEB-1354551]; NSF [DEB-1354426, DEB-1354551]; Division Of Environmental Biology [1354551] Funding Source: National Science Foundation	National Science Foundation (US) Division of Environmental Biology(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (US) Division of Environmental Biology (http://www.nsf.gov/div/index.jsp?div=DEB) under the following awards: DEB-1354426 and DEB-1354551.; This work was supported by NSF awards DEB-1354426 and DEB-1354551. We thank Botanic Gardens Conservation International and NatureServe for provision of data, and the Hipp and Havens-Kramer lab groups for feedback on previous versions of this manuscript.	Ananda J, 2009, ECOL ECON, V68, P2535, DOI 10.1016/j.ecolecon.2009.05.010; [Anonymous], 2013, NATURESERVE EXPL ONL; [Anonymous], 2013, PLANTSEARCH ONL DAT; Araya YN, 2012, J ECOL, V100, P1434, DOI 10.1111/1365-2745.12004; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BGCI, 2014, TECHN BACKGR DOC SUP; Boyle B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-16; Cadotte MW, 2013, P NATL ACAD SCI USA, V110, P8996, DOI 10.1073/pnas.1301685110; Cadotte MW, 2012, ECOLOGY, V93, pS223, DOI 10.1890/11-0426.1; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cavender-Bares J, 2012, ECOLOGY, V93, pS52, DOI 10.1890/11-0502.1; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Cheung WWL, 2008, ECOL ECON, V66, P193, DOI 10.1016/j.ecolecon.2007.09.001; Commoner B., 1971, N Y; Davies TJ, 2012, ECOLOGY, V93, P242, DOI 10.1890/11-1360.1; Davies TJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000620; Dinnage R, 2012, ECOL LETT, V15, P1308, DOI 10.1111/j.1461-0248.2012.01854.x; Falk DA, 1991, GENETICS CONSERVATIO; Farnsworth E, 2000, ANNU REV ECOL SYST, V31, P107, DOI 10.1146/annurev.ecolsys.31.1.107; Farnsworth EJ, 2006, BIOL CONSERV, V128, P1, DOI 10.1016/j.biocon.2005.09.010; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Griffiths KE, 2015, CONSERV BIOL, V29, P370, DOI 10.1111/cobi.12390; Guerrant EO, 2014, INT J PLANT SCI, V175, P11, DOI 10.1086/674131; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Hipp AL, 2015, AM J BOT, V102, P647, DOI 10.3732/ajb.1500119; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043912; Jackson PW, 2009, TRENDS PLANT SCI, V14, P578, DOI 10.1016/j.tplants.2009.08.011; Kangas J, 2005, FOREST ECOL MANAG, V207, P133, DOI 10.1016/j.foreco.2004.10.023; Kartesz JT, 1999, SYNTHESIS N AM FLORA; Kew RBG, 2015, STAT WORLDS PLANTS 2; Larkin DJ, 2015, J APPL ECOL, V52, P1638, DOI 10.1111/1365-2664.12516; Li DZ, 2009, TRENDS PLANT SCI, V14, P614, DOI 10.1016/j.tplants.2009.09.005; MathWorks, 2013, MATLAB REF MAN; Maunder M., 2004, EX SITU PLANT CONSER; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Nemhauser GL., 1988, INTEGER COMBINATORIA, DOI [10.1002/9781118627372, DOI 10.1002/9781118627372]; Orme D., 2013, CAPER COMP ANAL PHYL; Pammenter NW., 2000, PLANT SPEC BIOL, V15, P153, DOI [10.1046/j.1442-1984.2000.00035.x, DOI 10.1046/J.1442-1984.2000.00035.X]; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Pence VC, 2014, INT J PLANT SCI, V175, P40, DOI 10.1086/673301; Proches S, 2008, BIOSCIENCE, V58, P151, DOI 10.1641/B580209; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; R Development Core Team, 2014, R LANG ENV STAT COMP; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Saaty TL., 2008, INT J SERV SCI, V1, P2008, DOI [DOI 10.1504/IJSSCI.2008.017590, 10.1504/IJSSCI.2008.017590]; Saslis-Lagoudakis CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022275; Schatz GE, 2009, TRENDS PLANT SCI, V14, P638, DOI 10.1016/j.tplants.2009.08.012; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Verdu M, 2012, P ROY SOC B-BIOL SCI, V279, P1761, DOI 10.1098/rspb.2011.2268; Whitfeld TJS, 2014, J PLANT ECOL, V7, P202, DOI 10.1093/jpe/rtt020; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Zanne AE, 2013, DRYAD DIGITAL REPOSI; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	56	10	11	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156973	10.1371/journal.pone.0156973	http://dx.doi.org/10.1371/journal.pone.0156973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257671	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700165
J	Lin, C; Yuan, Y; Courtman, DW				Lin, Clifford; Yuan, Yifan; Courtman, David W.			Differentiation of Murine Bone Marrow-Derived Smooth Muscle Progenitor Cells Is Regulated by PDGF-BB and Collagen	PLOS ONE			English	Article							GROWTH FACTOR-BB; MESENCHYMAL STEM-CELLS; NEOINTIMAL FORMATION; IN-VITRO; FIBRILLAR COLLAGEN; KNOCKOUT MICE; TGF-BETA; ATHEROSCLEROSIS; PROLIFERATION; PROGRESSION	Smooth muscle cells (SMCs) are key regulators of vascular disease and circulating smooth muscle progenitor cells may play important roles in vascular repair or remodelling. We developed enhanced protocols to derive smooth muscle progenitors from murine bone marrow and tested whether factors that are increased in atherosclerotic plaques, namely platelet-derived growth factor-BB (PDGF-BB) and monomeric collagen, can influence the smooth muscle specific differentiation, proliferation, and survival of mouse bone marrow-derived progenitor cells. During a 21 day period of culture, bone marrow cells underwent a marked increase in expression of the SMC markers alpha-SMA (1.93 +/- 0.15 vs. 0.0008 +/- 0.0003 (ng/ng GAPDH) at 0 d), SM22-alpha (1.50 +/- 0.27 vs. 0.005 +/- 0.001 (ng/ng GAPDH) at 0 d) and SM-MHC (0.017 +/- 0.004 vs. 0.001 +/- 0.001 (ng/ng GAPDH) at 0 d). Bromodeoxyuridine (BrdU) incorporation experiments showed that in early culture, the smooth muscle progenitor subpopulation could be identified by high proliferative rates prior to the expression of smooth muscle specific markers. Culture of fresh bone marrow or smooth muscle progenitor cells with PDGF-BB suppressed the expression of alpha-SMA and SM22-alpha, in a rapidly reversible manner requiring PDGF receptor kinase activity. Progenitors cultured on polymerized collagen gels demonstrated expression of SMC markers, rates of proliferation and apoptosis similar to that of cells on tissue culture plastic; in contrast, cells grown on monomeric collagen gels displayed lower SMC marker expression, lower growth rates (319 +/- 36 vs. 635 +/- 97 cells/mm(2)), and increased apoptosis (5.3 +/- 1.6% vs. 1.0 +/- 0.5% (Annexin 5 staining)). Our data shows that the differentiation and survival of smooth muscle progenitors are critically affected by PDGF-BB and as well as the substrate collagen structure.	[Yuan, Yifan; Courtman, David W.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Lin, Clifford] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University of Ottawa; Ottawa Hospital Research Institute; Oregon Health & Science University	Courtman, DW (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.	dcourtman@ohri.ca	Yuan, Yifan/H-6569-2019	Yuan, Yifan/0000-0001-8645-3112	Ontario Graduate Scholarship; NSERC	Ontario Graduate Scholarship(Ontario Graduate Scholarship); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We are grateful to Ontario Graduate Scholarship for financial support to Y.Y. and NSERC for financial support to C.L.	Adiguzel E, 2009, VASC MED, V14, P73, DOI 10.1177/1358863X08094801; Akhtar S, 2013, ARTERIOSCL THROM VAS, V33, P679, DOI 10.1161/ATVBAHA.112.301162; Ball SG, 2007, INT J BIOCHEM CELL B, V39, P379, DOI 10.1016/j.biocel.2006.09.005; Banai S, 1998, CIRCULATION, V97, P1960, DOI 10.1161/01.CIR.97.19.1960; Bentzon JF, 2007, CIRCULATION, V116, P2053, DOI 10.1161/CIRCULATIONAHA.107.722355; Bentzon JF, 2006, ARTERIOSCL THROM VAS, V26, P2696, DOI 10.1161/01.ATV.0000247243.48542.9d; Bentzon JF, 2010, VASC PHARMACOL, V52, P11, DOI 10.1016/j.vph.2009.11.005; Brown XQ, 2010, J CELL PHYSIOL, V225, P115, DOI 10.1002/jcp.22202; CAMPBELL JH, 1989, ARTERIOSCLEROSIS, V9, P633, DOI 10.1161/01.ATV.9.5.633; Canavan HE, 2005, J BIOMED MATER RES A, V75A, P1, DOI 10.1002/jbm.a.30297; Chen CN, 2006, P NATL ACAD SCI USA, V103, P2665, DOI 10.1073/pnas.0510973103; Chou MT, 2010, BIOMATERIALS, V31, P4367, DOI 10.1016/j.biomaterials.2010.02.011; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Dandre F, 2004, AM J PHYSIOL-HEART C, V286, pH2042, DOI 10.1152/ajpheart.00625.2003; Daniel JM, 2011, J MOL CELL CARDIOL, V50, P273, DOI 10.1016/j.yjmcc.2010.10.030; Dorafshar AH, 2003, J SURG RES, V114, P179, DOI 10.1016/S0022-4804(03)00254-3; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Fassett J, 2006, MOL BIOL CELL, V17, P345, DOI 10.1091/mbc.E05-09-0871; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Guildford AL, 2011, J R SOC INTERFACE, V8, P641, DOI 10.1098/rsif.2010.0532; Josh F, 2013, J NIPPON MED SCH, V80, P140, DOI 10.1272/jnms.80.140; Kashiwakura Y, 2003, CIRCULATION, V107, P2078, DOI 10.1161/01.CIR.0000070082.64414.B5; Koyama H, 1996, CELL, V87, P1069, DOI 10.1016/S0092-8674(00)81801-2; Kruzliak P, 2016, ACTA HISTOCHEM, V118, P413, DOI 10.1016/j.acthis.2016.04.005; Kubota K, 2003, J SURG RES, V109, P43, DOI 10.1016/S0022-4804(02)00037-9; Kumar AHS, 2010, FASEB J, V24, P81, DOI 10.1096/fj.09-132225; Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052; Majesky MW, 2011, CIRC RES, V108, P365, DOI 10.1161/CIRCRESAHA.110.223800; Merkulova-Rainon T, 2012, CARDIOVASC RES, V95, P205, DOI 10.1093/cvr/cvs097; Metharom P, 2010, ARTERIOSCL THROM VAS, V30, P533, DOI 10.1161/ATVBAHA.109.200097; Orlandi A, 2010, BIOCHEM PHARMACOL, V79, P1706, DOI 10.1016/j.bcp.2010.01.027; Orr AW, 2009, ARTERIOSCL THROM VAS, V29, P225, DOI 10.1161/ATVBAHA.108.178749; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park HS, 2013, BIOCHEM BIOPH RES CO, V431, P326, DOI 10.1016/j.bbrc.2012.12.099; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Pyle AL, 2010, AM J PATHOL, V177, P4, DOI 10.2353/ajpath.2010.090615; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Salabei JK, 2013, BIOCHEM J, V451, P375, DOI 10.1042/BJ20121344; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Solchaga LA, 2013, CLIN DRUG INVEST, V33, P143, DOI 10.1007/s40261-013-0053-5; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Tanaka K, 2008, FASEB J, V22, P428, DOI 10.1096/fj.06-6884com; Uemura Y, 2013, FASEB J, V27, P25, DOI 10.1096/fj.12-213744; Zhao Y, 2014, J RECEPT SIG TRANSD, V34, P254, DOI 10.3109/10799893.2014.908915; Zoll J, 2008, CARDIOVASC RES, V77, P471, DOI 10.1093/cvr/cvm034; Zou SL, 2016, ANN THORAC SURG, V101, P2085, DOI 10.1016/j.athoracsur.2016.01.026	48	4	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156935	10.1371/journal.pone.0156935	http://dx.doi.org/10.1371/journal.pone.0156935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258003	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700159
J	Rasnick, R; Standifird, T; Reinbolt, JA; Cates, HE; Zhang, SN				Rasnick, Robert; Standifird, Tyler; Reinbolt, Jeffrey A.; Cates, Harold E.; Zhang, Songning			Knee Joint Loads and Surrounding Muscle Forces during Stair Ascent in Patients with Total Knee Replacement	PLOS ONE			English	Article							QUALITY-OF-LIFE; MEASURED IN-VIVO; DYNAMIC SIMULATIONS; FUNCTIONAL MOBILITY; OLDER-PEOPLE; CROUCH GAIT; ARTHROPLASTY; WALKING; OSTEOARTHRITIS; BIOMECHANICS	Total knee replacement (TKR) is commonly used to correct end-stage knee osteoarthritis. Unfortunately, difficulty with stair climbing often persists and prolongs the challenges of TKR patents. Complete understanding of loading at the knee is of great interest in order to aid patient populations, implant manufacturers, rehabilitation, and future healthcare research. Musculoskeletal modeling and simulation approximates joint loading and corresponding muscle forces during a movement. The purpose of this study was to determine if knee joint loadings following TKR are recovered to the level of healthy individuals, and determine the differences in muscle forces causing those loadings. Data from five healthy and five TKR patients were selected for musculoskeletal simulation. Variables of interest included knee joint reaction forces (JRF) and the corresponding muscle forces. A paired samples t-test was used to detect differences between groups for each variable of interest (p<0.05). No differences were observed for peak joint compressive forces between groups. Some muscle force compensatory strategies appear to be present in both the loading and push-off phases. Evidence from knee extension moment and muscle forces during the loading response phase indicates the presence of deficits in TKR in quadriceps muscle force production during stair ascent. This result combined with greater flexor muscle forces resulted in similar compressive JRF during loading response between groups.	[Rasnick, Robert; Zhang, Songning] Univ Tennessee, Dept Kinesiol Recreat & Sport Studies, Knoxville, TN 37996 USA; [Standifird, Tyler] Utah Valley Univ, Dept Exercise Sci & Outdoor Recreat, Orem, UT USA; [Reinbolt, Jeffrey A.] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN USA; [Cates, Harold E.] Tennessee Orthoped Clin, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; Utah System of Higher Education; Utah Valley University; University of Tennessee System; University of Tennessee Knoxville	Zhang, SN (corresponding author), Univ Tennessee, Dept Kinesiol Recreat & Sport Studies, Knoxville, TN 37996 USA.	szhang@utk.edu		Zhang, Songning/0000-0002-3712-9129	Div Of Chem, Bioeng, Env, & Transp Sys [1253317] Funding Source: National Science Foundation	Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Berti L, 2006, CLIN BIOMECH, V21, P610, DOI 10.1016/j.clinbiomech.2006.01.002; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Bruyere O, 2012, ARCH ORTHOP TRAUM SU, V132, P1583, DOI 10.1007/s00402-012-1583-7; Catani F, 2003, CLIN BIOMECH, V18, P410, DOI 10.1016/S0268-0033(03)00044-5; Catani F, 2009, J ORTHOP RES, V27, P1569, DOI 10.1002/jor.20941; D'Lima DD, 2007, J BIOMECH, V40, pS11, DOI 10.1016/j.jbiomech.2007.03.004; D'Lima DD, 2006, J ARTHROPLASTY, V21, P255, DOI 10.1016/j.arth.2005.07.011; D'Lima DD, 2005, CLIN ORTHOP RELAT R, P45, DOI 10.1097/01.blo.0000186559.62942.8c; Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; DeMers MS, 2014, J ORTHOP RES, V32, P769, DOI 10.1002/jor.22601; Dickstein R, 1998, GERONTOLOGY, V44, P204, DOI 10.1159/000022011; Fantozzi S, 2003, GAIT POSTURE, V17, P225, DOI 10.1016/S0966-6362(02)00096-6; Ghafari AS, 2009, P I MECH ENG H, V223, P863, DOI 10.1243/09544119JEIM578; Hawker G, 1998, J BONE JOINT SURG AM, V80A, P163, DOI 10.2106/00004623-199802000-00003; Heinlein B, 2009, CLIN BIOMECH, V24, P315, DOI 10.1016/j.clinbiomech.2009.01.011; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; Kim HJ, 2009, J ORTHOP RES, V27, P1326, DOI 10.1002/jor.20876; Ko Y, 2011, VALUE HEALTH, V14, P322, DOI 10.1016/j.jval.2010.08.005; Kristianslund E, 2012, J BIOMECH, V45, P666, DOI 10.1016/j.jbiomech.2011.12.011; Kumar D, 2013, OSTEOARTHR CARTILAGE, V21, P298, DOI 10.1016/j.joca.2012.11.008; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kutzner I, 2010, J BIOMECH, V43, P2164, DOI 10.1016/j.jbiomech.2010.03.046; Lundberg HJ, 2012, J BIOMECH, V45, P990, DOI 10.1016/j.jbiomech.2012.01.015; Mandeville D, 2007, CLIN BIOMECH, V22, P787, DOI 10.1016/j.clinbiomech.2007.04.002; Mundermann A, 2008, J ORTHOP RES, V26, P1167, DOI 10.1002/jor.20655; Paquette MR, 2014, KNEE, V21, P676, DOI 10.1016/j.knee.2014.02.020; Paquette MR, EFFECTS OF INCREASED; Petterson SC, 2008, MED SCI SPORT EXER, V40, P422, DOI [10.1249/mss.0b013e31815ef285, 10.1249/MSS.0b013e31815ef285]; Piazza SJ, 2001, J BIOMECH ENG-T ASME, V123, P599, DOI 10.1115/1.1406950; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Richards C, 2010, J BIOMECH, V43, P2595, DOI 10.1016/j.jbiomech.2010.05.006; Rouston RL., 2010, THESIS OHIO STATE U; Sasaki K, 2010, J BIOMECH, V43, P2780, DOI 10.1016/j.jbiomech.2010.06.011; Scuderi GR, 2012, CLIN ORTHOP RELAT R, V470, P3, DOI 10.1007/s11999-011-2135-0; Songning Zhang TS, 2014, 7TH WORLD CONGRESS O; Standifird TW, 2014, J ARTHROPLASTY, V29, P1857, DOI 10.1016/j.arth.2014.03.040; Startzell JK, 2000, J AM GERIATR SOC, V48, P567, DOI 10.1111/j.1532-5415.2000.tb05006.x; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Steele KM, 2010, J BIOMECH, V43, P2099, DOI 10.1016/j.jbiomech.2010.04.003; Taylor WR, 2004, J ORTHOP RES, V22, P625, DOI 10.1016/j.orthres.2003.09.003; Thelen DG, 2006, J BIOMECH, V39, P1107, DOI 10.1016/j.jbiomech.2005.02.010; Thelen DG, 2003, J BIOMECH, V36, P321, DOI 10.1016/S0021-9290(02)00432-3; Tiedemann A, 2008, AGE AGEING, V37, P430, DOI 10.1093/ageing/afn100; WATKINS MA, 1991, PHYS THER, V71, P90, DOI 10.1093/ptj/71.2.90	47	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156282	10.1371/journal.pone.0156282	http://dx.doi.org/10.1371/journal.pone.0156282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258086	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700051
J	Serra, L; Cercignani, M; Bruschini, M; Cipolotti, L; Mancini, M; Silvestri, G; Petrucci, A; Bucci, E; Antonini, G; Licchelli, L; Spano, B; Giacanelli, M; Caltagirone, C; Meola, G; Bozzali, M				Serra, Laura; Cercignani, Mara; Bruschini, Michela; Cipolotti, Lisa; Mancini, Matteo; Silvestri, Gabriella; Petrucci, Antonio; Bucci, Elisabetta; Antonini, Giovanni; Licchelli, Loretta; Spano, Barbara; Giacanelli, Manlio; Caltagirone, Carlo; Meola, Giovanni; Bozzali, Marco			"I Know that You Know that I Know": Neural Substrates Associated with Social Cognition Deficits in DM1 Patients	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY; ASPERGER-SYNDROME; MIND IMPAIRMENT; CTG REPEAT; BRAIN; PERSONALITY; EXPANSION; NETWORKS; CHILDREN	Myotonic dystrophy type-1 (DM1) is a genetic multi-systemic disorder involving several organs including the brain. Despite the heterogeneity of this condition, some patients with non-congenital DM1 can present with minimal cognitive impairment on formal testing but with severe difficulties in daily-living activities including social interactions. One explanation for this paradoxical mismatch can be found in patients' dysfunctional social cognition, which can be assessed in the framework of the Theory of Mind (ToM). We hypothesize here that specific disease driven abnormalities in DM1 brains may result in ToM impairments. We recruited 20 DM1 patients who underwent the "Reading the Mind in the Eyes" and the ToM-story tests. These patients, together with 18 healthy controls, also underwent resting-state functional MRI. A composite Theory of Mind score was computed for all recruited patients and correlated with their brain functional connectivity. This analysis provided the patients' "Theory of Mind-network", which was compared, for its topological properties, with that of healthy controls. We found that DM1 patients showed deficits in both tests assessing ToM. These deficits were associated with specific patterns of abnormal connectivity between the left inferior temporal and fronto-cerebellar nodes in DM1 brains. The results confirm the previous suggestions of ToM dysfunctions in patients with DM1 and support the hypothesis that difficulties in social interactions and personal relationships are a direct consequence of brain abnormalities, and not a reaction symptom. This is relevant not only for a better pathophysiological comprehension of DM1, but also for non-pharmacological interventions to improve clinical aspects and impact on patients' success in life.	[Serra, Laura; Cercignani, Mara; Bruschini, Michela; Mancini, Matteo; Spano, Barbara; Bozzali, Marco] IRCCS Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy; [Cercignani, Mara] Univ Sussex, Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Brighton, E Sussex, England; [Cipolotti, Lisa] Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, Queen Sq, London WC1N 3BG, England; [Mancini, Matteo] Univ Rome, Dept Engn, Rome, Italy; [Silvestri, Gabriella] Univ Cattolica Sacro Cuore, Dept Geriatr Orthopaed & Neurosci, Inst Neurol, I-00168 Rome, Italy; [Petrucci, Antonio; Giacanelli, Manlio] S Camillo Forlanini Hosp, Neuromuscular & Neurol Rare Dis Ctr, Rome, Italy; [Bucci, Elisabetta; Antonini, Giovanni; Licchelli, Loretta] Univ Roma La Sapienza, Fac Med & Psychol, Dept Neurol Mental Hlth & Sensory Organs NESMOS, Rome, Italy; [Caltagirone, Carlo] IRCCS Santa Lucia Fdn, Dept Clin & Behav Neurol, Rome, Italy; [Caltagirone, Carlo] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Meola, Giovanni] Univ Milan, Dept Neurol, IRCCS Policlin San Donato, Milan, Italy	IRCCS Santa Lucia; University of Brighton; University of Sussex; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Azienda Ospedaliera San Camillo-Forlanini; Sapienza University Rome; IRCCS Santa Lucia; University of Rome Tor Vergata; IRCCS Policlinico San Donato; University of Milan	Bozzali, M (corresponding author), IRCCS Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy.	m.bozzali@hsantalucia.it	Silvestri, Gabriella/J-8713-2018; Meola, Giovanni/K-4775-2016; Bozzali, Marco/AAC-1031-2022; Serra, Laura/K-5637-2016; Antonini, Giovanni/AAC-6698-2022; Mancini, Matteo/K-6627-2016; Spano', Barbara/K-9535-2016	Silvestri, Gabriella/0000-0002-1950-1468; Meola, Giovanni/0000-0001-6396-717X; Serra, Laura/0000-0002-2717-1286; Mancini, Matteo/0000-0001-7194-4568; cipolotti, lisa/0000-0001-5838-3647; petrucci, antonio/0000-0001-7950-4970; Cercignani, Mara/0000-0002-4550-2456; ANTONINI, Giovanni/0000-0002-7519-7739; Spano', Barbara/0000-0002-5291-0984; Bozzali, Marco/0000-0002-0568-2026	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	The Neuroimaging Laboratory is in part supported by grants obtained by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BARONCOHEN S, 1989, J CHILD PSYCHOL PSYC, V30, P285, DOI 10.1111/j.1469-7610.1989.tb00241.x; BARONCOHEN S, 1994, CAH PSYCHOL COGN, V13, P724; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Busch D, 2010, LATERALITY, V15, P610, DOI 10.1080/13576500903081806; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carluer L, 2015, CORTEX, V65, P19, DOI 10.1016/j.cortex.2014.12.010; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Cheng S, 1996, HUM MUTAT, V7, P304, DOI 10.1002/(SICI)1098-1004(1996)7:4<304::AID-HUMU3>3.0.CO;2-8; Dai ZJ, 2014, NEUROSCI BULL, V30, P217, DOI 10.1007/s12264-013-1421-0; DMello AM, 2015, NEUROIMAGE-CLIN, V7, P631, DOI 10.1016/j.nicl.2015.02.007; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Gonzalez I, 2000, NEUROLOGY, V54, P1218; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; JOHNSON ER, 1995, AM J PHYS MED REHAB, V74, pS104; Kobayakawa M, 2012, NEUROSCI RES, V72, P341, DOI 10.1016/j.neures.2012.01.005; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; Meola G, 2015, BBA-MOL BASIS DIS, V1852, P594, DOI 10.1016/j.bbadis.2014.05.019; Minnerop M, 2011, BRAIN, V134, P3527, DOI 10.1093/brain/awr299; Modoni A, 2008, J NEUROL, V255, P1737, DOI 10.1007/s00415-008-0017-5; Mothersill O, 2015, CEREBELLUM; Orsini A., 1997, WAIS R CONTRIBUTO TA; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Prior M., 2003, COGNIZIONE SOCIALE C; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007; Serafin M, 2004, GIORNALE ITALIANO PS, V4, P839, DOI DOI 10.1421/18849; Serra L, 2015, FUNCT NEUROL, V30, P21; Serra L, 2014, JAMA NEUROL, V71, P603, DOI 10.1001/jamaneurol.2014.130; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shamay-Tsoory SG, 2007, PSYCHIAT RES, V149, P11, DOI 10.1016/j.psychres.2005.10.018; Sistiaga A, 2010, PSYCHOL MED, V40, P487, DOI 10.1017/S0033291709990602; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Overwalle F, 2014, NEUROIMAGE, V86, P554, DOI 10.1016/j.neuroimage.2013.09.033; Wechsler D WAIS-R, 1997, SCAL INT WECHSL ADUL; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Winblad Stefan, 2006, Behav Brain Funct, V2, P16, DOI 10.1186/1744-9081-2-16; Wozniak JR, 2011, NEUROMUSCULAR DISORD, V21, P89, DOI 10.1016/j.nmd.2010.11.013; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yeh ZT, 2015, J CLIN EXP NEUROPSYC, V37, P128, DOI 10.1080/13803395.2014.992864; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	45	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156901	10.1371/journal.pone.0156901	http://dx.doi.org/10.1371/journal.pone.0156901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258100	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000377369700151
J	Veroux, M; Zerbo, D; Basile, G; Gozzo, C; Sinagra, N; Giaquinta, A; Sanfiorenzo, A; Veroux, P				Veroux, Massimiliano; Zerbo, Domenico; Basile, Giusi; Gozzo, Cecilia; Sinagra, Nunziata; Giaquinta, Alessia; Sanfiorenzo, Angelo; Veroux, Pierfrancesco			Simultaneous Native Nephrectomy and Kidney Transplantation in Patients With Autosomal Dominant Polycystic Kidney Disease	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; BILATERAL-NEPHRECTOMY; MANAGEMENT	Introduction To evaluate the feasibility of simultaneous unilateral nephrectomy with kidney transplantation and to determine the effect of this procedure on perioperative morbidity and mortality and graft and patient survival. Methods Between January 2000 and May 2015, 145 patients with autosomal dominant polycystic kidney disease (ADPKD) underwent kidney transplantation. Of those, 40 (27.5%) underwent concurrent ipsilateral native nephrectomy (group NT). Patients in group NT were compared with patients with ADPKD not undergoing concurrent nephrectomy (group NT-) and asymptomatic patients undergoing pretransplant nephrectomy (group PNT). Results The average follow-up was 66 months. The graft survival rate at 1 and 5 years was 95% and 87.5% versus 93% and 76.2% in the NT and NT- groups, respectively (P = .903 and P = .544, respectively); 1-year patient survival was 100% for NT and 97% for NT- patients (P = .288), whereas 5-year patient survival was 100% and 92% for NT and NT- groups, respectively (P = .128). After propensity score matching (34 patients per group) no significant differences were observed in 1-year (97.1% in NT and 94.1%; P = 1) and 5-year (88.2% in NT and 91.2% in NT-; P = 1) graft survival, and in 1-year (100% for both groups; P = 1) and 5-year (100% in NT and 94.1% in NT-; P = 1) patient survival. Perioperative mortality was 0% among NT and 1.2% among NT- patients, whereas perioperative surgical complications were similar in both groups. One- and 5-year graft and patient survival were similar between the NT and PNT groups, but patients in the PNT group had significantly lower levels of hemoglobin and residual diuresis volumes at the time of transplant. Moreover, PNT patients had a longer pretransplant dialysis and a longer time on the waiting list. Conclusions Simultaneous unilateral nephrectomy does not have a negative effect on patient and graft survival in patients with ADPKD and is associated with low morbidity. Pretransplant nephrectomy should be restricted only to highly symptomatic patients, whereas unilateral nephrectomy in asymptomatic patients should be performed during kidney transplantation only if massive kidney size precludes graft positioning.	[Veroux, Pierfrancesco] Univ Hosp Catania, Dept Med & Surg Sci, Vasc Surg & Organ Transplant Unit, Via Santa Sofia 84, I-95123 Catania, Italy; Univ Hosp Catania, Adv Technol GF Ingrassia, Via Santa Sofia 84, I-95123 Catania, Italy	University of Catania; University of Catania	Veroux, P (corresponding author), Univ Hosp Catania, Dept Med & Surg Sci, Vasc Surg & Organ Transplant Unit, Via Santa Sofia 84, I-95123 Catania, Italy.	veroux@unict.it	veroux, pierfrancesco/K-5195-2018; Veroux, Massimiliano/K-4821-2018	Veroux, Massimiliano/0000-0002-2780-6421; Gozzo, Cecilia/0000-0001-8997-6605				Ahmad SB, 2016, TRANSPLANTATION, V100, P407, DOI 10.1097/TP.0000000000000838; Akoh Jacob A, 2015, World J Nephrol, V4, P468, DOI 10.5527/wjn.v4.i4.468; [Anonymous], 2013, NEPHROL DIAL TRANSPL, V28, P1, DOI 10.1093/ndt/gft218; Bennett WM, 2013, NEPHROL DIAL TRANSPL, V28, P245, DOI 10.1093/ndt/gfs176; Brazda E, 1996, Ann Transplant, V1, P15; CASSUTOVIGUIER E, 1991, CLIN NEPHROL, V36, P105; Dengu F, 2015, EXP CLIN TRANSPLANT, V13, P209, DOI 10.6002/ect.2015.0104; Dinckan A, 2013, ANN TRANSPL, V18, P697, DOI 10.12659/AOT.889377; Drognitz O, 2006, TRANSPLANTATION, V81, P874, DOI 10.1097/01.tp.0000203319.93328.27; Fuller TF, 2005, J UROLOGY, V174, P2284, DOI 10.1097/01.ju.0000181208.06507.aa; Ghavamian R, 2012, BJU INT, V110, pE1008, DOI 10.1111/j.1464-410X.2012.11386.x; Glassmann DT, 2000, J UROLOGY, V164, P661, DOI 10.1016/S0022-5347(05)67276-X; Guo PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129317; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Ismail HR, 2005, TRANSPLANTATION, V80, P1124, DOI 10.1097/01.tp.0000179109.51593.87; Johnston O, 2005, RENAL FAILURE, V27, P309, DOI 10.1081/JDI-200056606; Kanaan N, 2014, NAT REV NEPHROL, V10, P455, DOI 10.1038/nrneph.2014.104; KEITH DS, 1994, J AM SOC NEPHROL, V4, P1661; Kirkman MA, 2011, BJU INT, V108, P590, DOI 10.1111/j.1464-410X.2010.09938.x; Kramer A, 2009, J UROLOGY, V181, P724, DOI 10.1016/j.juro.2008.10.008; Lucas SM, 2010, J UROLOGY, V5, P2054, DOI DOI 10.1016/J.JUR0.2010.06.150; Martin AD, 2012, BJU INT, V110, pE1003, DOI 10.1111/j.1464-410X.2012.11379.x; Meier-Kriesche HU, 2002, TRANSPLANTATION, V74, P1377, DOI 10.1097/00007890-200211270-00005; Neeff HP, 2013, NEPHROL DIAL TRANSPL, V28, P466, DOI 10.1093/ndt/gfs118; Nunes P, 2007, TRANSPL P, V39, P2483, DOI 10.1016/j.transproceed.2007.07.035; Patard JJ, 2004, J UROLOGY, V171, P2181, DOI 10.1097/01.ju.0000124846.37299.5e; Patel P, 2011, ANN ROY COLL SURG, V93, P391, DOI 10.1308/003588411X582690; RAYNER BL, 1990, CLIN NEPHROL, V34, P122; Rozanski J, 2005, TRANSPL P, V37, P666, DOI 10.1016/j.transproceed.2004.12.115; Shumate AM, 2016, J UROLOGY, V195, P141, DOI 10.1016/j.juro.2015.07.114; Skauby MH, 2012, TRANSPLANTATION, V94, P383, DOI 10.1097/TP.0b013e31825812b9; Termorshuizen F, 2004, J AM SOC NEPHROL, V15, P1061, DOI 10.1097/01.ASN.0000117976.29592.93; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; TURNER BI, 1983, J UROLOGY, V130, P240, DOI 10.1016/S0022-5347(17)51082-4; Tyson MD, 2013, J UROLOGY, V190, P2170, DOI 10.1016/j.juro.2013.05.057; Veroux M, 2016, TRANSPLANTATION, V100, pE3, DOI 10.1097/TP.0000000000000982; Yamamoto T, 2012, TRANSPLANTATION, V93, P794, DOI 10.1097/TP.0b013e318246f910	37	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155481	10.1371/journal.pone.0155481	http://dx.doi.org/10.1371/journal.pone.0155481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257690	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700015
J	Greulich, F; Rudat, C; Farin, HF; Christoffels, VM; Kispert, A				Greulich, Franziska; Rudat, Carsten; Farin, Henner F.; Christoffels, Vincent M.; Kispert, Andreas			Lack of Genetic Interaction between Tbx18 and Tbx2/Tbx20 in Mouse Epicardial Development	PLOS ONE			English	Article							T-BOX GENES; SMOOTH-MUSCLE; EXPRESSION; HEART; TBX20; ORIGIN; CELLS; ROLES; REPRESSION; POPULATION	The epicardium, the outermost layer of the heart, is an essential source of cells and signals for the formation of the cardiac fibrous skeleton and the coronary vasculature, and for the maturation of the myocardium during embryonic development. The molecular factors that control epicardial mobilization and differentiation, and direct the epicardial-myocardial cross-talk are, however, insufficiently understood. The T-box transcription factor gene Tbx18 is specifically expressed in the epicardium of vertebrate embryos. Loss of Tbx18 is dispensable for epicardial development, but may influence coronary vessel maturation. In contrast, over-expression of an activator version of TBX18 severely impairs epicardial development by premature differentiation of epicardial cells into SMCs indicating a potential redundancy of Tbx18 with other repressors of the T-box gene family. Here, we show that Tbx2 and Tbx20 are co-expressed with Tbx18 at different stages of epicardial development. Using a conditional gene targeting approach we find that neither the epicardial loss of Tbx2 nor the combined loss of Tbx2 and Tbx18 affects epicardial development. Similarly, we observed that the heterozygous loss of Tbx20 with and without additional loss of Tbx18 does not impact on epicardial integrity and mobilization in mouse embryos. Thus, Tbx18 does not function redundantly with Tbx2 or Tbx20 in epicardial development.	[Greulich, Franziska; Rudat, Carsten; Farin, Henner F.; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany; [Christoffels, Vincent M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Hannover Medical School; University of Amsterdam; Academic Medical Center Amsterdam	Kispert, A (corresponding author), Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany.	kispert.andreas@mh-hannover.de	Farin, Henner/AAC-2574-2021	Farin, Henner/0000-0003-1558-5366; Greulich, Franziska/0000-0001-8780-8528	Hannover Biomedical Research School (HBRS); German Research Foundation (DFG)	Hannover Biomedical Research School (HBRS); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the Hannover Biomedical Research School (HBRS) to FG, and by grants from the German Research Foundation (DFG) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) and for the Clinical Research Group KFO136 at Hannover Medical School to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanhaanen WTJ, 2011, J CLIN INVEST, V121, P534, DOI 10.1172/JCI44350; Aanhaanen WTJ, 2009, CIRC RES, V104, P1267, DOI 10.1161/CIRCRESAHA.108.192450; Acharya A, 2012, DEVELOPMENT, V139, P2139, DOI 10.1242/dev.079970; Begemann G, 2002, MECH DEVELOP, V114, P137, DOI 10.1016/S0925-4773(02)00040-0; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Cai CL, 2005, DEVELOPMENT, V132, P2475, DOI 10.1242/dev.01832; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Diman NYSG, 2014, CIRC RES, V115, P834, DOI 10.1161/CIRCRESAHA.115.304379; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Goering LM, 2003, P NATL ACAD SCI USA, V100, P9410, DOI 10.1073/pnas.1633548100; Greulich F, 2012, CARDIOVASC RES, V96, P476, DOI 10.1093/cvr/cvs277; Greulich F, 2011, CARDIOVASC RES, V91, P212, DOI 10.1093/cvr/cvr112; Grieskamp T, 2011, CIRC RES, V108, P813, DOI 10.1161/CIRCRESAHA.110.228809; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Haenig B, 2004, DEV GENES EVOL, V214, P407, DOI 10.1007/s00427-004-0415-3; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Jahr M, 2008, DEV DYNAM, V237, P3088, DOI 10.1002/dvdy.21713; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kirk EP, 2007, AM J HUM GENET, V81, P280, DOI 10.1086/519530; KOMIYAMA M, 1987, ANAT EMBRYOL, V176, P183, DOI 10.1007/BF00310051; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Perez-Pomares JM, 2011, CIRC RES, V109, P1429, DOI 10.1161/CIRCRESAHA.111.245589; Masters M, 2014, STEM CELL RES, V13, P683, DOI 10.1016/j.scr.2014.04.007; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Moore AW, 1999, DEVELOPMENT, V126, P1845; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Morgan SM, 1999, BLOOD, V93, P165, DOI 10.1182/blood.V93.1.165.401k25_165_175; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Norden J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045100; Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197; Papaioannou VE, 2014, DEVELOPMENT, V141, P3819, DOI 10.1242/dev.104471; Perez-Pomares JM, 1998, DEV BIOL, V200, P57, DOI 10.1006/dbio.1998.8949; Plageman TF, 2004, J BIOL CHEM, V279, P19026, DOI 10.1074/jbc.M314041200; Rudat C, 2012, CIRC RES, V111, P165, DOI 10.1161/CIRCRESAHA.112.273946; Sakabe NJ, 2012, HUM MOL GENET, V21, P2194, DOI 10.1093/hmg/dds034; Schlueter J, 2012, J CARDIOVASC TRANSL, V5, P641, DOI 10.1007/s12265-012-9377-4; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Singh R, 2012, CELL MOL LIFE SCI, V69, P1377, DOI 10.1007/s00018-011-0884-2; Stennard FA, 2005, DEVELOPMENT, V132, P2451, DOI 10.1242/dev.01799; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Takeuchi JK, 2005, DEVELOPMENT, V132, P2463, DOI 10.1242/dev.01827; Trowe MO, 2010, DEV BIOL, V342, P51, DOI 10.1016/j.ydbio.2010.03.014; VIRAGH S, 1981, ANAT REC, V201, P157, DOI 10.1002/ar.1092010117; Wakker V, 2010, GENESIS, V48, P195, DOI 10.1002/dvg.20596; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Wu SP, 2013, DEV BIOL, V383, P307, DOI 10.1016/j.ydbio.2013.08.019; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	59	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156787	10.1371/journal.pone.0156787	http://dx.doi.org/10.1371/journal.pone.0156787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253890	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700061
J	Cui, A; Quon, G; Rosenberg, AM; Yeung, RSM; Morris, Q				Cui, Ang; Quon, Gerald; Rosenberg, Alan M.; Yeung, Rae S. M.; Morris, Quaid		BBOP Study Consortium	Gene Expression Deconvolution for Uncovering Molecular Signatures in Response to Therapy in Juvenile Idiopathic Arthritis	PLOS ONE			English	Article							TERM-FOLLOW-UP; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; BLOOD; DEFENSINS; CELLS; INTERLEUKIN-8; NEUTROPHILS; PREDICTORS; PEPTIDES	Gene expression-based signatures help identify pathways relevant to diseases and treatments, but are challenging to construct when there is a diversity of disease mechanisms and treatments in patients with complex diseases. To overcome this challenge, we present a new application of an in silico gene expression deconvolution method, ISOpure-S1, and apply it to identify a common gene expression signature corresponding to response to treatment in 33 juvenile idiopathic arthritis (JIA) patients. Using pre-and post-treatment gene expression profiles only, we found a gene expression signature that significantly correlated with a reduction in the number of joints with active arthritis, a measure of clinical outcome (Spearman rho = 0.44, p = 0.040, Bonferroni correction). This signature may be associated with a decrease in T-cells, monocytes, neutrophils and platelets. The products of most differentially expressed genes include known biomarkers for JIA such as major histocompatibility complexes and interleukins, as well as novel biomarkers including a-defensins. This method is readily applicable to expression datasets of other complex diseases to uncover shared mechanistic patterns in heterogeneous samples.	[Cui, Ang] Univ Toronto, Div Engn Sci, Toronto, ON, Canada; [Quon, Gerald; Morris, Quaid] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Rosenberg, Alan M.] Univ Saskatchewan, Dept Pediat, Div Rheumatol, Saskatoon, SK, Canada; [Yeung, Rae S. M.] Hosp Sick Children, Div Rheumatol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Yeung, Rae S. M.] Hosp Sick Children, Div Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Yeung, Rae S. M.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Yeung, Rae S. M.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Yeung, Rae S. M.] Univ Toronto, Dept Med Sci, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Cui, Ang] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Quon, Gerald] Univ Calif Davis, Mol & Cellular Biol, Davis, CA 95616 USA	University of Toronto; University of Toronto; University of Saskatchewan; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Harvard University; Massachusetts Institute of Technology (MIT); University of California System; University of California Davis	Morris, Q (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON, Canada.; Yeung, RSM (corresponding author), Hosp Sick Children, Div Rheumatol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Yeung, RSM (corresponding author), Hosp Sick Children, Div Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Yeung, RSM (corresponding author), Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada.; Yeung, RSM (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Yeung, RSM (corresponding author), Univ Toronto, Dept Med Sci, Toronto, ON, Canada.; Morris, Q (corresponding author), Univ Toronto, Donnelly Ctr, Toronto, ON, Canada.; Morris, Q (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	rae.yeung@sickkids.ca; quaid.morris@utoronto.ca	Morris, Quaid/ABE-8343-2020; Roth, Johannes/AAA-8408-2021	Roth, Johannes/0000-0002-6109-1503; Lang, Bianca/0000-0002-5686-4276; Guzman, Jaime/0000-0001-8977-2581; Rezaei, Elham/0000-0001-6719-8013; Huber, Adam/0000-0002-6616-1689; Quon, Gerald/0000-0002-1716-0153; Turvey, Stuart/0000-0003-1599-1065; Benseler, Susanne Maria/0000-0001-5756-3638; Yeung, Rae/0000-0003-2361-725X; Houghton, Kristin/0000-0001-7174-1007; Cabral, David A./0000-0003-1840-9210; Morris, Quaid/0000-0002-2760-6999	Natural Sciences and Engineering Research Council (NSERC); Early Researcher Award from the Ontario Research Fund; Canadian Institutes of Health Research (CIHR) [82517, QNT-69301]; Canadian Arthritis Network [SRI-IJD-01]; Arthritis Society; University of Saskatchewan; Manitoba Institute of Child Health; McGill University; Memorial University; University of British Columbia; University of Sherbrooke	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Early Researcher Award from the Ontario Research Fund; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network; Arthritis Society; University of Saskatchewan; Manitoba Institute of Child Health; McGill University; Memorial University; University of British Columbia; University of Sherbrooke	This study was funded by a Natural Sciences and Engineering Research Council (NSERC) operating grant and an Early Researcher Award from the Ontario Research Fund to QM, team grants from the Canadian Institutes of Health Research (CIHR grant numbers 82517 and QNT-69301), Canadian Arthritis Network (SRI-IJD-01), and The Arthritis Society. Additional funding was provided by the University of Saskatchewan, Manitoba Institute of Child Health, McGill University, Memorial University, University of British Columbia, and University of Sherbrooke.	Arthritis P-I-R, 1991, ENHANCED PRODUCTION, V87, P463; Axtell RC, 2013, CLIN REV ALLERG IMMU, V44, P114, DOI 10.1007/s12016-011-8296-5; BEAULIEU AD, 1994, ARTHRITIS RHEUM, V37, P855, DOI 10.1002/art.1780370613; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bolen CR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-258; Bovin LF, 2004, IMMUNOL LETT, V93, P217, DOI 10.1016/j.imlet.2004.03.018; BRENNAN FM, 1990, EUR J IMMUNOL, V20, P2141, DOI 10.1002/eji.1830200938; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; ENDRESEN GKM, 1977, SCAND J RHEUMATOL, V6, P237, DOI 10.3109/03009747709095457; Espinosa M, 2012, PEDIATR REV, V33, P303, DOI 10.1542/pir.33-7-303; Flato B, 2003, J RHEUMATOL, V30, P386; Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202; Guzman J, 2014, ANN RHEUM DIS, P1; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jarvis JN, 2009, ARTHRITIS RHEUM-US, V60, P1488, DOI 10.1002/art.24450; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Lillard JW, 1999, P NATL ACAD SCI USA, V96, P651, DOI 10.1073/pnas.96.2.651; Matheson LA, 2008, J IMMUNOL METHODS, V339, P82, DOI 10.1016/j.jim.2008.08.003; Matsushima K, 1989, Cytokine, V1, P2, DOI 10.1016/1043-4666(89)91043-0; Minden K, 2002, ARTHRITIS RHEUM-US, V46, P2392, DOI 10.1002/art.10444; Moncrieffe H, 2010, PHARMACOGENET GENOM, V20, P665, DOI 10.1097/FPC.0b013e32833f2cd0; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Oen K, 2002, BEST PRACT RES CL RH, V16, P347, DOI 10.1053/berh.2002.0233; Packham JC, 2002, RHEUMATOLOGY, V41, P1428, DOI 10.1093/rheumatology/41.12.1428; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Petty RE, 2004, J RHEUMATOL, V31, P390; Prakken B, 2011, LANCET, V377, P2138, DOI 10.1016/S0140-6736(11)60244-4; Qiao WL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002838; Quon G, 2013, GENOME MED, V5, DOI 10.1186/gm433; Quon G, 2009, BIOINFORMATICS, V25, P2882, DOI 10.1093/bioinformatics/btp378; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Skov L, 2008, J IMMUNOL, V181, P669, DOI 10.4049/jimmunol.181.1.669; Vaschetto R, 2007, J LEUKOCYTE BIOL, V81, P1022, DOI 10.1189/jlb.0706435; Vordenbaumen S, 2011, POLYMERS-BASEL, V3, P1268, DOI 10.3390/polym3031268; Zak M, 2000, RHEUMATOLOGY, V39, P198, DOI 10.1093/rheumatology/39.2.198	36	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156055	10.1371/journal.pone.0156055	http://dx.doi.org/10.1371/journal.pone.0156055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244050	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100013
J	Hedrick, T; Danskin, B; Larsen, RS; Ollerenshaw, D; Groblewski, P; Valley, M; Olsen, S; Waters, J				Hedrick, Tristan; Danskin, Bethanny; Larsen, Rylan S.; Ollerenshaw, Doug; Groblewski, Peter; Valley, Matthew; Olsen, Shawn; Waters, Jack			Characterization of Channelrhodopsin and Archaerhodopsin in Cholinergic Neurons of Cre-Lox Transgenic Mice	PLOS ONE			English	Article							ACTIVATION; MODULATION; RECEPTORS	The study of cholinergic signaling in the mammalian CNS has been greatly facilitated by the advent of mouse lines that permit the expression of reporter proteins, such as opsins, in cholinergic neurons. However, the expression of opsins could potentially perturb the physiology of opsin-expressing cholinergic neurons or mouse behavior. Indeed, the published literature includes examples of cellular and behavioral perturbations in preparations designed to drive expression of opsins in cholinergic neurons. Here we investigate expression of opsins, cellular physiology of cholinergic neurons and behavior in two mouse lines, in which channelrhodopsin-2 (ChR2) and archaerhodopsin (Arch) are expressed in cholinergic neurons using the Cre-lox system. The two mouse lines were generated by crossing ChAT-Cre mice with Cre-dependent reporter lines Ai32(ChR2-YFP) and Ai35(Arch-GFP). In most mice from these crosses, we observed expression of ChR2 and Arch in only cholinergic neurons in the basal forebrain and in other putative cholinergic neurons in the forebrain. In small numbers of mice, off-target expression occurred, in which fluorescence did not appear limited to cholinergic neurons. Whole-cell recordings from fluorescently-labeled basal forebrain neurons revealed that both proteins were functional, driving depolarization (ChR2) or hyperpolarization (Arch) upon illumination, with little effect on passive membrane properties, spiking pattern or spike waveform. Finally, performance on a behavioral discrimination task was comparable to that of wild-type mice. Our results indicate that ChAT-Cre x reporter line crosses provide a simple, effective resource for driving indicator and opsin expression in cholinergic neurons with few adverse consequences and are therefore an valuable resource for studying the cholinergic system.	[Hedrick, Tristan] Northwestern Univ, 303 E Chicago Ave, Chicago, IL 60611 USA; [Danskin, Bethanny; Larsen, Rylan S.; Ollerenshaw, Doug; Groblewski, Peter; Valley, Matthew; Olsen, Shawn; Waters, Jack] Allen Inst Brain Sci, 551 N 34th St, Seattle, WA 98103 USA	Northwestern University; Allen Institute for Brain Science	Waters, J (corresponding author), Allen Inst Brain Sci, 551 N 34th St, Seattle, WA 98103 USA.	jackw@alleninstitute.org		Danskin, Bethanny/0000-0002-4832-1220; Valley, Matthew/0000-0002-7204-5457; Larsen, Rylan/0000-0002-7136-1175	Allen Institute for Brain Science; National Institute of Mental Health [5T32MH067564]; National Institute of Neurological Disorders and Stroke [NS078067]; Allen Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078067] Funding Source: NIH RePORTER	Allen Institute for Brain Science; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Allen Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the Allen Institute for Brain Science; National Institute of Mental Health award number 5T32MH067564 to TH; National Institute of Neurological Disorders and Stroke award number NS078067 to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful for the hard work and technical support of the many staff members in the Allen Institute. We also thank A. Nagy (Mount Sinai Hospital in Toronto) for providing the G4 ES cell line, used in the development of the Ai32D and Ai35D mouse lines. Funding was provided by the Allen Institute for Brain Science, award number 5T32MH067564 from the National Institute of Mental Health and award number NS078067 from the National Institute of Neurological Disorders and Stroke. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of health and National Institute of Neurological Disorders and Stroke. We thank the Allen Institute founders, Paul G Allen and Jody Allen, for their vision, encouragement and support.	Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Eiden LE, 1998, J NEUROCHEM, V70, P2227; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Hay YA, 2016, CEREB CORTEX, V26, P2549, DOI 10.1093/cercor/bhv085; Hedrick T, 2015, J NEUROPHYSIOL, V113, P2195, DOI 10.1152/jn.00716.2014; Hedrick T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011046; Holler T, 1996, NEUROSCI LETT, V212, P107, DOI 10.1016/0304-3940(96)12808-1; Kalmbach A, 2014, J NEUROPHYSIOL, V111, P258, DOI 10.1152/jn.00244.2013; Kalmbach A, 2012, J NEUROPHYSIOL, V107, P2008, DOI 10.1152/jn.00870.2011; Kolisnyk B, 2013, J NEUROSCI, V33, P10427, DOI 10.1523/JNEUROSCI.0395-13.2013; Luchicchi Antonio, 2014, Front Synaptic Neurosci, V6, P24, DOI 10.3389/fnsyn.2014.00024; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Pinto L, 2013, NAT NEUROSCI, V16, P1857, DOI 10.1038/nn.3552; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Saunders A, 2015, ELIFE, V4, DOI 10.7554/eLife.06412; von Engelhardt J, 2007, J NEUROSCI, V27, P5633, DOI 10.1523/JNEUROSCI.4647-06.2007	18	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156596	10.1371/journal.pone.0156596	http://dx.doi.org/10.1371/journal.pone.0156596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243816	gold, Green Submitted, Green Published			2022-12-26	WOS:000377146100051
J	Xu, YB; Guo, JY; Wang, LL; Jiang, R; Jin, XL; Liu, J; Fan, SD; Quan, CS; Ha, NC				Xu, Yongbin; Guo, Jianyun; Wang, Lulu; Jiang, Rui; Jin, Xiaoling; Liu, Jing; Fan, Shengdi; Quan, Chun-Shan; Ha, Nam-Chul			The Crystal Structure of the YknZ Extracellular Domain of ABC Transporter YknWXYZ from Bacillus amyloliquefaciens	PLOS ONE			English	Article							ESCHERICHIA-COLI; EFFLUX PUMP; SUBTILIS; MODEL; MACB; TOPOLOGY; TOOLS	Bacillus possesses the peptide toxin Sporulation-Delaying Protein (SDP), which can kill cells within a biofilm to support continued growth, thereby delaying the onset of biofilm sporulation. The four-component transporter YknWXYZ acts as a major SDP efflux pump to protect cells against the endogenous SDP toxin, for which YknYZ is a non-canonical ATP-binding cassette (ABC)-type transporter. YknYZ consists of the following two components: (1) an individual protein (YknY) and (2) a respective permease (YknZ). To date, the crystal structure, molecular function, and mechanism of action of the integral membrane protein YknZ remain to be elucidated. In this study, to characterize the structural and biochemical roles of YknZ in the functional assembly of YknWXYZ, we predicted and overexpressed the YknZ extracellular domain. We determined the crystal structure of B. amyloliquefaciens YknZ at a resolution of 2.0 angstrom. The structure revealed that the YknZ extracellular region exhibits significant structural similarity with the MacB periplasmic domain, which is a non-canonical ABC-type transporter in the tripartite macrolide-specific efflux pump in Gram-negative bacteria. We also found that the YknZ extracellular domain can directly bind to an extracellular component of YknX. This structural and biochemical study provides insights into the assembly of YknWXYZ, which may be relevant to understanding cannibalistic peptide toxin resistance in Bacillus and controlling bacterial growth.	[Xu, Yongbin; Guo, Jianyun; Jin, Xiaoling; Liu, Jing; Fan, Shengdi; Quan, Chun-Shan] Dalian Nationalities Univ, Coll Life Sci, Dept Bioengn, Dalian 116600, Peoples R China; [Xu, Yongbin] Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, Dalian 116023, Liaoning, Peoples R China; [Wang, Lulu] Dalian Polytech Univ, Sch Biol Engn, Dalian 116034, Liaoning, Peoples R China; [Jiang, Rui] Northeastern Univ, Coll Life & Hlth Sci, Shenyang 110004, Liaoning, Peoples R China; [Ha, Nam-Chul] Seoul Natl Univ, Dept Agr Biotechnol, Coll Agr & Life Sci, Seoul 151742, South Korea	Dalian Minzu University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Dalian Polytechnic University; Northeastern University - China; Seoul National University (SNU)	Xu, YB (corresponding author), Dalian Nationalities Univ, Coll Life Sci, Dept Bioengn, Dalian 116600, Peoples R China.; Xu, YB (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, Lab Biomed Mat Engn, Dalian 116023, Liaoning, Peoples R China.	yongbinxu@dlnu.edu.cn			National Natural Science Foundation of China [31200556, 21402024, 21272031]; China Postdoctoral Science Foundation [2013M540229]; Fundamental Research Funds for the Central Universities [DC201502020203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 31200556 to Y. Xu, Grant No. 21402024 to R. Jiang, and Grant No. 21272031 to C.S. Quan), the China Postdoctoral Science Foundation (Grant No. 2013M540229 to Y. Xu) and the Fundamental Research Funds for the Central Universities (Grant No. DC201502020203 to Y. Xu). This work made use of the BL17U beamline at the Shanghai Synchrotron Radiation Facility (SSRF) (Shanghai, China).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DeLano WL, 2004, ABSTR PAP AM CHEM S, V228, pU313; Ellermeier CD, 2006, GENE DEV, V20, P1911, DOI 10.1101/gad.1440606; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kobayashi N, 2003, FEBS LETT, V546, P241, DOI 10.1016/S0014-5793(03)00579-9; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lamsa A, 2012, MOL MICROBIOL, V84, P486, DOI 10.1111/j.1365-2958.2012.08038.x; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; Liu WT, 2010, P NATL ACAD SCI USA, V107, P16286, DOI 10.1073/pnas.1008368107; Long F, 2010, NATURE, V467, P484, DOI 10.1038/nature09395; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Song S, 2015, J MICROBIOL, V53, P355, DOI 10.1007/s12275-015-5248-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Xu Y, 2009, BIOCHEMISTRY-US, V48, P5218, DOI 10.1021/bi900415t; Yamada Y, 2012, J BACTERIOL, V194, P4386, DOI 10.1128/JB.00223-12; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Zgurskaya HI, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00100; Zgurskaya HI, 2009, BBA-PROTEINS PROTEOM, V1794, P794, DOI 10.1016/j.bbapap.2008.10.010	24	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155846	10.1371/journal.pone.0155846	http://dx.doi.org/10.1371/journal.pone.0155846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243566	gold, Green Submitted, Green Published			2022-12-26	WOS:000377146100009
J	Li, K; Dan, Z; Gesang, LB; Wang, H; Zhou, YJ; Du, YL; Ren, Y; Shi, YX; Nie, YQ				Li, Kang; Dan, Zeng; Gesang, Luobu; Wang, Hong; Zhou, Yongjian; Du, Yanlei; Ren, Yi; Shi, Yixiang; Nie, Yuqiang			Comparative Analysis of Gut Microbiota of Native Tibetan and Han Populations Living at Different Altitudes	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; DIET; COMMUNITY; BUTYRATE; CHILDREN; CANCER; AGE	The factors driving the composition of gut microbiota are still only partly understood but appear to include environmental, cultural, and genetic factors. In order to obtain more insight into the relative importance of these factors, we analyzed the microbiome composition in subjects of Tibetan or Han descent living at different altitudes. DNA was isolated from stool samples. Using polymerase chain reaction methodology, the 16S rRNA V1-V3 regions were amplified and the sequence information was analyzed by principal coordinates analysis and Lefse analyses. Contrasting the Tibetan and Han populations both living at the 3600 m altitude, we found that the Tibetan microbiome is characterized by a relative abundance of Prevotella whereas the Han stool was enriched in Bacteroides. Comparing the microbiome of Han stool obtained from populations living at different altitudes revealed a more energy efficient flora in samples from those living at higher altitude relative to their lower-altitude counterparts. Comparison of the stool microbiome of Tibetan herders living at 4800 m to rural Tibetans living at 3600 m altitude shows that the former have a flora enriched in butyrate-producing bacteria, possibly in response to the harsher environment that these herders face. Thus, the study shows that both altitude and genetic/cultural background have a significant influence on microbiome composition, and it represents the first attempt to compare stool microbiota of Tibetan and Han populations in relation to altitude.	[Li, Kang; Wang, Hong; Zhou, Yongjian; Du, Yanlei; Nie, Yuqiang] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Gastroenterol, Guangzhou 510180, Guangdong, Peoples R China; [Li, Kang; Dan, Zeng; Gesang, Luobu] Peoples Hosp Tibet Autonomous Reg, High Altitude Med Res Inst, Lhasa 850000, Peoples R China; [Ren, Yi; Shi, Yixiang] Shanghai Major Biopharm Technol Co Ltd, Shanghai 201203, Peoples R China	Guangzhou Medical University	Nie, YQ (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Gastroenterol, Guangzhou 510180, Guangdong, Peoples R China.	nieyqiang@sina.com			National "Twelfth Five-Year" Plan for Science & Technology Support of China [2013BAI05B04]; Natural Science Foundation of Guangdong Province, China [2014A030313679]; Key project for Natural Science Foundation in Tibet Autonomous Region, China	National "Twelfth Five-Year" Plan for Science & Technology Support of China; Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Key project for Natural Science Foundation in Tibet Autonomous Region, China	This study was supported by a grant from the National "Twelfth Five-Year" Plan for Science & Technology Support of China (2013BAI05B04), the Natural Science Foundation of Guangdong Province, China (2014A030313679), and the Key project for Natural Science Foundation in Tibet Autonomous Region, China (2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Dan Z, 2013, WORLD CHINESE J DIGE; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Konstantinov SR, 2013, TRENDS MOL MED, V19, P454, DOI 10.1016/j.molmed.2013.06.002; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lai-Yu K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093631, DOI 10.1371/J0URNAL.P0NE.0093631]; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Leon-Velarde F, 2005, HIGH ALT MED BIOL, V6, P147, DOI 10.1089/ham.2005.6.147; Liu Z., 2012, CHINA TIBETOLOGY, V1, P92; Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Moeller AH, 2014, P NATL ACAD SCI USA, V111, P16431, DOI 10.1073/pnas.1419136111; Nakayama J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08397; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Park Y, 2005, JAMA-J AM MED ASSOC, V294, P2849, DOI 10.1001/jama.294.22.2849; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Spaan M, 2013, ANTIVIR RES, V98, P469, DOI 10.1016/j.antiviral.2013.04.003; Toivanen P, 2003, ANN RHEUM DIS, V62, P807, DOI 10.1136/ard.62.9.807; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; vanGylswyk NO, 1996, INT J SYST BACTERIOL, V46, P559, DOI 10.1099/00207713-46-2-559; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129; Zhang J, 2015, ISME J, V9, P1979, DOI 10.1038/ismej.2015.11	41	48	57	6	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155863	10.1371/journal.pone.0155863	http://dx.doi.org/10.1371/journal.pone.0155863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232599	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000008
J	Gallastegui, E; Bicer, A; Orlando, S; Besson, A; Pujol, MJ; Bachs, O				Gallastegui, E.; Bicer, A.; Orlando, S.; Besson, A.; Pujol, M. J.; Bachs, O.			p27(Kip1) represses the Pitx2-mediated expression of p21(Cip1) and regulates DNA replication during cell cycle progression	ONCOGENE			English	Article							CDK INHIBITORS; PITX2; ACTIVATION; P21; DIFFERENTIATION; PROLIFERATION; REQUIREMENT; QUIESCENCE; RELEVANCE; MIGRATION	The tumor suppressor p21 regulates cell cycle progression and peaks at mid/late G1. However, the mechanisms regulating its expression during cell cycle are poorly understood. We found that embryonic fibroblasts from p27 null mice at early passages progress slowly through the cell cycle. These cells present an elevated basal expression of p21 suggesting that p27 participates to its repression. Mechanistically, we found that p27 represses the expression of Pitx2 (an activator of p21 expression) by associating with the ASE- regulatory region of this gene together with an E2F4 repressive complex. Furthermore, we found that Pitx2 binds to the p21 promoter and induces its transcription. Finally, silencing Pitx2 or p21 in proliferating cells accelerates DNA replication and cell cycle progression. Collectively, these results demonstrate an unprecedented connection between p27, Pitx2 and p21 relevant for the regulation of cell cycle progression and cancer and for understanding human pathologies associated with p27 germline mutations.	[Gallastegui, E.; Bicer, A.; Orlando, S.; Pujol, M. J.; Bachs, O.] Univ Barcelona, IDIBAPS, Dept Cell Biol Immunol & Neurosci, Barcelona, Spain; [Besson, A.] INSERM, UMR1037, Canc Res Ctr Toulouse, Toulouse, France; [Besson, A.] Univ Toulouse, Toulouse, France; [Besson, A.] CNRS ERL5294, Toulouse, France	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Bachs, O (corresponding author), Univ Barcelona, Biomed, Casanova 143, E-08036 Barcelona, Spain.	obachs@ub.edu	Besson, Arnaud/J-6254-2014; Bicer, Atilla/AAA-6738-2019; Orlando, Serena/AAA-7963-2019	Besson, Arnaud/0000-0002-9599-3943; Bicer, Atilla/0000-0003-4032-6534; Gallastegui Calvache, Edurne/0000-0003-0768-8648	Ministerio de Economia y Competitividad (MINECO) [SAF2012-38078]; Instituto de Salud Carlos III [RD12/0036/0054]; Fondation ARC pour la Recherche sur le Cancer; Ligue Nationale Contre le Cancer; Institut National du Cancer	Ministerio de Economia y Competitividad (MINECO); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France)	We would like to thank to Dr Hiroshi Hamada, Dr Chrissa Kioussi, Dr Charles P Emerson and Dr Nobuko Hagiwara for the kind gift of Pitx2-ASE luciferase vector, the expression vector for Pitx2, the expression vector for Zic1 and the expression vector for Sox6, respectively. This work was supported by grants from the Ministerio de Economia y Competitividad (MINECO) SAF2012-38078 and from the Instituto de Salud Carlos III RD12/0036/0054. AB is supported by grants from the Fondation ARC pour la Recherche sur le Cancer, Ligue Nationale Contre le Cancer and Institut National du Cancer. The data set has been deposited in ArrayExpress accession number E-MTAB-2790.	Aguilera C, 2004, P NATL ACAD SCI USA, V101, P16537, DOI 10.1073/pnas.0404429101; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Cao HJ, 2010, DEV BIOL, V347, P289, DOI 10.1016/j.ydbio.2010.08.031; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; de la Grange P, 2005, NUCLEIC ACIDS RES, V33, P4276, DOI 10.1093/nar/gki738; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Fung FKC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037076; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gallastegui E, 2011, J VIROL, V85, P3187, DOI 10.1128/JVI.01920-10; Heldring N, 2012, CNS NEUROL DISORD-DR, V11, P884, DOI 10.2174/1871527311201070884; Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10; Houtmeyers R, 2013, CELL MOL LIFE SCI, V70, P3791, DOI 10.1007/s00018-013-1285-5; Huang Y, 2010, CELL CYCLE, V9, P1333, DOI 10.4161/cc.9.7.11126; Jaime M, 2002, HEPATOLOGY, V35, P1063, DOI 10.1053/jhep.2002.32678; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; Kwon YH, 2002, J BIOL CHEM, V277, P41417, DOI 10.1074/jbc.M203388200; Li H, 2012, CELL STEM CELL, V11, P845, DOI 10.1016/j.stem.2012.09.014; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Liu Y, 2013, MOL CELL BIOCHEM, V384, P221, DOI 10.1007/s11010-013-1801-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malumbres M, 2011, PHYSIOL REV, V91, P973, DOI 10.1152/physrev.00025.2010; Meeh PF, 2009, NEOPLASIA, V11, P1074, DOI 10.1593/neo.09808; Montavon T, 2014, SEMIN CELL DEV BIOL, V34, P76, DOI 10.1016/j.semcdb.2014.06.005; Moreno CS, 2005, CANCER RES, V65, P10214, DOI 10.1158/0008-5472.CAN-05-0884; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Orlando S, 2015, NUCLEIC ACIDS RES, V43, P6860, DOI 10.1093/nar/gkv593; Pippa R, 2012, ONCOGENE, V31, P4207, DOI 10.1038/onc.2011.582; SALA A, 1994, CANCER RES, V54, P1402; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Starostina NG, 2012, TRENDS CELL BIOL, V22, P33, DOI 10.1016/j.tcb.2011.10.004	37	5	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 19	2017	36	3					350	361		10.1038/onc.2016.200	http://dx.doi.org/10.1038/onc.2016.200			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IB	27270438				2022-12-26	WOS:000394166000005
J	Tran, TTT; Postal, BG; Demignot, S; Ribeiro, A; Osinski, C; de Barros, JPP; Blachnio-Zabielska, A; Leturque, A; Rousset, M; Ferre, P; Hajduch, E; Carriere, V				Tran, Thi Thu Trang; Postal, Barbara Graziela; Demignot, Sylvie; Ribeiro, Agnes; Osinski, Celine; de Barros, Jean-Paul Pais; Blachnio-Zabielska, Agnieszka; Leturque, Armelle; Rousset, Monique; Ferre, Pascal; Hajduch, Eric; Carriere, Veronique			Short Term Palmitate Supply Impairs Intestinal Insulin Signaling via Ceramide Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; APOLIPOPROTEIN B48-CONTAINING LIPOPROTEINS; SKELETAL-MUSCLE CELLS; FREE FATTY-ACIDS; CACO-2 CELLS; SPHINGOLIPID METABOLISM; CHYLOMICRON PRODUCTION; ANIMAL-MODEL; SERINE PALMITOYLTRANSFERASE; NONFASTING TRIGLYCERIDES	The worldwide prevalence of metabolic diseases is increasing, and there are global recommendations to limit consumption of certain nutrients, especially saturated lipids. Insulin resistance, a common trait occurring in obesity and type 2 diabetes, is associated with intestinal lipoprotein overproduction. However, the mechanisms by which the intestine develops insulin resistance in response to lipid overload remain unknown. Here, we show that insulin inhibits triglyceride secretion and intestinal microsomal triglyceride transfer protein expression in vivo in healthy mice force-fed monounsaturated fatty acid-rich olive oil but not in mice force-fed saturated fatty acid-rich palm oil. Moreover, when mouse intestine and human Caco-2/TC7 enterocytes were treated with the saturated fatty acid, palmitic acid, the insulin-signaling pathway was impaired. We show that palmitic acid or palm oil increases ceramide production in intestinal cells and that treatment with a ceramide analogue partially reproduces the effects of palmitic acid on insulin signaling. In Caco-2/TC7 enterocytes, ceramide effects on insulin-dependent AKT phosphorylation are mediated by protein kinase C but not by protein phosphatase 2A. Finally, inhibiting de novo ceramide synthesis improves the response of palmitic acid-treated Caco-2/TC7 enterocytes to insulin. These results demonstrate that a palmitic acid-ceramide pathway accounts for impaired intestinal insulin sensitivity, which occurs within several hours following initial lipid exposure.	[Tran, Thi Thu Trang; Postal, Barbara Graziela; Demignot, Sylvie; Ribeiro, Agnes; Osinski, Celine; Leturque, Armelle; Rousset, Monique; Carriere, Veronique] Univ Paris Diderot, Univ Paris Sci & Lettres,Inst Cardiometab & Nutr, Sorbonne Univ,Univ Paris Descartes,Sorbonne Paris, CNRS,Ctr Rech Cordeliers,UPMC Univ Paris 06,INSER, F-75006 Paris, France; [de Barros, Jean-Paul Pais] Univ Bourgogne, INSERM UMR866, F-21070 Dijon, France; [Blachnio-Zabielska, Agnieszka] Med Univ Bialystok, PL-15089 Bialystok, Poland; [Ferre, Pascal; Hajduch, Eric] Univ Paris Diderot, Univ Paris Descartes,Ctr Rech Cordeliers, Sorbonne Paris Cite,Inst Cardiometab & Nutr ICAN, INSERM UMRS 1138,Sorbonne Univ,UPMC Univ Paris 06, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Universite Paris Cite; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Medical University of Bialystok; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Carriere, V (corresponding author), Ctr Rech Cordeliers, Equipe Armelle Leturque, UMRS U1138, 15 Rue Ecole Med, F-75006 Paris, France.	veronique.carriere@crc.jussieu.fr	Blachnio-Zabielsk, Agnieszka U/A-4879-2018; Leturque, Armelle/Q-9437-2017; Carrière, Véronique/AAQ-5027-2021; Ferré, Pascal/K-1250-2013; Ribeiro, Agnès/Q-9702-2017; Hajduch, Eric/B-7332-2008	Blachnio-Zabielsk, Agnieszka U/0000-0002-8055-0576; Leturque, Armelle/0000-0001-6570-6387; Carrière, Véronique/0000-0002-6263-0847; Ferré, Pascal/0000-0003-0115-7045; Ribeiro, Agnès/0000-0003-2063-6084; Hajduch, Eric/0000-0002-0125-7751; PAIS DE BARROS, Jean-Paul/0000-0002-5124-2283; Demignot, Sylvie/0000-0001-7149-1992	Institute of Cardiometabolism and Nutrition; Fondation pour la Recherche Medicale (Equipe FRM) [DEQ20140329504]	Institute of Cardiometabolism and Nutrition; Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale)	This work was supported in part by the Institute of Cardiometabolism and Nutrition and by Fondation pour la Recherche Medicale (Equipe FRM DEQ20140329504). The authors declare that they have no conflicts of interest with the contents of this article.	Adeli K, 2008, CURR OPIN LIPIDOL, V19, P221, DOI 10.1097/MOL.0b013e3282ffaf82; Allister EM, 2005, DIABETES, V54, P1676, DOI 10.2337/diabetes.54.6.1676; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Blouin CM, 2010, DIABETES, V59, P600, DOI 10.2337/db09-0897; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Castro BM, 2014, PROG LIPID RES, V54, P53, DOI 10.1016/j.plipres.2014.01.004; Chateau D, 2005, J CELL PHYSIOL, V202, P767, DOI 10.1002/jcp.20173; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Dash S, 2015, ANNU REV NUTR, V35, P265, DOI 10.1146/annurev-nutr-071714-034338; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; Duez H, 2008, ATHEROSCLEROSIS SUPP, V9, P33, DOI 10.1016/j.atherosclerosissup.2008.05.013; Duez H, 2006, ARTERIOSCL THROM VAS, V26, P1357, DOI 10.1161/01.ATV.0000222015.76038.14; Federico LM, 2006, DIABETES, V55, P1316, DOI 10.2337/db04-1084; Frochot V, 2012, AM J PHYSIOL-GASTR L, V302, pG1253, DOI 10.1152/ajpgi.00329.2011; Guo SD, 2014, J ENDOCRINOL, V220, pT1, DOI 10.1530/JOE-13-0327; Haas ME, 2013, TRENDS ENDOCRIN MET, V24, P391, DOI [10.101, 10.1016/j.tem.2013.04.001]; Haidari M, 2002, J BIOL CHEM, V277, P31646, DOI 10.1074/jbc.M200544200; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hassan RH, 2014, WORLD J DIABETES, V5, P244, DOI 10.4239/wjd.v5.i3.244; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hojjati MR, 2005, J BIOL CHEM, V280, P10284, DOI 10.1074/jbc.M412348200; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hooper AJ, 2015, CIRC RES, V116, P193, DOI 10.1161/CIRCRESAHA.116.304637; Hsieh J, 2008, ATHEROSCLEROSIS SUPP, V9, P7, DOI 10.1016/j.atherosclerosissup.2008.05.011; Huang H, 2011, OBESITY, V19, P2235, DOI 10.1038/oby.2011.107; Hussain MM, 2011, CLIN LIPIDOL, V6, P293, DOI 10.2217/CLP.11.21; Larsen PJ, 2014, MOL METAB, V3, P252, DOI 10.1016/j.molmet.2014.01.011; Leung N, 2004, ATHEROSCLEROSIS, V174, P235, DOI 10.1016/j.atherosclerosis.2004.02.005; Levy E, 1996, FEBS LETT, V393, P253, DOI 10.1016/0014-5793(96)00896-4; LEWIS GF, 1995, J CLIN INVEST, V95, P158, DOI 10.1172/JCI117633; LOIRDIGHI N, 1992, BIOCHIM BIOPHYS ACTA, V1175, P100, DOI 10.1016/0167-4889(92)90015-4; Marandi S, 2001, AM J PHYSIOL-GASTR L, V280, pG229, DOI 10.1152/ajpgi.2001.280.2.G229; Mathur SN, 1997, J LIPID RES, V38, P61; Nogueira JP, 2012, ARTERIOSCL THROM VAS, V32, P1039, DOI 10.1161/ATVBAHA.111.242073; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Padilla N, 2014, ARTERIOSCL THROM VAS, V34, P2330, DOI 10.1161/ATVBAHA.114.303849; Pauquai T, 2006, BIOCHEM J, V395, P393, DOI 10.1042/BJ20051359; Pavlic M, 2010, DIABETES, V59, P580, DOI 10.2337/db09-1297; Phillips Catherine, 2002, Int J Exp Diabetes Res, V3, P171; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Qin BL, 2007, DIABETES, V56, P450, DOI 10.2337/db06-0518; Reis A, 2013, J LIPID RES, V54, P1812, DOI 10.1194/jlr.M034330; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Uchida Y, 2014, BBA-MOL CELL BIOL L, V1841, P453, DOI 10.1016/j.bbalip.2013.09.003; Ussher JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037703; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; van Greevenbroek MMJ, 1996, ATHEROSCLEROSIS, V121, P139, DOI 10.1016/0021-9150(95)05712-9; Veilleux A, 2014, ARTERIOSCL THROM VAS, V34, P644, DOI 10.1161/ATVBAHA.113.302993	52	24	24	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16328	16338		10.1074/jbc.M115.709626	http://dx.doi.org/10.1074/jbc.M115.709626			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27255710	Green Published, hybrid			2022-12-26	WOS:000380585400036
J	Viswanathan, R; True, JD; Auble, DT				Viswanathan, Ramya; True, Jason D.; Auble, David T.			Molecular Mechanism of Mot1, a TATA-binding Protein (TBP)-DNA Dissociating Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; X-RAY STRUCTURES; DNA-BINDING; PREINITIATION COMPLEX; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURES; IN-VIVO; CHROMATIN INTERACTION; SWI2/SNF2 ATPASE; FAMILY-MEMBER	The essential Saccharomyces cerevisiae ATPase Mot1 globally regulates transcription by impacting the genomic distribution and activity of the TATA-binding protein (TBP). In vitro, Mot1 forms a ternary complex with TBP and DNA and can use ATP hydrolysis to dissociate the TBP-DNA complex. Prior work suggested an interaction between the ATPase domain and a functionally important segment of DNA flanking the TATA sequence. However, how ATP hydrolysis facilitates removal of TBP from DNA is not well understood, and several models have been proposed. To gain insight into the Mot1 mechanism, we dissected the role of the flanking DNA segment by biochemical analysis of complexes formed using DNAs with short single-stranded gaps. In parallel, we used a DNA tethered cleavage approach to map regions of Mot1 in proximity to the DNA under different conditions. Our results define non-equivalent roles for bases within a broad segment of flanking DNA required for Mot1 action. Moreover, we present biochemical evidence for two distinct conformations of the Mot1 ATPase, the detection of which can be modulated by ATP analogs as well as DNA sequence flanking the TATA sequence. We also show using purified complexes that Mot1 dissociation of a stable, high affinity TBP-DNA interaction is surprisingly inefficient, suggesting how other transcription factors that bind to TBP may compete with Mot1. Taken together, these results suggest that TBP-DNA affinity as well as other aspects of promoter sequence influence Mot1 function in vivo.	[Viswanathan, Ramya; True, Jason D.; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Auble, DT (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	auble@virginia.edu	Viswanathan, Ramya/L-5935-2019		National Institutes of Health [GM55763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763, T32GM008136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM55763 (to D. T. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamkewicz JI, 2000, J BIOL CHEM, V275, P21158, DOI 10.1074/jbc.M002639200; Adamkewicz JI, 2001, J BIOL CHEM, V276, P11883, DOI 10.1074/jbc.M010665200; Andrau JC, 2002, EMBO J, V21, P5173, DOI 10.1093/emboj/cdf485; Astumian RD, 2010, BIOPHYS J, V98, P2401, DOI 10.1016/j.bpj.2010.02.040; Auble DT, 1999, MOL CELL BIOL, V19, P412; AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Auble DT, 1997, MOL CELL BIOL, V17, P4842, DOI 10.1128/MCB.17.8.4842; Butryn A., 2015, ELIFE, V4; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chicca JJ, 1998, MOL CELL BIOL, V18, P1701, DOI 10.1128/MCB.18.3.1701; Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Darst RP, 2001, EMBO J, V20, P2028, DOI 10.1093/emboj/20.8.2028; Dasgupta A, 2002, P NATL ACAD SCI USA, V99, P2666, DOI 10.1073/pnas.052397899; de Graaf P, 2010, J CELL SCI, V123, P2663, DOI 10.1242/jcs.064097; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Geisberg JV, 2004, MOL CELL, V14, P479, DOI 10.1016/j.molcel.2004.05.003; Geisberg JV, 2002, MOL CELL BIOL, V22, P8122, DOI 10.1128/MCB.22.23.8122-8134.2002; Geisberg JV, 2001, MOL CELL BIOL, V21, P2736, DOI 10.1128/MCB.21.8.2736-2742.2001; GORBALENYA AE, 1988, FEBS LETT, V235, P16, DOI 10.1016/0014-5793(88)81226-2; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Gupta S, 2007, BIOCHEMISTRY-US, V46, P9886, DOI 10.1021/bi7003608; Hauk G, 2011, CURR OPIN STRUC BIOL, V21, P719, DOI 10.1016/j.sbi.2011.09.003; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Hopfner KP, 2012, CURR OPIN STRUC BIOL, V22, P225, DOI 10.1016/j.sbi.2012.02.007; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Klejman MP, 2004, MOL CELL BIOL, V24, P10072, DOI 10.1128/MCB.24.22.10072-10082.2004; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; Lewis R, 2008, NUCLEIC ACIDS RES, V36, P1881, DOI 10.1093/nar/gkn040; Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106; Ludwigsen J, 2013, EMBO REP, V14, P1092, DOI 10.1038/embor.2013.160; MARUTA S, 1993, J BIOL CHEM, V268, P7093; Miller G, 2006, NAT STRUCT MOL BIOL, V13, P603, DOI 10.1038/nsmb1117; Montgomerie S, 2008, NUCLEIC ACIDS RES, V36, pW202, DOI 10.1093/nar/gkn255; Moyle-Heyrman G, 2012, J BIOL CHEM, V287, P9002, DOI 10.1074/jbc.M111.333484; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Mukherjee Srabani, 2003, Biological Procedures Online, V5, P78, DOI 10.1251/bpo49; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Nodelman IM, 2013, EMBO REP, V14, P1098, DOI 10.1038/embor.2013.158; Pereira LA, 2001, MOL CELL BIOL, V21, P7523, DOI 10.1128/MCB.21.21.7523-7534.2001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poorey K, 2013, SCIENCE, V342, P369, DOI 10.1126/science.1242369; Poorey K, 2010, GENOME RES, V20, P1679, DOI 10.1101/gr.109504.110; Rana TM, 1990, BIOCONJUGATE CHEM, V1, P357, DOI 10.1021/bc00005a010; REDDY P, 1991, CELL, V65, P349, DOI 10.1016/0092-8674(91)90168-X; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Schmidt BD, 2002, BIOCHEMISTRY-US, V41, P4186, DOI 10.1021/bi015582r; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Sprouse RO, 2008, J BIOL CHEM, V283, P24935, DOI 10.1074/jbc.M803749200; Sprouse RO, 2006, EMBO J, V25, P1492, DOI 10.1038/sj.emboj.7601050; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Tora L, 2010, TRENDS BIOCHEM SCI, V35, P309, DOI 10.1016/j.tibs.2010.01.007; van Werven FJ, 2008, GENE DEV, V22, P2359, DOI 10.1101/gad.1682308; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Viswanathan R, 2011, BBA-GENE REGUL MECH, V1809, P488, DOI 10.1016/j.bbagrm.2011.05.012; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Wollmann P, 2011, NATURE, V475, P403, DOI 10.1038/nature10215; Zentner GE, 2013, MOL CELL BIOL, V33, P4996, DOI 10.1128/MCB.01218-13; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	68	4	5	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15714	15726		10.1074/jbc.M116.730366	http://dx.doi.org/10.1074/jbc.M116.730366			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27255709	Green Published, hybrid			2022-12-26	WOS:000380584200025
J	Chen, YP; Cossman, J; Jayasuriya, CT; Li, X; Guan, YJ; Fonseca, V; Yang, K; Charbonneau, C; Yu, HC; Kanbe, K; Ma, P; Darling, E; Chen, Q				Chen, Yupeng; Cossman, Jack; Jayasuriya, Chathuraka T.; Li, Xin; Guan, Yingjie; Fonseca, Vera; Yang, Kun; Charbonneau, Cherie; Yu, Hongchuan; Kanbe, Katsuaki; Ma, Peter; Darling, Eric; Chen, Qian			Deficient Mechanical Activation of Anabolic Transcripts and Post-Traumatic Cartilage Degeneration in Matrilin-1 Knockout Mice	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; MATRIX PROTEIN; CHONDROCYTE DIFFERENTIATION; COLLAGEN-II; IN-SITU; OSTEOARTHRITIS; ORGANIZATION; PROGRESSION; MATURATION; AGGRECAN	Matrilin-1 (Matn1), a cartilage-specific peri-cellular and extracellular matrix (ECM) protein, has been hypothesized to regulate ECM interactions and transmit mechanical signals in cartilage. Since Matn1 knock-out (Matn1(-/-)) mice exhibit a normal skeleton, its function in vivo is unclear. In this study, we found that the anabolic Acan and Col2a transcript levels were significantly higher in wildtype (Matn1(+/+)) mouse cartilage than that of MATN1(-/-) mice in vivo. However, such difference was not observed between Matn1(+/+) and MATN1(-/-) chondrocytes cultured under stationary conditions in vitro. Cyclic loading significantly stimulated Acan and Col2a transcript levels in Matn1(+/+) but not in MATN1(-/-) chondrocytes. This suggests that, while Matn1(+/+) chondrocytes increase their anabolic gene expression in response to mechanical loading, the MATN1(-/-) chondrocytes fail to do so because of the deficiency in mechanotransduction. We also found that altered elastic modulus of cartilage matrix in Matn1(-/-) mice, suggesting the mechanotransduction has changed due to the deficiency of Matn1. To understand the impact of such deficiency on joint disease, mechanical loading was altered in vivo by destabilization of medial meniscus. While Matn1(+/+) mice exhibited superficial fissures and clefts consistent with mechanical damage to the articular joint, Matn1(-/-) mice presented more severe cartilage lesions characterized by proteoglycan loss and disorganization of cells and ECM. This suggests that Matn1 deficiency affects pathogenesis of post-traumatic osteoarthritis by failing to up-regulate anabolic gene expression. This is the first demonstration of Matn1 function in vivo, which suggests its protective role in cartilage degeneration under altered mechanical environment.	[Chen, Yupeng; Yu, Hongchuan; Chen, Qian] Xi An Jiao Tong Univ, Bone & Joint Res Ctr, Affiliated Hosp 1, Xian 710061, Peoples R China; [Chen, Yupeng; Yu, Hongchuan; Chen, Qian] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710061, Peoples R China; [Chen, Yupeng; Cossman, Jack; Jayasuriya, Chathuraka T.; Li, Xin; Guan, Yingjie; Yang, Kun; Charbonneau, Cherie; Yu, Hongchuan; Darling, Eric; Chen, Qian] Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Providence, RI 02903 USA; [Chen, Yupeng; Cossman, Jack; Jayasuriya, Chathuraka T.; Li, Xin; Guan, Yingjie; Yang, Kun; Charbonneau, Cherie; Yu, Hongchuan; Darling, Eric; Chen, Qian] Brown Univ, Warren Alpert Med Sch, Providence, RI 02903 USA; [Fonseca, Vera; Darling, Eric] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Kanbe, Katsuaki] Tokyo Womens Med Univ, Dept Orthopaed Surg, Med Ctr East, Tokyo, Japan; [Ma, Peter] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Darling, Eric] Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University; Tokyo Women's Medical University; University of Michigan System; University of Michigan; Brown University	Chen, YP; Chen, Q (corresponding author), Xi An Jiao Tong Univ, Bone & Joint Res Ctr, Affiliated Hosp 1, Xian 710061, Peoples R China.; Chen, YP; Chen, Q (corresponding author), Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710061, Peoples R China.; Chen, YP; Chen, Q (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Providence, RI 02903 USA.; Chen, YP; Chen, Q (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02903 USA.	Yupeng_Chen@Brown.edu; Qian_Chen@Brown.edu	Chen, Qian/C-4354-2011	Chen, Qian/0000-0003-4406-5618; Jayasuriya, Chathuraka/0000-0002-2705-0679; LI, XIN/0000-0003-0003-8554; Darling, Eric/0000-0002-3932-8623	NIH [P20 GM104937, P30GM103410]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR069383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937, P30GM103410] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH (P20 GM104937, P30GM103410). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359; CHEN Q, 1995, DEV BIOL, V172, P293, DOI 10.1006/dbio.1995.0024; Chen ZJ, 2009, EUR J HUM GENET, V17, P525, DOI 10.1038/ejhg.2008.203; Coles JM, 2008, J BIOMECH, V41, P541, DOI 10.1016/j.jbiomech.2007.10.013; Darling EM, 2010, BIOPHYS J, V98, P2848, DOI 10.1016/j.bpj.2010.03.037; Deak F, 1999, MATRIX BIOL, V18, P55, DOI 10.1016/S0945-053X(98)00006-7; Fleming BC, 2015, KNEE SURG SPORT TR A, V23, P1161, DOI 10.1007/s00167-014-2932-6; Fresquet M, 2010, J BIOL CHEM, V285, P34048, DOI 10.1074/jbc.M110.154443; Fujisawa T, 1999, J BIOCHEM-TOKYO, V125, P966, DOI 10.1093/oxfordjournals.jbchem.a022376; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Guan YJ, 2011, FASEB J, V25, P4457, DOI 10.1096/fj.11-185132; Hauser N, 1996, J BIOL CHEM, V271, P32247, DOI 10.1074/jbc.271.50.32247; Huang XM, 1999, DEV DYNAM, V216, P434, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<434::AID-DVDY11>3.3.CO;2-O; Kanbe K, 2007, J BONE MINER RES, V22, P318, DOI 10.1359/JBMR.061104; Klatt AR, 2000, J BIOL CHEM, V275, P3999, DOI 10.1074/jbc.275.6.3999; Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x; Natoli RM, 2009, BIORHEOLOGY, V46, P451, DOI 10.3233/BIR-2009-0554; Neacsu CD, 2014, J BIOL CHEM, V289, P1505, DOI 10.1074/jbc.M113.529933; Nicolae C, 2007, J BIOL CHEM, V282, P22163, DOI 10.1074/jbc.M610994200; Nordenvall R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104681; Okimura A, 1997, ARTHRITIS RHEUM, V40, P1029, DOI 10.1002/art.1780400606; PAULSSON M, 1982, BIOCHEM J, V207, P207, DOI 10.1042/bj2070207; Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1; van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200; WINTERBOTTOM N, 1992, DEV DYNAM, V193, P266, DOI 10.1002/aja.1001930307; Yang Xu, 2006, J Orthop Surg Res, V1, P15, DOI 10.1186/1749-799X-1-15	29	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156676	10.1371/journal.pone.0156676	http://dx.doi.org/10.1371/journal.pone.0156676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270603	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561000028
J	Durnez, W; Van Damme, S				Durnez, Wouter; Van Damme, Stefaan			No Evidence for Threat-Induced Spatial Prioritization of Somatosensory Stimulation during Pain Control Using a Synchrony Judgment Paradigm	PLOS ONE			English	Article							TEMPORAL-ORDER JUDGMENTS; CATASTROPHIZING SCALE; ATTENTION	Topical research efforts on attention to pain often take a critical look at the modulatory role of top-down factors. For instance, it has been shown that the fearful expectation of pain at a location of the body directs attention towards that body part. In addition, motivated attempts to control this pain were found to modulate this prioritization effect. Such studies have often used a temporal order judgment task, requiring participants to judge the order in which two stimuli are presented by indicating which one they perceived first. As this constitutes a forced-choice response format, such studies may be subject to response bias. The aim of the current study was to address this concern. We used a ternary synchrony judgment paradigm, in which participants judged the order in which two somatosensory stimuli occurred. Critically, participants now also had the option to give a `simultaneous' response when they did not perceive a difference. This way we eliminated the need for guessing, and thus reduced the risk of response bias. One location was threatened with the possibility of pain in half of the trials, as predicted by an auditory cue. Additionally, half of the participants (pain control group) were encouraged to avoid pain stimuli by executing a quick button press. The other half (comparison group) performed a similar action, albeit unrelated to the occurrence of pain. Our data did not support threat-induced spatial prioritization, nor did we find evidence that pain control attempts influenced attention in any way.	[Durnez, Wouter; Van Damme, Stefaan] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	Ghent University	Van Damme, S (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	Stefaan.VanDamme@UGent.be	Van Damme, Stefaan/D-3500-2012	Van Damme, Stefaan/0000-0003-0347-1855; Durnez, Wouter/0000-0001-8045-8801	Research Foundation Flanders (FWO) [3G005611]; Ghent University (Special Research Fund) [BOF11/STA/004]	Research Foundation Flanders (FWO)(FWO); Ghent University (Special Research Fund)(Ghent University)	This work was supported by Research Foundation Flanders (FWO; Grant 3G005611) and by Ghent University (Special Research Fund; Grant BOF11/STA/004).	Alcala-Quintana R, 2013, BEHAV RES METHODS, V45, P972, DOI 10.3758/s13428-013-0325-2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bulcke CV, 2014, ACTA PSYCHOL, V153, P113, DOI 10.1016/j.actpsy.2014.09.014; De Paepe AL, 2014, NEUROPSYCHOLOGIA, V56, P219, DOI 10.1016/j.neuropsychologia.2014.01.016; De Ruddere L, 2013, PAIN, V154, P669, DOI 10.1016/j.pain.2012.12.018; Durnez W, 2017, PSYCHOL RES-PSYCH FO, V81, P309, DOI 10.1007/s00426-015-0712-7; Durnez W, 2015, J PAIN, V16, P135, DOI 10.1016/j.jpain.2014.10.012; Garcia-Perez MA, 2012, PSYCHON B REV, V19, P820, DOI 10.3758/s13423-012-0278-y; HOLM S, 1979, SCAND J STAT, V6, P65; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; Moseley GL, 2009, BRAIN, V132, P3142, DOI 10.1093/brain/awp224; Notebaert L, 2011, PAIN, V152, P1068, DOI 10.1016/j.pain.2011.01.020; Schneider KA, 2003, COGNITIVE PSYCHOL, V47, P333, DOI 10.1016/S0010-0285(03)00035-5; Schrooten MGS, 2012, PAIN MANAG, V2, P141, DOI [10.2217/PMT.12.2, 10.2217/pmt.12.2]; Spence C, 2003, PERCEPT PSYCHOPHYS, V65, P318, DOI 10.3758/BF03194803; Spence C, 2001, J EXP PSYCHOL GEN, V130, P799, DOI 10.1037//0096-3445.130.4.799; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Stevens M, 2006, BEHAV RES METHODS, V38, P280, DOI 10.3758/BF03192779; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; Van Damme S, 2012, PAIN, V153, P1226, DOI 10.1016/j.pain.2012.02.027; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Van Damme S, 2009, BRAIN RES, V1253, P100, DOI 10.1016/j.brainres.2008.11.072; van Eijk RLJ, 2008, PERCEPT PSYCHOPHYS, V70, P955, DOI 10.3758/PP.70.6.955; Van Hulle L, 2015, PERCEPT MOTOR SKILL, V120, P219, DOI 10.2466/24.PMS.120v13x1; Van Hulle L, 2013, EXP BRAIN RES, V224, P295, DOI 10.1007/s00221-012-3311-5; Vanden Bulcke C, 2013, PAIN, V154, P1464, DOI 10.1016/j.pain.2013.05.009; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; WEINSTEIN SIDNEY, 1968, P195; Wiech K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00046; Zampini M, 2005, NEUROSCI LETT, V381, P217, DOI 10.1016/j.neulet.2005.01.085; Zampini M, 2007, NEUROSCI LETT, V414, P75, DOI 10.1016/j.neulet.2006.12.006	32	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156648	10.1371/journal.pone.0156648	http://dx.doi.org/10.1371/journal.pone.0156648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27270456	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561000027
J	Huang, LF; Lin, KH; He, SL; Chen, JL; Jiang, JZ; Chen, BH; Hou, YS; Chen, RS; Hong, CY; Ho, SL				Huang, Li-Fen; Lin, Kuan-Hung; He, Siou-Luan; Chen, Jyh-Lang; Jiang, Jian-Zhi; Chen, Bo-Hong; Hou, Yi-Syuan; Chen, Ruey-Shyang; Hong, Chwan-Yang; Ho, Shin-Lon			Multiple Patterns of Regulation and Overexpression of a Ribonuclease-Like Pathogenesis-Related Protein Gene, OsPR10a, Conferring Disease Resistance in Rice and Arabidopsis	PLOS ONE			English	Article							STARVATION-INDUCED RIBONUCLEASE; DEFENSE-RELATED PROTEINS; BIRCH POLLEN ALLERGEN; AMINO-ACID-SEQUENCE; BET V 1; PHOSPHATE-STARVATION; PROTEOMIC ANALYSIS; MOLECULAR CHARACTERIZATION; SELF-INCOMPATIBILITY; DISULFIDE BONDS	An abundant 17 kDa RNase, encoded by OsPR10a (also known as PBZ1), was purified from Pi-starved rice suspension-cultured cells. Biochemical analysis showed that the range of optimal temperature for its RNase activity was 40-70 degrees C and the optimum pH was 5.0. Disulfide bond formation and divalent metal ion Mg2+ were required for the RNase activity. The expression of OsPR10a::GUS in transgenic rice was induced upon phosphate (Pi) starvation, wounding, infection by the pathogen Xanthomonas oryzae pv. oryzae (Xoo), leaf senescence, anther, style, the style-ovary junction, germinating embryo and shoot. We also provide first evidence in whole-plant system, demonstrated that OsPR10a-overexpressing in rice and Arabidopsis conferred significant level of enhanced resistance to infection by the pathogen Xoo and Xanthomona campestris pv. campestris (Xcc), respectively. Transgenic rice and Arabidopsis overexpressing OsPR10a significantly increased the length of primary root under phosphate deficiency (-P-i) condition. These results showed that OsPR10a might play multiple roles in phosphate recycling in phosphate-starved cells and senescing leaves, and could improve resistance to pathogen infection and/or against chewing insect pests. It is possible that Pi acquisition or homeostasis is associated with plant disease resistance. Our findings suggest that gene regulation of OsPR10a could act as a good model system to unravel the mechanisms behind the correlation between Pi starvation and plant-pathogen interactions, and also provides a potential application in crops disease resistance.	[Huang, Li-Fen] Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Jhongli, Taiwan; [Lin, Kuan-Hung] Chinese Culture Univ, Dept Hort & Biotechnol, Taipei, Taiwan; [He, Siou-Luan] Natl Taiwan Univ, Inst Plant Biol, Taipei 10764, Taiwan; [Chen, Jyh-Lang] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Jiang, Jian-Zhi; Chen, Bo-Hong; Ho, Shin-Lon] Natl Chiayi Univ, Dept Agron, Chiayi 60004, Taiwan; [Hou, Yi-Syuan] Natl Chiayi Univ, Dept Plant Med, Chiayi 60004, Taiwan; [Chen, Ruey-Shyang] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi 60004, Taiwan; [Hong, Chwan-Yang] Natl Taiwan Univ, Dept Agr Chem, Taipei 10764, Taiwan; [Chen, Jyh-Lang] Taipei Municipal Dazhi High Sch, Taipei, Taiwan	Yuan Ze University; Chinese Culture University; National Taiwan University; National Taiwan Normal University; National Chiayi University; National Chiayi University; National Chiayi University; National Taiwan University	Ho, SL (corresponding author), Natl Chiayi Univ, Dept Agron, Chiayi 60004, Taiwan.	slho@mail.ncyu.edu.tw	Hong, Chwan-Yang/AAI-6999-2020		Ministry of Science and Technology of the Republic of China [NSC-93-2311-B-415-002, MOST-104-2313-B-415-003]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the grants from the Ministry of Science and Technology of the Republic of China (https://www.most.gov.tw/). The grant numbers are NSC-93-2311-B-415-002 and MOST-104-2313-B-415-003. Both grants' recipient is: Dr. Shin-Lon Ho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL S, 1987, PLANTA, V172, P71, DOI 10.1007/BF00403030; Bantignies B, 2000, PLANT MOL BIOL, V42, P871, DOI 10.1023/A:1006475303115; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; BOWLES DJ, 1990, ANNU REV BIOCHEM, V59, P873, DOI 10.1146/annurev.bi.59.070190.004301; BREITENEDER H, 1995, EUR J BIOCHEM, V233, P484, DOI 10.1111/j.1432-1033.1995.484_2.x; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; Bufe A, 1996, PLANTA, V199, P413, DOI 10.1007/BF00195733; Chakraborty J, 2011, J BIOMOL STRUCT DYN, V29, P67, DOI 10.1080/07391102.2011.10507375; Chen MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037654; Chen Z, 2004, PLANT MOL BIOL, V55, P83, DOI 10.1007/s11103-004-0438-1; Cheng ZY, 2015, NATURE, V521, P213, DOI 10.1038/nature14243; Choi C, 2015, NEW PHYTOL, V208, P846, DOI 10.1111/nph.13516; Choi DS, 2012, PLANT CELL, V24, P1675, DOI 10.1105/tpc.112.095869; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dai XY, 2016, J EXP BOT, V67, P947, DOI 10.1093/jxb/erv515; del Pozo JC, 1999, PLANT J, V19, P579, DOI 10.1046/j.1365-313X.1999.00562.x; DICKINSON H G, 1990, Bioessays, V12, P155, DOI 10.1002/bies.950120403; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gallie DR, 2002, PLANT CELL TISS ORG, V68, P163, DOI 10.1023/A:1013818117026; Graham MY, 2003, PHYSIOL MOL PLANT P, V63, P141, DOI 10.1016/j.pmpp.2003.11.002; HARING V, 1990, SCIENCE, V250, P937, DOI 10.1126/science.2237440; Hashimoto M, 2004, PLANT CELL PHYSIOL, V45, P550, DOI 10.1093/pcp/pch063; Ho SL, 2013, PLANT MOL BIOL, V81, P347, DOI 10.1007/s11103-012-0006-z; Ho SL, 2000, PLANT PHYSIOL, V122, P57, DOI 10.1104/pp.122.1.57; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Hwang SH, 2008, PLANTA, V227, P1141, DOI 10.1007/s00425-007-0687-8; JOST W, 1991, EUR J BIOCHEM, V198, P1, DOI 10.1111/j.1432-1033.1991.tb15978.x; Jwa NS, 2001, BIOCHEM BIOPH RES CO, V286, P973, DOI 10.1006/bbrc.2001.5507; KANDASAMY MK, 1994, DEVELOPMENT, V120, P3405; Kim SG, 2011, MOL CELLS, V31, P25, DOI 10.1007/s10059-011-0004-z; Kim ST, 2004, PROTEOMICS, V4, P3569, DOI 10.1002/pmic.200400999; Kim ST, 2003, PROTEOMICS, V3, P2368, DOI 10.1002/pmic.200300577; Kim ST, 2008, J PROTEOME RES, V7, P1750, DOI 10.1021/pr700878t; Kim ST, 2008, PLANT CELL REP, V27, P593, DOI 10.1007/s00299-007-0485-6; Klaas M, 2011, ANN BOT-LONDON, V108, P677, DOI 10.1093/aob/mcr186; Kock M, 1998, PLANTA, V204, P404, DOI 10.1007/s004250050273; Kock M, 2006, J EXP BOT, V57, P3717, DOI 10.1093/jxb/erl124; Lebel S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-184; Lei Mingguang, 2011, Plant Physiol, V156, P1116, DOI 10.1104/pp.110.171736; Liu JJ, 2005, PLANTA, V221, P159, DOI 10.1007/s00425-004-1428-x; Liu JJ, 2003, PHYSIOL PLANTARUM, V119, P544, DOI 10.1046/j.1399-3054.2003.00200.x; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; LOFFLER A, 1993, EUR J BIOCHEM, V214, P627, DOI 10.1111/j.1432-1033.1993.tb17962.x; LOFFLER A, 1992, PLANT PHYSIOL, V98, P1472, DOI 10.1104/pp.98.4.1472; Ma JF, 2001, PLANT PHYSIOL, V127, P1773, DOI 10.1104/pp.010271; MASCARENHAS JP, 1993, PLANT CELL, V5, P1303, DOI 10.1105/tpc.5.10.1303; McGhee JD, 2001, MOL PLANT MICROBE IN, V14, P877, DOI 10.1094/MPMI.2001.14.7.877; Midoh N, 1996, PLANT CELL PHYSIOL, V37, P9, DOI 10.1093/oxfordjournals.pcp.a028918; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakashita H, 2002, PLANT CELL PHYSIOL, V43, P823, DOI 10.1093/pcp/pcf097; Park CJ, 2004, PLANT J, V37, P186, DOI 10.1046/j.1365-313X.2003.01951.x; Peret B, 2011, TRENDS PLANT SCI, V16, P442, DOI 10.1016/j.tplants.2011.05.006; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Ravichandran S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-107; Sels J, 2008, PLANT PHYSIOL BIOCH, V46, P941, DOI 10.1016/j.plaphy.2008.06.011; SIMPSON RB, 1990, MOL PLANT MICROBE IN, V3, P233, DOI 10.1094/MPMI-3-233; Singer SD, 2012, PLANT CELL REP, V31, P13, DOI 10.1007/s00299-011-1167-y; Takeuchi K, 2011, PLANT CELL PHYSIOL, V52, P1686, DOI 10.1093/pcp/pcr105; Tanaka N, 2000, J MOL BIOL, V298, P859, DOI 10.1006/jmbi.2000.3707; Tran HT, 2008, PROTEOMICS, V8, P4317, DOI 10.1002/pmic.200800292; Tsay YG, 2000, ANAL BIOCHEM, V287, P55, DOI 10.1006/abio.2000.4837; Tsay YG, 2005, ANAL BIOCHEM, V339, P83, DOI 10.1016/j.ab.2004.12.031; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Walter MH, 1996, EUR J BIOCHEM, V239, P281, DOI 10.1111/j.1432-1033.1996.0281u.x; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; WILSON CM, 1975, ANNU REV PLANT PHYS, V26, P187, DOI 10.1146/annurev.pp.26.060175.001155; Xie YR, 2010, J PLANT PHYSIOL, V167, P121, DOI 10.1016/j.jplph.2009.07.004; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067413; Yan QJ, 2008, PLANT PHYSIOL BIOCH, V46, P93, DOI 10.1016/j.plaphy.2007.10.002; Zhou J, 2008, PLANT PHYSIOL, V146, P1673, DOI 10.1104/pp.107.111443; Zhou XJ, 2002, PLANT SCI, V162, P629, DOI 10.1016/S0168-9452(02)00002-X	75	26	27	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156414	10.1371/journal.pone.0156414	http://dx.doi.org/10.1371/journal.pone.0156414			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258121	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700062
J	Kito, M; Maeda, D; Kudo-Asabe, Y; Sato, N; Shih, IM; Wang, TL; Tanaka, M; Terada, Y; Goto, A				Kito, Masahiko; Maeda, Daichi; Kudo-Asabe, Yukitsugu; Sato, Naoki; Shih, Ie-Ming; Wang, Tian-Li; Tanaka, Masamitsu; Terada, Yukihiro; Goto, Akiteru			Expression of Cell Competition Markers at the Interface between p53 Signature and Normal Epithelium in the Human Fallopian Tube	PLOS ONE			English	Article							INTRAEPITHELIAL CARCINOMA; SEROUS CARCINOMA; REGULATOR; DIAGNOSIS; PATHWAY	There is a growing body of evidence regarding cell competition between normal and mutant mammalian cells, which suggest that it may play a defensive role in the early phase of carcinogenesis. In vitro study in the past has shown that overexpression of vimentin in normal epithelial cells at the contact surface with transformed cells is essential for the cell competition involved in epithelial defense against cancer. In this study, we attempted to examine cell competition in human tissue in vivo by investigating surgically resected human fallopian tubes that contain p53 signatures and serous tubal intraepithelial lesions (STILs), a linear expansion of p53-immunopositive/TP53 mutant tubal epithelial cells that are considered as precursors of pelvic high grade serous carcinoma. Immunofluorescence double staining for p53 and the cell competition marker vimentin was performed in 21 sections of human fallopian tube tissue containing 17 p53 signatures and 4 STILs. The intensities of vimentin expression at the interface between p53-positive cells at the end of the p53 signature/STIL and adjacent p53-negative normal tubal epithelial cells were compared with the background tubal epithelium. As a result, the average vimentin intensity at the interfaces relative to the background intensity was 1.076 (95% CI, 0.9412 - 1.211 for p53 signature and 0.9790 (95% CI, 0.7206 - 1.237) for STIL. Thus, it can be concluded that overexpression of the cell competition marker vimentin are not observed in human tissue with TP53 alterations.	[Kito, Masahiko; Maeda, Daichi; Kudo-Asabe, Yukitsugu; Goto, Akiteru] Akita Univ, Grad Sch Med, Dept Cellular & Organ Pathol, Akita 010, Japan; [Kito, Masahiko; Sato, Naoki; Terada, Yukihiro] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita 010, Japan; [Shih, Ie-Ming; Wang, Tian-Li] Johns Hopkins Med Inst, Dept Pathol Oncol & Gynecol & Obstet, Baltimore, MD 21205 USA; [Tanaka, Masamitsu] Akita Univ, Grad Sch Med, Dept Mol Med & Biochem, Akita 010, Japan	Akita University; Akita University; Johns Hopkins University; Johns Hopkins Medicine; Akita University	Maeda, D (corresponding author), Akita Univ, Grad Sch Med, Dept Cellular & Organ Pathol, Akita 010, Japan.	maeda-tky@umin.ac.jp	Goto, Akiteru/P-5775-2014; sdsd, shihieih/ABE-6190-2020	Goto, Akiteru/0000-0001-8776-9004	Japan Society for the Promotion of Science [26870129]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (KAKENHI) from the Japan Society for the Promotion of Science. Grant number: 26870129.	Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Jarboe E, 2008, INT J GYNECOL PATHOL, V27, P1, DOI 10.1097/pgp.0b013e31814b191f; Kajita M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5428; Kajita M, 2010, J CELL SCI, V123, P171, DOI 10.1242/jcs.057976; Kobayashi Y, 2015, CLIN CANCER RES, V21, P4652, DOI 10.1158/1078-0432.CCR-14-3368; Kuhn E, 2012, J PATHOL, V226, P421, DOI 10.1002/path.3023; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Levayer R, 2015, NATURE, V524, P476, DOI 10.1038/nature14684; Mamada H, 2015, J CELL SCI, V128, P790, DOI 10.1242/jcs.163675; Miyoshi I, 2002, MOL REPROD DEV, V63, P168, DOI 10.1002/mrd.10175; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Norman M, 2012, J CELL SCI, V125, P59, DOI 10.1242/jcs.085803; Ohoka A, 2015, J CELL SCI, V128, P781, DOI 10.1242/jcs.163113; Petrova Evgeniya, 2011, Commun Integr Biol, V4, P171, DOI 10.4161/cib.4.2.14232; Portela M, 2010, DEV CELL, V19, P562, DOI 10.1016/j.devcel.2010.09.004; Sherman-Baust CA, 2014, J PATHOL, V233, P228, DOI 10.1002/path.4353; Tamori Y, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000422; Vang R, 2012, INT J GYNECOL PATHOL, V31, P243, DOI 10.1097/PGP.0b013e31823b8831; Visvanathan K, 2011, AM J SURG PATHOL, V35, P1766, DOI 10.1097/PAS.0b013e31822f58bc; Wu SK, 2014, NAT CELL BIOL, V16, P167, DOI 10.1038/ncb2900	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156069	10.1371/journal.pone.0156069	http://dx.doi.org/10.1371/journal.pone.0156069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258067	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700031
J	Trachana, SP; Pilalis, E; Gavalas, NG; Tzannis, K; Papadodima, O; Liontos, M; Rodolakis, A; Vlachos, G; Thomakos, N; Haidopoulos, D; Lykka, M; Koutsoukos, K; Kostouros, E; Terpos, E; Chatziioannou, A; Dimopoulos, MA; Bamias, A				Trachana, Sofia-Paraskevi; Pilalis, Eleftherios; Gavalas, Nikos G.; Tzannis, Kimon; Papadodima, Olga; Liontos, Michalis; Rodolakis, Alexandros; Vlachos, Georgios; Thomakos, Nikolaos; Haidopoulos, Dimitrios; Lykka, Maria; Koutsoukos, Konstantinos; Kostouros, Efthimios; Terpos, Evagelos; Chatziioannou, Aristotelis; Dimopoulos, Meletios-Athanasios; Bamias, Aristotelis			The Development of an Angiogenic Protein "Signature" in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PLATINUM RESISTANCE; POOR-PROGNOSIS; CELLS; EXPRESSION; CARCINOMA; CHEMOTHERAPY; PROGRESSION; RECURRENCE; CISPLATIN	Advanced ovarian cancer (AOC) is one of the leading lethal gynecological cancers in developed countries. Based on the important role of angiogenesis in ovarian cancer oncogenesis and expansion, we hypothesized that the development of an "angiogenic signature" might be helpful in prediction of prognosis and efficacy of anti-angiogenic therapies in this disease. Sixty-nine samples of ascitic fluid-35 from platinum sensitive and 34 from platinum resistant patients managed with cytoreductive surgery and 1st-line carboplatin-based chemotherapy- were analyzed using the Proteome Profiler (TM) Human Angiogenesis Array Kit, screening for the presence of 55 soluble angiogenesis-related factors. A protein profile based on the expression of a subset of 25 factors could accurately separate resistant from sensitive patients with a success rate of approximately 90%. The protein profile corresponding to the "sensitive" subset was associated with significantly longer PFS (8 [95% Confidence Interval {CI}: 8-9] vs. 20 months [95% CI: 15-28]; Hazard ratio {HR}: 8.3, p< 0.001) and OS (20.5 months [95% CI: 13.5-30] vs. 74 months [95% CI: 36-not reached]; HR: 5.6 [95% CI: 2.8-11.2]; p< 0.001). This prognostic performance was superior to that of stage, histology and residual disease after cytoreductive surgery and the levels of vascular endothelial growth factor (VEGF) in ascites. In conclusion, we developed an "angiogenic signature" for patients with AOC, which can be used, after appropriate validation, as a prognostic marker and a tool for selection for anti-angiogenic therapies.	[Trachana, Sofia-Paraskevi; Gavalas, Nikos G.; Tzannis, Kimon; Liontos, Michalis; Lykka, Maria; Koutsoukos, Konstantinos; Kostouros, Efthimios; Terpos, Evagelos; Dimopoulos, Meletios-Athanasios; Bamias, Aristotelis] Univ Athens, Alexandra Gen Hosp, Sch Med, Dept Clin Therapeut, Athens 11528, Greece; [Pilalis, Eleftherios; Papadodima, Olga; Chatziioannou, Aristotelis] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Metab Engn & Bioinformat Program, Athens, Greece; [Rodolakis, Alexandros; Vlachos, Georgios; Thomakos, Nikolaos; Haidopoulos, Dimitrios] Univ Athens, Sch Med, Alexandra Gen Hosp, Dept Obstet & Gynecol 1, Athens 11528, Greece	Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; National Hellenic Research Foundation; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens	Trachana, SP (corresponding author), Univ Athens, Alexandra Gen Hosp, Sch Med, Dept Clin Therapeut, Athens 11528, Greece.	sp.voula@yahoo.com	Dimopoulos, Meletios Athanasios/AAD-4130-2019; Papadodima, Olga/AAU-6664-2021; Terpos, Evangelos/AAD-3667-2019; Koutsoukos, Konstantinos/AAE-8238-2019; Liontos, Michalis/ABA-7587-2020; Liontos, Michalis/AAF-1965-2019	Liontos, Michalis/0000-0001-7192-4575; Pilalis, Eleftherios/0000-0002-5253-5256; Papadodima, Olga/0000-0003-3896-4270; Dimopoulos, Meletios/0000-0001-8990-3254	Hellenic Society of Medical Oncology (HeSMO)	Hellenic Society of Medical Oncology (HeSMO)	This work was supported by an educational grant of the Hellenic Society of Medical Oncology (HeSMO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anai S, 2007, MOL CANCER THER, V6, P101, DOI 10.1158/1535-7163.MCT-06-0367; Bamberger ES, 2002, J CLIN PATHOL-MOL PA, V55, P348, DOI 10.1136/mp.55.6.348; Bamias A, 2007, GYNECOL ONCOL, V106, P75, DOI 10.1016/j.ygyno.2007.02.029; Bamias A, 2012, CRIT REV ONCOL HEMAT, V84, P314, DOI 10.1016/j.critrevonc.2012.04.002; Bamias A, 2008, GYNECOL ONCOL, V108, P421, DOI 10.1016/j.ygyno.2007.10.018; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Biroccio A, 2000, FASEB J, V14, P652, DOI 10.1096/fasebj.14.5.652; Bonneau C, 2015, GYNECOL ONCOL, V136, P112, DOI 10.1016/j.ygyno.2014.10.024; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Chen Y, 2012, INT J MOL SCI, V13, P13264, DOI 10.3390/ijms131013264; Cheng C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055309, DOI 10.1371/JOURNAL.PONE.0055309]; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Davidson B, 2006, CLIN CANCER RES, V12, P791, DOI 10.1158/1078-0432.CCR-05-2516; Del Bufalo D, 2002, MOL PHARMACOL, V61, P524, DOI 10.1124/mol.61.3.524; Eckstein N, 2008, J BIOL CHEM, V283, P739, DOI 10.1074/jbc.M706287200; Gan Y, 2006, PHARM RES, V6, P1324; Gourley C, 2014, P AN M AM SOC CLIN, V32, P5502, DOI [10.1200/jco.2014.32.15_suppl.5502, DOI 10.1200/jco.2014.32.15_suppl.5502]; Hata K, 2004, CANCER CHEMOTH PHARM, V53, P68, DOI 10.1007/s00280-003-0693-x; Howlader N., 2016, SEER CANC STAT REV; KENT JT, 1983, BIOMETRIKA, V70, P163, DOI 10.1093/biomet/70.1.163; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kim W, 2012, J BREAST CANCER, V15, P230, DOI 10.4048/jbc.2012.15.2.230; Korampalli TS, 2011, INT J ONCOL, V39, P1033, DOI 10.3892/ijo.2011.1117; Lloyd KL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1101-8; Lose F, 2010, GYNECOL ONCOL, V119, P479, DOI 10.1016/j.ygyno.2010.08.014; MARKMAN M, 1991, J CLIN ONCOL, V9, P389, DOI 10.1200/JCO.1991.9.3.389; Matei D, 2007, CANCER BIOL THER, V6, P1951, DOI 10.4161/cbt.6.12.4976; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Meirelles K, 2012, P NATL ACAD SCI USA, V109, P2358, DOI 10.1073/pnas.1120733109; Michaelis M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-80; Miyamoto S, 2011, CLIN CANCER RES, V10, P1058; Monk BJ, 2014, LANCET ONCOL, V15, P799, DOI 10.1016/S1470-2045(14)70244-X; Morimoto Yukiko, 2004, Gan To Kagaku Ryoho, V31, P2195; Niero EL, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-37; Obermayr E, 2013, GYNECOL ONCOL, V128, P15, DOI 10.1016/j.ygyno.2012.09.021; Peterson VM, 2013, P NATL ACAD SCI USA, V110, pE4978, DOI 10.1073/pnas.1315370110; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Ray KC, 2009, GASTROENTEROLOGY, V137, P1785, DOI 10.1053/j.gastro.2009.07.067; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Rustin GJS, 2011, INT J GYNECOL CANCER, V21, P419, DOI 10.1097/IGC.0b013e3182070f17; Salani R, 2011, AM J OBSTET GYNECOL, V204, P466, DOI 10.1016/j.ajog.2011.03.008; Sallinen H, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-696; Secord AA, 2014, GYNECOL ONCOL, V135, P349, DOI 10.1016/j.ygyno.2014.08.033; Su Y, 2003, BIOINFORMATICS, V19, P1578, DOI 10.1093/bioinformatics/btg179; Tanaka Y, 2005, CLIN CANCER RES, V11, P4783, DOI 10.1158/1078-0432.CCR-04-1426; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Taylor DD, 2009, GYNECOL ONCOL, V115, P112, DOI 10.1016/j.ygyno.2009.06.031; Tran E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015625; Tu SP, 2005, GASTROENTEROLOGY, V128, P361, DOI 10.1053/j.gastro.2004.11.058; Watanabe Y, 2003, CANCER LETT, V200, P173, DOI 10.1016/S0304-3835(03)00413-0; Yang H, 2013, INT J GYNECOL CANCER, V23, P2, DOI 10.1097/IGC.0b013e3182749139	51	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156403	10.1371/journal.pone.0156403	http://dx.doi.org/10.1371/journal.pone.0156403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258020	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700059
J	Yang, RP; Mo, YL; Liu, CM; Wang, YQ; Ma, JX; Zhang, Y; Li, H; Zhang, X				Yang, Ruiping; Mo, Yanling; Liu, Changming; Wang, Yongqi; Ma, Jianxiang; Zhang, Yong; Li, Hao; Zhang, Xian			The Effects of Cattle Manure and Garlic Rotation on Soil under Continuous Cropping of Watermelon (Citrullus lanatus L.)	PLOS ONE			English	Article							CHEMICAL-PROPERTIES; FUSARIUM-WILT; AEROBIC RICE; PLANT; MANAGEMENT; YIELD; AMENDMENTS; FERTILIZER; DISEASE; SYSTEM	Continuous cropping of watermelon (Citrullus lanatus L.) can lead to reduced yield and quality. We aimed to determine the effects of cattle manure addition and rotation with green garlic to improve yield and reduce disease incidence in watermelon and to examine the effects on the biological and chemical characteristics of the soil. Field experiments were performed during 2012-2014 on land previously under two years of continuous watermelon cropping in northwest China. We examined three treatment combinations: watermelon and garlic rotation, cattle manure application before watermelon planting, and combined cattle manure addition and crop rotation. Watermelon monoculture was retained as a control. Watermelon yield was significantly higher and disease incidence was lower in the treatments than the control. The populations of soil bacteria and actinomycetes and the bacteria/fungi ratio increased significantly and soil enzyme activities were generally enhanced under treatments. Available nutrients and soil organic matter contents were much higher under experimental treatments than the control. Results suggest both cattle manure application and garlic rotation can ameliorate the negative effects of continuous cropping. The combined treatment of cattle manure addition and green garlic rotation was optimal to increase yield, reduce disease incidence and enhance soil quality.	[Yang, Ruiping; Mo, Yanling; Wang, Yongqi; Ma, Jianxiang; Zhang, Yong; Li, Hao; Zhang, Xian] Northwest A&F Univ, Coll Hort, Yangling, Peoples R China; [Liu, Changming] Shangluo Univ, Coll Biol Pharm & Food Engn, Shangluo, Peoples R China; [Wang, Yongqi] Hanzhong City Agrotechnol Extens Ctr, Hanzhong, Peoples R China	Northwest A&F University - China; Shangluo University	Zhang, X (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Peoples R China.	zhangxian098@126.com	Zhang, Kevin/F-5215-2010		Modern Agro-industry Technology Research System of China [CARS-26-18]; county key technology project in Shaanxi province, China [2012XY-27]	Modern Agro-industry Technology Research System of China; county key technology project in Shaanxi province, China	This study was supported by the Modern Agro-industry Technology Research System of China (CARS-26-18), and the county key technology project in Shaanxi province, China (No. 2012XY-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Monaim MF, 2012, CROP PROT, V32, P41, DOI 10.1016/j.cropro.2011.10.011; Abo-Elyousr KAM, 2009, PLANT PATHOLOGY J, V25, P189, DOI 10.5423/PPJ.2009.25.2.189; Ahmad I, 2013, PAK J BOT, V45, P695; Alburquerque JA, 2012, EUR J AGRON, V43, P119, DOI 10.1016/j.eja.2012.06.001; Alvey S, 2001, PLANT SOIL, V231, P45, DOI 10.1023/A:1010386800937; Antonious GF, 2003, J ENVIRON SCI HEAL B, V38, P479, DOI 10.1081/PFC-120021667; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; BAO SD, 2000, AGR SOIL ANAL, P39; BARBER SA, 1990, PLANT SOIL, V124, P183, DOI 10.1007/BF00009257; Borges CD, 2013, ARCH AGRON SOIL SCI, V59, P1471, DOI 10.1080/03650340.2012.725938; BREMNER JM, 1983, COMMUN SOIL SCI PLAN, V14, P905, DOI 10.1080/00103628309367418; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; Chen X, 1993, WATERMELON PLANT DIS; Corwin DL, 2005, COMPUT ELECTRON AGR, V46, P103, DOI 10.1016/j.compag.2004.11.002; Dai XQ, 2013, FIELD CROP RES, V149, P141, DOI 10.1016/j.fcr.2013.04.027; Davis JR, 2001, AM J POTATO RES, V78, P291, DOI 10.1007/BF02875694; Dick WA, 2000, SOIL BIOL BIOCHEM, V32, P1915, DOI 10.1016/S0038-0717(00)00166-8; Eivazi F., 2001, Plant nutrition: food security and sustainability of agro-ecosystems through basic and applied research. Fourteenth International Plant Nutrition Colloquium, Hannover, Germany, P686; ElTarabily KA, 1996, PLANT SOIL, V183, P279, DOI 10.1007/BF00011443; Fumagalli P, 2014, J ENVIRON MANAGE, V145, P35, DOI 10.1016/j.jenvman.2014.06.001; Gong B, 2013, SCI HORTICULTURAE, V1161, P49; Guan Y. M, 1986, SOIL ENZYMES RES MET; Huang LF, 2013, J CHEM ECOL, V39, P232, DOI 10.1007/s10886-013-0244-9; Jia ZH, 2011, ALLELOPATHY J, V27, P87; Jones DL, 2004, NEW PHYTOL, V163, P459, DOI 10.1111/j.1469-8137.2004.01130.x; Kapkiyai JJ, 1999, SOIL BIOL BIOCHEM, V31, P1773, DOI 10.1016/S0038-0717(99)00088-7; Khan MA, 2010, PAK J BOT, V42, P4353; Larney FJ, 1996, AGRON J, V88, P921, DOI 10.2134/agronj1996.00021962003600060012x; Larney FJ, 2012, CAN J SOIL SCI, V92, P19, DOI [10.4141/cjss2010-064, 10.4141/CJSS2010-064]; Liu L- L, 2015, PLOS ONE, V10; Liu SuHui, 2010, Scientia Agricultura Sinica, V43, P1000; Michel VV, 1998, PHYTOPATHOLOGY, V88, P300, DOI 10.1094/PHYTO.1998.88.4.300; Mkhabela MS, 2005, AGR ECOSYST ENVIRON, V106, P57, DOI 10.1016/j.agee.2004.07.014; Moreira A, 2015, COMMUN SOIL SCI PLAN, V46, P1157, DOI 10.1080/00103624.2015.1033542; Naramabuye FX, 2008, AGR ECOSYST ENVIRON, V124, P136, DOI 10.1016/j.agee.2007.08.005; Nie LX, 2007, PLANT SOIL, V300, P185, DOI 10.1007/s11104-007-9402-6; Ren LX, 2008, SOIL BIOL BIOCHEM, V40, P834, DOI 10.1016/j.soilbio.2007.11.003; Sradnick A, 2013, APPL SOIL ECOL, V63, P23, DOI 10.1016/j.apsoil.2012.09.011; Sui N, 2015, FIELD CROP RES, V172, P132, DOI 10.1016/j.fcr.2014.11.011; Tejada M, 2006, J ENVIRON QUAL, V35, P1010, DOI 10.2134/jeq2005.0460; Thomas GW, 1996, METHODS SOIL ANAL PA, P475; Whalen JK, 2002, CAN J SOIL SCI, V82, P227, DOI 10.4141/S01-030; Wu FengZhi, 2006, Plant Nutrition and Fertilizer Science, V12, P554; Xiao XM, 2012, ACTA AGR SCAND B-S P, V62, P696, DOI 10.1080/09064710.2012.697571; Xu WH, 2015, PHYSIOL MOL PLANT P, V90, P12, DOI 10.1016/j.pmpp.2015.02.003; Xu WH, 2015, EUR J PLANT PATHOL, V141, P209, DOI 10.1007/s10658-014-0528-0; Xue JiCheng, 1995, Journal of Nanjing Agricultural University, V18, P53; Yang YuHong, 2011, Acta Agronomica Sinica, V37, P105; Yao HY, 2007, SCIENTIFIC, P185; Zhou KQ, 2015, FIELD CROP RES, V171, P138, DOI 10.1016/j.fcr.2014.10.017	50	13	24	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156515	10.1371/journal.pone.0156515	http://dx.doi.org/10.1371/journal.pone.0156515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258145	gold, Green Submitted, Green Published			2022-12-26	WOS:000377369700071
J	Mwangungulu, SP; Sumaye, RD; Limwagu, AJ; Siria, DJ; Kaindoa, EW; Okumu, FO				Mwangungulu, Stephen Peter; Sumaye, Robert David; Limwagu, Alex Julius; Siria, Doreen Josen; Kaindoa, Emmanuel Wilson; Okumu, Fredros Oketch			Crowdsourcing Vector Surveillance: Using Community Knowledge and Experiences to Predict Densities and Distribution of Outdoor-Biting Mosquitoes in Rural Tanzania	PLOS ONE			English	Article							DAR-ES-SALAAM; RIFT-VALLEY FEVER; PARTICIPATORY-GIS; CARBON-DIOXIDE; MALARIA; TRANSMISSION; MANAGEMENT; DESIGN; DENGUE; CHIKUNGUNYA	Lack of reliable techniques for large-scale monitoring of disease-transmitting mosquitoes is a major public health challenge, especially where advanced geo-information systems are not regularly applicable. We tested an innovative crowd-sourcing approach, which relies simply on knowledge and experiences of residents to rapidly predict areas where disease-transmitting mosquitoes are most abundant. Guided by community-based resource persons, we mapped boundaries and major physical features in three rural Tanzanian villages. We then selected 60 community members, taught them basic map-reading skills, and offered them gridded maps of their own villages (grid size: 200mx200m) so they could identify locations where they believed mosquitoes were most abundant, by ranking the grids from one (highest density) to five (lowest density). The ranks were interpolated in ArcGIS-10 (ESRI-USA) using inverse distance weighting (IDW) method, and re-classified to depict areas people believed had high, medium and low mosquito densities. Finally, we used odor-baited mosquito traps to compare and verify actual outdoor mosquito densities in the same areas. We repeated this process for 12 months, each time with a different group of 60 residents. All entomological surveys depicted similar geographical stratification of mosquito densities in areas classified by community members as having high, medium and low vector abundance. These similarities were observed when all mosquito species were combined, and also when only malaria vectors were considered. Of the 12,412 mosquitoes caught, 60.9% (7,555) were from areas considered by community members as having high mosquito densities, 28% (3,470) from medium density areas, and 11.2% (1,387) from low density areas. This study provides evidence that we can rely on community knowledge and experiences to identify areas where mosquitoes are most abundant or least abundant, even without entomological surveys. This crowd-sourcing method could be further refined and validated to improve community-based planning of mosquito control operations at low-cost.	[Mwangungulu, Stephen Peter; Sumaye, Robert David; Limwagu, Alex Julius; Siria, Doreen Josen; Kaindoa, Emmanuel Wilson; Okumu, Fredros Oketch] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Mwangungulu, Stephen Peter] Ardhi Univ, Sch Geospatial Sci & Technol, Dar Es Salaam, Tanzania; [Sumaye, Robert David] Inst Trop Med, B-2000 Antwerp, Belgium; [Kaindoa, Emmanuel Wilson; Okumu, Fredros Oketch] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Parktown, South Africa	Ifakara Health Institute; Institute of Tropical Medicine (ITM); University of Witwatersrand	Okumu, FO (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania.; Okumu, FO (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Parktown, South Africa.	fredros@ihi.or.tz		Kaindoa, Dr. Emmanuel W/0000-0001-6170-5694; Sumaye, Robert/0000-0001-9734-3226	Global Health Discovery Program of the Bill & Melinda Gates Foundation [53214, OPP103574]; Low and Middle Income Countries Stars in Global Health Program by Grand Challenges Canada(TM) [0012-01-01-01-01]; Wellcome Trust Fellowships in Public Health and Tropical Medicine [WT102350/Z/13/Z, 100540/Z/12/Z]; Grand Challenges Explorations Award	Global Health Discovery Program of the Bill & Melinda Gates Foundation; Low and Middle Income Countries Stars in Global Health Program by Grand Challenges Canada(TM); Wellcome Trust Fellowships in Public Health and Tropical Medicine; Grand Challenges Explorations Award	This work was funded by a Grand Challenges Explorations Award, from the Global Health Discovery Program of the Bill & Melinda Gates Foundation (Grant Numbers: 53214 and OPP103574), the Low and Middle Income Countries Stars in Global Health Program by Grand Challenges Canada (TM) (Grant Number: 0012-01-01-01-01). Fredros Okumu and Emmanuel Kaindoa were also supported by Wellcome Trust Fellowships in Public Health and Tropical Medicine (Grant numbers: WT102350/Z/13/Z and 100540/Z/12/Z respectively).; We would like to thank all community members who participated in community participatory mapping exercises, and all volunteers for their participation in sampling mosquitoes during the entire study period. This work was funded by a Grand Challenges Explorations Award, from the Global Health Discovery Program of the Bill & Melinda Gates Foundation (Grant Numbers: 53214 and OPP103574), the Low and Middle Income Countries Stars in Global Health Program by Grand Challenges Canada (TM) (Grant Number: 0012-01-01-01-01). Fredros Okumu and Emmanuel Kaindoa were also supported by Wellcome Trust Fellowships in Public Health and Tropical Medicine (Grant numbers: WT102350/Z/13/Z and 100540/Z/12/Z respectively). We thank Lina Finda and Paul Kaefer for conducting rigorous grammar and language checks in the manuscript	Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000401; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Carter R, 2002, INT J PARASITOL, V32, P1617, DOI 10.1016/S0020-7519(02)00190-X; Chaki PP, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-21; Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003335; Cinderby S, 2005, APPL GEOGR, V25, P143, DOI 10.1016/j.apgeog.2005.03.003; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Dongus S, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-37; Driedger SM, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-53; Dunn CE, 2007, PROG HUM GEOG, V31, P616, DOI 10.1177/0309132507081493; Duval-Diop D, 2010, COMMUNITY DEV, V41, P32, DOI 10.1080/15575330903288854; Elwood S., 1998, CARTOGR GEOGR INFORM, V25, P77, DOI [10.1559/152304098782594553, DOI 10.1559/152304098782594553]; Estelles-Arolas E, 2012, J INF SCI, V38, P189, DOI 10.1177/0165551512437638; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Freifeld CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000376; Gao H, 2011, IEEE INTELL SYST, V26, P10, DOI 10.1109/MIS.2011.52; Geubbels E, 2015, INT J EPIDEMIOL; Goodchild MF, 2010, INT J DIGIT EARTH, V3, P231, DOI 10.1080/17538941003759255; Gutierrez J, 2008, ENVIRON PLANN B, V35, P480, DOI 10.1068/b33043; Hanafi-Bojd AA, 2012, ACTA TROP, V122, P132, DOI 10.1016/j.actatropica.2012.01.003; Hertz JT, 2012, AM J TROP MED HYG, V86, P171, DOI 10.4269/ajtmh.2012.11-0393; Hudson-Smith A, 2009, SOC SCI COMPUT REV, V27, P524, DOI 10.1177/0894439309332299; Luengo-Oroz MA, 2012, J MED INTERNET RES, V14; Maman S, 2009, FIELD METHOD, V21, P368, DOI 10.1177/1525822X09341718; McCall MK, 2005, GEOGR J, V171, P340, DOI 10.1111/j.1475-4959.2005.00173.x; McCall MK, 2003, HABITAT INT, V27, P549, DOI 10.1016/S0197-3975(03)00005-5; Mohamed M, 2010, AM J TROP MED HYG, V83, P22, DOI 10.4269/ajtmh.2010.09-0318; Moi ML, 2010, EMERG INFECT DIS, V16, P1770, DOI 10.3201/eid1611.101061; Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Okolloh Ory, 2009, PARTICIPATORY LEARNI, V59, P65; Okumu F, 2010, J MED ENTOMOL, V47, P274, DOI 10.1603/ME09114; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-12; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Qiu YT, 2007, J MED ENTOMOL, V44, P970, DOI 10.1603/0022-2585(2007)44[970:AOMTBW]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ranard BL, 2014, J GEN INTERN MED, V29, P187, DOI 10.1007/s11606-013-2536-8; Renggli S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-85; Saitoh Y, 2004, J AM MOSQUITO CONTR, V20, P261; Sandstrom P, 2003, AMBIO, V32, P557, DOI 10.1639/0044-7447(2003)032[0557:CRBPMR]2.0.CO;2; Schellenberg JRMA, 1999, T ROY SOC TROP MED H, V93, P225, DOI 10.1016/S0035-9203(99)90001-9; Simonsen PE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0507-5; Sims MH, 2014, J HOSP MED, V9, P451, DOI 10.1002/jhm.2204; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; STEPHENS C, 1995, B WORLD HEALTH ORGAN, V73, P97; Stevens M, 2010, WROKSH UB CROWDS; Sumaye RD, 2012, MALARIAWORLD J, V3; Sumaye RD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002356; Sumaye RD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003536; Unabor H, 2014, INT J SCI ENG RES, V5, P2; Weiner D., 2003, URISA J, V15, P61; Whitla P, 2009, CONT MANAGEMENT RES, V5; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organization, 2014, DENG OUTBR UN REP TA; Worrall E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-338; Zimmerman J, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P1677	60	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156388	10.1371/journal.pone.0156388	http://dx.doi.org/10.1371/journal.pone.0156388			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253869	gold, Green Published, Green Submitted			2022-12-26	WOS:000377218700023
J	Martinez-Sernandez, V; Orbegozo-Medina, RA; Romaris, F; Paniagua, E; Ubeira, FM				Martinez-Sernandez, Victoria; Orbegozo-Medina, Ricardo A.; Romaris, Fernanda; Paniagua, Esperanza; Ubeira, Florencio M.			Usefulness of ELISA Methods for Assessing LPS Interactions with Proteins and Peptides	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; ANTIMICROBIAL PEPTIDE; ENDOTOXIN REMOVAL; BIOLOGICAL-ACTIVITY; FASCIOLA-HEPATICA; ESCHERICHIA-COLI; KAPPA-B; HEMOGLOBIN; NEUTRALIZATION; RECEPTORS	Lipopolysaccharide (LPS), the major constituent of the outer membrane of Gram-negative bacteria, can trigger severe inflammatory responses during bacterial infections, possibly leading to septic shock. One approach to combatting endotoxic shock is to neutralize the most conserved part and major mediator of LPS activity (lipid A) with LPS-binding proteins or peptides. Although several available assays evaluate the biological activity of these molecules on LPS (e.g. inhibition of LPS-induced TNF-alpha production in macrophages), the development of simple and cost-effective methods that would enable preliminary screening of large numbers of potential candidate molecules is of great interest. Moreover, it would be also desirable that such methods could provide information about the possible biological relevance of the interactions between proteins and LPS, which may enhance or neutralize LPS-induced inflammatory responses. In this study, we designed and evaluated different types of ELISA that could be used to study possible interactions between LPS and any protein or peptide. We also analysed the usefulness and limitations of the different ELISAs. Specifically, we tested the capacity of several proteins and peptides to bind FITC-labeled LPSs from Escherichia coli serotypes O111:B4 and O55:B5 in an indirect ELISA and in two competitive ELISAs including casein hydrolysate (hCAS) and biotinylated polymyxin B (captured by deglycosylated avidin; PMX) as LPS-binding agents in the solid phase. We also examined the influence of pH, detergents and different blocking agents on LPS binding. Our results showed that the competitive hCAS-ELISA performed under mildly acidic conditions can be used as a general method for studying LPS interactions, while the more restrictive PMX-ELISA may help to identify proteins/peptides that are likely to have neutralizing properties in vitro or in vivo.	[Martinez-Sernandez, Victoria; Orbegozo-Medina, Ricardo A.; Romaris, Fernanda; Paniagua, Esperanza; Ubeira, Florencio M.] Univ Santiago de Compostela, Lab Parasitol, Dept Microbiol & Parasitol, Fac Farm, Santiago De Compostela, Spain	Universidade de Santiago de Compostela	Ubeira, FM (corresponding author), Univ Santiago de Compostela, Lab Parasitol, Dept Microbiol & Parasitol, Fac Farm, Santiago De Compostela, Spain.	fm.ubeira@usc.es		Ubeira, Florencio/0000-0001-7312-2752; Romaris Martinez, Fernanda/0000-0002-0633-674X; Paniagua Crespo, Maria Esperanza/0000-0002-4435-0200; Orbegozo Medina, Ricardo Alfredo/0000-0002-5281-9718	Ministerio de Ciencia e Innovacion, Spain [AGL2011-30563-C03]; Xunta de Galicia, Spain [GPC2014/058]; European Fund for Regional Development (FEDER); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario); Spanish Ministerio de Economia y Competitividad (Programa de Formacion de Personal Investigador)	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia, Spain(Xunta de Galicia); European Fund for Regional Development (FEDER)(European Commission); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario); Spanish Ministerio de Economia y Competitividad (Programa de Formacion de Personal Investigador)	This work was funded by Ministerio de Ciencia e Innovacion, Spain, Grant AGL2011-30563-C03; Xunta de Galicia, Spain, Grant GPC2014/058; and the European Fund for Regional Development (FEDER). VMS holds a predoctoral fellowship from the Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario) and RAOM is recipient of a fellowship from the Spanish Ministerio de Economia y Competitividad (Programa de Formacion de Personal Investigador). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anspach FB, 2001, J BIOCHEM BIOPH METH, V49, P665, DOI 10.1016/S0165-022X(01)00228-7; Augusto LA, 2003, BIOCHEMISTRY-US, V42, P3929, DOI 10.1021/bi0268394; Bahl N, 2011, J BIOL CHEM, V286, P37793, DOI 10.1074/jbc.M111.245472; Bhunia A, 2010, J BIOL CHEM, V285, P3883, DOI 10.1074/jbc.M109.065672; Bhunia A, 2009, CHEM-EUR J, V15, P2036, DOI 10.1002/chem.200802635; Brandenburg K, 2003, J BIOL CHEM, V278, P47660, DOI 10.1074/jbc.M304743200; Chen XM, 2006, J MED CHEM, V49, P7754, DOI 10.1021/jm0610447; Cheng X, 2015, NUTRIENTS, V7, P3119, DOI 10.3390/nu7053119; Das D, 2015, CHEMPHYSCHEM, V16, P753, DOI 10.1002/cphc.201402739; David SA, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P413; de Haas CJC, 1999, INFECT IMMUN, V67, P2790, DOI 10.1128/IAI.67.6.2790-2796.1999; de Haas CJC, 2000, J IMMUNOL METHODS, V242, P79, DOI 10.1016/S0022-1759(00)00207-6; Domadia PN, 2010, J AM CHEM SOC, V132, P18417, DOI 10.1021/ja1083255; Elass-Rochard E, 1998, INFECT IMMUN, V66, P486, DOI 10.1128/IAI.66.2.486-491.1998; Drago-Serrano ME, 2012, INT IMMUNOPHARMACOL, V12, P1, DOI 10.1016/j.intimp.2011.11.002; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; Geumann C, 2010, ANAL BIOCHEM, V402, P161, DOI 10.1016/j.ab.2010.03.037; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Habich C, 2005, J IMMUNOL, V174, P1298, DOI 10.4049/jimmunol.174.3.1298; Howe J, 2008, MED CHEM, V4, P520, DOI 10.2174/157340608786242089; Huang JX, 2012, J LIPIDS, V2012, DOI 10.1155/2012/475153; Hurley JC, 2013, TOXINS, V5, P2589, DOI 10.3390/toxins5122589; Jang H, 2009, BMB REP, V42, P462, DOI 10.5483/BMBRep.2009.42.7.462; KACA W, 1994, J BIOL CHEM, V269, P25078; Kacprzyk L, 2007, BBA-BIOMEMBRANES, V1768, P2667, DOI 10.1016/j.bbamem.2007.06.020; Kang Y, 2000, PROCESS BIOCHEM, V36, P85, DOI 10.1016/S0032-9592(00)00182-5; Kellogg TA, 1999, J SURG RES, V85, P136, DOI 10.1006/jsre.1999.5595; Kurasawa T, 1996, FEMS IMMUNOL MED MIC, V13, P293, DOI 10.1111/j.1574-695X.1996.tb00254.x; Li P, 2004, J BIOL CHEM, V279, P50150, DOI 10.1074/jbc.M405606200; Mares J, 2009, J BIOL CHEM, V284, P11498, DOI 10.1074/jbc.M806587200; Martin L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00404; Martinez-Sernandez V, 2014, BIO PROTOCOL, V4, pe1298; Martinez-Sernandez V, 2014, J BIOL CHEM, V289, P1441, DOI 10.1074/jbc.M113.499517; Mukhopadhya A, 2014, FOOD SCI NUTR, V2, P712, DOI 10.1002/fsn3.153; OHNO N, 1989, EUR J BIOCHEM, V186, P629, DOI 10.1111/j.1432-1033.1989.tb15253.x; PETERSON AA, 1985, J BACTERIOL, V162, P738, DOI 10.1128/JB.162.2.738-745.1985; Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6; Porro M, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P403; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Rodriguez E, 2008, ALLERGY, V63, P219, DOI 10.1111/j.1398-9995.2007.01564.x; Roth RJ, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P389; Sasaki H, 2008, BIOPHYS J, V95, P986, DOI 10.1529/biophysj.108.129197; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Srivastava RM, 2012, J BIOL CHEM, V287, P1980, DOI 10.1074/jbc.M111.302893; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; TAKADA K, 1994, INFECT IMMUN, V62, P1171, DOI 10.1128/IAI.62.4.1171-1175.1994; Tsuzuki H, 2001, J SURG RES, V100, P127, DOI 10.1006/jsre.2001.6227; Ubeira FM, 2009, AM J TROP MED HYG, V81, P156, DOI 10.4269/ajtmh.2009.81.156; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; van der Bruggen T, 1999, INFECT IMMUN, V67, P3824, DOI 10.1128/IAI.67.8.3824-3829.1999; VOGT RF, 1987, J IMMUNOL METHODS, V101, P43, DOI 10.1016/0022-1759(87)90214-6; Youn JH, 2011, EUR J IMMUNOL, V41, P2753, DOI 10.1002/eji.201141391	54	9	9	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156530	10.1371/journal.pone.0156530	http://dx.doi.org/10.1371/journal.pone.0156530			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249227	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700050
J	Park, J; Park, JW; Oh, H; Maria, FS; Kang, J; Tian, XC				Park, Joonghoon; Park, Jong Woo; Oh, Hawmok; Maria, Fernanda S.; Kang, Jaeku; Tian, Xiuchun			Gene-Specific Assessment of Guanine Oxidation as an Epigenetic Modulator for Cardiac Specification of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							C-G TRANSVERSIONS; METHYLATION PATTERNS; DNA OXIDATION; 8-OXOGUANINE; CARDIOMYOGENESIS; DIFFERENTIATION; EXPRESSION; BASE; DEMETHYLATION; INHERITANCE	Epigenetics have essential roles in development and human diseases. Compared to the complex histone modifications, epigenetic changes on mammalian DNA are as simple as methylation on cytosine. Guanine, however, can be oxidized as an epigenetic change which can undergo base-pair transversion, causing a genetic difference. Accumulating evidence indicates that reactive oxygen species (ROS) are important signaling molecules for embryonic stem cell (ESC) differentiation, possibly through transient changes on genomic DNA such as 7,8-dihydro-8-oxoguanine (8-oxoG). Technical limitations on detecting such DNA modifications, however, restrict the investigation of the role of 8-oxoG in ESC differentiation. Here, we developed a Hoogsteen base pairing-mediated PCR-sequencing assay to detect 8-oxoG lesions that can subsequently cause G to T transversions during PCR. We then used this assay to assess the epigenetic and transient 8-oxoG formation in the Tbx5 gene of R1 mouse ESCs subjected to oxidative stress by removing 2-mercaptoethanol (2ME) from the culture media. To our surprise, significantly higher numbers of 8-oxoG-mediated G.C to C.G transversion, not G.C to T.A, were detected at 7th and 9th base position from the transcription start site of exon 1 of Tbx5 in ESCs in the (-) 2ME than (+) 2ME group (p < 0.05). This was consistent with the decrease in the amount of amplifiable of DNA harboring the 8-oxoG lesions at the Tbx5 promoter region in the oxidative stressed ESCs. The ESCs responded to oxidative stress, possibly through the epigenetic effects of guanine oxidation with decreased proliferation (p < 0.05) and increased formation of beating embryoid bodies (EBs; p < 0.001). Additionally, the epigenetic changes of guanine induced up-regulation of Ogg1 and PolB, two base excision repairing genes for 8-oxoG, in ESCs treated with (-) 2ME (p < 0.01). Together, we developed a gene-specific and direct quantification assay for guanine oxidation. Using oxidative stressed mouse ESCs, we validated this assay and assessed the epigenetic effects of 8-oxoG by studying expression of DNA repair genes, ESC proliferation, and EB formation.	[Park, Joonghoon; Maria, Fernanda S.; Tian, Xiuchun] Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; [Park, Joonghoon; Maria, Fernanda S.; Tian, Xiuchun] Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; [Park, Jong Woo; Oh, Hawmok] Sungkyunkwan Univ, Sch Pharm, Res Ctr Epigenome Regulat, Suwon 440746, South Korea; [Maria, Fernanda S.] Univ Sao Paulo, Dept Anim Reprod, Coll Vet Med, BR-05508 Sao Paulo, Brazil; [Kang, Jaeku] Konyang Univ, Dept Pharmacol, Coll Med, Daejeon 302718, South Korea; [Park, Joonghoon] LG Life Sci R&D Pk, Daejon 305380, South Korea	University of Connecticut; University of Connecticut; Sungkyunkwan University (SKKU); Universidade de Sao Paulo; Konyang University; Konyang University Hospital	Tian, XC (corresponding author), Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA.; Tian, XC (corresponding author), Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA.	xiuchun.tian@uconn.edu	Kang, Jaeku/D-4933-2011	Kang, Jaeku/0000-0002-8660-7940	USDA [58-1265-0-040]; Multi-state Research Project [W2171]; Basic Science Research Program through National Research Foundation (NRF) of Korea; Ministry of Education [NRF-2015R1D1A3A01019948]; LG Life Sciences	USDA(United States Department of Agriculture (USDA)); Multi-state Research Project; Basic Science Research Program through National Research Foundation (NRF) of Korea; Ministry of Education; LG Life Sciences	This study was supported by funding from the USDA (58-1265-0-040) and Multi-state Research Project (W2171) to XT, and from the Basic Science Research Program through the National Research Foundation (NRF) of Korea, the Ministry of Education (NRF-2015R1D1A3A01019948), to JK. LG Life Sciences provided support in the form of salaries for authors (JP), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Amente S, 2010, ONCOGENE, V29, P3691, DOI 10.1038/onc.2010.120; Amente S, 2010, CELL CYCLE, V9, P3002, DOI 10.4161/cc.9.15.12499; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Bartsch C, 2011, FREE RADICAL BIO MED, V51, P432, DOI 10.1016/j.freeradbiomed.2011.04.029; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Buggisch M, 2007, J CELL SCI, V120, P885, DOI 10.1242/jcs.03386; CastroObregon S, 1996, FEBS LETT, V381, P93, DOI 10.1016/0014-5793(96)00088-9; Cheedipudi S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00019; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Clark Tyson A, 2011, Genome Integr, V2, P10, DOI 10.1186/2041-9414-2-10; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Crespo FL, 2010, STEM CELLS, V28, P1132, DOI 10.1002/stem.441; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Gillespie MN, 2009, ANN NY ACAD SCI, V1177, P140, DOI 10.1111/j.1749-6632.2009.05036.x; Henderson PT, 2002, BIOCHEMISTRY-US, V41, P914, DOI 10.1021/bi0156355; Heo JS, 2011, J CELL BIOCHEM, V112, P1880, DOI 10.1002/jcb.23108; Hirst M, 2009, INT J BIOCHEM CELL B, V41, P136, DOI 10.1016/j.biocel.2008.09.011; Inbar-Feigenberg M, 2013, FERTIL STERIL, V99, P607, DOI 10.1016/j.fertnstert.2013.01.117; Jena NR, 2005, J PHYS CHEM B, V109, P14205, DOI 10.1021/jp050646j; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; Jin J, 2014, MOL MED REP, V10, P761, DOI 10.3892/mmr.2014.2315; Kim C, 2009, CLONING STEM CELLS, V11, P89, DOI 10.1089/clo.2008.0053; Kino K, 2005, MUTAT RES-FUND MOL M, V571, P33, DOI 10.1016/j.mrfmmm.2004.10.010; Kino K, 2001, CHEM BIOL, V8, P369, DOI 10.1016/S1074-5521(01)00019-9; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kremer TM, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-16; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; NEGISHI K, 1992, CARCINOGENESIS, V13, P1615, DOI 10.1093/carcin/13.9.1615; Nikolova EN, 2013, BIOPOLYMERS, V99, P955, DOI 10.1002/bip.22334; Olinski R, 2007, ACTA BIOCHIM POL, V54, P11, DOI 10.18388/abp.2007_3265; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Ratel D, 2006, BIOESSAYS, V28, P309, DOI 10.1002/bies.20342; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Saxowsky TT, 2008, P NATL ACAD SCI USA, V105, P18877, DOI 10.1073/pnas.0806464105; Sheng W, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-46; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Takimoto K, 1999, MUTAT RES-GEN TOX EN, V445, P93, DOI 10.1016/S1383-5718(99)00138-2; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; WIGLER MH, 1981, CELL, V24, P285, DOI 10.1016/0092-8674(81)90317-2; Wu M, 2014, CELL RES, V24, P1201, DOI 10.1038/cr.2014.113; Yamamura N, 2012, EXP MOL PATHOL, V93, P35, DOI 10.1016/j.yexmp.2012.03.012; Yan SF, 2014, CURR PHARM DESIGN, V20, P1604, DOI 10.2174/13816128113199990544; Yoshihara M, 2014, DNA RES, V21, P603, DOI 10.1093/dnares/dsu023; Zarakowska E, 2014, MUTAT RES-GEN TOX EN, V764, P58, DOI 10.1016/j.mrgentox.2013.09.002; Zhou LM, 2014, PHARMAZIE, V69, P198, DOI 10.1691/ph.2014.3822	49	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0155792	10.1371/journal.pone.0155792	http://dx.doi.org/10.1371/journal.pone.0155792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249188	Green Submitted, gold, Green Published			2022-12-26	WOS:000377184700020
J	Shao, PL; Liao, JD; Wong, TW; Wang, YC; Leu, S; Yip, HK				Shao, Pei-Lin; Liao, Jiunn-Der; Wong, Tak-Wah; Wang, Yi-Cheng; Leu, Steve; Yip, Hon-Kan			Enhancement of Wound Healing by Non-Thermal N-2/Ar Micro-Plasma Exposure in Mice with Fractional-CO2-Laser-Induced Wounds	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NITRIC-OXIDE; HUMAN SKIN; REPAIR; STERILIZATION; ANGIOGENESIS; REGENERATION; MECHANISMS; EXPRESSION; MIGRATION	Micro-plasma is a possible alternative treatment for wound management. The effect of micro-plasma on wound healing depends on its composition and temperature. The authors previously developed a capillary-tube-based micro-plasma system that can generate micro-plasma with a high nitric oxide-containing species composition and mild working temperature. Here, the efficacy of micro-plasma treatment on wound healing in a laser-induced skin wound mouse model was investigated. A partial thickness wound was created in the back skin of each mouse and then treated with micro-plasma. Non-invasive methods, namely wound closure kinetics, optical coherence tomography (OCT), and laser Doppler scanning, were used to measure the healing efficiency in the wound area. Neo-tissue growth and the expressions of matrix metallopeptidase-3 (MMP-3) and laminin in the wound area were assessed using histological and immunohistochemistry (IHC) analysis. The results show that micro-plasma treatment promoted wound healing. Micro-plasma treatment significantly reduced the wound bed region. The OCT images and histological analysis indicates more pronounced tissue regrowth in the wound bed region after micro-plasma treatment. The laser Doppler images shows that micro-plasma treatment promoted blood flow in the wound bed region. The IHC results show that the level of laminin increased in the wound bed region after micro-plasma treatment, whereas the level of MMP-3 decreased. Based on these results, micro-plasma has potential to be used to promote the healing of skin wounds clinically.	[Shao, Pei-Lin; Liao, Jiunn-Der; Wang, Yi-Cheng] Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 70101, Taiwan; [Liao, Jiunn-Der] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 70101, Taiwan; [Wong, Tak-Wah] Natl Cheng Kung Univ, Dept Dermatol, Dept Biochem & Mol Biol, Med Coll & Hosp, Tainan 70101, Taiwan; [Leu, Steve; Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung 83301, Taiwan; [Leu, Steve; Yip, Hon-Kan] Chang Gung Univ, Coll Med, Kaohsiung 83301, Taiwan; [Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, Kaohsiung 83301, Taiwan; [Shao, Pei-Lin] Asia Univ, Dept Nursing, Taichung 41354, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Asia University Taiwan	Liao, JD (corresponding author), Natl Cheng Kung Univ, Dept Mat Sci & Engn, Tainan 70101, Taiwan.	jdliao@mail.ncku.edu.tw	Leu, Steve/D-6807-2011; Sun, Cheuk-Kwan/K-5723-2012	Leu, Steve/0000-0002-1738-1028; 	Ministry of Science and Technology of Taiwan [NSC 101-2321-B-006-012, MOST 103-2622-B-006-010]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan (grant number: NSC 101-2321-B-006-012 and MOST 103-2622-B-006-010). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjunan KP, 2012, J R SOC INTERFACE, V9, P147, DOI 10.1098/rsif.2011.0220; Atiyeh Bishara S., 2002, Current Pharmaceutical Biotechnology, V3, P179, DOI 10.2174/1389201023378283; Beckrich K, 1999, NURS ECON, V17, P263; Chen Ming, 2009, Critical Reviews in Biomedical Engineering, V37, P399, DOI 10.1615/CritRevBiomedEng.v37.i4-5.50; CLARK RAF, 1993, DERMATOL CLIN, V11, P647, DOI 10.1016/S0733-8635(18)30218-3; Crovetti G, 2004, TRANSFUS APHER SCI, V30, P145, DOI 10.1016/j.transci.2004.01.004; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ermolaeva SA, 2011, J MED MICROBIOL, V60, P75, DOI 10.1099/jmm.0.020263-0; Garcia-Alcantara E, 2013, ARCH MED RES, V44, P169, DOI 10.1016/j.arcmed.2013.02.001; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Granger DL, 1996, METHOD ENZYMOL, V268, P142; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Haertel B, 2014, BIOMOL THER, V22, P477, DOI 10.4062/biomolther.2014.105; Halfmann H, 2007, J PHYS D APPL PHYS, V40, P4145, DOI 10.1088/0022-3727/40/14/008; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Hosoya A, 2008, HISTOCHEM CELL BIOL, V130, P1165, DOI 10.1007/s00418-008-0499-3; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kanta Jiri, 2011, Acta Medica (Hradec Kralove), V54, P97; Liebmann J, 2011, NITRIC OXIDE-BIOL CH, V24, P8, DOI 10.1016/j.niox.2010.09.005; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Thi MHN, 2014, PLASMA PROCESS POLYM, V11, P1076, DOI 10.1002/ppap.201400072; Ngo MHT, 2014, PLASMA PROCESS POLYM, V11, P80, DOI 10.1002/ppap.201300098; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Moisan M, 2002, PURE APPL CHEM, V74, P349, DOI 10.1351/pac200274030349; Orringer JS, 2004, ARCH DERMATOL, V140, P1326, DOI 10.1001/archderm.140.11.1326; Podoleanu AG, 2000, OPT EXPRESS, V7, P292, DOI 10.1364/OE.7.000292; RIGAL C, 1991, J INVEST DERMATOL, V96, P777, DOI 10.1111/1523-1747.ep12471745; SCHMITT JM, 1995, DERMATOLOGY, V191, P93, DOI 10.1159/000246523; Schwentker A, 2002, NITRIC OXIDE-BIOL CH, V7, P1, DOI 10.1016/S1089-8603(02)00002-2; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Stallmeyer B, 1999, J INVEST DERMATOL, V113, P1090, DOI 10.1046/j.1523-1747.1999.00784.x; STANLEY JR, 1981, J INVEST DERMATOL, V77, P240, DOI 10.1111/1523-1747.ep12480082; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Tomic-Canic Marjana, 2008, Adv Skin Wound Care, V21, P487, DOI 10.1097/01.ASW.0000323563.59885.1c; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Weller R, 2003, CLIN EXP DERMATOL, V28, P511, DOI 10.1046/j.1365-2230.2003.01365.x; Welzel J, 2001, SKIN RES TECHNOL, V7, P1, DOI 10.1034/j.1600-0846.2001.007001001.x; Weng CC, 2011, INT J RADIAT BIOL, V87, P936, DOI 10.3109/09553002.2011.577503; Witte MB, 2002, AM J SURG, V183, P406, DOI 10.1016/S0002-9610(02)00815-2; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055; Yu Y, 2011, J HUAZHONG U SCI-MED, V31, P390, DOI 10.1007/s11596-011-0387-2; Zheng Z, 2014, WOUND REPAIR REGEN, V22, P660, DOI 10.1111/wrr.12212	45	24	24	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156699	10.1371/journal.pone.0156699	http://dx.doi.org/10.1371/journal.pone.0156699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248979	Green Submitted, gold, Green Published			2022-12-26	WOS:000377184700068
J	Wu, KY; Chen, CNN; Soong, K				Wu, Kuoyan; Chen, Ching-Nen Nathan; Soong, Keryea			Long Distance Dispersal Potential of Two Seagrasses Thalassia hemprichii and Halophila ovalis	PLOS ONE			English	Article							DECIPIENS OSTENFELD HYDROCHARITACEAE; SEED RESERVE; FRAGMENTS; HABITAT; MARINE; COLONIZATION; MECHANISMS	The wide distribution of many seagrasses may be attributable to exploitation of currents. However, many species have seeds heavier than seawater, limiting surface floating, and thus, deep water becomes a potential barrier between suitable habitats. In this investigation, we studied the dispersal potential of various life history stages of two species of seagrasses, Thalassia hemprichii and Halophila ovalis, at Dongsha Atoll and Penghu Islands in Taiwan Strait, west Pacific. The adult plants of both species, often dislodged naturally from substrate by waves, could float, but only that of T. hemprichii could float for months and still remain alive and potentially able to colonize new territories. The seedlings of T. hemprichii could also float for about a month once failing to anchor to substrate of coral sand, but that of H. ovalis could not. The fruits and seeds of T. hemprichii could both float, but for too short a duration to enable long distance travel; those seeds released from long floating fruits had low germination rates in our tests. Obviously, their seeds are not adaptive for long distance dispersal. Fruits and seeds of H. ovalis do not float. The potential of animals as vectors was tested by feeding fruits and seeds of both species to a goose, a duck, and two fish in the laboratory. The fruits and seeds of T. hemprichii were digested and could no longer germinate; those of H. ovalis could pass through the digestive tracts and have a much higher germination rates than uningested controls. Therefore, birds could be important vectors for long distance dispersal of H. ovalis. The two seagrasses adopted very different dispersal mechanisms for long distance travel, and both exploited traits originally adaptive for other purposes.	[Wu, Kuoyan; Chen, Ching-Nen Nathan; Soong, Keryea] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung 80424, Taiwan; [Chen, Ching-Nen Nathan; Soong, Keryea] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan	National Sun Yat Sen University; National Sun Yat Sen University	Soong, K (corresponding author), Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung 80424, Taiwan.; Soong, K (corresponding author), Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Kaohsiung 80424, Taiwan.	keryea@gmail.com			Ministry of Science and Technology, Taiwan [MOST 102-2221E-110-053-MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Support was provided by MOST 102-2221-E-110-053-MY2 to CNC by the Ministry of Science and Technology, Taiwan [www.most.gov.tw]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN JR, 1994, MAR ECOL PROG SER, V103, P119, DOI 10.3354/meps103119; BIRCH WR, 1981, AQUAT BOT, V11, P79, DOI 10.1016/0304-3770(81)90048-6; Clark CJ, 2005, ECOLOGY, V86, P2684, DOI 10.1890/04-1325; Connell J, 1970, DYNAMICS POPULATION; Corlett RT, 2009, BIOTROPICA, V41, P592, DOI 10.1111/j.1744-7429.2009.00503.x; Di Carlo G, 2005, MAR BIOL, V147, P1261, DOI 10.1007/s00227-005-0035-0; Figuerola J, 2003, GLOBAL ECOL BIOGEOGR, V12, P427, DOI 10.1046/j.1466-822X.2003.00043.x; Figuerola J, 2002, FRESHWATER BIOL, V47, P483, DOI 10.1046/j.1365-2427.2002.00829.x; Godley BJ, 2003, MAR ECOL PROG SER, V253, P279, DOI 10.3354/meps253279; Hall LM, 2006, MAR ECOL PROG SER, V310, P109, DOI 10.3354/meps310109; Harwell MC, 2002, ECOLOGY, V83, P3319, DOI 10.2307/3072082; Heck KL, 2008, ECOSYSTEMS, V11, P1198, DOI 10.1007/s10021-008-9155-y; HIGHSMITH RC, 1980, OECOLOGIA, V46, P322, DOI 10.1007/BF00346259; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kallstrom B, 2008, AQUAT BOT, V88, P148, DOI 10.1016/j.aquabot.2007.09.005; Kendrick GA, 2012, BIOSCIENCE, V62, P56, DOI 10.1525/bio.2012.62.1.10; Ko C, 2004, TAXONOMIC DISTRIBUT; van Dijk JK, 2009, MAR ECOL PROG SER, V390, P67, DOI 10.3354/meps08190; KUO J, 1992, BOT MAR, V35, P197, DOI 10.1515/botm.1992.35.3.197; Lacap CDA, 2002, MAR ECOL PROG SER, V235, P75, DOI 10.3354/meps235075; Lee CL, 2015, MAR ECOL PROG SER, V525, P65, DOI 10.3354/meps11220; Les DH, 2003, INT J PLANT SCI, V164, P917, DOI 10.1086/378650; Les DH, 1997, SYST BOT, V22, P443, DOI 10.2307/2419820; Lo L, 2014, INVESTIGATION BREEDI; McMahon K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0878; MCMILLAN C, 1988, AQUAT BOT, V31, P177, DOI 10.1016/0304-3770(88)90047-2; MCMILLAN C, 1989, AQUAT BOT, V34, P375, DOI 10.1016/0304-3770(89)90080-6; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; OPDAM P, 1991, LANDSCAPE ECOL, V5, P93, DOI 10.1007/BF00124663; Ostenfeld C, 1908, REP DAN BIOL STN, V16, P1; Royo AA, 2008, CAN J FOREST RES, V38, P1634, DOI 10.1139/X07-247; SCHUETTE JL, 1995, PLANT PHYSIOL, V108, P1251, DOI 10.1104/pp.108.3.1251; SETCHELL WILLIAM ALBERT, 1929, UNIV CALIFORNIA PUBL BOT, V14, P389; Sheppard JK, 2006, J EXP MAR BIOL ECOL, V334, P64, DOI 10.1016/j.jembe.2006.01.011; Shie I, 2011, FISH RES I SPECIAL R, V34, P27; Shie I, 2014, FISH RES I SPECIAL R, V45, P24; Soong K, 2013, PLOS ONE, DOI [10.1371/journal.pone0074143, DOI 10.1371/JOURNAL.PONE0074143]; Sumoski SE, 2012, MAR ECOL PROG SER, V471, P1, DOI 10.3354/meps10145; Thomson FJ, 2010, J ECOL, V98, P1310, DOI 10.1111/j.1365-2745.2010.01724.x; Wilkinson DM, 1997, J BIOGEOGR, V24, P61, DOI 10.1111/j.1365-2699.1997.tb00050.x; Yamamuro M, 2005, J OCEANOGR, V61, P183, DOI 10.1007/s10872-005-0030-6	42	20	20	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156585	10.1371/journal.pone.0156585	http://dx.doi.org/10.1371/journal.pone.0156585			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248695	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700056
J	Lima, MJ; Muir, KR; Docherty, HM; McGowan, NWA; Forbes, S; Heremans, Y; Heimberg, H; Casey, J; Docherty, K				Lima, Maria J.; Muir, Kenneth R.; Docherty, Hilary M.; McGowan, Neil W. A.; Forbes, Shareen; Heremans, Yves; Heimberg, Harry; Casey, John; Docherty, Kevin			Generation of Functional Beta-Like Cells from Human Exocrine Pancreas	PLOS ONE			English	Article							INSULIN-PRODUCING CELLS; EMBRYONIC STEM-CELLS; IN-VITRO EXPANSION; EPITHELIAL-MESENCHYMAL TRANSITION; ISLET-LIKE CLUSTERS; SECRETING CELLS; EFFICIENT DIFFERENTIATION; ACINAR-CELLS; TRANSDIFFERENTIATION; EXPRESSION	Transcription factor mediated lineage reprogramming of human pancreatic exocrine tissue could conceivably provide an unlimited supply of islets for transplantation in the treatment of diabetes. Exocrine tissue can be efficiently reprogrammed to islet-like cells using a cocktail of transcription factors: Pdx1, Ngn3, MafA and Pax4 in combination with growth factors. We show here that overexpression of exogenous Pax4 in combination with suppression of the endogenous transcription factor ARX considerably enhances the production of functional insulin-secreting beta-like cells with concomitant suppression of alpha-cells. The efficiency was further increased by culture on laminin-coated plates in media containing low glucose concentrations. Immunocytochemistry revealed that reprogrammed cultures were composed of similar to 45% islet-like clusters comprising >80% monohormonal insulin(+) cells. The resultant beta-like cells expressed insulin protein levels at similar to 15-30% of that in adult human islets, efficiently processed proinsulin and packaged insulin into secretory granules, exhibited glucose responsive insulin secretion, and had an immediate and prolonged effect in normalising blood glucose levels upon transplantation into diabetic mice. We estimate that approximately 3 billion of these cells would have an immediate therapeutic effect following engraftment in type 1 diabetes patients and that one pancreas would provide sufficient tissue for numerous transplants.	[Lima, Maria J.; Muir, Kenneth R.; Docherty, Hilary M.; Docherty, Kevin] Univ Aberdeen, Inst Med Sci, Sch Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland; [McGowan, Neil W. A.; Casey, John] Univ Edinburgh, Royal Edinburgh Infirm, Dept Surg, Edinburgh EH16 4SU, Midlothian, Scotland; [Forbes, Shareen] Univ Edinburgh, Endocrinol Unit, Queens Med Res Inst, Univ BHF Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Heremans, Yves; Heimberg, Harry] Vrije Univ Brussel, Diabet Res Ctr, B-1090 Brussels, Belgium	University of Aberdeen; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; Vrije Universiteit Brussel	Lima, MJ (corresponding author), Univ Aberdeen, Inst Med Sci, Sch Med Sci, Foresterhill, Aberdeen AB25 2ZD, Scotland.	m.lima@abdn.ac.uk	Lima, Maria Joao/HHR-9895-2022; Forbes, Shareen/AAG-1816-2021	Lima, Maria Joao/0000-0003-0597-7892; Forbes, Shareen/0000-0002-9127-0641; Heimberg, Harry/0000-0003-1954-7375	Medical Research Council [MR/J015277/1]; National Services Division of NHS Scotland; Wellcome Trust / Scottish Translational Medicine and Therapeutics Initiative [85664]; MRC [MR/J015377/1] Funding Source: UKRI; Medical Research Council [MR/J015377/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Services Division of NHS Scotland; Wellcome Trust / Scottish Translational Medicine and Therapeutics Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Medical Research Council MR/J015277/1. The Scottish National Islet Transplant Programme is funded by the National Services Division of NHS Scotland. KRM was funded by a Fellowship from the Wellcome Trust / Scottish Translational Medicine and Therapeutics Initiative 85664.	Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849; Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Bar Y, 2012, J BIOL CHEM, V287, P17269, DOI 10.1074/jbc.M111.319152; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Blum B, 2014, ELIFE, V3, DOI 10.7554/eLife.02809; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Cho CHH, 2012, DIABETOLOGIA, V55, P3284, DOI 10.1007/s00125-012-2687-x; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Corritore E, 2014, CELL REPROGRAM, V16, P456, DOI 10.1089/cell.2014.0025; Courtney M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003934; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fanjul M, 2010, J HISTOCHEM CYTOCHEM, V58, P807, DOI 10.1369/jhc.2010.955807; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Furuya F, 2013, J BIOL CHEM, V288, P16155, DOI 10.1074/jbc.M112.438192; Gage BK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144100; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Hao E, 2006, NAT MED, V12, P310, DOI 10.1038/nm1367; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Jiang FX, 1999, DIABETES, V48, P722, DOI 10.2337/diabetes.48.4.722; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Koizumi M, 2004, SURGERY, V136, P449, DOI 10.1016/j.surg.2004.05.024; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lechner A, 2005, BIOCHEM BIOPH RES CO, V327, P581, DOI 10.1016/j.bbrc.2004.12.043; Lee J, 2013, ELIFE, V2, DOI 10.7554/eLife.00940; Lima MJ, 2013, DIABETES, V62, P2821, DOI 10.2337/db12-1256; Lima MJ, 2012, MOL CELL ENDOCRINOL, V358, P69, DOI 10.1016/j.mce.2012.02.024; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Minami K, 2008, J BIOL CHEM; Misiti S, 2005, J CELL PHYSIOL, V204, P286, DOI 10.1002/jcp.20293; Muir KR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140352; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rackham CL, 2011, DIABETOLOGIA, V54, P1127, DOI 10.1007/s00125-011-2053-4; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rooman I, 2000, DIABETOLOGIA, V43, P907, DOI 10.1007/s001250051468; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Spijker S, 1997, J BIOL CHEM, V272, P4116, DOI 10.1074/jbc.272.7.4116; Swales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037055; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tateishi K, 2008, J BIOL CHEM, V283, P31601, DOI 10.1074/jbc.M806597200; Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Yeung TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038189; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	55	23	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156204	10.1371/journal.pone.0156204	http://dx.doi.org/10.1371/journal.pone.0156204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243814	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100020
J	Sousa, FF; Mendes, SM; Santos-Amaya, OF; Araujo, OG; Oliveira, EE; Pereira, EJG				Sousa, Fernanda F.; Mendes, Simone M.; Santos-Amaya, Oscar F.; Araujo, Octavio G.; Oliveira, Eugenio E.; Pereira, Eliseu J. G.			Life-History Traits of Spodoptera frugiperda Populations Exposed to Low-Dose Bt Maize	PLOS ONE			English	Article							EUROPEAN CORN-BORER; HELIOTHIS-VIRESCENS LEPIDOPTERA; HELICOVERPA-ZEA LEPIDOPTERA; FIELD-EVOLVED RESISTANCE; BACILLUS-THURINGIENSIS; FALL ARMYWORM; INSECT RESISTANCE; TRANSGENIC COTTON; CRY1F RESISTANCE; NATURAL ENEMIES	Exposure to Bacillus thuringiensis (Bt) toxins in low-and moderate-dose transgenic crops may induce sublethal effects and increase the rate of Bt resistance evolution, potentially compromising control efficacy against target pests. We tested this hypothesis using the fall armyworm Spodoptera frugiperda, a major polyphagous lepidopteran pest relatively tolerant to Bt notorious for evolving field-relevant resistance to single-gene Bt maize. Late-instar larvae were collected from Bt Cry1Ab and non-Bt maize fields in five locations in Brazil, and their offspring was compared for survival, development, and population growth in rearing environment without and with Cry1Ab throughout larval development. Larval survival on Cry1Ab maize leaves varied from 20 to 80% among the populations. Larvae reared on Cry1Ab maize had seven-day delay in development time in relation to control larvae, and such delay was shorter in offspring of armyworms from Cry1Ab maize. Population growth rates were 50-70% lower for insects continuously exposed to Cry1Ab maize relative to controls, showing the population-level effect of Cry1Ab, which varied among the populations and prior exposure to Cry1Ab maize in the field. In three out of five populations, armyworms derived from Bt maize reared on Cry1Ab maize showed higher larval weight, faster larval development and better reproductive performance than the armyworms derived from non-Bt maize, and one of these populations showed better performance on both Cry1Ab and control diets, indicating no fitness cost of the resistance trait. Altogether, these results indicate that offspring of armyworms that developed on field-grown, single-gene Bt Cry1Ab maize had reduced performance on Cry1Ab maize foliage in two populations studied, but in other three populations, these offspring had better overall performance on the Bt maize foliage than that of the armyworms from non-Bt maize fields, possibly because of Cry1Ab resistance alleles in these populations. Implications of these findings for resistance management of S. frugiperda in Bt crops are discussed.	[Sousa, Fernanda F.; Santos-Amaya, Oscar F.; Oliveira, Eugenio E.; Pereira, Eliseu J. G.] Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil; [Santos-Amaya, Oscar F.; Pereira, Eliseu J. G.] Univ Fed Vicosa, Inst Nacl Ciencia & Tecnol Interacoes Planta Prag, BR-36570900 Vicosa, MG, Brazil; [Mendes, Simone M.; Araujo, Octavio G.] Embrapa Milho & Sorgo, Nucleo Fitossanidade, BR-35701970 Sete Lagoas, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Pereira, EJG (corresponding author), Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil.; Pereira, EJG (corresponding author), Univ Fed Vicosa, Inst Nacl Ciencia & Tecnol Interacoes Planta Prag, BR-36570900 Vicosa, MG, Brazil.	eliseu.pereira@ufv.br	Pereira, Eliseu José Guedes/C-5365-2015; de Oliveira, Eugênio Eduardo/F-4045-2016; de Oliveira, Eugenio Eduardo/ABE-8935-2021; Amaya, Oscar Fernando Santos/AAO-7338-2020	Pereira, Eliseu José Guedes/0000-0002-8957-6465; de Oliveira, Eugenio Eduardo/0000-0003-1174-6564; Amaya, Oscar Fernando Santos/0000-0001-5259-0370; Mendes, Simone/0000-0002-9773-9017	Arthur Bernardes Foundation (FUNARBE); Minas Gerais State Foundation for Research Aid (FAPEMIG); National Council of Scientific and Technological Development (CNPq); CAPES Foundation; Brazilian Ministry of Education	Arthur Bernardes Foundation (FUNARBE); Minas Gerais State Foundation for Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Ministry of Education	The authors are thankful for funds provided by the Arthur Bernardes Foundation (FUNARBE), the Minas Gerais State Foundation for Research Aid (FAPEMIG), the National Council of Scientific and Technological Development (CNPq), and the CAPES Foundation, Brazilian Ministry of Education. They also thank the staff and research assistants at the Brazilian Agricultural Research Corporation, Maize and Sorghum Center (Embrapa Milho & Sorgo), especially those in the Nucleo de Fitossanidade, that hosted and assisted F. F. Sousa in her master thesis research project.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; de Moraes ARA, 2015, BRAGANTIA, V74, P50, DOI 10.1590/1678-4499.0367; Alves Leite N, 2014, B INSECTOL, V67, P265; Andow DA, 2015, J ECON ENTOMOL; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Bernardi O, 2015, J ECON ENTOMOL, V108, P2711, DOI 10.1093/jee/tov219; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Carey JR., 1993, APPL DEMOGRAPHY BIOL; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; Chen Mao, 2006, Insect Science, V13, P409, DOI 10.1111/j.1744-7917.2006.00110.x; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Dutton A, 2005, ENTOMOL EXP APPL, V114, P161, DOI 10.1111/j.1570-7458.2005.00239.x; Eizaguirre M, 2005, J ECON ENTOMOL, V98, P464, DOI 10.1603/0022-0493-98.2.464; Environmental Protection Agency, 1998, FIFRA SCI ADV PAN M; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Federici BA, 2005, J INVERTEBR PATHOL, V89, P30, DOI 10.1016/j.jip.2005.06.007; Fernandes OD, 2010, REV BRAS MILHO SORGO, V2, P25, DOI DOI 10.18512/1980-6477/RBMS.V2N2P25-35; Frizzas MR, 2014, CIENC RURAL, V44, P203, DOI 10.1590/S0103-84782014000200002; Garcia M, 2015, PEST MANAG SCI, V71, P1631, DOI 10.1002/ps.3971; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1991, ENTOMOL EXP APPL, V58, P1, DOI 10.1007/BF00163307; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Gulzar A, 2015, ECOTOXICOLOGY, V24, P1815, DOI 10.1007/s10646-015-1517-6; Horner TA, 2003, J ECON ENTOMOL, V96, P914, DOI 10.1603/0022-0493-96.3.914; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112958; Huang FN, 2011, ENTOMOL EXP APPL, V140, P1, DOI 10.1111/j.1570-7458.2011.01138.x; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; James C., 2013, GLOBAL STATUS COMMER; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; JOHNSON MT, 1992, ENVIRON ENTOMOL, V21, P586, DOI 10.1093/ee/21.3.586; Kasten P. Jr., 1978, Revista de Agricultura, V53, P68; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Leite NA, 2016, ENTOMOL EXP APPL, V158, P236, DOI 10.1111/eea.12399; Li B, 2015, PEST MANAG SCI, V71, P1433, DOI 10.1002/ps.3948; Liu XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090366; Liu YB, 1999, NATURE, V400, P519, DOI 10.1038/22919; Lourencao ALF, 2013, CIENTIFICA, V41, P164; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; MACINTOSH SC, 1990, J INVERTEBR PATHOL, V56, P258, DOI 10.1016/0022-2011(90)90109-J; Maia AHN, 2000, J ECON ENTOMOL, V93, P511, DOI 10.1603/0022-0493-93.2.511; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Mendes SM, 2012, BIOSCI J, V28, P753; Mendes SM, 2011, PESQUI AGROPECU BRAS, V46, P239, DOI 10.1590/S0100-204X2011000300003; Nyouki FFR, 1996, J ENTOMOL SCI, V31, P52, DOI 10.18474/0749-8004-31.1.52; Omoto C, 2016, PEST MANAG SCI, V72, P1727, DOI 10.1002/ps.4201; Onstad DW, 2013, J ECON ENTOMOL, V106, P1103, DOI 10.1603/EC12287; Onstad DW, 2014, INSECT RESISTANCE MA, P1, DOI DOI 10.1016/B978-0-12-396955-2.00001-1; Peck SL, 1999, J ECON ENTOMOL, V92, P1, DOI 10.1093/jee/92.1.1; Pereira EJG, 2011, J APPL ENTOMOL, V135, P17, DOI 10.1111/j.1439-0418.2009.01488.x; Pereira EJG, 2008, B ENTOMOL RES, V98, P621, DOI 10.1017/S0007485308005920; Ritchie S.W, 1992, IOWA STATE U SCI TEC; Roush RT, 1997, PESTIC SCI, V51, P328, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;328::AID-PS650&gt;3.0.CO;2-B; SALAMA HS, 1981, J INVERTEBR PATHOL, V38, P220, DOI 10.1016/0022-2011(81)90126-9; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Santos-Amaya OF, 2016, CROP PROT, V81, P154, DOI 10.1016/j.cropro.2015.12.014; Santos-Amaya OF, 2015, SCI REP-UK, V5, DOI 10.1038/srep18243; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sedaratian A, 2013, J APPL ENTOMOL, V137, P540, DOI 10.1111/jen.12030; Siegfried BD, 2001, ENTOMOL EXP APPL, V100, P15, DOI 10.1023/A:1019250807782; Southwood TRE, 2000, ECOLOGICAL METHODS; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Storer NP, 2001, J ECON ENTOMOL, V94, P1268, DOI 10.1603/0022-0493-94.5.1268; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; TABASHNIK BE, 1982, ENVIRON ENTOMOL, V11, P1137, DOI 10.1093/ee/11.6.1137; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Uesugi A, 2015, ECOL ENTOMOL, V40, P221, DOI 10.1111/een.12177; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Waquil JM, 2010, REV BRAS MILHO SORGO, V3, P161; Waquil JM, 2013, PESQUI AGROPECU BRAS, V48, P1529, DOI 10.1590/S0100-204X2013001200001; WESELOH RM, 1983, J INVERTEBR PATHOL, V41, P99, DOI 10.1016/0022-2011(83)90240-9; Westbrook JK, 2016, INT J BIOMETEOROL, V60, P255, DOI 10.1007/s00484-015-1022-x; Zoerb AC, 2003, CROP PROT, V22, P179, DOI 10.1016/S0261-2194(02)00143-6	74	26	28	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156608	10.1371/journal.pone.0156608	http://dx.doi.org/10.1371/journal.pone.0156608			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243977	gold, Green Published, Green Submitted			2022-12-26	WOS:000377146100053
J	Liu, Z; Lam, N; Wang, E; Virden, RA; Pawel, B; Attiyeh, EF; Maris, JM; Thiele, CJ				Liu, Z.; Lam, N.; Wang, E.; Virden, R. A.; Pawel, B.; Attiyeh, E. F.; Maris, J. M.; Thiele, C. J.			Identification of CASZ1 NES reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma	ONCOGENE			English	Article							NUCLEAR EXPORT SIGNALS; TRANSCRIPTION FACTOR; P53 TETRAMERIZATION; GENE-EXPRESSION; CRM1 INHIBITOR; DNA-DAMAGE; IN-VIVO; PROTEIN; LOCALIZATION; PHOSPHORYLATION	As a transcription factor, localization to the nucleus and the recruitment of cofactors to regulate gene transcription is essential. Nuclear localization and nucleosome remodeling and histone deacetylase (NuRD) complex binding are required for the zinc-finger transcription factor CASZ1 to function as a neuroblastoma (NB) tumor suppressor. However, the critical amino acids (AAs) that are required for CASZ1 interaction with NuRD complex and the regulation of CASZ1 subcellular localization have not been characterized. Through alanine scanning, immunofluorescence cell staining and co-immunoprecipitation, we define a critical region at the CASZ1 N terminus (AAs 23-40) that mediates the CASZ1b nuclear localization and NuRD interaction. Furthermore, we identified a nuclear export signal (NES) at the N terminus (AAs 176-192) that contributes to CASZ1 nuclear-cytoplasmic shuttling in a chromosomal maintenance 1 -dependent manner. An analysis of CASZ1 protein expression in a primary NB tissue microarray shows that high nuclear CASZ1 staining is detected in tumor samples from NB patients with good prognosis. In contrast, cytoplasmic-restricted CASZ1 staining or low nuclear CASZ1 staining is found in tumor samples from patients with poor prognosis. These findings provide insight into mechanisms by which CASZ1 regulates transcription, and suggests that regulation of CASZ1 subcellular localization may impact its function in normal development and pathologic conditions such as NB tumorigenesis.	[Liu, Z.; Lam, N.; Wang, E.; Virden, R. A.; Thiele, C. J.] NCI, Pediat Oncol Branch, 9000 Rockville Pike,Bldg 10,Room 1W-3940,MSC 1105, Bethesda, MD 20892 USA; [Pawel, B.; Attiyeh, E. F.; Maris, J. M.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Thiele, CJ (corresponding author), NCI, Pediat Oncol Branch, 9000 Rockville Pike,Bldg 10,Room 1W-3940,MSC 1105, Bethesda, MD 20892 USA.	thielec@mail.nih.gov			Intramural Research Program of the NIH; National Cancer Institute; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010788] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Gregory Wray from the Institute for Genome Sciences and Policy, Duke University for generously providing the tyrosine hydroxylase promoter-pGL4.1-luc (TH-Luc) construct; Nisha Pawer and Neeraj Prasad of the POB, NCI for making the CASZ1b and mutant-EGFP constructs. We appreciate the insightful discussions with Drs Dinah Singer and David Levens of the CCR, NCI on this study. This work was supported by the Intramural Research Program of the NIH, National Cancer Institute and Center for Cancer Research.	Bottardi S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004827; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Charpentier MS, 2013, DEV CELL, V25, P132, DOI 10.1016/j.devcel.2013.03.003; Chayka O, 2009, JNCI-J NATL CANCER I, V101, P663, DOI 10.1093/jnci/djp063; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; CUI X, 1992, DEVELOPMENT, V116, P943; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gerecitano J, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0067-3; Henrich KO, 2012, CANCER RES, V72, P6079, DOI 10.1158/0008-5472.CAN-12-2230; Hoff AM, 2015, ONCOTARGET, V6, P36587, DOI 10.18632/oncotarget.5500; Ishizawa J, 2015, PHARMACOL THERAPEUT, V153, P25, DOI 10.1016/j.pharmthera.2015.06.001; Jiang JH, 2011, CANCER RES, V71, P5546, DOI 10.1158/0008-5472.CAN-10-3423; Jiao W, 2006, J BIOL CHEM, V281, P38098, DOI 10.1074/jbc.M605271200; Jordan VK, 2015, APPL CLIN GENET, V8, P189, DOI 10.2147/TACG.S65698; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kulisz A, 2008, MOL CELL BIOL, V28, P1553, DOI 10.1128/MCB.00935-07; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Liang SH, 1999, J BIOL CHEM, V274, P32699, DOI 10.1074/jbc.274.46.32699; Liu Z, 2011, CELL DEATH DIFFER, V18, P1174, DOI 10.1038/cdd.2010.187; Liu ZT, 2011, EURASIP J ADV SIG PR, DOI 10.1155/2011/490289; Liu ZZ, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00001; Liu ZH, 2006, BIOCHEM BIOPH RES CO, V344, P834, DOI 10.1016/j.bbrc.2006.03.207; Liu ZH, 2014, J BIOL CHEM, V289, P29801, DOI 10.1074/jbc.M114.570416; Malki S, 2010, INT J BIOCHEM CELL B, V42, P411, DOI 10.1016/j.biocel.2009.09.020; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mattar P, 2015, NEURON, V85, P497, DOI 10.1016/j.neuron.2014.12.052; MELLERICK DM, 1992, NEURON, V9, P789, DOI 10.1016/0896-6273(92)90234-5; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Nguyen Kevin T, 2012, Int J Biochem Mol Biol, V3, P137; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Prieto G, 2014, BIOINFORMATICS, V30, P1220, DOI 10.1093/bioinformatics/btu016; Ranganathan P, 2012, BLOOD, V120, P1765, DOI 10.1182/blood-2012-04-423160; Rehberg S, 2002, MOL CELL BIOL, V22, P5826, DOI 10.1128/MCB.22.16.5826-5834.2002; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Sakakibara K, 2011, BLOOD, V118, P3922, DOI 10.1182/blood-2011-01-333138; Schmitz M, 2012, INT J CANCER, V131, pE593, DOI 10.1002/ijc.27433; Schulte JH, 2009, INT J CANCER, V124, P2488, DOI 10.1002/ijc.24204; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeuchi F, 2010, CIRCULATION, V121, P2302, DOI 10.1161/CIRCULATIONAHA.109.904664; Vacalla CMH, 2002, MECH DEVELOP, V118, P265, DOI 10.1016/S0925-4773(02)00282-4; Virden RA, 2012, MOL CELL BIOL, V32, P1518, DOI 10.1128/MCB.06039-11; Wang C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001564; Warner LR, 2009, BRAIN RES, V1288, P1, DOI 10.1016/j.brainres.2009.06.086; Winter C, 2008, PEDIATR BLOOD CANCER, V51, P10, DOI 10.1002/pbc.21475; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	52	8	8	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 5	2017	36	1					97	109		10.1038/onc.2016.179	http://dx.doi.org/10.1038/onc.2016.179			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK6XJ	27270431	Green Accepted			2022-12-26	WOS:000394069100009
J	Carrasco-Benso, MP; Rivero-Gutierrez, B; Lopez-Minguez, J; Anzola, A; Diez-Noguera, A; Madrid, JA; Lujan, JA; Martinez-Augustin, O; Scheer, FAJL; Garaulet, M				Carrasco-Benso, Maria P.; Rivero-Gutierrez, Belen; Lopez-Minguez, Jesus; Anzola, Andrea; Diez-Noguera, Antoni; Madrid, Juan A.; Lujan, Juan A.; Martinez-Augustin, Olga; Scheer, Frank A. J. L.; Garaulet, Marta			Human adipose tissue expresses intrinsic circadian rhythm in insulin sensitivity	FASEB JOURNAL			English	Article						obesity; glucose tolerance; diabetes	GLUCOSE-TOLERANCE; DIURNAL-VARIATION; SECRETION; CLOCK; ADIPONECTIN	In humans, insulin sensitivity varies according to time of day, with decreased values in the evening and at night. Mechanisms responsible for the diurnal variation in insulin sensitivity are unclear. We investigated whether human adipose tissue (AT) expresses intrinsic circadian rhythms in insulin sensitivity that could contribute to this phenomenon. Subcutaneous and visceral AT biopsies were obtained from extremely obese participants (body mass index, 41.8 +/- 6.3 kg/m(2); 46 +/- 11 y) during gastric-bypass surgery. To assess the rhythm in insulin signaling, AKT phosphorylation was determined every 4 h over 24 h in vitro in response to different insulin concentrations (0, 1, 10, and 100 nM). Data revealed that subcutaneous AT exhibited robust circadian rhythms in insulin signaling (P < 0.00001). Insulin sensitivity reached its maximum (acrophase) around noon, being 54% higher than during midnight (P = 0.009). The amplitude of the rhythm was positively correlated with in vivo sleep duration (r = 0.53; P = 0.023) and negatively correlated with in vivo bedtime (r = -0.54; P = 0.020). No circadian rhythms were detected in visceral AT (P = 0.643). Here, we demonstrate the relevance of the time of the day for how sensitive AT is to the effects of insulin. Subcutaneous AT shows an endogenous circadian rhythm in insulin sensitivity that could provide an underlying mechanism for the daily rhythm in systemic insulin sensitivity.Carrasco-Benso, M. P., Rivero-Gutierrez, B., Lopez-Minguez, J., Anzola, A., Diez-Noguera, A., Madrid, J. A., Lujan, J. A., Martinez-Augustin, O., Scheer, F. A. J. L., Garaulet, M. Human adipose tissue expresses intrinsic circadian rhythm in insulin sensitivity.	[Carrasco-Benso, Maria P.; Lopez-Minguez, Jesus; Madrid, Juan A.; Garaulet, Marta] Univ Murcia, Biomed Res Inst Murcia IMIB Arrixaca, Fac Biol, Dept Physiol,Biol, Murcia, Spain; [Rivero-Gutierrez, Belen; Anzola, Andrea; Martinez-Augustin, Olga] Univ Granada, Inst Invest Biosanitaria Granada, Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Dept Biochem & Mol Biol 2,Sch Pharm, Granada, Spain; [Diez-Noguera, Antoni] Univ Barcelona, Fac Pharm, Dept Physiol, Barcelona, Spain; [Lujan, Juan A.] Univ Hosp Virgen de la Arrixaca, Gen Surg Serv, Murcia, Spain; [Scheer, Frank A. J. L.] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Scheer, Frank A. J. L.] Harvard Med Sch, Div Sleep Med, Boston, MA USA	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; University of Barcelona; Hospital Clinico Universitario Virgen de la Arrixaca; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Scheer, FAJL (corresponding author), Brigham & Womens Hosp, Med Chronobiol Program, Div Sleep & Circadian Disorders, 221 Longwood Ave, Boston, MA 02115 USA.; Garaulet, M (corresponding author), Univ Murcia, Dept Physiol, Campus Espinardo, E-30100 Murcia, Spain.	fscheer@bwh.harvard.edu; garaulet@um.es	Augustin, Olga Martínez/K-6720-2014; Garaulet, Marta/K-6625-2014; Rivero-Gutiérrez, Belen/K-8784-2019; Scheer, Frank A.J.L./C-2795-2012	Augustin, Olga Martínez/0000-0001-8291-3468; Garaulet, Marta/0000-0002-4066-3509; Rivero-Gutiérrez, Belen/0000-0002-1263-0873; Scheer, Frank A.J.L./0000-0002-2014-7582; Lujan Mompean, Juan Antonio/0000-0003-4987-7578; Madrid, Juan Antonio/0000-0002-9286-1371; Maria Paz, Carrasco-Benso/0000-0001-5611-4929	Spanish Government of Economy and Competitiveness [SAF2014-52480-R]; European Regional Development Fund (ERDF) [SAF2011-22812]; Seneca Foundation from the Government of Murcia [15123/PI/10]; U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [R01-DK099512]; U.S. National Institutes of Health (National Heart, Lung, and Blood Institute) [R01-HL118601]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099512] Funding Source: NIH RePORTER	Spanish Government of Economy and Competitiveness; European Regional Development Fund (ERDF)(European Commission); Seneca Foundation from the Government of Murcia(Fundacion Seneca); U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Spanish Government of Economy and Competitiveness (Grant SAF2014-52480-R) and from European Regional Development Fund (ERDF) (to M.G.), Grant SAF2011-22812 (to O.M.-A.), the Seneca Foundation from the Government of Murcia (15123/PI/10; to M.G.), and by U.S. National Institutes of Health Grants R01-DK099512 (National Institute of Diabetes and Digestive and Kidney Diseases) and R01-HL118601 (National Heart, Lung, and Blood Institute) (to F.A.J.L.S.). Author contributions: M. P. Carrasco-Benso conducted the experiments, performed the cultures, analyzed data, and wrote the paper; B. Rivero-Gutierrez performed Western blot experiments; J. Lopez-Minguez performed the cultures; A. Anzola performed Western blot experiments; A. Diez-Noguera analyzed circadian data; J. A. Madrid gave advice for circadian aspects; J. A. Lujan recruited the study participants and performed the biopsies; O. Martinez-Augustin directed the Western blot experiments; and F. A. J. L. Scheer and M. Garaulet designed research, wrote the paper, and have primary responsibility for final content.	Anothaisintawee T, 2016, SLEEP MED REV, V30, P11, DOI 10.1016/j.smrv.2015.10.002; Barnea M, 2015, MOL CELL ENDOCRINOL, V399, P284, DOI 10.1016/j.mce.2014.10.018; Batschelet E, 1981, CIRCULAR STAT BIOL, V111; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Broussard JL, 2012, ANN INTERN MED, V157, P549, DOI 10.7326/0003-4819-157-8-201210160-00005; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; CARROLL KF, 1973, DIABETES, V22, P333, DOI 10.2337/diab.22.5.333; Corbalan-Tutau D, 2014, PHYSIOL BEHAV, V123, P231, DOI 10.1016/j.physbeh.2012.06.005; Garaulet M, 2006, J PHYSIOL BIOCHEM, V62, P245, DOI 10.1007/BF03165753; Garaulet M, 2007, PUBLIC HEALTH NUTR, V10, P1145, DOI 10.1017/S1368980007000638; Garaulet M, 2011, J CELL PHYSIOL, V226, P2075, DOI 10.1002/jcp.22531; Gomez-Abellan P, 2010, ENDOCRINOLOGY, V151, P115, DOI 10.1210/en.2009-0647; Gomez-Santos C, 2009, OBESITY, V17, P1481, DOI 10.1038/oby.2009.164; Harfmann BD, 2015, J BIOL RHYTHM, V30, P84, DOI 10.1177/0748730414561638; Jakubowicz D, 2013, OBESITY, V21, P2504, DOI 10.1002/oby.20460; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Morris CJ, 2015, P NATL ACAD SCI USA, V112, pE2225, DOI 10.1073/pnas.1418955112; Nakajima K, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0147-0; Pagani L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013376; Saad A, 2012, DIABETES, V61, P2691, DOI 10.2337/db11-1478; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Saini C, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00095; Scheer FAJL, 2010, DIABETOLOGIA, V53, P2401, DOI 10.1007/s00125-010-1869-7; Scheer FAJL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000721; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; SERVICE FJ, 1983, DIABETOLOGIA, V25, P316, DOI 10.1007/BF00253193; SHAPIRO ET, 1988, J CLIN ENDOCR METAB, V67, P307, DOI 10.1210/jcem-67-2-307; Van Cauter E, 2011, DIABETIC MED, V28, P1455, DOI 10.1111/j.1464-5491.2011.03459.x; van der Spek R, 2012, PROG BRAIN RES, V199, P183, DOI 10.1016/B978-0-444-59427-3.00011-3; VANCAUTER E, 1991, J CLIN INVEST, V88, P934, DOI 10.1172/JCI115396; Yoshino J, 2014, J CLIN ENDOCR METAB, V99, pE1666, DOI 10.1210/jc.2014-1579	31	45	47	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3117	3123		10.1096/fj.201600269RR	http://dx.doi.org/10.1096/fj.201600269RR			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27256623	Green Published			2022-12-26	WOS:000382816300012
J	Croasdell, A; Sime, PJ; Phipps, RP				Croasdell, Amanda; Sime, Patricia J.; Phipps, Richard P.			Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes	FASEB JOURNAL			English	Article						inflammation; LPS; MD-2; microRNA-146a; SPM	TOLL-LIKE RECEPTORS; LIPID MEDIATORS; PROMOTE RESOLUTION; ACUTE-INFLAMMATION; PROTECTS MICE; MEMBER RELB; LIPOXIN A4; D1; LIPOPOLYSACCHARIDE; PATHWAY	TLRs are critical for innate immunity, but excessive activation can lead to tissue damage and disease. Specialized proresolving mediators (SPMs), including resolvin D2 (RvD2), promote the active resolution of inflammation. How SPMs regulate early LPS signaling, including activation of TLR4, is unknown. We treated human THP-1 monocytic cells and primary human blood monocytes with RvD2 and LPS to evaluate modulation of TLRs. miRNA-146a overexpression and inhibition were used to dissect the mechanism of RvD2-mediated actions. We validated our studies using ELISAs for cytokines, PCR, Western blot analysis, and flow cytometry. Cells treated with 0.1% ethanol (control for RvD2) and/or PBS (control for LPS), and control microRNA mimics and inhibitors were used as controls. RvD2 reduced LPS-induced cytokines and TLR4 expression in human monocytes by up to 75%. In THP-1 cells, RvD2 reduced expression of TLR4, lymphocyte antigen 96 (MD-2), and downstream signals (MyD88, TRIF, and TAK1). These effects were partially mediated through RvD2 induction of microRNA-146a, and RvD2's actions were blocked by microRNA-146a inhibition. These new findings reveal the ability of RvD2 to reduce TLR4 expression and attenuate LPS-induced inflammation, providing a new area of SPM activity to investigate in this major area of therapeutic research.Croasdell, A., Sime, P. J., Phipps, R. P. Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes.	[Croasdell, Amanda; Sime, Patricia J.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Box 850,Del Monte Bldg,601 Elmwood Ave, Rochester, NY 14642 USA; [Sime, Patricia J.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Phipps, RP (corresponding author), Univ Rochester, Sch Med & Dent, Dept Environm Med, Box 850,Del Monte Bldg,601 Elmwood Ave, Rochester, NY 14642 USA.	richard_phipps@urmc.rochester.edu			U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [T32ES007026, P30ES01247]; NIH National Heart, Lung, and Blood Institute [R01HL120908, T32HL066988]; NIH Clinical and Translational Science Institute (CTSI) Incubator [UL1RR024160]; NIH CTSI Trainee Pilot [8UL1TR000042]; PhRMA Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120908, T32HL066988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007026, P30ES001247] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Clinical and Translational Science Institute (CTSI) Incubator(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CTSI Trainee Pilot(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank the University of Rochester Medical Center Blood Bank and A. Casey for phlebotomy assistance in collecting blood donations, C. Woeller for his guidance on the microRNA experiments, and the University of Rochester Medical Center Flow Cytometry Core for its flow cytometry assistance. This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grants T32ES007026 and P30ES01247; NIH National Heart, Lung, and Blood Institute Grants R01HL120908 and T32HL066988; NIH Clinical and Translational Science Institute (CTSI) Incubator Grant UL1RR024160, NIH CTSI Trainee Pilot Grant 8UL1TR000042; and the PhRMA Foundation. Author contributions: A. Croasdell designed and performed experiments, analyzed and interpreted data, and wrote the manuscript. P. Sime and R. Phipps designed experiments, interpreted data, and wrote the manuscript. All authors are members of the Lung Biology and Disease Program (University of Rochester School of Medicine and Dentistry).	Abdulnour RE, 2016, MUCOSAL IMMUNOL, V9, P1278, DOI 10.1038/mi.2015.129; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen F, 2014, EUR J CLIN MICROBIOL, V33, P457, DOI 10.1007/s10096-013-1978-6; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; Croasdell A, 2016, J IMMUNOL, V196, P2742, DOI 10.4049/jimmunol.1502331; Croasdell A, 2015, AM J PHYSIOL-LUNG C, V309, pL888, DOI 10.1152/ajplung.00125.2015; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; El Gazzar M, 2011, J LEUKOCYTE BIOL, V90, P509, DOI 10.1189/jlb.0211074; Gu Z, 2016, INNATE IMMUN-LONDON, V22, P186, DOI 10.1177/1753425916628618; Hashimoto A, 2007, J RHEUMATOL, V34, P2144; He XB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/945169; Hsiao HM, 2015, AM J PATHOL, V185, P3189, DOI 10.1016/j.ajpath.2015.08.008; Hsiao HM, 2014, J IMMUNOL, V193, P4980, DOI 10.4049/jimmunol.1400313; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Huang C, 2016, INT IMMUNOPHARMACOL, V32, P46, DOI 10.1016/j.intimp.2016.01.009; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Koltsida O, 2013, EMBO MOL MED, V5, P762, DOI 10.1002/emmm.201201891; Kong X, 2015, MOL MED REP, V12, P895, DOI 10.3892/mmr.2015.3443; Kovach MA, 2011, INT IMMUNOPHARMACOL, V11, P1399, DOI 10.1016/j.intimp.2011.05.013; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Lafferty EI, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-57; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Lastrucci C, 2015, FASEB J, V29, P1914, DOI 10.1096/fj.14-259341; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li YH, 2009, AM J PHYSIOL-REG I, V297, pR1670, DOI 10.1152/ajpregu.00445.2009; Liao ZL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-110; Maris NA, 2006, EUR RESPIR J, V28, P622, DOI 10.1183/09031936.06.00010806; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; McMillan DH, 2013, AM J PHYSIOL-LUNG C, V304, pL774, DOI 10.1152/ajplung.00352.2012; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Pace E, 2011, HUM IMMUNOL, V72, P54, DOI 10.1016/j.humimm.2010.09.009; Palmer CD, 2011, J LEUKOCYTE BIOL, V90, P459, DOI 10.1189/jlb.0311145; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Perera PY, 1997, J IMMUNOL, V158, P4422; Ramon S, 2012, J IMMUNOL, V189, P1036, DOI 10.4049/jimmunol.1103483; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Szatmary Z, 2012, GEN PHYSIOL BIOPHYS, V31, P357, DOI 10.4149/gpb_2012_048; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tesse R, 2011, ALLERGY, V66, P307, DOI 10.1111/j.1398-9995.2010.02489.x; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tumurkhuu G, 2015, J IMMUNOL, V194, P1686, DOI 10.4049/jimmunol.1402123; Wang B, 2011, PULM PHARMACOL THER, V24, P434, DOI 10.1016/j.pupt.2011.04.001; Wang YH, 2014, INFLAMMATION, V37, P1903, DOI 10.1007/s10753-014-9922-1; Wu DR, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/964012; Xie N, 2014, J IMMUNOL, V193, P327, DOI 10.4049/jimmunol.1400203; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zago M, 2014, TOXICOL LETT, V226, P107, DOI 10.1016/j.toxlet.2014.01.020	66	19	20	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3181	3193		10.1096/fj.201600375R	http://dx.doi.org/10.1096/fj.201600375R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27256622	Green Published			2022-12-26	WOS:000382816300018
J	Klaus, M; Ostrowski, MP; Austerjost, J; Robbins, T; Lowry, B; Cane, DE; Khosla, C				Klaus, Maja; Ostrowski, Matthew P.; Austerjost, Jonas; Robbins, Thomas; Lowry, Brian; Cane, David E.; Khosla, Chaitan			Protein-Protein Interactions, Not Substrate Recognition, Dominate the Turnover of Chimeric Assembly Line Polyketide Synthases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							6-DEOXYERYTHRONOLIDE B SYNTHASE; BIOSYNTHESIS; DOMAINS; MODULES; DESIGN; SPECIFICITY; MECHANISM; RAPAMYCIN; GENES	The potential for recombining intact polyketide synthase (PKS) modules has been extensively explored. Both enzyme-substrate and protein-protein interactions influence chimeric PKS activity, but their relative contributions are unclear. We now address this issue by studying a library of 11 bimodular and 8 trimodular chimeric PKSs harboring modules from the erythromycin, rifamycin, and rapamycin synthases. Although many chimeras yielded detectable products, nearly all had specific activities below 10% of the reference natural PKSs. Analysis of selected bimodular chimeras, each with the same upstream module, revealed that turnover correlated with the efficiency of intermodular chain translocation. Mutation of the acyl carrier protein (ACP) domain of the upstream module in one chimera at a residue predicted to influence ketosynthase-ACP recognition led to improved turnover. In contrast, replacement of the ketoreductase domain of the upstream module by a paralog that produced the enantiomeric ACP-bound diketide caused no changes in processing rates for each of six heterologous downstream modules compared with those of the native diketide. Taken together, these results demonstrate that protein-protein interactions play a larger role than enzyme-substrate recognition in the evolution or design of catalytically efficient chimeric PKSs.	[Klaus, Maja; Ostrowski, Matthew P.; Austerjost, Jonas; Robbins, Thomas; Lowry, Brian; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Klaus, Maja; Ostrowski, Matthew P.; Austerjost, Jonas; Robbins, Thomas; Lowry, Brian; Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Klaus, Maja; Ostrowski, Matthew P.; Austerjost, Jonas; Robbins, Thomas; Lowry, Brian; Khosla, Chaitan] Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA; [Cane, David E.] Brown Univ, Dept Chem, Providence, RI 02912 USA	Stanford University; Stanford University; Stanford University; Brown University	Khosla, C (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA.	khosla@stanford.edu		Khosla, Chaitan/0000-0001-6529-495X	National Institutes of Health [GM 087934, GM 022172]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087934, R01GM022172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM 087934 (to C. K.) and GM 022172 (to D. E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Buchholz TJ, 2009, ACS CHEM BIOL, V4, P41, DOI 10.1021/cb8002607; CORTES J, 1990, NATURE, V348, P176, DOI 10.1038/348176a0; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Hartung IV, 2005, J AM CHEM SOC, V127, P11202, DOI 10.1021/ja051430y; Hughes AJ, 2011, CHEM BIOL, V18, P165, DOI 10.1016/j.chembiol.2010.12.014; Jacobsen JR, 1998, BIOCHEMISTRY-US, V37, P4928, DOI 10.1021/bi9729920; Kapur S, 2012, P NATL ACAD SCI USA, V109, P4110, DOI 10.1073/pnas.1118734109; Kapur S, 2010, P NATL ACAD SCI USA, V107, P22066, DOI 10.1073/pnas.1014081107; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Khosla C, 2014, BIOCHEMISTRY-US, V53, P2875, DOI 10.1021/bi500290t; Lowry B, 2016, ACS CENTRAL SCI, V2, P14, DOI 10.1021/acscentsci.5b00321; Lowry B, 2013, J AM CHEM SOC, V135, P16809, DOI 10.1021/ja409048k; McDaniel R, 1997, CHEM BIOL, V4, P667, DOI 10.1016/S1074-5521(97)90222-2; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Menzella HG, 2007, CHEM BIOL, V14, P143, DOI 10.1016/j.chembiol.2006.12.002; Ostrowski MP, 2016, J ANTIBIOT, V69, P507, DOI 10.1038/ja.2016.41; Park SR, 2010, J ANTIBIOT, V63, P434, DOI 10.1038/ja.2010.71; Pfeifer BA, 2001, SCIENCE, V291, P1790, DOI 10.1126/science.1058092; Ranganathan A, 1999, CHEM BIOL, V6, P731, DOI 10.1016/S1074-5521(00)80020-4; Robbins T, 2016, CURR OPIN STRUC BIOL, V41, P10, DOI 10.1016/j.sbi.2016.05.009; SCHWECKE T, 1995, P NATL ACAD SCI USA, V92, P7839, DOI 10.1073/pnas.92.17.7839; Tsuji SY, 2001, BIOCHEMISTRY-US, V40, P2326, DOI 10.1021/bi002463n; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Watanabe K, 2003, J BIOL CHEM, V278, P42020, DOI 10.1074/jbc.M305339200; Wu N, 2001, J AM CHEM SOC, V123, P6465, DOI 10.1021/ja010219t; You YO, 2013, J AM CHEM SOC, V135, P7406, DOI 10.1021/ja4014776; Yu TW, 1999, P NATL ACAD SCI USA, V96, P9051, DOI 10.1073/pnas.96.16.9051	28	38	39	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16404	16415		10.1074/jbc.M116.730531	http://dx.doi.org/10.1074/jbc.M116.730531			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27246853	Green Published, hybrid			2022-12-26	WOS:000380585400042
J	Buonocore, JJ; Lambert, KF; Burtraw, D; Sekar, S; Driscoll, CT				Buonocore, Jonathan J.; Lambert, Kathleen F.; Burtraw, Dallas; Sekar, Samantha; Driscoll, Charles T.			An Analysis of Costs and Health Co-Benefits for a US Power Plant Carbon Standard	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; FINE PARTICULATE MATTER; TERM CLIMATE-CHANGE; FUTURE AIR-QUALITY; POLLUTION; OZONE; POLICY; METAANALYSIS; MITIGATION; LIFE	Reducing carbon dioxide (CO2) emissions from power plants can have important "co-benefits" for public health by reducing emissions of air pollutants. Here, we examine the costs and health co-benefits, in monetary terms, for a policy that resembles the U.S. Environmental Protection Agency's Clean Power Plan. We then examine the spatial distribution of the co-benefits and costs, and the implications of a range of cost assumptions in the implementation year of 2020. Nationwide, the total health co-benefits were $29 billion 2010 USD (95% CI: $2.3 to $68 billion), and net co-benefits under our central cost case were $12 billion (95% CI: -$15 billion to $51 billion). Net co-benefits for this case in the implementation year were positive in 10 of the 14 regions studied. The results for our central case suggest that all but one region should experience positive net benefits within 5 years after implementation.	[Buonocore, Jonathan J.] Harvard Univ, Ctr Hlth & Global Environm, TH Chan Sch Publ Hlth, Boston, MA 02215 USA; [Lambert, Kathleen F.] Harvard Univ, Harvard Forest, Petersham, MA 01366 USA; [Burtraw, Dallas; Sekar, Samantha] Resources Future Inc, Washington, DC 20036 USA; [Driscoll, Charles T.] Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA; [Sekar, Samantha] Stanford Univ, Emmett Interdisciplinary Program Environm & Resou, Palo Alto, CA 94305 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Resources for the Future; Syracuse University; Stanford University	Buonocore, JJ (corresponding author), Harvard Univ, Ctr Hlth & Global Environm, TH Chan Sch Publ Hlth, Boston, MA 02215 USA.	jbuonocore@mail.harvard.edu	Driscoll, Charles/F-9832-2014	Driscoll, Charles/0000-0003-2692-2890	William and Flora Hewlett Foundation [2013-9458, 2014-1413]; Grantham Foundation for the Protection of the Environment through Harvard University [271065]; Mistra's Indigo research program; FORMAS Human Cooperation to Manage Natural Resources; Division Of Environmental Biology [1633026] Funding Source: National Science Foundation	William and Flora Hewlett Foundation; Grantham Foundation for the Protection of the Environment through Harvard University; Mistra's Indigo research program; FORMAS Human Cooperation to Manage Natural Resources; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by grants from the William and Flora Hewlett Foundation (Foundation Grant #s: 2013-9458 and 2014-1413) and the Grantham Foundation for the Protection of the Environment (Harvard Internal # 271065) through Harvard University, and by Mistra's Indigo research program and the FORMAS Human Cooperation to Manage Natural Resources through support to Resources for the Future. A listing of the known relevant funding sources and other relationships of the authors of this paper are below. The study design; collection, analysis, and interpretation of data; writing of the paper; and decision to submit for publication was solely conducted by the authors.	*AG HEALTHC RES QU, 2007, HEALTHC COST UT PROJ; Aldy JE, 1999, SOC NATUR RESOUR, V12, P93, DOI 10.1080/089419299279777; Allcott H, 2014, REV ECON STAT, V96, P779, DOI 10.1162/REST_a_00419; Allcott H, 2011, AM ECON REV, V101, P98, DOI 10.1257/aer.101.3.98; Anenberg SC, 2012, ENVIRON HEALTH PERSP, V120, P831, DOI 10.1289/ehp.1104301; [Anonymous], 2010, CARBON IWG SC TECHNI, P1; Arimura TH, 2012, ENERG J, V33, P63, DOI 10.5547/01956574.33.2.4; Arrow K, 2013, SCIENCE, V341, P349, DOI 10.1126/science.1235665; Buonocore JJ, 2016, NAT CLIM CHANGE, V6, P100, DOI [10.1038/NCLIMATE2771, 10.1038/nclimate2771]; Burtraw D, 2015, ENVIRON RESOUR ECON, V62, P217, DOI 10.1007/s10640-015-9963-4; Burtraw D, 2014, AM ECON REV, V104, P557, DOI 10.1257/aer.104.5.557; Byun D.W., 1999, SCI ALGORITHMS EPA M; COLBECK I, 1984, SCI TOTAL ENVIRON, V34, P87, DOI 10.1016/0048-9697(84)90043-3; Cropper ML, 2000, VALUING ENV BENEFITS; Luke C, 2006, ENVIRON INT, V32, P815, DOI 10.1016/j.envint.2006.03.012; Driscoll CT, 2015, NAT CLIM CHANGE, V5, P535, DOI 10.1038/nclimate2598; Eisenstein EL, 2001, MED CARE, V39, P824, DOI 10.1097/00005650-200108000-00008; Epstein PR, 2011, ANN NY ACAD SCI, V1219, P73, DOI 10.1111/j.1749-6632.2010.05890.x; Garcia-Menendez F, 2015, ENVIRON SCI TECHNOL, V49, P7580, DOI 10.1021/acs.est.5b01324; GDS Associates I, 2013, MICH EL NAT GAS EN E; Gerarden Todd D, 2015, ASSESSING ENERGY EFF; Gillingham K, 2014, REV ENV ECON POLICY, V8, P18, DOI 10.1093/reep/ret021; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Huynh M, 2006, PAEDIATR PERINAT EP, V20, P454, DOI 10.1111/j.1365-3016.2006.00759.x; ICF International, 2013, INT PLANN MOD; Jerrett M, 2009, NEW ENGL J MED, V360, P1085, DOI 10.1056/NEJMoa0803894; Ji M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/2/024006; Levy JI, 2012, AM J EPIDEMIOL, V175, P1091, DOI 10.1093/aje/kwr457; Louis MES, 2008, AM J PREV MED, V35, P527, DOI 10.1016/j.amepre.2008.08.023; Mills D, 2014, CLIM CHANGE; Moore FC, 2015, NAT CLIM CHANGE, V5, P127, DOI [10.1038/NCLIMATE2481, 10.1038/nclimate2481]; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Nemet GF, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014007; Plachinski SD, 2014, ATMOS ENVIRON, V94, P180, DOI 10.1016/j.atmosenv.2014.03.028; Roman HA, 2012, RISK ANAL, V32, P2133, DOI 10.1111/j.1539-6924.2012.01826.x; Shin HH, 2014, EPIDEMIOLOGY, V25, P835, DOI 10.1097/EDE.0000000000000162; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Shindell DT, 2015, CLIMATIC CHANGE, V130, P313, DOI 10.1007/s10584-015-1343-0; Talbott EO, 2015, ENVIRON RES, V140, P414, DOI 10.1016/j.envres.2015.04.021; Thompson TM, 2014, NAT CLIM CHANGE, V4, P917, DOI [10.1038/nclimate2342, 10.1038/NCLIMATE2342]; U. S. Energy Information, 2013, DOEEIA0383, V1, P1; U. S. Environmental Protection Agency, 2015, REG IMP AN CLEAN POW; U.S. Environmental Protection Agency, 2015, CARB POLL EM GUID EX, P1560; U.S. Environmental Protection Agency, 2015, BENMAP; U.S. Environmental Protection Agency Office of Air Quality Planning and Standards Health and Environmental Impacts Division, 2011, REG IMP AN FIN MERC; US EPA, 2015, TECHN SUPP DOC SOC C, P1, DOI [10.1017/CBO9781107415324.004.SW-846, DOI 10.1017/CBO9781107415324.004.SW-846]; Van Dingenen R, 2009, ATMOS ENVIRON, V43, P604, DOI 10.1016/j.atmosenv.2008.10.033; West JJ, 2013, NAT CLIM CHANGE, V3, P885, DOI [10.1038/nclimate2009, 10.1038/NCLIMATE2009]; Williams RC, 2002, J ENVIRON ECON MANAG, V44, P261, DOI 10.1006/jeem.2001.1237; Wittig VE, 2007, PLANT CELL ENVIRON, V30, P1150, DOI 10.1111/j.1365-3040.2007.01717.x; Zanobetti A, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-58	51	22	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156308	10.1371/journal.pone.0156308	http://dx.doi.org/10.1371/journal.pone.0156308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27270222	Green Published, gold			2022-12-26	WOS:000377561000011
J	Devarajan, K				Devarajan, Kadambari			The Antsy Social Network: Determinants of Nest Structure and Arrangement in Asian Weaver Ants	PLOS ONE			English	Article							OECOPHYLLA-SMARAGDINA; PLANT MUTUALISM; HYMENOPTERA; COMPETITION	Asian weaver ants (Oecophylla smaragdina) are arboreal ants that are known to form mutualistic complexes with their host trees. They are eusocial ants that build elaborate nests in the canopy in tropical areas. A colony comprises of multiple nests, usually on multiple trees, and the boundaries of the colony may be difficult to identify. However, they provide the ideal model for studying group living in invertebrates since there are a definite number of nests for a given substrate, the tree. Here, we briefly examine the structure of the nests and the processes involved in the construction and maintenance of these nests. We have described the spatial arrangement of weaver ant nests on trees in two distinct tropical clusters, a few hundred kilometres apart in India. Measurements were made for 13 trees with a total of 71 nests in the two field sites. We have considered a host of biotic and abiotic factors that may be crucial in determining the location of the nesting site by Asian weaver ants. Our results indicate that tree characteristics and architecture followed by leaf features help determine nest location in Asian weaver ants. While environmental factors may not be as influential to nest arrangement, they seem to be important determinants of nest structure. The parameters that may be considered in establishing the nests could be crucial in picking the evolutionary drivers for colonial living in social organisms.	[Devarajan, Kadambari] Natl Ctr Biol Sci, Wildlife Conservat Soc India Program, Post Grad Programme Wildlife Biol & Conservat, Bengaluru, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Devarajan, K (corresponding author), Natl Ctr Biol Sci, Wildlife Conservat Soc India Program, Post Grad Programme Wildlife Biol & Conservat, Bengaluru, India.	kadambari.devarajan@gmail.com			National Centre for Biological Sciences	National Centre for Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the National Centre for Biological Sciences (URL: http://ncbs.res.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Bluthgen N, 2002, J ANIM ECOL, V71, P793, DOI 10.1046/j.1365-2656.2002.00647.x; Bochynek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095112; BRADSHAW JWS, 1975, NATURE, V258, P230, DOI 10.1038/258230a0; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; COLE AC, 1948, AM MIDL NAT, V39, P641, DOI 10.2307/2421529; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Dlussky GM, 2008, ACTA PALAEONTOL POL, V53, P615, DOI 10.4202/app.2008.0406; Dunn RR, 2007, EVOL ECOL RES, V9, P1349; Edwards DP, 2006, P ROY SOC B-BIOL SCI, V273, P595, DOI 10.1098/rspb.2005.3273; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; HOLLDOBLER B, 1977, P NATL ACAD SCI USA, V74, P2072, DOI 10.1073/pnas.74.5.2072; Holldobler B, 1977, SCI AM, P237; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; JAISSON P, 1980, NATURE, V286, P388, DOI 10.1038/286388a0; Jander R, 1998, ETHOLOGY, V104, P743, DOI 10.1111/j.1439-0310.1998.tb00108.x; JANZEN DH, 1966, EVOLUTION, V20, P249, DOI 10.1111/j.1558-5646.1966.tb03364.x; Lach L, 2011, OIKOS, V120, P9, DOI 10.1111/j.1600-0706.2010.18803.x; Mele PV, 2008, INT J PEST MANAGE, V55, P57, DOI [10.1080/09670870802450276, DOI 10.1080/09670870802450276]; Newey PS, 2010, ECOLOGY, V91, P2366, DOI 10.1890/09-0561.1; Palmer TM, 2003, ECOLOGY, V84, P2843, DOI 10.1890/02-0528; Peng RK, 2011, AGR FOREST ENTOMOL, V13, P165, DOI 10.1111/j.1461-9563.2010.00514.x; Peng RK, 1998, AUST J ENTOMOL, V37, P249, DOI 10.1111/j.1440-6055.1998.tb01579.x; Ramachandran P, 2011, COMPUT SCI ENG, V13, P40, DOI 10.1109/MCSE.2011.35; Reh D, 1906, SCI AM S, V1575, P25241; Santos JC, 2005, SOCIOBIOLOGY, V46, P27; Schluns EA, 2009, MOL ECOL, V18, P156, DOI 10.1111/j.1365-294X.2008.04020.x; Sribandit W, 2008, ASIAN MYRMECOL, V2, P129; Stanton ML, 1999, NATURE, V401, P578, DOI 10.1038/44119; Stanton ML, 2002, ECOL MONOGR, V72, P347, DOI 10.1890/0012-9615(2002)072[0347:CCTOIA]2.0.CO;2; Van Mele P, 2008, AGR FOREST ENTOMOL, V10, P13, DOI 10.1111/j.1461-9563.2007.00350.x; WAY MJ, 1951, NATURE, V168, P302, DOI 10.1038/168302b0; WILSON EDWARD O., 1964, PSYCHE, V71, P93, DOI 10.1155/1964/17612	33	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156681	10.1371/journal.pone.0156681	http://dx.doi.org/10.1371/journal.pone.0156681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27271037	Green Published, gold			2022-12-26	WOS:000377561000031
J	Ghanbarian, H; Wagner, N; Polo, B; Baudouy, D; Kiani, J; Michiels, JF; Cuzin, F; Rassoulzadegan, M; Wagner, KD				Ghanbarian, Hossein; Wagner, Nicole; Polo, Beatrice; Baudouy, Delphine; Kiani, Jafar; Michiels, Jean-Francois; Cuzin, Francois; Rassoulzadegan, Minoo; Wagner, Kay-Dietrich			Dnmt2/Trdmt1 as Mediator of RNA Polymerase II Transcriptional Activity in Cardiac Growth	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; METHYLTRANSFERASE DNMT2; B2 RNA; P-TEFB; HYPERTROPHY; METHYLATION; COMPLEXES; MOUSE; DNA; INHERITANCE	Dnmt2/Trdmt1 is a methyltransferase, which has been shown to methylate tRNAs. Deficient mutants were reported to exhibit various, seemingly unrelated, defects in development and RNA-mediated epigenetic heredity. Here we report a role in a distinct developmental regulation effected by a noncoding RNA. We show that Dnmt2-deficiency in mice results in cardiac hypertrophy. Echocardiographic measurements revealed that cardiac function is preserved notwithstanding the increased dimensions of the organ due to cardiomyocyte enlargement. Mechanistically, activation of the P-TEFb complex, a critical step for cardiac growth, results from increased dissociation of the negatively regulating Rn7sk non-coding RNA component in Dnmt2-deficient cells. Our data suggest that Dnmt2 plays an unexpected role for regulation of cardiac growth by modulating activity of the P-TEFb complex.	[Ghanbarian, Hossein] Shahid Beheshti Univ Med Sci, Dept Biotechnol, Sch Adv Technol Med, Tehran, Iran; [Wagner, Nicole; Baudouy, Delphine; Michiels, Jean-Francois; Wagner, Kay-Dietrich] Univ Nice Sophia Antipolis, IRCAN, Fac Med, CNRS UMR7284,INSERM U1081, F-06100 Nice, France; [Wagner, Nicole; Polo, Beatrice; Baudouy, Delphine; Cuzin, Francois; Rassoulzadegan, Minoo; Wagner, Kay-Dietrich] Univ Nice Sophia Antipolis, CNRS, INSERM, iBV, F-06100 Nice, France; [Michiels, Jean-Francois] CHU Nice, Dept Pathol, F-06202 Nice, France; [Kiani, Jafar] Iran Univ Med Sci, Fac Adv Technol Med, Dept Mol Med, Tehran, Iran	Shahid Beheshti University Medical Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Iran University of Medical Sciences	Wagner, KD (corresponding author), Univ Nice Sophia Antipolis, IRCAN, Fac Med, CNRS UMR7284,INSERM U1081, F-06100 Nice, France.; Rassoulzadegan, M; Wagner, KD (corresponding author), Univ Nice Sophia Antipolis, CNRS, INSERM, iBV, F-06100 Nice, France.	minoo@unice.fr; kwagner@unice.fr	Ghanbarian, Hossein/P-6082-2019; Wagner, Kay-Dietrich/E-6119-2016; Rassoulzadegan, Minoo/O-7939-2016	Wagner, Kay-Dietrich/0000-0001-5483-7760; Wagner, Nicole/0000-0002-2746-0707; Kiani, Jafar/0000-0002-5907-5846	French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE program [ANR-11-LABX-0028-01]; Association pour la Recherche sur le Cancer; Fondation de France; Ligue Nationale Contre le Cancer; Agence Nationale de la Recherche France [ANR-08-GENOPAT-011 Epipath-Parapath]; Shahid Beheshti University of Medical Sciences, Iran	French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE program(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation de France(Fondation de France); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche France(French National Research Agency (ANR)); Shahid Beheshti University of Medical Sciences, Iran	This work was supported by the French Government (National Research Agency, ANR) through the "Investments for the Future" LABEX SIGNALIFE program (reference ANR-11-LABX-0028-01), the Association pour la Recherche sur le Cancer and Fondation de France (KDW), the Ligue Nationale Contre le Cancer and Agence Nationale de la Recherche France (ANR-08-GENOPAT-011 Epipath-Parapath) (MR). HG was the recipient of a scholarship from Shahid Beheshti University of Medical Sciences, Iran.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Cherrier T, 2013, P NATL ACAD SCI USA, V110, P12655, DOI 10.1073/pnas.1220136110; Coelho OR, 2013, CIRCULATION, V128, P1225, DOI 10.1161/CIRCULATIONAHA.112.000438; DANIELS GR, 1985, NATURE, V317, P819, DOI 10.1038/317819a0; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Kiani J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003498; Kulkarni PA, 2004, RECENT PROG HORM RES, V59, P125, DOI 10.1210/rp.59.1.125; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Rai K, 2007, GENE DEV, V21, P261, DOI 10.1101/gad.1472907; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Sano M, 2004, EMBO J, V23, P3559, DOI 10.1038/sj.emboj.7600351; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Tuorto F, 2015, EMBO J, V34, P2350, DOI 10.15252/embj.201591382; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Wagner KD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6852; Yadlapalli S, 2013, NATURE, V498, P251, DOI 10.1038/nature12106; Yakovchuk P, 2011, TRANSCR-AUSTIN, V2, P45, DOI 10.4161/trns.2.1.14306; Yakovchuk P, 2009, P NATL ACAD SCI USA, V106, P5569, DOI 10.1073/pnas.0810738106; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5	30	28	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156953	10.1371/journal.pone.0156953	http://dx.doi.org/10.1371/journal.pone.0156953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270731	Green Published, Green Submitted, gold			2022-12-26	WOS:000377560200027
J	Cusimano, MD; Ilie, G; Mullen, SJ; Pauley, CR; Stulberg, JR; Topolovec-Vranic, J; Zhang, S				Cusimano, Michael D.; Ilie, Gabriela; Mullen, Sarah J.; Pauley, Christopher R.; Stulberg, Jennifer R.; Topolovec-Vranic, Jane; Zhang, Stanley			Aggression, Violence and Injury in Minor League Ice Hockey: Avenues for Prevention of Injury	PLOS ONE			English	Article							BODY-CHECKING; BRAIN-INJURY; CONCUSSION EDUCATION; BAYESIAN NETWORK; YOUTH HOCKEY; RISK-FACTORS; SPORT; PSYCHOLOGY; BEHAVIOR; PLAYERS	Background In North America, more than 800,000 youth are registered in organized ice hockey leagues. Despite the many benefits of involvement, young players are at significant risk for injury. Body-checking and aggressive play are associated with high frequency of game-related injury including concussion. We conducted a qualitative study to understand why youth ice hockey players engage in aggressive, injury-prone behaviours on the ice. Methods Semi-structured interviews were conducted with 61 minor ice hockey participants, including male and female players, parents, coaches, trainers, managers and a game official. Players were aged 13-15 playing on competitive body checking teams or on non-body checking teams. Interviews were manually transcribed, coded and analyzed for themes relating to aggressive play in minor ice hockey. Results Parents, coaches, teammates and the media exert a large influence on player behavior. Aggressive behavior is often reinforced by the player's social environment and justified by players to demonstrate loyalty to teammates and especially injured teammates by seeking revenge particularly in competitive, body-checking leagues. Among female and male players in non-body checking organizations, aggressive play is not reinforced by the social environment. These findings are discussed within the framework of social identity theory and social learning theory, in order to understand players' need to seek revenge and how the social environment reinforces aggressive behaviors. Conclusion This study provides a better understanding of the players' motivations and environmental influences around aggressive and violent play which may be conducive to injury. The findings can be used to help design interventions aimed at reducing aggression and related injuries sustained during ice hockey and sports with similar cultures and rules.	[Cusimano, Michael D.; Mullen, Sarah J.; Pauley, Christopher R.; Zhang, Stanley] St Michaels Hosp, Injury Prevent Res Off, Dept Surg, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela] Dalhousie Univ, Fac Med, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Stulberg, Jennifer R.] Univ Toronto, Family & Community Med, Toronto, ON, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Fac Med, Occupat Sci & Occupat Therapy, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Dalhousie University; University of Toronto; University of Toronto	Cusimano, MD (corresponding author), St Michaels Hosp, Injury Prevent Res Off, Dept Surg, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	cusimanom@smh.ca	Cusimano, Michael/GWR-1025-2022; Ilie, Gabriela/AAM-9122-2021; Cusimano, Michael/X-4059-2019; Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212	Canadian Institutes of Health Research Strategic Team Grant [TIR-103946]; Ontario Neurotrauma Foundation; St. Michael's Hospital Foundation	Canadian Institutes of Health Research Strategic Team Grant; Ontario Neurotrauma Foundation; St. Michael's Hospital Foundation	This research was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) Strategic Team Grant in Applied Injury Research #TIR-103946, the Ontario Neurotrauma Foundation (http://onf.org), as well as the St. Michael's Hospital Foundation (http://www.stmichaelsfoundation.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PL, 2014, REV PSICOL DEPORTE, V23, P395; Anderson E., 2010, SPORT THEORY AND SOC; [Anonymous], 2012, CULTURE; Arnold E, 2002, WHOSE PUCK IS IT ANY; BANDURA A, 1978, J COMMUN, V28, P12, DOI 10.1111/j.1460-2466.1978.tb01621.x; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bawa H BM, 2004, SPORTS RELATED INJUR; Beddoes-Jones F., 2004, TRAINING JOURNAL, V16; Bortoli L, 2012, PSYCHOL SPORT EXERC, V13, P397, DOI 10.1016/j.psychsport.2012.01.001; Bronfenbrenner U., 1988, PERSONS CONTEXT DEV, P25; Bruner MW, 2015, J APPL SPORT PSYCHOL, V27, P351, DOI 10.1080/10413200.2015.1010661; Bruner MW, 2013, GROUP DYN-THEOR RES, V17, P30, DOI 10.1037/a0030114; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Carron AV, 1982, JOURNAL OF SPORT PSY; Celozzi MJ, 1981, JOURNAL OF SPORT BEH; Chalabaev A, 2013, PSYCHOL SPORT EXERC, V14, P136, DOI 10.1016/j.psychsport.2012.10.005; Chapman J., 2006, MANAGE DECIS, V44, P1391, DOI [DOI 10.1108/00251740610715713, 10.1108/00251740610715713.]; Chicau Borrego C, 2012, J HUMAN KINETICS, V34, P119; Cohen J, 1977, STATISTICAL POWER AN; Cope CJ, 2011, INT J SPORT EXERC PS, V9, P19, DOI 10.1080/1612197X.2011.563124; Cusimano MD, 2012, CANADIAN MEDICAL ASS; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; Cusimano Michael D, 2011, Open Med, V5, pe57; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; Demorest Rebecca A, 2003, Curr Sports Med Rep, V2, P337; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Emery CA, 2009, CLIN J SPORT MED, V19, P207, DOI 10.1097/JSM.0b013e31819d658e; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Ford DW, 2012, JOURNAL OF SPORT ADM, V4; Frederick EL, 2013, CONTRACT NO 1; Freedman J, 1970, AGGRESSION SOCIAL PS, P101; Fu T, 2015, CANADIAN JOURNAL OF, V42; Fuster-Parra P, 2015, HUM MOVEMENT SCI, V40, P98, DOI 10.1016/j.humov.2014.12.005; Fuster-Parra P, 2014, QUAL QUANT, V48, P1473, DOI 10.1007/s11135-013-9848-y; Gillis C., 2014, HOW PARENTS AND THEI; Gould D, 2006, BRIT J SPORT MED, V40, P632, DOI 10.1136/bjsm.2005.024927; Grindel Scott H, 2003, Curr Sports Med Rep, V2, P18, DOI 10.1249/00149619-200302000-00005; Hancock B, 1998, AN INTRODUCTION TO Q; Hardy J, 2005, SMALL GR RES, V36, P166, DOI 10.1177/1046496404266715; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; Ilie G, 2014, JOURNAL OF NEUROTRAU; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Janis IL., 1997, GROUPTHINK; Jeffery-Tosoni S, 2015, J SPORT BEHAV, V38, P3; Juhn MS, 2002, CLIN J SPORT MED, V12, P46, DOI 10.1097/00042752-200201000-00014; Kimmel M., 1987, THE LIFE OF A MANS S, P53; Kirker B, 2000, RES Q EXERCISE SPORT, V71, P373, DOI 10.1080/02701367.2000.10608920; Kleiber DA, 1981, JOURNAL OF SPORT PSY, V3; Lacey A, 2001, TRENT FOCUS FOR RESE; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Loughead TM, 2001, JOURNAL OF SPORT BEH; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Mageau GA, 2003, J SPORT SCI, V21, P883, DOI 10.1080/0264041031000140374; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchie A, 2003, CAN MED ASSOC J, V169, P124; MARCOTTE G, 1993, ASTM STP, V1212, P103, DOI DOI 10.1520/STP13128S; Mugno D A, 1985, Can J Appl Sport Sci, V10, P26; NASH JE, 1981, YOUTH SOC, V13, P229, DOI 10.1177/0044118X8101300202; Patton M. Q., 1990, QUALITATIVE EVALUATI; Pediatrics AAo, 2000, PEDIATRICS PT 1, V105, P657; Perry JL, 2013, ATHLETIC INSIGHT, V5, P197; R M. The Bertuzzi Incident, 2004, GLOBE MAIL; Roberts WO, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.11.1102; Rothe J. P., 2000, UNDERTAKING QUALITAT; Rutten EA, 2007, J YOUTH ADOLESCENCE, V36, P255, DOI 10.1007/s10964-006-9085-y; Schwandt T. A., 2007, THE SAGE DICTIONARY; Shah C.P., 2003, PUBLIC HEALTH AND PR; Sheldon JP, 2001, RES Q EXERCISE SPORT, V72, P304, DOI 10.1080/02701367.2001.10608965; Shirazi M, 2015, CANADIAN JOURNAL OF, P42; Smith MD, 1979, CANADIAN JOURNAL OF, P105; Sports C., 2015, NHL HOCKEY INJURIES; Steinfeldt JA, PSYCHOLOGY OF MEN MA, V12, P324; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Surveillance Epidemiology Division CfCDPPHAoC, 2014, CHRONIC DISEASES AND, V34, P272; Tajfel H, 2004, THE SOCIAL IDENTITY; Taylor S J, 1981, Monogr Am Assoc Ment Defic, P71; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Traclet A, 2015, AGGRESSIVE BEHAV, V41, P123, DOI 10.1002/ab.21561; TUCKMAN BW, 1965, PSYCHOL BULL, V63, P384, DOI 10.1037/h0022100; Villani S, 2001, J AM ACAD CHILD PSY, V40, P392, DOI 10.1097/00004583-200104000-00007; Warsh JM, 2009, CLIN J SPORT MED, V19, P134, DOI 10.1097/JSM.0b013e3181987783; Wiese-Bjornstal DM, 2014, REV PSICOL DEPORTE, V23, P411; Wojtys EM, 2015, SPORTS HEALTH, V7, P108, DOI 10.1177/1941738115572986	89	12	13	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156683	10.1371/journal.pone.0156683	http://dx.doi.org/10.1371/journal.pone.0156683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258426	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700103
J	Jeong, BY; Uddin, MJ; Park, JH; Lee, JH; Lee, HB; Miyata, T; Ha, H				Jeong, Bo Yeong; Uddin, Md Jamal; Park, Jong Hee; Lee, Jung Hwa; Lee, Hi Bahl; Miyata, Toshio; Ha, Hunjoo			Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model	PLOS ONE			English	Article							RENAL INTERSTITIAL FIBROSIS; SMALL-MOLECULE INHIBITOR; OBSTRUCTIVE NEPHROPATHY; URETERAL OBSTRUCTION; DEFICIENCY; PAI-1; DISEASE; MICE; BENEFITS	Diabetic nephropathy is the leading cause of end-stage renal disease worldwide, but no effective therapeutic strategy is available. Because plasminogen activator inhibitor-1 (PAI-1) is increasingly recognized as a key factor in extracellular matrix (ECM) accumulation in diabetic nephropathy, this study examined the renoprotective effects of TM5275 and TM5441, two novel orally active PAI-1 inhibitors that do not trigger bleeding episodes, in streptozotocin (STZ)-induced diabetic mice. TM5275 (50 mg/kg) and TM5441 (10 mg/kg) were administered orally for 16 weeks to STZ-induced diabetic and age-matched control mice. Relative to the control mice, the diabetic mice showed significantly increased (p < 0.05) plasma glucose and creatinine levels, urinary albumin excretion, kidney-to-body-weight ratios, glomerular volume, and fractional mesangial area. Markers of fibrosis and inflammation along with PAI-1 were also upregulated in the kidney of diabetic mice, and treatment with TM5275 and TM5441 effectively inhibited albuminuria, mesangial expansion, ECM accumulation, and macrophage infiltration in diabetic kidneys. Furthermore, in mouse proximal tubular epithelial (mProx24) cells, both TM5275 and TM5441 effectively inhibited PAI-1-induced mRNA expression of fibrosis and inflammation markers and also reversed PAI-1-induced inhibition of plasmin activity, which confirmed the efficacy of the TM compounds as PAI-1 inhibitors. These data suggest that TM compounds could be used to prevent diabetic kidney injury.	[Jeong, Bo Yeong; Uddin, Md Jamal; Park, Jong Hee; Lee, Jung Hwa; Ha, Hunjoo] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, 52 Ewhayeodae Gil, Seoul 120750, South Korea; [Lee, Hi Bahl] Kims Clin & Dialysis Unit, Myrang, South Korea; [Miyata, Toshio] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Res, Sendai, Miyagi 980, Japan	Ewha Womans University; Tohoku University	Ha, H (corresponding author), Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, 52 Ewhayeodae Gil, Seoul 120750, South Korea.	hha@ewha.ac.kr	Miyata, Toshio/A-4872-2010; Uddin, Md Jamal/W-3434-2017	Uddin, Md Jamal/0000-0003-2911-3255; Ha, Hunjoo/0000-0002-5601-1265	NRF [NRF-2014R1A2A1A11050945]; NST - Korean Government [DRC-2014-1-KBSI]	NRF; NST - Korean Government	It is noted that this work was supported by NRF-2014R1A2A1A11050945 from an NRF grant (www.nrf.re.kr) and DRC-2014-1-KBSI from an NST grant (www.nst.re.kr) funded by the Korean Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban CR, 2008, VASC HEALTH RISK MAN, V4, P575; Boe AE, 2013, CIRCULATION, V128, P2318, DOI 10.1161/CIRCULATIONAHA.113.003192; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; CARMELIET P, 1993, J CLIN INVEST, V92, P2756, DOI 10.1172/JCI116893; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Collins SJ, 2006, NEPHRON EXP NEPHROL, V104, pE23, DOI 10.1159/000093673; Declerck PJ, 2013, SEMIN THROMB HEMOST, V39, P356, DOI 10.1055/s-0033-1334487; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Edgtton KL, 2004, KIDNEY INT, V66, P68, DOI 10.1111/j.1523-1755.2004.00707.x; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Huang WT, 2012, AM J RESP CELL MOL, V46, P87, DOI 10.1165/rcmb.2011-0139OC; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; Hwang I, 2012, DIABETES, V61, P728, DOI 10.2337/db11-0584; Ichimura A, 2013, ARTERIOSCL THROM VAS, V33, P935, DOI 10.1161/ATVBAHA.113.301224; Izuhara Y, 2008, ARTERIOSCL THROM VAS, V28, P672, DOI 10.1161/ATVBAHA.107.157479; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Kobayashi N, 2015, AM J PHYSIOL-RENAL, V308, pF614, DOI 10.1152/ajprenal.00616.2014; LANE PH, 1993, KIDNEY INT, V43, P661, DOI 10.1038/ki.1993.95; Mao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092686; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Nicholas SB, 2005, KIDNEY INT, V67, P1297, DOI 10.1111/j.1523-1755.2005.00207.x; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Pelisch N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124510; Peters H, 2004, KIDNEY INT, V66, P1434, DOI 10.1111/j.1523-1755.2004.00906.x; Placencio VR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133786; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Seo JY, 2009, AM J NEPHROL, V30, P481, DOI 10.1159/000242477; Vaughan DE, 2007, CURR DRUG TARGETS, V8, P962, DOI 10.2174/138945007781662364; Weisberg AD, 2005, ARTERIOSCL THROM VAS, V25, P365, DOI 10.1161/01.ATV.0000152356.85791.52	35	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157012	10.1371/journal.pone.0157012	http://dx.doi.org/10.1371/journal.pone.0157012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258009	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700169
J	Li, YK; Liu, QC; Liu, F; Zhu, PF; Zhang, LC; Zhou, XJ; Sun, CY; Cheng, YH				Li, Yukui; Liu, Qingchuan; Liu, Fei; Zhu, Pengfei; Zhang, Lichao; Zhou, Xiujie; Sun, Chongyu; Cheng, Yunhuan			Effects of Different Ratios of Sewage Sludge and Cattle Manure on Growth and Propagation of Eisenia Fetida	PLOS ONE			English	Article							PERIONYX-EXCAVATUS; VERMISTABILIZATION; REPRODUCTION; OLIGOCHAETA; STABILIZATION; REQUIREMENTS; NUTRIENT; INDUSTRY; DENSITY; WASTES	Domestic sewage sludge and cattle manure are rich in nutrition elements, but without proper disposal, are harmful to the environment. Here with an indoor culture method, we used Eisenia fetida to dispose different ratios of sewage sludge and cattle manure, and thereby investigated the effects and acting rules of these sludge-manure mixtures on the growth and reproduction of E. fetida. We find these mixtures are food sources for E. fetida, and their physiochemical properties are significantly changed after disposal by earthworms. Paired samples t-test shows the average change after different treatments is -20.37% for total organic carbon, 85.71% for total Kjeldahl N, -6.67% for total P, 8.33% for pH, -24.78% for EC (ms.cm(-1)), and -57.10% for C/N ratio. The average growth rate after treatment CD-70 is 9.20 mg.worm(-1).day(-1); the average growth rates of E. fetida on day 0-28, day 29-56, and day 57-91 are 9.33, 11.90 and 6.95 mg.worm(-1).day(-1), respectively, indicating a trend of "rapid-rapidest-slow" growth. Other treatments all show this trend. Though all earthworms developed reproductive rings during the test periods, the appearing time and the cocoon production time both differed among these treatments. The cocoon production amount is maximized to 233 after treatment CD-70. The cocoon production rates are significantly different among these treatments, and the maximum and mean are 0.32 and 0.17-.32, cocoons.worm(-1).day(-1), respectively. E. fetida can modestly enrich Cd, but is not very effective over Sb or other heavy metals. E. fetida can remove a part of heavy metals from sewage sludge and cattle manure. Generally, the mixtures of sewage sludge and cattle manure can largely affect the growth and propagation of E. fetida in a ratio-dependent way.	[Li, Yukui; Liu, Fei; Zhu, Pengfei; Zhang, Lichao; Zhou, Xiujie; Sun, Chongyu; Cheng, Yunhuan] Huaibei Normal Univ, Sch Environm Sci, Huaibei, Anhui, Peoples R China; [Liu, Qingchuan] Hefei Univ Technol, Coll Food Sci, Hefei, Anhui, Peoples R China	Huaibei Normal University; Hefei University of Technology	Liu, F (corresponding author), Huaibei Normal Univ, Sch Environm Sci, Huaibei, Anhui, Peoples R China.	liufei66@mail.ahnu.edu.cn		LIU, Fei/0000-0003-4378-5007	National Science Foundation of China [41371444]; China Spark Program [2014GA710040]; Anhui Provincial Natural Science Project [KJ2013ZD07, 1301ZC04064]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Spark Program; Anhui Provincial Natural Science Project	This work was financially supported by the National Science Foundation of China (Project No. 41371444), the China Spark Program (2014GA710040); and Anhui Provincial Natural Science Project (No. KJ2013ZD07, No. 1301ZC04064;). Talent Cultivation Plan of Huaibei City: 20130306. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal S, 2000, BIORESOURCE TECHNOL, V73, P95, DOI 10.1016/S0960-8524(99)00173-X; Bettinelli M, 2000, ANAL CHIM ACTA, V424, P289, DOI 10.1016/S0003-2670(00)01123-5; Bhat SA, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-014-0780-y; Bhat SA, 2014, ENVIRON SCI POLLUT R, V21, P8112, DOI 10.1007/s11356-014-2758-2; Chauhan H. K., 2012, World Journal of Zoology, V7, P23; Cynthia J. M., 2012, Advances in Applied Science Research, V3, P1092; Dominguez J, 2000, PEDOBIOLOGIA, V44, P24, DOI 10.1078/S0031-4056(04)70025-6; Dominguez J, 1997, PEDOBIOLOGIA, V41, P566; Dominguez-Crespo MA, 2012, WATER AIR SOIL POLL, V223, P915, DOI 10.1007/s11270-011-0913-7; Edwards Clive A., 1998, P327; Garg V. K., 2006, Environmentalist, V26, P269, DOI 10.1007/s10669-006-8641-z; Hait S, 2011, BIORESOURCE TECHNOL, V102, P2812, DOI 10.1016/j.biortech.2010.10.031; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; International Standard Organisation (ISO), 1995, 112611995 ISO; Molina MJ, 2013, BIORESOURCE TECHNOL, V137, P88, DOI 10.1016/j.biortech.2013.03.029; KALE RD, 1982, PEDOBIOLOGIA, V23, P419; KAPLAN DL, 1980, SOIL BIOL BIOCHEM, V12, P347, DOI 10.1016/0038-0717(80)90008-5; Karmegam Natchimuthu, 2009, Environmentalist, V29, P287, DOI 10.1007/s10669-008-9195-z; Khare NSA, 2005, APPL ECOL ENV RES, V4, P85; Khwairakpam M, 2009, J HAZARD MATER, V161, P948, DOI 10.1016/j.jhazmat.2008.04.088; Kirchberger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123465; Kizilkaya R, 2004, ECOL ENG, V22, P141, DOI 10.1016/j.ecoleng.2004.04.002; Kumar D. S., 2013, Annual Review and Research in Biology, V3, P574; Kumar J. I. Nirmal, 2010, International Journal of Environment and Waste Management, V5, P379, DOI 10.1504/IJEWM.2010.032015; LEE KE, 1992, SOIL BIOL BIOCHEM, V24, P1765, DOI 10.1016/0038-0717(92)90185-Z; Liu F, 2013, J MATER CYCLES WASTE, V15, P482, DOI 10.1007/s10163-013-0157-2; Loh TC, 2005, BIORESOURCE TECHNOL, V96, P111, DOI 10.1016/j.biortech.2003.03.001; Lv BY, 2013, BIORESOURCE TECHNOL, V132, P320, DOI 10.1016/j.biortech.2013.01.006; Ministry of Environmental Protection of the People's Republic of China, 6322011 HJ MIN ENV P; Ndegwa PM, 2000, BIORESOURCE TECHNOL, V71, P5, DOI 10.1016/S0960-8524(99)00055-3; NEUHAUSER EF, 1980, OIKOS, V35, P93, DOI 10.2307/3544730; Rajpal A, 2014, J MATER CYCLES WASTE, V16, P219, DOI 10.1007/s10163-013-0167-0; REINECKE AJ, 1992, SOIL BIOL BIOCHEM, V24, P1295, DOI 10.1016/0038-0717(92)90109-B; SATCHELL JE, 1984, SOIL BIOL BIOCHEM, V16, P191, DOI 10.1016/0038-0717(84)90111-1; Siddique Jaweria, 2005, Pakistan Journal of Zoology, V37, P211; Singh D, 2012, BIORESOURCE TECHNOL, V112, P179, DOI 10.1016/j.biortech.2012.02.101; Singh J, 2010, ECOTOX ENVIRON SAFE, V73, P430, DOI 10.1016/j.ecoenv.2009.08.019; Singh KC HK., 2012, WORLD J ZOOL, V7, P23; Suthar Surindra, 2008, International Journal of Environment and Waste Management, V2, P84, DOI 10.1504/IJEWM.2008.016994; Suthar Surindra, 2008, International Journal of Environment and Waste Management, V2, P584, DOI 10.1504/IJEWM.2008.021862; Suthar S, 2009, J HAZARD MATER, V163, P199, DOI 10.1016/j.jhazmat.2008.06.106; Suthar S, 2010, ECOL ENG, V36, P703, DOI 10.1016/j.ecoleng.2009.12.016; Tripathi G, 2004, BIORESOURCE TECHNOL, V92, P275, DOI 10.1016/j.biortech.2003.09.005; Xie D, 2016, ENV SCI POLLUT R, P1; Zirbes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032564	45	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156492	10.1371/journal.pone.0156492	http://dx.doi.org/10.1371/journal.pone.0156492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257977	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700068
J	Wilson, MR; Brown, E; Keys, C; Strain, E; Luo, Y; Muruvanda, T; Grim, C; Beaubrun, JJG; Jarvis, K; Ewing, L; Gopinath, G; Hanes, D; Allard, MW; Musser, S				Wilson, Mark R.; Brown, Eric; Keys, Chris; Strain, Errol; Luo, Yan; Muruvanda, Tim; Grim, Christopher; Beaubrun, Junia Jean-Gilles; Jarvis, Karen; Ewing, Laura; Gopinath, Gopal; Hanes, Darcy; Allard, Marc W.; Musser, Steven			Whole Genome DNA Sequence Analysis of Salmonella subspecies enterica serotype Tennessee obtained from related peanut butter foodborne outbreaks	PLOS ONE			English	Article							LIMITED GENETIC DIVERSITY; ESCHERICHIA-COLI; ENTERITIDIS; TYPHIMURIUM; SCHEME; EVOLUTION; VIRULENCE; STRAINS	Establishing an association between possible food sources and clinical isolates requires discriminating the suspected pathogen from an environmental background, and distinguishing it from other closely-related foodborne pathogens. We used whole genome sequencing (WGS) to Salmonella subspecies enterica serotype Tennessee (S. Tennessee) to describe genomic diversity across the serovar as well as among and within outbreak clades of strains associated with contaminated peanut butter. We analyzed 71 isolates of S. Tennessee from disparate food, environmental, and clinical sources and 2 other closely-related Salmonella serovars as outgroups (S. Kentucky and S. Cubana), which were also shot-gun sequenced. A whole genome single nucleotide polymorphism (SNP) analysis was performed using a maximum likelihood approach to infer phylogenetic relationships. Several monophyletic lineages of S. Tennessee with limited SNP variability were identified that recapitulated several food contamination events. S. Tennessee clades were separated from outgroup salmonellae by more than sixteen thousand SNPs. Intra-serovar diversity of S. Tennessee was small compared to the chosen outgroups (1,153 SNPs), suggesting recent divergence of some S. Tennessee clades. Analysis of all 1,153 SNPs structuring an S. Tennessee peanut butter outbreak cluster revealed that isolates from several food, plant, and clinical isolates were very closely related, as they had only a few SNP differences between them. SNP-based cluster analyses linked specific food sources to several clinical S. Tennessee strains isolated in separate contamination events. Environmental and clinical isolates had very similar whole genome sequences; no markers were found that could be used to discriminate between these sources. Finally, we identified SNPs within variable S. Tennessee genes that may be useful markers for the development of rapid surveillance and typing methods, potentially aiding in traceback efforts during future outbreaks. Using WGS can delimit contamination sources for foodborne illnesses across multiple outbreaks and reveal otherwise undetected DNA sequence differences essential to the tracing of bacterial pathogens as they emerge.	[Wilson, Mark R.] US FDA, CFSAN, College Pk, MD USA; [Brown, Eric; Keys, Chris; Strain, Errol; Luo, Yan; Muruvanda, Tim; Grim, Christopher; Allard, Marc W.; Musser, Steven] Battelle Mem Inst, Crystal City, VA 22202 USA; [Grim, Christopher; Beaubrun, Junia Jean-Gilles; Jarvis, Karen; Ewing, Laura; Gopinath, Gopal; Hanes, Darcy] US FDA, DVA, VMB, CFSAN,OARSA, Laurel, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Allard, MW (corresponding author), Battelle Mem Inst, Crystal City, VA 22202 USA.	marc.allard@fda.hhs.gov		Holloway, Courtney Jean/0000-0003-3661-1957				Allard MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055254; Allard MW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-32; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P521; [Anonymous], 1993, JAMA, V270, P432; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Beaubrun JJG, 2014, FOOD MICROBIOL, V42, P181, DOI 10.1016/j.fm.2014.02.008; Bell C, 2002, SALMONELLA PRACTICAL; Botteldoorn N, 2010, ZOONOSES PUBLIC HLTH, V57, P345, DOI 10.1111/j.1863-2378.2008.01216.x; Centers for Disease Control and Prevention, 2009, MORB MORTAL WKLY REP; Centers for Disease Control and Prevention (CDC), SALM STRAINS TABL OU; Cheng CM, 2008, J FOOD PROTECT, V71, P2436, DOI 10.4315/0362-028X-71.12.2436; Chin C., 2010, NEW ENGL J MED, V364, p[1, 33]; Davis S, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.20; den Bakker HC, 2011, APPL ENVIRON MICROB, V77, P8648, DOI 10.1128/AEM.06538-11; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Gilmour MW, 2004, PLASMID, V52, P182, DOI 10.1016/j.plasmid.2004.06.006; Guard Jean, 2011, BMC Res Notes, V4, P369, DOI 10.1186/1756-0500-4-369; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Karberg KA, 2011, P NATL ACAD SCI USA, V108, P20154, DOI 10.1073/pnas.1109451108; Kim M, 2012, J VIROL, V86, P10894, DOI 10.1128/JVI.01796-12; Klimke W, 2009, NUCLEIC ACIDS RES, V37, pD216, DOI 10.1093/nar/gkn734; Lee JH, 2012, J VIROL, V86, P3404, DOI 10.1128/JVI.07226-11; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-88; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lienau EK, 2011, NEW ENGL J MED, V364, P981, DOI 10.1056/NEJMc1100443; Liu FY, 2011, APPL ENVIRON MICROB, V77, P4520, DOI 10.1128/AEM.00468-11; Louie K. K., 1993, Morbidity and Mortality Weekly Report, V42, P516; Mattick KL, 2000, APPL ENVIRON MICROB, V66, P4921, DOI 10.1128/AEM.66.11.4921-4925.2000; McQuiston JR, 2008, J BACTERIOL, V190, P7060, DOI 10.1128/JB.01552-07; Nguyen C. H., 2013, Journal of Biology, Agriculture and Healthcare, V3, P36; Nguyen CH, 2013, AGRICULTURE, V3, DOI [10.3390/agriculture30x000x, DOI 10.3390/AGRICULTURE30X000X]; Nielsen Newswire, 2009, NIELSEN NEWSWIRE; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; Olson AB, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-87; Partridge SR, 2012, ANTIMICROB AGENTS CH, V56, P2166, DOI 10.1128/AAC.05796-11; Saeed AM, 2006, J AOAC INT, V89, P504; Shachar D, 2006, J FOOD PROTECT, V69, P2687, DOI 10.4315/0362-028X-69.11.2687; Shah DH, 2012, FOODBORNE PATHOG DIS, V9, P258, DOI 10.1089/fpd.2011.1009; Shin H, 2012, J VIROL, V86, P1284, DOI 10.1128/JVI.06696-11; Soyer Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-264; STANLEY J, 1992, FEMS MICROBIOL LETT, V90, P153, DOI [10.1111/j.1574-6968.1992.tb05143.x, 10.1016/0378-1097(92)90620-4]; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P3688, DOI 10.1128/JCM.43.8.3688-3698.2005; Timme RE, 2012, J BACTERIOL, V194, P5994, DOI 10.1128/JB.01289-12; WARD LR, 1987, EPIDEMIOL INFECT, V99, P291, DOI 10.1017/S0950268800067765; Wise MG, 2009, J MICROBIOL METH, V76, P18, DOI 10.1016/j.mimet.2008.09.006; World Health Organization, DRUG RES SALM; Xi ML, 2008, J FOOD PROTECT, V71, P2067, DOI 10.4315/0362-028X-71.10.2067; Zheng J, 2007, EMERG INFECT DIS, V13, P1932, DOI 10.3201/eid1312.070185; Zwickl DJ., 2006, GENETIC ALGORITHM AP	51	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0146929	10.1371/journal.pone.0146929	http://dx.doi.org/10.1371/journal.pone.0146929			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258142	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700002
J	Xu, PP; Zang, AP; Chen, HY; Cai, WM				Xu, Peipei; Zang, Aiping; Chen, Haiying; Cai, Weiming			The Small G Protein AtRAN1 Regulates Vegetative Growth and Stress Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							GTP-BINDING PROTEIN; COLD-STRESS; IMPORTIN BETA; CELL-CYCLE; TRANSCRIPTIONAL ACTIVATOR; OSMOTIC-STRESS; PLANT-GROWTH; ORYZA-SATIVA; RAN-GTPASE; RICE	The evolutionarily conserved small G-protein Ran plays important role in nuclear translocation of proteins, cell cycle regulation, and nuclear envelope maintenance in mammalian cells and yeast. Arabidopsis Ran proteins are encoded by a family of four genes and are highly conserved at the protein level. However, their biological functions are poorly understood. We report here that AtRAN1 plays an important role in vegetative growth and the molecular improvement of stress tolerance in Arabidopsis. AtRAN1 overexpression promoted vegetative growth and enhanced abiotic tolerance, while the atran1 atran3 double mutant showed higher freezing sensitivity than WT. The AtRAN1 gene is ubiquitously expressed in plants, and the expression levels are higher in the buds, flowers and siliques. Subcellular localization results showed that AtRAN1 is mainly localized in the nucleus, with some present in the cytoplasm. AtRAN1 could maintain cell division and cell cycle progression and promote the formation of an intact nuclear envelope, especially under freezing conditions.	[Xu, Peipei; Zang, Aiping; Chen, Haiying; Cai, Weiming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, 300 Fenglin Rd, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cai, WM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	wmcai@sibs.ac.cn	xu, peipei/AAS-4967-2021	xu, peipei/0000-0002-8944-3339	Strategic Priority Research Program on Space Science of the Chinese Academy of Sciences [XDA04020202-15, XDA04020415]; National Natural Science Foundation of China [31570859, 31500236, 31070237, 90917009]; China Manned Space Flight Technology Project	Strategic Priority Research Program on Space Science of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Manned Space Flight Technology Project	This work was supported by the Strategic Priority Research Program on Space Science of the Chinese Academy of Sciences (grant No. XDA04020202-15, XDA04020415), the National Natural Science Foundation of China (No. 31570859, No. 31500236, No. 31070237 and No. 90917009) and the China Manned Space Flight Technology Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Strategic Priority Research Program on Space Science of the Chinese Academy of Sciences (grant No. XDA04020202-15, XDA04020415), the National Natural Science Foundation of China (No. 31570859, No. 31500236, No. 31070237 and No. 90917009) and the China Manned Space Flight Technology Project.	ACH RA, 1994, P NATL ACAD SCI USA, V91, P5863, DOI 10.1073/pnas.91.13.5863; Chen N, 2011, PLANT CELL ENVIRON, V34, P52, DOI 10.1111/j.1365-3040.2010.02225.x; Chinnusamy V, 2008, CURR TOP MICROBIOL, V326, P235; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Di Fiore B, 2004, CELL CYCLE, V3, P305; Ellenberg J, 1999, METHODS, V19, P362, DOI 10.1006/meth.1999.0872; Espinosa-Ruiz A, 1999, PLANT J, V20, P529, DOI 10.1046/j.1365-313X.1999.00626.x; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gilmour SJ, 2000, PLANT PHYSIOL, V124, P1854, DOI 10.1104/pp.124.4.1854; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Haizel T, 1997, PLANT J, V11, P93, DOI 10.1046/j.1365-313X.1997.11010093.x; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Horvath BM, 2006, EMBO J, V25, P4909, DOI 10.1038/sj.emboj.7601362; Imin N, 2004, PROTEOMICS, V4, P1873, DOI 10.1002/pmic.200300738; Kim Young-Hwa, 2013, Journal of Plant Biotechnology, V40, P9, DOI 10.5010/JPB.2013.40.1.009; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Liu PW, 2014, MOL PLANT, V7, P1316, DOI 10.1093/mp/ssu041; Luo YJ, 2013, PLANT J, V75, P377, DOI 10.1111/tpj.12207; Ma L, 2008, PLANT PHYSIOL, V148, P223, DOI 10.1104/pp.108.120527; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; Mazzucotelli E, 2008, PLANT SCI, V174, P420, DOI 10.1016/j.plantsci.2008.02.005; Miche L, 2006, MOL PLANT MICROBE IN, V19, P502, DOI 10.1094/MPMI-19-0502; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; REN MD, 1993, J CELL BIOL, V120, P313, DOI 10.1083/jcb.120.2.313; Rose A, 2001, P NATL ACAD SCI USA, V98, P15377, DOI 10.1073/pnas.261459698; Sazer S, 2000, J CELL SCI, V113, P1111; Sinha VB, 2014, MOL BIOL REP, V41, P5989, DOI 10.1007/s11033-014-3476-z; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Thalhammer A, 2014, METHODS MOL BIOL, V1166, P15, DOI 10.1007/978-1-4939-0844-8_3; Thomashow MF, 1998, PLANT PHYSIOL, V118, P1, DOI 10.1104/pp.118.1.1; Vernoud V, 2003, PLANT PHYSIOL, V131, P1191, DOI 10.1104/pp.013052; Verslues PE, 2006, PLANT J, V47, P776, DOI 10.1111/j.1365-313X.2006.02833.x; Wang X, 2006, PLANT PHYSIOL, V140, P91, DOI 10.1104/pp.105.071670; Xin Z, 2000, PLANT CELL ENVIRON, V23, P893, DOI 10.1046/j.1365-3040.2000.00611.x; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Xu PP, 2014, J EXP BOT, V65, P3277, DOI 10.1093/jxb/eru178; Xu SH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002159; Yano A, 2006, ANN BOT-LONDON, V98, P1179, DOI 10.1093/aob/mcl211; Yasuda Y, 2006, EXP CELL RES, V312, P512, DOI 10.1016/j.yexcr.2005.11.017; Ying L, 2014, PLANT PHYSIOL BIOCH, V79, P77, DOI 10.1016/j.plaphy.2014.03.004; Zang AP, 2010, J EXP BOT, V61, P777, DOI 10.1093/jxb/erp341; Zhang CM, 2002, EUR J CELL BIOL, V81, P623, DOI 10.1078/0171-9335-00288; Zhang CM, 2001, CURR BIOL, V11, P208, DOI 10.1016/S0960-9822(01)00053-7; Zhao JF, 2007, PLANT CELL, V19, P3805, DOI 10.1105/tpc.106.048900; Zhao JS, 2007, PLANT CELL REP, V26, P1521, DOI 10.1007/s00299-007-0362-3; Zhu JH, 2004, P NATL ACAD SCI USA, V101, P9873, DOI 10.1073/pnas.0403166101	50	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0154787	10.1371/journal.pone.0154787	http://dx.doi.org/10.1371/journal.pone.0154787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258048	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700010
J	Zhang, QY; Zhao, Y; Zhang, RY; Wei, YY; Yi, HG; Shao, F; Chen, F				Zhang, Qiuyi; Zhao, Yang; Zhang, Ruyang; Wei, Yongyue; Yi, Honggang; Shao, Fang; Chen, Feng			A Comparative Study of Five Association Tests Based on CpG Set for Epigenome-Wide Association Studies	PLOS ONE			English	Article							DIFFERENTIALLY METHYLATED LOCI; DNA METHYLATION; CLASSIFICATION; CHALLENGES; REGRESSION; REDUCTION; SURVIVAL	An epigenome-wide association study (EWAS) is a large-scale study of human disease-associated epigenetic variation, specifically variation in DNA methylation. High throughput technologies enable simultaneous epigenetic profiling of DNA methylation at hundreds of thousands of CpGs across the genome. The clustering of correlated DNA methylation at CpGs is reportedly similar to that of linkage-disequilibrium (LD) correlation in genetic single nucleotide polymorphisms (SNP) variation. However, current analysis methods, such as the t-test and rank-sum test, may be underpowered to detect differentially methylated markers. We propose to test the association between the outcome (e.g case or control) and a set of CpG sites jointly. Here, we compared the performance of five CpG set analysis approaches: principal component analysis (PCA), supervised principal component analysis (SPCA), kernel principal component analysis (KPCA), sequence kernel association test (SKAT), and sliced inverse regression (SIR) with Hotelling's T-2 test and t-test using Bonferroni correction. The simulation results revealed that the first six methods can control the type I error at the significance level, while the t-test is conservative. SPCA and SKAT performed better than other approaches when the correlation among CpG sites was strong. For illustration, these methods were also applied to a real methylation dataset.	[Zhang, Qiuyi; Zhao, Yang; Zhang, Ruyang; Wei, Yongyue; Yi, Honggang; Shao, Fang; Chen, Feng] Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Nanjing 211166, Jiangsu, Peoples R China	Nanjing Medical University	Chen, F (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Biostat, Nanjing 211166, Jiangsu, Peoples R China.	fengchen@njmu.edu.cn	zhao, yang/GXF-4424-2022; Wei, Yongyue/GYV-5660-2022	Wei, Yongyue/0000-0002-1132-1796; Chen, Feng/0000-0002-2699-7190	National Natural Science Foundation of China [81530088, 81473070, 81373102, 81402763, 81402764, 81202283]; Jiangsu Natural Science Foundation [BK20140907]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [14KJA310002]; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Top-notch Academic Programs Project of Jiangsu Higher Education Institutions [TAPP: PPZY2015A067]; Qing-lan Project of Jiangsu Province; Excellent Young Teacher Project of Nanjing Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Top-notch Academic Programs Project of Jiangsu Higher Education Institutions; Qing-lan Project of Jiangsu Province; Excellent Young Teacher Project of Nanjing Medical University	This work was supported by National Natural Science Foundation of China (No. 81530088, 81473070, 81373102, 81402763, 81402764, 81202283), Jiangsu Natural Science Foundation (No. BK20140907), Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 14KJA310002), the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD) and Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (TAPP: PPZY2015A067). The work was also supported by the Qing-lan Project of Jiangsu Province and the Excellent Young Teacher Project of Nanjing Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair E, 2006, J AM STAT ASSOC, V101, P119, DOI 10.1198/016214505000000628; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bock C, 2012, NAT REV GENET, V13, P705, DOI 10.1038/nrg3273; Bock C, 2009, EPIGENOMICS-UK, V1, P99, DOI 10.2217/EPI.09.6; Cai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062495; Chen X, 2008, BIOINFORMATICS, V24, P2474, DOI 10.1093/bioinformatics/btn458; Chen X, 2010, GENET EPIDEMIOL, V34, P716, DOI 10.1002/gepi.20532; Chen Y, 2014, GENET EPIDEMIOL, V38, P42, DOI 10.1002/gepi.21774; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Gao QS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-75; Jolliffe I.T, 2002, PRINCIPAL COMPONENTS, V2nd, P487; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; LI KC, 1991, J AM STAT ASSOC, V86, P316, DOI 10.2307/2290563; Liu Y, 2014, AM J HUM GENET, V94, P485, DOI 10.1016/j.ajhg.2014.02.011; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Liu ZQ, 2005, J BIOMED BIOTECHNOL, P155, DOI 10.1155/JBB.2005.155; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mika S, 1998, KERNEL PCA AND DE NO, P7; Miller J, 2002, RANDGEN A PROGRAM FO; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Saadati M, 2014, STAT MED, V33, P5347, DOI 10.1002/sim.6251; Scholkopf B., 1997, Artificial Neural Networks - ICANN '97. 7th International Conference Proceedings, P583, DOI 10.1007/BFb0020217; Thomas M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-137; Wang S, 2011, GENET EPIDEMIOL, V35, P686, DOI 10.1002/gepi.20619; Wang Xuexia, 2009, BMC Proc, V3 Suppl 7, pS28; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Xu HY, 2013, GENET EPIDEMIOL, V37, P377, DOI 10.1002/gepi.21726; Yi HG, 2015, J BIOMED RES, V29, P298, DOI 10.7555/JBR.29.20140043; Yip WK, 2014, GENET EPIDEMIOL, V38, P714, DOI 10.1002/gepi.21851; Zeng P, 2015, J BIOMED RES, V29, P285, DOI 10.7555/JBR.29.20140007; Zhao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044978	35	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156895	10.1371/journal.pone.0156895	http://dx.doi.org/10.1371/journal.pone.0156895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258058	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700150
J	Angrisano, T; Pero, R; Brancaccio, M; Coretti, L; Florio, E; Pezone, A; Calabro, V; Falco, G; Keller, S; Lembo, F; Avvedimento, VE; Chiariotti, L				Angrisano, Tiziana; Pero, Raffaela; Brancaccio, Mariarita; Coretti, Lorena; Florio, Ermanno; Pezone, Antonio; Calabro, Viola; Falco, Geppino; Keller, Simona; Lembo, Francesca; Avvedimento, Vittorio Enrico; Chiariotti, Lorenzo			Cyclical DNA Methylation and Histone Changes Are Induced by LPS to Activate COX-2 in Human Intestinal Epithelial Cells	PLOS ONE			English	Article							CYCLOOXYGENASE-2 GENE-EXPRESSION; INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; UP-REGULATION; COLON-CANCER; CHROMATIN; PATTERNS; PROSTAGLANDINS; INFECTIONS; PREVENTION	Bacterial lipopolysaccharide (LPS) induces release of inflammatory mediators both in immune and epithelial cells. We investigated whether changes of epigenetic marks, including selected histone modification and DNA methylation, may drive or accompany the activation of COX-2 gene in HT-29 human intestinal epithelial cells upon exposure to LPS. Here we describe cyclical histone acetylation (H3), methylation (H3K4, H3K9, H3K27) and DNA methylation changes occurring at COX-2 gene promoter overtime after LPS stimulation. Histone K27 methylation changes are carried out by the H3 demethylase JMJD3 and are essential for COX-2 induction by LPS. The changes of the histone code are associated with cyclical methylation signatures at the promoter and gene body of COX-2 gene.	[Angrisano, Tiziana; Calabro, Viola; Falco, Geppino] Univ Naples Federico II, Dipartimento Biol, Monte St Angelo Via Cintia 21, I-80126 Naples, Italy; [Pero, Raffaela; Brancaccio, Mariarita; Coretti, Lorena; Florio, Ermanno; Pezone, Antonio; Keller, Simona; Avvedimento, Vittorio Enrico; Chiariotti, Lorenzo] Dipartimento Med Mol & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy; [Pero, Raffaela; Coretti, Lorena; Florio, Ermanno; Pezone, Antonio; Keller, Simona; Chiariotti, Lorenzo] Ist Endocrinol & Oncol Sperimentale CNR, Via S Pansini 5, I-80131 Naples, Italy; [Lembo, Francesca] Univ Naples Federico II, Dipartimento Farm, Via D Montesano 47, I-80131 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Angrisano, T (corresponding author), Univ Naples Federico II, Dipartimento Biol, Monte St Angelo Via Cintia 21, I-80126 Naples, Italy.; Chiariotti, L (corresponding author), Dipartimento Med Mol & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy.; Chiariotti, L (corresponding author), Ist Endocrinol & Oncol Sperimentale CNR, Via S Pansini 5, I-80131 Naples, Italy.	tangrisa@unina.it; chiariot@unina.it	Pezone, Antonio/Y-2016-2019; Brancaccio, Mariarita/AAC-4285-2021; Chiariotti, Lorenzo/AAC-5262-2022; Angrisano, Tiziana/AAC-5353-2022; Pezone, Antonio/AAL-3765-2021; Coretti, Lorena/ADL-9896-2022; Calabro, Viola/H-6156-2013; PERO, Raffaela/L-1461-2015	Pezone, Antonio/0000-0002-0068-6212; Brancaccio, Mariarita/0000-0002-4161-512X; Pezone, Antonio/0000-0002-0068-6212; Angrisano, Tiziana/0000-0002-5940-5278; falco, geppino/0000-0001-6193-7233; Coretti, Lorena/0000-0002-1289-7842; FLORIO, ERMANNO/0000-0001-6961-0059; PERO, Raffaela/0000-0003-2182-5530; Calabro, Viola/0000-0002-6508-8889	Epigenomics Flagship Project - EPIGEN; C.N.R.; POR Campania FSE; Project CREME; Regione Campania; Associazione Italiana per la Ricerca sul Cancro-AIRC [IG 16983]; EPIGEN Flagship Project	Epigenomics Flagship Project - EPIGEN; C.N.R.(Consiglio Nazionale delle Ricerche (CNR)); POR Campania FSE(Regione Campania); Project CREME; Regione Campania(Regione Campania); Associazione Italiana per la Ricerca sul Cancro-AIRC(Fondazione AIRC per la ricerca sul cancro); EPIGEN Flagship Project	This work was supported by grant from Epigenomics Flagship Project - EPIGEN, C.N.R. to LCh, by POR Campania FSE 2007-2013, Project CREME, to TA, by Regione Campania, l.5, to LCh, and by Associazione Italiana per la Ricerca sul Cancro-AIRC (IG 16983) to VEA. LCo, fellowship by EPIGEN Flagship Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisano T, 2013, J INVEST DERMATOL, V133, P2101, DOI 10.1038/jid.2013.143; Angrisano T, 2012, MED MICROBIOL IMMUN, V201, P249, DOI 10.1007/s00430-011-0227-9; Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; Boros J, 2014, MOL CELL BIOL, V34, P3662, DOI 10.1128/MCB.00205-14; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chiariotti L, 2013, MED MICROBIOL IMMUN, V202, P327, DOI 10.1007/s00430-013-0301-6; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Debnath T, 2013, MOLECULES, V18, P7253, DOI 10.3390/molecules18067253; Dhiman VK, 2015, ONCOTARGET, V6, P42575, DOI 10.18632/oncotarget.6471; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marnett LJ, 2002, ANNU REV PHARMACOL, V42, P55, DOI 10.1146/annurev.pharmtox.42.082301.164620; Mehta S, 2015, IMMUNOL CELL BIOL, V93, P233, DOI 10.1038/icb.2014.101; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Michikawa Y, 2013, CLIN MED INSIGHTS-GA, V6, P13, DOI 10.4137/CGast.S11917; Minarovits J, 2009, ACTA MICROBIOL IMM H, V56, P1, DOI 10.1556/AMicr.56.2009.1.1; Ogino S, 2008, CLIN CANCER RES, V14, P8221, DOI 10.1158/1078-0432.CCR-08-1841; Park GY, 2004, AM J PHYSIOL-LUNG C, V286, pL956, DOI 10.1152/ajplung.00338.2003; Pero R, 2011, INT J MED MICROBIOL, V301, P140, DOI 10.1016/j.ijmm.2010.06.009; Singh VP, 2003, PROSTAG OTH LIPID M, V71, P163, DOI 10.1016/S1098-8823(03)00038-8; Soumaoro LT, 2004, CLIN CANCER RES, V10, P8465, DOI 10.1158/1078-0432.CCR-04-0653; Suzuki M, 2003, INFECT IMMUN, V71, P3503, DOI 10.1128/IAI.71.6.3503-3511.2003; Tagliaferri D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147683; Toyota M, 2000, CANCER RES, V60, P4044; Tsujii M, 2013, DIGESTION, V87, P12, DOI 10.1159/000343898; Wang DZ, 2008, CANCER LETT, V267, P197, DOI 10.1016/j.canlet.2008.03.004; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7	34	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156671	10.1371/journal.pone.0156671	http://dx.doi.org/10.1371/journal.pone.0156671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253528	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700049
J	Ericsson, E; Tesselaar, E; Sjoberg, F				Ericsson, Elin; Tesselaar, Erik; Sjoberg, Folke			Effect of Electrode Belt and Body Positions on Regional Pulmonary Ventilation- and Perfusion-Related Impedance Changes Measured by Electric Impedance Tomography	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; INDUCED LUNG INJURY; PRONE POSITION; BEAM CT; EIT; GRAVITY; POSTURE; TIME	Ventilator-induced or ventilator-associated lung injury (VILI/VALI) is common and there is an increasing demand for a tool that can optimize ventilator settings. Electrical impedance tomography (EIT) can detect changes in impedance caused by pulmonary ventilation and perfusion, but the effect of changes in the position of the body and in the placing of the electrode belt on the impedance signal have not to our knowledge been thoroughly evaluated. We therefore studied ventilation-related and perfusion-related changes in impedance during spontaneous breathing in 10 healthy subjects in five different body positions and with the electrode belt placed at three different thoracic positions using a 32-electrode EIT system. We found differences between regions of interest that could be attributed to changes in the position of the body, and differences in impedance amplitudes when the position of the electrode belt was changed. Ventilation-related changes in impedance could therefore be related to changes in the position of both the body and the electrode belt. Perfusion-related changes in impedance were probably related to the interference of major vessels. While these findings give us some insight into the sources of variation in impedance signals as a result of changes in the positions of both the body and the electrode belt, further studies on the origin of the perfusion-related impedance signal are needed to improve EIT further as a tool for the monitoring of pulmonary ventilation and perfusion.	[Ericsson, Elin; Tesselaar, Erik; Sjoberg, Folke] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Tesselaar, Erik] Linkoping Univ, Dept Med & Hlth Sci, Dept Radiat Phys, Linkoping, Sweden; [Sjoberg, Folke] Linkoping Univ, Dept Hand & Plast Surg, Linkoping, Sweden; [Sjoberg, Folke] Linkoping Univ, Burn Clin, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University	Tesselaar, E (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.; Tesselaar, E (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Dept Radiat Phys, Linkoping, Sweden.	erik.tesselaar@liu.se						Adler A, 2002, PHYSIOL MEAS, V33, P679; Albert RK, 2000, AM J RESP CRIT CARE, V161, P1660, DOI 10.1164/ajrccm.161.5.9901037; Beillas P, 2009, STAPP CAR CRASH JO, V53, P127; Bodenstein M, 2009, CRIT CARE MED, V37, P713, DOI 10.1097/CCM.0b013e3181958d2f; Caruana LR, 2015, ANAESTH INTENS CARE, V43, P88, DOI 10.1177/0310057X1504300113; Costa ELV, 2008, CRIT CARE MED, V36, P1230, DOI 10.1097/CCM.0b013e31816a0380; Drake R, 2014, GRAYS ANATOMY STUDEN, P121; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Elke G, 2013, PHYSIOL MEAS, V34, P1303, DOI 10.1088/0967-3334/34/10/1303; Eyuboglu B M, 1987, Clin Phys Physiol Meas, V8 Suppl A, P167, DOI 10.1088/0143-0815/8/4A/021; Ferrario D, 2012, IEEE T BIO-MED ENG, V59, P3000, DOI 10.1109/TBME.2012.2209116; Frerichs I, 1996, PHYSIOL MEAS, V17, pA149, DOI 10.1088/0967-3334/17/4A/019; Frerichs I, 2002, J APPL PHYSIOL, V93, P660, DOI 10.1152/japplphysiol.00081.2002; Frerichs I, 2002, IEEE T MED IMAGING, V21, P646, DOI 10.1109/TMI.2002.800585; Frerichs I, 2001, J APPL PHYSIOL, V91, P39, DOI 10.1152/jappl.2001.91.1.39; Frerichs I, 2009, RESPIRATION, V77, P282, DOI 10.1159/000193994; Galvin I, 2007, BRIT J ANAESTH, V98, P420, DOI 10.1093/bja/aem036; Gattinoni L, 2013, AM J RESP CRIT CARE, V188, P1286, DOI 10.1164/rccm.201308-1532CI; Glenny RW, 2009, INTENS CARE MED, V35, P1833, DOI 10.1007/s00134-009-1649-3; Grant CA, 2011, CRIT CARE, V15, DOI 10.1186/cc9985; Hayes A. R., 2013, SCI C, V57, P111; Kunst PWA, 1998, PHYSIOL MEAS, V19, P481, DOI 10.1088/0967-3334/19/4/003; LEATHARD AD, 1994, PHYSIOL MEAS, V15, pA137, DOI 10.1088/0967-3334/15/2A/018; Li Y, 2014, ACTA ANAESTH SCAND, V58, P716, DOI 10.1111/aas.12323; Nguyen DT, 2012, PHYSIOL MEAS, V33, P695, DOI 10.1088/0967-3334/33/5/695; Noordegraaf AV, 1998, PHYSIOL MEAS, V19, P263, DOI 10.1088/0967-3334/19/2/013; Noordegraaf AV, 1996, PHYSIOL MEAS, V17, P179, DOI 10.1088/0967-3334/17/3/004; Pelosi P, 2002, EUR RESPIR J, V20, P1017, DOI 10.1183/09031936.02.00401702; Pulletz S, 2010, ACTA ANAESTH SCAND, V54, P751, DOI 10.1111/j.1399-6576.2010.02233.x; Reifferscheid F, 2011, RESPIROLOGY, V16, P523, DOI 10.1111/j.1440-1843.2011.01929.x; Riedel T, 2005, INTENS CARE MED, V31, P1522, DOI 10.1007/s00134-005-2734-x; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Victorino JA, 2004, AM J RESP CRIT CARE, V169, P791, DOI 10.1164/rccm.200301-133OC; West JB, 1978, REGIONAL DIFFERENCES, V74, P426; Wolf GK, 2013, CRIT CARE MED, V41, P1296, DOI 10.1097/CCM.0b013e3182771516	35	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155913	10.1371/journal.pone.0155913	http://dx.doi.org/10.1371/journal.pone.0155913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253433	gold, Green Published, Green Submitted			2022-12-26	WOS:000377218700010
J	Lohkamp, LN; Schinz, M; Gehlhaar, C; Guse, K; Thomale, UW; Vajkoczy, P; Heppner, FL; Koch, A				Lohkamp, Laura-Nanna; Schinz, Maren; Gehlhaar, Claire; Guse, Katrin; Thomale, Ulrich-Wilhelm; Vajkoczy, Peter; Heppner, Frank L.; Koch, Arend			MGMT Promoter Methylation and BRAF V600E Mutations Are Helpful Markers to Discriminate Pleomorphic Xanthoastrocytoma from Giant Cell Glioblastoma	PLOS ONE			English	Article							LONG-TERM SURVIVAL; CODON 132 MUTATION; CANCER ETIOLOGY; IDH2 MUTATIONS; PHASE-3 TRIAL; FUSION GENE; GLIOMAS; P53; TUMORS; TEMOZOLOMIDE	Giant Cell Glioblastoma (gcGBM) and Pleomorphic Xanthoastrocytoma (PXA) are rare astroglial tumors of the central nervous system. Although they share certain histomorphological and immunohistochemical features, they are characterized by different clinical behavior and prognosis. Nevertheless, few cases remain uncertain, as their histomorphological hallmarks and immunophenotypes do correspond to the typical pattern neither of gcGBM nor PXA. Therefore, in addition to the routinely used diagnostic histochemical and immunohistochemical markers like Gomori, p53 and CD34, we analyzed if genetic variations like MGMT promoter methylation, mutations in the IDH1/2 genes, or BRAF mutations, which are actually used as diagnostic, prognostic and predictive molecular markers in anaplastic glial tumors, could be helpful in the differential diagnostic of both tumor entities. We analyzed 34 gcGBM and 20 PXA for genetic variations in the above-named genes and found distinct distributions between both groups. MGMT promoter hypermethylation was observed in 3 out of 20 PXA compared to 14 out of 34 gcGBM (15% vs. 41.2%, p-value 0.09). BRAF V600E mutations were detected in 50% of the PXA but not in any of the gcGBM (50% vs. 0%, p-value < 0.001). IDH1 R132 and IDH R172 mutations were not present in any of the PXA and gcGBM cases. Our data indicate, that in addition to the histological and immunohistochemical evaluation, investigation of MGMT promoter methylation and in particular BRAF V600E mutations represent reliable additional tools to sustain differentiation of gcGBM from PXA on a molecular basis. Based on these data specific BRAF kinase inhibitors could represent a promising agent in the therapy of PXA and their use should be emphasized.	[Lohkamp, Laura-Nanna; Schinz, Maren; Gehlhaar, Claire; Guse, Katrin; Heppner, Frank L.; Koch, Arend] Charite, Dept Neuropathol, D-13353 Berlin, Germany; [Thomale, Ulrich-Wilhelm; Vajkoczy, Peter] Charite, Dept Neurosurg & Pediat Neurosurg, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lohkamp, LN (corresponding author), Charite, Dept Neuropathol, D-13353 Berlin, Germany.	Laura-Nanna.Lohkamp@charite.de	Heppner, Frank/ABH-8393-2020	Heppner, Frank/0000-0001-9816-8917				Antonelli M, 2015, PEDIATR BLOOD CANCER, V62, P724, DOI 10.1002/pbc.25272; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bar EE, 2008, J NEUROPATH EXP NEUR, V67, P878, DOI 10.1097/NEN.0b013e3181845622; Capper D, 2011, ACTA NEUROPATHOL, V122, P11, DOI 10.1007/s00401-011-0841-z; Chamberlain MC, 2013, J NEURO-ONCOL, V114, P237, DOI 10.1007/s11060-013-1176-5; Chang HT, 2006, CHILD NERV SYST, V22, P609, DOI 10.1007/s00381-005-0005-3; Dahiya S, 2014, NEURO-ONCOLOGY, V16, P318, DOI 10.1093/neuonc/not146; Dias-Santagata D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017948; Dougherty MJ, 2010, NEURO-ONCOLOGY, V12, P621, DOI 10.1093/neuonc/noq007; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Giannini C, 2001, NEUROGENETICS, V3, P159, DOI 10.1007/s100480100116; Giannini C, 1999, CANCER, V85, P2033, DOI 10.1002/(SICI)1097-0142(19990501)85:9<2033::AID-CNCR22>3.3.CO;2-Q; Giannini C., 2007, WHO CLASSIFICATION T; Gomori E, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-8; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hainaut P, 1997, NUCLEIC ACIDS RES, V25, P151, DOI 10.1093/nar/25.1.151; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hussain SP, 1998, CANCER RES, V58, P4023; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Kaulich K, 2002, J NEUROPATH EXP NEUR, V61, P1092, DOI 10.1093/jnen/61.12.1092; Kleihues P BP, 2007, WHO CLASSIFICATION T, P46; Kleinschmidt-DeMasters BK, 2013, AM J SURG PATHOL, V37, P685, DOI 10.1097/PAS.0b013e31827f9c5e; Koelsche C, 2014, BRAIN PATHOL, V24, P221, DOI 10.1111/bpa.12111; Korshunov A, 2009, ACTA NEUROPATHOL, V118, P401, DOI 10.1007/s00401-009-0550-z; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Malmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6; Martinez-Diaz H, 2003, ARCH PATHOL LAB MED, V127, P1187; Marucci G, 2011, J NEURO-ONCOL, V105, P397, DOI 10.1007/s11060-011-0605-6; MeyerPuttlitz B, 1997, AM J PATHOL, V151, P853; Mikeska T, 2007, J MOL DIAGN, V9, P368, DOI 10.2353/jmoldx.2007.060167; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Reifenberger G, 2003, ACTA NEUROPATHOL, V105, P358, DOI 10.1007/s00401-002-0652-3; Riemenschneider MJ, 2010, ACTA NEUROPATHOL, V120, P567, DOI 10.1007/s00401-010-0736-4; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Weller M, 2013, LANCET ONCOL, V14, pE370, DOI 10.1016/S1470-2045(13)70168-2; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wick WG, 2013, NEUROLOGY, V81, P1515, DOI 10.1212/WNL.0b013e3182a95680; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zakrzewska M, 2009, CANCER GENET CYTOGEN, V193, P93, DOI 10.1016/j.cancergencyto.2009.04.023	44	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156422	10.1371/journal.pone.0156422	http://dx.doi.org/10.1371/journal.pone.0156422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253461	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700028
J	Robach, P; Trebes, G; Lasne, F; Buisson, C; Mechin, N; Mazzarino, M; de la Torre, X; Roustit, M; Kerivel, P; Botre, F; Bouzat, P				Robach, Paul; Trebes, Gilles; Lasne, Francoise; Buisson, Corinne; Mechin, Nathalie; Mazzarino, Monica; de la Torre, Xavier; Roustit, Matthieu; Kerivel, Patricia; Botre, Francesco; Bouzat, Pierre			Drug Use on Mont Blanc: A Study Using Automated Urine Collection	PLOS ONE			English	Article							HIGH-ALTITUDE; LIQUID-CHROMATOGRAPHY; EXERCISE CAPACITY; ACETAZOLAMIDE; SLEEP; PHARMACOLOGY; PERFORMANCE; PATTERNS; MASS	Mont Blanc, the summit of Western Europe, is a popular but demanding high-altitude ascent. Drug use is thought to be widespread among climbers attempting this summit, not only to prevent altitude illnesses, but also to boost physical and/or psychological capacities. This practice may be unsafe in this remote alpine environment. However, robust data on medication during the ascent of Mont Blanc are lacking. Individual urine samples from male climbers using urinals in mountain refuges on access routes to Mont Blanc (Gouter and Cosmiques mountain huts) were blindly and anonymously collected using a hidden automatic sampler. Urine samples were screened for a wide range of drugs, including diuretics, glucocorticoids, stimulants, hypnotics and phosphodiesterase 5 (PDE-5) inhibitors. Out of 430 samples analyzed from both huts, 35.8% contained at least one drug. Diuretics (22.7%) and hypnotics (12.9%) were the most frequently detected drugs, while glucocorticoids (3.5%) and stimulants (3.1%) were less commonly detected. None of the samples contained PDE-5 inhibitors. Two substances were predominant: the diuretic acetazolamide (20.6%) and the hypnotic zolpidem (8.4%). Thirty three samples were found positive for at least two substances, the most frequent combination being acetazolamide and a hypnotic (2.1%). Based on a novel sampling technique, we demonstrate that about one third of the urine samples collected from a random sample of male climbers contained one or several drugs, suggesting frequent drug use amongst climbers ascending Mont Blanc. Our data suggest that medication primarily aims at mitigating the symptoms of altitude illnesses, rather than enhancing performance. In this hazardous environment, the relatively high prevalence of hypnotics must be highlighted, since these molecules may alter vigilance.	[Robach, Paul; Kerivel, Patricia] Ecole Natl Sports Montagne, Site Ecole Natl Ski & Alpinisme, Chamonix Mt Blanc, France; [Robach, Paul; Roustit, Matthieu] Univ Grenoble Alpes, HP2, Grenoble, France; [Robach, Paul; Roustit, Matthieu] INSERM, HP2, Grenoble, France; [Trebes, Gilles] CHU Grenoble, Pole Urgences Med Aigue, F-38043 Grenoble, France; [Lasne, Francoise; Buisson, Corinne; Mechin, Nathalie] Agence Francaise Lutte Dopage, Dept Anal, Chatenay Malabry, France; [Mazzarino, Monica; de la Torre, Xavier; Botre, Francesco] Federaz Med Sport Italiana, Lab Antidoping, Rome, Italy; [Roustit, Matthieu] CHU Grenoble, INSERM, Pharmacol Clin, Pole Rech,CIC1406, F-38043 Grenoble, France; [Botre, Francesco] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy; [Bouzat, Pierre] CHU Grenoble, Pole Anesthesie Reanimat, F-38043 Grenoble, France; [Bouzat, Pierre] Univ Grenoble Alpes, INSERM, U836, Inst Neurosci, Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Sapienza University Rome; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Robach, P (corresponding author), Ecole Natl Sports Montagne, Site Ecole Natl Ski & Alpinisme, Chamonix Mt Blanc, France.; Robach, P (corresponding author), Univ Grenoble Alpes, HP2, Grenoble, France.; Robach, P (corresponding author), INSERM, HP2, Grenoble, France.	paul.robach@ensm.sports.gouv.fr	de la Torre, Xavier/AAO-3059-2020; Bouzat, Pierre/AAC-4105-2019; Bouzat, Pierre/L-6881-2014; Botre, Francesco/AFL-3227-2022; Roustit, Matthieu/M-6927-2014	de la Torre, Xavier/0000-0001-8037-6750; Bouzat, Pierre/0000-0003-4667-6738; Botre, Francesco/0000-0001-5296-8126; Roustit, Matthieu/0000-0003-4475-1626	Agence Francaise de Lutte contre le Dopage; Fondation Petzl; Federation Francaise des Clubs Alpins et de Montagne	Agence Francaise de Lutte contre le Dopage; Fondation Petzl; Federation Francaise des Clubs Alpins et de Montagne	This study was supported by the Agence Francaise de Lutte contre le Dopage, the Fondation Petzl and the Federation Francaise des Clubs Alpins et de Montagne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton CH, 2001, BRIT J PSYCHIAT, V178, P101, DOI 10.1192/bjp.178.2.101; Bartsch P, 2013, NEW ENGL J MED, V369, P1666, DOI 10.1056/NEJMc1309747; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Beaumont M, 2007, SLEEP, V30, P1527, DOI 10.1093/sleep/30.11.1527; BRADWELL AR, 1986, LANCET, V1, P1001; CAMPINSFALCO P, 1994, J CHROMATOGR B, V654, P85, DOI 10.1016/0378-4347(94)00005-0; Cheron-Launay M, 2011, ADDICT BEHAV, V36, P743, DOI 10.1016/j.addbeh.2011.02.013; Clore JN, 2009, ENDOCR PRACT, V15, P469, DOI 10.4158/EP08331.RAR; Cone EJ, 2003, J ANAL TOXICOL, V27, P386, DOI 10.1093/jat/27.7.386; Docherty JR, 2008, BRIT J PHARMACOL, V154, P606, DOI 10.1038/bjp.2008.124; Dubowitz G, 1998, BRIT MED J, V316, P587, DOI 10.1136/bmj.316.7131.587; Fischler M, 2009, AM J RESP CRIT CARE, V180, P346, DOI 10.1164/rccm.200808-1348OC; Ghofrani HA, 2004, ANN INTERN MED, V141, P169, DOI 10.7326/0003-4819-141-3-200408030-00005; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; HERRAEZHERNANDEZ R, 1992, J CHROMATOGR-BIOMED, V582, P181, DOI 10.1016/0378-4347(92)80317-J; Jackson SJ, 2010, HIGH ALT MED BIOL, V11, P217, DOI 10.1089/ham.2010.1003; Lagnaoui R, 2004, EUR J CLIN PHARMACOL, V60, P523, DOI 10.1007/s00228-004-0808-2; Luks AM, 2008, HIGH ALT MED BIOL, V9, P195, DOI 10.1089/ham.2008.1025; Luks AM, 2010, WILD ENVIRON MED, V21, P146, DOI 10.1016/j.wem.2010.03.002; Mazzarino M, 2016, J PHARMACEUT BIOMED, V117, P47, DOI 10.1016/j.jpba.2015.08.007; Messner R., 2013, DESNIVEL MAGAZINE; ONeil D., 2013, OUTSIDE MAGAZINE; Petzl-Foundation, 2012, MONT BLANC CAN WE RE; Roggla G, 1993, Schweiz Z Sportmed, V41, P103; Subedi BH, 2010, WILD ENVIRON MED, V21, P345, DOI 10.1016/j.wem.2010.09.006; Tsianos G, 2006, EUR J APPL PHYSIOL, V96, P32, DOI 10.1007/s00421-005-0066-8; Vermeeren A, 2004, CNS DRUGS, V18, P297, DOI 10.2165/00023210-200418050-00003; WADA, 2016, WORLD ANT AG 2016 PR	29	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156786	10.1371/journal.pone.0156786	http://dx.doi.org/10.1371/journal.pone.0156786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253728	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700060
J	Mandal, AK				Mandal, Anil K.			Acute Corneal Hydrops in Children with Primary Infantile Glaucoma: A Report of 31 Cases over 23 Years at the LVPEI	PLOS ONE			English	Article							COMBINED TRABECULOTOMY-TRABECULECTOMY; PRIMARY CONGENITAL GLAUCOMA; PRIMARY DEVELOPMENTAL GLAUCOMA; C-AUGMENTED TRABECULECTOMY; ILLUMINATED MICROCATHETER; EXTERNAL TRABECULOTOMY; VISUAL-ACUITY; CIRCUMFERENTIAL TRABECULOTOMY; PEDIATRIC GLAUCOMA; CHILDHOOD GLAUCOMA	Purpose Relatively little data exist regarding the outcomes of children with primary infantile glaucoma presenting with acute corneal hydrops. The aim of our study was to determine the surgical outcome of children of infantile glaucoma who presented with acute corneal hydrops. Methods In total, 38 eyes of 31 consecutive children of infantile glaucoma presented with acute corneal hydrops who underwent primary combined trabeculotomy-trabeculectomy (CTT) by a single surgeon from January 1990 to December 2012 at the LV Prasad Eye Institute (LVPEI), a tertiary eye care centre in Southern India were enrolled in this retrospective study. Primary outcome measures were intraocular pressure (IOP) control (IOP <= 16 mmHg under anaesthesia or IOP <= 21 mmHg without anaesthesia) and clearance of corneal edema. Secondary outcome measures were visual acuity (VA), corneal diameter, bleb appearance, intraoperative and postoperative complications. Results Mean age at presentation was 6.4 months (range, 2-11 months) and seven eyes (23%) had bilateral affliction. At presentation, all eyes (100%) had moderate to severe degree of corneal edema with a mean preoperative IOP of 25.6 +/- 5.1 mmHg. Postoperatively, the IOP reduced to 12.0 +/- 3.8 mmHg (difference = -13.6, 95% CI = -15.7 to -11.5, t = -13.18, p<0.0001), and the percentage reduction in IOP was 53.05%. Preoperatively 83% of the eyes were on antiglaucoma medication, and postoperatively 2 eyes (5.3%) required 1 antiglaucoma medication for control of IOP. Preoperatively, corneal edema was present in all eyes and postoperatively it cleared in all of them. Significant myopic astigmatism was present in 28 eyes (74%), the commonest being compound myopic astigmatism (75%) followed by simple myopic astigmatism (21%). Normal VA (best-corrected VA; BCVA >= 20/60) was achieved in 44.4% of the eyes and 22.2% eyes had low vision (BCVA, <20/60 to 20/400). Complete success (IOP control and clearance of corneal oedema) was obtained in 94.7% eyes. There were no significant intraoperative or postoperative complications. Two thirds of the patients showed low, elevated functional filtering bleb. No patient had any bleb leak, blebitis or bleb related endophthalmitis. The median follow-up was 36 months (range 2-228 months). Conclusions Primary CTT is safe and effective in controlling IOP, resulting in complete clearance of corneal edema with modest visual improvement in children of infantile glaucoma presenting with acute corneal hydrops. The outcome of the study will have a positive impact on counseling the parents preoperatively.	[Mandal, Anil K.] LV Prasad Eye Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, Andhra Pradesh, India	L. V. Prasad Eye Institute	Mandal, AK (corresponding author), LV Prasad Eye Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, Andhra Pradesh, India.	mandal@lvpei.org	Mandal, Anil/AAY-4809-2020		Hyderabad Eye Research Foundation	Hyderabad Eye Research Foundation	This study was supported by Hyderabad Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hazmi A, 2005, BRIT J OPHTHALMOL, V89, P449, DOI 10.1136/bjo.2004.047761; BECK AD, 1995, ARCH OPHTHALMOL-CHIC, V113, P1200, DOI 10.1001/archopht.1995.01100090126034; Biglan AW, 2006, J AAPOS, V10, P7, DOI 10.1016/j.jaapos.2005.10.001; BIGLAN AW, 1979, J PEDIAT OPHTH STRAB, V16, P377; Chen TC, 2014, OPHTHALMOLOGY, V121, P2107, DOI 10.1016/j.ophtha.2014.05.010; Daw NW, 1998, ARCH OPHTHALMOL-CHIC, V116, P502, DOI 10.1001/archopht.116.4.502; DELUISE VP, 1983, SURV OPHTHALMOL, V28, P1, DOI 10.1016/0039-6257(83)90174-1; ELDER MJ, 1994, BRIT J OPHTHALMOL, V78, P745, DOI 10.1136/bjo.78.10.745; Girkin CA, 2012, J AAPOS, V16, P424, DOI 10.1016/j.jaapos.2012.05.013; HAAS J, 1968, INVEST OPHTH VISUAL, V7, P140; Hoskins H D Jr, 1984, J Pediatr Ophthalmol Strabismus, V21, P153; HYVARINEN L, 1980, ACTA OPHTHALMOL, V58, P507; Ishida Kyoko, 2005, Ophthalmol Clin North Am, V18, P431, DOI 10.1016/j.ohc.2005.05.009; Khaw PT, 1996, BRIT J OPHTHALMOL, V80, P495, DOI 10.1136/bjo.80.6.495; Khitri MR, 2012, J AAPOS, V16, P376, DOI 10.1016/j.jaapos.2012.05.007; Ko F, 2015, PROG BRAIN RES, V221, P177, DOI 10.1016/bs.pbr.2015.06.005; Lim ME, 2015, J AAPOS, V19, P145, DOI 10.1016/j.jaapos.2015.01.008; Luntz M H, 1984, J Pediatr Ophthalmol Strabismus, V21, P150; Mandal AK, 2007, EYE, V21, P764, DOI 10.1038/sj.eye.6702324; Mandal AK, 1997, OPHTHALMOLOGY, V104, P996, DOI 10.1016/S0161-6420(97)30195-X; Mandal AK, 2006, EYE, V20, P135, DOI 10.1038/sj.eye.6701817; Mandal AK, 2004, OPHTHALMOLOGY, V111, P283, DOI 10.1016/j.ophtha.2003.05.027; Mandal AK, 1998, OPHTHALMOLOGY, V105, P974, DOI 10.1016/S0161-6420(98)96022-5; Mandal AK, 1999, OPHTHALMIC SURG LAS, V30, P473; Mandal AK., 2006, PEDIAT GLAUCOMAS; Mandal AK, 2013, NEW ENGL J MED, V369, P74, DOI 10.1056/NEJMicm1213817; Mandal Anil K., 2002, Indian Journal of Ophthalmology, V50, P13; Mandal Anil K., 1993, Indian Journal of Ophthalmology, V41, P51; MAYER DL, 1995, INVEST OPHTH VIS SCI, V36, P671; MCPHERSON SD, 1980, OPHTHALMOLOGY, V87, P302; MCPHERSON SD, 1973, AM J OPHTHALMOL, V76, P918, DOI 10.1016/0002-9394(73)90081-0; MCPHERSON SD, 1983, AM J OPHTHALMOL, V95, P427, DOI 10.1016/0002-9394(83)90260-X; Mullaney PB, 1999, ARCH OPHTHALMOL-CHIC, V117, P457; OCONNOR G, 1994, BRIT J OPHTHALMOL, V78, P735, DOI 10.1136/bjo.78.10.735; Papadopoulos M, 2014, EYE, V28, P931, DOI 10.1038/eye.2014.140; Patil B, 2015, OPHTHALMOLOGY, V122, P87, DOI 10.1016/j.ophtha.2014.07.029; Rao GN, 2015, EYE, V29, P30, DOI 10.1038/eye.2014.239; Richardson K T Jr, 1967, Trans Am Acad Ophthalmol Otolaryngol, V71, P833; Sarkisian SR, 2010, J AAPOS, V14, P412, DOI 10.1016/j.jaapos.2010.07.010; TELLER DY, 1986, DEV MED CHILD NEUROL, V28, P779; Temkar S, 2015, AM J OPHTHALMOL, V159, P490, DOI 10.1016/j.ajo.2014.12.001; Wright KW, 2012, PEDIAT OPHTHALMOLOGY, P231; Zacharia PT, 1998, OPHTHALMIC SURG LAS, V29, P318; Zagora SL, 2015, AM J OPHTHALMOL, V159, P788, DOI 10.1016/j.ajo.2015.01.019	44	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156108	10.1371/journal.pone.0156108	http://dx.doi.org/10.1371/journal.pone.0156108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249057	Green Published, gold			2022-12-26	WOS:000377184700029
J	Sassi, C; Ridge, PG; Nalls, MA; Gibbs, R; Ding, JH; Lupton, MK; Troakes, C; Lunnon, K; Al-Sarraj, S; Brown, KS; Medway, C; Lord, J; Turton, J; Morgan, K; Powell, JF; Kauwe, JS; Cruchaga, C; Bras, J; Goate, AM; Singleton, AB; Guerreiro, R; Hardy, J				Sassi, Celeste; Ridge, Perry G.; Nalls, Michael A.; Gibbs, Raphael; Ding, Jinhui; Lupton, Michelle K.; Troakes, Claire; Lunnon, Katie; Al-Sarraj, Safa; Brown, Kristelle S.; Medway, Christopher; Lord, Jenny; Turton, James; Morgan, Kevin; Powell, John F.; Kauwe, John S.; Cruchaga, Carlos; Bras, Jose; Goate, Alison M.; Singleton, Andrew B.; Guerreiro, Rita; Hardy, John		ARUK Consortium	Influence of Coding Variability in APP-A beta Metabolism Genes in Sporadic Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; MISSENSE MUTATIONS; DEGRADING ENZYMES; COMMON VARIANTS; SEQUENCING DATA; RECEPTOR LR11; SORL1; ABCA7	The cerebral deposition of A beta(42), a neurotoxic proteolytic derivate of amyloid precursor protein (APP), is a central event in Alzheimer's disease (AD)(Amyloid hypothesis). Given the key role of APP-A beta metabolism in AD pathogenesis, we selected 29 genes involved in APP processing, A beta degradation and clearance. We then used exome and genome sequencing to investigate the single independent (single-variant association test) and cumulative (gene-based association test) effect of coding variants in these genes as potential susceptibility factors for AD, in a cohort composed of 332 sporadic and mainly late-onset AD cases and 676 elderly controls from North America and the UK. Our study shows that common coding variability in these genes does not play a major role for the disease development. In the single-variant association analysis, the main hits, none of which statistically significant after multiple testing correction (1.9e(-4)<p-value<0.05), were found to be rare coding variants (0.009%<MAF<1.4%) with moderate to strong effect size (1.84<OR<Inf) that map to genes mainly involved in A beta extracellular degradation (TTR, ACE), clearance (LRP1) and APP trafficking and recycling (SORL1). These results were partially replicated in the gene-based analysis (c-alpha and SKAT tests), that reports ECE1, LYZ and TTR as nominally associated to AD (1.7e(-3) <p-value <0.05). In concert with previous studies, we suggest that 1) common coding variability in APP-A beta genes is not a critical factor for AD development and 2) A beta degradation and clearance, rather than A beta production, may play a key role in the etiology of sporadic AD.	[Sassi, Celeste; Bras, Jose; Guerreiro, Rita; Hardy, John] UCL Inst Neurol, Dept Mol Neurosci, Weston Res Labs, Reta Lila, London, England; [Sassi, Celeste; Nalls, Michael A.; Gibbs, Raphael; Ding, Jinhui; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Sassi, Celeste] Charite, Dept Expt Neurol, Ctr Stroke Res Berlin CSB, D-13353 Berlin, Germany; [Sassi, Celeste] German Ctr Neurodegenerat Dis DZNE, Berlin Site, Berlin, Germany; [Ridge, Perry G.; Kauwe, John S.] Brigham Young Univ, Neurosci, Dept Biol, Provo, UT 84602 USA; [Lupton, Michelle K.; Troakes, Claire; Lunnon, Katie; Al-Sarraj, Safa; Powell, John F.] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Lupton, Michelle K.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Brown, Kristelle S.; Medway, Christopher; Lord, Jenny; Turton, James; Morgan, Kevin] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Translat Cell Sci Human Genet, Nottingham NG7 2RD, England; [Cruchaga, Carlos] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Goate, Alison M.] Icahn Sch Med Mt Sinai, Icahn Med Inst, New York, NY 10029 USA	University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Brigham Young University; University of London; King's College London; QIMR Berghofer Medical Research Institute; University of Nottingham; Washington University (WUSTL); Icahn School of Medicine at Mount Sinai	Hardy, J (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, Weston Res Labs, Reta Lila, London, England.	j.hardy@ucl.ac.uk	Singleton, Andrew B/C-3010-2009; Powell, John F/G-4412-2011; Lunnon, Katie/C-4638-2012; Guerreiro, Rita J L/A-1327-2011; Cruchaga, Carlos/ABF-4065-2020; Bras, Jose MT/A-1428-2011; Hardy, John/C-2451-2009; Gibbs, J. Raphael/A-3984-2010; Lord, Jenny/GYJ-1039-2022; Lord, Jenny/AAR-5643-2021; Kauwe, John/AAC-6646-2021; Kehoe, Patrick/P-8760-2018	Powell, John F/0000-0001-6124-439X; Lunnon, Katie/0000-0001-7570-6065; Cruchaga, Carlos/0000-0002-0276-2899; Hardy, John/0000-0002-3122-0423; Gibbs, J. Raphael/0000-0002-6985-0658; Lord, Jenny/0000-0002-0539-9343; Kauwe, John/0000-0001-8641-2468; Goate, Alison/0000-0002-0576-2472; Kehoe, Patrick/0000-0002-7542-1139; Bras, Jose/0000-0001-8186-0333; Troakes, Claire/0000-0002-1790-7376; Todd, Stephen/0000-0002-2312-9195; Morgan, Kevin/0000-0002-8217-2396; Lowe, James/0000-0002-9856-1599; McGuinness, Bernadette/0000-0002-7028-5633; Hooper, Nigel/0000-0002-5811-3484; Turton, James/0000-0003-2681-0477; Guerreiro, Rita/0000-0001-5879-3486	Alzheimer's Research UK; Medical Research Council (MRC); Wellcome Trust/MRC Joint Call in Neurodegeneration Award [WT089698]; National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; Big Lottery; Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health (Department of Health and Human Services) [ZO1 AG000950-10]; ARUK; AS; Brains for Dementia Research programme - Alzheimer's Research UK; Alzheimer's Society;  [P50 AG016574];  [U01 AG006786];  [R01 AG18023]; NATIONAL INSTITUTE ON AGING [U01AG052411, RF1AG044546, Z01AG000950, ZIAAG000950, R01AG018023, R01AG044546, P50AG016574, P01AG003991, U24AG021886, ZIAAG000957, P50AG005681, U01AG006786, P01AG026276] Funding Source: NIH RePORTER; Alzheimers Research UK [ARUK-TRFUS2012-3] Funding Source: researchfish; Medical Research Council [G1100695, MR/L016397/1] Funding Source: researchfish; MRC [G1100695, MR/L016397/1] Funding Source: UKRI	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust/MRC Joint Call in Neurodegeneration Award; National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; Big Lottery; Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health (Department of Health and Human Services); ARUK(Alzheimer's Research UK (ARUK)); AS; Brains for Dementia Research programme - Alzheimer's Research UK; Alzheimer's Society; ; ; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Alzheimer's Research UK, the Medical Research Council (MRC), the Wellcome Trust/MRC Joint Call in Neurodegeneration Award (WT089698) to the UK Parkinson's Disease Consortium (whose members are from the University College London Institute of Neurology, the University of Sheffield, and the MRC Protein Phosphorylation Unit at the University of Dundee), grants (P50 AG016574, U01 AG006786, and R01 AG18023), the National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; the Big Lottery (to Dr. Morgan); a fellowship from Alzheimer's Research UK (to Dr. Guerreiro); and the Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health (Department of Health and Human Services Project number, ZO1 AG000950-10). The MRC London Neurodegenerative Diseases Brain Bank and the Manchester Brain Bank from Brains for Dementia Research are jointly funded from ARUK and AS. Tissue samples were supplied by The London Neurodegenerative Diseases Brain Bank, which receives funding from the MRC and as part of the Brains for Dementia Research programme, jointly funded by Alzheimer's Research UK and Alzheimer's Society.; This study was supported by the Alzheimer's Research UK, the Medical Research Council (MRC), the Wellcome Trust/MRC Joint Call in Neurodegeneration Award (WT089698) to the UK Parkinson's Disease Consortium (whose members are from the University College London Institute of Neurology, the University of Sheffield, and the MRC Protein Phosphorylation Unit at the University of Dundee), grants (P50 AG016574, U01 AG006786, and R01 AG18023), the National Institute for Health Research Biomedical Research Unit in Dementia at University College London Hospitals, University College London; the Big Lottery (to Dr. Morgan); a fellowship from Alzheimer's Research UK (to Dr. Guerreiro); and the Intramural Research Programs of the National Institute on Aging and the National Institute of Neurological Disease and Stroke, National Institutes of Health (Department of Health and Human Services Project number, ZO1 AG000950-10). The MRC London Neurodegenerative Diseases Brain Bank and the Manchester Brain Bank from Brains for Dementia Research are jointly funded from ARUK and AS. The Alzheimer's Research UK (ARUK) Consortium: Peter Passmore, David Craig, Janet Johnston, Bernadette McGuinness, Stephen Todd, Queen's University Belfast, UK; Reinhard Heun, Royal Derby Hospital, UK; Heike Kolsch, University of Bonn, Germany; Patrick G. Kehoe, University of Bristol, UK; Nigel M. Hooper, University of Leeds, UK; Emma R.L.C. Vardy, University of Newcastle, UK; David M. Mann, Stuart Pickering-Brown, University of Manchester, UK; Kristelle Brown, James Lowe, Kevin Morgan, University of Nottingham, UK; A. David Smith, Gordon Wilcock, Donald Warden, University of Oxford (OPTIMA), UK; Clive Holmes, University of Southampton, UK.; Tissue samples were supplied by The London Neurodegenerative Diseases Brain Bank, which receives funding from the MRC and as part of the Brains for Dementia Research programme, jointly funded by Alzheimer's Research UK and Alzheimer's Society.	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Benitez BA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003685; Choi SH, 2007, J NEUROSCI, V27, P7006, DOI 10.1523/JNEUROSCI.1919-07.2007; Costa R, 2008, FEBS LETT, V582, P936, DOI 10.1016/j.febslet.2008.02.034; Cuenco KT, 2011, NEUROBIOL AGING, V32, P249, DOI 10.1016/j.neurobiolaging.2009.02.014; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; Feulner TM, 2010, MOL PSYCHIATR, V15, P756, DOI 10.1038/mp.2008.141; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kamboh MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.45; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee JH, 2007, ARCH NEUROL-CHICAGO, V64, P501, DOI 10.1001/archneur.64.4.501; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2009, NEUROBIOL AGING, V30, P1091, DOI 10.1016/j.neurobiolaging.2007.10.011; Liu GY, 2014, MOL NEUROBIOL, V50, P757, DOI 10.1007/s12035-014-8670-4; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Miyashita A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058618; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nalivaeva NN, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00235, 10.3389/fnagi.2014.00235]; Nalivaeva NN, 2004, ANN NY ACAD SCI, V1035, P21, DOI 10.1196/annals.1332.002; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Pottier C, 2012, MOL PSYCHIATR, V17, P875, DOI 10.1038/mp.2012.15; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Reitz C, 2013, JAMA-J AM MED ASSOC, V309, P1483, DOI 10.1001/jama.2013.2973; Revesz T, 2009, ACTA NEUROPATHOL, V118, P115, DOI 10.1007/s00401-009-0501-8; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rossi GP, 1999, CARDIOVASC RES, V43, P300, DOI 10.1016/S0008-6363(99)00110-8; Sassi C, 2014, NEUROBIOL AGING; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Steinberg S, 2015, NAT GENET; Tan EK, 2009, NEUROBIOL AGING, V30, P1048, DOI 10.1016/j.neurobiolaging.2007.10.013; Vardarajan BN, 2015, ANN NEUROL, V77, P215, DOI 10.1002/ana.24305; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019229; Wati H, 2009, BRAIN PATHOL, V19, P48, DOI 10.1111/j.1750-3639.2008.00166.x; Yamazaki H, 1996, J BIOL CHEM, V271, P24761, DOI 10.1074/jbc.271.40.24761; Yu L, 2015, JAMA NEUROL, V72, P15, DOI 10.1001/jamaneurol.2014.3049; Zou K, 2009, J BIOL CHEM, V284, P31914, DOI 10.1074/jbc.M109.011437	53	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0150079	10.1371/journal.pone.0150079	http://dx.doi.org/10.1371/journal.pone.0150079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249223	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700001
J	Song, XZ; Peng, C; Li, GS; He, ZG; Wang, HZ				Song, Xianzhi; Peng, Chi; Li, Gensheng; He, Zhenguo; Wang, Haizhu			Optimization of Operation Parameters for Helical Flow Cleanout with Supercritical CO2 in Horizontal Wells Using Back-Propagation Artificial Neural Network	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; GENETIC ALGORITHM; PERMEABILITY PREDICTION; WELLBORE CLEANOUT; COMPLEX NETWORK; CARBON-DIOXIDE; OIL; SVM; TEMPERATURE; MODEL	Sand production and blockage are common during the drilling and production of horizontal oil and gas wells as a result of formation breakdown. The use of high-pressure rotating jets and annular helical flow is an effective way to enhance horizontal wellbore cleanout. In this paper, we propose the idea of using supercritical CO2 (SC-CO2) as washing fluid in water-sensitive formation. SC-CO2 is manifested to be effective in preventing formation damage and enhancing production rate as drilling fluid, which justifies tis potential in wellbore cleanout. In order to investigate the effectiveness of SC-CO2 helical flow cleanout, we perform the numerical study on the annular flow field, which significantly affects sand cleanout efficiency, of SC-CO2 jets in horizontal wellbore. Based on the field data, the geometry model and mathematical models were built. Then a numerical simulation of the annular helical flow field by SC-CO2 jets was accomplished. The influences of several key parameters were investigated, and SC-CO2 jets were compared to conventional water jets. The results show that flow rate, ambient temperature, jet temperature, and nozzle assemblies play the most important roles on wellbore flow field. Once the difference between ambient temperatures and jet temperatures is kept constant, the wellbore velocity distributions will not change. With increasing lateral nozzle size or decreasing rear/forward nozzle size, suspending ability of SC-CO2 flow improves obviously. A back-propagation artificial neural network (BP-ANN) was successfully employed to match the operation parameters and SC-CO2 flow velocities. A comprehensive model was achieved to optimize the operation parameters according to two strategies: cost-saving strategy and local optimal strategy. This paper can help to understand the distinct characteristics of SC-CO2 flow. And it is the first time that the BP-ANN is introduced to analyze the flow field during wellbore cleanout in horizontal wells.	[Song, Xianzhi; Peng, Chi; Li, Gensheng; He, Zhenguo; Wang, Haizhu] China Univ Petr, State Key Lab Petr Resource & Prospecting, Beijing, Peoples R China; [Song, Xianzhi; Peng, Chi; Li, Gensheng; He, Zhenguo; Wang, Haizhu] China Univ Petr, Coll Petr Engn, Beijing, Peoples R China	China University of Petroleum; China University of Petroleum	Song, XZ (corresponding author), China Univ Petr, State Key Lab Petr Resource & Prospecting, Beijing, Peoples R China.; Song, XZ (corresponding author), China Univ Petr, Coll Petr Engn, Beijing, Peoples R China.	songxz@cup.edu.cn			Science Foundation of China University of Petroleum, Beijing [2462013 BJRC002, YJRC-2013-04]; National Natural Science Foundation of China [U1562212, 51304226]	Science Foundation of China University of Petroleum, Beijing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper is funded by Science Foundation of China University of Petroleum, Beijing (No. 2462013 BJRC002 and No. YJRC-2013-04 received by XZS; URL: www.cup.edu.cn), National Natural Science Foundation of China (U1562212 received by GSL; URL: http://www.nsfc.gov.cn/) and National Natural Science Foundation of China (No. 51304226 received by HZW; URL: www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adankon Mathias M., 2015, ENCY BIOMETRICS, P1504; Ahmadi MA, 2013, GEOPHYS PROSPECT, V61, P582, DOI 10.1111/j.1365-2478.2012.01080.x; Al-Adwani F, 2009, SPE DRILL COMPLETION, V24, P599, DOI 10.2118/114050-PA; Arora S, 201010065902 ARXIV; Balabin RM, 2011, ANALYST, V136, P1703, DOI 10.1039/c0an00387e; Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005; Byvatov E, 2003, J CHEM INF COMP SCI, V43, P1882, DOI 10.1021/ci0341161; Chen WH, 2005, COMPUT OPER RES, V32, P2617, DOI 10.1016/j.cor.2004.03.019; Danquigny J, 2013, P SPE ARCT EXTR ENV; Duan MQ, 2009, SPE DRILL COMPLETION, V24, P229, DOI 10.2118/106707-PA; El-Abbasy MS, 2014, AUTOMAT CONSTR, V45, P50, DOI 10.1016/j.autcon.2014.05.003; Fenghour A, 1998, J PHYS CHEM REF DATA, V27, P31, DOI 10.1063/1.556013; Fomin YD, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.022111; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20052; Gao ZK, 2015, PHYS LETT A, V379, P790, DOI 10.1016/j.physleta.2014.09.004; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Gupta A.P., 2006, THESIS LOUISIANA STA; Gupta A.P., 2005, P SPE ANN TECHN C EX; HASAN AR, 1994, SPE PROD FACIL, V9, P211, DOI 10.2118/22948-PA; Hobbs D, 2002, OIL GAS J, V100, P52; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Ihmels EC, 2001, IND ENG CHEM RES, V40, P4470, DOI 10.1021/ie001135g; Irani R, 2011, J PETROL SCI ENG, V78, P6, DOI 10.1016/j.petrol.2011.05.006; Irani R, 2011, EXPERT SYST APPL, V38, P9862, DOI 10.1016/j.eswa.2011.02.046; Ishida T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052788; Kankar PK, 2011, EXPERT SYST APPL, V38, P1876, DOI 10.1016/j.eswa.2010.07.119; Kaydani H, 2011, J PETROL SCI ENG, V78, P497, DOI 10.1016/j.petrol.2011.07.017; Kolle JJ., 2000, P ETCE OMAE 2000 JOI; Li GS, 2012, P IADC SPE AS PAC DR; Li J, 2001, SPE J, V6, P356, DOI 10.2118/74710-PA; Lin YC, 2008, COMP MATER SCI, V43, P752, DOI 10.1016/j.commatsci.2008.01.039; Marcano-Cedeno A, 2011, EXPERT SYST APPL, V38, P9573, DOI 10.1016/j.eswa.2011.01.167; Mellit A, 2010, SOL ENERGY, V84, P807, DOI 10.1016/j.solener.2010.02.006; Moraes R, 2013, EXPERT SYST APPL, V40, P621, DOI 10.1016/j.eswa.2012.07.059; Pakhale GK., 2010, INT J ENG TECHNOLOGY, V2, P245, DOI 10.7763/IJET.2010.V2.128; Peng S, 2012, P IADC SPE AS PAC DR; Pradhan B, 2013, COMPUT GEOSCI-UK, V51, P350, DOI 10.1016/j.cageo.2012.08.023; Ramadan A, 2001, J PETROL SCI ENG, V30, P129, DOI 10.1016/S0920-4105(01)00108-5; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rosine R.S., 2005, 2005 SPEICOTA COILED, DOI [10.2118/94057-MS, DOI 10.2118/94057-MS]; Sach M, 2008, SPE PROD OPER, V23, P379, DOI 10.2118/106857-PA; Samanta B, 2003, ENG APPL ARTIF INTEL, V16, P657, DOI 10.1016/j.engappai.2003.09.006; Sanchez RA, 1999, SPE J, V4, P101, DOI 10.2118/56406-PA; Shah SN, 2007, INT J MULTIPHAS FLOW, V33, P51, DOI 10.1016/j.ijmultiphaseflow.2006.06.006; Song X., 2012, IADC SPE AS PAC DRIL; Song XZ, 2010, J PETROL SCI ENG, V75, P71, DOI 10.1016/j.petrol.2010.10.015; Song XZ, 2014, SPE J, V19, P45, DOI 10.2118/156335-PA; Song XZ, 2010, PETROL SCI, V7, P385, DOI 10.1007/s12182-010-0082-0; Span R, 1996, J PHYS CHEM REF DATA, V25, P1509, DOI 10.1063/1.555991; Terry H, 2010, P IADC SPE AS PAC DR; VESOVIC V, 1990, J PHYS CHEM REF DATA, V19, P763, DOI 10.1063/1.555875; Wang YL, 2010, P 20 INT OFFSH POL E; Wang YY, 2011, P 21 INT OFFSH POL E; Wu TK, 2008, EXPERT SYST APPL, V34, P1846, DOI 10.1016/j.eswa.2007.02.026; Yu SW, 2008, APPL MATH COMPUT, V195, P66, DOI 10.1016/j.amc.2007.04.088; Yu YF, 2009, MODELLING SIMULATION, P333; Zhou Y, 2003, P CAN INT PETR C JUN	60	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156358	10.1371/journal.pone.0156358	http://dx.doi.org/10.1371/journal.pone.0156358			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249026	gold, Green Submitted, Green Published			2022-12-26	WOS:000377184700038
J	Wilke, S; Groenveld, D; Grittner, U; List, J; Floel, A				Wilke, Skadi; Groenveld, Dennis; Grittner, Ulrike; List, Jonathan; Floeel, Agnes			cSPider - Evaluation of a Free and Open-Source Automated Tool to Analyze Corticomotor Silent Period	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MILD COGNITIVE IMPAIRMENT; HUMAN MOTOR CORTEX; CORTICAL EXCITABILITY; INTRACORTICAL INHIBITION; SPORTS CONCUSSION; BRAIN-STIMULATION; IFCN COMMITTEE; MUSCLE; INDIVIDUALS	Background The corticomotor silent period (CSP), as assessed noninvasively by transcranial magnetic stimulation (TMS) in the primary motor cortex, has been found to reflect intracortical inhibitory mechanisms. Analysis of CSP is mostly conducted manually. However, this approach is time-consuming, and comparison of results from different laboratories may be compromised by inter-rater variability in analysis. No open source program for automated analysis is currently available. Methods/Results Here, we describe cross-validation with the manual analysis of an in-house written automated tool to assess CSP (cSPider). Results from automated routine were compared with results of the manual evaluation. We found high inter-method reliability between automated and manual analysis (p<0.001), and significantly reduced time for CSP analysis (median = 10.3 sec for automated analysis of 10 CSPs vs. median = 270 sec for manual analysis of 10 CSPs). cSPider can be downloaded free of charge. Conclusion cSPider allows automated analysis of CSP in a reliable and time-efficient manner. Use of this open-source tool may help to improve comparison of data from different laboratories.	[Wilke, Skadi; Groenveld, Dennis; List, Jonathan; Floeel, Agnes] Charite, Dept Neurol, D-13353 Berlin, Germany; [Groenveld, Dennis] Univ Twente, Dept Biomed Engn, POB 217, NL-7500 AE Enschede, Netherlands; [Grittner, Ulrike; Floeel, Agnes] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Floeel, Agnes] Charite, NeuroCure Cluster Excellence, D-13353 Berlin, Germany; [Grittner, Ulrike] Charite, Dept Biostat & Clin Epidemiol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Twente; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wilke, S; Floel, A (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.; Floel, A (corresponding author), Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany.; Floel, A (corresponding author), Charite, NeuroCure Cluster Excellence, D-13353 Berlin, Germany.	skadi.wilke@charite.de; agnes.floeel@charite.de	Grittner, Ulrike/I-2026-2019; Floel, Agnes/A-9426-2017	Grittner, Ulrike/0000-0003-2595-0224; Wilke, Skadi/0000-0002-1424-516X	Deutsche Forschungsgemeinschaft [Fl- 365 379-8/1, 379-10/1, 379-11/1, DFG-Exc-257]; Bundesministerium fur Bildung und Forschung [FKZ0315673A, 01EO0801, 01GY1144]; Charite Universitatsmedizin Berlin; Berlin Institute of Health	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Charite Universitatsmedizin Berlin; Berlin Institute of Health	This work was supported by grants from the Deutsche Forschungsgemeinschaft (AF: Fl- 365 379-8/1; 379-10/1; 379-11/1; DFG-Exc-257, http://www.dfg.de/), and Bundesministerium fur Bildung und Forschung (AF: FKZ0315673A; 01EO0801; 01GY1144, https://www.bmbf.de/). JL is a participant in the Charite Clinical Scientist Program funded by the Charite Universitatsmedizin Berlin and the Berlin Institute of Health (http://www.charite.de/charite/, https://www.bihealth.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2002, J CLIN NEUROPHYSIOL, V19, P307, DOI 10.1097/00004691-200208000-00005; [Anonymous], 2014, NATURE, V514, P536, DOI 10.1038/514536a; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; CANTELLO R, 1992, NEUROLOGY, V42, P1951; Cantello R, 2002, J CLIN NEUROPHYSIOL, V19, P272, DOI 10.1097/00004691-200208000-00003; Chen R, 1999, EXP BRAIN RES, V128, P539, DOI 10.1007/s002210050878; Damron LA, 2008, J NEUROSCI METH, V173, P121, DOI 10.1016/j.jneumeth.2008.06.001; Daskalakis ZJ, 2003, CLIN NEUROPHYSIOL, V114, P938, DOI 10.1016/S1388-2457(03)00038-5; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Durkovic J, 2008, MANAG INFORATION SYS, V3; Easterbrook SM, 2014, NAT GEOSCI, V7, P779, DOI 10.1038/ngeo2283; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garvey MA, 2001, CLIN NEUROPHYSIOL, V112, P1451, DOI 10.1016/S1388-2457(01)00581-8; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hautzinger M., 2006, BECK DEPRESSIONS INV; Ho KH, 1998, EXP BRAIN RES, V122, P433, DOI 10.1007/s002210050531; Huang YD, 2013, BRIEF BIOINFORM, V14, P391, DOI 10.1093/bib/bbs078; Inghilleri M, 1996, EXP BRAIN RES, V109, P467; Julkunen P, 2013, J NEUROSCI METH, V217, P75, DOI 10.1016/j.jneumeth.2013.04.019; Kallioniemi E, 2014, CLIN NEUROPHYSIOL, V125, P2247, DOI 10.1016/j.clinph.2014.03.012; King NKK, 2006, J NEUROSCI METH, V150, P96, DOI 10.1016/j.jneumeth.2005.06.007; List J, 2014, BRAIN STIMUL, V7, P381, DOI 10.1016/j.brs.2014.02.006; Macdonell RAL, 2001, NEUROLOGY, V57, P706, DOI 10.1212/WNL.57.4.706; McClintock SM, 2011, BIOL PSYCHIAT, V70, P19, DOI 10.1016/j.biopsych.2011.02.031; McDonnell MN, 2006, EXP BRAIN RES, V173, P86, DOI 10.1007/s00221-006-0365-2; Menzler K, 2014, EPILEPSIA, V55, P362, DOI 10.1111/epi.12515; Nilsson J, 1997, J CLIN NEUROPHYSIOL, V14, P136, DOI 10.1097/00004691-199703000-00006; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Poston B, 2012, EUR J NEUROSCI, V36, P2964, DOI 10.1111/j.1460-9568.2012.08212.x; Rabago CA, 2009, CLIN NEUROPHYSIOL, V120, P1577, DOI 10.1016/j.clinph.2009.04.020; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siebner HR, 1998, MUSCLE NERVE, V21, P1209, DOI 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.3.CO;2-O; Tataroglu C, 2004, SEIZURE-EUR J EPILEP, V13, P481, DOI 10.1016/j.seizure.2003.11.003; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, NEUROREPORT, V24, P46, DOI 10.1097/WNR.0b013e32835c36b8; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; van Kuijk AAA, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-1; WILSON SA, 1993, J NEUROL SCI, V114, P216, DOI 10.1016/0022-510X(93)90301-E; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; ZIEMANN U, 1993, NEUROSCI LETT, V156, P167, DOI 10.1016/0304-3940(93)90464-V	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156066	10.1371/journal.pone.0156066	http://dx.doi.org/10.1371/journal.pone.0156066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249017	gold, Green Published, Green Submitted			2022-12-26	WOS:000377184700028
J	Martinez, G; Dozo, MT; Gelfo, JN; Marani, H				Martinez, Gaston; Teresa Dozo, Maria; Gelfo, Javier N.; Marani, Hernan			Cranial Morphology of the Late Oligocene Patagonian Notohippid Rhynchippus equinus Ameghino, 1897 (Mammalia, Notoungulata) with Emphases in Basicranial and Auditory Region	PLOS ONE			English	Article							DESEADAN LATE OLIGOCENE; ANATOMY; SKULL; OSTEOLOGY; XENARTHRA; BOLIVIA; PALEOECOLOGY; BIOGEOGRAPHY; PLACENTALIA; ARGENTINA	"Notohippidae" is a probably paraphyletic family of medium sized notoungulates with complete dentition and early tendency to hypsodonty. They have been recorded from early Eocene to early Miocene, being particularly diverse by the late Oligocene. Although Rhynchippus equinus Ameghino is one of the most frequent notohippids in the fossil record, there are scarce data about cranial osteology other than the classical descriptions which date back to the early last century. In this context, we describe the exceptionally preserved specimen MPEF PV 695 (based on CT scanning technique and 3D reconstruction) with the aim of improving our knowledge of the species, especially regarding auditory region (petrosal, tympanic and surrounding elements), sphenoidal and occipital complexes. Besides a modular description of the whole skull, osteological correlates identified on the basicranium are used to infer some soft-tissue elements, especially those associated with vessels that supply the head, mainly intracranially. One of the most informative elements was the petrosal bone, whose general morphology matches that expected for a toxodont. The endocranial surface, together with the surrounding parietal, basisphenoid, occipital, and squamosal, enabled us to propose the location and communication of main venous sinuses of the lateral head wall (temporal, inferior and sigmoid sinuses), whereas the tympanic aspect and the identification of a posterior carotid artery canal provided strong evidence in support of an intratympanic course of the internal carotid artery, a controversial issue among notoungulates. Regarding the arrangement of tympanic and paratympanic spaces, the preservation of the specimen allowed us to appreciate the three connected spaces that constitute a heavily pneumatized middle ear; the epitympanic sinus, the tympanic cavity itself, and the ventral expansion of the tympanic cavity through the notably inflated bullae. We hope this study stimulates further inquires and provides potentially informative data for future research involving other representatives of the order.	[Martinez, Gaston; Teresa Dozo, Maria] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Inst Patagon Geol & Paleontol, Puerto Madryn, Chubut, Argentina; [Martinez, Gaston] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina; [Gelfo, Javier N.] Consejo Nacl Invest Cient & Tecn, Museo La Plata, Div Paleontol Vertebrados, La Plata, Buenos Aires, Argentina; [Gelfo, Javier N.] Univ Nacl La Plata, Fac Ciencias Nat & Museo, RA-1900 La Plata, Buenos Aires, Argentina; [Marani, Hernan] Univ Nacl Patagonia San Juan Bosco, Fac Ciencias Nat, Puerto Madryn, Chubut, Argentina	Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; National University of La Plata; Museo La Plata; Universidad Nacional de la Patagonia San Juan Bosco	Martinez, G (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Inst Patagon Geol & Paleontol, Puerto Madryn, Chubut, Argentina.; Martinez, G (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, RA-5000 Cordoba, Argentina.	gmartinez@cenpat-conicet.gob.ar	Gelfo, Javier N./AAW-1905-2021	Gelfo, Javier N./0000-0002-9989-5902				Agnolin FL, 2011, MAMM BIOL, V76, P101, DOI 10.1016/j.mambio.2010.12.001; Ameghino F., 1897, B I GEOGRAFICO ARGEN, V18, P405; Ameghino F., 1895, B I GEOGRAFICO ARGEN, V15, P1; Ameghino F., 1901, B ACAD NACL CIENCIAS, V16, P349; Beck RMD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1278; Billet G, 2008, ZOOL J LINN SOC-LOND, V152, P153, DOI 10.1111/j.1096-3642.2007.00388.x; Billet G, 2013, J VERTEBR PALEONTOL, V33, P455, DOI 10.1080/02724634.2013.722153; Billet G, 2011, J SYST PALAEONTOL, V9, P481, DOI 10.1080/14772019.2010.528456; Billet G, 2011, NATURWISSENSCHAFTEN, V98, P509, DOI 10.1007/s00114-011-0795-y; Billet G, 2010, J MAMM EVOL, V17, P21, DOI 10.1007/s10914-009-9123-0; Billet G, 2009, ZOOL J LINN SOC-LOND, V155, P458, DOI 10.1111/j.1096-3642.2008.00445.x; Bond M., 1986, ACT 4 C ARG PAL BIOE, V2, P173; Bond Mariano, 1993, Ameghiniana, V30, P59; Bown Thomas M., 1993, Journal of Vertebrate Paleontology, V13, p27A; Buckley M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2671; Cerdeno E, 2015, J SYST PALAEONTOL, V13, P943, DOI 10.1080/14772019.2014.982727; Cerdeno E, 2010, J VERTEBR PALEONTOL, V30, P1805, DOI 10.1080/02724634.2010.520781; CIFELLI R L, 1989, Bulletin of the Museum of Comparative Zoology, V152, P1; Cifelli R.L., 1985, Topics in Geobiology, V4, P249; CIFELLI RL, 1993, MAMMAL PHYLOGENY : PLACENTALS, P195; Feruglio E., 1949, DESCRIPCION GEOLOGIC; Forasiepi AM, 2015, PALAEONTOL Z, V89, P611, DOI 10.1007/s12542-014-0233-5; Gabbert SL, 2004, B AM MUS NAT HIST, P177, DOI 10.1206/0003-0090(2004)285<0177:C>2.0.CO;2; Lopez DAG, 2011, AMEGHINIANA, V48, P3, DOI 10.5710/AMGH.v48i1(262); Gaudin TJ, 2011, ANN CARNEGIE MUS, V80, P5, DOI 10.2992/007.080.0102; Iturralde-Vinent MA, 2006, INT GEOL REV, V48, P791, DOI 10.2747/0020-6814.48.9.791; Kondrashov P.E., 2004, PALEOGENE MAMMALS NE, V26, P195; Kondrashov PE, 2005, RES 2 C LAT AM PAL V, P144; Kramarz AG, 2011, PALAEONTOL Z, V85, P185, DOI 10.1007/s12542-010-0087-4; Lema H., 2001, B SERVICIO GEOLOGICO, V261, P1; Linnaeus C, 1766, SYSTEMA NATURAE REGN; Loomis FB., 1914, DESEADO FORMATION PA; Lopez Guillermo M., 2010, P143; MacPhee RDE, 2014, B AM MUS NAT HIST, P1; MacPhee RDE, 1981, CONTRIB PRIMATOL, V18, P1; Macrini TE, 2010, J ANAT, V233, P442; Mead James G., 2009, Smithsonian Contributions to Zoology, P1; Moore W.J., 1981, MAMMALIAN SKULL; Muchlinski MN, 2008, ANAT REC, V291, P1221, DOI 10.1002/ar.20742; NOVACEK MJ, 1986, B AM MUS NAT HIST, V183, P1; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; O'Leary MA, 2010, B AM MUS NAT HIST, P4; Owen R., 1853, PHILOS T ROY SOC LON, V143, P291, DOI DOI 10.1098/RSTL.1853.0011; Patterson B., 1972, P247; PATTERSON B, 1977, Fieldiana Geology, V33, P397; Patterson B., 1934, Field Museum Publications Chicago Geological Series, V6, P83; Patterson B., 1932, FIELD MUSEUM NATURAL, V6, P1; Patterson B., 1936, FIELD MUSEUM NATURAL, V6, P199; Pezzuchi H., 2000, B SERVICIO GEOLOGICO, V244, P1; Re G., 2010, PALEONTOLOGY GRAN BA, P46; REGUERO MA, 1996, NATURALIA PATAGONICA, V4, P43; Reguero MA, 2007, J PALEONTOL, V81, P1301, DOI 10.1666/05-100.1; Reig O.A., 1981, Monographiae Naturae, P1; Roth S., 1903, ANALES MUSEO LA PLAT, V5, P1; Rougier G.W., 1992, Journal of Vertebrate Paleontology, V12, P188; Rougier Guillermo W., 2006, P269; Shockey BJ, 1997, J VERTEBR PALEONTOL, V17, P584, DOI 10.1080/02724634.1997.10011005; Simpson G. G., 1936, American Museum Novitates, V824, P1; SIMPSON GEORGE GAYLORD, 1934, AMER MUS NOVITATES, V750, P1; SIMPSON GEORGE GAYLORD, 1948, BULL AMER MUS NAT HIST, V91, P1; SIMPSON GEORGE GAYLORD, 1932, AMER MUS NOVITATES [NEW YORK], V578, P1; SIMPSON GEORGE GAYLORD, 1932, AMER MUS NOVITATES [NEW YORK], V577, P1; Simpson GG., 1967, B AM MUS NAT HIST, V137, P1; SORIA M F, 1989, Anais da Academia Brasileira de Ciencias, V61, P157; Dozo MT, 2016, J MAMM EVOL, V23, P1, DOI 10.1007/s10914-015-9298-5; Dozo MT, 2010, J VERTEBR PALEONTOL, V30, P1818, DOI 10.1080/02724634.2010.521534; van der Klaauw CJ, 1931, B AM MUS NAT HIST, V62, P1; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Welker F, 2015, NATURE, V522, P81, DOI 10.1038/nature14249; Wible J.R., 1990, Journal of Vertebrate Paleontology, V10, P183; Wible John R., 1993, American Museum Novitates, V3072, P1; Wible JR, 2010, ANN CARNEGIE MUS, V79, P1, DOI 10.2992/007.079.0101; Wible JR, 2009, J MAMM EVOL, V16, P199, DOI 10.1007/s10914-009-9116-z; Wible JR, 2008, ANN CARNEGIE MUS, V77, P321, DOI 10.2992/0097-4463-77.3.321; Wible John R., 1995, American Museum Novitates, V3149, P1; WIBLE JR, 1987, ZOOL J LINN SOC-LOND, V91, P107, DOI 10.1111/j.1096-3642.1987.tb01725.x; Wible JR, 2004, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2004)281<0001:NDOTSA>2.0.CO;2; Wible JR, 2004, ANN CARNEGIE MUS, V73, P117; Wible JR, 2000, B AM MUS NAT HIST, P4	79	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156558	10.1371/journal.pone.0156558	http://dx.doi.org/10.1371/journal.pone.0156558			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232883	Green Published, gold			2022-12-26	WOS:000376883000042
J	Lu, J; Song, G; Tang, Q; Yin, J; Zou, C; Zhao, Z; Xie, X; Xu, H; Huang, G; Wang, J; Lee, DF; Khokha, R; Yang, H; Shen, J				Lu, J.; Song, G.; Tang, Q.; Yin, J.; Zou, C.; Zhao, Z.; Xie, X.; Xu, H.; Huang, G.; Wang, J.; Lee, D-F; Khokha, R.; Yang, H.; Shen, J.			MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1	ONCOGENE			English	Article							SELF-RENEWAL; ALDEHYDE DEHYDROGENASE; CANCER; NOTCH; DIFFERENTIATION; MICRORNA-26A; TUMORIGENESIS; PATHWAY; PROLIFERATION; REGENERATION	MicroRNAs (miRNAs) are important epigenetic regulators of gene expression. Although several miRNAs have been implicated in osteosarcoma, their role in regulation of osteosarcoma cancer stem cells (CSCs) remains unknown. Here we demonstrated that miR-26a is downregulated in osteosarcoma CSCs when derived by either sarcosphere generation, chemodrug or aldehyde dehydrogenase (ALDH) activity selection. Lentiviral overexpression of miR-26a in ZOS and 143B osteosarcoma cells decreases the expression of stem cell markers and suppresses sarcosphere formation, as well as ALDH activity. Moreover, miR-26a overexpression inhibits the tumor cell growth both in vitro and in vivo. We further demonstrate that miR-26a directly target Jagged1, one of the Notch ligand, and that its tumor suppressive effects are mediated through inhibition of Jaggedl/Notch signaling. Importantly, reduced miR-26a expression, as determined by in situ hybridization in patient tumors (n=92), is associated with lung metastasis and poor overall survival of osteosarcoma patients. Together, these data suggest the essential role of miR-26a/Jaggedl/Notch pathway in regulating the stem cell-like traits of osteosarcoma cells and provide a potential target for osteosarcoma therapy.	[Lu, J.; Song, G.; Tang, Q.; Yin, J.; Zou, C.; Zhao, Z.; Xie, X.; Xu, H.; Huang, G.; Wang, J.; Shen, J.] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Musculoskeletal Oncol, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China; [Lee, D-F] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Khokha, R.] Univ Hlth Network, Ontario Canc Inst, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Yang, H.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; University of Texas System; University of Texas Health Science Center Houston; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Sun Yat Sen University	Shen, J (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Musculoskeletal Oncol, 58 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.; Yang, H (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	yanghl@mail.sysu.edu.cn; shenjingnan@126.com		Khokha, Rama/0000-0002-6028-1524	National Natural Science Foundation of China [81272939, 81472506]; Natural Science Foundation of Guangdong Province [S2013020012460]; National Institutes of Health (NIH) Pathway to Independence Award [R00 CA181496]; CPRIT Award [RR160019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Institutes of Health (NIH) Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT Award	This research was supported by National Natural Science Foundation of China (81272939 and 81472506 to JS) and Natural Science Foundation of Guangdong Province (S2013020012460 to JS). D-FL is the Cancer Prevention Research Institute of Texas (CPRIT) scholar in Cancer Research and supported by National Institutes of Health (NIH) Pathway to Independence Award R00 CA181496 and CPRIT Award RR160019. We thank Jingling Zhao (Sun Yat-Sen University) for expert technical assistance and Meghan Lambie (University of Toronto) for language editing.	Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu-Roy U, 2013, CANCER LETT, V338, P158, DOI 10.1016/j.canlet.2012.05.028; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Di Fiore R, 2014, INT J ONCOL, V45, P2013, DOI 10.3892/ijo.2014.2618; Donnem T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-6; Engin F, 2009, HUM MOL GENET, V18, P1464, DOI 10.1093/hmg/ddp057; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fu XH, 2013, P NATL ACAD SCI USA, V110, P17892, DOI 10.1073/pnas.1317397110; Fujiwara T, 2014, STEM CELLS, V32, P959, DOI 10.1002/stem.1618; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Haydon RC, 2007, CLIN ORTHOP RELAT R, P237, DOI 10.1097/BLO.0b013e31802b683c; Hopkins TG, 2016, NUCLEIC ACIDS RES, V44, P1227, DOI 10.1093/nar/gkv1515; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Li Y, 2013, BIOMATERIALS, V34, P5048, DOI 10.1016/j.biomaterials.2013.03.052; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Lu JC, 2015, J CLIN INVEST, V125, P1839, DOI 10.1172/JCI78437; Mitra A, 2015, ONCOTARGET, V6, P10697, DOI 10.18632/oncotarget.4037; Mu XD, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00143; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Salvatori B, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.151; Shcherbata HR, 2006, CELL CYCLE, V5, P172, DOI 10.4161/cc.5.2.2343; Siclari VA, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-78; Siegel HJ, 2008, EXPERT REV ANTICANC, V8, P1257, DOI 10.1586/14737140.8.8.1257; Song QC, 2014, ONCOL REP, V31, P1263, DOI 10.3892/or.2014.2989; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; Tanaka M, 2009, BRIT J CANCER, V100, P1957, DOI 10.1038/sj.bjc.6605060; Tang QL, 2012, JNCI-J NATL CANCER I, V104, P749, DOI 10.1093/jnci/djs210; Tang QL, 2011, CANCER LETT, V311, P113, DOI 10.1016/j.canlet.2011.07.016; Tao JN, 2014, CANCER CELL, V26, P390, DOI 10.1016/j.ccr.2014.07.023; Wang L, 2011, INT J CANCER, V128, P294, DOI 10.1002/ijc.25331; Wang X., 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072015; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang AD, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/187509; Zou CY, 2008, ACTA PHARMACOL SIN, V29, P325, DOI 10.1111/j.1745-7254.2008.00756.x	44	70	75	4	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2017	36	2					231	241		10.1038/onc.2016.194	http://dx.doi.org/10.1038/onc.2016.194			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK5AA	27270422				2022-12-26	WOS:000393938100008
J	Selth, LA; Das, R; Townley, SL; Coutinho, I; Hanson, AR; Centenera, MM; Stylianou, N; Sweeney, K; Soekmadji, C; Jovanovic, L; Nelson, CC; Zoubeidi, A; Butler, LM; Goodall, GJ; HoIlier, BG; Gregory, PA; Tilley, WD				Selth, L. A.; Das, R.; Townley, S. L.; Coutinho, I.; Hanson, A. R.; Centenera, M. M.; Stylianou, N.; Sweeney, K.; Soekmadji, C.; Jovanovic, L.; Nelson, C. C.; Zoubeidi, A.; Butler, L. M.; Goodall, G. J.; HoIlier, B. G.; Gregory, P. A.; Tilley, W. D.			A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer	ONCOGENE			English	Article							MICRORNA EXPRESSION PROFILES; CIRCULATING TUMOR-CELLS; MESENCHYMAL TRANSITION; ANDROGEN RECEPTOR; METASTATIC COLONIZATION; MIR-200 FAMILY; BREAST-CANCER; MESSENGER-RNA; PROGRESSION; REPRESSION	MicroRNA-375 (miR-375) is frequently elevated in prostate tumors and cell-free fractions of patient blood, but its role in genesis and progression of prostate cancer is poorly understood. In this study, we demonstrated that miR-375 is inversely correlated with epithelial-mesenchymal transition signatures (EMT) in clinical samples and can drive mesenchymal-epithelial transition (MET) in model systems. Indeed, miR-375 potently inhibited invasion and migration of multiple prostate cancer lines. The transcription factor YAP1 was found to be a direct target of miR-375 in prostate cancer. Knockdown of YAP1 phenocopied miR-375 overexpression, and overexpression of YAP1 rescued anti-invasive effects mediated by miR-375. Furthermore, transcription of the miR-375 gene was shown to be directly repressed by the EMT transcription factor, ZEB1. Analysis of multiple patient cohorts provided evidence for this ZEB1-miR-375-YAP1 regulatory circuit in clinical samples. Despite its anti -invasive and anti-EMT capacities, plasma miR-375 was found to be correlated with circulating tumor cells in men with metastatic disease. Collectively, this study provides new insight into the function of miR-375 in prostate cancer, and more broadly identifies a novel pathway controlling epithelial plasticity and tumor cell invasion in this disease.	[Selth, L. A.; Das, R.; Townley, S. L.; Coutinho, I.; Hanson, A. R.; Tilley, W. D.] Univ Adelaide, Sch Med, Dame Roma Mitchell Canc Res Labs, Level 4,Hanson Inst Bldg,DX 650 801, Adelaide, SA 5005, Australia; [Selth, L. A.; Das, R.; Townley, S. L.; Coutinho, I.; Hanson, A. R.; Centenera, M. M.; Butler, L. M.; Tilley, W. D.] Univ Adelaide, Freemasons Fdn, Ctr Mens Hlth, Discipline Med, Adelaide, SA, Australia; [Selth, L. A.; Das, R.; Townley, S. L.; Coutinho, I.; Hanson, A. R.; Centenera, M. M.; Butler, L. M.; Goodall, G. J.; Gregory, P. A.; Tilley, W. D.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Centenera, M. M.; Butler, L. M.] South Australian Hlth & Med Res Inst, Canc Theme, Adelaide, SA, Australia; [Stylianou, N.; Sweeney, K.; Soekmadji, C.; Jovanovic, L.; Nelson, C. C.; HoIlier, B. G.] Queensland Univ Technol, Princess Alexandra Hosp, Translat Res Inst,Inst Hlth & Biomed Innovat, Australian Prostate Canc Res Ctr Queensland, Brisbane, Qld, Australia; [Zoubeidi, A.] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Goodall, G. J.; Gregory, P. A.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Goodall, G. J.] Univ South Australia, Adelaide, SA, Australia; [Goodall, G. J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Hanson Institute; University of Adelaide; University of Adelaide; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); Queensland University of Technology (QUT); University of British Columbia; Centre for Cancer Biology; SA Pathology; University of South Australia; University of Adelaide	Selth, LA (corresponding author), Univ Adelaide, Sch Med, Dame Roma Mitchell Canc Res Labs, Level 4,Hanson Inst Bldg,DX 650 801, Adelaide, SA 5005, Australia.	luke.selth@adelaide.edu.au	Stylianou, Nataly/GOP-1782-2022; Gregory, Philip/F-4089-2013; Selth, Luke/AAH-4823-2021; Butler, Lisa/AAP-9088-2020; Butler, Lisa M/C-9843-2010; Soekmadji, Carolina/M-2757-2016	Gregory, Philip/0000-0002-0999-0632; Selth, Luke/0000-0002-4686-1418; Butler, Lisa/0000-0003-2698-3220; Soekmadji, Carolina/0000-0002-6920-6627; coutinho, isabel/0000-0003-3389-033X; centenera, margaret/0000-0002-2206-0632; Stylianou, Nataly/0000-0002-8006-5730; Goodall, Gregory/0000-0003-1294-0692; Tilley, Wayne/0000-0003-1893-2626	Young Investigator Awards from the Prostate Cancer Foundation [14]; Prostate Cancer Foundation of Australia (PCFA)/Movember [YI 0810, YI 0412]; PCFA/Movember/Cancer Australia [1012337, 1043482]; National Health and Medical Research Council [1083961]; Cancer Council of South Australia; Queensland government Smart Futures Fund Fellowship; Movember Foundation; Prostate Cancer Foundation of Australia through Movember Revolutionary Team Awards; National Breast Cancer Foundation [CG-10-04] Funding Source: researchfish	Young Investigator Awards from the Prostate Cancer Foundation; Prostate Cancer Foundation of Australia (PCFA)/Movember; PCFA/Movember/Cancer Australia; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of South Australia(Cancer Council South Australia); Queensland government Smart Futures Fund Fellowship; Movember Foundation; Prostate Cancer Foundation of Australia through Movember Revolutionary Team Awards; National Breast Cancer Foundation	The YAP1 3'-UTR plasmids were a kind gift from Prof Takashi Takahashi, Nagoya University. The results published here are in part based on the data generated by The Cancer Genome Atlas, established by the National Cancer Institute and the National Human Genome Research Institute, and we are grateful to the specimen donors and relevant research groups associated with this project. We also acknowledge the ENCODE Consortium and the Myers laboratory at the HudsonAlpha Institute for Biotechnology for generating the ZEB1 ChIP-seq data set used in this study. This work was supported by: Young Investigator Awards from the Prostate Cancer Foundation (the Foundation 14 award; LAS) and the Prostate Cancer Foundation of Australia (PCFA)/Movember (YI 0810; LAS, YI 0412; MMC) and grants from PCFA/Movember/Cancer Australia (Grant IDs 1012337 and 1043482; WDT, LAS and LMB) and the National Health and Medical Research Council (Grant ID 1083961). PAG is supported by a Beat Cancer Project fellowship from the Cancer Council of South Australia. BGH is supported by a Queensland government Smart Futures Fund Fellowship. The research programs of LAS, MMC, LMB, CCN, BGH and WDT are supported by the Movember Foundation and the Prostate Cancer Foundation of Australia through Movember Revolutionary Team Awards.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Banyard J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03151; Bitting RL, 2014, CANCER METAST REV, V33, P441, DOI 10.1007/s10555-013-9483-z; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brase JC, 2011, INT J CANCER, V128, P608, DOI 10.1002/ijc.25376; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Christensen LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096767; Chu ML, 2014, ONCOL REP, V31, P34, DOI 10.3892/or.2013.2810; Costa-Pinheiro P, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0076-2; Das R, 2014, TRENDS MOL MED, V20, P643, DOI 10.1016/j.molmed.2014.09.004; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; de Souza Rocha Simonini P, 2010, CANCER RES, V70, P9175, DOI DOI 10.1158/0008-5472.CAN-10-1318; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gasch C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15980; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Kohn KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035716; Kolesnikoff N, 2014, J BIOL CHEM, V289, P11194, DOI 10.1074/jbc.M113.529172; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Lin PC, 2013, CANCER RES, V73, P1232, DOI 10.1158/0008-5472.CAN-12-2968; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Lokman NA, 2012, INT J MOL SCI, V13, P9959, DOI 10.3390/ijms13089959; Madhavan D, 2012, CLIN CANCER RES, V18, P5972, DOI 10.1158/1078-0432.CCR-12-1407; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marrocco DL, 2007, MOL CANCER THER, V6, P51, DOI 10.1158/1535-7163.MCT-06-0144; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Moore NL, 2012, ENDOCR-RELAT CANCER, V19, P599, DOI 10.1530/ERC-12-0065; Nauseef JT, 2011, NAT REV UROL, V8, P428, DOI 10.1038/nrurol.2011.85; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; Nishikawa E, 2011, CANCER RES, V71, P6165, DOI 10.1158/0008-5472.CAN-11-1020; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Schaefer A, 2010, NAT REV UROL, V7, P286, DOI 10.1038/nrurol.2010.45; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Selth LA, 2013, BRIT J CANCER, V109, P641, DOI 10.1038/bjc.2013.369; Selth LA, 2012, ENDOCR-RELAT CANCER, V19, pR99, DOI 10.1530/ERC-12-0010; Selth LA, 2012, INT J CANCER, V131, P652, DOI 10.1002/ijc.26405; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; Wu JN, 2014, CANCER-AM CANCER SOC, V120, P818, DOI 10.1002/cncr.28485; Yu XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030605; Yuan TC, 2006, ENDOCR-RELAT CANCER, V13, P151, DOI 10.1677/erc.1.01043; Zhang JS, 2012, CANCER METAST REV, V31, P653, DOI 10.1007/s10555-012-9368-6	55	81	84	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 5	2017	36	1					24	34		10.1038/onc.2016.185	http://dx.doi.org/10.1038/onc.2016.185			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK6XJ	27270433	Green Accepted			2022-12-26	WOS:000394069100003
J	Huang, X; Zheng, Y; Zhang, F; Wei, ZQ; Wang, YG; Carrell, RW; Read, RJ; Chen, GQ; Zhou, AW				Huang, Xin; Zheng, Ying; Zhang, Fei; Wei, Zhenquan; Wang, Yugang; Carrell, Robin W.; Read, Randy J.; Chen, Guo-Qiang; Zhou, Aiwu			Molecular Mechanism of Z alpha 1-Antitrypsin Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA(1)-ANTITRYPSIN DEFICIENCY; SERPIN POLYMERIZATION; ALPHA-1-PROTEINASE INHIBITOR; CONFORMATIONAL DISEASE; ANGSTROM STRUCTURE; CRYSTAL-STRUCTURE; SALT BRIDGE; SECRETION; DEFECT; LOOP	The Z mutation (E342K) of alpha 1-antitrypsin (alpha 1-AT), carried by 4% of Northern Europeans, predisposes to early onset of emphysema due to decreased functional alpha 1-AT in the lung and to liver cirrhosis due to accumulation of polymers in hepatocytes. However, it remains unclear why the Z mutation causes intracellular polymerization of nascentZ alpha 1-AT and why 15% of the expressed Z alpha 1-AT is secreted into circulation as functional, but polymerogenic, monomers. Here, we solve the crystal structure of the Z-monomer and have engineered replacements to assess the conformational role of residue Glu-342 in alpha 1-AT. The results reveal that Z alpha 1-AT has a labile strand 5 of the central beta-sheet A (s5A) with a consequent equilibrium between a native inhibitory conformation, as in its crystal structure here, and an aberrant conformation with s5A only partially incorporated into the central beta-sheet. This aberrant conformation, induced by the loss of interactions from the Glu-342 side chain, explains why Z alpha 1-AT is prone to polymerization and readily binds to a 6-mer peptide, and it supports that annealing of s5A into the central beta-sheet is a crucial step in the serpins' metastable conformational formation. The demonstration that the aberrant conformation can be rectified through stabilization of the labile s5A by binding of a small molecule opens a potential therapeutic approach for Z alpha 1-AT deficiency.	[Huang, Xin; Chen, Guo-Qiang] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China; [Huang, Xin; Chen, Guo-Qiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Huang, Xin; Chen, Guo-Qiang] Univ Chinese Acad Sci, Shanghai 200025, Peoples R China; [Zheng, Ying; Zhang, Fei; Wei, Zhenquan; Wang, Yugang; Chen, Guo-Qiang; Zhou, Aiwu] Shanghai Jiao Tong Univ, Hongqiao Int Inst Med,Shanghai Tongren Hosp,Sch M, Fac Basic Med,Chem Biol Div Shanghai Univ E Inst, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China; [Carrell, Robin W.; Read, Randy J.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; University of Cambridge	Chen, GQ (corresponding author), Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai 200025, Peoples R China.; Chen, GQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China.; Chen, GQ (corresponding author), Univ Chinese Acad Sci, Shanghai 200025, Peoples R China.; Zhou, AW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Hongqiao Int Inst Med, 280 Chongqing Rd, Shanghai 200025, Peoples R China.	chengq@shsmu.edu.cn; aiwuzhou@gmail.com	Read, Randy J/L-1418-2013	Read, Randy J/0000-0001-8273-0047; ZHOU, Aiwu/0000-0002-2555-5091	National Basic Research Program of China 973 Program [2014CB910304]; National Natural Science Foundation of China [31370727, 31170724, 81572090]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai PuJiang Program; Innovation Program of Shanghai Municipal Education Commission [12ZZ113]; Wellcome Trust [082961/Z/07/Z]; British Heart Foundation Senior Research Fellowship; British Heart Foundation [PG/09/072/27945] Funding Source: researchfish	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai PuJiang Program(Shanghai Pujiang Program); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation Senior Research Fellowship; British Heart Foundation(British Heart Foundation)	This work was supported in part by National Basic Research Program of China 973 Program Grant 2014CB910304, National Natural Science Foundation of China Grants 31370727, 31170724, and 81572090, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Shanghai PuJiang Program, and Innovation Program of Shanghai Municipal Education Commission Grant 12ZZ113. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Principal Research Fellowship 082961/Z/07/Z from the Wellcome Trust.r Supported by a British Heart Foundation Senior Research Fellowship. To whom correspondence may be addressed: Hongqiao International Institute of Medicine, Shanghai Jiao Tong University School of Medicine, 280 Chongqing Rd., Shanghai 200025, China. Tel.: 86-13916791990; E-mail: aiwuzhou@gmail.com.	Arakawa T, 2006, BBA-PROTEINS PROTEOM, V1764, P1677, DOI 10.1016/j.bbapap.2006.08.012; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BRANTLY M, 1988, SCIENCE, V242, P1700, DOI 10.1126/science.2904702; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; COX DW, 1986, FEBS LETT, V205, P255, DOI 10.1016/0014-5793(86)80908-5; Davies MJ, 2008, INT J BIOCHEM CELL B, V40, P1273, DOI 10.1016/j.biocel.2007.12.017; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Dolmer K, 2012, J BIOL CHEM, V287, P12425, DOI 10.1074/jbc.M111.315465; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Ekeowa UI, 2009, CLIN SCI, V116, P837, DOI 10.1042/CS20080484; Elliott PR, 2000, PROTEIN SCI, V9, P1274, DOI 10.1110/ps.9.7.1274; FOREMAN RC, 1987, FEBS LETT, V216, P79, DOI 10.1016/0014-5793(87)80760-3; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Hughes VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102617; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; James EL, 1999, J BIOL CHEM, V274, P9482, DOI 10.1074/jbc.274.14.9482; Kass I, 2012, BIOPHYS J, V102, P2856, DOI 10.1016/j.bpj.2012.05.023; Krishnan B, 2011, NAT STRUCT MOL BIOL, V18, P222, DOI 10.1038/nsmb.1976; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; Levina V, 2009, PROTEIN EXPRES PURIF, V68, P226, DOI 10.1016/j.pep.2009.06.011; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Mahadeva R, 2002, J BIOL CHEM, V277, P6771, DOI 10.1074/jbc.C100722200; Mallyat M, 2007, J MED CHEM, V50, P5357, DOI 10.1021/jm070687z; MAST AE, 1992, BIOCHEMISTRY-US, V31, P2720, DOI 10.1021/bi00125a012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; OLSON ST, 1981, J BIOL CHEM, V256, P1065; Ordonez A, 2015, FASEB J, V29, P2667, DOI 10.1096/fj.14-267351; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; SCHULZE AJ, 1990, EUR J BIOCHEM, V194, P51, DOI 10.1111/j.1432-1033.1990.tb19425.x; SHARP HL, 1969, J LAB CLIN MED, V73, P934; SIFERS RN, 1989, J BIOL CHEM, V264, P2997; Skinner R, 1998, J MOL BIOL, V283, P9, DOI 10.1006/jmbi.1998.2083; Stratikos E, 1999, P NATL ACAD SCI USA, V96, P4808, DOI 10.1073/pnas.96.9.4808; Teckman JH, 2004, J PEDIATR GASTR NUTR, V39, P34, DOI 10.1097/00005176-200407000-00007; Tsutsui Y, 2012, P NATL ACAD SCI USA, V109, P4467, DOI 10.1073/pnas.1109125109; WU Y, 1990, FEBS LETT, V268, P21, DOI 10.1016/0014-5793(90)80962-I; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787; Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078; Zhou A, 2008, J MOL BIOL, V375, P36, DOI 10.1016/j.jmb.2007.10.055; Zhou AW, 2010, NATURE, V468, P108, DOI 10.1038/nature09505; Zhou AW, 2003, J BIOL CHEM, V278, P15116, DOI 10.1074/jbc.M211663200	54	19	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15674	15686		10.1074/jbc.M116.727826	http://dx.doi.org/10.1074/jbc.M116.727826			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27246852	Green Published, hybrid			2022-12-26	WOS:000380584200022
J	Nie, LY; Grell, E; Malviya, VN; Xie, H; Wang, JK; Michel, H				Nie, Laiyin; Grell, Ernst; Malviya, Viveka Nand; Xie, Hao; Wang, Jingkang; Michel, Hartmut			Identification of the High-affinity Substrate-binding Site of the Multidrug and Toxic Compound Extrusion (MATE) Family Transporter from Pseudomonas stutzeri	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONDING TRANSCRIPTIONAL REGULATOR; ESCHERICHIA-COLI; VIBRIO-PARAHAEMOLYTICUS; LIGAND-BINDING; EFFLUX PUMPS; PROTEIN NORM; I-TASSER; FLUORESCENCE; SUPERFAMILY; ANTIPORTER	Multidrug and toxic compound extrusion (MATE) transporters exist in all three domains of life. They confer multidrug resistance by utilizing H+ or Na+ electrochemical gradients to extrude various drugs across the cell membranes. The substrate binding and the transport mechanism of MATE transporters is a fundamental process but so far not fully understood. Here we report a detailed substrate binding study of NorM_PS, a representative MATE transporter from Pseudomonas stutzeri. Our results indicate that NorM_PS is a proton-dependent multidrug efflux transporter. Detailed binding studies between NorM_PS and 4',6-diamidino-2-phenylindole (DAPI) were performed by isothermal titration calorimetry (ITC), differential scanning calorimetry (DSC), and spectrofluorometry. Two exothermic binding events were observed from ITC data, and the high-affinity event was directly correlated with the extrusion of DAPI. The affinities are about 1 mu M and 0.1 mM for the high and low affinity binding, respectively. Based on our homology model of NorM_PS, variants with mutations of amino acids that are potentially involved in substrate binding, were constructed. By carrying out the functional characterization of these variants, the critical amino acid residues (Glu-257 and Asp-373) for high-affinity DAPI binding were determined. Taken together, our results suggest a new substrate-binding site for MATE transporters.	[Nie, Laiyin; Wang, Jingkang] Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Collaborat Innovat Ctr Chem Sci & Chem Engn, Tianjin 300072, Peoples R China; [Nie, Laiyin; Grell, Ernst; Malviya, Viveka Nand; Xie, Hao; Michel, Hartmut] Max Planck Inst Biophys, Dept Mol Membrane Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany	Tianjin University; Max Planck Society	Wang, JK (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, State Key Lab Chem Engn, Collaborat Innovat Ctr Chem Sci & Chem Engn, Tianjin 300072, Peoples R China.; Michel, H (corresponding author), Max Planck Inst Biophys, Dept Mol Membrane Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany.	wangjkch@tju.edu.cn; hartmut.michel@biophys.mpg.de		Xie, Hao/0000-0002-2422-2527	Max Planck Society; Deutsche Forschungsgemeinschaft Cluster of Excellence Frankfurt on Macromolecular Complexes Frankfurt; International Science and Technology Cooperation Program of China [2013DFE43150]; China Scholarship Council;  [CRC 807]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft Cluster of Excellence Frankfurt on Macromolecular Complexes Frankfurt; International Science and Technology Cooperation Program of China; China Scholarship Council(China Scholarship Council); 	This work was supported in part by the Max Planck Society, Deutsche Forschungsgemeinschaft Cluster of Excellence Frankfurt on Macromolecular Complexes Frankfurt and CRC 807, and International Science and Technology Cooperation Program of China Grant 2013DFE43150. The authors declare that they have no conflict of interest with the contents of this article.r Supported by the China Scholarship Council and the Max Planck Society.	Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Chen J, 2002, J BACTERIOL, V184, P572, DOI 10.1128/JB.184.2.572-576.2002; COOLS AA, 1986, EXPERIENTIA, V42, P954, DOI 10.1007/BF01941777; Du DJ, 2015, TRENDS MICROBIOL, V23, P311, DOI 10.1016/j.tim.2015.01.010; FAVILLA R, 1993, BIOPHYS CHEM, V46, P217, DOI 10.1016/0301-4622(93)80015-B; Green FJ., 1990, SIGMA ALDRICH HDB ST, P626; HARD T, 1990, PHOTOCHEM PHOTOBIOL, V51, P77, DOI 10.1111/j.1751-1097.1990.tb01686.x; HAYASHI Y, 1989, METHOD ENZYMOL, V172, P514; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Heng J, 2015, CELL RES, V25, P1060, DOI 10.1038/cr.2015.94; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; Islam ST, 2013, ENVIRON MICROBIOL, V15, P1001, DOI 10.1111/j.1462-2920.2012.02890.x; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jin Y, 2014, J BIOL CHEM, V289, P14624, DOI 10.1074/jbc.M113.546770; Kaur J, 2014, J BIOL CHEM, V289, P1377, DOI 10.1074/jbc.M113.510743; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Lalucat J, 2006, MICROBIOL MOL BIOL R, V70, P510, DOI 10.1128/MMBR.00047-05; Lewinson O, 2001, BIOCHEMISTRY-US, V40, P12612, DOI 10.1021/bi011040y; Lu M, 2013, NAT STRUCT MOL BIOL, V20, P1310, DOI 10.1038/nsmb.2687; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Markham PN, 1996, J BACTERIOL, V178, P1473, DOI 10.1128/jb.178.5.1473-1475.1996; MAZZINI A, 1992, BIOPHYS CHEM, V42, P101, DOI 10.1016/0301-4622(92)80012-T; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; NOBLE RC, 1994, DIAGN MICR INFEC DIS, V19, P51, DOI 10.1016/0732-8893(94)90051-5; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Otsuka M, 2005, J BACTERIOL, V187, P1552, DOI 10.1128/JB.187.5.1552-1558.2005; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rycovska A, 2012, BBA-BIOMEMBRANES, V1818, P1342, DOI 10.1016/j.bbamem.2012.02.004; Sikora CW, 2005, BIOPHYS J, V88, P475, DOI 10.1529/biophysj.104.049247; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Vasquez V, 2007, BIOCHEMISTRY-US, V46, P6766, DOI 10.1021/bi700322k; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; Wei YN, 2004, J BIOL CHEM, V279, P39251, DOI 10.1074/jbc.M407044200; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wong K, 2014, TRENDS BIOCHEM SCI, V39, P8, DOI 10.1016/j.tibs.2013.11.002; Yang JY, 2016, PROTEINS, V84, P233, DOI 10.1002/prot.24918; Yernool D, 2003, BIOCHEMISTRY-US, V42, P12981, DOI 10.1021/bi030161q; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	41	20	20	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15503	15514		10.1074/jbc.M116.728618	http://dx.doi.org/10.1074/jbc.M116.728618			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27235402	hybrid, Green Published			2022-12-26	WOS:000380584200008
J	Yano, T; Takeda, H; Uematsu, A; Yamanaka, S; Nomura, S; Nemoto, K; Iwasaki, T; Takahashi, H; Sawasaki, T				Yano, Tomoya; Takeda, Hiroyuki; Uematsu, Atsushi; Yamanaka, Satoshi; Nomura, Shunsuke; Nemoto, Keiichirou; Iwasaki, Takahiro; Takahashi, Hirotaka; Sawasaki, Tatsuya			AGIA Tag System Based on a High Affinity Rabbit Monoclonal Antibody against Human Dopamine Receptor D1 for Protein Analysis	PLOS ONE			English	Article							NF-KAPPA-B; FUNCTIONAL ANNOTATION; CELL; PURIFICATION; EXPRESSION; PEPTIDE; PHOSPHORYLATION; PHOSPHATASE; EFFICIENT; EPITOPE	Polypeptide tag technology is widely used for protein detection and affinity purification. It consists of two fundamental elements: a peptide sequence and a binder which specifically binds to the peptide tag. In many tag systems, antibodies have been used as binder due to their high affinity and specificity. Recently, we obtained clone Ra48, a high-affinity rabbit monoclonal antibody (mAb) against dopamine receptor D1 (DRD1). Here, we report a novel tag system composed of Ra48 antibody and its epitope sequence. Using a deletion assay, we identified EEAAGIARP in the C-terminal region of DRD1 as the minimal epitope of Ra48 mAb, and we named this sequence the "AGIA" tag, based on its central sequence. The tag sequence does not include the four amino acids, Ser, Thr, Tyr, or Lys, which are susceptible to post-translational modification. We demonstrated performance of this new tag system in biochemical and cell biology applications. SPR analysis demonstrated that the affinity of the Ra48 mAb to the AGIA tag was 4.90 x 10(-9) M. AGIA tag showed remarkably high sensitivity and specificity in immunoblotting. A number of AGIA-fused proteins overexpressed in animal and plant cells were detected by anti-AGIA antibody in immunoblotting and immunostaining with low background, and were immunoprecipitated efficiently. Furthermore, a single amino acid substitution of the second Glu to Asp (AGIA/E2D) enabled competitive dissociation of AGIA/E2D-tagged protein by adding wild-type AGIA peptide. It enabled one-step purification of AGIA/E2D-tagged recombinant proteins by peptide competition under physiological conditions. The sensitivity and specificity of the AGIA system makes it suitable for use in multiple methods for protein analysis.	[Yano, Tomoya; Takeda, Hiroyuki; Uematsu, Atsushi; Yamanaka, Satoshi; Nomura, Shunsuke; Nemoto, Keiichirou; Iwasaki, Takahiro; Takahashi, Hirotaka; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr PROS, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan	Ehime University	Sawasaki, T (corresponding author), Ehime Univ, Proteosci Ctr PROS, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	sawasaki@ehime-u.ac.jp		Sawasaki, Tatsuya/0000-0002-7952-0556	Ministry of Education, Culture, Sports, Science and Technology, Japan; JSPS KAKENHI Grant [24710251, 25117719, 25290077, 26640130, 26750375]; Grants-in-Aid for Scientific Research [15J03774] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was mainly supported by Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan (T.S.). This work was also partially supported by JSPS KAKENHI Grant Numbers 24710251 (H. Takeda), 25117719 (T.S.), 25290077 (T.S.), 26640130 (T.S.), and 26750375 (H. Takeda). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht FE, 1996, J CLIN INVEST, V97, P2283, DOI 10.1172/JCI118670; BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; De Ceuninck L, 2013, J CELL SCI, V126, P3770, DOI 10.1242/jcs.131250; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FUXE K, 1985, DOPAMINE NEUROENDOCR, P11, DOI DOI 10.1007/978-3-642-69948-1_2; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hopp TP, 1988, NATURE BIOTECHNOLOGY; Iwasaki T, 2013, MOL BIOL CELL, V24, P748, DOI 10.1091/mbc.E11-08-0740; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Knorre DG, 2009, ACTA NATURAE, V1, P29, DOI 10.32607/20758251-2009-1-3-29-51; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Krueger KE, 2006, MOL CELL PROTEOMICS, V5, P1799, DOI 10.1074/mcp.R600009-MCP200; Liguori MJ, 2001, HYBRIDOMA, V20, P189, DOI 10.1089/027245701750293529; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Mage RG, 2006, DEV COMP IMMUNOL, V30, P137, DOI 10.1016/j.dci.2005.06.017; Malhotra A, 2009, METHOD ENZYMOL, V463, P239, DOI 10.1016/S0076-6879(09)63016-0; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Molestina RE, 2003, J CELL SCI, V116, P4359, DOI 10.1242/jcs.00683; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nemoto K, 2015, J BIOL CHEM, V290, P16665, DOI 10.1074/jbc.M114.617274; Okamura Y, 2015, NUCLEIC ACIDS RES, V43, pD82, DOI 10.1093/nar/gku1163; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ozawa T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0052383, DOI 10.1371/J0URNAL.P0NE.0052383]; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rossi S, 2005, AM J CLIN PATHOL, V124, P295, DOI 10.1309/NR8HN08GDPVEMU08; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2008, FEBS LETT, V582, P221, DOI 10.1016/j.febslet.2007.12.004; Schmidt PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037779; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Tadokoro D, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.65; Takahashi H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-39; Takeda H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11333; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Uchinomiya S, 2014, INORG CHEM, V53, P1816, DOI 10.1021/ic401612z; Ullman EF, 1996, CLIN CHEM, V42, P1518; User N., 2003, MASS SPECTROMETRY BA, P1; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Wood DW, 2014, CURR OPIN STRUC BIOL, V26, P54, DOI 10.1016/j.sbi.2014.04.006; Xu Y., 2015, CURR TOP MED CHEM; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	47	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156716	10.1371/journal.pone.0156716	http://dx.doi.org/10.1371/journal.pone.0156716			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271343	Green Submitted, gold, Green Published			2022-12-26	WOS:000377560200012
J	Smith, DK; Mendoza, MCB; Stryker, JE; Rose, CE				Smith, Dawn K.; Mendoza, Maria C. B.; Stryker, Jo Ellen; Rose, Charles E.			PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009-2015	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS PREP; HIV-INFECTION; ANTIRETROVIRAL PROPHYLAXIS; HEALTH-CARE; KNOWLEDGE; RISK; PREVENTION; MEN; SEX; IMPLEMENTATION	Objectives As trials were assessing the safety and efficacy of daily oral antiretroviral preexposure prophylaxis (PrEP) for the prevention of HIV infection, there was a clear need to understand the evolution of knowledge of, and attitudes toward, PrEP among primary care clinicians. Methods Physicians and nurse practitioners were surveyed in 2009 (n = 1500), 2010 (n = 1504), 2012 (n = 1503), 2013 (n = 1507), 2014 (n = 1508) and 2015 (n = 1501) to assess their awareness of PrEP, willingness to prescribe PrEP, and whether they support use of public funds to pay for PrEP. Pharmacists (n = 251) were surveyed about PrEP in 2012 only. Descriptive statistics were computed for physician demographics and PrEP- related questions. Prevalence ratios for willingness to prescribe PrEP were computed using Poisson regression analysis. Results Awareness of PrEP was low among clinicians (2009: 24%, 2010: 29%) but increased after trials reported effectiveness (2012: 49%, 2013: 51%, 2014: 61%, 2015: 66%). Following a description of PrEP with an estimated effectiveness of 75%, across 6 of the study years 91% of clinicians indicated a willingness to prescribe PrEP to at least one group at high risk of HIV acquisition. A smaller majority of clinicians indicated support for public funding of PrEP in 2009: 59%, 2010: 53%, and 2013: 63%. Conclusions In surveys conducted before and after the release of PrEP trial results, primary care clinicians were largely unaware of PrEP. They indicated high levels of willingness to prescribe it for patients at high risk of HIV acquisition and expressed interest in education about how to deliver this new clinical HIV prevention method. It will be important to continue monitoring clinician knowledge, attitudes, and practices as the use of PrEP increases in the US.	[Smith, Dawn K.; Mendoza, Maria C. B.; Stryker, Jo Ellen; Rose, Charles E.] Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent DHAP, Natl Ctr HIV Viral Hepatitis STD & TB Prevent NCH, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Smith, DK (corresponding author), Ctr Dis Control & Prevent CDC, Div HIV AIDS Prevent DHAP, Natl Ctr HIV Viral Hepatitis STD & TB Prevent NCH, Atlanta, GA 30333 USA.	dsmith1@cdc.gov						Arnold EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040603; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Blumenthal J, 2015, AIDS BEHAV, V19, P802, DOI 10.1007/s10461-015-0996-z; Centers for Disease Control and Prevention, 2014, PREEXP PROPH PREV HI, P1; Centers for Disease Control and Prevention, 2013, HIV SURV SUPPL REP; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Khawcharoenporn T, 2012, AIDS PATIENT CARE ST, V26, P222, DOI 10.1089/apc.2011.0202; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Laws RA, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-66; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Mullins TLK, 2015, AIDS PATIENT CARE ST, V29, P193, DOI 10.1089/apc.2014.0273; Puro V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-217; Rahangdale Lisa, 2014, J AIDS Clin Res, V5, P1000307; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Smith DK, 2013, MMWR-MORBID MORTAL W, V62, P463; Spector AY, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/1747-597X-10-1; Tellalian D, 2013, AIDS PATIENT CARE ST, V27, P553, DOI 10.1089/apc.2013.0173; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Thrun MW, 2014, LGBT HEALTH, V1, P75, DOI 10.1089/lgbt.2014.0007; Tripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1b; Voetsch AC, 2007, JAIDS-J ACQ IMM DEF, V46, P378, DOI 10.1097/QAI.0b013e3181576874; White JM, 2012, AIDS PATIENT CARE ST, V26, P395, DOI 10.1089/apc.2012.0030; Whiteside YO, 2011, AIDS PATIENT CARE ST, V25, P365, DOI 10.1089/apc.2010.0224; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7	27	115	115	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156592	10.1371/journal.pone.0156592	http://dx.doi.org/10.1371/journal.pone.0156592			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258374	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700084
J	Bhatara, A; Laukka, P; Boll-Avetisyan, N; Granjon, L; Elfenbein, HA; Banziger, T				Bhatara, Anjali; Laukka, Petri; Boll-Avetisyan, Natalie; Granjon, Lionel; Elfenbein, Hillary Anger; Banziger, Tanja			Second Language Ability and Emotional Prosody Perception	PLOS ONE			English	Article							RECOGNITION; CHINESE	The present study examines the effect of language experience on vocal emotion perception in a second language. Native speakers of French with varying levels of self-reported English ability were asked to identify emotions from vocal expressions produced by American actors in a forced-choice task, and to rate their pleasantness, power, alertness and intensity on continuous scales. Stimuli included emotionally expressive English speech (emotional prosody) and non-linguistic vocalizations (affect bursts), and a baseline condition with Swiss-French pseudo-speech. Results revealed effects of English ability on the recognition of emotions in English speech but not in non-linguistic vocalizations. Specifically, higher English ability was associated with less accurate identification of positive emotions, but not with the interpretation of negative emotions. Moreover, higher English ability was associated with lower ratings of pleasantness and power, again only for emotional prosody. This suggests that second language skills may sometimes interfere with emotion recognition from speech prosody, particularly for positive emotions.	[Bhatara, Anjali; Granjon, Lionel] CNRS, UMR 8242, Lab Psychol Percept, Paris, France; [Bhatara, Anjali; Granjon, Lionel] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Laukka, Petri] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden; [Laukka, Petri] Sodertorn Univ, Sch Social Sci, Huddinge, Sweden; [Boll-Avetisyan, Natalie] Univ Potsdam, Dept Linguist, Potsdam, Germany; [Elfenbein, Hillary Anger] Washington Univ, John M Olin Sch Business, St Louis, MO 63130 USA; [Banziger, Tanja] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Stockholm University; Sodertorn University; University of Potsdam; Washington University (WUSTL); Mid-Sweden University	Bhatara, A (corresponding author), CNRS, UMR 8242, Lab Psychol Percept, Paris, France.; Bhatara, A (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.	bhatara@gmail.com	Laukka, Petri/B-5259-2008	Laukka, Petri/0000-0001-8771-6818; Boll-Avetisyan, Natalie/0000-0001-5446-946X	Marie Curie Incoming International Fellowship, Cordis, European Commission [302452]	Marie Curie Incoming International Fellowship, Cordis, European Commission	This work was funded by a Marie Curie Incoming International Fellowship, Cordis, European Commission, Project 302452 to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrov R, 2013, TRAMES-J HUMANIT SOC, V17, P159, DOI 10.3176/tr.2013.2.04; Banziger T, 2012, EMOTION, V12, P1161, DOI 10.1037/a0025827; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bhatara A, 2013, J ACOUST SOC AM, V134, P3828, DOI 10.1121/1.4823848; Boll-Avetisyan N, 2016, BILING-LANG COGN, V19, P971, DOI 10.1017/S1366728915000425; Bryant GA, 2008, J COGN CULT, V8, P135, DOI 10.1163/156770908X289242; Cordaro DT, 2016, EMOTION, V16, P117, DOI 10.1037/emo0000100; Dromey C, 2005, SPEECH COMMUN, V47, P351, DOI 10.1016/j.specom.2004.09.010; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Elfenbein HA, 2003, CURR DIR PSYCHOL SCI, V12, P159, DOI 10.1111/1467-8721.01252; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Graham C., 2001, IRAL-INT REV APPL LI, V39, P19, DOI DOI 10.1515/IRAL.39.1.19; Ilie G, 2006, MUSIC PERCEPT, V23, P319, DOI 10.1525/mp.2006.23.4.319; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Laukka P, 2010, P LREC 2010 WORKSH C, P53; Laukka P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00353; Marion V, 2007, J SPEECH LANG HEAR R, V50, P940, DOI 10.1044/1092-4388(2007/067); Paulmann S, 2014, COGNITION EMOTION, V28, P230, DOI 10.1080/02699931.2013.812033; Pell MD, 2011, COGNITION EMOTION, V25, P834, DOI 10.1080/02699931.2010.516915; R Core Team, R LANG ENV STAT COMP; Sauter D, 2010, CURR DIR PSYCHOL SCI, V19, P36, DOI 10.1177/0963721409359290; Sauter DA, 2010, P NATL ACAD SCI USA, V107, P2408, DOI 10.1073/pnas.0908239106; Shochi T, 2010, SPEECH PROSODY  0226, P1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhu YY, 2013, DUTCH J APPL LINGUIS, V2, P170, DOI 10.1075/dujal.2.2.03zhu	26	7	7	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156855	10.1371/journal.pone.0156855	http://dx.doi.org/10.1371/journal.pone.0156855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DN6XB	27253326	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700066
J	Burger, MC; Zeiner, PS; Jahnke, K; Wagner, M; Mittelbronn, M; Steinbach, JP				Burger, Michael C.; Zeiner, Pia S.; Jahnke, Kolja; Wagner, Marlies; Mittelbronn, Michel; Steinbach, Joachim P.			Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; RISK-FACTORS; MALIGNANT GLIOMAS; RANDOMIZED-TRIAL; DISSEMINATION; EFFICACY; OUTCOMES; RECURRENCE; CYTARABINE; PATTERNS	Leptomeningeal dissemination of a primary brain tumor is a condition which is challenging to treat, as it often occurs in rather late disease stages in highly pretreated patients. Its prognosis is dismal and there is still no accepted standard of care. We report here a good clinical effect with a partial response in three out of nine patients and a stable disease with improvement on symptoms in two more patients following systemic anti-angiogenic treatment with bevacizumab (BEV) alone or in combination with chemo-and/or radiotherapy in a series of patients with leptomeningeal dissemination from primary brain tumors (diffuse astrocytoma WHO degrees II, anaplastic astrocytoma WHO degrees III, anaplastic oligodendroglioma WHO degrees III, primitive neuroectodermal tumor and glioblastoma, both WHO degrees IV). This translated into effective symptom control in five out of nine patients, but only moderate progression-free and overall survival times were reached. Partial responses as assessed by RANO criteria were observed in three patients (each one with anaplastic oligodendroglioma, primitive neuroectodermal tumor and glioblastoma). In these patients progression-free survival (PFS) intervals of 17, 10 and 20 weeks were achieved. In three patients (each one with diffuse astrocytoma, anaplastic astrocytoma and primitive neuroectodermal tumor) stable disease was observed with PFS of 13, 30 and 8 weeks. Another three patients (all with glioblastoma) were primary non-responders and deteriorated rapidly with PFS of 3 to 4 weeks. No severe adverse events were seen. These experiences suggest that the combination of BEV with more conventional therapy schemes with chemo-and/or radiotherapy may be a palliative treatment option for patients with leptomeningeal dissemination of brain tumors.	[Burger, Michael C.; Steinbach, Joachim P.] Goethe Univ Frankfurt, Dr Senckenberg Inst Neurooncol, D-60054 Frankfurt, Germany; [Zeiner, Pia S.; Mittelbronn, Michel] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany; [Zeiner, Pia S.; Jahnke, Kolja] Goethe Univ Frankfurt, Dept Neurol, D-60054 Frankfurt, Germany; [Wagner, Marlies] Goethe Univ Frankfurt, Inst Neuroradiol, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Burger, MC (corresponding author), Goethe Univ Frankfurt, Dr Senckenberg Inst Neurooncol, D-60054 Frankfurt, Germany.	michael.burger@kgu.de	Wagner, Marlies/AAZ-5487-2021; Wagner, Marlies/AAL-3357-2020; Wagner, Marlies/GQA-9181-2022	Mittelbronn, Michel/0000-0002-2998-052X				Alatakis S, 2001, SURG NEUROL, V56, P33, DOI 10.1016/S0090-3019(01)00459-1; Bae JS, 2011, J KOREAN NEUROSURG S, V49, P334, DOI 10.3340/jkns.2011.49.6.334; Chamberlain MC, 2003, NEUROSURGERY, V52, P324, DOI 10.1227/01.NEU.0000043929.31608.62; Dardis C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00220; Braganca KC, 2010, J NEURO-ONCOL, V100, P443, DOI 10.1007/s11060-010-0200-2; Fiorentino A, 2012, INT J NEUROSCI, V122, P691, DOI 10.3109/00207454.2012.704456; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Glantz MJ, 1999, J CLIN ONCOL, V17, P3110, DOI 10.1200/JCO.1999.17.10.3110; Herrlinger U, 2004, BRIT J CANCER, V91, P219, DOI 10.1038/sj.bjc.6601953; Hsieh PC, 2008, CHILD NERV SYST, V24, P1463, DOI 10.1007/s00381-008-0697-2; Huang TY, 1999, J NEURO-ONCOL, V45, P9, DOI 10.1023/A:1006377312403; Karaca M, 2006, NEUROL INDIA, V54, P428; Knizetova P, 2008, CELL CYCLE, V7, P2553, DOI 10.4161/cc.7.16.6442; Li KG, 2011, MED ONCOL, V28, P1116, DOI 10.1007/s12032-010-9580-6; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mandel JJ, 2014, J NEURO-ONCOL, V120, P597, DOI 10.1007/s11060-014-1592-1; Narita Y, 2013, JPN J CLIN ONCOL, V43, P587, DOI 10.1093/jjco/hyt051; Noh JH, 2015, ACTA NEUROCHIR, V157, P569, DOI 10.1007/s00701-015-2344-5; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Privitera G, 2009, J ONCOL, V2009, DOI 10.1155/2009/247873; Ruben JD, 2006, INT J RADIAT ONCOL, V65, P499, DOI 10.1016/j.ijrobp.2005.12.002; Saito R, 2003, J NEURO-ONCOL, V61, P227, DOI 10.1023/A:1022536828345; Sandmann T, 2015, J CLIN ONCOL, V33, P2735, DOI 10.1200/JCO.2015.61.5005; SCHWANINGER M, 1992, J NEURO-ONCOL, V12, P93; Scott BJ, 2014, J NEURO-ONCOL, V119, P361, DOI 10.1007/s11060-014-1486-2; Sengupta S, 2015, OXF MED CASE REP, P254, DOI 10.1093/omcr/omv010; Slongo ML, 2007, NEURO-ONCOLOGY, V9, P384, DOI 10.1215/15228517-2007-032; Taal W, 2014, LANCET ONCOL, V15, P943, DOI 10.1016/S1470-2045(14)70314-6; Thompson EM, 2011, J NEURO-ONCOL, V103, P353, DOI 10.1007/s11060-010-0397-0; VERTOSICK FT, 1990, NEUROSURGERY, V27, P516, DOI 10.1227/00006123-199010000-00002; Vredenburgh JJ, 2010, ONCOLOGIST, V15, P1329, DOI 10.1634/theoncologist.2010-0105; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Zuniga RM, 2009, J NEURO-ONCOL, V91, P329, DOI 10.1007/s11060-008-9718-y	33	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155315	10.1371/journal.pone.0155315	http://dx.doi.org/10.1371/journal.pone.0155315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253224	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700005
J	de Baaij, JHF; Kompatscher, A; Viering, DHHM; Bos, C; Bindels, RJM; Hoenderop, JGJ				de Baaij, Jeroen H. F.; Kompatscher, Andreas; Viering, Daan H. H. M.; Bos, Caro; Bindels, Rene J. M.; Hoenderop, Joost G. J.			P2X6 Knockout Mice Exhibit Normal Electrolyte Homeostasis	PLOS ONE			English	Article							RENAL TUBULAR TRANSPORT; RECEPTOR SUBUNITS; P2X(6) RECEPTORS; ION CHANNELS; ATP; NUCLEOTIDES; ACTIVATION; PURINOCEPTORS; FAMILY; ALPHA	ATP-mediated signaling is an important regulator of electrolyte transport in the kidney. The purinergic cation channel P2X6 has been previously localized to the distal convoluted tubule (DCT), a nephron segment important for Mg2+ and Na+ reabsorption, but its role in ion transport remains unknown. In this study, P2x6 knockout (P2x6(-/-)) mice were generated to investigate the role of P2X6 in renal electrolyte transport. The P2x6(-/-) animals displayed a normal phenotype and did not differ physiologically from wild type mice. Differences in serum concentration and 24-hrs urine excretion of Na+, K+, Mg2+ and Ca2+ were not detected between P2x6(+/+), P2x6(+/-) and P2x6(-/-) mice. Quantitative PCR was applied to examine potential compensatory changes in renal expression levels of other P2x subunits and electrolyte transporters, including P2x1-5, P2x7, Trpm6, Ncc, Egf, Cldn16, Scnn1, Slc12a3, Slc41a1, Slc41a3, Cnnm2, Kcnj10 and Fxyd2. Additionally, protein levels of P2X2 and P2X4 were assessed in P2x6(+/+) and P2x6(-/-) mouse kidneys. However, significant changes in expression were not detected. Furthermore, no compensatory changes in gene expression could be demonstrated in heart material isolated from P2x6(-/-) mice. Except for a significant (P<0.05) upregulation of P2x2 in the heart of P2x6(-/-) mice compared to the P2x6(+/+) mice. Thus, our data suggests that purinergic signaling via P2X6 is not significantly involved in the regulation of renal electrolyte handling under normal physiological conditions.	[de Baaij, Jeroen H. F.; Kompatscher, Andreas; Viering, Daan H. H. M.; Bos, Caro; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Dept Physiol, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Dept Physiol, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	joost.hoenderop@radboudumc.nl	Bos, Caro/V-2390-2017; de Baaij, Jeroen/P-5704-2015; Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014; Viering, Daan/T-7808-2018	Bos, Caro/0000-0001-5016-9435; de Baaij, Jeroen/0000-0003-2372-8486; Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544; Viering, Daan/0000-0002-6398-0646	Netherlands Organization for Scientific Research [NWO VICI 016.130.668]; EURenOmics project from the European Union [305608]; NWO [Rubicon 825.14.021]; Dutch Kidney Foundation [Kolff 14OKG17]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); EURenOmics project from the European Union; NWO(Netherlands Organization for Scientific Research (NWO)); Dutch Kidney Foundation	This work was supported by grants from the Netherlands Organization for Scientific Research (NWO VICI 016.130.668) and the EURenOmics project from the European Union seventh Framework Programme (FP7/2007-2013, agreement no. 305608). Dr. Jeroen de Baaij is supported by grants from NWO (Rubicon 825.14.021) and the Dutch Kidney Foundation (Kolff 14OKG17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arulkumaran N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00194; Banfi C, 2005, J MOL CELL CARDIOL, V39, P929, DOI 10.1016/j.yjmcc.2005.09.002; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Booth JWR, 2012, CLIN NEPHROL, V78, P154, DOI 10.5414/CN107325; Cheung KK, 2015, PURINERG SIGNAL, V11, P127, DOI 10.1007/s11302-014-9441-4; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Collo G, 1996, J NEUROSCI, V16, P2495; CUSACK NJ, 1990, ANN NY ACAD SCI, V603, P172; Dai LJ, 2001, AM J PHYSIOL-RENAL, V281, pF833, DOI 10.1152/ajprenal.0349.2000; de Baaij JHF, 2014, PFLUG ARCH EUR J PHY, V466, P1941, DOI 10.1007/s00424-014-1440-3; de Baaij JHF, 2013, AM J PHYSIOL-RENAL, V305, pF1563, DOI 10.1152/ajprenal.00322.2013; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; Foltz CJ, 1999, LAB ANIMAL, V28, P28; Diaz-Hernandez JI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123121; Jones CA, 2004, MOL PHARMACOL, V65, P979, DOI 10.1124/mol.65.4.979; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Kim MJ, 2014, NEPHROL DIAL TRANSPL, V29, P1350, DOI 10.1093/ndt/gfu019; Le KT, 1998, J NEUROSCI, V18, P7152; Leipziger J, 2011, CURR OPIN NEPHROL HY, V20, P518, DOI 10.1097/MNH.0b013e3283487393; Marques RD, 2012, AM J PHYSIOL-RENAL, V302, pF487, DOI 10.1152/ajprenal.00570.2011; Menzies RI, 2015, ACTA PHYSIOL, V213, P232, DOI 10.1111/apha.12412; Musa H, 2009, N-S ARCH PHARMACOL, V379, P541, DOI 10.1007/s00210-009-0403-2; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Ormond SJ, 2006, MOL PHARMACOL, V69, P1692, DOI 10.1124/mol.105.020404; Orriss IR, 2012, BONE, V51, P389, DOI 10.1016/j.bone.2012.06.013; Praetorius HA, 2010, ANNU REV PHYSIOL, V72, P377, DOI 10.1146/annurev-physiol-021909-135825; Sprinthall R., 2011, BASIC STATISTICAL AN; Stokes L, 2011, HYPERTENSION, V58, P1086, DOI 10.1161/HYPERTENSIONAHA.111.176180; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Thebault S, 2009, J AM SOC NEPHROL, V20, P78, DOI 10.1681/ASN.2008030327; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wildman SSP, 2008, J AM SOC NEPHROL, V19, P731, DOI 10.1681/ASN.2007040443; Wildman SSP, 2008, NEPHRON PHYSIOL, V108, P60, DOI 10.1159/000122028; Wildman SSP, 2009, J AM SOC NEPHROL, V20, P1480, DOI 10.1681/ASN.2008070686	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156803	10.1371/journal.pone.0156803	http://dx.doi.org/10.1371/journal.pone.0156803			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27254077	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700062
J	Penterling, C; Drexler, GA; Bohland, C; Stamp, R; Wilke, C; Braselmann, H; Caldwell, RB; Reindl, J; Girst, S; Greubel, C; Siebenwirth, C; Mansour, WY; Borgmann, K; Dollinger, G; Unger, K; Friedl, AA				Penterling, Corina; Drexler, Guido A.; Boehland, Claudia; Stamp, Ramona; Wilke, Christina; Braselmann, Herbert; Caldwell, Randolph B.; Reindl, Judith; Girst, Stefanie; Greubel, Christoph; Siebenwirth, Christian; Mansour, Wael Y.; Borgmann, Kerstin; Dollinger, Guenther; Unger, Kristian; Friedl, Anna A.			Depletion of Histone Demethylase Jarid1A Resulting in Histone Hyperacetylation and Radiation Sensitivity Does Not Affect DNA Double-Strand Break Repair	PLOS ONE			English	Article							DAMAGE RESPONSE PROTEIN; DEACETYLASE INHIBITORS; VALPROIC ACID; ONCOMETABOLITE 2-HYDROXYGLUTARATE; TRANSCRIPTIONAL REPRESSION; H3K4 DEMETHYLASE; GASTRIC-CANCER; TUMOR-CELLS; CHROMATIN; RBP2	Histone demethylases have recently gained interest as potential targets in cancer treatment and several histone demethylases have been implicated in the DNA damage response. We investigated the effects of siRNA-mediated depletion of histone demethylase Jarid1A (KDM5A, RBP2), which demethylates transcription activating tri- and dimethylated lysine 4 at histone H3 (H3K4me3/me2), on growth characteristics and cellular response to radiation in several cancer cell lines. In unirradiated cells Jarid1A depletion lead to histone hyperacetylation while not affecting cell growth. In irradiated cells, depletion of Jarid1A significantly increased cellular radiosensitivity. Unexpectedly, the hyperacetylation phenotype did not lead to disturbed accumulation of DNA damage response and repair factors 53BP1, BRCA1, or Rad51 at damage sites, nor did it influence resolution of radiation-induced foci or rejoining of reporter constructs. We conclude that the radiation sensitivity observed following depletion of Jarid1A is not caused by a deficiency in repair of DNA double-strand breaks.	[Penterling, Corina; Drexler, Guido A.; Boehland, Claudia; Stamp, Ramona; Friedl, Anna A.] Univ Munich, Dept Radiat Oncol, Munich, Germany; [Wilke, Christina; Braselmann, Herbert; Caldwell, Randolph B.; Unger, Kristian] Helmholtz Ctr Munich, Res Unit Radiat Cytogenet, Neuherberg, Germany; [Reindl, Judith; Girst, Stefanie; Greubel, Christoph; Dollinger, Guenther] Univ Bundeswehr Munchen, Inst Angew Phys & Messtech, Neubiberg, Germany; [Siebenwirth, Christian] Tech Univ Munich, Dept Radiat Oncol, D-80290 Munich, Germany; [Mansour, Wael Y.; Borgmann, Kerstin] Univ Med Ctr Hamburg Eppendorf, Lab Radiobiol & Expt Radiooncol, Hamburg, Germany; [Mansour, Wael Y.] Cairo Univ, Natl Canc Inst, Dept Tumor Biol, Cairo, Egypt; [Unger, Kristian; Friedl, Anna A.] Helmholtz Ctr Munich, Clin Cooperat Grp Personalized Radiotherapy Head, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Bundeswehr University Munich; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Friedl, AA (corresponding author), Univ Munich, Dept Radiat Oncol, Munich, Germany.; Friedl, AA (corresponding author), Helmholtz Ctr Munich, Clin Cooperat Grp Personalized Radiotherapy Head, Neuherberg, Germany.	anna.friedl@lrz.uni-muenchen.de	Friedl, Anna A/B-1628-2010; Unger, Kristian/F-3730-2018	Friedl, Anna A/0000-0002-7425-6151; Unger, Kristian/0000-0002-0374-2320; Reindl, Judith/0000-0002-3238-8586; Mansour, Wael/0000-0003-0641-2885; Caldwell, Randolph/0000-0003-3933-3243	European Commission FP7 Network of Excellence DoReMi (Low Dose research towards Multidisciplinary Integration) [FP7-249689]; Deutsche Forschungsgemeinschaft DFG Cluster of Excellence "Munich Centre for Advanced Photonics"	European Commission FP7 Network of Excellence DoReMi (Low Dose research towards Multidisciplinary Integration); Deutsche Forschungsgemeinschaft DFG Cluster of Excellence "Munich Centre for Advanced Photonics"(German Research Foundation (DFG))	This work was supported by European Commission FP7 Network of Excellence DoReMi (Low Dose research towards Multidisciplinary Integration), FP7-249689, www.doremi-noe.net, to AAF and GD; Deutsche Forschungsgemeinschaft DFG Cluster of Excellence "Munich Centre for Advanced Photonics", www.dfg.de, to AAF and GD. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R A LANGUAGE AND ENV; Auer S, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-139; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Beshiri Michael L, 2010, J Vis Exp, DOI 10.3791/2101; Bhaskara S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-27; Blattmann C, 2012, STRAHLENTHER ONKOL, V188, P168, DOI 10.1007/s00066-011-0028-5; Braselmann H, 2014, CFASSAY STAT ANAL CO; Chang LJ, 2012, CANCER BIOL THER, V13, P1047, DOI 10.4161/cbt.21047; Chicas A, 2012, P NATL ACAD SCI USA, V109, P8971, DOI 10.1073/pnas.1119836109; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Cowell IG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001057; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Drexler GA, 2015, J BIOSCIENCES, V40, P629, DOI 10.1007/s12038-015-9535-3; Drexler GA, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0350-7; Du GH, 2011, RADIAT RES, V176, P706, DOI 10.1667/RR2592.1; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Fukuda T, 2015, CANCER SCI, V106, P1050, DOI 10.1111/cas.12717; Ganai SA, 2015, J BIOMOL STRUCT DYN, V33, P1185, DOI 10.1080/07391102.2014.938247; Gilbert N, 2007, J CELL BIOL, V177, P401, DOI 10.1083/jcb.200607133; Girst S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02511; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Greubel C, 2008, RADIAT ENVIRON BIOPH, V47, P423, DOI 10.1007/s00411-008-0182-z; Grigaravicius P, 2009, CHEMPHYSCHEM, V10, P79, DOI 10.1002/cphc.200800725; Groselj B, 2013, BRIT J CANCER, V108, P748, DOI 10.1038/bjc.2013.21; Hable V, 2009, NUCL INSTRUM METH B, V267, P2090, DOI 10.1016/j.nimb.2009.03.071; Hable V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041943; Hauptner A, 2004, RADIAT ENVIRON BIOPH, V42, P237, DOI 10.1007/s00411-003-0222-7; Hayakawa T, 2007, GENES CELLS, V12, P811, DOI 10.1111/j.1365-2443.2007.01089.x; Hendriks IA, 2015, CELL REP, V10, P1778, DOI 10.1016/j.celrep.2015.02.033; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Hou JL, 2012, AM J TRANSL RES, V4, P247; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Huang Po-Hsien, 2011, Mol Cell Pharmacol, V3, P39; Huang PH, 2011, MOL PHARMACOL, V79, P197, DOI 10.1124/mol.110.067702; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Islam ABMMK, 2011, CELL CYCLE, V10, P413, DOI 10.4161/cc.10.3.14705; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Karagiannis TC, 2007, ONCOGENE, V26, P3963, DOI 10.1038/sj.onc.1210174; Kawano T, 2010, INT J ONCOL, V37, P787, DOI 10.3892/ijo_00000728; Kernytsky A, 2015, BLOOD, V125, P296, DOI 10.1182/blood-2013-10-533604; Khoury-Haddad H, 2015, CELL CYCLE, V14, P950, DOI 10.1080/15384101.2015.1014147; Khoury-Haddad H, 2014, P NATL ACAD SCI USA, V111, pE728, DOI 10.1073/pnas.1317585111; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Kim JA, 2007, J CELL BIOL, V178, P209, DOI 10.1083/jcb.200612031; Klein BJ, 2014, CELL REP, V6, P325, DOI 10.1016/j.celrep.2013.12.021; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Kralj M, 2003, CANCER GENE THER, V10, P457, DOI 10.1038/sj.cgt.7700588; Kuo YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125343; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Li LP, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-81; Li SC, 2013, NEURO-ONCOLOGY, V15, P57, DOI 10.1093/neuonc/nos261; Li X, 2014, P NATL ACAD SCI USA, V111, P7096, DOI 10.1073/pnas.1324036111; Liang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069784; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Makita N, 2015, ONCOL REP, V34, P1185, DOI 10.3892/or.2015.4089; Mannironi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086002; Mansour WY, 2008, NUCLEIC ACIDS RES, V36, P4088, DOI 10.1093/nar/gkn347; Mansour WY, 2013, DNA REPAIR, V12, P1134, DOI 10.1016/j.dnarep.2013.10.005; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Marcon E, 2014, CELL REP, V8, P297, DOI 10.1016/j.celrep.2014.05.050; Mariotti LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079541; McGrath J, 2015, PHARMACOL THERAPEUT, V150, P1, DOI 10.1016/j.pharmthera.2015.01.002; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nagy Z, 2009, TRENDS CELL BIOL, V19, P617, DOI 10.1016/j.tcb.2009.08.010; Neumayer G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110994; Nishibuchi G, 2014, J BIOL CHEM, V289, P28956, DOI 10.1074/jbc.M114.573725; Outchkourov NS, 2013, CELL REP, V3, P1071, DOI 10.1016/j.celrep.2013.02.030; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; PERRY M, 1981, J BIOL CHEM, V256, P3313; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Reindl J, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/6/066005; Seiler DM, 2011, CHROMOSOME RES, V19, P883, DOI 10.1007/s10577-011-9244-1; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Splinter J, 2010, MUTAGENESIS, V25, P289, DOI 10.1093/mutage/geq005; Takata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075622; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Taylor GCA, 2013, GENOME RES, V23, P2053, DOI 10.1101/gr.155028.113; Teng YC, 2013, CANCER RES, V73, P4711, DOI 10.1158/0008-5472.CAN-12-3165; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Vasilatos SN, 2013, CARCINOGENESIS, V34, P1196, DOI 10.1093/carcin/bgt033; Vasireddy Raja S, 2010, J Vis Exp, DOI 10.3791/2203; Wang X., 2014, B PATIENTS RHEUM ART, V2014, P1; Williams K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096545; Wu S, 2014, CELL CYCLE, V13, P2869, DOI 10.4161/15384101.2014.946834; Xie LQ, 2011, EMBO J, V30, P1473, DOI 10.1038/emboj.2011.91; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yin F, 2014, MOL CELL BIOL, V34, P158, DOI 10.1128/MCB.00631-13; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Young LC, 2013, J BIOL CHEM, V288, P21376, DOI 10.1074/jbc.M113.491514; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004; Zinner R, 2007, ADV ENZYME REGUL, V47, P223, DOI 10.1016/j.advenzreg.2007.01.005	99	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156599	10.1371/journal.pone.0156599	http://dx.doi.org/10.1371/journal.pone.0156599			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253695	Green Submitted, gold, Green Published			2022-12-26	WOS:000377218700041
J	Agudelo, M; Figueroa, G; Parira, T; Yndart, A; Munoz, K; Atluri, V; Samikkannu, T; Nair, MP				Agudelo, Marisela; Figueroa, Gloria; Parira, Tiyash; Yndart, Adriana; Munoz, Karla; Atluri, Venkata; Samikkannu, Thangavel; Nair, Madhavan P.			Profile of Class I Histone Deacetylases (HDAC) by Human Dendritic Cells after Alcohol Consumption and In Vitro Alcohol Treatment and Their Implication in Oxidative Stress: Role of HDAC Inhibitors Trichostatin A and Mocetinostat	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; GENE-EXPRESSION; COMBINATION; MECHANISMS; RESPONSES; DRINKING; RATS	Epigenetic mechanisms have been shown to play a role in alcohol use disorders (AUDs) and may prove to be valuable therapeutic targets. However, the involvement of histone deacetylases (HDACs) on alcohol-induced oxidative stress of human primary monocyte-derived dendritic cells (MDDCs) has not been elucidated. In the current study, we took a novel approach combining ex vivo, in vitro and in silico analyses to elucidate the mechanisms of alcohol-induced oxidative stress and role of HDACs in the periphery. ex vivo and in vitro analyses of alcohol-modulation of class I HDACs and activity by MDDCs from self-reported alcohol users and non-alcohol users was performed. Additionally, MDDCs treated with alcohol were assessed using qRT-PCR, western blot, and fluorometric assay. The functional effects of alcohol-induce oxidative stress were measured in vitro using PCR array and in silico using gene expression network analysis. Our findings show, for the first time, that MDDCs from self-reported alcohol users have higher levels of class I HDACs compare to controls and alcohol treatment in vitro differentially modulates HDACs expression. Further, HDAC inhibitors (HDACi) blocked alcohol-induction of class I HDACs and modulated alcohol-induced oxidative stress related genes expressed by MDDCs. In silico analysis revealed new target genes and pathways on the mode of action of alcohol and HDACi. Findings elucidating the ability of alcohol to modulate class I HDACs may be useful for the treatment of alcohol-induced oxidative damage and may delineate new potential immune-modulatory mechanisms.	[Agudelo, Marisela; Figueroa, Gloria; Parira, Tiyash; Yndart, Adriana; Munoz, Karla; Atluri, Venkata; Samikkannu, Thangavel; Nair, Madhavan P.] Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Agudelo, Marisela; Yndart, Adriana; Munoz, Karla; Atluri, Venkata; Samikkannu, Thangavel; Nair, Madhavan P.] Florida Int Univ, Inst NeuroImmune Pharmacol, Herbert Wertheim Coll Med, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Agudelo, M (corresponding author), Florida Int Univ, Dept Immunol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.; Agudelo, M (corresponding author), Florida Int Univ, Inst NeuroImmune Pharmacol, Herbert Wertheim Coll Med, Miami, FL 33199 USA.	magudelo@fiu.edu	Atluri, Venkata/G-3277-2014	Atluri, Venkata/0000-0002-8070-6745	National Institute on Alcohol Abuse and Alcoholism [K99/R00 AA021264, R00 AA021264]; National Institute on Drug Abuse [R01DA034547]; Department of Immunology, Institute of Neuroimmune Pharmacology, Herbert Wertheim College of Medicine; FIU- Office of Research and Economic Development; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA021264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034547] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Department of Immunology, Institute of Neuroimmune Pharmacology, Herbert Wertheim College of Medicine; FIU- Office of Research and Economic Development; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research is supported by the National Institute on Alcohol Abuse and Alcoholism, award K99/R00 AA021264 and partially by the National Institute on Drug Abuse, award # R01DA034547. Additional support as part of startup package has been received from the Department of Immunology, Institute of Neuroimmune Pharmacology, Herbert Wertheim College of Medicine, and FIU- Office of Research and Economic Development.; This research is supported by the National Institute on Alcohol Abuse and Alcoholism, award R00 AA021264 and partially by the National Institute on Drug Abuse, award # R01DA034547. Additional support as part of startup package has been received from the Department of Immunology, Institute of Neuroimmune Pharmacology, Herbert Wertheim College of Medicine, and FIU- Office of Research and Economic Development.	Agudelo M, 2013, DRUG ALCOHOL DEPEN, V133, P789, DOI 10.1016/j.drugalcdep.2013.08.023; Agudelo M, 2012, ALCOHOL, V46, P635, DOI 10.1016/j.alcohol.2012.03.005; Agudelo M, 2011, ALCOHOL CLIN EXP RES, V35, P1550, DOI 10.1111/j.1530-0277.2011.01492.x; Aloman C, 2007, GASTROENTEROLOGY, V132, P698, DOI 10.1053/j.gastro.2006.11.016; Aloman C, 2011, ALCOHOL CLIN EXP RES, V35, P776, DOI 10.1111/j.1530-0277.2010.01397.x; [Anonymous], 2010, RETH DRINK ALC YOUR; Lopez-Moreno JA, 2015, ALCOHOL CLIN EXP RES, V39, P1939, DOI 10.1111/acer.12850; Arora DS, 2013, NEUROPSYCHOPHARMACOL, V38, P1674, DOI 10.1038/npp.2013.65; Balasubramanian S, 2009, CANCER LETT, V280, P211, DOI 10.1016/j.canlet.2009.02.013; Chang SL, 2014, INT REV NEUROBIOL, V118, P403, DOI 10.1016/B978-0-12-801284-0.00013-0; Del Boca FK, 2000, ADDICTION, V95, pS347; Dolganiuc A, 2003, ALCOHOL CLIN EXP RES, V27, P1023, DOI 10.1097/01.ALC.0000071745.63433.32; Gray J, 2012, CANCER BIOL THER, V13, P614, DOI 10.4161/cbt.19848; Gray SG, 2006, EPIGENETICS-US, V1, P67, DOI 10.4161/epi.1.2.2678; Greenfield TK, 2014, ALCOHOL RES-CURR REV, V36, P39; Haorah J, 2008, FREE RADICAL BIO MED, V45, P1542, DOI 10.1016/j.freeradbiomed.2008.08.030; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kirpich I, 2013, ALCOHOL CLIN EXP RES, V37, P1920, DOI 10.1111/acer.12172; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Liu XQ, 2011, INT J CLIN EXP MED, V4, P252; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; Nair MPN, 2005, AAPS J, V7, pE572, DOI 10.1208/aapsj070358; Pandey D, 2014, ARTERIOSCL THROM VAS, V34, P1556, DOI 10.1161/ATVBAHA.114.303685; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Rikiishi H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/830260; Romeo J, 2010, P NUTR SOC, V69, P341, DOI 10.1017/S0029665110001904; Saiyed ZM, 2011, NEUROCHEM INT, V58, P656, DOI 10.1016/j.neuint.2011.02.004; Sanchis-Segura C, 2009, NEUROPSYCHOPHARMACOL, V34, P2642, DOI 10.1038/npp.2009.125; Sarkar S, 2013, ALCOHOL CLIN EXP RES, V37, P1082, DOI 10.1111/acer.12077; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sun JY, 2011, CL LYMPH MYELOM LEUK, V11, P152, DOI 10.3816/CLML.2011.n.036; Szabo G, 2004, ALCOHOL CLIN EXP RES, V28, P824, DOI 10.1097/01.ALC.0000127104.80398.9B; Szabo G, 1999, CONSEQUENCES ALCOHOL, P830; Wang R, 2010, NEUROSCI LETT, V483, P137, DOI 10.1016/j.neulet.2010.07.080; Warnault V, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.4; Watson P Marc D, 2009, Commun Integr Biol, V2, P11; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	39	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156421	10.1371/journal.pone.0156421	http://dx.doi.org/10.1371/journal.pone.0156421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249803	Green Published, Green Submitted, gold			2022-12-26	WOS:000377184700043
J	Cruz-Rivera, E; Malaquias, MAE				Cruz-Rivera, Edwin; Malaquias, Manuel Antonio E.			Ecosystem Alterations and Species Range Shifts: An Atlantic-Mediterranean Cephalaspidean Gastropod in an Inland Egyptian Lake	PLOS ONE			English	Article							SYSTEMATIC REVISION; MARINE; QARUN; MOLLUSCA; QUARUN; OCEAN; SALINIZATION; MESOGRAZERS; DIVERSITY; INFERENCE	The eastern Atlantic and Mediterranean marine Cephalaspidea gastropod Haminoea orbignyana was collected from Lake Qarun (Fayoum, Egypt), a landlocked lake that has undergone a shift from freshwater to estuarine conditions in the past 100 years. Species identity was confirmed by both morphological (anatomical dissection and scanning electron microscopy) and molecular methods (COI gene phylogeny). Observations suggested a robust population of H. orbignyana in the lake with a density of ca. 64 individuals/m(2) and ca. 105 egg masses/m(2) during surveys conducted in the summer of 2013. The vast majority of snails and egg masses were found under rocks. Observations of egg masses in the lab showed a gradual change from whitish to yellow-green as the eggs matured and the release of veliger larvae alone after about a week. Although adult cephalaspideans readily consumed filamentous red and green algae, and cyanobacteria, laboratory trials showed that they consumed significantly more of the red alga Ceramium sp., than of the green alga Cladophora glomerata, with consumption of Oscillatoria margaritifera being similar to those on the two algae. When grown on these resources for 16 days, H. orbignyana maintained their mass on the rhodophyte and cyanobacterium, but not in starvation controls. No cephalaspideans grew over the course of this experiment. Lake Qarun has been periodically restocked with Mediterranean fishes and prawns since the 1920s to maintain local fisheries, which represents a possible route of colonization for H. orbignyana. Yet, based on literature records, it seems more likely that invasion of the lake by this gastropod species has occurred only within the last 20 years. As human activities redistribute species through direct and indirect means, the structure of the community of this inland lake has become unpredictable and the long-term effects of these recent introductions are unknown.	[Cruz-Rivera, Edwin] Univ Virgin Isl, Dept Biol Sci, 2 John Brewers Bay, St Thomas, VI 00802 USA; [Malaquias, Manuel Antonio E.] Univ Bergen, Phylogenet Systemat & Evolut Res Grp, Sect Taxon & Evolut, Dept Nat Hist,Univ Museum Bergen, PB 7800, N-5020 Bergen, Norway	University of the Virgin Islands; University of Bergen	Malaquias, MAE (corresponding author), Univ Bergen, Phylogenet Systemat & Evolut Res Grp, Sect Taxon & Evolut, Dept Nat Hist,Univ Museum Bergen, PB 7800, N-5020 Bergen, Norway.	Manuel.Malaquias@uib.no	Malaquias, Manuel/N-2450-2019	Malaquias, Manuel/0000-0002-9668-945X; Cruz-Rivera, Edwin/0000-0002-5376-9863	Faculty Improvement Grant from the American University in Cairo	Faculty Improvement Grant from the American University in Cairo	ECR was supported by a Faculty Improvement Grant from the American University in Cairo. MAEM received no specific funding for this work.	Abd Ellah RG., 2009, EGYPT J FISH MAR SCI, V1, P51; ABDELMALEK SA, 1980, HYDROBIOLOGIA, V75, P201, DOI 10.1007/BF00006483; Abu-Zied RH, 2011, J PALEOLIMNOL, V45, P167, DOI 10.1007/s10933-010-9489-2; Allen RM, 2014, MAR BIOL RES, V10, P515, DOI 10.1080/17451000.2013.831177; Behrens DW, 2008, INDOPACIFIC NUDIBRAN; Birks Hilary H., 2001, Aquatic Ecology, V35, P405, DOI 10.1023/A:1013265310922; Bouchet P, 2015, HAMINOEA ORBIGNYANA; Bower DS, 2012, WILDLIFE RES, V39, P705, DOI 10.1071/WR11214; CARLSON C., 2003, MICRONESICA, V35-36, P272; Cheek CA, 2016, ECOL FRESHW FISH, V25, P340, DOI 10.1111/eff.12214; Crocetta F, 2013, ZOOKEYS, P91, DOI 10.3897/zookeys.277.4362; Cruz-Rivera E, 2006, CORAL REEFS, V25, P617, DOI 10.1007/s00338-006-0134-5; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Eilertsen MH, 2013, ZOOL J LINN SOC-LOND, V167, P389, DOI 10.1111/zoj.12013; El-Shabrawy GM, 2009, MONOGR BIOL, V89, P95; El-Shabrawy GM, 2001, J EGYPTIAN ACAD SOC, V2, P29; EL-ZARKA SALAH EL-DIN, 1963, JOUR CONS, V28, P126; EZZAT AA, 1979, J FISH BIOL, V14, P39, DOI 10.1111/j.1095-8649.1979.tb03493.x; Flower RJ, 2006, J PALEOLIMNOL, V35, P1, DOI 10.1007/s10933-005-6393-2; Fouda M, INFORM SHEET RAMSAR; Gardner EW, 2012, MEM I EGYPT, V18, P1; GIBSON GD, 1995, MAR ECOL PROG SER, V121, P139, DOI 10.3354/meps121139; GIBSON GD, 1989, VELIGER, V32, P409; Gillis PL, 2011, ENVIRON POLLUT, V159, P1702, DOI 10.1016/j.envpol.2011.02.032; Gosliner Terrence M., 2006, Proceedings of the California Academy of Sciences, V57, P1003; Hanson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077457; HART BT, 1991, HYDROBIOLOGIA, V210, P105, DOI 10.1007/BF00014327; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ISHAK MM, 1980, AQUACULTURE, V21, P365, DOI 10.1016/0044-8486(80)90072-1; ISHAK MM, 1982, AQUACULTURE, V27, P251, DOI 10.1016/0044-8486(82)90060-6; James KR, 2003, AUST J BOT, V51, P703, DOI 10.1071/BT02110; Lapointe NWR, 2012, BIOL INVASIONS, V14, P1931, DOI 10.1007/s10530-012-0204-2; Lowe S., 2000, ENCY BIOL INVASIONS; Luque G, 2014, BIOL INVASIONS, V16, P981, DOI 10.1007/s10530-013-0561-5; Macali A, 2013, SCI MAR, V77, P649, DOI 10.3989/scimar.03858.05M; Malaquias MAE, 2006, J MOLLUS STUD, V72, P89, DOI 10.1093/mollus/eyi052; Malaquias MAE, 2004, J MAR BIOL ASSOC UK, V84, P767, DOI 10.1017/S0025315404009890h; Malaquias MAE, 2008, ZOOL J LINN SOC-LOND, V153, P453, DOI 10.1111/j.1096-3642.2008.00369.x; Mansour H. A., 2008, Egyptian Journal of Biology, V10, P54; Marchetti MP, 2001, ECOL APPL, V11, P530, DOI 10.2307/3060907; Mead A, 2011, J NAT HIST, V45, P2463, DOI 10.1080/00222933.2011.595836; MESHAL AH, 1977, J CONSEIL, V37, P137; Miyazono S, 2015, SCI TOTAL ENVIRON, V511, P444, DOI 10.1016/j.scitotenv.2014.12.079; Mollo E, 2008, P NATL ACAD SCI USA, V105, P4582, DOI 10.1073/pnas.0709355105; Naguib M., 1961, Kieler Meeresforschungen, V17, P94; Neves R, 2009, J MOLLUS STUD, V75, P127, DOI 10.1093/mollus/eyp004; Ohnheiser LT, 2013, ZOOL J LINN SOC-LOND, V167, P273, DOI 10.1111/zoj.12000; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; POINER A, 1989, TETRAHEDRON, V45, P617; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; Rambaut A., 2007, TRACER V1 4; Rogers CN, 1998, MAR ECOL PROG SER, V166, P301, DOI 10.3354/meps166301; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSE K D, 1972, Nautilus, V85, P141; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Schaefer K, 1996, OPHELIA, V45, P17, DOI 10.1080/00785326.1996.10432460; Smith EA., 1908, J MOLLUS STUD, V8, P9; Soliman G.F., 1989, B I OCEANOGR FISH AR, V15, P93; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Too CC, 2014, ZOOTAXA, V3794, P355, DOI 10.11646/zootaxa.3794.3.3; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wahed MSMA, 2015, AQUAT GEOCHEM, V21, P31, DOI 10.1007/s10498-015-9253-3; Zabbey N, 2013, J MAR BIOL ASSOC UK, V93, P249, DOI 10.1017/S0025315411001615; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	66	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156760	10.1371/journal.pone.0156760	http://dx.doi.org/10.1371/journal.pone.0156760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248835	Green Published, gold, Green Submitted			2022-12-26	WOS:000377184700077
J	Batistel, F; Osorio, JS; Ferrari, A; Trevisi, E; Socha, MT; Loor, JJ				Batistel, Fernanda; Osorio, Johan S.; Ferrari, Annarita; Trevisi, Erminio; Socha, Michael T.; Loor, Juan J.			Immunometabolic Status during the Peripartum Period Is Enhanced with Supplemental Zn, Mn, and Cu from Amino Acid Complexes and Co from Co Glucoheptonate	PLOS ONE			English	Article							ORGANIC TRACE MINERALS; TRANSITION DAIRY-COWS; OXIDATIVE STRESS; LIVER-FUNCTION; ANTIINFLAMMATORY RESPONSE; REPRODUCTIVE-PERFORMANCE; INFLAMMATORY CONDITIONS; IMMUNE-RESPONSE; SMARTAMINE M; METABOLISM	The peripartum (or transition) period is the most-critical phase in the productive life of lactating dairy cows and optimal supply of trace minerals through more bioavailable forms could minimize the negative effects associated with this phase. Twenty Holstein cows received a common prepartal diet and postpartal diet. Both diets were partially supplemented with an inorganic (INO) mix of Zn, Mn, and Cu to supply 35, 45, and 6 ppm, respectively, of the diet dry matter (DM). Cows were assigned to treatments in a randomized completed block design, receiving an daily oral bolus with INO or organic trace minerals (AAC) Zn, Mn, Cu, and Co to achieve 75, 65, 11, and 1 ppm supplemental, respectively, in the diet DM. Liver tissue and blood samples were collected throughout the experiment. The lower glutamic-oxaloacetic transaminase concentration after 15 days in milk in AAC cows indicate lower hepatic cell damage. The concentration of cholesterol and albumin increased, while IL-6 decreased over time in AAC cows compared with INO indicating a lower degree of inflammation and better liver function. Although the acute-phase protein ceruloplasmin tended to be lower in AAC cows and corresponded with the reduction in the inflammatory status, the tendency for greater serum amyloid A concentration in AAC indicated an inconsistent response on acute-phase proteins. Oxygen radical absorbance capacity increased over time in AAC cows. Furthermore, the concentrations of nitric oxide, nitrite, nitrate, and the ferric reducing ability of plasma decreased with AAC indicating a lower oxidative stress status. The expression of IL10 and ALB in liver tissue was greater overall in AAC cows reinforcing the anti-inflammatory response detected in plasma. The greater overall expression of PCK1 in AAC cows indicated a greater gluconeogenic capacity, and partly explained the greater milk production response over time. Overall, feeding organic trace minerals as complexed with amino acids during the transition period improved liver function and decreased inflammation and oxidative stress.	[Batistel, Fernanda; Osorio, Johan S.; Loor, Juan J.] Univ Illinois, Dept Anim Sci, 1207 West Gregory Dr, Urbana, IL 61801 USA; [Batistel, Fernanda; Osorio, Johan S.; Loor, Juan J.] Univ Illinois, Div Nutr Sci, 1207 West Gregory Dr, Urbana, IL 61801 USA; [Ferrari, Annarita; Trevisi, Erminio] Univ Cattolica Sacro Cuore, Ist Zootecn Fac Sci Agr Alimentari & Ambientali, I-29122 Piacenza, Italy; [Socha, Michael T.] Zinpro Corp, Eden Prairie, MN 55344 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Catholic University of the Sacred Heart; Zinpro Corporation	Loor, JJ (corresponding author), Univ Illinois, Dept Anim Sci, 1207 West Gregory Dr, Urbana, IL 61801 USA.; Loor, JJ (corresponding author), Univ Illinois, Div Nutr Sci, 1207 West Gregory Dr, Urbana, IL 61801 USA.	jloor@illinois.edu	Loor, Juan J./H-3760-2012; Batistel, Fernanda/AAD-3867-2019; Osorio, Johan/J-3703-2019; Ferrari, Anna Rita/AAB-9899-2019	Loor, Juan J./0000-0003-1586-4365; Osorio, Johan/0000-0001-6192-0917; Ferrari, Anna Rita/0000-0002-5397-6184; Batistel, Fernanda/0000-0001-7313-7153	National Institute of Food and Agriculture [ILLU-538-914]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Zinpro Corporation	National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Zinpro Corporation	Juan Loor (JL) was supported by National Institute of Food and Agriculture (Grant: ILLU-538-914). Fernanda Batistel (FB) was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Zinpro Corporation provided support to JL and Michael Socha (MS). Zinpro Corporation had a role in the study design and provided financial support to cover costs of animal use, data collection, and sample analyses. The specific roles of the authors are articulated in the 'author contributions' section.	ALDRED AR, 1993, ACUTE PHASE PROTEINS, P21; Allard JP, 1998, AM J CLIN NUTR, V67, P143, DOI 10.1093/ajcn/67.1.143; Aschenbach JR, 2010, IUBMB LIFE, V62, P869, DOI 10.1002/iub.400; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bertoni G, 2008, J DAIRY SCI, V91, P3300, DOI 10.3168/jds.2008-0995; Bertoni G, 2015, ANIM PROD SCI, V55, P943, DOI 10.1071/AN14863; Bertoni G., 1993, 8 INT S TRAC EL MAN, P662; Bertoni G, 2013, VET CLIN N AM-FOOD A, V29, P413, DOI 10.1016/j.cvfa.2013.04.004; Bionaz M, 2007, J DAIRY SCI, V90, P1740, DOI 10.3168/jds.2006-445; BROWN DH, 1980, J MED CHEM, V23, P729, DOI 10.1021/jm00181a006; CAO GH, 1993, FREE RADICAL BIO MED, V14, P303, DOI 10.1016/0891-5849(93)90027-R; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Celi P, 2011, OXID STRESS APPL BAS, P191, DOI 10.1007/978-1-61779-071-3_13; Copple BL, 2010, SEMIN LIVER DIS, V30, P195, DOI 10.1055/s-0030-1253228; Credille BC, 2014, J VET INTERN MED, V28, P1606, DOI 10.1111/jvim.12418; Doepel L, 2009, J DAIRY SCI, V92, P3233, DOI 10.3168/jds.2008-1595; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Eldaim MAA, 2010, J DAIRY RES, V77, P27, DOI 10.1017/S0022029909990276; Elsasser TH, 2000, BIOLOGY OF ANIMAL STRESS, P77, DOI 10.1079/9780851993591.0077; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Goff JP, 2002, J DAIRY SCI, V85, P1427, DOI 10.3168/jds.S0022-0302(02)74210-0; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Henning SM, 1997, FREE RADICAL BIO MED, V23, P936, DOI 10.1016/S0891-5849(97)00097-X; Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028; Huzzey JM, 2015, PREV VET MED, V120, P291, DOI 10.1016/j.prevetmed.2015.04.011; Ingvartsen KL, 2000, J DAIRY SCI, V83, P1573, DOI 10.3168/jds.S0022-0302(00)75029-6; Jacometo CB, 2015, J DAIRY SCI, V98, P7717, DOI 10.3168/jds.2015-9359; Jahan N, 2015, VET IMMUNOL IMMUNOP, V165, P119, DOI 10.1016/j.vetimm.2015.04.003; Jansen T., 2012, FRONT PHARMACOL, V16, P3016; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Lee SH, 2013, ENDOCRINOLOGY, V154, P1029, DOI 10.1210/en.2012-1445; Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005; Martinov MV, 2010, BBA-PROTEINS PROTEOM, V1804, P89, DOI 10.1016/j.bbapap.2009.10.004; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363; Mohommad MK, 2012, NUTR CLIN PRACT, V27, P8, DOI 10.1177/0884533611433534; NRC, 2001, NUTR REQ DAIR CATTL, V7th; Osorio JS, 2016, J DAIRY SCI, V99, P1868, DOI 10.3168/jds.2015-10040; Osorio JS, 2014, J DAIRY SCI, V97, P7437, DOI 10.3168/jds.2013-7679; Osorio JS, 2014, J DAIRY SCI, V97, P7451, DOI 10.3168/jds.2014-8680; Prasad AS, 2014, J TRACE ELEM MED BIO, V28, P364, DOI 10.1016/j.jtemb.2014.07.019; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Rabiee AR, 2010, J DAIRY SCI, V93, P4239, DOI 10.3168/jds.2010-3058; REYNOLDS CK, 1988, J DAIRY SCI, V71, P1803, DOI 10.3168/jds.S0022-0302(88)79749-0; Rink L, 2000, J NUTR, V130, p1407S, DOI 10.1093/jn/130.5.1407S; Satre MA, 2001, FEBS LETT, V491, P266, DOI 10.1016/S0014-5793(01)02211-6; Schweigert FJ, 2001, CURR OPIN CLIN NUTR, V4, P477, DOI 10.1097/00075197-200111000-00002; Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI 10.1007/s10787-007-0013-x; SKINNER JG, 1991, VET REC, V128, P147, DOI 10.1136/vr.128.7.147; SOBOCINSKI PZ, 1982, ANN NY ACAD SCI, V389, P354, DOI 10.1111/j.1749-6632.1982.tb22149.x; Sordillo LM, 2014, ANIM PROD SCI, V54, P1204, DOI 10.1071/AN14503; Sordillo LM, 2009, VET IMMUNOL IMMUNOP, V128, P104, DOI 10.1016/j.vetimm.2008.10.305; Spears JW, 2008, VET J, V176, P70, DOI 10.1016/j.tvjl.2007.12.015; Spears JW, 2003, J NUTR, V133, p1506S, DOI 10.1093/jn/133.5.1506S; SUNDERMAN FW, 1970, CLIN CHEM, V16, P903; Swecker WS, 2014, VET CLIN N AM-FOOD A, V30, P671, DOI 10.1016/j.cvfa.2014.07.008; Trevisan M, 2001, AM J EPIDEMIOL, V154, P348, DOI 10.1093/aje/154.4.348; Trevisi E, 2013, J DAIRY SCI, V96, P5712, DOI 10.3168/jds.2012-6375; Trevisi E., 2010, Energy and protein metabolism and nutrition. 3rd EAAP International Symposium on Energy and Protein Metabolism and Nutrition, Parma, Italy, 6-10 September, 2010, P489; Trevisi E, 2012, RES VET SCI, V93, P695, DOI 10.1016/j.rvsc.2011.11.008; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Van Merris V, 2004, J DAIRY SCI, V87, P980, DOI 10.3168/jds.S0022-0302(04)73243-9; Wang RL, 2013, BIOL TRACE ELEM RES, V152, P16, DOI 10.1007/s12011-012-9585-4; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	65	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155804	10.1371/journal.pone.0155804	http://dx.doi.org/10.1371/journal.pone.0155804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243218	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100007
J	Fischer, S; Hirche, C; Diehm, Y; Nuutila, K; Kiefer, J; Gazyakan, E; Bueno, EM; Kremer, T; Kneser, U; Pomahac, B				Fischer, Sebastian; Hirche, Christoph; Diehm, Yannick; Nuutila, Kristo; Kiefer, Jurij; Gazyakan, Emre; Bueno, Ericka M.; Kremer, Thomas; Kneser, Ulrich; Pomahac, Bohdan			Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue	PLOS ONE			English	Article							LONG-TERM; BREAST RECONSTRUCTION; IN-VIVO; AUGMENTATION; SATISFACTION; ZAFIRLUKAST; OUTCOMES	Background The fibrotic capsule that surrounds silicone implants consists mainly of collagen. The FDA-approved collagenase of the bacterium clostridium histolyticum provides a reasonable treatment option. Safety and efficacy at the female breast site must be evaluated before clinical utilization. Materials and Methods We incubated 20 samples of fibrotic capsule as well as 12 full thickness skin grafts harvested from the female breast site for 24 hours with different doses of collagenase. Outcome measures involved histological assessment of thickness and density of the capsule tissue as well as the skin grafts. Furthermore, we performed a collagen assay and immunohistochemistry staining for collagen subtypes. Results Collagenase treatment was able to degrade human capsule contracture tissue ex-vivo. The remaining collagen subtype after degradation was type 4 only. 0.3 mg/ml of collagenase was most effective in reducing capsule thickness when compared with higher concentrations. Of note, effectiveness was inversely related to capsule density, such that there was less reduction in thickness with higher capsule densities and vice versa. Furthermore, the application of 0.3 mg/ml collagenase did not lead to thinning or perforation of full thickness skin grafts. Conclusion Adjustment of collagenase dose will depend on thickness and density of the contracted capsule. A concentration of 0.3 mg/ml seems to be safe and effective in an ex-vivo setting. The remaining collagen subtype 4 is suitable to serve as a neo-capsule/acellular tissue matrix. Collagenase treatment for capsular contracture may soon become a clinical reality.	[Fischer, Sebastian; Diehm, Yannick; Nuutila, Kristo; Bueno, Ericka M.; Pomahac, Bohdan] Harvard Univ, Sch Med, Dept Surg, Div Plast Surg,Brigham & Womens Hosp, Boston, MA 02115 USA; [Fischer, Sebastian; Hirche, Christoph; Diehm, Yannick; Kiefer, Jurij; Gazyakan, Emre; Kremer, Thomas; Kneser, Ulrich] Heidelberg Univ, BG Trauma Ctr Ludwigshafen, Dept Hand Plast & Reconstruct Surg, Burn Trauma Ctr, Ludwigshafen, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Ruprecht Karls University Heidelberg	Fischer, S (corresponding author), Harvard Univ, Sch Med, Dept Surg, Div Plast Surg,Brigham & Womens Hosp, Boston, MA 02115 USA.; Fischer, S (corresponding author), Heidelberg Univ, BG Trauma Ctr Ludwigshafen, Dept Hand Plast & Reconstruct Surg, Burn Trauma Ctr, Ludwigshafen, Germany.	sfischer4@partners.org	Pomahac, Bohdan/AAH-1792-2019	Pomahac, Bohdan/0000-0003-3703-8240; , Sebastian/0000-0003-3445-1902				Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Araco A, 2009, PLAST RECONSTR SURG, V124, P1808, DOI 10.1097/PRS.0b013e3181bf7f26; Cordeiro PG, 2014, PLAST RECONSTR SURG, V134, P588, DOI 10.1097/PRS.0000000000000523; Fischer S, 2015, PLAST RECONSTR SURG, V136, P981, DOI 10.1097/PRS.0000000000001698; Godin B, 2007, ADV DRUG DELIVER REV, V59, P1152, DOI 10.1016/j.addr.2007.07.004; Gryskiewicz Joe M, 2003, Aesthet Surg J, V23, P98, DOI 10.1067/maj.2003.19; Handel N, 2006, PLAST RECONSTR SURG, V117, P757, DOI 10.1097/01.prs.0000201457.00772.1d; Holmich LR, 2007, ANN PLAS SURG, V59, P597, DOI 10.1097/SAP.0b0l3e3I803c7c78; Holzer LA, 2009, NEW ENGL J MED, V361, P2579; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; LEMPERLE G, 1980, ACTA CHIR BELG, V79, P159; LEMPERLE G, 1993, AESTHET PLAST SURG, V17, P317, DOI 10.1007/BF00437105; Levine LA, 2015, J SEX MED, V12, P248, DOI 10.1111/jsm.12731; Marques M, 2010, PLAST RECONSTR SURG, V126, P769, DOI 10.1097/PRS.0b013e3181e5f7bf; Mazzocchi M, 2012, INT J IMMUNOPATH PH, V25, P935, DOI 10.1177/039463201202500411; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; Peimer CA, 2015, J HAND SURG-AM, V40, P1597, DOI 10.1016/j.jhsa.2015.04.036; Reid Russell R, 2005, Aesthet Surg J, V25, P26, DOI 10.1016/j.asj.2004.12.003; Rohrich RJ, 1999, PLAST RECONSTR SURG, V103, P1759, DOI 10.1097/00006534-199905060-00033; Scuderi N, 2007, INT J IMMUNOPATH PH, V20, P577, DOI 10.1177/039463200702000315; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; SPEAR SL, 1991, PLAST RECONSTR SURG, V87, P483, DOI 10.1097/00006534-199103000-00015; Syed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031430; Tamboto H, 2010, PLAST RECONSTR SURG, V126, P835, DOI 10.1097/PRS.0b013e3181e3b456; van Ravenzwaay B, 2004, HUM EXP TOXICOL, V23, P421, DOI 10.1191/0960327104ht471oa; Wick G, 2010, TRENDS IMMUNOL, V31, P110, DOI 10.1016/j.it.2009.12.001; Young VL, 1998, PLAST RECONSTR SURG, V102, P884, DOI 10.1097/00006534-199809030-00043	27	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156428	10.1371/journal.pone.0156428	http://dx.doi.org/10.1371/journal.pone.0156428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232716	Green Published, gold, Green Submitted			2022-12-26	WOS:000376883000033
J	Yu, ZW; Liu, JM; Wang, XW; Zhu, XJ; Wang, DX; Han, GQ				Yu, Zhiwen; Liu, Jiming; Wang, Xiaowei; Zhu, Xianjun; Wang, Daxing; Han, Guoqiang			Efficient Vaccine Distribution Based on a Hybrid Compartmental Model	PLOS ONE			English	Article							SARS; TRANSMISSION; COMPUTATION; STRATEGIES; CHOLERA; HAITI	To effectively and efficiently reduce the morbidity and mortality that may be caused by outbreaks of emerging infectious diseases, it is very important for public health agencies to make informed decisions for controlling the spread of the disease. Such decisions must incorporate various kinds of intervention strategies, such as vaccinations, school closures and border restrictions. Recently, researchers have paid increased attention to searching for effective vaccine distribution strategies for reducing the effects of pandemic outbreaks when resources are limited. Most of the existing research work has been focused on how to design an effective age-structured epidemic model and to select a suitable vaccine distribution strategy to prevent the propagation of an infectious virus. Models that evaluate age structure effects are common, but models that additionally evaluate geographical effects are less common. In this paper, we propose a new SEIR (susceptible-exposed-infectious sC recovered) model, named the hybrid SEIR-V model (HSEIR-V), which considers not only the dynamics of infection prevalence in several age-specific host populations, but also seeks to characterize the dynamics by which a virus spreads in various geographic districts. Several vaccination strategies such as different kinds of vaccine coverage, different vaccine releasing times and different vaccine deployment methods are incorporated into the HSEIR-V compartmental model. We also design four hybrid vaccination distribution strategies (based on population size, contact pattern matrix, infection rate and infectious risk) for controlling the spread of viral infections. Based on data from the 2009-2010 H1N1 influenza epidemic, we evaluate the effectiveness of our proposed HSEIR-V model and study the effects of different types of human behaviour in responding to epidemics.	[Yu, Zhiwen; Wang, Xiaowei; Zhu, Xianjun; Wang, Daxing; Han, Guoqiang] S China Univ Technol, Sch Engn & Comp Sci, Guangzhou 510641, Guangdong, Peoples R China; [Liu, Jiming] Hong Kong Baptist Univ, Dept Comp, Kowloon Tong, Hong Kong, Peoples R China	South China University of Technology; Hong Kong Baptist University	Yu, ZW (corresponding author), S China Univ Technol, Sch Engn & Comp Sci, Guangzhou 510641, Guangdong, Peoples R China.; Liu, JM (corresponding author), Hong Kong Baptist Univ, Dept Comp, Kowloon Tong, Hong Kong, Peoples R China.	zhwyu@scut.edu.cn; jiming@comp.hkbu.edu.hk			Hong Kong Research Grants Council [HKBU211212, HKBU12202415]; NSFC [61332002, 61300044, 61472145, 61572199, 61502173]; Guangdong Natural Science Funds for Distinguished Young Scholars [S2013050014677]; Fundamental Research Funds for the Central Universities [2014G0007, 2015PT016]; Guangdong Key Laboratory of Popular High Performance Computers [SZU-GDPHPCL2015]; Science and Technology Planning Project of Guangdong Province, China [2015A050502011, 2013B090500015, 2016A050503015]; Key Enterprises and Innovation Organizations in Nanshan District in Shenzhen [KC2013ZDZJ0007A]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); NSFC(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds for Distinguished Young Scholars; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Guangdong Key Laboratory of Popular High Performance Computers; Science and Technology Planning Project of Guangdong Province, China; Key Enterprises and Innovation Organizations in Nanshan District in Shenzhen	The authors thank the staff of the Centre for Health Protection (CHP) of the Department of Health in Hong Kong for their sharing of the 2009 H1N1 prevalence data, and they thank Xia Shang for all of his earlier inputs. The authors would like to thank the handling editor and the anonymous reviewers for their constructive comments. They would like to acknowledge the funding support from Hong Kong Research Grants Council (HKBU211212 & HKBU12202415). The authors are grateful for the constructive advice received from the anonymous reviewers of this paper. The work described in this paper was partially funded by the grants from the NSFC No. 61332002, No. 61300044, No. 61472145, No. 61572199, and No. 61502173, the grant from the Guangdong Natural Science Funds for Distinguished Young Scholars (No. S2013050014677), the Fundamental Research Funds for the Central Universities (No. 2014G0007 and 2015PT016), the grant from Guangdong Key Laboratory of Popular High Performance Computers (No. SZU-GDPHPCL2015), the grant from Science and Technology Planning Project of Guangdong Province, China (No. 2015A050502011, No. 2013B090500015, No. 2016A050503015), the grant from Key Enterprises and Innovation Organizations in Nanshan District in Shenzhen (Project No. KC2013ZDZJ0007A).	ANDERSON R M, 1991; Andrews JR, 2011, LANCET, V377, P1248, DOI 10.1016/S0140-6736(11)60273-0; Araz OM, 2012, HEALTH CARE MANAG SC, V15, P175, DOI 10.1007/s10729-012-9199-6; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Chen JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118521; Cowling BJ, 2010, EPIDEMIOLOGY, V21, P842, DOI 10.1097/EDE.0b013e3181f20977; Cruz-Aponte M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-207; Daley D. J., 2001, EPIDEMIC MODELLING I; Date KA, 2011, EMERG INFECT DIS, V17, P2105, DOI 10.3201/eid1711.110822; de Blasio BF, 2012, PLOS ONE, V7, P327, DOI 10.1371/journal.pone.0030018; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dimitrov NB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016094; Drazen JM, 2003, NEW ENGL J MED, V349, P319, DOI 10.1056/NEJMp038118; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ghosh S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014307; Grijalva CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118457; Hancock PA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003809; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hollingsworth TD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001076; Hsieh YH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-106; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297; Kelso JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013797; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628; Lee S, 2012, B MATH BIOL, V74, P958, DOI 10.1007/s11538-011-9704-y; Lee VJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-76; Li P, 2015, BRIEF FUNCT GENOMICS, V14, P143, DOI 10.1093/bfgp/elu036; Liu JM, 2011, J MED SYST, V35, P1153, DOI 10.1007/s10916-011-9734-x; Mandavilli A, 2003, NAT MED, V9, P487, DOI 10.1038/nm0503-487; Matrajt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013767; Mbah MLN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024577; Medlock Jan, 2009, PLoS Curr, V1, pRRN1134; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Milne G, 2010, J R SOC INTERFACE, V7, P573, DOI 10.1098/rsif.2009.0312; Moss R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014505; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Oles K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063813; Oles K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036026; Oshitani H, 2008, EMERG INFECT DIS, V14, P875, DOI 10.3201/eid1406.070839; Piccardi C, 1998, IEEE T BIO-MED ENG, V45, P591, DOI 10.1109/10.668749; Poletto C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00476; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Rinaldo A, 2012, P NATL ACAD SCI USA, V109, P6602, DOI 10.1073/pnas.1203333109; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; Shim E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S4; Tang SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010911; Tuite AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010520; US Government Accountability Office, 2005, INFL VACC SHORT 2004; Valdano E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004152; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Wang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119923; Xia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065271; You JHS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033123; Yu ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118085; Yuan EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115826; Zamiri A, 2015, IEEE J BIOMED HEALTH, V19, P735, DOI 10.1109/JBHI.2014.2338213; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zhang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032203; Zhou XC, 2013, IEEE T BIO-MED ENG, V60, P446, DOI 10.1109/TBME.2012.2228264; Zhou XC, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2132132; Zhou Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027169; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024	64	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155416	10.1371/journal.pone.0155416	http://dx.doi.org/10.1371/journal.pone.0155416			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27233015	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000003
J	Zhang, RH; Chang, M; Zhang, M; Wu, YJ; Qu, XL; Huang, SJ				Zhang, Ruihui; Chang, Ming; Zhang, Meng; Wu, Youjun; Qu, Xiaolu; Huang, Shanjin			The Structurally Plastic CH2 Domain Is Linked to Distinct Functions of Fimbrins/Plastins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; Arabidopsis; Arp2; 3 complex; cytoskeleton; microfilaments; plant	POLLEN-TUBE GROWTH; ACTIN-BINDING-PROTEINS; CALPONIN HOMOLOGY DOMAINS; ALPHA-ACTININ; F-ACTIN; ARP2/3 COMPLEX; MUSCULAR-DYSTROPHY; MISSENSE MUTATIONS; FISSION YEAST; HUMAN FIMBRIN	Fimbrins/plastins have been implicated in the generation of distinct actin structures, which are linked to different cellular processes. Historically, fimbrins/plastins were mainly considered as generating tight actin bundles. Here, we demonstrate that different members of the fimbrin/plastin family have diverged biochemically during evolution to generate either tight actin bundles or loose networks with distinct biochemical and biophysical properties. Using the phylogenetically and functionally distinct Arabidopsis fimbrins FIM4 and FIM5 we found that FIM4 generates both actin bundles and cross-linked actin filaments, whereas FIM5 only generates actin bundles. The distinct functions of FIM4 and FIM5 are clearly observed at single-filament resolution. Domain swapping experiments showed that cooperation between the conformationally plastic calponin-homology domain 2 (CH2) and the N-terminal headpiece determines the function of the full-length protein. Our study suggests that the structural plasticity of fimbrins/plastins has biologically meaningful consequences, and provides novel insights into the structure-function relationship of fimbrins/plastins as well as shedding light on how cells generate distinct actin structures.	[Zhang, Ruihui; Zhang, Meng; Wu, Youjun; Huang, Shanjin] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China; [Chang, Ming; Qu, Xiaolu; Huang, Shanjin] Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Beijing 100084, Peoples R China; [Qu, Xiaolu] Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Zhang, Ruihui; Zhang, Meng] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wu, Youjun] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Tsinghua University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Dartmouth College	Huang, SJ (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing 100093, Peoples R China.; Huang, SJ (corresponding author), Tsinghua Univ, Sch Life Sci, Ctr Plant Biol, Beijing 100084, Peoples R China.	sjhuang@tsinghua.edu.cn	Huang, Shanjin/M-4112-2017	Huang, Shanjin/0000-0001-9517-2515; zhang, ruihui/0000-0003-1010-7242	Ministry of Science and Technology of China [2013CB945100]; National Natural Science Foundation of China [31125004]; Tsinghua-Peking Joint Center for Life Sciences; China Postdoctoral Science Foundation [2015M571028]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Joint Center for Life Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported in part by Ministry of Science and Technology of China Grant 2013CB945100 and National Natural Science Foundation of China Grant 31125004. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by post-doctorate fellowships from Tsinghua-Peking Joint Center for Life Sciences and China Postdoctoral Science Foundation Grant 2015M571028.	ADAMS AEM, 1995, MOL CELL BIOL, V15, P69, DOI 10.1128/MCB.15.1.69; Amann KJ, 2001, NAT CELL BIOL, V3, P306, DOI 10.1038/35060104; Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Bao CC, 2012, PLANT J, V71, P962, DOI 10.1111/j.1365-313X.2012.05044.x; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Blanchoin L, 2001, CURR BIOL, V11, P1300, DOI 10.1016/S0960-9822(01)00395-5; BRETSCHER A, 1980, J CELL BIOL, V86, P335, DOI 10.1083/jcb.86.1.335; Chang M, 2015, PLANT J, V83, P515, DOI 10.1111/tpj.12910; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Clement M, 2009, PLANT CELL, V21, P2963, DOI 10.1105/tpc.109.069104; Courson DS, 2010, J BIOL CHEM, V285, P26350, DOI 10.1074/jbc.M110.123117; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galkin VE, 2003, J MOL BIOL, V331, P967, DOI 10.1016/S0022-2836(03)00842-8; Galkin VE, 2002, J CELL BIOL, V157, P243, DOI 10.1083/jcb.200111097; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Galkin VE, 2006, J MOL BIOL, V359, P478, DOI 10.1016/j.jmb.2006.03.044; GLENNEY JR, 1981, J BIOL CHEM, V256, P9283; Henderson DM, 2010, P NATL ACAD SCI USA, V107, P9632, DOI 10.1073/pnas.1001517107; Hofer D, 1997, J CELL SCI, V110, P765; Hoffmann C, 2014, J CELL SCI, V127, P583, DOI 10.1242/jcs.134536; Huang S, 2005, PLANT CELL, V17, P486, DOI 10.1105/tpc.104.028555; Huang SJ, 2015, J INTEGR PLANT BIOL, V57, P40, DOI 10.1111/jipb.12293; Huang SJ, 2003, J BIOL CHEM, V278, P44832, DOI 10.1074/jbc.M306670200; Hussey PJ, 2002, PHILOS T R SOC B, V357, P791, DOI 10.1098/rstb.2002.1086; Jorde S, 2011, MICROBIOL RES, V166, P137, DOI 10.1016/j.micres.2010.09.003; Ketelaar T, 2002, PLANT CELL, V14, P2941, DOI 10.1105/tpc.005892; Klein MG, 2004, STRUCTURE, V12, P999, DOI 10.1016/j.str.2004.04.010; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Kovar DR, 2000, PLANT J, V24, P625, DOI 10.1046/j.1365-313x.2000.00907.x; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Lee JY, 2005, PLANT CELL, V17, P2817, DOI 10.1105/tpc.105.034330; LIN CS, 1994, MOL CELL BIOL, V14, P2457, DOI 10.1128/MCB.14.4.2457; Liu J, 2004, J MOL BIOL, V338, P115, DOI 10.1016/j.jmb.2004.02.034; Liu XN, 2015, MOL PLANT, V8, P1694, DOI 10.1016/j.molp.2015.09.013; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; MATSUDAIRA P, 1994, J CELL BIOL, V126, P285, DOI 10.1083/jcb.126.2.285; Matsudaira Paul, 1994, Seminars in Cell Biology, V5, P165, DOI 10.1006/scel.1994.1021; Michelot A, 2011, CURR BIOL, V21, pR560, DOI 10.1016/j.cub.2011.06.019; MOOSEKER MS, 1983, CELL, V35, P11, DOI 10.1016/0092-8674(83)90202-7; Morley SC, 2013, IMMUNOL REV, V256, P48, DOI 10.1111/imr.12102; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2001, J CELL SCI, V114, P3; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Prassler J, 1997, MOL BIOL CELL, V8, P83, DOI 10.1091/mbc.8.1.83; PREVOST MC, 1992, INFECT IMMUN, V60, P4088; Qu XL, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00786; Qu XL, 2013, PLANT CELL, V25, P1803, DOI 10.1105/tpc.113.110940; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Schmidt SM, 2007, PHYSIOL MOL PLANT P, V71, P135, DOI 10.1016/j.pmpp.2008.01.001; Shi M, 2013, PLANT J, V73, P747, DOI 10.1111/tpj.12065; Singh SM, 2010, P NATL ACAD SCI USA, V107, P15069, DOI 10.1073/pnas.1008818107; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Skau CT, 2011, J BIOL CHEM, V286, P26964, DOI 10.1074/jbc.M111.239004; Staiger CJ, 2004, ANNU PLANT REV, V10, P32; STOSSEL TP, 1985, ANNU REV CELL BIOL, V1, P353, DOI 10.1146/annurev.cb.01.110185.002033; Su H, 2012, PLANT CELL, V24, P4539, DOI 10.1105/tpc.112.099358; THIMANN KV, 1992, PROTOPLASMA, V171, P153, DOI 10.1007/BF01403730; Thomas C, 2009, CELL MOTIL CYTOSKEL, V66, P940, DOI 10.1002/cm.20389; TWELL D, 1989, PLANT PHYSIOL, V91, P1270, DOI 10.1104/pp.91.4.1270; Waller F, 2002, PROTOPLASMA, V219, P72, DOI 10.1007/s007090200007; Wang C, 2010, J IMMUNOL, V185, P7487, DOI 10.4049/jimmunol.1001424; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; Wear MA, 2000, CURR BIOL, V10, pR891, DOI 10.1016/S0960-9822(00)00845-9; Wu JQ, 2001, MOL BIOL CELL, V12, P1061, DOI 10.1091/mbc.12.4.1061; Wu YJ, 2010, PLANT CELL, V22, P3745, DOI 10.1105/tpc.110.080283; Yamakita Y, 2003, J BIOL CHEM, V278, P17937, DOI 10.1074/jbc.M208739200; Yang CS, 2011, CELL ADHES MIGR, V5, P402, DOI 10.4161/cam.5.5.16971; Young P, 2000, EMBO J, V19, P6331, DOI 10.1093/emboj/19.23.6331; Zhang H, 2010, PLANT CELL, V22, P2749, DOI 10.1105/tpc.110.076257; Zhang M, 2016, J EXP BOT, V67, P3407, DOI 10.1093/jxb/erw160; Zheng YY, 2013, PLANT CELL, V25, P3405, DOI 10.1105/tpc.113.117820	73	13	13	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17881	17896		10.1074/jbc.M116.730069	http://dx.doi.org/10.1074/jbc.M116.730069			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27261463	Green Published, hybrid			2022-12-26	WOS:000383241300032
J	Volz, P; Krause, N; Balke, J; Schneider, C; Walter, M; Schneider, F; Schlesinger, R; Alexiev, U				Volz, Pierre; Krause, Nils; Balke, Jens; Schneider, Constantin; Walter, Maria; Schneider, Franziska; Schlesinger, Ramona; Alexiev, Ulrike			Light and pH-induced Changes in Structure and Accessibility of Transmembrane Helix B and Its Immediate Environment in Channelrhodopsin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence; fluorescence anisotropy; membrane protein; optogenetics; protein conformation; channelrhodopsin; fluorescence quenching	TIME-RESOLVED DETECTION; COBRA ALPHA-TOXIN; SURFACE-CHARGE; FLUORESCENCE SPECTROSCOPY; ACETYLCHOLINE-RECEPTOR; CYTOPLASMIC SURFACE; TRANSIENT MOVEMENT; SENSORY RHODOPSIN; GPCR RHODOPSIN; BACTERIORHODOPSIN	A variant of the cation channel channelrhodopsin-2 from Chlamydomonas reinhardtii (CrChR2) was selectively labeled at position Cys-79 at the end of the first cytoplasmic loop and the beginning of transmembrane helix B with the fluorescent dye fluorescein (acetamidofluorescein). We utilized (i) time-resolved fluorescence anisotropy experiments to monitor the structural dynamics at the cytoplasmic surface close to the inner gate in the dark and after illumination in the open channel state and (ii) time-resolved fluorescence quenching experiments to observe the solvent accessibility of helix B at pH 6.0 and 7.4. The light-induced increase in final anisotropy for acetamidofluorescein bound to the channel variant with a prolonged conducting state clearly shows that the formation of the open channel state is associated with a large conformational change at the cytoplasmic surface, consistent with an outward tilt of helix B. Furthermore, results from solute accessibility studies of the cytoplasmic end of helix B suggest a pH-dependent structural heterogeneity that appears below pH 7. At pH 7.4 conformational homogeneity was observed, whereas at pH 6.0 two protein fractions exist, including one in which residue 79 is buried. This inaccessible fraction amounts to 66% in nanodiscs and 82% in micelles. Knowledge about pH-dependent structural heterogeneity may be important for CrChR2 applications in optogenetics.	[Volz, Pierre; Krause, Nils; Balke, Jens; Schneider, Constantin; Walter, Maria; Schlesinger, Ramona; Alexiev, Ulrike] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany; [Schneider, Franziska] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Schneider, Franziska] Univ Freiburg, Univ Herzzentrum Freiburg Bad Krozingen, Elsasser Str 2q, D-79110 Freiburg, Germany; [Schneider, Franziska] Univ Freiburg, Fak Med, Elsasser Str 2q, D-79110 Freiburg, Germany; [Alexiev, Ulrike] Free Univ Berlin, Dept Phys, Arnimallee 14, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Universitats Herzzentrum Freiburg; University of Freiburg; University of Freiburg; Free University of Berlin	Alexiev, U (corresponding author), Free Univ Berlin, Dept Phys, Arnimallee 14, D-14195 Berlin, Germany.	ulrike.alexiev@fu-berlin.de	Schlesinger, Ramona/W-2620-2018; Alexiev, Ulrike/L-8478-2016	Schlesinger, Ramona/0000-0002-7716-4439; 	Deutsche Forschungsgemeinschaft [Sfb1078, Sfb1112]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft: Sfb1078, project A2 (to U. A.), project B4 (to R. S.), project B2 (to P. Hegemann), and Sfb1112, project B03 to (U. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexiev U, 2000, J BIOL CHEM, V275, P13431, DOI 10.1074/jbc.275.18.13431; Alexiev U, 2003, J MOL BIOL, V328, P705, DOI 10.1016/S0022-2836(03)00326-7; ALEXIEV U, 1995, P NATL ACAD SCI USA, V92, P372, DOI 10.1073/pnas.92.2.372; ALEXIEV U, 1994, BIOCHEMISTRY-US, V33, P13693, DOI 10.1021/bi00250a020; ALEXIEV U, 1995, FEBS LETT, V373, P81, DOI 10.1016/0014-5793(95)00985-I; Alexiev U, 2014, BBA-BIOENERGETICS, V1837, P694, DOI 10.1016/j.bbabio.2013.10.008; Bamann C, 2010, BIOCHEMISTRY-US, V49, P267, DOI 10.1021/bi901634p; Berndt A, 2009, NAT NEUROSCI, V12, P229, DOI 10.1038/nn.2247; Bockmann RA, 2005, BIOPHYS J, V88, P3191, DOI 10.1529/biophysj.105.060426; Boreham A, 2011, ACS MED CHEM LETT, V2, P724, DOI 10.1021/ml200092m; DICKOPF S, 1995, P NATL ACAD SCI USA, V92, P11519, DOI 10.1073/pnas.92.25.11519; Dutta A, 2010, BIOCHEMISTRY-US, V49, P6329, DOI 10.1021/bi100339x; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; JOHNSON DA, 1985, BIOPHYS J, V48, P949, DOI 10.1016/S0006-3495(85)83858-3; JOHNSON DA, 1990, J BIOL CHEM, V265, P7360; Kato HE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8177; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; Kim TY, 2007, PHOTOCHEM PHOTOBIOL, V83, P378, DOI 10.1562/2006-06-21-RA-943; Kim TY, 2012, EUR J CELL BIOL, V91, P300, DOI 10.1016/j.ejcb.2011.03.009; Kim TY, 2009, PHOTOCHEM PHOTOBIOL, V85, P570, DOI 10.1111/j.1751-1097.2008.00525.x; Kirchberg K, 2013, BBA-BIOENERGETICS, V1827, P276, DOI 10.1016/j.bbabio.2012.10.014; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Krause N, 2013, FEBS LETT, V587, P3309, DOI 10.1016/j.febslet.2013.08.043; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Lorenz-Fonfria VA, 2015, P NATL ACAD SCI USA, V112, pE5796, DOI 10.1073/pnas.1511462112; Lorenz-Fonfria VA, 2014, BBA-BIOENERGETICS, V1837, P626, DOI 10.1016/j.bbabio.2013.10.014; Moller M, 2009, PHOTOCHEM PHOTOBIOL, V85, P501, DOI 10.1111/j.1751-1097.2008.00528.x; Moukhametzianov R, 2006, NATURE, V440, P115, DOI 10.1038/nature04520; Muller M, 2015, J MOL BIOL, V427, P341, DOI 10.1016/j.jmb.2014.11.004; Nack M, 2010, PHOTOCH PHOTOBIO SCI, V9, P194, DOI 10.1039/b9pp00157c; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Pieper J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228103; Radzwill N, 2001, BIOPHYS J, V80, P2856, DOI 10.1016/S0006-3495(01)76252-2; Richter C, 2015, PHYS CHEM CHEM PHYS, V17, P30590, DOI 10.1039/c5cp05454k; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Ritter E, 2013, J BIOL CHEM, V288, P10451, DOI 10.1074/jbc.M112.446427; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; Sattig T, 2013, ANGEW CHEM INT EDIT, V52, P9705, DOI 10.1002/anie.201301698; Schneider F, 2015, ANNU REV BIOPHYS, V44, P167, DOI 10.1146/annurev-biophys-060414-034014; Schroder GF, 2005, BIOPHYS J, V89, P3757, DOI 10.1529/biophysj.105.069500; Sineshchekov OA, 2009, PHOTOCHEM PHOTOBIOL, V85, P556, DOI 10.1111/j.1751-1097.2008.00524.x; Stehfest K, 2010, J MOL BIOL, V398, P690, DOI 10.1016/j.jmb.2010.03.031; Watanabe HC, 2013, J MOL BIOL, V425, P1795, DOI 10.1016/j.jmb.2013.01.033; WATT RM, 1979, J BIOL CHEM, V254, P1684; Wegener AA, 2000, J MOL BIOL, V301, P881, DOI 10.1006/jmbi.2000.4008	45	12	12	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17382	17393		10.1074/jbc.M115.711200	http://dx.doi.org/10.1074/jbc.M115.711200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27268055	Green Published, hybrid			2022-12-26	WOS:000382643800037
J	Duan, YJ; Ma, GE; Huang, XG; D'Amore, PA; Zhang, F; Lei, HT				Duan, Yajian; Ma, Gaoen; Huang, Xionggao; D'Amore, Patricia A.; Zhang, Feng; Lei, Hetian			The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-STEP GENERATION; CRISPR-CAS9 SYSTEM; P53; POLYMORPHISM; CANCER; PROTEIN; GENES; MICE; IDENTIFICATION; METAANALYSIS	The G309 allele of SNPs in the mouse double minute (MDM2) promoter locus is associated with a higher risk of cancer and proliferative vitreoretinopathy (PVR), but whether SNP G309 contributes to the pathogenesis of PVR is to date unknown. The clustered regularly interspaced short palindromic repeats (CRISPR)-associated endonuclease (Cas) 9 from Streptococcus pyogenes (SpCas9) can be harnessed to manipulate a single or multiple nucleotides in mammalian cells. Here we delivered SpCas9 and guide RNAs using dual adeno-associated virus-derived vectors to target theMDM2genomic locus together with a homologous repair template for creating the mutation of MDM2 T309G in human primary retinal pigment epithelial (hPRPE) cells whose genotype is MDM2 T309T. The next-generation sequencing results indicated that there was 42.51% MDM2 G309 in the edited hPRPE cells using adeno-associated viral CRISPR/Cas9. Our data showed that vitreous induced an increase in MDM2 and subsequent attenuation of p53 expression in MDM2 T309G hPRPE cells. Furthermore, our experimental results demonstrated that MDM2 T309G in hPRPE cells enhanced vitreous-induced cell proliferation and survival, suggesting that this SNP contributes to the pathogenesis of PVR.	[Duan, Yajian; Ma, Gaoen; Huang, Xionggao; D'Amore, Patricia A.; Lei, Hetian] Harvard Med Sch, Schepens Eye Res Inst, Boston, MA 02114 USA; [Duan, Yajian; Ma, Gaoen; Huang, Xionggao; D'Amore, Patricia A.; Lei, Hetian] Harvard Med Sch, Massachusetts Eye & Ear, Boston, MA 02114 USA; [Duan, Yajian; Ma, Gaoen; Huang, Xionggao; D'Amore, Patricia A.; Lei, Hetian] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02114 USA; [D'Amore, Patricia A.] Harvard Med Sch, Dept Pathol, Boston, MA 02114 USA; [Zhang, Feng] Broad Inst Massachusetts Inst Technol & Harvard U, Cambridge, MA 02142 USA; [Duan, Yajian] Shanxi Eye Hosp, Taiyuan 030000, Shanxi, Peoples R China	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Shanxi Medical University	Lei, HT (corresponding author), Harvard Med Sch, Schepens Eye Res Inst, Massachusetts Eye & Ear, Dept Ophthalmol, 20 Staniford St, Boston, MA 02114 USA.	Hetian_lei@meei.harvard.edu	D'Amore, Patricia A/G-5660-2017; Macrae, Rhiannon/AAX-1536-2020	D'Amore, Patricia A/0000-0001-9652-8974; Lei, Hetian/0000-0003-4091-1936	National Institutes of Health, NEI Grant [R01 EY012509]; National Institutes of Health, NEI Core Grant [P30EY003790]; NATIONAL EYE INSTITUTE [R01EY012509, P30EY003790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	National Institutes of Health, NEI Grant; National Institutes of Health, NEI Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in whole by the National Institutes of Health, NEI Grant R01 EY012509 (to H. L.) and in part by the National Institutes of Health, NEI Core Grant P30EY003790. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Boersma BJ, 2006, J NATL CANCER I, V98, P911, DOI 10.1093/jnci/djj245; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bougeard G, 2006, J MED GENET, V43, P531, DOI 10.1136/jmg.2005.037952; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; CONNOR TB, 1989, J CLIN INVEST, V83, P1661, DOI 10.1172/JCI114065; Cui J, 2009, EXP EYE RES, V88, P438, DOI 10.1016/j.exer.2008.10.020; Gao J, 2014, THER CLIN RISK MANAG, V10, P269, DOI 10.2147/TCRM.S60680; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEAVER PK, 1989, GRAEF ARCH CLIN EXP, V227, P323, DOI 10.1007/BF02169405; Lei HT, 2015, MOL CELL BIOL, V35, P1673, DOI 10.1128/MCB.01248-14; Lei HT, 2012, AM J PATHOL, V181, P866, DOI 10.1016/j.ajpath.2012.05.036; Lei HT, 2011, MOL CELL BIOL, V31, P1788, DOI 10.1128/MCB.01321-10; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LUNA RMD, 1995, NATURE, V378, P203; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Morescalchi F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/269787; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pastor-Idoate S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082283; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Scherer SE, 2006, NATURE, V440, P346, DOI 10.1038/nature04569; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Uhrinova S, 2005, J MOL BIOL, V350, P587, DOI 10.1016/j.jmb.2005.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang LH, 2014, TUMOR BIOL, V35, P3167, DOI 10.1007/s13277-013-1413-8; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Yu HP, 2011, MOL CARCINOGEN, V50, P697, DOI 10.1002/mc.20806; Zarrin AA, 1999, BBA-GENE STRUCT EXPR, V1446, P135, DOI 10.1016/S0167-4781(99)00067-6	47	23	23	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16339	16347		10.1074/jbc.M116.729467	http://dx.doi.org/10.1074/jbc.M116.729467			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27246850	Green Published, hybrid			2022-12-26	WOS:000380585400037
J	Clouet, S; Di Pietrantonio, L; Daskalopoulos, EP; Esfahani, H; Horckmans, M; Vanorle, M; Lemaire, A; Balligand, JL; Beauloye, C; Boeynaems, JM; Communi, D				Clouet, Sophie; Di Pietrantonio, Larissa; Daskalopoulos, Evangelos-Panagiotis; Esfahani, Hrag; Horckmans, Michael; Vanorle, Marion; Lemaire, Anne; Balligand, Jean-Luc; Beauloye, Christophe; Boeynaems, Jean-Marie; Communi, Didier			Loss of Mouse P2Y(6) Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTP REDUCES INFARCT; MYOCARDIAL HYPERTROPHY; KNOCKOUT MICE; NATRIURETIC PEPTIDES; HEART FUNCTION; RAT-HEART; CARDIOMYOCYTES; EXPRESSION; ISCHEMIA; PROTEINS	The study of the mechanisms leading to cardiac hypertrophy is essential to better understand cardiac development and regeneration. Pathological conditions such as ischemia or pressure overload can induce a release of extracellular nucleotides within the heart. We recently investigated the potential role of nucleotide P2Y receptors in cardiac development. We showed that adult P2Y(4)-null mice displayed microcardia resulting from defective cardiac angiogenesis. Here we show that loss of another P2Y subtype called P2Y(6), a UDP receptor, was associated with a macrocardia phenotype and amplified pathological cardiac hypertrophy. Cardiomyocyte proliferation and size were increased in vivo in hearts of P2Y(6)-null neonates, resulting in enhanced postnatal heart growth. We then observed that loss of P2Y(6) receptor enhanced pathological cardiac hypertrophy induced after isoproterenol injection. We identified an inhibitory effect of UDP on in vitro isoproterenol-induced cardiomyocyte hyperplasia and hypertrophy. The present study identifies mouse P2Y(6) receptor as a regulator of cardiac development and cardiomyocyte function. P2Y(6) receptor could constitute a therapeutic target to regulate cardiac hypertrophy.	[Clouet, Sophie; Di Pietrantonio, Larissa; Horckmans, Michael; Vanorle, Marion; Lemaire, Anne; Boeynaems, Jean-Marie; Communi, Didier] Univ Libre Bruxelles, IRIBHM, Inst Interdisciplinary Res, B-1070 Brussels, Belgium; [Daskalopoulos, Evangelos-Panagiotis; Beauloye, Christophe] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Cardiovasc Res, B-1200 Brussels, Belgium; [Esfahani, Hrag; Balligand, Jean-Luc] Catholic Univ Louvain, Unit Pharmacol & Therapeut, UCL FATH 5349, B-1200 Brussels, Belgium; [Boeynaems, Jean-Marie] Univ Libre Bruxelles, Erasme Hosp, Dept Lab Med, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles	Communi, D (corresponding author), Bldg C,5th Fl,Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.	communid@ulb.ac.be	Daskalopoulos, Evangelos/AAE-2815-2020; Balligand, Jean-Luc J/D-7543-2012	BALLIGAND, Jean-Luc/0000-0002-0522-4156	Fonds de la Recherche Scientifique Medicale of Belgium; Action de Recherche Concertee of the Communaute Francaise de Belgique, an Interuniversity Attraction Pole grant from the Politique Scientifique Federale [IAP-P7/40]; Prime Minister's Office, Federal Service for Science, Technology and Culture; Fonds Lokumo; European Community [LSHB-2003-503337]; Fonds National de la Recherche Scientifique/FRIA, Belgium; Universite libre de Bruxelles, Belgium	Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Action de Recherche Concertee of the Communaute Francaise de Belgique, an Interuniversity Attraction Pole grant from the Politique Scientifique Federale; Prime Minister's Office, Federal Service for Science, Technology and Culture; Fonds Lokumo; European Community(European Commission); Fonds National de la Recherche Scientifique/FRIA, Belgium(Fonds de la Recherche Scientifique - FNRS); Universite libre de Bruxelles, Belgium	This work was supported in part by the Fonds de la Recherche Scientifique Medicale of Belgium, Action de Recherche Concertee of the Communaute Francaise de Belgique, an Interuniversity Attraction Pole grant from the Politique Scientifique Federale (IAP-P7/40), the Prime Minister's Office, Federal Service for Science, Technology and Culture, by Fonds Lokumo, managed by the Fondation Roi Baudouin, grants from the Fonds de la Recherche Scientifique Medicale (F.R.S.M.), the Fonds d'Encouragement a la Recherche (F.E.R.), the Fonds Emile DEFAY, the Walloon Region (Programme d'Excellence CIBLES), and LifeSciHealth program of the European Community Grant LSHB-2003-503337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Fonds National de la Recherche Scientifique/FRIA, Belgium.r Supported by Universite libre de Bruxelles, Belgium.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; Bar I, 2008, MOL PHARMACOL, V74, P777, DOI 10.1124/mol.108.046904; Belge C, 2014, CIRCULATION, V129, P451, DOI 10.1161/CIRCULATIONAHA.113.004940; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; BOLUYT MO, 1995, AM J PHYSIOL-HEART C, V269, pH638; Catalucci D, 2008, FRONT BIOSCI-LANDMRK, V13, P312, DOI 10.2741/2681; Cheung KK, 2015, PURINERG SIGNAL, V11, P127, DOI 10.1007/s11302-014-9441-4; Cohen R, 2011, BIOCHEM PHARMACOL, V82, P1126, DOI 10.1016/j.bcp.2011.07.094; Ellmers LJ, 2002, AM J PHYSIOL-HEART C, V283, pH707, DOI 10.1152/ajpheart.00677.2001; Erkens R, 2015, FREE RADICAL BIO MED, V89, P906, DOI 10.1016/j.freeradbiomed.2015.10.409; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Garcia RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111385; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; Horckmans M, 2015, J IMMUNOL, V194, P1874, DOI 10.4049/jimmunol.1401364; Horckmans M, 2012, AM J PHYSIOL-HEART C, V303, pH835, DOI 10.1152/ajpheart.00256.2012; Horckmans M, 2012, ANGIOGENESIS, V15, P349, DOI 10.1007/s10456-012-9265-1; Hudlicka O, 1996, J VASC RES, V33, P266, DOI 10.1159/000159155; JACKSON T, 1990, MOL CELL BIOL, V10, P3709, DOI 10.1128/MCB.10.7.3709; Lu J, 2012, GENE THER, V19, P522, DOI 10.1038/gt.2011.133; Mitsuyama S, 2013, J MOL CELL CARDIOL, V59, P95, DOI 10.1016/j.yjmcc.2013.02.012; Murad N, 2000, CLIN EXP PHARMACOL P, V27, P352, DOI 10.1046/j.1440-1681.2000.03254.x; Nahrendorf M, 2005, CARDIOVASC RES, V65, P419, DOI 10.1016/j.cardiores.2004.10.006; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Ozakca I, 2013, AM J PHYSIOL-HEART C, V304, pH1267, DOI 10.1152/ajpheart.00352.2012; Poolman RA, 1999, CIRC RES, V85, P117, DOI 10.1161/01.RES.85.2.117; Prasad V, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/251598; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Stachon P, 2014, ARTERIOSCL THROM VAS, V34, P2237, DOI 10.1161/ATVBAHA.114.303585; Stansfield WE, 2009, ANN THORAC SURG, V88, P1916, DOI 10.1016/j.athoracsur.2009.07.038; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Wihlborg AK, 2006, CIRC RES, V98, P970, DOI 10.1161/01.RES.0000217402.73402.cd; Yitzhaki S, 2005, BIOCHEM PHARMACOL, V69, P1215, DOI 10.1016/j.bcp.2005.01.018; Yitzhaki S, 2006, BIOCHEM PHARMACOL, V72, P949, DOI 10.1016/j.bcp.2006.07.019; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	39	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15841	15852		10.1074/jbc.M115.684118	http://dx.doi.org/10.1074/jbc.M115.684118			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27231349	Green Published, hybrid			2022-12-26	WOS:000380584200036
J	Baumgarten, TJ; Oeltzschner, G; Hoogenboom, N; Wittsack, H; Schnitzler, A; Lange, J				Baumgarten, Thomas J.; Oeltzschner, Georg; Hoogenboom, Nienke; Wittsack, Hansoejrg; Schnitzler, Alfons; Lange, Joachim			Beta Peak Frequencies at Rest Correlate with Endogenous GABA plus /Cr Concentrations in Sensorimotor Cortex Areas	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; EDITED MR SPECTROSCOPY; OSCILLATORY ACTIVITY; MOTOR CORTEX; NETWORK OSCILLATIONS; HAND REPRESENTATION; GAMMA FREQUENCY; MOVEMENT; ASYMMETRY; AMPLITUDE	Neuronal oscillatory activity in the beta band (15-30 Hz) is a prominent signal within the human sensorimotor cortex. Computational modeling and pharmacological modulation studies suggest an influence of GABAergic interneurons on the generation of beta band oscillations. Accordingly, studies in humans have demonstrated a correlation between GABA concentrations and power of beta band oscillations. It remains unclear, however, if GABA concentrations also influence beta peak frequencies and whether this influence is present in the sensorimotor cortex at rest and without pharmacological modulation. In the present study, we investigated the relation between endogenous GABA concentration (measured by magnetic resonance spectroscopy) and beta oscillations (measured by magnetoencephalography) at rest in humans. GABA concentrations and beta band oscillations were measured for left and right sensorimotor and occipital cortex areas. A significant positive linear correlation between GABA concentration and beta peak frequency was found for the left sensorimotor cortex, whereas no significant correlations were found for the right sensorimotor and the occipital cortex. The results show a novel connection between endogenous GABA concentration and beta peak frequency at rest. This finding supports previous results that demonstrated a connection between oscillatory beta activity and pharmacologically modulated GABA concentration in the sensorimotor cortex. Furthermore, the results demonstrate that for a predominantly right-handed sample, the correlation between beta band oscillations and endogenous GABA concentrations is evident only in the left sensorimotor cortex.	[Baumgarten, Thomas J.; Oeltzschner, Georg; Hoogenboom, Nienke; Schnitzler, Alfons; Lange, Joachim] Univ Dusseldorf, Fac Med, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [Oeltzschner, Georg] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Oeltzschner, Georg] Kennedy Krieger Inst, FM Kirby Ctr Funct Brain Imaging, Baltimore, MD USA; [Oeltzschner, Georg; Wittsack, Hansoejrg] Univ Dusseldorf, Dept Diagnost & Intervent Radiol, Fac Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Johns Hopkins University; Kennedy Krieger Institute; Heinrich Heine University Dusseldorf	Baumgarten, TJ (corresponding author), Univ Dusseldorf, Fac Med, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany.	Thomas.Baumgarten@med.uni-duesseldorf.de	Schnitzler, Alfons/AAT-1054-2021; Schnitzler, Alfons/Q-5520-2019; Baumgarten, Thomas J/AAV-3608-2021; Oeltzschner, Georg/X-9520-2019	Schnitzler, Alfons/0000-0002-6414-7939; Baumgarten, Thomas J/0000-0001-8544-1048; Oeltzschner, Georg/0000-0003-3083-9811	Deutsche Forschungsgemeinschaft [SFB974 B07, LA 2400/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (SFB974 B07, Grant LA 2400/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi O, 2015, J NEUROSCIENCE METHO; Baker MR, 2003, J PHYSIOL-LONDON, V546, P931, DOI 10.1113/jphysiol.2002.029553; Baumgarten TJ, 2015, P NATL ACAD SCI USA, V112, P12187, DOI 10.1073/pnas.1501438112; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buzsaki G., 2006, RHYTHMS BRAIN; Cousijn H, 2014, P NATL ACAD SCI USA, V111, P9301, DOI 10.1073/pnas.1321072111; Durst CR, 2015, MAGN RESON IMAGING, V33, P611, DOI 10.1016/j.mri.2015.02.015; Edden RAE, 2014, J MAGN RESON IMAGING, V40, P1445, DOI 10.1002/jmri.24478; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Haegens S, 2011, P NATL ACAD SCI USA, V108, P10708, DOI 10.1073/pnas.1107297108; Hall SD, 2011, NEUROIMAGE, V56, P1506, DOI 10.1016/j.neuroimage.2011.02.025; Hall SD, 2010, HUM BRAIN MAPP, V31, P581, DOI 10.1002/hbm.20889; Harris AD, 2014, MAGN RESON MED, V72, P941, DOI 10.1002/mrm.25009; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Kilavik BE, 2013, EXP NEUROL, V245, P15, DOI 10.1016/j.expneurol.2012.09.014; Kilavik BE, 2012, CEREB CORTEX, V22, P2148, DOI 10.1093/cercor/bhr299; Lange J, 2012, CEREB CORTEX, V22, P2564, DOI 10.1093/cercor/bhr329; Liu ZM, 2012, NEUROIMAGE, V59, P2073, DOI 10.1016/j.neuroimage.2011.10.042; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Mullins PG, 2014, NEUROIMAGE, V86, P43, DOI 10.1016/j.neuroimage.2012.12.004; Muthukumaraswamy SD, 2013, NEUROIMAGE, V66, P36, DOI 10.1016/j.neuroimage.2012.10.054; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Near J, 2015, MAGN RESON MED, V73, P44, DOI 10.1002/mrm.25094; Neuper C, 2001, INT J PSYCHOPHYSIOL, V43, P41, DOI 10.1016/S0167-8760(01)00178-7; Neuper C, 2001, CLIN NEUROPHYSIOL, V112, P2084, DOI 10.1016/S1388-2457(01)00661-7; Oeltzschner G., 2015, METABOLIC BRAIN DIS, P1; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Puts NAJ, 2011, J NEUROSCI, V31, P16556, DOI 10.1523/JNEUROSCI.4489-11.2011; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; Roopun AK, 2006, P NATL ACAD SCI USA, V103, P15646, DOI 10.1073/pnas.0607443103; Salenius S, 1997, J NEUROPHYSIOL, V77, P3401, DOI 10.1152/jn.1997.77.6.3401; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Soros P, 1999, NEUROSCI LETT, V271, P89, DOI 10.1016/S0304-3940(99)00528-5; Stagg CJ, 2014, NEUROIMAGE, V86, P19, DOI 10.1016/j.neuroimage.2013.01.009; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Steingruber H.J., 2011, HAND DOMINANZ TEST; Triggs WJ, 1999, BRAIN RES, V835, P324, DOI 10.1016/S0006-8993(99)01629-7; Tzagarakis C, 2010, J NEUROSCI, V30, P11270, DOI 10.1523/JNEUROSCI.6026-09.2010; van Dijk H, 2010, P NATL ACAD SCI USA, V107, P900, DOI 10.1073/pnas.0908821107; van Ede F, 2010, NEUROIMAGE, V51, P867, DOI 10.1016/j.neuroimage.2010.02.053; Volkmann J, 1998, J NEUROPHYSIOL, V79, P2149, DOI 10.1152/jn.1998.79.4.2149; Yamawaki N, 2008, NEUROSCIENCE, V151, P386, DOI 10.1016/j.neuroscience.2007.10.021; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	46	33	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156829	10.1371/journal.pone.0156829	http://dx.doi.org/10.1371/journal.pone.0156829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258089	gold, Green Submitted, Green Published			2022-12-26	WOS:000377369700141
J	Benson, NU; Asuquo, FE; Williams, AB; Essien, JP; Ekong, CI; Akpabio, O; Olajire, AA				Benson, Nsikak U.; Asuquo, Francis E.; Williams, Akan B.; Essien, Joseph P.; Ekong, Cyril I.; Akpabio, Otobong; Olajire, Abaas A.			Source Evaluation and Trace Metal Contamination in Benthic Sediments from Equatorial Ecosystems Using Multivariate Statistical Techniques	PLOS ONE			English	Article							QUA IBOE ESTUARY; PEARL RIVER DELTA; HEAVY-METALS; SURFACE SEDIMENTS; RISK-ASSESSMENT; SOURCE IDENTIFICATION; POLLUTION; WATER; SOUTH; SPECIATION	Trace metals (Cd, Cr, Cu, Ni and Pb) concentrations in benthic sediments were analyzed through multi-step fractionation scheme to assess the levels and sources of contamination in estuarine, riverine and freshwater ecosystems in Niger Delta (Nigeria). The degree of contamination was assessed using the individual contamination factors (ICF) and global contamination factor (GCF). Multivariate statistical approaches including principal component analysis (PCA), cluster analysis and correlation test were employed to evaluate the interrelationships and associated sources of contamination. The spatial distribution of metal concentrations followed the pattern Pb>Cu>Cr>Cd>Ni. Ecological risk index by ICF showed significant potential mobility and bioavailability for Cu, Cu and Ni. The ICF contamination trend in the benthic sediments at all studied sites was Cu>Cr>Ni>Cd>Pb. The principal component and agglomerative clustering analyses indicate that trace metals contamination in the ecosystems was influenced by multiple pollution sources.	[Benson, Nsikak U.; Williams, Akan B.] Covenant Univ, Dept Chem, Environm Chem Unit, Ota, Nigeria; [Asuquo, Francis E.] Univ Calabar, Fac Marine Sci, Calabar, Nigeria; [Essien, Joseph P.] Univ Uyo, Dept Microbiol, Uyo, Nigeria; [Ekong, Cyril I.] Ritman Univ, Dept Chem Sci, Ikot Ekpene, Akwa Ibom State, Nigeria; [Akpabio, Otobong] Univ Uyo, Dept Chem, Uyo, Akwa Ibom State, Nigeria; [Olajire, Abaas A.] Univ Technol, Dept Pure & Appl Chem, Ind & Environm Chem Unit, Ogbomosho, Nigeria	Covenant University; University of Calabar; University of Uyo; University of Uyo	Benson, NU (corresponding author), Covenant Univ, Dept Chem, Environm Chem Unit, Ota, Nigeria.	nsikak.benson@cu.edu.ng	Benson, Nsikak/F-6522-2011	Benson, Nsikak/0000-0002-1285-579X; Essien, Joseph/0000-0002-7844-9954; Asuquo, Francis Emile/0000-0002-8964-0949				*AOAC, 1975, METH SOIL AN; Arabie P., 1996, CLUSTERING CLASSIFIC, DOI DOI 10.1142/1930; ASUQUO FE, 1991, MAR POLLUT BULL, V22, P150; Bastami KD, 2014, MAR POLLUT BULL, V81, P262, DOI 10.1016/j.marpolbul.2014.01.029; Benson NU, 2008, ENVIRON MONIT ASSESS, V146, P253, DOI 10.1007/s10661-007-0077-5; Benson Nsikak U., 2008, Environmentalist, V28, P275, DOI 10.1007/s10669-007-9140-6; Benson Nsikak U., 2008, Environmentalist, V28, P195, DOI 10.1007/s10669-007-9127-3; Benson NU, 2007, CURRENT SCI, V96, P781; Chang ML, 2007, J ENV ENG MANAGE, V17, P143; Cheng Z, 2013, CHEMOSPHERE, V90, P2142, DOI 10.1016/j.chemosphere.2012.11.017; Diaz-de Alba M, 2011, J HAZARD MATER, V190, P177, DOI 10.1016/j.jhazmat.2011.03.020; Dong AG, 2012, ACTA OCEANOL SIN, V31, P88, DOI 10.1007/s13131-012-0195-y; Essien JP, 2009, ENVIRON RES, V109, P690, DOI 10.1016/j.envres.2009.04.005; Essien Joseph P., 2008, Toxicological and Environmental Chemistry, V90, P259, DOI 10.1080/02772240701550497; Essien JP, 2005, WORLD J MICROB BIOT, V21, P567, DOI 10.1007/s11274-004-3910-9; Everitt B. S., 2001, CLUSTER ANAL; Folk R.L., 1974, PETROLOGY SEDIMENTAR; Forstner U, 2008, TRENDS CHALLENGES SE, V8, P281; Gao XL, 2012, WATER RES, V46, P1901, DOI 10.1016/j.watres.2012.01.007; GIBBS RJ, 1993, ENVIRON POLLUT, V81, P297, DOI 10.1016/0269-7491(93)90212-7; Goher M.E., 2014, EGYPT J AQUATIC RES, V40, P213, DOI [10.1016/j.ejar.2014.09.004, DOI 10.1016/j.ejar.2014.09.004]; Han YM, 2006, SCI TOTAL ENVIRON, V355, P176, DOI 10.1016/j.scitotenv.2005.02.026; Ianni C, 2010, MICROCHEM J, V96, P203, DOI 10.1016/j.microc.2009.07.016; Ip CCM, 2007, ENVIRON POLLUT, V147, P311, DOI 10.1016/j.envpol.2006.06.028; Islam MS, 2015, ECOL INDIC, V48, P282, DOI 10.1016/j.ecolind.2014.08.016; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Li F, 2013, BIOL TRACE ELEM RES, V155, P301, DOI 10.1007/s12011-013-9789-2; Lin YC, 2013, MAR POLLUT BULL, V76, P266, DOI 10.1016/j.marpolbul.2013.08.027; Liu WX, 2003, ENVIRON POLLUT, V121, P377, DOI 10.1016/S0269-7491(02)00234-8; Loska K, 2003, CHEMOSPHERE, V51, P723, DOI 10.1016/S0045-6535(03)00187-5; Luis AT, 2011, SCI TOTAL ENVIRON, V409, P4312, DOI 10.1016/j.scitotenv.2011.06.052; Maanan M, 2015, ENVIRON SCI POLLUT R, V20, P4729; Morelli G, 2014, MAR POLLUT BULL, V89, P435, DOI 10.1016/j.marpolbul.2014.10.002; Nemati K, 2009, MICROCHEM J, V91, P227, DOI 10.1016/j.microc.2008.12.001; Nguyen HL, 2009, WATER AIR SOIL POLL, V200, P119, DOI 10.1007/s11270-008-9898-2; Parvaresh H, 2011, BIOL TRACE ELEM RES, V143, P1121, DOI 10.1007/s12011-010-8891-y; Passos ED, 2010, MICROCHEM J, V96, P50, DOI 10.1016/j.microc.2010.01.018; Radojevic M., 1999, PRACTICAL ENV ANAL; Ray WD, 1992, J R STAT SOC A, DOI [10.2307/2982904, DOI 10.2307/2982904]; Sahuquillo A, 2003, TRAC-TREND ANAL CHEM, V22, P152, DOI 10.1016/S0165-9936(03)00303-0; Saleem M, 2015, ENV NANOTECHNOLOGY M, P1; Schumacher B., 2002, METHODS DETERMINATIO; Singh KP, 2005, WATER AIR SOIL POLL, V166, P321, DOI 10.1007/s11270-005-5268-5; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Udosen E. D., 2006, Trends in Applied Sciences Research, V1, P292; Wang JW, 2014, MAR POLLUT BULL, V87, P364, DOI 10.1016/j.marpolbul.2014.07.048; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; XLSTAT, 2015, XLSTAT PRO; Zhang CS, 2008, GEODERMA, V146, P378, DOI 10.1016/j.geoderma.2008.06.013; Zhang HG, 2011, J ENVIRON SCI-CHINA, V23, P1937, DOI 10.1016/S1001-0742(10)60644-4; Zhao S, 2012, J HAZARD MATER, V241, P164, DOI 10.1016/j.jhazmat.2012.09.023; Zhuang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094145; [No title captured]	54	34	35	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156485	10.1371/journal.pone.0156485	http://dx.doi.org/10.1371/journal.pone.0156485			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257934	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700067
J	Ertl, NG; O'Connor, WA; Papanicolaou, A; Wiegand, AN; Elizur, A				Ertl, Nicole G.; O'Connor, Wayne A.; Papanicolaou, Alexie; Wiegand, Aaron N.; Elizur, Abigail			Transcriptome Analysis of the Sydney Rock Oyster, Saccostrea glomerata: Insights into Molluscan Immunity	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; FRESH-WATER MUSSEL; CRASSOSTREA-GIGAS; PACIFIC OYSTER; ANTIOXIDANT ENZYMES; SIGNALING PATHWAYS; INNATE IMMUNITY; EASTERN OYSTER; MOLECULAR-CLONING	Background Oysters have important ecological functions in their natural environment, acting as global carbon sinks and improving water quality by removing excess nutrients from the water column. During their life-time oysters are exposed to a variety of pathogens that can cause severe mortality in a range of oyster species. Environmental stressors encountered in their habitat can increase the susceptibility of oysters to these pathogens and in general have been shown to impact on oyster immunity, making immune parameters expressed in these marine animals an important research topic. Results Paired-end Illumina high throughput sequencing of six S. glomerata tissues exposed to different environmental stressors resulted in a total of 484,121,702 paired-end reads. When reads and assembled transcripts were compared to the C. gigas genome, an overall low level of similarity at the nucleotide level, but a relatively high similarity at the protein level was observed. Examination of the tissue expression pattern showed that some transcripts coding for cathepsins, heat shock proteins and antioxidant proteins were exclusively expressed in the haemolymph of S. glomerata, suggesting a role in innate immunity. Furthermore, analysis of the S. glomerata ORFs showed a wide range of genes potentially involved in innate immunity, from pattern recognition receptors, components of the Toll-like signalling and apoptosis pathways to a complex antioxidant defence mechanism. Conclusions This is the first large scale RNA-Seq study carried out in S. glomerata, showing the complex network of innate immune components that exist in this species. The results confirmed that many of the innate immune system components observed in mammals are also conserved in oysters; however, some, such as the TLR adaptors MAL, TRIF and TRAM are either missing or have been modified significantly. The components identified in this study could help explain the oysters' natural resilience against pathogenic microorganisms encountered in their natural environment.	[Ertl, Nicole G.; O'Connor, Wayne A.; Wiegand, Aaron N.; Elizur, Abigail] Univ Sunshine Coast, Sippy Downs, Qld 4556, Australia; [Ertl, Nicole G.] Australian Seafood Cooperat Res Ctr, Bedford Pk, SA, Australia; [O'Connor, Wayne A.] Dept Primary Ind, Taylors Beach, NSW, Australia; [Papanicolaou, Alexie] Commonwealth Sci & Ind Res Org CSIRO Ecosyst Sci, Black Mt Labs, Canberra, ACT, Australia	University of the Sunshine Coast; NSW Department of Primary Industries; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Elizur, A (corresponding author), Univ Sunshine Coast, Sippy Downs, Qld 4556, Australia.	AElizur@usc.edu.au	Papanicolaou, Alexie/A-1618-2011; O'Connor, Wayne/AAL-8097-2020	Papanicolaou, Alexie/0000-0002-3635-6848; O'Connor, Wayne/0000-0002-0972-4668; Elizur, Abigail/0000-0002-2960-302X; ERTL, Nicole/0000-0002-0442-3882	Fisheries Research & Development Corporation (FRDC); Australian Seafood Cooperative Research Centre (CRC) [2011/718]; University of the Sunshine Coast, Australia; Australian Seafood CRC; University of the Sunshine Coast scholarship; Queensland Education and Training International (QETI)	Fisheries Research & Development Corporation (FRDC)(Fisheries R&D Corp); Australian Seafood Cooperative Research Centre (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); University of the Sunshine Coast, Australia; Australian Seafood CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); University of the Sunshine Coast scholarship; Queensland Education and Training International (QETI)	This project was funded by the Fisheries Research & Development Corporation (FRDC - http://frdc.com.au/), the Australian Seafood Cooperative Research Centre (CRC - http://www.seafoodcrc.com/) (2011/718 to NGE, AE and WAO), and the University of the Sunshine Coast, Australia. NGE was supported by an Australian Seafood CRC and University of the Sunshine Coast scholarship, as well as a scholarship from Queensland Education and Training International (QETI). The funding parties had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEMA CM, 1993, J LEUKOCYTE BIOL, V54, P379, DOI 10.1002/jlb.54.5.379; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ashe PC, 2003, PROG NEURO-PSYCHOPH, V27, P199, DOI 10.1016/S0278-5846(03)00016-2; Bachali S, 2002, J MOL EVOL, V54, P652, DOI 10.1007/s00239-001-0061-6; BACHERE E, 1995, AQUACULTURE, V132, P17, DOI 10.1016/0044-8486(94)00389-6; Balakrishnan A, 2013, INNATE IMMUN-LONDON, V19, P339, DOI 10.1177/1753425912465098; Bebianno MJ, 2005, AQUAT TOXICOL, V75, P354, DOI 10.1016/j.aquatox.2005.08.013; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berthe FCJ, 2004, AQUAT LIVING RESOUR, V17, P433, DOI 10.1051/alr:2004051; Bettencourt R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-559; Bhandari T, 2014, INFECT DIS THER; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Butt D, 2006, AQUACULTURE, V251, P159, DOI 10.1016/j.aquaculture.2005.05.045; Butt D, 2007, MAR FRESHWATER RES, V58, P213, DOI 10.1071/MF06080; Cantacessi C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002284; Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021; Cheriyath V, 2011, J INTERF CYTOK RES, V31, P173, DOI 10.1089/jir.2010.0105; Cherkasov AS, 2007, J THERM BIOL, V32, P162, DOI 10.1016/j.jtherbio.2007.01.005; Cho SG, 2002, J BIOCHEM MOL BIOL, V35, P24, DOI 10.5483/BMBRep.2002.35.1.024; Choi SH, 2013, FISH SHELLFISH IMMUN, V35, P476, DOI 10.1016/j.fsi.2013.05.001; CHU FLE, 1994, MAR ENVIRON RES, V38, P243, DOI 10.1016/0141-1136(94)90026-4; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conner JR, 2010, P NATL ACAD SCI USA, V107, P11477, DOI 10.1073/pnas.1006894107; CONTE A, 1995, FEBS LETT, V365, P120, DOI 10.1016/0014-5793(95)00439-G; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Cordeiro Q, 2009, REV BRAS PSIQUIATR, V31, P131, DOI 10.1590/S1516-44462009000200009; Creese A, 2014, AQUACULTURE PRODUCTI; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Dang C, 2011, FISH SHELLFISH IMMUN, V31, P1034, DOI 10.1016/j.fsi.2011.09.003; Deng Y, 2014, BIOSCI BIOTECH BIOCH, P1; Dimarcq JL, 1998, BIOPOLYMERS, V47, P465, DOI 10.1002/(SICI)1097-0282(1998)47:6<465::AID-BIP5>3.0.CO;2-#; Edge KJ, 2012, ECOTOXICOLOGY, V21, P1415, DOI 10.1007/s10646-012-0895-2; Ellis RP, 2011, FISH SHELLFISH IMMUN, V30, P1209, DOI 10.1016/j.fsi.2011.03.017; Fang Y, 2013, COMP BIOCHEM PHYS C, V157, P54, DOI 10.1016/j.cbpc.2012.10.002; Feng Y, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/170352; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x; Ge H, 2012, GENE, V506, P417, DOI 10.1016/j.gene.2012.06.038; Glick BR, 2003, MOL BIOTECHNOLOGY PR, P23; Gonzalez M, 2007, P NATL ACAD SCI USA, V104, P17759, DOI 10.1073/pnas.0702281104; Gosling E, 2003, BIVALVE MOLLUSCS BIO; Gourdon I, 2001, NITRIC OXIDE-BIOL CH, V5, P1, DOI 10.1006/niox.2000.0327; Green TJ, 2010, MAR ECOL PROG SER, V402, P161, DOI 10.3354/meps08430; Green TJ, 2009, FISH SHELLFISH IMMUN, V26, P799, DOI 10.1016/j.fsi.2009.03.003; Guha S, 2008, INDIAN J BIOCHEM BIO, V45, P75; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hancock REW, 2006, IMMUNOBIOLOGY, V211, P315, DOI 10.1016/j.imbio.2005.10.017; Harris AJ, 2014, HYPOXIA, V2, P47, DOI 10.2147/HP.S50269; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Higgins CB, 2011, J ENVIRON QUAL, V40, P271, DOI 10.2134/jeq2010.0203; Ho KKY, 2014, MAR POLLUT BULL, V85, P499, DOI 10.1016/j.marpolbul.2014.02.023; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Hook SE, 2014, MAR GENOM, V18, P109, DOI 10.1016/j.margen.2014.08.003; Hu H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-60; Hu XJ, 2014, FISH SHELLFISH IMMUN, V40, P446, DOI 10.1016/j.fsi.2014.07.005; Huan P, 2012, MAR BIOTECHNOL, V14, P69, DOI 10.1007/s10126-011-9389-0; Huang BY, 2014, MOL BIOL REP, V41, P6481, DOI 10.1007/s11033-014-3531-9; Hughes FM, 2010, FISH SHELLFISH IMMUN, V29, P247, DOI 10.1016/j.fsi.2010.03.003; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jantsch J, 2011, J LEUKOCYTE BIOL, V90, P551, DOI 10.1189/jlb.1210683; Jenny MJ, 2002, MAR BIOTECHNOL, V4, P81, DOI 10.1007/s10126-001-0072-8; Jo PG, 2008, COMP BIOCHEM PHYS C, V147, P460, DOI 10.1016/j.cbpc.2008.02.001; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Kawabe S, 2012, MAR BIOTECHNOL, V14, P106, DOI 10.1007/s10126-011-9394-3; Kim SY, 2010, IMMUNOLOGY, V129, P516, DOI 10.1111/j.1365-2567.2009.03203.x; Kiss T, 2010, APOPTOSIS, V15, P313, DOI 10.1007/s10495-009-0446-3; Kohchi C, 2009, ANTICANCER RES, V29, P817; Kuchel RP, 2012, AQUACULTURE, V362, P33, DOI 10.1016/j.aquaculture.2012.07.027; Kuchel RP, 2010, FISH SHELLFISH IMMUN, V29, P930, DOI 10.1016/j.fsi.2010.07.033; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Kutikhin AG, 2013, GENOMICS PATTERN REC, P1; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lee Youngdeuk, 2014, Journal of Coastal Life Medicine, V2, P447; Leite RB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-741; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu L, 2011, DEV COMP IMMUNOL, V35, P227, DOI 10.1016/j.dci.2010.09.010; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Malagoli D, 2007, FISH SHELLFISH IMMUN, V23, P171, DOI 10.1016/j.fsi.2006.10.004; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Meng XL, 2014, FISH SHELLFISH IMMUN, V38, P287, DOI 10.1016/j.fsi.2014.03.009; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Nell JA, 2006, AQUAC RES, V37, P693, DOI 10.1111/j.1365-2109.2006.01482.x; Niu DH, 2014, DEV COMP IMMUNOL, V46, P241, DOI 10.1016/j.dci.2014.04.012; Niu DH, 2013, DEV COMP IMMUNOL, V41, P94, DOI 10.1016/j.dci.2013.04.014; Niyogi S, 2001, SCI TOTAL ENVIRON, V281, P237, DOI 10.1016/S0048-9697(01)00850-6; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Palumbo A, 2005, COMP BIOCHEM PHYS A, V142, P241, DOI 10.1016/j.cbpb.2005.05.043; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Paul-Pont I, 2014, AQUACULTURE, V422, P146, DOI 10.1016/j.aquaculture.2013.12.009; Pauletto M, 2014, FISH SHELLFISH IMMUN, V37, P154, DOI 10.1016/j.fsi.2014.01.017; Peters R, 2003, AQUACULTURE, V223, P29, DOI 10.1016/S0044-8486(03)00169-8; Peterson CH, 2003, MAR ECOL PROG SER, V264, P249, DOI 10.3354/meps264249; Philipp EER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033091; Piontkivska H, 2011, COMP BIOCHEM PHYS D, V6, P103, DOI 10.1016/j.cbd.2010.10.003; Poole AZ, 2014, DEV COMP IMMUNOL, V46, P480, DOI 10.1016/j.dci.2014.06.002; Prentis PJ, 2014, MAR GENOM, V18, P113, DOI 10.1016/j.margen.2014.08.004; Rauta PR, 2014, IMMUNOL LETT, V158, P14, DOI 10.1016/j.imlet.2013.11.013; Ren Q, 2014, DEV COMP IMMUNOL, V42, P286, DOI 10.1016/j.dci.2013.09.012; Ren Q, 2013, FISH SHELLFISH IMMUN, V34, P1287, DOI 10.1016/j.fsi.2013.02.014; Rosa RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025594; Ruesink JL, 2005, ANNU REV ECOL EVOL S, V36, P643, DOI 10.1146/annurev.ecolsys.36.102003.152638; Segarra A, 2010, VIRUS RES, V153, P92, DOI 10.1016/j.virusres.2010.07.011; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Taylor JM, 2008, NUCLEIC ACIDS RES, V36, P4845, DOI 10.1093/nar/gkn444; Teaniniuraitemoana V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-491; Toubiana M, 2014, DEV COMP IMMUNOL, V45, P300, DOI 10.1016/j.dci.2014.03.021; Toubiana M, 2013, DEV COMP IMMUNOL, V40, P158, DOI 10.1016/j.dci.2013.02.006; Trevisan R, 2012, AQUAT TOXICOL, V108, P85, DOI 10.1016/j.aquatox.2011.09.023; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Wang LL, 2013, DEV COMP IMMUNOL, V39, P2, DOI 10.1016/j.dci.2012.06.014; Wang XW, 2013, FISH SHELLFISH IMMUN, V34, P981, DOI 10.1016/j.fsi.2012.08.008; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wu BJ, 2011, DEV COMP IMMUNOL, V35, P764, DOI 10.1016/j.dci.2011.02.009; Wu D, 2013, FISH SHELLFISH IMMUN, V34, P1033, DOI 10.1016/j.fsi.2012.12.009; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xiang ZM, 2014, FISH SHELLFISH IMMUN, V40, P514, DOI 10.1016/j.fsi.2014.08.006; Yang YH, 2013, INT REV IMMUNOL, V32, P249, DOI 10.3109/08830185.2012.755176; Yu ZN, 2006, AQUACULTURE, V254, P160, DOI 10.1016/j.aquaculture.2005.10.016; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang LL, 2012, AQUAC RES, V43, P1071, DOI 10.1111/j.1365-2109.2011.02910.x; Zhang T, 2014, DEV COMP IMMUNOL, V45, P141, DOI 10.1016/j.dci.2014.02.015; Zhao J, 2007, MOL IMMUNOL, V44, P1198, DOI 10.1016/j.molimm.2006.06.008; Zhao JM, 2007, MOL IMMUNOL, V44, P360, DOI 10.1016/j.molimm.2006.02.025; Zhao JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013480; Zhao XX, 2012, MAR BIOTECHNOL, V14, P730, DOI 10.1007/s10126-012-9438-3	141	36	36	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156649	10.1371/journal.pone.0156649	http://dx.doi.org/10.1371/journal.pone.0156649			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258386	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700094
J	Khatri, I; Sharma, S; Ramya, TNC; Subramanian, S				Khatri, Indu; Sharma, Shailza; Ramya, T. N. C.; Subramanian, Srikrishna			Complete Genomes of Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, Two Phylogenetically Distinct Probiotics	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DIFFICILE-INDUCED COLITIS; ORIGINAL RESEARCH; RAPID ANNOTATION; COG DATABASE; BACTERIOCINS; SPORES; STRAIN; GENES; IDENTIFICATION	Several spore-forming strains of Bacillus are marketed as probiotics due to their ability to survive harsh gastrointestinal conditions and confer health benefits to the host. We report the complete genomes of two commercially available probiotics, Bacillus coagulans S-lac and Bacillus subtilis TO-A JPC, and compare them with the genomes of other Bacillus and Lactobacillus. The taxonomic position of both organisms was established with a maximum-likelihood tree based on twenty six housekeeping proteins. Analysis of all probiotic strains of Bacillus and Lactobacillus reveal that the essential sporulation proteins are conserved in all Bacillus probiotic strains while they are absent in Lactobacillus spp. We identified various antibiotic resistance, stress-related, and adhesion-related domains in these organisms, which likely provide support in exerting probiotic action by enabling adhesion to host epithelial cells and survival during antibiotic treatment and harsh conditions.	[Khatri, Indu; Sharma, Shailza; Ramya, T. N. C.; Subramanian, Srikrishna] CSIR Inst Microbial Technol, Sect 39A, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Ramya, TNC; Subramanian, S (corresponding author), CSIR Inst Microbial Technol, Sect 39A, Chandigarh, India.	ramya@imtech.res.in; krishna@imtech.res.in	Khatri, Indu/Y-2429-2018; subramanian, srikrishna/N-3018-2019; Chakravarthy, Ramya T. N./AAJ-7507-2021	Khatri, Indu/0000-0002-7993-1953; subramanian, srikrishna/0000-0002-3263-1048; Sharma, Shailza/0000-0001-5746-1447	Council of Scientific Research (CSIR) Network project on Man as a super-organism: Understanding the Human Microbiome [HUM-CSIR-BSC0119]; University Grants Commission (UGC); Council of Scientific and Industrial Research (CSIR)	Council of Scientific Research (CSIR) Network project on Man as a super-organism: Understanding the Human Microbiome; University Grants Commission (UGC)(University Grants Commission, India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific Research (CSIR) Network project on Man as a super-organism: Understanding the Human Microbiome (HUM-CSIR-BSC0119). IK and SS acknowledge the University Grants Commission (UGC) and Council of Scientific and Industrial Research (CSIR), respectively, for their research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baron M, 2009, POSTGRAD MED, V121, P114, DOI 10.3810/pgm.2009.03.1971; Cavazzoni V, 1998, BRIT POULTRY SCI, V39, P526, DOI 10.1080/00071669888719; Chen CC, 2010, PEDIATR INFECT DIS J, V29, P135, DOI 10.1097/INF.0b013e3181b530bf; Claus D., 1986, BERGEYS MANUAL SYSTE, P1105, DOI DOI 10.1016/0922-338X(92)90270-5; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cutting SM, 2011, FOOD MICROBIOL, V28, P214, DOI 10.1016/j.fm.2010.03.007; D'Arienzo R, 2006, RES MICROBIOL, V157, P891, DOI 10.1016/j.resmic.2006.06.001; De Clerck E, 2004, SYST APPL MICROBIOL, V27, P50, DOI 10.1078/0723-2020-00250; De Vecchi E., 2006, INT J PROBIOT PREBIO, V1, P3; Dolin BJ, 2009, METHOD FIND EXP CLIN, V31, P655, DOI 10.1358/mf.2009.31.10.1441078; Duc LH, 2004, APPL ENVIRON MICROB, V70, P2161, DOI 10.1128/AEM.70.4.2161-2171.2004; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endres JR, 2011, FOOD CHEM TOXICOL, V49, P1174, DOI 10.1016/j.fct.2011.02.012; Endres JR, 2009, FOOD CHEM TOXICOL, V47, P1231, DOI 10.1016/j.fct.2009.02.018; Fitzpatrick LR, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-13; Fitzpatrick LR, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-16; Galperin MY, 2012, ENVIRON MICROBIOL, V14, P2870, DOI 10.1111/j.1462-2920.2012.02841.x; Gao F, 2013, NUCLEIC ACIDS RES, V41, pD90, DOI 10.1093/nar/gks990; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gueimonde M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00202; Hoa NT, 2000, APPL ENVIRON MICROB, V66, P5241, DOI 10.1128/AEM.66.12.5241-5247.2000; Hoa TT, 2001, APPL ENVIRON MICROB, V67, P3819, DOI 10.1128/AEM.67.9.3819-3823.2001; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Hong HA, 2009, RES MICROBIOL, V160, P134, DOI 10.1016/j.resmic.2008.11.002; Hun L, 2009, POSTGRAD MED, V121, P119, DOI 10.3810/pgm.2009.03.1984; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; La Ragione RM, 2003, VET MICROBIOL, V94, P245, DOI 10.1016/S0378-1135(03)00077-4; La Ragione RM, 2001, VET MICROBIOL, V79, P133, DOI 10.1016/S0378-1135(00)00350-3; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Le Marrec C, 2000, APPL ENVIRON MICROB, V66, P5213, DOI 10.1128/AEM.66.12.5213-5220.2000; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Minot S. S., 2015, ONE CODEX SENSITIVE, DOI [10.1101/027607, DOI 10.1101/027607]; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Natale DA, 2000, GENETICA, V108, P9, DOI 10.1023/A:1004031323748; Natarajan P, 2015, J GENET GENOMICS, V42, P43, DOI 10.1016/j.jgg.2014.07.002; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Patel AK, 2010, APPL BIOCHEM BIOTECH, V160, P140, DOI 10.1007/s12010-009-8583-2; Payot T, 1999, ENZYME MICROB TECH, V24, P191, DOI 10.1016/S0141-0229(98)00098-2; Pinchuk IV, 2001, ANTIMICROB AGENTS CH, V45, P3156, DOI 10.1128/AAC.45.11.3156-3161.2001; Riazi S, 2009, J APPL MICROBIOL, V106, P1370, DOI 10.1111/j.1365-2672.2008.04105.x; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Rogha Mehran, 2014, Gastroenterol Hepatol Bed Bench, V7, P156; Sanders M E, 2003, Compr Rev Food Sci Food Saf, V2, P101, DOI 10.1111/j.1541-4337.2003.tb00017.x; Saneian Hossein, 2015, Gastroenterol Hepatol Bed Bench, V8, P56; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Sharma P, 2014, FOOD RES INT, V57, P176, DOI 10.1016/j.foodres.2014.01.025; Sonenshein AL, 1993, BACILLUS SUBTILIS OT; Sorokulova I, 2013, J PROB HLTH, V1; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sudha MR, 2012, INDIAN J MICROBIOL, V52, P396, DOI 10.1007/s12088-011-0233-z; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; Zheng GL, 2000, J BACTERIOL, V182, P3266, DOI 10.1128/JB.182.11.3266-3273.2000	64	31	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156745	10.1371/journal.pone.0156745	http://dx.doi.org/10.1371/journal.pone.0156745			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258038	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700119
J	Wang, R; Gong, L; Xue, XL; Qin, X; Ma, R; Luo, HY; Zhang, YJ; Yao, B; Su, XY				Wang, Rong; Gong, Li; Xue, Xianli; Qin, Xing; Ma, Rui; Luo, Huiying; Zhang, Yongjie; Yao, Bin; Su, Xiaoyun			Identification of the C-Terminal GH5 Domain from CbCel9B/Man5A as the First Glycoside Hydrolase with Thermal Activation Property from a Multimodular Bifunctional Enzyme	PLOS ONE			English	Article							BACTERIUM CALDICELLULOSIRUPTOR-BESCII; THERMOPHILIC BETA-MANNANASE; PLANT BIOMASS; DEGRADING ENZYMES; PICHIA-PASTORIS; GENE-CLUSTER; DSM 6725; CLONING; EXPRESSION; ENDO-1,4-BETA-MANNOSIDASE	Caldicellulosiruptor bescii encodes at least six unique multimodular glycoside hydrolases crucial for plant cell wall polysaccharides degradation, with each having two catalytic domains separated by two to three carbohydrate binding modules. Among the six enzymes, three have one N- or C-terminal GH5 domain with identical amino acid sequences. Despite a few reports on some of these multimodular enzymes, little is known about how the conserved GH5 domains behave, which are believed to be important due to the gene duplication. We thus cloned a representative GH5 domain from the C-terminus of a multimodular protein, i.e. the bifunctional cellulase/mannanase CbCel9B/Man5A which has been reported, and expressed it in Escherichia coli. Without any appending CBMs, the recombinant CbMan5A was still able to hydrolyze a variety of mannan substrates with different backbone linkages or side-chain decorations. While CbMan5A displayed the same pH optimum as CbCel9B/Man5A, it had an increased optimal temperature (90 degrees C) and moreover, was activated by heating at 70 degrees C and 80 degrees C, a property not ever reported for the full-length protein. The turnover numbers of CbMan5A on mannan substrates were, however, lower than those of CbCel9B/Man5A. These data suggested that evolution of CbMan5A and the other domains into a single polypeptide is not a simple assembly; rather, the behavior of one module may be affected by the other ones in the full-length enzyme. The differential scanning calorimetry analysis further indicated that heating CbMan5A was not a simple transition state process. To the best knowledge of the authors, CbMan5A is the first glycoside hydrolase with thermal activation property identified from a multimodular bifunctional enzyme.	[Wang, Rong; Gong, Li; Xue, Xianli; Qin, Xing; Ma, Rui; Luo, Huiying; Yao, Bin; Su, Xiaoyun] Chinese Acad Agr Sci, Feed Res Inst, Key Lab Feed Biotechnol, Minist Agr, Beijing 100081, Peoples R China; [Wang, Rong; Zhang, Yongjie] Shanxi Univ, Sch Life Sci, Taiyuan 030006, Shanxi, Peoples R China; [Gong, Li] Zhejiang Univ, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Shanxi University; Zhejiang University	Zhang, YJ (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan 030006, Shanxi, Peoples R China.	zhangyj2008@sxu.edu.cn; binyao@caas.cn; suxiaoyun@caas.cn	Zhang, Yong-Jie/B-9054-2009	Zhang, Yong-Jie/0000-0002-6331-2189	Elite Youth Program of Chinese Academy of Agricultural Sciences; National Natural Science Foundation of China [31400067]; Fundamental Research Funds for Central Public Interest Institutes of the Chinese Academy of Agricultural Sciences [2015ZL045]; National High Technology Research, and Development Program of China 863 program [2012AA022208]; China Modern Agriculture Research System [CARS-42]	Elite Youth Program of Chinese Academy of Agricultural Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Public Interest Institutes of the Chinese Academy of Agricultural Sciences; National High Technology Research, and Development Program of China 863 program(National High Technology Research and Development Program of China); China Modern Agriculture Research System	1. Elite Youth Program of Chinese Academy of Agricultural Sciences. Grant number: n/a. http://www.caas.net.cn/kjcxgczl/zytz/237653.shtml 2. National Natural Science Foundation of China (31400067). http://www.nsfc.gov.cn/ 3. Fundamental Research Funds for Central Public Interest Institutes of the Chinese Academy of Agricultural Sciences (2015ZL045). http://www.caas.cn 4. National High Technology Research, and Development Program of China 863 program (no. 2012AA022208), http://www.863.gov.cn/ 5. China Modern Agriculture Research System (CARS-42), http://www.moa.gov.cn/; This research was supported by the Elite Youth Program of Chinese Academy of Agricultural Sciences, the National Natural Science Foundation of China (31400067), and the Fundamental Research Funds for Central Public Interest Institutes of the Chinese Academy of Agricultural Sciences (2015ZL045), the National High Technology Research, and Development Program of China 863 program (no. 2012AA022208), and the China Modern Agriculture Research System (CARS-42).	Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Chen XL, 2007, J BIOTECHNOL, V128, P452, DOI 10.1016/j.jbiotec.2006.11.003; Chung D, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0147-1; Dam P, 2011, NUCLEIC ACIDS RES, V39, P3240, DOI 10.1093/nar/gkq1281; Do BC, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-59; Dodd D, 2009, J BACTERIOL, V191, P3328, DOI 10.1128/JB.01628-08; Hsiao YM, 2010, J AGR FOOD CHEM, V58, P1653, DOI 10.1021/jf903637s; KLUMP H, 1992, J BIOL CHEM, V267, P22681; Kong FS, 2014, PROCESS BIOCHEM, V49, P775, DOI 10.1016/j.procbio.2014.02.008; Liang D, 2015, BIOCHEM BIOPH RES CO, V467, P334, DOI 10.1016/j.bbrc.2015.09.156; Lu HQ, 2014, APPL MICROBIOL BIOT, V98, P2155, DOI 10.1007/s00253-013-5112-6; Lu HQ, 2013, APPL MICROBIOL BIOT, V97, P8121, DOI 10.1007/s00253-012-4656-1; Luo HY, 2012, J IND MICROBIOL BIOT, V39, P547, DOI 10.1007/s10295-011-1067-8; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moon YH, 2011, APPL ENVIRON MICROB, V77, P5157, DOI 10.1128/AEM.00353-11; Rathi P, 2000, BIOTECHNOL LETT, V22, P495, DOI 10.1023/A:1005604617440; Soysal C, 2008, J FOOD PROCESS PRES, V32, P1034, DOI 10.1111/j.1745-4549.2008.00298.x; STUTZENBERGER F, 1986, ENZYME MICROB TECH, V8, P205, DOI 10.1016/0141-0229(86)90088-8; Su XY, 2013, APPL ENVIRON MICROB, V79, P1481, DOI 10.1128/AEM.03265-12; Su XY, 2012, APPL ENVIRON MICROB, V78, P2230, DOI 10.1128/AEM.06814-11; Summpunn P, 2011, J MICROBIOL, V49, P86, DOI 10.1007/s12275-011-0357-1; Velikodvorskaia G A, 2013, Mol Biol (Mosk), V47, P667; Wang CH, 2015, APPL MICROBIOL BIOT, V99, P1217, DOI 10.1007/s00253-014-5979-x; Yang H, 2015, FOOD CHEM, V173, P283, DOI 10.1016/j.foodchem.2014.10.022; Yang SJ, 2009, APPL ENVIRON MICROB, V75, P4762, DOI 10.1128/AEM.00236-09; Yi ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084172; Young J, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0142-6; Yu S, 2015, BIOTECHNOL LETT; Zhang YL, 2008, ACTA CRYSTALLOGR F, V64, P209, DOI 10.1107/S1744309108002832	29	11	11	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156802	10.1371/journal.pone.0156802	http://dx.doi.org/10.1371/journal.pone.0156802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258548	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700132
J	Zeng, NF; Mancuso, JE; Zivkovic, AM; Smilowitz, JT; Ristenpart, WD				Zeng, Nancy F.; Mancuso, Jordan E.; Zivkovic, Angela M.; Smilowitz, Jennifer T.; Ristenpart, William D.			Red Blood Cells from Individuals with Abdominal Obesity or Metabolic Abnormalities Exhibit Less Deformability upon Entering a Constriction	PLOS ONE			English	Article							INSULIN-RESISTANCE; MICROFLUIDIC DEVICE; ASSOCIATION; VISCOSITY; RELEASE; PROFILE; RISK; ATP	Abdominal obesity and metabolic syndrome (MS) are multifactorial conditions associated with increased risk of cardiovascular disease and type II diabetes mellitus. Previous work has demonstrated that the hemorheological profile is altered in patients with abdominal obesity and MS, as evidenced for example by increased whole blood viscosity. To date, however, no studies have examined red blood cell (RBC) deformability of blood from individuals with obesity or metabolic abnormalities under typical physiological flow conditions. In this study, we pumped RBCs through a constriction in a microfluidic device and used high speed video to visualize and track the mechanical behavior of similar to 8,000 RBCs obtained from either healthy individuals (n = 5) or obese participants with metabolic abnormalities (OMA) (n = 4). We demonstrate that the OMA+ cells stretched on average about 25% less than the healthy controls. Furthermore, we examined the effects of ingesting a high-fat meal on RBC mechanical dynamics, and found that the postprandial period has only a weak effect on the stretching dynamics exhibited by OMA+ cells. The results suggest that chronic rigidification of RBCs plays a key role in the increased blood pressure and increased whole blood viscosity observed in OMA individuals and was independent of an acute response triggered by consumption of a high-fat meal.	[Zeng, Nancy F.; Mancuso, Jordan E.; Ristenpart, William D.] Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA; [Zivkovic, Angela M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Smilowitz, Jennifer T.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ristenpart, WD (corresponding author), Univ Calif Davis, Dept Chem Engn, Davis, CA 95616 USA.	wdristenpart@ucdavis.edu	Ristenpart, William/AAG-4462-2021	Zivkovic, Angela/0000-0002-2828-7862	National Science Foundation Biomechanics and Mechanobiology grant [1201245]; National Institute of Health [T32-GM008799]; NSF [1201245]; NIGMS-NIH [T32-GM008799]; Div Of Civil, Mechanical, & Manufact Inn [1201245] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008799] Funding Source: NIH RePORTER	National Science Foundation Biomechanics and Mechanobiology grant; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIGMS-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Science Foundation Biomechanics and Mechanobiology grant # 1201245; National Institute of Health grant # T32-GM008799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Primary support for this research was provided by NSF grant number 1201245 (Biomechanics and Mechanobiology, CMMI). Partial support for this research was provided by grant number T32-GM008799 from NIGMS-NIH. The authors would like to thank the Foods for Health Institute at UC Davis, the USDA, Agricultural Research Service, Western Human Nutrition Research Center and the National Dairy Council (Rosemont, IL) for supplying the blood samples for our experiments.	Ageno W, 2009, J THROMB HAEMOST, V7, P736, DOI 10.1111/j.1538-7836.2009.03327.x; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Aloulou I, 2006, CLIN HEMORHEOL MICRO, V35, P207; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Brun JF, 2004, CLIN HEMORHEOL MICRO, V30, P203; Caimi G, 2001, INT J OBESITY, V25, P1856, DOI 10.1038/sj.ijo.0801824; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DEMMER E, 2016, J NUTR SCI, V5; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ervin RB, 2003, NATL HLTH STAT REPOR, V2009, P1; Faustino V, 2014, BIOCHIP J, V8, P42, DOI 10.1007/s13206-014-8107-1; Forsyth AM, 2010, MICROVASC RES, V80, P37, DOI 10.1016/j.mvr.2010.03.008; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Grundy SM, 2006, CURR OPIN CARDIOL, V21, P1, DOI 10.1097/01.hco.0000200416.65370.a0; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Gyawali P, 2012, CLIN LIPIDOL, V7, P709, DOI 10.2217/CLP.12.65; Helal O, 2011, NUTR METAB CARDIOVAS, V21, P665, DOI 10.1016/j.numecd.2010.01.004; Irace C, 2006, NMCD, V19, P476; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Lee SS, 2009, BIOMED MICRODEVICES, V11, P1021, DOI 10.1007/s10544-009-9319-3; Lo Presti R, 2002, CLIN HEMORHEOL MICRO, V26, P241; Marossy A, 2009, CLIN HEMORHEOL MICRO, V42, P239, DOI 10.3233/CH-2009-1192; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Perez-Martinez P, 2014, EUR J CLIN INVEST, V44, P1053, DOI 10.1111/eci.12339; Price AK, 2004, ANAL CHEM, V76, P4849, DOI 10.1021/ac0495992; Rodrigues RO, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-0014-2; TANGELDER GJ, 1988, AM J PHYSIOL, V254, pH1059, DOI 10.1152/ajpheart.1988.254.6.H1059; Toker S, 2005, DIABETES-METAB RES, V21, P197, DOI 10.1002/dmrr.502; Uyuklu M, 2009, CLIN HEMORHEOL MICRO, V41, P269, DOI 10.3233/CH-2009-1178; Vaya A, 2011, CLIN HEMORHEOL MICRO, V49, P493, DOI 10.3233/CH-2011-1499; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Wiernsperger N, 2007, MICROCIRCULATION, V14, P403, DOI 10.1080/10739680701285617; Yaginuma T, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4820414; Zeng NF, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4904058; Zhang L, 2006, INT J CARDIOL, V112, P229, DOI 10.1016/j.ijcard.2005.11.104; Zhao R, 2006, BIORHEOLOGY, V43, P747	38	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156070	10.1371/journal.pone.0156070	http://dx.doi.org/10.1371/journal.pone.0156070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258098	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700032
J	Zhong, XR; Dong, ZW; Dong, H; Li, JY; Peng, ZX; Deng, L; Zhu, XH; Sun, Y; Lu, XS; Shen, FX; Su, XY; Zhang, LY; Gu, Y; Zheng, H				Zhong, Xiaorong; Dong, Zhengwei; Dong, Hua; Li, Jiayuan; Peng, Zuxiang; Deng, Ling; Zhu, Xuehua; Sun, Yun; Lu, Xuesong; Shen, Fuxiao; Su, Xinying; Zhang, Liying; Gu, Yi; Zheng, Hong			Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients	PLOS ONE			English	Article							OVARIAN-CANCER; SOMATIC MUTATIONS; SURVIVAL; CHEMOTHERAPY; CARRIERS; THERAPY; WOMEN; GERMLINE; BRCANESS; OUTCOMES	Background The prevalence of BRCA1/2 variants in Chinese breast cancer patients varies among studies. Germline or somatic BRCA1/2 mutations are associated with sensitivity to poly(ADPribose) polymerase-1 inhibitors and DNA-damaging agents. We aimed to investigate the distribution of both somatic and germline BRCA1/2 variants in unselected Chinese breast cancer patients, and explore their roles in tumor phenotype and disease prognosis. Methods 507 breast cancer patients, unselected for family history of breast cancer or age at diagnosis, were prospectively enrolled from West China Hospital between Feb. 2008 and Feb. 2014. BRCA1/2 variants in the exons/flanking regions were detected in fresh-frozen tumors using next-generation sequencing and confirmed by independent methods. Germline/somatic status was validated by Sanger sequencing in paired blood/normal tissue. Results BRCA1/2 pathogenic or likely pathogenic (P/LP) variants were detected in 50 patients (9.9%), including 40 germline carriers (18 in BRCA1, 22 in BRCA2), 9 patients with somatic variants (3 in BRCA1, 6 in BRCA2), and 1 patient with concurrent germline/somatic variants in BRCA2. The triple-negative (21.4%) and Luminal B (9.7%) subtypes had higher rates of BRCA1/2 variants. In patients with disease stage 0 similar to II, presence of a germline or somatic BRCA1 P/LP variant increased the risk of relapse as compared to non-carriers [univariate hazard ratio (HR): 3.70, P = 0.04]. Germline BRCA1 P/LP variants, which were associated with aggressive tumor phenotypes, predicted worse disease-free survival in the subgroup of stage 0 similar to II (HR: 4.52, P = 0.02) and N0 (HR: 5.4, P = 0.04) compared to non-carriers. Conclusion A high frequency of germline and somatic BRCA1/2 P/LP variants was detected in unselected Chinese breast cancer patients. Luminal B subtype should be considered as a high-risk population of BRCA1/2 mutation, in addition to triple-negative breast cancer. BRCA1 status was associated with aggressive tumor phenotype and worse disease progression in early stage breast cancer patients.	[Zhong, Xiaorong; Peng, Zuxiang; Deng, Ling; Zheng, Hong] Sichuan Univ, Lab Mol Diag Canc, State Key Lab Biotherapy, Natl Collaborat Innovat Ctr Biotherapy,West China, Chengdu 610064, Sichuan, Peoples R China; [Dong, Zhengwei; Dong, Hua; Zhu, Xuehua; Sun, Yun; Lu, Xuesong; Shen, Fuxiao; Su, Xinying; Gu, Yi] AstraZeneca, Asia & Emerging Markets iMed, Shanghai, Peoples R China; [Li, Jiayuan] Sichuan Univ, Dept Epidemiol & Biostat, West China Sch Publ Hlth, Chengdu 610064, Sichuan, Peoples R China; [Peng, Zuxiang] Sichuan Univ, Dept Thyroid & Breast Surg, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Liying] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Zheng, Hong] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; AstraZeneca; Sichuan University; Sichuan University; Memorial Sloan Kettering Cancer Center; Sichuan University	Gu, Y (corresponding author), AstraZeneca, Asia & Emerging Markets iMed, Shanghai, Peoples R China.	yigu68@yahoo.com; hzheng@scu.edu.cn	li, jia/GVT-7587-2022		AstraZeneca; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by AstraZeneca (Recipient: ZH). The funder provided support in the form of salaries for authors [ZD, HD, XHZ, YS, XL, FS, XS and YG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; [Anonymous], [No title captured]; Atchley DP, 2008, J CLIN ONCOL, V26, P4282, DOI 10.1200/JCO.2008.16.6231; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chalasani P, 2013, ONCOLOGIST, V18, P909, DOI 10.1634/theoncologist.2013-0039; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Couch FJ, 2015, J CLIN ONCOL, V33, P304, DOI 10.1200/JCO.2014.57.1414; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gonzalez-Angulo AM, 2011, CLIN CANCER RES, V17, P1082, DOI 10.1158/1078-0432.CCR-10-2560; Goodwin PJ, 2012, J CLIN ONCOL, V30, P19, DOI 10.1200/JCO.2010.33.0068; Guideline Recommendations for HER2 Detection in Breast Cancer Group, 2014, Zhonghua Bing Li Xue Za Zhi, V43, P262; Guideline Recommendations for Immunohistochemistry Detection in Breast Cancer Group, 2015, Zhonghua Bing Li Xue Za Zhi, V44, P237; Hennessy BTJ, 2010, J CLIN ONCOL, V28, P3570, DOI 10.1200/JCO.2009.27.2997; Huzarski T, 2013, J CLIN ONCOL, V31, P3191, DOI 10.1200/JCO.2012.45.3571; Kim H, 2012, BREAST CANCER RES TR, V134, P1315, DOI 10.1007/s10549-012-2159-5; Kim J., 2013, INT J RES STUDIES ED, V2, P15, DOI [DOI 10.4048/JBC.2013.16.4.357, 10.5861/ijrset.2012.170, DOI 10.5861/IJRSET.2012.170]; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kwong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043994; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Li WF, 2008, BREAST CANCER RES TR, V110, P99, DOI 10.1007/s10549-007-9708-3; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Maksimenko J, 2014, ONCOL LETT, V7, P278, DOI 10.3892/ol.2013.1684; Melchor L, 2013, HUM GENET, V132, P845, DOI 10.1007/s00439-013-1299-y; Moller P, 2007, INT J CANCER, V121, P1017, DOI 10.1002/ijc.22789; Oza AM, 2015, LANCET ONCOL, V16, P87, DOI 10.1016/S1470-2045(14)71135-0; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Quinn JE, 2003, CANCER RES, V63, P6221; Rennert G, 2007, NEW ENGL J MED, V357, P115, DOI 10.1056/NEJMoa070608; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Suter NM, 2004, CANCER EPIDEM BIOMAR, V13, P181, DOI 10.1158/1055-9965.EPI-03-0196; Tassone P, 2003, BRIT J CANCER, V88, P1285, DOI 10.1038/sj.bjc.6600859; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Wang C, 2015, ANN ONCOL, V26, P523, DOI 10.1093/annonc/mdu559; Yang X, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0005-2; Yu JH, 2014, J BREAST CANCER, V17, P129, DOI 10.4048/jbc.2014.17.2.129; Zhong Q, 2015, CLIN CANCER RES, V21, P211, DOI 10.1158/1078-0432.CCR-14-1816	38	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156789	10.1371/journal.pone.0156789	http://dx.doi.org/10.1371/journal.pone.0156789			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257965	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700128
J	Biljecki, F; Ohori, KA; Ledoux, H; Peters, R; Stoter, J				Biljecki, Filip; Ohori, Ken Arroyo; Ledoux, Hugo; Peters, Ravi; Stoter, Jantien			Population Estimation Using a 3D City Model: A Multi-Scale Country-Wide Study in the Netherlands	PLOS ONE			English	Article							AREAL INTERPOLATION; BUILDING POPULATION; LAND-COVER; URBAN-POPULATION; CENSUS; STOCK; CLASSIFICATION; ACCURACY; DENSITY; IMAGERY	The remote estimation of a region's population has for decades been a key application of geographic information science in demography. Most studies have used 2D data (maps, satellite imagery) to estimate population avoiding field surveys and questionnaires. As the availability of semantic 3D city models is constantly increasing, we investigate to what extent they can be used for the same purpose. Based on the assumption that housing space is a proxy for the number of its residents, we use two methods to estimate the population with 3D city models in two directions: (1) disaggregation (areal interpolation) to estimate the population of small administrative entities (e.g. neighbourhoods) from that of larger ones (e.g. municipalities); and (2) a statistical modelling approach to estimate the population of large entities from a sample composed of their smaller ones (e.g. one acquired by a government register). Starting from a complete Dutch census dataset at the neighbourhood level and a 3D model of all 9.9 million buildings in the Netherlands, we compare the population estimates obtained by both methods with the actual population as reported in the census, and use it to evaluate the quality that can be achieved by estimations at different administrative levels. We also analyse how the volume-based estimation enabled by 3D city models fares in comparison to 2D methods using building footprints and floor areas, as well as how it is affected by different levels of semantic detail in a 3D city model. We conclude that 3D city models are useful for estimations of large areas (e.g. for a country), and that the 3D approach has clear advantages over the 2D approach.	[Biljecki, Filip; Ohori, Ken Arroyo; Ledoux, Hugo; Peters, Ravi; Stoter, Jantien] Delft Univ Technol, Geoinformat 3D, Delft, Netherlands	Delft University of Technology	Biljecki, F (corresponding author), Delft Univ Technol, Geoinformat 3D, Delft, Netherlands.	f.biljecki@tudelft.nl	Biljecki, Filip/B-9829-2013	Biljecki, Filip/0000-0002-6229-7749; Stoter, Jantien/0000-0002-1393-7279	Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; TU Delft Open Access Fund	Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; TU Delft Open Access Fund	This research is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. The publication of this paper was funded by the TU Delft Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors gratefully acknowledge the received financial support.	Akbar M, 2013, ENVIRON MODELL SOFTW, V39, P24, DOI 10.1016/j.envsoft.2011.12.006; Alahmadi M, 2016, IEEE J-STARS, V9, P1959, DOI 10.1109/JSTARS.2014.2374175; Alahmadi M, 2015, INT J REMOTE SENS, V36, P4315, DOI 10.1080/01431161.2015.1079666; Alahmadi M, 2013, COMPUT ENVIRON URBAN, V41, P167, DOI 10.1016/j.compenvurbsys.2013.06.002; ALGARNI AM, 1995, MATH COMPUT MODEL, V22, P95, DOI 10.1016/0895-7177(95)00104-A; Anderson SJ, 2010, INT J REMOTE SENS, V31, P5733, DOI 10.1080/01431161.2010.496798; Anderson W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100037; Aringer K., 2014, INNOVATIONS 3D GEOIN, P143; Bagan H, 2012, REMOTE SENS ENVIRON, V127, P210, DOI 10.1016/j.rse.2012.09.011; Bahu Jean-Marie, 2014, International Journal of 3-D Information Modeling, V3, P1, DOI 10.4018/ij3dim.2014070101; Bakillah M, 2014, INT J GEOGR INF SCI, V28, P1940, DOI 10.1080/13658816.2014.909045; Bartie P, 2010, COMPUT ENVIRON URBAN, V34, P518, DOI 10.1016/j.compenvurbsys.2010.06.002; Belgiu M, 2014, REMOTE SENS-BASEL, V6, P1347, DOI 10.3390/rs6021347; Biljecki F., 2014, ISPRS ANN PHOTOGRAMM, V2, P31, DOI [10.5194/isprsannals-II-2-31-2014, DOI 10.5194/ISPRSANNALS-II-2-31-2014]; Biljecki F, 2016, ISPRS J PHOTOGRAMM, V116, P42, DOI 10.1016/j.isprsjprs.2016.03.003; Biljecki F, 2015, ISPRS INT GEO-INF, V4, P2842, DOI 10.3390/ijgi4042842; Biljecki F, 2015, INT J GEOGR INF SCI, V29, P2269, DOI 10.1080/13658816.2015.1073292; Biljecki F, 2014, COMPUT ENVIRON URBAN, V48, P1, DOI 10.1016/j.compenvurbsys.2014.05.004; Billen R., 2014, 3D CITY MODELS URBAN, P1; Boeters R, 2015, INT J GEOGR INF SCI, V29, P2248, DOI 10.1080/13658816.2015.1072201; Brinegrar SJ, 2010, CARTOGR GEOGR INF SC, V37, P273, DOI 10.1559/152304010793454327; Chen K, 2002, INT J REMOTE SENS, V23, P37, DOI 10.1080/01431160010014297; de Kluijver H., 2003, Computers, Environment and Urban Systems, V27, P85, DOI 10.1016/S0198-9715(01)00038-2; Deng CB, 2010, INT J REMOTE SENS, V31, P5673, DOI 10.1080/01431161.2010.496806; Doll CNH, 2006, ECOL ECON, V57, P75, DOI 10.1016/j.ecolecon.2005.03.007; Dong PL, 2010, INT J REMOTE SENS, V31, P5571, DOI 10.1080/01431161.2010.496804; Ehrlich D, 2005, GEOINFORMATION DISAS, P901; Eicher C. L., 2001, CARTOGR GEOGR INF SC, V28, P125, DOI [10.1559/152304001782173727, DOI 10.1559/152304001782173727]; Fisher PF, 1996, PROF GEOGR, V48, P299, DOI 10.1111/j.0033-0124.1996.00299.x; FISHER PF, 1995, ENVIRON PLANN A, V27, P211, DOI 10.1068/a270211; Fisher-Gewirtzman D, 2013, SURV REV, V45, P451, DOI 10.1179/1752270613Y.0000000059; Flowerdew R., 1991, PAPERS REG SCI, V70, P303, DOI DOI 10.1007/BF01434424; Gaughan AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055882; Goetz M, 2013, INT J GEOGR INF SCI, V27, P845, DOI 10.1080/13658816.2012.721552; GOODCHILD MF, 1980, GEO-PROCESSING, V1, P297; Greger K, 2015, T GIS, V19, P129, DOI 10.1111/tgis.12086; Groger G, 2012, ISPRS J PHOTOGRAMM, V71, P12, DOI 10.1016/j.isprsjprs.2012.04.004; Haala N, 2010, ISPRS J PHOTOGRAMM, V65, P570, DOI 10.1016/j.isprsjprs.2010.09.006; Hargreaves AJ, 2015, COMPUT ENVIRON URBAN, V54, P280, DOI 10.1016/j.compenvurbsys.2015.08.001; Harvey JT, 2002, INT J REMOTE SENS, V23, P2071, DOI 10.1080/01431160110075901; Hay SI, 2005, TROP MED INT HEALTH, V10, P1073, DOI 10.1111/j.1365-3156.2005.01487.x; Hecht R., 2015, INT J CART, V1, P18, DOI [https://doi.org/10.1080/23729333.2015.1055644, 10.1080/23729333.2015.1055644, DOI 10.1080/23729333.2015.1055644]; Hecht R, 2013, ISPRS INT J GEO-INF, V2, P1066, DOI 10.3390/ijgi2041066; Henn A, 2012, GEOINFORMATICA, V16, P281, DOI 10.1007/s10707-011-0131-x; Hermosilla T, 2012, LANDSCAPE URBAN PLAN, V106, P124, DOI 10.1016/j.landurbplan.2012.02.008; Hermosilla T., 2012, P GEOPROCESSING 2012, P232; Hillson R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112241; Holt J. B., 2004, CARTOGR GEOGR INF SC, V31, P103, DOI [10.1559/1523040041649407, DOI 10.1559/1523040041649407]; INSPIRE Thematic Working Group Buildings, 2013, D2 8 3 2 INSPIRE DAT; Kaden Robert, 2014, International Journal of 3-D Information Modeling, V3, P35, DOI 10.4018/ij3dim.2014040103; Kavgic M, 2010, BUILD ENVIRON, V45, P1683, DOI 10.1016/j.buildenv.2010.01.021; Kennedy E, 2004, J QUANT CRIMINOL, V20, P243, DOI 10.1023/B:JOQC.0000037733.74321.14; Kohler N, 2002, BUILD RES INF, V30, P226, DOI 10.1080/09613210110102238; Kolbe, 2009, 3D GEOINFORMATION SC, P15, DOI DOI 10.1007/978-3-540-87395-2_2; Kolbe T. H., 2015, PHOTOGRAMMETRIC WEEK, P343; Kolbe TH, 2007, INT ARCH PHOTOGRAMME, VXXXVI-2, P8; KRAUS S P, 1974, Remote Sensing of Environment, V3, P35, DOI 10.1016/0034-4257(74)90036-4; Kressler F., 2008, OBJECT BASED IMAGE A, P611; Kunze C, 2015, COMPUT ENVIRON URBAN, V53, P4, DOI 10.1016/j.compenvurbsys.2015.04.002; Langford M, 2006, COMPUT ENVIRON URBAN, V30, P161, DOI 10.1016/j.compenvurbsys.2004.07.001; Langford M, 2006, PROF GEOGR, V58, P294, DOI 10.1111/j.1467-9272.2006.00569.x; Langford M, 2013, GEOGR ANAL, V45, P324, DOI 10.1111/gean.12012; Ledoux H, 2011, INT J GEOGR INF SCI, V25, P557, DOI 10.1080/13658811003623277; Levy P.S., 2008, SAMPLING POPULATIONS, P121; Lin J, 2015, APPL GEOGR, V58, P41, DOI 10.1016/j.apgeog.2015.01.006; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Liu X., 2002, P 3 S REM SENS URB A, P153; Liu XH, 2008, INT J GEOGR INF SCI, V22, P431, DOI 10.1080/13658810701492225; Lo CP, 2008, GISCI REMOTE SENS, V45, P131, DOI 10.2747/1548-1603.45.2.131; LO CP, 1995, INT J REMOTE SENS, V16, P17, DOI 10.1080/01431169508954369; LO CP, 1977, ANN ASSOC AM GEOGR, V67, P246, DOI 10.1111/j.1467-8306.1977.tb01137.x; Lu DS, 2006, INT J REMOTE SENS, V27, P3553, DOI 10.1080/01431160600617202; Lu ZY, 2011, PHOTOGRAMM ENG REM S, V77, P1145, DOI 10.14358/PERS.77.11.1145; Lu ZY, 2010, INT J REMOTE SENS, V31, P5587, DOI 10.1080/01431161.2010.496801; Lwin KK, 2016, INT J GEOGR INF SCI, V30, P1579, DOI 10.1080/13658816.2016.1143099; Lwin KK, 2011, GEOJOURNAL LIB, V100, P87, DOI 10.1007/978-94-007-0671-2_6; Lwin K, 2009, T GIS, V13, P401, DOI 10.1111/j.1467-9671.2009.01171.x; Maantay J.A., 2007, CARTOGR GEOGR INF SC, V34, P77, DOI [DOI 10.1559/152304007781002190, 10.1559/152304007781002190]; Meinel G, 2009, BUILD RES INF, V37, P468, DOI 10.1080/09613210903159833; Mennis J, 2003, PROF GEOGR, V55, P31; Mennis J., 2006, CARTOGR GEOGR INF SC, V33, P179, DOI [10.1559/152304006779077309, DOI 10.1559/152304006779077309]; Mennis J, 2009, GEOGR COMPASS, V3, P727, DOI 10.1111/j.1749-8198.2009.00220.x; Musialski P, 2013, COMPUT GRAPH FORUM, V32, P146, DOI 10.1111/cgf.12077; Neidhart H., 2004, INT ARCH PHOTOGRAM B, V35, P715; Nouvel R, 2015, ENERG BUILDINGS, V107, P204, DOI 10.1016/j.enbuild.2015.08.021; Ogren M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155328; Ohori KA, 2015, ISPRS INT J GEO-INF, V4, P1055, DOI 10.3390/ijgi4031055; Ohori KA, 2015, INT J GEOGR INF SCI, V29, P1166, DOI 10.1080/13658816.2015.1010535; Pozzi F, 2005, PHOTOGRAMM ENG REM S, V71, P719, DOI 10.14358/PERS.71.6.719; Qiu F, 2010, CARTOGR GEOGR INF SC, V37, P239, DOI 10.1559/152304010792194949; Rottensteiner F, 2014, ISPRS J PHOTOGRAMM, V93, P256, DOI 10.1016/j.isprsjprs.2013.10.004; Sadahiro Y., 1999, J GEOGR SYST, V1, P323, DOI [DOI 10.1007/S101090050017, 10.1007/s101090050017]; Serna A, 2014, ISPRS J PHOTOGRAMM, V93, P243, DOI 10.1016/j.isprsjprs.2014.03.015; Shiravi S, 2015, ENVIRON PLANN B, V42, P708, DOI 10.1068/b130144p; Silvan-Cardenas JL, 2010, INT J REMOTE SENS, V31, P5605, DOI 10.1080/01431161.2010.496800; Sirmacek B, 2012, IEEE J-STARS, V5, P59, DOI 10.1109/JSTARS.2011.2178399; Spoorenberg T, 2015, POPULATION SOC, V527, P1; Spoorenberg T, 2015, ASIAN POPUL STUD, V11, P4, DOI 10.1080/17441730.2014.972084; Sridharan H, 2013, GEOGR ANAL, V45, P238, DOI 10.1111/gean.12010; Steiger E, 2015, COMPUT ENVIRON URBAN, V54, P255, DOI 10.1016/j.compenvurbsys.2015.09.007; Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042; Stoter J, 2016, GEOINFORMATIONSSYSTE, V3, P100; Stoter J, 2008, INT J GEOGR INF SCI, V22, P907, DOI 10.1080/13658810701739039; Stoter J, 2015, LECT NOTES GEOINF CA, P207, DOI 10.1007/978-3-319-12181-9_13; Sutton P., 1997, Computers, Environment and Urban Systems, V21, P227, DOI 10.1016/S0198-9715(97)01005-3; Suveg D, 2004, ISPRS J PHOTOGRAMM, V58, P202, DOI 10.1016/j.isprsjprs.2003.09.006; Swanson DA, 2012, POPUL RES POLICY REV, V31, P235, DOI 10.1007/s11113-012-9227-8; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; Tobler WR, 1969, AREA, V1, P30; Truong-Hong L, 2015, COMPUT GRAPH-UK, V49, P82, DOI 10.1016/j.cag.2015.03.001; Tutschku K, 1998, IEEE INFOCOM SER, P1054, DOI 10.1109/INFCOM.1998.662915; Ural S, 2011, INT J APPL EARTH OBS, V13, P841, DOI 10.1016/j.jag.2011.06.004; van der Sande C, 2010, SENSORS-BASEL, V10, P8198, DOI 10.3390/s100908198; van Oosterom P, 2015, COMPUT GRAPH-UK, V49, P92, DOI 10.1016/j.cag.2015.01.007; van Winden K, 2016, T GIS, V20, P664, DOI 10.1111/tgis.12186; Vine MF, 1997, ENVIRON HEALTH PERSP, V105, P598, DOI 10.2307/3433605; VROM, 2008, GEOM BAG VERD; Wandl DIA, 2014, LANDSCAPE URBAN PLAN, V130, P50, DOI 10.1016/j.landurbplan.2014.06.010; WELCH R, 1980, REMOTE SENS ENVIRON, V9, P1, DOI 10.1016/0034-4257(80)90043-7; Wright JK, 1936, GEOGR REV, V26, P103, DOI 10.2307/209467; Wu C., 2005, Computers, Environment and Urban Systems, V29, P558, DOI 10.1016/j.compenvurbsys.2005.01.006; Wu CS, 2007, GEOGR ANAL, V39, P26, DOI 10.1111/j.1538-4632.2006.00694.x; Wu S., 2005, GISCI REMOTE SENS, V42, P80, DOI [10.2747/1548-1603.42.1.80, DOI 10.2747/1548-1603.42.1.80]; Wu SS, 2008, PROF GEOGR, V60, P121, DOI 10.1080/00330120701724251; Xie YH, 2015, IEEE GEOSCI REMOTE S, V12, P1111, DOI 10.1109/LGRS.2014.2385597; Xie YC, 1995, COMPUT ENVIRON URBAN, V19, P287, DOI 10.1016/0198-9715(95)00028-3; Xie ZX, 2006, GISCI REMOTE SENS, V43, P233, DOI 10.2747/1548-1603.43.3.233; Xiong B, 2015, ISPRS J PHOTOGRAMM, V101, P275, DOI 10.1016/j.isprsjprs.2015.01.002; Xiong B, 2014, ISPRS J PHOTOGRAMM, V93, P227, DOI 10.1016/j.isprsjprs.2014.01.007; Yew Yuan, 1997, Computers, Environment and Urban Systems, V21, P245, DOI 10.1016/S0198-9715(97)01003-X; Zandbergen PA, 2010, CARTOGR GEOGR INF SC, V37, P199, DOI 10.1559/152304010792194985; Zhan FB, 2010, INT J REMOTE SENS, V31, P5689, DOI 10.1080/01431161.2010.496802; Zhu LL, 2015, REMOTE SENS-BASEL, V7, P6710, DOI 10.3390/rs70606710; Zoraghein H, 2016, COMPUT ENVIRON URBAN, V58, P19, DOI 10.1016/j.compenvurbsys.2016.03.004	134	37	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156808	10.1371/journal.pone.0156808	http://dx.doi.org/10.1371/journal.pone.0156808			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27254151	gold, Green Published, Green Submitted			2022-12-26	WOS:000377218700063
J	Zhu, FJ; Schlupp, I; Tiedemann, R				Zhu, Fangjun; Schlupp, Ingo; Tiedemann, Ralph			Sequence Evolution and Expression of the Androgen Receptor and Other Pathway-Related Genes in a Unisexual Fish, the Amazon Molly, Poecilia formosa, and Its Bisexual Ancestors	PLOS ONE			English	Article							HYBRID ORIGIN; SEX REVERSAL; ESTROGEN; TELEOST; HYBRIDIZATION; MODEL; AROMATASE; POLYPLOIDY; ISOFORMS; GOLDFISH	The all-female Amazon molly (Poecilia formosa) originated from a single hybridization of two bisexual ancestors, Atlantic molly (Poecilia mexicana) and sailfin molly (Poecilia latipinna). As a gynogenetic species, the Amazon molly needs to copulate with a heterospecific male, but the genetic information of the sperm-donor does not contribute to the next generation, as the sperm only acts as the trigger for the diploid eggs' embryogenesis. Here, we study the sequence evolution and gene expression of the duplicated genes coding for androgen receptors (ars) and other pathway-related genes, i.e., the estrogen receptors (ers) and cytochrome P450, family19, subfamily A, aromatase genes (cyp19as), in the Amazon molly, in comparison to its bisexual ancestors. Mollies possess-as most other teleost fish-two copies of the ar, er, and cyp19a genes, i.e., ara/ar beta, era/er beta 1, and cyp19a1 (also referred as cyp19a1a)/cyp19a2 (also referred to as cyp19a1b), respectively. Non-synonymous single nucleotide polymorphisms (SNPs) among the ancestral bisexual species were generally predicted not to alter protein function. Some derived substitutions in the P. mexicana and one in P. formosa are predicted to impact protein function. We also describe the gene expression pattern of the ars and pathway-related genes in various tissues (i.e., brain, gill, and ovary) and provide SNP markers for allele specific expression research. As a general tendency, the levels of gene expression were lowest in gill and highest in ovarian tissues, while expression levels in the brain were intermediate in most cases. Expression levels in P. formosa were conserved where expression did not differ between the two bisexual ancestors. In those cases where gene expression levels significantly differed between the bisexual species, P. formosa expression was always comparable to the higher expression level among the two ancestors. Interestingly, er beta 1 was expressed neither in brain nor in gill in the analyzed three molly species, which implies a more important role of era in the estradiol synthesis pathway in these tissues. Furthermore, our data suggest that interactions of steroid-signaling pathway genes differ across tissues, in particular the interactions of ars and cyp19as.	[Zhu, Fangjun; Tiedemann, Ralph] Univ Potsdam, Inst Biochem & Biol, Univ Evolutionary Biol Systemat Zool, Potsdam, Germany; [Schlupp, Ingo] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	University of Potsdam; University of Oklahoma System; University of Oklahoma - Norman	Tiedemann, R (corresponding author), Univ Potsdam, Inst Biochem & Biol, Univ Evolutionary Biol Systemat Zool, Potsdam, Germany.	tiedeman@uni-potsdam.de		Tiedemann, Ralph/0000-0002-2604-6336	University of Potsdam	University of Potsdam	Financial support was provided by the University of Potsdam.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; AVISE JC, 1991, EVOLUTION, V45, P1530, DOI 10.1111/j.1558-5646.1991.tb02657.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Beukeboom LW, 1998, J EVOLUTION BIOL, V11, P755, DOI 10.1007/s000360050117; Bohne A, 2013, MOL BIOL EVOL, V30, P2268, DOI 10.1093/molbev/mst124; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Callard GV, 2001, J STEROID BIOCHEM, V79, P305, DOI 10.1016/S0960-0760(01)00147-9; Cao MX, 2012, COMP BIOCHEM PHYS A, V162, P303, DOI 10.1016/j.cbpa.2012.03.021; Chakraborty T, 2011, J STEROID BIOCHEM, V123, P115, DOI 10.1016/j.jsbmb.2010.11.015; Chapman MA, 2007, EVOLUTION, V61, P1773, DOI 10.1111/j.1558-5646.2007.00134.x; Choi Y., 2012, P ACM C BIOINF COMP, P414, DOI 10.1145/2382936.2382989; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Conley A, 2001, REPRODUCTION, V121, P685, DOI 10.1530/rep.0.1210685; DARNELL RM, 1968, COPEIA, P354; Diotel N, 2010, FRONT NEUROENDOCRIN, V31, P172, DOI 10.1016/j.yfrne.2010.01.003; Douard V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-336; Gabor CR, 2012, PHYSIOL BEHAV, V105, P885, DOI 10.1016/j.physbeh.2011.10.024; Gabor CR, 2010, HORM BEHAV, V57, P427, DOI 10.1016/j.yhbeh.2010.01.012; Gui JF, 2010, SCI CHINA LIFE SCI, V53, P409, DOI 10.1007/s11427-010-0092-6; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hubbs CL, 1932, SCIENCE, V76, P628, DOI 10.1126/science.76.1983.628; Iwanowicz LR, 2014, FISH SHELLFISH IMMUN, V40, P109, DOI 10.1016/j.fsi.2014.06.021; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katsu Y, 2013, J APPL TOXICOL, V33, P41, DOI 10.1002/jat.1707; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kishida M, 2001, ENDOCRINOLOGY, V142, P740, DOI 10.1210/en.142.2.740; Kobayashi H, 2005, ZOOL SCI, V22, P1163, DOI 10.2108/zsj.22.1163; Kobayashi T, 2003, CYTOGENET GENOME RES, V101, P289, DOI 10.1159/000074351; Lamatsch DK, 2000, CYTOGENET CELL GENET, V91, P148, DOI 10.1159/000056836; Lampert KP, 2008, PHILOS T R SOC B, V363, P2901, DOI 10.1098/rstb.2008.0040; Lampert KP, 2006, J GENET, V85, P67, DOI 10.1007/BF02728973; Laudet V, 2002, NUCL RECEPTOR FACTSB; Le Page Y, 2010, EUR J NEUROSCI, V32, P2105, DOI 10.1111/j.1460-9568.2010.07519.x; Mable BK, 2004, BIOL J LINN SOC, V82, P453, DOI 10.1111/j.1095-8312.2004.00332.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; MerchantLarios H, 1997, GEN COMP ENDOCR, V107, P373, DOI 10.1006/gcen.1997.6946; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Meyer A, 2006, MOL ECOL, V15, P721, DOI 10.1111/j.1365-294X.2006.02810.x; Munchrath LA, 2010, J COMP NEUROL, V518, P3302, DOI 10.1002/cne.22401; Niemeitz Andreas, 2002, Acta Ethologica, V5, P45, DOI 10.1007/s10211-002-0065-2; Ogino Y, 2004, FEBS LETT, V575, P119, DOI 10.1016/j.febslet.2004.08.046; Overgard AC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piferrer F, 2001, AQUACULTURE, V197, P229, DOI 10.1016/S0044-8486(01)00589-0; Ptacek MB, 2005, ANIM BEHAV, V70, P1339, DOI 10.1016/j.anbehav.2005.03.019; R Development Core Team RFFSC, 2008, R LANG ENV STAT COMP, P2673; Reitzel AM, 2010, MOL BIOL EVOL, V27, P2211, DOI 10.1093/molbev/msq129; Ryan MJ, 1996, ANIM BEHAV, V52, P1225, DOI 10.1006/anbe.1996.0270; Salzburger W, 2002, MOL ECOL, V11, P619, DOI 10.1046/j.0962-1083.2001.01438.x; SCHARTL M, 1995, EVOLUTION, V49, P827, DOI 10.1111/j.1558-5646.1995.tb02319.x; SCHARTL M, 1995, NATURE, V373, P68, DOI 10.1038/373068a0; Schedina Ina Maria, 2014, BMC Research Notes, V7, P1, DOI 10.1186/1756-0500-7-249; SCHEIB D, 1983, DIFFERENTIATION, V23, pS87; Schlupp I, 2005, ANNU REV ECOL EVOL S, V36, P399, DOI 10.1146/annurev.ecolsys.36.102003.152629; Schlupp I, 2002, J BIOGEOGR, V29, P1, DOI 10.1046/j.1365-2699.2002.00651.x; SCHULTZ RJ, 1969, AM NAT, V103, P605, DOI 10.1086/282629; Schupp I, 2005, BIOL LETT-UK, V1, P169, DOI 10.1098/rsbl.2005.0306; Sone K, 2005, GEN COMP ENDOCR, V143, P151, DOI 10.1016/j.ygcen.2005.03.007; Sorensen PW, 2005, GEN COMP ENDOCR, V140, P164, DOI 10.1016/j.ygcen.2004.11.006; SORENSEN PW, 1994, ACTA PHYSIOL SCAND, V152, P191, DOI 10.1111/j.1748-1716.1994.tb09799.x; Stacey N, 2009, HORMONAL PHEROMONES; Staub NL, 1997, GEN COMP ENDOCR, V108, P1, DOI 10.1006/gcen.1997.6962; Stock M, 2010, MOL ECOL, V19, P5204, DOI 10.1111/j.1365-294X.2010.04869.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tiedemann R, 2005, MOL ECOL NOTES, V5, P586, DOI 10.1111/j.1471-8286.2005.00993.x; Tiwary BK, 2009, MOL BIOL EVOL, V26, P123, DOI 10.1093/molbev/msn233; TURNER BJ, 1980, EVOLUTION, V34, P917, DOI 10.1111/j.1558-5646.1980.tb04029.x; Unal G, 2014, COMP BIOCHEM PHYS B, V172, P67, DOI 10.1016/j.cbpb.2014.04.002; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VRIJENHOEK RC, 1989, EVOLUTION ECOLOGY UN, P24; Zhang ZH, 2014, SCI CHINA LIFE SCI, V57, P889, DOI 10.1007/s11427-014-4707-1	76	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156209	10.1371/journal.pone.0156209	http://dx.doi.org/10.1371/journal.pone.0156209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249369	Green Published, gold, Green Submitted			2022-12-26	WOS:000377184700031
J	Eissa, N; Hussein, H; Wang, HX; Rabbi, MF; Bernstein, CN; Ghia, JE				Eissa, Nour; Hussein, Hayam; Wang, Hongxing; Rabbi, Mohammad F.; Bernstein, Charles N.; Ghia, Jean-Eric			Stability of Reference Genes for Messenger RNA Quantification by Real-Time PCR in Mouse Dextran Sodium Sulfate Experimental Colitis	PLOS ONE			English	Review							HOUSEKEEPING GENES; NORMALIZING GENES; RT-PCR; EXPRESSION; SELECTION; MODELS; IDENTIFICATION; CELLS; QPCR	Background Many animal models have been developed to characterize the complexity of colonic inflammation. In dextran sodium sulfate (DSS) experimental colitis in mice the choice of reference genes is critical for accurate quantification of target genes using quantitative real time PCR (RT-qPCR). No studies have addressed the performance of reference genes in mice DSS-experimental colitis. This study aimed to determine the stability of reference genes expression (RGE) in DSS-experimental murine colitis. Methods Colitis was induced in male C57BL/6 mice using DSS5% for 5 days, control group received water. RNA was extracted from inflamed and non-inflamed colon. Using RT-qPCR, comparative analysis of 13 RGE was performed according to predefined criteria and relative colonic TNF-alpha and IL-1 beta gene expression was determined by calculating the difference in the threshold cycle. Results Colitis significantly altered the stability of mucosal RGE. Commonly used glyceraldehyde-3-phosphate dehydrogenase (Gapdh), beta-actin (Actb), or beta 2-microglobulin (beta 2m) showed the highest variability within the inflamed and control groups. Conversely, TATA-box-binding protein (Tbp) and eukaryotic translation elongation factor 2 (Eef2) were not affected by inflammation and were the most stable genes. Normalization of colonic TNF-alpha and IL-1 beta mRNA levels was dependent on the reference gene used. Depending on the genes used to normalize the data, statistical significance varied from significant when TBP/Eef2 were used to non-significant when Gapdh, Actb or beta 2m were used. Conclusions This study highlights the appropriate choice of RGE to ensure adequate normalization of RT-qPCR data when using this model. Suboptimal RGE may explain controversial results from published studies. We recommend using Tbp and Eef2 instead of Gapdh, Actb or beta 2m as reference genes.	[Eissa, Nour; Wang, Hongxing; Rabbi, Mohammad F.; Ghia, Jean-Eric] Univ Manitoba, Immunol, Winnipeg, MB, Canada; [Eissa, Nour; Ghia, Jean-Eric] Univ Manitoba, Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Hussein, Hayam] Ohio State Univ, Coll Vet Med, Dept Vet Clin Sci, Columbus, OH 43210 USA; [Bernstein, Charles N.; Ghia, Jean-Eric] Univ Manitoba, Internal Med Sect Gastroenterol, Winnipeg, MB, Canada; [Bernstein, Charles N.; Ghia, Jean-Eric] Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB, Canada; [Wang, Hongxing] Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University System of Ohio; Ohio State University; University of Manitoba; University of Manitoba; Capital Medical University	Ghia, JE (corresponding author), Univ Manitoba, Immunol, Winnipeg, MB, Canada.; Ghia, JE (corresponding author), Univ Manitoba, Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada.; Ghia, JE (corresponding author), Univ Manitoba, Internal Med Sect Gastroenterol, Winnipeg, MB, Canada.; Ghia, JE (corresponding author), Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB, Canada.	Jean-Eric.Ghia@umanitoba.ca	, 复之-王红星/ABF-3671-2020; Eissa, Nour/E-1464-2013	Eissa, Nour/0000-0002-3484-6720; Ghia, Jean-Eric/0000-0002-3018-9719; Hussein, Hayam/0000-0003-4595-3094	Canadian Foundation for Innovation; Crohn's and Colitis Canada; Research Manitoba; Canadian Institutes of Health Research; Children's Hospital Research Institute of Manitoba	Canadian Foundation for Innovation(Canada Foundation for Innovation); Crohn's and Colitis Canada; Research Manitoba; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Children's Hospital Research Institute of Manitoba	This study was supported by grants from Canadian Foundation for Innovation, Crohn's and Colitis Canada, Research Manitoba, the Canadian Institutes of Health Research to JEG and the Children's Hospital Research Institute of Manitoba to NE and JEG.	Adachi H, 2015, GENES CELLS, V20, P625, DOI 10.1111/gtc.12254; Adamski MG, 2013, J BIOMOL SCREEN, V18, P1008, DOI 10.1177/1087057113489882; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bamias G, 2013, INFLAMM BOWEL DIS, V19, P2840, DOI 10.1097/01.MIB.0000435440.22484.e8; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chassaing B, 2014, CURRENT PROTOCOLS IM; Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054; COOPER HS, 1993, LAB INVEST, V69, P238; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Derks NM, 2008, NEUROSCIENCE, V156, P305, DOI 10.1016/j.neuroscience.2008.07.047; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Liu L- L, 2015, PLOS ONE, V10; Meldgaard M, 2006, J NEUROSCI METH, V156, P101, DOI 10.1016/j.jneumeth.2006.02.008; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Munyaka PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142536; Munyaka PM, 2016, J BASIC MICROBIOLOGY; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Park KT, 2011, INFLAMM BOWEL DIS, V17, P1603, DOI 10.1002/ibd.21488; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rabbi MF, 2014, BIOCHEM PHARMACOL, V89, P386, DOI 10.1016/j.bcp.2014.03.003; Reid LH, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-150; Ren SW, 2010, MOL VIS, V16, P1076; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Stephens Alexandre S, 2011, BMC Res Notes, V4, P410, DOI 10.1186/1756-0500-4-410; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Tatsumi K, 2008, BIOCHEM BIOPH RES CO, V374, P106, DOI 10.1016/j.bbrc.2008.06.103; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Troost FJ, 2006, PHYSIOL GENOMICS, V25, P242, DOI 10.1152/physiolgenomics.00114.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp721; Wang FC, 2010, ANAL BIOCHEM, V399, P211, DOI 10.1016/j.ab.2009.12.029; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980	40	49	49	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156289	10.1371/journal.pone.0156289	http://dx.doi.org/10.1371/journal.pone.0156289			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244258	gold, Green Submitted, Green Published			2022-12-26	WOS:000377146100024
J	Huang, XQ; Xue, J; Lin, M; Zhu, YS				Huang, Xiaoqiang; Xue, Jing; Lin, Min; Zhu, Yushan			Use of an Improved Matching Algorithm to Select Scaffolds for Enzyme Design Based on a Complex Active Site Model	PLOS ONE			English	Article							ATOMIC-LEVEL ACCURACY; COMPUTATIONAL DESIGN; CRYSTAL-STRUCTURE; DIRECTED EVOLUTION; KEMP ELIMINASE; SEQUENCE SELECTION; PENICILLIN ACYLASE; PROTEIN DESIGN; CATALYSIS; ESTERASE	Active site preorganization helps native enzymes electrostatically stabilize the transition state better than the ground state for their primary substrates and achieve significant rate enhancement. In this report, we hypothesize that a complex active site model for active site preorganization modeling should help to create preorganized active site design and afford higher starting activities towards target reactions. Our matching algorithm ProdaMatch was improved by invoking effective pruning strategies and the native active sites for ten scaffolds in a benchmark test set were reproduced. The root-mean squared deviations between the matched transition states and those in the crystal structures were <1.0 angstrom for the ten scaffolds, and the repacking calculation results showed that 91% of the hydrogen bonds within the active sites are recovered, indicating that the active sites can be preorganized based on the predicted positions of transition states. The application of the complex active site model for de novo enzyme design was evaluated by scaffold selection using a classic catalytic triad motif for the hydrolysis of p-nitrophenyl acetate. Eighty scaffolds were identified from a scaffold library with 1,491 proteins and four scaffolds were native esterase. Furthermore, enzyme design for complicated substrates was investigated for the hydrolysis of cephalexin using scaffold selection based on two different catalytic motifs. Only three scaffolds were identified from the scaffold library by virtue of the classic catalytic triad-based motif. In contrast, 40 scaffolds were identified using a more flexible, but still preorganized catalytic motif, where one scaffold corresponded to the a-amino acid ester hydrolase that catalyzes the hydrolysis and synthesis of cephalexin. Thus, the complex active site modeling approach for de novo enzyme design with the aid of the improved ProdaMatch program is a promising approach for the creation of active sites with high catalytic efficiencies towards target reactions.	[Huang, Xiaoqiang; Xue, Jing; Lin, Min; Zhu, Yushan] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China	Tsinghua University	Zhu, YS (corresponding author), Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China.	yszhu@tsinghua.edu.cn			National Natural Science Foundation of China [21276136, 21476123]; National High Technology Research and Development (863) Program of China [2012AA021204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development (863) Program of China(National High Technology Research and Development Program of China)	YZ was financially supported by the National Natural Science Foundation of China (Grant Numbers: 21276136, 21476123), and the National High Technology Research and Development (863) Program of China (Grant Number: 2012AA021204).	Arnold FH, 1998, ACCOUNTS CHEM RES, V31, P125, DOI 10.1021/ar960017f; Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Barends TRM, 2003, J BIOL CHEM, V278, P23076, DOI 10.1074/jbc.M302246200; Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Benson DE, 2000, P NATL ACAD SCI USA, V97, P6292, DOI 10.1073/pnas.97.12.6292; Blomberg R, 2013, NATURE, V503, P418, DOI 10.1038/nature12623; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; BRYAN P, 1986, P NATL ACAD SCI USA, V83, P3743, DOI 10.1073/pnas.83.11.3743; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; Fazelinia H, 2009, PROTEIN SCI, V18, P180, DOI 10.1002/pro.2; Frushicheva MP, 2014, CURR OPIN CHEM BIOL, V21, P56, DOI 10.1016/j.cbpa.2014.03.022; Frushicheva MP, 2010, P NATL ACAD SCI USA, V107, P16869, DOI 10.1073/pnas.1010381107; Furnham N, 2014, NUCLEIC ACIDS RES, V42, pD485, DOI 10.1093/nar/gkt1243; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HELLINGA HW, 1991, J MOL BIOL, V222, P763, DOI 10.1016/0022-2836(91)90510-D; Hilvert D, 2000, ANNU REV BIOCHEM, V69, P751, DOI 10.1146/annurev.biochem.69.1.751; Huang XQ, 2013, PROTEIN SCI, V22, P929, DOI 10.1002/pro.2275; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Khersonsky O, 2012, P NATL ACAD SCI USA, V109, P10358, DOI 10.1073/pnas.1121063109; Kim Y, 2000, STRUCTURE, V8, P1059, DOI 10.1016/S0969-2126(00)00505-0; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Larsen NA, 2002, NAT STRUCT BIOL, V9, P17, DOI 10.1038/nsb742; Lassila JK, 2006, P NATL ACAD SCI USA, V103, P16710, DOI 10.1073/pnas.0607691103; Lei YL, 2011, PROTEIN SCI, V20, P1566, DOI 10.1002/pro.685; Levisson M, 2012, PROTEINS, V80, P1545, DOI 10.1002/prot.24041; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malisi C, 2009, PROTEINS, V77, P74, DOI 10.1002/prot.22418; McVey CE, 2001, J MOL BIOL, V313, P139, DOI 10.1006/jmbi.2001.5043; Nosrati GR, 2012, PROTEIN SCI, V21, P697, DOI 10.1002/pro.2055; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; Privett HK, 2012, P NATL ACAD SCI USA, V109, P3790, DOI 10.1073/pnas.1118082108; Rajagopalan S, 2014, NAT CHEM BIOL, V10, P386, DOI 10.1038/nchembio.1498; Richter F, 2012, J AM CHEM SOC, V134, P16197, DOI 10.1021/ja3037367; Richter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019230; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Smith AJT, 2008, J AM CHEM SOC, V130, P15361, DOI 10.1021/ja803213p; Spiller B, 1999, P NATL ACAD SCI USA, V96, P12305, DOI 10.1073/pnas.96.22.12305; Tantillo DJ, 1998, CURR OPIN CHEM BIOL, V2, P743, DOI 10.1016/S1367-5931(98)80112-9; Terzyan S, 2000, PROTEIN SCI, V9, P1783, DOI 10.1110/ps.9.9.1783; Tian Y, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2742-x; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; Xiang ZX, 2001, J MOL BIOL, V311, P421, DOI 10.1006/jmbi.2001.4865; Xue J, 2016, J MOL MODEL, V22, DOI 10.1007/s00894-016-2915-2; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhang CS, 2012, PROTEINS, V80, P1078, DOI 10.1002/prot.24009; Zhu XL, 2009, J COMPUT CHEM, V30, P256, DOI 10.1002/jcc.21050	54	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156559	10.1371/journal.pone.0156559	http://dx.doi.org/10.1371/journal.pone.0156559			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243223	Green Published, gold, Green Submitted			2022-12-26	WOS:000377146100047
J	Hoebel, J; Rattay, P; Prutz, F; Rommel, A; Lampert, T				Hoebel, Jens; Rattay, Petra; Pruetz, Franziska; Rommel, Alexander; Lampert, Thomas			Socioeconomic Status and Use of Outpatient Medical Care: The Case of Germany	PLOS ONE			English	Article							INCOME-RELATED INEQUALITIES; SELF-REPORTED UTILIZATION; HEALTH-CARE; SERVICES UTILIZATION; PARTICIPATION; ADULTS; INTERVIEW; PATIENT; ACCESS; ASSOCIATION	Background Socially disadvantaged people have an increased need for medical care due to a higher burden of health problems and chronic diseases. In Germany, outpatient care is chiefly provided by office-based general practitioners and specialists in private practice. People are free to choose the physician they prefer. In this study, national data were used to examine differences in the use of outpatient medical care by socioeconomic status (SES). Methods The analyses were based on data from 6,754 participants in the Robert Koch Institute's German Health Interview and Examination Survey for Adults (DEGS1) aged between 18 and 69 years. The number of outpatient physician visits during the past twelve months was assessed for several medical specializations. SES was determined based on education, occupation, and income. Associations between SES and physician visits were analysed using logistic regression and zero-truncated negative binomial regression for count data. Results After adjusting for sociodemographic factors and health indicators, outpatients with low SES had more contacts with general practitioners than outpatients with high SES (men: incidence rate ratio [IRR] = 1.25; 95% confidence interval [CI] = 1.08-1.46; women: IRR = 1.20; 95% CI = 1.07-1.34). The use of specialists was lower in people with low SES than in those with high SES when sociodemographic factors and health indicators were adjusted for (men: odds ratio [OR] = 0.68; 95% CI = 0.51-0.91; women: OR = 0.56; 95% CI = 0.41-0.77). This applied particularly to specialists in internal medicine, dermatology, and gynaecology. The associations remained after additional adjustment for the type of health insurance and the regional density of office-based physicians. Conclusion The findings suggest that socially disadvantaged people are seen by general practitioners more often than the socially better-off, who are more likely to visit a medical specialist. These differences may be due to differences in patient preferences, physician factors, physician-patient interaction, and potential barriers to accessing specialist care.	[Hoebel, Jens; Rattay, Petra; Lampert, Thomas] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Unit Social Determinants Hlth, Berlin, Germany; [Pruetz, Franziska; Rommel, Alexander] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Unit Hlth Reporting, Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Hoebel, J (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Unit Social Determinants Hlth, Berlin, Germany.	j.hoebel@rki.de			ministry finances the RKI	ministry finances the RKI	The German Health Interview and Examination Survey for Adults (DEGS) is part of the Federal Health Monitoring (FHM) in Germany. The FHM is administered by the Robert Koch Institute (RKI) on behalf of the German Federal Ministry of Health. The ministry finances the RKI and gives substantial funds for the FHM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors are employees of the RKI. No one of the authors received specific funding for this work.	Baumeister SE, 2004, GESUNDHEITSWESEN, V66, P175, DOI 10.1055/s-2004-813028; Bergmann E, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1365, DOI 10.1007/s00103-005-1167-6; Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298; Bormann C., 2014, HLTH CARE UTILIZATIO, P29, DOI [10.1007/978-1-4614-9191-0_3, DOI 10.1007/978-1-4614-9191-0_3]; Boyle Sean, 2011, Health Syst Transit, V13, P1; Brauns H, 2003, ADV CROSS NATL COMP, P221, DOI [10.1007/978-1-4419-9186-7_11, DOI 10.1007/978-1-4419-9186-7_11]; Bremer P, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0036-0; Bremer P, 2013, PRAVENT GESUNDHEIT, V8, P15, DOI 10.1007/s11553-012-0368-8; Busse R, 2014, HEALT SYST TRANSIT, V16, P1; Cox B, 2009, INT J PUBLIC HEALTH, V54, P55, DOI 10.1007/s00038-009-7104-y; Cylus J, 2015, HEALTH POLICY, V119, P1133, DOI 10.1016/j.healthpol.2015.07.004; Devaux M, 2015, EUR J HEALTH ECON, V16, P21, DOI 10.1007/s10198-013-0546-4; Droomers M, 2004, EUR J PUBLIC HEALTH, V14, P311, DOI 10.1093/eurpub/14.3.311; Ernst J, 2014, GESUNDHEITSWESEN, V76, P187, DOI 10.1055/s-0033-1361150; European Commission, 2013, HLTH IN EU FIN REP C; GANZEBOOM HBG, 1992, SOC SCI RES, V21, P1, DOI 10.1016/0049-089X(92)90017-B; Garcia-Armesto Sandra, 2010, Health Syst Transit, V12, P1; Geyer S, 2015, ARCH GYNECOL OBSTET, V291, P623, DOI 10.1007/s00404-014-3421-3; Gruber S, 2010, J PUBLIC HEALTH-HEID, V18, P351, DOI 10.1007/s10389-010-0321-2; Hoebel J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-913; Hoebel J, 2013, DTSCH ARZTEBL INT, V110, P679, DOI 10.3238/arztebl.2013.0679; Hoffmann F, 2012, GESUNDHEITSWESEN, V74, P291, DOI 10.1055/s-0031-1275711; JanSSen Christian, 2012, Psychosoc Med, V9, pDoc07, DOI 10.3205/psm000085; Jordan S, 2015, BUNDESGESUNDHEITSBLA, V58, P942, DOI 10.1007/s00103-015-2200-z; Kamtsiuris P, 2013, BUNDESGESUNDHEITSBLA, V56, P620, DOI 10.1007/s00103-012-1650-9; Kassenarztliche Bundesvereinigung, 2011, BUND 2011; Klein J., 2014, HLTH CARE UTILIZATIO, P117; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4; Lostao L, 2007, J EPIDEMIOL COMMUN H, V61, P416, DOI 10.1136/jech.2006.047126; Lungen M, 2009, AUSMASS GRUNDE UNGLE; Lungen M, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-1; Mackenbach, 2006, HLTH INEQUALITIES EU; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot MG., 2006, SOCIAL DETERMINANTS; Mielck A, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-52; O'Malley MS, 2001, AM J PUBLIC HEALTH, V91, P49; Peersman W, 2014, EUR J PUBLIC HEALTH, V24, P91, DOI 10.1093/eurpub/ckt079; Rattay P, 2013, BUNDESGESUNDHEITSBLA, V56, P832, DOI 10.1007/s00103-013-1665-x; Reibling N, 2010, GESUNDHEITSWESEN, V72, P447, DOI 10.1055/s-0029-1234101; Ruckert IM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-232; Sass AC, 2015, BUNDESGESUNDHEITSBLA, V58, P533, DOI 10.1007/s00103-015-2146-1; Schafer Willemijn, 2010, Health Syst Transit, V12, pv; Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-730; Seidel D, 2009, J CANCER RES CLIN, V135, P533, DOI 10.1007/s00432-008-0485-0; Sorensen TH, 2009, HEALTH POLICY, V92, P180, DOI 10.1016/j.healthpol.2009.03.011; Starker A, 2013, BUNDESGESUNDHEITSBLA, V56, P858, DOI 10.1007/s00103-012-1655-4; Stirbu I, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-288; Swart Enno, 2012, Psychosoc Med, V9, pDoc10, DOI 10.3205/psm000088; Terraneo M, 2015, SOC SCI MED, V126, P154, DOI 10.1016/j.socscimed.2014.12.028; Thode N, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P296, DOI 10.1007/s00103-004-1004-3; van Doorslaer E, 2004, HEALTH ECON, V13, P629, DOI 10.1002/hec.919; von dem Knesebeck O, 2009, GESUNDHEITSWESEN, V71, P59, DOI 10.1055/s-0028-1119371; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; Zok K, 2005, WIDOMONITOR, V2, P1	54	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155982	10.1371/journal.pone.0155982	http://dx.doi.org/10.1371/journal.pone.0155982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232878	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000010
J	Maeyashiki, A; Akahane, M; Sugiura, H; Ohkusa, Y; Okabe, N; Imamura, T				Maeyashiki, Akie; Akahane, Manabu; Sugiura, Hiroaki; Ohkusa, Yasushi; Okabe, Nobuhiko; Imamura, Tomoaki			Development and Application of an Alert System to Detect Cases of Food Poisoning in Japan	PLOS ONE			English	Article							SPONTANEOUS REPORTING SYSTEM; SIGNAL-DETECTION; DAILY QUESTIONNAIRE; ODDS RATIO; HEALTH	Recent public health concerns regarding commercial food products have increased the need to develop an automated method to detect food product-related health events. We developed and verified a method for the early detection of potentially harmful events caused by commercial food products. We collected data from daily internet-based questionnaires examining the presence or absence of symptoms and information about food purchased by the respondents. Using these data, we developed a method to detect possible health concerns regarding commercialized food products. To achieve this, we combined the signal detection method used in the reporting system of adverse effects of pharmaceutical products and the Early Aberration Reporting System (EARS) used by the United States Centers for Disease Control. Whiteleg shrimp (Litopenaeus vannamei), which had odds ratio and Odds(-) of 8.99 and 4.13, respectively, was identified as a possible causative food product for diarrhea and vomiting. In conclusion, this study demonstrated that food distributors can implement post-marketing monitoring of the safety of food products purchased via the internet.	[Maeyashiki, Akie; Akahane, Manabu; Sugiura, Hiroaki; Imamura, Tomoaki] Nara Med Univ, Dept Publ Hlth Hlth Management & Policy, Sch Med, Kashihara, Nara 634, Japan; [Ohkusa, Yasushi] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Okabe, Nobuhiko] Kawasaki City Publ Hlth Inst Publ Hlth, Kawasaki, Kanagawa, Japan	Nara Medical University; National Institute of Infectious Diseases (NIID)	Maeyashiki, A (corresponding author), Nara Med Univ, Dept Publ Hlth Hlth Management & Policy, Sch Med, Kashihara, Nara 634, Japan.	hamue@naramed-u.ac.jp	Akahane, Manabu/GYD-5539-2022		Health Labour Sciences Research Grant; Tomoaki Imamura	Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Tomoaki Imamura	This study was supported by a Health Labour Sciences Research Grant. The author who received the funding is Tomoaki Imamura. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, EMERG INFECT DIS, V3, P581; Centers for Disease Control and Prevention, NAT STRAT BIOS; Council for International Organizations of Medical Sciences, 2010, PRACT ASP SIGN DET P; Dart RC, 2009, DRUG ALCOHOL DEPEN, V105, pS26, DOI 10.1016/j.drugalcdep.2009.08.011; Hauben M, 2009, DRUG SAFETY, V32, P99, DOI 10.2165/00002018-200932020-00003; Hepburn P, 2008, FOOD CHEM TOXICOL, V46, P9, DOI 10.1016/j.fct.2007.09.008; Hutwagner L, 2003, J URBAN HEALTH, V80, pI89; Lindquist M, 1999, PHARMACOEPIDEM DR S, V8, pS15, DOI 10.1002/(SICI)1099-1557(199904)8:1+<S15::AID-PDS402>3.3.CO;2-2; Meyboom RHB, 1997, DRUG SAFETY, V16, P355, DOI 10.2165/00002018-199716060-00002; Nguyen M, 2012, PHARMACOEPIDEM DR S, V21, P291, DOI 10.1002/pds.2323; Newkirk R, 2011, FOODBORNE PATHOG DIS, V8, P433, DOI 10.1089/fpd.2010.0731; Ooba N, 2010, PHARMACOEPIDEM DR S, V19, P1159, DOI 10.1002/pds.2014; Rothman KJ, 2004, PHARMACOEPIDEM DR S, V13, P519, DOI 10.1002/pds.1001; Sano T, 2013, INT J ENVIRON HEAL R, V23, P247, DOI 10.1080/09603123.2012.717916; Sugiura H, 2010, EPIDEMIOL INFECT, V138, P1493, DOI 10.1017/S095026880999149X; Sugiura H, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1872; Sumi Y, 2008, J TOXICOL SCI, V33, P485, DOI 10.2131/jts.33.485; van der Heijden PGM, 2002, STAT MED, V21, P2027, DOI 10.1002/sim.1157; van Puijenbroek EP, 2003, DRUG SAFETY, V26, P293, DOI 10.2165/00002018-200326050-00001; van Puijenbroek EP, 2002, PHARMACOEPIDEM DR S, V11, P3, DOI 10.1002/pds.668; van Puijenbroek EP, 2001, BRIT J CLIN PHARMACO, V52, P579, DOI 10.1046/j.0306-5251.2001.01501.x; van Puijenbroek EP, 1999, BRIT J CLIN PHARMACO, V47, P689, DOI 10.1046/j.1365-2125.1999.00957.x; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; World Health Organization, SAF MED GUID DET REP	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156395	10.1371/journal.pone.0156395	http://dx.doi.org/10.1371/journal.pone.0156395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27231884	gold, Green Published, Green Submitted			2022-12-26	WOS:000376883000028
J	Chiu, LY; Hsin, IL; Yang, TY; Sung, WW; Chi, JY; Chang, JT; Ko, JL; Sheu, GT				Chiu, L-Y; Hsin, I-L; Yang, T-Y; Sung, W-W; Chi, J-Y; Chang, J. T.; Ko, J-L; Sheu, G-T			The ERK-ZEB1 pathway mediates epithelial mesenchymal transition in pemetrexed resistant lung cancer cells with suppression by vinca alkaloids	ONCOGENE			English	Article							TRANSCRIPTION FACTOR SNAIL; TGF-BETA; E-CADHERIN; THYMIDYLATE SYNTHASE; SIGNALING PATHWAYS; MULTITARGETED ANTIFOLATE; MULTIDRUG-RESISTANCE; CARCINOMA-CELLS; SMAD PROTEINS; TUMOR-CELLS	High thymidylate synthase (TS) level in cancer tissue is considered to result in resistance to pemetrexed therapy for advanced stages of nonsquamous non-small cell lung cancers. To further investigate the mechanism of pemetrexed resistance and potential prognostic outcomes in lung cancer, we established pemetrexed-resistant lung adenocarcinoma cell sublines from CL1 harboring a mutated TP53 gene (R248W) and A549 harboring wild-type TP53. We found the TS expression is upregulated in both pemetrexed-resistant sublines and the reduced TS level achieved through shRNA inhibition resulted in higher pemetrexed sensitivity. We also demonstrated that the acquisitions of pemetrexed resistance enhances epithelial mesenchymal transition (EMT) in vivo with a mice animal model and in vitro with CL1 and A549 sublines, which was associated with upregulation of ZEB1 which, in turn, downregulates E-cadherin and upregulates fibronectin. When ERK1/2 phosphorylation was reduced by an inhibitor (U0126) or siRNA inhibition, both pemetrexed-resistant sublines reduced their migration and invasion abilities. Therefore, the ERK-mediated pathways induce apoptosis with pemetrexed treatment, and may in turn mediate EMT when cancer cells are resistant to pemetrexed. We further demonstrated that the growth of pemetrexed-resistant tumors could be inhibited by vinblastine in vivo and vincristine in vitro. Our data indicate that pemetrexed resistance could be relieved by non-cross-resistant chemotherapeutic drugs such as vinca alkaloids and might be independent to TP53 status. Furthermore, the phosphorylation of ERK was reduced by vincristine. This finding provides a new insight for overcoming pemetrexed resistance and metastasis by application of vinca alkaloids.	[Chiu, L-Y; Chi, J-Y; Chang, J. T.; Ko, J-L; Sheu, G-T] Chung Shan Med Univ, Inst Med, Res Bldg Room 702,110 Sec 1,Jianguo N Rd, Taichung 402, Taiwan; [Hsin, I-L] Changhua Christian Hosp, Inflammat Res & Drug Dev Ctr, Changhua, Taiwan; [Yang, T-Y] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Sung, W-W] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Sung, W-W] Chung Shan Med Univ Hosp, Dept Med Educ, Taichung, Taiwan; [Sung, W-W] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan; [Ko, J-L; Sheu, G-T] Chung Shan Med Univ Hosp, Dept Med Oncol & Chest Med, Taichung, Taiwan	Chung Shan Medical University; Changhua Christian Hospital; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital	Sheu, GT (corresponding author), Chung Shan Med Univ, Inst Med, Res Bldg Room 702,110 Sec 1,Jianguo N Rd, Taichung 402, Taiwan.	gtsheu@csmu.edu.tw	Sung, Wen-Wei/P-5053-2019; Sheu, Gwo-Tarng/H-8855-2019; Chang, Jinghua/AAV-5620-2021	Sung, Wen-Wei/0000-0002-2375-0029; Sheu, Gwo-Tarng/0000-0002-1299-3375; Ko, Jiunn-Liang/0000-0001-6855-9239	Ministry of Science and Technology, Taiwan [MOST-103-2320-6-040-015, MOST-104-2320-B-040-003]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Ministry of Science and Technology, Taiwan (MOST-103-2320-6-040-015, MOST-104-2320-B-040-003).	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Bakin AV, 2002, J CELL SCI, V115, P3193; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Buque A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063338; Calvert H, 2002, SEMIN ONCOL, V29, P54, DOI 10.1053/sonc.2002.30761; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen CY, 2011, LUNG CANCER, V74, P132, DOI 10.1016/j.lungcan.2011.01.024; Chiu LY, 2010, TOXICOL LETT, V192, P408, DOI 10.1016/j.toxlet.2009.11.018; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dhillon AS, 2015, ONCOGENE, V34, P4421, DOI 10.1038/onc.2014.374; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hiscox S, 2006, INT J CANCER, V118, P290, DOI 10.1002/ijc.21355; Kajiyama H, 2007, INT J ONCOL, V31, P277; KARTNER N, 1983, SCIENCE, V221, P1285, DOI 10.1126/science.6137059; Liu Y, 2013, CANCER CHEMOTH PHARM, V72, P1125, DOI 10.1007/s00280-013-2299-2; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Massague J, 2000, GENE DEV, V14, P627; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Moudi M, 2013, INT J PREVENTIVE MED, V4, P1231; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nishihara A, 1998, GENES CELLS, V3, P613, DOI 10.1046/j.1365-2443.1998.00217.x; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Ozasa H, 2010, CANCER SCI, V101, P161, DOI 10.1111/j.1349-7006.2009.01358.x; Piek E, 1999, J CELL SCI, V112, P4557; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; Rollins KD, 2005, CLIN THER, V27, P1343, DOI 10.1016/j.clinthera.2005.09.010; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Schultz RM, 1999, ANTICANCER RES, V19, P437; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Shih C, 1997, CANCER RES, V57, P1116; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Takkunen M, 2006, J HISTOCHEM CYTOCHEM, V54, P1263, DOI 10.1369/jhc.6A6958.2006; Tavares ALP, 2006, DEV DYNAM, V235, P1589, DOI 10.1002/dvdy.20771; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang ZW, 2010, DRUG RESIST UPDATE, V13, P109, DOI 10.1016/j.drup.2010.07.001; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Yang T, 2011, TRANSPORT DYNAMICS, P663; Yang TY, 2013, MOL CARCINOGEN, V52, P183, DOI 10.1002/mc.21842; Yee DS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-162; Zhang D, 2011, CANCER LETT, V309, P228, DOI 10.1016/j.canlet.2011.06.006; Zucali PA, 2014, LUNG CANCER, V84, P265, DOI 10.1016/j.lungcan.2013.11.011	47	73	75	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2017	36	2					242	253		10.1038/onc.2016.195	http://dx.doi.org/10.1038/onc.2016.195			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK5AA	27270426	Green Published, hybrid			2022-12-26	WOS:000393938100009
J	Elf, S; Lin, R; Xia, S; Pan, Y; Shan, C; Wu, S; Lonial, S; Gaddh, M; Arellano, ML; Khoury, HJ; Khuri, FR; Lee, BH; Boggon, TJ; Fan, J; Chen, J				Elf, S.; Lin, R.; Xia, S.; Pan, Y.; Shan, C.; Wu, S.; Lonial, S.; Gaddh, M.; Arellano, M. L.; Khoury, H. J.; Khuri, F. R.; Lee, B. H.; Boggon, T. J.; Fan, J.; Chen, J.			Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin	ONCOGENE			English	Article							PROTEIN-KINASE; CANCER CELLS; DEFICIENCY; AMPK; ATTACHMENT; FAMILY	The oxidative pentose phosphate pathway (PPP) is crucial for cancer cell metabolism and tumor growth. We recently reported that targeting a key oxidative PPP enzyme, 6-phosphogluconate dehydrogenase (6PGD), using our novel small-molecule 6PGD inhibitors Physcion and its derivative 53, shows anticancer effects. Notably, humans with genetic deficiency of either 6PGD or another oxidative PPP enzyme, glucose-6-phosphate dehydrogenase, exhibit non-immune hemolytic anemia upon exposure to aspirin and various antimalarial drugs. Inspired by these clinical observations, we examined the anticancer potential of combined treatment with 6PGD inhibitors and antimalarial drugs. We found that stable knockdown of 6PGD sensitizes leukemia cells to antimalarial agent dihydroartemisinin (DHA). Combined treatment with DHA and Physcion activates AMP-activated protein kinase, leading to synergistic inhibition of human leukemia cell viability. Moreover, our combined therapy synergistically attenuates tumor growth in xenograft nude mice injected with human K562 leukemia cells and cell viability of primary leukemia cells from human patients, but shows minimal toxicity to normal hematopoietic cells in mice as well as red blood cells and mononucleocytes from healthy human donors. Our findings reveal the potential for combined therapy using optimized doses of Physcion and DHA as a novel antileukemia treatment without inducing hemolysis.	[Elf, S.; Lin, R.; Xia, S.; Pan, Y.; Shan, C.; Lonial, S.; Gaddh, M.; Arellano, M. L.; Khoury, H. J.; Khuri, F. R.; Fan, J.; Chen, J.] Emory Univ, Sch Med, Winship Canc Inst Emory, Dept Hematol & Med Oncol, 1365-C Clifton Rd NE C3002, Atlanta, GA 30322 USA; [Wu, S.] Emory Univ, Sch Med, Dept Chem, Atlanta, GA 30322 USA; [Lee, B. H.] Novartis Inst BioMed Res, Cambridge, MA USA; [Boggon, T. J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Emory University; Emory University; Novartis; Yale University	Chen, J (corresponding author), Emory Univ, Sch Med, Winship Canc Inst Emory, Dept Hematol & Med Oncol, 1365-C Clifton Rd NE C3002, Atlanta, GA 30322 USA.	jchen@emory.edu	Khuri, Fadlo R./AAU-4942-2020; Xia, Siyuan/AAM-9606-2020	Khuri, Fadlo R./0000-0002-8638-7618; Xia, Siyuan/0000-0001-6756-3519	NIH [CA140515, CA183594, CA174786]; Pharmacological Sciences Training Grant [T32 GM008602]; DoD [W81XWH-12-1-0217]; NATIONAL CANCER INSTITUTE [R01CA120272, R01CA140515, R01CA174786, R01CA183594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacological Sciences Training Grant; DoD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Hematology Division Tissue Bank, Winship Cancer Institute of Emory for providing primary tissue samples from leukemia patients. This work was supported in part by NIH grants CA140515, CA183594, CA174786 (to JC), the Pharmacological Sciences Training Grant T32 GM008602 (to SE), DoD grant W81XWH-12-1-0217 (to JC). SE is an NIH pre-doctoral fellow and an ARCS Foundation Scholar. JC is WCI 5K Scholar, Georgia Cancer Coalition Distinguished Scholar, American Cancer Society Basic Research Scholar and Scholar of the Leukemia and Lymphoma Society.	BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; Caprari P, 2001, ANN HEMATOL, V80, P41, DOI 10.1007/s002770000233; Chakrabarti KR, 2015, ONCOTARGET, V6, P36292, DOI 10.18632/oncotarget.5345; Choudhury Yashmin, 2014, Oncoscience, V1, P446; Corrons JLV, 1996, AM J HEMATOL, V53, P221; Di JM, 2010, MOL BIOL REP, V37, P1849, DOI 10.1007/s11033-009-9620-5; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; HA J, 1994, J BIOL CHEM, V269, P22162; Hadad S, 2008, 2008 ASCO BREAST CAN; Hadad SM, 2014, CLIN TRANSL ONCOL, V16, P746, DOI 10.1007/s12094-013-1144-8; Lin RT, 2015, NAT CELL BIOL, V17, P1484, DOI 10.1038/ncb3255; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Spears LD, 2010, FASEB J S, V24, pIb674; Wang SJ, 2011, CANCER CHEMOTH PHARM, V68, P1421, DOI 10.1007/s00280-011-1643-7	15	42	43	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2017	36	2					254	262		10.1038/onc.2016.196	http://dx.doi.org/10.1038/onc.2016.196			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK5AA	27270429	Green Accepted			2022-12-26	WOS:000393938100010
J	Ramadoss, S; Guo, G; Wang, CY				Ramadoss, S.; Guo, G.; Wang, C-Y			Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53	ONCOGENE			English	Article							STEM-CELLS; MESENCHYMAL TRANSITION; TUMOR; METHYLATION; ACETYLATION; TRANSCRIPTION; METASTASIS; ACTIVATION; MECHANISMS; BIOLOGY	Invasive growth and apoptosis resistance of breast cancer cells are associated with metastasis and disease relapse. Here we identified that the lysine-specific demethylase KDM3A played a dual role in breast cancer cell invasion and apoptosis by demethylating histone and the non-histone protein p53, respectively. While inducing pro-invasive genes by erasing repressive histone H3 lysine 9 methylation, KDM3A promotes chemoresistance by demethylating p53. KDM3A suppressed pro-apoptotic functions of p53 by erasing p53-K372me1, as this methylation is crucial for the stability of chromatin-bound p53. Unexpectedly, depletion of KDM3A was capable of reactivating mutated p53 to induce the expression of pro-apoptotic genes in breast cancer with mutant p53. Moreover, KDM3A knockdown also potently inhibited tumorigenic potentials of breast cancer stem-like cells and rendered them sensitive to apoptosis induced by chemotherapeutic drugs. Taken together, our results suggest that KDM3A might be a potential therapeutic target for human breast cancer treatment and prevention.	[Ramadoss, S.; Guo, G.; Wang, C-Y] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, 10833 Le Conte Ave, Los Angeles, CA 90095 USA; [Ramadoss, S.; Guo, G.; Wang, C-Y] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, 10833 Le Conte Ave, Los Angeles, CA 90095 USA; [Wang, C-Y] Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Wang, CY (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.; Wang, CY (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	cunywang@ucla.edu			NIH [R3713848, DE15964]; Shapiro Family Charitable Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023874, R37DE013848, R01DE015964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shapiro Family Charitable Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the NIH grants R3713848 and DE15964 and the Shapiro Family Charitable Foundation. We thank Dr Yi Zhang for the generous gift of KDM3A plasmid.	Alexander S, 2012, TRENDS MOL MED, V18, P13, DOI 10.1016/j.molmed.2011.11.003; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Campaner S, 2011, MOL CELL, V43, P681, DOI 10.1016/j.molcel.2011.08.007; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Cheng L, 2010, TOXICOL PATHOL, V38, P62, DOI 10.1177/0192623309354109; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI200215392; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Ding XM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003884; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Ginestier C, 2012, CELL CYCLE, V11, P2583, DOI 10.4161/cc.21092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Jiao XM, 2010, J BIOL CHEM, V285, P8218, DOI 10.1074/jbc.M110.100792; Joerger AC, 2007, ADV CANCER RES, V97, P1, DOI 10.1016/S0065-230X(06)97001-8; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Kwon M, 2014, CANCER GENE THER, V21, P179, DOI 10.1038/cgt.2014.17; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lehnertz B, 2011, MOL CELL, V43, P673, DOI 10.1016/j.molcel.2011.08.006; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Perez RE, 2010, J CELL PHYSIOL, V225, P394, DOI 10.1002/jcp.22285; Ramadoss S, 2012, J BIOL CHEM, V287, P44508, DOI 10.1074/jbc.M112.424903; Ramadoss S, 2011, MOL CELL BIOL, V31, P924, DOI 10.1128/MCB.00576-10; Scully OJ, 2012, CANCER GENOM PROTEOM, V9, P311; Shetzer Y, 2014, CARCINOGENESIS, V35, P1196, DOI 10.1093/carcin/bgu073; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Wade MA, 2015, NUCLEIC ACIDS RES, V43, P196, DOI 10.1093/nar/gku1298; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004	46	63	69	0	34	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 5	2017	36	1					47	59		10.1038/onc.2016.174	http://dx.doi.org/10.1038/onc.2016.174			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK6XJ	27270439	Green Accepted			2022-12-26	WOS:000394069100005
J	Montagner, C; Nigen, M; Jacquin, O; Willet, N; Dumoulin, M; Karsisiotis, AI; Roberts, GCK; Damblon, C; Redfield, C; Matagne, A				Montagner, Caroline; Nigen, Michael; Jacquin, Olivier; Willet, Nicolas; Dumoulin, Mireille; Karsisiotis, Andreas Ioannis; Roberts, Gordon C. K.; Damblon, Christian; Redfield, Christina; Matagne, Andre			The Role of Active Site Flexible Loops in Catalysis and of Zinc in Conformational Stability of Bacillus cereus 569/H/9 beta-Lactamase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROAD-SPECTRUM INHIBITOR; TIGHT-BINDING INHIBITOR; STANDARD NUMBERING SCHEME; BACTEROIDES-FRAGILIS; CRYSTAL-STRUCTURE; SUBSTRATE-BINDING; ANTIBIOTIC-RESISTANCE; POTENT INHIBITORS; THIOMANDELIC ACID; NMR-SPECTROSCOPY	Metallo-beta-lactamases catalyze the hydrolysis of most beta-lactam antibiotics and hence represent a major clinical concern. The development of inhibitors for these enzymes is complicated by the diversity and flexibility of their substrate-binding sites, motivating research into their structure and function. In this study, we examined the conformational properties of the Bacillus cereus beta-lactamase II in the presence of chemical denaturants using a variety of biochemical and biophysical techniques. The apoenzyme was found to unfold cooperatively, with a Gibbs free energy of stabilization (Delta G(0)) of 32 +/- 2kJ.mol(-1). For holoBcII, a first non-cooperative transition leads to multiple interconverting native-like states, in which both zinc atoms remain bound in an apparently unaltered active site, and the protein displays a well organized compact hydrophobic core with structural changes confined to the enzyme surface, but with no catalytic activity. Two-dimensional NMR data revealed that the loss of activity occurs concomitantly with perturbations in two loops that border the enzyme active site. A second cooperative transition, corresponding to global unfolding, is observed at higher denaturant concentrations, with Delta G(0) value of 65 +/- 1.4 kJ.mol(-1). These combined data highlight the importance of the two zinc ions in maintaining structure as well as a relatively well defined conformation for both active site loops to maintain enzymatic activity.	[Montagner, Caroline; Nigen, Michael; Jacquin, Olivier; Willet, Nicolas; Dumoulin, Mireille; Matagne, Andre] Univ Liege, Inst Chim B6, Ctr Ingn Prot, Lab Enzymol & Repliement Prot, B-4000 Liege, Sart Tilman, Belgium; [Damblon, Christian] Univ Liege, Inst Chim B6, Dept Chim, B-4000 Liege, Sart Tilman, Belgium; [Karsisiotis, Andreas Ioannis] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Roberts, Gordon C. K.] Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England; [Redfield, Christina] Univ Oxford, Dept Biochem, South Parks Rd, Oxford OX1 3QU, England; [Nigen, Michael] UMII, Montpellier SupAgro, CIRAD, INRA,UMR Ingn Agropolymeres & Technol Emergentes, F-34060 Montpellier 01, France; [Willet, Nicolas] Univ Liege, Dept Chim, B-4000 Liege, Sart Tilman, Belgium	University of Liege; University of Liege; University of Essex; University of Leicester; University of Oxford; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; University of Liege	Matagne, A (corresponding author), Univ Liege, Inst Chim B6, Ctr Ingn Prot, Lab Enzymol & Repliement Prot, B-4000 Liege, Sart Tilman, Belgium.	amatagne@ulg.ac.be	Karsisiotis, Andreas Ioannis/G-3622-2013	Matagne, Andre/0000-0001-6417-6791; Redfield, Christina/0000-0001-7297-7708; Karsisiotis, Andreas Ioannis/0000-0001-7413-5045	European Commission [228461]; BioNMR projects [261863]	European Commission(European CommissionEuropean Commission Joint Research Centre); BioNMR projects	We acknowledge Prof Jean-Marie Frere critical reading of the manuscript and Prof: Roger H. Pain for his suggestion of a 'punchy" title. Also, we are grateful to Dr. Catherine Goodman (acting on behalf of the Journal of Biological Chemistry) for valuable suggestions to improve the manuscript Some NMR experiments in Oxford, United Kingdom, were collected with access provided by the European Commission's Framework Program 7 (FP7) East-NMR (Contract 228461) and BioNMR projects (Contract 261863).	Baier F, 2014, J MOL BIOL, V426, P2442, DOI 10.1016/j.jmb.2014.04.013; Bebrone C., 2012, BETA LACTAMASES, P41; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Carfi A, 1998, ACTA CRYSTALLOGR D, V54, P313, DOI 10.1107/S0907444997010627; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Concha NO, 2000, BIOCHEMISTRY-US, V39, P4288, DOI 10.1021/bi992569m; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Creighton TE., 2010, BIOPHYSICAL CHEM NUC; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2; Damblon C, 1999, J AM CHEM SOC, V121, P11575, DOI 10.1021/ja992896h; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Docquier JD, 2003, J ANTIMICROB CHEMOTH, V51, P257, DOI 10.1093/jac/dkg067; Dragani B, 1999, J MOL BIOL, V291, P481, DOI 10.1006/jmbi.1999.2965; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Fast W, 2013, BBA-PROTEINS PROTEOM, V1834, P1648, DOI 10.1016/j.bbapap.2013.04.024; FELICI A, 1993, BIOCHEM J, V291, P151, DOI 10.1042/bj2910151; Fink A. L., 2012, BETA LACTAMASES, P41; Fitzgerald M. D., 2004, HDB METALLOPROTEINS, V3, P217; Fitzgerald PMD, 1998, BIOCHEMISTRY-US, V37, P6791, DOI 10.1021/bi9730339; Frere J. M., 2012, BETA LACTAMASES, P41; Frere J.-M., 2012, BETA LACTAMASES; Frere JM, 2005, J ANTIMICROB CHEMOTH, V55, P1051, DOI 10.1093/jac/dki155; FRERE JM, 1995, MOL MICROBIOL, V16, P385, DOI 10.1111/j.1365-2958.1995.tb02404.x; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Garau G, 2004, ANTIMICROB AGENTS CH, V48, P2347, DOI 10.1128/AAC.48.7.2347-2349.2004; Gonzalez JM, 2010, BIOCHEMISTRY-US, V49, P7930, DOI 10.1021/bi100894r; Heinz U, 2004, CELL MOL LIFE SCI, V61, P2827, DOI 10.1007/s00018-004-4214-9; Hemmingsen L, 2001, J AM CHEM SOC, V123, P10329, DOI 10.1021/ja0112240; Hubbard SJ., 1993, COMPUTER PROGRAM; Huntley JJA, 2000, BIOCHEMISTRY-US, V39, P13356, DOI 10.1021/bi001210r; Huntley JJA, 2003, PROTEIN SCI, V12, P1368, DOI 10.1110/ps.0305303; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Jacquin O., 2011, THESIS; Jacquin O, 2009, J MOL BIOL, V392, P1278, DOI 10.1016/j.jmb.2009.07.092; Karsisiotis AI, 2014, METALLOMICS, V6, P1181, DOI 10.1039/c4mt00066h; Karsisiotis AI, 2014, BIOMOL NMR ASSIGN, V8, P313, DOI 10.1007/s12104-013-9507-1; Karsisiotis AI, 2013, BIOCHEM J, V456, P397, DOI 10.1042/BJ20131003; Kim Y, 2013, FASEB J, V27, P1917, DOI 10.1096/fj.12-224014; King AM, 2014, NATURE, V510, P503, DOI 10.1038/nature13445; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Krauss M, 2003, J PHYS CHEM B, V107, P1215, DOI 10.1021/jp027097r; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Lakowitcz J.R, 1999, PRINCIPLES FLUORESCE, P237, DOI DOI 10.1007/978-1-4757-3061-6_8; Lassaux P, 2011, ANTIMICROB AGENTS CH, V55, P1248, DOI 10.1128/AAC.01486-09; Lehninger A. L., 2013, PRINCIPLES BIOCH; Livermore DM, 2000, CURR OPIN MICROBIOL, V3, P489, DOI 10.1016/S1369-5274(00)00128-4; Matagne A, 1999, NAT PROD REP, V16, P1, DOI 10.1039/a705983c; MATAGNE A, 1990, BIOCHEM J, V265, P131, DOI 10.1042/bj2650131; Meini MR, 2014, ANTIBIOTICS-BASEL, V3, P285, DOI 10.3390/antibiotics3030285; Moali C, 2003, CHEM BIOL, V10, P319, DOI 10.1016/S1074-5521(03)00070-X; Mollard C, 2001, J BIOL CHEM, V276, P45015, DOI 10.1074/jbc.M107054200; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Neuwald AF, 1997, NUCLEIC ACIDS RES, V25, P1665, DOI 10.1093/nar/25.9.1665; Nozaki Y, 1972, Methods Enzymol, V26, P43; Oelschlaeger P, 2010, J MED CHEM, V53, P3013, DOI 10.1021/jm9012938; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Page MI, 2008, BIOINORG CHEM APPL, V2008, DOI 10.1155/2008/576297; Palm-Espling ME, 2012, BBA-MOL CELL RES, V1823, P1594, DOI 10.1016/j.bbamcr.2012.01.013; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Paul-Soto R, 1999, J BIOL CHEM, V274, P13242, DOI 10.1074/jbc.274.19.13242; PAYNE DJ, 1993, J MED MICROBIOL, V39, P93, DOI 10.1099/00222615-39-2-93; Payne DJ, 2002, ANTIMICROB AGENTS CH, V46, P1880, DOI 10.1128/AAC.46.6.1880-1886.2002; Pfeil W., 1998, PROTEIN STABILITY FO; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; Rasia RM, 2004, J BIOL CHEM, V279, P26046, DOI 10.1074/jbc.M311373200; Rasia RM, 2002, BIOCHEMISTRY-US, V41, P1853, DOI 10.1021/bi010933n; Rasmussen BA, 1997, ANTIMICROB AGENTS CH, V41, P223, DOI 10.1128/AAC.41.2.223; Redfield C, 1999, CURR BIOL, V9, pR313, DOI 10.1016/S0960-9822(99)80199-7; Rossolini GM, 2006, FUTURE MICROBIOL, V1, P295, DOI 10.2217/17460913.1.3.295; Rydzik AM, 2014, ANGEW CHEM INT EDIT, V53, P3129, DOI 10.1002/anie.201310866; SABATH LD, 1966, BIOCHEM J, V98, pC11, DOI 10.1042/bj0980011C; Salsbury FR, 2009, J MOL MODEL, V15, P133, DOI 10.1007/s00894-008-0410-0; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scrofani SDB, 1999, BIOCHEMISTRY-US, V38, P14507, DOI 10.1021/bi990986t; Selevsek N, 2009, J BIOL CHEM, V284, P16419, DOI 10.1074/jbc.M109.001305; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Spencer J, 2006, ANGEW CHEM INT EDIT, V45, P1022, DOI 10.1002/anie.200502984; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Toney JH, 1998, CHEM BIOL, V5, P185, DOI 10.1016/S1074-5521(98)90632-9; Toney JH, 2001, J BIOL CHEM, V276, P31913, DOI 10.1074/jbc.M104742200; Valdez CE, 2013, J CHEM THEORY COMPUT, V9, P730, DOI 10.1021/ct300712j; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Vandenameele J, 2010, BIOCHEMISTRY-US, V49, P4264, DOI 10.1021/bi100369d; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waley SG, 1992, CHEM BLACTAMS, P198; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Whitford D., 2005, PROTEINS STRUCTURE F; Wittung-Stafshede P, 2002, ACCOUNTS CHEM RES, V35, P201, DOI 10.1021/ar010106e; Wommer S, 2002, J BIOL CHEM, V277, P24142, DOI 10.1074/jbc.M202467200; Yang YJ, 1999, J BIOL CHEM, V274, P15706, DOI 10.1074/jbc.274.22.15706; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036	102	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16124	16137		10.1074/jbc.M116.719005	http://dx.doi.org/10.1074/jbc.M116.719005			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27235401	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000380585400018
J	Da Silveira, NS; Niebuhr, BBS; Muylaert, RD; Ribeiro, MC; Pizo, MA				Da Silveira, Natalia Stefanini; Niebuhr, Bernardo Brandao S.; Muylaert, Renata de Lara; Ribeiro, Milton Cezar; Pizo, Marco Aurelio			Effects of Land Cover on the Movement of Frugivorous Birds in a Heterogeneous Landscape	PLOS ONE			English	Article							WHITE-THROATED ROBINS; SEED DISPERSAL; ANIMAL MOVEMENT; HABITAT USE; SEARCH PATTERNS; FOREST BIRDS; LEVY FLIGHT; ECOLOGY; RESPONSES; SUCCESS	Movement is a key spatiotemporal process that enables interactions between animals and other elements of nature. The understanding of animal trajectories and the mechanisms that influence them at the landscape level can yield insight into ecological processes and potential solutions to specific ecological problems. Based upon optimal foraging models and empirical evidence, we hypothesized that movement by thrushes is highly tortuous (low average movement speeds and homogeneous distribution of turning angles) inside forests, moderately tortuous in urban areas, which present intermediary levels of resources, and minimally tortuous (high movement speeds and turning angles next to 0 radians) in open matrix types (e.g., crops and pasture). We used data on the trajectories of two common thrush species (Turdus rufiventris and Turdus leucomelas) collected by radio telemetry in a fragmented region in Brazil. Using a maximum likelihood model selection approach we fit four probability distribution models to average speed data, considering short-tailed, long-tailed, and scale-free distributions (to represent different regimes of movement variation), and one distribution to relative angle data. Models included land cover type and distance from forest-matrix edges as explanatory variables. Speed was greater farther away from forest edges and increased faster inside forest habitat compared to urban and open matrices. However, turning angle was not influenced by land cover. Thrushes presented a very tortuous trajectory, with many displacements followed by turns near 180 degrees. Thrush trajectories resembled habitat and edge dependent, tortuous random walks, with a well-defined movement scale inside each land cover type. Although thrushes are habitat generalists, they showed a greater preference for forest edges, and thus may be considered edge specialists. Our results reinforce the importance of studying animal movement patterns in order to understand ecological processes such as seed dispersal in fragmented areas, where the percentage of remaining habitat is dwindling.	[Da Silveira, Natalia Stefanini; Niebuhr, Bernardo Brandao S.; Muylaert, Renata de Lara; Ribeiro, Milton Cezar] Univ Estadual Paulista, Dept Ecol, Spatial Ecol & Conservat Lab, Sao Paulo, Brazil; [Pizo, Marco Aurelio] Univ Estadual Paulista, Dept Zool, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Da Silveira, NS (corresponding author), Univ Estadual Paulista, Dept Ecol, Spatial Ecol & Conservat Lab, Sao Paulo, Brazil.	nat.stefanini@gmail.com	Da Silveira, Natália Stefanini/AAG-2576-2021; Muylaert, Renata L./AAD-7248-2020; Niebuhr, Bernardo Brandão/O-2339-2016	Muylaert, Renata L./0000-0002-6466-6210; Niebuhr, Bernardo Brandão/0000-0002-0453-315X	Centro Nacional de Desenvolvimento Cientifico e tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a pesquisa do Estado de Sao Paulo [2013/50421-2]; Brazilian Research Council (CNPq); Coordination for the Improvement of Higher Education Personnel (CAPES); Sao Paulo Research Foundation FAPESP [2013/50421-2]; CNPq	Centro Nacional de Desenvolvimento Cientifico e tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Centro Nacional de Desenvolvimento Cientifico e tecnologico (http://http://www.cnpq.br/) (MAP and MCR); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://http://www.capes.gov.br/) (NSS); and Fundacao de Amparo a pesquisa do Estado de Sao Paulo 2013/50421-2 (http://http://www.fapesp.br/) (MCR and MAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to everyone who assisted us in data collection and technical support, to the owners of the areas where the studies were conducted, particularly at Sitio Moinho Velho, to M. Galetti for critically reading the manuscript, and to F. Martello for providing graphic support on the images. We thank the anonymous reviewers for the invaluable suggestions for improving the manuscript. F. Barros, P. Rogeri, A. C. Silveira, F. S. Silveira and many others assisted us in the field. C. J. Leal and M. King for proofreading the manuscript. The Brazilian Research Council (CNPq), the Coordination for the Improvement of Higher Education Personnel (CAPES) and Sao Paulo Research Foundation FAPESP (2013/50421-2) funded our study. MAP and MCR receive research grants from CNPq.	Adams C. E., 2009, URBAN WILDLIFE MANAG; [Anonymous], 1998, QUANTITATIVE ANAL MO; [Anonymous], 2011, BIODIVERSITY HOTSPOT, DOI [10.1007/978-3-642-20992-5_21, DOI 10.1007/978-3-642-20992-5_21]; Armesto JJ, 2001, AUSTRAL ECOL, V26, P311, DOI 10.1046/j.1442-9993.2001.01116.x; Barton PS, 2015, ENVIRON MANAGE, V56, P791, DOI 10.1007/s00267-015-0570-5; Bartumeus F, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434002; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Benhamou S, 2014, ECOL LETT, V17, P261, DOI 10.1111/ele.12225; Berry B.J.L., 2008, URBAN ECOLOGY INT PE, P25, DOI [10.1007/978-0-387-73412-5_3, DOI 10.1007/978-0-387-73412-5_3]; Bolker B., 2012, BBMLE TOOLS GEN MAXI; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; Buckingham DL, 1999, BIRD STUDY, V46, P157, DOI 10.1080/00063659909461127; Byrne RW, 2009, ANIM BEHAV, V77, P619, DOI 10.1016/j.anbehav.2008.11.014; Calenge C, 2009, ECOL INFORM, V4, P34, DOI 10.1016/j.ecoinf.2008.10.002; Clement P., 2000, THRUSHES; Clough Y, 2009, BIOL CONSERV, V142, P1032, DOI 10.1016/j.biocon.2008.12.027; Cohen EB, 2005, J FIELD ORNITHOL, V76, P279, DOI 10.1648/0273-8570-76.3.279; Cohen EB, 2004, AUK, V121, P404, DOI 10.1642/0004-8038(2004)121[0404:SHUAMO]2.0.CO;2; Cortes MC, 2013, BIOL REV, V88, P255, DOI 10.1111/j.1469-185X.2012.00250.x; Del Hoyo J, 2005, HDB BIRDS WORLD CUCK; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; FALK JH, 1976, ECOLOGY, V57, P141, DOI 10.2307/1936405; Forman R.T.T., 1986, LANDSCAPE ECOL; Forsman JT, 2001, ANIM BEHAV, V62, P1067, DOI 10.1006/anbe.2001.1856; Franchin Alexandre Gabriel, 2004, Biotemas, V17, P179; Gabriel VA, 2005, THESIS U ESTADUAL PA; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Garcia D, 2013, ECOGRAPHY, V36, P197, DOI 10.1111/j.1600-0587.2012.07519.x; Garcia D, 2010, CONSERV BIOL, V24, P1070, DOI 10.1111/j.1523-1739.2009.01440.x; Gillies CS, 2011, ECOL APPL, V21, P944, DOI 10.1890/09-2090.1; Goodwin BJ, 2002, OIKOS, V99, P552, DOI 10.1034/j.1600-0706.2002.11824.x; Gurarie E, 2016, J ANIM ECOL, V85, P69, DOI 10.1111/1365-2656.12379; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hansbauer MM, 2008, BIOL CONSERV, V141, P782, DOI 10.1016/j.biocon.2008.01.002; Hansbauer MM, 2010, LANDSCAPE ECOL, V25, P407, DOI 10.1007/s10980-009-9418-9; Holmes R.T., 1990, P387; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Jeltsch F, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-6; Johnson CJ, 2002, J ANIM ECOL, V71, P225, DOI 10.1046/j.1365-2656.2002.00595.x; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Kolzsch A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0424; Lomascolo SB, 2010, WILSON J ORNITHOL, V122, P674, DOI 10.1676/09-167.1; Herrera JM, 2009, BIOL CONSERV, V142, P149, DOI 10.1016/j.biocon.2008.10.008; Morales JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065216; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Motta-Junior José Carlos, 2007, Biota Neotrop., V7, P0, DOI 10.1590/S1676-06032007000200038; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Neuschulz EL, 2013, AUSTRAL ECOL, V38, P374, DOI 10.1111/j.1442-9993.2012.02417.x; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Pena D, 2014, RELATORIA ADM 2013 S, P5; Pizo MA, 2004, ORNITOL NEOTROP, V15, P117; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Reyna-Hurtado R, 2012, J MAMMAL, V93, P124, DOI 10.1644/10-MAMM-A-384.1; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodrigues RR, 2011, FOREST ECOL MANAG, V261, P1605, DOI 10.1016/j.foreco.2010.07.005; Sasal Y, 2013, OIKOS, V122, P95, DOI 10.1111/j.1600-0706.2012.20669.x; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Sekercioglu CH, 2007, CONSERV BIOL, V21, P482, DOI 10.1111/j.1523-1739.2007.00655.x; SHEDD DH, 1982, AUK, V99, P342; Sick H, 2001, ORNITOLOGIA BRASILEI; Sims DW, 2012, J ANIM ECOL, V81, P432, DOI 10.1111/j.1365-2656.2011.01914.x; Snow B, 1998, BIRDS AND BERRIES; Spiegel O, 2007, ECOL LETT, V10, P718, DOI 10.1111/j.1461-0248.2007.01062.x; Spiegel O, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-5; Tambosi LR, 2014, RESTOR ECOL, V22, P169, DOI 10.1111/rec.12049; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Vogel HF, 2012, BIOTA NEOTROP, V12, P241; Vogel HF, 2011, BIOTA NEOTROP, V11, P35, DOI 10.1590/S1676-06032011000300002; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; Wosniack ME, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0887	82	27	29	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156688	10.1371/journal.pone.0156688	http://dx.doi.org/10.1371/journal.pone.0156688			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257810	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700106
J	Golding, A; Guay, JA; Herrera-Rincon, C; Levin, M; Kaplan, DL				Golding, Anne; Guay, Justin A.; Herrera-Rincon, Celia; Levin, Michael; Kaplan, David L.			A Tunable Silk Hydrogel Device for Studying Limb Regeneration in Adult Xenopus Laevis	PLOS ONE			English	Article							DRUG-DELIVERY; FIBROIN; ENVIRONMENT; CARTILAGE; PATHWAYS; RELEASE; POLYMER	In certain amphibian models limb regeneration can be promoted or inhibited by the local wound bed environment. This research introduces a device that can be utilized as an experimental tool to characterize the conditions that promotes limb regeneration in the adult frog ( Xenopus laevis) model. In particular, this device was designed to manipulate the local wound environment via a hydrogel insert. Initial characterization of the hydrogel insert revealed that this interaction had a significant influence on mechanical forces to the animal, due to the contraction of the hydrogel. The material and mechanical properties of the hydrogel insert were a factor in the device design in relation to the comfort of the animal and the ability to effectively manipulate the amputation site. The tunable features of the hydrogel were important in determining the pro-regenerative effects in limb regeneration, which was measured by cartilage spike formation and quantified by micro-computed tomography. The hydrogel insert was a factor in the observed morphological outcomes following amputation. Future work will focus on characterizing and optimizing the device's observed capability to manipulate biological pathways that are essential for limb regeneration. However, the present work provides a framework for the role of a hydrogel in the device and a path forward for more systematic studies.	[Golding, Anne] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA; [Guay, Justin A.; Herrera-Rincon, Celia; Levin, Michael] Tufts Univ, Dept Biol, Ctr Regenerat & Dev Biol, Medford, MA USA; [Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Tufts University; Tufts University; Tufts University	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu	Herrera-Rincon, Celia/M-3100-2019; Levin, Michael/A-5918-2011	Herrera-Rincon, Celia/0000-0003-0748-8718; Levin, Michael/0000-0001-7292-8084	NIH [R01 AR005593, R01 AR061988]; W. M. Keck Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation)	NIH (R01 AR005593, R01 AR061988) funding for DK and ML and W. M. Keck Foundation to ML and DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha R, 2011, J SURG RES, V171, P700, DOI 10.1016/j.jss.2011.07.007; Ahadian S, 2015, BIOCONJUGATE CHEM, V26, P1984, DOI 10.1021/acs.bioconjchem.5b00360; Alzahrani MM, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00214; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bielefeld KA, 2013, CELL MOL LIFE SCI, V70, P2059, DOI 10.1007/s00018-012-1152-9; Boudrant J, 2010, PROCESS BIOCH, V45, P1757; Carlson B. M., 2007, PRINCIPLES REGENERAT; Caroline W., 2009, DEV DYNAM, V238, P1226; Carter DR, 2001, J BIOMECHANICS; Chao Edmund Y S, 2003, Eur Cell Mater, V6, P72; Chin MS, 2010, TISSUE ENG PART C-ME, V16, P397, DOI 10.1089/ten.TEC.2009.0185; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Coughlan DC, 2004, J CONTROL RELEASE, V98, P97, DOI 10.1016/j.jconrel.2004.04.014; Dawson Lindsay A, 2016, REGENERATION, DOI [10.1002/reg2.51, DOI 10.1002/REG2.51]; DENT JN, 1962, J MORPHOL, V110, P61, DOI 10.1002/jmor.1051100105; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Fernando WA, 2011, DEV BIOL, V350, P301, DOI 10.1016/j.ydbio.2010.11.035; Haremaki T, 2015, DEV BIOL, V408, P305, DOI 10.1016/j.ydbio.2015.07.013; Hechavarria D, 2010, MED ENG PHYS, V32, P1065, DOI 10.1016/j.medengphy.2010.07.010; Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.2005.12.009; Hudson EP, 2005, CURR OPIN BIOTECH, V16, P637, DOI 10.1016/j.copbio.2005.10.004; Imoto T, 1997, CELL MOL LIFE SCI, V53, P215, DOI 10.1007/PL00000593; Kareska S, 2010, FACTORS AFFECTING HY, V7; KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431; Kramarenko EY, 2006, POLYM SCI SER C+, V48, P1, DOI 10.1134/S1811238206010012; Laftah WA, 2011, POLYM-PLAST TECHNOL, V50, P1475, DOI 10.1080/03602559.2011.593082; Lancerotto L, 2014, ADV WOUND CARE, V3, P626, DOI 10.1089/wound.2013.0491; Leppik LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep18353; Lin GF, 2013, DEV CELL, V24, P41, DOI 10.1016/j.devcel.2012.11.017; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; MULLERGERBL M, 1987, J ANAT, V154, P103; Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009; Olczyk P, 2014, ROLE EXTRACELLULAR M, V2014, P12; Partlow BP, 2014, ADV FUNCT MATER, V24, P4615, DOI 10.1002/adfm.201400526; Pufe T, 2004, AM J PATHOL, V164, P185, DOI 10.1016/S0002-9440(10)63109-4; Qiu Y, 2012, ADV DRUG DELIVER REV, V64, P49, DOI 10.1016/j.addr.2012.09.024; Rao N, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-32; Ratner BD, 2004, CHEM ENG; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Sambasivarao SV, 2013, CURR OPIN STRUC BIOL, V18, P1199, DOI DOI 10.1016/J.MICINF.2011.07.011.INNATE; Santosh N, 2011, DEV DYNAM, V240, P1127, DOI 10.1002/dvdy.22503; Satoh A, 2005, DEV DYNAM, V233, P1444, DOI 10.1002/dvdy.20484; Schumacher M, 2001, BRAIN RES REV, V37, P343, DOI 10.1016/S0165-0173(01)00139-4; SKINNER HCW, 1975, YALE J BIOL MED, V48, P377; Stocum DL, 2011, DEV DYNAM, V240, P943, DOI 10.1002/dvdy.22553; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Timasheff SN, 1996, PROTEIN STAB FOLD TH, V379, P253; Tsonis PA, 2000, DEV BIOL, V221, P273, DOI 10.1006/dbio.2000.9667; Vernon AE, 2003, DEVELOPMENT, V130, P71, DOI 10.1242/dev.00180; Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007; Wiegand C, 2013, WOUND REPAIR REGEN, V21, P793, DOI 10.1111/wrr.12111; Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1; Wu YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054764; Yuehuei HA., 2003, HDB HISTOLOGY METHOD	56	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155618	10.1371/journal.pone.0155618	http://dx.doi.org/10.1371/journal.pone.0155618			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257960	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700018
J	Tan, SGD; Kim, S; Hon, JKF; Leo, HL				Tan, Sean Guo-Dong; Kim, Sangho; Hon, Jimmy Kim Fatt; Leo, Hwa Liang			A D-Shaped Bileaflet Bioprosthesis which Replicates Physiological Left Ventricular Flow Patterns	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; VORTEX FORMATION; FLUID-MECHANICS; MITRAL-VALVES; HEART; ECHOCARDIOGRAPHY; HEMODYNAMICS; AXISYMMETRY; MODEL	Prior studies have shown that in a healthy heart, there exist a large asymmetric vortex structure that aids in establishing a steady flow field in the left ventricle. However, the implantation of existing artificial heart valves at the mitral position is found to have a negative effect on this physiological flow pattern. In light of this, a novel D-shaped bileaflet porcine bio-prosthesis (GD valve) has been designed based on the native geometry mitral valve, with the hypothesis that biomimicry in valve design can restore physiological left ventricle flow patterns after valve implantation. An in-vitro experiment using two dimensional particle velocimetry imaging was carried out to determine the hemodynamic performance of the new bileaflet design and then compared to that of the well-established St. Jude Epic valve which functioned as a control in the experiment. Although both valves were found to have similar Reynolds shear stress and Turbulent Kinetic Energy levels, the novel D-shape valve was found to have lower turbulence intensity and greater mean kinetic energy conservation.	[Tan, Sean Guo-Dong; Kim, Sangho; Leo, Hwa Liang] Natl Univ Singapore, Fac Engn, Dept Biomed Engn, Block E4,04-08,4 Engn Dr 3, Singapore 117583, Singapore; [Hon, Jimmy Kim Fatt] Natl Univ Singapore, Dept Surg, Yong Loo Lin Sch Med, Kent Ridge Rd, Singapore 119228, Singapore	National University of Singapore; National University of Singapore	Leo, HL (corresponding author), Natl Univ Singapore, Fac Engn, Dept Biomed Engn, Block E4,04-08,4 Engn Dr 3, Singapore 117583, Singapore.	bielhl@nus.edu.sg	Hon, Jimmy/B-5445-2012; Kim, Sangho/I-7032-2012; Leo, Hwa Liang/B-6946-2011	Kim, Sangho/0000-0002-1045-5928; Leo, Hwa Liang/0000-0003-0592-6470				Abe H, 2013, EUR HEART J-CARD IMG, V14, P1049, DOI 10.1093/ehjci/jet049; Bach DS, 1997, PROG CARDIOVASC DIS, V39, P543, DOI 10.1016/S0033-0620(97)80013-8; Charonko JJ, 2013, ANN BIOMED ENG, V41, P1049, DOI 10.1007/s10439-013-0755-0; Elbaz MSM, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0078-9; Elbaz MS, 2016, MAGN RESON MED, DOI [10.1002/26129, DOI 10.1002/26129]; Ertesvag IS, 2000, COMBUST SCI TECHNOL, V159, P213, DOI 10.1080/00102200008935784; Falahatpisheh A, 2015, ANN BIOMED ENG, V43, P2349, DOI 10.1007/s10439-015-1302-y; Falahatpisheh A, 2015, EUR J MECH B-FLUID, V49, P264, DOI 10.1016/j.euromechflu.2014.09.003; Faludi R, 2010, J THORAC CARDIOV SUR, V139, P1501, DOI 10.1016/j.jtcvs.2009.07.060; Gharib M, 2006, P NATL ACAD SCI USA, V103, P6305, DOI 10.1073/pnas.0600520103; Jamieson WRE, 2011, J THORAC CARDIOV SUR, V141, P1449, DOI 10.1016/j.jtcvs.2010.05.055; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Kefayati S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098209; Kilner PJ, 2000, NATURE, V404, P759, DOI 10.1038/35008075; KIM WY, 1995, J AM COLL CARDIOL, V26, P224, DOI 10.1016/0735-1097(95)00141-L; Le TB, 2012, EUR J MECH B-FLUID, V35, P20, DOI 10.1016/j.euromechflu.2012.01.013; MAGILLIGAN DJ, 1985, J THORAC CARDIOV SUR, V89, P499; Okafor IU, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0154-9; Pedrizzetti G, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108101; Pedrizzetti G, 2015, ANN BIOMED ENG, V43, P26, DOI 10.1007/s10439-014-1101-x; Pedrizzetti G, 2014, NAT REV CARDIOL, V11, P545, DOI 10.1038/nrcardio.2014.75; Pedrizzetti G, 2010, ANN BIOMED ENG, V38, P769, DOI 10.1007/s10439-010-9928-2; Pierrakos O, 2006, J BIOMECH ENG-T ASME, V128, P527, DOI 10.1115/1.2205863; Querzoli G, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3371720; Rodevand O, 1999, J AM SOC ECHOCARDIOG, V12, P500, DOI 10.1016/S0894-7317(99)70087-8; SALLAM AM, 1984, BIORHEOLOGY, V21, P783; Shen M, 2001, ANN THORAC SURG, V71, pS408, DOI 10.1016/S0003-4975(01)02506-1; Sotiropoulos F, 2016, ANNU REV FLUID MECH, V48, P259, DOI 10.1146/annurev-fluid-122414-034314; Valfre C, 2010, EUR J CARDIO-THORAC, V38, P141, DOI 10.1016/j.ejcts.2010.01.046; Wang Q, 2013, ANN BIOMED ENG, V41, P142, DOI 10.1007/s10439-012-0620-6	30	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156580	10.1371/journal.pone.0156580	http://dx.doi.org/10.1371/journal.pone.0156580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258099	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700082
J	McNeil, B; Lowry, D; Larson, S; Griffing, D				McNeil, Bryan; Lowry, Dayv; Larson, Shawn; Griffing, Denise			Feeding Behavior of Subadult Sixgill Sharks (Hexanchus griseus) at a Bait Station	PLOS ONE			English	Article							PREY CAPTURE BEHAVIOR; FUNCTIONAL-MORPHOLOGY; KINEMATIC ANALYSIS; JAW PROTRUSION; NURSE SHARK; MECHANISM; SUCTION; EVOLUTION; PERFORMANCE	This is the first in-situ study of feeding behaviors exhibited by bluntnose sixgill sharks. Bait was placed beneath the Seattle Aquarium pier situated on the waterfront in Elliott Bay, Puget Sound, Washington at 20m of water depth. Cameras and lights were placed around the bait box to record sixgill shark presence and behavior while feeding. Analysis of feeding behavior revealed that sixgills utilize a bite comparable to many other elasmobranchs and aquatic vertebrates, have the ability to protrude their upper jaw, change their feeding behavior based on the situation, and employ sawing and lateral tearing during manipulation. The versatility of their feeding mechanism and the ability of sixgills to change their capture and food manipulation behaviors may have contributed to the species' worldwide distribution and evolutionary success.	[McNeil, Bryan; Larson, Shawn; Griffing, Denise] Seattle Aquarium, Seattle, WA 98101 USA; [Lowry, Dayv] Washington Dept Fish & Wildlife, Olympia, WA USA	Washington Department of Fish & Wildlife (WDFW)	McNeil, B (corresponding author), Seattle Aquarium, Seattle, WA 98101 USA.	b.mcneil@seattleaquarium.org		Lowry, Dayv/0000-0003-1159-3828	Seattle Aquarium; Royal Caribbean Ocean Fund	Seattle Aquarium; Royal Caribbean Ocean Fund	The Seattle Aquarium (www.seattleaquarium.org) supported this study by using its staff, volunteers, facilities, research equipment, and access to Elliott Bay. Any staff member that assisted in the design, data collection and analysis, decision to publish, or preparation of the manuscript are authors on this paper. (BM) The Royal Caribbean Ocean Fund (http://www.royalcaribbean.com/ourCompany/environment/oceanFund.do) supported this study through funds and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (SL)	Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; Barans Charles A., 1994, Journal of the Elisha Mitchell Scientific Society, V110, P49; Castro J. I., 1983, SHARKS N AM WATERS; Celona Antonio, 2005, Bollettino del Museo Civico di Storia Naturale di Venezia, V56, P137; Compagno L. J. V., 2002, FAO SPECIES CATALOGU, V2; Compagno L. J. V, 1984, SHARKS WORLD ANNOT 1, V4; COMPAGNO LJV, 1977, AM ZOOL, V17, P303; Curtis T, 2012, GLOBAL PERSPECTIVES, VFirst, P477; Dunbrack R, 2003, CAN J ZOOL, V81, P1107, DOI 10.1139/Z03-087; EBERT DA, 1994, S AFR J MARINE SCI, V14, P213; EBERT DA, 1986, COPEIA, P131; Edmonds MA, 2001, ENVIRON BIOL FISH, V62, P415, DOI 10.1023/A:1012205518704; Ferrara TL, 2011, J BIOMECH, V44, P430, DOI 10.1016/j.jbiomech.2010.09.028; Ferry-Graham LA, 1998, J EXP BIOL, V201, P2433; FerryGraham LA, 1997, J EXP BIOL, V200, P1255; Griffing D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087081; Hammerschlag Neil, 2012, P91; IUCN (n.d.), IUCN REDL THREAT SPE; Jones EG, 2003, MAR ECOL PROG SER, V251, P75, DOI 10.3354/meps251075; Kyne PM, 2012, CONSERVATION STATUS, P156; Larson S, 2011, CONSERV GENET, V12, P679, DOI 10.1007/s10592-010-0174-9; LAUDER GV, 1980, J MORPHOL, V163, P283, DOI 10.1002/jmor.1051630305; LAUDER GV, 1979, J ZOOL, V187, P543; Lowry D, 2008, J R SOC INTERFACE, V5, P641, DOI 10.1098/rsif.2007.1189; Lowry D, 2007, MAR BIOL, V151, P2013, DOI 10.1007/s00227-007-0642-z; Lowry D, 2007, J EXP MAR BIOL ECOL, V341, P153, DOI 10.1016/j.jembe.2006.07.018; Lowry DC, 2005, THESIS U S FLORIDA, P1; MAISEY J G, 1980, American Museum Novitates, P1; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; Martin RA, 1998, SWIMMING JURASSIC SH; Matott MP, 2005, ENVIRON BIOL FISH, V74, P163, DOI 10.1007/s10641-005-7435-3; MOSS SA, 1972, J ZOOL, V167, P423; MOSS SA, 1977, AM ZOOL, V17, P355; Motta PJ, 1997, J EXP BIOL, V200, P2765; Motta PJ, 2004, CRC MAR BIOL SER, P165; Motta PJ, 2002, COPEIA, P24, DOI 10.1643/0045-8511(2002)002[0024:KAOSFI]2.0.CO;2; MOTTA PJ, 1984, COPEIA, P1; MOTTA PJ, 1982, J MORPHOL, V174, P283, DOI 10.1002/jmor.1051740305; Nauwelaerts S, 2007, J R SOC INTERFACE, V4, P341, DOI 10.1098/rsif.2006.0180; NORTON SF, 1993, J EXP BIOL, V176, P11; Sasko DE, 2006, ZOOLOGY, V109, P171, DOI 10.1016/j.zool.2005.12.005; Tricas T.C., 1985, Memoirs of the Southern California Academy of Sciences, V9, P81; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; Wainwright PC, 2001, J EXP BIOL, V204, P3039; WESTNEAT MW, 1989, J MORPHOL, V202, P129, DOI 10.1002/jmor.1052020202; Whitenack LB, 2010, BIOL J LINN SOC, V100, P271, DOI 10.1111/j.1095-8312.2010.01421.x; Wilga CD, 1998, J EXP BIOL, V201, P1345; Wilga CD, 2002, BIOL J LINN SOC, V75, P483, DOI 10.1046/j.1095-8312.2002.00037.x; Wilga CD, 2001, AM ZOOL, V41, P1248, DOI 10.1668/0003-1569(2001)041[1248:EOUJPM]2.0.CO;2; Wilga CD, 2000, BIOL J LINN SOC, V71, P165; WU EH, 1994, J MORPHOL, V222, P175, DOI 10.1002/jmor.1052220205; ZANGERL R, 1975, Palaeontology (Oxford), V18, P333	52	13	13	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156730	10.1371/journal.pone.0156730	http://dx.doi.org/10.1371/journal.pone.0156730			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243237	Green Published, gold, Green Submitted			2022-12-26	WOS:000377146100067
J	Shuaib, A; Hartwell, A; Kiss-Toth, E; Holcombe, M				Shuaib, Aban; Hartwell, Adam; Kiss-Toth, Endre; Holcombe, Mike			Multi-Compartmentalisation in the MAPK Signalling Pathway Contributes to the Emergence of Oscillatory Behaviour and to Ultrasensitivity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; CELL-CYCLE ARREST; NEGATIVE-FEEDBACK; GENE-EXPRESSION; NUCLEAR TRANSLOCATION; TRANSDUCTION PATHWAYS; COMPLEX-FORMATION; SYSTEMS BIOLOGY; RAS	Signal transduction through the Mitogen Activated Protein Kinase (MAPK) pathways is evolutionarily highly conserved. Many cells use these pathways to interpret changes to their environment and respond accordingly. The pathways are central to triggering diverse cellular responses such as survival, apoptosis, differentiation and proliferation. Though the interactions between the different MAPK pathways are complex, nevertheless, they maintain a high level of fidelity and specificity to the original signal. There are numerous theories explaining how fidelity and specificity arise within this complex context; spatio-temporal regulation of the pathways and feedback loops are thought to be very important. This paper presents an agent based computational model addressing multi-compartmentalisation and how this influences the dynamics of MAPK cascade activation. The model suggests that multi-compartmentalisation coupled with periodic MAPK kinase (MAPKK) activation may be critical factors for the emergence of oscillation and ultrasensitivity in the system. Finally, the model also establishes a link between the spatial arrangements of the cascade components and temporal activation mechanisms, and how both contribute to fidelity and specificity of MAPK mediated signalling.	[Shuaib, Aban; Kiss-Toth, Endre] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England; [Shuaib, Aban; Holcombe, Mike] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Shuaib, Aban] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England; [Hartwell, Adam] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield, S Yorkshire, England; [Holcombe, Mike] Univ Sheffield, Adv Comp Res Ctr, Sheffield Bioincubator, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Holcombe, M (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.; Holcombe, M (corresponding author), Univ Sheffield, Adv Comp Res Ctr, Sheffield Bioincubator, Sheffield, S Yorkshire, England.	m.holcombe@sheffield.ac.uk	Kiss-Toth, Endre/A-8596-2014; Kiss-Toth, Endre/AAC-4252-2020	Kiss-Toth, Endre/0000-0003-4406-4017; Kiss-Toth, Endre/0000-0003-4406-4017; Varma, Susheel/0000-0003-1687-2754; Shuaib, Aban/0000-0002-6137-8205	Biotechnology and Biological Sciences Research Council BBSRC Doctoral Training Grant [BB/F016840/1]	Biotechnology and Biological Sciences Research Council BBSRC Doctoral Training Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funded by Biotechnology and Biological Sciences Research Council BBSRC Doctoral Training Grant BB/F016840/1 (www.bbsrc.ac.uk).	Adra SF, 2008, TECHNICAL REPORT; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Angermann BR, 2012, NAT METHODS, V9, P283, DOI [10.1038/NMETH.1861, 10.1038/nmeth.1861]; Baldassare JJ, 1999, J IMMUNOL, V162, P5367; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 2004, BIOPHYS J, V87, P733, DOI 10.1529/biophysj.104.040469; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Bray D, 1997, P NATL ACAD SCI USA, V94, P13493, DOI 10.1073/pnas.94.25.13493; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chickarmane V, 2007, J THEOR BIOL, V244, P68, DOI 10.1016/j.jtbi.2006.05.013; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choi TG, 2011, BBA-MOL CELL RES, V1813, P1412, DOI 10.1016/j.bbamcr.2011.04.001; Coakley S, 2006, SIMULATION, V38, P33; Colpoys WE, 2005, CELL SIGNAL, V17, P891, DOI 10.1016/j.cellsig.2004.11.014; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Eblen ST, 2004, MOL CELL BIOL, V24, P2308, DOI 10.1128/MCB.24.6.2308-2317.2004; Ferrell JE, 2009, FEBS LETT, V583, P3999, DOI 10.1016/j.febslet.2009.10.068; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gaumont-Leclerc MF, 2004, J BIOL CHEM, V279, P46802, DOI 10.1074/jbc.M403893200; Hanada M, 1998, FEBS LETT, V437, P172, DOI 10.1016/S0014-5793(98)01229-0; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hao Bai, 2014, PLOS COMPUT IN PRESS; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Harris VK, 2000, J BIOL CHEM, V275, P10802, DOI 10.1074/jbc.275.15.10802; Hilioti Z, 2008, CURR BIOL, V18, P1700, DOI 10.1016/j.cub.2008.09.027; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kageyama R, 2012, WIRES DEV BIOL, V1, P629, DOI 10.1002/wdev.46; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kholodenko BN, 2000, BIOCHEM J, V350, P901, DOI 10.1042/0264-6021:3500901; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Klann MT, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-71; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Le Dreau G, 2012, DEV NEUROBIOL, V72, P1471, DOI 10.1002/dneu.22015; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Legewie S, 2007, BIOPHYS J, V93, P2279, DOI 10.1529/biophysj.107.109132; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu P, 2011, BIOPHYS J, V101, P2572, DOI 10.1016/j.bpj.2011.10.025; Mallavarapu A, 2009, J R SOC INTERFACE, V6, P257, DOI 10.1098/rsif.2008.0205; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Morley SJ, 1997, FEBS LETT, V418, P327, DOI 10.1016/S0014-5793(97)01405-1; Mugler A, 2012, BIOPHYS J, V102, P1069, DOI 10.1016/j.bpj.2012.02.005; Munoz-Garcia J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000330; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nakayama K, 2008, CURR BIOL, V18, pR332, DOI 10.1016/j.cub.2008.03.013; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]; Ortega F, 2006, FEBS J, V273, P3915, DOI 10.1111/j.1742-4658.2006.05394.x; Plowman SJ, 2008, MOL CELL BIOL, V28, P4377, DOI 10.1128/MCB.00050-08; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Sabouri-Ghomi M, 2008, J THEOR BIOL, V250, P209, DOI 10.1016/j.jtbi.2007.09.001; Sarma Uddipan, 2012, BMC Res Notes, V5, P287, DOI 10.1186/1756-0500-5-287; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Shankaran H, 2011, MOL CARCINOGEN, V50, P424, DOI 10.1002/mc.20724; Shankaran H, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.90; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Smith ER, 2004, J CELL BIOL, V164, P689, DOI 10.1083/jcb.200312028; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Vetterkind S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030409; Wang X, 2006, BIOPHYS J, V90, P1961, DOI 10.1529/biophysj.105.073874; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Zhao Q, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055004; Zhou Q, 2012, BRIT J PHARMACOL, V166, P1756, DOI 10.1111/j.1476-5381.2012.01875.x	78	9	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156139	10.1371/journal.pone.0156139	http://dx.doi.org/10.1371/journal.pone.0156139			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243235	Green Accepted, Green Published, gold			2022-12-26	WOS:000377146100017
J	Yubero, D; Brandi, N; Ormazabal, A; Garcia-Cazorla, A; Perez-Duenas, B; Campistol, J; Ribes, A; Palau, F; Artuch, R; Armstrong, J				Yubero, Delia; Brandi, Nuria; Ormazabal, Aida; Garcia-Cazorla, Angels; Perez-Duenas, Belen; Campistol, Jaime; Ribes, Antonia; Palau, Francesc; Artuch, Rafael; Armstrong, Judith		Working Grp	Targeted Next Generation Sequencing in Patients with Inborn Errors of Metabolism	PLOS ONE			English	Article							EXONIC SPLICING ENHANCER; MOLECULAR DIAGNOSIS; MENDELIAN DISORDERS; HARTNUP DISORDER; GENE; DEFICIENCY; MUTATION; DISEASES; ACID; CHILDHOOD	Background Next-generation sequencing (NGS) technology has allowed the promotion of genetic diagnosis and are becoming increasingly inexpensive and faster. To evaluate the utility of NGS in the clinical field, a targeted genetic panel approach was designed for the diagnosis of a set of inborn errors of metabolism (IEM). The final aim of the study was to compare the findings for the diagnostic yield of NGS in patients who presented with consistent clinical and biochemical suspicion of IEM with those obtained for patients who did not have specific biomarkers. Methods The subjects studied (n = 146) were classified into two categories: Group 1 (n = 81), which consisted of patients with clinical and biochemical suspicion of IEM, and Group 2 (n = 65), which consisted of IEM cases with clinical suspicion and unspecific biomarkers. A total of 171 genes were analyzed using a customtargeted panel of genes followed by Sanger validation. Results Genetic diagnosis was achieved in 50% of patients (73/146). In addition, the diagnostic yield obtained for Group 1 was 78% (63/81), and this rate decreased to 15.4% (10/65) in Group 2 (X-2 = 76.171; p < 0.0001). Conclusions A rapid and effective genetic diagnosis was achieved in our cohort, particularly the group that had both clinical and biochemical indications for the diagnosis.	[Yubero, Delia; Ormazabal, Aida; Artuch, Rafael] Hosp St Joan Deu, Dept Clin Biochem, Barcelona, Spain; [Yubero, Delia; Ormazabal, Aida; Artuch, Rafael] Hosp St Joan Deu, Inst Invest Sanitaria St Joan Deu, Barcelona, Spain; [Brandi, Nuria] Univ Barcelona, Fac Med, Barcelona 7, Spain; [Brandi, Nuria; Palau, Francesc; Armstrong, Judith] Hosp St Joan Deu, Mol & Genet Med Sect, Barcelona, Spain; [Garcia-Cazorla, Angels; Perez-Duenas, Belen; Campistol, Jaime] Hosp St Joan Deu, Dept Neurol, Barcelona, Spain; [Ribes, Antonia] Hosp Clin Barcelona, Inst Bioquim Clin, Barcelona, Spain; [Ormazabal, Aida; Garcia-Cazorla, Angels; Perez-Duenas, Belen; Campistol, Jaime; Ribes, Antonia; Palau, Francesc; Artuch, Rafael; Armstrong, Judith] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Armstrong, J (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain.	jarmstrong@hsjdbcn.org	Palau, Francesc/A-9391-2014; Martí-Carrera, Itxaso/AGP-5583-2022; Perez-Duenas, Belen/AAG-9054-2019	Palau, Francesc/0000-0002-8635-5421; Martí-Carrera, Itxaso/0000-0003-0578-9568; Yubero, Delia/0000-0001-7742-0589; Malaga, Ignacio/0000-0003-4074-6870; KIZILTAN, GUNES/0000-0001-9284-198X; Olive, Montse/0000-0001-5727-0165; Ribes Rubio, Antonia/0000-0002-2249-246X; Artuch, Rafael/0000-0002-3422-9685	Spanish Ministry of Health (Fondo de Investigacion Sanitaria) [PI11/02350, PI11/00078]; Spanish Ministry of Health (Instituto de Salud Carlos III) [PI11/02350, PI11/00078]; Spanish Ministry of Health (FEDER) [PI11/02350, PI11/00078]; "programa de intensificacion de la actividad investigadora", from ISCIII	Spanish Ministry of Health (Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Health (Instituto de Salud Carlos III)(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Health (FEDER); "programa de intensificacion de la actividad investigadora", from ISCIII	This research was funded by grants PI11/02350 and PI11/00078 from the Spanish Ministry of Health (Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III and FEDER). R. Artuch is supported by the "programa de intensificacion de la actividad investigadora", from ISCIII.	Azize NAA, 2014, J HUM GENET, V59, P593, DOI 10.1038/jhg.2014.69; Blau N., 2003, PHYS GUIDE LAB DIAGN; Blau N., 2008, LAB GUIDE METHODS BI; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Cao YY, 2014, MOL GENET METAB, V113, P261, DOI 10.1016/j.ymgme.2014.10.004; De Giorgis V, 2013, SEIZURE-EUR J EPILEP, V22, P803, DOI 10.1016/j.seizure.2013.07.003; Feng YM, 2015, GENET MED, V17, P99, DOI 10.1038/gim.2014.80; Gu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094100; Homolova K, 2010, HUM MUTAT, V31, P437, DOI 10.1002/humu.21206; Kingsmore SF, 2011, EXPERT REV MOL DIAGN, V11, P855, DOI [10.1586/erm.11.70, 10.1586/ERM.11.70]; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Li N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15769; Miller MJ, 2015, MOL GENET METAB, V116, P139, DOI 10.1016/j.ymgme.2015.08.011; Molero-Luis M, 2013, DEV MED CHILD NEUROL, V55, P559, DOI 10.1111/dmcn.12116; Palhais B, 2015, NUCLEIC ACIDS RES, V43, P4627, DOI 10.1093/nar/gkv275; Pearson TS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0342-7; Perez-Duenas B, 2011, ARCH NEUROL-CHICAGO, V68, P615, DOI 10.1001/archneurol.2011.80; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Shashi V, 2014, GENET MED, V16, P176, DOI 10.1038/gim.2013.99; Singer D, 2011, CHANNELS, V5, P408, DOI 10.4161/chan.5.5.16470; Trujillano D, 2014, EUR J HUM GENET, V22, P528, DOI 10.1038/ejhg.2013.175; Wang J, 2013, GENET MED, V15, P106, DOI 10.1038/gim.2012.104; Wong LJC, 2013, MITOCHONDRION, V13, P379, DOI 10.1016/j.mito.2013.02.001; Yavarna T, 2015, HUM GENET, V134, P967, DOI 10.1007/s00439-015-1575-0; Yohe S, 2015, ARCH PATHOL LAB MED, V139, P204, DOI 10.5858/arpa.2013-0625-OA; Yu H, 2013, MOL GENET METAB, V110, P465, DOI 10.1016/j.ymgme.2013.09.018; Zhang W, 2014, TOP CURR CHEM, V336, P19, DOI 10.1007/128_2012_325	29	34	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156359	10.1371/journal.pone.0156359	http://dx.doi.org/10.1371/journal.pone.0156359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243974	Green Published, gold, Green Submitted			2022-12-26	WOS:000377146100032
J	Parletta, N; Niyonsenga, T; Duff, J				Parletta, Natalie; Niyonsenga, Theophile; Duff, Jacques			Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; DIETARY SUPPLEMENTATION; DOCOSAHEXAENOIC ACID; SUSTAINED ATTENTION; CONTROLLED-TRIAL; ADHD; BEHAVIOR; PREVALENCE; CHILDHOOD; COGNITION	Background There is evidence that children with Attention Deficit Hyperactivity Disorder (ADHD) and Autistic Spectrum Disorder (ASD) have lower omega-3 polyunsaturated fatty acid (n-3 PUFA) levels compared with controls and conflicting evidence regarding omega-6 (n-6) PUFA levels. Objectives This study investigated whether erythrocyte n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) were lower and n-6 PUFA arachidonic acid (AA) higher in children with ADHD, ASD and controls, and whether lower n-3 and higher n-6 PUFAs correlated with poorer scores on the Australian Twin Behaviour Rating Scale (ATBRS; ADHD symptoms) and Test of Variable Attention (TOVA) in children with ADHD, and Childhood Autism Rating Scale (CARS) in children with ASD. Methods Assessments and blood samples of 565 children aged 3-17 years with ADHD (n = 401), ASD (n = 85) or controls (n = 79) were analysed. One-way ANOVAs with Tukey's post-hoc analysis investigated differences in PUFA levels between groups and Pearson's correlations investigated correlations between PUFA levels and ATBRS, TOVA and CARS scores. Results Children with ADHD and ASD had lower DHA, EPA and AA, higher AA/EPA ratio and lower n-3/n-6 than controls (P < 0.001 except AA between ADHD and controls: P = 0.047). Children with ASD had lower DHA, EPA and AA than children with ADHD (P < 0.001 for all comparisons). ATBRS scores correlated negatively with EPA (r = -.294, P < 0.001), DHA (r = -.424, P < 0.001), n-3/n-6 (r = -.477, P < 0.001) and positively with AA/EPA (r = .222, P <. 01). TOVA scores correlated positively with DHA (r = .610, P < 0.001), EPA (r = .418, P < 0.001) AA (r =.199, P < 0.001), and n-3/n-6 (r = .509, P < 0.001) and negatively with AA/EPA (r = -.243, P < 0.001). CARS scores correlated significantly with DHA (r =. 328, P = 0.002), EPA (r = -.225, P = 0.038) and AA (r = .251, P = 0.021). Conclusions Children with ADHD and ASD had low levels of EPA, DHA and AA and high ratio of n-6/n-3 PUFAs and these correlated significantly with symptoms. Future research should further investigate abnormal fatty acid metabolism in these disorders.	[Parletta, Natalie; Niyonsenga, Theophile] Univ S Australia, Ctr Populat Hlth Res, Sch Hlth Sci, Adelaide, SA 5001, Australia; [Duff, Jacques] Behav Neurotherapy Clin, Doncaster, Vic, Australia; [Duff, Jacques] Australian Autism ADHD Fdn, Doncaster, Vic, Australia	University of South Australia	Duff, J (corresponding author), Behav Neurotherapy Clin, Doncaster, Vic, Australia.; Duff, J (corresponding author), Australian Autism ADHD Fdn, Doncaster, Vic, Australia.	info@autism-ADHD.org.au	Parletta, Natalie/A-7880-2008; Niyonsenga, Theophile/C-3759-2014	Parletta, Natalie/0000-0003-2322-5555; Niyonsenga, Theophile/0000-0002-6723-0316	National Health and Medical Research Council [320860, 631947]; Australian Autism ADHD Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Autism ADHD Foundation	NP is supported by National Health and Medical Research Council Program Grant funding (# 320860 and 631947). The Australian Autism ADHD Foundation funded the cost of HREC and publishing the paper.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Antalis CJ, 2006, PROSTAG LEUKOTR ESS, V75, P299, DOI 10.1016/j.plefa.2006.07.004; Bell JG, 2000, PROSTAG LEUKOTR ESS, V63, P21, DOI 10.1054/plef.2000.0186; Bell JG, 2004, PROSTAG LEUKOTR ESS, V71, P201, DOI 10.1016/j.plefa.2004.03.008; Bloch MH, 2011, J AM ACAD CHILD PSY, V50, P991, DOI 10.1016/j.jaac.2011.06.008; Bos DJ, 2015, NEUROPSYCHOPHARMACOL, V40, P2298, DOI 10.1038/npp.2015.73; Brigandi SA, 2015, INT J MOL SCI, V16, P10061, DOI 10.3390/ijms160510061; Bu B, 2006, PROSTAG LEUKOTR ESS, V74, P215, DOI 10.1016/j.plefa.2006.02.001; Charach A, 2004, J AM ACAD CHILD PSY, V43, P559, DOI 10.1097/00004583-200405000-00009; Chen JR, 2004, J NUTR BIOCHEM, V15, P467, DOI 10.1016/j.jnutbio.2004.01.008; Colter AL, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-8; Curtis LT, 2008, J ALTERN COMPLEM MED, V14, P79, DOI 10.1089/acm.2007.0610; Gow RV, 2015, CURR OPIN CLIN NUTR, V18, P133, DOI 10.1097/MCO.0000000000000140; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; GREENBERG LM, 1993, J CHILD PSYCHOL PSYC, V34, P1019, DOI 10.1111/j.1469-7610.1993.tb01105.x; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hawkey E, 2014, CLIN PSYCHOL REV, V34, P496, DOI 10.1016/j.cpr.2014.05.005; Howard AL, 2011, J ATTEN DISORD, V15, P403, DOI 10.1177/1087054710365990; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Jensen PS, 2004, PEDIATRICS, V113, P762; Johnson CR, 2008, J DEV PHYS DISABIL, V20, P437, DOI 10.1007/s10882-008-9111-y; Johnson M, 2009, J ATTEN DISORD, V12, P394, DOI 10.1177/1087054708316261; Joshi K, 2006, PROSTAG LEUKOTR ESS, V74, P17, DOI 10.1016/j.plefa.2005.10.001; Kohlboeck G, 2012, ANN NUTR METAB, V60, P247, DOI 10.1159/000337552; Laasonen M, 2009, PROSTAG LEUKOTR ESS, V81, P79, DOI 10.1016/j.plefa.2009.04.004; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Llorente AM, 2008, CHILD NEUROPSYCHOL, V14, P314, DOI 10.1080/09297040701563578; McNamara RK, 2010, AM J CLIN NUTR, V91, P1060, DOI 10.3945/ajcn.2009.28549; Miller CS, 2001, ANN NY ACAD SCI, V933, P1, DOI 10.1017/CBO9780511666452.002; Milte CM, 2015, J ATTEN DISORD, V19, P954, DOI 10.1177/1087054713510562; Milte CM, 2012, NUTRITION, V28, P670, DOI 10.1016/j.nut.2011.12.009; Milte CM, 2011, J CHILD HEALTH CARE, V15, P299, DOI 10.1177/1367493511403953; Milte CM, 2009, NUTR REV, V67, P573, DOI 10.1111/j.1753-4887.2009.00229.x; Ming X, 2005, PROSTAG LEUKOTR ESS, V73, P379, DOI 10.1016/j.plefa.2005.06.002; Molina BSG, 2007, J AM ACAD CHILD PSY, V46, P1028, DOI 10.1097/chi.0b013e3180686d96; Montgomery P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066697; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Ng KH, 2009, BRIT J NUTR, V102, P1635, DOI 10.1017/S0007114509990821; Nikolas MA, 2010, J ABNORM PSYCHOL, V119, P1, DOI 10.1037/a0018010; Parletta N, 2013, J NUTR BIOCHEM, V24, P725, DOI 10.1016/j.jnutbio.2013.01.002; Partty A, 2015, PEDIATR RES, V77, P823, DOI 10.1038/pr.2015.51; Pliszka SR, 1998, J CLIN PSYCHIAT, V59, P50; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Reiersen Angela M, 2008, Expert Rev Neurother, V8, P657, DOI 10.1586/14737175.8.4.657; Richardson AJ, 2005, PEDIATRICS, V115, P1360, DOI 10.1542/peds.2004-2164; Richardson AJ, 2004, LIPIDS, V39, P1215, DOI 10.1007/s11745-004-1350-z; Richardson AJ, 2000, PROSTAG LEUKOTR ESS, V63, P1, DOI 10.1054/plef.2000.0184; Richardson AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043909; Rowland AS, 2002, MENT RETARD DEV D R, V8, P162, DOI 10.1002/mrdd.10036; SCHOPLER E, 1980, J AUTISM DEV DISORD, V10, P91, DOI 10.1007/BF02408436; Shamberger RJ, 1997, J ADV MED, V10, P195; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Sinn N, 2008, PROSTAG LEUKOTR ESS, V78, P311, DOI 10.1016/j.plefa.2008.04.004; Sinn N, 2008, BIOSCI HYPOTHESES, V1, P103, DOI DOI 10.1016/j.bihy.2008.02.003; Sinn N, 2008, NUTR REV, V66, P558, DOI 10.1111/j.1753-4887.2008.00107.x; Sinn N, 2007, J DEV BEHAV PEDIATR, V28, P82, DOI 10.1097/01.DBP.0000267558.88457.a5; Sinn N, 2006, INT REV RES MENT RET, V32, P159, DOI 10.1016/S0074-7750(06)32006-X; Sinn N, 2010, NUTRIENTS, V2, P128, DOI 10.3390/nu2020128; Swanson JM, 2007, J AM ACAD CHILD PSY, V46, P1015, DOI 10.1097/chi.0b013e3180686d7e; Transler C, 2010, J ATTEN DISORD, V14, P232, DOI 10.1177/1087054709347250; Vaisman N, 2008, AM J CLIN NUTR, V87, P1170, DOI 10.1093/ajcn/87.5.1170; Vancassel S, 2001, PROSTAG LEUKOTR ESS, V65, P1, DOI 10.1054/plef.2001.0281; Wall R, 2012, AM J CLIN NUTR, V95, P1278, DOI 10.3945/ajcn.111.026435; Wiest MM, 2009, PROSTAG LEUKOTR ESS, V80, P221, DOI 10.1016/j.plefa.2009.01.007; Wiles NJ, 2009, EUR J CLIN NUTR, V63, P491, DOI 10.1038/sj.ejcn.1602967; Willemsen LEM, 2008, EUR J NUTR, V47, P183, DOI 10.1007/s00394-008-0712-0; Young GS, 2004, LIPIDS, V39, P117, DOI 10.1007/s11745-004-1209-3; Zablotsky B, 2013, NATL HLTH STAT REPOR	70	58	59	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156432	10.1371/journal.pone.0156432	http://dx.doi.org/10.1371/journal.pone.0156432			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232999	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000376883000035
J	Agarwal, S; Yadav, A; Tiwari, SK; Seth, B; Chauhan, LKS; Khare, P; Ray, RS; Chaturvedi, RK				Agarwal, Swati; Yadav, Anuradha; Tiwari, Shashi Kant; Seth, Brashket; Chauhan, Lalit Kumar Singh; Khare, Puneet; Ray, Ratan Singh; Chaturvedi, Rajnish Kumar			Dynamin-related Protein 1 Inhibition Mitigates Bisphenol A-mediated Alterations in Mitochondrial Dynamics and Neural Stem Cell Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPOCAMPAL NEUROGENESIS; CYTOCHROME-C; FISSION; AUTOPHAGY; DISEASE; FUSION; EXPOSURE; BRAIN; DRP1; DISRUPTION	The regulatory dynamics of mitochondria comprises well orchestrated distribution and mitochondrial turnover to maintain the mitochondrial circuitry and homeostasis inside the cells. Several pieces of evidence suggested impaired mitochondrial dynamics and its association with the pathogenesis of neurodegenerative disorders. We found that chronic exposure of synthetic xenoestrogen bisphenolA(BPA), a component of consumer plastic products, impaired autophagy-mediated mitochondrial turnover, leading to increased oxidative stress, mitochondrial fragmentation, and apoptosis in hippocampal neural stem cells (NSCs). It also inhibited hippocampal derived NSC proliferation and differentiation, as evident by the decreased number of BrdU-and beta-III tubulin-positive cells. All these effects were reversed by the inhibition of oxidative stress using N-acetyl cysteine. BPA up-regulated the levels of Drp-1 (dynamin-related protein 1) and enhanced its mitochondrial translocation, with no effect on Fis-1, Mfn-1, Mfn-2, and Opa-1 in vitro and in the hippocampus. Moreover, transmission electron microscopy studies suggested increased mitochondrial fission and accumulation of fragmented mitochondria and decreased elongated mitochondria in the hippocampus of the rat brain. Impaired mitochondrial dynamics by BPA resulted in increased reactive oxygen species and malondialdehyde levels, disruption of mitochondrial membrane potential, and ATP decline. Pharmacological (Mdivi-1) and genetic (Drp-1siRNA) inhibition of Drp-1 reversed BPA-induced mitochondrial dysfunctions, fragmentation, and apoptosis. Interestingly, BPA-mediated inhibitory effects on NSC proliferation and neuronal differentiations were also mitigated by Drp-1 inhibition. On the other hand, Drp-1 inhibition blocked BPA-mediated Drp-1 translocation, leading to decreased apoptosis of NSC. Overall, our studies implicate Drp-1 as a potential therapeutic target against BPA-mediated impaired mitochondrial dynamics and neurodegeneration in the hippocampus.	[Agarwal, Swati; Yadav, Anuradha; Tiwari, Shashi Kant; Seth, Brashket; Khare, Puneet; Chaturvedi, Rajnish Kumar] IITR, CSIR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; [Ray, Ratan Singh] IITR, CSIR, Photobiol Lab, Syst Toxicol & Hlth Risk Assessment Grp, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; [Agarwal, Swati; Yadav, Anuradha; Tiwari, Shashi Kant; Seth, Brashket; Chaturvedi, Rajnish Kumar] IITR, CSIR, Acad Sci & Innovat Res, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India; [Chauhan, Lalit Kumar Singh] IITR, CSIR, Cent Instrumentat Facil, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR)	Chaturvedi, RK (corresponding author), IITR, CSIR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.	rajnish@iitr.res.in	Tiwari, Shashi Kant/R-8533-2018; Chaturvedi, Rajnish/AAZ-9955-2020	Tiwari, Shashi Kant/0000-0002-6121-6249; Chaturvedi, Rajnish Kumar/0000-0001-9591-7636	Council of Scientific and Industrial Research-Network Grant InDepth [BSC0111]; Lady Tata Memorial Trust Young Scientist Grant; Council of Scientific and Industrial Research, New Delhi	Council of Scientific and Industrial Research-Network Grant InDepth; Lady Tata Memorial Trust Young Scientist Grant; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research-Network Grant InDepth BSC0111, a Lady Tata Memorial Trust Young Scientist Grant (to R. K. C.), and Senior Research Fellowships from the Council of Scientific and Industrial Research, New Delhi (to S. A. and B. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal S, 2015, J BIOL CHEM, V290, P21163, DOI 10.1074/jbc.M115.648998; Alaimo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091848; Alaimo A, 2013, NEUROSCI LETT, V554, P76, DOI 10.1016/j.neulet.2013.08.061; Arrazola MS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00166; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bonet-Ponce L, 2015, BBA-MOL BASIS DIS, V1852, P1400, DOI 10.1016/j.bbadis.2015.03.006; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Carelli V, 2015, ANN NEUROL, V78, P21, DOI 10.1002/ana.24410; Carvalho C, 2015, EXPERT REV NEUROTHER, V15, P867, DOI 10.1586/14737175.2015.1058160; Cavallucci V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.511; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Cereghetti GM, 2010, CELL DEATH DIFFER, V17, P1785, DOI 10.1038/cdd.2010.61; Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chaturvedi RK, 2012, HUM MOL GENET, V21, P3474, DOI 10.1093/hmg/dds178; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2004, CURR TOP DEV BIOL, V59, P119, DOI 10.1016/S0070-2153(04)59005-1; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen HC, 2006, CURR OPIN CELL BIOL, V18, P453, DOI 10.1016/j.ceb.2006.06.004; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cui Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23300; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Egnaczyk GF, 2001, BIOCHEMISTRY-US, V40, P11706, DOI 10.1021/bi002852h; Fehlberg S, 2002, BIOCHEM J, V362, P573, DOI 10.1042/0264-6021:3620573; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Godoy JA, 2014, J BIOL CHEM, V289, P36179, DOI 10.1074/jbc.M114.557009; Guedes-Dias P, 2016, NEUROBIOL DIS, V90, P51, DOI 10.1016/j.nbd.2015.09.008; Hroudova J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/175062; Huang BX, 2014, MED HYPOTHESES, V82, P245, DOI 10.1016/j.mehy.2013.10.023; Huc L, 2012, TOXICOL IN VITRO, V26, P709, DOI 10.1016/j.tiv.2012.03.017; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jiang Y, 2014, J APPL TOXICOL, V34, P1012, DOI 10.1002/jat.2924; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mao CP, 2014, J CELL MOL MED, V18, P2404, DOI 10.1111/jcmm.12420; Masuo Y, 2011, J TOXICOL ENV HEAL B, V14, P346, DOI 10.1080/10937404.2011.578557; Mishra D, 2012, TOXICOL SCI, V127, P84, DOI 10.1093/toxsci/kfs004; Mistry SK, 2002, P NATL ACAD SCI USA, V99, P1621, DOI 10.1073/pnas.022646599; Mizushima N, 2011, COLD SH Q B, V76, P397, DOI 10.1101/sqb.2011.76.011023; Mourier A, 2015, J CELL BIOL, V208, P429, DOI 10.1083/jcb.201411100; Ooe H, 2005, TOXICOL SCI, V88, P114, DOI 10.1093/toxsci/kfi278; Pahuja R, 2015, ACS NANO, V9, P4850, DOI 10.1021/nn506408v; Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665; Pla-Martin D, 2013, NEUROBIOL DIS, V55, P140, DOI 10.1016/j.nbd.2013.03.010; Purnell PR, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-86; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Reddy PH, 2014, J ALZHEIMERS DIS, V40, P245, DOI 10.3233/JAD-132060; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sheridan C, 2010, MITOCHONDRION, V10, P640, DOI 10.1016/j.mito.2010.08.005; Singhal NK, 2015, J BIOMED NANOTECHNOL, V11, P2211, DOI 10.1166/jbn.2015.2107; Su YC, 2013, HUM MOL GENET, V22, P4545, DOI 10.1093/hmg/ddt301; Tiwari MN, 2013, FREE RADICAL BIO MED, V65, P704, DOI 10.1016/j.freeradbiomed.2013.07.042; Tiwari SK, 2016, MOL NEUROBIOL, V53, P3010, DOI 10.1007/s12035-015-9197-z; Tiwari SK, 2015, MOL NEUROBIOL, V52, P1735, DOI 10.1007/s12035-014-8940-1; Tiwari SK, 2015, MOL NEUROBIOL, V51, P1395, DOI 10.1007/s12035-014-8817-3; Tiwari SK, 2014, ACS NANO, V8, P76, DOI 10.1021/nn405077y; Wang WZ, 2013, HUM MOL GENET, V22, P4706, DOI 10.1093/hmg/ddt319; Watanabe Y, 2011, J CELL SCI, V124, P2692, DOI 10.1242/jcs.081232; Wisniewski P, 2015, TOXICOLOGY, V329, P1, DOI 10.1016/j.tox.2015.01.002; Xia W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090443; Xie Meina, 2014, Wei Sheng Yan Jiu, V43, P962; Yoshii SR, 2015, BBA-MOL CELL RES, V1853, P2797, DOI 10.1016/j.bbamcr.2015.01.013	70	65	71	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					15923	15939		10.1074/jbc.M115.709493	http://dx.doi.org/10.1074/jbc.M115.709493			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27252377	Green Published, hybrid			2022-12-26	WOS:000380585400002
J	Patel, T; Chang, F; Mohammed, HT; Raman-Wilms, L; Jurcic, J; Khan, A; Sproule, B				Patel, Tejal; Chang, Feng; Mohammed, Heba Tallah; Raman-Wilms, Lalitha; Jurcic, Jane; Khan, Ayesha; Sproule, Beth			Knowledge, Perceptions and Attitudes toward Chronic Pain and Its Management: A Cross-Sectional Survey of Frontline Pharmacists in Ontario, Canada	PLOS ONE			English	Article							CHRONIC NONCANCER PAIN; PRIMARY-CARE; COMMUNITY PHARMACISTS; DIABETIC-NEUROPATHY; OPIOIDS; EPIDEMIOLOGY; PREVALENCE; PHYSICIANS; PATTERNS; BELIEFS	The treatment of chronic pain consumes a significant share of primary care. Community and family health team pharmacists frequently see patients with chronic pain, thus have the opportunity to improve their care. To assess the knowledge, perceptions, and attitudes of Ontario pharmacists, we invited 5,324 Ontario pharmacists, to participate in an online survey we developed using Qualtrics. The 31-question survey gathered demographic information, assessed pharmacists' knowledge of three chronic pain conditions; chronic lower back pain (CLBP, eight true/false statements); chronic headache disorder (CHD, eight true/false statements) and painful diabetic neuropathy (PDN, seven true/false statements), and their attitudes toward and perceptions of patients with these conditions, and knowledge, attitudes, and perceptions of opioids in pain management. We received 688 responses (12.9%) and 392 pharmacists completed the survey. The mean age of respondents was 48.5 years and 48.5% were male. More than 50% of respondents were in practice for more than 20 years and 58.7% worked 25-40 hours per week. The mean knowledge scores were 4.5/8, 5.5/8, and 5.3/8 for CBLP, CHD, and PDN respectively. While 95% of respondents were aware of the increasing death rates due to opioid use, only half were familiar with the Canadian guideline for safe opioid prescribing for non-cancer use. Responses were compared based on gender, time in practice and location of practice. Pharmacists with more than ten years of experience scored significantly higher than those with less experience. Fewer differences were found in comparisons of gender and location of practice. Safe and effective care of chronic pain patients, particularly with opioids, will require additional pharmacist education.	[Patel, Tejal; Chang, Feng; Mohammed, Heba Tallah; Khan, Ayesha] Univ Waterloo, Sch Pharm, Kitchener, ON, Canada; [Patel, Tejal] Ctr Family Med, Family Hlth Team, Kitchener, ON, Canada; [Patel, Tejal; Jurcic, Jane] McMaster Univ, Dept Family Med, DeGroote Sch Med, Hamilton, ON L8S 4L8, Canada; [Chang, Feng] Gateway Ctr Excellence Rural Hlth, Seaforth, ON, Canada; [Mohammed, Heba Tallah] Aim Shams Univ, Dept Community Med, Cairo, Egypt; [Raman-Wilms, Lalitha; Sproule, Beth] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Sproule, Beth] Ctr Addict & Mental Hlth, Toronto, ON, Canada	University of Waterloo; McMaster University; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Patel, T (corresponding author), Univ Waterloo, Sch Pharm, Kitchener, ON, Canada.; Patel, T (corresponding author), Ctr Family Med, Family Hlth Team, Kitchener, ON, Canada.; Patel, T (corresponding author), McMaster Univ, Dept Family Med, DeGroote Sch Med, Hamilton, ON L8S 4L8, Canada.	t5patel@uwaterloo.ca	Patel, Tejal/ABG-6213-2021; Mohammed, Heba/AAF-8484-2020	Sproule, Beth/0000-0001-7960-3696	government of Ontario [06674]	government of Ontario	This study was supported by a grant from the government of Ontario (Ministry grant no. 06674).	ANDERSSON HI, 1993, CLIN J PAIN, V9, P174, DOI 10.1097/00002508-199309000-00004; [Anonymous], 2013, 1 DO NO HARM RESP CA; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boulanger A, 2007, PAIN RES MANAG, V12, P39, DOI 10.1155/2007/762180; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Canadian Council for Accreditation of Pharmacy Programs (CCAPP), CCAPP PHARM TECHN PR; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; Duby JJ, 2004, AM J HEALTH-SYST PH, V61, P160, DOI 10.1093/ajhp/61.2.160; Elliott AM, 1999, LANCET, V354, P1248, DOI 10.1016/S0140-6736(99)03057-3; Fine PG, 2011, PAIN MED, V12, P996, DOI 10.1111/j.1526-4637.2011.01187.x; Furlan AD, 2010, CAN MED ASSOC J, V182, P923, DOI 10.1503/cmaj.100187; Gatchel RJ, 2014, AM PSYCHOL, V69, P119, DOI 10.1037/a0035514; Gilson AM, 2010, J PAIN SYMPTOM MANAG, V40, P599, DOI 10.1016/j.jpainsymman.2010.02.011; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Grahmann Paula H, 2004, J Pain Palliat Care Pharmacother, V18, P7; Greenwald BD, 1999, J PAIN SYMPTOM MANAG, V17, P369, DOI 10.1016/S0885-3924(99)00010-X; Gureje O, 1998, JAMA-J AM MED ASSOC, V280, P147, DOI 10.1001/jama.280.2.147; Iyer S, 2013, EXPERT OPIN PHARMACO, V14, P1765, DOI 10.1517/14656566.2013.811490; Jensen R, 2008, LANCET NEUROL, V7, P354, DOI 10.1016/S1474-4422(08)70062-0; Joranson D E, 2001, J Am Pharm Assoc (Wash), V41, P213; Jouini G, 2014, J PAIN RES, V7, P163, DOI 10.2147/JPR.S56884; Kahan M, 2006, CAN FAM PHYSICIAN, V52, P1091; Kent Peter M, 2005, Chiropr Osteopat, V13, P13, DOI 10.1186/1746-1340-13-13; Labianca R, 2012, CLIN DRUG INVEST, V32, P53, DOI 10.2165/11630080-000000000-00000; Lalonde L, 2014, PAIN RES MANAG, V19, P241, DOI 10.1155/2014/760145; Laurent S., 2002, RURAL CANADA ACCESS; Lipton RB, 2004, NEUROLOGY, V62, P1926, DOI 10.1212/WNL.62.11.1926; Martin BA, 2010, RES SOC ADMIN PHARM, V6, P155, DOI 10.1016/j.sapharm.2010.05.001; National Association of Pharmacy Regulatory Authorities (NAPRA), MOD STAND PRACT CAN, P2009; Office of National Drug Control Policy / The White House, 2011, PERSCR DRUG AB PREV; Passmore C, 2002, FAM MED, V34, P281; Phillips CJ, 2008, CHRONIC PAIN HLTH PO, P41, DOI DOI 10.1002/9783527622665.CH4; Prefontaine K, 2013, BRIT J OCCUP THER, V76, P280, DOI 10.4276/030802213X13706169932905; Reitsma ML, 2011, CHRON DIS INJ CAN, V31, P157; Roth CS, 2007, J REHABIL RES DEV, V44, P263, DOI 10.1682/JRRD.2006.05.0055; SCHMIDT FL, 1986, J APPL PSYCHOL, V71, P432, DOI 10.1037/0021-9010.71.3.432; Schopflocher D, 2011, PAIN RES MANAG, V16, P445, DOI 10.1155/2011/876306; Schrader Susan L, 2005, S D J Med, V58, P423; Silcock J, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-10; Sproule BA, 1999, J CLIN PSYCHOPHARM, V19, P367, DOI 10.1097/00004714-199908000-00014; Sproule B, 2009, CAN FAM PHYSICIAN, V55, P68; Sproule BA, 2011, DRUG ALCOHOL REV, V30, P327, DOI 10.1111/j.1465-3362.2010.00270.x; Tousignant-Laflamme Y, 2012, PAIN RES MANAG, V17, P341, DOI 10.1155/2012/506352; Veves A, 2008, PAIN MED, V9, P660, DOI 10.1111/j.1526-4637.2007.00347.x; Vowles KE, 2015, PAIN, V156, P569, DOI 10.1097/01.j.pain.0000460357.01998.f1; Wenghofer EF, 2011, CAN FAM PHYSICIAN, V57, P324; Wenzel RG, 2005, HEADACHE, V45, P47, DOI 10.1111/j.1526-4610.2005.05010.x; Wenzel RG, 2002, ANN PHARMACOTHER, V36, P612; Wolfert MZ, 2010, PAIN MED, V11, P425, DOI 10.1111/j.1526-4637.2009.00761.x	51	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157151	10.1371/journal.pone.0157151	http://dx.doi.org/10.1371/journal.pone.0157151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DO1TC	27270723	gold, Green Submitted, Green Published			2022-12-26	WOS:000377561000068
J	Callaghan, B; Lydon, H; Roelants, SLKW; Van Bogaert, INA; Marchant, R; Banat, IM; Mitchell, CA				Callaghan, Breedge; Lydon, Helen; Roelants, Sophie L. K. W.; Van Bogaert, Inge N. A.; Marchant, Roger; Banat, Ibrahim M.; Mitchell, Christopher A.			Lactonic Sophorolipids Increase Tumor Burden in Apc(min+/-) Mice	PLOS ONE			English	Article							CANCER CELLS; MICROBIAL-PRODUCTION; IGE PRODUCTION; FOOD-INDUSTRY; APC GENE; BIOSURFACTANTS; APOPTOSIS; SEPSIS; MOUSE; MODEL	Sophorolipids (SL) are amphiphilic biosurfactant molecules consisting of a disaccharide sophorose with one fatty acid at the C1 position and optional acetylation at the C6' and C6 '' positions. They exist in a closed ring lactonic (LSL) or open acidic (ASL) structure Sophorolipids are produced in crude mixtures in economically viable amounts by the yeast Starmerella bombicola and used in a variety of consumer products. Varying levels of antiproliferative and anti-cancer activity of crude sophorolipid mixtures are described in a number of tumor cell lines in vitro. However, significant inter-study variation exists in the composition of sophorolipid species as well as other biologically active compounds in these mixtures, which makes interpretation of in vitro and in vivo studies difficult. We produced a 96% pure C18:1 lactonic sophorolipid that dose-dependently reduces the viability of colorectal cancer, as well as normal human colonic and lung cell lines in vitro. Oral administration of vehicle-only; or lactonic sophorolipids (50 mg/kg for 70 days), to Apcmin(+/-) mice resulted in an increase in the number (55.5 +/- 3.3 vs 70.50 +/- 7.8: p < 0.05) and size (modal size 2mm vs 4mm) of intestinal polyps. Lactonic administration resulted in a systematic effect via reduced hematocrit (49.5 +/- 1.0 vs 28.2 +/- 2.0 vs: p<0.03) and splenomegaly (0.56 +/- 0.03g vs 0.71 +/- 0.04g; p<0.01) confirming exacerbation of disease progression in this model.	[Callaghan, Breedge; Lydon, Helen; Marchant, Roger; Banat, Ibrahim M.; Mitchell, Christopher A.] Univ Ulster, Ctr Mol Biosci, Biomed Sci Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland; [Roelants, Sophie L. K. W.; Van Bogaert, Inge N. A.] Univ Ghent, Fac Biosci Engn, Ctr Ind Biotechnol & Biocatalysis InBio Be, Coupure Links 653, B-9000 Ghent, Belgium	Ulster University; Ghent University	Mitchell, CA (corresponding author), Univ Ulster, Ctr Mol Biosci, Biomed Sci Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland.	ca.mitchell@ulster.ac.uk	Mitchell, Christopher/ABH-1426-2020	Mitchell, Christopher/0000-0002-4422-7499; Banat, Ibrahim/0000-0001-8964-2840; Van Bogaert, Inge/0000-0001-8144-6466	European FP7 Project Biosurfing [289219]	European FP7 Project Biosurfing	This research was funded by the European FP7 Project Biosurfing, Grant number 289219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banat IM, 2010, APPL MICROBIOL BIOT, V87, P427, DOI 10.1007/s00253-010-2589-0; Bluth MH, 2008, J ALLERGY CLIN IMMUN, V121, pS2, DOI 10.1016/j.jaci.2007.12.011; Bluth MH, 2006, CRIT CARE MED, V34, P188, DOI 10.1097/01.CCM.0000196212.56885.50; Bognolo G, 1999, COLLOID SURFACE A, V152, P41, DOI 10.1016/S0927-7757(98)00684-0; Casteleyn C, 2010, LAB ANIM-UK, V44, P176, DOI 10.1258/la.2009.009112; Cavalero DA, 2003, J BIOTECHNOL, V103, P31, DOI 10.1016/S0168-1656(03)00067-1; Chen J, 2006, APPL MICROBIOL BIOT, V72, P52, DOI 10.1007/s00253-005-0243-z; CROSBY WH, 1959, BLOOD, V14, P399, DOI 10.1182/blood.V14.4.399.399; de Oliveira MR, REV SOPHOROLIPIDS PR; Finnerty William R., 1994, Current Opinion in Biotechnology, V5, P291, DOI 10.1016/0958-1669(94)90031-0; Fracchia L, 2012, BIOMEDICAL SCI ENG T, P325; Fracchia L., 2012, BIOMEDICAL SCI ENG T, P326; Fracchia L, 2015, AIMS BIOENG, V2, P144, DOI 10.3934/bioeng.2015.3.144; Fu SL, 2008, J SURG RES, V148, P77, DOI 10.1016/j.jss.2008.03.005; Goodlad RA, 2006, CARCINOGENESIS, V27, P2133, DOI 10.1093/carcin/bgl113; Hagler M, 2007, J ALLERGY CLIN IMMUN, V119, pS263, DOI 10.1016/j.jaci.2006.12.399; Hardin R, 2007, J SURG RES, V142, P314, DOI 10.1016/j.jss.2007.04.025; Isoda H, 1997, BIOSCI BIOTECH BIOCH, V61, P609, DOI 10.1271/bbb.61.609; Jing C, 2006, ENZYME MICROB TECH, V39, P501, DOI 10.1016/j.enzmictec.2005.12.022; Koley D, 2010, P NATL ACAD SCI USA, V107, P16783, DOI 10.1073/pnas.1011614107; Kralova I, 2009, J DISPER SCI TECHNOL, V30, P1363, DOI 10.1080/01932690902735561; Kumar V., 2012, ROBBINS BASIC PATHOL, V14, P928; Lang S, 1999, APPL MICROBIOL BIOT, V51, P22, DOI 10.1007/s002530051358; Levin Jacquelyn, 2011, J Clin Aesthet Dermatol, V4, P31; Li JS, 2016, APPL MICROBIOL BIOT, V100, P1307, DOI 10.1007/s00253-015-7091-2; Ma XJ, 2012, J COLLOID INTERF SCI, V376, P165, DOI 10.1016/j.jcis.2012.03.007; Manzke C, 1999, PROZESSABHA NGIGE AU; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Montoneri E, 2009, WASTE MANAGE, V29, P383, DOI 10.1016/j.wasman.2008.01.011; MOSER AR, 1993, P NATL ACAD SCI USA, V90, P8977, DOI 10.1073/pnas.90.19.8977; Mulligan CN, 2005, ENVIRON POLLUT, V133, P183, DOI 10.1016/j.envpol.2004.06.009; Napolitano LM, 2006, CRIT CARE MED, V34, P258, DOI 10.1097/01.CCM.0000196082.26483.F0; Nitschke M, 2007, TRENDS FOOD SCI TECH, V18, P252, DOI 10.1016/j.tifs.2007.01.002; Nunez A, 2001, CHROMATOGRAPHIA, V53, P673, DOI 10.1007/BF02493019; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Petroianu A, 2007, EXPERT OPIN DRUG SAF, V6, P199, DOI 10.1517/14740338.6.2.199; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Ribeiro IAC, 2015, J MOL RECOGNIT, V28, P155, DOI 10.1002/jmr.2403; Rodrigues LR, 2010, ADV EXP MED BIOL, V672, P75; Roelants SL, 2015, BIOTECHNOLOGY BIOENG; Shah V, 2005, ANTIMICROB AGENTS CH, V49, P4093, DOI 10.1128/AAC.49.10.4093-4100.2005; Shao LJ, 2012, J SURG RES, V173, P286, DOI 10.1016/j.jss.2010.09.013; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Van Bogaert INA, 2007, APPL MICROBIOL BIOT, V76, P23, DOI 10.1007/s00253-007-0988-7; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yekkala K, 2007, MOL CANCER RES, V5, P1296, DOI 10.1158/1541-7786.MCR-07-0232; You SJ, 2006, INT J EXP PATHOL, V87, P227, DOI 10.1111/j.1365-2613.2006.00477.x	47	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156845	10.1371/journal.pone.0156845	http://dx.doi.org/10.1371/journal.pone.0156845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27271048	Green Published, gold, Green Submitted			2022-12-26	WOS:000377560200021
J	Ma, ZH; Huang, BL; Xu, SS; Chen, Y; Cao, GQ; Ding, GC; Lin, SZ				Ma, Zhihui; Huang, Binlong; Xu, Shanshan; Chen, Yu; Cao, Guangqiu; Ding, Guochang; Lin, Sizu			Ion Flux in Roots of Chinese Fir (Cunninghamia lanceolata (Lamb.) Hook) under Aluminum Stress	PLOS ONE			English	Article							COMPETITIVE AL-3+ INHIBITION; NET MG-2+ UPTAKE; OXALIC-ACID; TOXICITY; RESISTANCE; CALCIUM; H+; POTASSIUM; TOLERANCE; SECRETION	Chinese fir is a tall, fast-growing species that is unique to southern China. In Chinese fir plantations, successive plantings have led to a decline in soil fertility, and aluminum toxicity is thought to be one of the main reasons for this decline. In this study, Non-invasive Microtest Technology was used to study the effect of aluminum stress on the absorption of 4 different ions in the roots of the Chinese fir clone FS01. The results are as follows: with increased aluminum concentration and longer periods of aluminum stress, the H+ ion flow gradually changed from influx into efflux; there was a large variation in the K+ efflux, which gradually decreased with increasing duration of aluminum stress; and 1 h of aluminum stress uniformly resulted in Ca2+ influx, but it changed from influx to efflux after a longer period of aluminum stress. Changes in the different concentrations of aluminum had the largest influence on Mg2+.	[Ma, Zhihui] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou, Fujian, Peoples R China; [Ma, Zhihui; Huang, Binlong; Xu, Shanshan; Chen, Yu; Cao, Guangqiu; Ding, Guochang; Lin, Sizu] State Forestry Adm Engn Res Ctr Chinese Fir, Fuzhou, Fujian, Peoples R China; [Huang, Binlong] Fujian Prov Forestry Survey & Design Inst, Fuzhou, Fujian, Peoples R China; [Xu, Shanshan; Chen, Yu; Cao, Guangqiu; Ding, Guochang; Lin, Sizu] Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University	Lin, SZ (corresponding author), State Forestry Adm Engn Res Ctr Chinese Fir, Fuzhou, Fujian, Peoples R China.; Lin, SZ (corresponding author), Fujian Agr & Forestry Univ, Coll Forestry, Fuzhou, Fujian, Peoples R China.	szlin53@126.com			local special program "Chinese fir plantations in colleges and universities cultivate innovative team building" [6213c0111]	local special program "Chinese fir plantations in colleges and universities cultivate innovative team building"	Funding for this work was provided by central financial support from the local special program "Chinese fir plantations in colleges and universities cultivate innovative team building" (6213c0111).; Funding for this work was provided by central financial support from the local special program "Chinese fir plantations in colleges and universities cultivate innovative team building" (6213c0111). We thank the Center for Genomics and Biotechnology, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University for providing the ultra-thin semiautomatic microtome. We also thank AJE (American Journal Experts) for editing our manuscript for grammar, punctuation, diction and spelling.	BARCELO J, 1990, J PLANT NUTR, V13, P1, DOI 10.1080/01904169009364057; Bose J, 2013, PLANT CELL PHYSIOL, V54, P1093, DOI 10.1093/pcp/pct064; Cao YP, 2011, MOL BIOL REP, V38, P4839, DOI 10.1007/s11033-010-0618-9; Chen L, 2012, PLANTA, V235, P375, DOI 10.1007/s00425-011-1514-9; Chen Q, 2015, PLANT CELL PHYSL; CUMMING JR, 1985, CAN J BOT, V63, P1099, DOI 10.1139/b85-151; Facanha AR, 2002, PLANT PHYSIOL, V129, P1763, DOI 10.1104/pp.001651; FOY CD, 1988, COMMUN SOIL SCI PLAN, V19, P959, DOI 10.1080/00103628809367988; KASAI M, 1992, PLANT CELL PHYSIOL, V33, P1035; Kawano T, 2003, BIOCHEM BIOPH RES CO, V308, P35, DOI 10.1016/S0006-291X(03)01286-5; Kinraide TB, 2003, EUR J SOIL SCI, V54, P323, DOI 10.1046/j.1365-2389.2003.00538.x; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; LAZOF DB, 1994, PLANT PHYSIOL, V106, P1107, DOI 10.1104/pp.106.3.1107; Li J, 2014, PLANT AN GEN 22 C; Liu K, 2001, PLANT CELL, V13, P1453, DOI 10.1105/tpc.13.6.1453; Ma JF, 1998, PLANT PHYSIOL, V117, P753, DOI 10.1104/pp.117.3.753; [马丽 Ma Li], 2010, [海洋科学, Marine Sciences], V34, P41; Ma QF, 2002, ANN BOT-LONDON, V89, P241, DOI 10.1093/aob/mcf017; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Matsumoto H, 2000, INT REV CYTOL, V200, P1, DOI 10.1016/S0074-7696(00)00001-2; MATSUMOTO H, 1991, DEV PLANT SOIL SCI, V45, P825; NICHOL BE, 1993, PLANT PHYSIOL, V101, P1263, DOI 10.1104/pp.101.4.1263; OLIVETTI GP, 1995, PLANT PHYSIOL, V109, P123; Poschenrieder C, 2008, SCI TOTAL ENVIRON, V400, P356, DOI 10.1016/j.scitotenv.2008.06.003; Qing Y, 2000, CHINESE J OIL CROP S, V122, P68; Rengel Z, 1996, NEW PHYTOL, V134, P389, DOI 10.1111/j.1469-8137.1996.tb04356.x; RENGEL Z, 1990, PLANT PHYSIOL, V93, P1261, DOI 10.1104/pp.93.3.1261; RENGEL Z, 1989, PLANT PHYSIOL, V91, P1407, DOI 10.1104/pp.91.4.1407; RENGEL Z, 1989, PLANT SOIL, V116, P223, DOI 10.1007/BF02214551; RYAN PR, 1993, PLANT PHYSIOL, V102, P975, DOI 10.1104/pp.102.3.975; RYAN PR, 1994, PLANTA, V192, P98; Shen H, 2005, PLANT PHYSIOL, V138, P287, DOI 10.1104/pp.104.058065; ULRICH B, 1980, SOIL SCI, V130, P193, DOI 10.1097/00010694-198010000-00005; Wang CY, 2013, J PROTEOMICS, V78, P281, DOI 10.1016/j.jprot.2012.09.035; Wang H, 2015, NEW PHYTOL, V205, P273, DOI 10.1111/nph.13011; Zhang ZY, 2011, PLANT CELL REP, V30, P1701, DOI 10.1007/s00299-011-1078-y; ZHAO XJ, 1987, PLANT PHYSIOL, V83, P159, DOI 10.1104/pp.83.1.159; Zheng SJ, 1998, PLANT PHYSIOL, V117, P745, DOI 10.1104/pp.117.3.745	38	8	8	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156832	10.1371/journal.pone.0156832	http://dx.doi.org/10.1371/journal.pone.0156832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270726	Green Published, Green Submitted, gold			2022-12-26	WOS:000377560200020
J	Abu-Madi, M; Behnke, JM; Sharma, A; Bearden, R; Al-Banna, N				Abu-Madi, Marawan; Behnke, Jerzy M.; Sharma, Aarti; Bearden, Rebecca; Al-Banna, Nadia			Prevalence of Virulence/Stress Genes in Campylobacter jejuni from Chicken Meat Sold in Qatari Retail Outlets	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; HOSPITALIZED CHILDREN; RAW CHICKEN; IDENTIFICATION; CARCASSES; SPP.; COLI; PCR; GASTROENTERITIS; INFECTIONS	Chicken meat from the shelves of supermarkets in Qatar was tested for the presence of Campylobacter spp. and the presence of five virulence genes (htrB, cdtB, clpP, cadF and ciaB) was assessed in isolates. Forty eight percent of the chickens provided for supermarkets by Saudi (53%) and Qatari (45.9%) producers were found to be contaminated and the most important factor affecting the overall prevalence of contaminated chickens was the store from which chicken samples originated. Variation in prevalence of Campylobacter in chicken meat from different stores was evident even when the same producer supplied the three stores in our survey. Differences in the prevalence and in the combinations of virulence genes in isolates that can and cannot grow in a classic maintenance medium (Karmali) were identified, providing a starting point for linking presence/absence of particular virulence genes with actual in vivo virulence and pathogenicity. Because of the relatively low infective doses of Campylobacter that are required to initiate infection in humans, it will be important to explore further the relationships we identified between certain Campylobacter virulence genes and their capacity for survival in poultry meat, and hence their contribution to the incidence of campylobacteriosis.	[Abu-Madi, Marawan; Sharma, Aarti; Bearden, Rebecca] Qatar Univ, Dept Biomed Sci, Coll Hlth Sci, Biomed Res Ctr, POB 2713, Doha, Qatar; [Behnke, Jerzy M.] Univ Nottingham, Sch Life Sci, Univ Pk, Nottingham NG7 2RD, England; [Al-Banna, Nadia] Qatar Univ, Coll Med, POB 2713, Doha, Qatar	Qatar University; University of Nottingham; Qatar University	Abu-Madi, M (corresponding author), Qatar Univ, Dept Biomed Sci, Coll Hlth Sci, Biomed Res Ctr, POB 2713, Doha, Qatar.	abumadi@qu.edu.qa	Bearden, Rebecca/AAO-1851-2021	Bearden, Rebecca/0000-0001-9342-5304; Abu-Madi, Marawan/0000-0001-7843-1255	National Priority Research Program from the Qatar National Research Fund a member of Qatar Foundation [NPRP4-164-4-001]	National Priority Research Program from the Qatar National Research Fund a member of Qatar Foundation(Qatar National Research Fund (QNRF))	This publication was made possible by a National Priority Research Program grant number NPRP4-164-4-001 from the Qatar National Research Fund (http://www.qnrf.org/), a member of Qatar Foundation. The statements made herein are solely the responsibility of the authors. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acke E, 2009, VET REC, V164, P44, DOI 10.1136/vr.164.2.44; AKHTER J, 1994, J INT MED RES, V22, P47, DOI 10.1177/030006059402200106; Al-Mahmeed A, 2006, J MED MICROBIOL, V55, P839, DOI 10.1099/jmm.0.46500-0; Al-Shaikh Sana A., 2007, Acta Microbiologica et Immunologica Hungarica, V54, P139, DOI 10.1556/AMicr.54.2007.2.4; ALFREIHI H, 1993, E AFR MED J, V70, P267; Ansari-Lari M, 2011, INT J FOOD MICROBIOL, V144, P475, DOI 10.1016/j.ijfoodmicro.2010.11.003; Chaisowwong W, 2012, J VET MED SCI, V74, P43, DOI 10.1292/jvms.11-0305; Chansiripornchai N, 2009, J VET MED SCI, V71, P839, DOI 10.1292/jvms.71.839; COVER TL, 1990, FEMS MICROBIOL LETT, V70, P301, DOI 10.1016/S0378-1097(05)80012-6; Datta S, 2003, J MED MICROBIOL, V52, P345, DOI 10.1099/jmm.0.05056-0; Denis M, 2001, J APPL MICROBIOL, V91, P255, DOI 10.1046/j.1365-2672.2001.01380.x; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; Ghazwan J, 2006, THESIS ARABIAN GULF, V66; Ghunaim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119268; GRIFFITHS PL, 1990, J APPL BACTERIOL, V69, P281, DOI 10.1111/j.1365-2672.1990.tb01519.x; Habib I, 2008, FOOD MICROBIOL, V25, P65, DOI 10.1016/j.fm.2007.07.010; Horrocks SM, 2009, ANAEROBE, V15, P18, DOI 10.1016/j.anaerobe.2008.09.001; Ismaeel AY, 2002, SAUDI MED J, V23, P1064; Jain D, 2008, J MED MICROBIOL, V57, P267, DOI 10.1099/jmm.0.47317-0; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Jorgensen F, 2002, INT J FOOD MICROBIOL, V76, P151, DOI 10.1016/S0168-1605(02)00027-2; Josefsen MH, 2010, APPL ENVIRON MICROB, V76, P5097, DOI 10.1128/AEM.00411-10; Jumaa PA, 2005, J CHEMOTHERAPY, V17, P376, DOI 10.1179/joc.2005.17.4.376; KARMALI MA, 1986, J CLIN MICROBIOL, V23, P743, DOI 10.1128/JCM.23.4.743-747.1986; Keener KM, 2004, COMPR REV FOOD SCI F, V3, P105, DOI 10.1111/j.1541-4337.2004.tb00060.x; Konkel ME, 1998, INFECT IMMUN, V66, P3666, DOI 10.1128/IAI.66.8.3666-3672.1998; Konkel ME, 1999, J CLIN MICROBIOL, V37, P510, DOI 10.1128/JCM.37.3.510-517.1999; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Murphy C, 2006, J APPL MICROBIOL, V100, P623, DOI 10.1111/j.1365-2672.2006.02903.x; Oliver JD, 2005, J MICROBIOL, V43, P93; Oyarzabal OA, 2007, J MICROBIOL METH, V69, P129, DOI 10.1016/j.mimet.2006.12.011; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Rahimi E, 2010, POULTRY SCI, V89, P1015, DOI 10.3382/ps.2009-00090; Rahimi E, 2010, AFR J MICROBIOL RES, V4, P1620; Rohlf F.J., 1995, STAT TABLES; Rozynek E, 2005, J MED MICROBIOL, V54, P615, DOI 10.1099/jmm.0.45988-0; SAHA SK, 1991, APPL ENVIRON MICROB, V57, P3388, DOI 10.1128/AEM.57.11.3388-3389.1991; SETHI SK, 1989, PEDIATR INFECT DIS J, V8, P593, DOI 10.1097/00006454-198909000-00005; Son I, 2007, INT J FOOD MICROBIOL, V113, P16, DOI 10.1016/j.ijfoodmicro.2006.06.033; Stern NJ, 2003, EPIDEMIOL INFECT, V130, P23, DOI 10.1017/S0950268802007914; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Szymanski CM, 2012, GUT MICROBES, V3, P135, DOI 10.4161/gmic.19488; Taremi M, 2006, INT J FOOD MICROBIOL, V108, P401, DOI 10.1016/j.ijfoodmicro.2005.12.010; Tauxe R V, 1988, MMWR CDC Surveill Summ, V37, P1; Vellinga A, 2002, EMERG INFECT DIS, V8, P19, DOI 10.3201/eid0801.010129; Whitehouse CA, 1998, INFECT IMMUN, V66, P1934, DOI 10.1128/IAI.66.5.1934-1940.1998; Yehia HM, 2014, INT J FOOD CONTAMINA, V1, P2, DOI [10.1186/s40550-014-0002-y, DOI 10.1186/S40550-014-0002-Y]; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	50	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156938	10.1371/journal.pone.0156938	http://dx.doi.org/10.1371/journal.pone.0156938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258021	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700160
J	Fields, JA; Li, JQ; Gulbronson, CJ; Hendrixson, DR; Thompson, SA				Fields, Joshua A.; Li, Jiaqi; Gulbronson, Connor J.; Hendrixson, David R.; Thompson, Stuart A.			Campylobacter jejuni CsrA Regulates Metabolic and Virulence Associated Proteins and Is Necessary for Mouse Colonization	PLOS ONE			English	Article							RNA-BINDING PROTEIN; ESCHERICHIA-COLI; BIOFILM FORMATION; OXIDATIVE STRESS; POLYSACCHARIDE ADHESIN; CHICKEN COLONIZATION; BACILLUS-SUBTILIS; EPITHELIAL-CELLS; GENOME SEQUENCE; MOTILITY	Campylobacter jejuni infection is a leading bacterial cause of gastroenteritis and a common antecedent leading to Gullian-Barre syndrome. Our previous data suggested that the RNA-binding protein CsrA plays an important role in regulating several important phenotypes including motility, biofilm formation, and oxidative stress resistance. In this study, we compared the proteomes of wild type, csrA mutant, and complemented csrA mutant C. jejuni strains in an effort to elucidate the mechanisms by which CsrA affects virulence phenotypes. The putative CsrA regulon was more pronounced at stationary phase (111 regulated proteins) than at mid-log phase (25 regulated proteins). Proteins displaying altered expression in the csrA mutant included diverse metabolic functions, with roles in amino acid metabolism, TCA cycle, acetate metabolism, and various other cell processes, as well as pathogenesis-associated characteristics such as motility, chemotaxis, oxidative stress resistance, and fibronectin binding. The csrA mutant strain also showed altered autoagglutination kinetics when compared to the wild type. CsrA specifically bound the 5' end of flaA mRNA, and we demonstrated that CsrA is a growth-phase dependent repressor of FlaA expression. Finally, the csrA mutant exhibited reduced ability to colonize in a mouse model when in competition with the wild type, further underscoring the role of CsrA in C. jejuni colonization and pathogenesis.	[Fields, Joshua A.; Li, Jiaqi; Thompson, Stuart A.] Augusta Univ, Dept Med, Div Infect Dis, Augusta, GA 30912 USA; [Fields, Joshua A.] Georgia Mil Coll Augusta, Dept Nat Sci, Augusta, GA 30907 USA; [Gulbronson, Connor J.; Hendrixson, David R.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University System of Georgia; Augusta University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Thompson, SA (corresponding author), Augusta Univ, Dept Med, Div Infect Dis, Augusta, GA 30912 USA.	stthomps@augusta.edu		Gulbronson, Connor/0000-0002-2977-7185; Thompson, Stuart/0000-0002-0457-6926	Georgia Regents University; National Institutes of Health [R01AI055715, R56AI084160, R01AI103267]; NIH [R01AI065539, T32AI007520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055715, R56AI084160, R01AI103267, T32AI007520, R01AI065539] Funding Source: NIH RePORTER	Georgia Regents University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported by a pilot study research grant from Georgia Regents University, by National Institutes of Health grants R01AI055715, R56AI084160, and R01AI103267 (to S.A.T.), and NIH grant R01AI065539 (to D.R.H.). C.J.G. was supported by NIH training grant T32AI007520. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH.	Agladze K, 2005, J BACTERIOL, V187, P8237, DOI 10.1128/JB.187.24.8237-8246.2005; Apel D, 2012, J BACTERIOL, V194, P2342, DOI 10.1128/JB.06041-11; Atack JM, 2008, J BACTERIOL, V190, P5279, DOI 10.1128/JB.00100-08; Baillon MLA, 1999, J BACTERIOL, V181, P4798, DOI 10.1128/JB.181.16.4798-4804.1999; Baker CS, 2007, J BACTERIOL, V189, P5472, DOI 10.1128/JB.00529-07; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Boehm M, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-3; Bras AM, 1999, J BACTERIOL, V181, P3298; Brondsted L, 2005, APPL ENVIRON MICROB, V71, P3205, DOI 10.1128/AEM.71.6.3205-3212.2005; Bronowski C, 2014, FEMS MICROBIOL LETT, V356, P8, DOI 10.1111/1574-6968.12488; Butcher J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1661-7; Cerca N, 2008, FEMS MICROBIOL LETT, V283, P36, DOI 10.1111/j.1574-6968.2008.01142.x; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; Elvers KT, 2004, J BACTERIOL, V186, P5332, DOI 10.1128/JB.186.16.5332-5341.2004; Fields JA, 2008, J BACTERIOL, V190, P3411, DOI 10.1128/JB.01928-07; Flanagan RC, 2009, INFECT IMMUN, V77, P2399, DOI 10.1128/IAI.01266-08; Flint A, 2014, INFECT IMMUN, V82, P2266, DOI 10.1128/IAI.01528-13; Goller CC, 2008, CURR TOP MICROBIOL, V322, P37; Guccione E, 2010, ENVIRON MICROBIOL, V12, P576, DOI 10.1111/j.1462-2920.2009.02096.x; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; Haddock G, 2010, MICROBIOL-SGM, V156, P3079, DOI 10.1099/mic.0.039867-0; Heimesaat MM, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-16; Hofreuter D, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00137; Hwang S, 2012, J BACTERIOL, V194, P6883, DOI 10.1128/JB.01636-12; Irsfeld M, 2014, J BASIC MICROB, V54, P1403, DOI 10.1002/jobm.201400054; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; Jones MK, 2008, APPL ENVIRON MICROB, V74, P7064, DOI 10.1128/AEM.01810-08; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Joslin SN, 2008, J BACTERIOL, V190, P2422, DOI 10.1128/JB.01827-07; Jowiya W, 2015, INFECT IMMUN, V83, P4884, DOI 10.1128/IAI.01064-15; Kalmokoff M, 2006, J BACTERIOL, V188, P4312, DOI 10.1128/JB.01975-05; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kassem II, 2014, MICROBIOLOGYOPEN, V3, P168, DOI 10.1002/mbo3.158; Kim JC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00751; Kudirkiene E, 2012, CURR MICROBIOL, V65, P398, DOI 10.1007/s00284-012-0170-z; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Li J, 2016, UNPUB; Liu MY, 1997, J BACTERIOL, V179, P4639, DOI 10.1128/jb.179.14.4639-4642.1997; Liu YW, 2014, MICROBIOL-SGM, V160, P2053, DOI 10.1099/mic.0.080713-0; Lynnes T, 2013, FEMS MICROBIOL LETT, V344, P95, DOI 10.1111/1574-6968.12174; Marchant J, 2002, TRENDS MICROBIOL, V10, P155, DOI 10.1016/S0966-842X(02)02323-5; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Morin M, 2016, MOL MICROBIOL; Mukherjee S, 2011, MOL MICROBIOL, V82, P447, DOI 10.1111/j.1365-2958.2011.07822.x; Pajaniappan M, 2008, MOL MICROBIOL, V68, P474, DOI 10.1111/j.1365-2958.2008.06161.x; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Patterson-Fortin LM, 2013, J MOL BIOL, V425, P3662, DOI 10.1016/j.jmb.2012.12.010; Pruss BM, 2010, ARCH MICROBIOL, V192, P715, DOI 10.1007/s00203-010-0599-z; Rathbun KM, 2009, FEMS MICROBIOL LETT, V300, P188, DOI 10.1111/j.1574-6968.2009.01795.x; Rathbun KM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-160; Reuter M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054390; Rubinchik S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-141; St Maurice M, 2007, J BACTERIOL, V189, P4764, DOI 10.1128/JB.00287-07; Stahl M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00005; Stead D, 2000, APPL ENVIRON MICROB, V66, P3110, DOI 10.1128/AEM.66.7.3110-3112.2000; Stintzi A, 2005, INFECT IMMUN, V73, P1797, DOI 10.1128/IAI.73.3.1797-1810.2005; Svensson SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106063; Svensson SL, 2009, MOL MICROBIOL, V71, P253, DOI 10.1111/j.1365-2958.2008.06534.x; Trachoo N, 2002, J FOOD PROTECT, V65, P1110, DOI 10.4315/0362-028X-65.7.1110; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; van der Stel AX, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00567; van Vliet AHM, 1999, J BACTERIOL, V181, P6371, DOI 10.1128/JB.181.20.6371-6376.1999; van Vliet AHM, 2002, FEMS MICROBIOL REV, V26, P173, DOI 10.1111/j.1574-6976.2002.tb00609.x; van Vliet AHM, 2001, FEMS MICROBIOL LETT, V196, P189, DOI 10.1016/S0378-1097(01)00067-2; Velayudhan J, 2002, MICROBIOL-SGM, V148, P685, DOI 10.1099/00221287-148-3-685; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Weerakoon DR, 2008, J BACTERIOL, V190, P915, DOI 10.1128/JB.01647-07; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Weingarten RA, 2008, APPL ENVIRON MICROB, V74, P1367, DOI 10.1128/AEM.02261-07; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Wright JA, 2009, MICROBIOL-SGM, V155, P80, DOI 10.1099/mic.0.021790-0; Yakhnin AV, 2010, MOL MICROBIOL, V76, P690, DOI 10.1111/j.1365-2958.2010.07126.x	74	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156932	10.1371/journal.pone.0156932	http://dx.doi.org/10.1371/journal.pone.0156932			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257952	gold, Green Published, Green Submitted			2022-12-26	WOS:000377369700158
J	Kondratick, CM; Boehm, EM; Dieckman, LM; Powers, KT; Sanchez, JC; Mueting, SR; Washington, MT				Kondratick, Christine M.; Boehm, Elizabeth M.; Dieckman, Lynne M.; Powers, Kyle T.; Sanchez, Julio C.; Mueting, Samuel R.; Washington, M. Todd			Identification of New Mutations at the PCNA Subunit Interface that Block Translesion Synthesis	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; FAMILY DNA-POLYMERASES; XERODERMA-PIGMENTOSUM; DAMAGE TOLERANCE; POL-ETA; REPLICATION; PROTEIN; BYPASS; REPAIR; ROLES	Proliferating cell nuclear antigen (PCNA) plays an essential role in DNA replication and repair by interacting with a large number of proteins involved in these processes. Two amino acid substitutions in PCNA, both located at the subunit interface, have previously been shown to block translesion synthesis (TLS), a pathway for bypassing DNA damage during replication. To better understand the role of the subunit interface in TLS, we used random mutagenesis to generate a set of 33 PCNA mutants with substitutions at the subunit interface. We assayed the full set of mutants for viability and sensitivity to ultraviolet (UV) radiation. We then selected a subset of 17 mutants and measured their rates of cell growth, spontaneous mutagenesis, and UV-induced mutagenesis. All except three of these 17 mutants were partially or completely defective in induced mutagenesis, which indicates a partial or complete loss of TLS. These results demonstrate that the integrity of the subunit interface of PCNA is essential for efficient TLS and that even conservative substitutions have the potential to disrupt this process.	[Kondratick, Christine M.; Boehm, Elizabeth M.; Powers, Kyle T.; Sanchez, Julio C.; Mueting, Samuel R.; Washington, M. Todd] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Dieckman, Lynne M.] Creighton Univ, Dept Chem, Omaha, NE 68178 USA	University of Iowa; Creighton University	Washington, MT (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA.	todd-washington@uiowa.edu		Washington, Todd/0000-0001-8680-2992; Mueting, Samuel/0000-0001-7476-5186; Powers, Kyle/0000-0003-3240-6534	National Institute of General Medicine [TGM081433, GM108027]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108027, R01GM081433] Funding Source: NIH RePORTER	National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by TGM081433 and GM108027 from the National Institute of General Medicine to MTW.	Amin NS, 1996, GENETICS, V144, P479; Dieckman LM, 2013, DNA REPAIR, V12, P367, DOI 10.1016/j.dnarep.2013.02.007; Dieckman Lynne M, 2012, Subcell Biochem, V62, P281, DOI 10.1007/978-94-007-4572-8_15; Freudenthal BD, 2011, J MOL BIOL, V406, P9, DOI 10.1016/j.jmb.2010.12.015; Freudenthal BD, 2009, ACTA CRYSTALLOGR D, V65, P560, DOI 10.1107/S0907444909011329; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 1999, J BIOL CHEM, V274, P15975, DOI 10.1074/jbc.274.23.15975; Lawrence CW, 2002, DNA REPAIR, V1, P425, DOI 10.1016/S1568-7864(02)00038-1; Lehmann AR, 2003, CELL CYCLE, V2, P300, DOI 10.4161/cc.2.4.407; Lehmann AR, 2005, FEBS LETT, V579, P873, DOI 10.1016/j.febslet.2004.11.029; LuCore SD, 2015, BIOPHYS J, V109, P816, DOI 10.1016/j.bpj.2015.06.062; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Northam MR, 2006, EMBO J, V25, P4316, DOI 10.1038/sj.emboj.7601320; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Washington MT, 2010, BBA-PROTEINS PROTEOM, V1804, P1113, DOI 10.1016/j.bbapap.2009.07.004; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Zhang HS, 2006, GENETICS, V173, P1983, DOI 10.1534/genetics.106.058545; Zhuang ZH, 2008, P NATL ACAD SCI USA, V105, P5361, DOI 10.1073/pnas.0801310105	27	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157023	10.1371/journal.pone.0157023	http://dx.doi.org/10.1371/journal.pone.0157023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258147	gold, Green Submitted, Green Published			2022-12-26	WOS:000377369700172
J	Park, KM; Im, SI; Kim, EK; Lee, SC; Park, SJ; Kim, JS; On, YK				Park, Kyoung-min; Im, Sung Il; Kim, Eun Kyoung; Lee, Sang-chol; Park, Seung-jung; Kim, June Soo; On, Young Keun			Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?	PLOS ONE			English	Article							CLINICAL-COURSE; OBSTRUCTION; POPULATION; SEVERITY; EXERCISE; AFFIRM; STROKE; MARKER; VOLUME; IMPACT	Hypertrophic cardiomyopathy (HCM) is a cardiac disease associated with a high incidence of atrial fibrillation (AF). Recent studies have suggested that interventricular septum thickness may influence the risk stratification of patients with AF. We evaluated the effects of septal hypertrophy on morbidity and mortality in patients with HCM. Patients were followed for a median of 6.1 years and were divided into two groups according to the extent of septal hypertrophy. A total of 1,360 HCM patients were enrolled: 482(33%) apical or apicoseptal, 415(28%) asymmetric septal, 388(27%) basal septal, 38(2.6%) concentric, and 37(2.5%) diffuse and mixed type. Ninety-two all-cause deaths and 21 cardiac deaths occurred. The total event rates were significantly higher for patients with HCM with more extensive septal hypertrophy (group A) compared to those with HCM +/- focal septal hypertrophy (group B), regardless of type (p<0.001). Arrhythmias occurred in 502 patients, with a significantly higher incidence in group A than in group B (p<0.001). Among patients with arrhythmias, the incidence of AF was significantly higher in group A than group B (p<0.001). In univariate Cox analysis, a greater extent of septal hypertrophy (p<0.001), E/E' ratio (p = 0.011), and mitral regurgitation grade (p = 0.003) were significantly associated with developing AF. In multivariate Cox analyses, a greater extent of septal hypertrophy [ odds ratio (OR) 5.44 (2.29-12.92), p<0.001] in patients with HCM was significantly associated with developing AF. In conclusion, a greater extent of septal hypertrophy is an independent predictor of progression to AF in patients with HCM.	[Park, Kyoung-min; Kim, Eun Kyoung; Lee, Sang-chol; Park, Seung-jung; Kim, June Soo; On, Young Keun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul 135710, South Korea; [Im, Sung Il] Kosin Univ, Coll Med, Kosin Univ Gospel Hosp, Div Cardiol,Dept Internal Med, Busan 602702, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	On, YK (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul 135710, South Korea.	yk.on@samsung.com						Apostolakis S, 2014, INT J CARDIOL, V170, P303, DOI 10.1016/j.ijcard.2013.11.002; Autore C, 2005, J AM COLL CARDIOL, V45, P1076, DOI 10.1016/j.jacc.2004.12.067; Avegliano G, 2014, J CARDIOVASC MED, V15, P207, DOI 10.2459/JCM.0b013e3283638093; BONOW RO, 1985, CIRCULATION, V72, P853, DOI 10.1161/01.CIR.72.4.853; Doi Y, 2001, J Cardiol, V37 Suppl 1, P133; Geske JB, 2013, J AM COLL CARDIOL, V61, P2456, DOI 10.1016/j.jacc.2013.04.004; Kim SH, 2013, INT HEART J, V54, P207, DOI 10.1536/ihj.54.207; KLUES HG, 1995, J AM COLL CARDIOL, V26, P1699, DOI 10.1016/0735-1097(95)00390-8; Kubo T, 2009, CIRC J, V73, P1599, DOI 10.1253/circj.CJ-09-0140; Maron BJ, 2000, CIRCULATION, V102, P858; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; Maron BJ, 2002, J AM COLL CARDIOL, V39, P301, DOI 10.1016/S0735-1097(01)01727-2; MARON BJ, 1994, AM J CARDIOL, V73, P577, DOI 10.1016/0002-9149(94)90337-9; Maron MS, 2009, J AM COLL CARDIOL, V54, P866, DOI 10.1016/j.jacc.2009.04.072; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; Olshansky B, 2005, J AM COLL CARDIOL, V45, P2026, DOI 10.1016/j.jacc.2005.03.020; Sadoul N, 1997, CIRCULATION, V96, P2987, DOI 10.1161/01.CIR.96.9.2987; Tsang TSM, 2001, MAYO CLIN PROC, V76, P467, DOI 10.4065/76.5.467; Yang H, 2005, J AM SOC ECHOCARDIOG, V18, P1074, DOI 10.1016/j.echo.2005.06.011	20	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156410	10.1371/journal.pone.0156410	http://dx.doi.org/10.1371/journal.pone.0156410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258035	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700060
J	Einsfeldt, K; Baptista, IC; Castanheira, JC; Pereira, V; Costa-Amaral, IC; da Costa, ES; Ribeiro, MCM; Land, MGP; Alves, TLM; Larentis, AL; Almeida, RV				Einsfeldt, Karen; Baptista, Isis Cavalcante; Castanheira, Juliana Christina; Pereira, Vicente; Costa-Amaral, Isabele Campos; da Costa, Elaine Sobral; Menks Ribeiro, Maria Cecilia; Poirot Land, Marcelo Gerardin; Moitinho Alves, Tito Livio; Larentis, Ariane Leites; Almeida, Rodrigo Volcan			Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PROMISING CHEMOTHERAPEUTIC-AGENT; CELL-CYCLE ARREST; IN-VITRO; ERWINIA-ASPARAGINASE; EXPRESSION; RESISTANCE; SYNTHETASE; APOPTOSIS; CHILDREN	L-asparaginase is an enzyme used as a chemotherapeutic agent, mainly for treating acute lymphoblastic leukemia. In this study, the gene of L-asparaginase from Zymomonas mobilis was cloned in pET vectors, fused to a histidine tag, and had its codons optimized. The L-asparaginase was expressed extracellularly and intracellularly (cytoplasmically) in Escherichia coli in far larger quantities than obtained from the microorganism of origin, and sufficient for initial cytotoxicity tests on leukemic cells. The in silico analysis of the protein from Z. mobilis indicated the presence of a signal peptide in the sequence, as well as high identity to other sequences of L-asparaginases with antileukemic activity. The protein was expressed in a bioreactor with a complex culture medium, yielding 0.13 IU/mL extracellular L-asparaginase and 3.6 IU/mL intracellular L-asparaginase after 4 h of induction with IPTG. The cytotoxicity results suggest that recombinant L-asparaginase from Z. mobilis expressed extracellularly in E. coli has a cytotoxic and cytostatic effect on leukemic cells.	[Einsfeldt, Karen; Baptista, Isis Cavalcante; Castanheira, Juliana Christina; Moitinho Alves, Tito Livio] Univ Fed Rio de Janeiro UFRJ, COPPE, Programa Engn Quim, Rio De Janeiro, Brazil; [Einsfeldt, Karen; Castanheira, Juliana Christina; Almeida, Rodrigo Volcan] Univ Fed Rio de Janeiro UFRJ, Inst Quim, Programa Posgrad Bioquim, Rio De Janeiro, Brazil; [Baptista, Isis Cavalcante; da Costa, Elaine Sobral; Menks Ribeiro, Maria Cecilia; Poirot Land, Marcelo Gerardin] Univ Fed Rio de Janeiro UFRJ, Programa Posgrad Clin Med, Rio De Janeiro, Brazil; [Costa-Amaral, Isabele Campos; Larentis, Ariane Leites] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Estudos Saude Trabalhador & Ecol Humana CESTE, Escola Nacl Saude Publ Sergio Arouca ENSP, Programa Saude Publ & Meio Ambiente, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Almeida, RV (corresponding author), Univ Fed Rio de Janeiro UFRJ, COPPE, Programa Engn Quim, Rio De Janeiro, Brazil.	karen.einsfeldt@gmail.com; arianelarentis@fiocruz.br; volcan@iq.ufrj.br	Alves, Tito/AAC-3177-2021; Almeida, Rodrigo V/I-4362-2013; Almeida, Rodrigo/AAE-3019-2019; land, marcelo g p/O-9286-2018; Almeida, Rodrigo/GZH-0682-2022	Almeida, Rodrigo V/0000-0002-0164-6044; Almeida, Rodrigo/0000-0002-0164-6044; land, marcelo g p/0000-0001-9792-3167; 				Abud AKS, 2004, Patent BR, Patent No. [PI0404952-7, 04049527]; Alves TLM, 1998, APPL BIOCHEM BIOTECH, V70-2, P463, DOI 10.1007/BF02920160; Alves TLM, 2014, Patent, Patent No. [BR1020140005854, 1020140005854]; ARISTIDOU AA, 1995, BIOTECHNOL PROGR, V11, P475, DOI 10.1021/bp00034a019; Avramis VI, 2007, ANTICANCER RES, V27, P2561; Avramis VI, 2012, ANTICANCER RES, V32, P2423; Avramis VI, 2005, CLIN PHARMACOKINET, V44, P367, DOI 10.2165/00003088-200544040-00003; Avramis VI, 2002, BLOOD, V99, P1986, DOI 10.1182/blood.V99.6.1986; Bansal S, 2012, FASEB J, V26, P1161, DOI 10.1096/fj.11-191254; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cappelletti D, 2008, BIOCHEM BIOPH RES CO, V377, P1222, DOI 10.1016/j.bbrc.2008.10.118; Den Boer ML, 2003, J CLIN ONCOL, V21, P3262, DOI 10.1200/JCO.2003.11.031; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dorrie J, 2001, CANCER RES, V61, P4731; Douer D, 2007, BLOOD, V109, P2744, DOI 10.1182/blood-2006-07-035006; DUNLOP PC, 1980, J BIOL CHEM, V255, P1542; Duval M, 2002, BLOOD, V99, P2734, DOI 10.1182/blood.V99.8.2734; Ferraz HC, 2000, APPL BIOCHEM BIOTECH, V89, P43, DOI 10.1385/ABAB:89:1:43; Fine BM, 2005, CANCER RES, V65, P291; Fonseca EF, 2004, LAT AM APPL RES, V34, P187; Guo QL, 2002, ACTA PHARMACOL SIN, V23, P946; Holleman A, 2003, BLOOD, V102, P4541, DOI 10.1182/blood-2002-11-3612; HORIG H, 1993, J CELL BIOCHEM, V53, P343, DOI 10.1002/jcb.240530412; Husain I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148877; Khushoo A, 2005, APPL MICROBIOL BIOT, V68, P189, DOI 10.1007/s00253-004-1867-0; Khushoo A, 2004, PROTEIN EXPRES PURIF, V38, P29, DOI 10.1016/j.pep.2004.07.009; Kotzia GA, 2005, J BIOTECHNOL, V119, P309, DOI 10.1016/j.jbiotec.2005.04.016; Kotzia GA, 2007, J BIOTECHNOL, V127, P657, DOI 10.1016/j.jbiotec.2006.07.037; Kozak M, 2000, ACTA BIOCHIM POL, V47, P807, DOI 10.18388/abp.2000_3998; Krejci O, 2004, LEUKEMIA, V18, P434, DOI 10.1038/sj.leu.2403259; Kurtzberg J, 2000, HOLLAND FREI CANC ME; Labrou NE, 2010, CURR MED CHEM, V17, P2183, DOI 10.2174/092986710791299920; LEE SM, 1989, APPL BIOCHEM BIOTECH, V22, P1, DOI 10.1007/BF02922693; Matsuo Y, 1998, LEUKEMIA RES, V22, P567, DOI 10.1016/S0145-2126(98)00050-2; Narta UK, 2007, CRIT REV ONCOL HEMAT, V61, P208, DOI 10.1016/j.critrevonc.2006.07.009; OHNO R, 1970, BLOOD-J HEMATOL, V35, P250, DOI 10.1182/blood.V35.2.250.250; Panosyan EH, 2004, J PEDIAT HEMATOL ONC, V26, P217, DOI 10.1097/00043426-200404000-00002; Pedreira CE, 2013, TRENDS BIOTECHNOL, V31, P415, DOI 10.1016/j.tibtech.2013.04.008; Ramakers-van Woerden NL, 2000, BLOOD, V96, P1094; Rizzari C, 2013, CURR OPIN ONCOL, V25, pS1, DOI 10.1097/CCO.0b013e32835d7d85; ROSENFELD C, 1977, NATURE, V267, P841, DOI 10.1038/267841a0; Sanches M, 2007, CURR CHEM BIOL, V1, P75, DOI DOI 10.2174/2212796810701010075; Scotti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013892; Severo JB, 2014, BRAZ J CHEM ENG, V31, P1003, DOI 10.1590/0104-6632.20140314s00002537; Shiloach J, 2005, BIOTECHNOL ADV, V23, P345, DOI 10.1016/j.biotechadv.2005.04.004; Sommi P, 2002, EXP CELL RES, V281, P128, DOI 10.1006/excr.2002.5629; Stams WAG, 2005, BLOOD, V105, P4223, DOI 10.1182/blood-2004-10-3892; Stams WAG, 2003, BLOOD, V101, P2743, DOI 10.1182/blood-2002-08-2446; TABACCO A, 1979, CLIN CHEM, V25, P336; Tripathi NK, 2009, DEFENCE SCI J, V59, P137, DOI 10.14429/dsj.59.1501; Ueno T, 1997, LEUKEMIA, V11, P1858, DOI 10.1038/sj.leu.2400834; van den Berg H, 2011, LEUKEMIA LYMPHOMA, V52, P168, DOI 10.3109/10428194.2010.537796; Verma N, 2007, CRIT REV BIOTECHNOL, V27, P45, DOI 10.1080/07388550601173926; Wilberg KQ, 1997, BRAZ J CHEM ENG, V14; Yun MK, 2007, J MOL BIOL, V369, P794, DOI 10.1016/j.jmb.2007.03.061	55	17	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156692	10.1371/journal.pone.0156692	http://dx.doi.org/10.1371/journal.pone.0156692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253887	gold, Green Published			2022-12-26	WOS:000377218700051
J	Zhang, SY; Wu, K; Liu, YF; Lin, YT; Zhang, X; Zhou, J; Zhang, H; Pan, T; Fu, YS				Zhang, Shaoying; Wu, Kang; Liu, Yufeng; Lin, Yingtong; Zhang, Xu; Zhou, Jie; Zhang, Hui; Pan, Ting; Fu, Yongshui			Finasteride Enhances the Generation of Human Myeloid-Derived Suppressor Cells by Up-Regulating the COX2/PGE(2) Pathway	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; TRANSPLANT TOLERANCE; POSITIVE FEEDBACK; PROSTAGLANDIN E-2; MESSENGER-RNA; T-CELLS; INHIBITION; COX-2; INDOMETHACIN; BIOLOGY	Myeloid-derived suppressor cells (MDSCs) have been known to be a key factor in the regulation of the immune system under numerous conditions such as tumors, infections, autoimmune diseases, and transplantations. In contrast to the proposed deleterious role of MDSCs in tumors and infections, MDSCs with their suppressive function are now proved to have the beneficial potential of suppressing the autoimmune response and promoting tolerance to transplantation. Therefore, the expansion of MDSCs could be a promising therapeutic strategy for many diseases. In this study, we aimed to identify FDA-approved drugs that could aid in the expansion of functional MDSCs. We performed a high-throughput screening (HTS) of FDA-approved drugs based on the in vitro human MDSC-differentiation system and identified finasteride (FIN) to have the best potency to aid the generation of human MDSCs. The FIN-induced MDSCs were quite similar to monocytic MDSCs with regard to their surface phenotype, morphology, immunosuppressive function, and related gene expression. Next, we aimed to determine the mechanism of action of FIN and found that FIN induced the expansion of MDSCs through up-regulation of the COX2/PGE(2) pathway by enhancing the activity of COX2 promoter. In addition, the administration of indomethacin (IND), a COX2 inhibitor, abrogated the effect of FIN. Based on these results, we suggested that FIN could find applications in the future in the expansion of MDSCs. Further development of FIN-like compounds could be a novel strategy for generating functional MDSCs for immunosuppressive therapies in various immune disorder conditions.	[Zhang, Shaoying; Wu, Kang; Liu, Yufeng; Lin, Yingtong; Zhang, Xu; Zhou, Jie; Zhang, Hui; Pan, Ting] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Shaoying; Wu, Kang; Liu, Yufeng; Zhang, Xu; Zhou, Jie; Zhang, Hui; Pan, Ting] Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Yingtong; Zhang, Xu; Zhou, Jie; Zhang, Hui; Pan, Ting] Sun Yat Sen Univ, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yufeng; Zhou, Jie] Zhongshan Sch Med, Affiliated Guangzhou Women & Childrens Med Ctr, Program Immunol, Guangzhou, Guangdong, Peoples R China; [Fu, Yongshui] Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Blood Center	Pan, T (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China.; Pan, T (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China.; Pan, T (corresponding author), Sun Yat Sen Univ, Guangdong Engn Res Ctr Antimicrobial Agent & Immu, Guangzhou 510275, Guangdong, Peoples R China.; Fu, YS (corresponding author), Guangzhou Blood Ctr, Guangzhou, Guangdong, Peoples R China.	pant8@mail.sysu.edu.cn; fuyongshui1969@yahoo.com	Pan, Ting/AAX-1933-2021	Fu, Yongshui/0000-0003-0886-2193	National Natural Science Foundation of China [81273145, 301500740]; Science and Technology Project of Guangzhou city [201509010009]; National Special Research Program for Important Infectious Diseases [2013ZX10001004]; Guangdong Innovative Research Team Program [2009010058]; Natural Science Foundation of Guangdong [2015A030310442]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangzhou city; National Special Research Program for Important Infectious Diseases; Guangdong Innovative Research Team Program; Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was funded by the National Natural Science Foundation of China (No. 81273145), Science and Technology Project of Guangzhou city (No. 201509010009) to YS Fu; National Special Research Program for Important Infectious Diseases (No. 2013ZX10001004), Guangdong Innovative Research Team Program (No. 2009010058) to H Zhang; National Natural Science Foundation of China (No. 301500740) and Natural Science Foundation of Guangdong (No. 2015A030310442) to T Pan.	Abastado J-P, 2012, TUMOR MICROENVIRONME, P64; Aggarwal S, 2010, STEROIDS, V75, P109, DOI 10.1016/j.steroids.2009.10.005; Black WC, 1996, BIOORG MED CHEM LETT, V6, P725, DOI 10.1016/0960-894X(96)00100-X; Boros P, 2010, HUM IMMUNOL, V71, P1061, DOI 10.1016/j.humimm.2010.08.001; Bunt SK, 2009, J LEUKOCYTE BIOL, V85, P996, DOI 10.1189/jlb.0708446; Chen S, 2011, CLIN EXP IMMUNOL, V166, P134, DOI 10.1111/j.1365-2249.2011.04445.x; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Cripps JG, 2011, INT IMMUNOPHARMACOL, V11, P789, DOI 10.1016/j.intimp.2011.01.026; Di Silverio F, 2005, EUR UROL, V47, P72, DOI 10.1016/j.eururo.2004.08.024; Dilek N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00208; Dilek N, 2010, CURR OPIN ORGAN TRAN, V15, P765, DOI 10.1097/MOT.0b013e3283401742; Dugast AS, 2008, J IMMUNOL, V180, P7898, DOI 10.4049/jimmunol.180.12.7898; Faour WH, 2001, J BIOL CHEM, V276, P31720, DOI 10.1074/jbc.M104036200; Fujimoto Y, 2005, INT IMMUNOPHARMACOL, V5, P1131, DOI 10.1016/j.intimp.2005.01.014; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Giuliano F, 2002, J PHARMACOL EXP THER, V303, P1001, DOI 10.1124/jpet.102.041244; GOODWIN JS, 1983, J CLIN IMMUNOL, V3, P295, DOI 10.1007/BF00915791; Guillonneau C, 2015, TRANSPLANTATION, V99, P2017, DOI 10.1097/TP.0000000000000858; Haile LA, 2012, IMMUNOL INVEST, V41, P581, DOI 10.3109/08820139.2012.680635; Hartel C, 2004, SCAND J IMMUNOL, V60, P412, DOI 10.1111/j.0300-9475.2004.01481.x; Kurumbail RG, 2001, CURR OPIN STRUC BIOL, V11, P752, DOI 10.1016/S0959-440X(01)00277-9; Kusmartsev S, 2005, J IMMUNOL, V174, P4880, DOI 10.4049/jimmunol.174.8.4880; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Mao YM, 2014, CLIN CANCER RES, V20, P4096, DOI 10.1158/1078-0432.CCR-14-0635; Marhaba R, 2007, J IMMUNOL, V179, P5071, DOI 10.4049/jimmunol.179.8.5071; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj Srinivas, 2009, Cancer Res, V69, P7503, DOI 10.1158/0008-5472.CAN-09-2152; Najjar YG, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00049; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Obermajer N, 2012, ONCOIMMUNOLOGY, V1, P762, DOI 10.4161/onci.19681; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Shim JS, 2014, INT J BIOL SCI, V10, P654, DOI 10.7150/ijbs.9224; Smith Angela B, 2009, Ther Clin Risk Manag, V5, P535; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Veltman JD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-464; Wang YG, 2016, SEMIN ARTHRITIS RHEU, V45, P490, DOI 10.1016/j.semarthrit.2015.07.003; Westendorf AM, 2006, GASTROENTEROLOGY, V131, P510, DOI 10.1053/j.gastro.2006.05.015; Wysowski DK, 2004, NEW ENGL J MED, V350, P1359; Yin BJ, 2010, J IMMUNOL, V185, P5828, DOI 10.4049/jimmunol.0903636; Yin Y, 2015, J BIOL CHEM, V290, P35, DOI 10.1074/jbc.M114.598631; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Zhang Q, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/421927; Zhang YJ, 2014, RNA, V20, P1878, DOI 10.1261/rna.045633.114	46	8	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156549	10.1371/journal.pone.0156549	http://dx.doi.org/10.1371/journal.pone.0156549			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253400	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700039
J	Chen, Q; Bei, JJ; Liu, C; Feng, SB; Zhao, WB; Zhou, Z; Yu, ZP; Du, XJ; Hu, HY				Chen, Qiang; Bei, Jun-Jie; Liu, Chuan; Feng, Shi-Bin; Zhao, Wei-Bo; Zhou, Zhou; Yu, Zheng-Ping; Du, Xiao-Jun; Hu, Hou-Yuan			HMGB1 Induces Secretion of Matrix Vesicles by Macrophages to Enhance Ectopic Mineralization	PLOS ONE			English	Article							ACCELERATES VASCULAR CALCIFICATION; GROUP BOX 1; MEDIATED MINERALIZATION; EXTRACELLULAR VESICLES; ALKALINE-PHOSPHATASE; GROWTH-PLATE; BONE; EXPRESSION; DIFFERENTIATION; OSTEOGENESIS	Numerous clinical conditions have been linked to ectopic mineralization (EM). This process of pathological biomineralization is complex and not fully elucidated, but thought to be started within matrix vesicles (MVs). We hypothesized that high mobility group box 1 (HMGB1), a cytokine associated with biomineralizing process under physiological and pathological conditions, induces EM via promoting MVs secretion from macrophages. In this study, we found that HMGB1 significantly promoted secretion of MVs from macrophages and subsequently led to mineral deposition in elevated Ca/Pi medium in vitro. Transmission electron microscopy of calcifying MVs showed formation of hydroxyapatite crystals in the vesicle interior. Subcutaneous injection into mice with MVs derived from HMGB1-treated cells showed a greater potential to initiate regional mineralization. Mechanistic experiments revealed that HMGB1 activated neutral sphingomyelinase2 (nSMase2) that involved the receptor for advanced glycation end products (RAGE) and p38 MAPK (upstream of nSMase2). Inhibition of nSMase2 with GW4869 or p38 MAPK with SB-239063 prevented MVs secretion and mineral deposition. Collectively, HMGB1 induces MVs secretion from macrophages at least in part, via the RAGE/p38 MAPK/nSMase2 signaling pathway. Our findings thus reveal a novel mechanism by which HMGB1 induces ectopic mineralization.	[Chen, Qiang; Bei, Jun-Jie; Feng, Shi-Bin; Zhao, Wei-Bo; Hu, Hou-Yuan] Third Mil Med Univ, Southwest Hosp, Dept Cardiol, Chongqing, Peoples R China; [Liu, Chuan; Zhou, Zhou; Yu, Zheng-Ping] Third Mil Med Univ, Fac Prevent Med, Dept Occupat Hlth, Chongqing, Peoples R China; [Du, Xiao-Jun] Monash Univ, Baker IDI Heart & Diabet Inst, Expt Cardiol, Melbourne, Vic 3004, Australia; [Du, Xiao-Jun] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Chen, Qiang] Naval Univ Engn, Dept Out Patient, Wuhan, Peoples R China	Army Medical University; Army Medical University; Baker Heart and Diabetes Institute; Monash University; Monash University; Wuhan Naval University of Engineering	Hu, HY (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Cardiol, Chongqing, Peoples R China.	houyuanhu@hotmail.com			National Natural Science Foundation of China [81270362, 81470561]; State Project For Essential Drug Research and Development [2013ZX09103003-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Project For Essential Drug Research and Development	This work was supported by grants from the National Natural Science Foundation of China (No. 81270362 and No. 81470561) and State Project For Essential Drug Research and Development (No. 2013ZX09103003-001). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens I, 2015, THROMB HAEMOSTASIS, V114, P994, DOI 10.1160/TH14-12-1073; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Anderson H Clarke, 2003, Curr Rheumatol Rep, V5, P222, DOI 10.1007/s11926-003-0071-z; Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Avogaro A, 2014, EXPERT OPIN THER TAR, V18, P595, DOI 10.1517/14728222.2014.894021; Bowman MAH, 2011, ARTERIOSCL THROM VAS, V31, P337, DOI 10.1161/ATVBAHA.110.217745; Cai JJ, 2015, ANTIOXID REDOX SIGN, V23, P1351, DOI 10.1089/ars.2015.6408; Chen NX, 2008, J BONE MINER RES, V23, P1798, DOI 10.1359/JBMR.080604; Chen NX, 2013, AM J NEPHROL, V37, P191, DOI 10.1159/000347031; Curti AM, 2009, J THROMB HAEMOST, V7, P701, DOI 10.1111/j.1538-7836.2009.03304.x; De Vilder EYG, 2015, WORLD J CLIN CASES, V3, P556, DOI 10.12998/wjcc.v3.i7.556; DEAN DD, 1992, BONE MINER, V17, P172, DOI 10.1016/0169-6009(92)90731-R; Ebert R, 2015, STEM CELL RES, V15, P231, DOI 10.1016/j.scr.2015.06.008; Filosto S, 2012, J BIOL CHEM, V287, P514, DOI 10.1074/jbc.M111.315481; Golub EE, 2011, SEMIN IMMUNOPATHOL, V33, P409, DOI 10.1007/s00281-010-0230-z; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; Gordon JAR, 2007, BONE, V41, P462, DOI 10.1016/j.bone.2007.04.191; Hao JJ, 2004, BONE, V34, P921, DOI 10.1016/j.bone.2004.01.020; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Ibrahim ZA, 2013, MOL IMMUNOL, V56, P739, DOI 10.1016/j.molimm.2013.07.008; Ikeda K, 2012, BIOCHEM BIOPH RES CO, V425, P39, DOI 10.1016/j.bbrc.2012.07.045; Jia L, 2014, BLOOD, V123, P1709, DOI 10.1182/blood-2013-10-529610; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P2320, DOI 10.1161/01.ATV.0000145573.36113.8a; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Kapustin AN, 2011, CIRC RES, V109, pE1, DOI 10.1161/CIRCRESAHA.110.238808; Khavandgar Z, 2011, J CELL BIOL, V194, P277, DOI 10.1083/jcb.201102051; Kirsch T, 1997, BIOCHEMISTRY-US, V36, P3359, DOI 10.1021/bi9626867; Kirsch T, 2000, J BIOL CHEM, V275, P35577, DOI 10.1074/jbc.M005648200; Li QL, 2014, MATRIX BIOL, V33, P23, DOI 10.1016/j.matbio.2013.06.003; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Morhayim J, 2015, FASEB J, V29, P274, DOI 10.1096/fj.14-261404; Nahar NN, 2008, J BONE MINER METAB, V26, P514, DOI 10.1007/s00774-008-0859-z; New SEP, 2013, ARTERIOSCL THROM VAS, V33, P1753, DOI 10.1161/ATVBAHA.112.300128; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Otsuka F, 2014, ARTERIOSCL THROM VAS, V34, P724, DOI 10.1161/ATVBAHA.113.302642; Passmore M, 2015, EUR J CARDIO-THORAC, V48, pE20, DOI 10.1093/ejcts/ezv244; Qi SC, 2013, INT ENDOD J, V46, P1153, DOI 10.1111/iej.12112; Rosenthal AK, 2011, ARTHRITIS RHEUM-US, V63, P401, DOI 10.1002/art.30120; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shapiro IM, 2015, BONE, V79, P29, DOI 10.1016/j.bone.2015.05.013; Sheen CR, 2015, J BONE MINER RES, V30, P824, DOI 10.1002/jbmr.2420; Vogel S, 2015, J CLIN INVEST, V125, P4638, DOI 10.1172/JCI81660; Wang YY, 2013, INFLAMMATION, V36, P1592, DOI 10.1007/s10753-013-9704-1; Wang ZH, 2015, J ENDODONT, V41, P871, DOI 10.1016/j.joen.2015.01.006; Yang JP, 2008, J CELL PHYSIOL, V214, P730, DOI 10.1002/jcp.21268; Zhou Z, 2008, J BONE MINER RES, V23, P1084, DOI 10.1359/JBMR.080234; Zhou Zheng, 2011, Front Biosci (Schol Ed), V3, P768, DOI 10.2741/s185	51	29	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156686	10.1371/journal.pone.0156686	http://dx.doi.org/10.1371/journal.pone.0156686			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243975	Green Submitted, Green Published, gold			2022-12-26	WOS:000377146100062
J	Loof, T; Kramer, S; Gaedeke, J; Neumayer, HH; Peters, H				Loof, Tanja; Kraemer, Stephanie; Gaedeke, Jens; Neumayer, Hans-Hellmut; Peters, Harm			IL-17 Expression in the Time Course of Acute Anti-Thy1 Glomerulonephritis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EXPERIMENTAL CRESCENTIC GLOMERULONEPHRITIS; CD4 T-CELLS; AIRWAY NEUTROPHILIA; CARDIAC FIBROBLASTS; EPITHELIAL-CELLS; RENAL-DISEASE; TGF-BETA; INTERLEUKIN-17; LINEAGE	Background Interleukin-17 (IL-17) is a new pro-inflammatory cytokine involved in immune response and inflammatory disease. The main source of IL-17 is a subset of CD4(+) T-helper cells, but is also secreted by non-immune cells. The present study analyzes expression of IL-17 in the time course of acute anti-thy1 glomerulonephritis and the role of IL-17 as a potential link between inflammation and fibrosis. Methods Anti-thy1 glomerulonephritis was induced into male Wistar rats by OX-7 antibody injection. After that, samples were taken on days 1, 5, 10 (matrix expansion phase), 15 and 20 (resolution phase). PBS-injected animals served as controls. Proteinuria and histological matrixes score served as the main markers for disease severity. In in vitro experiments, NRK-52E cells were used. For cytokine expressions, mRNA and protein levels were analyzed by utilizing RT-PCR, in situ hybridization and immunofluorescence. Results Highest IL-17 mRNA-expression (6.50-fold vs. con; p < 0.05) was found on day 5 after induction of anti-thy1 glomerulonephritis along the maximum levels of proteinuria (113 +/- 13 mg/d; p < 0.001), histological glomerular-matrix accumulation (82%; p < 0.001) and TGF-beta 1 (2.2-fold; p< 0.05), IL-6 mRNA expression (36-fold; p < 0.05). IL-17 protein expression co-localized with the endothelial cell marker PECAM in immunofluorescence. In NRK-52E cells, co-administration of TGF-beta 1 and IL-6 synergistically up-regulated IL-17 mRNA 4986-fold (p < 0.001). Conclusions The pro-inflammatory cytokine IL-17 is up-regulated in endothelial cells during the time course of acute anti-thy1 glomerulonephritis. In vitro, NRK-52E cells secrete IL-17 under pro-fibrotic and pro-inflammatory conditions.	[Loof, Tanja; Kraemer, Stephanie; Gaedeke, Jens; Neumayer, Hans-Hellmut; Peters, Harm] Charite, Dept Nephrol, Campus Charite Mitte, D-13353 Berlin, Germany; [Loof, Tanja; Kraemer, Stephanie; Gaedeke, Jens; Neumayer, Hans-Hellmut; Peters, Harm] Charite, Ctr Cardiovasc Res, Campus Charite Mitte, D-13353 Berlin, Germany; [Kraemer, Stephanie] German Inst Human Nutr, Potsdam, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Peters, H (corresponding author), Charite, Dept Nephrol, Campus Charite Mitte, D-13353 Berlin, Germany.; Peters, H (corresponding author), Charite, Ctr Cardiovasc Res, Campus Charite Mitte, D-13353 Berlin, Germany.	Harm.Peters@charite.de	Peters, Harm/AAE-5643-2019	Peters, Harm/0000-0003-1441-7512				Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; BAGCHUS WM, 1986, LAB INVEST, V55, P680; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Floege J, 1997, Adv Nephrol Necker Hosp, V27, P15; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; HORII Y, 1993, KIDNEY INT, V43, pS71; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; KLAHR S, 1988, NEW ENGL J MED, V318, P1657; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kramer S, 2005, AM J PHYSIOL-RENAL, V289, pF359, DOI 10.1152/ajprenal.00442.2004; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Loverre A, 2011, AM J TRANSPLANT, V11, P1248, DOI 10.1111/j.1600-6143.2011.03529.x; Lubberts E, 2008, CYTOKINE, V41, P84, DOI 10.1016/j.cyto.2007.09.014; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Nardelli DT, 2008, FEMS IMMUNOL MED MIC, V53, P265, DOI 10.1111/j.1574-695X.2008.00431.x; NARITA I, 1995, LAB INVEST, V72, P17; NICE Clinical guideline, 2014, CHRONIC KIDNEY DIS A; Ofstad J, 2005, AM J PHYSIOL-RENAL, V288, pF665, DOI 10.1152/ajprenal.00226.2004; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Paust HJ, 2009, J AM SOC NEPHROL, V20, P969, DOI 10.1681/ASN.2008050556; Peters H, 2004, KIDNEY INT, V66, P1434, DOI 10.1111/j.1523-1755.2004.00906.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phoon RKS, 2008, J AM SOC NEPHROL, V19, P477, DOI 10.1681/ASN.2007030392; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Rodriguez-Iturbe B, 2001, KIDNEY INT, V59, P1626, DOI 10.1046/j.1523-1755.2001.0590051626.x; Steinmetz OM, 2011, J AM SOC NEPHROL, V22, P472, DOI 10.1681/ASN.2010040435; STERZEL RB, 1993, KIDNEY INT, V43, pS26; Summers SA, 2009, J AM SOC NEPHROL, V20, P2518, DOI 10.1681/ASN.2009030337; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Van Kooten C, 1998, J AM SOC NEPHROL, V9, P1526; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Venkatachalam K, 2008, AM J PHYSIOL-HEART C, V294, pH2078, DOI 10.1152/ajpheart.01363.2007; WALDHERR R, 1993, PEDIATR NEPHROL, V7, P471, DOI 10.1007/BF00857578; Wu CC, 2011, EXP DIABETES RES, DOI 10.1155/2011/514738; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yu XQ, 1999, AM J PATHOL, V154, P833, DOI 10.1016/S0002-9440(10)65330-8; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	52	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156480	10.1371/journal.pone.0156480	http://dx.doi.org/10.1371/journal.pone.0156480			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243813	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100040
J	Vargas, DY; Kramer, FR; Tyagi, S; Marras, SAE				Vargas, Diana Y.; Kramer, Fred Russell; Tyagi, Sanjay; Marras, Salvatore A. E.			Multiplex Real-Time PCR Assays that Measure the Abundance of Extremely Rare Mutations Associated with Cancer	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; CELL LUNG-CANCER; COLORECTAL-CANCER; MOLECULAR BEACONS; KRAS MUTATIONS; NUCLEIC-ACIDS; HYBRIDIZATION; GEFITINIB; PROBES; THERMODYNAMICS	We describe the use of "SuperSelective" primers that enable the detection and quantitation of somatic mutations whose presence relates to cancer diagnosis, prognosis, and therapy, in real-time PCR assays that can potentially analyze rare DNA fragments present in blood samples (liquid biopsies). The design of these deoxyribonucleotide primers incorporates both a relatively long "5' anchor sequence" that hybridizes strongly to target DNA fragments, and a very short, physically and functionally separate, "3' foot sequence" that is perfectly complementary to the mutant target sequence, but mismatches the wild-type sequence. As few as ten mutant fragments can reliably be detected in the presence of 1,000,000 wild-type fragments, even when the difference between the mutant and the wild type is only a single nucleotide polymorphism. Multiplex PCR assays employing a set of SuperSelective primers, and a corresponding set of differently colored molecular beacon probes, can be used in situations where the different mutations, though occurring in different cells, are located in the same codon. These non-symmetric real-time multiplex PCR assays contain limited concentrations of each SuperSelective primer, thereby enabling the simultaneous determination of each mutation's abundance by comparing its threshold value to the threshold value of a reference gene present in the sample.	[Vargas, Diana Y.; Kramer, Fred Russell; Tyagi, Sanjay; Marras, Salvatore A. E.] Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA; [Kramer, Fred Russell; Marras, Salvatore A. E.] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07102 USA; [Tyagi, Sanjay] Rutgers State Univ, New Jersey Med Sch, Dept Med, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Kramer, FR (corresponding author), Rutgers State Univ, Publ Hlth Res Inst, Newark, NJ 07102 USA.; Kramer, FR (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07102 USA.	fred.kramer@rutgers.edu		Tyagi, Sanjay/0000-0001-7303-5827; Marras, Salvatore/0000-0003-2040-0354	Public Health Research Institute, Rutgers University	Public Health Research Institute, Rutgers University	This research, the open access charge for the publication of this paper, and the salaries of all of the authors of this manuscript were supported by the laboratory's (Public Health Research Institute, Rutgers University) share of the income received from the non-exclusive licensing of molecular beacons technology by PHRI Properties, Inc., which is a nonprofit corporation wholly owned by Rutgers University. Neither PHRI Properties, Inc., nor any of its approximately 75 molecular beacons licensees, had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RF, 2015, CLIN CHIM ACTA, V439, P97, DOI 10.1016/j.cca.2014.10.011; Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; Bonnet G, 1998, P NATL ACAD SCI USA, V95, P8602, DOI 10.1073/pnas.95.15.8602; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Goddard NL, 2000, PHYS REV LETT, V85, P2400, DOI 10.1103/PhysRevLett.85.2400; Hazbon MH, 2004, J CLIN MICROBIOL, V42, P1236, DOI 10.1128/JCM.42.3.1236-1242.2004; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Holmstrom ED, 2014, BIOPHYS J, V106, P220, DOI 10.1016/j.bpj.2013.11.008; Jia YW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05921; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li QQ, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e5; LIVAK KJ, 1995, PCR METH APPL, V4, P357; LOMELI H, 1989, CLIN CHEM, V35, P1826; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Makarov V, 2011, US Patent Application, Patent No. [2011/0129832, 20110129832]; Marras SAE, 2014, Patent Cooperation Treaty Publication WO, Patent No. [2014/124290, 2014124290]; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P5332, DOI 10.1093/nar/21.23.5332; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pierce KE, 2005, P NATL ACAD SCI USA, V102, P8609, DOI 10.1073/pnas.0501946102; Poddar SK, 2000, MOL CELL PROBE, V14, P25, DOI 10.1006/mcpr.1999.0278; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shen YQ, 2001, J PHYS CHEM B, V105, P12202, DOI 10.1021/jp0121926; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Tie J, 2015, ANN ONCOL, V26, P1715, DOI 10.1093/annonc/mdv177; Todd AV, 2013, Patent Cooperation Treaty PublicationWO, Patent No. [2013/123552, 2013123552]; Tong JHM, 2014, CANCER BIOL THER, V15, P768, DOI 10.4161/cbt.28550; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Tyagi S, 1998, NAT BIOTECHNOL, V16, P49, DOI 10.1038/nbt0198-49; Tyagi S, 2001, US Patents, Patent No. [6,365,729, 6365729]; Tyagi S, US Patents, Patent No. [6,277,607, 6277607]; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	16	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156546	10.1371/journal.pone.0156546	http://dx.doi.org/10.1371/journal.pone.0156546			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244445	Green Published, gold, Green Submitted			2022-12-26	WOS:000377146100044
J	Epelboin, Y; Quintric, L; Guevelou, E; Boudry, P; Pichereau, V; Corporeau, C				Epelboin, Yanouk; Quintric, Laure; Guevelou, Eric; Boudry, Pierre; Pichereau, Vianney; Corporeau, Charlotte			The Kinome of Pacific Oyster Crassostrea gigas, Its Expression during Development and in Response to Environmental Factors	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FACTOR-BETA SUPERFAMILY; LIGHT-CHAIN KINASE; TYROSINE KINASE; CAENORHABDITIS-ELEGANS; BIVALVE MOLLUSK; DOPAMINERGIC-NEURONS; MOLECULAR-MECHANISMS; SIGNAL-TRANSDUCTION; REPRODUCTIVE-CYCLE	Oysters play an important role in estuarine and coastal marine habitats, where the majority of humans live. In these ecosystems, environmental degradation is substantial, and oysters must cope with highly dynamic and stressful environmental constraints during their lives in the intertidal zone. The availability of the genome sequence of the Pacific oyster Crassostrea gigas represents a unique opportunity for a comprehensive assessment of the signal transduction pathways that the species has developed to deal with this unique habitat. We performed an in silico analysis to identify, annotate and classify protein kinases in C. gigas, according to their kinase domain taxonomy classification, and compared with kinome already described in other animal species. The C. gigas kinome consists of 371 protein kinases, making it closely related to the sea urchin kinome, which has 353 protein kinases. The absence of gene redundancy in some groups of the C. gigas kinome may simplify functional studies of protein kinases. Through data mining of transcriptomes in C. gigas, we identified part of the kinome which may be central during development and may play a role in response to various environmental factors. Overall, this work contributes to a better understanding of key sensing pathways that may be central for adaptation to a highly dynamic marine environment.	[Epelboin, Yanouk; Guevelou, Eric; Boudry, Pierre; Corporeau, Charlotte] IFREMER, UMR CNRS UBO IRD Ifremer 6539, Lab Sci Environm Marin, Plouzane, France; [Quintric, Laure] IFREMER, Serv Ressources Informat & Commun, Plouzane, France; [Pichereau, Vianney] UBO, UMR CNRS UBO IRD Ifremer 6539, Lab Sci Environm Marin, Plouzane, France; [Guevelou, Eric] Virginia Inst Marine Sci, Coll William & Mary, Aquaculture Genet & Breeding Technol Ctr, Gloucester Point, VA 23062 USA	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Ifremer; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; William & Mary; Virginia Institute of Marine Science	Corporeau, C (corresponding author), IFREMER, UMR CNRS UBO IRD Ifremer 6539, Lab Sci Environm Marin, Plouzane, France.	charlotte.corporeau@ifremer.fr	Boudry, Pierre/M-3213-2019; PICHEREAU, Vianney/B-2168-2008; PICHEREAU, Vianney/Q-7236-2019; Guévélou, Eric/A-8670-2014; Boudry, Pierre/G-2406-2010	PICHEREAU, Vianney/0000-0003-1078-9407; PICHEREAU, Vianney/0000-0003-1078-9407; Guévélou, Eric/0000-0001-6716-6310; Corporeau, charlotte/0000-0003-1187-358X; Boudry, Pierre/0000-0002-5150-2276				Al Quobaili F, 2012, METABOLISM, V61, P1512, DOI 10.1016/j.metabol.2012.07.011; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berthelin C, 2000, COMP BIOCHEM PHYS B, V125, P359, DOI 10.1016/S0305-0491(99)00187-X; Berwick DC, 2012, HUM MOL GENET, V21, P4966, DOI 10.1093/hmg/dds342; Bettinger BT, 2007, J CELL BIOCHEM, V101, P34, DOI 10.1002/jcb.21289; Boening DW, 1999, ENVIRON MONIT ASSESS, V55, P459, DOI 10.1023/A:1005995217901; Boutet I, 2008, GENE, V407, P130, DOI 10.1016/j.gene.2007.10.005; Bradham CA, 2006, DEV BIOL, V300, P180, DOI 10.1016/j.ydbio.2006.08.074; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; Cambray S, 2009, MOL CELL BIOL, V29, P726, DOI 10.1128/MCB.01180-08; Cao HM, 2004, EXP CELL RES, V294, P159, DOI 10.1016/j.yexcr.2003.11.010; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chen ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031337; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clark MS, 2013, ECOL EVOL, V3, P3283, DOI 10.1002/ece3.719; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cohen SM, 2015, BIOCHEM BIOPH RES CO, V460, P88, DOI 10.1016/j.bbrc.2015.02.146; Corporeau C, 2011, MAR BIOTECHNOL, V13, P971, DOI 10.1007/s10126-010-9361-4; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Deshmukh K, 2010, PROG BIOPHYS MOL BIO, V102, P1, DOI 10.1016/j.pbiomolbio.2009.12.009; Doroquez DB, 2006, CRIT REV BIOCHEM MOL, V41, P339, DOI 10.1080/10409230600914344; Duda T, 2011, BIOCHEMISTRY-US, V50, P1213, DOI 10.1021/bi1018978; Epelboin Y, 2015, CHEM RES TOXICOL, V28, P1831, DOI 10.1021/acs.chemrestox.5b00269; Erce MA, 2012, PROTEOMICS, V12, P564, DOI 10.1002/pmic.201100397; Escoubas JM, 1999, FEBS LETT, V453, P293, DOI 10.1016/S0014-5793(99)00737-1; Fleury E, 2008, GENE, V410, P187, DOI 10.1016/j.gene.2007.12.017; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Gale M, 1998, PHARMACOL THERAPEUT, V78, P29, DOI 10.1016/S0163-7258(97)00165-4; Glatz G, 2013, J BIOL CHEM, V288, P8596, DOI 10.1074/jbc.M113.452235; Goldberg JM, 2006, PLOS GENET, V2, P291, DOI 10.1371/journal.pgen.0020038; Goodchild CG, 2015, SCI TOTAL ENVIRON, V512, P201, DOI 10.1016/j.scitotenv.2015.01.065; Gotoh I, 2001, J BIOL CHEM, V276, P4276, DOI 10.1074/jbc.M008595200; Gourgou E, 2010, J EXP BIOL, V213, P347, DOI 10.1242/jeb.036277; Green TJ, 2014, FISH SHELLFISH IMMUN, V36, P151, DOI 10.1016/j.fsi.2013.10.026; Green TJ, 2013, FISH SHELLFISH IMMUN, V35, P382, DOI 10.1016/j.fsi.2013.04.051; Gricourt L, 2003, GEN COMP ENDOCR, V134, P44, DOI 10.1016/S0016-6480(03)00217-X; Guevelou E, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109728; Guevelou E, 2013, J COMP PHYSIOL B, V183, P597, DOI 10.1007/s00360-013-0743-6; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo L, 2016, AQUACULT INT, V24, P327, DOI 10.1007/s10499-015-9928-1; Guo XM, 2015, FISH SHELLFISH IMMUN, V46, P107, DOI 10.1016/j.fsi.2015.05.018; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hayashi K, 2012, CELL STRUCT FUNCT, V37, P21; Heide I, 1998, ANN HEMATOL, V77, P199, DOI 10.1007/s002770050443; Herpin A, 2005, FEBS J, V272, P3424, DOI 10.1111/j.1742-4658.2005.04761.x; Herpin A, 2005, MECH DEVELOP, V122, P695, DOI 10.1016/j.mod.2004.12.004; Herpin A, 2002, GENE, V301, P21, DOI 10.1016/S0378-1119(02)01082-X; Hopkins AE, 1936, ADAPTATION FEEDING M; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jouaux A, 2012, GEN COMP ENDOCR, V176, P28, DOI 10.1016/j.ygcen.2011.12.008; Kawabe S, 2010, FISHERIES SCI, V76, P841, DOI 10.1007/s12562-010-0263-1; Kefaloyianni E, 2005, J EXP BIOL, V208, P4427, DOI 10.1242/jeb.01924; KIM L, 1995, MOL CELL BIOL, V15, P4553; Kim YS, 2002, DEV BIOL, V249, P367, DOI 10.1006/dbio.2002.0768; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Knippschild U, 2005, ONKOLOGIE, V28, P508, DOI 10.1159/000087137; Kolaiti RM, 2011, MAR BIOTECHNOL, V13, P505, DOI 10.1007/s10126-010-9321-z; Kuhl M, 2001, MECH DEVELOP, V106, P61, DOI 10.1016/S0925-4773(01)00416-6; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Lang RP, 2009, MAR BIOTECHNOL, V11, P650, DOI 10.1007/s10126-009-9181-6; Lapraz F, 2006, DEV BIOL, V300, P132, DOI 10.1016/j.ydbio.2006.08.048; LaRonde-LeBlanc N, 2005, BBA-PROTEINS PROTEOM, V1754, P14, DOI 10.1016/j.bbapap.2005.07.037; Le Quere H, 2009, GENE, V436, P101, DOI 10.1016/j.gene.2009.01.010; Lelong C, 2000, EUR J BIOCHEM, V267, P3986, DOI 10.1046/j.1432-1327.2000.01432.x; Li Z, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115890, DOI 10.1371/J0URNAL.P0NE.0115890]; Lopez A, 2005, P ACL WORKSH BUILD U, P83; Maier LS, 2007, CARDIOVASC RES, V73, P631, DOI 10.1016/j.cardiores.2006.11.005; Malumbres M, 2011, PHYSIOL REV, V91, P973, DOI 10.1152/physrev.00025.2010; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Manning G, 2005, GENOMIC OVERVIEW PRO, DOI [10.1895/wormbook.1.60.1, DOI 10.1895/W0RMB00K.1.60.1]; Manning G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r66; Mantovani J, 2011, FEBS LETT, V585, P967, DOI 10.1016/j.febslet.2010.12.015; Marchi B, 2005, BIOMETALS, V18, P179, DOI 10.1007/s10534-004-6254-x; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Murayama T, 2013, CURR BIOL, V23, P1007, DOI 10.1016/j.cub.2013.04.052; Nguyen CL, 2012, MOL CELL BIOL, V32, P3963, DOI 10.1128/MCB.00436-12; PALMER PA, 1995, COMP BIOCHEM PHYS A, V110, P171, DOI 10.1016/0300-9629(94)00105-3; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Portillo-Lopez A, 2003, BIOL CELL, V95, P275, DOI 10.1016/S0248-4900(03)00054-6; POULOS JE, 1995, GEN COMP ENDOCR, V100, P61, DOI 10.1006/gcen.1995.1133; Putzke AP, 2005, DEVELOPMENT, V132, P3185, DOI 10.1242/dev.01900; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Roux MM, 2006, DEV BIOL, V300, P416, DOI 10.1016/j.ydbio.2006.09.006; Saha S, 2009, J NEUROSCI, V29, P9210, DOI 10.1523/JNEUROSCI.2281-09.2009; Satoh T, 1996, FEBS LETT, V386, P230, DOI 10.1016/0014-5793(96)00449-8; Schenk PW, 1999, BBA-MOL CELL RES, V1449, P1, DOI 10.1016/S0167-4889(98)00178-5; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Silberbach M, 2001, CELL SIGNAL, V13, P221, DOI 10.1016/S0898-6568(01)00139-5; Smith HK, 2013, GENETICS, V194, P885, DOI 10.1534/genetics.113.152660; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stull JT, 2011, ARCH BIOCHEM BIOPHYS, V510, P120, DOI 10.1016/j.abb.2011.01.017; Sun LL, 2014, MOL BIOL REP, V41, P2757, DOI 10.1007/s11033-014-3130-9; Sun XG, 2000, J BIOL CHEM, V275, P7470, DOI 10.1074/jbc.275.11.7470; Sundaram Meera V, 2006, WormBook, P1; Sussarellu R, 2010, MAR GENOM, V3, P133, DOI 10.1016/j.margen.2010.08.005; Takei Y, 2001, COMP BIOCHEM PHYS B, V129, P559, DOI 10.1016/S1096-4959(01)00366-9; Theillet FX, 2012, J BIOMOL NMR, V54, P217, DOI 10.1007/s10858-012-9674-x; Thiyagarajan V, 2009, J PROTEOME RES, V8, P2708, DOI 10.1021/pr800976u; Timmins-Schiffman E, 2013, CONSERV PHYSIOL, V1, DOI [10.1093/conphys/cot009, DOI 10.1093/C0NPHYS/C0T009]; VESELY DL, 1993, COMP BIOCHEM PHYS B, V106, P535, DOI 10.1016/0305-0491(93)90129-S; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang XL, 2015, MOL HUM REPROD, V21, P136, DOI 10.1093/molehr/gau097; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WONG SKF, 1992, J CLIN INVEST, V90, P299, DOI 10.1172/JCI115862; Yamamoto T, 2005, J BIOL CHEM, V280, P16979, DOI 10.1074/jbc.M412433200; Yao C, 2010, NEUROBIOL DIS, V40, P73, DOI 10.1016/j.nbd.2010.04.002; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yoshida K, 2008, BIOCHEM PHARMACOL, V76, P1389, DOI 10.1016/j.bcp.2008.05.021; Zeng Z, 2013, COMP BIOCHEM PHYS B, V166, P203, DOI 10.1016/j.cbpb.2013.09.003; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhao ZG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045675, 10.1371/journal.pone.0046244]	126	12	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155435	10.1371/journal.pone.0155435	http://dx.doi.org/10.1371/journal.pone.0155435			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27231950	Green Published, gold			2022-12-26	WOS:000376883000004
J	Tong, JF; Meng, L; Wang, XW; Liu, LX; Lyu, LD; Wang, C; Li, Y; Gao, Q; Yang, C; Niu, C				Tong, Jingfeng; Meng, Lu; Wang, Xinwei; Liu, Lixia; Lyu, Liangdong; Wang, Chuan; Li, Yang; Gao, Qian; Yang, Chen; Niu, Chen			The FBPase Encoding Gene glpX Is Required for Gluconeogenesis, Bacterial Proliferation and Division In Vivo of Mycobacterium marinum	PLOS ONE			English	Article							CENTRAL GLYCOLYTIC GENES; CELL-SIZE; CARBON METABOLISM; ESCHERICHIA-COLI; TUBERCULOSIS; MACROPHAGES; SEQUENCE; GROWTH; SENSOR	Lipids have been identified as important carbon sources for Mycobacterium tuberculosis (Mtb) to utilize in vivo. Thus gluconeogenesis bears a key role for Mtb to survive and replicate in host. A rate-limiting enzyme of gluconeogenesis, fructose 1, 6-bisphosphatase (FBPase) is encoded by the gene glpX. The functions of glpX were studied in M. marinum, a closely related species to Mtb. The glpX deletion strain (Delta glpX) displayed altered gluconeogenesis, attenuated virulence, and altered bacterial proliferation. Metabolic profiles indicate an accumulation of the FBPase substrate, fructose 1, 6-bisphosphate (FBP) and altered gluconeogenic flux when Delta glpX is cultivated in a gluconeogenic carbon substrate, acetate. In both macrophages and zebrafish, the proliferation of Delta glpX was halted, resulting in dramatically attenuated virulence. Intracellular Delta glpX exhibited an elongated morphology, which was also observed when Delta glpX was grown in a gluconeogenic carbon source. This elongated morphology is also supported by the observation of unseparated multi-nucleoid cell, indicating that a complete mycobacterial division in vivo is correlated with intact gluconeogenesis. Together, our results indicate that glpX has essential functions in gluconeogenesis, and plays an indispensable role in bacterial proliferation in vivo and virulence of M. marinum.	[Tong, Jingfeng; Meng, Lu; Wang, Xinwei; Lyu, Liangdong; Wang, Chuan; Li, Yang; Gao, Qian; Niu, Chen] Fudan Univ, Sch Basic Med Sci, MOE, Shanghai 200433, Peoples R China; [Tong, Jingfeng; Meng, Lu; Wang, Xinwei; Lyu, Liangdong; Wang, Chuan; Li, Yang; Gao, Qian; Niu, Chen] Fudan Univ, Sch Basic Med Sci, MOH Key Lab Med Mol Virol, Shanghai 200433, Peoples R China; [Meng, Lu; Gao, Qian] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Meng, Lu; Gao, Qian] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Wang, Xinwei] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Liu, Lixia; Yang, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Niu, C (corresponding author), Fudan Univ, Sch Basic Med Sci, MOE, Shanghai 200433, Peoples R China.; Niu, C (corresponding author), Fudan Univ, Sch Basic Med Sci, MOH Key Lab Med Mol Virol, Shanghai 200433, Peoples R China.; Yang, C (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Synthet Biol, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	chenyang@sibs.ac.cn; chniu@fudan.edu.cn	Meng, Lu/GXN-0092-2022; Lyu, Liangdong/C-6557-2014	Lyu, Liangdong/0000-0001-6391-6030	National Natural Science Foundation of China [81201256, 31421061, 81271790]; NIH/FIC Global Infectious Diseases Training Grant [D43TW007887, 08004034-01]; Shanghai Committee of Science and Technology [14140902900]; Fudan's UROP [14107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH/FIC Global Infectious Diseases Training Grant; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Fudan's UROP	This research is supported by National Natural Science Foundation of China (81201256 to C. Niu, 31421061 to C. Yang, 81271790 to Q. Gao), a subaward (08004034-01, Amd7) of NIH/FIC Global Infectious Diseases Training Grant (D43TW007887), and the Shanghai Committee of Science and Technology (grant No. 14140902900) to C. Niu. Y. Li is a recipient of Fudan's UROP #14107. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Beste DJV, 2013, CHEM BIOL, V20, P1012, DOI 10.1016/j.chembiol.2013.06.012; Chauhan A, 2006, MOL MICROBIOL, V62, P132, DOI 10.1111/j.1365-2958.2006.05333.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Cronan MR, 2014, DIS MODEL MECH, V7, P777, DOI 10.1242/dmm.016089; Santangelo MD, 2011, J BIOL CHEM, V286, P40219, DOI 10.1074/jbc.M111.259440; Dey B, 2014, SEMIN IMMUNOL, V26, P486, DOI 10.1016/j.smim.2014.09.002; Doan T, 2003, MOL MICROBIOL, V47, P1709, DOI 10.1046/j.1365-2958.2003.03404.x; Dong DD, 2012, INFECT IMMUN, V80, P43, DOI 10.1128/IAI.05249-11; Dziedzic R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011058; England K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-79; Ganapathy U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8912; Gutka HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138436; Gutka HJ, 2011, APPL BIOCHEM BIOTECH, V164, P1376, DOI 10.1007/s12010-011-9219-x; Gutka HJ, 2011, ACTA CRYSTALLOGR F, V67, P710, DOI 10.1107/S1744309111014722; Hill NS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003663; Kieser KJ, 2015, P NATL ACAD SCI; Kochanowski K, 2013, P NATL ACAD SCI USA, V110, P1130, DOI 10.1073/pnas.1202582110; Lemuth K, 2008, APPL ENVIRON MICROB, V74, P7002, DOI 10.1128/AEM.01327-08; Lerner TR, 2015, CELL MICROBIOL, V17, P1277, DOI 10.1111/cmi.12480; Marrero J, 2010, P NATL ACAD SCI USA, V107, P9819, DOI 10.1073/pnas.1000715107; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Movahedzadeh F, 2004, MICROBIOL-SGM, V150, P3499, DOI 10.1099/mic.0.27204-0; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; Myllymaki H, 2015, EXPERT OPIN DRUG DIS, V10, P871, DOI 10.1517/17460441.2015.1049529; Puckett S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004144; Ramakrishnan L., 2014, COLD SPRING HARB SYM, V78, P179; Reith J, 2011, APPL MICROBIOL BIOT, V92, P1, DOI 10.1007/s00253-011-3486-x; Rhee KY, 2011, TRENDS MICROBIOL, V19, P307, DOI 10.1016/j.tim.2011.03.008; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Stinear TP, 2008, GENOME RES, V18, P729, DOI 10.1101/gr.075069.107; Takaki K, 2013, NAT PROTOC, V8, P1114, DOI 10.1038/nprot.2013.068; Vadia S, 2015, CURR OPIN MICROBIOL, V24, P96, DOI 10.1016/j.mib.2015.01.011; Wang QL, 2015, INFECT IMMUN, V83, P2844, DOI 10.1128/IAI.03081-14; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045; Zorrilla S, 2007, BIOCHEMISTRY-US, V46, P14996, DOI 10.1021/bi701805e	39	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156663	10.1371/journal.pone.0156663	http://dx.doi.org/10.1371/journal.pone.0156663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27233038	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000051
J	Nickerson, ML; Witte, N; Im, KM; Turan, S; Owens, C; Misner, K; Tsang, SX; Cai, Z; Wu, S; Dean, M; Costello, JC; Theodorescu, D				Nickerson, M. L.; Witte, N.; Im, K. M.; Turan, S.; Owens, C.; Misner, K.; Tsang, S. X.; Cai, Z.; Wu, S.; Dean, M.; Costello, J. C.; Theodorescu, D.			Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response	ONCOGENE			English	Article							INVASIVE BLADDER-CANCER; WHOLE-GENOME; IMPACT ANALYSIS; IDENTIFICATION; VISUALIZATION; ANNOTATION; RESOURCE; CHEMOSENSITIVITY; REGULARIZATION; COMBINATION	The utility of tumor-derived cell lines is dependent on their ability to recapitulate underlying genomic aberrations and primary tumor biology. Here, we sequenced the exomes of 25 bladder cancer (BCa) cell lines and compared mutations, copy number alterations (CNAs), gene expression and drug response to BCa patient profiles in The Cancer Genome Atlas (TCGA). We observed a mutation pattern associated with altered CpGs and APOBEC-family cytosine deaminases similar to mutation signatures derived from somatic alterations in muscle-invasive (Ml) primary tumors, highlighting a major mechanism(s) contributing to cancer associated alterations in the BCa cell line exomes. Non-silent sequence alterations were confirmed in 76 cancer-associated genes, including mutations that likely activate oncogenes TERT and PIK3CA, and alter chromatin-associated proteins (MLL3, ARID1A, CHD6 and KDM6A) and established BCa genes (TP53, RB1, CDKN2A and TSC1). We identified alterations in signaling pathways and proteins with related functions, including the PI3K/mTOR pathway, altered in 60% of lines; BRCA DNA repair, 44%; and SYNE1-SYNE2, 60%. Homozygous deletions of chromosome 9p21 are known to target the cell cycle regulators CDKN2A and CDKN2B. This loci was commonly lost in BCa cell lines and we show the deletions extended to the polyamine enzyme methylthioadenosine (MTA) phosphorylase (MTAP) in 36% of lines, transcription factor DMRTA1 (27%) and antiviral interferon epsilon (IFNE, 19%). Overall, the BCa cell line genomic aberrations were concordant with those found in BCa patient tumors. We used gene expression and copy number data to infer pathway activities for cell lines, then used the inferred pathway activities to build a predictive model of cisplatin response. When applied to platinum-treated patients gathered from TCGA, the model predicted treatment-specific response. Together, these data and analysis represent a valuable community resource to model basic tumor biology and to study the pharmacogenomics of BCa.	[Nickerson, M. L.; Turan, S.; Misner, K.; Dean, M.] NCI, Canc & Inflammat Program, NIH, Frederick, MD 21701 USA; [Witte, N.; Costello, J. C.] Univ Colorado, Computat Biosci Program, Aurora, CO USA; [Im, K. M.] Data Sci Genom LLC, Ellicott City, MD USA; [Owens, C.; Theodorescu, D.] Univ Colorado, Dept Surg Urol, Aurora, CO USA; [Tsang, S. X.] BGI Shenzhen, Shenzhen, Peoples R China; [Cai, Z.; Wu, S.] Shenzhen Second Peoples Hosp, Shenzhen, Peoples R China; [Costello, J. C.; Theodorescu, D.] Univ Colorado, Dept Pharmacol, Anschutz Med Campus,12801 E 17th Ave, Aurora, CO 80045 USA; [Costello, J. C.; Theodorescu, D.] Univ Colorado, Ctr Comprehens Canc, Anschutz Med Campus,13001 E 17th Pl,F-434, Aurora, CO 80045 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Beijing Genomics Institute (BGI); Second People's Hospital of Shenzhen; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Costello, JC (corresponding author), Univ Colorado, Dept Pharmacol, Anschutz Med Campus,12801 E 17th Ave, Aurora, CO 80045 USA.; Theodorescu, D (corresponding author), Univ Colorado, Ctr Comprehens Canc, Anschutz Med Campus,13001 E 17th Pl,F-434, Aurora, CO 80045 USA.	james.costello@ucdenver.edu; dan.theodorescu@ucdenver.edu	Dean, Michael/R-7501-2019; Dean, Michael C/G-8172-2012	Dean, Michael C/0000-0003-2234-0631; Costello, James/0000-0003-3158-9682	NIH [CA143971, CA075115]; Intramural Research Program of the NIH; National Cancer Institute, Center for Cancer Research; National Library of Medicine T15 training grant [LM009451]; Shenzhen municipal science and technology project [CXZZ20140826163906370]; NATIONAL CANCER INSTITUTE [R01CA143971, R01CA075115, R29CA075115, P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075092] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM009451] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine T15 training grant; Shenzhen municipal science and technology project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We would like to thank Dr Neeraj Agarwal for providing the TERT experimental data. This work was in part supported by NIH grants CA143971 and CA075115 for DT; Intramural Research Program of the NIH, the National Cancer Institute, Center for Cancer Research for MLN and MD; National Library of Medicine T15 training grant LM009451 for NW; Shenzhen municipal science and technology project CXZZ20140826163906370 for SW.	1000 Genomes Project Consortium, 2012, Nature, V491, P56, DOI 10.1038/nature11632; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bertino JR, 2011, CANCER BIOL THER, V11, P627, DOI 10.4161/cbt.11.7.14948; Borah S, 2015, SCIENCE, V347, P1006, DOI 10.1126/science.1260200; Cao W, 2005, BIOCHEM BIOPH RES CO, V330, P1034, DOI 10.1016/j.bbrc.2005.02.188; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Earl J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1450-3; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fung KY, 2013, SCIENCE, V339, P1088, DOI 10.1126/science.1233321; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Goodspeed A, 2016, MOL CANCER RES, V14, P3, DOI 10.1158/1541-7786.MCR-15-0189; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Havaleshko DM, 2007, MOL CANCER THER, V6, P578, DOI 10.1158/1535-7163.MCT-06-0497; Heidenblad M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-3; Hermant P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071320; Iyer G, 2013, J CLIN ONCOL, V31, P3133, DOI 10.1200/JCO.2012.46.5740; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kim J, 2015, CLIN CANCER RES, V21, P4514, DOI 10.1158/1078-0432.CCR-14-1215; Lee JK, 2007, P NATL ACAD SCI USA, V104, P13086, DOI 10.1073/pnas.0610292104; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li H, 2014, MOL CANCER RES, V12, P571, DOI 10.1158/1541-7786.MCR-13-0396; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; Messing E, 2006, J UROLOGY, V176, P500, DOI 10.1016/j.juro.2006.03.061; Morrison CD, 2014, P NATL ACAD SCI USA, V111, pE672, DOI 10.1073/pnas.1313580111; Mouradov D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Nickerson ML, 2014, CLIN CANCER RES, V20, P4935, DOI 10.1158/1078-0432.CCR-14-0330; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Riester M, 2012, CLIN CANCER RES, V18, P1323, DOI 10.1158/1078-0432.CCR-11-2271; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Seshan W, DNACOPY DNA COPY NUM; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith SC, 2011, LANCET ONCOL, V12, P137, DOI 10.1016/S1470-2045(10)70296-5; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; STADLER WM, 1994, CANCER RES, V54, P2060; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Vuong H, 2015, BIOINFORMATICS, V31, P2748, DOI 10.1093/bioinformatics/btv200; Vuong H, 2014, BIOINFORMATICS, V30, P1013, DOI 10.1093/bioinformatics/btt655; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wijesundara DK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00412; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yap KL, 2014, CLIN CANCER RES, V20, P6605, DOI 10.1158/1078-0432.CCR-14-0257; Yu M, 2015, NATURE, V520, P307, DOI 10.1038/nature14397; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	56	59	60	2	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 5	2017	36	1					35	46		10.1038/onc.2016.172	http://dx.doi.org/10.1038/onc.2016.172			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK6XJ	27270441	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000394069100004
J	Zhang, Q; Harding, R; Hou, F; Dong, AP; Walker, JR; Bteich, J; Tong, YF				Zhang, Qi; Harding, Rachel; Hou, Feng; Dong, Aiping; Walker, John R.; Bteich, Joseph; Tong, Yufeng			Structural Basis of the Recruitment of Ubiquitin-specific Protease USP15 by Spliceosome Recycling Factor SART3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; dimerization; protein-protein interaction; site-directed mutagenesis; ubiquitin-dependent protease; deubiquitinase; half-a-tetratricopeptide repeats	CANCER-PATIENTS; POSTTRANSLATIONAL MODIFICATIONS; MACROMOLECULAR CRYSTALLOGRAPHY; DEUBIQUITINATING ENZYME; SART3-DERIVED PEPTIDES; CRYSTAL-STRUCTURE; DOMAINS; COMPLEX; IDENTIFICATION; RECOGNITION	Ubiquitin-specific proteases (USPs) USP15 and USP4 belong to a subset of USPs featuring an N-terminal tandem domain in USP (DUSP) and ubiquitin-like (UBL) domain. Squamous cell carcinoma antigen recognized by T-cell 3 (SART3), a spliceosome recycling factor, binds to the DUSP-UBL domain of USP15 and USP4, recruiting them to the nucleus from the cytosol to control deubiquitination of histone H2B and spliceosomal proteins, respectively. To provide structural insight, we solved crystal structures of SART3 in the apo-form and in complex with the DUSP-UBL domain of USP15 at 2.0 and 3.0 , respectively. Structural analysis reveals SART3 contains 12 half-a-tetratricopeptide (HAT) repeats, organized into two subdomains, HAT-N and HAT-C. SART3 dimerizes through the concave surface of HAT-C, whereas the HAT-C convex surface binds USP15 in a novel bipartite mode. Isothermal titration calorimetry measurements and mutagenesis analysis confirmed key residues of USP15 involved in the interaction and indicated USP15 binds 20-fold stronger than USP4.	[Zhang, Qi; Harding, Rachel; Hou, Feng; Dong, Aiping; Walker, John R.; Tong, Yufeng] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Bteich, Joseph] Ontario Inst Canc Res, Drug Discovery Program, Toronto, ON M5G 0A3, Canada; [Tong, Yufeng] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5G 1L7, Canada	University of Toronto; Structural Genomics Consortium; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto	Tong, YF (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.; Tong, YF (corresponding author), Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5G 1L7, Canada.	yufeng.tong@utoronto.ca		Zhang, Qi/0000-0003-1121-8817; /0000-0002-5255-895X; Harding, Rachel/0000-0002-1134-391X; Tong, Yufeng/0000-0001-7740-1812	AbbVie [1097737]; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute; Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD) [115766]; Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute, Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD Grant 115766), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust. X-ray diffraction data were collected at the Canadian Light Source (14) and at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, which is operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Aasland R, 2002, FEBS LETT, V513, P141, DOI 10.1016/S0014-5793(01)03295-1; Bai Y, 2007, MOL CELL, V25, P863, DOI 10.1016/j.molcel.2007.01.034; Champion EA, 2008, MOL CELL BIOL, V28, P6547, DOI 10.1128/MCB.00906-08; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Clerici M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6399; Elliott PR, 2011, FEBS LETT, V585, P3385, DOI 10.1016/j.febslet.2011.09.040; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furugaki K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101854; Grochulski P, 2011, J SYNCHROTRON RADIAT, V18, P681, DOI 10.1107/S0909049511019431; Hammani K, 2012, P NATL ACAD SCI USA, V109, P5651, DOI 10.1073/pnas.1200318109; Harada K, 2001, INT J CANCER, V93, P623, DOI 10.1002/ijc.1391; Harper S, 2014, BIOCHEMISTRY-US, V53, P2966, DOI 10.1021/bi500116x; Harper S, 2011, BIOCHEMISTRY-US, V50, P7995, DOI 10.1021/bi200726e; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Ideguchi H, 2002, BIOCHEM J, V367, P87, DOI 10.1042/BJ20011851; Ito M, 2000, INT J CANCER, V88, P633, DOI 10.1002/1097-0215(20001115)88:4<633::AID-IJC18>3.3.CO;2-E; Kabiri M, 2014, BIOMACROMOLECULES, V15, P3463, DOI 10.1021/bm5004515; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Long L, 2014, J BIOL CHEM, V289, P8916, DOI 10.1074/jbc.M114.551754; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Park JK, 2016, NUCLEIC ACIDS RES, V44, P5424, DOI 10.1093/nar/gkw218; Paulson AR, 2012, RNA, V18, P1154, DOI 10.1261/rna.032524.112; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Preker PJ, 1998, TRENDS BIOCHEM SCI, V23, P15, DOI 10.1016/S0968-0004(97)01156-0; Rader SD, 2002, RNA, V8, P1378, DOI 10.1017/s1355838202020010; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Suefuji Y, 2001, BRIT J CANCER, V84, P915, DOI 10.1054/bjoc.2000.1690; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vlasschaert C, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0511-1; Whitmill A, 2016, LIFE SCI, V149, P79, DOI 10.1016/j.lfs.2016.02.062; Yang D, 1999, CANCER RES, V59, P4056	42	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2016	291	33					17283	17292		10.1074/jbc.M116.740787	http://dx.doi.org/10.1074/jbc.M116.740787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV0XK	27255711	Green Published, hybrid			2022-12-26	WOS:000382643800029
J	Raychaudhuri, K; Chaudhary, N; Gurjar, M; D'Souza, R; Limzerwala, J; Maddika, S; Dalal, SN				Raychaudhuri, Kumarkrishna; Chaudhary, Neelam; Gurjar, Mansa; D'Souza, Roseline; Limzerwala, Jazeel; Maddika, Subbareddy; Dalal, Sorab N.			14-3-3 sigma Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; STRUCTURAL BASIS; NUCLEAR EXPORT; CANCER-CELLS; HUMAN CDC25C; SIGMA GENE; IN-VITRO; EXPRESSION; BINDING	Loss of 14-3-3 sigma has been observed in multiple tumor types; however, the mechanisms by which 14-3-3 sigma loss leads to tumor progression are not understood. The experiments in this report demonstrate that loss of 14-3-3 sigma leads to a decrease in the expression of epithelial markers and an increase in the expression of mesenchymal markers, which is indicative of an induction of the epithelial to mesenchymal transition (EMT). The EMTwas accompanied by an increase in migration and invasion in the 14-3-3 sigma(-/-) cells. 14-3-3 sigma(-/-) cells show increased stabilization of c-Jun, resulting in an increase in the expression of the EMT transcription factor slug. 14-3-3 sigma induces the ubiquitination and degradation of c-Jun in an FBW7-dependent manner. c-Jun ubiquitination is dependent on the presence of an intact nuclear export pathway as c-Jun is stabilized and localized to the nucleus in the presence of a nuclear export inhibitor. Furthermore, the absence of 14-3-3 sigma leads to the nuclear accumulation and stabilization of c-Jun, suggesting that 14-3-3 sigma regulates the subcellular localization of c-Jun. Our results have identified a novel mechanism by which 14-3-3 sigma maintains the epithelial phenotype by inhibiting EMT and suggest that this property of 14-3-3 sigma might contribute to its function as a tumor suppressor gene.	[Raychaudhuri, Kumarkrishna; Gurjar, Mansa; D'Souza, Roseline; Limzerwala, Jazeel; Dalal, Sorab N.] Tata Mem Hosp, ACTREC, KS215, Sect 22, Kharghar 410210, Navi Mumbai, India; [Chaudhary, Neelam; Maddika, Subbareddy] CDFD, Lab Cell Death & Cell Survival, Hyderabad 500001, Andhra Pradesh, India; [Chaudhary, Neelam] Manipal Univ, Grad Studies, Manipal 576104, Karnataka, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Dalal, SN (corresponding author), Tata Mem Hosp, ACTREC, KS215, Sect 22, Kharghar 410210, Navi Mumbai, India.	sdalal@actrec.gov.in	Raychaudhuri, Kumarkrishna/AAB-4589-2021	Raychaudhuri, Kumarkrishna/0000-0001-5198-8651; Limzerwala, Jazeel/0000-0002-4309-9173; Chaudhary, Neelam/0000-0002-0327-2824; Gurjar, Mansa/0000-0002-1613-5191	Advanced Center for Treatment, Research and Education in Cancer, Tata Memorial Centre	Advanced Center for Treatment, Research and Education in Cancer, Tata Memorial Centre	This work was supported in part by an intramural grant from the Advanced Center for Treatment, Research and Education in Cancer, Tata Memorial Centre (to S. N. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; Akahira J, 2004, CLIN CANCER RES, V10, P2687, DOI 10.1158/1078-0432.CCR-03-0510; Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Basu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123979; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Benzinger A, 2005, CELL RES, V15, P219, DOI 10.1038/sj.cr.7290290; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chandra S, 2013, J CELL SCI, V126, P3782, DOI 10.1242/jcs.124719; Chaudhary N, 2014, MOL CELL BIOL, V34, P3754, DOI 10.1128/MCB.00101-14; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Chen Y, 2013, BIOCHEM BIOPH RES CO, V435, P356, DOI 10.1016/j.bbrc.2013.04.086; Dalal SN, 2004, CELL CYCLE, V3, P672; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Ding XM, 2013, J BIOL CHEM, V288, P10241, DOI 10.1074/jbc.M112.443655; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Fan LC, 2015, ONCOGENE, V34, P5252, DOI 10.1038/onc.2014.445; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gosavi P, 2011, CELL MOL LIFE SCI, V68, P1439, DOI 10.1007/s00018-010-0531-3; Graves PR, 2001, ONCOGENE, V20, P1839, DOI 10.1038/sj.onc.1204259; Gui Ting, 2012, J Signal Transduct, V2012, P289243, DOI 10.1155/2012/289243; Hajra KM, 2002, CANCER RES, V62, P1613; He QT, 2013, BBA-GEN SUBJECTS, V1830, P5258, DOI 10.1016/j.bbagen.2013.07.028; Henriksson ML, 2002, EUR J BIOCHEM, V269, P4921, DOI 10.1046/j.1432-1033.2002.03191.x; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Herron BJ, 2005, NAT GENET, V37, P1210, DOI 10.1038/ng1652; Hosing A.S., 2009, THESIS; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Howe LR, 2003, CANCER RES, V63, P1906; Iwata N, 2000, ONCOGENE, V19, P5298, DOI 10.1038/sj.onc.1203898; Jiao XM, 2010, J BIOL CHEM, V285, P8218, DOI 10.1074/jbc.M110.100792; JONES DH, 1995, FEBS LETT, V368, P55, DOI 10.1016/0014-5793(95)00598-4; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Khapare N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038561; Kundu ST, 2008, INT J CANCER, V123, P2303, DOI 10.1002/ijc.23797; Kusewitt DF, 2009, J INVEST DERMATOL, V129, P491, DOI 10.1038/jid.2008.222; Laronga C, 2000, J BIOL CHEM, V275, P23106, DOI 10.1074/jbc.M905616199; Lee MY, 2012, AM J TRANSL RES, V4, P1; Phan L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8530; Ling C, 2010, GENE DEV, V24, P947, DOI 10.1101/gad.1896810; Liu TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057968; Lodygin D, 2004, ONCOGENE, V23, P9034, DOI 10.1038/sj.onc.1208004; Lodygin D, 2003, ONCOGENE, V22, P5519, DOI 10.1038/sj.onc.1206854; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Luanpitpong S, 2016, ONCOGENE, V35, P2824, DOI 10.1038/onc.2015.351; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Mei Y, 2008, NEUROSCIENCE, V151, P771, DOI 10.1016/j.neuroscience.2007.10.057; Migliorini D, 2011, J CLIN INVEST, V121, P1329, DOI 10.1172/JCI45784; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Nistico P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011908; Osada H, 2002, ONCOGENE, V21, P2418, DOI 10.1038/sj.onc.1205303; Pang MF, 2016, ONCOGENE, V35, P748, DOI 10.1038/onc.2015.133; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; PRASAD GL, 1992, CELL GROWTH DIFFER, V3, P507; Roberts BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077012; Sehgal L, 2014, J CELL SCI, V127, P2174, DOI 10.1242/jcs.125807; Spector D. L., 1998, CELLS LAB MANUAL, V2, P862; Steinacker P, 2005, MOL CELL BIOL, V25, P1339, DOI 10.1128/MCB.25.4.1339-1346.2005; Su CH, 2011, CANCER RES, V71, P884, DOI 10.1158/0008-5472.CAN-10-2518; Su CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-243; Suzuki H, 2000, CANCER RES, V60, P4353; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; Tanno B, 2010, J BIOL CHEM, V285, P29434, DOI 10.1074/jbc.M109.089045; Telles E, 2011, CELL CYCLE, V10, P776, DOI 10.4161/cc.10.5.14954; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Urano T, 2004, BIOCHEM BIOPH RES CO, V319, P795, DOI 10.1016/j.bbrc.2004.05.056; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; VANHEUSDEN GPH, 1995, EUR J BIOCHEM, V229, P45; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Wang L, 2015, J PATHOL, V237, P411, DOI 10.1002/path.4582; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wels C, 2011, J INVEST DERMATOL, V131, P1877, DOI 10.1038/jid.2011.142; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Wu YC, 2016, ONCOGENE, V35, P2123, DOI 10.1038/onc.2015.274; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang HL, 2006, MOL CANCER THER, V5, P253, DOI 10.1158/1535-7163.MCT-05-0395; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Yang HY, 2003, MOL CELL BIOL, V23, P7096, DOI 10.1128/MCB.23.20.7096-7107.2003; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu J, 2014, HEPATOB PANCREAT DIS, V13, P184, DOI 10.1016/S1499-3872(14)60029-1; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200; Zhang Y, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-145; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou BHP, 2005, CELL CYCLE, V4, P772, DOI 10.4161/cc.4.6.1744; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	101	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16068	16081		10.1074/jbc.M116.723767	http://dx.doi.org/10.1074/jbc.M116.723767			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27261462	Green Published, hybrid			2022-12-26	WOS:000380585400013
J	Xu, LH; Venkataramani, P; Ding, YC; Liu, Y; Deng, YY; Yong, GL; Xin, LY; Ye, RJ; Zhang, LH; Yang, L; Liang, ZX				Xu, Linghui; Venkataramani, Prabhadevi; Ding, Yichen; Liu, Yang; Deng, Yinyue; Yong, Grace Lisi; Xin, Lingyi; Ye, Ruijuan; Zhang, Lianhui; Yang, Liang; Liang, Zhao-Xun			A Cyclic di-GMP-binding Adaptor Protein Interacts with Histidine Kinase to Regulate Two-component Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PILZ DOMAIN PROTEINS; MEDIATED MULTISTEP PHOSPHORELAY; PSEUDOMONAS-AERUGINOSA; SWARMING MOTILITY; BIOFILM FORMATION; DIGUANYLATE CYCLASE; XANTHOMONAS-CAMPESTRIS; TWITCHING MOTILITY; GENE-EXPRESSION; HD-GYP	The bacterial messenger cyclic di-GMP (c-di-GMP) binds to a diverse range of effectors to exert its biological effect. Despite the fact that free-standing PilZ proteins are by far the most prevalent c-di-GMP effectors known to date, their physiological function and mechanism of action remain largely unknown. Here we report that the free-standing PilZ protein PA2799 from the opportunistic pathogen Pseudomonas aeruginosa interacts directly with the hybrid histidine kinase SagS. We show that PA2799 (named as HapZ: histidine kinase associated PilZ) binds directly to the phosphoreceiver (REC) domain of SagS, and that the SagS-HapZ interaction is further enhanced at elevated c-di-GMP concentration. We demonstrate that binding of HapZ to SagS inhibits the phosphotransfer between SagS and the downstream protein HptB in a c-di-GMP-dependent manner. In accordance with the role of SagS as a motile-sessile switch and biofilm growth factor, we show that HapZ impacts surface attachment and biofilm formation most likely by regulating the expression of a large number of genes. The observations suggest a previously unknown mechanism whereby c-di-GMP mediates two-component signaling through a PilZ adaptor protein.	[Xu, Linghui; Venkataramani, Prabhadevi; Ding, Yichen; Yong, Grace Lisi; Xin, Lingyi; Ye, Ruijuan; Yang, Liang; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore; [Ding, Yichen; Liu, Yang; Yang, Liang] Nanyang Technol Univ, SCELSE, 60 Nanyang Dr, Singapore 637551, Singapore; [Xu, Linghui; Deng, Yinyue] South China Agr Univ, Guangdong Innovat & Entrepreneurial Res Team Soci, Guangzhou 510642, Guangdong, Peoples R China; [Zhang, Lianhui] South China Agr Univ, Integrat Microbiol Res Ctr, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou 510642, Guangdong, Peoples R China	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; South China Agricultural University; South China Agricultural University	Yang, L; Liang, ZX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.; Yang, L (corresponding author), Nanyang Technol Univ, SCELSE, 60 Nanyang Dr, Singapore 637551, Singapore.	yangliang@ntu.edu.sg; zxliang@ntu.edu.sg	Yang, Liang/C-8487-2011; Yichen, Ding/R-5036-2019; Liang, Zhao-Xun/A-2191-2011; yang, liu/GVU-8760-2022; liu, yang/HHY-8583-2022	Yang, Liang/0000-0002-2362-0128; Venkataramani, Prabhadevi/0000-0001-9106-0102; Liang, Zhao-Xun/0000-0002-3128-1330	NIH [P30 DK089507]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Pseudomonas mutant strains were obtained from the mutant library supported by Grant NIH P30 DK089507.	Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; An SQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004429; Baraquet C, 2012, NUCLEIC ACIDS RES, V40, P7207, DOI 10.1093/nar/gks384; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Bhuwan M, 2012, J BIOL CHEM, V287, P1903, DOI 10.1074/jbc.M111.256586; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06; Chambers JR, 2014, MOL MICROBIOL, V92, P471, DOI 10.1111/mmi.12562; Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12; Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1; De N, 2009, J MOL BIOL, V393, P619, DOI 10.1016/j.jmb.2009.08.030; Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x; Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05; Gupta K, 2013, J BACTERIOL, V195, P4975, DOI 10.1128/JB.00732-13; Gupta R, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-30; Ha DG, 2011, J BACTERIOL, V193, P6770, DOI 10.1128/JB.05929-11; Habazettl J, 2011, J BIOL CHEM, V286, P14304, DOI 10.1074/jbc.M110.209007; Haussler S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000166; He M, 2014, INFECT IMMUN, V82, P445, DOI 10.1128/IAI.01238-13; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Ho CL, 2013, J AM CHEM SOC, V135, P566, DOI 10.1021/ja310497x; Hsu JL, 2008, J BIOL CHEM, V283, P9933, DOI 10.1074/jbc.M708836200; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Kong WN, 2013, MOL MICROBIOL, V88, P784, DOI 10.1111/mmi.12223; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Li Z, 2012, J BIOL CHEM, V287, P30191, DOI 10.1074/jbc.M112.378273; Liao JL, 2012, J BACTERIOL, V194, P4823, DOI 10.1128/JB.00765-12; Lin CT, 2006, RES MICROBIOL, V157, P169, DOI 10.1016/j.resmic.2005.06.012; Lori C, 2015, NATURE, V523, P236, DOI 10.1038/nature14473; Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Mikkelsen H, 2011, ENVIRON MICROBIOL, V13, P1666, DOI 10.1111/j.1462-2920.2011.02495.x; Morgan JLW, 2014, NAT STRUCT MOL BIOL, V21, P489, DOI 10.1038/nsmb.2803; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Pasunooti S, 2010, J MOL CATAL B-ENZYM, V67, P98, DOI 10.1016/j.molcatb.2010.07.012; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Petrova OE, 2011, J BACTERIOL, V193, P6614, DOI 10.1128/JB.00305-11; Petrova OE, 2010, J BACTERIOL, V192, P5275, DOI 10.1128/JB.00387-10; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; Petters T, 2012, MOL MICROBIOL, V84, P147, DOI 10.1111/j.1365-2958.2012.08015.x; Pitzer JE, 2011, INFECT IMMUN, V79, P1815, DOI 10.1128/IAI.00075-11; Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066; Qi YN, 2011, J BIOL CHEM, V286, P2910, DOI 10.1074/jbc.M110.196220; Rao F, 2009, ANAL BIOCHEM, V389, P138, DOI 10.1016/j.ab.2009.03.031; Rasmussen TB, 2005, J BACTERIOL, V187, P1799, DOI 10.1128/JB.187.5.1799-1814.2005; Russell MH, 2013, MBIO, V4, DOI 10.1128/mBio.00001-13; Ryan RP, 2012, MOL MICROBIOL, V86, P557, DOI 10.1111/mmi.12000; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; Tian ZX, 2009, MICROB PATHOGENESIS, V47, P237, DOI 10.1016/j.micpath.2009.08.003; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; Tolker-Nielsen T., 2011, CURR PROTOC MICROBIO, V21; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Whitney JC, 2015, J BIOL CHEM, V290, P12451, DOI 10.1074/jbc.M115.645051; Whitney JC, 2012, J BIOL CHEM, V287, P23582, DOI 10.1074/jbc.M112.375378; Wilksch JJ, 2011, PLOS PATHOG, V7, DOI [10.1371/journal.ppat.1002204, 10.1371/journal.ppat.1002179]; Yang FH, 2015, APPL ENVIRON MICROB, V81, P4358, DOI 10.1128/AEM.04044-14; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Yang L, 2009, ANTIMICROB AGENTS CH, V53, P2432, DOI 10.1128/AAC.01283-08	71	22	22	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 29	2016	291	31					16112	16123		10.1074/jbc.M116.730887	http://dx.doi.org/10.1074/jbc.M116.730887			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HF	27231351	Green Published, hybrid			2022-12-26	WOS:000380585400017
J	Gomaa, MR; Kandeil, A; Kayed, AS; Elabd, MA; Zaki, SA; Abu Zeid, D; El Rifay, AS; Mousa, AA; Farag, MM; McKenzie, PP; Webby, RJ; Ali, MA; Kayali, G				Gomaa, Mokhtar R.; Kandeil, Ahmed; Kayed, Ahmed S.; Elabd, Mona A.; Zaki, Shaimaa A.; Abu Zeid, Dina; El Rifay, Amira S.; Mousa, Adel A.; Farag, Mohamed M.; McKenzie, Pamela P.; Webby, Richard J.; Ali, Mohamed A.; Kayali, Ghazi			Serological Evidence of Human Infection with Avian Influenza A H7virus in Egyptian Poultry Growers	PLOS ONE			English	Article							RISK-FACTORS; HUMAN-BEINGS; VIRUS; H5N1; TRANSMISSION; PROTEINS; WORKERS; H7	Avian influenza viruses circulate widely in birds, with occasional human infections. Poultry-exposed individuals are considered to be at high risk of infection with avian influenza viruses due to frequent exposure to poultry. Some avian H7 viruses have occasionally been found to infect humans. Seroprevalence of neutralizing antibodies against influenza A/H7N7 virus among poultry-exposed and unexposed individuals in Egypt were assessed during a three-years prospective cohort study. The seroprevalence of antibodies ( titer, >= 80) among exposed individuals was 0%, 1.9%, and 2.1% annually while the seroprevalence among the control group remained 0% as measured by virus microneutralization assay. We then confirmed our results using western blot and immunofluorescence assays. Although human infection with H7 in Egypt has not been reported yet, our results suggested that Egyptian poultry growers are exposed to avian H7 viruses. These findings highlight the need for surveillance in the people exposed to poultry to monitor the risk of zoonotic transmission of avian influenza viruses.	[Gomaa, Mokhtar R.; Kandeil, Ahmed; Kayed, Ahmed S.; Elabd, Mona A.; Zaki, Shaimaa A.; Abu Zeid, Dina; El Rifay, Amira S.; Ali, Mohamed A.] Natl Res Ctr, Ctr Sci Excellence Influenza Viruses, Giza, Egypt; [Mousa, Adel A.; Farag, Mohamed M.] Al Azhar Univ, Fac Sci, Dept Bot & Microbiol, Cairo, Egypt; [McKenzie, Pamela P.; Webby, Richard J.; Kayali, Ghazi] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kayali, Ghazi] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Kayali, Ghazi] Human Link, Hazmieh, Lebanon	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Al Azhar University; St Jude Children's Research Hospital; University of Texas System; University of Texas Health Science Center Houston	Ali, MA (corresponding author), Natl Res Ctr, Ctr Sci Excellence Influenza Viruses, Giza, Egypt.; Kayali, G (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.; Kayali, G (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.; Kayali, G (corresponding author), Human Link, Hazmieh, Lebanon.	mohamedahmedali2004@yahoo.com; ghazi@human-link.org	Kandeil, Ahmed Mohamed/B-3345-2016; Ali, Mohamed A/N-8768-2017; Webby, Richard J/N-5657-2018; Kandeil, Ahmed/N-5473-2019; Gomaa, Mokhtar Rizk/N-9125-2018; Refay, Amira El/I-6183-2019	Kandeil, Ahmed Mohamed/0000-0003-3253-6961; Ali, Mohamed A/0000-0002-5615-3212; Kandeil, Ahmed/0000-0003-3253-6961; sayed, amira/0000-0002-6181-1072; Gomaa, Mokhtar/0000-0001-7947-3609; Kayed, Ahmed/0000-0002-0439-3476; Abu Zeid, Dina/0000-0002-3671-3067; Elabd, Mona/0000-0002-1417-8307; Zaki, Shaimaa/0000-0002-3761-5581	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201400006C]; Egyptian Science and Technology Development Fund [5175]; American Lebanese Syrian Associated Charities (ALSAC)	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Egyptian Science and Technology Development Fund(Science and Technology Development Fund (STDF)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract number HHSN272201400006C, the Egyptian Science and Technology Development Fund, under contract number 5175, and supported by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract number HHSN272201400006C, the Egyptian Science and Technology Development Fund, under contract number 5175, and supported by the American Lebanese Syrian Associated Charities (ALSAC).	Afifi MAA, 2013, TROP ANIM HEALTH PRO, V45, P687, DOI 10.1007/s11250-012-0243-9; Ahad A, 2014, PREV VET MED, V117, P610, DOI 10.1016/j.prevetmed.2014.10.007; Di Trani L, 2012, AVIAN DIS, V56, P1068, DOI 10.1637/10184-041012-ResNote.1; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gerloff NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068522; Gomaa MR, 2015, J INFECT DIS, V211, P1399, DOI 10.1093/infdis/jiu529; Kandeil A, 2013, ARCH VIROL, V158, P619, DOI 10.1007/s00705-012-1529-y; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Kayali G, 2014, EMERG INFECT DIS, V20, P542, DOI 10.3201/eid2004.131295; Kayali G, 2011, EMERG INFECT DIS, V17, P2306, DOI 10.3201/eid1712.110683; Kayali G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-685; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Meleigy M, 2007, LANCET, V370, P553, DOI 10.1016/S0140-6736(07)61274-4; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Puzelli S, 2014, EMERG INFECT DIS, V20, P1745, DOI 10.3201/eid2010.140512; Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222; Toner ES, 2013, CLIN INFECT DIS, V56, P1206, DOI 10.1093/cid/cit047; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; WEBSTER RG, 1981, NEW ENGL J MED, V304, P911; WHO/GIP, 2003, CUM NUMB CONF HUM CA; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2015, AV INFL A H5N1 EG; Zhang T, 2014, EMERG INFECT DIS, V20, P2076, DOI 10.3201/eid2012.140911	26	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155294	10.1371/journal.pone.0155294	http://dx.doi.org/10.1371/journal.pone.0155294			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258357	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700013
J	Ip, P; Ho, FKW; So, HK; Chan, DFY; Ho, M; Tso, W; Nelson, EAS				Ip, Patrick; Ho, Frederick Ka Wing; So, Hung-Kwan; Chan, Dorothy Fung-ying; Ho, Matthew; Tso, Winnie; Nelson, E. Anthony S.			Socioeconomic Gradient in Childhood Obesity and Hypertension: A Multilevel Population-Based Study in a Chinese Community	PLOS ONE			English	Article							BODY-MASS INDEX; RISK-FACTORS; BLOOD-PRESSURE; ADOLESCENTS; OVERWEIGHT; CHILDREN; ASSOCIATIONS; PREVALENCE; EPIDEMIC; WEIGHT	Background This study aims to assess evidence for any socioeconomic gradients in childhood obesity and hypertension in a population-representative sample in Hong Kong, China. Methods The data of a stratified random sampled growth survey collected in 2005-2006 was matched with a population by-census. Obesity was defined using the International Obesity Task Force standard and hypertension was defined using the Hong Kong norm table. Family socioeconomic status (SES) was measured by maternal education level. Neighbourhood SES was measured by median household income of the neighbourhood. Multilevel Poisson regression models with robust standard error were used to test the association. Body mass indices of children's parents were included as potential confounders. Intra-school/neighbourhood correlations were adjusted using random factors. Results Totally 14842 children (age 6-19 years) included in the analysis, in which 16.6% of them were overweight or obese. Children whose mother only completed secondary school or below had higher risk of childhood obesity (RR 1.41, 95% CI 1.13-1.76, p = 0.003) and hypertension (RR 1.18, 95% CI 1.01-1.36, p = 0.03). Meanwhile, children in the lowest neighbourhood SES group had higher risk of childhood underweight (RR 1.61, 95% CI 1.04-2.49, p = 0.03), overweight (RR 1.35, 95% CI 1.05-1.72, p = 0.02), and obesity (RR 2.07, 95% CI 1.11-3.88, p = 0.02). Conclusions Socioeconomic gradient in childhood obesity and hypertension existed in Hong Kong, one of the most developed cities in China. These results have implications for policymakers and public health experts and highlight the need to monitor trends in other parts of China.	[Ip, Patrick; Ho, Frederick Ka Wing; Ho, Matthew; Tso, Winnie] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [So, Hung-Kwan; Chan, Dorothy Fung-ying; Nelson, E. Anthony S.] Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong	Chan, DFY (corresponding author), Chinese Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China.	dorothychan@cuhk.edu.hk	Ho, Matthew/ACZ-8423-2022; Ho, Frederick/M-6407-2017; Ho, Frederick/AAS-2647-2021; Nelson, E Anthony S/ABF-4238-2020; Tso, Wan Yee Winnie/C-4751-2009	Ho, Frederick/0000-0001-7190-9025; Ho, Frederick/0000-0001-7190-9025; Nelson, E Anthony S/0000-0002-2521-3403; Tso, Wan Yee Winnie/0000-0002-5859-015X; So, Hung-kwan/0000-0002-6188-7587	Hong Kong Paediatric Society	Hong Kong Paediatric Society	This original growth survey was supported by Department funds and the Hong Kong Paediatric Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Arnett DK, 2001, AM J HYPERTENS, V14, P200, DOI 10.1016/S0895-7061(00)01262-0; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boles M, 2004, J OCCUP ENVIRON MED, V46, P737, DOI 10.1097/01.jom.0000131830.45744.97; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Census and Statistics Department of Hong Kong SAR Government, 2007, BAS TABL TERT PLANN; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Davison K K, 2001, Obes Rev, V2, P159, DOI 10.1046/j.1467-789x.2001.00036.x; Drewnowski A, 2005, AM J CLIN NUTR, V82, p265S, DOI 10.1093/ajcn/82.1.265S; Due P, 2009, INT J OBESITY, V33, P1084, DOI 10.1038/ijo.2009.128; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Guldan GS, 2014, HONG KONG MED J, V20, P30; Hui LL, 2003, INT J OBESITY, V27, P1411, DOI 10.1038/sj.ijo.0802423; Hui S., 2001, HLTH PHYS ACTIVITY H; Imai K, 2011, AM POLIT SCI REV, V105, P765, DOI 10.1017/S0003055411000414; Ip P, J PEDIAT IN PRESS; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; LAUER RM, 1989, PEDIATRICS, V84, P633; Leung LCK, 2011, ARCH DIS CHILD, V96, P804, DOI 10.1136/adc.2010.202770; MacKinnon DP, 2008, ENCY CLIN PSYCHOL; Moreno LA, 2007, CURR OPIN CLIN NUTR, V10, P336, DOI 10.1097/MCO.0b013e3280a94f59; National High Blood Pressure Education Program, 1996, PEDIATRICS, V98, P649, DOI DOI 10.1542/PEDS.98.4.649; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; SALLIS JF, 1994, PEDIATR EXERC SCI, V6, P302; Sanders Lee M, 2009, Pediatrics, V124 Suppl 3, pS306, DOI 10.1542/peds.2009-1162G; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; So HK, 2011, BRIT J NUTR, V106, P742, DOI 10.1017/S0007114511000754; So HK, 2010, J HUM HYPERTENS, V24, P646, DOI 10.1038/jhh.2009.117; So HK, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-320; Stamatakis E, 2010, INT J OBESITY, V34, P41, DOI 10.1038/ijo.2009.217; Sung RYT, 2008, J HYPERTENS, V26, P678, DOI 10.1097/HJH.0b013e3282f42270; The HKSAR Government, 2013, HALF YEARL EC REP 20; Tingley D, 2014, J STAT SOFTW, V59; Wang YF, 2001, INT J EPIDEMIOL, V30, P1129, DOI 10.1093/ije/30.5.1129; Yin H Shonna, 2009, Pediatrics, V124 Suppl 3, pS289, DOI 10.1542/peds.2009-1162E; Yu ZJ, 2000, B WORLD HEALTH ORGAN, V78, P1296; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	41	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156945	10.1371/journal.pone.0156945	http://dx.doi.org/10.1371/journal.pone.0156945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27258094	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000377369700162
J	Saksens, NTM; Lechanteur, YTE; Verbakel, SK; Groenewoud, JMM; Daha, MR; Schick, T; Fauser, S; Boon, CJF; Hoyng, CB; den Hollander, AI				Saksens, Nicole T. M.; Lechanteur, Yara T. E.; Verbakel, Sanne K.; Groenewoud, Joannes M. M.; Daha, Mohamed R.; Schick, Tina; Fauser, Sascha; Boon, Camiel J. F.; Hoyng, Carel B.; den Hollander, Anneke I.			Analysis of Risk Alleles and Complement Activation Levels in Familial and Non-Familial Age-Related Macular Degeneration	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; CHOROIDAL NEOVASCULARIZATION; COMPONENT 3; FACTOR-B; GENE; ASSOCIATION; VARIANT; CFH; METAANALYSIS; AGGREGATION	Aims Age-related macular degeneration (AMD) is a multifactorial disease, in which complement-mediated inflammation plays a pivotal role. A positive family history is an important risk factor for developing AMD. Certain lifestyle factors are shown to be significantly associated with AMD in non-familial cases, but not in familial cases. This study aimed to investigate whether the contribution of common genetic variants and complement activation levels differs between familial and sporadic cases with AMD. Methods and Results 1216 AMD patients (281 familial and 935 sporadic) and 1043 controls (143 unaffected members with a family history of AMD and 900 unrelated controls without a family history of AMD) were included in this study. Ophthalmic examinations were performed, and lifestyle and family history were documented with a questionnaire. Nine single nucleotide polymorphisms (SNPs) known to be associated with AMD were genotyped, and serum concentrations of complement components C3 and C3d were measured. Associations were assessed in familial and sporadic individuals. The association with risk alleles of the age-related maculopathy susceptibility 2 (ARMS2) gene was significantly stronger in sporadic AMD patients compared to familial cases (p = 0.017 for all AMD stages and p = 0.003 for advanced AMD, respectively). ARMS2 risk alleles had the largest effect in sporadic cases but were not significantly associated with AMD in densely affected families. The C3d/C3 ratio was a significant risk factor for AMD in sporadic cases and may also be associated with familial cases. In patients with a densely affected family this effect was particularly strong with ORs of 5.37 and 4.99 for all AMD and advanced AMD respectively. Conclusion This study suggests that in familial AMD patients, the common genetic risk variant in ARMS2 is less important compared to sporadic AMD. In contrast, factors leading to increased complement activation appear to play a larger role in patients with a positive family history compared to sporadic patients. A better understanding of the different contributions of risk factors in familial compared to non-familial AMD will aid the development of reliable prediction models for AMD, and may provide individuals with more accurate information regarding their individual risk for AMD. This information is especially important for individuals who have a positive family history for AMD.	[Saksens, Nicole T. M.; Lechanteur, Yara T. E.; Verbakel, Sanne K.; Boon, Camiel J. F.; Hoyng, Carel B.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Groenewoud, Joannes M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Daha, Mohamed R.] Leiden Univ, Nijmegen Med Ctr, Dept Nephrol, Leiden, Netherlands; [Schick, Tina; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Boon, Camiel J. F.] Leiden Univ, Med Ctr, Dept Ophthalmol, Albinusdreef 2, Leiden, Netherlands; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC; University of Cologne; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands.; den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	Anneke.denHollander@radboudumc.nl	Lehtimäki, Terho/AAD-1094-2022; Hollander, Anneke den/N-4911-2014; Lechanteur, Yara/ABB-6875-2020; Verbakel, Sanne K/P-8160-2015; Groenewoud, Hans JMM/R-3588-2017; Boon, CJF/P-7534-2014	Lehtimäki, Terho/0000-0002-2555-4427; Lechanteur, Yara/0000-0003-0951-4625; Verbakel, Sanne K/0000-0002-0187-379X; Groenewoud, Hans JMM/0000-0002-4974-150X; Boon, CJF/0000-0002-6737-7932	Foundation Fighting Blindness USA [C-GE-0811-0548-RAD04]; Salentein fellowship part of the 'Diana-Hermes foundation'; MD Fonds; Nederlandse Oogonderzoek Stichting; Oogfonds; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Nederlands Oogheelkundig Onderzoek; Gelderse Blindenstichting	Foundation Fighting Blindness USA; Salentein fellowship part of the 'Diana-Hermes foundation'; MD Fonds; Nederlandse Oogonderzoek Stichting; Oogfonds; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid; Stichting Nederlands Oogheelkundig Onderzoek; Gelderse Blindenstichting	This work was supported by: Foundation Fighting Blindness USA (grant C-GE-0811-0548-RAD04; received by Anneke den Hollander); Salentein fellowship part of the 'Diana-Hermes foundation' (received by Carel Hoyng); Anneke den Hollander and Carel Hoyng received: MD Fonds, Nederlandse Oogonderzoek Stichting, Oogfonds, Algemene Nederlandse Vereniging ter Voorkoming van Blindheid, Stichting Nederlands Oogheelkundig Onderzoek, and Gelderse Blindenstichting. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar L, 2014, GENET MED, V16, P231, DOI 10.1038/gim.2013.115; Boon CJE, 2008, AM J HUM GENET, V82, P516, DOI 10.1016/j.ajhg.2007.11.007; Chakravarthy U, 2013, OPHTHALMOLOGY, V120, P342, DOI 10.1016/j.ophtha.2012.08.004; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Duvvari MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094165; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Howard KP, 2014, INVEST OPHTH VIS SCI, V55, P2592, DOI 10.1167/iovs.13-13763; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein B E, 2001, Ophthalmic Epidemiol, V8, P251, DOI 10.1076/opep.8.4.251.1612; KLEIN ML, 1994, ARCH OPHTHALMOL-CHIC, V112, P932, DOI 10.1001/archopht.1994.01090190080025; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; MEYERS SM, 1995, AM J OPHTHALMOL, V120, P757, DOI 10.1016/S0002-9394(14)72729-1; Mokwa NF, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/385915; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Park KH, 2009, INVEST OPHTH VIS SCI, V50, P3386, DOI 10.1167/iovs.08-3231; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Ristau T, 2014, INVEST OPHTH VIS SCI, V55, P210, DOI 10.1167/iovs.13-13248; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Saksens NTM, 2014, INVEST OPHTH VIS SCI, V55, P7085, DOI 10.1167/iovs.14-14659; Saksens NTM, 2014, PROG RETIN EYE RES, V39, P23, DOI 10.1016/j.preteyeres.2013.11.001; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Shahid H, 2012, BRIT J OPHTHALMOL, V96, P427, DOI 10.1136/bjophthalmol-2011-300193; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Sobrin L, 2010, EUR J HUM GENET, V18, P496, DOI 10.1038/ejhg.2009.185; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Thakkinstian A, 2011, AM J EPIDEMIOL, V173, P1365, DOI 10.1093/aje/kwr025; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; van de Ven JPH, 2012, ARCH OPHTHALMOL-CHIC, V130, P1038, DOI 10.1001/archophthalmol.2012.265; van de Ven JPH, 2012, MOL VIS, V18, P2271; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yu Y, 2014, HUM MOL GEN IN PRESS; Zipfel PF, 2010, ADV EXP MED BIOL, V703, P9, DOI 10.1007/978-1-4419-5635-4_2	45	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0144367	10.1371/journal.pone.0144367	http://dx.doi.org/10.1371/journal.pone.0144367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258093	Green Published, gold, Green Submitted			2022-12-26	WOS:000377369700001
J	Singh, J; Mukhopadhyay, CS; Kaur, S; Malhotra, P; Sethi, RS; Choudhary, RK				Singh, Jasdeep; Mukhopadhyay, C. S.; Kaur, Simarjeet; Malhotra, Puneet; Sethi, R. S.; Choudhary, R. K.			Identification of the MicroRNA Repertoire in TLR-Ligand Challenged Bubaline PBMCs as a Model of Bacterial and Viral Infection	PLOS ONE			English	Article							MACROPHAGE RESPONSE; IMMUNE-RESPONSES; EXPRESSION; BOVINE; MODULATE; INNATE; RECOGNITION; CYTOKINES; PATHWAY; CELLS	In the present study, we used high-throughput sequencing, miRNA-seq, to discover and explore the expression profiles of known and novel miRNAs in TLR ligand-stimulated vis-a-vis non-stimulated (i.e. Control) peripheral blood mononuclear cells (PBMCs) isolated from blood of healthy Murrah buffaloes. Six small RNA (sRNA) libraries were multiplexed in Ion Torrent PI chip and sequenced on Ion Proton System. The reads obtained were aligned to the Bos taurus genome (UMD3.1 assembly), which is phylogenetically closest species to buffalo (Bubalus bubalis). A total of 160 bovine miRNAs were biocomputationally identified in buffalo PBMCs and 130 putatively novel miRNAs (not enlisted in the bovine mirBase) were identified. All of these 290 miRNAs identified across the six treatment and control samples represent the repertoire of novel miRNAs for the buffalo species. The expression profiles of these miRNAs across the samples have been represented by sample dendrogram and heatmap plots. The uniquely expressed miRNAs in each treatment and control groups were identified. A few miRNAs were expressed at very high levels while the majority of them were moderately expressed. The miRNAs bta-miR-103 and -191 were found to be highly abundant and expressed in all the samples. Other abundantly expressed miRNAs include bta-miR-19b, -29b, -15a, -19a, -30d, -30b-5p and members of let family (let 7a-5p, let 7g & let 7f) in LPS and CpG treated PBMCS and bta-miR-191, -103 & -19b in Poly I:C stimulated PBMCs. Only one novel miRNA (bta-miR-11039) out of 130 identified putatively novel miRNAs, was expressed in all the six samples and differentially expressed (> 2-fold) miRNAs were identified. Six of the differentially expressed miRNAs across the groups (bta-miR-421, bta-let-7i, bta-miR-138, bta-miR-21-5p, bta-miR-222 and bta-miR-27b) were subsequently confirmed by TaqMan quantitative reverse transcription polymerase chain reaction (qRTPCR). Furthermore, the target genes of differentially expressed miRNAs were enriched for the roles in innate immunity and TLR signaling pathways. This maiden study on profiling and cataloguing of bubaline miRNAs expressed in TLR-ligand stimulated PBMCs will provide an important reference point for future studies on regulatory roles of miRNAs in immune system of buffaloes.	[Singh, Jasdeep; Mukhopadhyay, C. S.; Sethi, R. S.; Choudhary, R. K.] Guru Angad Dev Vet & Anim Sci Univ, Post Grad Inst Vet Educ & Res, Sch Anim Biotechnol, Ludhiana, Punjab, India; [Kaur, Simarjeet; Malhotra, Puneet] Guru Angad Dev Vet & Anim Sci Univ, Dept Anim Genet & Breeding, Ludhiana, Punjab, India; [Sethi, R. S.] Univ Saskatchewan, Western Coll Vet Med, Dept Biomed Sci, Saskatoon, SK S7N 0W0, Canada	Guru Angad Dev Veterinary & Animal Sciences University (GADVASU); Guru Angad Dev Veterinary & Animal Sciences University (GADVASU); University of Saskatchewan	Mukhopadhyay, CS (corresponding author), Guru Angad Dev Vet & Anim Sci Univ, Post Grad Inst Vet Educ & Res, Sch Anim Biotechnol, Ludhiana, Punjab, India.	csmbioinfo@gmail.com	SETHI, RS/ABC-5353-2020; Mukhopadhyay, Chandra Sekhar/A-1182-2017; Choudhary, Ratan/AEU-0526-2022; Choudhary, Ratan K./AAE-6117-2022	SETHI, RS/0000-0003-0416-8946; Mukhopadhyay, Chandra Sekhar/0000-0002-4545-4204; Choudhary, Ratan K./0000-0001-5601-7635; Singh, Jasdeep/0000-0002-6479-4482	Science and Engineering Research Board, Department of Science and Technology, Ministry of Science of Technology, Government of India [SERC-LS-293-2011, SR/FT/LS-22/2011]	Science and Engineering Research Board, Department of Science and Technology, Ministry of Science of Technology, Government of India	The work has been funded by Science and Engineering Research Board, Department of Science and Technology, Ministry of Science of Technology, Government of India (SERC-LS-293-2011, File Number SR/FT/LS-22/2011 serb.gov.in/pdfs/.../SERBYS-Life-Sciences-List-of-Projects-2012-13.pdf).	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Bae IS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122554; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Buchanan R, 2012, VET IMMUNOL IMMUNOP, V145, P453, DOI 10.1016/j.vetimm.2012.01.001; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Furuse Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106434; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hsieh CH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-69; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jin WW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-181; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lawless N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057543; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Liang GX, 2015, MOL IMMUNOL, V66, P57, DOI 10.1016/j.molimm.2014.10.014; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Mahdipour M, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0075-8; Mena A, 2003, OLIGONUCLEOTIDES, V13, P245, DOI 10.1089/154545703322460621; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Moles R, 2015, VIRUSES-BASEL, V7, P4047, DOI 10.3390/v7072805; Mutwiri G, 2003, VET IMMUNOL IMMUNOP, V91, P89, DOI 10.1016/S0165-2427(02)00246-5; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Qi JN, 2012, FEBS LETT, V586, P1201, DOI 10.1016/j.febslet.2012.03.011; Rau CS, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-014-0106-y; Satoh M, 2012, IMMUNOBIOLOGY, V217, P533, DOI 10.1016/j.imbio.2011.08.005; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Singh J, 2015, INT J ADV RES, V3, P929; Singh Y, 2013, J BIOL CHEM, V288, P5056, DOI 10.1074/jbc.C112.439778; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Sun MJ, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1110-x; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Vegh P, 2015, TUBERCULOSIS, V95, P60, DOI 10.1016/j.tube.2014.10.011; Vegh P, 2013, VET IMMUNOL IMMUNOP, V155, P238, DOI 10.1016/j.vetimm.2013.08.004; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	46	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156598	10.1371/journal.pone.0156598	http://dx.doi.org/10.1371/journal.pone.0156598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257788	Green Submitted, gold, Green Published			2022-12-26	WOS:000377369700085
J	Castell-Miller, CV; Gutierrez-Gonzalez, JJ; Tu, ZJ; Bushley, KE; Hainaut, M; Henrissat, B; Samac, DA				Castell-Miller, Claudia V.; Gutierrez-Gonzalez, Juan J.; Tu, Zheng Jin; Bushley, Kathryn E.; Hainaut, Matthieu; Henrissat, Bernard; Samac, Deborah A.			Genome Assembly of the Fungus Cochliobolus miyabeanus, and Transcriptome Analysis during Early Stages of Infection on American Wildrice (Zizania palustris L.)	PLOS ONE			English	Article							POLYKETIDE VIRULENCE FACTOR; FUNCTIONAL-ANALYSIS; BROWN SPOT; HC-TOXIN; CYTOCHROME-P450 MONOOXYGENASE; MOLECULAR CHARACTERIZATION; MULTIDRUG-RESISTANCE; ASPERGILLUS-NIDULANS; CLADOSPORIUM-FULVUM; CERATO-PLATANIN	The fungus Cochliobolus miyabeanus causes severe leaf spot disease on rice (Oryza sativa) and two North American specialty crops, American wildrice (Zizania palustris) and switchgrass (Panicum virgatum). Despite the importance of C. miyabeanus as a disease-causing agent in wildrice, little is known about either the mechanisms of pathogenicity or host defense responses. To start bridging these gaps, the genome of C. miyabeanus strain TG12bL2 was shotgun sequenced using Illumina technology. The genome assembly consists of 31.79 Mbp in 2,378 scaffolds with an N-50 = 74,921. It contains 11,000 predicted genes of which 94.5% were annotated. Approximately 10% of total gene number is expected to be secreted. The C. miyabeanus genome is rich in carbohydrate active enzymes, and harbors 187 small secreted peptides (SSPs) and some fungal effector homologs. Detoxification systems were represented by a variety of enzymes that could offer protection against plant defense compounds. The non-ribosomal peptide synthetases and polyketide synthases (PKS) present were common to other Cochliobolus species. Additionally, the fungal transcriptome was analyzed at 48 hours after inoculation in planta. A total of 10,674 genes were found to be expressed, some of which are known to be involved in pathogenicity or response to host defenses including hydrophobins, cutinase, cell wall degrading enzymes, enzymes related to reactive oxygen species scavenging, PKS, detoxification systems, SSPs, and a known fungal effector. This work will facilitate future research on C. miyabeanus pathogen-associated molecular patterns and effectors, and in the identification of their corresponding wildrice defense mechanisms.	[Castell-Miller, Claudia V.; Samac, Deborah A.] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA; [Gutierrez-Gonzalez, Juan J.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Gutierrez-Gonzalez, Juan J.; Samac, Deborah A.] USDA ARS Plant Sci Res Unit, St Paul, MN USA; [Tu, Zheng Jin] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Bushley, Kathryn E.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Hainaut, Matthieu; Henrissat, Bernard] Aix Marseille Univ, CNRS UMR 7257, Marseille, France; [Hainaut, Matthieu; Henrissat, Bernard] AFMB, USC 1408, INRA, Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Castell-Miller, CV (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN USA.	caste007@umn.edu	Gutierrez-Gonzalez, Juan J/B-1387-2018; Samac, Deborah/ABC-8744-2021; Henrissat, Bernard/J-2475-2012; Bushley, Kathryn E/AAX-6372-2021	Gutierrez-Gonzalez, Juan J/0000-0002-6795-6192; Samac, Deborah/0000-0002-1847-0508; Henrissat, Bernard/0000-0002-3434-8588; 	United States Department of Agriculture-Agricultural Research Service (ARS-USDA); Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; ARS [ARS-0424185] Funding Source: Federal RePORTER	United States Department of Agriculture-Agricultural Research Service (ARS-USDA); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding was provided by United States Department of Agriculture-Agricultural Research Service (ARS-USDA).r We would like to thank Bruce Elckloff from the Mayo Clinic, Rochester, MN for sequencing the C. miyabeanus isolate, and Dr. B. Gillian Turgeon and Bradford Condon for NRPS sequence data from the C. miyabeanus WK-1C and C. heterostrophus C4 and C5 strains, and other ascomycetes used in the analyses, and to Dr. B. Gillian Turgeon and the U.S. Department of Energy Joint Genome Institute (http://genome.jgi.doe.gov) for sharing the C. miyabeanus WK-1C DNA sequences and proteins. The genome and transcriptome of C. miyabeanus work were sequenced and annotated by the U.S. Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.	Ahn JH, 2001, BIOSCI BIOTECH BIOCH, V65, P1406, DOI 10.1271/bbb.65.1406; Ahn JH, 1998, MOL GEN GENET, V260, P462, DOI 10.1007/s004380050917; Ahn JH, 1997, MOL PLANT MICROBE IN, V10, P207, DOI 10.1094/MPMI.1997.10.2.207; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alarco AM, 1997, J BIOL CHEM, V272, P19304, DOI 10.1074/jbc.272.31.19304; ApelBirkhold PC, 1996, APPL ENVIRON MICROB, V62, P4129, DOI 10.1128/AEM.62.11.4129-4135.1996; Arenas YC, 2010, PHYSIOL MOL PLANT P, V74, P376, DOI 10.1016/j.pmpp.2010.06.003; Au TK, 2000, LIFE SCI, V67, P733, DOI 10.1016/S0024-3205(00)00668-8; Baccelli I., 2005, FRONT PLANT SCI, V5, P1; Baidyaroy D, 2001, PLANT CELL, V13, P1609, DOI 10.1105/tpc.13.7.1609; Baker SE, 2006, MOL PLANT MICROBE IN, V19, P139, DOI 10.1094/MPMI-19-0139; Bayry J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002700; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhadauria V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-327; BISSINGER PH, 1994, J BIOL CHEM, V269, P4180; Boddi S, 2004, FEMS MICROBIOL LETT, V233, P341, DOI [10.1016/j.femsle.2004.03.001, 10.1111/j.1574-6968.2004.tb09501.x]; Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Burton RA, 2009, MOL PLANT, V2, P873, DOI 10.1093/mp/ssp063; Bushley KE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-26; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castell-Miller CV, 2012, PLANT PATHOL, V61, P903, DOI 10.1111/j.1365-3059.2011.02581.x; Cheng YQ, 2000, J BIOL CHEM, V275, P4906, DOI 10.1074/jbc.275.7.4906; Cheng YQ, 1999, MICROBIOL-UK, V145, P3539, DOI 10.1099/00221287-145-12-3539; Condon BJ, 2012, PLOS GENET, V9, P1; Condon BJ, 2013, GENOMICS PLANT ASS F, P41; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; DATNOFF LE, 1991, PLANT DIS, V75, P729, DOI 10.1094/PD-75-0729; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Jonge R, 2009, TRENDS MICROBIOL, V17, P151, DOI 10.1016/j.tim.2009.01.002; de Waard MA, 2006, PEST MANAG SCI, V62, P195, DOI 10.1002/ps.1150; Degani O., 2014, Advances in Bioscience and Biotechnology, V5, P340, DOI 10.4236/abb.2014.54042; Del Sorbo G, 2000, FUNGAL GENET BIOL, V30, P1, DOI 10.1006/fgbi.2000.1206; Farr D. F., 1989, Fungi on plants and plant products in the United States.; Ferrer-Sevillano F, 2007, EUKARYOT CELL, V6, P514, DOI 10.1128/EC.00226-06; FUKUSHIMA Y, 1993, BIOORG MED CHEM LETT, V3, P1219, DOI 10.1016/S0960-894X(00)80319-4; Ganem S, 2004, EUKARYOT CELL, V3, P1653, DOI 10.1128/EC.3.6.1653-1663.2004; Gutierrez-Gonzalez JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-471; Hartl L, 2012, APPL MICROBIOL BIOT, V93, P533, DOI 10.1007/s00253-011-3723-3; JOHNSON DR, 1992, PLANT DIS, V76, P1193, DOI 10.1094/PD-76-1193; Jorgensen TR, 2007, MICROBIOL-SGM, V153, P1963, DOI 10.1099/mic.0.2006/005090-0; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kim JY, 2014, PROTEOMICS, V14, P2307, DOI 10.1002/pmic.201400066; Kim KH, 2007, MOL PLANT PATHOL, V8, P23, DOI 10.1111/j.1364-3703.2006.00366.x; Kleemann Jochen, 2012, PLoS Pathog, V8, pe1002643, DOI 10.1371/journal.ppat.1002643; Klutts JS, 2006, FEMS YEAST RES, V6, P499, DOI 10.1111/j.1567-1364.2006.00054.x; KOHLS CL, 1987, PLANT DIS, V71, P419, DOI 10.1094/PD-71-0419; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Krupinsky J, 2004, CAN J PLANT PATHOL, V26, P371; Kubicek CP, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P396; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Lauge R, 1997, MOL PLANT MICROBE IN, V10, P725, DOI 10.1094/MPMI.1997.10.6.725; Leandro MJ, 2006, BIOCHEM J, V395, P543, DOI 10.1042/BJ20051465; Lee BN, 2005, EUKARYOT CELL, V4, P545, DOI 10.1128/EC.4.3.545-555.2005; Lev S, 2005, EUKARYOT CELL, V4, P443, DOI 10.1128/EC.4.2.443-454.2005; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Llorente B, 2000, FEBS LETT, V475, P237, DOI 10.1016/S0014-5793(00)01698-7; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lorang J, 2012, SCIENCE, V338, P659, DOI 10.1126/science.1226743; Lowe RGT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002515; Lu SW, 2003, P NATL ACAD SCI USA, V100, P5980, DOI 10.1073/pnas.0931375100; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; Mingot JM, 1999, J BIOL CHEM, V274, P14545, DOI 10.1074/jbc.274.21.14545; Moffatt AM, 1998, THESIS; Moktali V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-525; Moriwaki A, 2007, MICROBIOL RES, V162, P108, DOI 10.1016/j.micres.2006.01.014; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Motteram J, 2009, MOL PLANT MICROBE IN, V22, P790, DOI 10.1094/MPMI-22-7-0790; Murphy JM, 1996, MOL PLANT MICROBE IN, V9, P290, DOI 10.1094/MPMI-9-0290; Nyvall RF, 1999, PLANT DIS, V83, P936, DOI 10.1094/PDIS.1999.83.10.936; Oelke E.A., 2007, SAGA GRAIN TRIBUTE M; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Oide S, 2007, EUKARYOT CELL, V6, P1339, DOI 10.1128/EC.00111-07; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; Ou SH, 1985, RICE DIS; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pazzagli L, 2014, PLANT SCI, V228, P79, DOI 10.1016/j.plantsci.2014.02.009; Podobnik B, 2008, J MED CHEM, V51, P3480, DOI 10.1021/jm800030e; Porter R, 2010, VARIETY TRIAL RESULT; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; REIMMANN C, 1994, GENE, V146, P221, DOI 10.1016/0378-1119(94)90296-8; Rose MS, 2002, MOL PLANT MICROBE IN, V15, P883, DOI 10.1094/MPMI.2002.15.9.883; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Scott-Craig JS, 1998, APPL ENVIRON MICROB, V64, P1497; SCOTTCRAIG JS, 1990, PLANT CELL, V2, P1191, DOI 10.1105/tpc.2.12.1191; SCOTTCRAIG JS, 1992, J BIOL CHEM, V267, P26044; Seidl Verena, 2008, Fungal Biology Reviews, V22, P36, DOI 10.1016/j.fbr.2008.03.002; Sexton AC, 2009, FUNGAL GENET BIOL, V46, P201, DOI 10.1016/j.fgb.2008.10.014; Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x; Stergiopoulos I, 2010, P NATL ACAD SCI USA, V107, P7610, DOI 10.1073/pnas.1002910107; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Tonukari NJ, 2003, DNA SEQUENCE, V14, P103, DOI 10.1080/1042517031000073727; Tonukari NJ, 2000, PLANT CELL, V12, P237, DOI 10.1105/tpc.12.2.237; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trojer P, 2003, NUCLEIC ACIDS RES, V31, P3971, DOI 10.1093/nar/gkg473; Turgeon BG, 2008, MYCOL RES, V112, P200, DOI 10.1016/j.mycres.2007.10.012; Turgeon BG, 2007, ADV GENET, V57, P219, DOI 10.1016/S0065-2660(06)57006-3; Turgeon BG, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P376; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; VIDHYASEKARAN P, 1992, PHYSIOL MOL PLANT P, V41, P307, DOI 10.1016/0885-5765(92)90018-Q; WOLPERT TJ, 1985, EXPERIENTIA, V41, P1524, DOI 10.1007/BF01964789; XIAO JZ, 1991, PHYTOPATHOLOGY, V81, P58, DOI 10.1094/Phyto-81-58; Xu XW, 2010, MOL PHYLOGENET EVOL, V55, P1008, DOI 10.1016/j.ympev.2009.11.018; Yang G, 1996, PLANT CELL, V8, P2139, DOI 10.1105/tpc.8.11.2139; Yazawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062460; Yoder OC, 1988, ADV PLANT PATHOL, P93, DOI 10.1016/B978-0-12-033706-4.50009-8; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino Daniel R, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1105s31	116	5	5	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0154122	10.1371/journal.pone.0154122	http://dx.doi.org/10.1371/journal.pone.0154122			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253872	Green Published, gold, Green Submitted			2022-12-26	WOS:000377218700002
J	Stahel, P; Cant, JP; MacPherson, JAR; Berends, H; Steele, MA				Stahel, Priska; Cant, John P.; MacPherson, Jayden A. R.; Berends, Harma; Steele, Michael A.			A Mechanistic Model of Intermittent Gastric Emptying and Glucose-Insulin Dynamics following a Meal Containing Milk Components	PLOS ONE			English	Article							MINIMAL MODEL; SENSITIVITY; KINETICS; SECRETION; PLASMA	To support decision-making around diet selection choices to manage glycemia following a meal, a novel mechanistic model of intermittent gastric emptying and plasma glucose-insulin dynamics was developed. Model development was guided by postprandial timecourses of plasma glucose, insulin and the gastric emptying marker acetaminophen in infant calves fed meals of 2 or 4 L milk replacer. Assigning a fast, slow or zero first-order gastric emptying rate to each interval between plasma samples fit acetaminophen curves with prediction errors equal to 9% of the mean observed acetaminophen concentration. Those gastric emptying parameters were applied to glucose appearance in conjunction with minimal models of glucose disposal and insulin dynamics to describe postprandial glycemia and insulinemia. The final model contains 20 parameters, 8 of which can be obtained by direct measurement and 12 by fitting to observations. The minimal model of intestinal glucose delivery contains 2 gastric emptying parameters and a third parameter describing the time lag between emptying and appearance of glucose in plasma. Sensitivity analysis of the aggregate model revealed that gastric emptying rate influences area under the plasma insulin curve but has little effect on area under the plasma glucose curve. This result indicates that pancreatic responsiveness is influenced by gastric emptying rate as a consequence of the quasi-exponential relationship between plasma glucose concentration and pancreatic insulin release. The fitted aggregate model was able to reproduce the multiple postprandial rises and falls in plasma glucose concentration observed in calves consuming a normal-sized meal containing milk components.	[Stahel, Priska; Cant, John P.] Univ Guelph, Dept Anim Biosci, Guelph, ON N1G 2W1, Canada; [MacPherson, Jayden A. R.; Steele, Michael A.] Univ Alberta, Dept Agr Food & Nutr Serv, Edmonton, AB, Canada; [Berends, Harma] Trouw Nutr R&D, Boxmeer, North Brabant, Netherlands	University of Guelph; University of Alberta	Stahel, P (corresponding author), Univ Guelph, Dept Anim Biosci, Guelph, ON N1G 2W1, Canada.	pstahel@uoguelph.ca	Cant, John/ABF-5323-2021	Cant, John/0000-0003-2021-1764; Berends, Harma/0000-0003-0535-5575	Trouw Nutrition RD	Trouw Nutrition RD	The co-author Harma Berends is employed by Trouw Nutrition R&D, Boxmeer, The Netherlands, but this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Trouw Nutrition R&D provided support in the form of salary for author Harma Berends, but did not have any additional role in the model design and evaluation, decision to publish, or final preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Barosa C, 2012, METABOLISM, V61, P250, DOI 10.1016/j.metabol.2011.06.022; BELL FR, 1973, J PHYSIOL-LONDON, V228, P499, DOI 10.1113/jphysiol.1973.sp010096; Benschop DL, 2009, LIVEST SCI, V122, P177, DOI 10.1016/j.livsci.2008.08.011; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Burattini R, 2012, COMPUT METH PROG BIO, V107, P248, DOI 10.1016/j.cmpb.2011.07.002; Cant J. P., 2006, P69, DOI 10.1079/9781845930059.0069; CLEMENTS JA, 1978, CLIN PHARMACOL THER, V24, P420; Dalla Man C, 2002, IEEE T BIO-MED ENG, V49, P419, DOI 10.1109/10.995680; Dedik L, 2007, DIABETES RES CLIN PR, V77, P377, DOI 10.1016/j.diabres.2006.12.017; Gannon MC, 2001, METABOLISM, V50, P93, DOI 10.1053/meta.2001.19442; Hinshaw L, 2014, AM J PHYSIOL-ENDOC M, V307, pE494, DOI 10.1152/ajpendo.00199.2014; Janssen P, 2011, ALIMENT PHARM THER, V33, P880, DOI 10.1111/j.1365-2036.2011.04609.x; Le Huerou-Luron I, 1998, COMP BIOCHEM PHYS A, V119, P817, DOI 10.1016/S1095-6433(98)01021-6; MacPherson JAR, J DAIRY SCI IN PRESS; MALAISSE WJ, 1973, DIABETOLOGIA, V9, P167, DOI 10.1007/BF01219778; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; PACINI G, 1986, COMPUT METH PROG BIO, V23, P113, DOI 10.1016/0169-2607(86)90106-9; PETIT HV, 1987, J DAIRY SCI, V70, P2570, DOI 10.3168/jds.S0022-0302(87)80326-0; Stellaard F, 2000, SCAND J GASTROENTERO, V35, P819, DOI 10.1080/003655200750023183; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; TOFFOLO G, 1980, DIABETES, V29, P979, DOI 10.2337/diabetes.29.12.979; VIST GE, 1995, J PHYSIOL-LONDON, V486, P523, DOI 10.1113/jphysiol.1995.sp020831; WOLEVER TMS, 1991, AM J CLIN NUTR, V54, P846, DOI 10.1093/ajcn/54.5.846; Xu C, 2000, J ANIM PHYSIOL AN N, V83, P49, DOI 10.1046/j.1439-0396.2000.00249.x	24	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156443	10.1371/journal.pone.0156443	http://dx.doi.org/10.1371/journal.pone.0156443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253712	Green Submitted, gold, Green Published			2022-12-26	WOS:000377218700030
J	Visser, O; Hautvast, JLA; van der Velden, K; Hulscher, MEJL				Visser, Olga; Hautvast, Jeannine L. A.; van der Velden, Koos; Hulscher, Marlies E. J. L.			Intention to Accept Pertussis Vaccination for Cocooning: A Qualitative Study of the Determinants	PLOS ONE			English	Article							HEALTH-CARE WORKERS; INCREASE INFLUENZA VACCINATION; CHILDHOOD VACCINATION; BOOSTER VACCINE; PREGNANT-WOMEN; DISEASE BURDEN; UNITED STATES; LOW RATES; ATTITUDES; IMMUNIZATION	Context Several countries have reported a resurgence of pertussis in the last decades. This puts infants (especially <6 months) at risk of severe complications, because they are too young to be fully protected by vaccination. The global pertussis initiative has proposed pertussis vaccination of young infants' close contacts, in order to reduce pertussis transmission and the burden of the disease on infants. Our aim is to explore the perceived determinants (barriers and facilitators) of intention to accept vaccination among the possible target groups of pertussis vaccination for cocooning. Consideration of these determinants is necessary to optimise the uptake of the vaccination. Methods We conducted 13 focus groups and six individual semi-structured interviews with members of possible target groups for pertussis cocooning (i.e. parents, maternity assistants, midwives, and paediatric nurses) in the Netherlands. Here, both maternal pertussis vaccination as well as pertussis cocooning has not been implemented. The topic list was based on a literature review and a barrier framework. All interviews were transcribed verbatim and two researchers performed thematic content analysis. Findings The participants' risk perception, outcome expectations, general vaccination beliefs, moral norms, opinion of others, perceived autonomy, anticipated regret, decisional uncertainty, and perceived organisational barriers were all factors that influenced the intention to accept pertussis vaccination for cocooning. Discussion This study has identified nine perceived determinants that influence the intention to accept pertussis cocooning vaccination. We add the following determinants to the literature: perceived cost-effectiveness (as a concept of outcome expectations), justice (as a concept of moral norms), anticipated regret, and decisional uncertainty. We recommend considering these determinants in vaccination programmes for pertussis cocooning vaccination. Experience, information and trust emerged as predominant themes within these determinants. These themes require particular attention in future research on vaccination acceptance, especially with regard to their role in use and implementation in policy and practice.	[Visser, Olga; Hautvast, Jeannine L. A.; van der Velden, Koos] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Hulscher, Marlies E. J. L.] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Visser, O (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands.	olga.visser@radboudumc.nl	Hautvast, J.L.A./L-4352-2015; Hulscher, Marlies/B-1229-2014; Visser, Olga/G-5077-2016; van der Velden, J./H-8101-2014	Hulscher, Marlies/0000-0002-2160-4810; Visser, Olga/0000-0003-1228-2108; 	Dutch Organisation for Health Research and Development (ZonMw) [204000023]	Dutch Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The Dutch Organisation for Health Research and Development (ZonMw) funded the research project that led to this article (project number: 204000023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirthalingam G, 2013, ARCH DIS CHILD, V98, P552, DOI 10.1136/archdischild-2012-302968; Baron-Epel O, 2012, VACCINE, V30, P3151, DOI 10.1016/j.vaccine.2012.02.074; Baron-Epel O, 2013, HUM VACC IMMUNOTHER, V9, P100, DOI 10.4161/hv.22503; Beck Ulrich, 1992, RISK SOCIETY TOWARDS; Beel ER, 2014, VACCINE, V32, P2540, DOI 10.1016/j.vaccine.2014.03.056; Beel ER, 2013, HUM VACC IMMUNOTHER, V9, P1926, DOI 10.4161/hv.25096; Black S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001738; Blume S, 2006, SOC SCI MED, V62, P628, DOI 10.1016/j.socscimed.2005.06.020; Bodeker B, 2014, VACCINE, V32, P4131, DOI 10.1016/j.vaccine.2014.06.007; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Burns DL, 2014, J INFECT DIS, V209, pS32, DOI 10.1093/infdis/jit491; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Cheng PJ, 2010, VACCINE, V28, P5641, DOI 10.1016/j.vaccine.2010.05.078; Chiappini E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-151; Clarke M, 2015, VACCINE, V33, P7337, DOI 10.1016/j.vaccine.2015.10.068; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Aguilar-Diaz FD, 2011, ARCH MED RES, V42, P652, DOI 10.1016/j.arcmed.2011.12.006; Dempsey AF, 2015, HUM VACC IMMUNOTHER, P1; Donnan EJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-676; Dube E, 2012, HEALTH EDUC RES, V27, P1069, DOI 10.1093/her/cys088; Forsyth KD, 2007, VACCINE, V25, P2634, DOI 10.1016/j.vaccine.2006.12.017; Giddens Anthony, 1990, CONSEQUENCES MODERNI; Godin G, 2010, INFECT CONT HOSP EP, V31, P689, DOI 10.1086/653614; Goins WP, 2007, INFECT CONT HOSP EP, V28, P1284, DOI 10.1086/521654; Gowda C, 2013, HUM VACC IMMUNOTHER, V9, P1755, DOI 10.4161/hv.25085; Greenberg David P, 2005, Pediatr Infect Dis J, V24, pS39, DOI 10.1097/01.inf.0000160911.65632.e1; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2013, IMPROVING PATIENT CARE: THE IMPLEMENTATION OF CHANGE IN HEALTH CARE, 2ND EDITION, pXIII; Hak E, 2005, VACCINE, V23, P3103, DOI 10.1016/j.vaccine.2005.01.074; Hakim H, 2011, VACCINE, V29, P5963, DOI 10.1016/j.vaccine.2011.06.041; Harmsen IA, 2014, MODEL PARENTS INTENT; Hayles EH, 2016, AUST NZ J OBSTET GYN; Hayles EH, 2015, VACCINE, V33, P228, DOI 10.1016/j.vaccine.2014.10.074; Healy CM, 2011, CLIN INFECT DIS, V52, P157, DOI 10.1093/cid/ciq001; Heininger U, 2014, PEDIATR INFECT DIS J, V33, P147, DOI 10.1097/01.inf.0000435503.44620.74; Hobson-West P, 2007, SOCIOL HEALTH ILL, V29, P198, DOI 10.1111/j.1467-9566.2007.00544.x; Hofmann F, 2006, INFECTION, V34, P142, DOI 10.1007/s15010-006-5109-5; Hollmeyer H, 2013, INFLUENZA OTHER RESP, V7, P604, DOI 10.1111/irv.12002; Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056; Juraskova I, 2011, WOMEN HEALTH ISS, V21, P71, DOI 10.1016/j.whi.2010.08.004; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Lagoe C, 2015, PSYCHOL HEALTH MED, V20, P18, DOI 10.1080/13548506.2014.911923; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Leboucher B, 2012, VACCINE, V30, P5472, DOI 10.1016/j.vaccine.2012.06.071; Leder S, 2015, PSYCHOL HEALTH, V30, P165, DOI 10.1080/08870446.2014.954574; Lehmann BA, 2015, J HOSP INFECT, V89, P202, DOI 10.1016/j.jhin.2014.11.009; Lehmann BA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-407; Liao Q, 2013, VACCINE, V31, P4084, DOI 10.1016/j.vaccine.2013.07.009; Looijmans-van den Akker I, 2009, VACCINE, V27, P4724, DOI 10.1016/j.vaccine.2009.05.013; Lu PJ, 2014, VACCINE, V32, P572, DOI 10.1016/j.vaccine.2013.11.077; MacDougall DM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009062; Mclntyre P, 2009, CURR OPIN INFECT DIS, V22, P215, DOI 10.1097/QCO.0b013e32832b3540; Mercier H, 2011, BEHAV BRAIN SCI, V34, P57, DOI 10.1017/S0140525X10000968; Miller BL, 2011, VACCINE, V29, P3850, DOI 10.1016/j.vaccine.2011.03.058; Miller E, 2014, WHO SAGE PERTUSSIS W; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; O'Leary ST, 2015, PEDIATR INFECT DIS J, V34, P1244, DOI 10.1097/INF.0000000000000873; O'Neill O, 2003, J MED ETHICS, V29, P4, DOI 10.1136/jme.29.1.4; Peretti-Watel P, 2014, SOC SCI MED, V109, P10, DOI 10.1016/j.socscimed.2014.02.035; Poltorak M, 2005, SOC SCI MED, V61, P709, DOI 10.1016/j.socscimed.2004.12.014; Smith PJ, 2004, PEDIATRICS, V114, P187, DOI 10.1542/peds.114.1.187; Suryadevara M, 2014, VACCINE, V32, P7000, DOI 10.1016/j.vaccine.2014.10.018; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Top KA, 2010, VACCINE, V28, P2169, DOI 10.1016/j.vaccine.2009.12.060; Tuckerman JL, 2015, HUM VACC IMMUNOTHER, V11, P704, DOI 10.1080/21645515.2015.1008886; Urwyler P, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-397; Van der Maas N, 2014, KINKHOESTSURVEILLANC; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; Vasilevska M, 2014, INFECT CONT HOSP EP, V35, P699, DOI 10.1086/676427; Wicker S, 2008, EXPERT REV VACCINES, V7, P1325, DOI 10.1586/14760584.7.9.1325; Wiley KE, 2013, VACCINE, V31, P3972, DOI 10.1016/j.vaccine.2013.06.015; Williams WW, 2014, NONINFLUENZA VACCINA, P95; Winter K, 2012, J PEDIATR-US, V161, P1091, DOI 10.1016/j.jpeds.2012.05.041; Wong CY, 2015, HUM VACC IMMUNOTHER, V11, P1165, DOI 10.1080/21645515.2015.1019188; Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018	78	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0155861	10.1371/journal.pone.0155861	http://dx.doi.org/10.1371/journal.pone.0155861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN6XB	27253386	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700008
J	Haraguchi, T; Miyoshi, H; Hiraoka, K; Yokoyama, S; Ishibashi, Y; Hashiguchi, T; Matsuda, K; Hamada, T; Okawa, T; Shiba, N; Ohshima, K				Haraguchi, Toshiaki; Miyoshi, Hiroaki; Hiraoka, Koji; Yokoyama, Shintaro; Ishibashi, Yukinao; Hashiguchi, Toshihiro; Matsuda, Koutaro; Hamada, Tetsuya; Okawa, Takahiro; Shiba, Naoto; Ohshima, Koichi			GATA3 Expression Is a Poor Prognostic Factor in Soft Tissue Sarcomas	PLOS ONE			English	Article							LUMINAL CELL FATE; BREAST-CANCER; MAMMARY-GLAND; LUNG-CANCER; CYCLIN D1; DIFFERENTIATION; METASTASIS; SURVIVAL; SYSTEM; OVEREXPRESSION	Objective Recent studies have investigated the significance of GATA3 expression in patients with various malignant tumors. However, no previous studies have evaluated the clinicopathological importance of GATA3 expression in soft tissue sarcomas (STS) patients. Methods We evaluated GATA3 expression in 76 STS cases using immunohistochemical analysis, and statistically compared clinicopathological characteristics between GATA3-positive and GATA3-negative cases. Result GATA3-positive expression was significantly associated with a higher mitotic count (P < 0.0001). Disease-free survival (DFS) of GATA3-positive cases was significantly shorter than that of cases without GATA3 expression (P = 0.0104). Overall survival (OS) of GATA3-positive cases was significantly shorter than that of cases without GATA3 expression (P = 0.0006). GATA3-positive expression was significantly associated with shorter DFS in both univariate analysis (hazard ratio [HR], 2.719; P = 0.012) and multivariate analysis (HR, 2.711; P = 0.014). GATA3-positive expression was also significantly associated with worse OS in both univariate analysis (HR, 5.730; P = 0.0007) and multivariate analysis (HR, 5.789; P = 0.0008). Conclusion These results indicate that GATA3 is an independent prognostic factor and suggest that evaluation of GATA3 expression might enable more effective clinical follow-up using prognostic stratification of STS patients.	[Haraguchi, Toshiaki; Miyoshi, Hiroaki; Yokoyama, Shintaro; Ishibashi, Yukinao; Hashiguchi, Toshihiro; Matsuda, Koutaro; Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan; [Haraguchi, Toshiaki; Hiraoka, Koji; Ishibashi, Yukinao; Matsuda, Koutaro; Hamada, Tetsuya; Okawa, Takahiro; Shiba, Naoto] Kurume Univ, Sch Med, Dept Orthoped Surg, Kurume, Fukuoka 830, Japan; [Yokoyama, Shintaro; Hashiguchi, Toshihiro] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 830, Japan	Kurume University; Kurume University; Kurume University	Miyoshi, H (corresponding author), Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan.	miyoshi_hiroaki@med.kurume-u.ac.jp	Yokoyama, Shintaro/HHC-8479-2022					Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Chen HR, 2014, INT J PHOTOENERGY, V2014, DOI 10.1155/2014/643532; Chen YZ, 2011, CANCER LETT, V302, P63, DOI 10.1016/j.canlet.2010.12.014; Ciocca V, 2009, HUM PATHOL, V40, P489, DOI 10.1016/j.humpath.2008.09.010; Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO;2-3; Constantinidou A, 2013, EXPERT REV ANTICANC, V13, P211, DOI [10.1586/ERA.12.161, 10.1586/era.12.161]; Deyrup AT, 2006, HISTOPATHOLOGY, V48, P42, DOI 10.1111/j.1365-2559.2005.02288.x; Donati V, 2005, CLIN CANCER RES, V11, P6459, DOI 10.1158/1078-0432.CCR-05-0541; Dydensborg AB, 2009, ONCOGENE, V28, P2634, DOI 10.1038/onc.2009.126; Gatta G, 2011, EUR J CANCER, V47, P2493, DOI 10.1016/j.ejca.2011.08.008; Gulbinas A, 2006, J HISTOCHEM CYTOCHEM, V54, P161, DOI 10.1369/jhc.5A6626.2005; GUSTAFSON P, 1994, ACTA ORTHOP SCAND, V65, P1; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Ishibashi Y, 2015, ONCOL REP, V33, P1667, DOI 10.3892/or.2015.3806; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Keshari RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087195; Kim Joonseok, 2013, Case Rep Med, V2013, P131395, DOI 10.1155/2013/131395; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lahat G, 2008, ANN SURG ONCOL, V15, P2739, DOI 10.1245/s10434-008-9970-6; Liu CY, 2010, ANN SURG ONCOL, V17, P2102, DOI 10.1245/s10434-010-0997-0; Mariani L, 2005, CANCER-AM CANCER SOC, V103, P402, DOI 10.1002/cncr.20778; Miettinen M, 2014, AM J SURG PATHOL, V38, P13, DOI 10.1097/PAS.0b013e3182a0218f; Molenaar JJ, 2010, ONCOGENE, V29, P2739, DOI 10.1038/onc.2010.21; Peng HW, 2015, MOL MED REP, V11, P881, DOI 10.3892/mmr.2014.2809; Hernandez RAS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0873-z; SHIGA K, 1993, ANTICANCER RES, V13, P1293; Shim BY, 2010, CANCER RES TREAT, V42, P144, DOI 10.4143/crt.2010.42.3.144; Stojadinovic A, 2002, ANN SURG, V235, P424, DOI 10.1097/00000658-200203000-00015; Tokito T, 2016, EUR J CANCER, V55, P7, DOI 10.1016/j.ejca.2015.11.020; Tominaga N, 2012, ANN ONCOL, V23, P3051, DOI 10.1093/annonc/mds120; TROJANI M, 1984, INT J CANCER, V33, P37, DOI 10.1002/ijc.2910330108; Tsarovina K, 2004, DEVELOPMENT, V131, P4775, DOI 10.1242/dev.01370; Weitz J, 2003, J CLIN ONCOL, V21, P2719, DOI 10.1200/JCO.2003.02.026; Wu YY, 2012, AM J CANCER RES, V2, P104; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972; Zheng Rena, 2010, Genes Cancer, V1, P1178, DOI 10.1177/1947601911404223	39	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156524	10.1371/journal.pone.0156524	http://dx.doi.org/10.1371/journal.pone.0156524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249072	gold, Green Published, Green Submitted			2022-12-26	WOS:000377184700049
J	Lin, Q; Qian, J; Zhao, CN; Wang, DL; Liu, CR; Wang, ZD; Sun, CD; Chen, KS				Lin, Qiong; Qian, Jing; Zhao, Chenning; Wang, Dengliang; Liu, Chunrong; Wang, Zhidong; Sun, Chongde; Chen, Kunsong			Low Temperature Induced Changes in Citrate Metabolism in Ponkan (Citrus reticulata Blanco cv. Ponkan) Fruit during Maturation	PLOS ONE			English	Article							ORGANIC-ACIDS; DEFICIT IRRIGATION; GENE-EXPRESSION; WATER-STRESS; SUGARS; GROWTH; QUALITY; ACCUMULATION; SECRETION; MECHANISM	Citrate is the most important organic acid in citrus fruit, and its concentration in fruit cells is regulated mainly by the balance between synthesis and degradation. Ponkan (Citrus reticulate Blanco cv. Ponkan) is one of the major citrus cultivars grew in China, and the fruit are picked before fully mature to avoid bad weather. Greenhouse production is widely used to prolong the maturation period and improve the quality of Ponkan fruit by maintaining adequate temperature and providing protection from adverse weather. In this research, Ponkan fruit cultivated in either a greenhouse or open field were used to investigate differences in the expression of genes related to citrate metabolism during maturation in the two environments. The citrate contents were higher in open field fruit, and were mainly correlated with expressions of CitPEPCs, CitCSs, CitAco3 and CitGAD4, which were significantly increased. In addition, the impacts of low temperature (LT) and water stress (WS) on citrate metabolism in Ponkan were investigated during fruit maturation. The citrate contents in LT fruit were significantly increased, by between 1.4-1.9 fold, compared to the control; it showed no significant difference in fruit with water stress treatment compared to the control fruit. Furthermore, the expressions of CitPEPCs, CitCSs, CitAco3 and CitGAD4 were significantly increased in response to LT treatment, but showed no significant difference in WS compared to the control fruit. Thus, it can be concluded that low temperature may be the main factor influencing citrate metabolism during maturation in Ponkan fruit.	[Lin, Qiong; Qian, Jing; Zhao, Chenning; Sun, Chongde; Chen, Kunsong] Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, State Agr Minist Lab Hort Plant Growth Dev & Qual, Lab Fruit Qual Biol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Qiong; Wang, Zhidong] Chinese Acad Agr Sci, Inst Food Sci & Technol, Key Opening Lab Agr Prod Proc & Qual Control, Minist Agr, Beijing 100193, Peoples R China; [Wang, Dengliang; Liu, Chunrong] Quzhou Acad Agr Sci, Quzhou, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Food Science & Technology, CAAS; Ministry of Agriculture & Rural Affairs	Sun, CD (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, State Agr Minist Lab Hort Plant Growth Dev & Qual, Lab Fruit Qual Biol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	adesun2006@zju.edu.cn			Program of International Science and Technology Cooperation [2011DFB31580]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAD38B03]; Project of the Science and Technology Department of Zhejiang Province [2013C02019-1]	Program of International Science and Technology Cooperation; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Project of the Science and Technology Department of Zhejiang Province	This research was supported by Program of International Science and Technology Cooperation (2011DFB31580), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BAD38B03) and the Project of the Science and Technology Department of Zhejiang Province (2013C02019-1).; We thank Prof. Donald Grierson from the University of Nottingham (UK) for his efforts in editing language of the whole paper. This research was supported by Program of International Science and Technology Cooperation (2011DFB31580), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BAD38B03) and the Project of the Science and Technology Department of Zhejiang Province (2013C02019-1).	ANDERSEN PC, 1995, J AM SOC HORTIC SCI, V120, P36, DOI 10.21273/JASHS.120.1.36; Araujo WL, 2012, PLANT CELL ENVIRON, V35, P1, DOI 10.1111/j.1365-3040.2011.02332.x; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; Bugaud C, 2009, FRUITS, V64, P63, DOI 10.1051/fruits/2009001; Carrari F, 2003, PLANT PHYSIOL, V133, P1322, DOI 10.1104/pp.103.026716; Cercos M, 2006, PLANT MOL BIOL, V62, P513, DOI 10.1007/s11103-006-9037-7; Chen M, 2013, PLANT MOL BIOL REP, V31, P1131, DOI 10.1007/s11105-013-0583-2; Chen M, 2012, SCI HORTIC-AMSTERDAM, V147, P118, DOI 10.1016/j.scienta.2012.09.011; Deng W, 2009, PLANTA, V230, P355, DOI 10.1007/s00425-009-0945-z; des Gachons CP, 2005, J SCI FOOD AGR, V85, P73, DOI 10.1002/jsfa.1919; Ferreyra MLF, 2006, PHYSIOL PLANTARUM, V128, P224, DOI 10.1111/j.1399-3054.2006.00744.x; [龚荣高 GONG Ronggao], 2006, [四川农业大学学报, Journal of Sichuan Agricultural University], V24, P402; Gong RongGao, 2006, Journal of Fruit Science, V23, P805; Gonzalez-Altozano P, 2000, J HORTIC SCI BIOTECH, V75, P388, DOI 10.1080/14620316.2000.11511256; Gonzalez-Altozano P, 1999, J HORTIC SCI BIOTECH; Han DG, 2012, BIOL PLANTARUM, V56, P50, DOI 10.1007/s10535-012-0015-4; Hardy N.W., 2012, PLANT METABOLOMICS M; HARDY PJ, 1968, PLANT PHYSIOL, V43, P224, DOI 10.1104/pp.43.2.224; Hudina M, 2000, PHYTON-ANN REI BOT A, V40, P91; Hummel I, 2010, PLANT PHYSIOL, V154, P357, DOI 10.1104/pp.110.157008; Kallsen CE, 2011, HORTSCIENCE, V46, P1163, DOI 10.21273/HORTSCI.46.8.1163; Lechaudel M, 2005, J SCI FOOD AGR, V85, P251, DOI 10.1002/jsfa.1968; Li XF, 2000, PLANT PHYSIOL, V123, P1537, DOI 10.1104/pp.123.4.1537; Lin Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119410; Lin Q, 2015, GENE, V554, P64, DOI 10.1016/j.gene.2014.10.025; Lobit P, 2003, J EXP BOT, V54, P2489, DOI 10.1093/jxb/erg264; Morgan MJ, 2013, PLANT PHYSIOL, V161, P397, DOI 10.1104/pp.112.209619; Osorio S, 2012, PLANT METABOLOMICS; Pineros MA, 2002, PLANT PHYSIOL, V129, P1194, DOI 10.1104/pp.002295; RUFFNER HP, 1982, VITIS, V21, P247; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Thakur A, 2012, SCI HORTIC-AMSTERDAM, V135, P112, DOI 10.1016/j.scienta.2011.12.013; TIMPA JD, 1986, PLANT PHYSIOL, V82, P724, DOI 10.1104/pp.82.3.724; Wu BH, 2007, J EXP BOT, V58, P2583, DOI 10.1093/jxb/erm126; Yin XR, 2012, PLANTA, V235, P895, DOI 10.1007/s00425-011-1553-2; Yun Z, 2012, J EXP BOT, V63, P2873, DOI 10.1093/jxb/err390; Zhao ZQ, 2003, PLANTA, V217, P794, DOI 10.1007/s00425-003-1043-2; Zhou JY, 2010, SCI HORTIC-AMSTERDAM, V126, P229, DOI 10.1016/j.scienta.2010.07.019	39	32	34	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0156703	10.1371/journal.pone.0156703	http://dx.doi.org/10.1371/journal.pone.0156703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27249065	gold, Green Published, Green Submitted			2022-12-26	WOS:000377184700070
J	Boerema, A; Peeters, A; Swolfs, S; Vandevenne, F; Jacobs, S; Staes, J; Meire, P				Boerema, Annelies; Peeters, Alain; Swolfs, Sanne; Vandevenne, Floor; Jacobs, Sander; Staes, Jan; Meire, Patrick			Soybean Trade: Balancing Environmental and Socio-Economic Impacts of an Intercontinental Market	PLOS ONE			English	Article							ECOSYSTEM SERVICES; LAND-USE; FOOD SECURITY; AMAZON; EXTERNALITIES; FORESTS; CONSERVATION; FRONTIER; BRAZIL; POLICY	The trade in soybean, an important animal feed product, exemplifies the environmental and socio-economic impact of global markets and global agricultural policy. This paper analyses the impact of increasing production of soybean in the exporting countries (deforestation and grassland conversion) as well as in importing regions (decrease in permanent grassland by substitution of grass as feed). Ecosystem services monetary values were used to calculate the environmental and socio-economic impact of observed land use changes. This is balanced against the economic value of the global soybean trade. The results prove that consumption choices in one region have real effects on the supply of ecosystem services at a large spatial scale. Conclusively, solutions to make this global market more sustainable are discussed.	[Boerema, Annelies; Swolfs, Sanne; Vandevenne, Floor; Jacobs, Sander; Staes, Jan; Meire, Patrick] Univ Antwerp, Dept Biol, Ecosyst Management Res Grp, B-2020 Antwerp, Belgium; [Peeters, Alain] RHEA Res Ctr, Brussels, Belgium; [Jacobs, Sander] Res Inst Nat & Forest INBO, Res Grp Nat & Soc, Brussels, Belgium; [Jacobs, Sander] Belgian Biodivers Platform BBPF, Brussels, Belgium	University of Antwerp; Research Institute for Nature & Forest	Boerema, A (corresponding author), Univ Antwerp, Dept Biol, Ecosyst Management Res Grp, B-2020 Antwerp, Belgium.	annelies.boerema@uantwerpen.be	Boerema, Annelies/A-7565-2018; Boerema, Annelies/N-4660-2019	Boerema, Annelies/0000-0001-5094-733X; Boerema, Annelies/0000-0001-5094-733X; Jacobs, Sander/0000-0003-4674-4817				[Anonymous], ENV IND REP 2014 ENV; Bithas K, 2011, ECOL ECON, V70, P1703, DOI 10.1016/j.ecolecon.2011.05.014; Chomitz KM, 2001, 2687 WORLD BANK, P1; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; D'Odorico P, 2013, ADV WATER RESOUR, V51, P326, DOI 10.1016/j.advwatres.2012.01.013; Dalgaard R, 2008, INT J LIFE CYCLE ASS, V13, P240, DOI 10.1065/lca2007.06.342; Dauvergne P, 2010, J PEASANT STUD, V37, P631, DOI 10.1080/03066150.2010.512451; Dros JM, 2004, MANAGING SOY BOOM 2, P1; EC, 2014, EUR STAT; EEA, 2015, EUR ENV STAT OUTL 20; FAO, 2014, SAT FOOD AGR ORG UN; Farley J, 2012, ECOSYST SERV, V1, P40, DOI 10.1016/j.ecoser.2012.07.002; Fearnside PM, 1999, ENVIRON CONSERV, V26, P305, DOI 10.1017/S0376892999000429; FEFAC (Federation Europeenne des Fabricants D'aliments Composes pour Animaux), 2009, FEED FOOD STAT YB 20; Garrett RD, 2013, LAND USE POLICY, V31, P385, DOI 10.1016/j.landusepol.2012.08.002; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Grote U, 2005, ENVIRON SCI POLICY, V8, P439, DOI 10.1016/j.envsci.2005.05.001; Hecht SB, 2005, DEV CHANGE, V36, P375, DOI 10.1111/j.0012-155X.2005.00415.x; Jacobs S., 2014, ECOSYSTEM SERVICES G, DOI [10.1016/B978-0-12-419964-4.02002-3, DOI 10.1016/B978-0-12-419964-4.02002-3]; Klemick H, 2011, J ENVIRON ECON MANAG, V61, P95, DOI 10.1016/j.jeem.2010.07.003; Lv Y, 2010, ECOL ECON, V69, P1436, DOI 10.1016/j.ecolecon.2008.12.014; Macedo MN, 2012, P NATL ACAD SCI; Muller C, 2003, SERIE TEXTOS DISCUSS, V308; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Olsen N, 2009, FINANCIAL COSTS REDD, P1; Peeters A, 2012, GRASSLAND SCI EUR, V17, P17; Peeters A., 2013, ECOSYSTEM SERVICES G, P191, DOI [10.1016/B978-0-12-419964-4.00017-2, DOI 10.1016/B978-0-12-419964-4.00017-2]; Pengue WA, 2005, TRANSGENIC CROPS ARG; Pengue WA, 2004, ENV SOCIOECONOMIC IM; Rulli MC, 2013, P NATL ACAD SCI USA, V110, P892, DOI 10.1073/pnas.1213163110; Schilling M, 2011, ENERG POLICY, V39, P990, DOI 10.1016/j.enpol.2010.11.030; Schmitz C, 2012, GLOBAL ENVIRON CHANG, V22, P189, DOI 10.1016/j.gloenvcha.2011.09.013; Schnepf R.D, 2001, WRS013 USDA MARK TRA; Smaling EMA, 2008, AGR ECOSYST ENVIRON, V128, P185, DOI 10.1016/j.agee.2008.06.005; Steward C, 2007, AGR HUM VALUES, V24, P107, DOI 10.1007/s10460-006-9030-4; van Huis A, 2013, ANNU REV ENTOMOL, V58, P563, DOI 10.1146/annurev-ento-120811-153704; VERADIAZ M, 2005, TROPICAL DEFORESTATI; Viglizzo EF, 2006, ECOL ECON, V57, P140, DOI 10.1016/j.ecolecon.2005.03.025; Von Witzke H, 2009, EU AGR PRODUCTION TR; Westerdahl H, 2012, P ROY SOC B-BIOL SCI, V279, P577, DOI 10.1098/rspb.2011.0917; Westhoek H, 2014, GLOBAL ENVIRON CHANG, V26, P196, DOI 10.1016/j.gloenvcha.2014.02.004; Yu Y, 2013, GLOBAL ENVIRON CHANG, V23, P1178, DOI 10.1016/j.gloenvcha.2013.04.006	43	73	74	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0155222	10.1371/journal.pone.0155222	http://dx.doi.org/10.1371/journal.pone.0155222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN5XX	27244079	gold, Green Submitted, Green Published			2022-12-26	WOS:000377146100003
J	Dynowski, JF; Nebelsick, JH; Klein, A; Roth-Nebelsick, A				Dynowski, Janina F.; Nebelsick, James H.; Klein, Adrian; Roth-Nebelsick, Anita			Computational Fluid Dynamics Analysis of the Fossil Crinoid Encrinus liliiformis (Echinodermata: Crinoidea)	PLOS ONE			English	Article							PARTICLE CAPTURE; PREY CAPTURE; SUSPENSION; FOOD; FLOW; MECHANISMS; PALEOECOLOGY; OCTOCORAL; VELOCITY; FEEDERS	Crinoids, members of the phylum Echinodermata, are passive suspension feeders and catch plankton without producing an active feeding current. Today, the stalked forms are known only from deep water habitats, where flow conditions are rather constant and feeding velocities relatively low. For feeding, they form a characteristic parabolic filtration fan with their arms recurved backwards into the current. The fossil record, in contrast, provides a large number of stalked crinoids that lived in shallow water settings, with more rapidly changing flow velocities and directions compared to the deep sea habitat of extant crinoids. In addition, some of the fossil representatives were possibly not as flexible as today's crinoids and for those forms alternative feeding positions were assumed. One of these fossil crinoids is Encrinus liliiformis, which lived during the middle Triassic Muschelkalk in Central Europe. The presented project investigates different feeding postures using Computational Fluid Dynamics to analyze flow patterns forming around the crown of E. liliiformis, including experimental validation by Particle Image Velocimetry. The study comprises the analysis of different flow directions, velocities, as well as crown orientations. Results show that inflow from lateral and oral leads to direct transport of plankton particles into the crown and onto the oral surface. With current coming from the "rear" (aboral) side of the crinoid, the conical opening of the crown produces a backward oriented flow in its wake that transports particles into the crown. The results suggest that a conical feeding position may have been less dependent on stable flow conditions compared to the parabolic filtration fan. It is thus assumed that the conical feeding posture of E. liliiformis was suitable for feeding under dynamically changing flow conditions typical for the shallow marine setting of the Upper Muschelkalk.	[Dynowski, Janina F.; Roth-Nebelsick, Anita] Staatliches Museum Nat Kunde, Stuttgart, Germany; [Dynowski, Janina F.; Nebelsick, James H.] Univ Tubingen, Fachbereich Geowissensch, Tubingen, Germany; [Klein, Adrian] Univ Bonn, Inst Zool, Bonn, Germany	Eberhard Karls University of Tubingen; University of Bonn	Nebelsick, JH (corresponding author), Univ Tubingen, Fachbereich Geowissensch, Tubingen, Germany.	nebelsick@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [NE 537/24-1, RO 3250/20-1]; Ministry for Education and Research (Bundesministerium fuer Bildung und Forschung); Ministry for Science, Research and Arts Baden-Wuerttemberg (Ministerium fuer Wissenschaft, Forschung und Kunst Baden-Wuerttemberg); bwUniCluster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry for Education and Research (Bundesministerium fuer Bildung und Forschung); Ministry for Science, Research and Arts Baden-Wuerttemberg (Ministerium fuer Wissenschaft, Forschung und Kunst Baden-Wuerttemberg); bwUniCluster	This work was supported by Deutsche Forschungsgemeinschaft, grant number NE 537/24-1 (to JHN) and grant number RO 3250/20-1 (to ARN) (http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the bwGRiD project (http://www.bw-grid.de) member of the German D-Grid initiative, funded by the Ministry for Education and Research (Bundesministerium fuer Bildung und Forschung) and the Ministry for Science, Research and Arts Baden-Wuerttemberg (Ministerium fuer Wissenschaft, Forschung und Kunst Baden-Wuerttemberg), and bwUniCluster (http://www.bwhpc-c5.de) for computational resources, and Dr. Marek Dynowski for helpful advices in HPC. We also thank Prof. Dr. Bleckmann for providing access to the PIV facilities, the technical staff of the SMNS for support in resin model creation, and Jan-Peter Friedrich for critical discussions. David L. Meyer, Michael LaBarbera and two anonymous reviewers is thanked for their thorough reviews and helpful advices for improving this manuscript.	AIGNER T, 1992, SEDIMENT GEOL, V80, P115, DOI 10.1016/0037-0738(92)90035-P; Aigner T., 1985, LECT NOTES EARTH SCI, V3; [Anonymous], 2011, AERODYNAMIK STUMPFEN; AUSICH WI, 1986, PALAEONTOLOGY, V29, P85; Ausich William I., 1999, P3, DOI 10.1017/CBO9780511626159.003; BAUMILLER TK, 1991, B MAR SCI, V48, P731; BAUMILLER TK, 1992, J PALEONTOL, V66, P658, DOI 10.1017/S0022336000024501; BAUMILLER TK, 1989, LETHAIA, V22, P317, DOI 10.1111/j.1502-3931.1989.tb01348.x; Baumiller TK, 1987, ECH BIOL P 6 INT ECH, V1988, P786; Baumiller TK, 2008, ANNU REV EARTH PL SC, V36, P221, DOI [10.1146/annurev.earth.36.031207.124116, 10.1146/annurev.earth36.031207.124116]; Baumiller TK, 2007, PALAEONTOL ELECTRON, V10; Baumiller Tomasz K., 1993, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V190, P279; Baumiller Tomasz K., 1997, Paleontological Society Papers, V3, P45; BEST BA, 1988, BIOL BULL-US, V175, P332, DOI 10.2307/1541723; Birenheide R, 1996, BIOL BULL, V191, P1, DOI 10.2307/1543055; Bohaty J, 2011, ACTA PALAEONTOL POL, V56, P615, DOI 10.4202/app.2010.0020; Breimer A., 1978, TREATISE INVERTEBR T, V1, P9; Brower JC, 2007, J PALEONTOL, V81, P1284, DOI 10.1666/05-034.1; Brower JC, 2011, J PALEONTOL, V85, P369, DOI 10.1666/10-066.1; CONAN G, 1981, DEEP-SEA RES, V28, P441, DOI 10.1016/0198-0149(81)90136-9; Donovan SK, 2008, ZOOTAXA, P31; Dynowski Janina F., 2011, Swiss Journal of Palaeontology, V130, P53, DOI 10.1007/s13358-010-0007-y; Dynowski JF, 2015, THESIS EBERHARD KARL; Featherstone Charles M., 1998, P155; Feist-Burkhardt S., 2008, GEOLOGY CENTRAL EURO, P749, DOI DOI 10.1144/CEV2P.1; Geyer OF., 2011, GEOLOGIE BADEN WURTT, V5; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; GRIMMER JC, 1990, ACTA ZOOL-STOCKHOLM, V71, P61, DOI 10.1111/j.1463-6395.1990.tb01070.x; Hagdorn H, 1991, MUSCHELKALK FIELD GU, P7; Hagdorn Hans, 1999, P164, DOI 10.1017/CBO9780511626159.023; HAUGH BN, 1978, LETHAIA, V11, P145, DOI 10.1111/j.1502-3931.1978.tb01300.x; HEINZELLER T, 1995, ACTA ZOOL-STOCKHOLM, V76, P25, DOI 10.1111/j.1463-6395.1995.tb00979.x; Heinzeller Thomas, 1994, P9; Hess H., 2011, TREATISE INVERTEBRAT, V3, P28; HOLLAND ND, 1987, BIOL BULL, V173, P552, DOI 10.2307/1541700; Humphries S, 2009, P NATL ACAD SCI USA, V106, P7882, DOI 10.1073/pnas.0809063106; JEFFERIES RPS, 1989, PALAEONTOLOGY, V32, P483; JORGENSEN CB, 1983, MAR ECOL PROG SER, V11, P89, DOI 10.3354/meps011089; Kitazawa K, 2007, MAR BIOL, V152, P959, DOI 10.1007/s00227-007-0746-5; Kitazawa K, 2010, J EXP MAR BIOL ECOL, V395, P80, DOI 10.1016/j.jembe.2010.08.018; LABARBERA M, 1984, AM ZOOL, V24, P71; LASKER HR, 1981, MAR ECOL PROG SER, V5, P61, DOI 10.3354/meps005061; LATOUCHE RW, 1980, MAR BIOL, V60, P39, DOI 10.1007/BF00395604; LAWRENCE JM, 1987, ACQUISITION NUTR FUN, P17; LEONARD AB, 1989, J EXP MAR BIOL ECOL, V127, P81, DOI 10.1016/0022-0981(89)90210-4; Linck O, 1954, AUS DER HEIMAT, V62, P225; Linck O, 1965, JAHRESHEFTE GEOLOGIS, V7, P123; MACURDA DB, 1974, NATURE, V247, P394, DOI 10.1038/247394a0; Messing C.G., 1985, Echinoderms, V1984, P185; Messing Charles G., 1997, Paleontological Society Papers, V3, P3; Meyer D.L., 1982, P25; MEYER DL, 1979, MAR BIOL, V51, P361, DOI 10.1007/BF00389214; MEYER DL, 1973, MAR BIOL, V22, P105, DOI 10.1007/BF00391776; Moore RC, 1978, TREATISE INVERTEBRAT, pT7; PATTERSON MR, 1991, BIOL BULL-US, V180, P93, DOI 10.2307/1542432; PATTERSON MR, 1984, BIOL BULL-US, V167, P613, DOI 10.2307/1541414; Pawson DL, 2007, ZOOTAXA, P749, DOI 10.11646/zootaxa.1668.1.31; Riisgard HU, 2010, MAR ECOL PROG SER, V418, P255, DOI 10.3354/meps08755; Roux M., 1987, Echinoderm Studies, V2, P1; RUBENSTEIN DI, 1977, AM NAT, V111, P981, DOI 10.1086/283227; SHIMETA J, 1991, OCEANOGR MAR BIOL, V29, P191; SILVESTER NR, 1983, J THEOR BIOL, V103, P265, DOI 10.1016/0022-5193(83)90028-0; TRAGER G, 1993, BIOL BULL-US, V185, P20, DOI 10.2307/1542127; TRAGER GC, 1990, MAR BIOL, V105, P117, DOI 10.1007/BF01344277; VANIERLAND ET, 1984, J PLANKTON RES, V6, P29, DOI 10.1093/plankt/6.1.29; Vogel S, 2020, LIFE MOVING FLUIDS P; Vollrath A., 1957, JAHRESHEFTE GEOLOGIS, V2, P119; WELCH JR, 1978, PALEOBIOLOGY, V4, P89, DOI 10.1017/S0094837300005728; Wildish D., 1997, BENTHIC SUSPENSION F; Wilkie I.C., 2004, P371, DOI 10.1201/9780203970881.ch61; Wisshak M, 2009, PALAEOGEOGR PALAEOCL, V271, P77, DOI 10.1016/j.palaeo.2008.09.015; [No title captured]	72	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156408	10.1371/journal.pone.0156408	http://dx.doi.org/10.1371/journal.pone.0156408			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243221	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100037
J	Fransen, HP; Peeters, PHM; Beulens, JWJ; Boer, JMA; de Wit, GA; Onland-Moret, NC; van der Schouw, YT; Bueno-de-Mesquita, HB; Hoekstra, J; Elias, SG; May, AM				Fransen, Heidi P.; Peeters, Petra H. M.; Beulens, Joline W. J.; Boer, Jolanda M. A.; de Wit, G. Ardine; Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; Bueno-de-Mesquita, H. Bas; Hoekstra, Jeljer; Elias, Sjoerd G.; May, Anne M.			Exposure to Famine at a Young Age and Unhealthy Lifestyle Behavior Later in Life	PLOS ONE			English	Article							1944-1945 DUTCH FAMINE; FOOD FREQUENCY QUESTIONNAIRE; EPIC-NL COHORT; BREAST-CANCER; MEDITERRANEAN DIET; RELATIVE VALIDITY; RISK; CONSEQUENCES; CHILDHOOD; DISEASES	Background A healthy diet is important for normal growth and development. Exposure to undernutrition during important developmental periods such as childhood and adolescence can have effects later in life. Inhabitants of the west of the Netherlands were exposed to severe undernutrition during the famine in the last winter of the second World War (1944-1945). Objective We investigated if exposure of women to the Dutch famine during childhood and adolescence was associated with an unhealthy lifestyle later in life. Design We studied 7,525 women from the Prospect-EPIC cohort, recruited in 1993-97 and aged 0-18 years during the Dutch famine. An individual famine score was calculated based on self-reported information about experience of hunger and weight loss. We investigated the association between famine exposure in early life and four lifestyle factors in adulthood: smoking, alcohol consumption, physical activity level and a Mediterranean-style diet. Results Of the 7,525 included women, 46% were unexposed, 38% moderately exposed and 16% severely exposed to the Dutch famine. Moderately and severely exposed women were more often former or current smokers compared to women that did not suffer from the famine: adjusted prevalence ratio 1.10 (95% CI: 1.05; 1.14) and 1.18 (1.12; 1.25), respectively. They also smoked more pack years than unexposed women. Severely exposed women were more often physically inactive than unexposed women, adjusted prevalence ratio 1.32 (1.06; 1.64). Results did not differ between exposure age categories (0-9 and 10-17 years). We found no associations of famine exposure with alcohol consumption and no dose-dependent relations with diet. Conclusions Exposure to famine early in female life may be associated with higher prevalence of smoking and physical inactivity later in life, but not with unhealthy diet and alcohol consumption.	[Fransen, Heidi P.; Peeters, Petra H. M.; Beulens, Joline W. J.; de Wit, G. Ardine; Onland-Moret, N. Charlotte; van der Schouw, Yvonne T.; Elias, Sjoerd G.; May, Anne M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Fransen, Heidi P.; Boer, Jolanda M. A.; de Wit, G. Ardine; Bueno-de-Mesquita, H. Bas; Hoekstra, Jeljer] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Peeters, Petra H. M.; Bueno-de-Mesquita, H. Bas] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Bueno-de-Mesquita, H. Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Bueno-de-Mesquita, H. Bas] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Imperial College London; Utrecht University; Utrecht University Medical Center; Universiti Malaya	May, AM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	A.M.May@umcutrecht.nl	Elias, Sjoerd G/E-6057-2011; Onland-Moret, N. Charlotte/G-9185-2011; van der Schouw, Yvonne T./F-8327-2014; May, Anne M/G-9183-2011	Elias, Sjoerd G/0000-0003-3903-4024; Onland-Moret, N. Charlotte/0000-0002-2360-913X; van der Schouw, Yvonne T./0000-0002-4605-435X; Beulens, Joline/0000-0002-4181-0937; de Wit, G. Ardine/0000-0002-1375-7657; , jeljer/0000-0001-8252-8906	Dutch research council (NWO-ZonMW) [40-00812-98-10040]	Dutch research council (NWO-ZonMW)	This study was supported by a grant of the Dutch research council (NWO-ZonMW; grant no 40-00812-98-10040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampaabeng SK, 2013, J HEALTH ECON, V32, P1013, DOI 10.1016/j.jhealeco.2013.08.001; [Anonymous], 1944, MALNUTRITION STARV 2; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Beulens JWJ, 2010, INT J EPIDEMIOL, V39, P1170, DOI 10.1093/ije/dyp217; Bogin B., 1999, PATTERNS HUMAN GROWT, V2nd ed.; Burger G, 1948, MALNUTRITION STARV 1; Dirx MJM, 1999, CANCER CAUSE CONTROL, V10, P189, DOI 10.1023/A:1008821524297; Elias SG, 2004, J NATL CANCER I, V96, P539, DOI 10.1093/jnci/djh087; Elias SG, 2004, INT J CANCER, V108, P628, DOI 10.1002/ijc.11584; Elias SG, 2005, CANCER EPIDEM BIOMAR, V14, P1981, DOI 10.1158/1055-9965.EPI-04-0839; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Fracheboud J, 1998, INT J CANCER, V75, P694, DOI 10.1002/(SICI)1097-0215(19980302)75:5<694::AID-IJC6>3.0.CO;2-U; Fransen HP, 2015, PREV MED, V77, P119, DOI 10.1016/j.ypmed.2015.05.014; Hughes LAE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007951; Kesternich IS B, 2013, WR1015 RAND LAB POP; Lussana F, 2008, AM J CLIN NUTR, V88, P1648, DOI 10.3945/ajcn.2008.26140; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Simantov E, 2000, ARCH PEDIAT ADOL MED, V154, P1025, DOI 10.1001/archpedi.154.10.1025; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Solis CB, 2015, P NATL ACAD SCI USA, V112, pE738, DOI 10.1073/pnas.1417325112; Struijk EA, 2015, EUR J PUBLIC HEALTH, V25, P144, DOI 10.1093/eurpub/cku045; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; van Abeelen AFM, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/936509; van Abeelen AFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082636; van Abeelen AFM, 2012, DIABETES, V61, P2255, DOI 10.2337/db11-1559; van Abeelen AFM, 2012, EUR HEART J, V33, P538, DOI 10.1093/eurheartj/ehr228; Vucetic Z, 2010, NEUROSCIENCE, V168, P359, DOI 10.1016/j.neuroscience.2010.04.010; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	36	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156609	10.1371/journal.pone.0156609	http://dx.doi.org/10.1371/journal.pone.0156609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244088	gold, Green Published, Green Submitted			2022-12-26	WOS:000377146100054
J	Singhal, V; Maffazioli, GD; Ackerman, KE; Lee, H; Elia, EF; Woolley, R; Kolodny, G; Cypess, AM; Misra, M				Singhal, Vibha; Maffazioli, Giovana D.; Ackerman, Kate E.; Lee, Hang; Elia, Elisa F.; Woolley, Ryan; Kolodny, Gerald; Cypess, Aaron M.; Misra, Madhusmita			Effect of Chronic Athletic Activity on Brown Fat in Young Women	PLOS ONE			English	Article							ADIPOSE-TISSUE ACTIVITY; BODY-MASS INDEX; SECRETORY DYNAMICS; ENERGY-EXPENDITURE; ANOREXIA-NERVOSA; COLD; HUMANS; LEPTIN; WHITE; THERMOGENESIS	Background The effect of chronic exercise activity on brown adipose tissue (BAT) is not clear, with some studies showing positive and others showing negative associations. Chronic exercise is associated with increased resting energy expenditure (REE) secondary to increased lean mass and a probable increase in BAT. Many athletes are in a state of relative energy deficit suggested by lower fat mass and hypothalamic amenorrhea. States of severe energy deficit such as anorexia nervosa are associated with reduced BAT. There are no data regarding the impact of chronic exercise activity on BAT volume or activity in young women and it is unclear whether relative energy deficiency modifies the effects of exercise on BAT. Purpose We assessed cold induced BAT volume and activity in young female athletes compared with non-athletes, and further evaluated associations of BAT with measures of REE, body composition and menstrual status. Methods The protocol was approved by our Institutional Review Board. Written informed consent was obtained from all participants prior to study initiation. This was a cross-sectional study of 24 women (16 athletes and8 non-athletes) between 18-25 years of age. Athletes were either oligo-amenorrheic (n = 8) or eumenorrheic (n = 8). We used PET/CT scans to determine cold induced BAT activity, VMAX Encore 29 metabolic cart to obtain measures of REE, and DXA for body composition. Results Athletes and non-athletes did not differ for age or BMI. Compared with non-athletes, athletes had lower percent body fat (p = 0.002), higher percent leanmass (p = 0.01) and trended higher in REE (p = 0.09). BAT volume and activity in athletes trended lower than in non-athletes (p = 0.06; p = 0.07, respectively). We found negative associations of BAT activity with duration of amenorrhea (r = -0.46, p = 0.02). BAT volume correlated inversely with leanmass (r = -0.46, p = 0.02), and positively with percent body fat, irisin and thyroid hormones. Conclusions Our study shows a trend for lower BAT in young female athletes compared with non-athletes, and shows associations of brown fat with menstrual status and body composition. Brown fat may undergo adaptive reductions with increasing energy deficit.	[Singhal, Vibha; Misra, Madhusmita] Massachusetts Gen Hosp, Pediat Endocrine Unit, Boston, MA 02114 USA; [Singhal, Vibha; Maffazioli, Giovana D.; Ackerman, Kate E.; Lee, Hang; Elia, Elisa F.; Woolley, Ryan; Kolodny, Gerald; Misra, Madhusmita] Harvard Univ, Sch Med, Boston, MA USA; [Singhal, Vibha; Maffazioli, Giovana D.; Ackerman, Kate E.; Woolley, Ryan; Misra, Madhusmita] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; [Ackerman, Kate E.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Lee, Hang] Massachusetts Gen Hosp, Dept Biostat, Boston, MA 02114 USA; [Elia, Elisa F.; Kolodny, Gerald] Beth Israel Deaconess Med Ctr, Dept Radiol, Div Nucl Med & Mol Imaging, 330 Brookline Ave, Boston, MA 02215 USA; [Cypess, Aaron M.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Singhal, V (corresponding author), Massachusetts Gen Hosp, Pediat Endocrine Unit, Boston, MA 02114 USA.; Singhal, V (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Singhal, V (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA.	vsinghal1@partners.org	Singhal, Vibha/AAN-1432-2021; Misra, Madhusmita/X-8807-2018; Singhal, Vibha/AAP-3792-2020; Zamora, Cristina Cuesta/E-2864-2016	Misra, Madhusmita/0000-0002-9405-2981; Zamora, Cristina Cuesta/0000-0003-1121-9561	National Institutes of Health [1 UL1 RR025758-01, 1UL1TR001102-01, 1 R01 HD 060827-01A1, K24 HD071843]; Fundacion Alfonso Martin Escudero; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD071843] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, ZIADK075116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion Alfonso Martin Escudero; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants 1 UL1 RR025758-01, 1UL1TR001102-01, 1 R01 HD 060827-01A1, and K24 HD071843. E. Franquet was supported by Fundacion Alfonso Martin Escudero.	Albrecht E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08889; Baskaran C, 2016, EUR J ENDOCRINOL, V174, P503, DOI 10.1530/EJE-15-0875; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bredella MA, 2013, BONE, V53, P336, DOI 10.1016/j.bone.2012.12.046; Bredella MA, 2012, J CLIN ENDOCR METAB, V97, pE584, DOI 10.1210/jc.2011-2246; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Cypess AM, 2014, CELL METAB, V20, P408, DOI 10.1016/j.cmet.2014.07.025; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; De Matteis R, 2013, NUTR METAB CARDIOVAS, V23, P582, DOI 10.1016/j.numecd.2012.01.013; De Souza MJ, 2007, FERTIL STERIL, V88, P971, DOI 10.1016/j.fertnstert.2006.11.171; Dinas PC, 2015, CLIN ENDOCRINOL, V82, P147, DOI 10.1111/cen.12620; FOSTER DO, 1979, CAN J PHYSIOL PHARM, V57, P257, DOI 10.1139/y79-039; Grefhorst A, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0025-y; Haraguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111990; Lee P, 2014, INT J OBESITY, V38, P170, DOI 10.1038/ijo.2013.82; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Misra M, 2005, AM J PHYSIOL-ENDOC M, V289, pE373, DOI 10.1152/ajpendo.00041.2005; Monti V, 2006, J AM DIET ASSOC, V106, P9, DOI [10.1016/j.jada.2006.03.015, DOI 10.1016/J.JADA.2006.03.015]; Monti V, 2006, J AM DIET ASSOC, V106, P822, DOI 10.1016/j.jada.2006.03.015; Nattiv Aurelia, 2007, Med Sci Sports Exerc, V39, P1867; Obregon MJ, 2008, THYROID, V18, P185, DOI 10.1089/thy.2007.0254; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Vosselman MJ, 2015, INT J OBESITY, V39, P1696, DOI 10.1038/ijo.2015.130; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu MV, 2014, J BIOL CHEM, V289, P34129, DOI 10.1074/jbc.M114.591008	29	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156353	10.1371/journal.pone.0156353	http://dx.doi.org/10.1371/journal.pone.0156353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243823	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100031
J	Hughes, SM; Shu, ZQ; Levy, CN; Ferre, AL; Hartig, H; Fang, CF; Lentz, G; Fialkow, M; Kirby, AC; Waldorf, KMA; Veazey, RS; Germann, A; von Briesen, H; McElrath, MJ; Dezzutti, CS; Sinclair, E; Baker, CAR; Shacklett, BL; Gao, DY; Hladik, F				Hughes, Sean M.; Shu, Zhiquan; Levy, Claire N.; Ferre, April L.; Hartig, Heather; Fang, Cifeng; Lentz, Gretchen; Fialkow, Michael; Kirby, Anna C.; Waldorf, Kristina M. Adams; Veazey, Ronald S.; Germann, Anja; von Briesen, Hagen; McElrath, M. Juliana; Dezzutti, Charlene S.; Sinclair, Elizabeth; Baker, Chris A. R.; Shacklett, Barbara L.; Gao, Dayong; Hladik, Florian			Cryopreservation of Human Mucosal Leukocytes	PLOS ONE			English	Article							IMMUNE ACTIVATION; CELLS; VIABILITY; RESPONSES; FUNCTIONALITY; RECOVERY; QUALITY; VACCINE; TRIALS; PBMC	Background Understanding how leukocytes in the cervicovaginal and colorectal mucosae respond to pathogens, and how medical interventions affect these responses, is important for developing better tools to prevent HIV and other sexually transmitted infections. An effective cryopreservation protocol for these cells following their isolation will make studying them more feasible. Methods and Findings To find an optimal cryopreservation protocol for mucosal mononuclear leukocytes, we compared cryopreservation media and procedures using human vaginal leukocytes and confirmed our results with endocervical and colorectal leukocytes. Specifically, we measured the recovery of viable vaginal T cells and macrophages after cryopreservation with different cryopreservation media and handling procedures. We found several cryopreservation media that led to recoveries above 75%. Limiting the number and volume of washes increased the fraction of cells recovered by 10-15%, possibly due to the small cell numbers in mucosal samples. We confirmed that our cryopreservation protocol also works well for both endocervical and colorectal leukocytes. Cryopreserved leukocytes had slightly increased cytokine responses to antigenic stimulation relative to the same cells tested fresh. Additionally, we tested whether it is better to cryopreserve endocervical cells on the cytobrush or in suspension. Conclusions Leukocytes from cervicovaginal and colorectal tissues can be cryopreserved with good recovery of functional, viable cells using several different cryopreservation media. The number and volume of washes has an experimentally meaningful effect on the percentage of cells recovered. We provide a detailed, step-by-step protocol with best practices for cryopreservation of mucosal leukocytes.	[Hughes, Sean M.; Levy, Claire N.; Lentz, Gretchen; Fialkow, Michael; Kirby, Anna C.; Waldorf, Kristina M. Adams; Hladik, Florian] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Shu, Zhiquan; Fang, Cifeng; Gao, Dayong] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Shu, Zhiquan] Washington State Univ, Sch Mech & Mat Engn, Everett, WA USA; [Ferre, April L.; Shacklett, Barbara L.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Hartig, Heather] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Veazey, Ronald S.] Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Germann, Anja; von Briesen, Hagen] Fraunhofer Inst Biomed Engn IBMT, Div Med Biotechnol, Sulzbach, Germany; [McElrath, M. Juliana; Hladik, Florian] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [McElrath, M. Juliana; Hladik, Florian] Univ Washington, Dept Med, Seattle, WA USA; [McElrath, M. Juliana] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [McElrath, M. Juliana] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Dezzutti, Charlene S.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Dezzutti, Charlene S.] Magee Womens Res Inst, Pittsburgh, PA USA; [Sinclair, Elizabeth; Baker, Chris A. R.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Expt Med, San Francisco, CA USA; [Baker, Chris A. R.] Univ Calif San Francisco, Core Immunol Lab, San Francisco, CA 94143 USA; [Shacklett, Barbara L.] Univ Calif Davis, Sch Med, Dept Med, Div Infect Dis, Davis, CA 95616 USA; [Gao, Dayong] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Washington State University; University of California System; University of California Davis; University of California System; University of California San Francisco; Tulane University; Fraunhofer Gesellschaft; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; University of Washington; University of Washington Seattle	Hladik, F (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Gao, DY (corresponding author), Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.; Hladik, F (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Hladik, F (corresponding author), Univ Washington, Dept Med, Seattle, WA USA.; Gao, DY (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	dayong@uw.edu; florian@uw.edu	Hladik, Florian/G-1041-2012; Shacklett, Barbara/A-7288-2009	Hladik, Florian/0000-0002-0375-2764; Shacklett, Barbara/0000-0002-7067-732X; Shu, Zhiquan/0000-0002-9261-5832; Levy, Claire/0000-0003-3204-211X; Dezzutti, Charlene/0000-0001-5902-5841; Hughes, Sean/0000-0002-9409-9405	University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR), a National Institutes of Health [P30 AI027763]; Bill & Melinda Gates Foundation [OPP1032522]; National Institutes of Health [R33 AI0094412, UM1 AI068618, R01 AI057020]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057020, UM1AI068618] Funding Source: NIH RePORTER	University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR), a National Institutes of Health; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication was made possible with help from the University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (CFAR), a National Institutes of Health-funded program (http://www.nih.gov/; P30 AI027763). Funding was provided by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/; OPP1032522 to DG and FH) and the National Institutes of Health (Supplement to R33 AI0094412 to FH and DG, HVTN Mucosal Immunology Group Award to FH (parent award: UM1 AI068618 to MJM), and Administrative Supplement to R01 AI057020 to BLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bache SM, 2014, MAGRITTR FORWARD PIP; Bull M, 2007, J IMMUNOL METHODS, V322, P57, DOI 10.1016/j.jim.2007.02.003; Cohen CR, 2010, AIDS, V24, P2069, DOI 10.1097/QAD.0b013e32833c323b; Critchfield JW, 2007, J VIROL, V81, P5460, DOI 10.1128/JVI.02535-06; Daroczi G, 2015, PANDER R PANDOC WRIT; Ducar C, 2014, J IMMUNOL METHODS, V409, P9, DOI 10.1016/j.jim.2014.03.024; Filbert H, 2013, CANCER IMMUNOL IMMUN, V62, P615, DOI 10.1007/s00262-012-1359-5; Francois, 2015, READR READ TABULAR D; Fuller BJ, CRYO LETTERS, V25, P375; Germann A, 2011, BIOPRESERV BIOBANK, V9, P229, DOI 10.1089/bio.2010.0033; Harrell Jr FE, 2015, HMISC HARRELL MISCEL; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Imaizumi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088696; Lee YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063255, 10.1371/journal.pone.0054889]; Liebenberg LJ, 2011, J IMMUNOL METHODS, V367, P47, DOI 10.1016/j.jim.2011.01.013; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; McKinnon LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085675; Muyanja E, 2014, J CLIN INVEST, V124, P3147, DOI 10.1172/JCI75429; Neuwirth E., 2014, RCOLORBREWER COLORBR; Pinheiro J, 2015, NLME LINEAR NONLINEA; R Core Team, 2013, R LANG ENV STAT COMP; Sasnoor LM, 2003, J HEMATOTH STEM CELL, V12, P553, DOI 10.1089/152581603322448268; Schulz JC, 2012, J IMMUNOL METHODS, V382, P24, DOI 10.1016/j.jim.2012.05.001; Shu ZQ, 2016, BIOPRESERV BIOBANK, V14, P307, DOI 10.1089/bio.2015.0079; Shu ZQ, 2016, CRYOBIOLOGY, V72, P93, DOI 10.1016/j.cryobiol.2016.03.003; Stroncek DE, 2011, TRANSFUSION, V51, P2647, DOI 10.1111/j.1537-2995.2011.03210.x; Veeraputhiran M, 2010, CYTOTHERAPY, V12, P764, DOI 10.3109/14653241003745896; Wickham H., 2016, TIDYR EASILY TIDY DA; Wickham H., 2015, R PACKAGE VERSION, V0.4, P156; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Xie Y., 2015, DYNAMIC DOCUMENTS R, VSecond edition; Xie Y, 2015, KNITR GEN PURPOSE PA	33	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156293	10.1371/journal.pone.0156293	http://dx.doi.org/10.1371/journal.pone.0156293			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232996	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000376883000019
J	Watanabe, M; Roth, TL; Bauer, SJ; Lane, A; Romick-Rosendale, LE				Watanabe, Miki; Roth, Terri L.; Bauer, Stuart J.; Lane, Adam; Romick-Rosendale, Lindsey E.			Feasibility Study of NMR Based Serum Metabolomic Profiling to Animal Health Monitoring: A Case Study on Iron Storage Disease in Captive Sumatran Rhinoceros (Dicerorhinus sumatrensis)	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; DICEROS-BICORNIS; CREATININE; TISSUE; GENE; IDENTIFICATION; EXTRACTION; CLEARANCE; EQUATIONS; IMBALANCE	A variety of wildlife species maintained in captivity are susceptible to iron storage disease (ISD), or hemochromatosis, a disease resulting from the deposition of excess iron into insoluble iron clusters in soft tissue. Sumatran rhinoceros (Dicerorhinus sumatrensis) is one of the rhinoceros species that has evolutionarily adapted to a low-iron diet and is susceptible to iron overload. Hemosiderosis is reported at necropsy in many African black and Sumatran rhinoceroses but only a small number of animals reportedly die from hemochromatosis. The underlying cause and reasons for differences in susceptibility to hemochromatosis within the taxon remains unclear. Although serum ferritin concentrations have been useful in monitoring the progression of ISD in many species, there is some question regarding their value in diagnosing hemochromatosis in the Sumatran rhino. To investigate the metabolic changes during the development of hemochromatosis and possibly increase our understanding of its progression and individual susceptibility differences, the serum metabolome from a Sumatran rhinoceros was investigated by nuclear magnetic resonance (NMR)-based metabolomics. The study involved samples from female rhinoceros at the Cincinnati Zoo (n = 3), including two animals that died from liver failure caused by ISD, and the Sungai Dusun Rhinoceros Conservation Centre in Peninsular Malaysia (n = 4). Principal component analysis was performed to visually and statistically compare the metabolic profiles of the healthy animals. The results indicated that significant differences were present between the animals at the zoo and the animals in the conservation center. A comparison of the 43 serum metabolomes of three zoo rhinoceros showed two distinct groupings, healthy (n = 30) and unhealthy (n = 13). A total of eighteen altered metabolites were identified in healthy versus unhealthy samples. Results strongly suggest that NMR-based metabolomics is a valuable tool for animal health monitoring and may provide insight into the progression of this and other insidious diseases.	[Watanabe, Miki; Bauer, Stuart J.; Romick-Rosendale, Lindsey E.] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA; [Lane, Adam] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA; [Lane, Adam] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Roth, Terri L.] Cincinnati Zoo & Bot Garden, Ctr Conservat & Res Endangered Wildlife, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Watanabe, M (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA.	Miki.Watanabe@cchmc.org		Lane, Adam/0000-0002-5522-8112; Romick-Rosendale, Lindsey/0000-0002-7252-1193				Beben T, 2015, ADV CHRONIC KIDNEY D, V22, P337, DOI 10.1053/j.ackd.2015.05.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beutler E, 2001, BLOOD CELL MOL DIS, V27, P342, DOI 10.1006/bcmd.2001.0386; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Candra D, 2012, J ZOO WILDLIFE MED, V43, pS66, DOI 10.1638/2011-0127.1; CAREGARO L, 1994, ARCH INTERN MED, V154, P201, DOI 10.1001/archinte.154.2.201; Clauss M, 2012, J ZOO WILDLIFE MED, V43, pS6, DOI 10.1638/2011-0152.1; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Dejong CH, 2007, J NUTR S1, V137, p97S; Dejong CHC, 2007, J NUTR, V137, p1579S, DOI 10.1093/jn/137.6.1579S; Dierenfeld ES, 2006, ZOO BIOL, V25, P417, DOI 10.1002/zoo.20107; Dierenfeld ES, 2005, ZOO BIOL, V24, P51, DOI 10.1002/zoo.20043; Dove ADM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049379; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; FISCHER JE, 1974, AM J SURG, V127, P40, DOI 10.1016/0002-9610(74)90009-9; Gottschalk M, 2008, NMR BIOMED, V21, P809, DOI 10.1002/nbm.1258; JAMES JH, 1979, LANCET, V2, P772, DOI 10.1016/S0140-6736(79)92119-6; Jones OAH, 2008, MAR ECOL PROG SER, V369, P169, DOI 10.3354/meps07654; Kaddurah-Daouk R, 2008, ANNU REV PHARMACOL, V48, P653, DOI 10.1146/annurev.pharmtox.48.113006.094715; Korenaga M, 2015, LIVER INT, V35, P1303, DOI 10.1111/liv.12675; Kuwahata M, 2008, J NUTR BIOCHEM, V19, P438, DOI 10.1016/j.jnutbio.2007.05.011; MacAulay J, 2006, CAN J GASTROENTEROL, V20, P521, DOI 10.1155/2006/858053; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; Nicholson JK, 2011, PHARMACOGENOMICS, V12, P103, DOI 10.2217/PGS.10.157; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Niemuth J.N., 2014, Wildlife Biology in Practice, V10, P14; Nishitani S, 2004, BIOCHEM BIOPH RES CO, V313, P387, DOI 10.1016/j.bbrc.2003.11.023; Nishitani S, 2002, BIOCHEM BIOPH RES CO, V299, P693, DOI 10.1016/S0006-291X(02)02717-1; Olias P, 2012, J COMP PATHOL, V147, P542, DOI 10.1016/j.jcpa.2012.07.005; Paglia DE, 2012, J ZOO WILDLIFE MED, V43, pS92, DOI 10.1638/2011-0177.1; Parsons HM, 2009, ANALYST, V134, P478, DOI 10.1039/b808986h; Roth TL, 2016, P WORKSH IR OV DIS B, P14; Schock TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059521; Schock TB, 2012, FOOD CHEM, V133, P90, DOI 10.1016/j.foodchem.2011.12.077; Schock TB, 2010, METABOLOMICS, V6, P250, DOI 10.1007/s11306-009-0194-y; Serra MA, 2004, SCAND J GASTROENTERO, V39, P1149, DOI 10.1080/00365520410008024; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Smith JE, 1995, J ZOO WILDLIFE MED, V26, P525; SOETERS PB, 1976, LANCET, V2, P880; Southam AD, 2008, J PROTEOME RES, V7, P5277, DOI 10.1021/pr800353t; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Tajiri K, 2013, WORLD J GASTROENTERO, V19, P7620, DOI 10.3748/wjg.v19.i43.7620; Tuffnail W, 2009, METABOLOMICS, V5, P33, DOI 10.1007/s11306-008-0143-1; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Watanabe M, 2015, METABOLOMICS, V11, P1302, DOI 10.1007/s11306-015-0789-4; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; YAMATO M, 1995, INT HEPATOL COMMUN, V3, P91, DOI 10.1016/0928-4346(94)00159-3	49	7	8	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156318	10.1371/journal.pone.0156318	http://dx.doi.org/10.1371/journal.pone.0156318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232336	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000022
J	Yang, Y; Chen, F; Wan, DY; Liu, YH; Yang, L; Feng, HR; Cui, XL; Gao, X; Song, HF				Yang, Yi; Chen, Fang; Wan, Deyou; Liu, Yunhui; Yang, Li; Feng, Hongru; Cui, Xinling; Gao, Xin; Song, Haifeng			Expression and Characterization of a Potent Long-Acting GLP-1 Receptor Agonist, GLP-1-IgG2 sigma-Fc	PLOS ONE			English	Article							FUSION PROTEIN; PICHIA-PASTORIS; FC FUSION; ANALOG; LIRAGLUTIDE; GLUCOSE; SAFETY; TOLERABILITY; EXENDIN-4; EFFICACY	Human GLP-1 (glucagon-like peptide-1) can produce a remarkable improvement in glycemic control in patients with type 2 diabetes. However, its clinical benefits are limited by its short half-life, which is less than 2 min because of its small size and rapid enzymatic inactivation by dipeptidyl peptidase IV. We engineered GLP-1-IgG2 sigma-Fc, a 68-kDa fusion protein linking a variant human GLP-1 (A8G/G26E/R36G) to a human IgG2 sigma constant heavy-chain. A stably transfected Chinese hamster ovary cell line was obtained using electroporation. Western blotting showed that the expressed protein was immunoreactive to both GLP-1 and IgG antibodies. GLP-1-IgG2 sigma-Fc stimulated insulin secretion from INS-1 cells in a dose-and glucose-dependent manner and increased insulin mRNA expression. The half-life of GLP-1-IgG2 sigma-Fc in cynomolgus monkeys was approximately 57.1 +/- 4.5 h. In the KKAy mouse model of diabetes, one intraperitoneal injection of GLP-1-IgG2 sigma-Fc (1 mg/kg) reduced blood glucose levels for 5 days. A 4-week repeat-administration study identified sustained effects on blood glucose levels. Oral glucose tolerance tests conducted at the beginning and end of this 4-week period showed that GLP-1-IgG2 sigma-Fc produced a stable glucose lowering effect. In addition, KKAy mice treated with GLP-1-IgG2 sigma-Fc showed statistically significant weight loss from day 23. In conclusion, these properties of GLP-1-IgG2 sigma-Fc demonstrated that it represented a potential long-acting GLP-1 receptor agonist for the treatment of type 2 diabetes.	[Yang, Yi; Song, Haifeng] Anhui Med Univ, Hefei, Anhui, Peoples R China; [Yang, Yi; Chen, Fang; Wan, Deyou; Liu, Yunhui; Yang, Li; Feng, Hongru; Cui, Xinling; Gao, Xin; Song, Haifeng] Acad Mil Med Sci, Res Ctr Pharmacokinet, Beijing, Peoples R China	Anhui Medical University; Academy of Military Medical Sciences - China	Song, HF (corresponding author), Anhui Med Univ, Hefei, Anhui, Peoples R China.; Gao, X; Song, HF (corresponding author), Acad Mil Med Sci, Res Ctr Pharmacokinet, Beijing, Peoples R China.	gaox_amms@126.com; bapklab@yahoo.com			Natural Science Foundation of China [81272701]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Haifeng Song; 81272701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiram M, 2013, J CONTROL RELEASE, V172, P144, DOI 10.1016/j.jconrel.2013.07.021; Aroda VR, 2012, CLIN THER, V34, P1247, DOI 10.1016/j.clinthera.2012.04.013; ASTRUP A, 2012, INT J OBESITY, V36, P843, DOI DOI 10.1038/IJO.2011.158; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Buse JB, 2011, J CLIN ENDOCR METAB, V96, P1695, DOI 10.1210/jc.2010-2822; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Chung HS, 2011, REGUL PEPTIDES, V170, P1, DOI 10.1016/j.regpep.2011.05.002; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Glaesner W, 2010, DIABETES-METAB RES, V26, P287, DOI 10.1002/dmrr.1080; Hashimoto Y, 2000, BIOL PHARM BULL, V23, P941; Hou GJ, 2013, PEPTIDES, V40, P123, DOI 10.1016/j.peptides.2013.01.010; Huang YS, 2008, J PEPT SCI, V14, P588, DOI 10.1002/psc.942; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Levin D, 2015, TRENDS BIOTECHNOL, V33, P27, DOI 10.1016/j.tibtech.2014.11.001; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Liu M, 2010, J ETHNOPHARMACOL, V127, P32, DOI 10.1016/j.jep.2009.09.055; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Lorenz M, 2013, BIOORG MED CHEM LETT, V23, P4011, DOI 10.1016/j.bmcl.2013.05.022; Maccani A, 2014, BIOTECHNOL J, V9, P526, DOI 10.1002/biot.201300305; MacConell L, 2012, DIABETES METAB SYNDR, V5, P29, DOI 10.2147/DMSO.S28387; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Murage EN, 2010, J MED CHEM, V53, P6412, DOI 10.1021/jm100602m; Pratley Richard E, 2008, Rev Diabet Stud, V5, P73, DOI 10.1900/RDS.2008.5.73; Rossman Howard S, 2004, J Manag Care Pharm, V10, pS12; Russell-Jones D, 2010, INT J CLIN PRACT, V64, P1402, DOI 10.1111/j.1742-1241.2010.02465.x; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Siegel EG, 1999, REGUL PEPTIDES, V79, P93, DOI 10.1016/S0167-0115(98)00155-4; Vafa O, 2014, METHODS, V65, P114, DOI 10.1016/j.ymeth.2013.06.035; Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083509; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	32	2	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156449	10.1371/journal.pone.0156449	http://dx.doi.org/10.1371/journal.pone.0156449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232339	gold, Green Submitted, Green Published			2022-12-26	WOS:000376883000038
J	Mortensen, S; Jensen, JK; Andersen, GR				Mortensen, Sofia; Jensen, Jan K.; Andersen, Gregers R.			Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPONENT C2; CONVERTASE FORMATION; ALTERNATIVE PATHWAY; CLASSICAL PATHWAY; PROVIDES INSIGHTS; C-3 CONVERTASE; C3; BINDING; SCATTERING; RECOGNITION	The lectin (LP) and classical (CP) pathways are two of the three main activation cascades of the complement system. These pathways start with recognition of different pathogen-or danger-associated molecular patterns and include identical steps of proteolytic activation of complement component C4, formation of the C3 proconvertase C4b2, followed by cleavage of complement component C2 within C4b2 resulting in the C3 convertase C4b2a. Here, we describe the solution structures of the two central complexes of the pathways, C3 proconvertase and C3 convertase, as well as the unbound zymogen C2 obtained by small angle x-ray scattering analysis. We analyzed both native and enzymatically deglycosylated C4b2 and C2 and showed that the resulting structural models were independent of the glycans. The small angle x-ray scattering-derived models suggest a different activation mode for the CP/LP C3 proconvertase as compared with that established for the alternative pathway proconvertase C3bB. This is likely due to the rather different structural and functional properties of the proteases activating the proconvertases. The solution structure of a stabilized form of the active CP/LP C3 convertase C4b2a is strikingly similar to the crystal structure of the alternative pathway C3 convertase C3bBb, which is in accordance with their identical functions in cleaving the complement proteins C3 and C5.	[Mortensen, Sofia; Jensen, Jan K.; Andersen, Gregers R.] Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-800 Aarhus, Denmark	Aarhus University	Andersen, GR (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	gra@mbg.au.dk		Andersen, Gregers Rom/0000-0001-6292-3319; Jensen, Jan Kristian/0000-0002-7131-1418; Mortensen, Sofia/0000-0003-1631-6651	LUNA Nanomedicine Center; Lundbeck Foundation; Novo-Nordisk Foundation through Hallas-Moller Fellowship	LUNA Nanomedicine Center; Lundbeck Foundation(Lundbeckfonden); Novo-Nordisk Foundation through Hallas-Moller Fellowship	We thank the beamline staff at Petra P12 for support during data collection and in particular Dr. Cy Jeffries for help with data collection and analysis of the SAXS in-line and the RALS/RI experiments. We also thank Trine Gadeberg for practical assistance. Gregers R. Andersen was supported by the LUNA Nanomedicine Center, the Lundbeck Foundation, and by the Novo-Nordisk Foundation through a Hallas-Moller Fellowship.	Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Bernet J, 2004, J VIROL, V78, P9446, DOI 10.1128/JVI.78.17.9446-9457.2004; Bexborn F, 2008, MOL IMMUNOL, V45, P2370, DOI 10.1016/j.molimm.2007.11.003; Degn SE, 2014, P NATL ACAD SCI USA, V111, P13445, DOI 10.1073/pnas.1406849111; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Felix J, 2013, STRUCTURE, V21, P528, DOI 10.1016/j.str.2013.01.018; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; FISHELSON Z, 1982, J IMMUNOL, V129, P2603; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Harris CL, 2005, J BIOL CHEM, V280, P2569, DOI 10.1074/jbc.M410179200; HORIUCHI T, 1991, J IMMUNOL, V147, P584; Janssen BJC, 2009, EMBO J, V28, P2469, DOI 10.1038/emboj.2009.184; Kjaer TR, 2013, MOL IMMUNOL, V56, P222, DOI 10.1016/j.molimm.2013.05.220; Kojouharova M, 2010, MOL IMMUNOL, V47, P2154, DOI 10.1016/j.molimm.2010.05.011; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krishnan V, 2007, J MOL BIOL, V367, P224, DOI 10.1016/j.jmb.2006.12.039; Krishnan V, 2009, ACTA CRYSTALLOGR D, V65, P266, DOI 10.1107/S0907444909000389; Laich A, 2001, BBA-PROTEIN STRUCT M, V1544, P96, DOI 10.1016/S0167-4838(00)00208-9; Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341; Martini PGV, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-43; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; Milder FJ, 2006, STRUCTURE, V14, P1587, DOI 10.1016/j.str.2006.08.008; MILLER JA, 1968, P SOC EXP BIOL MED, V129, P127; Moharana K, 2014, STRUCTURE, V22, P866, DOI 10.1016/j.str.2014.04.012; Mortensen S, 2015, J IMMUNOL, V194, P5488, DOI 10.4049/jimmunol.1500087; MULLEREBERHARD HJ, 1967, J EXP MED, V125, P359, DOI 10.1084/jem.125.2.359; NAGASAWA S, 1977, P NATL ACAD SCI USA, V74, P2998, DOI 10.1073/pnas.74.7.2998; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Roumenina LT, 2009, BLOOD, V114, P2837, DOI 10.1182/blood-2009-01-197640; SITOMER G, 1966, IMMUNOCHEMISTRY, V3, P57, DOI 10.1016/0019-2791(66)90282-5; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106; VILLIERS MB, 1985, BIOCHEM J, V226, P429, DOI 10.1042/bj2260429; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; Wallis R, 2007, J BIOL CHEM, V282, P7844, DOI 10.1074/jbc.M606326200	40	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16494	16507		10.1074/jbc.M116.722017	http://dx.doi.org/10.1074/jbc.M116.722017			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27252379	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000380826700010
J	Marques, CMD; MacNeil, S				de Godoy Marques, Claudia Mirian; MacNeil, Sheila			Use of a Tissue Engineered Human Skin Model to Investigate the Effects of Wounding and of an Anti-Inflammatory on Melanoma Cell Invasion	PLOS ONE			English	Article							RECONSTRUCTED HUMAN SKIN; NECROSIS-FACTOR-ALPHA; STIMULATING HORMONE; CYCLOOXYGENASE-2 INHIBITOR; TUMOR-GROWTH; CANCER; FIBROBLASTS; INFLAMMATION; EXPRESSION; MIGRATION	An increasing number of studies suggest inflammation stimulates tumour invasion. In melanoma, despite recent advances in targeted therapy and immunomodulatory therapies, this cancer remains difficult to treat. Our previous studies show melanoma cells interact with skin cells in their invasion into tissue engineered skin and suggest inflammation stimulates invasion. The aim of this study was to investigate the use of an anti-inflammatory on melanoma invasion. To do this we developed a wounded and inflamed in vitro 3D melanoma model in which to investigate the use of an anti-inflammatory on melanoma invasion. The tissue engineered skin model was based on human de-epidermised acellular dermis to which keratinocytes, fibroblasts and three different melanoma cell lines were added in various combinations. A simple incisional wound was made in the model and TNF-alpha and fibrin were added to simulate conditions of inflammation. Topical ibuprofen in a hydrogel was added and the extent of melanoma invasion into the dermis was assessed under the various conditions. The results showed that penetration of two of the cell lines (HBL and A375SM) into the tissue engineered skin was exacerbated by wounding and ibuprofen significantly decreased invasion of A375SM cells and slightly reduced invasion of HBL cells. A third cell line, C8161, was aggressively invasive under all conditions to an extent that was not influenced by wounding, TNF-alpha or the addition of ibuprofen. In summary, the results for one these cell lines (and a trend for a second cell line) support the hypothesis that a wound environment is conducive to melanoma invasion but the local addition of an anti-inflammatory drug such as ibuprofen may attenuate invasion.	[de Godoy Marques, Claudia Mirian] Santa Catarina State Univ, Dept Hlth Sci, Florianopolis, SC, Brazil; [MacNeil, Sheila] Univ Sheffield, Dept Mat Sci & Engn, Kroto Res Inst, Sheffield, S Yorkshire, England	Universidade do Estado de Santa Catarina; University of Sheffield	MacNeil, S (corresponding author), Univ Sheffield, Dept Mat Sci & Engn, Kroto Res Inst, Sheffield, S Yorkshire, England.	s.macneil@sheffield.ac.uk			CAPES Foundation (Brazilian Government) [BEX 2475/04-9]	CAPES Foundation (Brazilian Government)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors gratefully acknowledge the CAPES Foundation (Brazilian Government) (Grant Number BEX 2475/04-9) for the support of CMGM's PhD research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the CAPES Foundation (Brazilian Government) for the support of Claudia MG Marques PhD research work.	Aliperti LA, 2011, ANN SURG ONCOL, V18, P603, DOI 10.1245/s10434-010-1442-0; [Anonymous], 2010, SEER STAT DAT INC SE; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Bogden AE, 1997, BRIT J CANCER, V75, P1021, DOI 10.1038/bjc.1997.175; BREGMAN MD, 1983, PROSTAGLANDINS, V26, P449, DOI 10.1016/0090-6980(83)90179-X; Briggs M, 2012, COCHRANE DB SYST REV, V11; Canton I, 2003, J INVEST DERMATOL, V121, P557, DOI 10.1046/j.1523-1747.2003.12417.x; Chakrabarty KH, 1999, BRIT J DERMATOL, V141, P811, DOI 10.1046/j.1365-2133.1999.03153.x; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Crusz SM, 2015, NAT REV CLIN ONCOL, V12, P584, DOI 10.1038/nrclinonc.2015.105; Edward M, 2005, CARCINOGENESIS, V26, P1215, DOI 10.1093/carcin/bgi064; Eggermont AMM, 2014, LANCET, V383, P816, DOI 10.1016/S0140-6736(13)60802-8; Eves P, 2003, CLIN EXP METASTAS, V20, P685, DOI 10.1023/B:CLIN.0000006824.41376.b0; Eves P, 2000, BRIT J DERMATOL, V142, P210, DOI 10.1046/j.1365-2133.2000.03287.x; Eves P, 2003, BRIT J CANCER, V89, P2004, DOI 10.1038/sj.bjc.6601349; Flach EH, 2011, MOL PHARMACEUT, V8, P2039, DOI 10.1021/mp200421k; GHANEM GE, 1988, INT J CANCER, V41, P248, DOI 10.1002/ijc.2910410216; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Goldbrunner RH, 1996, ANTICANCER RES, V16, P3679; Guan XM, 2015, ACTA PHARM SIN B, V5, P402, DOI 10.1016/j.apsb.2015.07.005; Katerinaki E, 2006, MELANOMA RES, V16, P11, DOI 10.1097/01.cmr.0000195698.58013.53; Kim E, 2013, CANCER RES, V73, P6874, DOI 10.1158/0008-5472.CAN-13-1720; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Larkin J, 2014, LANCET ONCOL, V15, P436, DOI 10.1016/S1470-2045(14)70051-8; Leiter Ulrike, 2014, Adv Exp Med Biol, V810, P120; Lejeune FJ, 2006, MELANOMA RES, V16, P263, DOI 10.1097/01.cmr.0000205020.17774.ae; Lewis DA, 2011, AGING-US, V3, P407, DOI 10.18632/aging.100318; Li J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150247; Little EG, 2012, DERMATOL CLIN, V30, P355, DOI 10.1016/j.det.2012.04.001; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Olszanski AJ, 2014, J MANAG CARE SPEC PH, V20, P346, DOI 10.18553/jmcp.2014.20.4.346; Redpath M, 2009, BRIT J DERMATOL, V161, P25, DOI 10.1111/j.1365-2133.2009.09220.x; Reed KB, 2012, MAYO CLIN PROC, V87, P328, DOI 10.1016/j.mayocp.2012.01.010; Reichle A, 2004, CANCER-AM CANCER SOC, V101, P2247, DOI 10.1002/cncr.20574; Ribas A, 2014, LANCET ONCOL, V15, P954, DOI 10.1016/S1470-2045(14)70301-8; Rizzi SC, 2010, EXPERT REV MED DEVIC, V7, P143, DOI [10.1586/erd.09.57, 10.1586/ERD.09.57]; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Spieth K, 2003, CANCER CHEMOTH PHARM, V52, P377, DOI 10.1007/s00280-003-0678-9; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Tiago M, 2014, TISSUE ENG PT A, V20, P2412, DOI [10.1089/ten.tea.2013.0473, 10.1089/ten.TEA.2013.0473]; Veierod Marit B, 2015, Tidsskr Nor Laegeforen, V135, P450, DOI 10.4045/tidsskr.14.1109; Woo KY, 2008, INT WOUND J, V5, P1, DOI 10.1111/j.1742-481X.2008.00474.x; Yorucu C, 2016, APPL SPECTROSC REV, V51, P243, DOI 10.1080/05704928.2015.1126840; Zhou LL, 2015, J CANCER, V6, P717, DOI 10.7150/jca.10865; Zhu NW, 2002, J INVEST DERMATOL, V119, P1165, DOI 10.1046/j.1523-1747.2002.19516.x	47	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0156931	10.1371/journal.pone.0156931	http://dx.doi.org/10.1371/journal.pone.0156931			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27270229	Green Published, gold, Green Accepted			2022-12-26	WOS:000377561000051
J	Girard, D; Tardif, JC; Demarble, JB; D'Antono, B				Girard, Dominique; Tardif, Jean-Claude; Demarble, Julie Boisclair; D'Antono, Bianca			Trait Hostility and Acute Inflammatory Responses to Stress in the Laboratory	PLOS ONE			English	Article							ACUTE PSYCHOLOGICAL STRESS; CORONARY-ARTERY-DISEASE; PHYSIOLOGICAL-RESPONSES; DEPRESSIVE SYMPTOMS; BLOOD-PRESSURE; INTERPERSONAL STRESS; PSYCHOSOCIAL FACTORS; CYTOKINE PRODUCTION; SOCIAL SUPPORT; HEALTHY-MEN	Hostility has been associated with higher basal levels of inflammation. The present study evaluated the association of hostility with acute stress-induced changes in inflammatory activity. One hundred and ninety-nine healthy men and women, aged 19-64 years, were exposed to a stress protocol involving four interpersonal stressors. Participants completed the Cook-Medley Hostility questionnaire and provided two blood samples for the measurement of inflammatory biomarkers (CRP, II-6, MPO, TNF-alpha, MCP-1, II-8, II-10, and II-18), prior to and following exposure to a standardized stress protocol. In univariate analyses, hostility was associated with significantly higher TNF-alpha, but lower II-8 and II-18 values post-stress, though only II-8 remained significant after controlling for baseline differences. In multivariate analyses, a significant Age by Hostility interaction emerged for II-6, while sex moderated the relation between hostility and II-10 reactivity. Following stress, hostility was associated with greater pro-inflammatory II-6 activity among younger individuals and to decreased anti-inflammatory II-10 activity in women. Future research is needed to replicate these findings and to evaluate their implication for disease.	[Girard, Dominique; Tardif, Jean-Claude; Demarble, Julie Boisclair; D'Antono, Bianca] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Girard, Dominique] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Tardif, Jean-Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Demarble, Julie Boisclair; D'Antono, Bianca] Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; University of Quebec; University of Quebec Montreal; Universite de Montreal; Universite de Montreal	D'Antono, B (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.; D'Antono, B (corresponding author), Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada.	bianca.d.antono@umontreal.ca		Girard, Dominique/0000-0001-7822-8724	Canadian Institutes of Health Research (CIHR) [79456, 111017]; Montreal Heart Institute Foundation	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Montreal Heart Institute Foundation	This study was supported by grants awarded to Dr D'Antono by the Canadian Institutes of Health Research (CIHR; MOP #79456 and #111017) and the Montreal Heart Institute Foundation. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	al'Absi M, 2000, INT J PSYCHOPHYSIOL, V37, P257, DOI 10.1016/S0167-8760(00)00108-2; BAREFOOT JC, 1983, PSYCHOSOM MED, V45, P59, DOI 10.1097/00006842-198303000-00008; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Bobjer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061466; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; Brummett BH, 2010, PSYCHOSOM MED, V72, P333, DOI 10.1097/PSY.0b013e3181d2f104; Bruun JM, 2003, HORM METAB RES, V35, P142, DOI 10.1055/s-2003-39074; Brydon L, 2010, J PSYCHOSOM RES, V68, P109, DOI 10.1016/j.jpsychores.2009.06.007; Bunde J, 2006, HEALTH PSYCHOL, V25, P493, DOI 10.1037/0278-6133.25.4.493; Buske-Kirschbaum A, 2007, BRAIN BEHAV IMMUN, V21, P92, DOI 10.1016/j.bbi.2006.03.006; Buske-Kirschbaum A, 2002, J NEUROIMMUNOL, V129, P161, DOI 10.1016/S0165-5728(02)00168-6; Chida Y, 2008, PSYCHOL BULL, V134, P829, DOI 10.1037/a0013342; Chida Y, 2010, HYPERTENSION, V55, P1026, DOI 10.1161/HYPERTENSIONAHA.109.146621; Coccaro EF, 2006, J PSYCHIAT RES, V40, P460, DOI 10.1016/j.jpsychires.2005.04.005; Connor TJ, 2005, J NEUROIMMUNOL, V159, P119, DOI 10.1016/j.jneuroim.2004.10.016; Cook W. W., 1954, PROPOSED HOSTILITY P, DOI [10.1037/h0060667, DOI 10.1037/H0060667]; Curtin NM, 2009, BRAIN BEHAV IMMUN, V23, P371, DOI 10.1016/j.bbi.2008.12.010; CUTOLO M, 1995, MEDIAT INFLAMM, V4, P138, DOI 10.1155/S096293519500024X; Czajkowski SM, 1997, AM J CARDIOL, V79, P1017, DOI 10.1016/S0002-9149(97)00040-4; D'Antono B, 2005, J BEHAV MED, V28, P267, DOI 10.1007/s10865-005-4663-0; D'Antono B, 2013, J PSYCHOSOM RES, V75, P262, DOI 10.1016/j.jpsychores.2013.05.010; Demarble JB, 2014, J PSYCHOSOM RES, V76, P384, DOI 10.1016/j.jpsychores.2014.02.010; Deschamps A, 2013, J CARDIOTHOR VASC AN, V27, P485, DOI 10.1053/j.jvca.2012.07.016; Dragomir AI, 2014, PSYCHOPHYSIOLOGY, V51, P921, DOI 10.1111/psyp.12231; Elovainio M, 2011, BIOL PSYCHOL, V87, P234, DOI 10.1016/j.biopsycho.2011.03.002; Everson SA, 1996, HYPERTENSION, V27, P1059, DOI 10.1161/01.HYP.27.5.1059; Feinstein DL, 2002, NEUROCHEM INT, V41, P357, DOI 10.1016/S0197-0186(02)00049-9; Gentile C, 2015, ANN BEHAV MED, V49, P112, DOI 10.1007/s12160-014-9639-2; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Gordon JL, 2012, PSYCHOPHYSIOLOGY, V49, P1082, DOI 10.1111/j.1469-8986.2012.01397.x; Graham JE, 2006, BRAIN BEHAV IMMUN, V20, P389, DOI 10.1016/j.bbi.2005.11.002; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hackett RA, 2015, PSYCHOSOM MED, V77, P458, DOI 10.1097/PSY.0000000000000172; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heesen C, 2002, BRAIN BEHAV IMMUN, V16, P282, DOI 10.1006/brbi.2001.0628; Heneka MT, 2002, J NEUROSCI, V22, P2434, DOI 10.1523/JNEUROSCI.22-07-02434.2002; Janicki-Deverts D, 2010, BRAIN BEHAV IMMUN, V24, P58, DOI 10.1016/j.bbi.2009.07.009; Juster RP, 2013, STRESS, V16, P616, DOI 10.3109/10253890.2013.835395; Kiecolt-Glaser JK, 2010, NEUROSCI BIOBEHAV R, V35, P33, DOI 10.1016/j.neubiorev.2009.09.003; Kiecolt-Glaser JK, 2005, ARCH GEN PSYCHIAT, V62, P1377, DOI 10.1001/archpsyc.62.12.1377; Kinzenbaw DA, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.149; Lavretsky H, 2012, AM J GERIAT PSYCHIAT, V20, P729, DOI 10.1097/JGP.0b013e31826573cf; Levesque K, 2010, PSYCHOPHYSIOLOGY, V47, P332, DOI 10.1111/j.1469-8986.2009.00943.x; Levesque K, 2009, BIOL PSYCHOL, V80, P354, DOI 10.1016/j.biopsycho.2008.12.003; Loria V, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/135625; Lutgendorf SK, 2004, BRAIN BEHAV IMMUN, V18, P55, DOI 10.1016/S0889-1591(03)00090-4; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pharmtox.35.1.417; Maes M, 2000, NEUROENDOCRINOL LETT, V21, P375; Maruyama Y, 2004, J NEPHROL, V17, pS72; Mezuk B, 2010, BRAIN BEHAV IMMUN, V24, P1294, DOI 10.1016/j.bbi.2010.06.006; Miller GE, 2003, J BEHAV MED, V26, P501, DOI 10.1023/A:1026273817984; Miller TQ, 1996, PSYCHOL BULL, V119, P322, DOI 10.1037/0033-2909.119.2.322; Mwendwa DT, 2013, BRAIN BEHAV IMMUN, V28, P72, DOI 10.1016/j.bbi.2012.10.019; O'Brien E, 2001, BMJ-BRIT MED J, V322, P531, DOI 10.1136/bmj.322.7285.531; OLWEUS D, 1980, PSYCHOSOM MED, V42, P253, DOI 10.1097/00006842-198003000-00003; Peters ML, 1999, PSYCHOSOM MED, V61, P513, DOI 10.1097/00006842-199907000-00016; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Prather AA, 2009, BRAIN BEHAV IMMUN, V23, P622, DOI 10.1016/j.bbi.2008.11.004; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Ranjit N, 2007, ARCH INTERN MED, V167, P174, DOI 10.1001/archinte.167.2.174; Rappaport LM, 2014, J COUNS PSYCHOL, V61, P253, DOI 10.1037/a0035625; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sherwood A, 2002, PSYCHOSOM MED, V64, P247, DOI 10.1097/00006842-200203000-00007; Smith TW, 2004, J PERS, V72, P1217, DOI 10.1111/j.1467-6494.2004.00296.x; SMITH TW, 1994, IRISH J PSYCHOL, V15, P8, DOI 10.1080/03033910.1994.10557991; SMITH TW, 1985, HEALTH PSYCHOL, V4, P503, DOI 10.1037/0278-6133.4.6.503; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Stewart JC, 2008, PSYCHOSOM MED, V70, P197, DOI 10.1097/PSY.0b013e3181642a0b; Suarez EC, 2003, PSYCHOSOM MED, V65, P523, DOI 10.1097/01.PSY.0000062530.94551.EA; Suarez EC, 2002, BRAIN BEHAV IMMUN, V16, P675, DOI 10.1016/S0889-1591(02)00019-3; Suarez EC, 1998, PSYCHOSOM MED, V60, P78, DOI 10.1097/00006842-199801000-00017; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; Tikkanen P., 1999, CHARACTERIZATION APP; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Yang YC, 2014, SOC SCI MED, V107, P124, DOI 10.1016/j.socscimed.2014.02.013; Yao Y, 2013, INT REV IMMUNOL, V32, P324, DOI 10.3109/08830185.2012.762361	79	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156329	10.1371/journal.pone.0156329	http://dx.doi.org/10.1371/journal.pone.0156329			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270459	Green Published, gold, Green Submitted			2022-12-26	WOS:000377560200007
J	Helft, L; Thompson, M; Bent, AF				Helft, Laura; Thompson, Mikayla; Bent, Andrew F.			Directed Evolution of FLS2 towards Novel Flagellin Peptide Recognition	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; BACTERIAL ELICITOR FLAGELLIN; DISEASE-RESISTANCE GENE; PLANT IMMUNE-RESPONSES; ELONGATION-FACTOR TU; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; RECEPTOR EFR; NICOTIANA-BENTHAMIANA	Microbe-associated molecular patterns (MAMPs) are molecules, or domains within molecules, that are conserved across microbial taxa and can be recognized by a plant or animal immune system. Although MAMP receptors have evolved to recognize conserved epitopes, the MAMPs in some microbial species or strains have diverged sufficiently to render them unrecognizable by some host immune systems. In this study, we carried out in vitro evolution of the Arabidopsis thaliana flagellin receptor FLAGELLIN-SENSING 2 (FLS2) to isolate derivatives that recognize one or more flagellin peptides from bacteria for which the wildtype Arabidopsis FLS2 confers little or no response. A targeted approach generated amino acid variation at FLS2 residues in a region previously implicated in flagellin recognition. The primary screen tested for elevated response to the canonical flagellin peptide from Pseudomonas aeruginosa, flg22. From this pool, we then identified five alleles of FLS2 that confer modest (quantitatively partial) recognition of an Erwinia amylovora flagellin peptide. Use of this Erwinia-based flagellin peptide to stimulate Arabidopsis plants expressing the resulting FLS2 alleles did not lead to a detectable reduction of virulent P. syringae pv. tomato growth. However, combination of two identified mutations into a single allele further increased FLS2-mediated responses to the E. amylovora flagellin peptide. These studies demonstrate the potential to raise the sensitivity of MAMP receptors toward particular targets.	[Helft, Laura; Thompson, Mikayla; Bent, Andrew F.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Helft, Laura] Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI USA; [Helft, Laura] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Thompson, Mikayla] Yale Univ, New Haven, CT 06520 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; Yale University	Bent, AF (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	afbent@wisc.edu	Bent, Andrew/E-5391-2016	Bent, Andrew/0000-0001-6610-9525	U.S. Department of Energy [DE-FG02-02ER15342]; NSF Predoctoral Fellowship	U.S. Department of Energy(United States Department of Energy (DOE)); NSF Predoctoral Fellowship(National Science Foundation (NSF))	This research was funded by the U.S. Department of Energy (http://science.energy.gov/bes/csgb/, Contract No. DE-FG02-02ER15342) to AFB and an NSF Predoctoral Fellowship (https://www.nsfgrfp.org) to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2010, PLANT PHYSIOL, V152, P267, DOI 10.1104/pp.109.148049; Albert M, 2010, J BIOL CHEM, V285, P19035, DOI 10.1074/jbc.M110.124800; Albert M, 2010, EUR J CELL BIOL, V89, P200, DOI 10.1016/j.ejcb.2009.11.015; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Aslam SN, 2009, MOL PLANT PATHOL, V10, P375, DOI [10.1111/j.1364-3703.2009.00537.x, 10.1111/J.1364-3703.2009.00537.X]; Bardoel BW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002206; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; Beck M, 2012, CURR OPIN PLANT BIOL, V15, P367, DOI 10.1016/j.pbi.2012.05.004; Belkhadirl Y, 2014, TRENDS BIOCHEM SCI, V39, P447, DOI 10.1016/j.tibs.2014.06.006; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bratkovic T, 2010, CELL MOL LIFE SCI, V67, P749, DOI 10.1007/s00018-009-0192-2; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Cao YR, 2014, ELIFE, V3, DOI 10.7554/eLife.03766; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Chapman S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110158; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Clarke CR, 2013, NEW PHYTOL, V200, P847, DOI 10.1111/nph.12408; Cook DE, 2015, ANNU REV PHYTOPATHOL, V53, P541, DOI 10.1146/annurev-phyto-080614-120114; Deng L, 2013, ANNU REV BIOPHYS, V42, P191, DOI 10.1146/annurev-biophys-083012-130422; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dou DL, 2012, CELL HOST MICROBE, V12, P484, DOI 10.1016/j.chom.2012.09.003; Dunning FM, 2007, PLANT CELL, V19, P3297, DOI 10.1105/tpc.106.048801; Segretin ME, 2014, MOL PLANT MICROBE IN, V27, P624, DOI 10.1094/MPMI-02-14-0040-R; Farnham G, 2006, P NATL ACAD SCI USA, V103, P18828, DOI 10.1073/pnas.0605777103; Faulkner C, 2013, P NATL ACAD SCI USA, V110, P9166, DOI 10.1073/pnas.1203458110; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Forsyth A, 2010, MOL PLANT MICROBE IN, V23, P1545, DOI 10.1094/MPMI-02-10-0047; Giannakopoulou A, 2015, MOL PLANT MICROBE IN, V28, P1316, DOI 10.1094/MPMI-07-15-0147-R; Gilbreth RN, 2012, CURR OPIN STRUC BIOL, V22, P413, DOI 10.1016/j.sbi.2012.06.001; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; Hann DR, 2007, PLANT J, V49, P607, DOI 10.1111/j.1365-313X.2006.02981.x; Harris CJ, 2013, P NATL ACAD SCI USA, V110, P21189, DOI 10.1073/pnas.1311134110; Helft L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021614; Hirai H, 2011, J BIOL CHEM, V286, P25519, DOI 10.1074/jbc.M111.254029; Jehle AK, 2013, PLANT CELL, V25, P2330, DOI 10.1105/tpc.113.110833; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kishimoto K, 2010, PLANT J, V64, P343, DOI 10.1111/j.1365-313X.2010.04328.x; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Koller T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111185; KUNKEL BN, 1993, PLANT CELL, V5, P865, DOI 10.1105/tpc.5.8.865; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Lane MD, 2014, CURR OPIN CHEM BIOL, V22, P129, DOI 10.1016/j.cbpa.2014.09.013; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Meindl T, 2000, PLANT CELL, V12, P1783, DOI 10.1105/tpc.12.9.1783; Minshull J, 2004, METHODS, V32, P416, DOI 10.1016/j.ymeth.2003.10.004; Miya A, 2007, P NATL ACAD SCI US; Mueller K, 2012, PLANT CELL, V24, P2213, DOI 10.1105/tpc.112.096073; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nicaise V, 2013, EMBO J, V32, P701, DOI 10.1038/emboj.2013.15; Padmanabhan M, 2009, CELL MICROBIOL, V11, P191, DOI 10.1111/j.1462-5822.2008.01260.x; Pel MJC, 2014, MOL PLANT MICROBE IN, V27, P603, DOI 10.1094/MPMI-02-14-0032-R; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Pfund C, 2004, MOL PLANT MICROBE IN, V17, P696, DOI 10.1094/MPMI.2004.17.6.696; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Robatzek S, 2013, PROTOPLASMA, V250, P671, DOI 10.1007/s00709-012-0459-6; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Segonzac C, 2011, PLANT PHYSIOL, V156, P687, DOI 10.1104/pp.110.171249; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Stirnweis D, 2014, MOL PLANT MICROBE IN, V27, P265, DOI 10.1094/MPMI-10-13-0297-FI; Sun WX, 2012, PLANT CELL, V24, P1096, DOI 10.1105/tpc.112.095919; Sun WX, 2011, MOL PLANT PATHOL, V12, P731, DOI [10.1111/j.1364-3703.2011.00707.x, 10.1111/J.1364-3703.2011.00707.X]; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Takakura Y, 2008, MOL PLANT PATHOL, V9, P525, DOI 10.1111/J.1364-3703.2008.00477.X; Takeuchi K, 2003, J BACTERIOL, V185, P6658, DOI 10.1128/JB.185.22.6658-6665.2003; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Tintor N, 2013, P NATL ACAD SCI USA, V110, P6211, DOI 10.1073/pnas.1216780110; Trda L, 2014, NEW PHYTOL, V201, P1371, DOI 10.1111/nph.12592; Vetter MM, 2012, MOL BIOL EVOL, V29, P1655, DOI 10.1093/molbev/mss011; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang SZ, 2015, MOL PLANT, V8, P1024, DOI 10.1016/j.molp.2015.01.012; Win J., 2012, COLD SPRING HARB SYM, V77, P235, DOI [10.1101/sqb.2012.77.015933, DOI 10.1101/SQB.2012.77.015933]; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zhang Z, 2013, J INTEGR PLANT BIOL, V55, P1212, DOI 10.1111/jipb.12080; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	94	10	10	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0157155	10.1371/journal.pone.0157155	http://dx.doi.org/10.1371/journal.pone.0157155			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270917	Green Published, Green Submitted, gold			2022-12-26	WOS:000377560200033
J	Zhunussova, A; Vitol, EA; Polyak, B; Tuleukhanov, S; Brooks, AD; Sensenig, R; Friedman, G; Orynbayeva, Z				Zhunussova, Aigul; Vitol, Elina A.; Polyak, Boris; Tuleukhanov, Sultan; Brooks, Ari D.; Sensenig, Richard; Friedman, Gary; Orynbayeva, Zulfiya			Mitochondria-Mediated Anticancer Effects of Non-Thermal Atmospheric Plasma	PLOS ONE			English	Article							PRESSURE PLASMA; COMPLEX II; CELLS; ROS; STERILIZATION; SUPEROXIDE; GENERATION; INHIBITORS; SUCCINATE	Non-thermal atmospheric pressure plasma has attracted great interest due to its multiple potential biomedical applications with cancer treatment being among the most urgent. To realize the clinical potential of non-thermal plasma, the exact cellular and molecular mechanisms of plasma effects must be understood. This work aimed at studying the prostate cancer specific mechanisms of non-thermal plasma effects on energy metabolism as a central regulator of cell homeostasis and proliferation. It was found that cancer cells with higher metabolic rate initially are more resistant to plasma treated phosphate-buffered saline (PBS) since the respiratory and calcium sensitive signaling systems were not responsive to plasma exposure. However, dramatic decline of cancer oxidative phosphorylation developed over time resulted in significant progression of cell lethality. The normal prostate cells with low metabolic activity immediately responded to plasma treated PBS by suppression of respiratory functions and sustained elevation of cytosolic calcium. However, over time the normal cells start recovering their mitochondria functions, proliferate and restore the cell population. We found that the non-thermal plasma induced increase in intracellular ROS is of primarily non-mitochondrial origin. The discriminate non-thermal plasma effects hold a promise for clinical cancer intervention.	[Zhunussova, Aigul; Polyak, Boris; Orynbayeva, Zulfiya] Drexel Univ, Coll Med, Dept Surg, Philadelphia, PA 19104 USA; [Zhunussova, Aigul; Tuleukhanov, Sultan] Al Farabi Kazakh Natl Univ, Dept Biophys & Biomed, Alma Ata, Kazakhstan; [Vitol, Elina A.; Friedman, Gary] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA; [Brooks, Ari D.; Sensenig, Richard] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Vitol, Elina A.] ECOLAB, RD&E, Global Sensor Syst Engn, Naperville, IL USA	Drexel University; Al-Farabi Kazakh National University; Drexel University; University of Pennsylvania; Ecolab Inc.	Orynbayeva, Z (corresponding author), Drexel Univ, Coll Med, Dept Surg, Philadelphia, PA 19104 USA.	zorynbay@drexelmed.edu	Vitol, Elina/U-5228-2019; Tuleuhanov, Sultan/O-1218-2014	Tuleukhanov, Sultan/0000-0002-9898-0507	Cornelius Beukenkamp endowment for studies of prostate cancer; Mary DeWitt Pettit Foundation	Cornelius Beukenkamp endowment for studies of prostate cancer; Mary DeWitt Pettit Foundation	This work was supported by Cornelius Beukenkamp endowment for studies of prostate cancer and the Mary DeWitt Pettit Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by Cornelius Beukenkamp endowment for studies of prostate cancer. The support of Mary DeWitt Pettit Foundation is appreciated.	Arjunan KP, 2012, J R SOC INTERFACE, V9, P147, DOI 10.1098/rsif.2011.0220; Burts ML, 2009, AM J INFECT CONTROL, V37, P729, DOI 10.1016/j.ajic.2009.03.010; De Geyter N, 2012, ANNU REV BIOMED ENG, V14, P255, DOI 10.1146/annurev-bioeng-071811-150110; Drose S, 2013, BBA-BIOENERGETICS, V1827, P578, DOI 10.1016/j.bbabio.2013.01.004; Ercan UK, 2013, PLASMA PROCESS POLYM, V10, P544, DOI 10.1002/ppap.201200104; Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01; FRIDMAN A, 2008, PLASMA CHEM; Fridman A, 2004, PLASMA PHYS ENG; Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; Gnaiger E., 2008, MITOCHONDRIAL DYSFUN, P27; Haertel B, 2014, BIOMOL THER, V22, P477, DOI 10.4062/biomolther.2014.105; Hofer C, 1999, EUR UROL, V36, P31, DOI 10.1159/000019923; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Howlader N. N. A., 2015, SEER CANC STAT REV; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kostov KG, 2010, SURF COAT TECH, V204, P2954, DOI 10.1016/j.surfcoat.2010.01.052; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Laroussi M, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/341; Lloyd G, 2010, PLASMA PROCESS POLYM, V7, P194, DOI 10.1002/ppap.200900097; Moreau M, 2008, BIOTECHNOL ADV, V26, P610, DOI 10.1016/j.biotechadv.2008.08.001; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Panngom K, CELL DEATH CENTRAL; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; Panov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072078; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Ralph SJ, 2011, PHARM RES-DORDR, V28, P2695, DOI 10.1007/s11095-011-0566-7; Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347; Schmidt A, 2015, J BIOL CHEM, V290, P6731, DOI 10.1074/jbc.M114.603555; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Tuhvatulin AI, 2012, ACTA NATURAE, V4, P82, DOI 10.32607/20758251-2012-4-3-82-87; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Zhang W, 2015, INT J BIOL SCI, V11, P1160, DOI 10.7150/ijbs.11439; Zhunussova A, 2015, AM J CANCER RES, V5, P1665	40	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2016	11	6							e0156818	10.1371/journal.pone.0156818	http://dx.doi.org/10.1371/journal.pone.0156818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1SU	27270230	gold, Green Submitted, Green Published			2022-12-26	WOS:000377560200018
J	Florio, AM; Raxworthy, CJ				Florio, Antonia M.; Raxworthy, Christopher J.			A Phylogeographic Assessment of the Malagasy Giant Chameleons (Furcifer verrucosus and Furcifer oustaleti)	PLOS ONE			English	Article							WESTERN INDIAN-OCEAN; PHYLOGENETIC-RELATIONSHIPS; MAXIMUM-LIKELIHOOD; MOLECULAR APPROACH; MITOCHONDRIAL-DNA; MADAGASCAR; SPECIATION; INFERENCE; DIVERSIFICATION; HYPOTHESES	The Malagasy giant chameleons (Furcifer oustaleti and Furcifer verrucosus) are sister species that are both broadly distributed in Madagascar, and also endemic to the island. These species are also morphologically similar and, because of this, have been frequently misidentified in the field. Previous studies have suggested that cryptic species are nested within this chameleon group, and two subspecies have been described in F. verrucosus. In this study, we utilized a phylogeographic approach to assess genetic diversification within these chameleons. This was accomplished by (1) identifying clades within each species supported by both mitochondrial and nuclear DNA, (2) assessing divergence times between clades, and (3) testing for niche divergence or conservatism. We found that both F. oustaleti and F. verrucosus could be readily identified based on genetic data, and within each species, there are two well-supported clades. However, divergence times are not contemporary and spatial patterns are not congruent. Diversification within F. verrucosus occurred during the Plio-Pleistocene, and there is evidence for niche divergence between a southwestern and southeastern clade, in a region of Madagascar that shows no obvious landscape barriers to dispersal. Diversification in F. oustaleti occurred earlier in the Pliocene or Miocene, and niche conservatism is supported with two genetically distinct clades separated at the Sofia River in northwestern Madagascar. Divergence within F. verrucosus is most consistent with patterns expected from ecologically mediated speciation, whereas divergence in F. oustaleti most strongly matches the patterns expected from the riverine barrier hypothesis.	[Florio, Antonia M.; Raxworthy, Christopher J.] Amer Museum Nat Hist, Dept Herpetol, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Florio, AM (corresponding author), Amer Museum Nat Hist, Dept Herpetol, New York, NY 10024 USA.	aflorio@amnh.org			Richard Gilder Graduate School (RGGS) at the American Museum of Natural History (AMNH); U.S. National Science Foundation [DEB 9984496, 0423286, 0641023, 1110593]	Richard Gilder Graduate School (RGGS) at the American Museum of Natural History (AMNH); U.S. National Science Foundation(National Science Foundation (NSF))	Research for this project was funded by the Richard Gilder Graduate School (RGGS) at the American Museum of Natural History (AMNH - http://www.amnh.org/our-research/richard-gilder-graduate-school) and the U.S. National Science Foundation (DEB 9984496, 0423286, 0641023 and 1110593 - http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research for this project was funded by the Richard Gilder Graduate School (RGGS) at the American Museum of Natural History (AMNH) and the U.S. National Science Foundation (DEB 9984496, 0423286, 0641023 and 1110593). Field studies in Madagascar were made possible due through the agreement of the Ministries des Eaux et Forets, the Association Nationale pour la Gestion des Aires Proteges (ANGAP), and the Universite d'Antananarivo, Departement de Biologie Animale (especially D. Rakotondravony and H. Razafindraibe). We also thank the many people who have aided or contributed to this research program including L. Haralson for morphological measurements, and A. Carnaval, R. DeSalle, and S. Perkins for useful feedback. C. Ingram generously provided several sequences for this study. All fieldwork was accomplished with the help of many people, including R. Andrianasolo, B. Falk, S. Mahaviasy, N. Rakotoarisoa, A. Rakotondrazafy, J. Randrianirina, and many local guides, reserve agents, and volunteers too numerous to mention. This manuscript was greatly improved thanks to the insight, comments, and edits made by two anonymous reviewers-thank you for your careful analysis of this study.	AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boettger O., 1894, Zweite Mittheilung Zool Anz, Vxvii, P137; Boumans L, 2007, MOL PHYLOGENET EVOL, V45, P822, DOI 10.1016/j.ympev.2007.05.028; Bourgat RM, 1968, ANN U MADAGASCAR SCI, V6, P235; Bromham L, 2003, NAT REV GENET, V4, P216, DOI 10.1038/nrg1020; Brown JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6046; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Brygoo E. R., 1971, Faune de Madagascar, V33, P1; Burbrink FT, 2011, MOL PHYLOGENET EVOL, V60, P445, DOI 10.1016/j.ympev.2011.05.009; Cernansky A, 2010, GEOBIOS-LYON, V43, P605, DOI 10.1016/j.geobios.2010.04.001; Chan LM, 2012, MOL ECOL, V21, P3839, DOI 10.1111/j.1365-294X.2012.05651.x; Conroy CJ, 2009, J AM ASSOC LAB ANIM, V48, P28; Craul M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-83; Cuvier G, 1829, REGNE ANIMAL, V2, P60; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESRI, 2011, DOC MAN; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falk BG, 2011, INT J PARASITOL, V41, P967, DOI 10.1016/j.ijpara.2011.05.004; Florio AM, 2012, J EVOLUTION BIOL, V25, P1399, DOI 10.1111/j.1420-9101.2012.02528.x; GILLETTE C.R., 2010, IRCF REPTILES AMPHIB, V17, P248; Glor RE, 2001, MOL ECOL, V10, P2661, DOI 10.1046/j.0962-1083.2001.01393.x; Goloboff P, 2008, CLADISTICS, V24, P91; Goodman SM, 2004, J BIOGEOGR, V31, P47, DOI 10.1111/j.1365-2699.2004.00953.x; Gray JE, 1831, ANIMAL KINGDOM GRIFF, V9, P53; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillenius D., 1959, Beaufortia, V8, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jury MR., 2003, NATURAL HIST MADAGAS, P75; Klaver C, 1986, ZOOLOGISCHES FORSCHU; Lapointe FJ, 2005, AM NAT, V166, P290, DOI 10.1086/431283; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Losos JB, 2003, TRENDS ECOL EVOL, V18, P220, DOI 10.1016/S0169-5347(03)00037-5; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Martin RD, 1972, PHIL T R SOC B, V264, P295; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Mertens R., 1966, Tierreich, V83, P1; Mocquard F., 1894, Compte Rendu Soc Philom, VNo. 9, P3; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Nei M, 2000, MOL PHYLOGENET EVOL; Nixon K.C., 2002, WINCLADA VERSION 1 0; Nougier J., 1986, Journal of African Earth Sciences, V5, P135, DOI 10.1016/0899-5362(86)90003-5; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Olivieri G, 2007, MOL PHYLOGENET EVOL, V43, P309, DOI 10.1016/j.ympev.2006.10.026; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2009, EVOLUTION, V63, P959, DOI 10.1111/j.1558-5646.2008.00596.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Portik DM, 2012, CONSERV GENET RESOUR, V4, P1, DOI 10.1007/s12686-011-9460-1; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2007, TRACER V1 4; Randrianambinina Blanchard, 2010, Madagascar Conservation & Development, V5, P95; Raxworthy CJ, 2008, J ZOOL, V275, P423, DOI 10.1111/j.1469-7998.2008.00460.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Raxworthy CJ, 2006, COPEIA, P711; Raxworthy CJ, 2002, NATURE, V415, P784, DOI 10.1038/415784a; Rocha S, 2005, BELG J ZOOL, V135, P39; Rodriguez-Robles JA, 2007, J BIOGEOGR, V34, P1546, DOI 10.1111/j.1365-2699.2007.01718.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Silvestro D, 2010, RAXMLGUI GRAPHICAL F; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; TAKAHATA N, 1985, GENETICS, V110, P325; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tolley KA, 2013, P R SOC B, P280; Tolley KA, 2011, J BIOGEOGR, V38, P1748, DOI 10.1111/j.1365-2699.2011.02529.x; Townsend T, 2002, MOL PHYLOGENET EVOL, V23, P22, DOI 10.1006/mpev.2001.1076; Townsend TM, 2009, SYST BIOL, V58, P641, DOI 10.1093/sysbio/syp073; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Warren BH, 2003, MOL PHYLOGENET EVOL, V29, P67, DOI 10.1016/S1055-7903(03)00063-0; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wesener T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028035; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Yoder AD, 2006, DEV PRIMATOL, P255, DOI 10.1007/0-387-31710-4_9; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	95	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0154144	10.1371/journal.pone.0154144	http://dx.doi.org/10.1371/journal.pone.0154144			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257819	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700006
J	Heininger, U; Andre, P; Chlibek, R; Kristufkova, Z; Kutsar, K; Mangarov, A; Meszner, Z; Nitsch-Osuch, A; Petrovic, V; Prymula, R; Usonis, V; Zavadska, D				Heininger, Ulrich; Andre, Philippe; Chlibek, Roman; Kristufkova, Zuzana; Kutsar, Kuulo; Mangarov, Atanas; Meszner, Zsofia; Nitsch-Osuch, Aneta; Petrovic, Vladimir; Prymula, Roman; Usonis, Vytautas; Zavadska, Dace			Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013	PLOS ONE			English	Article							PRESCHOOL BOOSTER VACCINATION; WHOLE-CELL; BORDETELLA-PERTUSSIS; REDUCED RISK; VACCINES; DISEASE; IMPACT; RESURGENCE; AGE; TRANSMISSION	We undertook an epidemiological survey of the annual incidence of pertussis reported from 2000 to 2013 in ten Central and Eastern European countries to ascertain whether increased pertussis reports in some countries share common underlying drivers or whether there are specific features in each country. The annual incidence of pertussis in the participating countries was obtained from relevant government institutions and/or national surveillance systems. We reviewed the changes in the pertussis incidence rates in each country to explore differences and/or similarities between countries in relation to pertussis surveillance; case definitions for detection and confirmation of pertussis; incidence and number of cases of pertussis by year, overall and by age group; population by year, overall and by age group; pertussis immunization schedule and coverage, and switch from whole-cell pertussis vaccines (wP) to acellular pertussis vaccines (aP). There was heterogeneity in the reported annual incidence rates and trends observed across countries. Reported pertussis incidence rates varied considerably, ranging from 0.01 to 96 per 100,000 population, with the highest rates generally reported in Estonia and the lowest in Hungary and Serbia. The greatest burden appears for the most part in infants (<1 year) in Bulgaria, Hungary, Latvia, Romania, and Serbia, but not in the other participating countries where the burden may have shifted to older children, though surveillance of adults may be inappropriate. There was no consistent pattern associated with the switch from wP to aP vaccines on reported pertussis incidence rates. The heterogeneity in reported data may be related to a number of factors including surveillance system characteristics or capabilities, different case definitions, type of pertussis confirmation tests used, public awareness of the disease, as well as real differences in the magnitude of the disease, or a combination of these factors. Our study highlights the need to standardize pertussis detection and confirmation in surveillance programs across Europe, complemented with carefully-designed seroprevalence studies using the same protocols and methodologies.	[Heininger, Ulrich] Univ Basel Childrens Hosp UKBB, Basel, Switzerland; [Andre, Philippe] Hosp Civils Lyon, Hop Edouard Herriot, Serv Hyg Epidemiol & Prevent, Lyon, France; [Chlibek, Roman] Univ Def, Dept Epidemiol, Hradec Kralove, Czech Republic; [Kristufkova, Zuzana] Slovak Med Univ, Fac Publ Hlth, Bratislava, Slovakia; [Kutsar, Kuulo] Estonian Hlth Board, Tallinn, Estonia; [Mangarov, Atanas] Hosp Infect Dis, Sofia, Bulgaria; [Meszner, Zsofia] Natl Inst Hlth Promot, Paediat Directorate, Budapest, Hungary; [Nitsch-Osuch, Aneta] Med Univ Warsaw, Dept Family Med, Warsaw, Poland; [Petrovic, Vladimir] Univ Novi Sad, Fac Med, Inst Publ Hlth Vojvodina, Novi Sad 21000, Serbia; [Prymula, Roman] Univ Hosp, Hradec Kralove, Czech Republic; [Usonis, Vytautas] Vilnius State Univ, Fac Med, Clin Childrens Dis, Vilnius, Lithuania; [Zavadska, Dace] Riga Stradins Univ, Dept Paediat, Riga, Latvia	CHU Lyon; University of Defence - Czech Republic; Slovak Medical University Bratislava; Medical University of Warsaw; University of Novi Sad; University Hospital Hradec Kralove; Vilnius University; Riga Stradins University	Heininger, U (corresponding author), Univ Basel Childrens Hosp UKBB, Basel, Switzerland.	ulrich.heininger@ukbb.ch	Naselsky, Pavel D/M-4799-2014; Kristufkova, Zuzana/AAB-7549-2019; Petrovic, Vladimir/L-7149-2018; Prymula, Roman/AEG-7401-2022; Chlibek, Roman/P-9084-2016; Usonis, Vytautas/R-6471-2019; Zavadska, Dace/GXF-4730-2022	Naselsky, Pavel D/0000-0002-8891-0273; Petrovic, Vladimir/0000-0002-2052-6232; NITSCH-OSUCH, ANETA/0000-0002-2622-7348; Zavadska, Dace/0000-0003-4892-3763	Sanofi Pasteur, Lyon, France; Sanofi Pasteur	Sanofi Pasteur, Lyon, France; Sanofi Pasteur	This study was funded by Sanofi Pasteur, Lyon, France. The study sponsor contributed to the design of the analysis plan, data collection and structuring, data analysis, and provided advice and input on the drafting of this document, but had no role in the decision to publish.; Editorial assistance with the preparation of the manuscript was provided by Richard Glover, inScience Communications, Springer Healthcare. Funding for this assistance was provided by Sanofi Pasteur.	Andre P, 2013, CLIN INFECT DIS, V57, P1658, DOI 10.1093/cid/cit552; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P385; [Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P203; Atwell JE, 2013, PEDIATRICS, V132, P624, DOI 10.1542/peds.2013-0878; Barkoff AM, 2015, PATHOG DIS, P73; Bisgard KM, 2005, PEDIATRICS, V116, pE285, DOI 10.1542/peds.2004-2759; Broutin H, 2010, P ROY SOC B-BIOL SCI, V277, P3239, DOI 10.1098/rspb.2010.0994; Carlson RM, 2008, PERTUSSIS SURVEILLAN; Celentano LP, 2005, PEDIATR INFECT DIS J, V24, P761, DOI 10.1097/01.inf.0000177282.53500.77; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Cherry JD, 2012, CLIN INFECT DIS, V54, P1756, DOI 10.1093/cid/cis302; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Cherry JD, 1999, CLIN INFECT DIS, V28, pS107, DOI 10.1086/515057; Clark TA, 2014, J INFECT DIS, V209, P978, DOI 10.1093/infdis/jiu001; Dalby T, 2013, EUR J CLIN MICROBIOL, V32, P1285, DOI 10.1007/s10096-013-1874-0; de Celles MD, 2014, P NATL ACAD SCI USA, V111, pE716, DOI 10.1073/pnas.1323795111; de Greeff SC, 2008, PEDIATR INFECT DIS J, V27, P218, DOI 10.1097/INF.0b013e318161a2b9; Dinu S, 2014, DIAGN MICR INFEC DIS, V78, P302, DOI 10.1016/j.diagmicrobio.2013.09.017; Epidemiological information system EPIS, ANN REP EP SIT SLOV; European Centre for Disease Prevention and Control, 2012, ANN EP REP 2012 VACC; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 VACC; European Centre for Disease Prevention and Control (ECDC), 2012, PERT; EUVAC.NET, 2009, PERT SURV REP 2003 2; Arlant LHF, 2014, EXPERT REV ANTI-INFE, V12, P1265, DOI 10.1586/14787210.2014.948846; Fisman DN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-694; Glass TA, 2013, ANNU REV PUBL HEALTH, V34, P61, DOI 10.1146/annurev-publhealth-031811-124606; Grimprel E, 1999, LANCET, V354, P1699, DOI 10.1016/S0140-6736(99)01576-7; Guiso N, 2011, EUR J CLIN MICROBIOL, V30, P307, DOI 10.1007/s10096-010-1104-y; Guiso N, 2014, J INFECTION, V68, pS119, DOI 10.1016/j.jinf.2013.09.022; He Q, 2012, EUROSURVEILLANCE, V9, P17; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hozbor D, 2009, J INFECTION, V59, P225, DOI 10.1016/j.jinf.2009.07.014; Hviid A, 2006, VACCINE, V24, P1401, DOI 10.1016/j.vaccine.2005.09.019; Institute of Public Health of Serbia, ANN REP COMM DIS 200; Jackson DW, 2014, EPIDEMIOL INFECT, V142, P672, DOI 10.1017/S0950268812003093; Jogi P, 2014, VACCINE, V32, P5311, DOI 10.1016/j.vaccine.2014.07.066; Kaczmarek MC, 2013, MED J AUSTRALIA, V198, P624, DOI 10.5694/mja13.10044; Klein NP, 2013, PEDIATRICS, V131, pE1716, DOI 10.1542/peds.2012-3836; Lavine JS, 2012, VACCINE, V30, P544, DOI 10.1016/j.vaccine.2011.11.065; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; Lutsar I, 2009, EUR J PEDIATR, V168, P407, DOI 10.1007/s00431-008-0754-6; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Misegades LK, 2012, JAMA-J AM MED ASSOC, V308, P2126, DOI 10.1001/jama.2012.14939; National Institute of Hygiene Department of Epidemiology and Chief Sanitary Inspectorate-Department of Communicable Diseases and Infection Prevention and Control, 2013, B NAT I PUBL HLTH; Paradowska-Stankiewicz Iwona, 2012, Przegl Epidemiol, V66, P211; Phillips Carl V, 2004, Epidemiol Perspect Innov, V1, P3, DOI 10.1186/1742-5573-1-3; Plotkin SA, 2014, CLIN INFECT DIS, V58, P830, DOI 10.1093/cid/cit934; Quinn HE, 2011, B WORLD HEALTH ORGAN, V89, P666, DOI 10.2471/BLT.11.086538; Riffelmann M, 2005, J CLIN MICROBIOL, V43, P4925, DOI 10.1128/JCM.43.10.4925-4929.2005; Savrasova L, 2013, RIGAS STRANDINA U 20; Sheridan SL, 2015, VACCINE, V33, P5027, DOI 10.1016/j.vaccine.2015.08.021; Sheridan SL, 2012, JAMA-J AM MED ASSOC, V308, P454, DOI 10.1001/jama.2012.6364; Skoff TH, 2012, ARCH PEDIAT ADOL MED, V166, P344, DOI 10.1001/archpediatrics.2011.1093; Smallridge WE, 2014, J INFECT DIS, V209, P1981, DOI 10.1093/infdis/jiu030; Statistics Lithuania, 2015, POP SOC STAT; Strebel P, 2001, J INFECT DIS, V183, P1353, DOI 10.1086/319853; Torres RSLA, 2015, J PEDIAT-BRAZIL, V91, P333, DOI [10.1016/j.jped.2014.09.004, 10.1016/j.jpedp.2015.04.006]; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Winter K, 2014, MMWR-MORBID MORTAL W, V63, P1129; Witt MA, 2013, CLIN INFECT DIS, V56, P1248, DOI 10.1093/cid/cit046; World Health Organization, 2003, WHO REC STAND SURV S; World Health Organization SAGE pertussis working group, 2014, BACKGR PAP WHO; Wymann MN, 2011, VACCINE, V29, P2058, DOI 10.1016/j.vaccine.2011.01.017; Zepp F, 2011, LANCET INFECT DIS, V11, P557, DOI 10.1016/S1473-3099(11)70007-X	67	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0155949	10.1371/journal.pone.0155949	http://dx.doi.org/10.1371/journal.pone.0155949			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257822	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700026
J	Zhao, H; Zhang, FC; Zhu, Q; Wang, J; Hong, WX; Zhao, LZ; Deng, YQ; Qiu, S; Zhang, Y; Cai, WP; Cao, WC; Qin, CF				Zhao, Hui; Zhang, Fu-Chun; Zhu, Qin; Wang, Jian; Hong, Wen-Xin; Zhao, Ling-Zhai; Deng, Yong-Qiang; Qiu, Shuang; Zhang, Yu; Cai, Wei-Ping; Cao, Wu-Chun; Qin, Cheng-Feng			Epidemiological and Virological Characterizations of the 2014 Dengue Outbreak in Guangzhou, China	PLOS ONE			English	Article							VIRUS SEROTYPE 3; FEVER; GUANGDONG; SEQUENCE	Dengue used to be recognized as an imported and sporadic disease in China. Since June 2014, an unexpected large dengue outbreak has attacked Guangzhou, China, resulting in more than 40,000 cases. Among the 1,942 laboratory-confirmed hospitalized dengue cases, 121 were diagnosed as severe dengue according to the 2009 WHO guideline, and 2 patients finally died. Laboratory diagnosis and virus isolation demonstrated that the majority (96%) cases were caused by dengue virus serotype 1 (DENV-1), and the others by serotype 2 (DENV-2). 14 DENV strains were isolated from the sera of acute-phase dengue patients during this outbreak, and the complete envelope (E) gene of 12 DENV-1 strains and two DENV-2 strains were determined using RT-PCR assay. Phylogenetic analysis based on the E gene revealed the DENV-1 strains isolated during the outbreak belonged to genotype I and V, respectively. These isolates formed three clades. DENV-2 isolates were assigned to the same clade belonging to genotype cosmopolitan. These strains isolated in 2014 were closely related to the isolates obtained from the same province, Guangdong, in 2013. No amino acid mutations known to increase virulence were identified throughout the E protein of isolates in 2014. These results indicate that dengue is turning into endemic in Guangdong, China, and extensive seroepidemiological investigation and mosquito control measures are critically needed in the future.	[Zhao, Hui; Deng, Yong-Qiang; Zhang, Yu; Cao, Wu-Chun; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China; [Zhang, Fu-Chun; Zhu, Qin; Wang, Jian; Hong, Wen-Xin; Zhao, Ling-Zhai; Qiu, Shuang; Cai, Wei-Ping] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Guangzhou Medical University	Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China.	qincf@bmi.ac.cn	Qin, Cheng-Feng/I-6839-2019	Qin, Cheng-Feng/0000-0002-0632-2807	Guangzhou Science and Technology Program for Public Wellbeing [2014Y2-00185, 201508020263]; Special Program of Guangdong Provincial Department of Science and Technology [2013A020229001, 2013A020229002]; Special Program of National Science and Technology of China [2013ZX10004805]; National Natural Science Foundation of China [81301491, 31270974]; Excellent Young Scientist Program of the National Natural Science Foundation of China [81522025]; Newton Advanced Fellowship from the Academy of Medical Sciences, UK; NSFC of China [81661130162]	Guangzhou Science and Technology Program for Public Wellbeing; Special Program of Guangdong Provincial Department of Science and Technology; Special Program of National Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Young Scientist Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Newton Advanced Fellowship from the Academy of Medical Sciences, UK; NSFC of China(National Natural Science Foundation of China (NSFC))	This study was supported by Guangzhou Science and Technology Program for Public Wellbeing (No. 2014Y2-00185 and No. 201508020263), the Special Program of Guangdong Provincial Department of Science and Technology (2013A020229001 and 2013A020229002), the Special Program of National Science and Technology of China (No. 2013ZX10004805), and the National Natural Science Foundation of China (No. 81301491 and No. 31270974). CF Qin was supported by the Excellent Young Scientist Program of the National Natural Science Foundation of China (No. 81522025) and the Newton Advanced Fellowship from the Academy of Medical Sciences, UK and the NSFC of China (No. 81661130162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chen B, 2015, LANCET, V385, P1621, DOI 10.1016/S0140-6736(15)60793-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Hong WX, 2013, J CLIN VIROL, V57, P184, DOI 10.1016/j.jcv.2013.02.012; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiang CS, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.26421; Jiang Tao, 2012, Virol J, V9, P125, DOI 10.1186/1743-422X-9-125; Jing QL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-87; Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1; Li TG, 2013, BIOMED ENVIRON SCI, V26, P994, DOI 10.3967/bes2013.036; OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084; Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594; Programme for Research and Training in Tropical Diseases, 2009, Dengue: guidelines for diagnosis, treatment, prevention and control; Qin CF, 2014, SCI CHINA LIFE SCI, V57, P1230, DOI 10.1007/s11427-014-4783-2; Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130; Sang SW, 2015, INFECT GENET EVOL, V32, P178, DOI 10.1016/j.meegid.2015.03.005; Schaffner F, 2014, LANCET INFECT DIS, V14, P1044, DOI 10.1016/S1473-3099(14)70925-9; Schmidt-Chanasit J, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.3.20681; Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396; Wang L J, 2014, ECOL ECON, V04, P29, DOI DOI 10.1016/J.JINF.2015.04.018; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Zhang FC, 2014, INT J INFECT DIS, V27, P4, DOI 10.1016/j.ijid.2014.03.1392; Zhao H, 2014, SCI CHINA LIFE SCI, V57, P1149, DOI 10.1007/s11427-014-4782-3; Zhao H, 2012, J VIROL, V86, P7021, DOI 10.1128/JVI.00858-12	25	23	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156548	10.1371/journal.pone.0156548	http://dx.doi.org/10.1371/journal.pone.0156548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27257804	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700076
J	Gong, XH; Huang, LD; Liu, X; Li, CY; Mao, XH; Liu, WZ; Huang, X; Chu, HT; Wang, YM; Wu, WQ; Lu, J				Gong, Xuehao; Huang, Leidan; Liu, Xin; Li, Chunyue; Mao, Xuhua; Liu, Weizong; Huang, Xian; Chu, Haiting; Wang, Yumei; Wu, Wanqing; Lu, Jun			Correlation Analysis between Polysomnography Diagnostic Indices and Heart Rate Variability Parameters among Patients with Obstructive Sleep Apnea Hypopnea Syndrome	PLOS ONE			English	Article							BLOOD-PRESSURE; AUTONOMIC ACTIVITY; SPECTRAL-ANALYSIS; RR-INTERVAL; ASSOCIATION; CATECHOLAMINES; OSCILLATIONS; DISEASE; RISK	Heart rate variability (HRV) can reflect the changes in the autonomic nervous system (ANS) that are affected by apnea or hypopnea events among patients with obstructive sleep apnea hypopnea syndrome (OSAHS). To evaluate the possibility of using HRV to screen for OSAHS, we investigated the relationship between HRV and polysomnography (PSG) diagnostic indices using electrocardiography (ECG) and PSG data from 25 patients with OSAHS and 27 healthy participants. We evaluated the relationship between various PSG diagnostic indices (including the apnea hypopnea index [AHI], micro-arousal index [MI], oxygen desaturation index [ODI]) and heart rate variability (HRV) parameters using Spearman's correlation analysis. Moreover, we used multiple linear regression analyses to construct linear models for the AHI, MI, and ODI. In our analysis, the AHI was significantly associated with relative powers of very low frequency (VLF [%]) (r = 0.641, P = 0.001), relative powers of high frequency (HF [%]) (r = -0.586, P = 0.002), ratio between low frequency and high frequency powers (LF/HF) (r = 0.545, P = 0.049), normalized powers of low frequency (LF [n.u.]) (r = 0.506, P = 0.004), and normalized powers of high frequency (HF [n.u.]) (r = -0.506, P = 0.010) among patients with OSAHS. The MI was significantly related to standard deviation of RR intervals (SDNN) (r = 0.550, P = 0.031), VLF [%] (r = 0.626, P = 0.001), HF [%] (r = -0.632, P = 0.001), LF/HF (r = 0.591, P = 0.011), LF [n.u.] (r = 0.553, P = 0.004), HF [n.u.] (r = -0.553, P = 0.004), and absolute powers of very low frequency (VLF [abs]) (r = 0.525, P = 0.007) among patients with OSAHS. The ODI was significantly correlated with VLF [%] (r = 0.617, P = 0.001), HF [%] (r = -0.574, P = 0.003), LF [n.u.] (r = 0.510, P = 0.012), and HF [n.u.] (r = -0.510, P = 0.012) among patients with OSAHS. The linear models for the PSG diagnostic indices were AHI = -38.357+1.318VLF [%], MI = -13.389+11.297LF/HF+0.266SDNN, and ODI = -55.588+1.715VLF [%]. However, the PSG diagnostic indices were not related to the HRV parameters among healthy participants. Our analysis suggests that HRV parameters are powerful tools to screen for OSAHS patients in place of PSG monitoring.	[Gong, Xuehao; Huang, Leidan; Liu, Weizong; Huang, Xian; Chu, Haiting] Shenzhen Univ, Peoples Hosp Shenzhen 2, Affiliated Hosp 1, Dept Ultrasound, Shenzhen, Guangdong, Peoples R China; [Huang, Leidan; Mao, Xuhua] Guangzhou Med Univ, Guangzhou, Guangdong, Peoples R China; [Liu, Xin; Li, Chunyue; Wu, Wanqing] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Shenzhen, Guangdong, Peoples R China; [Mao, Xuhua] Shenzhen Univ, Peoples Hosp Shenzhen 2, Affiliated Hosp 1, Dept Thyroid & Breast Surg, Shenzhen, Guangdong, Peoples R China; [Huang, Xian; Chu, Haiting] Anhui Med Univ, Hefei, Anhui, Peoples R China; [Wang, Yumei] Xili Peoples Hosp Shenzhen, Dept Resp Med, Shenzhen, Guangdong, Peoples R China; [Lu, Jun] Jinan Univ, Peoples Hosp Shenzhen, Clin Coll 2, Dept Ultrasound, Shenzhen, Guangdong, Peoples R China	Shenzhen University; Guangzhou Medical University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Shenzhen University; Anhui Medical University; Jinan University	Wu, WQ (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Shenzhen, Guangdong, Peoples R China.; Lu, J (corresponding author), Jinan Univ, Peoples Hosp Shenzhen, Clin Coll 2, Dept Ultrasound, Shenzhen, Guangdong, Peoples R China.	wq.wu@siat.ac.cn; lucy_youran@sina.com			Shenzhen Science and Technology Innovation Committee [JCYJ20140414170821285, CXZZ20140909004122087, JCYJ20150529164154046]; Guangdong Image-guided Therapy Innovation Team [2011S013]	Shenzhen Science and Technology Innovation Committee; Guangdong Image-guided Therapy Innovation Team	This work was supported by Shenzhen Science and Technology Innovation Committee (JCYJ20140414170821285, CXZZ20140909004122087, and JCYJ20150529164154046), http://www.szsti.gov.cn/; and Guangdong Image-guided Therapy Innovation Team (2011S013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Akselrod S., 1998, AUTONOMIC RESPONSES, P101; Albarrak M, 2005, SLEEP, V28, P1306, DOI 10.1093/sleep/28.10.1306; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Aydin M, 2004, TEX HEART I J, V31, P132; BAHARAV A, 1995, NEUROLOGY, V45, P1183, DOI 10.1212/WNL.45.6.1183; Camm AJ, 1996, CIRCULATION, V93, P1043; Camm AJ, 1996, EUR HEART J, V17, P354; [Diagnostic Classification Steering Committee American Sleep Disorders Association], 1990, INT CLASS SLEEP DIS, Vxii; DUPREZ D, 1995, EUR HEART J, V16, P1050, DOI 10.1093/oxfordjournals.eurheartj.a061046; EWING DJ, 1980, Q J MED, V49, P95; Fleisher LA, 1996, CLIN SCI, V90, P97, DOI 10.1042/cs0900097; FLETCHER EC, 1987, SLEEP, V10, P35, DOI 10.1093/sleep/10.1.35; Francis DP, 2000, CLIN SCI, V99, P125, DOI 10.1042/CS20000016; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Greenwood J, 1997, BR J CARDIOL, V4, P183; Greenwood J, 1997, BR J CARDIOL, V4, P154; Greenwood JP, 1998, HOSP MED, V59, P714; GUILLEMINAULT C, 1984, LANCET, V1, P126; Gula LJ, 2003, ANN NONINVAS ELECTRO, V8, P144, DOI 10.1046/j.1542-474X.2003.08209.x; Ip MSM, 2002, AM J RESP CRIT CARE, V165, P670, DOI 10.1164/ajrccm.165.5.2103001; JAFFE RS, 1994, J AUTONOM NERV SYST, V46, P37, DOI 10.1016/0165-1838(94)90142-2; Kim YS, 2015, J CRANIOFAC SURG, V26, P1592, DOI 10.1097/SCS.0000000000001782; Kushida CA, 2005, SLEEP, V28, P499, DOI 10.1093/sleep/28.4.499; Lucini D, 1992, Cardiologia, V37, P729; MARRONE O, 1993, CHEST, V103, P722, DOI 10.1378/chest.103.3.722; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Olson EJ, 2003, MAYO CLIN PROC, V78, P1545, DOI 10.4065/78.12.1545; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Park DH, 2008, J KOREAN MED SCI, V23, P226, DOI 10.3346/jkms.2008.23.2.226; Peker Y, 2006, EUR RESPIR J, V28, P596, DOI 10.1183/09031936.06.00107805; Ponikowski P, 1997, AM J PHYSIOL-HEART C, V272, pH438, DOI 10.1152/ajpheart.1997.272.1.H438; Pumprla J, 2002, INT J CARDIOL, V84, P1, DOI 10.1016/S0167-5273(02)00057-8; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Roche F, 1999, CIRCULATION, V100, P1411, DOI 10.1161/01.CIR.100.13.1411; Sateia MJ, 2003, CLIN CHEST MED, V24, P249, DOI 10.1016/S0272-5231(03)00014-5; SAUL JP, 1989, AM J PHYSIOL, V256, pH153, DOI 10.1152/ajpheart.1989.256.1.H153; Saunamaeki T, 2007, ACTA NEUROL SCAND, V116, P277, DOI 10.1111/j.1600-0404.2007.00901.x; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Shiomi T, 1996, SLEEP, V19, P370, DOI 10.1093/sleep/19.5.370; Tascilar E, 2009, TOHOKU J EXP MED, V219, P187, DOI 10.1620/tjem.219.187; Taylor JA, 1998, CIRCULATION, V98, P547, DOI 10.1161/01.CIR.98.6.547; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	44	34	34	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156628	10.1371/journal.pone.0156628	http://dx.doi.org/10.1371/journal.pone.0156628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253187	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700045
J	Romero-Romero, ML; Risso, VA; Martinez-Rodriguez, S; Gaucher, EA; Ibarra-Molero, B; Sanchez-Ruiz, JM				Luisa Romero-Romero, M.; Risso, Valeria A.; Martinez-Rodriguez, Sergio; Gaucher, Eric A.; Ibarra-Molero, Beatriz; Sanchez-Ruiz, Jose M.			Selection for Protein Kinetic Stability Connects Denaturation Temperatures to Organismal Temperatures and Provides Clues to Archaean Life	PLOS ONE			English	Article							LABORATORY RESURRECTIONS; ENERGETICS; MUTATIONS; EVOLUTION; RECONSTRUCTION; IDENTIFICATION; COOPERATIVITY; CONSERVATION; RIBONUCLEASE; MECHANISMS	The relationship between the denaturation temperatures of proteins (T-m values) and the living temperatures of their host organisms (environmental temperatures: T-ENV values) is poorly understood. Since different proteins in the same organism may show widely different T-m's, no simple universal relationship between T-m and T-ENV should hold, other than T-m >= T-ENV. Yet, when analyzing a set of homologous proteins from different hosts, T-m's are oftentimes found to correlate with T-ENV's but this correlation is shifted upward on the T-m axis. Supporting this trend, we recently reported T-m's for resurrected Precambrian thioredoxins that mirror a proposed environmental cooling over long geological time, while remaining a shocking similar to 50 degrees C above the proposed ancestral ocean temperatures. Here, we show that natural selection for protein kinetic stability (denaturation rate) can produce a T-m <-> T-ENV correlation with a large upward shift in T-m. A model for protein stability evolution suggests a link between the T-m shift and the in vivo lifetime of a protein and, more specifically, allows us to estimate ancestral environmental temperatures from experimental denaturation rates for resurrected Precambrian thioredoxins. The T-ENV values thus obtained match the proposed ancestral ocean cooling, support comparatively high Archaean temperatures, and are consistent with a recent proposal for the environmental temperature (above 75 degrees C) that hosted the last universal common ancestor. More generally, this work provides a framework for understanding how features of protein stability reflect the environmental temperatures of the host organisms.	[Luisa Romero-Romero, M.; Risso, Valeria A.; Martinez-Rodriguez, Sergio; Ibarra-Molero, Beatriz; Sanchez-Ruiz, Jose M.] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain; [Gaucher, Eric A.] Georgia Inst Technol, Sch Chem & Biochem, Sch Biol, Atlanta, GA 30332 USA; [Gaucher, Eric A.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Luisa Romero-Romero, M.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	University of Granada; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Weizmann Institute of Science	Sanchez-Ruiz, JM (corresponding author), Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain.	sanchezr@ugr.es	Romero Romero, Maria Luisa/B-2136-2019; MARTINEZ-RODRIGUEZ, SERGIO/H-3448-2015; risso, valeria a/H-2921-2015	Romero Romero, Maria Luisa/0000-0003-3397-6758; MARTINEZ-RODRIGUEZ, SERGIO/0000-0001-6675-1550; Sanchez Ruiz, Jose Manuel/0000-0002-9056-3928; risso, valeria a/0000-0001-8262-8843	Feder Funds; Spanish Ministry of Economy and Competitiveness [BIO2012-34937, BIO2015-66426-R, CSD2009-00088]; Junta de Andalucia [CVI-12483, P09-CVI-5073]; DuPont Young Professor Award; NASA Exobiology [NNX13AI08G, NNX13AI10G]	Feder Funds(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta de Andalucia(Junta de Andalucia); DuPont Young Professor Award; NASA Exobiology(National Aeronautics & Space Administration (NASA))	This work was supported by Feder Funds, Grants BIO2012-34937, BIO2015-66426-R and CSD2009-00088 (JMSR) from the Spanish Ministry of Economy and Competitiveness, Grant CVI-12483 (JMSR) from the "Junta de Andalucia", Grant P09-CVI-5073 (BIM) from the "Junta de Andalucia", DuPont Young Professor Award (EAG) and Grants NNX13AI08G & NNX13AI10G (EAG) from NASA Exobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Llera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017068; Akanuma S, 2013, P NATL ACAD SCI USA, V110, P11067, DOI 10.1073/pnas.1308215110; Andersen GR, 2003, TRENDS BIOCHEM SCI, V28, P434, DOI 10.1016/S0968-0004(03)00162-2; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bloom JD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100119; Bohley P, 1995, NATURWISSENSCHAFTEN, V82, P544, DOI 10.1007/s001140050230; Chan HS, 2011, ANNU REV PHYS CHEM, V62, P301, DOI 10.1146/annurev-physchem-032210-103405; Cisneros A, 2009, LAB CLIN RES BODY TE, P392; Corley SC, 2011, BIOPHYS J, V100, P2946, DOI 10.1016/j.bpj.2011.05.015; Costas M, 2009, J MOL BIOL, V385, P924, DOI 10.1016/j.jmb.2008.10.056; Dayhoff M., 1978, ATLAS PROTEIN SEQUEN; Dehouck Y, 2008, PROTEIN ENG DES SEL, V21, P275, DOI 10.1093/protein/gzn001; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Ferguson A, 2009, J MOL BIOL, V389, P619, DOI 10.1016/j.jmb.2009.04.011; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; FREIRE E, 1992, BIOCHEMISTRY-US, V31, P250, DOI 10.1021/bi00116a034; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Georgescu RE, 2001, EUR J BIOCHEM, V268, P1477, DOI 10.1046/j.1432-1327.2001.02014.x; Godoy-Ruiz R, 2005, BIOPHYS J, V89, P3320, DOI 10.1529/biophysj.105.067025; Godoy-Ruiz R, 2004, J MOL BIOL, V336, P313, DOI 10.1016/j.jmb.2003.12.048; Godoy-Ruiz R, 2006, J MOL BIOL, V362, P966, DOI 10.1016/j.jmb.2006.07.065; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Gromiha MM, 1999, BIOPHYS CHEM, V82, P51, DOI 10.1016/S0301-4622(99)00103-9; Hart KM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001994; HARTL DL, 1985, GENETICS, V111, P655; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HIGHKIN HR, 1958, AM J BOT, V45, P626, DOI 10.2307/2439237; Hobbs JK, 2012, MOL BIOL EVOL, V29, P825, DOI 10.1093/molbev/msr253; Hren MT, 2009, NATURE, V462, P205, DOI 10.1038/nature08518; Ibarra-Molero B, 1999, BIOCHEMISTRY-US, V38, P8138, DOI 10.1021/bi9905819; IbarraMolero B, 1996, BIOCHEMISTRY-US, V35, P14689, DOI 10.1021/bi961836a; Ingles-Prieto A, 2013, STRUCTURE, V21, P1690, DOI 10.1016/j.str.2013.06.020; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Jefferson RE, 2013, J AM CHEM SOC, V135, P15183, DOI 10.1021/ja407232b; Kaltenbach M, 2014, METHODS MOL BIOL, V1179, P69, DOI 10.1007/978-1-4939-1053-3_5; Kasting JF, 2013, SCIENCE, V339, P44, DOI 10.1126/science.1232662; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; LADBURY JE, 1994, BIOCHEMISTRY-US, V33, P3688, DOI 10.1021/bi00178a027; Romero-Romero ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023050; LUMRY R, 1954, J PHYS CHEM-US, V58, P110, DOI 10.1021/j150512a005; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Naganathan AN, 2010, P NATL ACAD SCI USA, V107, P8611, DOI 10.1073/pnas.1000988107; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; Ohsumi Y, 2006, IUBMB LIFE, V58, P363, DOI 10.1080/15216540600758539; Park C, 2007, J MOL BIOL, V368, P1426, DOI 10.1016/j.jmb.2007.02.091; Pedone E, 1999, BIOCHEM J, V339, P309, DOI 10.1042/0264-6021:3390309; Perez-Jimenez R, 2011, NAT STRUCT MOL BIOL, V18, P592, DOI 10.1038/nsmb.2020; Pey AL, 2008, PROTEINS, V71, P165, DOI 10.1002/prot.21670; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Privalov PL, 2007, BIOPHYS CHEM, V126, P16, DOI 10.1016/j.bpc.2006.05.004; Privalov PL, 2009, TRENDS BIOCHEM SCI, V34, P464, DOI 10.1016/j.tibs.2009.05.005; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; Richardson JM, 2000, BIOCHEMISTRY-US, V39, P11154, DOI 10.1021/bi000610b; Risso VA, 2015, MOL BIOL EVOL, V32, P440, DOI 10.1093/molbev/msu312; Risso VA, 2014, PROTEINS, V82, P887, DOI 10.1002/prot.24575; Risso VA, 2013, J AM CHEM SOC, V135, P2899, DOI 10.1021/ja311630a; Robert F, 2006, NATURE, V443, P969, DOI 10.1038/nature05239; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Roos G, 2007, J MOL BIOL, V368, P800, DOI 10.1016/j.jmb.2007.02.045; Sanchez IE, 2006, J MOL BIOL, V363, P422, DOI 10.1016/j.jmb.2006.08.020; Sanchez-Romero I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070013; Sanchez-Ruiz JM, 2007, BIOPHYS CHEM, V126, P43, DOI 10.1016/j.bpc.2006.05.021; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Tur-Arlandis G, 2010, BIOPHYS J, V98, pL12, DOI 10.1016/j.bpj.2009.11.028; van den Boorn SHJM, 2007, GEOLOGY, V35, P939, DOI 10.1130/G24096A.1; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; WENT FW, 1953, ANNU REV PLANT PHYS, V4, P347, DOI 10.1146/annurev.pp.04.060153.002023; Wijma HJ, 2013, CURR OPIN STRUC BIOL, V23, P588, DOI 10.1016/j.sbi.2013.04.008; Willems A., 2006, PROKARYOTES; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Wordsworth R, 2013, SCIENCE, V339, P64, DOI 10.1126/science.1225759; Wyganowski KT, 2013, J MOL BIOL, V425, P3403, DOI 10.1016/j.jmb.2013.06.028; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; Yamori W, 2005, PLANT CELL ENVIRON, V28, P536, DOI 10.1111/j.1365-3040.2004.01299.x; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Yewdell JW, 2011, CELL BIOL INT, V35, P457, DOI 10.1042/CBI20110055; ZALE SE, 1986, BIOCHEMISTRY-US, V25, P5432, DOI 10.1021/bi00367a014; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104	95	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156657	10.1371/journal.pone.0156657	http://dx.doi.org/10.1371/journal.pone.0156657			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253436	Green Submitted, gold, Green Published			2022-12-26	WOS:000377218700048
J	Pericleous, C; Ferreira, I; Borghi, O; Pregnolato, F; McDonnell, T; Garza-Garcia, A; Driscoll, P; Pierangeli, S; Isenberg, D; Ioannou, Y; Giles, I; Meroni, PL; Rahman, A				Pericleous, Charis; Ferreira, Isabel; Borghi, Orietta; Pregnolato, Francesca; McDonnell, Thomas; Garza-Garcia, Acely; Driscoll, Paul; Pierangeli, Silvia; Isenberg, David; Ioannou, Yiannis; Giles, Ian; Meroni, Pier Luigi; Rahman, Anisur			Measuring IgA Anti-beta 2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROOF-OF-CONCEPT; BETA(2)-GLYCOPROTEIN I; ANTICARDIOLIPIN ANTIBODIES; INTERNATIONAL-CONGRESS; BETA2-GLYCOPROTEIN I; REVISED CRITERIA; GLYCOPROTEIN-I; SYNDROME APS; AUTOANTIBODIES	Introduction Currently available clinical assays to detect antiphospholipid antibodies (aPL) test for IgG and IgM antibodies to cardiolipin (aCL) and beta(2)-glycoprotein I (a beta(2)GPI). It has been suggested that testing for IgA aPL and for antibodies to Domain I (DI), which carries the key antigenic epitopes of beta(2)GPI, could add value to these current tests. We performed an observational, multicenter cohort study to evaluate the utility of IgG, IgM and IgA assays to each of CL, beta(2)GPI and DI in APS. Methods Serum from 230 patients with APS (n = 111), SLE but not APS (n = 119), and 200 healthy controls were tested for IgG, IgM and IgA aCL, a beta(2)GPI and aDI activity. Patients with APS were further classified into thrombotic or obstetric APS. Logistic regression and receiver operator characteristic analyses were employed to compare results from the nine different assays. Results All assays displayed good specificity for APS; IgG aCL and IgG a beta(2)GPI assays however, had the highest sensitivity. Testing positive for IgA a beta(2)GPI resulted in a higher hazard ratio for APS compared to IgM a beta(2)GPI. Positive IgG, IgM or IgA aDI were all associated with APS, and in subjects positive for aCL and/or a beta(2)GPI, the presence of aDI raised the hazard ratio for APS by 3-5 fold. IgG aCL, a beta(2)GPI, aDI and IgA aDI were associated with thrombotic but not obstetric complications in patients with APS. Conclusion Measuring IgG aDI and IgA a beta(2)GPI and aDI may be useful in the management of patients with APS, particularly thrombotic APS.	[Pericleous, Charis; Ferreira, Isabel; McDonnell, Thomas; Isenberg, David; Ioannou, Yiannis; Giles, Ian; Rahman, Anisur] UCL, Div Med, Ctr Rheumatol Res, London, England; [Borghi, Orietta; Pregnolato, Francesca; Meroni, Pier Luigi] IRCCS Ist Auxol Italiano, Lab Immunorheumatol, Milan, Italy; [Garza-Garcia, Acely; Driscoll, Paul] MRC Natl Inst Med Res, Struct Biol, London, England; [Pierangeli, Silvia] Univ Texas Med Branch, Dept Internal Med, Div Rheumatol, Galveston, TX 77555 USA; [Ioannou, Yiannis] UCL Hosp, Arthrit Res UK Ctr Adolescent Rheumatol, London, England; [Ioannou, Yiannis] Great Ormond St Hosp Sick Children, Great Ormond St, London WC1N 3JH, England	University of London; University College London; IRCCS Istituto Auxologico Italiano; MRC National Institute for Medical Research; University of Texas System; University of Texas Medical Branch Galveston; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Pericleous, C (corresponding author), UCL, Div Med, Ctr Rheumatol Res, London, England.	c.pericleous@ucl.ac.uk	Giles, Ian/G-7471-2015; meroni, pier luigi/K-8473-2016; Pregnolato, Francesca/AAA-6698-2020; McDonnell, Thomas/Z-2464-2019	Giles, Ian/0000-0001-8913-3894; meroni, pier luigi/0000-0002-3394-1451; Pregnolato, Francesca/0000-0003-0574-5792; Pericleous, Charis/0000-0001-8804-0493; Borghi, Maria Orietta/0000-0001-8967-9678; McDonnell, Thomas/0000-0002-1712-9957; Garza-Garcia, Acely/0000-0003-0307-0138	Arthritis Research UK [19423, 20164]; University College London Hospitals National Institute for Health Research Biomedical Research Centre; Medical Research Council [U117574559]; Medical Research Council [1087259] Funding Source: researchfish; Rosetrees Trust [M281] Funding Source: researchfish; Versus Arthritis [19423] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); University College London Hospitals National Institute for Health Research Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Versus Arthritis(Versus Arthritis)	This work was supported by the following sources of funding: 1) Arthritis Research UK: Grant number 19423 - recipients AR, IG, YI, DI; 2) Arthritis Research UK: Grant number 20164 - recipient YI (www.arthritisresearchuk.org/); 3) University College London Hospitals National Institute for Health Research Biomedical Research Centre - support ethically approved work using human samples (www.uclhospitals.brc.nihr.ac.uk/); and 4) Medical Research Council: Grant number U117574559 - recipients AG, PD (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar C, 2010, BLOOD, V116, P1336, DOI 10.1182/blood-2009-12-260976; Agostinis C, 2014, BLOOD, V123, P3478, DOI 10.1182/blood-2013-11-537704; Akhter E, 2013, J RHEUMATOL, V40, P282, DOI 10.3899/jrheum.120084; Andreoli L, 2015, ARTHRITIS RHEUMATOL, V67, P2196, DOI 10.1002/art.39187; Andreoli L, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0343-1; Andreoli L, 2011, ANN RHEUM DIS, V70, P380, DOI 10.1136/ard.2010.137281; Banzato A, 2011, THROMB RES, V128, P583, DOI 10.1016/j.thromres.2011.04.021; Bertolaccini ML, 2014, AUTOIMMUN REV, V13, P917, DOI 10.1016/j.autrev.2014.05.001; Cousins L, 2015, ANN RHEUM DIS, V74, P317, DOI 10.1136/annrheumdis-2014-206483; Craig RJM, 2008, HLTH SURVEY ENGLAND; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; de Laat B, 2005, BLOOD, V105, P1540, DOI 10.1182/blood-2004-09-3387; De Laat B, 2009, J THROMB HAEMOST, V7, P1767, DOI 10.1111/j.1538-7836.2009.03588.x; de Laat B, 2011, ARTHRITIS RHEUM-US, V63, P3960, DOI 10.1002/art.30633; de Laat B, 2011, CURR RHEUMATOL REP, V13, P70, DOI 10.1007/s11926-010-0144-8; Florkowski Christopher M, 2008, Clin Biochem Rev, V29 Suppl 1, pS83; GALLI M, 1990, LANCET, V335, P1544, DOI 10.1016/0140-6736(90)91374-J; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Giles I, 2009, J IMMUNOL, V182, P4836, DOI 10.4049/jimmunol.0804241; Giles IP, 2003, MOL IMMUNOL, V40, P49, DOI 10.1016/S0161-5890(03)00100-7; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Ioannou Y, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-8; Ioannou Y, 2009, J THROMB HAEMOST, V7, P833, DOI 10.1111/j.1538-7836.2009.03316.x; Ioannou Y, 2007, ARTHRITIS RHEUM-US, V56, P280, DOI 10.1002/art.22306; Ioannou Y, 2010, BLOOD, V116, P1961, DOI 10.1182/blood-2009-04-215335; Iverson GM, 2006, J AUTOIMMUN, V27, P266, DOI 10.1016/j.jaut.2006.09.007; Iverson GM, 2002, J IMMUNOL, V169, P7097, DOI 10.4049/jimmunol.169.12.7097; Iverson GM, 1998, P NATL ACAD SCI USA, V95, P15542, DOI 10.1073/pnas.95.26.15542; Lakos G, 2012, ARTHRITIS RHEUM-US, V64, P1, DOI 10.1002/art.33349; Mahler M, 2012, AUTOIMMUN REV, V12, P313, DOI 10.1016/j.autrev.2012.05.006; MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120; Meroni PL, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4549; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mondejar R, 2014, CLIN CHIM ACTA, V431, P174, DOI 10.1016/j.cca.2014.01.047; Murthy V, 2013, ARTHRITIS RHEUM-US, V65, P3186, DOI 10.1002/art.38131; Pericleous C, 2015, RHEUMATOLOGY, V54, P722, DOI 10.1093/rheumatology/keu360; Pericleous C, 2011, MOL IMMUNOL, V49, P56, DOI 10.1016/j.molimm.2011.07.024; Petri M, 2000, J AUTOIMMUN, V15, P145, DOI 10.1006/jaut.2000.0409; Pierangeli SS, 2008, NAT PROTOC, V3, P840, DOI 10.1038/nprot.2008.48; Pierangeli SS, 2000, THROMB HAEMOSTASIS, V84, P388; Reddel SW, 2000, J AUTOIMMUN, V15, P91, DOI 10.1006/jaut.2000.0427; Swadzba J, 2014, LUPUS, V23, P395, DOI 10.1177/0961203314520841; Sweiss NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012280; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Willis R, 2013, ARTHRITIS RHEUM-US, V65, pS3; Willis R, 2012, SEMIN THROMB HEMOST, V38, P360, DOI 10.1055/s-0032-1313564; Wolgast L, 2015, J THROMB HAEMOST, V13, P13	47	35	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156407	10.1371/journal.pone.0156407	http://dx.doi.org/10.1371/journal.pone.0156407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253369	Green Published, Green Submitted, gold			2022-12-26	WOS:000377218700026
J	Menezes, L; Canedo, C; Batalha, H; Garda, AA; Gehara, M; Napoli, MF				Menezes, Lucas; Canedo, Clarissa; Batalha-Filho, Henrique; Garda, Adrian Antonio; Gehara, Marcelo; Napoli, Marcelo Felgueiras			Multilocus Phylogeography of the Treefrog Scinax eurydice (Anura, Hylidae) Reveals a Plio-Pleistocene Diversification in the Atlantic Forest	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; SPECIES LIMITS; DIVERSITY; NUCLEAR; BIODIVERSITY; BIOGEOGRAPHY; SYSTEMATICS; STABILITY	We aim to evaluate the genetic structure of an Atlantic Forest amphibian species, Scinax eurydice, testing the congruence among patterns identified and proposed by the literature for Pleistocene refugia, microrefugia, and geographic barriers to gene flow such as major rivers. Furthermore, we aim to evaluate predictions of such barriers and refugia on the genetic structure of the species, such as presence/absence of dispersal, timing since separation, and population expansions/contractions. We sequenced mitochondrial and nuclear genetic markers on 94 tissue samples from 41 localities. We inferred a gene tree and estimated genetic distances using mtDNA sequences. We then ran population clustering and assignment methods, AMOVA, and estimated migration rates among populations identified through mtDNA and nDNA analyses. We used a dated species tree, skyline plots, and summary statistics to evaluate concordance between population's distributions and geographic barriers and Pleistocene refugia. Scinax eurydice showed high mtDNA divergences and four clearly distinct mtDNA lineages. Species tree and population assignment tests supported the existence of two major clades corresponding to northeastern and southeastern Atlantic Forest in Brazil, each one composed of two other clades. Lineage splitting events occurred from late Pliocene to Pleistocene. We identified demographic expansions in two clades, and inexistent to low levels of migrations among different populations. Genetic patterns and demographic data support the existence of two northern Refuge and corroborate microrefugia south of the Doce/Jequitinhonha Rivers biogeographic divide. The results agree with a scenario of recent demographic expansion of lowland taxa. Scinax eurydice comprises a species complex, harboring undescribed taxa consistent with Pleistocene refugia. Two rivers lie at the boundaries among populations and endorse their role as secondary barriers to gene flow.	[Menezes, Lucas; Batalha-Filho, Henrique; Napoli, Marcelo Felgueiras] Univ Fed Bahia, Inst Biol, Programa Posgrad Diversidade Anim, Campus Univ Ondina,Rua Barao Jeremoabo, BR-40170115 Salvador, BA, Brazil; [Canedo, Clarissa; Napoli, Marcelo Felgueiras] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Quinta Boa Vista S-N, BR-20940040 Rio De Janeiro, RJ, Brazil; [Garda, Adrian Antonio] Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bot Ecol & Zool, LAR, Campus Univ, BR-59078900 Natal, RN, Brazil; [Gehara, Marcelo] Univ Fed Rio Grande do Norte, Programa Posgrad Sistemat & Evolucao, Ctr Biociencias, Campus Univ Lagoa Nova, BR-59078900 Natal, RN, Brazil; [Batalha-Filho, Henrique; Napoli, Marcelo Felgueiras] Univ Fed Bahia, Inst Biol, Dept Zool, Museu Zool, Campus Univ Ondina,Rua Barao Jeremoabo, BR-40170115 Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal da Bahia	Napoli, MF (corresponding author), Univ Fed Bahia, Inst Biol, Programa Posgrad Diversidade Anim, Campus Univ Ondina,Rua Barao Jeremoabo, BR-40170115 Salvador, BA, Brazil.; Napoli, MF (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Quinta Boa Vista S-N, BR-20940040 Rio De Janeiro, RJ, Brazil.; Napoli, MF (corresponding author), Univ Fed Bahia, Inst Biol, Dept Zool, Museu Zool, Campus Univ Ondina,Rua Barao Jeremoabo, BR-40170115 Salvador, BA, Brazil.	napoli@ufba.br	Napoli, Marcelo/G-3720-2012; Garda, Adrian Antonio/A-6636-2012; Canedo, Clarissa/C-5657-2014; Filho, Henrique Batalha/H-9355-2012; Gehara, Marcelo/J-6533-2014	Napoli, Marcelo/0000-0003-3843-0543; Garda, Adrian Antonio/0000-0002-1178-1207; Canedo, Clarissa/0000-0003-0637-4663; Filho, Henrique Batalha/0000-0001-7191-2814; 	CNPq [309672/2012-0]; Fundacao de Apoio a Pesquisa do Estado da Bahia (FAPESB) [BOL0596/2012]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [564940/2010-0]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [E-26/111/404/2012, E-26/102.818/2011]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MFN acknowledges the CNPq for research productivity grant (Proc. 309672/2012-0); LM acknowledges the Fundacao de Apoio a Pesquisa do Estado da Bahia (FAPESB) for scholarship (Proc. No. BOL0596/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Celio F. B. Haddad (Universidade Estadual Paulista), Miguel T. Rodrigues (Universidade de Sao Paulo), Ulisses Caramaschi and Jose P. Pombal-Jr (Museu Nacional), Luciana B. Nascimento (Pontificia Universidade Catolica de Minas Gerais), Renato N. Feio (Museu de Zoologia Joao Moojen de Oliveira), Paulo C. A. Garcia (Universidade Federal de Minas Gerais), Gustavo H. C. Vieira (Universidade Federal da Paraiba), and Robson W. Avila (Universidade Regional do Cariri) for allowing us to examine specimens under their care and for data access on related species; to Laboratorio de Pesquisa em Biodiversidade Molecular do Departamento de Vertebrados do Museu Nacional, Universidade Federal do Rio de Janeiro (supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, Proc. 564940/2010-0; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ, Proc. E-26/111/404/2012 and E-26/102.818/2011; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES), for the permission to use the laboratory structure during the research development. MFN acknowledges the CNPq for research productivity grant (Proc. 309672/2012-0); LM acknowledges the Fundacao de Apoio a Pesquisa do Estado da Bahia (FAPESB) for scholarship (Proc No. BOL0596/2012).	Alvarez-Presas M, 2014, HEREDITY, V112, P656, DOI 10.1038/hdy.2014.3; Amaro RC, 2012, MOL PHYLOGENET EVOL, V62, P880, DOI 10.1016/j.ympev.2011.11.004; Bastazini CV, 2007, HERPETOLOGICA, V63, P459, DOI 10.1655/0018-0831(2007)63[459:WEVBEC]2.0.CO;2; Batalha-Filho H, 2013, MOL PHYLOGENET EVOL, V67, P86, DOI 10.1016/j.ympev.2013.01.007; Batalha H, 2012, MOL PHYLOGENET EVOL, V65, P892, DOI 10.1016/j.ympev.2012.08.010; Batalha H, 2010, APIDOLOGIE, V41, P534, DOI 10.1051/apido/2010001; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Brunes TO, 2014, ZOOL SCR, V43, P586, DOI 10.1111/zsc.12079; Cabanne GS, 2013, J ORNITHOL, V154, P371, DOI 10.1007/s10336-012-0901-8; Cabanne GS, 2008, MOL PHYLOGENET EVOL, V49, P760, DOI 10.1016/j.ympev.2008.09.013; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2007, EVOLUTION, V61, P2942, DOI 10.1111/j.1558-5646.2007.00241.x; Carnaval Ana Carolina, 2014, Proc Biol Sci, V281, DOI 10.1098/rspb.2014.1461; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Clemente-Carvalho RBG, 2011, MOL PHYLOGENET EVOL, V61, P79, DOI 10.1016/j.ympev.2011.05.017; Crawford AJ, 2003, MOL ECOL, V12, P2525, DOI 10.1046/j.1365-294X.2003.01910.x; D'Horta FM, 2011, MOL ECOL, V20, P1923, DOI 10.1111/j.1365-294X.2011.05063.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duellman WE, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P255; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Feio R.N., 2008, BIOTA, V1, P1; Feio Renato Neves, 2002, Phyllomedusa, V1, P105; Fouquet A, 2012, BIOL J LINN SOC, V106, P356, DOI 10.1111/j.1095-8312.2012.01871.x; Fusinatto LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079504; Gehara M, 2013, CONSERV GENET, V14, P973, DOI 10.1007/s10592-013-0488-5; Gehara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103958; Grazziotin FG, 2006, MOL ECOL, V15, P3969, DOI 10.1111/j.1365-294X.2006.03057.x; Hartmann Marilia T., 2002, Herpetological Review, V33, P222; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maldonado-Coelho M, 2012, BIOL J LINN SOC, V105, P900, DOI 10.1111/j.1095-8312.2011.01823.x; Martins FM, 2009, BMC EVOL BIOL, V9, DOI [10.1186/1471-2148-9-36, 10.1186/1471-2148-9-294]; Miller M.A., 2010, P GAT COMP ENV WORKS; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Pombal-Junior Jose Perez, 1995, Naturalia (Rio Claro), V20, P213; Pritchard J.K., DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Projeto Radambrasil, 1983, 23 24 RIO DE JANEIRO, P775; R Core Team, 2021, R LANGUAGE ENV STAT; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ribeiro RA, 2011, HEREDITY, V106, P46, DOI 10.1038/hdy.2010.64; Tonini JFR, 2013, J ZOOL SYST EVOL RES, V51, P114, DOI 10.1111/jzs.12014; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strasburg JL, 2010, MOL BIOL EVOL, V27, P297, DOI 10.1093/molbev/msp233; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thome MTC, 2014, MOL ECOL, V23, P6152, DOI 10.1111/mec.12986; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Vasconcelos TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104130; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	61	18	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2016	11	6							e0154626	10.1371/journal.pone.0154626	http://dx.doi.org/10.1371/journal.pone.0154626			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6KZ	27248688	Green Published, gold, Green Submitted			2022-12-26	WOS:000377184700006
J	Blanquer, A; Hynowska, A; Nogues, C; Ibanez, E; Sort, J; Baro, MD; Ozkale, B; Pane, S; Pellicer, E; Barrios, L				Blanquer, Andreu; Hynowska, Anna; Nogues, Carme; Ibanez, Elena; Sort, Jordi; Dolors Baro, Maria; Ozkale, Berna; Pane, Salvador; Pellicer, Eva; Barrios, Leonardo			Effect of Surface Modifications of Ti40Zr10Cu38Pd12 Bulk Metallic Glass and Ti-6Al-4V Alloy on Human Osteoblasts In Vitro Biocompatibility	PLOS ONE			English	Article							BIOMEDICAL APPLICATIONS; TITANIUM SURFACE; LINEAGE CELLS; IMPLANTS; ADHESION; DIFFERENTIATION; TOPOGRAPHY; RESISTANT; BEHAVIOR; SEARCH	The use of biocompatible materials, including bulk metallic glasses (BMGs), for tissue regeneration and transplantation is increasing. The good mechanical and corrosion properties of Ti40Zr10Cu38Pd12 BMG and its previously described biocompatibility makes it a potential candidate for medical applications. However, it is known that surface properties like topography might play an important role in regulating cell adhesion, proliferation and differentiation. Thus, in the present study, Ti40Zr10Cu38Pd12 BMG and Ti6-Al-4V alloy were surface-modified electrochemically (nanomesh) or physically (microscratched) to investigate the effect of material topography on human osteoblasts cells (Saos-2) adhesion, proliferation and differentiation. For comparative purposes, the effect of mirror-like polished surfaces was also studied. Electrochemical treatments led to a highly interconnected hierarchical porous structure rich in oxides, which have been described to improve corrosion resistance, whereas microscratched surfaces showed a groove pattern with parallel trenches. Cell viability was higher than 96% for the three topographies tested and for both alloy compositions. In all cases, cells were able to adhere, proliferate and differentiate on the alloys, hence indicating that surface topography plays a minor role on these processes, although a clear cell orientation was observed on microscratched surfaces. Overall, our results provide further evidence that Ti40Zr10Cu38Pd12 BMG is an excellent candidate, in the present two topographies, for bone repair purposes.	[Blanquer, Andreu; Nogues, Carme; Ibanez, Elena; Barrios, Leonardo] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Edifici Cc, Bellaterra, Spain; [Hynowska, Anna; Sort, Jordi; Dolors Baro, Maria; Pellicer, Eva] Univ Autonoma Barcelona, Dept Fis, Edifici Cc, Bellaterra, Spain; [Sort, Jordi] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain; [Ozkale, Berna; Pane, Salvador] ETH, Inst Robot & Intelligent Syst, Multiscale Robot Lab, Zurich, Switzerland	Autonomous University of Barcelona; Autonomous University of Barcelona; ICREA; Swiss Federal Institutes of Technology Domain; ETH Zurich	Barrios, L (corresponding author), Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Edifici Cc, Bellaterra, Spain.; Pellicer, E (corresponding author), Univ Autonoma Barcelona, Dept Fis, Edifici Cc, Bellaterra, Spain.	eva.pellicer@uab.cat; lleonard.barrios@uab.cat	Sort, Jordi/GPP-6695-2022; Barrios, Leonardo/L-3315-2014; Blanquer, Andreu/W-5541-2019; Pellicer, Eva/G-2917-2014; Sort, Jordi/F-6582-2014; Nogues, Carme/A-2339-2009; Ibáñez, Elena/K-4320-2014	Barrios, Leonardo/0000-0002-6151-8503; Blanquer, Andreu/0000-0002-3551-1885; Pellicer, Eva/0000-0002-8901-0998; Sort, Jordi/0000-0003-1213-3639; Nogues, Carme/0000-0002-6361-8559; Ibáñez, Elena/0000-0002-0275-6958; Ozkale Edelmann, Berna/0000-0002-3016-9363; Pane, Salvador/0000-0003-0147-8287	Ministerio de Ciencia e Innovacion [TEC2011-29140-C03-03, MAT2014-57960-C03-3-R, MAT2014-57960-C03-1-R]; Generalitat de Catalunya [2014-SGR-524, 2014-SGR-1015]; Seventh Framework Program (EC) [FP7-PEOPLE-2010-ITN-264635]; Universitat Autonoma de Barcelona; Ministerio de Economia y Competitividad [RYC-2012-10839]; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Seventh Framework Program (EC); Universitat Autonoma de Barcelona; Ministerio de Economia y Competitividad(Spanish Government); ICREA(ICREA)	This work was supported by Ministerio de Ciencia e Innovacion (www.micinn.es/): TEC2011-29140-C03-03, Carme Nogues; MAT2014-57960-C03-3-R, Carme Nogues; MAT2014-57960-C03-1-R, Jordi Sort; Generalitat de Catalunya (web.gencat.cat/): 2014-SGR-524, Carme Nogues; 2014-SGR-1015, Jordi Sort; Seventh Framework Program (EC) (https://ec.europa.eu/research/fp7/): FP7-PEOPLE-2010-ITN-264635, Maria Dolors Baro; Universitat Autonoma de Barcelona (http://www.uab.cat/): PIF Predoctoral Grant, Andreu Blanquer; Ministerio de Economia y Competitividad (www.micinn.es/): RYC-2012-10839, Eva Pellicer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2010, J ADHES SCI TECHNOL, V24, P831, DOI 10.1163/016942409X12598231568186; Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051; Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004; Blanquer A, 2014, J MATER SCI-MATER M, V25, P163, DOI 10.1007/s10856-013-5041-z; Burleigh TD, 2009, J ELECTROCHEM SOC, V156, pC45, DOI 10.1149/1.3021029; Choe H, 2005, MAT SCI ENG A-STRUCT, V396, P99, DOI 10.1016/j.msea.2005.01.051; Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0; Czekanska EM, 2012, EUR CELLS MATER, V24, P1; Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049; de Peppo GM, 2014, INT J NANOMED, V9, P2499, DOI 10.2147/IJN.S58805; Deng ZN, 2014, INT J NANOMED, V9, P5565, DOI 10.2147/IJN.S71625; Fornell J, 2012, J ALLOY COMPD, V536, pS74, DOI 10.1016/j.jallcom.2011.10.057; Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004; Gittens RA, 2012, BIOMATERIALS, V33, P8986, DOI 10.1016/j.biomaterials.2012.08.059; Hermawan Hendra, 2011, BIOMED ENG, DOI [10.5772/19033, DOI 10.5772/19033]; Huang L, 2012, J BIOMED MATER RES B, V100B, P1472, DOI 10.1002/jbm.b.32715; Hynowska A, 2015, J BIOMED MATER RES B, V103, P1569, DOI 10.1002/jbm.b.33346; Hynowska A, 2013, MATERIALS, V6, P4930, DOI 10.3390/ma6114930; Li HF, 2012, J BIOMED MATER RES B, V100B, P1721, DOI 10.1002/jbm.b.32738; Mendonca DBS, 2011, BONE, V49, P463, DOI 10.1016/j.bone.2011.04.019; Minagar S, 2013, J BIOMED MATER RES A, V101, P2726, DOI 10.1002/jbm.a.34575; Olivares-Navarrete R, 2014, ANN BIOMED ENG, V42, P2551, DOI 10.1007/s10439-014-1108-3; Patel SB, 2014, J MATER CHEM B, V2, P3597, DOI 10.1039/c3tb21731k; Pisarek M, 2012, BIOMEDICAL ENG TECHN, P20, DOI [10.5772/48693, DOI 10.5772/48693]; Qin FX, 2007, MATER TRANS, V48, P1855, DOI 10.2320/matertrans.MJ200713; Qin FX, 2007, MATER TRANS, V48, P515, DOI 10.2320/matertrans.48.515; Saldana L, 2011, ACTA BIOMATER, V7, P4210, DOI 10.1016/j.actbio.2011.07.019; Vandrovcova M, 2011, PHYSIOL RES, V60, P403, DOI 10.33549/physiolres.932045; Vandrovcova M, 2012, J BIOMED MATER RES A, V100A, P1016, DOI 10.1002/jbm.a.34047; Yang WE, 2010, THIN SOLID FILMS, V518, P7545, DOI 10.1016/j.tsf.2010.05.045; Zareidoost A, 2012, J MATER SCI-MATER M, V23, P1479, DOI 10.1007/s10856-012-4611-9; Zhang EL, 2015, MAT SCI ENG C-MATER, V46, P148, DOI 10.1016/j.msec.2014.10.021; Zhou F, 2009, CHINESE SCI BULL, V54, P3200, DOI [10.1007/s11434-009-0366-1, 10.1007/S11434-009-0366-1]; Zhu LB, 2012, FOOD MICROBIOL, V30, P303, DOI 10.1016/j.fm.2011.12.001; Zhu SL, 2007, MAT SCI ENG A-STRUCT, V459, P233, DOI 10.1016/j.msea.2007.01.044	35	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156644	10.1371/journal.pone.0156644	http://dx.doi.org/10.1371/journal.pone.0156644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243628	Green Published, gold, Green Submitted			2022-12-26	WOS:000377146100059
J	Hubbard, CS; Becerra, L; Heinz, N; Ludwick, A; Rasooly, T; Wu, R; Johnson, A; Schechter, NL; Borsook, D; Nurko, S				Hubbard, Catherine S.; Becerra, Lino; Heinz, Nicole; Ludwick, Allison; Rasooly, Tali; Wu, Rina; Johnson, Adriana; Schechter, Neil L.; Borsook, David; Nurko, Samuel			Abdominal Pain, the Adolescent and Altered Brain Structure and Function	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; QUALITY-OF-LIFE; DORSOLATERAL PREFRONTAL CORTEX; POSTERIOR CINGULATE CORTEX; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; DEFAULT MODE NETWORK; CHRONIC BACK-PAIN; GRAY-MATTER; WORKING-MEMORY	Irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) disorder of unknown etiology. Although relatively common in children, how this condition affects brain structure and function in a pediatric population remains unclear. Here, we investigate brain changes in adolescents with IBS and healthy controls. Imaging was performed with a Siemens 3 Tesla Trio Tim MRI scanner equipped with a 32-channel head coil. A high-resolution T1-weighted anatomical scan was acquired followed by a T2-weighted functional scan. We used a surfacebased morphometric approach along with a seed-based resting-state functional connectivity (RS-FC) analysis to determine if groups differed in cortical thickness and whether areas showing structural differences also showed abnormal RS-FC patterns. Patients completed the Abdominal Pain Index and the GI Module of the Pediatric Quality of Life Inventory to assess abdominal pain severity and impact of GI symptoms on health-related quality of life (HRQOL). Disease duration and pain intensity were also assessed. Pediatric IBS patients, relative to controls, showed cortical thickening in the posterior cingulate (PCC), whereas cortical thinning in posterior parietal and prefrontal areas were found, including the dorsolateral prefrontal cortex (DLPFC). In patients, abdominal pain severity was related to cortical thickening in the intra-abdominal area of the primary somatosensory cortex (SI), whereas HRQOL was associated with insular cortical thinning. Disease severitymeasures correlated with cortical thickness in bilateral DLPFC and orbitofrontal cortex. Patients also showed reduced anti-correlations between PCC and DLPFC compared to controls, a finding that may reflect aberrant connectivity between default mode and cognitive control networks. We are the first to demonstrate concomitant structural and functional brain changes associated with abdominal pain severity, HRQOL related to GI-specific symptoms, and disease-specific measures in adolescents with IBS. It is possible such changes will be responsive to therapeutic intervention and may be useful as potential markers of disease progression or reversal.	[Hubbard, Catherine S.; Becerra, Lino; Ludwick, Allison; Rasooly, Tali; Johnson, Adriana; Borsook, David] Boston Childrens Hosp, Ctr Pain & Brain, Waltham, MA 02453 USA; [Hubbard, Catherine S.; Becerra, Lino; Schechter, Neil L.; Borsook, David] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Hubbard, Catherine S.; Becerra, Lino; Schechter, Neil L.; Borsook, David] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA; [Heinz, Nicole; Wu, Rina; Nurko, Samuel] Boston Childrens Hosp, Dept Med, Div Gastroenterol, Ctr Motil & Funct Gastrointestinal Disorders, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Hubbard, CS (corresponding author), Boston Childrens Hosp, Ctr Pain & Brain, Waltham, MA 02453 USA.; Hubbard, CS (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.; Hubbard, CS (corresponding author), Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA.	catherine.hubbard@childrens.harvard.edu		Nurko, Samuel/0000-0003-0936-4807	NINDS [K24 NS064050]; Mayday/Louis Herlands Chair for Pain Systems Neuroscience; Anesthesia Foundation; NIDDK [K24 DK082792]; Behrakis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mayday/Louis Herlands Chair for Pain Systems Neuroscience; Anesthesia Foundation; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Behrakis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by K24 NS064050 NINDS (DB), the Mayday/Louis Herlands Chair for Pain Systems Neuroscience (DB), the Anesthesia Foundation (DB), K24 DK082792 NIDDK (SN), and the Behrakis Foundation (SN).	Aizawa E, 2012, GASTROENTEROLOGY, V143, P1188, DOI 10.1053/j.gastro.2012.07.104; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Apkarian AV, 2010, HUMAN BRAIN IMAGING; Aziz Q, 1997, GASTROENTEROLOGY, V113, P50, DOI 10.1016/S0016-5085(97)70079-9; Aziz Q, 2000, J NEUROSCI, V20, P2657; Baker KS, 2016, CLIN J PAIN, V32, P673, DOI 10.1097/AJP.0000000000000313; Beck AT, 1996, PSYCHOL ASSESS; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Binkofski F, 1998, ANN NEUROL, V44, P811, DOI 10.1002/ana.410440516; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Bradford K, 2012, CLIN GASTROENTEROL H, V10, P385, DOI 10.1016/j.cgh.2011.12.018; Bruehl S, 2013, J PAIN, V14, P103, DOI 10.1016/j.jpain.2012.10.016; Buckalew N, 2008, PAIN MED, V9, P240, DOI 10.1111/j.1526-4637.2008.00412.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; CERVERO F, 1992, TRENDS NEUROSCI, V15, P374, DOI 10.1016/0166-2236(92)90182-8; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chanda ML, 2011, J PAIN, V12, P792, DOI 10.1016/j.jpain.2011.01.008; Chen L, 2009, PAIN, V143, P65, DOI 10.1016/j.pain.2009.01.022; Chitkara DK, 2008, AM J GASTROENTEROL, V103, P765, DOI 10.1111/j.1572-0241.2007.01722.x; Chorpita BF, 2000, BEHAV RES THER, V38, P835, DOI 10.1016/S0005-7967(99)00130-8; Cifre I, 2012, PSYCHOSOM MED, V74, P55, DOI 10.1097/PSY.0b013e3182408f04; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Crombez G, 2003, PAIN, V104, P639, DOI 10.1016/S0304-3959(03)00121-0; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis KD, 2008, NEUROLOGY, V70, P153, DOI 10.1212/01.wnl.0000295509.30630.10; Derbyshire Stuart W G, 2003, ScientificWorldJournal, V3, P1065; Derbyshire SWG, 2003, AM J GASTROENTEROL, V98, P12, DOI 10.1111/j.1572-0241.2003.07168.x; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dick BD, 2007, ANESTH ANALG, V104, P1223, DOI 10.1213/01.ane.0000263280.49786.f5; Drewes AM, 2006, EXP BRAIN RES, V174, P443, DOI 10.1007/s00221-006-0480-0; Drossman D, 2006, ROME 3 FUNCTIONAL GA; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; ECCLESTON C, 1994, BRIT J CLIN PSYCHOL, V33, P535, DOI 10.1111/j.2044-8260.1994.tb01150.x; Elsenbruch S, 2010, GUT, V59, P489, DOI 10.1136/gut.2008.175000; Elsenbruch S, 2011, BRAIN BEHAV IMMUN, V25, P386, DOI 10.1016/j.bbi.2010.11.010; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Furlong PL, 1998, EVOKED POTENTIAL, V108, P234, DOI 10.1016/S0168-5597(98)00016-1; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Hahn B, 2007, CEREB CORTEX, V17, P1664, DOI 10.1093/cercor/bhl075; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hauser G, 2014, WORLD J GASTROENTERO, V20, P6744, DOI 10.3748/wjg.v20.i22.6744; Hayes DJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-60; Hein G, 2008, J COGNITIVE NEUROSCI, V20, P2125, DOI 10.1162/jocn.2008.20148; Hemington KS, 2016, BRAIN STRUCT FUNCT, V221, P4203, DOI 10.1007/s00429-015-1161-1; Heymen S, 2010, CLIN J PAIN, V26, P104, DOI 10.1097/AJP.0b013e3181bff800; Hobday DI, 2001, BRAIN, V124, P361, DOI 10.1093/brain/124.2.361; Hong JY, 2016, NEUROGASTROENT MOTIL, V28, P127, DOI 10.1111/nmo.12710; Hong JY, 2014, J NEUROSCI, V34, P14252, DOI 10.1523/JNEUROSCI.1683-14.2014; Hong JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084564; Hu WT, 2015, INT J CLIN EXP MED, V8, P4311; Hubbard CS, 2015, NEUROGASTROENT MOTIL, V27, P1282, DOI 10.1111/nmo.12622; Hubbard CS, 2014, ENEURO, V1, DOI 10.1523/ENEURO.0006-14.2014; Hyams JS, 1996, J PEDIATR-US, V129, P220, DOI 10.1016/S0022-3476(96)70246-9; Icenhour A, 2015, NEUROGASTROENT MOTIL, V27, P114, DOI 10.1111/nmo.12489; Irimia A, 2015, NEUROGASTROENT MOTIL, V27, P1075, DOI 10.1111/nmo.12586; Jarcho JM, 2008, ALIMENT PHARM THER, V28, P344, DOI 10.1111/j.1365-2036.2008.03721.x; Jarrahi B, 2015, HUM BRAIN MAPP, V36, P4438, DOI 10.1002/hbm.22929; Jiang ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073932; Katsuki F, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00017; Kennedy PJ, 2014, PSYCHOL MED, V44, P1553, DOI 10.1017/S0033291713002171; Khalsa S, 2014, NEUROIMAGE, V102, P118, DOI 10.1016/j.neuroimage.2013.12.022; King CD, 2009, PAIN, V143, P172, DOI 10.1016/j.pain.2008.12.027; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kucyi A, 2014, J NEUROSCI, V34, P3969, DOI 10.1523/JNEUROSCI.5055-13.2014; Labus JS, 2014, PAIN, V155, P137, DOI 10.1016/j.pain.2013.09.020; Labus JS, 2013, GASTROENTEROLOGY, V145, P1253, DOI 10.1053/j.gastro.2013.08.016; Ladabaum U, 2001, GASTROENTEROLOGY, V120, P369, DOI 10.1053/gast.2001.21201; Laird KT, 2015, J PEDIATR PSYCHOL, V40, P517, DOI 10.1093/jpepsy/jsu118; Lee MC, 2014, NEUROPHARMACOLOGY, V84, P123, DOI 10.1016/j.neuropharm.2013.06.035; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Liu X, 2016, NEUROGASTROENT MOTIL, V28, P43, DOI 10.1111/nmo.12695; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Ma XF, 2015, CLIN NEUROPHYSIOL, V126, P1190, DOI 10.1016/j.clinph.2014.10.004; Maleki N, 2012, CEPHALALGIA, V32, P607, DOI 10.1177/0333102412445622; Mao CP, 2014, NEURORADIOLOGY, V56, P903, DOI 10.1007/s00234-014-1391-6; Martinsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108637; Mayer EA, 2015, PAIN, V156, pS50, DOI 10.1097/j.pain.0000000000000106; Mertz H, 2000, GASTROENTEROLOGY, V118, P842, DOI 10.1016/S0016-5085(00)70170-3; Miele E, 2004, PEDIATRICS, V114, P73, DOI 10.1542/peds.114.1.73; Montiel-Castro AJ, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00070; Moont R, 2011, PAIN, V152, P1469, DOI 10.1016/j.pain.2011.01.036; Moulton EA, 2012, J NEUROSCI, V32, P6024, DOI 10.1523/JNEUROSCI.0006-12.2012; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Naliboff BD, 1998, J PSYCHOSOM RES, V45, P485; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; OLSON CR, 1992, CEREB CORTEX, V2, P485, DOI 10.1093/cercor/2.6.485; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Palecek J, 2004, PHYSIOL RES, V53, pS125; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Pelphrey KA, 2008, ANN NY ACAD SCI, V1145, P283, DOI 10.1196/annals.1416.007; Peltz E, 2011, NEUROIMAGE, V54, P1324, DOI 10.1016/j.neuroimage.2010.09.012; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Petzke F, 2010, SCHMERZ, V24, P146, DOI 10.1007/s00482-010-0903-5; Piche M, 2009, J NEUROSCI, V29, P14236, DOI 10.1523/JNEUROSCI.2341-09.2009; Portincasa P, 2003, WORLD J GASTROENTERO, V9, P2293; Price JL, 1999, ANN NY ACAD SCI, V877, P383, DOI 10.1111/j.1749-6632.1999.tb09278.x; Price JL, 2007, ANN NY ACAD SCI, V1121, P54, DOI 10.1196/annals.1401.008; Qi RF, 2016, BRAIN IMAGING BEHAV, V10, P1127, DOI 10.1007/s11682-015-9478-1; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Ringel Y, 2008, GASTROENTEROLOGY, V134, P396, DOI 10.1053/j.gastro.2007.11.011; Robins DL, 2009, BRAIN COGNITION, V69, P269, DOI 10.1016/j.bandc.2008.08.007; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Roth RS, 2005, ARCH PHYS MED REHAB, V86, P1147, DOI 10.1016/j.apmr.2004.10.041; Schmidt-Wilcke T, 2006, PAIN, V125, P89, DOI 10.1016/j.pain.2006.05.004; Schwetz Ines, 2003, Curr Gastroenterol Rep, V5, P331, DOI 10.1007/s11894-003-0071-1; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Seminowicz DA, 2013, J PAIN, V14, P1573, DOI 10.1016/j.jpain.2013.07.020; Seminowicz DA, 2010, GASTROENTEROLOGY, V139, P48, DOI 10.1053/j.gastro.2010.03.049; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Surdea-Blaga T, 2012, WORLD J GASTROENTERO, V18, P616, DOI 10.3748/wjg.v18.i7.616; Sykes MA, 2003, J BEHAV MED, V26, P361, DOI 10.1023/A:1024209111909; Van Tilburg MAL, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12056; Varni JW, 2006, J DEV BEHAV PEDIATR, V27, P451, DOI 10.1097/00004703-200612000-00001; Varni JW, 2015, J PEDIATR-US, V166, P85, DOI 10.1016/j.jpeds.2014.08.022; Varni JW, 2014, J PEDIATR GASTR NUTR, V59, P347, DOI 10.1097/MPG.0000000000000414; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Verne GN, 2003, PAIN, V103, P99, DOI 10.1016/S0304-3959(02)00416-5; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Vogt BA, 1996, EUR J NEUROSCI, V8, P1461, DOI 10.1111/j.1460-9568.1996.tb01608.x; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Walker LS, 1997, PSYCHOL ASSESSMENT, V9, P392, DOI 10.1037/1040-3590.9.4.392; WALKER LS, 1991, J PEDIATR PSYCHOL, V16, P39, DOI 10.1093/jpepsy/16.1.39; Weissman-Fogel I, 2011, PAIN, V152, P384, DOI 10.1016/j.pain.2010.10.046; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Willis WD, 1999, P NATL ACAD SCI USA, V96, P7675, DOI 10.1073/pnas.96.14.7675; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Xue T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052927; Zhang Y, 2015, PAIN MED, V16, P911, DOI 10.1111/pme.12606	141	37	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156545	10.1371/journal.pone.0156545	http://dx.doi.org/10.1371/journal.pone.0156545			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27244227	Green Submitted, gold, Green Published			2022-12-26	WOS:000377146100043
J	Thottakkara, P; Ozrazgat-Baslanti, T; Hupf, BB; Rashidi, P; Pardalos, P; Momcilovic, P; Bihorac, A				Thottakkara, Paul; Ozrazgat-Baslanti, Tezcan; Hupf, Bradley B.; Rashidi, Parisa; Pardalos, Panos; Momcilovic, Petar; Bihorac, Azra			Application of Machine Learning Techniques to High-Dimensional Clinical Data to Forecast Postoperative Complications	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; SUPPORT VECTOR MACHINES; ACUTE KIDNEY INJURY; LOGISTIC-REGRESSION; RISK; CLASSIFICATION; PREDICTION; MORTALITY; ASSOCIATION; PERFORMANCE	Objective To compare performance of risk prediction models for forecasting postoperative sepsis and acute kidney injury. Design Retrospective single center cohort study of adult surgical patients admitted between 2000 and 2010. Patients 50,318 adult patients undergoing major surgery. Measurements We evaluated the performance of logistic regression, generalized additive models, naive Bayes and support vector machines for forecasting postoperative sepsis and acute kidney injury. We assessed the impact of feature reduction techniques on predictive performance. Model performance was determined using the area under the receiver operating characteristic curve, accuracy, and positive predicted value. The results were reported based on a 70/30 cross validation procedure where the data were randomly split into 70% used for training the model and the 30% for validation. Main Results The areas under the receiver operating characteristic curve for different models ranged between 0.797 and 0.858 for acute kidney injury and between 0.757 and 0.909 for severe sepsis. Logistic regression, generalized additive model, and support vector machines had better performance compared to Naive Bayes model. Generalized additive models additionally accounted for non-linearity of continuous clinical variables as depicted in their risk patterns plots. Reducing the input feature space with LASSO had minimal effect on prediction performance, while feature extraction using principal component analysis improved performance of the models. Conclusions Generalized additive models and support vector machines had good performance as risk prediction model for postoperative sepsis and AKI. Feature extraction using principal component analysis improved the predictive performance of all models.	[Thottakkara, Paul; Ozrazgat-Baslanti, Tezcan; Hupf, Bradley B.; Bihorac, Azra] Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL USA; [Rashidi, Parisa] Univ Florida, Dept Biomed Engn, Gainesville, FL USA; [Thottakkara, Paul; Pardalos, Panos; Momcilovic, Petar] Univ Florida, Ind & Syst Engn, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bihorac, A (corresponding author), Univ Florida, Coll Med, Dept Anesthesiol, Gainesville, FL USA.	abihorac@anest.ufl.edu	Bihorac, Azra/Q-6500-2016; Rashidi, Parisa/AAP-7261-2020; Pardalos, Panos/AAY-8591-2020	Bihorac, Azra/0000-0002-5745-2863; Rashidi, Parisa/0000-0003-4530-2048; 	National Institute of General Medical Sciences [P50 GM-111152]; Vision Grant Society of Critical Care Medicine; Astute Medial; I Heermann Anesthesia Foundation, Inc; NIH/NCATS Clinical and Translational Sciences Award: University of Florida [UL1: TR000064]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064, UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vision Grant Society of Critical Care Medicine; Astute Medial; I Heermann Anesthesia Foundation, Inc; NIH/NCATS Clinical and Translational Sciences Award: University of Florida; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by P50 GM-111152 National Institute of General Medical Sciences http://www.nigms.nih.gov: AB TOB, Vision Grant Society of Critical Care Medicine http://www.sccm.org: AB, Astute Medial, Inc http://www.astutemedical.com/US/Home: AB, I Heermann Anesthesia Foundation, Inc: AB and NIH/NCATS Clinical and Translational Sciences Award: University of Florida UL1: TR000064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2010, PAT SAF IND TECHN SP; Airaksinen J, 2016, EUR J PUBLIC HEALTH, V26, P417, DOI 10.1093/eurpub/ckv210; American College of Surgeons National Surgical Quality Improvement Program, 2015, SURG RISK CALC 2007; Ben Meskina S, 2013, INF TECHN E SERV ICI; Bihorac A, 2013, CRIT CARE MED, V41, P2570, DOI 10.1097/CCM.0b013e31829860fc; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Boulle M, 2005, LECT NOTES ARTIF INT, V3587, P228; Chapman A.D., 2006, GUIDE BEST PRACTICES; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chun FKH, 2007, BJU INT, V99, P794, DOI 10.1111/j.1464-410X.2006.06694.x; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; COPELAND GP, 1991, BRIT J SURG, V78, P356; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dombrovskiy VY, 2005, CRIT CARE MED, V33, P2555, DOI 10.1097/01.CCM.0000186748.64438.7B; Domingos P, 1997, MACH LEARN, V29, P103, DOI 10.1023/A:1007413511361; Du Y, 2004, ENG MED BIOL SOC 200; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Faradmal J, 2014, ASIAN PAC J CANCER P, V15, P5883, DOI 10.7314/APJCP.2014.15.14.5883; Glance LG, 2015, ANESTH ANALG, V120, P526, DOI 10.1213/ANE.0000000000000522; Han SR, 2009, RISK ANAL, V29, P1443, DOI 10.1111/j.1539-6924.2009.01280.x; HASTIE T, 1990, GENERALIZED ADDITIVE, V15; Heydari ST, 2012, J MED SYST, V36, P2449, DOI 10.1007/s10916-011-9711-4; Hobson CE, 2015, CRIT CARE CLIN; Hobson C, 2015, ANN SURG, V261, P1207, DOI 10.1097/SLA.0000000000000732; Huang Hsin-Hsiung, 2014, BMC Proc, V8, pS96, DOI 10.1186/1753-6561-8-S1-S96; Huang R, 2015, J HUM NUTR DIET, V28, P604, DOI 10.1111/jhn.12279; Huber M, 2016, ANN VASC SURG, V30, P72, DOI 10.1016/j.avsg.2015.04.092; Huen SC, 2012, ANN THORAC SURG, V93, P337, DOI 10.1016/j.athoracsur.2011.09.010; Khan NA, 2006, J GEN INTERN MED, V21, P177, DOI 10.1111/j.1525-1497.2006.00319.x; Korenkevych D, 2016, ANN SURG, V263, P1219, DOI 10.1097/SLA.0000000000001362; Kovalchik SA, 2015, J EPIDEMIOL COMMUN H, V69, P978, DOI 10.1136/jech-2015-205600; Kurt I, 2008, EXPERT SYST APPL, V34, P366, DOI 10.1016/j.eswa.2006.09.004; Lake APJ, 1997, BRIT J ANAESTH, V78, P228, DOI 10.1093/bja/78.2.228-a; Maroco Joao, 2011, BMC Res Notes, V4, P299, DOI 10.1186/1756-0500-4-299; Mittag F, 2012, HUM MUTAT, V33, P1708, DOI 10.1002/humu.22161; Miyagawa T, 2008, J HUM GENET, V53, P886, DOI 10.1007/s10038-008-0322-y; Osborne JW, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00370; Ozrazgat-Baslanti T, 2015, ANN SURG; Pang H, 2013, GENET EPIDEMIOL, V37, P276, DOI 10.1002/gepi.21721; Pebesma E., 2005, R NEWS, V5, P9; Pochet NLMM, 2006, ULTRASOUND OBST GYN, V27, P607, DOI 10.1002/uog.2791; Pyle, 1999, DATA PREPARATION DAT; Radford PD, 2015, INT J SURG, V13, P211, DOI 10.1016/j.ijsu.2014.11.049; Ramsay SE, 2015, J EPIDEMIOL COMMUN H, V69, P1224, DOI 10.1136/jech-2015-205542; Richardson R, 2015, SOC PSYCH PSYCH EPID, V50, P1641, DOI 10.1007/s00127-015-1092-4; Shariff-Marco S, 2015, J COMMUN HEALTH, V40, P1287, DOI 10.1007/s10900-015-0052-y; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; U.S. Department of Veterans Affairs VHA, 2015, NAT DRUG FIL REF TER; United States Census Bureau, 2010, AM FACTFINDER 2010; Van den Broeck J, 2005, PLOS MED, V2, P966, DOI 10.1371/journal.pmed.0020267; Verplancke T, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-56; Wald R, 2006, J VASC SURG, V43, P460, DOI 10.1016/j.jvs.2005.11.053; Westreich D, 2010, J CLIN EPIDEMIOL, V63, P826, DOI 10.1016/j.jclinepi.2009.11.020; Woo MJ, 2008, STAT MED, V27, P3805, DOI 10.1002/sim.3278; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yu W, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-16; Zarjou A, 2011, J AM SOC NEPHROL, V22, P999, DOI 10.1681/ASN.2010050484	59	90	92	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155705	10.1371/journal.pone.0155705	http://dx.doi.org/10.1371/journal.pone.0155705			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232332	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000006
J	Nwadozi, E; Roudier, E; Rullman, E; Tharmalingam, S; Liu, HY; Gustafsson, T; Haas, TL				Nwadozi, Emmanuel; Roudier, Emilie; Rullman, Eric; Tharmalingam, Sujeenthar; Liu, Hsin-yi; Gustafsson, Thomas; Haas, Tara L.			Endothelial FoxO proteins impair insulin sensitivity and restrain muscle angiogenesis in response to a high-fat diet	FASEB JOURNAL			English	Article						capillary; obesity; diabetes; microcirculation; gene expression	TRANSCRIPTION FACTOR FOXO1; NECROSIS-FACTOR-ALPHA; SKELETAL-MUSCLE; ADIPOSE-TISSUE; CAPILLARY DENSITY; INFLAMMATORY PATHWAYS; VASCULAR ENDOTHELIUM; ISCHEMIC MUSCLE; HUMAN OBESITY; RESISTANCE	Skeletal muscle microvascular dysfunction contributes to disease severity in type 2 diabetes. Recent studies indicate a role for Forkhead box O (FoxO) transcription factors in modulating endothelial cell phenotype. We hypothesized that a high-fat (HF) diet generates a dysfunctional vascular niche through an increased expression of endothelial FoxO. FoxO1 protein increased (+130%) in the skeletal muscle capillaries from HF compared to normal chow-fed mice. FoxO1 protein was significantly elevated in cultured endothelial cells exposed to the saturated fatty acid palmitate or the proinflammatory cytokine TNF-. In HF-fed mice, endothelium-directed depletion of FoxO1/3/4 (FoxO) improved insulin sensitivity (+110%) compared to that of the controls (FoxO(L/L)). The number of skeletal muscle capillaries increased significantly in the HF-FoxO mice. Transcript profiling of skeletal muscle identified significant increases in genes associated with angiogenesis and lipid metabolism in HF-FoxOvs. HF-FoxO(L/L) mice. HF-FoxO muscle also was characterized by a decrease in inflammation-related genes and an enriched M2 macrophage signature. We conclude that endothelial FoxO proteins promote insulin resistance in HF diet, which may in part result from FoxO proteins establishing an antiangiogenic and proinflammatory microenvironment within skeletal muscle. These findings provide mechanistic insight into the development of microvascular dysfunction in the progression of type 2 diabetes.Nwadozi, E., Roudier, E., Rullman, E., Tharmalingam, S., Liu, H.-Y., Gustafsson, T., Haas, T. L. Endothelial FoxO proteins impair insulin sensitivity and restrain muscle angiogenesis in response to a high-fat diet.	[Nwadozi, Emmanuel; Roudier, Emilie; Tharmalingam, Sujeenthar; Liu, Hsin-yi; Haas, Tara L.] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Rullman, Eric; Gustafsson, Thomas] Karolinska Inst, Dept Lab Med, Clin Physiol, Stockholm, Sweden; [Rullman, Eric] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Gustafsson, Thomas] Karolinska Univ Hosp, Dept Clin Physiol, Stockholm, Sweden	York University - Canada; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Haas, TL (corresponding author), York Univ, Angiogenesis Res Grp, Fac Hlth, Rm 339-341 Farquharson Bldg,4700 Keele St, Toronto, ON M3J 1P3, Canada.	thaas@yorku.ca	Gustafsson, Thomas/AAH-1056-2019	Gustafsson, Thomas/0000-0002-1559-4206; Nwadozi, Emmanuel/0000-0003-3572-9021	Canadian Institutes of Health Research [MOP-107537, MOP-130491]; Natural Science and Engineering Research Council of Canada; Ontario Graduate Scholarship; Swedish County Council (ALF); Swedish Society for Medical Research (SSMF)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Swedish County Council (ALF); Swedish Society for Medical Research (SSMF)	The authors thank Ghoncheh Abdifarkosh and Purnadeo Persaud (both from York University) for assistance with sample preparation. This work was funded by Canadian Institutes of Health Research Grants MOP-107537 (to T.L.H.) and MOP-130491 (to T.L.H. and E.Ro.). E.N. was supported by a Canadian Graduate Scholarship-Masters from the Natural Science and Engineering Research Council of Canada and an Ontario Graduate Scholarship. E.Ru. received funding from the Swedish County Council (ALF) and Swedish Society for Medical Research (SSMF). Author contributions: E. Nwadozi, E. Roudier, T. Gustafsson, and T. Haas designed the research; E. Nwadozi, E. Roudier, S. Tharmalingam, and H.-Y. Liu performed research and analyzed data; E. Rullman conducted bioinformatics; E. Nwadozi, E. Roudier, T. Gustafsson, and T. L. Haas wrote the paper. The authors declare no conflicts of interest.	Arner E, 2010, NEW ENGL J MED, V362, P1151, DOI 10.1056/NEJMc0910718; Aroor AR, 2013, METABOLISM, V62, P1543, DOI 10.1016/j.metabol.2013.07.001; Bilan Phillip J., 2009, Archives of Physiology and Biochemistry, V115, P176, DOI 10.1080/13813450903079314; Cornier MA, 2011, CIRCULATION, V124, P840, DOI 10.1161/CIRCULATIONAHA.110.968461; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gavin TP, 2005, J APPL PHYSIOL, V98, P315, DOI 10.1152/japplphysiol.00353.2004; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Hedman A, 2000, ACTA PHYSIOL SCAND, V169, P125; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Iso T, 2013, ARTERIOSCL THROM VAS, V33, P2549, DOI 10.1161/ATVBAHA.113.301588; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Karki S, 2015, ARTERIOSCL THROM VAS, V35, P1498, DOI 10.1161/ATVBAHA.114.305139; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAAKSO M, 1990, J CLIN INVEST, V85, P1844, DOI 10.1172/JCI114644; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Michaud J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-363; Milkiewicz M, 2011, AM J PATHOL, V178, P935, DOI 10.1016/j.ajpath.2010.10.042; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Pillon NJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE35, DOI 10.1152/ajpendo.00611.2014; Prior SJ, 2015, DIABETES, V64, P3386, DOI 10.2337/db14-1771; Roudier E, 2013, ANGIOGENESIS, V16, P759, DOI 10.1007/s10456-013-9353-x; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Silvennoinen M, 2013, ANGIOGENESIS, V16, P297, DOI 10.1007/s10456-012-9315-8; Sjostrand M, 2002, DIABETES, V51, P2742, DOI 10.2337/diabetes.51.9.2742; Slopack D, 2014, J PHYSIOL-LONDON, V592, P4069, DOI 10.1113/jphysiol.2014.275867; Steinberg HO, 2000, DIABETES, V49, P1231, DOI 10.2337/diabetes.49.7.1231; Sun XH, 2016, CIRC RES, V118, P810, DOI 10.1161/CIRCRESAHA.115.308166; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tanaka J, 2009, DIABETES, V58, P2344, DOI 10.2337/db09-0167; Tsuchiya K, 2012, CELL METAB, V15, P372, DOI 10.1016/j.cmet.2012.01.018; Vincent MA, 2004, DIABETES, V53, P1418, DOI 10.2337/diabetes.53.6.1418; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498	41	23	24	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3039	3052		10.1096/fj.201600245R	http://dx.doi.org/10.1096/fj.201600245R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27235148				2022-12-26	WOS:000382816300005
J	Chen, ZF; Zhang, L; Tang, AM; Callahan, C; Pristatsky, P; Swoyer, R; Cejas, P; Nahas, D; Galli, J; Cosmi, S; DiStefano, D; Hoang, V; Bett, A; Casimiro, D; Vora, KA				Chen, Zhifeng; Zhang, Lan; Tang, Aimin; Callahan, Cheryl; Pristatsky, Pavlo; Swoyer, Ryan; Cejas, Pedro; Nahas, Debbie; Galli, Jennifer; Cosmi, Scott; DiStefano, Daniel; Hoang, Van M.; Bett, Andrew; Casimiro, Danilo; Vora, Kalpit A.			Discovery and Characterization of Phage Display-Derived Human Monoclonal Antibodies against RSV F Glycoprotein	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; FUSION GLYCOPROTEIN; IN-VITRO; PROTEIN; NEUTRALIZATION; LIBRARIES; INFECTION; RECOGNITION; SELECTION; EPITOPES	Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in infants, the elderly and in immunosuppressed populations. The vast majority of neutralizing antibodies isolated from human subjects target the RSV fusion (F) glycoprotein, making it an attractive target for the development of vaccines and therapeutic antibodies. Currently, Synagis (R) (palivizumab) is the only FDA approved antibody drug for the prevention of RSV infection, and there is a great need for more effective vaccines and therapeutics. Phage display is a powerful tool in antibody discovery with the advantage that it does not require samples from immunized subjects. In this study, Morphosys HuCAL GOLD (R) phage libraries were used for panning against RSV prefusion and postfusion F proteins. Panels of human monoclonal antibodies (mAbs) against RSV F protein were discovered following phage library panning and characterized. Antibodies binding specifically to prefusion or postfusion F proteins and those binding both conformations were identified. 3B1 is a prototypic postfusion F specific antibody while 2E1 is a prototypic prefusion F specific antibody. 2E1 is a potent broadly neutralizing antibody against both RSV A and B strains. Epitope mapping experiments identified a conformational epitope spanning across three discontinuous sections of the RSV F protein, as well as critical residues for antibody interaction.	[Chen, Zhifeng; Zhang, Lan; Tang, Aimin; Callahan, Cheryl; Swoyer, Ryan; Cejas, Pedro; Nahas, Debbie; Galli, Jennifer; DiStefano, Daniel; Bett, Andrew; Casimiro, Danilo; Vora, Kalpit A.] Merck & Co Inc, Merck Res Labs, Dept Infect Dis & Vaccines Res, West Point, PA USA; [Pristatsky, Pavlo; Hoang, Van M.] Merck & Co Inc, Merck Res Labs, Vaccine Bioproc Res & Dev, West Point, PA USA; [Cosmi, Scott] Eurofins Lancaster Labs Profess Sci Serv, Lancaster, PA USA	Merck & Company; Merck & Company	Vora, KA (corresponding author), Merck & Co Inc, Merck Res Labs, Dept Infect Dis & Vaccines Res, West Point, PA USA.	kalpit.vora@merck.com		Galli, Jennifer/0000-0001-8577-4790; Chen, Zhifeng/0000-0002-9390-6527	Merck and Co., Inc.	Merck and Co., Inc.(Merck & Company)	The research was fully funded by Merck and Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON LJ, 1988, J VIROL, V62, P4232, DOI 10.1128/JVI.62.11.4232-4238.1988; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442; Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fong RH, 2014, J VIROL, V88, P14364, DOI 10.1128/JVI.01943-14; Gilman MSA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005035; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Homaira Nusrat, 2014, Int J Pediatr, V2014, P571609, DOI 10.1155/2014/571609; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; Huang RYC, 2014, ANAL BIOANAL CHEM, V406, P6541, DOI 10.1007/s00216-014-7924-3; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; KANG AS, 1991, P NATL ACAD SCI USA, V88, P4363, DOI 10.1073/pnas.88.10.4363; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Krebs B, 2001, J IMMUNOL METHODS, V254, P67, DOI 10.1016/S0022-1759(01)00398-2; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lopez JA, 1998, J VIROL, V72, P6922; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McLellan JS, 2015, CURR OPIN VIROL, V11, P70, DOI 10.1016/j.coviro.2015.03.002; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Nixon AE, 2014, MABS-AUSTIN, V6, P73, DOI 10.4161/mabs.27240; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; SANNA PP, 1995, P NATL ACAD SCI USA, V92, P6439, DOI 10.1073/pnas.92.14.6439; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Whimbey E, 2000, CURR CLIN TOPICS INF, V20, P232; Williams JV, 2007, J VIROL, V81, P8315, DOI 10.1128/JVI.00106-07; Wu SJ, 2007, J GEN VIROL, V88, P2719, DOI 10.1099/vir.0.82753-0	36	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156798	10.1371/journal.pone.0156798	http://dx.doi.org/10.1371/journal.pone.0156798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258388	Green Submitted, Green Published, gold			2022-12-26	WOS:000377369700131
J	Haycocks, JRJ; Grainger, DC				Haycocks, James R. J.; Grainger, David C.			Unusually Situated Binding Sites for Bacterial Transcription Factors Can Have Hidden Functionality	PLOS ONE			English	Article							POLYMERASE ALPHA-SUBUNIT; CRP-DEPENDENT PROMOTERS; AMP RECEPTOR PROTEIN; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; RNA-POLYMERASE; ACTIVATION; SEQUENCE; GENOME; TARGETS	A commonly accepted paradigm of molecular biology is that transcription factors control gene expression by binding sites at the 5' end of a gene. However, there is growing evidence that transcription factor targets can occur within genes or between convergent genes. In this work, we have investigated one such target for the cyclic AMP receptor protein (CRP) of enterotoxigenic Escherichia coli. We show that CRP binds between two convergent genes. When bound, CRP regulates transcription of a small open reading frame, which we term aatS, embedded within one of the adjacent genes. Our work demonstrates that non-canonical sites of transcription factor binding can have hidden functionality.	[Haycocks, James R. J.; Grainger, David C.] Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England	University of Birmingham	Grainger, DC (corresponding author), Univ Birmingham, Coll Life & Environm Sci, Sch Biosci, Inst Microbiol & Infect, Birmingham, W Midlands, England.	d.grainger@bham.ac.uk		Grainger, David/0000-0003-3375-5154	Wellcome Trust [WT085092MA]; BBSRC [BB/N005961/1]; Biotechnology and Biological Sciences Research Council [1363809, BB/N005961/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust Award Number WT085092MA to DCG and BBSRC Award Number BB/N005961/1 to DCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens M, 2002, INFECT IMMUN, V70, P2915, DOI 10.1128/IAI.70.6.2915-2925.2002; BELL A, 1990, NUCLEIC ACIDS RES, V18, P7243, DOI 10.1093/nar/18.24.7243; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; BUSBY S, 1983, J MOL BIOL, V167, P259, DOI 10.1016/S0022-2836(83)80335-0; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Crossman LC, 2010, J BACTERIOL, V192, P5822, DOI 10.1128/JB.00710-10; Efromovich S, 2008, METHOD ENZYMOL, V437, P211, DOI 10.1016/S0076-6879(07)37012-2; Ellis JC, 2003, TRENDS BIOCHEM SCI, V28, P521, DOI 10.1016/j.tibs.2003.08.002; Feltens R, 2003, P NATL ACAD SCI USA, V100, P5724, DOI 10.1073/pnas.0931462100; GASTON K, 1990, CELL, V62, P733, DOI 10.1016/0092-8674(90)90118-X; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Grainger DC, 2005, P NATL ACAD SCI USA, V102, P17693, DOI 10.1073/pnas.0506687102; Grainger DC, 2004, J BACTERIOL, V186, P6938, DOI 10.1128/JB.186.20.6938-6943.2004; Haycocks JRJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004605; Ishihama A, 2016, NUCLEIC ACIDS RES, V44, P2058, DOI 10.1093/nar/gkw051; Islam MS, 2012, BIOCHEM J, V441, P247, DOI 10.1042/BJ20110912; KOLB A, 1995, NUCLEIC ACIDS RES, V23, P819, DOI 10.1093/nar/23.5.819; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lloyd GS, 2008, FEMS MICROBIOL LETT, V288, P250, DOI 10.1111/j.1574-6968.2008.01365.x; LODGE J, 1992, FEMS MICROBIOL LETT, V95, P271; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Minch KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6829; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nishi J, 2003, J BIOL CHEM, V278, P45680, DOI 10.1074/jbc.M306413200; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Partridge JD, 2009, MOL MICROBIOL, V73, P680, DOI 10.1111/j.1365-2958.2009.06799.x; Rhodius VA, 1997, NUCLEIC ACIDS RES, V25, P326, DOI 10.1093/nar/25.2.326; Savery NJ, 1998, EMBO J, V17, P3439, DOI 10.1093/emboj/17.12.3439; Savery NJ, 2002, J BACTERIOL, V184, P2273, DOI 10.1128/JB.184.8.2273-2280.2002; Shimada T, 2008, NUCLEIC ACIDS RES, V36, P3950, DOI 10.1093/nar/gkn339; Shimada T, 2011, MOL MICROBIOL, V82, P378, DOI 10.1111/j.1365-2958.2011.07818.x; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; Storz G, 2014, ANNU REV BIOCHEM, V83, P753, DOI 10.1146/annurev-biochem-070611-102400; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wade JT, 2014, NAT REV MICROBIOL, V12, P647, DOI 10.1038/nrmicro3316; Waldminghaus T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-414; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Yamamoto K, 2011, J BACTERIOL, V193, P1477, DOI 10.1128/JB.01230-10	41	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0157016	10.1371/journal.pone.0157016	http://dx.doi.org/10.1371/journal.pone.0157016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258043	Green Published, gold			2022-12-26	WOS:000377369700170
J	Winther, KH; Cramon, P; Watt, T; Bjorner, JB; Ekholm, O; Feldt-Rasmussen, U; Groenvold, M; Rasmussen, AK; Hegedus, L; Bonnema, SJ				Winther, Kristian Hillert; Cramon, Per; Watt, Torquil; Bjorner, Jakob Bue; Ekholm, Ola; Feldt-Rasmussen, Ulla; Groenvold, Mogens; Rasmussen, Ase Krogh; Hegedus, Laszlo; Bonnema, Steen Joop			Disease-Specific as Well as Generic Quality of Life Is Widely Impacted in Autoimmune Hypothyroidism and Improves during the First Six Months of Levothyroxine Therapy	PLOS ONE			English	Article							PATIENT-CENTERED CARE; MEASURE THYPRO; QUESTIONNAIRE; THYROXINE; RELEVANT; SYMPTOMS; VALIDITY; OUTCOMES; THYDQOL; DESIGN	Background Hypothyroidism is often diagnosed, and subsequently treated, due to health-related quality of life (HRQL) issues. However, HRQL following treatment has never previously been assessed in longitudinal descriptive studies using validated instruments. Objective To investigate disease-specific (ThyPRO) and generic (SF-36) HRQL, following levothyroxine therapy in patients with hypothyroidism due to autoimmune thyroiditis. Methods This prospective cohort study was set at endocrine outpatient clinics at two Danish university hospitals. Seventy-eight consecutive patients were enrolled and completed HRQL questionnaires before, six weeks, and six months after initiation of levothyroxine therapy. Normative ThyPRO (n = 739) and SF-36 (n = 6,638) data were available for comparison and changes in HRQL following treatment were estimated and quantified. Results Prior to treatment, all ThyPRO scales were significantly impacted (p<0.0001), compared to the general population sample. The same was observed for seven of eight SF-36 scales, the exception being Bodily Pain. Tiredness (ThyPRO) and Vitality (SF-36) were the most markedly impacted scales. After six weeks of treatment, nine of thirteen ThyPRO scales had significantly improved. ThyPRO improvements were consistent at six months, where five of eight SF-36 scales had also significantly improved, but deficits persisted for a subset of both ThyPRO and SF-36 scales. Conclusions In this population of hypothyroid patients, HRQL was widely affected before treatment, with tiredness as the cardinal impairment according to both ThyPRO and SF-36. Many aspects of HRQL improved during the first six months of LT4 therapy, but full recovery was not obtained. Our results may help clinicians inform patients about expected clinical treatment effects.	[Winther, Kristian Hillert; Hegedus, Laszlo; Bonnema, Steen Joop] Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark; [Winther, Kristian Hillert; Hegedus, Laszlo; Bonnema, Steen Joop] Univ Southern Denmark, Dept Clin Res, Fac Hlth Sci, Odense, Denmark; [Cramon, Per; Feldt-Rasmussen, Ulla; Rasmussen, Ase Krogh] Rigshosp, Copenhagen Univ Hosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark; [Watt, Torquil] Gentofte Univ Hosp, Dept Internal Med, Copenhagen, Denmark; [Bjorner, Jakob Bue; Groenvold, Mogens] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Bjorner, Jakob Bue] Optum Insight Inc, Eden Prairie, MN USA; [Ekholm, Ola] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Groenvold, Mogens] Bispebjerg Hosp, Dept Palliat Med, Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Optum; University of Southern Denmark; University of Copenhagen; Bispebjerg Hospital	Winther, KH (corresponding author), Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense, Denmark.; Winther, KH (corresponding author), Univ Southern Denmark, Dept Clin Res, Fac Hlth Sci, Odense, Denmark.	kristian.winther@rsyd.dk	Bonnema, Steen/AAF-1198-2020; Bonnema, Steen/AAE-6558-2021; Feldt-Rasmussen, Ulla/AAB-9218-2021; Watt, Torquil/ABC-3252-2020	Feldt-Rasmussen, Ulla/0000-0002-5903-3355; Watt, Torquil/0000-0002-6001-7440; Gronvold, Mogens/0000-0002-3153-780X	Danish Agency for Science, Technology and Innovation: Council for Strategic Research; Danish Agency for Science, Technology and Innovation: Council for Independent Research [09-066886]; Agnes & Knut Morks Foundation; University of Southern Denmark; Region of Southern Denmark; Novo Nordisk Foundation; Odense University Hospital Research Council; Novo Nordisk Fonden [NNF15OC0014622] Funding Source: researchfish	Danish Agency for Science, Technology and Innovation: Council for Strategic Research; Danish Agency for Science, Technology and Innovation: Council for Independent Research; Agnes & Knut Morks Foundation; University of Southern Denmark; Region of Southern Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Odense University Hospital Research Council; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by research grants from the Danish Agency for Science, Technology and Innovation: Council for Strategic Research and Council for Independent Research (ID: 09-066886), and Agnes & Knut Morks Foundation. KHW is supported by grants from the University of Southern Denmark and the Region of Southern Denmark; UFR and LH are supported by an unrestricted grant from the Novo Nordisk Foundation. SB is supported by grants from Odense University Hospital Research Council. JBB is an employee of Optum Patient Insights. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Black N, 2013, BMJ-BRIT MED J, V346, pf167, DOI [DOI 10.1136/BMJ.F167, 10.1136/bmj.f167]; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Carle A, 2006, EUR J ENDOCRINOL, V154, P21, DOI 10.1530/eje.1.02068; Carle A, 2014, EUR J ENDOCRINOL, V171, P593, DOI 10.1530/EJE-14-0481; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Contopoulos-Ioannidis DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3006; Cramon P, 2015, THYROID, V25, P284, DOI 10.1089/thy.2014.0433; Dayan CM, 2013, EUR THYROID J, V2, P168, DOI 10.1159/000353777; Ekholm O, 2009, SCAND J PUBLIC HEALT, V37, P758, DOI 10.1177/1403494809341095; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hays R., 2005, ASSESSING QUALITY LI, P3; Kelderman-Bolk N, 2015, EUR J ENDOCRINOL, V173, P507, DOI 10.1530/EJE-15-0395; Krysiak R, 2015, CLIN ENDOCRINOL; McMillan C, 2008, VALUE HEALTH, V11, P285, DOI 10.1111/j.1524-4733.2007.00232.x; McMillan CV, 2004, THYROID, V14, P916, DOI 10.1089/thy.2004.14.916; Pedersen IB, 2007, J CLIN ENDOCR METAB, V92, P3122, DOI 10.1210/jc.2007-0732; Quinque EM, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-68; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Samuels MH, 2014, CURR OPIN ENDOCRINOL, V21, P377, DOI 10.1097/MED.0000000000000089; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; Stewart M, 2000, J FAM PRACTICE, V49, P796; Thvilum M, 2014, THYROID, V24, P802, DOI 10.1089/thy.2013.0555; Thvilum M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075789; Thvilum M, 2013, J CLIN ENDOCR METAB, V98, P1069, DOI 10.1210/jc.2012-3375; Tzelepis F, 2015, PATIENT PREFER ADHER, V9, P831, DOI 10.2147/PPA.S81975; Ware J.E., 2007, SF 36 HLTH SURVEY MA; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watt T, 2008, QUAL LIFE RES, V17, P1009, DOI 10.1007/s11136-008-9364-z; Watt T, 2007, THYROID, V17, P647, DOI 10.1089/thy.2007.0069; Watt T, 2015, THYROID, V25, P1069, DOI 10.1089/thy.2015.0209; Watt T, 2014, J CLIN ENDOCR METAB, V99, P3708, DOI 10.1210/jc.2014-1322; Watt T, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0126-z; Watt T, 2014, QUAL LIFE RES, V23, P327, DOI 10.1007/s11136-013-0462-1; Watt T, 2010, EUR J ENDOCRINOL, V162, P161, DOI 10.1530/EJE-09-0521; Watt T, 2009, QUAL LIFE RES, V18, P483, DOI 10.1007/s11136-009-9460-8; Wekking EM, 2005, EUR J ENDOCRINOL, V153, P747, DOI 10.1530/eje.1.02025; Wiersinga WM, 2014, NAT REV ENDOCRINOL, V10, P164, DOI 10.1038/nrendo.2013.258; Winther KH, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-115	39	84	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156925	10.1371/journal.pone.0156925	http://dx.doi.org/10.1371/journal.pone.0156925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN8ZV	27257805	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700156
J	Ordonez, YM; Fernandez, BR; Lara, LS; Rodriguez, A; Uribe-Velez, D; Sanders, IR				Marcela Ordonez, Yuli; Rocio Fernandez, Belen; Susana Lara, Lidia; Rodriguez, Alia; Uribe-Velez, Daniel; Sanders, Ian R.			Bacteria with Phosphate Solubilizing Capacity Alter Mycorrhizal Fungal Growth Both Inside and Outside the Root and in the Presence of Native Microbial Communities	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZA; PLANT-GROWTH; FLUORESCENT PSEUDOMONADS; SOIL BACTERIA; IN-VITRO; RHIZOSPHERE; RHIZOBACTERIA; INOCULATION; BIOCONTROL; DIVERSITY	Arbuscular mycorrhizal fungi (AMF) and phosphate solubilizing Pseudomonas bacteria (PSB) could potentially interact synergistically because PSB solubilize phosphate into a form that AMF can absorb and transport to the plant. However, very little is known about the interactions between these two groups of microorganisms and how they influence the growth of each other. We tested whether different strains of bacteria, that have the capacity to solubilize phosphate, are able to grow along AMF hyphae and differentially influence the growth of AMF both outside the roots of carrot in in vitro conditions and inside the roots of potato in the presence of a microbial community. We found strong effects of AMF on the growth of the different bacterial strains. Different bacterial strains also had very strong effects on the growth of AMF extraradical hyphae outside the roots of carrot and on colonization of potato roots by AMF. The differential effects on colonization occurred in the presence of a microbial community. Our results show that these two important groups of rhizosphere microorganisms indeed interact with each other. Such interactions could potentially lead to synergistic effects between the two groups but this could depend on whether the bacteria truly solubilize phosphate in the rhizosphere in the presence of microbial communities.	[Marcela Ordonez, Yuli; Rodriguez, Alia] Univ Nacl Colombia, Dept Biol, Fac Sci, Ciudad Univ Ave Carrera 30 45-03, Bogota, Colombia; [Rocio Fernandez, Belen] Univ Nacl Colombia, Fac Agron, Ciudad Univ Ave Carrera 30 45-03, Bogota, Colombia; [Susana Lara, Lidia; Uribe-Velez, Daniel] Univ Nacl Colombia, Inst Biotechnol, Ciudad Univ Ave Carrera 30 45-03, Bogota, Colombia; [Sanders, Ian R.] Univ Lausanne, Dept Ecol & Evolut, Biophore Bldg, CH-1015 Lausanne, Switzerland	Universidad Nacional de Colombia; Universidad Nacional de Colombia; Universidad Nacional de Colombia; University of Lausanne	Sanders, IR (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Biophore Bldg, CH-1015 Lausanne, Switzerland.	ian.sanders@unil.ch	Sanders, Ian R/T-9988-2017	Sanders, Ian R/0000-0002-9591-8214; Ordonez, Yuli M/0000-0001-8660-9869				Agnolucci M, 2015, BIOL FERT SOILS, V51, P379, DOI 10.1007/s00374-014-0989-5; Artursson V, 2005, ENVIRON MICROBIOL, V7, P1952, DOI 10.1111/j.1462-2920.2005.00868.x; Bago B, 1998, NEW PHYTOL, V139, P375, DOI 10.1046/j.1469-8137.1998.00199.x; Barroso CB, 2005, APPL SOIL ECOL, V29, P73, DOI 10.1016/j.apsoil.2004.09.005; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Bennasar A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-118; Bianciotto V, 2002, ANTON LEEUW INT J G, V81, P365, DOI 10.1023/A:1020544919072; Browne P, 2009, APPL SOIL ECOL, V43, P131, DOI 10.1016/j.apsoil.2009.06.010; Ceballos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070633; Collavino MM, 2008, BIOL FERT SOILS, V46, P727; Fortin JA, 2002, CAN J BOT, V80, P1, DOI 10.1139/b01-139; Frapolli M, 2007, ENVIRON MICROBIOL, V9, P1939, DOI 10.1111/j.1462-2920.2007.01310.x; Frey-Klett P, 2005, NEW PHYTOL, V165, P317, DOI 10.1111/j.1469-8137.2004.01212.x; Gamalero E, 2004, MYCORRHIZA, V14, P185, DOI 10.1007/s00572-003-0256-3; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Hariprasad P, 2009, PLANT SOIL, V316, P13, DOI 10.1007/s11104-008-9754-6; Human Z, 2002, AM J BOT, V89, P947, DOI 10.3732/ajb.89.6.947; Iwamoto T, 2000, FEMS MICROBIOL ECOL, V32, P129, DOI 10.1111/j.1574-6941.2000.tb00707.x; Johansson JF, 2004, FEMS MICROBIOL ECOL, V48, P1, DOI 10.1016/j.femsec.2003.11.012; Jorquera MA, 2008, BIOL FERT SOILS, V44, P1025, DOI 10.1007/s00374-008-0288-0; Lecomte J, 2011, FEMS MICROBIOL LETT, V317, P43, DOI 10.1111/j.1574-6968.2011.02209.x; Marschner P, 2001, MYCORRHIZA, V11, P297, DOI 10.1007/s00572-001-0136-7; Meyer JB, 2011, APPL ENVIRON MICROB, V77, P7345, DOI 10.1128/AEM.05434-11; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Naik PR, 2008, MICROB ECOL, V56, P492, DOI 10.1007/s00248-008-9368-9; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Nazir R, 2009, FEMS MICROBIOL ECOL, V71, P161; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Oteino N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00745; Owen D, 2015, APPL SOIL ECOL, V86, P41, DOI 10.1016/j.apsoil.2014.09.012; Rodriguez A, 2015, ISME J, V9, P1053, DOI 10.1038/ismej.2014.207; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Scheublin TR, 2010, ISME J, V4, P752, DOI 10.1038/ismej.2010.5; Sharma SB, 2013, SPRINGERPLUS, V2, DOI [10.1186/2193-1801-2-587, 10.1186/2193-1801-2-41]; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; StArnaud M, 1996, MYCOL RES, V100, P328, DOI 10.1016/S0953-7562(96)80164-X; Suarez-Moreno ZR, 2008, MICROBIOL-SGM, V154, P2048, DOI 10.1099/mic.0.2008/017780-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TISSERANT B, 1993, MYCOL RES, V97, P245, DOI 10.1016/S0953-7562(09)80248-7; Toljander JF, 2006, FEMS MICROBIOL LETT, V254, P34, DOI 10.1111/j.1574-6968.2005.00003.x; Toljander JF, 2007, FEMS MICROBIOL ECOL, V61, P295, DOI 10.1111/j.1574-6941.2007.00337.x; Toro M, 1997, APPL ENVIRON MICROB, V63, P4408, DOI 10.1128/AEM.63.11.4408-4412.1997; Trouvelot A., 1986, PHYSIOL GENETICAL AS, P217, DOI DOI 10.12691/AJMR-3-5-5; Uribe D, 1999, REV COLOMB BIOTECNOL, V2, P50; Uribe D, 2010, SOIL BIOL, V21, P235, DOI 10.1007/978-3-642-05076-3_11; Vyas P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-174; Walsh UF, 2001, CURR OPIN BIOTECH, V12, P289, DOI 10.1016/S0958-1669(00)00212-3; Zhang L, 2016, NEW PHYTOL, V210, P1022, DOI 10.1111/nph.13838	50	61	69	10	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0154438	10.1371/journal.pone.0154438	http://dx.doi.org/10.1371/journal.pone.0154438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253975	Green Submitted, Green Published, gold			2022-12-26	WOS:000377218700003
J	Huang, L; Wu, B; Zhao, JJ; Li, HT; Chen, WG; Zheng, YL; Ren, XP; Chen, YN; Zhou, XJ; Lei, Y; Liao, BS; Jiang, HF				Huang, Li; Wu, Bei; Zhao, Jiaojiao; Li, Haitao; Chen, Weigang; Zheng, Yanli; Ren, Xiaoping; Chen, Yuning; Zhou, Xiaojing; Lei, Yong; Liao, Boshou; Jiang, Huifang			Characterization and Transferable Utility of Microsatellite Markers in the Wild and Cultivated Arachis Species	PLOS ONE			English	Article							HYPOGAEA L.; ASSOCIATION ANALYSIS; DNA MARKERS; PEANUT; IDENTIFICATION; POLYMORPHISM; DIVERSITY; SEQUENCES; QUALITY; TRAITS	Microsatellite or simple sequence repeat (SSR) is one of the most widely distributed molecular markers that have been widely utilized to assess genetic diversity and genetic mapping for important traits in plants. However, the understanding of microsatellite characteristics in Arachis species and the currently available amount of high-quality SSR markers remain limited. In this study, we identified 16,435 genome survey sequences SSRs (GSS-SSRs) and 40,199 expressed sequence tag SSRs (EST-SSRs) in Arachis hypogaea and its wild relative species using the publicly available sequence data. The GSS-SSRs had a density of 159.9-239.8 SSRs/Mb for wild Arachis and 1,015.8 SSR/Mb for cultivated Arachis, whereas the EST-SSRs had the density of 173.5-384.4 SSR/Mb and 250.9 SSRs/Mb for wild and cultivated Arachis, respectively. The trinucleotide SSRs were predominant across Arachis species, except that the dinucleotide accounted for most in A. hypogaea GSSs. From Arachis GSS-SSR and EST-SSR sequences, we developed 2,589 novel SSR markers that showed a high polymorphism in six diverse A. hypogaea accessions. A genetic linkage map that contained 540 novel SSR loci and 105 anchor SSR loci was constructed by case of a recombinant inbred lines F-6 population. A subset of 82 randomly selected SSR markers were used to screen 39 wild and 22 cultivated Arachis accessions, which revealed a high transferability of the novel SSRs across Arachis species. Our results provided informative clues to investigate microsatellite patterns across A. hypogaea and its wild relative species and potentially facilitate the germplasm evaluation and gene mapping in Arachis species.	[Huang, Li; Wu, Bei; Zhao, Jiaojiao; Chen, Weigang; Zheng, Yanli; Ren, Xiaoping; Chen, Yuning; Zhou, Xiaojing; Lei, Yong; Liao, Boshou; Jiang, Huifang] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China; [Li, Haitao] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Jiang, HF (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China.	peanutlab@oilcrops.cn			National Natural Science Foundations of China [31401420, 31271764, 31471534, 31371662, 31461143022]; Plant Germplasm Resources Sharing Platform [2015NWB035]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Plant Germplasm Resources Sharing Platform	Support was provided by the National Natural Science Foundations of China (31401420) to LH; National Natural Science Foundations of China (31271764 and 31471534) to HJ; and National Natural Science Foundations of China (31371662 and 31461143022) to BL.; We thank Drs. Yingjie Xiao and Yongqing Jiao for helpful comments to the manuscript. This research was supported by the National Natural Science Foundations of China (31401420, 31271764, 31371662, 31471534 and 31461143022) and the Plant Germplasm Resources Sharing Platform (2015NWB035).	Bosamia TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129127; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Ferguson ME, 2004, THEOR APPL GENET, V108, P1064, DOI 10.1007/s00122-003-1535-2; Gautami B, 2012, MOL BREEDING, V30, P757, DOI 10.1007/s11032-011-9660-0; Gupta PK, 2000, EUPHYTICA, V113, P163, DOI 10.1023/A:1003910819967; HALWARD TM, 1991, GENOME, V34, P1013, DOI 10.1139/g91-156; Han B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141540; He GH, 1997, EUPHYTICA, V97, P143, DOI 10.1023/A:1002949813052; He Guohao, 2003, BMC Plant Biology, V3, P3, DOI 10.1186/1471-2229-3-3; Huang L, 2015, THEOR APPL GENET, V128, P1103, DOI 10.1007/s00122-015-2493-1; Jiang HF, 2014, J INTEGR PLANT BIOL, V56, P159, DOI 10.1111/jipb.12132; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; KOCHERT G, 1991, THEOR APPL GENET, V81, P565, DOI 10.1007/BF00226719; Kochert G, 1996, AM J BOT, V83, P1282, DOI 10.2307/2446112; Koilkonda P, 2012, MOL BREEDING, V30, P125, DOI 10.1007/s11032-011-9604-8; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Krapovickas A., 1994, Bonplandia, V8, P1; Li HT, 2013, THEOR APPL GENET, V126, P937, DOI 10.1007/s00122-012-2027-z; Li HT, 2011, MOL BREEDING, V28, P585, DOI 10.1007/s11032-010-9509-y; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu K, 2005, POWERMARKER INTEGRAT; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Pandey MK, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0133-4; Pandey MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105228; Proite K, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-7; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Seijo JG, 2004, AM J BOT, V91, P1294, DOI 10.3732/ajb.91.9.1294; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Shi JQ, 2014, DNA RES, V21, P53, DOI 10.1093/dnares/dst040; Shirasawa K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-80; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Subramanian V, 2000, GENOME, V43, P656, DOI 10.1139/gen-43-4-656; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Van O.J., 2001, JOINMAP R 3 0 SOFTWA; Wang H, 2012, BMC PLANT BIOL, V12, DOI [10.1186/1471-2229-12-10, 10.1186/1471-2229-12-194]; Wang ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119454; Wang ML, 2011, THEOR APPL GENET, V123, P1307, DOI 10.1007/s00122-011-1668-7; Wang Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep10638; Wu ZK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146383; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Yasodha R., 2011, Gene Conserve, P51	46	14	18	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2016	11	5							e0156633	10.1371/journal.pone.0156633	http://dx.doi.org/10.1371/journal.pone.0156633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN5XX	27243460	Green Published, Green Submitted, gold			2022-12-26	WOS:000377146100058
J	Dhokane, D; Karre, S; Kushalappa, AC; McCartney, C				Dhokane, Dhananjay; Karre, Shailesh; Kushalappa, Ajjamada C.; McCartney, Curt			Integrated Metabolo-Transcriptomics Reveals Fusarium Head Blight Candidate Resistance Genes in Wheat QTL-Fhb2	PLOS ONE			English	Article							TRANSGENIC ARABIDOPSIS-THALIANA; MARKER-ASSISTED SELECTION; TIME QUANTITATIVE PCR; TRITICUM-AESTIVUM L.; S-TRANSFERASE GENES; ENHANCED RESISTANCE; MYCOTOXIN DEOXYNIVALENOL; MASS-SPECTROMETRY; DEFENSE RESPONSES; RICE CHITINASE	Background Fusarium head blight (FHB) caused by Fusarium graminearum not only causes severe losses in yield, but also reduces quality of wheat grain by accumulating mycotoxins. Breeding for host plant resistance is considered as the best strategy to manage FHB. Resistance in wheat to FHB is quantitative in nature, involving cumulative effects of many genes governing resistance. The poor understanding of genetics and lack of precise phenotyping has hindered the development of FHB resistant cultivars. Though more than 100 QTLs imparting FHB resistance have been reported, none discovered the specific genes localized within the QTL region, nor the underlying mechanisms of resistance. Findings In our study recombinant inbred lines (RILs) carrying resistant (R-RIL) and susceptible (SRIL) alleles of QTL-Fhb2 were subjected to metabolome and transcriptome profiling to discover the candidate genes. Metabolome profiling detected a higher abundance of metabolites belonging to phenylpropanoid, lignin, glycerophospholipid, flavonoid, fatty acid, and terpenoid biosynthetic pathways in R-RIL than in S-RIL. Transcriptome analysis revealed up-regulation of several receptor kinases, transcription factors, signaling, mycotoxin detoxification and resistance related genes. The dissection of QTL-Fhb2 using flanking marker sequences, integrating metabolomic and transcriptomic datasets, identified 4-Coumarate: CoA ligase (4CL), callose synthase (CS), basic Helix Loop Helix (bHLH041) transcription factor, glutathione S-transferase (GST), ABC transporter-4 (ABC4) and cinnamyl alcohol dehydrogenase (CAD) as putative resistance genes localized within the QTL-Fhb2 region. Conclusion Some of the identified genes within the QTL region are associated with structural resistance through cell wall reinforcement, reducing the spread of pathogen through rachis within a spike and few other genes that detoxify DON, the virulence factor, thus eventually reducing disease severity. In conclusion, we report that the wheat resistance QTL-Fhb2 is associated with high rachis resistance through additive resistance effects of genes, based on cell wall enforcement and detoxification of DON. Following further functional characterization and validation, these resistance genes can be used to replace the genes in susceptible commercial cultivars, if nonfunctional, based on genome editing to improve FHB resistance.	[Dhokane, Dhananjay; Karre, Shailesh; Kushalappa, Ajjamada C.] McGill Univ, Dept Plant Sci, Macdonald Campus,21,111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [McCartney, Curt] Agr & Agri Food Canada, 195 Dafoe Rd, Winnipeg, MB R3T 2M9, Canada	McGill University; Agriculture & Agri Food Canada	Kushalappa, AC (corresponding author), McGill Univ, Dept Plant Sci, Macdonald Campus,21,111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	ajjamada.kushalappa@mcgill.ca	Karre, Shailesh/AAN-7955-2020		Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ), Quebec, Canada; Indian Council of Agricultural Research (ICAR), New Delhi; McGill University	Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ), Quebec, Canada; Indian Council of Agricultural Research (ICAR), New Delhi(Indian Council of Agricultural Research (ICAR)); McGill University	The authors would like to thank the Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec (MAPAQ), Quebec, Canada for providing grants for the project. DD thanks The Indian Council of Agricultural Research (ICAR), New Delhi for ICAR-International Fellowship, and Innovagrains and McGill University for financial assistance towards his graduate study.	Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Alves MS, 2014, PROTEOMES, V2, DOI 10.3390/proteomes2010085; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Balmerl D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00082; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Bhuiyan NH, 2009, J EXP BOT, V60, P509, DOI 10.1093/jxb/ern290; Blumke A., 2013, Advances in Bioscience and Biotechnology, V4, P810, DOI 10.4236/abb.2013.48106; Bollina V, 2011, PLANT MOL BIOL, V77, P355, DOI 10.1007/s11103-011-9815-8; Bollina V, 2010, MOL PLANT PATHOL, V11, P769, DOI 10.1111/j.1364-3703.2010.00643.x; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Buerstmayr H, 2002, THEOR APPL GENET, V104, P84, DOI 10.1007/s001220200009; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Campos L, 2014, MOL PLANT MICROBE IN, V27, P1159, DOI 10.1094/MPMI-04-14-0104-R; Cao A, 2011, MOL PLANT MICROBE IN, V24, P1020, DOI 10.1094/MPMI-03-11-0079; Cardinali A., 2006, PHYTOCHEM ADV RES, V661, P23; Chaudhary J, 1999, MOL ENDOCRINOL, V13, P774, DOI 10.1210/me.13.5.774; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Cuthbert PA, 2007, THEOR APPL GENET, V114, P429, DOI 10.1007/s00122-006-0439-3; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dean JD, 2005, J EXP BOT, V56, P1525, DOI 10.1093/jxb/eri145; Dean JD, 2003, FUNCT PLANT BIOL, V30, P821, DOI 10.1071/FP03080; Dedyukhina EG, 2014, EUR J LIPID SCI TECH, V116, P429, DOI 10.1002/ejlt.201300358; Didi V, 2015, J EXP BOT, V66, P5015, DOI 10.1093/jxb/erv222; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; Ehlting J, 1999, PLANT J, V19, P9, DOI 10.1046/j.1365-313X.1999.00491.x; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Eudes A, 2006, PLANTA, V225, P23, DOI 10.1007/s00425-006-0326-9; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fofana B, 2005, PHYTOPATHOLOGY, V95, P114, DOI 10.1094/PHYTO-95-0114; Gardiner SA, 2010, MOL PLANT MICROBE IN, V23, P962, DOI 10.1094/MPMI-23-7-0962; Ghaffari Mohammad Reza, 2010, Iranian Journal of Biotechnology, V8, P112; Golkari S, 2007, PLANT BIOTECHNOL J, V5, P38, DOI 10.1111/j.1467-7652.2006.00213.x; Gonzalez-Lamothe R, 2009, INT J MOL SCI, V10, P3400, DOI 10.3390/ijms10083400; Graca J, 2010, PHYTOCHEM REV, V9, P85, DOI 10.1007/s11101-009-9138-4; Gunnaiah R, 2014, PLANT PHYSIOL BIOCH, V83, P40, DOI 10.1016/j.plaphy.2014.07.002; Gunnaiah R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040695; Hamzehzarghani H, 2008, CAN J PLANT PATHOL, V30, P24, DOI 10.1080/07060660809507493; Han Q, 2016, SCI HORTIC-AMSTERDAM, V198, P370, DOI 10.1016/j.scienta.2015.11.047; Handa H, 2008, MOL BREEDING, V22, P71, DOI 10.1007/s11032-008-9157-7; Holme IB, 2013, PLANT BIOTECHNOL J, V11, P395, DOI 10.1111/pbi.12055; Ishihara A, 2008, PLANT J, V54, P481, DOI 10.1111/j.1365-313X.2008.03441.x; Jia HY, 2009, MOL PLANT MICROBE IN, V22, P1366, DOI 10.1094/MPMI-22-11-1366; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kage U, 2016, PLANT BIOTECHNOLOGY; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; Kosaka A, 2015, TOXINS, V7, P604, DOI 10.3390/toxins7020604; Kugler KG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-728; Kumar A, 2015, J CEREAL SCI, V64, P16, DOI 10.1016/j.jcs.2015.04.005; Kumaraswamy GK, 2012, PLANT PATHOL, V61, P509, DOI 10.1111/j.1365-3059.2011.02528.x; Kumaraswamy GK, 2011, EUR J PLANT PATHOL, V130, P29, DOI 10.1007/s10658-010-9729-3; Kushalappa AC, 2016, CRIT REV PLANT SCI, V35, P38, DOI 10.1080/07352689.2016.1148980; Kushalappa AC, 2013, TRENDS PLANT SCI, V18, P522, DOI 10.1016/j.tplants.2013.05.002; Lanubile A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-710; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Li X, 2015, MOL PLANT MICROBE IN, V28, P1237, DOI 10.1094/MPMI-03-15-0062-R; Liu SX, 2008, CEREAL RES COMMUN, V36, P195, DOI 10.1556/CRC.36.2008.Suppl.B.15; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malinovsky FG, 2014, PLANT PHYSIOL, V164, P1443, DOI 10.1104/pp.113.234625; MARTIN J. T., 1964, ANN REV PHYTO PATHOL, V2, P81, DOI 10.1146/annurev.py.02.090164.000501; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McCartney CA, 2007, MOL BREEDING, V20, P209, DOI 10.1007/s11032-007-9084-z; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; MILLER JD, 1985, PHYTOPATHOL Z, V113, P359; Mohammadi M., 2012, American-Eurasian Journal of Agricultural & Environmental Sciences, V12, P1431; Nishizawa Y, 1999, THEOR APPL GENET, V99, P383, DOI 10.1007/s001220051248; Parvez MM, 2004, BIOCHEM SYST ECOL, V32, P631, DOI 10.1016/j.bse.2003.12.002; Pohl C.H., 2011, SCI MICROBIAL PATHOG, V3, P61; Preisner M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-50; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Pushpa D, 2014, PLANT MOL BIOL REP, V32, P584, DOI 10.1007/s11105-013-0665-1; Raho N, 2011, J PLANT PHYSIOL, V168, P534, DOI 10.1016/j.jplph.2010.09.004; Ruelland E, 2013, PLANT SIGNAL BEHAV, V8, P307; Schauer N, 2006, TRENDS PLANT SCI, V11, P508, DOI 10.1016/j.tplants.2006.08.007; Schweiger W, 2013, MOL PLANT PATHOL, V14, P772, DOI 10.1111/mpp.12048; Shahrtash M, 2013, ROM J BIOL PLANT BIO, V158, P19; Shin SY, 2008, J EXP BOT, V59, P2371, DOI 10.1093/jxb/ern103; Shin S, 2012, J EXP BOT, V63, P4731, DOI 10.1093/jxb/ers141; Singh P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00124; Sudisha J, 2012, PROG BIOL CONTROL, V12, P379, DOI 10.1007/978-94-007-1933-0_17; Takahashi W, 2005, PLANT CELL REP, V23, P811, DOI 10.1007/s00299-004-0900-1; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Tronchet M, 2010, MOL PLANT PATHOL, V11, P83, DOI [10.1111/j.1364-3703.2009.00578.x, 10.1111/j.1364-3703.2009.00578.X]; Underwood W, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00085; Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269; Voigt CA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00168; Walley JW, 2013, CURR OPIN PLANT BIOL, V16, P520, DOI 10.1016/j.pbi.2013.06.011; Walter S, 2008, FUNCT INTEGR GENOMIC, V8, P421, DOI 10.1007/s10142-008-0089-4; Walter S, 2015, J EXP BOT, V66, P2583, DOI 10.1093/jxb/erv048; Wang FT, 2015, PHYSIOL MOL PLANT P, V90, P123, DOI 10.1016/j.pmpp.2015.04.007; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Xu B, 2011, NEW PHYTOL, V192, P611, DOI 10.1111/j.1469-8137.2011.03830.x; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yamamoto T, 2000, PLANT CELL REP, V19, P639, DOI 10.1007/s002999900174; Yang ZP, 2003, MOL BREEDING, V12, P309, DOI 10.1023/B:MOLB.0000006834.44201.48; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yogendra KN, 2015, J EXP BOT, V66, P7377, DOI 10.1093/jxb/erv434; Yogendra KN, 2015, FUNCT PLANT BIOL, V42, P284, DOI 10.1071/FP14177; Yogendra KN, 2014, FUNCT INTEGR GENOMIC, V14, P285, DOI 10.1007/s10142-013-0358-8; Zhou WC, 2005, GENOME, V48, P770, DOI 10.1139/g05-041	106	72	79	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0155851	10.1371/journal.pone.0155851	http://dx.doi.org/10.1371/journal.pone.0155851			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232496	Green Published, gold, Green Submitted			2022-12-26	WOS:000376883000007
J	Ramsey, JM; Cooper, JD; Bot, M; Guest, PC; Lamers, F; Weickert, CS; Penninx, BWJH; Bahn, S				Ramsey, Jordan M.; Cooper, Jason D.; Bot, Mariska; Guest, Paul C.; Lamers, Femke; Weickert, Cynthia S.; Penninx, Brenda W. J. H.; Bahn, Sabine			Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA)	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BIOMARKERS; INFLAMMATION; ASSOCIATION; DIAGNOSIS; HEALTH; SCHIZOPHRENIA; EPIDEMIOLOGY; INVENTORY; CORTISOL	Women have a consistently higher prevalence of major depressive disorder (MDD) than men. Hypotheses implicating hypothalamic-pituitary -adrenal, -gonadal, and -thyroid axes, immune response, genetic factors, and neurotransmitters have emerged to explain this difference. However, more evidence for these hypotheses is needed and new explanations must be explored. Here, we investigated sex differences in MDD markers using multiplex immunoassay measurements of 171 serum molecules in individuals enrolled in the Netherlands Study of Depression and Anxiety (N-MDD = 231; N-control = 365). We found 28 sex-dependent markers of MDD, as quantified by a significant interaction between sex and log(2-)transformed analyte concentration in a logistic regression with diagnosis (MDD/control) as the outcome variable (p < 0.05; q < 0.30). Among these were a number of male-specific associations between MDD and elevated levels of proteins involved in immune response, including C-reactive protein, trefoil factor 3, cystatin-C, fetuin-A, beta 2-microglobulin, CD5L, FASLG receptor, and tumor necrosis factor receptor 2. Furthermore, only male MDD could be classified with an accuracy greater than chance using the measured serum analytes (area under the ROC curve = 0.63). These findings may have consequences for the generalization of inflammatory hypotheses of depression to males and females and have important implications for the development of diagnostic biomarker tests for MDD. More studies are needed to validate these results, investigate a broader range of biological pathways, and integrate this data with brain imaging, genetic, and other relevant data.	[Ramsey, Jordan M.; Cooper, Jason D.; Guest, Paul C.; Bahn, Sabine] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Bot, Mariska; Lamers, Femke; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Bot, Mariska; Lamers, Femke; Penninx, Brenda W. J. H.] Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Weickert, Cynthia S.] Schizophrenia Res Inst, Neurosci Res Australia, Sydney, NSW, Australia; [Weickert, Cynthia S.] Univ New S Wales, Sydney, NSW, Australia; [Bahn, Sabine] Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands	University of Cambridge; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Neuroscience Research Australia; University of New South Wales Sydney; Erasmus University Rotterdam; Erasmus MC	Bahn, S (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.; Penninx, BWJH (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands.; Penninx, BWJH (corresponding author), Neurosci Campus Amsterdam, Amsterdam, Netherlands.; Bahn, S (corresponding author), Erasmus Univ, Med Ctr, Dept Neurosci, Rotterdam, Netherlands.	B.Penninx@vumc.nl; sb209@cam.ac.uk	Lamers, Femke/G-5161-2012; Penninx, Brenda WJH/S-7627-2017	Penninx, Brenda WJH/0000-0001-7779-9672; Lamers, Femke/0000-0003-4344-5766; Shannon Weickert, Cynthia/0000-0002-4560-0259; guest, paul/0000-0002-5030-7137	Stanley Medical Research Institute; European Union FP7 funding scheme: Marie Curie Actions Industry Academia Partnerships and Pathways (PSYCH-AID project) [286334]; NeuroBasic PharmaPhenomics project [0908]; Edmonton Churchill Scholarship; Cambridge Commonwealth Trust; FP7-Marie Curie Career Integration Grant [PCIG12-GA-2012-334065]; Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute); Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales; Neuroscience Research Australia; National Health and Medical Research Council (Australia) Senior Research Fellowship [1021970]	Stanley Medical Research Institute; European Union FP7 funding scheme: Marie Curie Actions Industry Academia Partnerships and Pathways (PSYCH-AID project); NeuroBasic PharmaPhenomics project; Edmonton Churchill Scholarship; Cambridge Commonwealth Trust; FP7-Marie Curie Career Integration Grant; Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute); Schizophrenia Research Institute; NSW Ministry of Health; Macquarie Group Foundation; University of New South Wales; Neuroscience Research Australia; National Health and Medical Research Council (Australia) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Stanley Medical Research Institute, the European Union FP7 funding scheme: Marie Curie Actions Industry Academia Partnerships and Pathways (nr. 286334, PSYCH-AID project), and the NeuroBasic PharmaPhenomics project (no. 0908). JMR was funded by the Edmonton Churchill Scholarship and the Cambridge Commonwealth Trust for the duration of the study. FL is supported by a FP7-Marie Curie Career Integration Grant (PCIG12-GA-2012-334065). The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services Research (NIVEL), and Netherlands Institute of Mental Health and Addiction (Trimbos Institute). Cynthia Shannon Weickert (CSW) is supported by Schizophrenia Research Institute (utilising infrastructure funding from the NSW Ministry of Health and the Macquarie Group Foundation), the University of New South Wales, and Neuroscience Research Australia. CSW is a recipient of a National Health and Medical Research Council (Australia) Senior Research Fellowship (#1021970).	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2014, R LANG ENV STAT COMP; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilello JA, 2015, J CLIN PSYCHIAT, V76, pE199, DOI 10.4088/JCP.14m09029; Bot M, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.88; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Chan MK, 2014, PROG NEUROBIOL, V122, P45, DOI 10.1016/j.pneurobio.2014.08.002; Cook GA, 1999, FEBS LETT, V456, P155, DOI 10.1016/S0014-5793(99)00940-0; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Dudoit S, 2008, SPRINGER SER STAT, P1; Evangelopoulos AA, 2012, INTERN MED J, V42, P517, DOI 10.1111/j.1445-5994.2011.02500.x; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; Faustman D, 2010, NAT REV DRUG DISCOV, V9, P482, DOI 10.1038/nrd3030; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Ford DE, 2004, ARCH INTERN MED, V164, P1010, DOI 10.1001/archinte.164.9.1010; Fyer AJ, 1999, AM J MED GENET, V88, P173, DOI 10.1002/(SICI)1096-8628(19990416)88:2<173::AID-AJMG15>3.0.CO;2-#; Goldstein JM, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00247; Gottschalk MG, 2016, J PSYCHIATR RES, V73, P53, DOI 10.1016/j.jpsychires.2015.11.012; Hinkelmann K, 2012, STRESS, V15, P105, DOI 10.3109/10253890.2011.582200; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Hyde JS, 2008, PSYCHOL REV, V115, P291, DOI 10.1037/0033-295X.115.2.291; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kessler RC, 2003, J AFFECT DISORDERS, V74, P5, DOI 10.1016/S0165-0327(02)00426-3; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Liukkonen T, 2006, BIOL PSYCHIAT, V60, P825, DOI 10.1016/j.biopsych.2006.02.016; Lopresti AL, 2014, PROG NEURO-PSYCHOPH, V48, P102, DOI 10.1016/j.pnpbp.2013.09.017; Maronna RA, 2002, TECHNOMETRICS, V44, P307, DOI 10.1198/004017002188618509; Martinez VG, 2014, CELL MOL IMMUNOL, V11, P343, DOI 10.1038/cmi.2014.12; Mason SJ, 2002, Q J ROY METEOR SOC, V128, P2145, DOI 10.1256/003590002320603584; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; NCAR-Research Applications Laboratory, 2015, VER WEATH FOR VER UT; O'Connell Joe, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P73; Owens M, 2014, P NATL ACAD SCI USA, V111, P3638, DOI 10.1073/pnas.1318786111; Papakostas GI, 2013, MOL PSYCHIATR, V18, P332, DOI 10.1038/mp.2011.166; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Pitychoutis PM, 2010, INT J NEUROPSYCHOPH, V13, P675, DOI 10.1017/S1461145710000465; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Ramsey JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078729; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Schmidt HD, 2011, NEUROPSYCHOPHARMACOL, V36, P2375, DOI 10.1038/npp.2011.151; Schwarz E, 2012, MOL PSYCHIATR, V17, P494, DOI 10.1038/mp.2011.42; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Steeb H, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-4; Toker S, 2005, J OCCUP HEALTH PSYCH, V10, P344, DOI 10.1037/1076-8998.10.4.344; van Buuren S, 2011, J STAT SOFTW, V45, P1; Vogelzangs N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.8; Wang J, 2013, ROBUST ROBUST LIB; Waring P, 1999, IMMUNOL CELL BIOL, V77, P312, DOI 10.1046/j.1440-1711.1999.00837.x; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9; Young E, 2010, MOL PSYCHIATR, V15, P23, DOI 10.1038/mp.2009.94; Zissis M, 2001, AM J GASTROENTEROL, V96, P2177, DOI 10.1111/j.1572-0241.2001.03881.x	62	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156624	10.1371/journal.pone.0156624	http://dx.doi.org/10.1371/journal.pone.0156624			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DN2GV	27232630	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000048
J	Natali, A; Gruber, JM; Dietzel, L; Stuart, MCA; van Grondelle, R; Croce, R				Natali, Alberto; Gruber, J. Michael; Dietzel, Lars; Stuart, Marc C. A.; van Grondelle, Rienk; Croce, Roberta			Light-harvesting Complexes (LHCs) Cluster Spontaneously in Membrane Environment Leading to Shortening of Their Excited State Lifetimes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; ALGA CHLAMYDOMONAS-REINHARDTII; PHOTOSYSTEM-II; CHLOROPLAST MEMBRANES; CIRCULAR-DICHROISM; XANTHOPHYLL CYCLE; ION-TRANSPORT; PROTEIN; FLUORESCENCE; AGGREGATION	The light reactions of photosynthesis, which include light-harvesting and charge separation, take place in the amphiphilic environment of the thylakoid membrane. The light-harvesting complex II (LHCII) is the main responsible for light absorption in plants and green algae and is involved in photoprotective mechanisms that regulate the amount of excited states in the membrane. The dual function of LHCII has been extensively studied in detergent micelles, but recent results have indicated that the properties of this complex differ in a lipid environment. In this work we checked these suggestions by studying LHCII in liposomes. By combining bulk and single molecule measurements, we monitored the fluorescence characteristics of liposomes containing single complexes up to densely packed proteoliposomes. We show that the natural lipid environment per se does not alter the properties of LHCII, which for single complexes remain very similar to that in detergent. However, we show that LHCII has the strong tendency to cluster in the membrane and that protein interactions and the extent of crowding modulate the lifetimes of the excited state in the membrane. Finally, the presence of LHCII monomers at low concentrations of complexes per liposome is discussed.	[Natali, Alberto; Gruber, J. Michael; van Grondelle, Rienk; Croce, Roberta] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Dietzel, Lars] Goethe Univ Frankfurt M, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Stuart, Marc C. A.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Electron Microscopy, NL-9747 AG Groningen, Netherlands	Vrije Universiteit Amsterdam; Goethe University Frankfurt; University of Groningen	Croce, R (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.	r.croce@vu.nl	Croce, Roberta/N-4067-2014; Dietzel, Lars/E-5249-2016; Croce, Roberta/HGU-9554-2022; Croce, Roberta/ABG-3595-2021; Gruber, Michael/C-8523-2015	Croce, Roberta/0000-0003-3469-834X; Dietzel, Lars/0000-0002-0579-2065; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Gruber, Michael/0000-0002-5427-6542	European Research Council (ERC) [281341]; Dutch organization for scientific research NWO via a Vici grant; ERC [267333]; Humboldt Foundation	European Research Council (ERC)(European Research Council (ERC)European Commission); Dutch organization for scientific research NWO via a Vici grant; ERC(European Research Council (ERC)European Commission); Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by the European Research Council (ERC) Consolidator Grant 281341 (ASAP) and by the Dutch organization for scientific research NWO via a Vici grant (to R. C.). The work was also supported by ERC Advanced Investigation Grant 267333 (to R. v. G.) and by the Humboldt Foundation in the course of a Feodor-Lynen fellowship (to L. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Akashi K, 1998, BIOPHYS J, V74, P2973, DOI 10.1016/S0006-3495(98)78004-X; Armbruster U, 2013, PLANT CELL, V25, P2661, DOI 10.1105/tpc.113.113118; Bassi R, 2000, PHOTOSYNTH RES, V64, P243, DOI 10.1023/A:1006409506272; Belgio E, 2012, BIOPHYS J, V102, P2761, DOI 10.1016/j.bpj.2012.05.004; Bell AJ, 2015, J BIOL CHEM, V290, P18429, DOI 10.1074/jbc.M115.663872; Bielczynski LW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00105; Borch J, 2009, BIOL CHEM, V390, P805, DOI 10.1515/BC.2009.091; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2014, NAT CHEM BIOL, V10, P492, DOI [10.1038/NCHEMBIO.1555, 10.1038/nchembio.1555]; Drop B, 2014, BBA-BIOENERGETICS, V1837, P63, DOI 10.1016/j.bbabio.2013.07.012; Drop B, 2011, J BIOL CHEM, V286, P44878, DOI 10.1074/jbc.M111.301101; Fischer N, 1997, BIOCHEMISTRY-US, V36, P93, DOI 10.1021/bi962244v; Georgakopoulou S, 2007, BIOCHEMISTRY-US, V46, P4745, DOI 10.1021/bi062031y; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Gruber JM, 2015, PHYS CHEM CHEM PHYS, V17, P19844, DOI 10.1039/c5cp01806d; Gundermann K, 2012, BBA-BIOENERGETICS, V1817, P1044, DOI 10.1016/j.bbabio.2012.03.008; Haferkamp S, 2008, PHOTOSYNTH RES, V95, P129, DOI 10.1007/s11120-007-9253-2; HOBE S, 1994, EMBO J, V13, P3423, DOI 10.1002/j.1460-2075.1994.tb06647.x; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Iwaszko E, 2004, J PHOTOCH PHOTOBIO B, V74, P13, DOI 10.1016/j.jphotobiol.2004.01.005; Jahns P, 2000, PLANT PHYSIOL BIOCH, V38, P371, DOI 10.1016/S0981-9428(00)00753-1; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Kirchhoff H, 2003, BBA-BIOENERGETICS, V1606, P105, DOI 10.1016/S0005-2728(03)00105-1; Kruger TPJ, 2014, BBA-BIOENERGETICS, V1837, P1027, DOI 10.1016/j.bbabio.2014.02.014; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liguori N, 2013, J AM CHEM SOC, V135, P18339, DOI 10.1021/ja4107463; Liu C, 2016, PHOTOSYNTH RES, V127, P109, DOI 10.1007/s11120-015-0176-z; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Natali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119211; Natali A, 2014, JOVE-J VIS EXP, DOI 10.3791/51852; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Puthiyaveetil S, 2014, P NATL ACAD SCI USA, V111, P15839, DOI 10.1073/pnas.1413739111; Roach T, 2014, CURR PROTEIN PEPT SC, V15, P351, DOI 10.2174/1389203715666140327105143; Rochaix JD, 2014, ANNU REV PLANT BIOL, V65, P287, DOI 10.1146/annurev-arplant-050213-040226; Rossetti FF, 2004, BIOPHYS J, V87, P1711, DOI 10.1529/biophysj.104.041780; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Ruban AV, 1997, BIOCHEMISTRY-US, V36, P7855, DOI 10.1021/bi9630725; Ruban AV, 1997, BBA-BIOENERGETICS, V1321, P61, DOI 10.1016/S0005-2728(97)00047-9; Suorsa M, 2015, PLANT J, V84, P360, DOI 10.1111/tpj.13004; Tian LJ, 2015, J PHYS CHEM LETT, V6, P2339, DOI 10.1021/acs.jpclett.5b00944; van Oort B, 2008, BIOPHYS J, V95, P5851, DOI 10.1529/biophysj.108.140467; Vieler A, 2007, CHEM PHYS LIPIDS, V150, P143, DOI 10.1016/j.chemphyslip.2007.06.224; Wardak A, 2000, J PHOTOCH PHOTOBIO B, V56, P12, DOI 10.1016/S1011-1344(00)00050-6; Wentworth M, 2000, FEBS LETT, V471, P71, DOI 10.1016/S0014-5793(00)01369-7; Wilk L, 2013, P NATL ACAD SCI USA, V110, P5452, DOI 10.1073/pnas.1205561110; Yang CH, 2006, BBA-BIOENERGETICS, V1757, P1642, DOI 10.1016/j.bbabio.2006.08.010; Zhou F, 2009, PHOTOSYNTH RES, V99, P185, DOI 10.1007/s11120-008-9388-9	50	54	57	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2016	291	32					16730	16739		10.1074/jbc.M116.730101	http://dx.doi.org/10.1074/jbc.M116.730101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS5MQ	27252376	hybrid, Green Published			2022-12-26	WOS:000380826700030
J	Yang, XM; Bam, M; Nagarkatti, PS; Nagarkatti, M				Yang, Xiaoming; Bam, Marpe; Nagarkatti, Prakash S.; Nagarkatti, Mitzi			RNA-seq Analysis of delta 9-Tetrahydrocannabinol-treated T Cells Reveals Altered Gene Expression Profiles That Regulate Immune Response and Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; INFLAMMATORY LUNG INJURY; FARNESOID X RECEPTOR; BREAST-CANCER CELLS; ALZHEIMERS-DISEASE; SUPPRESSOR-CELLS; TUMOR-SUPPRESSOR; DOWN-REGULATION; ACTIVATION; MICRORNA-146A	Marijuana has drawn significant public attention and concern both for its medicinal and recreational use. Delta 9-Tetrahydrocannabinol (THC), which is the main bioactive component in marijuana, has also been shown to possess potent anti-inflammatory properties by virtue of its ability to activate cannabinoid receptor-2 (CB-2) expressed on immune cells. In this study, we used RNA-seq to quantify the transcriptomes and transcript variants that are differentially regulated by THC in super antigen-activated lymph node cells and CD4(+) T cells. We found that the expressions of many transcripts were altered by THC in both total lymph node cells and CD4(+) T cells. Furthermore, the abundance of many miRNA precursors and long non-coding RNAs was dramatically altered in THC-treated mice. For example, the expression of miR-17/92 cluster and miR-374b/421 cluster was down-regulated by THC. On the other hand miR-146a, which has been shown to induce apoptosis, was up-regulated by THC. Long non-coding RNAs that are expressed from the opposite strand of CD27 and Appbp2 were induced by THC. In addition, THC treatment also caused alternative promoter usage and splicing. The functions of those altered transcripts were mainly related to immune response and cell proliferation.	[Yang, Xiaoming; Bam, Marpe; Nagarkatti, Prakash S.; Nagarkatti, Mitzi] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29209 USA	University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29209 USA.	Mitzi.Nagarkatti@uscmed.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759; Nagarkatti, Mitzi/0000-0002-5977-5615	National Institutes of Health [P01AT003961, P20GM103641, R01AT006888, R01ES019313, R01MH094755]; National Center for Complementary & Integrative Health [R01AT006888, P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AT003961, P20GM103641, R01AT006888, R01ES019313, and R01MH094755. The authors declare that they have no conflict of interest with the contents of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Argudin MA, 2010, TOXINS, V2, P1751, DOI 10.3390/toxins2071751; Aso E, 2016, J ALZHEIMERS DIS, V51, P489, DOI 10.3233/JAD-150913; Aso E, 2015, J ALZHEIMERS DIS, V43, P977, DOI 10.3233/JAD-141014; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Busbee PB, 2014, TOXICOL APPL PHARM, V274, P7, DOI 10.1016/j.taap.2013.10.022; Camacho IA, 2002, ARCH TOXICOL, V76, P570, DOI 10.1007/s00204-002-0390-2; Chen L, 2013, BIOCHEM BIOPH RES CO, V435, P745, DOI 10.1016/j.bbrc.2013.05.056; Dhainaut M, 2015, EMBO J, V34, P1336, DOI 10.15252/embj.201490312; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Eubanks LM, 2006, MOL PHARMACEUT, V3, P773, DOI 10.1021/mp060066m; Gaffal E, 2013, ALLERGY, V68, P994, DOI 10.1111/all.12183; Hao J, 2011, BIOCHEM BIOPH RES CO, V406, P552, DOI 10.1016/j.bbrc.2011.02.086; Hegde VL, 2008, MOL PHARMACOL, V74, P20, DOI 10.1124/mol.108.047035; Hegde VL, 2013, J BIOL CHEM, V288, P36810, DOI 10.1074/jbc.M113.503037; Hegde VL, 2010, EUR J IMMUNOL, V40, P3358, DOI 10.1002/eji.201040667; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Hill KP, 2015, JAMA-J AM MED ASSOC, V313, P2474, DOI 10.1001/jama.2015.6199; Himes BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056179; Hu HL, 2010, P NATL ACAD SCI USA, V107, P1506, DOI 10.1073/pnas.0907763107; Jiang Z, 2010, J GASTROENTEROL, V45, P17, DOI 10.1007/s00535-009-0135-6; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulhankova K, 2014, IMMUNOL RES, V59, P182, DOI 10.1007/s12026-014-8538-8; Kumaraswamy E, 2015, ONCOGENE, V34, P4333, DOI 10.1038/onc.2014.363; Kusmartsev SA, 2000, J IMMUNOL, V165, P779, DOI 10.4049/jimmunol.165.2.779; McKallip RJ, 2005, J IMMUNOL, V174, P3281, DOI 10.4049/jimmunol.174.6.3281; Morris KV, 2010, CELL CYCLE, V9, P2544, DOI 10.4161/cc.9.13.12145; Nagarkatti P, 2009, FUTURE MED CHEM, V1, P1333, DOI 10.4155/FMC.09.93; NEWTON CA, 1994, INFECT IMMUN, V62, P4015, DOI 10.1128/IAI.62.9.4015-4020.1994; Ocampo TL, 2015, ANN ALLERG ASTHMA IM, V114, P187, DOI 10.1016/j.anai.2015.01.004; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Pandey R, 2011, J PHARMACOL EXP THER, V338, P819, DOI 10.1124/jpet.111.182717; Park H, 2015, J BIOL CHEM, V290, P2831, DOI 10.1074/jbc.M114.591420; Rao GK, 2004, J LEUKOCYTE BIOL, V75, P884, DOI 10.1189/jlb.1203638; Rao R, 2015, BRIT J PHARMACOL, V172, P1792, DOI 10.1111/bph.13026; Rao R, 2015, TOXICOL SCI, V144, P284, DOI 10.1093/toxsci/kfu315; Rieder SA, 2012, BRIT J PHARMACOL, V167, P1244, DOI 10.1111/j.1476-5381.2012.02063.x; Rieder SA, 2011, INFECT IMMUN, V79, P3141, DOI 10.1128/IAI.00177-11; Rieder SA, 2010, IMMUNOBIOLOGY, V215, P598, DOI 10.1016/j.imbio.2009.04.001; Saeed AI, 2012, MICROSC MICROANAL, V18, P445, DOI 10.1017/S1431927612000190; Sandhu R, 2014, CARCINOGENESIS, V35, P2567, DOI 10.1093/carcin/bgu175; Sido JM, 2015, J LEUKOCYTE BIOL, V98, P435, DOI 10.1189/jlb.3A0115-030RR; Sun Q, 2014, PROSTATE, V74, P1613, DOI 10.1002/pros.22878; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yang XM, 2014, J BIOL CHEM, V289, P18707, DOI 10.1074/jbc.M113.545210; Zhang Y, 2012, MOL CANCER RES, V10, P516, DOI 10.1158/1541-7786.MCR-11-0473; Zhao JL, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00219; Zhao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109782; Zhong XY, 2012, GENE, V493, P44, DOI 10.1016/j.gene.2011.11.028	54	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 22	2016	291	30					15460	15472		10.1074/jbc.M116.719179	http://dx.doi.org/10.1074/jbc.M116.719179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS2HD	27268054	hybrid, Green Published			2022-12-26	WOS:000380584200004
J	Chen, QX; Hua, BZ				Chen, Qing-Xiao; Hua, Bao-Zhen			Ultrastructure and Morphology of Compound Eyes of the Scorpionfly Panorpa dubia (Insecta: Mecoptera: Panorpidae)	PLOS ONE			English	Article							FINE-STRUCTURE; COLOR-VISION; CHAOBORUS-CRYSTALLINUS; SUPERPOSITION EYE; OPTIC LOBES; LARVAL EYE; EVOLUTION; DORSAL; DIPTERA; LEPIDOPTERA	Mecoptera are unique in holometabolous insects in that their larvae have compound eyes. In the present study the cellular organisation and morphology of the compound eyes of adult individuals of the scorpionfly Panorpa dubia in Mecoptera were investigated by light, scanning electron, and transmission electron microscopy. The results showed that the compound eyes of adult P. dubia are of the apposition type, each eye comprising more than 1200 ommatidia. The ommatidium consists of a cornea, a crystalline cone made up of four cone cells, eight photoreceptors, two primary pigment cells, and 18 secondary pigment cells. The adult ommatidium has a fused rhabdom with eight photoreceptors. Seven photoreceptors extend from the proximal end of the crystalline cone to the basal matrix, whereas the eighth photoreceptor is shorter, extending from the middle level of the photoreceptor cluster to the basal matrix. The fused rhabdom is composed of the rhabdomeres of different photoreceptors at different levels. The adult ommatidia have the same cellular components as the larval ommatidia, but the tiering scheme is different.	[Chen, Qing-Xiao; Hua, Bao-Zhen] Northwest A&F Univ, Entomol Museum, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Chen, Qing-Xiao] Henan Univ Sci & Technol, Coll Forestry, Luoyang, Henan, Peoples R China	Northwest A&F University - China; Henan University of Science & Technology	Hua, BZ (corresponding author), Northwest A&F Univ, Entomol Museum, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huabzh@nwsuaf.edu.cn			National Natural Science Foundation of China [31172125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant No. 31172125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 1977, Proceedings of the Japanese Society for Systematic Zoology, VNo. 13, P81; Belusic G, 2013, J EXP BIOL, V216, P2081, DOI 10.1242/jeb.084194; Bierbrodt Erika, 1942, ZOOL JAHRB ABT ANAI U ONTOG TIERE, V68, P49; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Briscoe AD, 2001, MOL BIOL EVOL, V18, P2270, DOI 10.1093/oxfordjournals.molbev.a003773; Buchner E, 1984, PLENUM, P561, DOI DOI 10.1007/978-1-4613-2743-1_16; Burkhardt D., 1972, Information processing in the visual systems of arthropods. Symposium, Zurich, 1972. Editor R. Wehner., P147; Buschbeck EK, 2014, J EXP BIOL, V217, P2818, DOI 10.1242/jeb.085365; Buschbeck Elke K., 2008, Evolution Education and Outreach, V1, P448, DOI 10.1007/s12052-008-0086-z; BYERS GW, 1983, ANNU REV ENTOMOL, V28, P203, DOI 10.1146/annurev.en.28.010183.001223; Chapman RF, 2013, J CHEM INF MODEL, V5th; Chen QX, 2014, MICRON, V59, P8, DOI 10.1016/j.micron.2013.12.004; Chen QX, 2013, MICROSC RES TECHNIQ, V76, P862, DOI 10.1002/jemt.22240; Chen QX, 2012, MICRON, V43, P893, DOI 10.1016/j.micron.2012.03.006; Chen QX, 2012, J MORPHOL, V273, P561, DOI 10.1002/jmor.20001; CHOU I, 1981, Entomotaxonomia, V3, P1; EGUCHI E, 1971, Z VERGL PHYSIOL, V71, P201, DOI 10.1007/BF00297978; Friedrich M, 2011, J EXP ZOOL PART B, V316B, P484, DOI 10.1002/jez.b.21424; HARDIE RC, 1986, TRENDS NEUROSCI, V9, P419, DOI 10.1016/0166-2236(86)90136-0; Horridge G.A., 1975, P255; HORRIDGE GA, 1972, PROC R SOC SER B-BIO, V182, P457, DOI 10.1098/rspb.1972.0088; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Kelber A, 2003, INTEGR COMP BIOL, V43, P571, DOI 10.1093/icb/43.4.571; Kelber A, 2002, NATURE, V419, P922, DOI 10.1038/nature01065; KOLB G, 1977, ZOOMORPHOLOGIE, V87, P123, DOI 10.1007/BF01007602; Kristensen NP, 1999, EUR J ENTOMOL, V96, P237; Land M.F., 1981, HDB SENSORY PHYSL, P471, DOI DOI 10.1007/978-3-642-66907-14; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LAUGHLIN S, 1978, CELL TISSUE RES, V188, P427; MCLEAN M, 1977, TISSUE CELL, V9, P653, DOI 10.1016/0040-8166(77)90033-7; MEINECKE CC, 1981, CELL TISSUE RES, V216, P333; MELZER RR, 1991, ZOOMORPHOLOGY, V110, P227, DOI 10.1007/BF01633007; MELZER RR, 1994, INT J INSECT MORPHOL, V23, P261, DOI 10.1016/0020-7322(94)90023-X; MELZER RR, 1994, CELL TISSUE RES, V275, P283, DOI 10.1007/BF00319426; MELZER RR, 1994, ACTA ZOOL-STOCKHOLM, V75, P201, DOI 10.1111/j.1463-6395.1994.tb01207.x; MEYER EP, 1993, CELL TISSUE RES, V272, P17, DOI 10.1007/BF00323566; Mishra M, 2008, INSECT SCI, V15, P179, DOI 10.1111/j.1744-7917.2008.00199.x; Narendra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076015; Nilsson D.-E., 1989, P30; Oakley TH, 2003, INTEGR COMP BIOL, V43, P522, DOI 10.1093/icb/43.4.522; OGRADY GE, 1987, CAN J ZOOL, V65, P1454, DOI 10.1139/z87-228; Olberg RM, 2007, J COMP PHYSIOL A, V193, P685, DOI 10.1007/s00359-007-0223-0; Paulus H.F., 1979, P299; Paulus HF, 2000, J ZOOL SYST EVOL RES, V38, P189, DOI 10.1046/j.1439-0469.2000.383152.x; RIBI WA, 1978, CELL TISSUE RES, V191, P57; Rottmar B., 1966, Zoologische Jahrbuecher (Anatomie), V83, P497; Sakura M, 2003, ZOOL SCI, V20, P833, DOI 10.2108/zsj.20.833; Stavenga DG, 1995, PROG RETIN EYE RES, V15, P231, DOI 10.1016/1350-9462(95)00011-9; Strausfeld NJ, 2005, ARTHROPOD STRUCT DEV, V34, P235, DOI 10.1016/j.asd.2005.04.001; Suzuki N., 1989, P ARTHROPOD EMBRYOL, V24, P27; WARRANT EJ, 1990, J COMP PHYSIOL A, V167, P785; Wehner R, 2006, P NATL ACAD SCI USA, V103, P12575, DOI 10.1073/pnas.0604430103; Wei Y, 2010, MICRON, V41, P953, DOI 10.1016/j.micron.2010.07.005; WILLIAMS DS, 1982, CELL TISSUE RES, V225, P595; WILSON M, 1978, CELL TISSUE RES, V195, P205	56	8	9	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2016	11	6							e0156970	10.1371/journal.pone.0156970	http://dx.doi.org/10.1371/journal.pone.0156970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN8ZV	27258365	Green Published, Green Submitted, gold			2022-12-26	WOS:000377369700164
J	Karimi, M; Ghazanfari, F; Fadaei, A; Ahmadi, L; Shiran, B; Rabei, M; Fallahi, H				Karimi, Marzieh; Ghazanfari, Farahnaz; Fadaei, Adeleh; Ahmadi, Laleh; Shiran, Behrouz; Rabei, Mohammad; Fallahi, Hossein			The Small-RNA Profiles of Almond (Prunus dulcis Mill.) Reproductive Tissues in Response to Cold Stress	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; BINDING CASSETTE TRANSPORTERS; ARABIDOPSIS-THALIANA; DEGRADOME ANALYSIS; SALT STRESS; DIFFERENTIAL REGULATION; SOLANUM-LYCOPERSICON; MEDICAGO-TRUNCATULA; REGULATED MICRORNAS; POPULUS-EUPHRATICA	Spring frost is an important environmental stress that threatens the production of Prunus trees. However, little information is available regarding molecular response of these plants to the frost stress. Using high throughput sequencing, this study was conducted to identify differentially expressed miRNAs, both the conserved and the non-conserved ones, in the reproductive tissues of almond tolerant H genotype under cold stress. Analysis of 50 to 58 million raw reads led to identification of 174 unique conserved and 59 novel microRNAs (miRNAs). Differential expression pattern analysis showed that 50 miRNA families were expressed differentially in one or both of almond reproductive tissues (anther and ovary). Out of these 50 miRNA families, 12 and 15 displayed up-regulation and down-regulation, respectively. The distribution of conserved miRNA families indicated that miR482f harbor the highest number of members. Confirmation of miRNAs expression patterns by quantitative real-time PCR (qPCR) was performed in cold tolerant (H genotype) alongside a sensitive variety (Sh12 genotype). Our analysis revealed differential expression for 9 miRNAs in anther and 3 miRNAs in ovary between these two varieties. Target prediction of miRNAs followed by differential expression analysis resulted in identification of 83 target genes, mostly transcription factors. This study comprehensively catalogued expressed miRNAs under different temperatures in two reproductive tissues (anther and ovary). Results of current study and the previous RNA-seq study, which was conducted in the same tissues by our group, provide a unique opportunity to understand the molecular basis of responses of almond to cold stress. The results can also enhance the possibility for gene manipulation to develop cold tolerant plants.	[Karimi, Marzieh; Ghazanfari, Farahnaz; Fadaei, Adeleh; Ahmadi, Laleh; Shiran, Behrouz; Rabei, Mohammad] Shahrekord Univ, Fac Agr, Dept Plant Breeding & Biotechnol, POB 115, Shahrekord, Iran; [Shiran, Behrouz] Shahrekord Univ, Inst Biotechnol, POB 115, Shahrekord, Iran; [Fallahi, Hossein] Razi Univ, Sch Sci, Dept Biol, Bagh E Abrisham Kermansh, Iran; [Fallahi, Hossein] Kermanshah Univ Med Sci, Med Biol Res Ctr, Kermanshah, Iran	Shahrekord University; Shahrekord University; Razi University; Kermanshah University of Medical Sciences	Shiran, B (corresponding author), Shahrekord Univ, Fac Agr, Dept Plant Breeding & Biotechnol, POB 115, Shahrekord, Iran.; Shiran, B (corresponding author), Shahrekord Univ, Inst Biotechnol, POB 115, Shahrekord, Iran.; Fallahi, H (corresponding author), Razi Univ, Sch Sci, Dept Biol, Bagh E Abrisham Kermansh, Iran.; Fallahi, H (corresponding author), Kermanshah Univ Med Sci, Med Biol Res Ctr, Kermanshah, Iran.	shiran@agr.sku.ac.ir; h.fallahi@razi.ac.ir	Fallahi, Hossein/I-7541-2019; Karimi, Marzieh/ABF-1594-2021; Zhou, Man/S-4256-2016; Shiran, Behrouz/ABF-1831-2020	Fallahi, Hossein/0000-0002-8754-3491; Karimi, Marzieh/0000-0003-2066-2354; Shiran, Behrouz/0000-0001-9997-4718				Abdul Ghani, 2013, Pure and Applied Biology, V2, P104; Alisoltani A, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0929-z; Allen E, 2011, BIOCHEM J, V437, P505, DOI 10.1042/BJ20101764; Baloch I. A., 2014, Pure and Applied Biology, V3, P72; Baloch IA, 2013, PURE APPL BIOL, V2, P83, DOI DOI 10.19045/BSPAB.2013.23002; Barakat A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-481; Bhati KK, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00488; Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320; Bottino MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059423; Cao X, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1130; Chen L, 2012, BIOCHEM BIOPH RES CO, V417, P892, DOI 10.1016/j.bbrc.2011.12.070; Chiou TJ, 2007, PLANT CELL ENVIRON, V30, P323, DOI 10.1111/j.1365-3040.2007.01643.x; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; de Lima JC, 2012, GENET MOL BIOL, V35, P1069, DOI 10.1590/S1415-47572012000600023; Debouba M, 2006, J PLANT PHYSIOL, V163, P1247, DOI 10.1016/j.jplph.2005.09.012; Din M, 2014, GENE, V535, P198, DOI 10.1016/j.gene.2013.11.034; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Gupta OP, 2014, MOL BIOL REP, V41, P4623, DOI 10.1007/s11033-014-3333-0; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hauser R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002815; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Huang SQ, 2010, PLANT BIOTECHNOL J, V8, P887, DOI 10.1111/j.1467-7652.2010.00517.x; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Jeong DH, 2013, J PLANT BIOL, V56, P187, DOI 10.1007/s12374-013-0213-4; Ji Y, 2011, THESIS U SASKATCHEWA; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kawashima CG, 2009, PLANT J, V57, P313, DOI 10.1111/j.1365-313X.2008.03690.x; Kim S, 2004, MOL CELLS, V18, P300; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Koc I, 2015, BIOTECHNOL BIOTEC EQ, V29, P851, DOI 10.1080/13102818.2015.1061447; Kodad O, 2010, ITEA-INF TEC ECON AG, V106, P142; Kohil D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108851; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kwon SJ, PLANT CELL PHYSL, V48, P1713; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Li BS, 2013, PLANT MOL BIOL, V81, P525, DOI 10.1007/s11103-013-0010-y; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Martinez-Gomez P., 2007, Fruits and nuts, P229; Mawlong T, 2016, INDIAN J EXP BIOL, V54, P26; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Miranda C, 2005, HORTSCIENCE, V40, P357, DOI 10.21273/HORTSCI.40.2.357; Mousavi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104541; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Ni ZY, 2012, BIOCHEM BIOPH RES CO, V427, P330, DOI 10.1016/j.bbrc.2012.09.055; Omidvar V, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2015.02.0008; Piisila M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0434-4; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Ren YY, 2012, FUNCT INTEGR GENOMIC, V12, P327, DOI 10.1007/s10142-012-0271-6; Rubio-Pina JA, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue5-fulltext-10; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; Shuai P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-233; Sonali Bej, 2014, American Journal of Plant Sciences, V5, P748; Sun XC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1416-5; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2010, SEMIN CELL DEV BIOL, V21, P805, DOI 10.1016/j.semcdb.2010.04.001; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; Tian YH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0226-2; Unver Turgay, 2009, Int J Plant Genomics, V2009, P262463, DOI 10.1155/2009/262463; Valiollahi E, 2014, PLANT BIOTECHNOL REP, V8, P349, DOI 10.1007/s11816-014-0326-3; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang M, 2013, GENE, V530, P26, DOI 10.1016/j.gene.2013.08.009; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Warthmann N, 2008, MOL BIOL EVOL, V25, P892, DOI 10.1093/molbev/msn029; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Yadav SK, 2010, AGRON SUSTAIN DEV, V30, P515, DOI 10.1051/agro/2009050; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Zeng HQ, 2010, J PLANT PHYSIOL, V167, P1289, DOI 10.1016/j.jplph.2010.04.017; Zhang BH, 2015, J CELL PHYSIOL, V230, P1, DOI 10.1002/jcp.24685; Zhang JY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-449; Zhang Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0271-x; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhou M, 2013, PLANT PHYSIOL, V161, P1375, DOI 10.1104/pp.112.208702; Zhou SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122117; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zhou ZS, 2012, PLANT CELL ENVIRON, V35, P86, DOI 10.1111/j.1365-3040.2011.02418.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	88	21	23	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156519	10.1371/journal.pone.0156519	http://dx.doi.org/10.1371/journal.pone.0156519			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253370	gold, Green Published, Green Submitted			2022-12-26	WOS:000377218700036
J	Luippold, G; Bedenik, J; Voigt, A; Grempler, R				Luippold, Gerd; Bedenik, Jessica; Voigt, Anke; Grempler, Rolf			Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations	PLOS ONE			English	Article							KIDNEY; PATHOGENESIS; MECHANISMS; DISEASE	The chemical induction of diabetes with STZ has gained popularity because of the relative ease of rendering normal animals diabetic. Insulin substitution is required in STZ-rats in long-term studies to avoid ketoacidosis and consequently loss of animals. Aim of the present studies was to test different insulin preparations and different ways of administration in their ability to reduce blood glucose in STZ-induced diabetic rats. Single dosing of the long-acting insulin analogue glargine was able to dose-dependently reduce blood glucose over 4 h towards normoglycemia in STZ-treated rats. However, this effect was not sustained until 8 h post injection. A more sustained glucose-lowering effect was achieved using insulin-releasing implants. In STZ-rats, 1 insulin implant moderately lowered blood glucose levels 10 days after implantation, while 2 implants induced normoglycemia over the whole day. According to the glucose-lowering effect 1 as well as 2 insulin implants significantly reduced HbA(1c) measured after 26 days of implantation. In line with the improved glucose homeostasis due to the implants, urinary glucose excretion was also blunted in STZ-treated rats with 2 implants. Since diabetic nephropathy is one of the complications of longterm diabetes, renal function was characterized in the STZ-rat model. Increases in creatinine clearance and urinary albumin excretion resemble early signs of diabetic nephropathy. These functional abnormalities of the kidney could clearly be corrected with insulin-releasing implants 27 days after implantation. The data show that diabetic STZ-rats respond to exogenous insulin with regard to glucose levels as well as kidney parameters and a suitable dose of insulin implants for glucose control was established. This animal model together with the insulin dosing regimen is suitable to address diabetes-induced early diabetic nephropathy and also to study combination therapies with insulin for the treatment of type 1 diabetes.	[Luippold, Gerd; Bedenik, Jessica; Voigt, Anke] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetabol Dis Res, Biberach, Germany; [Grempler, Rolf] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Translat Med & Clin Pharmacol, Biberach, Germany	Boehringer Ingelheim; Boehringer Ingelheim	Luippold, G (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetabol Dis Res, Biberach, Germany.	gerd.luippold@boehringer-ingelheim.com			Boehringer Ingelheim Pharma GmbH Co.	Boehringer Ingelheim Pharma GmbH Co.(Boehringer Ingelheim)	Boehringer Ingelheim Pharma GmbH & Co. KG provided support in the form of salaries for authors [GL, JB, AV, RG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder did not directly benefit from the study and the study did not involve a product the funder sells.	Achenbach P, 2005, DIABETES, V54, pS25, DOI 10.2337/diabetes.54.suppl_2.S25; Arora MK, 2013, VASC PHARMACOL, V58, P259, DOI 10.1016/j.vph.2013.01.001; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Garg S, 2010, DIABETES TECHNOL THE, V12, P835, DOI 10.1089/dia.2010.0135; Kraynak AR, 1995, TOXICOL APPL PHARM, V135, P279, DOI 10.1006/taap.1995.1234; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Mikhailidis DP, 1992, J PHARM MED, V2, P241; Mora-Fernandez C, 2014, J PHYSIOL-LONDON, V592, P3997, DOI 10.1113/jphysiol.2014.272328; Premaratne E, 2015, DIABETES METAB, V41, P5, DOI 10.1016/j.diabet.2014.10.003; RASCH R, 1979, DIABETOLOGIA, V16, P185, DOI 10.1007/BF01219796; Rees DA, 2005, DIABETIC MED, V22, P359, DOI 10.1111/j.1464-5491.2005.01499.x; Schneider S, 2004, ARZNEIMITTELFORSCH, V54, P842; Singh P, 2014, ADV CHRONIC KIDNEY D, P21; Slaughter TN, 2013, AM J PHYSIOL-REG I, V305, pR727, DOI 10.1152/ajpregu.00382.2012; THOMPSON CS, 1994, CLIN SCI, V86, P593, DOI 10.1042/cs0860593	15	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2016	11	6							e0156346	10.1371/journal.pone.0156346	http://dx.doi.org/10.1371/journal.pone.0156346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN6XB	27253523	Green Submitted, Green Published, gold			2022-12-26	WOS:000377218700021
J	Kwarisiima, D; Balzer, L; Heller, D; Kotwani, P; Chamie, G; Clark, T; Ayieko, J; Mwangwa, F; Jain, V; Byonanebye, D; Petersen, M; Havlir, D; Kamya, MR				Kwarisiima, Dalsone; Balzer, Laura; Heller, David; Kotwani, Prashant; Chamie, Gabriel; Clark, Tamara; Ayieko, James; Mwangwa, Florence; Jain, Vivek; Byonanebye, Dathan; Petersen, Maya; Havlir, Diane; Kamya, Moses R.			Population-Based Assessment of Hypertension Epidemiology and Risk Factors among HIV-Positive and General Populations in Rural Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; BLOOD-PRESSURE; INFECTED PATIENTS; PREVALENCE; AWARENESS; COMMUNITY; MORTALITY; COUNTRIES; DISTRICT; THERAPY	Background Antiretroviral therapy scale-up in Sub-Saharan Africa has created a growing, aging HIV-positive population at risk for non-communicable diseases such as hypertension. However, the prevalence and risk factors for hypertension in this population remain incompletely understood. Methods We measured blood pressure and collected demographic data on over 65,000 adults attending multi-disease community health campaigns in 20 rural Ugandan communities (SEARCH Study: NCT01864603). Our objectives were to determine (i) whether HIV is an independent risk factor for hypertension, and (ii) awareness and control of hypertension in HIV-positive adults and the overall population. Results Hypertension prevalence was 14% overall, and 11% among HIV-positive individuals. 79% of patients were previously undiagnosed, 85% were not taking medication, and 50% of patients on medication had uncontrolled blood pressure. Multivariate predictors of hypertension included older age, male gender, higher BMI, lack of education, alcohol use, and residence in Eastern Uganda. HIV-negative status was independently associated with higher odds of hypertension (OR 1.2, 95% CI: 1.1-1.4). Viral suppression of HIV did not significantly predict hypertension among HIV-positives. Significance The burden of hypertension is substantial and inadequately controlled, both in HIV-positive persons and overall. Universal HIV screening programs could provide counseling, testing, and treatment for hypertension in Sub-Saharan Africa.	[Kwarisiima, Dalsone; Mwangwa, Florence; Byonanebye, Dathan; Kamya, Moses R.] Infect Dis Res Collaborat, Kampala, Uganda; [Balzer, Laura] Harvard Univ, Boston, MA 02115 USA; [Balzer, Laura; Heller, David; Kotwani, Prashant; Chamie, Gabriel; Clark, Tamara; Jain, Vivek; Havlir, Diane] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ayieko, James] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Petersen, Maya] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Heller, David] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA	Harvard University; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of California System; University of California Berkeley; Makerere University; Icahn School of Medicine at Mount Sinai	Kwarisiima, D (corresponding author), Infect Dis Res Collaborat, Kampala, Uganda.	dkwarisiima@mjap.or.ug; mkamya@infocom.co.ug	Byonanebye, Dathan/HDN-5435-2022	Heller, David/0000-0003-0060-8393; Byonanebye, Dathan M/0000-0001-9862-4724	Division of AIDS, NIAID of the National Institutes of Health [U01AI099959]; President's Emergency Plan for AIDS Relief and Gilead Sciences; FOGARTY INTERNATIONAL CENTER [R25TW009343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI099959] Funding Source: NIH RePORTER	Division of AIDS, NIAID of the National Institutes of Health; President's Emergency Plan for AIDS Relief and Gilead Sciences(Gilead Sciences); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this manuscript was supported by Division of AIDS, NIAID of the National Institutes of Health under award number U01AI099959 and in part by the President's Emergency Plan for AIDS Relief and Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Adewole OO, 2012, AFR HEALTH SCI, V10, P144; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2017, 2013 UNAIDS REP GLOB; [Anonymous], 2014, PROJ MORT BURD DIS 2; [Anonymous], 2005, UG NAT POL GUID HIV; Aoun S, 2000, Curr Hypertens Rep, V2, P478, DOI 10.1007/s11906-000-0031-1; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Balen J, 2010, EMERG THEMES EPIDEMI, V7, DOI 10.1186/1742-7622-7-7; Bergersen BM, 2003, EUR J CLIN MICROBIOL, V22, P731, DOI 10.1007/s10096-003-1034-z; Bertoia ML, 2012, HYPERTENSION, V60, P639, DOI 10.1161/HYPERTENSIONAHA.112.193714; Chamie G, 2015, LANCET HIV IN PRESS; Chamie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084317; Chamie G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043400; Chillo P, 2012, CARDIOVASC J AFR, V23, P90, DOI 10.5830/CVJA-2011-060; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Damasceno A, 2009, HYPERTENSION, V54, P77, DOI 10.1161/HYPERTENSIONAHA.109.132423; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; FORD ES, 1991, HYPERTENSION, V18, P598, DOI 10.1161/01.HYP.18.5.598; Gazzaruso C, 2003, J HYPERTENS, V21, P1377, DOI 10.1097/00004872-200307000-00028; Guwatudde D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138991; Havlir D, 2015, STUDY PROTOCOL SUSTA; Helelo TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112790; Jain V, 2013, CLIN INFECT DIS, V56, P598, DOI 10.1093/cid/cis881; Jerico C, 2005, AM J HYPERTENS, V18, P1396, DOI 10.1016/j.amjhyper.2005.05.016; Kayima J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2146-y; Kayima J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-54; Kotwani P, 2014, TROP MED INT HEALTH, V19, P459, DOI 10.1111/tmi.12273; Kotwani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1151; KURTZ TW, 1993, AM J MED, V94, P77, DOI 10.1016/0002-9343(93)90124-8; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P8, DOI 10.1093/ije/dyu019; Maher D, 2011, J HYPERTENS, V29, P1061, DOI 10.1097/HJH.0b013e3283466e90; Mattana J, 1999, AM J MED SCI, V317, P232, DOI 10.1097/00000441-199904000-00004; Mayega RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047632; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Muluneh AT, 2012, ETHIOP J HEALTH SCI, V22, P7; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; NISSINEN A, 1988, AM J EPIDEMIOL, V127, P488, DOI 10.1093/oxfordjournals.aje.a114825; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2011, CURR OPIN HIV AIDS, V6, P266, DOI 10.1097/COH.0b013e328347876c; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Petersen M, 2014, JAIDS-J ACQ IMM DEF, V67, pS8, DOI 10.1097/QAI.0000000000000253; Piacentini L, 2009, J INTERN MED, V265, P110, DOI 10.1111/j.1365-2796.2008.02041.x; R Core Team, 2021, R LANGUAGE ENV STAT; Schutte AE, 2012, INT J EPIDEMIOL, V41, P1114, DOI 10.1093/ije/dys106; Schwartz T, 2012, INT HEALTH, V4, P30, DOI 10.1016/j.inhe.2011.12.003; Seaberg EC, 2005, AIDS, V19, P953, DOI 10.1097/01.aids.0000171410.76607.f8; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; Twagirumukiza M, 2011, J HUM HYPERTENS, V25, P47, DOI 10.1038/jhh.2010.32; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Wamala JF, 2009, AFR HEALTH SCI, V9, P153; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363; World Health Organization, 2013, GLOB BRIEF HYP	59	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156309	10.1371/journal.pone.0156309	http://dx.doi.org/10.1371/journal.pone.0156309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27232186	Green Published, Green Submitted, gold			2022-12-26	WOS:000376883000021
J	Zhang, WZ; Lu, JY; Chen, JZ; Zhai, TT; Huang, BT; Li, DR; Chen, CZ				Zhang, Wu-Zhe; Lu, Jia-Yang; Chen, Jian-Zhou; Zhai, Tian-Tian; Huang, Bao-Tian; Li, De-Rui; Chen, Chuang-Zhen			A Dosimetric Study of Using Fixed-Jaw Volumetric Modulated Arc Therapy for the Treatment of Nasopharyngeal Carcinoma with Cervical Lymph Node Metastasis	PLOS ONE			English	Article							RADIOTHERAPY; TOMOTHERAPY; IMRT	Purpose To study the dosimetric difference between fixed-jaw volumetric modulated radiotherapy (FJ-VMAT) and large-field volumetric modulated radiotherapy (LF-VMAT) for nasopharyngeal carcinoma (NPC) with cervical lymph node metastasis. Methods Computed tomography (CT) datasets of 10 NPC patients undergoing chemoradiotherapy were used to generate LF-VMAT and FJ-VMAT plans in the Eclipse version 10.0 treatment planning system. These two kinds of plans were then compared with respect to planning-target-volume (PTV) coverage, conformity index (CI), homogeneity index (HI), organ-at-risk sparing, monitor units (MUs) and treatment time (TT). Results The FJ-VMAT plans provided lower D-2% of PGTVnd (PTV of lymph nodes), PTV1 (high-risk PTV) and PTV2 (low-risk PTV) than did the LF-VMAT plans, whereas no significant differences were observed in PGTVnx (PTV of primary nasopharyngeal tumor). The FJ-VMAT plans provided lower doses delivered to the planning organ at risk (OAR) volumes (PRVs) of both brainstem and spinal cord, both parotid glands and normal tissue than did the LF-VMAT plans, whereas no significant differences were observed with respect to the oral cavity and larynx. The MUs of the FJ-VMAT plans (683 +/- 87) were increased by 22% +/- 12% compared with the LF-VMAT plans (559 +/- 62). In terms of the TT, no significant difference was found between the two kinds of plans. Conclusions FJ-VMAT was similar or slightly superior to LF-VMAT in terms of PTV coverage and was significantly superior in terms of OAR sparing, at the expense of increased MUs.	[Zhang, Wu-Zhe; Lu, Jia-Yang; Chen, Jian-Zhou; Zhai, Tian-Tian; Huang, Bao-Tian; Li, De-Rui; Chen, Chuang-Zhen] Shantou Univ, Coll Med, Canc Hosp, Dept Radiat Oncol, Shantou, Guangdong, Peoples R China	Shantou University	Chen, CZ (corresponding author), Shantou Univ, Coll Med, Canc Hosp, Dept Radiat Oncol, Shantou, Guangdong, Peoples R China.	stccz@139.com	Chen, Jianzhou/AAW-1443-2021		Shantou University Medical College Clinical Research Enhancement Initiative [201424]; Shantou Medical Science and Technology Planning Project [(2015) 123]	Shantou University Medical College Clinical Research Enhancement Initiative; Shantou Medical Science and Technology Planning Project	This work was sponsored by Shantou University Medical College Clinical Research Enhancement Initiative (Grant No. 201424) and Shantou Medical Science and Technology Planning Project [Grant No. (2015) 123]. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JY, 2014, MED DOSIM, V39, P325, DOI 10.1016/j.meddos.2014.05.006; Hodapp N, 2012, STRAHLENTHER ONKOL, V188, P97, DOI 10.1007/s00066-011-0015-x; Huang B, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140183; Lee FKH, 2014, MED DOSIM, V39, P44, DOI 10.1016/j.meddos.2013.09.004; Lee TF, 2008, RADIOTHER ONCOL, V89, P89, DOI 10.1016/j.radonc.2008.05.010; Lu SH, 2012, RADIOTHER ONCOL, V104, P324, DOI 10.1016/j.radonc.2011.11.017; Paddick I, 2000, J NEUROSURG, V93, P219, DOI 10.3171/jns.2000.93.supplement_3.0219; Srivastava SP, 2011, MED DOSIM, V36, P6, DOI 10.1016/j.meddos.2009.10.002; Vanetti E, 2009, RADIOTHER ONCOL, V92, P111, DOI 10.1016/j.radonc.2008.12.008; Verbakel WFAR, 2009, INT J RADIAT ONCOL, V74, P252, DOI 10.1016/j.ijrobp.2008.12.033; White P, 2013, J RADIAT RES, V54, P532, DOI 10.1093/jrr/rrs111	11	4	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2016	11	5							e0156675	10.1371/journal.pone.0156675	http://dx.doi.org/10.1371/journal.pone.0156675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GV	27231871	Green Submitted, gold, Green Published			2022-12-26	WOS:000376883000052
